Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 144.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	23.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.5	144.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.0	0.0	0.0	0.0	26.8	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1678.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1319.0;Endothelial cells: 797.7;Hepatic stellate cells: 526.1;Hepatocytes: 910.1;Horizontal cells: 681.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Group enriched"	"Detected in some"	5	"AF22: 772.0;ASC diff: 223.5;Hep G2: 649.8;SK-MEL-30: 230.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	NA	NA	1630000000000	170000000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	451.5	182.3	157.5	149.8	158.5	5.6	295.3	169.3	223.5	227.2	163.3	257.0	141.2	306.2	244.1	218.3	228.4	452.4	312.8	149.8	175.0	311.4	1250.0	1678.3	98.2	192.9	167.6	101.7	91.5	153.7	135.3	445.2	193.0	293.8	316.3	129.9	131.8	226.7	147.8	71.5	182.7	520.0	196.2	240.6	171.6	58.9	190.7	53.9	202.7	285.6	59.2	847.0	160.2	192.7	0.3	0.0	772.0	0.0	223.5	16.2	2.0	93.1	25.5	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.4	10.1	649.8	0.0	0.8	0.8	36.9	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.2	0.0	0.0	0.2	2.0	3.3	0.0	0.1	1.8	0.9	0.8	0.0	0.3	0.3	0.7	1.8	0.0	230.1	3.2	0.0	0.3	0.3	0.1	6.7	1.5	0.5	0.7	0.3	0.7	0.2	0.5	15.4	0.0	0.1	0.0	1.5	0.0	0.8	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	157.5	158.5	169.3	223.5	149.8	175.0	192.9	167.6	193.0	196.2	190.7	192.7	1319.0	12.8	85.6	5.2	9.0	19.5	2.3	0.0	12.0	5.5	10.8	95.5	106.1	22.8	6.8	1.8	8.4	2.5	8.1	0.0	0.0	0.2	18.8	8.3	54.7	797.7	0.0	45.9	3.2	5.5	2.9	241.3	9.2	14.7	27.8	2.5	526.1	910.1	233.0	681.4	2.9	0.0	0.0	123.1	41.4	36.8	77.3	130.7	23.2	355.1	37.8	6.1	1.0	5.5	4.7	0.2	0.0	141.4	11.2	4.7	0.0	0.3	4.4	21.2	335.2	22.1	328.0	2.7	8.8	8.2	14.1	4.1	13.0	73.3	0.0	3.6
AADACL2	MGC72001	ENSG00000197953	"Arylacetamide deacetylase like 2"	Q6P093	3	151733916-151761339	"Predicted secreted proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 35.6"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 30.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 28: Keratinocytes - Keratinization"					"unprognostic (2.20e-2)"				"unprognostic (3.10e-3)"		"unprognostic (2.63e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.22e-1)"				"unprognostic (3.00e-1)"			"unprognostic (2.91e-4)"	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	35.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	30.7	0.1	0.1	0.0	0.0	0.0
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619803	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.7;brain: 8.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 71.5;Bipolar cells: 57.2;Excitatory neurons: 33.2;Inhibitory neurons: 34.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 11.6;HDLM-2: 16.9;Karpas-707: 29.0;SH-SY5Y: 17.3;U-266/70: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	15.7	1.7	1.5	1.7	2.2	0.2	2.8	8.9	5.2	5.3	0.0	0.7	0.5	2.7	0.2	0.4	2.7	0.5	4.2	2.1	2.1	0.5	0.1	0.5	2.8	2.2	3.3	0.1	0.1	0.0	0.5	0.0	2.4	0.4	0.7	5.9	2.6	0.6	0.1	0.1	0.7	2.6	1.3	1.6	0.7	0.2	3.6	1.4	0.2	0.3	1.6	0.9	0.6	1.4	0.0	0.0	0.1	0.0	11.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	0.0	0.1	0.0	0.0	0.6	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	9.8	1.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	1.2	0.5	2.8	3.7	0.1	0.3	3.2	4.2	0.1	0.9	0.0	0.6	3.6	1.2	1.5	2.2	8.9	5.2	2.1	2.1	2.2	3.3	2.4	1.3	3.6	1.4	0.4	0.0	0.0	71.5	2.6	0.0	0.0	0.0	0.0	57.2	0.3	0.3	10.9	0.0	0.0	0.0	6.2	0.0	3.8	0.1	0.0	0.0	0.3	0.2	0.5	0.2	0.0	0.0	33.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.1	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.5	1.1	2.2	0.0	13.0	1.3	0.0	0.0	0.7	5.9	0.0	0.0	0.9	2.4	2.3	0.0	0.4	2.5	0.2	0.1	0.0	0.0	0.0	7.8	0.6	0.1	0.0
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149052-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 52.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 58.4;Inhibitory neurons: 9.8;Rod photoreceptor cells: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.9;HAP1: 1.0;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057635	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.3	0.4	4.0	0.1	4.4	0.0	0.1	7.5	11.3	0.4	0.0	0.3	0.2	0.5	0.3	0.9	0.2	0.3	0.8	4.2	5.8	0.4	0.1	0.1	0.0	6.9	3.9	0.1	0.3	1.8	0.3	0.1	6.8	0.3	0.1	52.0	0.2	0.6	0.1	0.3	0.2	0.4	1.5	0.1	0.2	5.8	6.2	2.9	0.8	0.2	0.5	0.1	0.6	5.6	0.1	0.4	0.4	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.1	1.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.4	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.4	7.5	11.3	4.2	5.8	6.9	3.9	6.8	1.5	6.2	5.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.9	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	6.7	9.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.3	2.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
AC015802.6		ENSG00000284526	"Novel protein"		17	76563710-76570544	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 7.8;Endometrial ciliated cells: 17.7;Endometrial stromal cells: 17.9;Glandular and luminal cells: 12.7;Respiratory ciliated cells: 8.0"					"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 58.7;SK-MEL-30: 72.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"																					3.4	5.0	0.7	4.8	0.9	7.0	1.0	1.0	0.6	1.8	9.9	1.9	4.3	3.5	0.8	6.1	2.7	3.8	8.8	1.8	1.0	2.7	3.0	4.5	4.7	1.5	1.1	4.5	10.9	0.3	0.7	3.6	0.7	2.6	0.3	16.5	10.0	0.5	25.1	16.0	2.9	0.1	0.7	3.9	5.2	15.2	0.9	0.0	5.0	0.1	0.2	2.6	2.5	0.4	14.9	11.7	9.2	20.5	0.0	0.0	12.2	6.5	0.0	0.0	0.0	25.5	11.3	15.7	7.7	0.0	7.2	15.2	0.1	0.8	0.0	4.1	13.1	21.9	9.8	58.7	0.0	20.5	13.6	0.0	1.2	0.0	0.1	13.2	0.0	9.3	18.3	17.3	0.0	20.4	18.1	36.0	16.0	16.7	14.6	10.6	24.9	14.4	0.2	13.7	19.6	24.5	8.7	46.7	72.7	18.6	33.5	17.6	10.1	26.4	18.9	18.3	28.3	22.3	9.4	12.6	15.6	16.1	33.4	1.4	7.3	1.8	11.8	7.5	19.4	9.9	12.7	12.9	6.3	7.4	11.6	12.0	16.9	6.5	4.6	6.1	7.1	8.1	0.7	0.9	1.0	0.6	1.8	1.0	1.5	1.1	0.7	0.7	0.9	0.4	0.3	16.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.4	0.0	0.0	4.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	0.0	17.7	17.9	0.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	12.7	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.1	8.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.7	2.6	0.0	0.0
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	6	"Late spermatids: 3430.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	5.6	1.1	0.4	18.9	0.5	41.0	2.1	0.5	0.8	2.3	0.5	7.4	4.1	1.5	0.3	4.2	4.0	3.6	2.1	0.3	0.4	4.6	5.2	16.1	39.5	0.6	0.5	0.9	1.2	0.1	1.3	0.5	0.6	3.8	2.1	0.2	3.6	0.4	0.9	2.5	43.3	0.9	0.5	96.0	5.0	0.8	0.8	25.8	5.2	0.8	22.6	4.3	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.0	23.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	8.8	0.1	0.0	0.1	11.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	42.4	0.0	29.4	0.0	0.0	14.5	37.9	0.4	0.0	0.0	15.1	0.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.0	0.1	0.0	0.0	9.1	8.2	10.9	0.1	24.9	0.0	28.8	7.9	30.8	29.6	2.4	33.3	20.2	31.5	32.1	13.7	21.3	26.7	27.5	22.6	32.5	0.4	17.3	39.0	22.3	0.4	0.5	0.5	0.8	0.3	0.4	0.6	0.5	0.6	0.5	0.8	0.6	3.8	9.6	5.5	1.6	150.9	8.3	7.6	25.1	2.8	15.8	7.0	8.1	32.9	7.2	12.3	5.5	18.8	3.9	160.7	2.0	7.9	3.9	498.1	8.3	5.4	5.0	3.6	22.9	0.3	3.7	3.2	8.0	5.6	3.4	40.5	1.8	7.1	5.3	7.5	0.0	1.9	2.7	8.2	26.2	39.5	3430.7	20.2	27.9	24.9	2.8	38.3	11.7	332.7	0.5	1.0	5.5	0.0	15.4	68.0	4.6	1.3	3.8	44.6	20.4	19.7	7.5	8.1	15.6	10.5	1.5	7.4	4.4	268.3	0.9	1.6	3.5
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 98.2;skeletal muscle: 163.2;tongue: 48.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		990000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.7	20.9	2.2	16.8	7.9	2.0	37.1	32.5	5.0	0.0	7.6	4.9	2.6	0.2	2.3	3.2	1.3	12.5	8.0	98.2	8.8	4.1	4.4	3.5	66.1	54.2	4.6	4.3	4.7	8.3	0.7	72.7	8.1	1.8	5.7	7.1	1.6	163.2	1.3	9.1	0.5	26.2	3.5	2.4	3.9	58.1	3.6	2.3	48.0	1.5	1.4	3.7	10.5	0.0	0.2	0.2	0.2	0.3	0.0	7.9	0.3	0.0	0.1	0.2	13.0	0.1	0.0	0.6	0.0	1.2	0.6	2.0	0.1	0.0	4.6	0.5	0.2	0.1	0.2	0.1	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.1	13.9	19.7	0.1	4.3	0.0	0.2	1.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.8	1.5	0.1	0.8	0.0	2.9	0.0	0.0	0.2	0.5	6.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	16.8	37.1	32.5	8.0	98.2	66.1	54.2	72.7	26.2	58.1	10.5	0.5	0.0	0.0	3.3	0.5	0.8	20.9	0.9	6.2	13.5	2.9	1.1	6.4	5.7	0.4	0.0	0.0	8.2	0.9	86.2	0.0	10.5	0.0	0.5	1.5	2.1	3.5	37.7	4.7	39.7	2.6	3.0	1.5	2.4	0.0	7.4	2.2	0.4	0.8	55.5	9.7	12.0	0.0	0.3	6.6	0.4	0.6	1.7	1.8	1.0	4.6	11.4	0.0	8.5	0.8	20.1	118.3	0.7	1.8	20.4	45.6	1.1	0.1	6.8	0.0	13.5	4.9	4.1	8.0	1.7	1.0	7.1	0.6	1.4	4.6	15.2
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"Blood group antigen, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 320.5;breast: 278.2"	"Group enriched"	"Detected in many"	5	"Adipocytes: 383.6;Endothelial cells: 523.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 44.4;HSkMC: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (8.74e-3)"	"prognostic favorable (2.52e-5)"	"unprognostic (9.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.84e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.30e-2)"	320.5	13.4	17.7	42.0	21.8	14.5	278.2	34.6	25.5	141.7	21.6	67.0	15.3	125.0	21.5	63.6	121.2	59.2	42.2	18.4	18.6	34.5	1.8	146.8	49.3	21.4	17.7	21.4	15.8	9.7	11.6	10.4	23.2	72.9	19.4	23.7	61.3	24.5	51.7	85.3	60.9	107.7	24.9	82.1	57.0	8.6	17.0	33.2	47.7	30.2	40.8	112.4	113.1	22.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	44.4	0.0	0.0	5.5	0.0	0.0	30.7	0.0	0.0	3.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	21.8	34.6	25.5	18.4	18.6	21.4	17.7	23.2	24.9	17.0	22.0	383.6	6.4	10.8	1.6	1.0	0.0	1.7	0.0	2.8	78.4	3.6	3.7	15.1	0.0	1.8	0.0	2.1	0.4	0.8	0.0	0.0	0.0	2.2	0.4	1.0	523.8	0.0	81.3	3.6	9.8	0.2	18.9	0.0	0.4	5.1	0.0	7.5	0.0	1.1	6.7	3.2	0.0	0.0	0.8	0.0	3.7	1.2	2.2	0.0	1.0	0.0	5.9	0.0	0.5	0.3	0.0	0.0	0.4	0.1	2.2	0.0	0.1	0.7	3.7	0.0	3.9	4.5	0.2	0.5	4.0	0.0	0.1	1.1	0.1	0.0	2.3
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		3100000	"Cluster 44: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	64.9	30.2	24.0	43.9	27.2	34.7	46.7	33.6	55.5	33.2	22.5	35.4	49.3	34.4	34.7	30.5	36.0	31.1	27.1	24.7	66.5	47.5	27.5	35.3	42.7	80.3	48.6	21.3	46.3	37.4	22.4	42.4	76.5	62.6	35.7	23.2	39.1	28.5	15.3	28.9	43.7	42.5	34.2	39.1	38.9	32.2	43.1	48.4	30.8	14.9	40.3	36.7	29.2	43.7	127.1	423.2	194.8	168.8	296.1	274.4	178.3	174.0	188.0	213.7	266.3	217.9	141.8	204.7	108.8	245.2	200.6	197.2	253.9	298.0	177.8	184.9	243.0	117.3	228.3	227.5	136.9	191.9	147.1	219.8	88.3	376.9	75.6	140.0	228.7	155.0	147.4	158.5	180.4	130.0	317.8	107.6	127.6	84.8	75.7	205.2	236.2	262.2	221.0	222.4	364.7	200.2	124.5	382.8	133.7	167.6	229.4	181.0	248.4	165.7	135.5	169.0	291.0	91.9	127.0	193.0	280.3	145.7	137.5	32.2	29.2	36.5	30.9	30.9	29.1	21.6	24.4	27.7	33.0	18.3	18.1	20.3	14.6	24.0	39.8	19.1	34.3	33.8	24.0	27.2	33.6	55.5	24.7	66.5	80.3	48.6	76.5	34.2	43.1	43.7	28.2	28.9	26.2	12.4	20.5	25.0	10.0	25.4	12.5	12.1	38.6	21.6	12.6	31.5	21.0	23.9	4.2	22.6	25.9	26.7	11.7	33.8	73.3	31.6	35.3	33.4	65.9	34.3	10.9	33.6	46.5	28.9	23.4	29.2	15.2	28.7	41.4	53.0	31.0	18.5	14.7	54.0	20.3	39.0	25.9	17.5	61.8	27.6	32.0	16.9	42.9	7.6	25.7	11.6	13.6	42.9	16.2	51.1	17.4	35.9	40.4	87.0	31.1	9.4	13.1	17.6	25.7	17.9	36.0	21.6	33.0	22.2	25.1	49.0	22.2	15.5
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACTA2	ACTSA	ENSG00000107796	"Actin alpha 2, smooth muscle"	P62736	10	88935074-88991339	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 6678.8;seminal vesicle: 5920.3;smooth muscle: 8099.9"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1007.7;Peritubular cells: 5290.7;Sertoli cells: 3030.6;Smooth muscle cells: 2394.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 390.6;fHDF/TERT166: 641.1;HHSteC: 625.8;HSkMC: 345.1;hTERT-RPE1: 743.4;SuSa: 296.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 101.0"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	1035.2	241.6	54.0	728.1	61.4	3.9	838.4	52.7	121.1	2000.3	61.4	2755.1	248.9	6678.8	1360.1	1509.9	3104.3	906.1	1069.2	53.4	54.6	312.2	161.8	732.8	173.7	59.0	55.9	798.0	91.4	80.6	60.8	771.3	55.3	2642.8	866.4	8.2	414.7	5920.3	202.1	355.7	701.6	8099.9	54.1	452.1	1427.1	263.9	56.1	56.5	312.0	214.0	48.4	3002.5	1367.0	52.9	3.9	19.0	49.3	102.7	198.1	390.6	9.5	109.8	136.8	11.9	45.4	0.0	8.8	7.2	11.5	641.1	8.6	1.4	1.8	25.4	11.3	60.6	11.3	0.4	5.6	119.3	625.8	0.8	3.2	345.1	44.9	73.9	28.5	743.4	11.3	3.0	0.0	7.1	128.8	10.8	1.0	28.3	2.5	0.2	1.2	1.4	0.2	4.6	27.1	5.0	0.7	7.6	10.2	7.9	1.0	296.8	32.4	1.0	27.9	24.0	4.0	30.2	9.3	21.1	1.6	0.6	29.6	10.2	26.1	28.1	12.3	17.5	17.6	8.7	13.8	6.0	14.1	19.8	10.8	1.8	1.5	10.7	11.1	4.0	14.2	0.4	58.7	10.7	54.0	61.4	52.7	121.1	53.4	54.6	59.0	55.9	55.3	54.1	56.1	52.9	65.4	9.6	6.1	5.5	4.4	43.2	23.4	16.5	22.8	1.1	22.7	1007.7	25.1	2.8	5.2	0.0	6.2	16.3	7.3	1.9	1.9	1.8	11.1	11.1	225.4	41.1	0.0	4.0	3.6	0.9	16.8	316.3	10.7	8.2	5.7	448.9	474.0	4.6	37.7	0.0	1.1	2.7	4.1	5.4	67.6	48.8	141.4	12.6	55.2	61.8	4.2	13.4	4.1	1.0	0.3	2.0	3.0	5290.7	3.7	17.5	3.4	9.5	10.9	1.4	3030.6	72.0	2394.6	4.0	13.8	11.1	40.5	23.7	16.5	36.0	5.7	10.4
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5526409-5563902	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 22882.9;Pancreatic endocrine cells: 14370.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported					NA	NA		5800000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"CAB002621: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	2558.1	1235.8	2143.2	4250.8	2321.0	3598.4	2009.8	2400.1	2776.1	2274.6	2183.3	6581.2	1659.0	5033.9	1630.3	2928.9	2943.6	1772.1	817.6	2355.6	2315.8	1313.6	1759.9	2876.0	4394.2	2654.8	2338.9	1711.5	761.9	838.5	731.4	1817.2	2569.2	2027.1	2338.4	488.2	1470.2	2943.2	465.1	1541.7	2825.9	5736.8	2457.9	3009.5	2869.7	558.3	2483.4	3278.4	1317.9	524.0	4602.3	3720.8	2223.5	3045.4	7791.1	5198.8	5604.1	4658.2	2321.1	3120.3	6654.3	6049.6	4853.2	6209.7	4619.4	8249.5	4361.9	4522.7	4557.0	9445.4	4904.8	4820.3	3279.5	9453.9	4507.4	5324.6	1668.7	3974.3	4579.6	4520.6	3538.8	4733.2	9853.8	4098.5	2786.7	6863.0	1738.0	4128.6	5073.2	3561.3	2189.7	3513.0	6603.4	7531.9	4055.1	13162.1	6813.7	2468.5	3490.8	5658.6	3351.4	3419.7	5904.6	3175.8	1633.1	2746.9	5754.7	5822.1	2400.3	5088.3	5859.7	5314.8	7975.3	10437.4	7019.9	7000.1	8802.8	1902.3	2442.5	5082.1	5772.0	6622.6	12412.7	14674.1	18104.2	29636.6	10647.1	19648.6	8327.7	5139.6	7639.4	9512.9	19292.5	4844.1	5592.0	7894.3	18040.6	6233.1	22870.8	7122.2	11463.2	37406.8	2143.2	2321.0	2400.1	2776.1	2355.6	2315.8	2654.8	2338.9	2569.2	2457.9	2483.4	3045.4	2775.4	1150.6	680.4	142.4	4118.9	5737.0	9776.6	5792.0	3110.2	146.7	1564.0	2047.2	145.3	1080.9	2763.3	2144.5	85.5	3647.7	3989.3	3419.3	2277.4	6508.8	101.3	1422.1	2344.0	2768.4	1451.5	3170.9	129.3	6365.4	12480.2	2958.5	3136.1	2041.6	1539.9	2372.0	2163.5	2590.6	13977.7	269.2	101.3	2006.7	3694.5	7392.0	11420.0	199.7	1766.7	8486.4	2995.4	259.5	22882.9	1654.4	5237.9	116.1	302.2	14370.0	2899.8	2680.3	3040.4	4764.9	4968.2	2149.2	1453.8	146.7	3287.0	1398.2	5423.9	133.8	381.9	4376.1	4722.2	3257.7	5961.7	1688.9	1966.6	6941.4
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin gamma 2, smooth muscle"	P63267	2	73892314-73919865	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8846.3;seminal vesicle: 6238.4;smooth muscle: 8607.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 394.2;Smooth muscle cells: 287.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"T-reg: 8.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 63.8;BJ hTERT+: 53.5;BJ hTERT+ SV40 Large T+: 214.8;HHSteC: 55.1;SuSa: 52.5;U-251 MG: 229.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"midbrain: 11.8;spinal cord: 4.7"	"HPA041264, HPA041271"	Supported					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	189.6	37.1	2.8	724.8	3.9	0.0	138.2	2.8	10.0	494.7	4.8	8846.3	392.1	3622.6	124.6	1954.7	857.3	330.4	30.4	2.9	2.9	11.3	10.8	137.5	6.8	3.4	3.1	88.5	8.1	0.9	6.1	96.4	3.1	2250.2	1179.0	0.0	75.1	6238.4	16.3	91.8	1353.8	8607.9	2.9	16.6	2099.7	4.8	3.1	2.8	33.8	6.9	1.2	2914.5	667.3	2.8	0.7	0.3	20.5	0.3	0.0	0.0	63.8	13.5	53.5	214.8	38.6	6.7	0.0	0.3	0.9	0.0	0.4	0.1	36.9	0.0	28.3	0.1	0.0	0.0	2.9	0.5	55.1	0.2	0.6	0.5	0.3	29.0	0.0	1.5	0.0	0.2	0.0	0.0	0.5	0.0	2.9	7.9	0.2	0.0	0.1	0.2	0.4	3.1	0.5	13.6	0.6	2.3	0.3	2.8	1.2	52.5	0.0	0.3	0.0	1.1	2.3	2.5	229.9	0.1	0.3	0.8	0.7	1.0	0.9	0.2	0.5	0.3	0.2	0.3	0.1	0.1	0.8	0.3	0.4	0.1	0.4	0.5	0.1	0.2	0.4	0.1	8.6	2.4	2.8	3.9	2.8	10.0	2.9	2.9	3.4	3.1	3.1	2.9	3.1	2.8	3.5	0.0	0.5	0.0	0.4	4.5	2.7	0.5	0.6	0.0	9.8	394.2	14.6	0.0	0.1	0.0	0.0	7.4	0.7	0.0	0.0	0.0	5.8	2.8	1.5	3.1	0.0	0.0	0.1	0.0	36.8	74.1	0.0	4.8	0.0	1.0	22.9	0.3	5.4	0.0	0.1	0.0	0.0	0.0	10.4	26.6	0.3	1.0	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	10.8	0.0	0.4	0.8	0.0	6.6	1.8	287.8	0.2	3.2	0.4	7.7	6.4	1.7	8.4	0.0	3.7
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656448	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;pituitary gland: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	76	"SCLC-21H: 28.5;SH-SY5Y: 28.7"	"Low region specificity"	"Detected in all"							HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	0.0	1.8	13.8	0.0	14.5	0.0	0.0	9.4	20.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	8.5	0.0	0.0	0.0	0.0	4.4	1.8	0.0	0.8	0.1	15.3	0.0	4.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.5	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.5	9.4	20.7	14.9	8.5	4.4	1.8	4.3	1.7	3.9	11.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	19.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	1.2	0.0	3.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 524.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 364.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		210000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (8.00e-4)"	117.4	40.7	27.3	149.5	55.8	149.3	103.5	0.1	32.0	118.4	20.1	449.8	49.8	313.1	60.3	154.4	152.1	143.9	121.4	29.7	14.7	46.7	61.8	100.0	47.5	24.5	11.0	61.8	46.8	9.1	27.3	96.1	7.3	174.3	109.0	28.2	116.4	295.1	21.7	59.3	106.9	524.5	4.2	55.9	171.7	21.2	32.9	32.6	35.0	13.3	50.7	305.9	83.3	28.8	871.9	262.3	158.6	121.4	275.2	180.5	592.4	749.3	712.0	770.0	571.1	211.8	196.6	0.7	256.5	744.7	310.4	370.9	126.8	790.3	965.2	4.6	38.5	118.2	133.5	179.0	494.0	85.4	14.3	231.7	152.1	479.8	540.3	551.6	428.6	48.2	56.9	1.4	612.0	246.9	10.1	181.1	124.7	217.9	198.1	59.3	294.1	32.6	292.0	225.6	57.0	68.7	649.9	96.8	177.1	474.8	146.0	170.9	546.0	1085.2	432.8	126.9	662.5	113.8	47.8	3.9	314.4	115.7	584.4	64.6	67.5	137.1	5.7	28.8	7.1	0.1	22.7	12.4	45.5	0.2	103.9	92.2	364.2	4.5	8.9	2.0	9.6	89.2	27.3	55.8	0.1	32.0	29.7	14.7	24.5	11.0	7.3	4.2	32.9	28.8	44.7	38.5	25.1	19.6	4.0	119.3	154.9	137.4	82.0	74.7	88.6	157.6	60.3	51.5	36.0	42.3	246.0	155.3	3.0	17.2	3.9	186.8	34.0	65.8	112.8	135.5	38.5	21.9	102.7	144.9	351.8	88.9	34.1	90.2	7.6	15.9	129.5	96.6	79.5	18.5	29.7	57.3	59.0	100.9	82.1	10.7	35.8	96.4	30.2	34.7	105.1	6.0	4.1	9.0	4.3	203.7	28.0	245.6	0.6	132.6	2.4	15.3	47.8	80.8	177.5	30.0	270.6	19.4	18.4	51.8	59.8	66.9	22.7	20.9	47.0	67.1
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
ADAM15	MDC15	ENSG00000143537	"ADAM metallopeptidase domain 15"	Q13444	1	155050566-155062775	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.5;Extravillous trophoblasts: 172.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 26.5;myeloid DC: 64.0"	"Group enriched"	"Detected in all"	5	"dendritic cells: 64.0;monocytes: 39.1"	"Cell line enhanced"	"Detected in many"		"PC-3: 329.5;RPMI-8226: 361.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011633, HPA072878"	Uncertain		Uncertain	Vesicles		NA	NA		640000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA011633: AB_1844574, HPA072878: "	"unprognostic (6.35e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (5.83e-5)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.64e-9)"	"unprognostic (3.35e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.40e-2)"	70.1	18.5	12.5	21.4	16.0	34.1	64.7	16.9	13.9	40.3	7.1	38.3	16.4	42.5	7.6	79.1	41.5	21.6	63.1	10.5	13.8	32.4	15.1	50.0	10.0	20.2	15.1	25.5	25.5	30.0	14.1	39.1	16.8	40.0	23.8	3.4	45.3	16.7	22.7	107.9	31.3	38.6	17.3	28.8	44.2	4.9	17.1	7.3	31.6	32.4	13.6	38.9	57.3	18.0	112.0	35.0	7.0	153.2	54.9	45.6	66.3	48.2	60.9	60.1	40.5	25.9	63.3	30.9	210.7	63.5	26.7	135.9	34.5	147.9	15.8	14.3	44.9	7.6	63.1	25.3	95.5	63.4	7.9	48.7	153.8	60.5	86.6	82.6	274.7	9.3	11.9	124.8	45.2	64.7	0.5	47.1	21.6	193.4	329.5	10.0	20.5	361.8	43.7	29.7	20.8	44.7	105.2	131.2	41.8	10.7	194.8	38.9	205.1	58.6	24.6	58.9	54.1	13.9	11.7	13.7	42.7	47.6	65.4	0.0	39.1	0.8	9.5	26.5	6.5	2.0	4.7	5.6	64.0	2.1	2.0	2.5	1.4	1.6	6.2	5.3	8.9	22.8	12.5	16.0	16.9	13.9	10.5	13.8	20.2	15.1	16.8	17.3	17.1	18.0	164.5	3.2	6.7	8.8	6.6	48.9	30.4	81.6	47.8	9.7	34.6	20.7	11.5	35.8	38.3	9.2	29.2	13.0	8.1	100.4	0.0	33.4	1.7	13.3	9.2	120.8	12.7	4.6	8.1	25.5	172.4	19.8	85.6	15.4	1.3	8.5	62.2	19.9	31.7	6.7	9.8	80.7	18.3	65.0	43.6	1.3	17.4	27.2	14.2	15.9	28.8	8.8	13.4	9.0	16.8	42.1	50.9	18.0	8.0	55.2	47.4	2.6	22.9	17.0	13.1	15.7	14.5	0.8	6.4	91.2	57.1	17.8	8.6	2.7	76.9	40.0
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443532-206621127	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;parathyroid gland: 82.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 410.0;Inhibitory neurons: 236.6;Oligodendrocyte precursor cells: 127.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"memory CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 54.4;RH-30: 63.8;RPMI-8226: 172.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Secreted in brain"	NA	NA		890000	"Cluster 32: T-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	1.7	7.5	14.3	2.4	20.6	2.0	1.1	3.5	45.7	3.2	0.0	3.0	1.5	2.2	3.8	4.0	0.8	4.2	30.7	20.6	9.6	0.9	0.3	1.5	2.1	13.9	10.2	2.0	1.2	82.9	6.4	0.2	12.9	1.7	2.2	17.4	1.5	2.4	11.1	1.1	3.2	4.5	1.6	0.8	1.6	8.0	17.4	4.9	1.0	8.7	2.7	3.0	4.1	24.0	0.1	0.9	22.3	0.0	11.9	17.2	0.9	2.4	2.9	3.2	0.6	26.8	0.5	3.3	0.0	3.8	39.5	33.9	14.5	0.7	0.3	13.2	12.4	0.0	2.1	0.3	11.4	0.3	1.4	6.5	0.1	0.1	0.0	54.4	39.4	1.2	0.0	0.1	8.2	0.4	0.3	0.0	43.9	0.4	4.6	0.1	63.8	172.6	0.0	16.6	17.4	7.0	0.0	0.0	12.9	10.9	0.1	0.0	34.3	11.1	10.2	6.0	5.3	45.2	0.1	0.0	21.1	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	20.6	3.5	45.7	20.6	9.6	13.9	10.2	12.9	1.6	17.4	24.0	1.6	0.0	0.0	41.8	0.4	0.4	0.9	0.1	0.6	39.3	0.0	0.1	62.8	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	0.0	17.6	0.3	7.7	2.7	1.8	0.0	410.0	0.0	0.0	4.3	0.0	0.2	0.0	15.0	0.0	0.1	0.0	3.3	236.6	0.0	0.0	0.0	0.3	57.7	0.6	0.1	3.6	10.3	0.0	4.1	0.0	127.2	22.3	0.1	1.1	3.0	0.0	0.5	0.0	0.0	0.7	6.8	0.0	14.2	2.2	5.1	4.7	1.5	0.4	0.1	2.0	45.2	0.0	0.1
ADAMTS16	ADAMTS16s	ENSG00000145536	"ADAM metallopeptidase with thrombospondin type 1 motif 16"	Q8TE57	5	5140330-5320304	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;ovary: 10.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 7.3;Excitatory neurons: 44.7;Fibroblasts: 13.7;Granulosa cells: 22.2;Theca cells: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 3.9;SuSa: 3.5;U-2197: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA067668			Approved	"Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria"	"Secreted to extracellular matrix"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear membrane, Mitochondria"	"Nucleoplasm, Midbody ring"	"HPA067668: "	"unprognostic (8.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.64e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.29e-5)"	"unprognostic (1.20e-4)"	"unprognostic (1.46e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.86e-3)"	5.4	0.2	1.4	0.4	1.9	0.5	0.7	17.0	2.6	1.4	0.0	0.7	0.6	1.3	1.6	1.5	0.7	6.4	0.2	3.4	0.0	3.5	0.4	0.7	0.2	0.2	0.2	10.4	4.5	0.1	0.0	0.2	0.7	0.1	0.3	1.2	0.2	0.5	0.2	0.4	0.5	1.1	0.0	0.2	0.2	0.4	0.0	0.2	0.3	0.2	0.1	1.0	0.6	1.8	1.7	1.7	1.7	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.5	0.0	1.4	0.1	2.1	0.0	3.0	0.1	0.0	0.0	0.4	0.1	0.9	0.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	3.9	0.1	0.5	0.0	0.3	0.6	0.4	0.7	0.0	0.4	0.2	1.1	0.0	1.6	0.4	2.2	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.1	3.5	0.1	0.1	0.1	2.1	3.0	5.8	1.4	0.9	0.3	0.1	3.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	1.9	17.0	2.6	3.4	0.0	0.2	0.2	0.7	0.0	0.0	1.8	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.6	2.0	0.7	0.4	0.5	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	5.0	0.1	0.0	0.0	44.7	0.0	0.0	13.7	0.5	0.5	0.0	22.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	6.9	1.6	0.1	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759206-78811464	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 30.6"	"Cell type enriched"	"Detected in some"	4	"Theca cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 259.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.6	5.3	0.5	1.8	0.4	0.1	3.8	0.3	0.5	6.0	0.6	4.2	1.1	7.2	0.1	0.9	2.2	2.3	30.6	0.4	0.5	2.2	1.1	6.3	0.9	0.5	0.5	6.1	0.5	0.4	0.8	2.1	0.4	1.8	0.2	0.5	1.3	0.4	1.1	1.8	2.6	1.4	0.2	5.2	2.2	4.1	0.7	0.1	2.1	0.5	0.2	3.0	2.5	0.6	0.0	1.1	16.5	7.5	6.9	8.2	20.9	3.7	1.3	1.0	0.6	0.0	0.1	0.0	4.8	0.4	1.0	0.4	0.4	2.0	0.0	0.3	0.6	2.1	0.5	0.1	6.9	0.0	259.9	3.3	2.0	1.9	1.0	5.3	24.0	0.0	0.3	0.7	5.6	0.0	0.1	4.9	4.7	0.0	1.4	17.3	7.7	0.3	0.5	0.9	0.3	23.9	4.8	0.0	0.6	4.0	3.2	0.4	29.8	9.4	1.0	3.3	0.0	0.1	0.0	0.0	1.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.3	0.5	0.4	0.5	0.5	0.5	0.4	0.2	0.7	0.6	7.5	0.0	0.0	3.6	0.3	0.4	0.2	0.7	0.0	0.3	0.1	0.5	9.8	0.0	0.3	0.0	0.0	0.3	0.2	0.1	0.0	0.1	4.9	0.8	7.5	10.5	0.0	0.0	0.1	0.0	0.3	10.1	0.5	0.9	3.8	7.2	2.9	0.3	0.7	0.0	0.2	0.0	2.0	0.0	0.8	2.7	1.5	0.1	1.8	1.0	0.1	1.3	0.0	9.5	1.4	0.3	0.0	1.9	0.0	0.3	0.0	0.1	0.3	0.1	0.0	3.7	5.0	2.6	2.0	0.2	0.1	0.3	0.5	44.9	0.1	0.3
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24920237	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 58.4;Sertoli cells: 111.7;Smooth muscle cells: 62.8;Theca cells: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	94.4	17.3	43.5	17.3	55.1	17.7	74.6	36.7	50.1	66.7	28.4	27.5	10.9	56.4	20.5	30.4	62.1	23.0	36.6	43.3	43.4	25.9	6.6	42.5	18.9	41.6	43.8	71.9	15.7	17.0	41.7	83.6	41.1	40.6	15.8	4.2	21.6	33.0	15.2	38.4	34.4	35.3	36.9	30.4	25.0	9.8	50.6	11.4	36.8	20.4	18.1	36.4	48.9	44.9	76.5	40.4	17.2	28.3	84.5	75.4	29.6	32.3	65.9	37.1	37.8	38.6	25.1	26.0	6.2	53.2	51.0	54.5	43.1	54.5	24.0	58.4	55.8	43.0	40.0	1.7	64.0	24.0	24.6	55.7	47.5	36.6	50.8	23.6	33.8	27.9	15.5	49.2	19.3	43.6	17.9	2.1	14.9	39.9	24.4	38.8	75.3	59.5	15.5	38.7	31.6	19.1	45.8	54.2	30.2	13.0	13.5	22.5	33.5	59.7	34.2	39.1	54.1	42.4	101.6	113.6	18.7	39.2	31.4	2.6	1.5	0.0	0.4	1.6	0.3	5.5	0.9	0.5	9.5	6.0	0.7	0.5	0.0	1.2	0.4	9.0	3.4	1.0	43.5	55.1	36.7	50.1	43.3	43.4	41.6	43.8	41.1	36.9	50.6	44.9	14.6	0.0	1.8	17.0	8.2	11.0	4.2	4.1	5.2	3.0	18.6	8.0	2.8	0.0	1.3	1.8	0.0	1.0	5.2	5.0	0.0	0.9	0.3	1.9	42.2	10.6	1.2	5.2	40.1	0.0	2.1	25.5	2.0	2.2	18.4	3.7	5.0	0.3	12.6	0.0	36.8	6.0	2.0	5.4	6.9	3.9	58.4	10.1	7.2	21.5	4.0	1.6	0.0	15.1	33.2	1.0	5.8	29.3	4.9	11.2	8.3	0.2	1.1	2.2	111.7	6.5	62.8	0.4	2.4	4.4	11.8	1.2	7.2	92.9	12.1	3.9
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 90.9;Endothelial cells: 74.6;Hepatic stellate cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 2.9;TIME: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005070, HPA048344"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB005070: AB_2273639, HPA048344: AB_2680366"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favorable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavorable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	18.0	2.6	2.8	2.3	2.2	0.0	16.1	2.2	2.8	9.2	2.0	3.9	0.9	8.8	0.5	3.7	8.2	2.9	16.9	2.0	2.1	10.2	1.4	9.9	1.6	2.7	2.5	2.4	2.3	1.0	1.7	9.9	2.6	5.3	0.7	0.0	3.7	1.4	4.3	4.7	4.5	1.9	2.4	9.9	3.7	1.1	3.0	0.4	7.7	2.8	0.8	5.9	6.7	2.3	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	2.2	2.2	2.8	2.0	2.1	2.7	2.5	2.6	2.4	3.0	2.3	90.9	0.0	1.8	0.3	1.0	3.6	0.4	0.3	3.4	0.0	1.5	1.5	10.6	0.0	0.9	1.8	0.0	0.2	1.6	2.9	0.0	1.2	1.3	0.5	1.1	74.6	1.2	0.4	0.2	3.1	0.1	4.7	7.1	0.6	1.3	0.0	50.3	0.2	1.4	1.7	0.2	7.9	0.0	5.0	3.1	6.9	0.0	1.5	7.2	12.2	2.5	0.9	1.0	0.0	0.0	2.1	3.8	0.0	1.4	0.4	2.4	0.0	1.1	0.2	6.6	1.7	5.7	0.3	0.8	0.6	2.8	0.0	1.6	0.5	2.1	0.2
ADCYAP1	PACAP	ENSG00000141433	"Adenylate cyclase activating polypeptide 1"	P18509	18	904871-912172	"Predicted secreted proteins"	Neurogenesis	Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 13.4;granulocytes: 43.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065887	Supported	Supported			"Secreted in other tissues"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA065887: "	"unprognostic (2.68e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.09e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.87e-4)"	"unprognostic (9.58e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.94e-2)"	"prognostic favorable (2.91e-6)"	"unprognostic (2.24e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.74e-4)"	1.8	0.2	1.9	10.9	2.6	0.0	1.3	0.3	2.9	2.1	0.0	1.8	0.1	3.0	0.0	1.3	0.4	7.1	0.5	2.7	21.7	0.5	0.2	1.6	1.0	31.9	6.8	0.1	4.8	0.2	3.5	0.1	13.7	1.4	1.1	0.3	1.9	0.5	0.2	0.7	1.3	1.0	5.4	0.1	1.5	2.5	17.7	0.4	0.2	0.0	1.0	2.3	1.3	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.6	0.3	2.9	2.7	21.7	31.9	6.8	13.7	5.4	17.7	2.0	0.2	3.2	0.6	0.3	0.0	0.6	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.0	0.0	13.4	0.0	0.0	2.4	0.0	0.0	43.1	0.0	0.4	0.0	0.1	0.0	0.5	0.0	4.1	0.0	0.9	1.5	0.3	0.2	0.0	1.9	0.0	0.2	0.0	0.5	1.1	2.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.6	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.2
ADGRA1	"GPR123, KIAA1828"	ENSG00000197177	"Adhesion G protein-coupled receptor A1"	Q86SQ6	10	133070929-133131675	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 25.2;Hepatic stellate cells: 11.7;Inhibitory neurons: 24.6;Oligodendrocyte precursor cells: 29.1"	"Cancer enriched"	"Detected in single"	13	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"RH-30: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042773	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042773: AB_10794764"		"unprognostic (8.31e-2)"			"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"		"unprognostic (2.29e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.51e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.66e-1)"			0.0	3.8	16.3	0.0	14.2	0.0	0.0	3.3	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	18.8	15.2	0.4	0.2	0.1	0.0	9.8	18.5	0.0	0.1	0.0	2.8	0.0	10.9	0.0	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	4.2	0.2	0.0	0.7	38.4	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	14.2	3.3	27.5	18.8	15.2	9.8	18.5	10.9	4.2	38.4	15.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.5	0.0	2.7	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	29.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635282-69389506	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.6;pituitary gland: 23.7"	"Group enriched"	"Detected in some"	10	"Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.8;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8600		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	0.8	3.9	21.1	0.8	25.5	0.0	0.6	49.6	29.7	1.3	0.0	4.3	0.4	2.2	0.9	0.7	0.9	0.9	1.9	31.1	12.1	1.0	0.5	1.7	0.0	0.0	0.6	1.6	0.3	0.1	23.7	0.1	1.1	1.0	1.3	7.1	1.2	1.4	0.3	0.4	1.4	3.3	0.0	0.6	1.3	1.9	18.2	0.1	0.8	1.4	0.0	2.6	1.4	19.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	8.8	19.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.1	25.5	49.6	29.7	31.1	12.1	0.0	0.6	1.1	0.0	18.2	19.1	3.1	0.0	0.0	1795.3	0.3	0.0	0.1	0.0	0.0	47.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	4.8	0.6	0.0	0.0	3843.1	0.0	0.0	2.1	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	2738.1	0.0	0.0	0.6	0.0	3.1	5.0	1.3	0.0	216.4	1.0	0.8	0.0	2036.3	1210.5	0.1	0.0	8.6	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	7.4	11.8	3.2	0.2	0.0	0.0	0.0	0.5	0.0	0.1
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852522-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 104.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 428.1;Alveolar cells type 1: 291.7;Alveolar cells type 2: 539.9;Endothelial cells: 222.6;Hepatic stellate cells: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 25.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		55000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	69.8	22.8	15.1	6.9	15.0	0.0	46.0	15.0	18.0	10.4	8.6	9.9	5.7	16.0	7.7	7.0	15.0	16.9	51.6	12.8	15.1	58.9	13.0	104.5	8.5	16.6	15.6	6.5	6.4	13.2	6.7	50.6	18.2	8.9	5.7	1.8	5.9	9.2	30.4	7.7	8.5	21.8	13.8	40.5	8.4	3.1	21.6	3.7	32.2	70.2	3.2	11.4	10.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	74.1	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	15.0	18.0	12.8	15.1	16.6	15.6	18.2	13.8	21.6	15.3	428.1	291.7	539.9	2.0	2.9	0.0	0.2	0.0	2.2	0.0	1.5	2.9	16.2	8.6	89.7	1.8	0.0	0.2	1.1	0.6	11.7	0.2	10.6	0.8	1.2	222.6	0.0	0.0	8.4	0.0	1.1	9.0	2.6	0.4	12.6	0.0	251.3	4.0	0.2	0.0	1.0	0.5	0.0	13.7	0.0	4.8	3.1	2.7	0.0	104.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.6	0.5	0.2	48.1	0.7	98.6	9.6	80.1	0.2	0.9	0.6	0.0	0.3	1.8	15.5	0.1	0.8
ADGRG1	"GPR56, TM7LN4, TM7XN1"	ENSG00000205336	"Adhesion G protein-coupled receptor G1"	Q9Y653	16	57610652-57665580	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, G-protein coupled receptor, Heparin-binding, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 216.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 222.5;Exocrine glandular cells: 170.7;NK-cells: 208.1;Syncytiotrophoblasts: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 160.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 160.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 218.4;SK-BR-3: 277.7;SK-MEL-30: 297.8;TIME: 241.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046065	Uncertain				"Secreted to blood"	NA	NA		32000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA046065: AB_2679521"	"unprognostic (4.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (4.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (5.52e-7)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	50.9	13.2	79.6	12.7	67.7	19.6	50.5	46.9	115.2	36.3	0.0	36.7	26.1	19.7	84.2	46.7	52.2	69.6	36.8	68.7	71.5	158.9	4.2	37.3	5.2	64.6	76.2	5.3	59.8	28.4	17.7	101.3	73.9	31.7	33.4	6.6	92.2	57.5	15.7	87.5	19.3	19.8	54.8	12.3	47.9	45.4	92.5	28.9	216.3	16.9	15.6	37.1	37.8	51.6	41.8	47.1	12.0	0.6	0.0	0.1	127.7	8.5	3.9	14.4	2.6	34.7	218.4	0.2	110.5	8.2	196.1	149.1	0.0	103.4	5.1	1.6	0.0	5.1	56.0	39.3	0.3	0.4	2.1	2.4	143.8	24.5	10.2	15.8	118.1	1.0	0.1	1.2	3.2	51.4	107.3	0.8	1.7	143.3	42.6	3.8	1.4	30.8	209.4	134.9	38.2	1.2	2.0	277.7	297.8	8.4	123.8	0.8	241.4	25.6	38.0	1.5	96.2	0.2	2.1	0.6	200.5	0.7	62.9	2.9	0.8	0.2	160.3	0.5	1.9	0.3	10.5	62.6	0.2	0.1	5.3	45.2	3.3	30.6	0.7	0.3	0.2	37.1	79.6	67.7	46.9	115.2	68.7	71.5	64.6	76.2	73.9	54.8	92.5	51.6	107.7	9.6	11.9	113.9	3.7	0.0	24.1	0.0	11.4	0.9	29.6	27.2	4.3	15.7	21.7	79.1	0.0	222.5	120.4	17.7	27.4	33.9	74.0	24.6	4.3	53.9	20.6	17.7	3.5	170.7	25.1	4.7	29.0	45.2	5.1	88.2	30.0	0.5	22.8	0.0	4.9	23.2	0.0	3.5	0.0	31.3	3.1	6.1	0.0	41.2	1.1	4.8	208.1	85.5	1.3	101.1	12.3	0.0	19.1	15.2	5.6	132.6	16.8	0.5	0.0	1.6	7.1	2.7	0.9	23.0	0.0	186.5	35.1	0.4	24.6	19.5
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609601-100695479	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 42.9;liver: 24.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 23.9;Paneth cells: 14.0;Proximal enterocytes: 39.4"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056451			Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA056451: "		"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.1	0.0	0.9	0.0	2.2	0.1	0.2	0.1	0.5	0.0	5.2	42.9	0.3	0.0	0.2	0.6	0.7	0.2	0.0	0.0	0.1	24.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.2	2.9	0.2	0.1	0.0	0.1	0.2	39.3	1.5	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.2	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.0	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
ADM5	"AM5, C19orf76"	ENSG00000224420	"Adrenomedullin 5 (putative)"	C9JUS6	19	49688664-49690575	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 29.3;Endothelial cells: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.0"														"Secreted to blood"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.34e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.62e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.21e-11)"	"unprognostic (2.39e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.92e-3)"	"prognostic favorable (6.74e-4)"	7.8	0.8	1.9	0.7	1.9	1.3	6.0	4.5	2.9	3.7	1.5	2.4	0.8	4.3	0.3	3.3	5.0	0.6	1.8	2.0	1.9	3.5	1.8	4.3	1.0	1.9	1.9	2.0	1.8	0.1	2.7	0.7	2.2	3.9	0.2	1.5	2.6	0.4	3.9	5.0	2.9	0.8	1.8	6.7	2.3	3.0	2.2	0.7	2.6	0.4	0.7	3.6	3.6	1.9	3.4	5.7	3.3	2.3	0.1	0.0	3.9	0.3	0.3	1.1	0.6	6.6	3.1	5.1	1.2	0.2	0.3	1.0	5.9	1.9	0.4	6.0	11.3	5.8	1.6	4.3	0.1	1.7	3.8	0.6	4.2	0.7	0.5	0.8	1.1	5.4	4.2	3.7	0.2	5.4	2.6	18.0	4.4	0.6	1.6	7.4	2.5	5.3	0.5	5.9	2.0	0.9	0.8	1.6	1.6	0.8	3.6	2.5	0.9	1.8	6.6	0.9	1.4	12.6	10.7	5.9	1.2	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	4.5	2.9	2.0	1.9	1.9	1.9	2.2	1.8	2.2	1.9	29.3	0.0	1.5	1.3	1.4	6.1	1.4	1.4	6.2	4.3	5.4	6.1	0.1	1.5	1.5	0.0	0.0	0.5	1.0	1.8	0.0	0.5	8.1	3.0	1.9	47.3	1.2	0.0	0.3	1.1	0.5	2.2	1.5	6.0	0.0	0.7	5.0	0.3	0.3	0.0	0.4	1.5	0.0	1.0	4.9	4.3	0.6	1.3	5.4	0.0	0.2	0.9	0.0	0.0	0.9	0.6	0.4	0.7	0.2	1.9	0.3	0.0	1.6	2.4	0.0	2.9	1.5	1.1	1.2	6.2	6.3	0.1	1.3	0.3	1.6	1.1
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 17.9;Kupffer cells: 79.2;Late spermatids: 18.2;Macrophages: 26.3"					"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	40	"eosinophil: 601.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 601.6"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 108.1"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"																					4.5	15.0	8.9	4.3	9.2	0.2	5.5	10.6	14.6	4.4	8.8	6.6	4.5	1.9	0.2	2.5	3.6	5.8	3.4	8.8	12.3	1.6	3.3	3.5	6.4	16.1	11.1	1.8	1.8	3.1	2.6	2.8	14.9	2.4	5.1	1.0	2.8	2.4	0.5	0.9	9.4	4.8	13.5	4.3	3.0	1.2	16.9	3.5	1.4	1.0	2.7	4.3	1.7	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.0	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	8.1	601.6	0.0	5.6	0.1	0.2	0.0	0.0	15.0	0.1	0.1	0.1	2.0	0.1	2.1	3.0	0.0	2.5	8.9	9.2	10.6	14.6	8.8	12.3	16.1	11.1	14.9	13.5	16.9	21.8	0.2	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	7.3	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	1.8	0.2	17.9	0.0	0.0	0.0	0.0	79.2	4.4	18.2	0.3	26.3	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.1	0.4	0.0	1.6	0.0	0.0	0.1
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 9.0;Langerhans cells: 8.0;Sertoli cells: 32.9;Smooth muscle cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;EFO-21: 1.0"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in some"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	6.4	2.1	1.5	0.3	1.7	0.8	3.0	1.4	2.7	1.5	4.9	2.3	0.3	1.9	3.8	0.7	3.0	0.6	10.1	1.2	1.4	5.1	7.0	0.5	0.2	1.8	1.6	1.7	0.8	0.5	0.5	0.8	1.7	1.4	0.3	0.0	2.2	1.5	6.4	1.9	2.6	0.7	1.3	8.6	2.2	1.6	2.6	0.2	1.3	5.0	0.1	2.5	1.8	2.4	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.4	2.7	1.2	1.4	1.8	1.6	1.7	1.3	2.6	2.4	2.9	0.0	0.0	0.0	0.9	1.1	0.7	0.7	0.6	0.0	0.9	0.9	2.5	0.0	1.5	1.8	0.0	0.8	2.9	0.1	0.0	0.2	0.0	2.2	1.0	2.4	2.4	0.0	0.0	0.6	0.2	1.0	1.1	9.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.2	0.0	0.3	8.0	0.0	1.8	5.1	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.4	0.7	0.0	0.1	1.4	0.0	32.9	0.7	13.3	0.0	0.3	0.6	1.4	0.4	2.8	0.1	0.1	0.3
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148826611-148828623	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.1;Basal keratinocytes: 387.5;Basal respiratory cells: 146.6;Squamous epithelial cells: 276.0;Suprabasal keratinocytes: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 72.4;hTERT-HME1: 74.1;PC-3: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	19.5	1.6	4.5	3.2	4.7	12.5	18.7	5.1	4.4	13.5	1.8	2.3	1.9	2.3	1.7	15.1	4.1	3.8	6.7	5.3	4.2	1.1	14.2	19.5	4.1	6.0	5.6	0.9	1.2	2.2	0.3	9.9	6.2	9.0	2.8	0.6	4.2	1.5	11.7	21.8	2.1	3.7	6.2	7.9	7.5	0.5	7.1	2.7	1.0	8.6	6.0	6.8	7.2	7.6	23.3	0.1	0.1	0.0	0.8	0.2	0.0	4.3	13.2	6.0	6.7	0.0	9.7	0.1	6.1	1.3	21.5	20.0	0.0	27.9	6.9	0.0	0.6	0.0	5.1	0.0	0.6	0.1	11.0	0.1	72.4	2.0	74.1	5.0	2.8	0.0	0.1	8.3	16.0	0.0	0.0	12.9	0.4	0.2	31.2	6.7	4.1	13.0	3.2	5.8	0.1	0.1	5.4	0.4	2.0	2.5	0.0	7.0	12.3	0.0	5.0	7.2	3.5	1.9	0.0	0.2	0.0	15.1	2.6	16.5	21.8	67.8	151.4	37.1	112.3	21.5	34.3	93.0	24.7	15.6	5.8	53.3	35.4	37.2	53.3	28.4	2.3	53.4	4.5	4.7	5.1	4.4	5.3	4.2	6.0	5.6	6.2	6.2	7.1	7.6	196.1	112.2	31.6	1.6	16.5	387.5	36.6	146.6	127.5	0.5	23.3	15.2	18.6	0.0	67.4	0.0	0.0	0.4	59.2	3.7	0.0	2.4	0.5	3.2	0.5	40.3	3.0	1.3	0.0	0.2	0.3	6.2	35.7	3.0	118.6	0.1	6.8	14.1	17.7	0.0	0.0	3.1	16.2	20.8	54.9	0.7	0.0	21.1	30.2	15.9	4.0	4.1	90.6	0.0	0.1	8.6	0.1	0.0	23.2	23.5	0.1	0.1	27.8	5.0	0.0	19.8	9.6	0.7	0.1	276.0	245.4	0.5	40.1	0.1	3.5	61.5
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.5;parathyroid gland: 92.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 116.4;Distal tubular cells: 52.8;Early spermatids: 141.6;Late spermatids: 168.0;Paneth cells: 87.0;Proximal enterocytes: 127.0;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 14.8;T-reg: 13.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 93.9;RPMI-8226: 41.2;TIME: 57.7;U-138 MG: 42.4;U-266/84: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.5	0.2	1.9	14.2	2.1	1.1	3.3	0.6	2.2	0.4	35.2	80.7	82.4	0.3	13.7	1.5	0.6	1.6	0.3	2.0	0.0	9.8	1.4	11.1	9.4	0.1	0.1	0.2	0.8	92.9	0.0	2.4	0.1	0.4	58.5	0.6	0.8	24.4	1.0	18.9	98.5	2.6	0.1	1.3	38.2	22.6	0.4	2.6	0.5	0.1	12.7	10.2	0.3	1.1	4.1	0.0	0.0	0.0	0.5	0.9	0.1	1.5	0.8	1.0	0.7	3.6	1.9	0.1	1.7	0.7	2.4	1.9	0.0	11.2	1.4	0.1	0.0	0.3	0.8	0.1	0.3	0.1	0.2	0.0	20.4	10.4	23.6	17.5	93.9	0.7	23.0	0.0	3.1	0.1	0.2	0.6	0.3	0.1	5.8	0.0	0.3	41.2	1.7	0.2	0.1	0.2	1.5	0.0	0.8	2.8	0.0	0.8	57.7	42.4	2.0	0.7	2.6	1.2	47.1	0.0	7.9	1.3	0.2	2.7	0.0	0.0	0.0	0.3	2.6	0.2	3.7	0.3	0.1	0.2	14.8	1.3	0.3	0.1	0.2	0.2	13.5	1.7	1.9	2.1	0.6	2.2	2.0	0.0	0.1	0.1	0.1	0.1	0.4	1.1	0.2	0.0	1.1	0.7	4.0	5.1	0.3	3.9	0.6	0.0	0.1	1.9	0.1	0.0	2.6	5.5	0.0	0.2	0.1	116.4	52.8	0.7	141.6	0.2	0.0	0.3	5.4	2.7	13.1	2.4	0.2	1.1	32.1	0.1	5.7	0.0	0.0	0.2	11.4	0.0	0.4	40.7	2.0	0.8	1.5	168.0	1.8	3.1	1.8	0.0	27.9	0.0	1.0	1.0	0.1	7.9	87.0	0.7	7.8	0.6	127.0	0.7	0.8	0.0	0.0	0.2	1.2	1.6	0.7	0.4	5.7	0.1	6.2	0.0	52.3	0.5
AFAP1L1	FLJ36748	ENSG00000157510	"Actin filament associated protein 1 like 1"	Q8TED9	5	149271859-149343637	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 31.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 62.4;Cardiomyocytes: 39.3;Early spermatids: 105.4;Endothelial cells: 72.0;Extravillous trophoblasts: 47.1;Hepatic stellate cells: 47.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 42.6;HUVEC TERT2: 20.8;TIME: 33.9;WM-115: 79.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.91e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.52e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.88e-2)"	23.9	2.8	1.7	2.1	0.9	0.1	15.2	1.1	1.3	4.2	1.0	3.5	0.8	7.1	0.6	4.3	10.1	4.0	26.1	0.9	1.0	4.1	2.1	13.3	2.3	1.4	1.1	3.3	1.0	6.1	2.4	14.4	1.4	3.3	0.7	1.3	3.4	1.9	31.6	6.0	3.4	3.5	1.1	2.9	2.4	2.3	1.8	3.4	7.4	16.6	0.8	4.6	3.7	0.9	7.0	2.4	0.1	0.3	9.9	2.1	42.6	1.5	5.5	5.4	8.9	0.1	4.1	0.0	3.3	2.5	13.7	1.4	0.8	6.2	2.2	0.0	1.0	1.6	0.9	0.0	5.2	0.0	0.1	7.3	1.0	3.0	11.6	4.3	20.8	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	5.4	0.0	0.0	0.0	3.5	1.1	0.7	1.1	4.4	0.1	14.8	1.5	0.2	0.4	33.9	2.5	7.7	0.1	1.2	0.0	0.0	0.0	0.5	0.1	79.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.9	1.1	1.3	0.9	1.0	1.4	1.1	1.4	1.1	1.8	0.9	62.4	0.0	1.3	0.3	0.2	1.5	1.4	4.6	0.0	0.3	0.4	0.5	39.3	1.5	4.1	0.0	0.0	14.2	0.2	0.0	0.0	0.3	105.4	0.3	0.4	72.0	0.0	0.0	2.9	0.0	47.1	4.5	0.0	0.2	1.3	0.0	47.2	0.6	2.7	0.0	1.2	0.0	0.0	4.2	1.3	50.4	9.6	0.7	7.2	10.3	0.0	0.5	0.0	2.0	0.3	0.0	0.0	15.8	0.0	4.0	0.0	0.8	6.4	5.3	13.1	4.6	4.0	0.5	4.8	0.3	1.4	6.4	0.5	1.8	0.0	5.4
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 64.5;parathyroid gland: 68.7;thyroid gland: 82.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 40.5;Microglial cells: 34.7;Oligodendrocyte precursor cells: 122.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A-431: 74.4;CAPAN-2: 77.4;EFO-21: 56.4;HaCaT: 98.7;RPMI-8226: 51.3;RPTEC TERT1: 59.7"	"Low region specificity"	"Detected in all"							HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	7.6	2.4	15.7	4.2	12.9	0.1	10.2	21.5	13.1	21.8	5.9	13.0	3.9	23.9	13.2	9.3	22.9	4.5	4.7	11.8	12.4	17.6	1.7	5.3	4.3	12.9	12.8	15.1	11.9	68.7	2.4	18.4	13.6	13.1	5.1	3.7	6.9	23.9	3.0	9.8	6.4	18.9	13.6	64.5	5.9	1.4	13.3	13.5	82.2	4.4	7.6	5.9	14.7	13.5	74.4	10.8	10.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.1	77.4	0.1	56.4	0.6	1.1	98.7	0.2	27.2	0.2	1.5	0.1	0.0	0.7	0.0	3.0	0.0	2.7	0.0	28.9	8.1	7.1	0.3	0.3	2.8	0.0	0.2	0.0	3.1	1.9	0.1	0.5	2.0	0.5	0.9	0.8	51.3	59.7	0.6	0.3	0.5	2.3	1.7	2.9	16.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	1.6	1.1	1.2	0.0	1.6	0.3	0.9	0.1	0.4	0.0	0.1	1.8	0.6	15.7	12.9	21.5	13.1	11.8	12.4	12.9	12.8	13.6	13.6	13.3	13.5	14.6	0.0	0.0	0.7	1.2	12.4	7.3	3.1	5.2	0.8	1.8	5.3	2.2	0.0	1.8	40.5	0.0	1.5	2.4	8.1	0.0	0.6	1.0	5.3	7.4	14.5	0.0	0.8	6.5	14.3	1.2	10.7	3.1	9.5	0.0	0.3	13.2	0.0	0.5	1.7	10.1	1.8	0.0	0.0	3.7	3.0	3.1	0.5	5.4	34.7	0.6	3.2	0.0	122.6	0.6	23.2	1.7	1.9	0.1	3.7	2.2	0.4	1.5	0.6	19.7	21.4	24.7	0.0	0.8	2.3	6.8	0.3	3.4	2.4	2.2	4.3
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 133.9;liver: 62.1;skeletal muscle: 34.2"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.6	1.5	0.5	1.1	9.2	17.9	0.5	0.3	0.5	0.3	0.5	0.1	1.1	1.3	133.9	62.1	0.2	4.0	0.7	0.6	0.1	0.6	2.2	0.3	0.2	0.8	0.5	6.8	0.4	4.6	0.1	34.2	0.4	13.4	0.7	0.4	1.6	1.8	0.7	0.9	2.1	0.5	6.1	4.1	0.8	0.1	1.2	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.6	1.5	1.1	1.3	0.7	0.6	0.8	0.4	0.9	1.2	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGR2	"AG2, HAG-2, PDIA17, XAG-2"	ENSG00000106541	"Anterior gradient 2, protein disulphide isomerase family member"	O95994	7	16791811-16833433	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 638.7;intestine: 1224.0;stomach 1: 1402.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 1515.8;Distal enterocytes: 1026.4;Gastric mucus-secreting cells: 2605.5;Intestinal goblet cells: 3710.4;Paneth cells: 1101.6;Undifferentiated cells: 1543.1;Urothelial cells: 1017.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 475.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	15	"OE19: 20084.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007912	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		38000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007912: AB_1844879"	"unprognostic (6.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (8.79e-5)"	"unprognostic (6.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.22e-3)"	2.1	0.7	0.0	66.6	0.0	0.0	72.3	0.2	0.5	638.7	0.0	768.1	486.0	14.1	389.1	16.2	306.4	275.8	0.2	0.1	0.0	11.2	0.9	50.7	0.6	0.0	0.1	0.3	22.1	0.1	31.4	1.6	0.0	227.3	1224.0	0.0	475.3	181.0	0.2	2.5	379.2	45.2	0.0	0.9	1402.3	0.9	0.0	1.7	7.4	0.1	7.2	160.8	4.0	0.1	0.3	265.5	0.0	0.3	0.0	0.1	2.6	0.0	0.0	0.0	0.0	43.5	39.7	0.0	0.2	0.0	6.6	25.2	0.0	34.5	0.2	0.0	0.0	0.0	0.9	3.8	0.0	0.0	1.0	0.0	88.5	0.0	11.4	0.4	0.4	0.3	0.0	0.0	0.2	44.7	1.3	1.8	0.8	20084.0	154.2	1.0	0.0	5.2	631.3	371.6	1.7	2.1	0.0	98.8	0.0	1.0	1319.9	0.0	0.0	0.7	1.2	0.9	0.2	1.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	51.3	293.1	0.0	19.0	2.8	127.1	539.8	0.6	0.0	169.3	137.4	0.2	268.8	1515.8	80.9	0.0	6.0	0.4	1026.4	0.0	74.1	4.6	301.9	33.9	4.8	522.1	0.0	0.1	835.1	4.5	6.0	2605.5	365.3	43.9	0.0	0.0	1.7	240.8	0.0	0.1	3710.4	386.6	0.8	0.3	0.4	0.3	6.5	3.6	0.0	1.0	0.0	0.0	0.0	0.0	303.1	1101.6	0.0	2.6	426.9	517.9	0.2	781.0	0.0	0.0	0.0	76.9	0.4	0.2	5.3	2.8	3.3	13.1	0.0	1543.1	1017.8
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859412-16881987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 225.2;intestine: 237.6;lung: 152.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 861.1;Intestinal goblet cells: 701.9;Paneth cells: 744.5;Proximal enterocytes: 1051.2;Respiratory ciliated cells: 1771.2;Undifferentiated cells: 495.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Region enhanced"	"Detected in some"		"midbrain: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"OE19: 109.8;T-47d: 339.3"	"Region enriched"	"Detected in some"	5	"olfactory bulb: 4.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		67000		"Cluster 9: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum"	Vesicles	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.1	0.0	11.0	0.0	0.0	69.6	0.0	0.2	25.0	0.1	219.9	167.2	8.7	0.0	1.5	225.2	48.3	0.1	0.1	0.4	2.5	0.3	152.7	0.2	2.0	3.4	0.3	10.7	0.0	21.2	0.8	1.0	4.8	214.9	0.0	30.9	0.8	0.0	1.5	237.6	8.7	0.7	0.3	99.9	0.2	0.2	0.0	7.3	0.0	0.8	27.6	0.2	0.5	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	109.8	0.0	0.0	0.0	2.3	8.1	0.0	1.3	0.4	0.0	0.6	0.0	0.0	339.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	2.0	3.4	1.0	0.7	0.2	0.5	0.7	333.3	408.1	0.3	1.4	2.7	12.5	108.5	0.0	0.0	105.1	51.9	0.1	31.5	319.9	29.5	0.0	3.4	0.7	380.0	1.9	30.4	0.0	861.1	7.4	1.9	112.7	0.0	0.2	71.4	3.3	5.3	71.4	39.2	20.8	0.0	0.0	0.0	0.5	0.0	0.2	701.9	134.3	0.0	0.3	0.0	0.3	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	16.6	744.5	0.0	0.4	7.1	1051.2	0.0	1771.2	0.0	0.0	0.0	27.9	0.0	0.1	0.0	9.8	2.2	4.1	0.0	495.4	117.9
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
AIF1L	"C9orf58, FLJ12783, IBA2"	ENSG00000126878	"Allograft inflammatory factor 1 like"	Q9BQI0	9	131096476-131123152	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.4;kidney: 313.2;lymphoid tissue: 206.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 122.9;Collecting duct cells: 356.8;Distal tubular cells: 289.5;Extravillous trophoblasts: 383.2;Proximal tubular cells: 201.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 140.3;MCF7: 96.7;NTERA-2: 106.7;RPTEC TERT1: 299.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020522, HPA056852"	Enhanced					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"			"HPA020522: AB_2670463, HPA056852: AB_2683256"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.68e-1)"	"prognostic favorable (5.54e-6)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.20e-2)"	44.7	4.8	165.6	4.7	199.6	2.3	39.9	179.6	284.4	20.2	101.5	7.2	1.3	13.5	9.3	105.8	10.8	8.3	41.8	145.4	160.9	313.2	1.6	12.2	1.9	209.2	204.2	5.1	6.5	80.6	18.2	23.8	196.2	6.6	5.7	6.9	32.1	36.6	14.6	15.9	7.9	10.0	172.9	206.8	9.0	6.5	188.0	3.9	91.9	21.9	5.8	9.2	35.3	225.1	0.5	2.2	140.3	24.1	0.0	0.0	59.5	0.0	0.3	0.1	0.3	26.8	11.3	0.0	63.5	0.0	3.0	13.5	21.2	1.5	0.8	0.3	30.0	15.7	7.4	51.4	0.3	0.1	7.6	1.2	6.6	0.5	0.7	0.4	6.7	39.3	10.6	0.1	0.0	96.7	9.3	1.9	106.7	9.0	10.1	0.2	1.9	39.6	299.9	8.5	54.3	8.7	7.4	60.0	20.4	82.7	57.6	0.9	0.9	3.8	10.2	0.5	30.8	0.4	0.5	0.4	6.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	165.6	199.6	179.6	284.4	145.4	160.9	209.2	204.2	196.2	172.9	188.0	225.1	122.9	0.0	0.0	5.9	2.8	4.1	2.1	1.5	1.2	0.1	45.0	29.5	6.6	0.0	3.5	356.8	0.0	4.5	1.3	0.8	289.5	1.5	1.0	4.1	3.5	35.0	3.6	0.0	0.3	0.8	383.2	15.5	0.5	15.0	0.0	10.1	33.5	0.0	7.0	0.0	0.3	2.1	2.0	0.3	2.0	3.5	37.6	2.3	67.6	21.5	0.0	15.1	0.0	8.0	36.3	2.9	0.3	59.0	0.0	7.7	0.0	201.5	0.6	0.2	0.0	3.3	10.3	0.2	5.3	4.4	2.4	21.1	1.7	29.9	1.3	2.0
AIFM3	"AIFL, FLJ30473"	ENSG00000183773	"Apoptosis inducing factor mitochondria associated 3"	Q96NN9	22	20965108-20981360	"Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 70.4;choroid plexus: 136.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.1;Distal enterocytes: 76.5;Intestinal goblet cells: 31.3;Muller glia cells: 25.3;Paneth cells: 27.5;Undifferentiated cells: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 1.1;intermediate monocyte: 3.0;myeloid DC: 1.9;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 1.9;monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.6;HMC-1: 10.8;T-47d: 5.3;THP-1: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001271			Supported	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA001271: AB_1078114"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.49e-2)"	"unprognostic (9.99e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.13e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"prognostic favorable (7.13e-5)"	0.5	0.4	41.5	3.1	36.8	3.7	0.4	39.6	52.9	0.3	136.0	24.8	2.5	0.4	0.0	0.4	0.5	0.6	0.3	29.9	31.4	0.8	0.3	1.1	0.6	46.2	43.7	0.3	0.4	0.5	4.4	0.4	43.2	1.0	8.4	1.8	1.0	0.7	0.1	0.1	1.9	0.8	38.0	2.1	0.5	0.6	70.4	0.1	0.3	0.0	0.0	1.2	0.3	24.9	1.0	1.7	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.2	0.0	1.9	0.0	7.6	0.2	0.0	10.8	0.5	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	1.3	0.0	1.3	1.4	0.9	0.8	0.1	0.0	0.1	5.3	7.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.5	41.5	36.8	39.6	52.9	29.9	31.4	46.2	43.7	43.2	38.0	70.4	24.9	1.0	0.0	1.5	92.1	1.0	0.6	1.9	1.7	0.6	14.5	3.1	2.4	2.9	0.0	1.4	1.8	6.2	1.0	0.0	76.5	11.7	0.7	0.0	1.7	0.4	0.5	10.3	0.0	12.5	0.6	0.7	0.6	1.5	1.4	1.3	0.5	1.4	2.4	3.6	0.0	8.1	31.3	2.0	3.2	1.9	0.1	0.0	2.5	0.0	4.7	3.2	25.3	0.0	2.5	1.6	0.5	27.5	0.0	0.3	2.2	4.8	8.1	1.9	3.7	0.0	0.2	1.2	0.4	1.9	0.7	0.9	0.8	0.2	0.3	37.9	2.8
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282019-77559966	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 121.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 150.5;Excitatory neurons: 403.7;Inhibitory neurons: 167.3;Oligodendrocytes: 706.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 13.6;naive CD4 T-cell: 16.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 13.6;T-cells: 16.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;BJ: 67.8;fHDF/TERT166: 77.5;LHCN-M2: 189.9;U-2 OS: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: AB_2683383"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.0	1.6	75.9	1.5	101.2	3.9	18.9	19.4	115.0	1.3	0.8	2.6	1.0	0.7	0.6	1.0	1.0	1.0	1.0	121.0	31.5	1.4	0.1	0.4	2.3	27.2	30.2	0.5	1.6	0.7	3.4	1.2	25.6	2.3	1.0	3.0	3.0	2.1	0.3	2.0	1.0	0.8	31.0	2.1	2.4	9.4	31.7	0.8	1.1	0.8	1.5	0.7	0.7	81.1	0.2	3.6	2.9	0.1	34.8	93.7	1.2	67.8	14.4	10.8	4.6	0.5	1.7	0.6	0.5	77.5	4.4	0.4	0.2	0.0	5.5	2.6	0.7	0.5	1.2	0.4	1.8	0.6	0.2	11.6	0.5	2.1	4.3	37.9	31.5	0.3	0.9	0.7	189.9	0.7	0.0	0.6	3.9	18.4	24.5	1.7	7.1	1.6	29.3	1.1	15.3	3.5	0.2	0.2	4.4	0.3	0.3	0.5	7.9	26.1	58.4	1.6	2.2	15.2	14.7	0.3	5.2	3.5	9.8	1.2	0.8	0.1	3.8	0.2	0.5	0.9	3.6	1.9	13.6	0.9	16.3	9.1	0.6	0.2	0.2	1.5	1.7	2.3	75.9	101.2	19.4	115.0	121.0	31.5	27.2	30.2	25.6	31.0	31.7	81.1	0.7	0.0	0.0	10.7	0.4	0.3	0.4	0.0	1.2	1.3	54.0	27.3	1.1	0.0	0.0	1.8	0.0	1.9	5.6	0.3	7.9	0.3	150.5	1.1	0.1	1.3	12.0	0.8	403.7	0.6	56.3	1.5	1.1	1.7	0.0	0.0	0.4	0.0	2.4	13.5	167.3	0.3	0.0	0.0	0.6	29.2	1.2	0.4	3.6	41.2	1.9	0.0	47.4	60.8	706.6	0.1	1.1	0.7	0.1	2.9	0.0	7.8	0.0	0.3	0.0	1.2	6.3	10.2	91.0	0.0	0.3	2.9	4.2	0.1	0.2	0.1
AKNA	KIAA1968	ENSG00000106948	"AT-hook transcription factor"	Q7Z591	9	114334156-114394405	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 148.0;dendritic cells: 240.0;NK-cells: 265.7;Plasma cells: 137.3;Rod photoreceptor cells: 140.1;T-cells: 145.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 108.4;MOLT-4: 98.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052367, HPA063993"			Supported	Nucleoplasm,Centrosome		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Centrosome"		"HPA052367: AB_2681801, HPA063993: AB_2685169"	"unprognostic (5.19e-3)"	"prognostic favorable (1.22e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.12e-1)"	"prognostic favorable (1.25e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.13e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.19e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.29e-4)"	23.3	8.5	13.1	54.5	14.3	50.6	18.9	12.9	14.9	49.6	21.0	20.5	16.2	37.2	5.8	8.8	37.4	14.6	8.4	11.1	14.5	10.3	19.2	32.0	82.4	22.7	21.2	28.0	10.4	2.9	11.4	8.5	17.2	16.9	11.9	36.0	9.2	11.0	3.0	7.7	52.5	22.6	16.3	110.6	21.4	7.8	15.2	75.2	11.5	3.6	61.6	17.6	18.3	14.1	4.7	4.8	5.9	3.7	36.9	4.4	25.1	5.0	6.2	4.8	4.0	7.8	4.9	57.9	4.7	4.3	8.2	10.7	3.7	1.4	1.3	108.4	2.3	6.0	2.4	5.6	42.2	57.5	59.5	8.0	8.1	4.0	3.8	6.7	8.7	49.9	5.3	61.9	2.0	7.5	98.0	63.2	20.1	10.2	5.8	60.4	1.0	12.8	40.3	2.3	2.7	5.2	1.3	4.0	13.4	6.3	11.5	29.2	14.2	2.2	4.8	0.8	4.2	12.5	15.4	47.0	2.8	27.6	2.2	11.5	7.9	12.6	18.9	5.7	14.8	7.6	10.3	16.9	5.0	7.9	9.0	12.1	19.6	14.6	5.5	10.5	8.7	10.3	13.1	14.3	12.9	14.9	11.1	14.5	22.7	21.2	17.2	16.3	15.2	14.1	13.5	12.8	22.8	2.6	76.0	5.2	6.9	1.6	6.2	36.4	7.4	5.3	4.1	4.3	8.3	23.9	148.0	9.5	240.0	9.5	0.0	3.7	17.5	34.8	14.4	9.7	12.7	34.3	2.6	8.1	6.2	8.8	17.9	12.4	33.5	16.6	12.1	9.6	18.2	5.0	8.4	18.9	2.0	59.1	31.5	26.2	14.6	43.0	5.4	19.7	67.2	7.0	265.7	20.1	4.9	5.4	9.2	6.8	137.3	7.8	12.6	0.9	40.7	140.1	0.0	5.8	13.6	1.1	0.9	1.9	3.4	3.4	145.7	2.8	13.4	9.3
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 224.5;intestine: 614.8;stomach 1: 432.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	7.9	0.0	0.2	0.4	0.3	0.1	73.9	0.0	73.4	614.8	0.5	0.1	224.5	0.9	176.1	0.2	0.1	0.1	12.2	40.0	0.4	0.3	0.0	0.0	0.2	0.7	0.0	4.8	0.1	0.1	1.3	45.6	0.1	32.4	0.2	3.7	7.7	354.8	3.2	0.1	0.1	432.5	0.6	0.0	5.5	0.6	5.9	7.7	65.8	145.6	0.2	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28576948	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1384.6;choroid plexus: 589.6;retina: 1183.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.5;Horizontal cells: 274.2;Muller glia cells: 127.1;Proximal enterocytes: 120.0;Rod photoreceptor cells: 348.5"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 250.9;U-266/70: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		Yes	No		150000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavorable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	87.0	24.3	953.6	12.7	909.7	23.6	42.5	1238.3	1162.3	39.3	589.6	18.5	18.7	17.9	10.9	40.8	14.3	10.9	285.5	955.7	958.0	16.8	98.3	13.7	19.3	1297.5	962.6	39.1	4.9	12.1	30.6	4.1	1384.6	18.9	14.7	1183.1	19.9	15.8	4.8	74.5	43.9	12.4	926.9	24.4	23.3	14.2	1090.2	9.6	7.4	8.1	30.5	19.0	47.0	886.1	29.9	2.1	13.7	55.7	29.9	32.9	2.9	16.7	37.7	12.9	76.0	17.9	3.0	14.9	17.3	15.5	3.3	36.9	10.3	102.3	23.4	12.4	8.9	28.3	11.6	30.4	25.8	10.0	29.2	27.8	13.9	1.5	24.0	1.7	5.3	29.7	19.3	71.9	10.7	15.1	11.9	32.0	20.8	6.7	15.3	9.5	1.6	250.9	1.9	4.3	36.2	61.9	9.1	67.3	0.5	20.8	36.6	21.2	3.5	1.2	5.3	2.1	2.4	161.0	51.4	10.9	105.2	28.0	1.9	0.5	7.4	3.0	21.6	8.7	30.6	24.0	29.5	17.8	9.4	25.1	37.7	28.4	18.0	29.4	5.3	4.6	40.9	19.0	953.6	909.7	1238.3	1162.3	955.7	958.0	1297.5	962.6	1384.6	926.9	1090.2	886.1	4.2	0.0	15.8	97.6	9.8	7.5	20.3	80.5	8.6	112.5	9.0	11.0	22.1	11.5	29.3	7.3	106.3	1.1	9.5	31.7	3.9	21.9	0.9	1.0	3.0	11.3	21.6	3.2	19.2	10.2	6.5	5.8	6.6	1.2	13.3	4.9	14.3	93.1	5.4	274.2	41.3	12.9	28.5	4.4	5.3	1.3	9.3	3.1	24.9	21.5	34.1	127.1	12.3	26.7	16.8	12.4	12.4	10.1	2.6	6.1	120.0	2.1	11.8	348.5	13.1	6.4	10.1	0.3	3.2	7.9	10.9	1.5	17.0	11.7	5.1	7.8
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 10.9"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 274.2;Oligodendrocyte precursor cells: 433.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 31.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	0.3	0.6	2.2	0.2	2.4	0.0	0.1	0.7	2.8	0.1	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.5	3.9	0.0	0.0	0.1	0.0	4.4	6.8	0.0	0.0	0.0	1.3	0.0	10.9	0.0	0.2	0.7	0.1	0.1	0.0	0.1	0.3	0.1	2.9	0.0	0.1	1.2	2.7	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.4	31.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.7	2.8	1.5	3.9	4.4	6.8	10.9	2.9	2.7	2.1	0.0	0.0	0.0	66.6	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.5	0.1	0.2	0.0	0.0	12.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	274.2	0.0	0.0	0.0	0.0	41.2	0.0	0.5	0.0	7.5	0.0	0.6	0.0	433.8	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 72.8;lymphoid tissue: 93.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;granulocytes: 201.3;Hofbauer cells: 85.0;Kupffer cells: 78.5;Macrophages: 86.5;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 13.9;Daudi: 40.9;HMC-1: 24.0;U-266/70: 30.8;U-698: 11.0"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	16.8	8.4	1.4	8.4	1.1	31.1	12.7	2.8	2.9	6.1	1.0	11.0	3.0	6.9	0.3	10.7	11.1	3.4	6.7	1.2	1.8	8.3	5.5	72.8	6.7	4.1	2.5	2.6	23.2	0.9	3.2	3.6	2.7	11.8	2.3	0.1	14.1	1.5	2.1	5.6	35.8	4.9	2.5	93.9	9.3	2.1	2.2	2.6	4.7	3.7	8.9	40.0	7.9	4.2	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	7.4	40.9	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	8.6	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	2.7	0.0	5.2	0.7	0.0	0.0	0.2	0.0	0.1	0.1	0.6	0.0	0.0	2.2	0.0	0.0	30.8	2.8	11.0	0.0	0.1	0.0	462.5	225.6	317.6	0.3	198.4	0.6	133.9	5.3	1.7	119.7	98.5	0.7	0.5	457.8	0.2	210.5	2.4	1.2	136.1	1.4	1.1	2.8	2.9	1.2	1.8	4.1	2.5	2.7	2.5	2.2	4.2	0.7	16.0	38.4	1.3	63.7	1.1	7.3	0.2	1.2	1.3	7.3	4.3	2.2	12.8	9.5	9.2	2.1	0.7	1.7	1.7	0.0	20.9	0.5	0.7	0.5	3.0	7.1	1.7	2.8	21.6	2.0	1.7	13.7	4.4	201.3	2.2	3.6	1.1	85.0	0.0	1.1	2.0	14.2	78.5	17.8	1.1	0.3	86.5	0.0	47.8	59.5	0.7	4.1	4.0	1.4	18.4	0.6	0.0	13.8	4.0	9.4	0.2	2.6	0.3	13.1	0.3	1.1	0.3	1.1	9.2	1.4	4.1	5.9	0.7	3.2	45.3
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 487.2;lung: 183.3;lymphoid tissue: 138.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 691.3;granulocytes: 609.1;Hofbauer cells: 492.2;Langerhans cells: 335.4;Macrophages: 637.0;NK-cells: 280.2;T-cells: 368.6"	"Cancer enhanced"	"Detected in all"		"glioma: 49.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 9703.9;eosinophil: 4033.4;neutrophil: 4968.7;plasmacytoid DC: 3555.3"	"Group enriched"	"Detected in all"	8	"dendritic cells: 3555.3;granulocytes: 9703.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 658.4;HL-60: 352.3;HMC-1: 1072.9;THP-1: 434.2;U-937: 321.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	51.6	36.1	10.8	100.6	11.6	487.2	25.7	12.5	18.1	18.8	13.4	22.8	21.6	17.4	7.1	21.8	24.5	40.0	12.4	10.2	15.7	13.3	19.7	183.3	77.2	21.0	15.6	10.6	14.1	9.6	6.1	37.2	21.1	13.2	21.4	3.7	19.9	15.5	3.8	7.4	28.3	42.6	16.6	138.5	20.0	4.3	17.7	93.2	9.1	24.7	108.2	65.6	11.9	31.3	0.6	0.8	1.2	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	1.3	7.1	156.3	2.2	0.0	5.2	1.2	0.0	4.6	0.1	658.4	0.0	18.7	0.3	1.0	0.7	352.3	1072.9	0.8	0.2	0.1	37.9	8.1	1.4	33.3	0.1	3.2	1.9	0.1	19.8	12.7	0.0	0.0	0.2	3.2	3.9	12.4	1.4	0.3	10.2	0.1	0.2	0.3	0.9	2.3	0.0	434.2	1.1	0.0	3.2	0.3	2.6	66.2	0.5	103.8	1.0	321.1	1.4	9703.9	322.4	4033.4	546.0	17.2	808.3	477.9	536.4	449.0	198.5	489.2	271.6	260.7	4968.7	98.0	12.4	3555.3	843.9	775.2	10.8	11.6	12.5	18.1	10.2	15.7	21.0	15.6	21.1	16.6	17.7	31.3	3.5	41.7	102.0	0.0	117.6	23.7	2.6	1.8	1.2	0.0	3.3	9.1	4.1	10.0	23.7	0.0	0.0	3.1	691.3	4.0	15.6	2.3	5.6	14.3	0.7	17.2	26.4	27.1	0.4	1.0	4.0	11.2	21.4	0.7	609.1	1.9	7.1	1.8	492.2	0.0	0.4	2.0	4.1	144.3	335.4	4.5	4.7	637.0	42.7	13.1	217.1	0.1	280.2	0.5	0.3	6.4	3.1	4.1	31.1	1.5	7.3	2.0	11.1	0.1	32.9	4.4	4.0	0.4	1.1	1.7	24.7	4.9	368.6	0.0	2.0	1.4
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 141.2"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	141.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	128.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755540-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 14.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.2;Enteroendocrine cells: 15.1;Excitatory neurons: 6.6;Horizontal cells: 3.3;Inhibitory neurons: 5.7;Rod photoreceptor cells: 4.9"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: AB_2682423"	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.0	0.6	4.0	0.0	4.5	0.1	0.0	14.6	8.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.8	0.0	1.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	4.5	14.6	8.1	3.7	3.2	1.2	0.2	1.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922663-102933596	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Protein transport, Transport"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 83.5;kidney: 39.8;liver: 37.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 672.6;Intestinal goblet cells: 283.9;Paneth cells: 724.4;Proximal enterocytes: 2014.8;Proximal tubular cells: 348.9;Undifferentiated cells: 272.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 8.1;Hep G2: 9.9;U-698: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA000817	Approved				"Secreted in other tissues"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	1.4	0.0	0.1	1.1	0.2	0.1	0.5	0.1	0.2	1.5	0.0	33.0	43.5	0.1	0.0	5.6	1.1	1.9	0.0	0.2	0.1	39.8	37.8	1.7	0.1	0.3	0.1	0.1	0.7	0.0	0.5	0.0	0.3	0.7	3.0	0.0	1.2	0.0	0.0	2.3	83.5	0.1	0.1	0.5	8.0	0.8	0.1	0.1	0.8	0.0	0.0	0.3	2.5	0.3	0.3	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	9.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.1	0.7	1.2	0.0	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.7	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.3	0.2	9.6	0.5	0.7	18.0	13.4	23.4	1.3	12.0	3.3	13.1	2.0	1.5	140.2	6.1	20.2	0.0	2.7	4.7	672.6	33.2	1.8	4.8	8.2	1.1	0.6	19.2	0.8	0.1	0.7	4.1	0.9	61.7	10.5	4.5	1.9	0.4	52.6	0.6	1.7	0.1	283.9	6.1	1.6	2.3	6.3	0.6	3.1	7.2	0.0	0.1	0.2	1.0	0.0	0.1	11.1	724.4	0.7	4.5	28.1	2014.8	348.9	4.5	1.2	0.0	0.5	0.9	21.2	25.7	17.1	20.9	1.4	5.2	0.4	272.4	65.7
ANAPC15	"APC15, C11orf51, DKFZP564M082, HSPC020"	ENSG00000110200	"Anaphase promoting complex subunit 15"	P60006	11	72106378-72112780	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036596	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA036596: AB_10671961"	"unprognostic (1.17e-1)"	"unprognostic (5.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (9.18e-2)"	"unprognostic (3.35e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (9.34e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.08e-2)"	28.9	44.2	47.0	30.0	47.5	95.9	30.0	47.8	61.1	24.3	45.8	67.1	30.7	43.4	38.3	53.2	30.4	18.3	62.2	47.2	47.7	48.8	44.0	30.0	43.5	46.4	46.8	22.4	39.2	25.4	32.8	19.2	47.2	52.0	40.6	42.8	39.9	38.8	95.2	39.6	40.1	31.9	46.4	41.2	46.5	72.0	46.3	72.6	44.7	64.3	44.3	41.6	29.5	49.0	74.0	109.4	87.5	55.8	25.5	41.2	41.4	77.1	70.1	121.3	80.2	128.8	78.4	98.8	72.9	110.3	59.0	122.6	133.4	144.0	113.9	64.0	63.3	113.1	124.9	84.5	30.2	110.8	101.3	43.2	56.2	68.9	91.6	45.4	80.7	136.7	83.3	66.6	80.0	127.2	214.5	102.9	70.9	155.3	62.3	89.6	217.4	67.2	106.1	50.5	61.9	53.8	79.0	76.5	127.0	46.8	89.6	58.6	73.4	55.5	72.9	110.5	82.8	68.0	71.5	125.3	34.0	87.8	31.7	29.7	168.5	136.3	73.3	114.2	78.0	94.5	93.4	86.3	148.8	71.4	110.9	101.5	68.4	72.4	107.4	119.1	153.0	124.1	47.0	47.5	47.8	61.1	47.2	47.7	46.4	46.8	47.2	46.4	46.3	49.0	20.1	16.0	16.5	2.9	36.1	41.8	71.2	83.5	44.3	32.9	43.2	55.6	3.9	12.8	50.6	23.9	27.1	84.7	40.5	82.9	123.3	49.4	15.4	38.8	21.3	22.8	49.6	34.1	7.1	102.7	78.8	18.3	36.7	27.8	30.4	27.2	15.0	44.1	82.8	13.5	7.3	66.2	61.1	48.5	47.5	13.4	6.8	48.0	26.6	1.0	58.8	44.1	36.0	5.5	5.2	53.1	61.4	23.0	47.1	43.8	56.2	123.6	45.6	43.3	19.7	16.0	35.3	115.9	139.9	53.8	41.1	46.7	41.1	32.3	71.5	61.7
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.7;Endothelial cells: 182.2;Smooth muscle cells: 79.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 12.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"HMC-1: 17.9;HSkMC: 39.9;HUVEC TERT2: 62.6;WM-115: 22.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	NA	NA	3780000	110000	"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.52e-7)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.7	0.5	5.6	3.8	5.0	0.4	9.9	6.3	9.0	6.2	2.6	2.9	1.2	4.3	1.1	2.2	4.2	4.9	7.3	4.9	6.3	5.4	2.7	4.6	6.8	12.3	5.8	2.5	0.8	2.3	0.8	11.3	12.3	3.3	1.8	1.6	2.5	2.7	4.0	3.1	2.5	6.8	7.7	0.5	1.8	0.9	7.6	6.4	8.2	2.0	2.8	10.6	3.2	7.5	0.1	0.2	0.3	0.1	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	4.7	0.4	0.1	0.9	0.0	17.9	39.9	0.0	0.0	0.0	0.1	62.6	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.8	0.0	0.0	0.1	0.3	0.1	0.1	1.3	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	22.7	1.7	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.1	0.1	5.6	5.0	6.3	9.0	4.9	6.3	12.3	5.8	12.3	7.7	7.6	7.5	81.7	9.6	0.0	5.2	7.8	8.2	2.7	2.5	1.8	9.3	1.5	1.4	2.8	2.8	1.6	0.0	29.2	1.8	3.6	0.6	0.0	1.3	3.2	4.2	5.4	182.2	13.8	1.3	17.0	0.5	1.5	6.3	1.5	5.9	4.5	2.0	30.4	0.9	0.6	38.7	16.1	1.7	0.0	2.5	10.9	5.0	43.5	2.7	16.0	26.2	2.4	2.9	7.2	24.6	11.3	1.3	1.2	3.8	0.9	9.9	2.6	1.0	1.4	12.5	0.0	8.1	79.8	1.6	1.6	0.3	8.0	30.6	5.5	2.9	1.3	4.7
ANGPTL5		ENSG00000187151	"Angiopoietin like 5"	Q86XS5	11	101890674-101916522	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"ovary: 22.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 19.4;Langerhans cells: 11.3;Leydig cells: 27.7;Melanocytes: 7.2;Peritubular cells: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 2.7"					"Region enhanced"	"Detected in some"		"spinal cord: 3.3"	HPA038516	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA038516: AB_10672749"	"unprognostic (8.28e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.23e-2)"		"unprognostic (2.18e-1)"		"unprognostic (4.88e-2)"	"unprognostic (6.74e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-8)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.17e-3)"	4.3	0.2	0.1	0.0	0.2	0.0	5.5	0.2	0.4	0.2	0.4	0.3	0.1	0.0	4.4	0.2	0.3	0.2	2.7	0.2	0.2	0.0	0.0	0.9	0.1	0.2	0.1	22.4	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.4	0.2	0.4	2.4	0.2	0.0	0.2	0.0	0.1	1.6	0.1	0.0	0.7	1.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	2.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.3	0.0	6.2	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.9	0.6	0.8	0.0	0.0	2.7	0.0	0.1	19.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	11.3	0.8	27.7	0.1	7.2	4.7	0.0	0.2	0.0	1.0	0.2	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.2	1.0	0.2	0.2	0.0	5.5	0.1	0.5	5.7	0.0	0.0
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189355-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 4.1;Enteroendocrine cells: 1.8;Fibroblasts: 6.9;Melanocytes: 3.6;Microglial cells: 1.9"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	65	"SCLC-21H: 41.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	13	"spinal cord: 62.2"						"Secreted in other tissues"	NA	NA		1100000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	15.9	2.2	0.3	1.3	0.2	0.0	5.3	1.9	1.0	4.8	0.2	9.2	0.8	0.5	2.1	2.2	2.2	3.8	7.6	0.1	0.4	2.7	0.1	1.3	0.0	0.4	0.5	0.4	0.4	0.0	4.2	0.6	0.3	4.2	1.5	0.2	2.3	6.6	7.8	6.2	1.8	1.9	0.0	0.3	2.3	0.2	4.3	0.3	0.7	5.7	0.2	4.2	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	1.0	0.1	0.4	0.4	0.5	0.3	0.0	4.3	0.4	0.1	3.2	0.0	0.3	0.0	0.1	0.1	0.0	1.2	0.1	0.2	0.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.3	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 490.2;Excitatory neurons: 859.2;Inhibitory neurons: 881.3;Oligodendrocyte precursor cells: 592.6;Oligodendrocytes: 1579.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 50.3;SK-BR-3: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	6.3	6.7	45.5	6.5	86.5	2.1	21.5	144.9	82.3	12.0	0.0	26.0	39.3	23.0	125.2	16.9	19.1	21.5	81.1	60.8	86.1	95.4	16.6	24.6	6.1	82.7	61.3	11.6	11.2	131.8	14.5	15.6	97.0	20.0	20.9	123.2	42.6	40.5	80.5	39.9	27.2	13.2	21.2	10.8	15.5	8.0	87.3	9.1	41.6	94.1	7.4	10.8	14.1	114.4	8.7	4.9	30.3	0.4	0.0	1.8	23.3	0.6	0.4	0.1	0.6	22.2	16.6	0.5	9.8	0.6	0.9	12.1	16.4	14.9	0.5	0.5	11.0	0.2	9.7	0.1	6.2	0.1	0.4	14.6	9.3	7.8	0.4	26.1	3.6	0.0	4.3	20.6	6.9	29.0	0.2	1.0	13.8	23.3	26.6	0.1	21.7	4.3	5.4	50.3	15.6	2.8	0.6	49.4	0.0	33.6	28.7	0.1	10.0	0.9	2.9	13.3	1.5	0.9	0.2	0.2	5.5	0.2	18.9	1.6	0.2	0.5	2.7	0.2	2.4	4.1	4.6	1.5	0.1	1.1	5.0	1.2	0.7	1.5	0.3	2.5	0.8	1.0	45.5	86.5	144.9	82.3	60.8	86.1	82.7	61.3	97.0	21.2	87.3	114.4	0.9	44.8	174.3	20.2	14.5	19.1	21.9	17.8	38.7	490.2	26.8	20.6	189.3	12.8	42.5	53.3	225.2	38.8	3.4	62.9	19.6	10.6	28.3	139.8	26.2	3.9	30.6	0.0	859.2	8.6	9.9	13.2	15.8	153.3	12.6	66.9	7.9	0.5	4.7	43.7	881.3	12.1	14.2	4.8	1.4	11.5	28.0	3.3	8.8	23.4	4.4	41.4	0.0	592.6	1579.5	4.8	41.8	5.7	3.4	12.2	62.5	51.3	66.7	216.6	0.0	30.2	11.7	1.1	2.3	35.9	18.2	25.0	18.5	4.5	17.8	18.4
ANKRD40CL	"C17orf73, FLJ20694, LINC00483"	ENSG00000167117	"ANKRD40 C-terminal like"	Q53H64	17	50761029-50767557	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	11	"intestine: 60.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.1;HDLM-2: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 11: Basophils - Unknown function"		"Cluster 39: CACO-2 - Unknown function"					"unprognostic (2.98e-1)"		"unprognostic (1.96e-2)"	"unprognostic (2.02e-3)"			"unprognostic (2.76e-1)"	"unprognostic (4.52e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.05e-3)"	0.3	0.2	1.9	2.6	1.5	4.1	0.1	5.3	1.9	0.0	2.9	26.7	59.3	0.7	0.6	0.5	0.2	2.3	0.4	2.2	2.0	0.2	0.2	0.4	0.8	5.6	3.9	0.3	0.4	0.0		0.2	4.0	0.4	21.1	0.6	0.6	0.2	0.9	1.9	60.0	1.2	1.0	0.6	2.8	0.5	2.7	0.0	0.6	0.1	0.2	0.3		3.6	0.4	0.4	0.4	0.9	0.0	0.3	1.0	0.1	0.0	0.0	0.0	8.1	0.8	0.5	0.2	0.2	0.1	0.7	0.0	0.1	0.1	6.0	0.5	0.3	1.9	1.1	0.0	0.6	1.1	0.3	0.0	0.1	0.0	0.3	0.0	0.5	0.2	0.7	0.0	0.3	0.2	1.2	0.2	1.4	0.3	0.6	0.3	0.4	0.2	1.3	0.6	0.5	0.3	0.8	0.2	0.3	0.7	0.0	0.9	0.8	0.5	0.8	0.3	0.3	0.2	0.6	0.2	0.5	0.3	3.8	0.8	0.5	0.3	0.4	0.2	0.5	0.4	0.3	0.1	0.7	0.5	0.5	2.8	0.7	0.5	0.8	0.3	0.3	1.9	1.5	5.3	1.9	2.2	2.0	5.6	3.9	4.0	1.0	2.7	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 12.3;kidney: 5.9;liver: 13.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	2.1	0.2	0.0	0.0	8.9	9.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	7.1	0.2	0.0	0.0	0.7	0.1	12.3	0.2	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 226.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	8.8	0.3	3.8	0.4	4.4	0.0	6.6	2.2	3.3	4.3	5.0	1.9	0.7	1.8	1.4	1.7	3.2	1.1	8.0	2.5	2.4	1.2	0.2	7.2	0.1	3.2	3.2	1.5	0.9	1.3	0.6	4.1	3.4	2.5	0.6	226.0	1.3	1.0	2.0	1.1	1.7	1.5	3.0	3.4	2.2	10.1	3.9	0.3	2.4	4.4	0.2	2.4	3.5	2.8	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	4.4	2.2	3.3	2.5	2.4	3.2	3.2	3.4	3.0	3.9	2.8	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;prostate: 69.6;stomach 1: 28.1"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.2;Hep G2: 2.3;OE19: 2.5"	"Low region specificity"	"Detected in many"							HPA078464	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.3	0.3	0.2	1.0	0.7	3.6	0.2	0.2	1.0	0.3	0.0	16.3	10.7	0.5	0.0	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.0	1.2	0.2	0.5	0.4	0.0	0.2	0.1	0.4	69.6	10.1	0.0	4.9	0.2	0.0	0.2	14.7	0.1	0.3	0.3	28.1	0.2	0.8	0.0	0.2	0.0	0.0	0.2	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.2	1.0	0.2	0.2	1.2	0.2	0.4	0.3	0.8	1.6	1.2	0.0	0.0	1.6	0.7	0.3	0.8	0.8	1.2	0.2	1.9	2.7	1.6	0.0	0.2	0.0	0.0	0.6	0.1	2.6	0.0	2.7	0.1	0.8	0.7	2.1	3.0	0.0	4.8	4.2	5.6	2.0	80.0	1.9	0.0	12.4	2.9	3.9	1.5	0.0	2.7	53.4	0.0	1.3	0.0	0.0	3.4	0.7	1.8	7.5	0.0	1.4	0.0	1.0	6.9	6.4	1.9	2.2	0.5	11.9	3.6	2.8	0.0	0.6	0.0	0.8	1.0	0.1	1.7	0.1	0.0	0.7	0.3	2.6	2.4	0.8
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732137	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.1"	"Cell type enriched"	"Detected in many"	11	"Alveolar cells type 1: 240.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 40.4;NTERA-2: 37.0;U-2 OS: 17.6"					"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	6.6	4.0	7.6	1.1	10.5	0.3	3.7	6.0	7.3	4.4	0.9	0.6	0.3	0.5	3.1	1.3	1.1	1.7	5.0	8.3	12.2	0.8	0.8	43.1	1.9	13.8	11.5	0.3	0.4	15.1	0.5	1.2	14.8	4.1	1.0	19.6	2.4	4.4	10.5	3.1	0.6	0.7	18.6	0.8	0.8	3.9	12.6	4.0	9.3	6.8	0.9	1.2	1.2	17.9	0.1	0.0	1.9	0.0	0.0	0.0	2.2	0.8	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.7	4.0	0.2	5.5	0.5	5.6	0.0	0.0	0.0	1.5	0.1	3.1	0.3	0.1	40.4	0.0	0.1	0.0	0.0	0.5	0.4	0.3	0.0	37.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	2.1	0.1	1.9	0.5	0.0	4.8	0.0	1.0	0.0	0.0	17.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	10.5	6.0	7.3	8.3	12.2	13.8	11.5	14.8	18.6	12.6	17.9	1.7	240.4	12.6	0.0	0.0	0.0	4.7	0.0	13.1	20.5	6.2	3.4	6.2	0.0	19.8	0.0	4.2	0.1	0.0	0.0	0.0	0.9	0.2	0.4	1.5	1.6	0.0	0.0	0.0	0.0	0.3	10.9	0.0	0.1	1.3	2.2	6.1	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.6	3.0	0.0	0.0	0.2	17.8	0.0	0.0	0.0	1.5	0.1	1.2	0.0	3.1	0.0	0.2	3.6	1.6	0.0	8.7	3.3	0.6	1.6	1.5	0.0	0.1	0.3	0.8	0.4	1.1
ANXA2R	"AXIIR, C5orf39"	ENSG00000177721	"Annexin A2 receptor"	Q3ZCQ2	5	43039233-43043170	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.2;B-cells: 23.8;dendritic cells: 36.4;Endothelial cells: 24.8;Hepatic stellate cells: 38.2;NK-cells: 47.4;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"gdT-cell: 53.9;MAIT T-cell: 63.5;memory B-cell: 34.3;memory CD4 T-cell: 56.1;memory CD8 T-cell: 59.9;naive B-cell: 32.9;naive CD4 T-cell: 96.3;naive CD8 T-cell: 72.1;NK-cell: 24.8;T-reg: 66.5"	"Group enriched"	"Detected in all"	6	"B-cells: 34.3;NK-cells: 24.8;T-cells: 96.3"	"Cell line enhanced"	"Detected in many"		"HSkMC: 27.7;JURKAT: 33.1;MOLT-4: 30.0;REH: 30.9;U-937: 117.7"									HPA051482	Uncertain		Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA051482: AB_2681500"	"unprognostic (3.38e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.92e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (6.36e-8)"	"unprognostic (2.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.68e-1)"	4.7	1.3	3.2	12.1	3.2	19.8	3.9	3.0	3.8	3.5	3.5	2.5	3.3	2.4	1.7	1.8	3.3	3.5	2.9	2.8	2.9	2.0	1.3	4.6	26.1	3.4	3.3	1.2	0.8	0.6	1.1	3.2	3.2	2.7	2.7	0.1	1.7	1.2	2.5	2.1	8.2	2.1	3.5	15.8	3.3	1.5	3.3	25.2	2.7	3.0	17.2	3.2	3.8	4.0	2.1	2.1	1.6	1.2	2.6	8.0	0.4	0.5	0.3	0.5	0.6	3.9	1.9	6.8	6.5	1.6	2.2	0.8	5.0	0.5	0.5	13.3	4.0	2.2	5.9	1.8	4.1	2.6	0.8	27.7	0.2	2.4	0.2	0.1	16.2	33.1	1.5	8.9	2.1	3.1	30.0	4.1	0.0	1.7	14.8	30.9	3.6	3.9	0.7	1.1	5.7	0.0	2.7	0.7	0.7	0.2	0.7	4.9	9.9	0.5	0.0	0.8	2.5	4.4	6.7	3.3	3.6	117.7	1.4	5.6	3.5	1.7	53.9	2.5	63.5	34.3	56.1	59.9	3.5	32.9	96.3	72.1	3.2	24.8	8.1	5.2	66.5	26.6	3.2	3.2	3.0	3.8	2.8	2.9	3.4	3.3	3.2	3.5	3.3	4.0	32.2	0.0	9.9	0.0	23.8	3.7	1.4	0.3	2.2	0.1	1.9	2.2	1.3	4.3	1.5	0.0	0.0	0.4	36.4	0.5	0.0	0.1	4.0	1.1	5.0	24.8	1.8	8.2	0.0	0.0	1.1	7.2	1.5	0.8	15.2	4.1	38.2	1.4	8.7	0.0	0.0	0.1	2.0	18.2	5.6	1.5	1.5	7.5	7.2	0.0	7.1	0.2	47.4	0.0	0.0	0.1	0.0	0.4	7.8	1.2	1.0	0.4	2.0	0.0	0.0	3.4	3.7	0.7	1.6	1.2	2.3	0.4	66.0	0.3	0.5	1.4
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
AOC1	"ABP, ABP1, DAO"	ENSG00000002726	"Amine oxidase copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 227.2;kidney: 136.5;placenta: 496.7"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 272.2;Distal enterocytes: 517.5;Paneth cells: 532.1;Proximal enterocytes: 957.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"eosinophil: 31.2"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.5;HaCaT: 6.2;NB-4: 6.4;RPMI-8226: 7.7;THP-1: 27.1"					"Low region specificity"	"Detected in many"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	NA	NA		2500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.7	0.1	0.3	13.0	0.2	1.9	0.2	0.3	0.3	7.2	0.4	142.2	184.0	2.1	1.9	3.3	0.1	1.8	0.7	0.3	0.2	136.5	5.8	0.6	1.3	0.5	0.5	0.3	1.4	0.0	0.0	496.7	0.5	6.1	94.1	0.1	0.6	1.0	0.1	1.4	227.2	3.4	0.3	0.5	18.0	2.1	0.6	2.1	0.2	0.0	3.8	0.8	0.4	0.5	0.0	0.1	0.1	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	3.2	20.5	0.0	2.7	0.0	1.7	6.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.3	0.1	6.4	0.2	1.9	0.0	0.0	0.0	7.7	0.3	0.2	2.2	2.5	0.1	0.9	0.0	0.3	0.8	27.1	0.6	0.2	0.1	0.6	0.0	0.2	0.1	0.1	0.2	1.0	0.1	0.2	0.1	31.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.3	0.3	0.2	0.5	0.5	0.5	0.3	0.6	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.8	272.2	0.0	2.1	0.0	517.5	15.6	0.0	7.1	1.9	0.5	0.4	43.3	0.0	0.1	3.3	63.4	0.5	13.7	4.8	5.7	0.0	0.0	0.0	2.8	0.0	0.1	129.7	2.0	0.0	1.7	18.4	0.0	1.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	3.7	532.1	0.0	0.0	0.7	957.9	145.2	0.2	0.0	0.0	0.0	0.3	3.7	1.3	0.0	0.1	3.4	0.9	0.0	117.9	0.3
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 422.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 58.2;Peritubular cells: 74.9;Sertoli cells: 118.3;Smooth muscle cells: 93.0;Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"ASC diff: 307.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"	NA	NA		240000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (6.98e-4)"	422.8	48.4	2.6	31.9	3.2	1.4	169.2	2.5	4.2	52.8	2.7	210.8	17.3	95.1	33.5	88.0	84.8	50.7	50.2	2.9	2.5	24.1	19.1	218.6	12.4	2.5	2.5	26.5	12.0	8.4	5.4	28.0	2.6	59.1	41.0	1.7	14.7	103.6	17.8	24.6	57.6	144.8	2.3	21.4	66.6	12.8	2.4	5.9	28.2	22.9	3.9	142.1	50.9	2.5	0.1	1.5	0.2	1.0	307.5	0.3	5.0	0.3	0.1	0.2	0.8	0.9	0.0	0.7	0.7	0.1	0.2	0.5	0.8	0.2	0.8	1.5	5.7	0.4	0.5	18.4	0.8	0.3	1.0	3.3	1.0	0.3	0.8	0.0	0.2	2.2	0.3	1.7	0.6	0.2	0.2	1.4	0.7	0.1	0.4	0.7	0.8	3.0	0.1	2.2	0.3	0.4	0.0	0.2	2.0	2.2	0.1	0.1	0.0	0.3	2.7	1.2	0.4	4.8	5.9	0.6	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	3.2	2.5	4.2	2.9	2.5	2.5	2.5	2.6	2.3	2.4	2.5	58.2	3.2	6.0	0.0	0.5	2.9	0.1	0.0	2.2	0.0	1.1	2.2	9.5	0.0	1.9	0.0	0.0	0.1	0.4	0.1	0.0	0.2	4.5	0.8	2.3	12.3	0.0	0.0	0.4	0.2	0.1	11.3	0.0	1.4	1.3	2.1	20.7	0.2	1.4	0.0	0.3	0.1	0.0	1.4	2.7	2.6	3.4	0.9	3.6	3.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	74.9	0.0	0.4	0.1	1.4	1.0	0.4	118.3	2.6	93.0	1.1	1.3	0.7	1.8	0.3	0.6	74.6	0.1	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 subunit mu 2"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 162.0;Proximal tubular cells: 373.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.3;neutrophil: 7.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 172.8;Hep G2: 313.8;MCF7: 268.3;OE19: 156.7;RT4: 164.9;U-2 OS: 166.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	3.4	0.1	0.8	6.4	0.3	0.9	32.9	0.6	0.8	27.1	0.3	67.1	64.0	6.6	61.8	51.9	46.6	22.7	0.4	0.5	0.4	76.3	1.5	19.2	0.4	0.7	0.6	0.3	55.9	62.4	34.8	16.2	0.4	30.8	63.4	0.1	41.5	24.0	0.3	42.1	54.8	3.0	0.3	0.6	59.1	9.6	0.7	4.2	58.8	0.3	9.5	23.4	19.1	0.6	144.2	71.1	0.4	10.4	0.0	0.0	65.0	0.2	0.0	2.3	1.6	172.8	82.1	0.4	64.7	1.2	43.4	97.6	0.1	109.0	3.2	0.6	1.0	6.7	48.5	313.8	1.3	0.3	0.8	0.2	81.6	3.9	0.1	5.0	0.0	0.4	0.3	0.6	1.2	268.3	0.6	1.8	31.4	156.7	0.0	2.4	9.3	0.7	2.7	164.9	67.3	0.2	0.0	120.0	0.6	34.6	123.3	0.4	0.0	0.4	166.7	0.9	2.2	0.4	0.9	1.4	0.2	0.4	0.2	4.3	0.4	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.6	0.0	1.4	0.2	0.0	2.7	0.8	0.3	0.6	0.8	0.5	0.4	0.7	0.6	0.4	0.3	0.7	0.6	0.4	28.9	34.8	0.0	1.9	6.9	19.2	68.9	13.1	0.0	49.3	30.0	0.5	47.1	64.2	86.5	0.0	123.0	0.5	112.2	137.0	141.3	43.4	52.4	5.4	1.7	74.4	0.0	0.3	115.8	101.0	1.5	73.4	57.7	2.5	0.0	0.7	0.0	9.8	0.0	0.2	95.5	97.6	0.8	0.0	19.9	1.5	2.6	3.6	0.0	1.7	0.0	0.0	0.0	0.2	130.2	125.6	0.7	0.0	37.6	162.0	373.6	61.5	0.0	0.0	0.0	6.2	16.9	4.1	39.1	13.1	66.1	2.8	0.0	131.4	48.3
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 subunit beta 1"	O00203	5	78002326-78294698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		38000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: AB_2679333"	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favorable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	21.5	21.5	21.1	19.6	26.1	21.9	21.3	22.3	26.4	20.7	23.0	24.1	19.8	17.8	53.9	30.8	15.8	15.9	19.0	19.6	23.4	30.3	15.9	17.2	22.5	23.4	24.4	13.0	24.9	29.3	40.4	19.6	24.5	16.9	28.3	8.8	26.4	16.4	15.8	22.5	20.8	20.5	23.3	21.6	23.0	13.2	23.6	23.2	27.2	13.0	24.8	20.1	21.9	26.5	51.3	40.3	45.4	63.1	53.2	64.5	39.5	56.3	66.1	50.1	67.5	31.4	44.1	53.7	32.5	69.4	41.7	36.6	45.0	94.1	62.7	61.7	31.7	37.4	33.9	55.5	31.1	33.7	47.1	46.2	34.0	42.3	42.5	47.7	64.1	10.9	27.3	34.3	86.9	31.6	43.4	52.2	24.1	37.4	23.9	45.2	80.2	74.4	72.7	47.5	16.0	25.7	52.3	33.7	49.7	37.1	40.9	55.6	65.0	37.4	29.1	45.4	57.4	26.3	43.3	36.3	48.5	48.5	48.4	18.3	12.6	11.3	9.6	12.5	10.6	31.3	8.0	10.0	17.2	40.1	6.6	8.8	15.4	9.6	17.3	14.2	10.4	8.1	21.1	26.1	22.3	26.4	19.6	23.4	23.4	24.4	24.5	23.3	23.6	26.5	31.6	44.8	33.7	82.3	59.0	15.8	22.1	28.1	22.8	16.2	18.8	14.1	29.0	10.0	37.5	31.3	22.9	30.9	37.1	36.9	25.4	35.8	12.0	27.7	38.8	33.3	19.2	27.3	59.7	38.0	38.7	32.0	35.2	40.8	32.9	26.1	23.2	17.0	39.5	20.2	57.3	34.1	26.4	41.9	24.8	20.2	15.8	47.3	26.6	118.0	66.5	21.5	32.0	86.5	231.0	43.5	25.0	16.6	44.0	20.7	30.0	27.2	29.8	27.5	26.3	36.2	28.5	16.1	10.1	28.9	23.4	29.8	39.9	31.2	28.0	22.2
AP3B2	NAPTB	ENSG00000103723	"Adaptor related protein complex 3 subunit beta 2"	Q13367	15	82659281-82710112	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.7;pituitary gland: 18.8;retina: 33.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039467, HPA039818"	Enhanced	Supported	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039467: AB_10795143, HPA039818: AB_10795299"	"unprognostic (3.17e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.48e-6)"	"unprognostic (8.44e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.43e-2)"	0.7	4.5	15.3	0.9	18.6	1.1	1.4	15.5	20.7	0.9	0.0	1.1	0.7	1.1	2.3	0.7	0.9	0.4	0.2	19.6	5.5	0.6	0.2	0.3	0.5	15.6	5.4	1.2	2.1	12.7	18.8	0.6	13.2	1.4	0.6	33.0	0.9	1.4	0.3	0.9	0.9	1.3	1.1	0.7	1.1	6.2	4.7	1.0	2.1	0.4	1.3	0.8	0.6	11.3	0.2	0.4	9.5	3.2	1.6	0.2	5.7	0.5	0.0	0.8	0.2	0.4	0.4	0.8	4.9	0.2	1.8	0.9	1.0	0.0	0.2	3.2	0.7	0.3	0.4	0.2	0.3	0.4	1.8	1.0	1.1	0.1	0.7	0.1	0.0	2.8	1.0	0.7	0.1	2.5	0.3	0.5	9.5	0.1	0.1	0.3	0.0	0.2	0.0	17.3	29.0	17.5	3.2	1.4	2.4	1.0	0.2	1.9	0.2	0.3	0.9	0.4	1.3	1.6	8.8	0.7	2.2	0.5	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.3	0.2	0.9	0.1	0.1	0.4	0.0	0.1	15.3	18.6	15.5	20.7	19.6	5.5	15.6	5.4	13.2	1.1	4.7	11.3	0.1	0.0	1.1	20.9	0.1	0.4	2.1	0.6	1.2	18.4	1.5	2.3	0.8	0.0	0.1	0.0	27.1	0.1	0.2	0.1	0.0	0.2	8.0	0.2	0.6	0.1	13.9	0.0	61.7	0.4	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	13.5	56.9	0.5	6.1	0.0	0.6	5.4	0.9	0.1	0.0	4.7	0.0	4.1	0.0	44.7	22.8	0.0	0.1	0.4	1.2	0.7	0.0	0.4	0.0	58.6	0.0	1.3	0.7	9.8	3.1	0.7	0.1	0.0	0.1	0.2	0.0	0.6
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438341-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 145.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 88.2;dendritic cells: 149.1;Kupffer cells: 117.7;Macrophages: 93.4;Microglial cells: 381.3;NK-cells: 134.9;T-cells: 125.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 182.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 101.0;MOLT-4: 87.7;REH: 195.4;U-698: 204.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	30.7	4.7	7.0	47.8	8.0	45.5	14.5	10.4	7.6	3.5	5.7	6.1	7.1	2.2	1.6	3.4	5.9	11.6	5.7	7.6	10.4	5.0	38.3	15.5	50.0	16.4	12.5	1.5	4.3	1.6	2.8	8.8	18.0	2.6	6.7	0.6	5.1	2.1	1.4	3.4	17.8	7.5	16.0	56.6	9.2	0.8	15.5	145.4	3.5	2.7	44.3	10.5	3.6	27.3	0.1	1.8	0.0	0.0	12.8	21.2	11.3	37.0	7.2	20.8	19.8	0.0	0.0	101.0	0.5	24.9	22.2	0.1	0.0	0.0	28.6	0.0	0.0	73.3	0.2	0.0	0.0	13.9	0.1	30.3	0.0	0.7	0.0	2.6	0.0	40.5	0.1	62.0	0.0	0.0	87.7	19.5	0.1	7.9	0.0	195.4	0.1	72.4	5.8	0.0	0.1	0.0	3.4	0.3	0.1	0.3	0.1	47.6	0.1	0.0	0.5	6.8	0.1	16.8	0.0	204.7	16.9	71.0	0.0	81.5	23.8	58.5	30.2	23.6	24.9	32.6	25.8	25.9	15.4	39.5	29.3	28.8	182.9	19.1	38.9	50.3	27.2	13.4	7.0	8.0	10.4	7.6	7.6	10.4	16.4	12.5	18.0	16.0	15.5	27.3	3.2	0.0	25.3	1.6	88.2	1.1	0.1	0.1	0.6	0.1	1.6	3.2	1.0	8.6	2.6	3.7	0.0	2.2	149.1	0.1	0.0	3.9	0.4	0.7	12.8	4.7	0.0	28.2	1.1	0.0	20.7	15.0	3.6	0.4	23.4	0.1	6.8	28.9	59.9	0.0	2.9	0.2	0.0	117.7	18.4	0.3	0.0	93.4	3.6	381.3	65.2	0.0	134.9	4.0	1.5	0.1	0.1	0.0	41.7	0.1	0.0	5.1	3.7	0.2	0.0	0.9	11.3	0.1	1.1	0.4	0.1	1.4	125.9	0.4	0.1	0.1
APC2	APCL	ENSG00000115266	"APC regulator of WNT signaling pathway 2"	O95996	19	1446302-1473244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 64.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 142.4;Bipolar cells: 50.4;Excitatory neurons: 26.8;Horizontal cells: 45.4;Inhibitory neurons: 27.5;Muller glia cells: 29.4;Oligodendrocyte precursor cells: 28.1"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;SCLC-21H: 9.3;SH-SY5Y: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"		Yes	No				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: AB_2686874"	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	0.1	2.4	41.5	0.0	27.3	0.0	0.0	41.4	42.4	0.1	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.3	37.1	20.8	0.0	0.0	0.0	0.0	64.5	42.3	0.0	0.3	0.0	6.2	0.0	54.9	0.1	0.0	2.7	0.2	0.0	0.2	0.1	0.4	0.1	38.3	0.0	0.3	1.0	54.6	0.0	0.1	0.0	0.0	0.1	0.2	49.0	0.2	0.6	7.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.0	0.0	1.0	0.1	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.0	9.3	31.7	1.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.6	0.1	0.1	1.7	0.5	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	27.3	41.4	42.4	37.1	20.8	64.5	42.3	54.9	38.3	54.6	49.0	0.3	0.0	0.0	142.4	0.3	0.0	0.2	0.2	1.2	50.4	0.4	0.4	3.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.5	0.5	0.5	0.0	0.0	26.8	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	45.4	27.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.7	0.0	29.4	2.1	28.1	17.8	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	11.1	0.0	0.6	0.4	0.4	0.7	2.4	0.0	0.0	0.3	0.2	0.1	0.2
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879792	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 1201.6"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 147.1;Horizontal cells: 161.5;Oligodendrocytes: 461.3"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 81.6;AN3-CA: 162.9;HMC-1: 76.0;SCLC-21H: 87.2;SH-SY5Y: 89.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		6400000	"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavorable (2.65e-5)"	3.0	31.5	417.1	3.1	718.0	0.4	1.4	680.9	552.4	3.1	218.6	4.4	1.8	3.1	1.3	1.5	2.7	5.5	10.8	438.3	465.8	4.9	0.6	1.9	1.4	783.2	627.4	1.4	75.0	22.3	151.4	0.9	710.7	2.1	2.2	56.3	1.8	1.9	0.5	1.1	2.1	3.2	605.9	0.5	28.1	13.1	598.3	0.8	1.5	0.5	1.5	1.2	2.1	1201.6	4.4	40.0	81.6	162.9	7.1	3.2	10.4	5.6	3.5	7.8	1.1	7.3	6.3	0.8	66.5	21.0	27.7	2.2	26.1	2.6	5.2	48.9	3.7	0.3	10.6	5.2	2.0	0.2	76.0	3.6	1.8	3.2	0.1	28.8	3.1	6.1	2.7	1.2	25.0	8.3	0.2	0.3	3.9	16.5	16.5	7.2	0.4	1.1	1.4	1.1	87.2	89.3	23.1	3.8	0.8	23.9	20.8	4.3	1.3	61.3	28.8	32.9	4.3	2.4	1.6	0.3	42.3	1.1	33.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	417.1	718.0	680.9	552.4	438.3	465.8	783.2	627.4	710.7	605.9	598.3	1201.6	2.5	6.4	0.0	12.4	0.6	1.3	2.6	0.7	1.2	147.1	0.4	1.1	6.2	1.5	0.2	0.0	12.5	0.3	0.3	0.4	0.0	2.0	27.6	1.3	1.2	2.8	34.9	0.0	55.5	4.2	6.4	2.8	10.2	3.2	0.0	0.1	0.7	0.4	0.4	161.5	46.8	1.1	2.0	0.3	1.6	15.8	1.2	1.1	5.4	12.2	0.0	14.6	0.0	19.1	461.3	3.1	0.1	0.0	0.4	1.9	0.0	0.1	0.2	38.6	0.0	1.9	1.8	14.5	28.7	0.1	0.6	0.4	0.5	0.1	0.2	1.3
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 93.9;lymphoid tissue: 48.3;urinary bladder: 24.4"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	20.9	0.5	93.9	0.8	0.7	1.1	2.2	0.8	1.5	1.4	0.4	0.3	12.2	4.2	6.3	1.4	0.9	0.5	0.7	2.0	13.4	1.1	0.6	0.4	0.2	1.5	0.4	0.3	3.5	0.7	0.4	0.6	0.2	6.7	0.3	0.5	0.6	0.8	1.7	0.3	48.3	1.1	0.2	0.5	2.4	1.0	3.7	21.1	24.4	10.3	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.7	1.1	0.9	0.5	0.6	0.4	0.7	0.3	0.5	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;intestine: 12.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 256.0;Karpas-707: 283.6"									"HPA056980, HPA066719"			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favorable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	0.9	1.2	0.1	5.7	0.1	28.4	2.0	0.1	0.2	1.2	0.1	12.1	7.3	1.0	0.4	3.0	0.7	1.1	0.8	0.1	0.1	2.7	1.1	1.9	5.9	0.1	0.1	0.7	3.3	1.2	0.2	1.6	0.1	0.4	12.0	0.3	2.8	0.2	0.4	2.1	4.3	1.4	0.1	6.4	4.1	0.3	0.2	2.5	1.3	0.2	8.6	7.6	1.5	0.2	256.0	28.0	10.5	68.1	1.5	6.0	18.6	23.0	19.7	43.0	56.5	54.7	46.6	3.0	20.4	22.9	63.0	108.2	1.3	4.5	43.1	92.1	2.5	72.5	5.6	14.0	0.7	61.7	43.0	2.3	0.5	45.1	2.2	8.9	17.0	0.0	41.6	283.6	68.1	6.9	0.2	35.3	0.3	24.6	25.2	1.8	105.0	95.6	9.1	42.2	1.8	0.0	0.0	0.3	16.0	1.8	33.0	18.1	10.2	48.0	81.9	7.5	0.7	62.8	18.0	0.3	34.4	68.2	100.7	0.4	1.0	0.0	0.2	4.9	0.0	7.2	0.5	0.3	0.6	3.1	0.0	0.3	1.4	1.7	1.7	0.0	2.8	3.5	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	1.7	0.0	2.2	5.4	3.2	11.8	0.6	0.0	1.5	0.5	0.3	0.0	8.1	0.0	0.0	1.0	0.4	4.6	0.0	14.7	0.0	5.9	0.6	0.2	0.0	14.1	0.0	1.8	1.8	0.8	3.1	5.3	0.0	0.8	0.4	0.0	2.1	0.0	0.0	0.4	10.2	1.2	6.3	0.0	0.0	2.3	7.2	0.0	1.4	0.0	0.0	0.0	0.0	6.0	9.9	0.0	26.2	1.4	0.4	0.3	9.3	0.0	0.0	0.0	0.9	0.0	0.0	4.2	3.3	0.8	0.5	0.1	1.6	11.4
APOL3	"APOLIII, CG12-1"	ENSG00000128284	"Apolipoprotein L3"	O95236	22	36140330-36166177	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 59.1;Endothelial cells: 69.8;Hepatic stellate cells: 69.7;Kupffer cells: 38.7;NK-cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;ASC TERT1: 54.1;HDLM-2: 25.6;Karpas-707: 59.0"														"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"prognostic favorable (6.82e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (7.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	58.2	12.3	10.1	25.4	10.0	10.1	43.7	8.7	12.2	17.2	7.6	16.3	15.0	18.8	12.3	12.0	24.4	14.3	33.7	8.8	9.1	19.0	39.9	42.0	43.4	11.4	10.1	9.6	6.3	3.4	8.5	16.3	10.0	18.4	11.4	0.6	15.7	14.9	16.6	19.6	21.7	16.0	8.8	47.6	12.3	2.9	10.8	18.1	25.2	19.6	20.8	17.6	19.5	8.7	4.3	0.0	0.0	0.1	34.1	54.1	1.8	1.8	10.2	3.1	7.0	0.0	9.5	2.1	0.4	5.0	4.6	0.7	0.0	1.3	1.9	25.6	0.0	9.2	1.3	2.1	18.3	0.1	2.6	11.4	0.0	9.0	0.4	2.1	22.1	2.0	0.2	59.0	1.1	0.1	11.7	0.3	0.1	0.0	0.5	16.9	0.0	1.3	0.3	3.0	0.2	0.1	6.0	4.2	0.1	0.0	0.0	1.2	16.2	1.5	0.6	1.7	0.5	15.6	10.8	0.1	3.7	3.5	1.5	8.3	19.1	0.8	16.9	23.4	27.3	9.7	14.4	17.5	15.4	8.0	13.4	14.3	2.3	18.5	24.6	0.5	14.7	17.2	10.1	10.0	8.7	12.2	8.8	9.1	11.4	10.1	10.0	8.8	10.8	8.7	59.1	3.2	8.6	1.6	21.1	5.0	4.3	3.9	2.2	0.0	5.8	4.2	7.9	8.6	4.3	3.7	0.0	1.9	16.0	0.3	0.0	2.5	0.9	1.8	4.7	69.8	0.0	20.6	0.0	1.6	1.2	18.8	7.1	1.3	9.5	2.0	69.7	20.6	6.9	0.0	0.0	7.5	2.0	38.7	10.6	1.4	24.2	19.6	3.6	9.4	29.2	0.7	46.4	0.0	0.0	3.0	0.1	9.8	15.3	10.4	5.3	2.8	4.2	0.3	13.1	3.2	10.1	0.2	0.3	4.1	4.1	0.8	31.5	4.3	2.3	4.7
AQP12B	INSSA3	ENSG00000185176	"Aquaporin 12B"	A6NM10	2	240676418-240682906	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	334	"pancreas: 209.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042216	Supported					NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 45: Enterocytes - Digestion"			"HPA042216: AB_2677905"			"unprognostic (1.30e-1)"							"unprognostic (2.87e-2)"	"unprognostic (1.68e-1)"			"unprognostic (3.41e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	209.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228932	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	641	"intestine: 330.0;pancreas: 1280.1"	"Group enriched"	"Detected in some"	45	"Distal enterocytes: 1005.1;Paneth cells: 379.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.4;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.3	0.2	0.6	0.4	0.7	0.4	0.3	0.7	0.8	0.5	0.3	330.0	0.2	0.5	0.0	0.1	0.3	0.0	0.2	0.7	0.5	0.2	0.7	0.1	0.0	0.4	0.4	0.6	1280.1	0.0	0.1	0.1	0.4	0.3	160.3	0.1	0.1	0.3	0.1	0.4	0.2	1.2	0.4	0.1	0.8	0.5	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.8	0.7	0.5	0.4	0.4	0.4	0.4	0.6	0.6	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1005.1	0.0	0.1	1.4	0.2	1.3	0.1	13.1	0.0	0.8	11.0	0.1	0.0	0.0	0.3	8.9	0.4	0.0	0.0	0.1	1.7	0.6	15.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	379.5	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.4	1.7	0.2	12.9	0.1
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 702.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 313.9;Macrophages: 82.1"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Immune cell enriched"	"Detected in many"	20	"neutrophil: 1161.4"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 1161.4"	"Cell line enriched"	"Detected in some"	29	"U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA074762, CAB075684"	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	18.2	0.8	0.8	72.9	0.9	67.5	2.4	0.9	14.4	1.3	0.8	0.9	0.2	1.2	43.4	1.2	7.1	5.3	1.7	3.2	0.5	0.9	702.7	22.2	0.6	0.7	1.0	0.5	1.6	5.6	0.3	6.2	4.0	0.9	0.3	0.4	1.1	0.7	0.5	22.0	0.9	6.4	0.6	42.7	1.5	0.3	6.9	1.8	0.6	7.5	0.8	32.6	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.2	58.4	1.2	0.1	17.5	0.1	0.5	0.1	0.0	1.8	0.1	0.1	0.0	1161.4	0.3	23.0	0.6	0.3	18.9	0.8	0.9	0.9	14.4	3.2	0.5	0.7	1.0	4.0	0.6	6.9	0.8	0.7	0.0	12.2	0.3	2.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	5.7	3.1	0.0	0.0	0.3	0.5	0.0	0.0	0.1	2.1	0.3	0.1	0.7	0.0	13.9	2.4	0.2	0.9	1.9	0.0	1.8	7.6	0.0	7.9	313.9	40.8	0.0	0.8	0.0	0.0	28.5	6.2	1.9	0.3	82.1	0.0	0.0	18.9	0.0	1.0	0.5	0.2	0.5	0.0	0.0	0.7	0.2	0.0	0.3	1.5	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.8	1.5	0.0	0.0	0.1
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445136-74455005	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.9;placenta: 328.8;urinary bladder: 145.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 67.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 11.8;NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in many"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	48.1	4.6	0.1	36.7	0.1	129.9	61.6	0.1	0.8	19.2	1.8	18.7	3.3	3.7	0.2	43.4	13.2	74.1	20.5	0.3	0.1	2.5	4.0	36.1	1.9	0.3	0.2	12.4	4.5	1.5	9.5	328.8	0.8	6.5	18.9	0.1	11.7	0.7	18.4	15.3	10.2	6.5	0.2	10.0	20.2	9.3	0.4	7.1	5.4	0.8	3.0	145.6	13.8	0.4	15.9	107.3	0.0	0.0	0.9	1.4	0.0	3.2	5.0	0.7	2.9	379.0	59.8	0.0	8.0	0.0	0.0	17.4	0.1	648.1	6.5	0.1	0.0	0.4	2.8	18.0	191.9	2.3	0.4	5.9	644.0	37.8	1365.7	0.9	0.2	0.4	1.6	0.7	14.4	416.8	0.2	0.0	0.0	78.6	42.8	0.0	0.1	0.1	36.4	2.9	0.5	0.2	22.2	1.2	0.0	0.4	11.6	0.1	1.0	0.0	15.3	5.3	0.1	0.9	0.0	0.1	0.0	0.0	1.7	11.0	0.0	11.8	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.3	0.2	0.0	0.1	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.3	0.2	0.8	0.2	0.4	0.4	670.0	198.7	301.9	0.0	190.7	1119.1	1254.3	73.0	303.9	0.0	801.5	460.2	49.0	62.9	183.9	51.5	0.0	1.8	836.1	878.0	0.0	61.8	70.4	167.7	12.3	32.2	41.6	18.5	0.0	10.2	1.5	80.8	254.9	193.1	680.5	0.9	10.8	4.2	32.2	0.0	0.5	393.5	8.2	250.4	196.4	12.1	0.3	1271.1	33.8	0.0	1.7	0.8	20.6	0.0	0.0	497.1	909.8	1.2	352.1	115.3	55.7	0.7	53.3	0.2	19.7	10.3	20.2	68.3	51.1	194.5	342.4	1.1	473.6	1.2	308.9	2102.9
ARF3		ENSG00000134287	"ADP ribosylation factor 3"	P61204	12	48935723-48957487	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.99e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	63.1	73.4	113.5	79.9	151.8	66.7	53.1	53.9	154.2	66.9	31.4	98.0	57.7	59.8	71.0	79.5	59.2	46.6	45.2	167.5	102.3	85.6	45.9	71.0	50.6	70.1	77.1	47.3	46.3	138.1	75.2	58.6	71.7	55.2	89.0	78.0	55.1	59.2	16.9	68.2	65.4	72.0	70.2	60.7	55.3	48.9	128.4	73.3	69.5	16.7	69.8	64.8	51.0	100.4	212.1	305.2	131.0	116.7	106.5	77.4	124.8	137.8	173.0	158.5	136.4	407.0	272.1	168.6	201.4	151.2	124.4	171.7	182.9	186.8	142.4	206.8	94.2	274.5	243.0	118.3	66.5	212.1	213.5	87.4	145.2	172.8	102.3	172.1	170.9	111.8	170.4	89.0	137.1	256.7	158.1	116.7	185.4	338.5	162.4	150.4	75.0	111.6	173.3	265.7	134.7	122.7	148.6	171.2	129.7	144.4	290.1	167.1	238.8	117.3	187.1	74.2	87.3	86.0	210.4	123.0	154.7	162.0	68.4	5.7	39.0	27.7	13.5	25.2	10.6	13.1	15.6	16.8	52.1	12.7	8.4	9.8	54.8	18.7	17.1	40.2	14.0	21.3	113.5	151.8	53.9	154.2	167.5	102.3	70.1	77.1	71.7	70.2	128.4	100.4	35.8	25.6	33.2	19.6	31.4	60.3	41.5	92.2	61.5	34.5	60.2	40.6	10.1	54.3	47.4	99.3	10.4	56.4	54.4	228.4	66.5	114.8	49.9	41.3	31.8	55.0	70.8	26.5	44.3	90.7	119.8	42.7	34.1	48.9	27.9	59.5	57.5	48.7	132.8	43.7	36.8	71.5	75.3	86.9	81.2	101.9	40.7	79.9	44.4	18.7	128.1	57.4	50.4	14.6	20.6	103.2	176.3	37.2	37.6	60.5	78.9	143.3	45.8	24.1	32.9	24.0	52.3	52.6	63.8	61.6	65.8	69.0	31.3	43.2	67.3	56.7
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639941	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.2;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.7	0.9	2.0	7.9	2.5	24.2	1.7	2.1	2.1	1.5	1.2	7.5	6.1	1.5	1.0	5.3	0.8	1.7	0.7	1.7	1.9	0.6	1.3	1.7	13.5	2.6	3.0	0.6	2.6	1.2	0.7	4.3	2.6	0.6	8.8	0.5	1.2	0.5	0.9	4.4	7.6	4.8	2.5	2.8	3.6	8.6	2.2	26.1	1.3	0.4	14.3	2.8	1.9	3.0	80.8	69.4	73.1	46.2	5.0	13.0	39.6	78.5	50.2	80.0	63.3	52.2	41.5	43.5	23.7	49.9	91.3	56.9	55.3	43.8	110.9	83.5	27.4	132.6	68.9	33.5	2.0	103.8	55.5	4.3	5.5	61.6	50.9	15.2	61.5	94.4	101.0	112.7	95.3	31.7	58.6	39.7	44.6	71.6	44.5	67.8	141.7	38.2	28.4	41.6	64.7	44.5	72.9	46.2	17.6	37.6	63.6	115.8	35.3	102.5	74.1	42.0	87.2	38.3	63.7	123.7	44.4	129.1	91.8	0.1	0.3	0.8	0.5	0.5	0.2	0.3	1.0	0.9	0.4	0.2	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.3	2.0	2.5	2.1	2.1	1.7	1.9	2.6	3.0	2.6	2.5	2.2	3.0	0.7	0.0	2.3	0.3	4.6	4.8	1.1	2.4	2.2	0.2	1.3	1.7	0.9	4.3	1.9	1.8	0.0	9.8	2.9	6.2	0.0	0.8	4.7	3.8	2.6	2.0	0.0	38.7	1.0	0.8	23.7	3.5	8.6	2.8	0.0	21.1	1.8	2.1	9.5	0.0	0.6	7.8	0.0	6.5	4.2	5.0	0.6	3.5	0.0	1.0	3.9	0.1	2.1	0.5	1.4	0.5	2.9	0.4	18.6	1.4	1.1	0.4	1.4	1.0	6.6	1.4	3.3	24.7	22.6	10.5	2.3	3.1	5.4	2.0	14.1	2.1
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARHGAP17	"FLJ10308, FLJ13219, NADRIN, RICH1, WBP15"	ENSG00000140750	"Rho GTPase activating protein 17"	Q68EM7	16	24919389-25015666	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041703, HPA075891"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		21000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA041703: AB_10794304, HPA075891: "	"unprognostic (1.79e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (3.02e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.81e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.76e-4)"	46.0	40.5	8.2	15.2	9.8	9.2	37.2	9.2	10.2	29.9	9.6	32.7	11.3	28.9	7.9	33.6	28.6	11.9	48.1	7.9	9.2	25.9	22.9	31.8	24.9	10.6	9.5	24.8	24.1	9.3	30.3	15.3	10.4	23.6	12.2	2.3	21.3	7.9	41.0	34.3	39.2	11.6	8.7	66.8	28.9	25.5	9.7	12.0	28.2	11.1	20.9	25.6	29.8	11.6	28.5	16.7	21.9	23.1	22.0	23.0	23.7	18.1	19.3	20.9	20.4	25.9	11.5	13.0	12.0	36.4	19.9	7.7	21.8	12.8	22.2	20.0	26.1	10.8	37.8	43.3	25.0	15.5	10.7	29.4	7.7	22.6	16.3	15.0	35.7	11.7	14.3	0.0	23.6	20.8	14.3	19.8	25.2	8.1	13.7	68.1	17.9	5.2	25.9	6.4	14.6	14.5	18.6	20.5	8.2	17.5	11.1	40.2	46.7	15.5	11.9	35.6	15.1	13.0	17.3	7.5	19.1	22.6	14.1	5.6	9.7	9.0	6.3	17.5	5.7	25.3	5.5	6.3	14.6	22.8	6.2	6.1	4.8	6.2	15.8	25.9	8.0	8.1	8.2	9.8	9.2	10.2	7.9	9.2	10.6	9.5	10.4	8.7	9.7	11.6	33.8	9.6	11.0	26.8	46.3	14.5	6.8	8.9	14.2	6.4	11.0	9.7	24.9	7.2	9.1	5.5	10.4	11.1	36.3	49.5	3.9	13.3	6.3	30.6	21.8	32.3	21.0	16.2	28.8	16.0	18.9	16.0	15.3	66.4	7.0	16.9	26.7	6.8	27.1	10.1	33.0	21.8	8.2	30.3	21.7	10.8	13.4	25.2	16.0	59.0	22.8	6.4	14.4	40.2	68.9	17.6	27.2	11.7	11.5	11.1	35.4	5.0	8.5	7.5	26.3	15.5	43.8	7.0	11.7	24.7	24.0	15.7	21.1	15.9	19.7	12.2
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 440.8;Endothelial cells: 298.6;Prostatic glandular cells: 593.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	12	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"A-431: 118.8;hTERT-HME1: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	32.9	3.7	7.0	2.8	5.5	0.1	30.3	22.5	8.0	8.8	7.3	9.4	2.1	7.4	5.3	4.5	10.2	6.5	19.2	4.6	5.5	23.7	16.8	27.1	4.9	6.8	6.1	10.2	7.4	6.5	6.2	17.4	7.1	11.2	3.2	14.9	12.1	7.0	11.6	14.7	6.4	5.6	6.4	21.7	10.4	5.8	8.6	3.0	22.8	12.7	2.8	8.0	9.3	5.1	118.8	4.8	7.0	0.1	26.7	57.5	24.5	38.6	62.9	31.0	45.1	13.7	5.4	0.0	85.2	76.5	36.3	24.8	0.2	27.4	63.9	0.1	4.1	0.4	6.6	7.6	2.7	0.0	0.0	11.7	5.4	23.7	100.9	36.4	88.0	0.1	0.0	0.0	32.1	4.7	2.2	0.1	9.0	0.6	82.1	1.4	5.6	0.0	82.7	10.8	0.1	1.5	24.1	20.5	2.0	26.5	5.6	0.4	84.2	20.0	26.2	29.7	32.3	0.1	0.1	0.2	3.7	0.0	0.9	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	7.0	5.5	22.5	8.0	4.6	5.5	6.8	6.1	7.1	6.4	8.6	5.1	440.8	51.3	18.4	26.4	2.9	23.5	239.2	31.7	4.6	16.0	87.3	46.1	26.0	31.5	39.6	130.6	18.8	29.5	2.0	0.9	54.8	83.5	94.1	36.9	11.4	298.6	0.0	3.2	11.3	17.2	102.6	63.6	20.9	106.2	3.8	13.8	177.1	56.1	3.0	92.5	24.1	1.0	6.1	13.6	17.9	24.4	24.5	6.2	26.6	208.9	2.5	94.2	0.0	2.0	3.5	55.7	0.1	21.8	0.1	593.9	0.1	78.1	12.5	81.2	190.7	58.2	127.8	80.3	116.5	1.7	17.2	14.1	4.1	11.1	1.6	146.9
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.6;lymphoid tissue: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 71.6;dendritic cells: 103.4;Kupffer cells: 77.8;Macrophages: 79.1;monocytes: 133.0;NK-cells: 268.8;T-cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 118.2;HL-60: 92.5;HMC-1: 123.4;Karpas-707: 93.1;MOLT-4: 75.8;THP-1: 90.9;U-266/70: 138.6;U-266/84: 97.7;U-698: 97.9;U-937: 72.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	12.1	4.9	3.1	55.9	3.6	57.6	5.3	3.7	4.3	3.4	3.3	8.1	9.5	2.9	2.8	14.1	4.5	10.2	2.8	2.9	3.6	3.4	6.6	25.2	77.0	6.1	4.5	2.0	2.4	1.4	1.8	7.0	5.4	3.4	8.4	0.6	6.4	2.3	2.6	19.8	23.9	8.0	5.0	75.5	11.6	2.3	6.3	63.7	2.9	2.7	61.2	13.8	6.5	6.8	0.8	0.1	0.2	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.3	1.2	118.2	0.6	0.0	0.1	2.3	0.0	0.0	0.2	55.3	0.2	39.7	0.2	0.0	0.0	92.5	123.4	0.0	1.2	0.1	0.0	0.1	0.0	56.8	0.3	93.1	0.0	1.0	75.8	21.3	0.1	0.7	0.1	46.8	0.6	1.6	0.0	1.0	0.7	0.3	0.2	0.7	0.2	0.7	0.8	90.9	0.9	0.1	0.7	0.2	0.5	138.6	97.7	97.9	0.4	72.3	0.1	7.1	29.6	33.1	32.9	32.2	25.1	11.9	21.9	27.1	21.8	12.6	17.9	25.0	48.5	19.3	46.4	15.0	23.8	33.5	3.1	3.6	3.7	4.3	2.9	3.6	6.1	4.5	5.4	5.0	6.3	6.8	1.5	3.2	20.5	0.3	71.6	5.6	3.3	6.8	0.0	0.5	5.2	2.9	1.3	2.8	13.8	0.0	4.2	0.6	103.4	0.5	0.0	3.4	2.2	6.6	1.2	2.3	0.0	14.5	0.3	6.0	1.9	1.9	3.1	13.7	68.3	0.0	6.1	1.7	55.5	0.0	0.3	0.4	8.2	77.8	44.6	0.7	0.3	79.1	5.4	14.0	133.0	0.1	268.8	0.5	1.2	12.5	0.2	0.0	49.8	5.4	0.0	0.5	15.3	3.0	0.0	1.0	1.9	0.1	0.1	9.9	24.6	4.5	105.1	0.2	0.5	16.7
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 48.1;Cytotrophoblasts: 40.1;dendritic cells: 62.7;Extravillous trophoblasts: 56.6;Hofbauer cells: 40.0;monocytes: 72.4;Syncytiotrophoblasts: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 73.7;Karpas-707: 100.4;RPMI-8226: 74.7;THP-1: 92.3;U-266/70: 130.8;U-937: 72.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	11.2	5.5	3.6	43.1	3.4	68.3	5.5	4.4	7.5	4.2	5.1	12.4	7.2	3.5	0.5	5.5	6.7	5.0	4.4	3.3	4.4	7.8	7.4	39.5	58.4	9.1	5.4	2.0	2.7	0.8	4.5	6.0	6.9	5.9	2.6	8.7	6.4	1.5	2.1	3.9	53.2	2.2	7.6	106.1	10.9	3.5	8.1	32.9	9.0	0.8	18.6	6.6	5.5	11.4	11.2	2.1	0.1	12.1	0.0	0.0	27.8	0.1	0.0	0.0	0.0	29.2	13.9	73.7	3.0	0.0	0.4	9.6	2.1	0.6	0.0	54.7	1.0	10.1	22.6	3.5	0.4	48.6	56.2	0.0	2.9	0.1	0.0	0.0	0.1	46.8	6.8	100.4	0.0	0.6	54.5	43.4	7.6	1.9	5.4	52.0	0.3	74.7	0.0	0.2	0.6	0.2	16.8	0.0	4.5	0.7	3.5	92.3	4.8	0.2	1.9	0.2	0.3	130.8	60.2	58.8	0.3	72.1	5.4	6.7	24.4	25.3	45.7	21.2	38.8	15.9	52.2	54.1	22.5	18.3	68.9	53.6	37.0	28.0	20.9	13.3	43.5	59.8	3.6	3.4	4.4	7.5	3.3	4.4	9.1	5.4	6.9	7.6	8.1	11.4	2.0	48.1	8.4	0.0	17.8	0.0	0.0	0.0	0.0	0.0	15.2	11.0	0.0	0.0	1.8	11.0	0.0	40.1	62.7	0.0	0.0	2.6	0.0	4.5	0.7	1.6	0.0	0.0	0.0	3.8	56.6	1.3	0.0	3.5	3.8	0.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	72.4	0.0	0.0	0.0	0.0	7.8	0.0	0.0	15.2	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	75.5	30.2	0.1	0.0	0.0
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	280450-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 249.4;pancreas: 112.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	4.5	2.8	116.5	1.1	138.7	0.2	1.3	118.2	249.4	0.5	49.9	5.9	16.7	0.1	0.9	0.5	0.5	0.1	10.2	130.1	121.2	0.3	0.2	0.5	0.0	110.3	106.1	0.3	112.7	0.6	10.1	2.2	109.8	0.9	0.4	4.0	0.4	0.3	1.9	0.2	6.9	0.6	84.9	0.1	26.8	3.6	112.6	0.0	0.3	1.4	0.4	0.4	1.1	134.9	0.0	0.8	0.2	2.9	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	26.6	0.0	0.4	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.3	0.0	1.8	0.1	0.0	34.9	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.3	0.0	0.0	10.9	13.9	0.2	0.1	0.0	0.4	2.6	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.5	138.7	118.2	249.4	130.1	121.2	110.3	106.1	109.8	84.9	112.6	134.9	0.1	0.0	0.0	12.1	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.3	1.4	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.4	0.1	1.2	2.7	27.8	11.7	0.2	2.5	6.1	0.0	0.0	0.2	1.4	0.0	0.4	0.0	32.1	3.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	8.4	0.0	2.2	0.0	6.6	10.9	3.9	3.9	0.0	0.0	0.1	64.0	0.1	0.0	3.7	0.0	0.0	0.4	0.2	3.9	0.0	0.0	0.4	0.0	0.0	7.0	0.1
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322514	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.7;breast: 41.6"	"Group enriched"	"Detected in some"	4	"Adipocytes: 66.4;Endothelial cells: 48.9;Hepatic stellate cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	48	"HUVEC TERT2: 40.4;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044443, HPA063495"			Supported	"Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA044443: AB_10960424, HPA063495: AB_2685023"	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.7	5.9	4.6	4.1	4.2	0.0	41.6	4.1	4.7	8.7	3.0	6.9	3.1	10.9	1.6	4.8	9.8	7.3	35.5	4.1	4.1	15.8	2.9	22.1	3.1	4.7	4.5	3.8	4.2	3.4	4.0	14.7	4.8	8.0	2.0	0.2	5.1	3.5	13.2	7.7	6.5	7.2	4.0	7.9	6.9	2.2	5.2	1.6	12.4	10.9	1.8	12.3	8.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	49.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.2	4.1	4.7	4.1	4.1	4.7	4.5	4.8	4.0	5.2	3.6	66.4	0.0	3.0	0.3	0.5	2.8	0.3	0.0	0.6	0.8	0.5	0.4	8.9	2.8	0.0	1.8	0.0	0.0	0.2	0.1	0.0	0.0	3.3	0.4	0.2	48.9	0.0	0.0	0.2	0.0	0.1	1.0	0.0	1.3	0.0	0.0	37.1	0.0	0.1	0.0	0.5	0.0	0.0	1.4	2.8	4.4	0.0	0.5	7.2	11.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.1	0.0	1.6	1.5	0.4	0.2	0.2	1.0	0.1	0.3	0.7	0.0	0.3
ARHGEF38	FLJ20184	ENSG00000236699	"Rho guanine nucleotide exchange factor 38"	Q9NXL2	4	105552620-105708093	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 7.8;pancreas: 6.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 48.5;Breast glandular cells: 17.9;Respiratory ciliated cells: 31.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.8;RPTEC TERT1: 14.3;SK-BR-3: 8.0;T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036510, HPA045484"	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Centrosome	"HPA036510: AB_10672357, HPA045484: AB_2679345"	"unprognostic (1.49e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.47e-3)"	"unprognostic (2.79e-1)"	"unprognostic (6.14e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.16e-8)"	"unprognostic (2.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.19e-3)"	"unprognostic (6.45e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	7.8	0.0	0.0	2.5	0.0	2.6	1.9	0.2	5.5	0.1	0.6	3.2	0.0	0.0	0.0	3.9	0.1	3.6	0.0	0.0	0.0	0.0	6.5	0.0	2.0	0.0	0.0	5.7	4.2	0.0	4.9	0.4	0.3	0.5	2.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	48.5	0.0	0.2	0.0	1.1	1.1	0.0	0.0	17.9	6.1	1.8	4.3	12.6	12.9	0.0	0.2	0.2	9.8	9.8	6.8	1.9	12.6	0.5	0.3	8.4	0.0	0.3	5.8	0.1	0.3	9.2	7.8	0.0	0.0	0.0	0.1	0.1	0.0	0.3	14.8	10.2	0.0	0.2	0.4	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	2.4	6.4	0.0	0.1	9.4	4.8	0.5	31.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.8
ARHGEF6	"alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136780932	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	44.0	16.2	23.4	30.5	24.4	31.4	23.5	25.0	19.5	10.7	11.6	13.2	7.5	12.9	5.3	7.6	7.0	17.3	32.9	25.2	26.9	6.7	8.5	25.6	41.8	26.8	29.2	16.5	3.9	10.3	6.2	46.9	27.8	7.8	11.1	4.6	8.7	8.8	68.7	6.2	14.4	16.6	29.0	39.4	12.3	3.8	26.5	51.4	5.6	54.7	39.6	14.3	8.7	30.1	1.1	0.0	5.1	0.0	11.2	28.5	0.1	1.6	9.5	1.5	8.2	0.0	0.0	5.5	2.3	8.0	7.8	0.8	6.1	0.0	1.5	28.1	2.0	117.6	0.1	0.0	4.2	153.7	532.0	30.9	0.1	5.4	0.1	10.1	3.0	152.7	0.5	22.1	20.4	0.2	70.6	88.4	4.9	0.0	2.3	26.6	37.2	0.1	1.6	29.5	0.3	6.7	0.2	1.2	4.0	2.6	3.5	61.2	0.5	7.6	1.2	9.3	7.2	3.6	0.1	57.3	35.1	158.2	10.1	57.2	16.4	71.3	13.8	18.9	16.0	6.2	15.4	11.3	19.1	5.4	13.7	12.3	9.1	12.4	16.1	6.0	21.5	15.3	23.4	24.4	25.0	19.5	25.2	26.9	26.8	29.2	27.8	29.0	26.5	30.1	18.1	6.4	8.9	57.1	22.4	1.1	0.9	0.8	1.2	0.8	16.1	10.8	60.0	0.0	2.4	1.8	0.0	0.3	23.6	0.1	1.9	0.6	12.0	0.9	2.4	13.2	0.0	11.3	20.6	1.8	0.4	10.7	5.6	1.6	193.9	128.2	12.5	2.5	15.2	13.5	21.6	0.4	0.0	46.5	25.1	35.8	14.9	40.3	3.6	77.8	36.1	4.7	36.0	48.2	4.3	0.7	0.0	14.7	12.8	0.4	0.0	0.2	2.2	0.3	13.1	33.5	18.5	0.7	0.7	0.6	1.7	0.4	40.5	30.1	0.1	0.7
ARID5B	"FLJ21150, MRF2"	ENSG00000150347	"AT-rich interaction domain 5B"	Q14865	10	61901684-62096944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 968.2;Syncytiotrophoblasts: 920.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 115.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015037	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Cytosol"	"HPA015037: AB_1845015"	"unprognostic (3.31e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.75e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-2)"	50.0	8.1	2.9	21.2	5.8	6.9	34.3	3.2	11.3	37.2	20.7	17.5	10.2	39.0	4.6	20.2	20.6	39.3	18.3	4.4	1.6	21.4	8.3	18.3	18.8	7.8	6.9	17.5	6.2	13.3	10.0	21.0	11.4	18.3	11.7	4.1	15.8	10.2	87.2	18.1	14.2	42.5	0.9	16.9	11.5	6.9	9.0	13.1	7.8	11.9	16.7	30.9	19.6	9.7	2.2	0.9	6.0	14.7	13.0	34.0	1.2	42.9	115.2	29.9	23.3	52.7	2.3	3.9	10.1	41.4	4.3	14.3	20.6	6.5	36.0	13.7	6.1	2.1	10.4	13.5	23.9	0.6	25.2	43.3	3.4	17.6	20.2	26.2	3.9	7.5	1.9	5.7	9.9	7.7	14.4	1.1	1.1	10.2	13.5	17.7	9.8	1.1	20.1	23.9	3.3	4.4	19.2	10.6	12.8	13.1	8.7	0.7	3.3	16.5	22.0	25.1	10.9	0.4	0.0	11.4	14.3	0.8	5.4	9.6	1.2	0.8	13.3	2.8	1.8	37.5	19.7	11.8	2.2	41.2	12.8	8.4	2.2	12.3	8.2	1.0	30.9	5.4	2.9	5.8	3.2	11.3	4.4	1.6	7.8	6.9	11.4	0.9	9.0	9.7	86.2	131.4	70.7	54.5	199.8	968.2	453.9	111.3	105.9	54.4	112.8	96.6	72.8	27.1	96.3	51.5	0.0	187.8	89.1	7.5	99.7	56.1	31.7	164.7	231.0	134.1	36.4	5.2	167.8	14.6	150.7	343.6	21.4	457.7	24.6	37.6	119.2	7.4	51.0	74.0	181.9	18.7	22.4	44.1	162.4	20.1	151.6	43.6	138.7	34.7	39.0	17.2	58.7	74.4	155.8	41.1	25.2	60.5	234.5	193.7	5.4	304.8	38.4	3.6	131.5	496.3	463.9	8.2	5.8	65.7	477.8	920.4	178.2	24.3	41.7	233.9
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628507-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Hofbauer cells: 31.3;Kupffer cells: 34.8;Macrophages: 18.2;monocytes: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 38.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.9;HMC-1: 10.7;NB-4: 11.1;THP-1: 14.5;U-698: 6.6;U-937: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Intermediate filaments, Cytosol"		"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	0.8	0.8	0.5	3.9	0.5	3.5	0.7	0.6	0.7	0.6	0.8	1.0	1.2	0.2	0.2	1.0	0.3	1.1	0.4	0.4	0.6	0.1	0.6	2.2	6.9	1.0	0.7	0.2	0.1	0.3	0.3	1.9	0.8	0.2	1.5	0.1	0.6	0.2	0.3	0.6	1.9	0.7	0.7	4.8	0.6	0.3	1.0	3.7	0.4	0.4	3.9	1.3	0.8	1.2	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.1	0.6	0.0	5.2	10.7	0.1	0.1	0.0	0.0	0.0	0.4	5.1	0.3	0.1	0.0	1.3	4.9	11.1	0.1	0.0	0.0	5.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	3.5	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.6	0.0	6.3	0.0	21.8	15.3	16.3	0.1	17.9	0.2	7.9	0.3	0.3	8.1	10.1	0.8	0.4	38.0	0.8	13.4	8.6	0.3	4.4	0.5	0.5	0.6	0.7	0.4	0.6	1.0	0.7	0.8	0.7	1.0	1.2	0.9	0.0	1.1	0.0	18.2	0.3	0.3	0.2	1.2	0.7	1.0	0.9	0.6	2.8	0.0	0.0	0.0	4.7	3.4	1.7	0.0	0.0	1.7	0.1	0.1	1.2	1.2	6.9	0.0	0.0	5.1	0.3	0.0	0.1	7.6	0.0	1.8	0.6	31.3	0.0	0.0	3.4	0.0	34.8	3.5	1.3	0.3	18.2	0.0	3.7	19.2	0.3	1.0	0.0	0.1	0.1	10.2	0.0	2.9	0.1	4.2	0.1	2.3	0.5	0.0	0.3	0.2	1.5	0.3	4.1	0.0	1.5	1.2	0.5	3.1	0.4
ARL14	"ARF7, FLJ22595"	ENSG00000179674	"ADP ribosylation factor like GTPase 14"	Q8N4G2	3	160677160-160678448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 129.2;intestine: 51.2;stomach 1: 77.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 588.3;Gastric mucus-secreting cells: 377.7;Intestinal goblet cells: 154.6;Paneth cells: 519.2;Proximal enterocytes: 174.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 36.2;HaCaT: 9.0;OE19: 25.3;RT4: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (2.65e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.70e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-2)"	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.9	51.2	0.1	0.0	1.0	0.1	129.2	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.1	0.0	0.0	0.2	34.2	2.8	0.0	0.1	77.2	0.0	0.0	0.3	0.6	0.0	3.2	23.8	0.3	0.0	9.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	36.2	0.0	0.8	0.0	4.2	9.0	0.0	0.9	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	25.3	2.0	0.0	0.0	0.3	2.9	17.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.0	1.9	4.5	2.6	0.0	0.0	0.2	0.1	0.0	18.6	1.2	0.0	0.0	0.0	0.0	588.3	0.0	12.6	0.0	5.6	0.4	0.1	89.1	0.0	0.0	41.4	0.1	0.5	377.7	10.7	8.9	0.0	0.0	0.0	0.0	0.0	0.0	154.6	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.3	519.2	0.0	1.0	1.2	174.5	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.9	0.0	1.4	0.0	112.0	25.9
ARL4D	ARF4L	ENSG00000175906	"ADP ribosylation factor like GTPase 4D"	P49703	17	43398993-43401137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.3;Early spermatids: 220.8;Rod photoreceptor cells: 259.6;Squamous epithelial cells: 223.4;Suprabasal keratinocytes: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 32.3;naive B-cell: 36.1"	"Lineage enriched"	"Detected in all"	4	"B-cells: 36.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 57.1;hTCEpi: 76.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 8.7;cerebral cortex: 8.8;hippocampal formation: 5.7;olfactory bulb: 4.2;spinal cord: 5.4"	HPA060379	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Vesicles	"Golgi apparatus"	"HPA060379: AB_2684269"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-2)"	"prognostic favorable (1.16e-5)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.59e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (9.25e-4)"	21.0	4.3	7.9	2.2	8.7	0.9	7.2	9.1	11.6	29.3	12.6	27.9	2.0	20.2	4.7	82.2	22.1	7.3	12.7	8.1	7.1	30.5	56.4	16.2	1.6	5.6	5.7	9.7	2.2	8.1	21.6	7.7	5.7	11.0	3.5	85.1	16.9	15.2	1.9	44.9	6.0	14.8	5.4	16.7	7.6	32.1	5.7	1.6	38.3	3.4	3.0	28.5	39.5	9.3	8.7	10.9	6.7	5.2	12.5	17.2	3.1	21.0	21.5	14.6	18.8	9.7	37.7	0.1	10.3	22.6	10.0	23.4	4.5	32.0	10.0	1.9	7.5	0.7	8.7	22.5	57.1	2.4	2.1	19.2	76.1	21.3	45.8	13.2	6.3	2.3	1.4	0.4	14.3	0.5	5.4	5.0	7.1	0.8	10.1	9.1	1.5	1.0	24.9	18.8	7.9	5.6	16.5	0.4	15.8	14.4	30.6	8.5	1.3	21.0	6.7	27.2	6.4	2.1	1.1	0.0	25.8	1.9	7.1	0.1	2.8	2.1	5.1	4.3	3.2	32.3	4.2	4.7	8.4	36.1	4.6	5.2	0.0	2.1	1.4	2.5	1.0	4.6	7.9	8.7	9.1	11.6	8.1	7.1	5.6	5.7	5.7	5.4	5.7	9.3	28.8	0.0	1.7	0.7	37.9	224.3	41.4	142.2	132.1	155.5	35.3	60.6	12.7	5.7	49.5	132.4	116.7	39.9	37.4	1.5	76.3	2.3	220.8	55.5	33.3	32.2	11.9	4.0	9.1	1.8	24.1	52.3	5.6	69.6	0.0	20.7	22.9	29.7	8.1	16.8	9.3	5.4	26.4	4.1	77.9	55.3	15.8	16.6	26.6	1.0	1.4	70.1	2.1	2.5	1.3	3.7	0.9	22.6	1.4	9.5	0.3	17.6	7.6	259.6	13.1	11.1	45.1	25.0	9.2	223.4	254.6	105.5	31.7	19.3	4.6	78.1
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 260.8;lymphoid tissue: 170.1;skeletal muscle: 85.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 260.8"	"Immune cell enriched"	"Detected in single"	30	"plasmacytoid DC: 10.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 10.1"	"Cell line enhanced"	"Detected in some"		"JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 254.3"	HPA017303	Enhanced	Supported	Approved	Nucleoli,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		0.2	0.2	34.8	0.4	260.8	4.5	0.1	85.2	69.9	0.0	0.0	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.2	48.5	15.7	1.1	2.3	0.1	0.1	14.3	7.8	0.0	0.1	0.0	12.6	0.0	15.6	1.1	0.4	2.9	2.1	0.2	85.6	0.2	0.3	0.0	0.0	0.2	0.2	0.0	9.1	170.1	0.5	48.6	0.4	0.0	0.0	44.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.6	0.0	5.2	0.0	0.0	0.0	0.6	0.0	111.4	0.0	0.2	2.6	0.0	68.4	0.0	0.1	0.0	2.7	37.3	20.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	0.0	0.0	34.8	260.8	85.2	69.9	48.5	15.7	14.3	7.8	15.6	0.0	9.1	44.5	0.0	0.0	0.0	24.8	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.0	861.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	108.2	0.0	0.0	0.0	0.0	3.5	0.3	0.1	0.0	21.5	0.1	0.0	0.0	624.8	85.7	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.5	0.0	21.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ASAP1	"CENTB4, DDEF1, KIAA1249, PAP, ZG14P"	ENSG00000153317	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1"	Q9ULH1	8	130052104-130443674	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 345.8;Late spermatids: 460.2;Oligodendrocyte precursor cells: 622.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 11.6;monocytes: 6.7"	"Cell line enhanced"	"Detected in all"		"TIME: 167.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011136, CAB037292, HPA048565"	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		31000	"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Centrosome, Cytosol"		"CAB037292: AB_476723, HPA011136: AB_2668438, HPA048565: AB_2680445"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (7.68e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.63e-8)"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (3.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.22e-3)"	35.1	22.2	13.5	12.2	15.1	47.8	24.0	7.6	22.0	17.6	3.9	13.4	5.5	19.0	12.2	10.7	17.2	14.6	24.7	14.7	10.5	11.9	9.3	30.1	18.0	14.2	20.9	18.2	7.8	18.1	10.5	27.8	16.5	12.7	8.9	8.6	8.5	11.4	13.4	17.3	12.2	17.9	9.4	30.0	10.6	28.5	29.1	16.3	16.4	10.4	19.0	15.9	15.6	17.1	48.9	31.5	41.1	27.4	46.7	61.9	37.1	44.2	83.8	57.2	62.3	17.5	18.2	14.4	31.8	67.7	38.6	13.2	24.7	41.4	86.3	20.6	15.9	22.6	20.7	23.6	119.9	10.4	6.7	61.7	15.3	33.6	50.3	66.9	60.2	7.7	13.0	45.7	54.0	15.1	13.3	9.8	13.1	24.1	30.5	13.6	9.6	7.0	18.1	25.2	14.6	44.4	32.4	20.5	26.5	42.5	17.0	22.4	167.5	45.9	28.9	20.6	69.8	42.2	12.0	9.7	34.6	14.6	50.3	0.0	2.2	1.5	0.5	2.1	0.3	1.3	1.0	0.9	3.7	1.0	1.3	0.8	11.6	0.6	6.7	0.4	0.8	1.1	13.5	15.1	7.6	22.0	14.7	10.5	14.2	20.9	16.5	9.4	29.1	17.1	97.2	3.2	6.3	206.6	22.7	47.7	21.9	12.0	29.6	25.0	12.4	14.7	33.7	27.1	11.5	3.7	16.7	42.2	14.6	3.6	3.9	10.5	159.7	14.3	34.2	109.1	13.1	98.9	345.8	8.7	37.6	43.7	4.6	27.7	9.5	30.1	103.9	8.2	64.0	62.2	225.8	4.3	8.2	56.1	168.8	460.2	39.1	73.1	44.4	181.8	71.4	9.5	15.5	622.3	245.9	12.5	4.7	54.9	13.7	37.9	5.8	4.3	4.2	7.8	78.9	28.5	90.1	61.4	95.5	25.2	44.9	46.7	23.1	58.9	4.8	22.0
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 16.8;liver: 17.4;lymphoid tissue: 11.7;pancreas: 9.5;testis: 25.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 41.1;Proximal tubular cells: 38.1;Spermatogonia: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 25.8;EFO-21: 20.1;PC-3: 53.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	2.3	0.8	0.7	0.4	0.6	2.4	1.5	0.9	1.0	2.3	0.6	1.7	1.6	1.3	0.8	1.5	2.2	1.9	2.5	0.6	0.5	16.8	17.4	3.5	0.9	1.0	0.6	0.6	9.5	0.6	0.5	3.1	0.8	1.0	2.3	0.1	3.8	0.8	0.5	1.8	1.0	2.3	0.6	11.7	4.0	25.8	0.7	4.1	2.2	1.4	1.2	1.4	0.8	0.7	1.5	25.8	0.2	2.4	0.0	1.1	0.7	0.6	2.7	2.9	1.1	5.8	0.1	0.3	20.1	0.9	14.1	7.5	0.0	1.2	1.9	5.4	0.6	6.2	12.6	12.5	0.0	0.0	0.0	6.6	0.2	0.2	0.1	0.3	9.4	1.9	0.1	5.9	1.7	1.8	5.4	0.1	12.2	3.6	53.5	0.1	11.1	5.8	8.0	4.2	2.6	2.6	0.7	1.4	9.0	1.3	0.1	0.7	8.1	0.1	1.8	1.3	3.9	0.4	5.1	0.2	0.8	0.0	14.2	0.5	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.1	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.3	0.7	0.6	0.9	1.0	0.6	0.5	1.0	0.6	0.8	0.6	0.7	0.7	10.7	0.0	0.0	0.0	1.1	1.9	1.1	0.7	2.2	0.0	0.8	0.9	0.5	12.8	1.0	0.0	0.0	0.1	0.1	0.9	41.1	1.1	2.4	1.2	0.3	11.1	10.7	7.2	0.1	2.0	0.1	1.2	2.6	0.3	1.3	3.4	20.0	12.6	4.7	0.0	0.3	0.3	2.0	4.6	4.4	8.0	1.8	3.3	16.0	1.0	0.3	0.0	0.0	0.0	0.1	0.9	0.5	0.7	0.0	0.6	0.0	38.1	4.8	0.0	0.0	0.0	0.6	1.6	126.5	2.4	3.1	0.1	0.3	5.7	1.6	0.6
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119512-14136613	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.2;testis: 32.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.1;Early spermatids: 36.4;Erythroid cells: 43.6;Extravillous trophoblasts: 35.4;Spermatocytes: 73.2;Spermatogonia: 87.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 60.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 60.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	0.9	1.4	0.2	5.6	0.3	11.7	1.3	0.3	0.2	2.2	0.1	7.4	5.3	1.0	0.1	10.3	0.7	0.7	0.7	0.1	0.2	1.0	1.3	2.1	12.5	0.3	0.2	0.7	0.7	0.3	0.7	3.6	0.3	0.8	7.7	0.0	1.9	0.3	0.5	3.2	6.0	2.0	0.2	6.7	3.2	32.0	0.3	23.2	0.6	0.4	14.7	1.8	3.2	0.3	64.6	25.3	37.7	28.9	3.8	3.6	16.2	33.1	28.3	63.8	79.5	26.5	31.6	59.1	30.0	17.5	26.5	38.0	41.8	24.1	49.7	54.0	26.9	55.5	48.7	18.6	0.2	39.0	35.1	0.7	1.7	35.8	12.4	7.2	25.1	44.1	50.2	83.8	31.8	75.7	80.8	34.3	17.3	69.1	56.7	77.0	56.0	51.6	20.1	28.3	46.0	16.5	39.8	29.2	17.4	10.3	22.1	41.5	10.6	36.0	21.6	91.0	56.6	43.2	46.5	80.3	28.0	71.9	36.1	0.7	6.2	1.5	1.7	8.0	0.9	1.1	1.5	2.0	1.2	0.9	0.9	1.7	60.1	1.7	8.5	0.5	5.1	3.2	0.2	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.3	0.2	0.3	0.3	1.0	0.0	0.6	0.3	5.6	2.5	2.4	4.5	1.2	0.1	4.8	8.5	1.2	1.5	1.1	0.0	0.0	36.1	3.8	11.7	0.0	1.0	36.4	2.1	1.3	2.1	1.2	43.6	0.5	1.2	35.4	4.1	23.4	2.3	4.5	9.2	0.4	0.3	21.5	0.0	0.4	9.9	8.2	5.6	5.6	29.1	0.0	5.0	1.8	1.0	2.1	0.3	4.1	0.0	0.5	1.1	2.2	0.7	20.1	1.0	2.4	0.3	0.2	0.9	0.0	1.1	3.3	73.2	87.8	8.3	1.1	10.4	5.3	3.0	20.9	2.4
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPHD1		ENSG00000174939	"Aspartate beta-hydroxylase domain containing 1"	Q5U4P2	16	29900375-29919864	"Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 138.6;choroid plexus: 79.3;pituitary gland: 36.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 27.1;Enteroendocrine cells: 29.4;Excitatory neurons: 25.1;Gastric mucus-secreting cells: 32.1;Inhibitory neurons: 22.6;Oligodendrocytes: 29.3;Pancreatic endocrine cells: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 61.7;Hep G2: 79.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045175	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045175: AB_10959899"	"unprognostic (1.58e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.34e-3)"	"unprognostic (6.96e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.37e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (5.55e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.03e-2)"	5.5	5.1	113.3	0.7	119.8	0.1	0.8	106.3	138.6	1.3	79.3	1.3	2.5	3.0	0.1	0.4	1.3	14.8	0.8	108.6	101.7	4.4	0.7	1.1	0.2	113.3	113.9	1.3	9.1	0.8	36.4	0.2	111.9	1.5	0.9	2.3	4.9	0.5	0.2	0.3	1.7	1.4	110.4	0.3	20.9	5.9	110.1	0.0	0.1	0.2	0.2	0.8	0.4	117.6	3.3	14.5	0.0	16.7	0.0	2.4	0.9	15.8	5.1	18.0	12.9	35.1	61.7	6.2	39.4	10.5	13.0	2.4	2.0	4.2	3.4	1.0	2.4	3.1	50.9	79.1	29.1	0.7	40.5	18.3	3.9	26.7	2.7	19.4	0.7	11.3	0.2	13.1	4.3	32.1	0.9	0.6	23.0	13.7	13.8	1.2	0.0	2.5	18.4	0.4	47.3	19.3	0.2	26.1	5.2	0.3	10.0	11.9	1.2	7.5	13.2	0.4	4.5	1.1	0.4	0.6	23.7	41.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.3	119.8	106.3	138.6	108.6	101.7	113.3	113.9	111.9	110.4	110.1	117.6	0.7	0.0	5.1	4.9	0.1	0.6	4.8	2.5	0.0	19.2	4.3	3.9	0.3	27.1	0.5	1.8	4.2	0.0	0.0	2.6	1.9	17.3	1.9	0.7	9.4	0.9	29.4	0.0	25.1	20.2	0.4	7.8	32.1	1.4	1.3	0.5	0.0	0.2	4.0	6.7	22.6	4.2	6.1	0.0	0.3	1.2	0.3	0.9	1.8	5.6	0.0	1.7	0.0	9.0	29.3	29.3	0.3	0.7	0.1	8.1	1.7	3.7	0.3	10.2	0.0	0.2	2.5	1.2	1.0	0.0	0.6	0.3	0.2	4.8	4.2	2.8
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Assembly factor for spindle microtubules"	Q8IZT6	1	197084121-197146694	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 10.1;lymphoid tissue: 17.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 99.5;Granulosa cells: 121.1;Plasma cells: 44.8;Spermatocytes: 43.8;Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.2	0.1	0.0	3.0	0.0	10.1	0.4	0.0	0.1	0.2	0.0	1.6	2.1	0.3	0.0	1.5	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	5.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	1.9	0.0	0.2	0.0	0.0	2.7	1.9	0.7	0.0	0.9	1.1	3.2	0.1	17.0	0.1	0.0	5.1	0.6	0.4	0.2	44.6	22.9	39.1	23.2	1.9	5.5	14.7	35.1	23.2	32.6	25.6	16.7	31.1	45.4	12.5	27.5	13.8	40.2	33.6	12.1	39.1	41.8	25.4	33.1	56.1	12.8	0.4	51.9	20.5	0.6	1.0	26.1	15.2	7.3	31.5	32.9	41.8	50.7	29.0	16.0	40.6	10.3	17.8	24.8	6.4	30.2	55.5	31.7	7.4	11.4	20.4	29.5	50.6	20.6	9.5	20.8	26.9	12.7	28.9	20.9	20.0	34.9	61.2	13.9	21.6	26.8	14.9	11.0	42.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	1.1	1.3	5.8	6.1	1.5	4.0	2.2	0.1	2.4	2.4	1.1	0.0	1.3	1.8	0.0	20.0	7.8	7.7	0.0	0.3	3.9	2.9	6.2	4.3	0.0	99.5	2.0	0.0	14.8	9.8	13.3	8.1	1.3	121.1	6.4	2.2	11.6	0.0	4.8	6.8	4.1	6.4	2.4	4.5	0.6	6.4	0.0	0.0	0.9	0.7	4.1	0.0	1.0	0.5	0.2	1.5	44.8	2.0	0.4	0.4	0.8	0.3	0.0	0.6	7.0	43.8	44.7	27.1	3.4	3.7	9.1	5.7	16.9	2.1
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.9;brain: 29.8;retina: 14.0"	"Group enriched"	"Detected in some"	6	"Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	0.8	14.9	22.9	0.4	27.1	0.0	0.7	3.0	29.8	0.4	0.0	0.5	0.3	0.9	3.3	0.0	1.6	0.6	0.5	28.5	23.3	0.1	0.2	0.2	0.1	6.1	10.7	5.7	0.5	0.1	9.0	0.3	7.5	1.0	0.3	14.0	0.9	1.6	0.1	0.1	0.3	0.9	11.5	2.2	0.3	0.7	22.7	0.0	0.0	0.3	0.3	0.0	0.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	27.1	3.0	29.8	28.5	23.3	6.1	10.7	7.5	11.5	22.7	11.5	0.0	0.0	0.0	191.3	0.0	0.1	0.0	0.0	0.0	7.9	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.3	0.2	0.0	0.0	218.7	0.0	0.1	0.7	0.0	0.2	0.0	4.0	5.0	0.0	0.5	23.5	275.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	25.3	0.0	0.8	0.0	280.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.7	4.4	1.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
ASTN2	KIAA0634	ENSG00000148219	"Astrotactin 2"	O75129	9	116423112-117415070	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 354.6;Excitatory neurons: 370.0;Inhibitory neurons: 1011.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 900.3;Oligodendrocytes: 225.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027035	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoplasm	"HPA027035: AB_1845122"	"unprognostic (3.25e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.41e-3)"	"unprognostic (5.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.93e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	3.3	9.8	26.1	2.7	26.3	3.6	4.3	39.0	36.0	5.3	9.0	5.2	3.4	3.2	3.9	2.2	8.0	2.5	22.5	27.0	25.8	5.5	4.1	2.2	2.4	29.3	36.2	2.8	6.7	3.1	11.6	1.8	28.7	25.2	3.2	13.4	5.8	11.3	7.3	2.4	4.1	2.8	21.4	2.4	5.6	17.6	35.0	6.0	1.8	5.6	1.8	3.2	3.5	39.2	3.7	12.0	4.3	7.1	7.6	7.0	15.4	5.7	2.3	2.5	2.8	8.1	4.4	8.8	6.1	3.8	9.3	1.3	11.5	0.6	3.1	4.8	2.9	3.1	5.8	17.0	3.0	1.8	6.2	9.5	1.1	7.8	0.7	5.4	1.8	10.5	3.9	5.9	7.9	3.8	4.1	1.4	13.2	10.6	6.4	4.9	27.5	2.5	8.0	12.3	6.3	37.9	6.8	2.0	4.8	14.5	15.5	1.3	3.5	5.9	9.1	5.6	4.9	9.0	5.0	8.3	10.5	2.0	25.8	2.5	0.4	0.5	2.8	0.3	3.6	1.5	3.1	2.4	0.2	1.6	3.0	2.5	1.9	5.9	0.6	0.9	8.8	1.0	26.1	26.3	39.0	36.0	27.0	25.8	29.3	36.2	28.7	21.4	35.0	39.2	0.6	6.4	8.9	354.6	1.1	1.3	3.2	0.4	1.2	4.9	4.2	4.8	22.7	2.8	5.0	1.8	10.4	0.4	1.0	0.4	3.9	0.8	122.5	4.7	5.5	1.3	12.6	0.4	370.0	1.1	0.4	4.9	4.1	0.7	6.3	37.0	0.7	2.9	3.2	10.1	1011.0	1.0	0.0	0.0	1.6	228.2	2.8	1.0	0.0	36.5	0.2	3.0	0.0	900.3	225.9	0.5	2.1	5.7	3.6	11.7	5.7	6.9	11.7	5.1	0.0	1.9	2.0	7.7	13.2	0.3	0.6	0.3	3.8	1.9	1.8	2.2
ATCAY	BNIP-H	ENSG00000167654	"ATCAY kinesin light chain interacting caytaxin"	Q86WG3	19	3879864-3928082	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 46.6;pituitary gland: 25.6;retina: 17.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 128.5;Excitatory neurons: 67.0;Horizontal cells: 47.1;Inhibitory neurons: 82.2;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in some"	8	"glioma: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 13.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017755	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA017755: AB_2669655"	"unprognostic (7.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.83e-4)"	"unprognostic (7.22e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.67e-1)"	0.1	6.9	32.1	0.6	34.6	0.3	0.0	0.5	46.6	0.9	0.0	1.1	0.5	0.1	0.1	0.2	0.0	0.2	0.1	29.8	36.1	0.1	0.0	0.1	0.2	17.8	13.8	0.1	0.3	0.0	25.6	0.1	16.7	1.8	0.3	17.6	0.1	3.2	1.2	0.3	0.6	0.2	3.3	0.1	0.4	0.2	17.3	0.0	0.1	0.0	0.0	0.1	0.6	24.6	0.5	0.1	2.7	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.6	0.5	0.2	0.0	1.5	0.4	0.2	0.0	0.0	0.2	0.2	0.8	1.1	0.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.5	0.1	0.2	0.2	0.4	7.3	0.1	0.1	0.2	0.4	0.2	0.1	0.2	13.2	9.3	0.2	0.2	0.1	1.2	0.2	0.2	0.5	0.3	0.6	0.4	0.7	0.3	0.3	0.2	0.3	1.3	0.2	0.6	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.1	0.1	32.1	34.6	0.5	46.6	29.8	36.1	17.8	13.8	16.7	3.3	17.3	24.6	0.2	0.0	3.4	3.3	0.6	0.6	0.8	0.0	0.0	128.5	0.2	0.1	1.9	2.8	0.0	0.0	22.9	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.9	0.7	0.0	0.0	67.0	0.0	0.2	1.1	0.0	0.8	7.0	0.1	0.7	0.1	0.1	47.1	82.2	0.2	0.0	0.6	2.6	0.0	0.0	0.5	3.6	5.6	0.1	5.4	2.1	94.0	3.9	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	18.7	0.0	1.9	0.7	0.7	1.7	0.0	0.4	0.0	0.6	0.0	0.1	0.4
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 20.0"	"Cell type enriched"	"Detected in some"	30	"Intestinal goblet cells: 226.1"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA049400: "			"prognostic favorable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	226.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.1;gallbladder: 16.6;intestine: 45.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 136.4;Oligodendrocyte precursor cells: 293.0;Oligodendrocytes: 419.4;Undifferentiated cells: 90.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"WM-115: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034574	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.1	0.0	4.1	5.0	9.0	0.0	0.4	8.8	6.4	1.0	0.1	44.5	24.7	0.0	12.3	6.2	0.4	16.6	0.0	4.3	5.0	0.1	0.0	0.0	0.0	10.6	7.8	0.0	2.9	0.0	0.0	0.0	9.9	0.0	45.7	0.0	1.8	0.7	0.0	7.1	21.0	1.5	5.8	0.0	4.8	0.3	8.0	5.0	0.0	0.0	2.9	1.5	2.5	17.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	9.0	8.8	6.4	4.3	5.0	10.6	7.8	9.9	5.8	8.0	17.1	0.1	0.0	0.0	42.7	0.6	0.4	0.1	12.9	0.0	0.0	0.1	0.0	1.2	21.5	15.1	1.8	0.0	0.0	0.0	136.4	0.0	23.6	0.2	0.2	0.0	0.3	13.2	0.0	4.0	20.3	0.1	0.0	10.7	0.3	0.0	0.0	0.0	0.3	0.1	0.0	3.9	55.4	4.1	0.0	1.2	0.6	0.0	0.1	1.8	1.9	1.6	0.0	0.0	293.0	419.4	16.4	64.7	0.0	0.4	0.1	24.1	0.0	16.0	0.0	0.0	0.0	0.6	0.0	0.1	2.9	0.9	0.5	0.3	0.0	90.7	6.5
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 645.2;heart muscle: 157.7;retina: 292.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 418.1;Cone photoreceptor cells: 171.0;Horizontal cells: 213.7;Inhibitory neurons: 119.1;Late spermatids: 115.6;Rod photoreceptor cells: 291.4"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.7;JURKAT: 36.3;Karpas-707: 35.9;REH: 37.1;SCLC-21H: 128.2;SH-SY5Y: 57.7"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA		220000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	0.2	18.0	115.4	1.4	126.3	0.6	0.1	76.0	645.2	0.0	0.0	3.6	0.9	0.0	0.0	0.3	0.0	0.2	157.7	165.8	275.3	0.1	0.1	0.2	0.9	390.1	61.8	0.1	0.8	1.2	15.4	0.0	320.4	0.2	0.8	292.4	0.8	0.0	0.2	0.3	1.5	0.8	26.3	0.5	1.3	31.5	174.9	2.1	0.2	1.8	0.6	0.1	0.7	200.7	0.0	2.1	0.7	23.1	0.0	0.1	0.1	0.3	0.0	1.6	1.6	0.8	4.3	57.7	2.6	0.4	5.6	0.5	16.2	0.2	0.6	10.7	3.1	5.0	0.2	0.4	0.0	0.0	18.2	0.0	0.2	0.0	0.3	0.3	0.0	36.3	0.0	35.9	0.4	0.8	10.4	0.1	3.0	8.4	14.3	37.1	18.5	1.8	0.0	0.6	128.2	57.7	0.3	4.2	0.1	0.0	3.4	2.6	0.0	3.0	3.2	0.0	1.1	3.7	2.6	12.7	5.5	20.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	115.4	126.3	76.0	645.2	165.8	275.3	390.1	61.8	320.4	26.3	174.9	200.7	0.2	0.0	4.4	9.1	1.1	0.3	0.4	0.0	0.6	418.1	0.3	0.3	19.3	0.0	0.0	0.0	171.0	0.0	3.2	0.8	0.0	0.0	43.7	0.1	0.1	1.4	0.0	0.0	59.1	0.0	0.1	1.0	1.1	0.1	1.3	0.1	0.0	0.0	0.2	213.7	119.1	0.4	0.0	0.0	0.4	115.6	1.8	0.7	0.0	8.4	0.4	40.0	6.2	14.6	11.4	0.0	0.0	0.4	1.0	0.2	0.0	0.1	0.0	291.4	0.0	0.7	0.4	21.2	2.8	0.2	0.3	0.3	3.6	0.4	0.5	0.4
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 187.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.1;Endometrial ciliated cells: 6.5;Excitatory neurons: 23.7;Extravillous trophoblasts: 10.7;Inhibitory neurons: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 9.9;SH-SY5Y: 2.9;THP-1: 2.5;U-937: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported				NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 10: Non-specific - Unknown function"			"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.0	9.7	6.0	0.0	7.5	0.0	0.0	3.4	33.7	0.0	187.9	0.3	0.0	0.0	0.9	0.0	1.2	0.0	0.0	25.7	1.3	0.2	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.5	4.8	0.0	0.0	2.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	2.9	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	7.5	3.4	33.7	25.7	1.3	5.5	0.0	4.8	0.0	2.7	12.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	1.3	0.1	0.0	0.0	23.7	0.0	10.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	30.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.4	0.0	3.5	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.6	4.5	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626787-203744081	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 171.6;Oligodendrocyte precursor cells: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 200.0;BJ hTERT+: 276.4;fHDF/TERT166: 212.8;SuSa: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	58.9	25.0	39.7	25.6	36.3	16.0	16.6	0.0	33.5	47.5	0.3	58.2	12.5	104.5	20.1	32.5	48.4	25.2	59.5	40.2	13.3	9.9	9.3	35.1	12.8	8.0	8.0	40.6	9.9	11.8	3.8	40.6	11.2	33.0	30.2	42.5	7.1	69.7	14.4	54.8	14.4	175.3	0.2	12.2	15.4	27.4	44.7	21.7	15.1	27.7	19.4	37.2	15.3	2.6	45.7	7.8	15.6	15.1	120.4	175.1	84.5	200.0	276.4	32.1	27.4	3.8	22.8	9.8	28.8	212.8	43.5	43.5	22.6	27.7	34.3	126.5	8.0	28.7	37.4	2.5	43.1	42.0	51.3	130.5	26.9	102.9	16.2	81.6	63.5	57.1	12.9	20.3	25.1	2.5	44.3	14.5	9.7	8.7	24.2	22.3	11.6	16.7	11.3	4.0	4.6	6.7	68.3	10.5	30.2	222.1	9.3	21.4	54.9	80.5	11.4	136.6	48.3	13.4	20.9	5.4	80.7	31.0	24.5	3.2	2.0	0.0	8.7	1.3	6.4	0.9	5.4	7.2	2.2	0.3	1.3	3.4	4.0	3.8	2.2	3.7	5.7	2.7	39.7	36.3	0.0	33.5	40.2	13.3	8.0	8.0	11.2	0.2	44.7	2.6	171.6	89.8	68.2	127.6	9.9	97.1	18.9	43.1	41.5	4.8	11.2	9.4	76.5	7.2	35.0	18.4	2.1	27.9	56.2	2.2	0.0	35.3	5.8	78.0	92.4	67.6	23.9	35.9	55.9	14.9	18.9	56.0	13.7	89.7	10.1	30.6	58.9	18.2	38.5	117.8	9.8	2.4	14.2	14.7	38.8	4.8	43.8	20.4	26.6	37.5	18.1	136.1	66.9	199.0	40.4	31.4	11.1	38.0	27.6	48.2	7.2	3.3	39.7	7.8	19.7	50.7	81.2	21.7	2.8	54.7	150.9	26.0	59.7	8.0	3.3	62.0
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25371974-26025851	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.6;pituitary gland: 15.2;retina: 17.2"	"Group enriched"	"Detected in many"	6	"Excitatory neurons: 518.7;Inhibitory neurons: 727.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;JURKAT: 9.8;MOLT-4: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	0.1	2.1	5.5	0.3	6.7	0.0	0.6	8.0	21.6	0.2	0.0	0.4	0.3	0.6	1.8	0.0	0.0	0.1	0.1	8.7	19.3	0.3	0.0	0.8	0.6	12.8	4.6	0.2	0.6	0.0	15.2	0.2	12.1	0.1	0.2	17.2	0.1	0.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	2.9	6.6	1.0	0.1	0.1	0.2	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	19.9	0.1	0.0	0.0	0.0	0.6	0.5	9.8	0.0	0.0	1.7	0.1	3.9	0.0	2.0	0.0	0.7	0.0	2.7	0.9	0.2	0.0	3.2	0.0	0.2	0.2	0.1	0.2	0.0	0.4	0.2	0.0	1.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.1	5.5	6.7	8.0	21.6	8.7	19.3	12.8	4.6	12.1	0.2	6.6	6.8	0.7	0.0	12.2	9.4	0.8	1.0	0.2	0.3	0.0	21.5	1.5	0.3	2.5	1.5	0.4	0.0	95.9	1.5	0.4	0.0	0.0	0.3	39.0	1.2	23.6	2.6	0.0	0.8	518.7	0.0	0.4	1.7	1.1	0.9	5.1	3.7	0.0	0.0	3.2	21.9	727.7	0.0	0.0	0.0	0.7	30.3	0.9	0.3	0.0	9.4	0.0	7.2	1.0	88.4	24.7	0.0	0.0	1.2	0.1	0.2	0.0	1.3	0.3	91.6	13.1	0.3	0.8	19.8	12.5	0.0	0.4	1.1	1.8	10.1	0.1	0.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.1;lymphoid tissue: 60.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.5;Erythroid cells: 59.3;Extravillous trophoblasts: 89.1;Granulosa cells: 24.7;Hofbauer cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 7.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.5;T-cells: 7.9"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 1.3;white matter: 4.0"	"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.1	1.2	0.1	14.2	0.2	44.1	1.7	0.2	0.2	3.0	0.1	11.1	12.1	1.6	0.4	18.6	0.6	1.5	0.7	0.1	0.2	0.9	2.0	2.5	36.7	0.1	0.3	0.5	0.6	0.3	0.2	8.2	0.3	0.8	11.0	0.0	2.7	0.3	5.5	9.3	11.6	3.2	0.0	12.0	4.6	1.2	0.4	60.1	0.6	0.0	36.6	3.5	5.9	0.2	196.5	130.9	191.1	93.0	4.2	6.5	73.4	91.7	49.5	186.2	170.6	171.5	57.4	193.3	46.2	37.0	77.0	139.8	140.1	62.6	153.7	84.9	231.3	115.7	78.3	146.1	0.7	62.2	109.2	3.5	2.9	109.4	67.7	18.5	86.5	123.6	73.3	73.4	82.9	92.9	225.1	87.4	119.6	63.9	57.6	149.8	176.1	80.5	41.2	38.2	41.2	59.1	81.7	36.5	61.2	56.5	63.5	41.4	33.9	74.3	75.6	67.6	243.3	53.2	37.7	147.9	35.7	92.9	153.4	0.0	0.4	0.6	0.5	0.3	0.1	1.1	1.3	2.1	0.5	2.5	0.1	0.7	0.9	0.3	0.2	0.2	7.9	0.9	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.3	0.0	0.4	0.2	0.3	0.0	0.5	0.0	7.6	4.5	1.8	6.1	0.6	0.0	1.8	2.2	1.4	0.0	2.6	0.0	0.0	40.5	1.8	13.2	0.0	0.4	0.1	0.5	1.6	3.1	0.0	59.3	0.0	0.0	89.1	5.7	6.1	2.1	4.5	24.7	6.1	0.7	29.4	0.0	0.0	10.8	0.0	5.7	7.3	0.2	0.6	5.1	1.8	0.0	0.9	0.0	3.1	0.0	0.1	0.3	2.8	0.0	15.4	1.2	1.5	0.1	0.2	0.0	0.0	0.1	4.8	1.6	7.2	11.8	2.4	9.0	4.3	1.0	22.0	2.8
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 196.4;Intestinal goblet cells: 47.4;Paneth cells: 72.5;Proximal enterocytes: 94.1;Undifferentiated cells: 57.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 5.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 23.5;RPTEC TERT1: 27.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.6"	"HPA054092, HPA054684"	Approved				"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.0	0.3	2.5	0.9	8.6	0.0	2.6	0.7	3.7	2.2	1.9	22.4	27.3	0.7	1.3	1.6	1.3	5.5	0.0	2.4	4.6	0.2	0.1	0.1	0.0	2.0	2.1	0.3	3.3	0.0	1.8	0.0	1.3	0.4	37.4	0.8	4.5	0.1	0.0	0.8	33.7	0.8	1.3	0.0	5.0	0.4	6.9	1.0	1.2	0.3	2.0	1.3	2.3	0.7	0.0	0.9	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	23.5	0.0	0.2	0.2	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	6.3	0.2	0.6	0.0	2.7	0.1	27.1	1.7	4.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.7	0.2	1.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	8.6	0.7	3.7	2.4	4.6	2.0	2.1	1.3	1.3	6.9	0.7	0.1	0.0	0.0	6.5	0.3	0.0	0.5	0.1	0.0	7.4	8.0	8.1	2.2	10.0	5.3	5.5	0.0	0.0	0.2	196.4	0.0	7.5	0.4	0.2	5.9	0.4	28.9	0.0	3.6	4.7	0.0	0.2	13.3	0.2	4.5	0.8	0.0	0.0	0.0	0.0	4.8	47.4	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.4	0.0	11.1	1.0	9.2	72.5	0.0	0.0	0.6	94.1	0.1	1.5	0.2	0.0	0.1	0.4	0.1	1.7	0.5	0.0	0.0	0.5	0.0	57.7	9.7
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813576	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;salivary gland: 31.4;stomach 1: 43.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 65.8;Cytotrophoblasts: 78.9;Distal enterocytes: 108.4;Paneth cells: 67.4;Proximal enterocytes: 50.5;Syncytiotrophoblasts: 68.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 44.2;BEWO: 40.9;CAPAN-2: 112.5;OE19: 102.1;RT4: 41.3;SK-BR-3: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA		74000	"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.3	0.1	0.3	5.7	0.1	0.2	3.4	0.7	0.4	4.4	0.3	44.0	32.6	0.4	0.0	21.7	1.0	23.8	0.0	0.3	0.3	3.8	2.4	0.5	0.5	0.3	0.2	0.1	3.9	0.5	0.0	12.6	0.3	2.2	40.5	0.0	31.4	3.2	0.0	2.7	29.5	1.7	0.0	0.1	43.2	0.1	0.1	0.2	0.3	0.0	4.7	18.5	8.1	0.5	44.2	12.5	0.0	0.2	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.7	112.5	0.0	28.9	0.0	0.1	4.2	0.0	12.9	0.0	0.0	0.2	0.0	0.2	5.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.2	0.1	0.4	102.1	19.2	0.2	0.0	1.2	23.9	41.3	0.0	0.1	0.0	38.4	0.0	0.0	1.7	0.2	0.1	0.3	3.3	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.3	0.3	0.2	0.3	0.0	0.1	0.5	0.1	0.0	2.3	0.0	0.2	0.1	3.6	5.1	0.0	0.0	7.1	6.2	0.4	65.8	17.1	16.5	0.0	78.9	0.5	108.4	1.9	17.9	0.0	3.8	0.8	2.3	16.3	0.0	0.1	28.4	7.5	0.7	19.9	7.7	5.7	0.0	0.7	0.2	6.0	0.0	0.2	40.7	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	33.2	67.4	0.0	0.0	7.8	50.5	3.5	7.7	0.0	0.0	0.0	0.9	0.2	0.3	0.2	0.0	68.3	0.2	0.5	28.4	39.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203681-122208952	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoli	"HPA055261: AB_2682765"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.2	0.7	2.3	0.1	2.6	1.5	0.2	4.9	3.1	0.3	0.0	0.3	0.2	0.1	0.0	1.3	0.6	0.2	0.1	3.8	0.5	2.7	0.4	0.3	0.1	0.0	0.0	0.2	0.3	0.3	1.4	0.1	0.0	0.4	0.0	0.5	0.5	0.0	0.2	3.1	0.3	0.0	0.0	0.5	0.3	1.6	0.9	0.0	0.4	0.0	0.1	0.1	0.5	1.2	3.4	0.6	0.2	1.4	0.1	0.1	0.6	0.1	0.0	0.2	0.3	2.2	0.3	0.3	0.5	0.0	0.2	1.3	1.7	1.2	0.1	5.1	1.9	0.1	1.3	0.2	0.4	0.5	0.7	0.3	4.0	0.1	0.2	0.5	0.0	1.3	1.0	0.4	0.0	3.2	0.0	0.5	0.4	0.1	1.4	0.2	0.4	0.7	0.5	0.4	0.8	1.1	0.9	0.7	0.4	0.5	4.2	0.1	0.1	0.3	1.7	0.4	0.2	0.4	3.6	0.8	0.3	0.5	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.3	2.6	4.9	3.1	3.8	0.5	0.0	0.0	0.0	0.0	0.9	1.2	0.4	0.0	1.8	0.7	0.3	1.3	0.7	3.3	0.6	0.2	0.7	0.8	0.5	0.0	1.1	0.0	0.0	0.5	0.5	0.6	1.9	1.0	0.4	0.6	0.3	0.3	0.0	0.0	3.2	0.2	1.1	0.3	0.0	0.8	0.0	0.1	0.4	0.0	0.2	0.0	1.4	0.0	2.0	0.6	0.6	0.1	0.3	0.3	0.0	1.9	0.0	0.2	0.0	0.5	0.6	0.4	1.3	0.0	0.4	0.3	0.1	9.7	1.1	0.2	0.0	0.5	0.2	0.8	2.9	0.8	1.4	0.5	0.4	0.1	0.3	0.4
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 21.8;salivary gland: 6.4;stomach 1: 24.9"	"Group enriched"	"Detected in some"	20	"Gastric mucus-secreting cells: 23.0;Intestinal goblet cells: 60.8"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039805	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favorable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.8	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	16.8	0.0	6.4	0.0	0.0	0.0	7.0	0.3	0.0	0.0	24.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.0	0.0	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.2	23.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	60.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.6	1.4	0.0	0.0	0.3	1.2	0.1	0.2	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.2
B4GALNT1	"beta1-4GalNAc-T, GALGT, SPG26"	ENSG00000135454	"Beta-1,4-N-acetyl-galactosaminyltransferase 1"	Q00973	12	57623409-57633239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 61.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 10.0;Excitatory neurons: 22.0;Horizontal cells: 21.9;Inhibitory neurons: 13.4;Smooth muscle cells: 7.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008968	Enhanced				"Intracellular and membrane"	NA	NA		35000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008968: AB_1078253"	"unprognostic (3.18e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.73e-5)"	"unprognostic (1.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.18e-14)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.92e-4)"	1.9	1.1	26.9	1.9	29.7	0.0	0.7	29.3	61.1	1.3	0.6	2.7	0.5	2.1	2.7	0.7	0.7	1.1	3.3	34.9	21.9	0.8	0.4	0.6	0.6	16.7	11.8	0.3	0.3	0.3	1.7	0.4	20.5	2.6	1.2	4.2	1.8	5.0	9.5	0.6	1.2	2.5	8.1	0.6	0.9	0.7	19.1	0.3	1.2	7.2	1.0	1.2	1.6	29.9	7.5	38.2	18.2	38.7	0.3	0.1	0.4	3.0	11.3	19.0	17.5	2.8	21.9	3.0	47.9	13.2	35.9	3.3	15.3	2.1	5.2	67.4	2.6	1.8	10.1	9.9	0.4	3.1	4.1	0.1	0.9	11.0	0.5	6.7	0.2	11.4	8.7	34.8	2.4	13.5	2.5	0.1	13.0	0.9	7.7	0.1	27.1	8.0	0.1	0.1	34.9	12.3	3.1	1.1	0.4	0.9	7.0	3.3	0.0	22.8	28.1	24.0	26.1	37.0	34.0	2.6	28.9	2.3	45.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.9	29.7	29.3	61.1	34.9	21.9	16.7	11.8	20.5	8.1	19.1	29.9	0.8	0.0	0.0	2.6	0.0	0.4	0.0	0.0	0.0	10.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.0	0.8	0.0	0.0	22.0	0.2	0.2	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	21.9	13.4	0.0	0.0	0.0	0.3	0.7	2.8	0.1	3.6	2.8	2.6	0.7	0.0	4.5	2.7	0.5	0.0	3.0	0.0	0.1	0.0	0.2	0.0	2.6	6.6	0.6	7.5	1.6	4.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.5;Distal enterocytes: 3.9;Glandular and luminal cells: 5.2;Intestinal goblet cells: 11.5;Ionocytes: 4.1;Proximal enterocytes: 14.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015721	Approved					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	1.2	1.3	1.4	7.8	1.0	4.7	0.7	6.6	2.1	0.2	2.3	33.5	2.1	1.1	0.6	0.7	0.4	2.2	1.0	1.7	0.8	9.1	0.9	1.4	2.2	0.7	0.4	1.0	1.7	0.1	0.0	0.7	0.5	0.7	14.2	7.5	2.0	0.3	0.8	2.8	8.4	2.7	0.0	2.2	5.9	1.5	1.1	0.2	5.9	0.1	0.8	0.6	0.0	1.5	0.9	1.7	1.7	3.0	0.1	0.0	0.9	1.3	1.0	0.0	0.1	4.0	1.4	2.1	2.1	0.0	0.6	0.9	0.7	0.1	0.2	1.8	1.8	2.2	5.1	2.1	0.0	1.1	3.5	0.2	1.4	0.3	0.2	0.7	0.0	1.6	1.3	3.3	0.0	1.1	1.4	1.5	2.1	0.3	0.8	2.5	0.7	0.6	5.4	1.4	1.4	1.5	0.6	0.7	0.6	1.7	1.8	1.4	0.6	2.2	1.3	1.3	0.7	2.6	0.9	2.3	0.7	1.4	0.9	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	1.0	6.6	2.1	1.7	0.8	0.7	0.4	0.5	0.0	1.1	1.5	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.3	0.5	0.0	0.9	5.5	0.0	0.0	0.0	3.9	1.9	0.6	0.7	0.6	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	4.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	14.8	0.1	0.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.1
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	459939-563509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 61.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.1;Gastric mucus-secreting cells: 128.0;Glandular and luminal cells: 47.4;Late spermatids: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.5;HDLM-2: 13.2;HEK 293: 12.5;NTERA-2: 14.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.2	7.0	0.5	3.2	0.7	2.1	1.3	0.0	1.0	7.4	1.0	18.4	1.0	6.2	2.7	7.5	3.7	2.2	23.9	0.5	0.0	4.6	0.1	5.2	0.1	0.0	0.0	0.4	2.6	16.9	9.3	0.1	0.0	2.0	12.5	0.1	4.8	0.7	1.5	14.8	2.0	2.2	0.0	0.3	61.0	8.0	0.0	2.3	2.3	0.1	0.7	1.4	5.6	0.7	0.0	0.0	0.3	1.2	0.0	0.0	33.5	0.0	0.0	0.0	0.0	8.0	6.6	0.0	0.9	0.0	0.7	3.6	8.0	1.1	0.1	13.2	12.5	0.0	0.0	1.8	0.0	0.1	5.3	0.0	5.3	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.1	14.8	10.5	0.6	0.5	5.0	0.0	7.1	6.8	3.8	2.7	0.8	0.3	1.0	4.9	0.8	2.9	0.0	0.0	2.7	0.2	0.9	0.0	0.0	0.0	0.0	9.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	7.0	1.3	0.3	7.5	6.0	3.4	0.0	0.6	2.9	0.6	15.1	1.5	6.2	9.2	0.0	0.0	0.6	81.1	0.0	12.0	26.3	20.4	4.8	0.6	10.3	0.0	32.6	4.8	0.1	1.6	128.0	47.4	0.0	0.1	0.0	0.1	0.7	0.0	5.2	18.6	2.0	0.0	1.1	89.2	0.0	0.5	0.0	2.8	0.6	0.0	0.0	1.0	3.6	16.6	33.4	0.0	0.2	12.7	1.9	0.2	9.1	0.2	0.0	0.2	0.8	2.8	1.3	0.9	17.3	0.0	1.5	1.9	26.1	14.4
B4GALNT4	"FLJ25045, NGalNAc-T1"	ENSG00000182272	"Beta-1,4-N-acetyl-galactosaminyltransferase 4"	Q76KP1	11	369499-382117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;ovary: 27.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.2;Bipolar cells: 23.8;Excitatory neurons: 31.2;Horizontal cells: 33.7;Inhibitory neurons: 32.3;Muller glia cells: 45.6;Oligodendrocyte precursor cells: 28.1;Oligodendrocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 35.4;NTERA-2: 32.0;SCLC-21H: 39.5;SH-SY5Y: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043276, HPA053126"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	No				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cytosol"	Vesicles	"HPA043276: , HPA053126: AB_2682049"	"unprognostic (6.11e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.92e-3)"	"unprognostic (5.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.99e-3)"	"unprognostic (1.52e-10)"	"unprognostic (9.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-4)"	"unprognostic (1.25e-1)"	0.9	0.6	23.1	0.9	17.2	0.0	3.3	5.1	33.3	17.2	0.0	5.9	0.6	14.1	0.6	2.3	11.9	0.5	1.6	23.8	12.9	1.0	0.3	0.5	0.3	19.3	20.7	27.8	1.1	2.6	17.9	0.0	14.9	6.3	0.2	5.3	2.0	1.2	0.0	2.1	2.9	1.0	8.4	0.3	2.1	1.5	15.1	0.3	0.5	0.0	0.3	1.8	6.3	13.4	0.0	4.8	35.4	20.4	0.0	0.1	8.4	6.5	1.7	2.9	0.8	3.7	0.0	0.0	4.8	0.7	5.6	1.4	4.8	8.5	0.8	0.0	12.3	0.0	13.4	11.4	0.4	0.0	8.7	0.6	5.0	0.2	3.8	12.7	0.4	1.9	11.5	0.0	0.0	10.8	0.4	0.0	32.0	0.6	14.0	0.0	0.0	4.9	0.4	0.0	39.5	47.6	2.4	1.7	0.5	3.7	14.0	0.0	9.0	2.0	11.1	3.5	0.4	0.1	1.7	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	17.2	5.1	33.3	23.8	12.9	19.3	20.7	14.9	8.4	15.1	13.4	0.1	0.0	0.0	133.2	0.2	0.8	1.5	1.4	0.6	23.8	6.5	8.9	12.5	0.0	0.1	1.8	4.2	0.1	0.3	0.1	0.0	1.3	0.0	0.6	7.1	0.6	1.8	0.0	31.2	0.0	0.0	2.4	0.0	1.1	0.0	6.9	0.0	0.0	0.2	33.7	32.3	0.1	2.0	0.0	0.0	0.0	3.1	0.1	3.6	2.8	0.2	45.6	0.0	28.1	32.5	0.2	0.0	1.2	0.0	2.6	0.0	0.0	0.1	8.6	0.0	0.0	3.3	0.1	0.2	0.1	0.3	0.3	0.1	0.6	0.5	0.4
B4GALT6	beta4GalT-VI	ENSG00000118276	"Beta-1,4-galactosyltransferase 6"	Q9UBX8	18	31622247-31685836	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 25.3"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 101.3;Cone photoreceptor cells: 39.6;Excitatory neurons: 71.5;Inhibitory neurons: 103.7;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 46.8;WM-115: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020701, HPA058284"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"CAB020701: , HPA058284: AB_2683668"	"unprognostic (3.79e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.23e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.77e-1)"	"prognostic favorable (6.40e-5)"	"unprognostic (5.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	3.8	12.1	2.0	2.7	3.1	4.5	1.3	8.4	10.2	1.1	1.6	3.4	7.2	1.9	2.0	4.5	2.3	6.6	3.6	5.2	4.8	3.2	2.6	1.1	1.4	1.2	2.7	3.8	1.9	7.4	1.8	2.6	2.1	5.1	3.3	25.3	4.5	3.8	3.5	2.1	9.2	1.7	0.9	1.6	3.0	5.2	5.0	6.3	2.0	6.4	1.1	2.4	0.6	0.4	6.0	13.1	23.7	13.4	0.4	0.5	8.7	1.9	0.0	0.4	0.2	25.2	5.0	9.4	10.9	2.3	28.4	2.4	12.7	10.7	1.5	37.1	11.2	12.4	1.3	0.6	2.6	22.6	2.0	2.4	2.3	3.6	7.5	12.0	13.3	21.9	1.8	0.0	0.1	3.6	25.4	1.7	10.2	7.1	7.2	46.8	4.2	0.0	2.9	12.3	12.6	19.7	8.7	1.5	15.7	19.1	1.7	6.8	13.4	26.5	5.5	0.0	14.9	8.9	0.5	19.4	10.8	20.2	126.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.0	0.1	2.0	3.1	8.4	10.2	5.2	4.8	1.2	2.7	2.1	0.9	5.0	0.4	3.2	0.0	0.5	12.7	0.0	5.5	0.9	1.5	12.0	101.3	2.0	1.8	7.6	0.0	1.2	1.8	39.6	0.6	5.9	2.6	3.9	1.3	6.1	1.2	6.2	3.6	3.0	4.6	71.5	1.1	0.2	3.0	2.6	1.3	0.0	4.5	4.2	2.1	0.7	13.5	103.7	2.1	0.0	0.6	1.2	3.5	1.2	1.5	0.0	9.4	0.3	4.6	6.2	81.4	5.3	2.3	3.1	2.6	1.1	2.3	5.4	1.2	0.6	5.6	0.0	1.2	1.6	1.0	9.7	3.7	1.7	0.3	1.4	1.4	3.8	0.7
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
BAIAP2L2	"FLJ22582, pinkbar"	ENSG00000128298	"BAR/IMD domain containing adaptor protein 2 like 2"	Q6UXY1	22	38084652-38111015	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 98.6;kidney: 42.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 68.2;Intestinal goblet cells: 58.4;Oligodendrocytes: 31.0;Paneth cells: 32.6;Proximal enterocytes: 125.8;Undifferentiated cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 14.1;OE19: 44.2;RPTEC TERT1: 27.3;SK-MEL-30: 38.4;WM-115: 29.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in many"			HPA003043	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"HPA003043: AB_2227864"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.51e-2)"	2.5	1.1	3.1	2.8	3.0	0.1	1.8	2.6	6.1	3.7	2.8	41.0	98.6	2.1	0.4	9.7	1.9	14.9	0.8	3.1	2.6	42.5	3.7	0.9	0.3	2.8	2.8	1.5	2.7	0.1	3.5	0.2	2.9	2.5	12.7	0.4	1.9	0.3	1.2	2.4	81.6	0.8	2.6	1.4	8.5	5.9	2.7	0.6	3.1	0.1	0.4	1.2	3.4	3.7	0.2	12.3	0.0	0.0	0.3	1.9	1.5	3.0	0.0	0.0	0.2	9.6	0.8	0.2	4.6	2.7	0.0	1.6	0.0	0.4	0.0	0.3	0.4	0.9	0.0	14.1	0.6	0.0	0.8	0.3	0.7	7.0	0.5	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.6	0.3	1.1	44.2	0.0	0.4	0.0	0.8	27.3	0.1	0.2	0.2	0.0	5.3	38.4	0.1	0.3	0.2	0.1	0.1	0.4	0.0	0.0	0.9	0.1	0.2	0.0	0.0	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.0	2.6	6.1	3.1	2.6	2.8	2.8	2.9	2.6	2.7	3.7	0.2	0.0	0.0	7.8	0.5	0.8	0.2	1.0	1.2	2.8	0.3	0.3	1.1	17.2	0.2	0.0	2.1	0.3	0.2	68.2	1.9	0.6	0.7	2.2	3.8	0.3	27.6	0.0	17.2	0.0	1.2	0.8	21.9	12.8	0.0	0.5	0.4	0.9	0.5	6.7	13.1	58.4	0.0	0.3	0.2	0.5	1.2	0.2	5.4	5.6	0.1	0.2	1.0	7.5	31.0	5.4	32.6	1.2	0.3	0.2	125.8	19.1	0.1	1.4	0.0	0.2	1.3	1.3	4.4	1.4	1.1	0.4	0.5	0.3	41.4	0.5
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375848-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.0;salivary gland: 131.4;vagina: 72.2"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 128.5;Breast glandular cells: 50.4;Squamous epithelial cells: 136.4;Suprabasal keratinocytes: 82.5;Urothelial cells: 84.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 163.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.8;hippocampal formation: 1.7"	"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.3	0.0	0.1	1.3	0.3	0.0	14.9	1.1	0.3	24.2	5.5	7.0	17.9	0.1	0.2	158.0	16.7	4.7	0.2	0.3	0.4	5.4	0.0	0.3	0.7	3.0	1.6	0.0	10.3	0.3	1.7	3.6	3.2	4.8	4.9	0.2	131.4	0.6	2.2	34.8	13.0	0.2	1.8	0.0	6.4	2.4	0.4	0.4	0.3	39.3	8.8	0.4	72.2	2.9	23.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.3	0.0	1.0	20.9	0.0	5.1	0.0	163.7	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.1	0.0	3.9	0.0	6.2	0.0	0.0	0.0	20.6	0.9	0.0	0.0	39.8	0.0	0.3	0.2	0.0	0.0	19.4	0.1	0.4	3.8	0.1	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.1	0.3	0.3	0.4	3.0	1.6	3.2	1.8	0.4	2.9	0.2	0.0	1.1	0.3	0.5	43.1	128.5	8.7	3.4	0.6	50.4	16.9	0.5	4.3	8.0	0.0	0.0	13.4	0.8	29.4	7.9	23.7	7.2	11.3	0.6	1.2	1.8	0.0	1.8	0.7	5.8	2.7	6.6	4.6	0.0	0.0	0.0	0.2	1.9	0.0	0.3	13.4	0.0	0.3	2.2	1.6	0.0	0.7	10.6	0.0	0.1	0.7	0.0	0.0	0.3	6.2	29.8	0.4	0.9	25.6	34.0	3.4	11.8	0.3	0.0	0.6	1.7	0.1	5.3	136.4	82.5	4.2	1.7	0.0	19.4	84.8
BCAS1	"AIBC1, NABC1, PMES-2"	ENSG00000064787	"Brain enriched myelin associated protein 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 890.2;choroid plexus: 301.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.2	0.2	506.5	6.4	627.9	0.1	3.4	551.3	890.2	7.3	301.2	69.5	19.0	1.3	2.2	7.2	1.5	8.6	0.4	421.4	525.8	3.3	0.4	2.9	0.6	749.3	660.7	0.4	0.9	0.0	1.0	0.1	649.9	33.4	74.3	0.2	22.3	0.3	0.5	1.4	31.1	2.8	584.8	0.5	159.8	3.4	562.0	0.7	0.3	0.8	6.5	35.7	7.5	724.7	0.0	8.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	27.8	0.2	0.0	0.3	4.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	44.2	0.1	0.2	0.2	90.0	0.0	2.3	0.0	1.2	0.0	179.5	0.2	0.1	0.0	368.6	0.4	0.0	12.2	0.0	0.0	0.0	0.1	3.2	0.0	0.9	0.5	1.0	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.0	1.2	0.6	0.4	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.1	0.1	506.5	627.9	551.3	890.2	421.4	525.8	749.3	660.7	649.9	584.8	562.0	724.7	0.8	9.6	1.1	1.6	2.8	0.8	6.3	8.5	0.6	0.1	6.2	1.9	2.2	7.2	35.9	3.7	0.0	0.2	0.4	182.6	1.9	2.9	15.6	9.4	11.1	0.4	8.4	0.0	1.6	22.5	0.1	0.8	202.9	11.8	4.5	0.0	0.4	0.1	0.1	0.0	2.5	371.4	18.3	0.0	2.5	16.1	0.3	1.7	16.0	0.0	0.0	0.8	0.0	538.8	718.8	22.9	102.0	0.0	1.0	21.3	12.0	0.1	100.5	0.5	0.0	1.4	2.2	15.4	6.1	0.3	0.3	0.0	1.7	0.4	35.6	56.7
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"BAF chromatin remodeling complex subunit BCL11B"	Q9C0K0	14	99169287-99272197	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease variant, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;lymphoid tissue: 36.6;skin 1: 15.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.8;Basal squamous epithelial cells: 73.4;Excitatory neurons: 57.5;Inhibitory neurons: 105.7;NK-cells: 51.5;Suprabasal keratinocytes: 71.3;T-cells: 133.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 21.2;cerebral cortex: 17.2;hippocampal formation: 18.9"	"Group enriched"	"Detected in many"	8	"gdT-cell: 2.0;MAIT T-cell: 1.8;memory CD4 T-cell: 2.8;memory CD8 T-cell: 2.4;naive CD4 T-cell: 4.6;naive CD8 T-cell: 3.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"JURKAT: 38.3;MOLT-4: 47.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 64.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 30.0"	HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favorable (7.48e-4)"	0.4	0.3	8.0	5.1	21.2	4.9	1.1	0.0	17.2	0.9	0.0	1.2	2.0	0.2	0.5	4.3	0.3	0.9	0.1	18.9	1.1	0.3	0.4	1.1	10.2	0.3	0.8	0.2	0.1	0.0	0.2	0.1	0.0	0.5	1.4	0.0	1.7	0.3	0.2	15.0	3.5	0.2	1.5	4.4	1.9	0.5	2.0	36.6	0.8	0.0	7.5	1.3	2.9	3.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	1.7	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.2	0.0	0.0	38.3	0.0	4.1	0.0	2.8	47.3	0.8	0.5	3.6	0.0	7.0	0.0	0.0	0.0	2.6	3.7	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.7	0.2	0.0	2.6	0.1	0.0	2.0	0.7	0.0	0.0	0.0	0.1	2.0	0.0	1.8	0.0	2.8	2.4	0.0	0.0	4.6	3.1	0.0	0.3	0.0	0.0	2.0	0.8	8.0	21.2	0.0	17.2	18.9	1.1	0.3	0.8	0.0	1.5	2.0	3.9	1.3	3.2	0.0	1.3	6.4	62.8	1.6	6.3	73.4	0.4	4.3	4.4	3.8	4.3	1.3	0.0	0.0	0.1	44.2	3.8	1.9	0.2	0.2	0.2	0.2	1.2	1.2	5.3	57.5	0.5	0.0	3.3	2.0	0.3	5.1	0.2	3.3	0.3	0.3	0.0	105.7	4.9	2.0	1.0	11.4	0.4	0.6	4.0	5.4	1.0	4.9	0.0	51.5	32.2	2.0	1.1	5.4	0.0	24.4	0.6	10.1	0.5	0.3	0.1	0.0	0.5	1.9	1.6	5.8	42.7	71.3	0.0	133.4	0.1	9.7	0.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2A1	"ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1"	ENSG00000140379	"BCL2 related protein A1"	Q16548	15	79960892-79971196	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 617.3"	"Group enriched"	"Detected in many"	5	"B-cells: 177.4;granulocytes: 220.7;Hofbauer cells: 214.9;Langerhans cells: 508.2;Macrophages: 604.2;monocytes: 386.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.4"	"Group enriched"	"Detected in all"	4	"cerebral cortex: 39.7;pons: 12.5"	"Group enriched"	"Detected in all"	5	"eosinophil: 284.0;intermediate monocyte: 195.8;neutrophil: 534.0;non-classical monocyte: 378.9"	"Group enriched"	"Detected in all"	7	"granulocytes: 534.0;monocytes: 378.9"	"Cell line enriched"	"Detected in many"	5	"SK-MEL-30: 525.0"					"Low region specificity"	"Detected in single"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.19e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.54e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	28.6	1.7	2.5	105.1	2.7	617.3	4.3	2.8	39.7	4.3	4.3	5.9	4.6	2.8	1.5	2.4	8.4	17.4	4.6	2.4	2.7	3.4	14.7	59.0	72.0	4.9	3.9	0.9	4.7	0.9	1.3	20.4	12.5	2.3	5.9	0.6	4.4	0.9	0.9	1.7	8.0	13.5	3.4	57.9	5.6	0.4	6.3	17.2	2.4	10.8	56.7	52.1	1.7	5.8	0.4	1.4	0.0	0.1	0.6	0.9	0.0	0.0	6.9	0.0	0.6	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	14.3	4.1	1.5	0.0	0.6	0.0	1.4	2.2	3.7	111.4	2.0	0.1	8.2	0.0	0.2	0.7	0.6	0.0	0.4	0.2	0.0	0.1	19.3	0.1	0.0	3.5	0.2	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.0	525.0	0.0	0.0	5.0	0.0	51.8	4.9	0.2	1.1	0.5	0.3	4.3	2.3	40.3	27.4	24.2	42.3	284.0	24.5	195.8	13.9	64.4	31.3	32.4	25.2	44.2	38.1	35.1	534.0	21.5	378.9	5.0	8.0	49.1	2.5	2.7	2.8	39.7	2.4	2.7	4.9	3.9	12.5	3.4	6.3	5.8	7.6	22.4	57.3	0.0	177.4	11.0	0.8	50.9	0.6	0.1	2.9	3.7	4.3	0.0	38.0	1.8	0.0	1.9	33.9	0.3	1.9	2.2	1.3	12.0	4.2	6.2	0.0	1.3	0.1	1.6	2.3	8.4	2.0	41.1	220.7	0.2	1.4	1.6	214.9	0.0	0.1	0.1	2.0	60.5	508.2	1.5	0.0	604.2	33.8	0.0	386.0	0.3	13.4	0.0	0.0	6.5	0.1	0.0	14.6	1.4	0.1	0.8	13.8	0.2	0.0	1.3	4.8	0.3	0.2	0.5	10.2	4.5	53.3	0.1	0.2	1.8
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.5;stomach 1: 9.4;testis: 31.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 385.6;Late spermatids: 863.1"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 5.2;pancreatic cancer: 1.8;stomach cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.1;NTERA-2: 1.6;OE19: 2.0;RT4: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040665, HPA059846"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA040665: AB_10964282, HPA059846: "	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.0	0.0	0.1	2.5	0.1	0.1	0.5	0.0	0.1	0.2	0.1	10.7	13.7	0.1	0.1	0.2	0.1	1.2	0.0	0.2	0.0	0.1	0.5	0.4	1.3	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.1	15.5	0.0	0.9	0.0	0.0	0.0	12.9	0.4	0.0	0.7	9.4	31.4	0.0	1.2	0.0	0.0	0.8	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.3	1.6	0.2	0.4	2.9	3.2	0.0	0.3	2.5	1.3	0.7	2.8	4.5	1.8	0.0	0.1	0.2	30.1	0.0	0.3	385.6	1.2	0.2	0.7	6.7	0.0	2.1	7.5	0.0	0.5	28.5	0.8	0.0	0.1	0.0	0.3	0.2	0.0	1.4	45.0	2.0	0.3	3.8	863.1	5.6	0.9	0.0	0.0	3.8	0.1	0.0	1.5	1.1	2.6	22.9	3.8	0.5	4.0	95.0	0.0	5.0	1.0	6.6	1.2	0.6	6.5	2.8	0.0	0.4	0.1	0.6	0.1	30.6	9.4
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113876816-113887581	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2;stomach 1: 18.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 67.6;Exocrine glandular cells: 115.9;Intestinal goblet cells: 39.3;Pancreatic endocrine cells: 74.9;Proximal enterocytes: 133.2;Undifferentiated cells: 54.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 16.9;EFO-21: 5.4;OE19: 15.2;RPTEC TERT1: 5.5"	"Region enriched"	"Detected in some"	32	"cerebellum: 32.9"	"Low region specificity"	"Detected in all"			"HPA029732, HPA029733"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.2	0.1	1.2	3.1	1.4	13.2	0.5	2.7	1.9	3.9	0.4	32.5	43.2	1.0	5.2	2.2	0.6	8.3	0.2	1.4	1.4	0.7	0.2	0.5	0.2	1.2	1.7	0.1	9.6	0.1	0.1	0.1	1.1	0.3	26.9	1.3	0.3	0.2	0.3	0.2	41.8	0.8	0.8	0.5	18.4	0.8	1.1	1.2	0.1	0.0	0.2	0.5	0.6	1.3	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	2.2	0.3	0.1	0.0	15.2	0.0	0.1	0.3	0.6	5.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.3	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	1.4	2.7	1.9	1.4	1.4	1.2	1.7	1.1	0.8	1.1	1.3	0.6	0.0	1.3	2.0	0.9	0.4	5.0	3.4	2.2	1.6	0.3	0.3	0.4	4.3	12.2	23.9	6.2	0.1	1.0	67.6	0.0	4.1	1.4	4.3	0.5	1.2	2.4	0.0	2.3	115.9	0.0	1.2	29.6	5.5	0.0	0.4	0.0	0.3	0.8	1.7	1.8	39.3	6.1	0.6	5.0	0.2	0.0	1.6	0.0	0.0	2.5	0.3	0.0	0.5	1.6	74.9	23.3	0.0	1.0	2.7	133.2	0.4	6.3	2.6	0.0	6.6	2.2	0.6	0.6	2.0	1.1	0.1	1.8	0.4	54.9	14.9
BCL6	"BCL5, BCL6A, LAZ3, ZBTB27, ZNF51"	ENSG00000113916	"BCL6 transcription repressor"	P41182	3	187721377-187745725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Immunity, Inflammatory response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 485.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 205.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 269.1;non-classical monocyte: 76.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 269.1;monocytes: 76.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 166.4;HSkMC: 113.9;U-698: 231.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000307, HPA004899, HPA050645"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"CAB000307: AB_2063451, HPA004899: AB_1078273, HPA050645: AB_2681199"	"unprognostic (5.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.62e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.75e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.27e-9)"	"unprognostic (5.22e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.58e-2)"	143.0	49.4	54.3	53.9	53.4	123.7	126.9	85.9	57.9	100.0	35.0	87.1	7.5	68.1	16.4	44.6	140.7	45.6	72.1	50.9	68.7	37.0	65.3	110.5	56.0	104.1	69.4	65.6	49.2	11.3	44.8	15.3	74.2	57.5	10.3	34.2	70.3	22.2	485.9	160.7	34.4	43.0	55.9	106.3	58.4	18.6	69.0	43.2	50.4	96.6	47.7	90.6	81.5	64.1	5.1	13.8	14.4	3.2	98.1	78.0	14.9	16.5	39.2	18.4	19.4	9.4	7.6	166.4	11.5	21.0	11.7	7.7	4.4	10.6	15.3	33.8	5.1	0.2	6.7	22.5	51.5	2.1	0.9	113.9	68.8	22.7	32.9	60.1	10.2	4.2	1.6	27.6	18.2	5.7	5.5	1.3	1.4	3.0	10.3	45.4	7.0	0.8	13.6	23.2	3.1	0.2	18.8	8.1	11.0	30.2	35.3	5.9	21.2	43.7	7.1	16.6	7.5	21.2	7.2	231.6	24.2	6.0	31.7	8.8	33.0	18.9	5.5	37.3	5.4	6.6	3.4	5.0	24.6	15.3	2.1	2.3	269.1	3.9	76.4	4.0	3.1	30.7	54.3	53.4	85.9	57.9	50.9	68.7	104.1	69.4	74.2	55.9	69.0	64.1	35.7	19.2	67.4	66.0	22.7	47.3	14.7	18.8	205.5	10.9	55.3	54.6	71.4	14.3	28.9	16.5	20.9	1.4	36.0	3.5	0.0	12.2	13.3	36.2	26.7	25.0	4.8	3.2	7.6	12.5	2.7	57.3	12.2	51.4	11.4	9.4	15.0	51.2	11.9	0.0	19.6	2.3	16.2	67.5	74.4	8.6	28.9	48.1	35.6	7.5	16.8	39.1	1.0	50.8	7.8	7.9	0.3	18.8	14.2	27.9	1.2	1.5	29.5	9.7	32.9	77.0	84.9	0.4	1.2	72.4	61.5	4.1	30.0	10.3	2.8	29.7
BCL6B	"BAZF, ZBTB28, ZNF62"	ENSG00000161940	"BCL6B transcription repressor"	Q8N143	17	7023050-7030290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 37.8;Endothelial cells: 45.0;Hepatic stellate cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 53.2;HUVEC TERT2: 96.2;TIME: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059147, HPA075112"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA059147: AB_2683928, HPA075112: AB_2732279"	"unprognostic (5.61e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (8.56e-5)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.26e-2)"	29.8	5.6	8.1	5.7	7.0	0.1	15.4	6.2	9.2	5.7	4.4	4.4	3.2	7.7	0.7	3.8	5.1	13.4	23.3	6.5	6.9	13.4	4.0	28.9	5.5	7.8	7.1	2.9	3.8	3.1	5.5	19.9	7.3	4.5	2.2	0.6	4.0	3.5	11.5	4.4	4.9	7.7	6.6	13.0	4.3	2.0	10.1	2.0	12.0	14.7	2.1	7.9	4.8	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	18.2	0.0	0.0	0.5	0.0	53.2	0.0	0.0	0.0	0.1	0.0	96.2	0.2	3.4	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	38.2	0.8	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.2	9.2	6.5	6.9	7.8	7.1	7.3	6.6	10.1	6.7	37.8	3.2	4.2	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	45.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	23.6	0.2	0.1	0.0	0.0	0.2	0.0	1.9	2.3	0.0	0.0	0.3	3.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.2	0.0	0.9	0.8	0.6	1.5	0.4	1.3	0.1	0.2	0.9	0.0	0.5
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 45.3;skin 1: 17.3"	"Cell type enriched"	"Detected in some"	36	"Intestinal goblet cells: 136.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	HPA046229	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.2	0.6	0.7	0.7	2.3	0.5	2.8	0.8	0.2	0.5	45.3	0.1	0.5	0.7	0.2	0.3	0.6	0.4	0.7	0.5	0.2	0.3	0.4	0.5	0.9	0.8	0.5	0.2	0.3	0.0	0.4	0.8	0.3	14.0	1.5	0.9	0.3	0.3	17.3	15.5	0.7	0.2	0.5	0.3	0.4	1.1	0.2	0.6	0.1	4.9	0.2	1.4	1.5	0.3	0.2	0.7	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.8	1.3	1.1	0.3	0.0	0.2	0.7	0.0	0.2	0.2	1.3	0.6	0.9	1.2	0.3	0.1	0.4	1.9	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.5	0.2	1.1	0.3	0.6	1.0	0.1	0.7	0.1	0.4	0.2	0.3	0.3	0.7	0.7	0.5	0.0	0.1	0.8	0.6	0.1	1.0	0.3	0.3	0.6	0.7	0.3	0.5	0.3	0.5	1.0	0.7	0.5	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.1	0.0	0.7	0.5	0.4	0.4	0.4	0.1	0.6	0.1	0.2	0.6	0.7	2.8	0.8	0.7	0.5	0.9	0.8	0.8	0.2	1.1	1.5	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.1	3.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	136.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.8	0.1
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44788170	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 16.4;fallopian tube: 8.3;intestine: 27.4"	"Cell type enriched"	"Detected in some"	25	"Paneth cells: 1290.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-698: 1.8"					"Low region specificity"	"Detected in many"			HPA058564	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.2	1.9	1.2	0.7	1.1	0.7	0.5	2.2	1.3	1.6	16.4	27.4	9.1	0.7	3.0	0.2	8.3	0.2	0.3	0.8	1.7	0.5	0.6	1.9	0.6	1.9	3.3	0.5	0.3	0.3	2.7	0.2	1.5	0.4	16.0	1.1	0.3	0.5	0.4	2.2	8.1	0.5	1.3	0.5	0.4	0.7	1.6	0.5	0.6	0.1	0.4	0.3	0.2	1.0	0.0	0.2	0.3	0.4	0.1	0.1	1.1	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.2	0.0	0.8	2.5	0.1	0.0	0.3	0.2	0.3	0.1	0.2	0.6	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.8	0.3	0.1	0.1	0.1	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	1.8	0.4	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.8	0.6	0.7	0.0	0.5	0.2	0.5	0.1	0.3	0.0	0.3	0.6	0.1	1.2	1.1	2.2	1.3	0.8	1.7	1.9	3.3	1.5	1.3	1.6	1.0	0.2	0.0	0.0	0.0	0.8	0.3	0.8	3.4	0.0	0.8	0.4	1.0	0.5	0.0	4.2	5.5	0.0	0.3	0.4	31.2	1.9	0.7	0.0	26.7	0.5	0.2	2.4	0.0	1.9	0.8	0.2	0.6	0.5	1.2	0.0	0.3	0.4	0.0	0.3	0.0	4.3	3.2	0.0	0.0	0.9	0.2	0.9	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.6	1290.4	0.4	0.4	0.7	6.1	1.0	50.1	0.2	0.0	1.2	0.8	0.7	1.6	0.0	0.6	0.3	1.4	0.4	9.1	0.5
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064171	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 439.4;pituitary gland: 399.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 354.2;Granulosa cells: 260.7;Horizontal cells: 363.4;Muller glia cells: 716.1;Rod photoreceptor cells: 142.2"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 607.0;HBF TERT88: 680.4;HL-60: 1562.2;hTERT-RPE1: 1044.5;SCLC-21H: 465.3;U-937: 484.1"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.5	83.8	253.7	3.8	260.1	42.7	2.5	201.9	317.4	5.5	142.9	10.5	5.0	15.6	55.5	0.8	21.4	1.3	16.7	274.9	439.4	10.7	4.2	2.8	1.2	222.6	248.2	20.2	71.6	112.0	399.2	0.4	261.1	6.7	4.3	173.0	2.3	3.6	0.6	1.0	6.3	4.8	203.1	2.5	8.6	92.9	265.5	3.5	26.0	0.8	0.4	0.8	2.9	223.9	0.7	0.0	37.6	0.1	0.0	0.1	1.1	21.6	0.0	412.1	607.0	0.0	0.1	0.1	0.8	158.1	130.0	0.4	0.0	0.5	680.4	0.2	1.2	129.2	0.0	85.2	6.9	1562.2	2.6	9.2	0.0	89.3	0.1	1044.5	0.1	120.8	0.2	0.2	84.6	0.0	294.7	0.2	337.9	97.8	62.0	0.2	0.7	7.6	0.0	0.3	465.3	266.6	0.5	0.6	1.9	5.9	0.3	432.4	0.0	0.1	140.2	1.1	16.7	71.9	2.9	0.7	54.4	484.1	27.2	0.4	0.2	3.4	0.3	0.0	0.3	0.5	0.9	0.5	0.0	1.0	1.4	0.6	0.5	0.9	0.2	0.1	0.4	0.7	253.7	260.1	201.9	317.4	274.9	439.4	222.6	248.2	261.1	203.1	265.5	223.9	1.1	0.0	0.5	16.3	1.2	8.7	11.1	0.0	1.2	354.2	7.2	32.5	9.6	31.5	0.7	5.5	39.6	0.2	0.2	0.4	72.4	6.1	12.1	1.4	0.6	5.3	79.6	0.8	64.6	13.8	0.2	3.9	8.2	2.8	0.0	260.7	30.4	1.2	1.4	363.4	56.1	6.9	10.2	4.0	1.2	31.8	8.1	2.2	7.2	12.2	1.5	716.1	0.0	32.6	20.9	6.3	3.3	2.6	0.0	7.5	0.8	19.5	0.0	142.2	0.0	15.9	14.4	38.5	13.8	0.0	6.5	0.5	2.0	0.2	3.5	1.7
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156242184-156243317	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 19.9;choroid plexus: 10.8;intestine: 8.5"	"Cell type enhanced"	"Detected in some"		"Ionocytes: 4.1;Melanocytes: 3.6;Plasma cells: 2.8;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.8;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.6;NK-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.3;U-87 MG: 5.4"	"Region enriched"	"Detected in single"	9	"olfactory bulb: 7.8"	"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	15500000	2200000	"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	0.7	0.5	12.7	0.6	13.9	0.9	0.6	13.3	19.9	1.7	10.8	8.5	0.6	1.4	1.1	0.7	1.4	0.6	0.8	12.3	12.7	1.1	1.6	0.6	0.4	14.6	13.4	1.9	0.8	0.2	1.1	0.4	13.5	2.0	1.8	0.2	1.7	0.7	0.5	1.7	2.3	1.8	14.0	1.9	0.8	0.4	13.4	0.3	1.4	0.0	0.2	0.8	1.0	14.7	0.1	1.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.5	0.5	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.5	0.1	0.2	0.4	0.0	0.0	0.7	0.6	0.1	0.3	0.7	0.1	0.4	1.8	0.0	0.2	0.6	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.4	0.7	1.1	1.4	5.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.6	0.0	0.0	12.7	13.9	13.3	19.9	12.3	12.7	14.6	13.4	13.5	14.0	13.4	14.7	0.6	0.0	0.0	0.0	0.6	1.5	1.0	1.0	0.6	0.2	1.1	0.9	0.0	0.0	1.0	0.0	0.0	0.5	0.2	0.1	0.0	0.1	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.0	1.1	1.1	0.2	0.2	0.0	0.0	0.9	4.1	0.0	0.8	0.2	1.5	0.5	3.6	0.0	0.4	0.4	1.0	0.0	0.0	0.0	1.1	0.4	2.8	0.7	0.3	2.0	0.3	0.6	6.6	0.5	0.3	0.4	0.8	0.6	1.3	0.4	0.6	0.8	0.8	0.7
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 104.8;pancreas: 127.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 52.2;Breast myoepithelial cells: 22.1;Ductal cells: 34.3;Endometrial ciliated cells: 28.9;Exocrine glandular cells: 49.8;Glandular and luminal cells: 28.3;Pancreatic endocrine cells: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;BEWO: 15.4;CAPAN-2: 14.4;HaCaT: 22.5;MCF7: 22.8;RT4: 10.8;SK-BR-3: 11.0;T-47d: 14.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.7"	HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Intermediate filaments, Actin filaments, Cytosol"		"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favorable (9.04e-4)"	0.4	0.0	0.2	1.9	0.2	0.0	8.6	0.4	0.4	20.7	0.1	25.1	10.4	0.7	2.6	104.8	6.0	3.4	0.0	0.2	0.1	5.8	0.9	5.9	0.0	0.6	0.3	0.1	127.2	4.1	1.5	0.3	0.8	16.8	6.4	0.0	44.4	3.2	0.6	43.8	13.5	0.2	0.2	0.2	21.5	0.1	0.3	0.2	6.1	0.0	3.1	11.4	44.3	0.2	9.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	2.6	14.4	0.0	0.0	0.0	0.0	22.5	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	6.4	0.0	0.1	0.0	0.2	0.0	10.8	0.2	0.1	0.0	11.0	0.0	0.3	14.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.4	0.2	0.1	0.6	0.3	0.8	0.2	0.3	0.2	0.3	12.8	18.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.2	22.1	0.0	0.0	12.4	16.5	0.0	4.5	1.3	0.0	3.9	34.3	0.0	28.9	2.8	0.5	0.0	0.0	0.0	49.8	6.1	0.6	0.0	28.3	2.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.1	0.0	0.0	0.2	12.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.6	0.3	0.0	0.0
BIK	NBK	ENSG00000100290	"BCL2 interacting killer"	Q13323	22	43110750-43129712	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 17.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 329.3;Club cells: 215.6;Ionocytes: 443.5;Paneth cells: 140.5;Respiratory ciliated cells: 204.1;Urothelial cells: 175.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 72.9;plasmacytoid DC: 58.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 89.9;CAPAN-2: 44.3;Daudi: 44.2;U-698: 172.1"	"Not detected"	"Not detected"							HPA051360	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051360: AB_2681453"	"unprognostic (1.18e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.86e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.45e-5)"	"unprognostic (1.38e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.04e-1)"	0.2	2.3	0.2	4.1	0.4	4.1	4.9	0.7	0.3	2.8	0.0	8.5	3.6	0.2	1.2	11.3	3.0	3.1	0.3	0.5	0.0	3.8	0.5	1.4	11.6	0.0	0.0	0.3	2.5	1.6	1.0	0.1	0.1	11.4	5.2	0.2	17.5	0.5	0.0	3.5	5.3	0.2	0.0	2.9	13.4	2.0	0.1	1.4	1.8	0.1	11.2	2.6	6.5	0.0	89.9	0.7	0.2	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	28.8	44.3	44.2	4.2	0.0	0.9	19.5	4.8	1.9	0.0	0.7	6.7	0.1	0.6	4.9	0.7	21.2	4.1	0.0	8.8	0.0	0.0	0.3	0.2	9.5	0.3	2.0	0.0	22.9	16.9	28.9	6.7	24.2	7.3	0.2	0.1	20.6	0.9	2.6	1.7	0.0	3.1	8.2	6.5	3.1	1.6	28.9	0.8	0.1	2.4	0.2	1.0	10.4	17.1	172.1	0.0	2.2	0.2	1.8	2.9	72.9	2.7	0.7	4.3	17.1	9.5	4.2	10.4	11.7	6.4	3.5	11.3	0.9	0.8	58.6	7.1	6.3	0.2	0.4	0.7	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	4.2	0.0	9.3	12.6	32.7	329.3	3.4	0.0	39.7	24.1	0.7	17.2	215.6	7.3	0.0	1.4	7.9	43.0	7.9	62.2	0.3	17.7	0.8	2.3	50.6	5.7	0.3	16.2	1.2	0.9	90.7	9.1	0.0	0.1	5.3	0.7	0.9	0.0	0.2	52.9	443.5	1.4	4.8	0.4	0.0	4.0	35.6	0.0	6.4	0.0	1.0	0.0	0.1	105.2	140.5	0.7	79.7	53.1	10.2	15.7	204.1	0.0	0.0	0.0	14.9	0.2	11.0	16.1	11.8	1.0	12.9	0.3	53.9	175.3
BIRC5	"API4, EPR-1, survivin"	ENSG00000089685	"Baculoviral IAP repeat containing 5"	O15392	17	78214186-78225636	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Protease inhibitor, Repressor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9;lymphoid tissue: 41.0;testis: 19.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 74.7;Early spermatids: 94.1;Erythroid cells: 166.7;Extravillous trophoblasts: 162.0;Spermatocytes: 191.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 14.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 14.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002830, CAB004270"	Enhanced		Supported	"Cytokinetic bridge"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Cytokinetic bridge"		"CAB004270: AB_628302, HPA002830: AB_1857672"	"unprognostic (8.04e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.28e-6)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (3.56e-3)"	"unprognostic (4.53e-3)"	"unprognostic (2.87e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	0.9	1.1	0.3	8.5	0.5	37.9	5.1	0.6	0.6	1.9	0.4	6.7	7.9	1.6	0.0	12.8	0.6	1.1	0.5	0.4	0.4	0.7	2.1	1.9	16.2	0.6	0.6	0.4	0.6	0.2	0.2	6.1	0.5	0.6	8.0	0.1	1.8	0.2	1.1	5.8	7.6	4.3	0.4	5.8	3.7	19.6	1.0	41.0	0.4	0.1	16.3	2.6	3.2	0.8	139.1	126.2	111.3	121.5	6.7	11.3	41.0	103.6	57.5	144.0	94.2	104.0	52.9	140.7	41.5	60.5	108.7	71.9	113.6	66.6	125.2	48.2	157.5	93.2	71.4	123.1	0.8	90.8	67.0	3.9	4.5	79.8	59.2	21.0	103.5	104.3	118.8	116.0	112.6	79.7	195.5	86.2	83.4	96.3	218.0	100.5	180.2	108.4	34.5	50.2	136.8	94.8	80.3	88.6	71.7	54.1	117.5	84.8	39.5	173.1	152.6	76.0	150.4	83.3	72.2	163.3	63.3	37.8	154.4	0.0	0.0	0.0	0.7	0.0	0.1	2.4	4.1	2.8	0.8	0.2	0.0	0.4	0.5	2.4	0.0	0.2	14.1	3.1	0.3	0.5	0.6	0.6	0.4	0.4	0.6	0.6	0.5	0.4	1.0	0.8	1.2	0.0	20.0	0.0	15.9	8.2	3.7	12.2	2.8	0.7	7.7	8.6	2.3	2.8	10.8	0.0	0.0	74.7	3.3	10.7	0.0	2.0	94.1	5.4	5.1	8.8	3.0	166.7	0.4	0.0	162.0	15.1	8.6	6.9	9.5	42.7	12.8	2.7	52.1	0.0	0.2	17.1	10.2	13.7	13.8	68.4	3.1	9.6	1.8	0.0	0.6	0.4	7.2	0.0	0.3	0.4	2.5	0.7	50.2	2.8	3.2	0.1	2.6	0.5	6.6	0.9	15.2	191.1	58.2	31.3	6.5	19.2	10.1	3.4	38.8	6.3
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96189171-96271587	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.2;dendritic cells: 64.0;Microglial cells: 157.4;Plasma cells: 80.4;Proximal enterocytes: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"memory B-cell: 161.2;naive B-cell: 140.5;plasmacytoid DC: 231.5"	"Group enriched"	"Detected in many"	101	"B-cells: 161.2;dendritic cells: 231.5"	"Group enriched"	"Detected in some"	6	"Daudi: 68.7;REH: 168.4;RPMI-8226: 94.4;U-698: 251.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Vesicles	"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946"	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favorable (2.67e-6)"	2.2	3.2	3.8	27.5	3.4	10.1	6.3	2.4	4.1	7.1	13.9	16.9	38.9	2.4	30.1	39.9	6.1	10.8	1.0	3.5	5.1	28.5	39.2	6.6	57.6	4.7	4.0	1.5	12.1	17.4	1.8	6.4	5.0	7.3	18.2	1.4	10.9	13.2	0.5	8.0	34.0	3.0	3.8	54.0	29.2	1.3	4.9	10.6	11.6	1.1	70.5	9.9	15.8	5.2	0.3	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	68.7	0.4	0.0	0.3	0.6	0.1	0.8	0.1	5.5	0.2	0.3	0.3	0.1	0.0	0.1	1.4	0.1	8.7	0.0	0.0	0.1	0.0	0.8	0.3	6.4	0.0	0.7	0.4	0.2	0.2	0.2	0.0	168.4	0.3	94.4	0.9	13.0	0.3	0.3	0.2	15.1	0.1	0.2	23.7	1.1	0.2	0.2	0.8	0.1	0.2	5.4	0.4	251.4	0.1	0.5	0.1	0.3	1.6	0.2	0.3	1.3	0.1	161.2	0.3	0.2	20.6	140.5	0.1	0.1	1.1	1.9	0.1	231.5	0.6	8.1	3.8	3.4	2.4	4.1	3.5	5.1	4.7	4.0	5.0	3.8	4.9	5.2	0.4	6.4	7.7	0.7	94.2	1.1	21.0	13.1	21.1	0.0	4.1	3.4	1.2	30.0	7.3	40.5	0.0	23.0	64.0	9.2	27.4	14.6	3.1	14.4	1.9	0.3	4.9	5.3	1.0	13.8	17.5	0.7	35.7	22.9	1.3	0.0	2.9	27.8	22.8	0.0	1.3	19.4	30.5	9.0	13.8	1.1	0.3	18.2	1.8	157.4	4.8	0.0	0.0	2.5	0.9	4.4	22.4	0.0	80.4	5.1	64.6	2.3	3.4	0.0	6.6	0.3	0.7	1.6	0.1	34.7	1.4	41.5	3.6	0.5	22.5	23.8
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168753-57266641	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;choroid plexus: 43.8;thyroid gland: 45.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Basal squamous epithelial cells: 51.8;Cytotrophoblasts: 137.4;Oligodendrocyte precursor cells: 74.4;Squamous epithelial cells: 44.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 172.1;MCF7: 202.3;OE19: 94.4;RPMI-8226: 77.8;SK-BR-3: 128.4;U-698: 237.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	NA	NA	248000			"Cluster 27: Brain & Skin - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: AB_2683518"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	6.5	33.1	1.9	34.6	0.0	1.3	37.2	27.9	8.5	43.8	2.9	2.2	1.2	17.2	23.9	9.5	0.4	13.8	35.6	28.5	6.3	0.0	1.6	1.0	36.2	36.3	0.2	0.5	0.0	2.7	25.7	34.7	5.9	1.7	5.3	3.9	9.2	0.3	22.5	1.9	0.3	32.8	0.6	3.6	0.7	39.7	3.8	45.9	0.0	2.1	6.8	13.0	42.8	0.3	0.7	23.4	5.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	20.0	6.8	172.1	41.3	0.0	8.7	48.3	5.2	0.0	0.0	0.4	17.2	0.1	0.0	0.0	0.0	0.0	5.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	202.3	0.0	0.1	12.3	94.4	0.0	0.1	0.1	77.8	0.0	0.2	0.4	17.8	5.5	128.4	0.5	15.2	0.9	0.4	0.4	0.1	10.9	0.0	0.1	0.2	0.3	237.6	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	34.6	37.2	27.9	35.6	28.5	36.2	36.3	34.7	32.8	39.7	42.8	0.6	6.4	2.2	74.1	0.4	13.8	13.4	12.9	51.8	4.7	0.9	4.6	15.1	0.0	4.2	1.8	0.0	137.4	0.1	0.2	0.0	0.0	5.3	1.7	2.4	1.2	2.4	0.0	0.9	0.0	21.0	13.5	2.0	2.5	21.6	0.1	0.0	0.0	11.0	1.7	4.7	1.5	6.1	0.0	1.9	4.9	0.3	0.4	3.6	2.8	0.1	38.4	0.0	74.4	8.7	0.0	0.3	0.4	2.5	6.6	0.2	2.2	1.9	2.4	0.0	1.3	0.8	1.8	3.4	44.2	9.7	56.9	0.9	0.7	1.5	18.1
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"epididymis: 102.6"	"Group enriched"	"Detected in some"	4	"Endothelial cells: 28.2;Hepatic stellate cells: 93.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	77	"granulocytes: 7.6"	"Cell line enriched"	"Detected in some"	119	"HUVEC TERT2: 353.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	7.7	0.3	0.3	1.7	0.5	7.1	4.9	0.3	0.6	1.7	1.1	3.8	4.4	2.3	102.6	2.3	2.6	2.6	8.8	0.3	0.3	0.6	0.7	3.0	1.5	0.3	0.4	0.9	0.9	0.3	0.2	4.7	0.3	0.9	2.4	0.0	1.1	0.9	1.3	1.6	4.8	2.6	0.3	2.2	1.4	0.2	0.4	0.7	2.0	2.2	0.4	2.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	353.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.6	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.4	14.1	0.0	1.1	1.3	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.2	0.0	28.2	4.2	3.2	1.3	0.2	0.0	1.1	4.6	0.2	0.0	0.1	93.9	0.7	0.1	0.0	1.2	0.1	2.0	0.0	1.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.8	0.0	0.0	0.3	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.4	0.4
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"		Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	23.5	0.1	0.0	0.0	4.2	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BOK	"BCL2L9, BOKL, MGC4631"	ENSG00000176720	"BCL2 family apoptosis regulator BOK"	Q9UMX3	2	241551424-241574131	"Plasma proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 218.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 100.8;Oligodendrocytes: 47.0;Proximal tubular cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"TIME: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (6.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.30e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.09e-9)"	"unprognostic (9.48e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"	90.6	7.1	88.4	6.2	138.6	0.4	37.7	110.4	110.3	15.6	51.0	38.0	8.1	34.2	16.3	29.5	18.1	22.7	6.3	77.0	87.8	20.5	97.0	20.1	3.7	146.6	120.6	9.9	16.3	3.8	4.7	5.7	127.1	28.5	5.0	1.2	11.8	25.5	2.6	20.0	9.4	20.4	98.5	6.5	21.5	7.7	115.4	1.1	11.0	3.2	3.4	34.9	18.6	218.8	36.0	8.8	15.7	36.2	26.3	15.6	4.4	28.6	11.3	36.9	37.9	16.2	14.6	0.1	9.7	51.0	9.0	32.9	1.7	28.9	13.8	0.1	0.3	0.1	9.3	42.2	21.8	0.2	1.3	15.9	29.2	15.5	4.4	27.8	44.6	2.4	6.4	0.1	36.7	46.0	0.2	0.2	9.9	40.0	26.8	0.4	25.9	0.2	24.2	0.9	14.0	5.4	13.2	8.5	23.3	18.3	24.4	1.3	65.0	0.1	52.8	0.7	3.2	0.1	0.1	0.1	0.1	0.0	2.1	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.7	1.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.6	88.4	138.6	110.4	110.3	77.0	87.8	146.6	120.6	127.1	98.5	115.4	218.8	22.5	6.4	32.1	0.3	0.5	7.1	11.5	8.6	5.2	0.2	19.4	10.5	10.2	32.9	6.3	11.0	0.0	2.0	2.5	5.8	15.6	23.2	0.2	6.6	17.6	15.6	11.4	5.3	0.8	11.1	10.5	10.9	5.6	14.4	0.0	2.6	12.5	100.8	0.7	0.0	1.5	3.7	2.0	4.7	1.2	1.5	6.2	0.7	1.8	4.7	0.0	3.9	6.2	7.5	47.0	27.7	2.8	10.5	0.9	26.3	7.1	41.9	1.5	1.3	0.0	11.7	11.2	0.3	8.2	19.8	12.8	6.2	1.6	3.4	6.1	15.1
BRCA2	"BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11"	ENSG00000139618	"BRCA2 DNA repair associated"	P51587	13	32315086-32400268	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 3.1;testis: 2.7"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 115.4;Spermatogonia: 85.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA026815	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA026815: AB_10602692"	"unprognostic (9.36e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-9)"	"unprognostic (2.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.0	1.3	0.0	5.8	0.5	0.0	0.0	0.2	0.2	0.7	0.5	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.3	2.1	0.1	0.1	0.1	0.1	0.0	0.0	1.0	0.1	0.1	0.8	0.0	0.2	0.0	0.0	0.7	0.5	0.3	0.1	0.9	0.6	2.7	0.2	3.1	0.2	0.0	2.0	0.5	0.2	0.1	4.7	4.0	6.0	5.0	0.6	1.4	7.0	4.8	3.1	5.5	5.0	10.6	6.0	15.9	3.2	2.1	7.6	6.1	5.5	2.9	10.5	10.5	3.1	10.3	2.5	3.5	0.1	15.4	4.9	0.2	0.0	10.3	6.9	0.4	4.5	8.1	7.0	5.5	6.4	5.1	11.8	8.3	8.3	4.9	2.3	11.4	17.3	3.0	1.4	5.4	2.4	4.6	5.9	2.4	2.2	2.2	2.9	7.3	1.3	6.3	6.8	7.0	6.7	2.0	3.3	8.0	2.7	5.7	5.8	0.0	0.3	1.5	0.5	0.7	0.1	1.7	0.4	0.4	0.3	2.2	0.5	0.4	0.8	0.5	0.8	3.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	4.4	9.6	2.6	0.0	12.4	2.5	3.3	2.5	2.2	0.0	4.3	3.3	1.9	0.0	1.8	0.0	0.0	14.1	10.5	4.8	0.0	2.5	5.2	4.4	6.3	5.5	1.2	29.5	0.7	1.6	12.7	5.8	10.7	4.6	3.8	26.9	1.4	0.8	9.5	0.0	0.5	4.4	0.0	7.5	11.0	4.4	2.1	14.4	3.6	4.7	20.1	0.3	0.0	0.0	0.6	1.2	1.8	1.2	27.8	1.2	1.0	0.6	2.9	0.0	13.1	8.3	5.3	115.4	85.6	8.0	1.3	5.5	7.9	4.2	7.8	2.3
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369435	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.5"	"Group enriched"	"Detected in some"	8	"Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	0.1	3.8	28.8	0.0	23.3	0.0	2.4	20.5	43.5	0.5	0.0	0.2	0.2	0.7	4.9	0.6	0.0	1.4	1.8	35.7	17.8	1.7	0.6	1.9	0.0	9.6	20.6	0.1	0.0	0.0	1.6	0.0	16.8	1.5	0.1	5.3	0.7	5.2	0.3	0.1	0.6	0.1	16.0	0.3	0.2	0.5	27.7	0.8	0.3	0.1	0.0	0.3	0.2	18.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	17.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	7.4	3.2	0.0	0.0	0.0	6.0	0.6	0.0	0.0	1.1	1.8	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	23.3	20.5	43.5	35.7	17.8	9.6	20.6	16.8	16.0	27.7	18.8	0.1	0.0	0.0	178.9	0.0	0.0	0.5	0.5	0.0	8.7	8.1	4.2	0.9	0.0	0.1	0.0	25.0	0.1	0.0	0.3	0.0	0.0	2.1	0.5	15.9	0.5	2.4	0.0	285.7	0.0	0.0	0.4	0.0	0.4	0.0	0.2	2.9	0.0	0.3	1.7	163.4	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	8.4	0.0	1.6	0.0	204.6	4.9	0.1	0.0	0.4	0.0	0.4	0.0	23.9	0.0	2.6	0.0	0.0	0.4	1.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177170958-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.6;brain: 19.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 121.1;Excitatory neurons: 116.8;Inhibitory neurons: 148.3;Oligodendrocyte precursor cells: 96.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.7;PC-3: 1.3;REH: 2.1;SCLC-21H: 5.6;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.6	9.6	17.2	0.0	16.5	0.0	0.9	1.3	19.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	17.9	10.7	0.0	0.1	0.0	0.0	4.5	9.6	0.0	0.0	0.0	4.2	0.5	4.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	2.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	16.5	1.3	19.9	17.9	10.7	4.5	9.6	4.9	4.9	16.2	13.4	0.0	0.0	0.0	121.1	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.2	0.3	0.0	0.0	0.0	116.8	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.1	15.2	148.3	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	25.3	0.0	0.5	0.0	96.5	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554477-49671549	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 33.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 76.6;Horizontal cells: 25.2;Inhibitory neurons: 50.1;Oligodendrocyte precursor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 33.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.0;SCLC-21H: 4.4;SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	0.1	1.4	8.2	0.1	17.6	0.0	0.1	0.1	33.6	0.2	0.0	0.2	0.1	0.3	3.0	0.0	0.1	0.0	0.2	17.2	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.6	0.3	5.3	0.1	0.0	0.2	0.0	3.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.3	3.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	4.9	0.1	0.2	1.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.5	0.1	0.4	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.0	0.2	0.0	0.4	0.2	0.1	0.8	0.1	0.5	0.0	0.1	0.2	0.0	0.2	4.4	2.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	17.6	0.1	33.6	17.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	15.0	0.2	0.5	2.5	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.0	0.0	7.8	0.4	0.3	0.5	0.0	0.0	76.6	0.5	0.1	0.3	0.0	0.3	0.0	0.6	0.7	0.4	0.1	25.2	50.1	0.1	0.0	0.3	0.0	11.7	1.2	0.1	1.8	9.4	0.0	3.9	2.1	22.6	6.3	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	8.8	0.0	1.0	1.3	6.7	8.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1
BTNL3	"BTN9.1, BTNLR"	ENSG00000168903	"Butyrophilin like 3"	Q6UXE8	5	180988846-181006727	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	65	"intestine: 115.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 118.3;Intestinal goblet cells: 36.4;Paneth cells: 50.5;Proximal enterocytes: 176.0;Undifferentiated cells: 26.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	206	"neutrophil: 22.3"	"Lineage enriched"	"Detected in single"	206	"granulocytes: 22.3"	"Not detected"	"Not detected"																	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"						"unprognostic (4.07e-2)"		"unprognostic (3.64e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.00e-1)"		"unprognostic (1.10e-1)"	"unprognostic (5.57e-2)"		"unprognostic (2.19e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"		0.2	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	26.0	115.3	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.2	0.0	0.0	0.0	0.0	0.0	80.7	0.4	0.0	0.8	1.7	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.0	0.0	0.0	118.3	0.0	0.0	1.1	0.0	0.0	0.2	2.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	0.0	1.4	0.2	0.1	0.0	0.1	36.4	0.0	0.3	0.0	1.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	50.5	0.0	0.0	0.0	176.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.2	0.0
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 119.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 79.6;Proximal enterocytes: 178.9"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 233.4"	"Lineage enriched"	"Detected in many"	221	"granulocytes: 233.4"	"Group enriched"	"Detected in some"	28	"CACO-2: 39.3;OE19: 56.2"									HPA039738	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.6	0.3	0.2	2.1	0.2	7.3	0.5	0.2	0.4	0.0	0.1	26.7	119.0	0.1	0.0	0.2	1.3	6.9	0.3	0.2	0.3	0.6	0.6	2.6	0.3	0.3	0.3	0.1	1.7	0.2	0.2	0.2	0.4	0.1	25.7	0.0	0.1	0.0	0.3	0.0	86.5	0.6	0.2	3.1	7.2	5.5	0.3	0.2	1.1	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	56.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	1.6	0.0	0.2	0.4	0.0	0.1	1.0	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.4	0.0	0.5	0.0	0.4	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	0.3	0.4	0.2	0.3	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	8.6	0.1	0.0	0.0	0.0	0.0	79.6	0.0	0.2	0.3	0.0	0.0	0.6	3.6	0.0	0.3	2.6	0.0	0.2	12.2	0.0	0.0	0.0	11.7	0.1	0.8	0.0	0.1	29.6	0.0	4.5	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.3	0.0	0.0	0.0	178.9	0.1	0.8	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	15.6	0.1
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637528-110678063	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 221.5"	"Region enhanced"	"Detected in single"		"white matter: 1.7"	"Not detected"	"Not detected"			HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	0.5	0.4	0.1	8.4	0.3	11.9	1.2	0.1	0.1	0.9	0.0	4.3	4.0	1.0	3.5	4.7	0.5	0.9	0.6	0.1	0.1	0.3	0.6	1.2	15.9	0.1	0.6	0.4	0.2	0.7	0.0	3.2	0.3	0.3	5.7	0.1	0.9	0.1	0.1	2.7	3.5	2.2	0.0	5.6	1.9	30.3	0.4	27.5	0.4	0.2	17.0	2.4	1.6	0.3	96.0	29.4	68.5	46.8	3.8	5.3	38.8	50.9	32.9	85.6	62.3	58.3	55.0	64.7	30.9	30.1	80.1	43.2	93.9	35.0	105.7	51.4	45.6	221.5	26.2	50.6	0.8	63.5	57.0	1.7	2.8	65.2	33.1	12.7	49.8	73.2	96.8	126.5	76.8	33.7	126.3	39.0	71.2	39.4	55.3	69.3	64.2	102.7	18.3	27.0	48.3	21.4	34.2	31.4	27.2	44.1	24.0	60.6	19.1	39.7	57.5	28.8	69.0	67.3	65.5	75.4	24.2	48.6	69.8	1.1	0.0	0.2	0.2	0.0	0.3	0.5	0.9	0.5	0.1	0.5	0.6	0.4	0.0	0.5	0.0	0.9	1.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.3	0.0	0.4	0.3	0.2	0.0	1.5	0.0	5.5	0.5	0.5	2.0	0.6	0.0	0.9	0.8	1.1	0.0	1.6	0.0	0.0	5.8	2.5	2.4	0.0	0.3	13.5	4.5	1.5	1.1	0.0	24.8	0.2	0.0	9.8	2.2	2.0	2.2	0.0	66.1	1.8	0.3	8.1	0.0	0.2	3.1	4.1	1.6	1.4	7.5	0.3	2.0	0.0	0.0	0.6	0.0	0.0	0.5	1.0	0.1	0.0	0.4	35.2	0.5	0.3	0.1	1.8	0.0	6.6	0.2	3.7	85.6	20.0	4.0	0.4	0.7	2.9	0.5	5.9	0.9
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221123	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA008419			Supported	Cytosol		Yes	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	0.4	0.5	0.1	6.7	0.1	17.8	1.6	0.3	0.2	1.0	7.7	4.6	4.7	1.2	0.3	5.2	0.6	0.6	0.3	0.3	0.1	0.3	0.4	1.0	12.6	0.0	0.1	0.2	0.2	0.2	0.1	3.4	0.1	0.4	6.0	0.1	0.9	0.2	0.0	3.5	4.1	2.1	0.0	3.1	2.4	22.2	0.2	35.7	0.5	0.0	15.0	1.5	1.7	0.0	66.5	32.8	103.0	41.5	2.5	7.1	33.2	60.9	34.2	64.6	55.7	48.1	25.0	59.7	33.5	22.7	59.0	72.6	98.8	33.2	70.5	51.8	52.1	86.4	83.6	45.5	0.2	79.0	45.7	1.6	2.0	39.2	37.1	12.9	47.7	66.5	76.4	61.7	65.6	22.5	62.5	48.9	70.2	55.6	36.8	66.5	83.7	45.2	19.9	33.1	67.1	40.8	38.0	35.9	13.3	45.1	41.9	40.9	27.6	49.3	51.8	49.2	55.5	32.1	58.2	95.6	26.3	87.8	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	3.2	1.1	0.3	1.8	0.8	0.3	1.0	1.8	0.7	0.9	2.0	0.8	0.0	1.9	0.0	0.0	5.4	0.6	1.8	0.0	0.4	3.0	0.9	1.4	1.0	0.0	23.5	0.7	0.0	6.7	2.4	5.6	2.1	0.0	12.9	1.1	0.3	5.2	0.0	0.7	2.5	0.0	1.9	1.7	3.3	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.5	0.4	12.6	0.3	0.3	0.1	0.2	0.2	6.6	0.2	1.7	79.2	26.8	6.9	0.3	0.8	1.8	0.8	5.4	0.6
C10orf82	"Em:AC016825.4, MGC33547"	ENSG00000165863	"Chromosome 10 open reading frame 82"	Q8WW14	10	116663696-116670264	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 84.5"	"Group enriched"	"Detected in some"	113	"Early spermatids: 1053.9;Late spermatids: 1926.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;Hep G2: 2.8;NTERA-2: 1.4;SuSa: 2.5;T-47d: 3.5"	"Not detected"	"Not detected"							HPA043022			Approved	Mitochondria		Yes	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Mitochondria		"HPA043022: "	"unprognostic (9.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.52e-2)"		"unprognostic (3.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.07e-1)"	0.3	1.7	0.3	0.2	0.2	0.0	0.9	0.1	0.4	0.4	0.0	0.9	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.8	1.2	0.0	0.0	0.0	0.3	0.5	3.6	1.1	0.0	1.0	0.0	0.4	0.9	0.2	0.1	0.2	0.7	0.0	0.2	0.4	0.0	0.2	0.1	0.4	84.5	0.9	0.0	1.6	0.1	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.8	0.3	0.5	0.4	0.2	0.9	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	1.1	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1053.9	0.3	0.2	0.5	1.2	0.0	0.5	0.2	0.1	0.1	0.0	0.7	0.0	5.6	0.0	0.0	0.1	0.0	1.8	1.1	0.0	0.0	0.0	1926.7	9.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.3	0.0	0.7	0.1	0.1	0.0	0.0	13.1	0.4	0.2	10.5	8.0	0.0	0.0	0.0	0.1	8.0	1.2	0.3
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173801-84185294	"Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 193.2;intestine: 274.9;vagina: 115.3"	"Group enriched"	"Detected in some"	11	"Distal enterocytes: 853.2;Intestinal goblet cells: 267.6;Paneth cells: 815.9;Proximal enterocytes: 364.8;Undifferentiated cells: 402.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 91.5;head and neck cancer: 102.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 52.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.4	0.0	0.0	16.8	0.0	0.0	0.5	0.0	0.0	46.7	0.0	268.5	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	274.9	0.1	21.7	2.6	0.0	38.5	21.5	13.1	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	17.4	33.5	115.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	52.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.8	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.1	853.2	0.0	0.0	0.4	3.3	0.8	0.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	267.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	815.9	0.0	0.0	1.0	364.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	46.0	2.3	0.0	1.4	0.0	402.8	46.4
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 68.0"	"Group enriched"	"Detected in some"	20	"Distal enterocytes: 212.2;Paneth cells: 132.8;Proximal enterocytes: 506.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;SiHa: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavorable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavorable (6.97e-5)"		"prognostic unfavorable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	15.4	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.0	0.1	10.4	68.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	64.2	0.7	0.1	0.0	2.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	132.8	0.0	0.0	0.0	506.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	8.4	0.2
C11orf96	AG2	ENSG00000187479	"Chromosome 11 open reading frame 96"	Q7Z7L8	11	43925342-43943878	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 750.2;ovary: 721.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 796.5;Endometrial stromal cells: 906.3;Fibroblasts: 801.3;Granulosa cells: 982.4;Peritubular cells: 474.3;Smooth muscle cells: 1942.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"SH-SY5Y: 197.7"	"Low region specificity"	"Detected in all"							HPA038843	Uncertain		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Focal adhesion sites, Cytosol"		"HPA038843: AB_10673296"	"unprognostic (1.55e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.42e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.19e-2)"	478.3	199.0	28.7	39.2	24.3	4.9	203.5	26.1	34.2	305.0	18.4	151.0	19.7	283.4	8.7	44.8	750.2	61.1	269.3	24.8	44.4	226.8	179.2	377.9	6.8	93.8	42.4	721.3	60.7	3.2	126.5	15.4	38.5	157.3	8.4	1.3	22.2	14.3	110.8	97.2	130.3	28.4	35.1	54.4	240.2	67.8	44.5	5.0	119.4	10.3	0.7	176.3	148.1	21.0	0.0	0.0	0.0	0.0	4.0	2.0	1.1	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.5	0.5	2.1	0.1	0.4	0.0	0.0	0.0	2.9	6.2	0.1	0.0	0.8	0.5	0.6	0.3	0.1	1.4	0.0	0.0	1.2	2.1	2.3	0.0	0.0	0.0	2.4	2.7	1.7	0.0	0.9	10.3	0.7	4.7	0.0	0.0	2.2	197.7	0.0	0.0	19.4	5.5	0.0	2.3	2.7	9.2	3.8	2.3	0.2	22.5	0.2	3.2	7.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	24.3	26.1	34.2	24.8	44.4	93.8	42.4	38.5	35.1	44.5	21.0	796.5	6.4	139.9	0.0	1.9	92.9	15.2	1.6	5.2	15.4	8.2	13.7	6.0	0.0	1.9	0.0	2.1	1.5	13.7	0.3	0.0	4.5	4.3	34.1	906.3	260.3	0.0	2.7	0.0	0.6	4.4	801.3	4.1	183.3	13.9	982.4	172.7	6.4	3.8	1.7	0.0	0.2	0.0	8.4	171.8	13.9	215.6	27.1	174.3	0.0	0.1	2.7	0.0	0.0	0.0	1.9	0.0	474.3	9.4	73.6	0.0	0.0	0.9	9.3	302.4	173.2	1942.9	2.1	1.5	6.5	88.5	3.1	14.2	243.9	0.1	50.5
C12orf76	FLJ40142	ENSG00000174456	"Chromosome 12 open reading frame 76"		12	110027028-110073634	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"brain: 77.2;choroid plexus: 44.0"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 174.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 60.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA039713	Uncertain		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 51: Myeloid cells - Hemostasis"	"Actin filaments"	"Plasma membrane"	"HPA039713: AB_2676640"	"unprognostic (9.20e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"prognostic favorable (6.44e-5)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (2.09e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	4.0	5.0	58.2	5.4	61.5	2.4	7.4	67.2	76.0	6.8	44.0	6.2	3.5	5.6	9.9	3.9	10.3	3.7	4.0	59.5	61.6	8.4	10.1	8.0	8.5	64.9	63.6	8.4	6.4	3.9	10.2	8.0	67.3	6.7	4.7	16.6	5.0	5.1	6.7	4.6	5.7	3.4	60.0	9.2	4.6	8.3	61.3	7.1	9.6	4.1	6.1	5.5	5.4	77.2	3.8	7.5	10.7	8.8	5.2	12.2	10.9	3.4	3.0	7.3	5.0	4.8	4.3	8.1	4.6	1.8	5.0	8.8	4.2	5.4	5.0	9.8	9.9	8.5	7.2	13.3	7.2	13.6	16.2	13.7	14.9	4.7	11.3	19.7	10.7	13.4	13.0	3.0	5.4	4.1	4.3	25.2	9.4	5.1	6.1	10.5	7.0	12.5	11.2	4.1	26.4	12.5	5.3	2.8	11.1	13.3	8.4	6.2	6.2	3.5	4.9	3.4	1.5	8.4	12.8	4.4	8.2	6.3	3.5	60.0	10.2	11.0	6.4	7.8	9.2	18.6	12.7	7.1	10.9	11.6	17.4	10.2	5.8	18.8	5.2	9.7	12.8	12.0	58.2	61.5	67.2	76.0	59.5	61.6	64.9	63.6	67.3	60.0	61.3	77.2	22.5	32.1	17.0	13.4	15.2	7.9	16.2	18.7	13.6	26.4	24.9	39.8	7.1	18.6	10.5	16.5	2.1	30.2	13.3	6.4	35.2	11.6	31.0	42.3	18.7	18.3	6.1	14.5	32.0	15.1	10.5	17.7	6.6	17.4	5.1	22.8	21.8	22.4	26.4	32.0	28.5	10.7	16.2	24.2	13.1	13.5	26.1	35.9	19.6	15.0	25.3	39.4	24.7	53.3	174.6	11.8	7.5	33.8	10.2	11.7	13.3	38.6	33.9	20.9	6.6	16.4	16.5	25.2	11.3	9.0	8.5	12.0	21.8	15.4	9.5	9.8
C15orf48	"COXFA4L3, MIR147BHG, NMES1"	ENSG00000166920	"Chromosome 15 open reading frame 48"	Q9C002	15	45430579-45448761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 924.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2962.4;Exocrine glandular cells: 2020.8;Langerhans cells: 2043.7;Pancreatic endocrine cells: 3493.6;Paneth cells: 2254.4;Proximal enterocytes: 2942.0;Undifferentiated cells: 1875.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.3;intermediate monocyte: 1.6;myeloid DC: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 70.9;CAPAN-2: 128.8;GAMG: 126.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012943	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA012943: AB_2668774"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.48e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-1)"	2.2	0.3	0.5	98.5	0.5	88.0	30.7	0.4	3.2	38.9	0.7	863.4	61.9	5.3	0.2	172.4	6.8	45.9	0.8	0.5	0.5	5.8	6.0	11.5	5.7	0.6	0.4	0.7	13.0	0.1	0.5	46.4	1.3	13.9	924.2	3.6	23.0	11.5	0.4	69.9	341.3	31.3	0.4	2.3	107.6	128.1	1.0	7.0	5.2	0.2	84.8	38.9	46.6	0.6	70.9	18.1	0.2	0.3	0.9	0.0	2.7	3.5	25.1	4.6	12.7	2.9	128.8	0.2	3.1	0.4	126.2	1.8	2.3	0.9	10.7	7.0	1.9	0.0	0.2	0.5	11.2	0.1	29.1	1.3	1.2	22.9	0.0	0.0	0.0	0.5	0.1	0.5	0.6	3.5	0.1	1.8	0.1	31.4	0.3	0.0	0.4	0.4	2.7	5.7	0.1	0.6	4.1	8.0	0.3	14.0	1.4	1.6	0.6	0.4	1.6	1.0	0.9	2.1	1.2	0.4	1.9	0.7	0.5	0.0	1.3	0.1	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.8	0.5	0.5	0.4	3.2	0.5	0.5	0.6	0.4	1.3	0.4	1.0	0.6	5.5	16.0	15.0	0.3	20.4	66.4	20.2	846.0	1.2	0.5	143.2	111.9	1.0	188.8	1117.6	5.5	0.0	286.2	7.4	2962.4	3.9	811.3	188.3	29.2	11.0	11.6	645.1	0.0	0.2	2020.8	450.3	16.4	250.2	67.7	33.0	0.2	1.4	3.7	398.4	114.4	0.1	1408.8	270.6	25.9	2043.7	235.4	7.2	388.4	58.7	0.0	489.4	0.7	1.0	0.5	0.4	3493.6	2254.4	7.5	4.1	200.5	2942.0	18.7	700.9	1.2	0.0	1.2	75.2	567.9	124.4	10.6	61.2	165.5	13.9	0.1	1875.4	633.4
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 108.3;thyroid gland: 228.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1400000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	17.8	4.2	20.0	6.0	21.6	0.2	12.8	18.8	28.3	20.2	15.0	6.3	17.6	3.5	87.1	6.7	12.4	45.0	18.8	19.4	19.9	16.8	0.3	108.3	0.9	19.9	18.5	2.8	5.4	0.1	5.7	0.9	19.0	4.2	5.0	0.5	35.0	1.1	0.2	0.6	7.9	4.9	19.6	0.6	82.4	1.2	22.6	2.8	228.8	3.9	2.2	14.4	3.2	22.7	0.0	0.1	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	2.5	1.3	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.7	0.3	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.0	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	20.0	21.6	18.8	28.3	19.4	19.9	19.9	18.5	19.0	19.6	22.6	22.7	0.9	44.8	268.1	23.2	0.0	0.4	1.8	0.3	0.6	0.5	23.6	18.0	2.8	0.0	70.4	0.0	0.0	0.1	0.1	0.1	113.5	0.0	1.7	3.7	0.4	1.3	0.0	0.0	0.9	7.8	0.1	43.8	17.3	0.3	5.1	0.0	0.0	0.0	6.0	0.0	0.7	0.6	6.1	0.0	0.4	2.7	9.3	0.7	0.0	11.2	0.0	0.3	0.0	1.0	1.6	0.7	0.4	14.7	0.0	5.0	0.0	1.5	16.9	0.2	0.0	1.9	1.9	0.8	0.1	0.6	0.3	0.3	0.6	0.0	0.7	5.0
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304164-38305006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 515.3;skin 1: 331.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2060.3;Pancreatic endocrine cells: 2590.4;Paneth cells: 1697.3;Proximal enterocytes: 1756.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"myeloid DC: 22.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 22.2"	"Cell line enhanced"	"Detected in many"		"A-431: 745.5;A549: 1228.0;CAPAN-2: 767.1;HBEC3-KT: 744.6;hTCEpi: 799.2;OE19: 678.3;PC-3: 659.8"	"Not detected"	"Not detected"							"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		460000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	43.1	5.0	2.8	17.6	3.1	3.6	25.5	2.9	4.4	82.4	2.9	187.5	186.7	6.1	0.6	515.3	91.5	49.5	32.9	2.3	2.6	28.2	1.3	91.3	0.9	3.1	3.0	4.6	8.9	0.5	12.7	7.9	3.4	26.2	104.1	0.1	123.3	18.3	3.9	331.1	189.5	4.0	2.5	10.7	151.5	1.5	3.8	4.1	18.9	4.3	30.8	102.2	224.3	2.5	745.5	1228.0	0.0	0.6	0.0	0.0	1.2	1.0	0.0	0.0	0.0	77.1	767.1	0.0	394.2	0.0	0.7	300.1	0.0	744.6	0.0	0.4	0.5	0.4	244.2	20.0	5.4	0.0	0.2	0.0	799.2	0.3	493.3	3.3	10.2	0.9	0.4	0.5	0.8	220.4	0.1	1.9	0.4	678.3	659.8	0.2	0.2	2.8	469.5	255.2	0.8	0.8	416.6	340.8	0.8	1.6	103.7	2.3	141.6	0.5	201.9	0.7	2.8	0.7	2.4	3.7	0.1	0.2	0.2	2.1	0.6	2.2	0.2	0.0	0.4	0.1	0.5	0.1	22.2	1.4	0.7	0.3	1.0	0.4	0.1	1.8	0.0	18.2	2.8	3.1	2.9	4.4	2.3	2.6	3.1	3.0	3.4	2.5	3.8	2.5	29.1	535.2	172.9	0.0	5.4	225.3	28.4	508.7	436.5	0.0	32.5	25.5	2.4	267.4	418.0	55.2	0.0	8.6	1.7	2060.3	1.9	207.7	0.7	144.3	26.0	18.4	76.1	3.6	0.1	753.8	1.3	44.7	353.7	273.2	38.2	3.7	3.6	0.4	1.3	0.0	0.0	842.0	99.7	1.4	15.1	5.1	4.1	32.9	1.8	0.0	4.9	0.0	0.0	0.0	0.0	2590.4	1697.3	0.0	5.7	35.7	1756.4	51.7	212.5	0.0	0.0	0.4	14.3	1.8	1.9	629.0	348.4	3.1	7.9	0.0	691.9	188.4
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018522-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.3;lung: 72.9;stomach 1: 58.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 176.3;Alveolar cells type 2: 99.4;Club cells: 68.5;Urothelial cells: 128.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 65.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 57.7;CAPAN-2: 99.5;HaCaT: 123.1;HBEC3-KT: 118.6;hTCEpi: 61.4;RPTEC TERT1: 56.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		180000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.4	0.0	1.6	0.0	0.8	10.4	0.0	0.1	15.1	0.0	8.9	24.5	0.2	0.7	102.3	2.6	9.8	0.5	0.0	0.0	8.4	0.5	72.9	0.0	0.0	0.0	0.1	12.9	0.0	0.3	0.2	0.0	50.9	8.4	0.0	29.4	1.9	0.5	37.7	20.3	0.3	0.0	0.2	58.7	0.9	0.0	0.3	4.2	0.5	16.1	20.6	31.2	0.0	57.7	7.7	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.1	99.5	0.0	6.5	0.0	0.0	123.1	0.0	118.6	0.0	0.1	0.0	10.6	1.0	1.6	0.0	0.0	0.6	0.0	61.4	0.0	34.2	0.0	0.0	0.2	6.9	0.1	0.0	0.1	0.1	0.2	0.1	37.3	3.3	0.0	0.0	0.2	56.4	15.1	0.1	0.3	1.1	11.1	0.5	0.4	0.2	0.2	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	176.3	99.4	0.0	0.3	20.8	53.0	26.8	10.8	0.0	5.4	7.2	49.9	30.0	68.5	11.0	0.0	0.1	0.1	40.7	15.6	24.3	5.7	6.7	1.4	1.7	10.7	0.0	0.1	24.4	0.0	1.6	50.4	14.9	6.3	0.0	0.0	0.0	0.2	0.0	0.1	19.8	12.2	0.0	1.2	5.5	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	60.7	35.3	0.0	0.3	56.5	31.8	0.3	41.0	0.0	0.0	0.0	2.8	0.1	0.0	24.3	23.3	0.0	0.3	0.1	8.9	128.1
C1orf198	"DKFZp667D152, FLJ14525, FLJ16283, FLJ38847, MGC10710"	ENSG00000119280	"Chromosome 1 open reading frame 198"	Q9H425	1	230837119-230869589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 192.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 13.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 138.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004798	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		80000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004798: AB_1848722"	"unprognostic (7.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (3.53e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.77e-2)"	39.7	13.4	77.5	11.0	106.4	5.3	30.0	93.3	83.7	36.5	41.1	35.2	11.8	38.8	14.9	14.9	32.7	32.3	45.4	72.6	85.0	17.3	14.7	66.9	15.5	108.4	105.1	27.3	27.9	20.1	7.6	31.1	108.9	21.4	11.4	9.8	23.4	32.3	106.2	34.0	13.9	46.1	97.8	18.0	29.9	6.8	94.5	6.6	34.9	26.1	9.1	33.2	26.4	131.3	22.4	16.7	44.9	30.8	81.9	59.9	76.7	40.4	63.7	20.4	20.6	53.0	12.3	26.8	24.5	138.1	10.3	14.1	23.5	8.9	15.0	87.5	22.3	4.2	15.0	17.9	35.7	13.9	4.0	72.9	13.4	8.1	8.9	43.7	12.9	16.9	8.7	9.0	14.1	15.0	11.0	6.6	52.6	49.5	13.7	25.6	32.1	6.0	16.2	26.7	26.0	41.5	20.5	27.2	14.2	23.6	34.6	11.8	10.3	32.9	32.8	7.7	24.5	16.0	7.7	8.0	8.7	8.7	95.3	13.1	1.3	0.3	2.0	2.7	2.4	1.9	1.3	0.8	1.7	1.2	2.6	2.3	1.0	2.9	1.3	0.2	0.6	4.7	77.5	106.4	93.3	83.7	72.6	85.0	108.4	105.1	108.9	97.8	94.5	131.3	11.1	192.3	23.2	35.3	1.2	26.0	13.1	6.4	7.4	2.0	32.7	23.7	36.4	32.9	17.3	11.0	10.4	17.5	1.3	2.6	1.9	41.9	11.4	8.2	8.9	11.6	5.4	9.9	2.6	26.3	32.2	33.2	3.6	10.6	2.5	15.1	8.6	4.5	11.0	25.2	5.3	9.0	8.2	1.8	19.4	8.3	13.4	11.6	65.8	13.1	3.6	12.8	0.0	6.0	67.5	31.1	3.7	9.1	2.5	21.3	2.8	7.4	12.2	4.6	32.9	26.8	45.1	10.4	5.7	8.9	29.0	12.9	3.4	5.2	6.9	18.7
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281877-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Nucleoli rim"		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.2	0.1	0.3	2.9	0.3	0.2	14.5	0.7	0.5	8.2	0.3	32.4	43.9	1.3	13.0	17.0	6.1	9.9	0.1	0.3	0.2	21.8	6.2	9.0	0.1	0.3	0.4	0.1	22.8	10.3	8.4	1.6	0.4	8.1	30.2	0.5	19.5	3.8	0.0	16.2	38.7	1.2	0.2	0.1	29.1	0.3	0.3	1.0	16.9	0.0	2.3	3.2	8.1	0.8	12.1	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	12.6	39.8	0.0	0.3	0.0	0.0	9.0	0.0	5.6	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.0	0.2	0.1	33.1	0.0	0.1	0.1	0.4	1.0	7.8	4.6	0.3	0.1	13.8	0.0	2.1	15.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.7	0.5	0.3	0.2	0.3	0.4	0.4	0.2	0.3	0.8	0.1	22.4	16.1	0.3	0.6	1.1	6.2	11.5	2.8	0.0	22.4	12.8	0.0	28.6	13.8	22.0	0.0	12.9	0.0	125.9	29.4	21.3	0.1	8.5	1.4	0.2	33.6	0.0	0.0	33.7	3.9	0.2	25.5	14.2	0.0	0.0	0.0	1.2	0.7	0.0	0.0	42.4	8.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.3	100.8	0.0	0.0	6.6	128.1	39.6	7.3	0.0	0.0	0.0	0.7	0.3	0.0	8.9	2.6	4.7	0.3	0.0	37.0	8.8
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636628-22639678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1092.6"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 1663.2;Kupffer cells: 5007.4;Macrophages: 1874.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"intermediate monocyte: 226.1;non-classical monocyte: 181.7"	"Lineage enriched"	"Detected in many"	60	"monocytes: 226.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.3;NB-4: 1.4;RPMI-8226: 7.1;SCLC-21H: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		2700000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	375.1	235.6	86.6	134.0	85.6	53.9	95.9	85.8	135.3	75.8	120.0	142.8	172.3	43.1	26.0	58.3	75.6	172.4	74.8	82.9	93.7	56.2	208.8	404.3	532.3	126.7	110.1	37.5	34.3	26.2	46.3	256.3	110.3	47.1	120.2	4.1	48.1	54.6	14.8	21.8	190.1	195.0	107.5	1092.6	90.8	38.2	109.4	100.3	36.5	49.3	68.0	257.5	30.4	131.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.3	0.0	0.0	0.5	0.2	7.1	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.4	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	5.2	0.1	0.1	226.1	0.0	0.0	0.1	0.1	3.7	0.0	0.0	0.0	0.5	0.3	181.7	0.0	0.0	9.7	86.6	85.6	85.8	135.3	82.9	93.7	126.7	110.1	110.3	107.5	109.4	131.6	17.4	35.3	55.8	0.0	19.0	18.4	2.3	0.0	2.2	0.4	5.1	24.6	8.9	37.1	18.0	0.0	0.0	8.7	2.7	0.5	0.0	0.0	4.5	0.2	0.5	46.0	1.8	41.0	0.0	0.2	11.3	9.6	0.0	0.2	21.5	0.2	76.1	26.2	1663.2	0.0	0.0	0.1	0.0	5007.4	291.4	9.9	13.1	1874.2	26.6	20.6	16.7	0.3	0.0	0.0	0.1	0.0	0.1	0.4	2.8	1.3	0.1	1.1	15.3	0.8	78.9	7.4	4.6	0.7	2.1	4.2	16.8	18.2	11.8	0.0	0.2	1.3
C1QB		ENSG00000173369	"Complement C1q B chain"		1	22652762-22661637	"Human disease related genes, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lung: 546.4;lymphoid tissue: 990.2"	"Group enriched"	"Detected in many"	28	"Hofbauer cells: 1451.0;Kupffer cells: 4559.7;Macrophages: 1747.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	71	"intermediate monocyte: 140.6;non-classical monocyte: 101.2"	"Lineage enriched"	"Detected in many"	85	"monocytes: 140.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 4: Macrophages - Innate immune response"			"HPA052116: AB_2681735"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	439.2	229.0	95.8	149.4	94.2	53.5	87.1	97.2	148.7	65.4	132.6	162.0	186.0	27.7	26.4	63.0	50.5	194.9	62.6	89.8	107.7	18.3	243.4	546.4	514.6	161.0	143.3	39.6	40.0	28.5	1.8	249.2	138.4	28.0	146.0	7.8	44.9	51.2	5.3	6.1	186.1	261.4	138.2	990.2	88.0	39.9	142.2	72.0	23.6	38.6	58.4	255.8	1.1	185.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.8	0.4	0.0	0.0	0.5	0.3	0.6	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.8	0.0	0.1	0.1	0.0	0.2	0.0	1.7	0.0	0.0	140.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.8	101.2	0.0	0.0	5.3	95.8	94.2	97.2	148.7	89.8	107.7	161.0	143.3	138.4	138.2	142.2	185.8	13.8	12.8	22.1	0.0	17.1	6.2	2.1	0.0	1.8	1.2	4.9	23.1	5.5	24.3	10.5	3.7	0.0	6.6	2.7	0.6	0.0	0.0	3.3	0.1	0.2	65.9	0.0	32.8	0.1	0.0	9.6	5.9	0.0	0.1	11.4	0.1	52.1	26.0	1451.0	0.0	0.1	0.0	0.0	4559.7	92.1	7.8	8.4	1747.2	0.0	34.7	5.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	2.3	1.0	0.3	1.1	3.6	3.9	59.2	4.0	3.2	0.4	0.9	5.7	4.5	9.6	6.1	0.2	0.0	1.5
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643633-22648110	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 950.7"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 1356.5;Kupffer cells: 2134.6;Macrophages: 1040.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"intermediate monocyte: 57.2"	"Lineage enriched"	"Detected in single"	541	"monocytes: 57.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 2.6;U-266/70: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	2100000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	285.2	196.0	60.1	159.7	58.6	43.5	70.5	64.8	97.1	51.9	90.6	133.2	179.9	36.3	13.5	55.3	67.4	155.4	58.6	54.9	75.5	41.2	169.6	290.8	370.2	124.7	105.4	32.1	37.5	22.1	39.6	204.9	105.0	37.8	91.3	3.9	51.6	44.5	12.9	18.3	195.7	164.7	100.4	950.7	94.8	33.9	106.0	75.7	29.2	31.8	50.7	191.8	24.6	159.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.2	0.0	0.0	0.6	0.2	2.6	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	57.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	1.2	60.1	58.6	64.8	97.1	54.9	75.5	124.7	105.4	105.0	100.4	106.0	159.3	13.4	6.4	5.2	0.3	13.7	8.9	1.1	0.0	2.8	0.6	4.9	24.5	1.6	15.7	3.1	0.0	0.0	5.8	2.3	0.4	0.0	0.0	3.2	0.0	0.1	34.5	0.0	27.2	0.0	0.2	9.5	4.4	0.0	0.1	5.1	0.1	25.4	6.6	1356.5	0.0	0.1	0.1	0.0	2134.6	202.4	3.6	6.2	1040.7	7.2	29.0	23.6	0.4	0.0	0.0	0.0	0.0	1.1	1.2	0.9	0.4	0.0	0.4	0.7	0.6	46.0	2.5	1.8	0.4	0.8	3.3	6.5	9.9	3.5	0.0	0.0	0.7
C22orf23	"EVG1, FLJ32787, LOC84645"	ENSG00000128346	"Chromosome 22 open reading frame 23"	Q9BZE7	22	37943050-37953669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 95.5"	"Group enriched"	"Detected in some"	7	"Early spermatids: 292.5;Late spermatids: 312.9;Spermatocytes: 241.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;U-138 MG: 31.4;U-87 MG: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000650			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA000650: AB_2732391"	"unprognostic (6.09e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.42e-5)"	"unprognostic (1.50e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.80e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.46e-2)"	2.9	2.6	3.9	5.6	8.8	3.0	0.8	9.5	5.1	1.7	4.7	3.4	2.9	8.3	1.3	14.0	12.4	6.4	5.1	4.7	7.7	2.3	0.4	5.0	3.6	12.8	10.4	2.5	8.6	1.1	4.8	5.3	11.0	5.0	0.1	3.5	10.3	0.2	5.7	26.0	3.8	0.1	8.2	2.3	9.0	95.5	9.7	0.2	8.2	0.0	0.1	6.2	1.2	16.1	6.6	5.3	11.1	10.3	0.2	0.4	13.7	18.4	0.5	0.5	0.7	6.3	5.9	3.5	5.0	0.4	11.7	31.8	0.4	0.1	0.6	6.7	13.4	2.0	4.6	4.3	0.5	5.4	4.4	0.4	0.2	2.2	0.2	15.4	0.1	2.6	2.3	2.0	0.1	4.1	0.3	3.2	1.6	6.6	4.6	6.0	16.1	1.3	0.1	29.4	5.6	4.0	8.2	3.2	10.3	17.5	3.6	7.3	27.8	31.4	10.2	25.1	10.0	4.6	2.0	1.6	46.9	2.5	18.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.8	9.5	5.1	4.7	7.7	12.8	10.4	11.0	8.2	9.7	16.1	0.2	0.0	2.4	1.3	0.0	0.3	0.1	1.8	0.0	0.2	0.3	0.8	0.1	1.5	1.9	0.0	0.0	0.1	0.1	0.1	1.9	0.4	292.5	16.8	0.6	0.6	0.0	0.0	0.5	0.4	0.1	0.5	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	312.9	6.8	0.5	0.0	1.0	0.0	2.2	0.0	1.0	5.6	0.3	0.0	5.3	0.0	0.1	0.0	1.8	37.8	1.2	0.0	0.5	0.4	241.3	5.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1
C2orf80	"GONDA1, LOC389073"	ENSG00000188674	"Chromosome 2 open reading frame 80"	Q0P641	2	208165343-208190030	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	4	"brain: 31.8"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 25.8;Inhibitory neurons: 11.7;Oligodendrocyte precursor cells: 31.7"	"Cancer enriched"	"Detected in single"	41	"glioma: 11.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042639			Approved	"Golgi apparatus"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA042639: AB_10794915"					"unprognostic (6.36e-2)"					"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.05e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.98e-2)"			0.0	0.1	21.0	0.4	26.5	1.1	0.0	6.3	31.8	0.0	7.4	0.2	0.2	0.1	0.0	0.9	0.1	0.2	0.1	27.2	20.5	0.1	0.3	0.0	0.2	11.6	13.3	0.2	0.0	0.1	1.0	0.1	13.9	0.2	0.2	1.4	0.3	0.4	0.3	0.4	0.3	0.1	11.0	0.1	0.2	0.6	17.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.5	1.7	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.3	3.2	0.6	0.5	0.3	0.4	0.2	0.5	0.3	0.3	0.2	0.7	0.3	0.3	4.6	0.5	0.3	0.8	0.1	0.1	21.0	26.5	6.3	31.8	27.2	20.5	11.6	13.3	13.9	11.0	17.0	15.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.8	0.0	1.0	0.0	31.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 36.8;Hofbauer cells: 161.5;Kupffer cells: 139.7;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 898.6;eosinophil: 450.8;intermediate monocyte: 273.6;non-classical monocyte: 371.3"	"Group enriched"	"Detected in many"	20	"granulocytes: 898.6;monocytes: 371.3"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 148.0"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	18.0	10.6	3.8	40.1	4.0	22.9	6.7	4.7	5.7	6.8	4.4	7.4	6.6	3.8	1.5	3.9	5.9	16.2	4.4	3.9	6.9	3.1	10.8	18.6	12.4	10.1	6.3	3.7	6.0	3.3	2.5	22.0	9.0	3.3	6.8	0.8	5.6	4.3	1.4	2.0	9.7	15.6	8.3	21.4	5.3	2.1	7.8	4.9	2.4	2.6	5.1	15.2	2.7	15.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.9	0.5	3.8	0.0	0.0	1.6	0.0	0.0	2.2	0.1	0.0	0.0	0.1	0.0	0.0	12.0	0.0	0.0	1.4	15.6	148.0	0.7	0.0	0.2	0.4	0.3	0.7	1.2	4.0	8.2	0.7	0.0	0.7	5.2	0.1	0.0	0.0	0.1	3.1	15.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	6.6	0.6	0.5	0.4	0.1	0.3	0.3	0.0	0.4	8.5	6.4	0.4	898.6	105.0	450.8	21.8	273.6	26.9	0.2	10.6	14.5	31.1	0.3	2.0	7.8	14.0	4.1	371.3	2.8	11.0	76.0	3.8	4.0	4.7	5.7	3.9	6.9	10.1	6.3	9.0	8.3	7.8	15.6	0.7	0.0	3.0	0.3	1.1	0.5	0.1	0.1	0.0	0.1	0.3	0.9	0.6	1.5	2.5	0.0	2.1	0.7	5.9	0.0	0.0	0.0	3.0	0.0	0.1	6.6	0.0	0.8	0.4	0.2	1.0	0.6	0.0	0.0	36.8	0.0	1.8	0.8	161.5	0.0	0.3	0.0	0.0	139.7	19.8	4.2	1.2	105.7	0.0	8.4	16.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.7	0.4	19.7	0.7	1.0	0.0	0.2	0.0	0.6	1.5	8.6	0.1	0.0	0.0
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185076838-185153060	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;smooth muscle: 14.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.7;Bipolar cells: 76.8;Melanocytes: 39.2;Oligodendrocyte precursor cells: 143.2;Peritubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.9;SCLC-21H: 16.4;SK-BR-3: 7.2;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	2.2	0.8	10.8	2.4	8.5	0.1	1.3	7.2	8.8	3.1	0.0	11.1	2.6	9.8	2.6	5.1	5.2	2.2	2.0	9.9	9.1	0.5	0.3	0.9	0.4	15.9	11.5	2.3	0.2	2.1	0.8	1.3	10.1	5.1	4.1	3.9	3.0	8.4	0.5	1.5	3.6	14.8	13.6	2.1	2.8	4.0	12.0	0.3	1.1	0.6	0.6	4.9	2.0	14.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	2.6	0.1	0.4	0.0	1.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.1	0.0	0.6	2.2	0.1	0.5	0.0	0.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.8	2.0	0.1	0.0	3.9	0.0	0.0	0.4	16.4	0.1	0.8	7.2	0.4	0.0	0.4	1.8	0.6	0.0	1.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	10.8	8.5	7.2	8.8	9.9	9.1	15.9	11.5	10.1	13.6	12.0	14.0	5.1	0.0	0.0	45.7	1.0	4.1	0.3	0.0	0.6	76.8	1.0	0.5	1.6	0.0	0.0	0.0	0.0	10.8	0.0	9.1	0.0	0.1	1.2	0.1	2.3	4.4	1.2	0.0	13.8	0.2	0.6	3.8	0.0	0.1	0.0	3.9	6.8	0.0	4.0	3.3	19.4	8.8	0.0	0.6	0.7	1.5	3.4	0.3	39.2	6.5	0.6	2.5	0.0	143.2	10.1	0.5	2.2	49.7	0.1	0.3	4.6	0.1	0.0	7.3	6.6	1.3	15.4	6.8	12.5	0.2	1.8	0.8	0.2	1.8	6.3	0.3
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"	A0A1B0GTC6	3	109118252-109151401	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 70.4;kidney: 13.9;liver: 19.8"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 169.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA		2900000		"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.1	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.2	0.0	0.0	5.4	70.4	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.2	13.9	19.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	64.6	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453925-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 45.4;Distal enterocytes: 61.3;Exocrine glandular cells: 51.8;Oligodendrocyte precursor cells: 46.8;Pancreatic endocrine cells: 53.6;Paneth cells: 67.2;Proximal enterocytes: 52.3;Syncytiotrophoblasts: 47.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.6"	"Group enriched"	"Detected in some"	5	"OE19: 64.6;RT4: 81.0;SK-BR-3: 32.6;T-47d: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	3.4	0.3	2.7	3.0	2.9	3.8	3.8	5.3	4.3	10.2	5.9	25.5	17.7	6.7	0.2	2.1	2.8	9.2	0.4	3.5	4.2	12.4	36.0	3.7	0.5	4.9	4.9	0.2	24.9	16.0	1.2	7.6	4.2	1.7	23.7	4.6	28.2	6.8	0.2	1.6	19.6	4.0	4.5	0.3	20.7	1.4	4.9	0.2	1.5	0.4	4.3	8.8	2.9	4.1	0.1	0.2	3.2	0.3	0.0	0.0	4.2	0.7	0.0	0.0	0.0	12.6	5.2	0.1	3.0	0.0	0.1	0.4	0.2	0.8	0.1	0.0	0.4	0.0	8.3	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	14.3	0.2	0.2	0.5	64.6	1.7	0.1	7.8	0.2	12.7	81.0	0.9	0.3	0.5	32.6	1.0	4.0	113.1	0.7	0.6	0.4	4.5	0.2	1.6	0.2	0.1	0.5	0.0	6.9	5.6	0.9	1.4	2.1	0.6	0.2	0.4	0.2	0.3	0.4	0.2	0.5	0.5	0.8	8.6	0.8	0.1	1.6	0.7	0.3	2.7	2.9	5.3	4.3	3.5	4.2	4.9	4.9	4.2	4.5	4.9	4.1	0.3	0.0	12.6	45.4	0.7	0.3	7.8	4.9	0.0	0.6	7.1	3.9	0.2	27.1	10.1	11.0	0.0	6.7	0.2	61.3	11.7	25.2	1.2	9.5	0.4	0.9	9.6	0.0	2.3	51.8	4.7	0.3	33.6	5.5	0.0	0.0	0.0	13.1	0.7	0.0	2.4	28.0	4.1	0.0	0.3	2.4	0.0	0.2	3.6	22.5	0.6	5.3	0.0	46.8	1.8	53.6	67.2	0.0	0.0	7.8	52.3	9.2	12.3	1.0	0.0	0.2	0.9	0.3	0.2	0.5	0.0	47.5	0.4	0.1	31.8	19.1
C4orf50	FLJ46481	ENSG00000181215	"Chromosome 4 open reading frame 50"	Q6ZRC1	4	5897373-6200555	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	22	"brain: 4.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 12.7;Inhibitory neurons: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (7.02e-3)"	"unprognostic (6.55e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.35e-2)"	"unprognostic (9.94e-5)"	"unprognostic (4.31e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.88e-6)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.68e-2)"	0.0	0.0	2.7	0.0	4.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	0.0	2.6	2.5	0.5	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.7	5.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.0	1.1	0.4	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 149.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA050769	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Nucleoli	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.1	0.0	0.5	2.1	0.4	0.0	12.4	0.2	0.4	10.4	0.1	32.8	19.0	2.3	0.0	3.0	3.7	5.5	0.0	0.4	0.1	0.2	0.8	5.8	0.0	0.6	0.4	0.0	5.1	0.0	0.1	0.0	0.6	17.0	41.6	0.0	25.4	1.4	0.0	5.4	15.1	1.2	0.2	0.1	32.9	0.0	0.5	0.1	0.1	0.0	0.2	1.2	0.4	0.6	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	149.2	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.3	0.0	0.0	18.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.1	0.6	0.4	0.6	0.2	0.5	0.6	0.4	9.6	16.3	0.3	0.2	0.3	3.4	5.9	6.2	0.0	20.5	10.8	0.1	20.0	14.5	0.0	0.0	0.0	0.1	35.4	0.0	6.0	0.0	4.0	2.0	0.5	25.9	0.0	0.1	11.1	0.0	0.2	25.0	13.9	0.0	0.0	0.0	3.3	0.1	0.0	0.1	139.7	40.7	0.0	1.0	0.0	0.0	0.6	10.6	0.0	0.0	0.0	0.0	0.0	0.1	3.9	40.0	0.0	0.0	12.4	4.4	0.0	5.2	0.0	0.0	0.4	0.9	0.0	0.0	10.9	0.4	0.0	0.4	0.0	79.8	5.5
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1798.9;intestine: 2109.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 11487.3"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	987	"HEL: 1022.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced					NA	NA		4600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	2.0	0.4	0.4	0.5	0.3	1798.9	2.1	1.0	1.5	0.3	0.0	1023.3	0.2	1.6	0.1	0.7	2.2	0.3	1.6	0.2	0.2	2.0	6.7	5.9	0.2	0.3	0.3	0.4	0.3	0.1	1.9	20.7	0.3	0.4	2109.9	0.4	1.1	1.8	1.0	1.4	1.8	30.7	0.1	35.4	2.3	0.2	0.5	0.5	0.9	3.4	0.1	0.4	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1022.7	0.0	0.5	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.4	0.3	1.0	1.5	0.2	0.2	0.3	0.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	4.2	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	2565.3	0.0	0.0	0.5	0.1	0.0	0.5	45.8	11487.3	11.8	0.0	0.0	0.1	0.0	0.1	22.3	0.0	4.2	4.4	0.0	0.0	12.1	159.4	0.0	11.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	13.0	2.2	0.0	754.9	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	0.1	298.4	0.0
CA10	"CA-RPX, CARPX, HUCEP-15"	ENSG00000154975	"Carbonic anhydrase 10"	Q9NS85	17	51630313-52160017	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 54.9;cervix: 21.8;retina: 44.5"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 1607.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.2;RT4: 2.1;SCLC-21H: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054825, HPA057837"	Supported		Approved	Vesicles	"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA054825: AB_2682617, HPA057837: AB_2683542"		"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.43e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.18e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"		0.0	3.2	22.9	0.0	21.0	0.0	0.0	54.9	27.2	21.8	7.9	0.4	0.3	0.2	0.0	0.0	0.4	0.1	0.0	23.0	20.6	7.2	0.0	0.0	0.0	33.4	19.3	1.9	0.2	0.0	3.9	1.0	33.4	0.0	0.1	44.5	1.2	0.0	0.0	0.0	0.5	0.1	19.5	0.0	0.1	10.2	30.6	0.0	0.0	0.0	0.0	0.1	0.1	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.2	2.1	6.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	21.0	54.9	27.2	23.0	20.6	33.4	19.3	33.4	19.5	30.6	17.6	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	211.9	0.0	0.0	0.4	0.0	0.0	3.7	4.2	0.0	0.1	0.0	15.6	0.0	134.5	0.0	0.0	0.3	0.0	0.0	343.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	17.0	0.0	0.0	0.0	0.2	84.4	1.2	0.1	0.0	14.0	0.0	5.1	0.0	1607.5	4.2	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	11.9	0.0	0.1	0.0	1.5	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463968-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 687.4;stomach 1: 1108.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1773.2;Erythroid cells: 2448.1;Gastric mucus-secreting cells: 1380.7;Muller glia cells: 1536.4;Paneth cells: 781.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 51.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 263.8;HEK 293: 1097.8;THP-1: 461.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001550, CAB010102"	Enhanced					NA	Yes		570000000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	7.4	10.1	95.9	36.8	127.5	246.8	37.9	122.1	143.8	5.0	444.0	687.4	285.2	2.9	10.6	19.8	2.7	112.7	15.9	105.2	107.8	331.2	273.5	43.1	6.6	115.5	112.0	0.4	55.1	10.1	6.1	19.6	114.2	1.9	643.6	390.4	74.7	68.4	42.7	81.0	31.3	32.3	98.2	8.4	1108.7	21.2	115.6	5.1	15.9	62.8	4.3	2.9	5.2	145.5	3.7	2.8	12.2	0.0	0.1	0.0	31.2	0.0	0.0	0.0	0.0	15.1	0.9	0.0	9.5	0.0	0.1	263.8	37.4	13.2	0.0	0.0	1097.8	35.8	17.0	0.5	0.0	23.7	5.1	0.0	63.9	0.0	3.7	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.4	41.4	3.7	86.5	0.0	21.2	1.3	0.5	3.7	8.8	0.2	0.3	5.0	0.0	0.1	9.6	0.0	461.5	0.0	0.0	6.6	0.0	0.4	0.4	1.0	0.1	1.8	0.1	0.0	51.2	5.3	8.6	0.2	15.0	7.4	1.3	0.1	0.8	15.4	3.0	0.0	0.0	12.6	0.1	13.4	1.4	0.0	33.3	95.9	127.5	122.1	143.8	105.2	107.8	115.5	112.0	114.2	98.2	115.6	145.5	19.4	16.0	79.9	34.0	19.6	90.6	1.3	152.5	17.6	23.1	56.9	18.4	19.8	430.4	22.4	161.8	64.6	15.2	2.4	1773.2	348.3	60.1	65.9	3.3	1.3	26.7	30.5	2448.1	1.4	11.3	403.1	6.4	1380.7	8.3	15.9	0.4	4.2	135.6	35.4	13.5	22.3	116.0	10.2	11.0	216.5	232.1	3.4	51.8	74.7	6.5	6.6	1536.4	1.0	3.0	226.4	16.1	781.9	2.2	10.3	3.5	0.3	468.2	3.9	66.1	0.0	12.1	8.2	3.1	2.8	31.2	111.7	17.1	11.7	0.7	390.8	0.5
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149942-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.6"	"Group enriched"	"Detected in many"	16	"Adipocytes: 704.2;Distal enterocytes: 1289.3;Paneth cells: 2368.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 99.5"	"Lineage enriched"	"Detected in single"	995	"granulocytes: 99.5"	"Cell line enhanced"	"Detected in single"		"OE19: 1.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 300.3"	"Low region specificity"	"Detected in all"			"HPA011089, HPA017258"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA		190000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	83.0	2.3	17.8	3.1	18.8	19.5	80.9	86.8	34.2	12.7	13.9	263.6	3.8	6.0	51.9	1.0	5.0	38.3	55.2	22.8	13.9	47.6	0.7	87.2	0.6	13.4	17.8	6.2	31.8	16.9	15.7	8.6	22.8	8.2	172.6	0.1	10.4	36.9	30.5	3.8	11.2	2.7	12.7	16.0	10.0	1.3	15.1	1.6	74.6	42.3	0.1	6.2	5.6	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.5	0.0	0.0	0.0	0.0	0.1	17.8	18.8	86.8	34.2	22.8	13.9	13.4	17.8	22.8	12.7	15.1	14.9	704.2	0.0	2.4	1.3	1.5	1.5	0.3	0.0	2.2	0.0	2.3	2.5	9.1	0.0	0.6	14.7	0.0	0.0	1.2	1289.3	33.2	11.7	0.5	0.6	13.0	88.3	19.3	0.0	3.8	0.2	0.0	4.4	0.0	0.2	11.4	23.2	1.4	0.0	0.6	0.0	1.4	24.6	0.0	0.0	1.2	0.1	0.6	1.1	0.0	23.4	0.0	0.1	0.0	1.0	0.4	0.1	2368.3	0.0	1.2	0.1	14.9	72.4	0.7	0.0	6.6	5.0	23.4	0.1	0.0	0.1	1.1	0.0	2.4	0.4	41.7	0.3
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844414-66854153	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 57.0"	"Cell type enriched"	"Detected in some"	40	"Paneth cells: 3026.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 1.1;THP-1: 1.9"	"Region enhanced"	"Detected in all"		"cerebellum: 67.2"	"Low region specificity"	"Detected in many"			HPA047237	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.0	0.0	5.1	0.2	6.7	0.0	0.1	4.8	10.7	0.0	2.1	57.0	6.9	0.1	0.9	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	0.0	0.0	3.8	3.5	0.0	0.0	0.0	0.1	0.0	3.5	0.0	48.6	0.0	0.0	0.2	0.0	0.0	10.0	1.1	2.6	0.0	0.0	0.5	4.7	0.1	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.7	4.8	10.7	8.0	3.1	3.8	3.5	3.5	2.6	4.7	5.6	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3026.3	0.0	0.0	0.5	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	39.9	0.1
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;pituitary gland: 6.8;testis: 5.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 388.8;Inhibitory neurons: 330.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Group enriched"	"Detected in many"	8	"amygdala: 5.9;basal ganglia: 7.8;cerebral cortex: 10.2;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022919, HPA044347"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Mitochondria		"HPA022919: , HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.0	2.8	5.9	0.1	7.8	0.0	0.0	0.8	10.2	0.3	0.0	0.4	0.0	0.0	0.6	0.0	3.1	0.4	0.3	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.8	6.8	0.0	0.0	0.5	0.1	3.5	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.3	5.1	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	3.7	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	7.8	0.8	10.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	43.4	0.0	0.0	0.1	0.0	0.0	11.7	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.0	0.2	0.1	0.0	0.0	388.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.7	330.9	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	17.8	0.6	1.7	0.0	16.1	10.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	8.2	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 42.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 188.7;Inhibitory neurons: 116.0;Oligodendrocyte precursor cells: 73.9;Oligodendrocytes: 34.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;NB-4: 1.0;NTERA-2: 1.1;U-266/70: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.0	1.0	33.5	0.6	30.5	1.2	0.0	0.0	34.6	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.7	0.0	0.3	42.8	3.4	1.3	0.0	0.1	0.4	4.6	6.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.2	9.7	0.4	0.1	1.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.5	30.5	0.0	34.6	42.8	3.4	4.6	6.2	0.9	9.7	3.8	1.1	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.4	0.0	0.0	188.7	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	116.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.5	0.0	0.2	0.0	73.9	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909278-53943950	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 32.0;Horizontal cells: 134.6;Inhibitory neurons: 43.3;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.3"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 52.8;GAMG: 14.6;HMC-1: 40.8;hTERT-RPE1: 51.4;SH-SY5Y: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"							"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			0.0	0.4	44.2	0.0	38.8	0.0	0.0	37.5	56.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	38.9	0.0	0.0	0.0	0.0	39.9	41.2	0.0	0.1	0.1	6.6	0.0	38.9	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	0.0	31.9	0.0	0.1	0.5	50.5	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	7.0	52.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	40.8	0.4	0.0	0.1	0.0	51.4	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	38.8	37.5	56.6	43.9	38.9	39.9	41.2	38.9	31.9	50.5	45.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	32.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	134.6	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.2	0.0	23.1	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 287.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 464.8;Astrocytes: 980.7;Bipolar cells: 566.6;Muller glia cells: 489.9;Oligodendrocyte precursor cells: 676.5;Oligodendrocytes: 622.8;Rod photoreceptor cells: 759.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 8.0;myeloid DC: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.1;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 294.7;WM-115: 187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		220000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	7.1	29.9	46.9	6.1	59.2	0.4	17.0	78.7	53.0	21.3	6.1	11.7	7.8	17.4	103.7	12.6	22.6	12.1	25.7	47.6	57.4	29.1	65.3	72.0	14.1	41.1	40.1	12.3	16.0	56.6	26.0	37.9	44.6	15.2	8.1	287.7	38.0	28.0	7.2	10.9	8.8	8.6	30.3	8.0	12.5	50.5	55.8	8.6	69.7	8.1	14.6	13.1	4.8	38.0	0.4	23.3	25.6	0.1	0.0	0.0	0.1	24.1	41.1	3.1	0.3	294.7	26.1	0.0	75.9	36.5	25.2	4.8	4.8	27.4	2.0	1.0	38.3	0.0	7.8	114.5	0.3	0.1	56.5	0.0	38.6	0.0	63.8	16.5	1.1	17.3	0.0	2.7	4.3	19.3	20.0	0.6	24.0	0.3	0.0	0.1	0.4	61.6	44.8	0.9	50.2	107.1	0.0	25.4	21.7	102.4	92.4	1.3	0.0	2.3	44.9	23.3	13.0	64.9	98.9	18.7	36.3	0.2	187.5	0.2	0.0	0.0	8.0	0.0	3.4	1.5	2.9	2.1	8.1	0.3	0.1	1.8	0.0	0.5	0.1	0.0	4.7	1.9	46.9	59.2	78.7	53.0	47.6	57.4	41.1	40.1	44.6	30.3	55.8	38.0	14.0	464.8	195.3	980.7	6.5	20.6	26.7	2.8	19.4	566.6	22.1	22.5	61.7	34.3	27.5	36.8	350.3	71.6	6.8	1.5	11.7	39.2	189.1	88.5	6.0	10.6	7.8	5.3	301.7	2.0	5.0	13.2	3.6	126.9	24.1	36.8	2.9	45.9	36.8	30.3	310.9	2.1	4.1	8.5	20.9	224.0	5.9	14.2	44.4	60.0	13.3	489.9	2.1	676.5	622.8	9.3	0.5	4.1	88.9	38.5	0.3	8.2	8.7	759.5	0.0	13.3	11.7	55.2	23.0	9.2	23.4	32.2	8.1	5.2	4.3	13.5
CADM2	"IGSF4D, Necl-3, NECL3, SynCAM2"	ENSG00000175161	"Cell adhesion molecule 2"	Q8N3J6	3	84958989-86074429	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"brain: 42.1;retina: 94.9"	"Group enriched"	"Detected in many"	6	"Astrocytes: 1985.3;Excitatory neurons: 4097.4;Inhibitory neurons: 3632.5;Oligodendrocyte precursor cells: 3613.6;Oligodendrocytes: 5060.4"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;AN3-CA: 31.4;U-266/70: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010024	Enhanced					NA	NA		250000	"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA010024: AB_2068039"	"unprognostic (2.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-4)"	"unprognostic (8.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.07e-5)"	"unprognostic (9.82e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.16e-2)"	4.7	4.6	10.8	0.4	20.7	0.0	1.7	12.8	42.1	0.6	0.0	3.5	0.3	0.2	0.5	1.0	3.0	0.9	2.7	20.7	13.0	0.1	0.8	0.5	0.1	15.2	17.4	0.6	0.7	0.4	2.9	0.2	16.3	1.7	1.0	94.9	0.6	4.4	3.9	0.3	0.9	0.4	7.0	0.2	1.8	0.5	21.1	0.2	0.4	4.1	0.1	0.9	0.9	14.6	0.0	0.1	10.9	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.5	0.0	0.0	0.0	0.0	3.6	2.3	0.9	0.0	0.0	0.0	0.0	0.0	1.1	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	20.7	12.8	42.1	20.7	13.0	15.2	17.4	16.3	7.0	21.1	14.6	57.3	0.0	1.1	1985.3	0.0	1.0	0.7	0.1	5.7	230.3	2.2	3.4	13.2	0.0	0.8	0.0	519.1	0.3	0.2	0.7	0.0	0.2	3.0	0.1	0.5	3.5	1.8	0.0	4097.4	0.2	0.2	3.6	0.0	0.1	0.0	0.3	2.9	0.0	0.4	94.2	3632.5	0.5	0.0	0.0	0.8	2.1	1.8	1.4	3.6	145.2	0.0	60.8	0.0	3613.6	5060.4	0.2	0.0	0.4	0.0	0.7	0.1	0.1	0.0	576.3	0.0	265.0	0.9	0.4	6.4	1.6	1.0	0.0	0.3	0.5	0.1	0.3
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 151.6;placenta: 80.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 146.4;Excitatory neurons: 35.5;Fibroblasts: 39.5;Horizontal cells: 35.3;Inhibitory neurons: 40.5;Muller glia cells: 39.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 65.0;HSkMC: 218.8;hTERT-HME1: 118.5;WM-115: 60.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported			"Intracellular and membrane"	NA	NA		800000		"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	17.3	7.9	102.0	15.1	139.6	0.1	9.2	151.6	145.4	27.6	1.2	28.2	4.4	3.9	1.3	11.5	9.2	6.2	18.1	143.1	96.2	2.2	0.6	5.0	14.3	87.4	84.1	1.5	2.2	0.2	31.0	80.6	120.7	5.1	14.4	66.8	5.9	4.7	2.3	13.0	15.8	6.1	66.3	13.3	11.1	3.0	99.4	1.2	7.3	6.5	9.8	16.2	31.0	60.8	0.0	0.0	0.6	0.0	4.2	1.2	0.0	0.0	0.0	9.4	1.8	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	3.7	0.0	0.0	65.0	0.0	0.2	218.8	0.0	0.1	118.5	0.0	5.3	0.0	0.0	0.2	2.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	4.1	0.0	0.0	5.0	0.0	0.1	9.1	0.0	32.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.0	139.6	151.6	145.4	143.1	96.2	87.4	84.1	120.7	66.3	99.4	60.8	4.2	0.0	0.5	11.4	0.0	6.6	0.1	0.0	0.6	146.4	0.1	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.0	0.0	0.2	8.0	0.0	0.0	35.5	0.0	0.8	39.5	0.5	0.0	0.0	0.0	3.6	0.0	1.2	35.3	40.5	0.0	0.0	0.0	10.7	8.3	0.6	0.3	24.9	1.9	0.0	39.4	0.0	18.6	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	16.3	3.6	3.1	2.6	0.3	4.3	0.7	0.6	0.0	0.0	0.1
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875416	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.6;retina: 184.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 772.6;Cone photoreceptor cells: 627.6;Excitatory neurons: 830.8;Inhibitory neurons: 1152.7;Oligodendrocyte precursor cells: 266.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 11.5;SCLC-21H: 19.7;SK-MEL-30: 9.0;U-698: 13.2;U-87 MG: 20.5"									HPA059328	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059328: AB_2683982"	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	0.4	16.4	32.2	2.0	47.7	0.1	0.7	18.7	84.6	2.8	0.0	2.8	3.2	0.6	2.5	0.2	0.4	2.4	16.7	32.1	26.0	0.2	0.2	0.8	0.5	83.2	39.7	1.9	13.5	0.2	39.6	0.2	84.5	3.6	2.4	184.3	1.4	2.8	0.1	1.4	3.3	0.8	4.1	0.6	3.0	3.2	33.0	0.6	0.2	0.0	0.7	0.4	1.4	61.7	0.0	0.0	0.8	0.0	4.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	11.5	0.0	0.1	0.0	0.0	0.0	0.0	19.7	1.5	0.0	0.0	9.0	0.4	0.0	0.0	0.1	1.6	0.1	3.3	0.9	0.0	1.7	13.2	20.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	47.7	18.7	84.6	32.1	26.0	83.2	39.7	84.5	4.1	33.0	61.7	0.0	0.0	1.9	93.0	0.1	1.3	0.2	0.0	0.0	772.6	0.5	2.8	25.6	7.2	0.0	0.0	627.6	0.1	0.0	0.4	0.0	4.1	1.1	0.2	1.1	0.9	95.9	0.0	830.8	0.4	0.0	3.2	0.0	0.1	42.5	0.2	0.0	0.0	0.0	47.1	1152.7	5.0	0.0	0.0	1.6	2.1	15.2	0.0	8.8	30.0	0.0	21.3	0.0	266.9	27.0	0.9	1.3	2.6	0.0	0.3	0.7	0.1	0.0	64.7	0.0	3.2	1.2	0.2	0.7	0.0	0.1	0.0	0.4	36.9	1.8	0.2
CALB1	CALB	ENSG00000104327	"Calbindin 1"	P05937	8	90058608-90095475	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 320.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 26.1;Collecting duct cells: 27.6;Cone photoreceptor cells: 91.8;Distal tubular cells: 31.3;Horizontal cells: 99.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.8;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 134.9;EFO-21: 189.8;HeLa: 65.9"	"Region enhanced"	"Detected in all"		"cerebellum: 430.7"	"Group enriched"	"Detected in all"	4	"basal ganglia: 49.7;cerebellum: 119.6"	"CAB002138, HPA023099, HPA056734"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.82e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.37e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.42e-1)"	2.4	1.6	7.4	2.0	31.3	1.3	1.7	63.0	21.1	5.5	0.0	1.7	3.2	1.2	3.4	8.5	1.9	1.4	0.9	9.2	14.0	320.6	2.6	3.6	0.9	16.8	10.4	1.2	2.5	2.2	8.4	3.9	6.3	0.8	2.5	54.1	1.7	0.5	1.9	3.5	2.7	1.3	15.9	1.3	2.3	3.6	32.1	2.7	2.5	0.3	1.2	0.5	0.1	7.8	134.9	6.1	30.2	1.2	1.1	4.9	4.0	2.0	5.8	0.7	1.1	2.9	15.1	0.5	189.8	0.1	0.8	47.8	46.0	54.6	9.1	0.3	2.5	3.2	65.9	0.7	5.3	0.8	4.4	1.5	17.3	2.5	25.4	7.0	36.1	2.6	9.9	3.4	35.9	0.6	1.9	0.1	45.3	2.9	17.9	1.3	1.2	3.9	12.9	0.7	5.0	2.9	38.2	2.3	0.6	45.8	1.7	1.1	0.1	3.9	28.1	6.6	11.9	3.1	3.9	1.0	0.5	0.9	0.2	1.5	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.4	0.3	0.0	0.4	7.4	31.3	63.0	21.1	9.2	14.0	16.8	10.4	6.3	15.9	32.1	7.8	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.1	1.5	0.0	0.0	27.6	91.8	0.0	0.0	0.0	31.3	0.0	14.9	0.0	0.1	0.3	3.5	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	99.3	14.7	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	15.8	0.0	1.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.8	0.0	0.3	0.4	0.3	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.9;thyroid gland: 20.7"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Group enriched"	"Detected in many"	4	"hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.5	0.6	0.2	0.1	1.4	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.3	6.8	1.0	0.8	0.1	0.1	8.9	11.6	0.1	1.5	0.3	2.2	0.1	18.9	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.3	0.1	0.1	0.3	1.0	0.0	20.7	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.6	0.3	6.8	8.9	11.6	18.9	2.3	1.0	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 70.7;lung: 76.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 173.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	70.7	6.3	3.4	12.3	4.0	0.4	15.8	6.1	4.4	27.8	3.4	6.9	6.0	21.5	4.6	8.6	11.4	24.4	20.4	3.9	3.8	14.0	12.6	76.8	7.9	11.1	6.2	15.7	4.3	13.0	3.6	11.7	10.8	7.3	9.5	0.9	7.1	7.7	6.2	3.9	6.3	27.1	15.5	8.6	7.1	2.7	3.9	4.6	28.3	20.2	9.1	14.1	4.7	15.2	0.2	0.0	8.8	0.0	6.2	1.6	0.0	0.8	1.3	0.1	1.0	0.0	1.0	0.0	2.3	0.7	0.2	0.0	0.0	0.6	0.2	1.5	0.5	1.5	0.0	0.2	4.9	0.2	0.0	4.6	0.2	0.3	2.1	0.5	173.6	0.1	0.0	2.5	1.2	0.0	0.8	0.1	0.5	0.0	0.0	0.0	3.1	0.5	40.5	0.0	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.2	25.3	0.7	0.1	0.1	0.4	6.2	0.1	0.7	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	9.2	0.0	0.8	0.1	0.1	1.0	1.0	2.6	0.0	0.9	3.4	4.0	6.1	4.4	3.9	3.8	11.1	6.2	10.8	15.5	3.9	15.2	138.3	0.0	11.9	19.6	1.2	9.3	2.3	1.7	21.6	0.2	0.8	1.8	12.3	2.8	3.6	0.0	0.0	0.4	2.4	0.0	3.9	0.3	0.8	3.1	92.7	248.7	0.0	4.8	15.4	0.4	0.2	56.5	1.1	1.7	5.1	12.3	259.2	1.8	0.9	0.0	2.1	0.0	2.0	10.3	29.7	1.0	7.8	15.4	10.6	47.8	16.1	0.0	1.0	293.0	1.0	0.1	0.0	2.6	4.9	1.9	0.0	13.2	2.8	0.1	6.6	4.1	21.5	1.3	0.7	18.2	6.8	0.3	3.0	6.0	0.0	1.8
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970729	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 916.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1190.3;Leydig cells: 1745.0;Peritubular cells: 2005.6;Sertoli cells: 2294.3;Smooth muscle cells: 2549.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 736.3;fHDF/TERT166: 1202.8;U-138 MG: 733.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		39000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	225.8	119.2	27.3	164.9	35.0	1.3	161.1	28.1	47.6	241.6	37.2	916.1	80.3	523.3	150.7	275.6	304.4	203.2	115.0	26.9	29.1	134.7	224.4	155.5	75.4	32.3	30.4	326.2	52.5	32.7	53.3	430.0	30.9	348.9	149.8	13.1	70.3	781.7	46.5	76.0	233.1	688.4	27.9	129.2	324.2	52.7	33.4	28.5	114.1	75.2	34.4	505.3	208.0	28.8	115.9	75.3	163.3	146.1	572.7	464.8	161.6	661.6	736.3	227.2	246.6	138.3	3.5	0.7	153.3	1202.8	148.1	26.9	106.0	202.3	308.4	1.5	38.9	4.0	87.8	94.7	375.6	1.5	0.8	360.9	153.6	252.8	147.4	343.6	193.0	0.0	0.6	1.6	338.7	0.3	0.6	3.2	197.7	0.1	25.6	1.4	146.6	2.3	46.9	32.2	29.0	72.1	235.3	31.7	90.0	491.0	7.2	1.4	508.5	733.2	130.0	143.8	230.3	0.9	1.1	1.3	259.0	0.8	573.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	2.9	27.3	35.0	28.1	47.6	26.9	29.1	32.3	30.4	30.9	27.9	33.4	28.8	400.6	22.4	17.6	43.1	7.3	420.4	379.6	218.8	164.4	172.0	115.5	466.1	456.5	228.8	33.5	44.1	6.2	202.7	5.0	0.3	23.5	392.6	61.0	89.4	1190.3	432.9	3.6	16.0	95.4	23.6	903.9	886.9	16.3	206.2	5.1	251.0	422.0	638.4	43.5	92.5	58.3	1.2	28.5	21.0	112.8	83.6	1745.0	38.8	336.2	94.6	8.4	140.6	6.2	98.5	158.8	146.0	0.2	2005.6	4.2	456.9	0.1	332.1	11.3	21.2	2294.3	326.1	2549.3	12.1	12.2	70.1	171.8	276.6	27.5	414.1	0.8	36.7
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128773400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 504.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 2467.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		21000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.60e-5)"	115.8	56.6	20.6	137.9	22.7	22.8	66.2	22.8	28.5	133.5	54.7	97.5	37.6	113.6	61.1	60.4	57.1	92.7	236.9	24.5	23.5	45.1	74.2	68.5	38.8	24.1	22.2	54.8	52.6	85.0	28.8	211.8	24.2	113.0	81.3	19.6	67.7	150.1	82.1	29.9	40.0	328.4	22.3	47.5	62.5	39.8	33.2	31.0	77.1	117.1	45.2	160.1	48.2	26.6	257.8	207.4	486.6	152.7	1348.5	1229.5	270.9	1821.7	1378.1	577.5	770.7	238.6	388.3	100.0	351.5	2467.8	850.4	144.9	258.2	318.2	826.5	80.6	138.2	136.6	283.7	295.0	657.1	187.2	254.3	930.5	223.6	868.3	370.6	904.4	537.3	116.4	237.9	172.8	1131.8	141.0	130.2	95.5	305.2	247.0	197.3	122.9	333.3	164.5	243.5	132.7	44.3	238.2	595.4	481.5	753.1	932.2	106.2	145.6	799.8	1706.6	234.2	1350.8	754.6	306.8	385.7	224.8	1478.6	223.6	1857.2	21.7	38.8	23.5	28.3	41.4	27.9	23.7	19.5	22.0	33.4	16.6	17.1	20.0	4.5	26.2	35.7	32.9	23.4	31.2	20.6	22.7	22.8	28.5	24.5	23.5	24.1	22.2	24.2	22.3	33.2	26.6	67.3	22.4	38.5	25.5	29.9	81.3	68.1	82.0	31.3	28.2	51.7	42.7	247.0	25.8	62.7	25.8	18.8	116.8	25.0	14.4	17.6	69.5	11.4	37.5	186.3	104.0	19.7	42.3	37.7	60.5	504.7	198.8	37.2	72.8	59.6	62.6	113.2	54.2	136.9	28.6	47.0	55.9	22.4	58.9	70.7	9.3	100.3	44.6	120.9	27.2	26.3	32.4	21.6	31.2	32.2	71.5	11.4	118.8	140.9	110.6	12.6	17.7	57.2	12.8	59.2	64.9	162.8	27.1	41.9	30.9	76.9	243.0	30.9	69.7	26.1	90.5
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 236.9;pituitary gland: 167.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 155.7;Excitatory neurons: 72.6;Horizontal cells: 72.3;Inhibitory neurons: 128.5"	"Cancer enriched"	"Detected in some"	4	"pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"	0.2	17.9	55.4	0.8	42.4	0.1	0.1	2.5	75.0	0.2	0.0	4.7	2.4	0.0	0.1	0.1	0.2	0.0	0.2	38.1	236.9	0.2	0.3	0.4	0.2	47.6	74.8	0.2	3.4	0.6	167.6	0.0	71.8	0.5	0.5	11.1	0.2	0.1	0.1	0.3	2.3	0.3	30.1	0.6	2.4	4.3	88.5	0.0	0.4	0.0	0.1	0.2	0.9	35.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	42.4	2.5	75.0	38.1	236.9	47.6	74.8	71.8	30.1	88.5	35.0	0.2	0.0	0.0	26.1	0.1	0.3	0.0	0.0	0.0	155.7	0.8	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	2.2	0.0	0.5	0.6	19.5	0.0	72.6	0.0	0.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.1	72.3	128.5	1.5	0.0	0.0	0.4	2.0	0.0	0.2	0.0	18.7	0.0	11.5	0.0	10.6	20.1	0.6	0.0	0.4	0.1	0.6	0.0	0.4	0.0	31.7	0.0	0.2	0.5	16.3	7.9	0.0	0.0	0.3	2.8	0.2	0.1	0.0
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2N2	CaM-KIIN	ENSG00000163888	"Calcium/calmodulin dependent protein kinase II inhibitor 2"	Q96S95	3	184259213-184261553	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 104.3;pancreas: 33.6;pituitary gland: 39.6"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 62.2;Inhibitory neurons: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 21.2;REH: 33.4;SCLC-21H: 33.2;U-138 MG: 32.1"	"Low region specificity"	"Detected in all"							"HPA050835, HPA075200"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Centrosome"		"HPA050835: AB_2681253, HPA075200: "	"unprognostic (7.28e-2)"	"prognostic favorable (9.77e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.72e-3)"	"unprognostic (5.17e-9)"	"unprognostic (3.47e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-3)"	0.1	14.6	60.0	0.2	29.5	0.0	0.1	45.8	49.8	0.1	0.0	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	36.0	69.1	0.2	0.7	0.1	0.0	95.7	70.7	0.1	33.6	0.8	39.6	0.1	79.5	0.3	0.0	5.5	0.2	0.1	0.0	0.2	0.2	0.1	50.7	0.1	0.5	0.2	104.3	0.0	0.1	0.0	0.0	0.1	0.1	29.7	21.2	0.5	3.2	1.7	0.5	0.5	2.2	0.5	6.2	4.0	4.1	1.2	1.1	2.0	5.4	0.3	13.0	2.8	1.1	0.7	2.2	16.1	1.4	0.7	0.5	0.9	0.1	1.4	3.0	0.5	1.0	0.6	2.8	1.4	0.0	0.9	0.3	7.5	0.6	14.5	0.4	1.1	13.3	1.5	8.4	33.4	9.4	3.2	0.9	5.0	33.2	7.3	3.9	1.7	0.3	0.3	13.3	0.2	0.2	32.1	15.0	4.3	6.7	4.1	8.1	6.8	8.1	3.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	29.5	45.8	49.8	36.0	69.1	95.7	70.7	79.5	50.7	104.3	29.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	12.2	0.3	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.4	0.2	3.6	0.0	7.8	4.3	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.8	0.0	62.2	45.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	2.8	0.0	2.0	0.0	7.5	2.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595863-7618304	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 62.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: AB_2684698"	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.4	3.3	3.2	0.8	4.4	0.0	5.3	2.5	9.0	7.7	0.1	10.3	14.9	0.5	2.3	24.8	3.1	1.6	0.4	4.2	0.7	12.0	24.3	4.6	0.2	2.5	0.0	0.5	20.6	2.7	8.2	0.4	0.4	10.2	2.4	3.2	18.1	4.5	0.2	62.7	11.5	0.1	0.0	0.6	15.5	13.0	0.2	0.5	11.1	0.0	1.1	3.6	13.4	2.4	11.2	1.8	0.3	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	26.7	5.8	3.1	4.5	0.0	1.2	9.7	4.3	2.8	0.0	2.0	10.1	0.0	0.5	15.6	0.0	0.0	4.4	0.0	5.5	0.0	0.4	0.4	0.0	4.5	0.9	0.0	0.0	13.0	0.2	0.2	6.6	8.4	4.7	0.7	0.0	3.7	1.9	6.0	8.2	8.7	1.3	12.5	0.0	1.6	10.4	1.7	0.0	0.0	2.0	0.0	0.4	5.0	1.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.4	2.5	9.0	4.2	0.7	2.5	0.0	0.4	0.0	0.2	2.4	0.2	9.6	19.2	3.3	1.1	9.8	2.7	2.4	3.4	22.7	19.3	12.1	1.5	20.0	5.3	9.2	0.0	0.5	0.2	40.0	3.9	5.7	4.4	9.6	1.4	1.5	13.1	0.0	9.1	11.8	0.7	0.2	38.7	13.5	5.7	8.6	0.4	24.8	0.2	10.1	10.1	22.4	0.0	1.9	1.2	2.9	1.5	1.0	0.0	1.9	0.0	1.5	0.0	4.5	0.6	13.1	28.4	0.0	0.6	6.2	29.2	15.6	2.9	13.4	0.0	0.0	1.1	0.4	2.8	9.8	18.9	0.5	0.9	1.5	18.4	8.0
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.2;stomach 1: 28.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 76.6;Gastric mucus-secreting cells: 50.0;Proximal enterocytes: 35.2;Undifferentiated cells: 18.1;Urothelial cells: 19.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 9.3;SK-BR-3: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.0	0.0	0.8	0.0	1.4	0.0	7.2	0.9	1.3	9.7	1.0	11.4	20.8	0.2	0.3	0.9	1.1	2.8	0.0	0.7	0.8	2.5	0.2	7.2	0.0	1.1	1.3	0.0	3.6	0.4	0.2	0.0	1.0	3.8	24.6	0.0	1.2	0.1	0.0	0.2	29.2	0.2	1.0	0.1	28.5	0.1	1.1	0.0	0.0	0.0	0.6	4.1	0.5	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	9.3	0.1	0.4	0.0	21.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.9	1.3	0.7	0.8	1.1	1.3	1.0	1.0	1.1	2.3	0.0	6.4	3.1	0.3	0.0	0.0	10.2	3.5	4.0	0.0	4.2	1.8	1.3	0.0	76.6	1.8	0.0	0.0	0.0	16.9	0.0	1.3	0.8	2.0	0.0	0.1	15.0	0.0	0.3	5.3	0.0	0.6	50.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	1.5	12.0	6.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.4	1.9	6.2	0.0	0.0	2.7	35.2	0.2	12.4	0.0	0.0	0.0	6.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	18.1	19.4
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 291.1"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.7	6.3	1.0	0.1	14.9	0.1	1.7	1.1	2.3	23.6	8.0	0.1	11.1	0.6	1.3	14.3	0.0	2.3	3.6	1.7	0.3	21.3	0.1	2.7	1.5	0.2	2.9	0.0	0.1	0.3	1.1	2.9	33.0	0.3	8.5	1.4	0.8	2.3	4.6	1.1	2.0	0.3	291.1	0.6	1.8	0.0	0.2	0.0	0.3	12.3	0.7	2.5	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.7	1.0	0.1	1.7	2.3	3.6	2.7	1.5	1.1	2.0	1.8	2.5	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.2;stomach 1: 60.3"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 25.6;Gastric mucus-secreting cells: 93.8;Intestinal goblet cells: 71.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 10.7;SCLC-21H: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483, HPA062050"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Golgi apparatus"	"CAB033483: AB_1119945, HPA020398: AB_2670429, HPA062050: "	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.0	0.6	1.4	0.9	2.2	0.0	0.4	1.3	1.2	0.4	0.0	13.7	6.6	0.2	0.5	0.2	2.5	0.6	0.4	1.1	1.4	0.0	0.0	7.5	0.0	2.1	1.7	0.6	0.2	1.0	0.0	0.0	1.8	0.6	22.2	5.0	11.3	0.1	0.2	0.1	11.7	0.5	1.9	0.0	60.3	0.2	1.7	0.1	0.1	0.1	0.0	2.0	0.1	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.5	10.7	0.0	0.4	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.4	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	1.3	1.2	1.1	1.4	2.1	1.7	1.8	1.9	1.7	3.4	0.0	25.6	3.0	0.3	0.1	0.0	0.6	0.7	0.0	0.0	0.6	0.3	6.0	0.0	3.2	0.0	0.0	0.1	0.0	4.1	0.0	0.2	5.2	1.5	0.1	0.1	3.0	0.0	0.4	0.2	0.0	0.4	93.8	0.5	2.5	0.1	0.0	0.0	0.1	0.0	0.4	71.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.6	1.7	5.0	0.0	0.2	0.5	3.3	0.1	8.2	1.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.1	1.5
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line subunit alpha 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007470, HPA007643"	Uncertain		Approved	Cytosol		No	No		4500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA007470: AB_1845985, HPA007643: AB_2667886"	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	26.3	20.1	17.0	20.0	17.3	43.3	21.8	22.5	25.8	18.0	16.9	24.4	20.4	19.7	19.0	20.8	14.2	20.7	45.7	21.3	17.5	37.3	33.9	23.8	20.1	17.0	17.1	12.6	13.4	19.4	7.5	24.9	20.5	20.3	23.9	13.4	14.6	20.5	64.3	12.3	23.4	28.1	14.5	22.3	20.0	8.7	19.6	16.4	22.8	53.1	17.3	28.1	11.3	18.3	30.0	19.5	19.8	25.2	35.9	37.8	9.8	28.7	41.3	28.8	32.7	14.5	38.1	20.8	46.5	41.3	36.1	18.2	20.4	24.1	45.4	22.7	14.9	31.3	18.0	24.6	22.2	21.2	40.9	30.2	26.9	22.9	21.9	34.8	63.2	12.9	20.8	35.2	57.9	13.0	28.3	35.6	29.5	31.3	16.8	19.7	26.2	42.1	69.3	24.6	20.6	23.5	27.7	104.1	29.7	25.0	14.5	25.0	23.0	47.0	14.6	37.5	28.5	27.7	21.0	39.6	28.0	29.6	34.0	57.3	34.8	45.6	11.1	45.6	13.2	14.4	13.5	11.9	33.2	12.6	12.9	13.1	69.4	15.9	54.9	18.1	18.1	45.3	17.0	17.3	22.5	25.8	21.3	17.5	17.0	17.1	20.5	14.5	19.6	18.3	177.9	73.7	67.4	44.4	109.4	243.1	219.8	224.3	94.4	106.6	85.1	67.3	219.4	71.4	146.5	171.0	27.1	151.7	96.2	147.4	516.5	193.1	9.6	139.4	113.7	189.5	121.2	263.9	59.2	160.3	204.0	124.8	103.5	340.1	126.2	48.8	262.3	110.6	314.1	107.7	48.0	102.6	286.8	238.5	274.9	16.2	74.6	262.9	181.5	64.6	222.4	164.5	72.1	49.8	47.1	193.1	147.5	110.9	83.0	140.9	182.6	519.7	99.7	95.9	92.1	122.8	188.9	43.1	47.0	94.1	218.8	144.1	108.6	78.7	109.9	207.0
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.9;dendritic cells: 47.2;Microglial cells: 49.6;NK-cells: 28.8;Pancreatic endocrine cells: 24.9;Plasma cells: 26.7;T-cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 122.7;K-562: 50.1;RT4: 91.4;U-698: 108.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"	1.3	3.1	6.9	21.8	1.5	18.5	1.2	1.8	1.5	2.3	1.0	2.4	3.7	1.3	0.2	1.3	2.2	8.8	1.0	1.3	4.9	1.6	1.6	4.7	47.3	4.2	8.4	1.3	1.4	0.7	0.9	0.5	3.7	1.4	2.3	0.2	3.3	1.6	0.6	0.7	18.3	0.6	3.0	31.5	7.5	1.7	14.0	20.9	1.5	0.2	29.5	17.1	1.3	4.6	16.7	2.6	0.1	0.1	0.0	0.0	12.2	0.1	0.0	0.5	0.0	32.4	35.5	122.7	29.2	0.0	0.0	27.2	0.0	0.4	0.3	42.1	1.1	0.1	3.1	0.3	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.8	23.1	13.3	50.1	0.0	0.0	0.3	4.7	0.0	44.9	20.6	0.1	5.9	0.1	30.7	11.4	91.4	0.3	1.5	0.1	0.2	0.1	17.7	0.2	2.5	15.4	0.2	11.8	0.1	0.1	12.3	0.1	108.0	0.0	0.0	0.2	0.5	0.0	0.0	7.7	0.0	7.2	5.4	4.4	5.2	0.9	6.2	2.9	5.3	0.2	5.5	0.0	31.4	3.5	2.9	6.9	1.5	1.8	1.5	1.3	4.9	4.2	8.4	3.7	3.0	14.0	4.6	0.5	0.0	0.0	0.7	34.9	0.0	0.3	0.3	0.6	0.6	0.3	0.4	2.0	0.0	0.3	1.8	0.0	0.0	47.2	0.7	0.0	4.6	0.2	0.4	0.3	0.6	0.0	0.8	2.1	5.3	0.0	1.6	14.3	0.7	5.7	8.6	0.4	0.2	1.5	0.0	1.6	0.3	0.0	2.4	1.8	0.4	0.3	5.4	3.6	49.6	1.0	0.1	28.8	1.0	0.6	24.9	0.0	0.0	26.7	0.3	0.0	0.1	1.0	0.2	0.0	0.3	0.9	1.5	0.2	0.0	0.3	0.0	28.6	4.5	0.4	8.1
CARHSP1	"CRHSP-24, CSDC1"	ENSG00000153048	"Calcium regulated heat stable protein 1"	Q9Y2V2	16	8852942-8869012	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 422.7"	"Group enriched"	"Detected in all"	7	"Early spermatids: 2062.2;Late spermatids: 6999.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051911	Enhanced					NA	Yes		280000	"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA051911: AB_2681660"	"unprognostic (4.08e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.76e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"prognostic favorable (7.24e-4)"	101.4	132.5	49.4	33.7	75.0	70.0	67.7	46.8	58.4	101.7	46.5	46.4	31.3	38.2	13.5	193.7	51.0	33.8	48.2	50.1	50.8	109.6	188.2	116.7	46.9	56.1	49.7	68.5	54.8	9.8	33.2	59.2	51.2	35.3	25.6	3.0	110.7	13.9	17.4	34.5	47.1	24.2	47.6	56.7	52.5	422.7	51.0	59.6	35.9	21.3	59.4	45.8	101.7	60.4	84.2	134.8	200.2	40.3	52.1	83.0	98.9	110.7	93.5	92.9	117.8	95.4	224.6	109.1	70.2	83.5	70.9	82.0	79.3	87.9	65.4	87.9	102.1	34.5	108.1	369.8	177.5	59.2	84.6	181.7	40.0	91.8	60.7	87.8	92.6	241.5	94.5	136.1	120.5	152.0	313.5	147.6	124.6	89.0	82.2	367.0	245.9	179.3	75.5	56.0	119.0	153.2	104.9	106.1	104.0	112.4	134.9	60.3	99.9	77.8	144.9	94.6	57.4	67.6	77.4	135.0	173.9	71.9	134.9	81.6	29.6	35.8	25.8	14.3	16.1	17.5	25.0	25.3	25.8	28.6	17.0	23.7	89.2	41.6	19.0	47.4	62.8	20.8	49.4	75.0	46.8	58.4	50.1	50.8	56.1	49.7	51.2	47.6	51.0	60.4	166.3	25.6	9.1	19.6	48.9	42.7	67.2	158.4	22.8	8.0	71.4	38.0	6.0	221.6	86.4	82.8	6.2	141.5	65.1	152.6	54.8	619.1	2062.2	101.9	82.0	145.3	144.9	147.5	4.4	241.8	312.6	86.4	42.8	114.4	39.3	118.0	128.8	323.5	70.5	11.8	5.9	107.7	91.6	62.4	55.3	6999.5	96.3	36.1	58.7	9.4	66.5	7.7	121.5	8.0	25.6	340.0	179.5	73.0	63.9	139.3	174.2	479.0	70.9	11.2	111.7	31.2	95.5	72.7	52.7	84.2	42.1	153.5	65.1	17.0	108.4	169.8
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644988-67657569	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;intestine: 13.4;lymphoid tissue: 21.6"	"Group enriched"	"Detected in some"	4	"B-cells: 3.6;dendritic cells: 3.7;T-cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 64.2;JURKAT: 47.3;MOLT-4: 64.6;REH: 105.6;RPMI-8226: 58.4;U-698: 107.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041402	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"	0.9	0.5	5.9	12.5	6.3	5.9	0.5	4.5	11.4	0.4	2.4	2.0	1.8	0.3	0.1	0.9	0.5	1.2	0.3	9.8	5.1	0.9	0.8	1.7	21.6	5.6	4.0	0.2	0.4	0.1	4.5	0.2	5.4	0.8	0.7	0.3	1.4	0.1	0.0	0.4	13.4	0.2	3.4	19.9	1.9	0.9	4.9	20.9	1.2	0.0	10.9	1.5	0.7	6.8	0.2	0.1	0.1	0.3	0.0	0.1	18.1	0.6	0.0	0.5	0.0	9.6	0.6	64.2	1.1	0.0	0.1	0.1	6.0	0.0	0.0	14.3	7.5	3.8	0.3	1.2	0.5	7.1	0.6	0.1	0.0	0.0	0.1	0.1	0.0	47.3	0.9	1.0	0.0	1.1	64.6	32.2	10.7	0.3	0.3	105.6	0.1	58.4	0.0	0.0	15.9	1.7	0.1	0.2	0.5	1.5	0.4	1.9	0.2	0.9	2.0	0.1	0.4	17.6	33.4	107.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.7	0.1	0.0	0.4	0.2	0.1	0.0	0.4	0.0	0.3	0.7	0.1	5.9	6.3	4.5	11.4	9.8	5.1	5.6	4.0	5.4	3.4	4.9	6.8	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969366	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	45.7	21.7	7.0	69.4	7.2	48.5	44.4	7.4	12.4	26.4	8.6	27.6	62.4	18.4	33.1	47.7	34.9	50.1	17.8	7.5	8.0	33.3	54.1	61.3	80.2	9.7	8.1	43.2	52.5	4.7	11.0	70.2	8.7	21.7	30.7	2.0	55.2	15.5	7.5	46.7	58.8	32.2	8.3	71.1	42.4	4.9	9.0	57.2	15.6	18.1	82.1	76.5	30.5	8.7	33.8	9.5	0.0	12.9	58.2	140.4	27.8	68.0	103.2	80.5	117.0	22.4	128.5	22.3	123.1	71.5	110.4	52.7	0.0	94.3	78.8	22.4	0.4	53.1	7.4	55.8	158.2	48.5	19.2	122.6	127.0	97.9	144.4	104.7	143.8	0.5	1.3	0.0	64.4	2.8	26.1	46.7	0.0	71.6	28.2	21.4	21.5	14.2	64.9	46.2	0.6	0.4	60.8	31.6	49.3	0.7	11.9	62.5	93.2	84.4	30.4	80.8	40.5	0.0	0.0	0.3	42.2	105.5	63.4	136.4	292.0	50.6	208.9	312.9	224.8	141.9	155.6	193.9	205.5	144.4	93.4	138.5	667.2	226.2	255.4	35.4	257.9	410.9	7.0	7.2	7.4	12.4	7.5	8.0	9.7	8.1	8.7	8.3	9.0	8.7	78.1	60.9	60.8	0.3	87.4	55.8	63.3	130.1	21.1	0.0	40.8	48.4	5.6	47.1	107.0	22.0	0.0	129.1	80.4	12.4	15.6	157.5	0.6	35.9	27.7	73.0	20.9	12.4	0.0	189.9	103.0	53.6	33.1	45.7	34.8	32.6	82.1	34.7	116.7	0.0	0.2	37.8	73.2	168.0	81.2	2.1	29.2	105.2	30.2	23.4	141.5	1.9	177.1	1.5	0.2	148.5	8.6	20.7	50.5	31.1	85.4	41.1	86.1	0.4	6.6	38.1	34.2	0.2	0.5	25.8	45.9	115.9	102.1	36.8	32.9	80.0
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700021-115768714	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1056.7"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 777.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"HSkMC: 13.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 43.1"	"Low region specificity"	"Detected in all"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.25e-5)"	31.9	3.0	3.5	6.4	2.3	0.0	8.9	2.8	4.0	8.0	2.0	59.8	3.3	17.2	6.5	38.5	14.7	6.6	1056.7	1.8	3.6	3.5	0.6	5.3	0.8	1.9	4.8	5.3	1.2	1.6	0.9	1.6	2.1	13.8	17.0	0.3	7.6	20.2	182.1	4.9	9.1	39.1	1.9	0.8	14.2	1.5	6.4	1.6	4.1	165.0	1.3	43.9	6.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.8	4.0	1.8	3.6	1.9	4.8	2.1	1.9	6.4	1.9	2.7	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.6	0.2	0.1	0.4	777.8	0.0	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	15.5	0.3	0.0	4.8	0.0	0.0	0.7	0.0	0.3	17.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	20.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	1.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	92.1	11.0	73.4	0.1	0.4	0.2	0.3	0.0	0.1	0.0	0.0	0.0
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402449-42423256	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 575.1;Alveolar cells type 1: 429.5;Breast myoepithelial cells: 154.9;Cytotrophoblasts: 159.8;Endothelial cells: 217.4;Smooth muscle cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 1105.9;fHDF/TERT166: 796.6;TIME: 920.9;U-138 MG: 912.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		440000	"Cluster 11: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	397.8	65.3	42.6	69.1	47.2	3.7	295.3	55.8	40.9	239.9	50.6	314.0	30.8	344.3	56.8	101.0	207.5	78.1	220.9	35.4	49.7	66.4	21.0	202.8	30.0	68.8	55.0	162.5	28.4	26.5	34.8	151.3	60.1	181.5	50.7	3.6	84.2	215.4	144.8	161.9	104.1	242.3	53.5	109.0	132.8	22.6	47.2	16.6	112.4	92.7	24.0	255.4	192.3	58.0	315.9	264.8	5.5	69.8	342.3	409.6	6.9	1105.9	477.8	432.2	340.5	134.6	20.1	0.5	216.3	796.6	177.4	509.7	46.8	331.6	351.0	1.1	9.5	137.5	154.8	66.1	215.8	0.3	1.2	283.0	120.5	340.8	115.8	230.2	592.3	0.4	95.5	1.3	187.9	5.0	7.4	1.6	25.8	48.1	1.8	0.6	173.3	0.6	186.1	1.6	0.4	2.0	371.9	6.4	91.7	145.2	29.8	2.0	920.9	912.0	429.5	330.9	407.9	0.8	0.9	1.6	270.7	0.5	104.8	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	42.6	47.2	55.8	40.9	35.4	49.7	68.8	55.0	60.1	53.5	47.2	58.0	575.1	429.5	117.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	55.4	154.9	0.0	0.0	50.8	23.9	0.0	159.8	3.4	0.0	3.9	45.6	0.0	11.7	130.4	217.4	0.0	0.0	0.0	4.4	11.3	114.2	0.0	16.9	63.1	116.3	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.5	0.0	0.0	0.5	0.0	0.0	1.1	3.6	0.0	0.0	0.0	211.7	0.0	0.0	0.0	0.0	77.2	4.5	6.6	0.0	0.0
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 113.7;Inhibitory neurons: 112.5;Oligodendrocyte precursor cells: 123.1;T-cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	17.3	5.8	5.6	6.7	4.6	11.9	11.0	17.4	5.9	6.8	5.8	6.3	6.2	6.3	4.3	3.5	8.8	8.4	12.2	5.2	7.3	4.3	4.4	9.9	14.5	4.4	5.3	10.0	3.6	2.3	3.8	6.5	5.7	4.7	5.1	9.2	6.7	2.3	7.8	6.8	8.2	3.0	2.0	8.5	8.3	6.4	6.5	4.3	9.1	5.1	6.9	10.0	6.5	4.0	2.4	3.2	10.7	5.4	11.8	12.1	6.8	7.6	4.0	2.3	3.7	4.1	2.6	5.2	5.4	4.2	3.6	3.9	1.5	1.4	2.8	3.8	4.0	2.8	16.1	2.7	17.7	2.0	2.0	11.9	4.3	6.2	16.7	8.5	7.9	5.2	3.0	15.5	5.0	2.8	2.9	1.3	3.6	2.9	4.4	6.1	3.1	0.9	5.9	10.2	8.2	8.9	9.5	1.1	11.9	7.3	2.4	4.3	4.8	32.0	2.6	4.5	2.0	8.8	0.7	8.3	8.6	1.7	2.1	0.7	1.4	2.8	8.9	0.9	7.9	2.1	4.6	5.1	1.3	4.8	3.9	7.0	1.0	10.2	2.0	3.1	5.7	1.7	5.6	4.6	17.4	5.9	5.2	7.3	4.4	5.3	5.7	2.0	6.5	4.0	26.0	16.0	6.1	57.8	43.1	10.8	6.9	35.6	25.6	42.6	12.0	9.7	43.7	2.8	13.7	12.9	27.1	10.1	113.7	12.8	5.9	8.4	34.1	20.9	47.0	34.0	12.6	10.8	48.9	7.8	83.2	55.2	43.8	26.4	8.8	21.3	33.2	8.1	13.9	3.3	112.5	18.8	6.1	13.5	17.1	14.4	7.5	14.6	16.0	74.9	9.0	7.5	59.8	123.1	100.3	15.5	8.6	10.9	53.1	8.9	17.6	3.9	20.2	28.9	6.6	23.6	28.9	11.1	13.3	10.3	7.0	45.4	111.5	5.5	9.9	7.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800652	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.3;intestine: 50.9;skin 1: 42.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 108.6;Pancreatic endocrine cells: 95.0;Paneth cells: 108.1;Proximal enterocytes: 154.6;Undifferentiated cells: 67.1;Urothelial cells: 76.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.6;BEWO: 28.9;CACO-2: 28.3;CAPAN-2: 56.9;HaCaT: 41.0;HBEC3-KT: 34.8;hTCEpi: 26.0;OE19: 37.3;RT4: 34.7;SK-BR-3: 31.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm,Aggresome		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Aggresome	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.1	0.0	3.1	0.0	0.0	5.1	0.0	0.1	8.0	0.0	25.0	50.9	0.9	0.1	39.3	2.5	4.4	0.0	0.0	0.0	7.4	21.1	1.3	0.0	0.0	0.0	0.1	20.6	1.6	0.5	0.4	0.0	11.8	11.7	0.1	13.3	2.4	0.1	42.4	38.6	0.6	0.0	0.0	17.7	0.7	0.0	0.3	1.7	0.0	4.0	8.3	18.4	0.0	43.6	0.0	0.0	0.1	0.0	0.0	28.9	0.0	0.0	0.0	0.0	28.3	56.9	0.0	0.0	0.0	0.0	41.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.3	0.0	0.0	0.0	0.0	0.0	34.7	0.4	0.1	0.0	31.1	0.0	0.2	22.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	15.0	44.0	30.8	16.5	0.0	9.3	7.4	0.2	4.3	27.7	7.3	0.0	5.8	0.2	108.6	1.9	53.8	0.1	7.0	1.3	0.9	17.4	0.0	0.4	48.9	2.3	0.5	59.7	15.5	0.0	0.0	0.0	11.1	0.3	0.0	0.9	40.0	18.3	0.0	1.4	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.0	0.3	95.0	108.1	0.0	0.1	34.4	154.6	17.2	9.8	0.0	0.0	0.0	1.3	0.0	2.6	29.9	25.7	2.5	0.7	0.0	67.1	76.9
CBLN2		ENSG00000141668	"Cerebellin 2 precursor"	Q8IUK8	18	72536680-72638521	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 32.5"	"Cell type enriched"	"Detected in some"	13	"Excitatory neurons: 508.3"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 54.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"	NA	NA		1400000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.03e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.09e-5)"	"unprognostic (7.10e-2)"	"unprognostic (6.27e-3)"		"unprognostic (7.39e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.37e-4)"	"unprognostic (5.01e-4)"	"unprognostic (8.15e-2)"	"unprognostic (6.07e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.93e-2)"	0.4	0.2	7.9	0.3	17.3	0.0	0.1	0.0	32.5	0.3	0.0	1.8	1.5	0.0	0.0	0.0	0.1	0.0	0.1	3.3	0.2	2.5	0.4	0.0	0.0	5.9	4.5	0.1	0.0	0.0	0.2	0.0	8.7	0.9	1.5	5.1	0.0	5.1	0.0	0.8	2.5	0.8	0.0	0.0	0.1	0.2	13.8	0.0	0.0	0.0	0.7	0.1	0.0	12.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	54.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	17.3	0.0	32.5	3.3	0.2	5.9	4.5	8.7	0.0	13.8	12.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	37.8	0.0	508.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.3	0.6	0.6	0.0	0.0	10.3	0.0	0.5	0.0	9.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CBX2	"CDCA6, MGC10561"	ENSG00000173894	"Chromobox 2"	Q14781	17	79778148-79787983	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 7.3;testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.5;Granulosa cells: 10.4;Late spermatids: 39.1;Spermatogonia: 14.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 96.4;SK-BR-3: 134.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023083	Approved		Supported	Nucleoplasm		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA023083: AB_2671063"	"unprognostic (1.37e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.25e-11)"	"unprognostic (1.05e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.34e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-8)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.07e-1)"	1.4	0.3	1.1	0.7	0.9	2.2	1.2	0.8	0.9	1.3	0.5	0.5	0.4	1.2	1.8	4.2	1.0	0.6	2.3	0.8	0.7	1.6	0.4	1.2	1.3	1.0	0.9	2.1	1.3	0.5	0.2	2.2	1.1	0.6	0.2	0.5	0.9	0.5	0.7	2.1	0.6	0.7	0.8	1.6	0.5	12.8	1.0	7.3	0.5	1.1	1.3	1.0	1.6	1.0	7.5	20.5	37.0	67.4	0.4	0.5	13.2	2.7	1.2	1.3	2.4	21.2	1.7	29.7	5.8	0.3	4.7	3.8	43.0	1.2	0.9	4.3	23.3	1.5	24.0	14.2	1.4	9.0	6.1	0.7	2.6	0.7	1.7	1.6	7.5	31.3	20.8	2.3	1.4	31.3	47.3	22.1	36.8	10.3	23.4	96.4	27.7	18.0	1.5	10.5	45.1	69.8	11.7	134.7	8.0	17.6	24.5	13.4	5.4	13.1	38.4	4.0	5.3	8.7	4.8	18.3	0.5	24.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.8	0.9	0.8	0.7	1.0	0.9	1.1	0.8	1.0	1.0	5.3	0.0	0.0	0.3	0.1	1.0	0.3	0.4	0.0	1.0	0.6	1.8	2.5	0.0	0.3	1.8	2.1	0.4	2.9	0.4	1.9	3.6	32.5	0.9	1.8	8.6	0.0	5.9	0.1	0.9	1.4	0.8	1.1	1.8	0.0	10.4	3.6	1.1	1.2	0.0	0.0	0.8	0.0	0.6	0.9	39.1	0.6	0.5	3.6	0.0	0.8	4.3	0.0	0.0	0.3	1.1	0.0	0.7	0.5	0.7	0.0	0.8	0.1	0.4	0.0	0.3	1.0	1.6	14.3	4.1	1.4	0.3	1.2	0.9	0.5	0.9
CBX6		ENSG00000183741	"Chromobox 6"	O95503	22	38861422-38872249	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048653	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Mitochondria"		"HPA048653: AB_2680479"	"unprognostic (1.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.97e-2)"	"prognostic favorable (2.46e-6)"	"unprognostic (2.75e-1)"	"unprognostic (1.27e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-2)"	16.3	22.4	67.1	16.5	53.6	28.3	12.3	9.9	83.6	21.0	0.0	39.3	6.5	34.0	14.5	13.3	27.0	11.3	17.7	88.2	10.1	18.7	6.3	17.2	14.2	16.6	14.0	24.4	17.1	49.5	27.5	4.3	10.0	22.0	7.2	8.5	13.7	25.9	8.9	8.2	17.1	26.1	5.5	15.9	20.5	4.3	21.8	12.5	19.0	6.7	15.3	31.0	11.9	30.8	40.3	41.7	9.1	31.3	68.5	38.2	2.8	42.8	24.5	21.8	20.3	21.1	36.5	65.3	31.2	29.5	15.3	46.8	17.0	18.3	11.9	63.1	53.0	6.7	18.5	7.4	37.2	32.6	31.1	57.0	9.1	49.7	23.5	30.1	24.9	18.4	14.9	32.2	15.1	45.5	20.2	9.5	8.1	23.1	31.9	29.9	30.5	25.9	31.3	37.4	44.3	9.8	27.5	36.4	23.7	3.2	25.0	19.3	32.7	18.9	57.9	33.2	29.6	32.9	34.1	23.5	37.0	33.6	40.1	2.2	9.1	4.7	18.6	12.4	15.3	6.7	12.6	13.1	9.1	7.7	10.3	12.6	4.0	9.1	12.5	46.1	8.0	20.0	67.1	53.6	9.9	83.6	88.2	10.1	16.6	14.0	10.0	5.5	21.8	30.8	30.5	16.0	14.7	9.8	25.1	33.9	47.4	18.4	16.5	100.4	42.6	31.6	27.5	52.9	22.1	73.5	39.6	12.4	83.0	9.6	35.2	102.6	1.1	6.9	46.0	36.4	122.7	17.7	28.9	50.1	2.0	48.5	3.1	17.5	6.3	18.7	46.8	32.4	19.8	124.5	27.3	3.2	30.5	40.8	121.1	2.9	74.3	33.2	81.8	14.0	91.1	91.2	57.7	15.1	23.3	46.9	9.1	80.9	24.5	58.9	0.1	51.7	18.0	59.4	72.3	54.4	85.1	4.2	6.8	10.4	34.0	4.7	35.8	40.9	0.9	82.6
CCDC178	"C18orf34, FLJ44050"	ENSG00000166960	"Coiled-coil domain containing 178"	Q5BJE1	18	32937402-33441101	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.9;testis: 15.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.2;Early spermatids: 89.0;Late spermatids: 76.8;Spermatocytes: 49.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"HUVEC TERT2: 5.1;U-87 MG: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.15e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.95e-4)"	"unprognostic (4.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.94e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-3)"	"unprognostic (9.03e-3)"	10.9	0.3	0.2	0.2	0.3	0.0	7.8	0.0	0.4	2.7	0.1	0.8	0.5	1.3	2.2	0.6	1.5	2.5	0.5	0.2	0.3	2.8	0.1	0.7	0.2	0.4	0.6	4.0	0.1	0.0	0.6	0.0	0.2	3.5	0.5	0.1	0.5	2.0	0.3	0.7	0.6	1.5	0.4	7.6	0.6	15.2	0.1	0.1	0.8	0.0	0.6	2.1	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.2	0.3	0.4	0.6	0.2	0.4	0.1	0.2	29.2	0.0	0.0	0.3	0.0	0.4	0.4	0.0	2.2	0.0	0.1	0.4	0.3	0.0	0.0	1.8	0.0	0.0	0.1	0.0	9.8	0.0	89.0	0.6	0.3	12.8	0.0	0.0	7.9	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	76.8	1.8	0.2	0.0	2.8	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.7	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.2	49.4	16.3	0.1	0.3	0.0	0.0	6.1	0.0	0.0
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183644-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.5;Late spermatids: 15.1;Sertoli cells: 46.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;AF22: 6.3;hTERT-RPE1: 2.4;SH-SY5Y: 4.3;U-2 OS: 2.5;U-87 MG: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	1.1	5.3	12.3	0.9	12.0	0.1	1.0	11.2	21.4	3.5	1.1	1.8	0.2	5.4	0.3	0.9	1.0	1.3	2.3	10.8	25.7	0.7	0.3	0.8	0.2	18.3	12.5	7.5	0.6	5.8	11.6	2.3	24.5	1.4	0.4	5.0	0.4	0.8	0.9	0.4	0.9	1.4	7.5	0.9	1.0	6.2	11.9	0.0	0.9	0.4	0.0	2.0	1.5	10.8	0.0	2.7	6.3	0.2	0.5	0.5	0.0	0.2	1.2	0.3	0.5	0.3	0.1	0.0	0.1	0.2	1.6	0.1	0.6	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.3	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.7	2.5	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	12.0	11.2	21.4	10.8	25.7	18.3	12.5	24.5	7.5	11.9	10.8	1.2	0.0	0.0	2.6	1.1	0.0	0.1	0.0	6.2	2.3	0.3	1.9	0.6	0.0	0.6	0.0	0.0	0.7	2.0	0.1	0.0	0.3	62.5	0.4	9.4	3.1	5.3	0.0	5.6	0.0	0.6	11.2	1.1	0.2	0.0	4.2	6.8	0.0	0.9	5.0	12.7	0.0	0.0	0.3	0.0	15.1	0.3	0.5	0.0	1.0	0.0	3.0	0.0	1.5	1.1	0.1	0.0	2.2	0.2	0.1	0.0	0.0	5.1	7.0	46.0	8.6	7.6	12.7	1.8	2.2	0.0	1.5	3.2	1.8	0.0	0.0
CCDC71L	"C7orf74, FLJ36031"	ENSG00000253276	"Coiled-coil domain containing 71 like"	Q8N9Z2	7	106654360-106661158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067925	Approved		Approved	"Golgi apparatus,Actin filaments,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Actin filaments"	Cytosol	"HPA067925: AB_2685925"	"unprognostic (1.51e-1)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.03e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (3.34e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.35e-2)"	51.5	9.8	2.7	19.6	2.7	15.8	18.7	2.0	2.9	13.1	3.3	14.6	6.5	16.9	2.8	6.8	36.2	10.8	8.2	2.9	3.2	18.1	46.7	22.1	9.6	8.2	2.8	10.1	9.3	5.2	6.4	3.7	3.7	11.2	5.4	1.0	12.6	6.6	5.3	6.2	15.8	7.2	3.3	18.7	16.3	6.9	4.6	14.5	10.2	2.5	8.0	40.0	9.3	3.6	24.8	5.1	7.4	8.9	16.3	15.4	0.0	37.0	47.5	14.2	15.4	0.7	15.3	16.5	12.6	63.3	27.1	2.8	3.6	10.7	11.7	38.7	8.5	2.1	0.9	0.0	25.5	8.4	19.4	13.2	6.4	6.5	3.7	24.1	50.0	9.2	56.0	39.9	17.1	7.1	11.5	13.3	16.0	2.0	17.0	15.4	2.1	3.3	7.3	1.4	3.2	22.1	23.9	8.6	55.9	15.4	3.9	10.1	22.0	31.4	2.9	3.7	14.6	38.4	3.8	13.5	24.3	10.8	35.3	4.9	0.6	1.8	1.1	0.4	0.8	1.3	0.8	0.8	0.4	0.9	0.4	0.6	4.1	0.6	0.7	1.4	1.7	0.5	2.7	2.7	2.0	2.9	2.9	3.2	8.2	2.8	3.7	3.3	4.6	3.6	44.0	3.2	11.6	1.0	9.4	8.2	50.5	2.1	6.8	4.3	39.9	33.0	6.2	18.6	1.6	5.5	2.1	3.0	26.2	12.9	11.7	7.4	1.2	18.7	78.7	21.4	6.6	11.6	1.8	10.7	7.4	47.8	3.6	20.2	12.0	3.3	45.7	34.4	8.1	6.7	2.8	7.3	4.1	10.0	13.9	2.1	21.8	22.5	12.4	1.9	6.5	5.0	10.3	2.5	1.8	13.9	10.1	17.7	4.3	11.0	10.1	4.7	6.8	4.8	0.0	24.5	30.1	7.1	4.9	4.0	5.1	3.3	13.7	3.4	9.5	18.3
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 21.7;HMC-1: 83.3;Karpas-707: 22.0;THP-1: 34.5;U-937: 25.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"	8.5	6.7	14.9	15.1	15.1	47.6	5.3	20.1	21.6	5.6	15.3	17.8	4.0	3.5	0.3	12.9	6.5	8.5	5.5	15.3	15.0	6.5	7.3	21.1	28.6	17.2	15.5	3.1	4.1	0.9	4.5	1.7	17.5	7.8	3.6	1.4	14.4	2.5	1.2	4.5	34.1	1.2	15.4	86.1	8.9	17.4	15.4	17.4	5.4	0.8	13.8	8.3	7.7	15.9	0.3	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.0	0.0	3.4	19.7	2.9	1.1	0.5	1.6	0.1	0.6	0.0	21.7	0.0	15.0	4.6	1.1	0.8	9.4	83.3	0.0	0.0	0.2	0.0	1.3	0.5	6.3	0.5	22.0	0.7	0.9	12.7	7.7	0.7	3.7	0.5	11.9	0.3	18.5	0.3	0.3	4.8	0.0	0.0	0.5	1.1	0.1	2.6	34.5	0.0	0.0	0.7	0.1	0.2	4.7	1.5	15.8	1.0	25.3	0.4	2.9	4.6	6.7	3.5	3.6	1.0	1.6	2.0	2.9	1.6	2.0	1.8	2.2	9.2	6.5	2.5	2.7	0.6	1.3	14.9	15.1	20.1	21.6	15.3	15.0	17.2	15.5	17.5	15.4	15.4	15.9	3.3	0.0	10.7	5.2	30.3	2.7	4.5	10.5	0.6	45.2	5.7	4.8	13.5	4.3	9.9	9.2	0.0	2.9	34.9	46.0	0.0	12.8	11.1	8.7	2.6	4.4	18.0	7.0	2.6	28.9	5.8	3.1	51.0	6.8	26.6	2.2	6.1	10.4	14.5	0.0	2.0	24.4	8.2	26.0	26.6	15.8	1.5	27.3	5.4	12.2	35.0	15.4	64.9	2.0	0.6	35.0	33.2	0.7	24.9	2.9	36.1	3.2	22.7	4.7	0.0	2.8	2.8	13.7	8.7	2.0	1.6	1.4	31.7	10.0	32.4	15.7
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983288-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 632.7"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 1156.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"HUVEC TERT2: 92.1"					"Low region specificity"	"Detected in all"			"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	NA	NA	5200000	37000000		"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	411.9	102.7	0.4	6.4	0.3	3.3	400.7	0.2	1.7	192.0	2.8	66.6	2.9	198.0	59.3	62.0	233.5	69.3	98.6	0.3	0.3	69.2	82.6	66.4	49.0	0.5	0.3	44.1	22.6	12.4	39.5	0.9	0.7	97.4	9.8	0.0	61.9	49.5	55.9	93.3	50.5	94.3	0.4	632.7	67.5	16.0	0.4	34.4	123.9	24.5	28.2	116.8	177.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.7	0.3	0.3	0.5	0.3	0.7	0.4	0.4	0.3	136.5	0.0	8.2	0.0	2.2	1.9	0.1	0.0	3.4	0.0	0.6	1.1	0.2	18.6	0.6	0.0	0.0	0.0	0.1	2.0	0.0	0.0	24.2	0.4	0.3	203.8	0.0	26.7	0.0	0.0	0.0	9.4	0.0	0.2	1.3	0.0	1156.5	11.0	0.3	0.0	0.0	1.0	0.0	58.8	3.1	63.8	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	2.3	1.1	2.6	0.0	0.0	0.3	2.3	0.0	0.0	2.0	1.4	0.0	1.8	0.1	0.6	0.2
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.0;liver: 31.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.8	0.1	0.1	0.4	0.1	0.3	0.3	0.0	59.7	37.6	0.1	0.0	0.2	9.6	9.2	0.0	0.1	0.1	10.0	31.6	2.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.0	0.0	0.1	0.1	0.0	0.1	62.0	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	4.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103827-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 3753.7;Hofbauer cells: 849.7;Macrophages: 1168.2;NK-cells: 1232.8;Plasma cells: 974.5;T-cells: 1948.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 414.7"	"Group enriched"	"Detected in all"	6	"granulocytes: 135.0;T-cells: 414.7"	"Group enriched"	"Detected in some"	6	"U-266/70: 51.6;U-266/84: 13.3"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	38.9	28.0	2.0	32.0	2.0	192.9	10.5	3.4	5.5	16.0	4.1	9.9	7.6	10.3	6.4	15.0	8.2	45.1	4.4	2.0	1.9	6.8	84.2	33.9	34.3	3.2	2.9	5.0	15.6	12.0	2.5	17.8	2.8	7.6	11.1	0.1	5.1	3.4	1.0	0.9	11.4	18.0	2.5	65.3	10.3	2.7	2.1	24.1	5.9	4.5	15.4	56.4	4.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	51.6	13.3	0.2	0.2	0.1	0.0	14.4	3.4	135.0	414.7	4.8	101.6	8.4	46.0	240.6	2.3	17.7	13.8	181.7	55.8	42.8	11.1	2.6	0.5	138.9	2.0	2.0	3.4	5.5	2.0	1.9	3.2	2.9	2.8	2.5	2.1	3.3	52.3	0.0	54.5	0.0	135.9	15.6	1.9	0.3	24.5	1.5	26.3	49.3	11.2	14.3	7.2	0.0	0.0	9.7	3753.7	1.2	0.0	0.4	20.8	3.7	4.7	77.6	1.2	60.9	0.0	0.4	11.3	18.9	118.3	5.5	60.8	0.2	21.4	10.5	849.7	1.7	0.0	1.5	0.0	429.4	428.0	32.6	0.9	1168.2	51.6	3.7	10.5	1.1	1232.8	0.0	0.0	0.2	0.1	0.4	974.5	0.8	0.4	2.8	5.8	5.2	0.0	3.9	20.9	0.4	0.4	11.0	14.5	25.9	1948.3	0.0	0.9	1.6
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 122.1;lymphoid tissue: 135.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2049.9;NK-cells: 2344.0;T-cells: 1947.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 6788.6;memory CD8 T-cell: 7164.3"	"Group enriched"	"Detected in all"	7	"NK-cells: 2041.1;T-cells: 7164.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 94.1;NB-4: 539.9;THP-1: 139.9;U-937: 120.1"									CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	2900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	17.2	17.1	3.9	36.3	4.0	122.1	19.5	3.8	6.5	15.5	5.4	27.7	48.7	15.7	14.4	15.8	14.0	42.9	8.9	3.9	3.7	7.5	28.4	57.4	135.2	7.3	4.3	16.9	7.0	3.0	3.8	6.3	6.4	10.4	25.6	0.3	33.5	7.9	4.8	4.0	84.5	10.5	5.8	123.9	47.9	4.6	4.7	29.5	11.5	2.7	33.4	31.4	9.5	6.1	0.7	0.5	0.2	0.0	0.5	0.4	0.8	0.3	4.0	17.8	20.8	0.4	1.7	0.3	1.6	0.9	1.3	0.9	0.0	0.0	2.3	6.5	0.3	0.0	1.5	0.6	0.5	94.1	0.8	0.1	0.2	5.5	0.3	0.0	0.2	0.1	0.1	12.5	0.2	0.6	0.1	539.9	0.5	0.0	0.0	0.6	0.2	14.0	0.2	0.5	0.1	0.5	0.2	1.2	13.4	0.5	0.2	139.9	0.3	0.6	0.3	0.6	0.4	14.2	6.6	0.8	0.4	120.1	1.3	657.8	30.0	35.8	6788.6	21.3	4221.0	61.3	1394.5	7164.3	49.8	41.6	332.4	4032.4	189.9	2041.1	26.1	46.5	25.9	6664.4	3.9	4.0	3.8	6.5	3.9	3.7	7.3	4.3	6.4	5.8	4.7	6.1	22.4	99.3	244.4	0.3	55.2	7.4	1.3	6.0	4.6	1.3	19.9	18.2	5.4	21.5	41.7	1.8	0.0	1.8	2049.9	3.1	1.9	6.3	1.2	5.5	5.4	24.2	1.8	106.3	0.5	0.2	7.1	26.0	46.9	6.7	80.8	0.2	45.0	7.0	33.8	0.0	0.3	3.5	0.0	48.0	25.0	0.1	0.3	256.3	12.4	2.8	38.5	0.4	2344.0	0.0	0.4	1.6	6.9	0.4	179.5	1.7	2.4	6.7	29.2	1.1	0.0	6.5	28.2	1.1	1.2	5.5	6.3	16.0	1947.0	0.1	3.5	1.9
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffold protein"	Q9NUG4	20	32010438-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 141.6"	"Cell type enriched"	"Detected in some"	5	"Theca cells: 248.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HUVEC TERT2: 9.0;NTERA-2: 4.6;RH-30: 3.2;SCLC-21H: 7.7;TIME: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA008434: AB_1845671, HPA071063: AB_2686339"	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	15.9	5.4	7.2	1.6	7.3	0.0	15.0	9.5	6.8	8.7	4.2	4.6	1.3	8.9	0.6	3.7	7.7	2.5	23.2	6.1	5.8	13.3	2.2	11.8	1.5	6.8	6.4	3.6	2.6	1.4	4.1	7.8	7.0	5.8	1.1	0.4	3.4	1.8	4.8	3.9	5.4	3.3	6.1	141.6	4.2	1.6	7.3	0.8	10.2	4.8	0.9	6.4	6.3	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.0	0.9	0.0	0.0	0.0	2.4	0.0	0.0	4.6	0.1	0.0	0.6	3.2	0.1	0.0	0.0	7.7	0.9	0.2	0.0	0.0	1.1	2.5	0.0	4.8	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	7.3	9.5	6.8	6.1	5.8	6.8	6.4	7.0	6.1	7.3	5.2	45.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.5	0.6	4.6	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.2	32.1	0.0	0.0	2.9	0.2	0.0	1.0	0.0	0.2	0.0	4.3	24.3	0.0	0.0	3.3	2.4	0.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.8	0.3	0.6	0.1	0.3	0.0	0.1	248.7	0.0	0.1
CCNA1	CT146	ENSG00000133101	"Cyclin A1"	P78396	13	36431520-36442870	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.2;testis: 81.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 162.4;Endometrial ciliated cells: 119.1;Late spermatids: 91.1;Spermatocytes: 285.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 20.7;head and neck cancer: 6.2;ovarian cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	103	"basophil: 49.2"	"Lineage enriched"	"Detected in single"	301	"granulocytes: 49.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 350.9;NB-4: 71.4;THP-1: 71.5;U-937: 90.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060646, HPA077614"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA060646: AB_2684336, HPA077614: "	"unprognostic (1.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.89e-3)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (1.70e-4)"		"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (4.04e-6)"	"unprognostic (7.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-2)"	0.4	0.9	5.9	0.4	5.9	2.1	0.7	2.3	7.8	5.8	4.1	0.6	0.4	3.7	7.0	0.4	18.0	0.7	0.3	5.5	7.3	0.5	0.1	1.4	0.3	5.3	5.4	0.5	0.1	22.2	8.2	0.0	10.7	0.5	0.1	1.0	0.6	0.1	1.2	0.3	0.3	8.2	4.9	0.6	0.4	81.3	6.1	0.4	0.6	0.4	0.6	0.6	1.1	4.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	15.2	0.1	15.5	1.2	12.9	1.4	0.1	0.0	0.7	0.0	0.4	0.0	0.6	8.0	350.9	0.3	34.1	0.7	2.8	5.5	0.9	1.7	0.0	0.5	0.2	4.4	0.4	71.4	2.5	0.0	8.8	0.0	8.3	0.0	2.3	0.0	2.5	5.8	0.0	8.4	0.2	1.8	0.0	71.5	4.5	0.0	0.0	0.1	2.9	0.8	0.0	0.0	0.3	90.3	0.6	49.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.9	5.9	2.3	7.8	5.5	7.3	5.3	5.4	10.7	4.9	6.1	4.0	0.1	0.0	0.6	0.3	0.3	0.6	0.6	19.1	0.0	0.4	0.5	1.4	0.4	0.0	10.3	0.0	0.0	0.1	0.0	0.1	0.0	0.2	162.4	119.1	1.8	0.4	0.0	0.0	3.5	0.0	0.8	1.1	0.0	31.9	5.1	2.2	0.0	0.0	0.2	0.0	3.0	0.0	6.1	0.0	1.8	91.1	3.1	1.1	0.0	0.0	0.0	1.4	0.0	0.5	0.4	0.0	0.0	2.6	0.0	0.7	0.0	0.1	29.3	0.8	6.6	0.5	1.5	285.7	2.4	0.0	0.4	0.3	0.9	0.0	0.1	1.1
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201711-46208313	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.5"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 81.2;Hofbauer cells: 117.4;Kupffer cells: 171.9;Macrophages: 74.2;monocytes: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 330.3;RPMI-8226: 158.5;U-266/70: 57.7;U-266/84: 183.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.95e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	21.0	4.7	2.1	42.5	2.3	24.8	4.0	2.4	3.1	2.5	2.6	5.6	7.3	2.5	1.6	3.4	2.8	11.7	2.4	1.9	2.6	4.9	17.2	18.7	10.9	5.2	3.2	2.1	3.1	1.9	0.9	26.4	4.5	1.6	7.3	0.3	2.1	2.6	1.3	0.6	6.6	15.5	4.7	30.8	4.9	1.7	4.9	5.7	1.0	3.3	10.2	16.7	0.7	7.4	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.3	0.7	1.5	0.1	0.4	0.0	3.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	6.1	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	330.3	0.0	0.2	0.2	13.0	0.0	0.0	0.0	0.1	0.0	158.5	0.0	5.6	0.0	0.0	0.0	0.4	1.3	0.9	0.2	35.5	0.0	0.8	0.0	0.0	0.2	57.7	183.7	0.1	29.1	26.5	0.4	82.5	125.1	25.8	10.5	76.2	50.1	2.9	0.1	8.5	53.9	0.2	0.1	1.4	113.4	84.5	51.3	18.9	0.1	50.6	2.1	2.3	2.4	3.1	1.9	2.6	5.2	3.2	4.5	4.7	4.9	7.4	0.3	3.2	3.0	0.0	2.0	0.9	0.0	0.0	0.6	0.0	0.1	0.5	0.6	0.0	1.3	0.0	0.0	1.3	15.9	0.0	1.9	0.0	0.4	0.1	0.6	1.6	0.0	1.7	0.0	0.0	81.2	2.4	0.0	0.0	3.8	0.0	1.4	1.2	117.4	0.0	0.0	0.0	0.0	171.9	23.5	0.1	0.0	74.2	5.4	9.4	51.5	0.2	7.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	3.2	1.5	0.2	0.0	0.4	0.5	0.0	0.2	0.2	1.7	2.9	6.0	0.0	0.0	0.0
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 240.5"	"Cell type enriched"	"Detected in many"	4	"Kupffer cells: 1756.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.2;monocytes: 76.1"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.8;HSkMC: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	171.8	85.6	6.1	152.5	7.0	17.6	50.8	5.2	18.4	25.6	21.5	48.7	12.4	27.3	3.6	16.4	68.1	43.5	52.7	4.9	7.9	27.3	89.7	131.7	54.4	15.8	10.9	23.1	21.4	8.8	11.4	109.4	18.0	15.5	21.6	4.3	25.9	7.2	11.4	15.3	52.9	130.4	7.2	240.5	35.6	9.7	55.9	18.7	17.2	17.6	7.2	68.5	16.3	10.3	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	76.1	0.5	0.1	6.4	0.0	0.0	0.0	0.1	65.2	0.0	0.0	0.0	1.7	0.0	0.0	1.0	0.1	20.1	6.1	7.0	5.2	18.4	4.9	7.9	15.8	10.9	18.0	7.2	55.9	10.3	2.7	3.2	8.3	0.0	3.8	1.5	0.2	0.0	0.0	0.1	0.1	0.3	4.6	7.2	5.0	0.0	2.1	1.5	0.5	0.0	0.0	0.0	4.3	0.0	0.1	13.9	0.0	3.6	0.4	0.0	1.9	3.0	0.5	0.0	5.1	0.1	17.9	13.9	269.9	0.0	0.5	0.0	0.0	1756.1	30.9	6.4	5.0	387.9	0.0	2.8	41.1	0.9	1.0	0.0	0.0	0.0	0.0	1.2	1.0	0.1	0.0	0.2	1.6	0.2	118.3	1.7	4.0	3.9	2.6	0.5	1.0	3.0	1.3	0.0	0.0	0.1
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 53.6;Hofbauer cells: 78.6;Kupffer cells: 23.5;Macrophages: 17.5;monocytes: 13.8;Plasma cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.0;naive B-cell: 78.9"	"Group enriched"	"Detected in many"	25	"B-cells: 78.9;dendritic cells: 23.5;monocytes: 34.5"	"Group enriched"	"Detected in some"	10	"Daudi: 45.2;Karpas-707: 41.1;U-266/70: 33.1;U-266/84: 49.0;U-698: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"		Yes	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (9.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.85e-3)"	"unprognostic (2.25e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	1.6	0.7	0.7	9.7	0.7	2.4	6.7	0.6	1.2	0.5	0.4	2.1	2.0	0.5	0.2	0.4	0.4	1.6	0.4	0.8	0.7	0.3	2.5	1.6	23.2	1.5	1.5	0.2	0.3	0.2	0.1	3.2	2.0	0.5	2.7	0.3	1.1	0.4	0.1	0.2	3.9	1.8	1.0	12.9	2.2	0.4	1.8	2.5	0.3	0.2	23.3	3.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.2	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	41.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.1	0.6	0.2	33.1	49.0	12.3	0.0	2.7	0.0	0.3	11.8	0.9	0.0	20.4	0.0	77.0	0.1	0.1	22.1	78.9	0.0	0.0	0.9	1.8	34.5	23.5	0.1	8.5	0.7	0.7	0.6	1.2	0.8	0.7	1.5	1.5	2.0	1.0	1.8	2.1	0.1	0.0	0.5	0.3	53.6	0.4	0.1	0.0	0.0	0.1	1.8	1.1	0.7	1.5	0.0	0.0	0.0	0.4	4.0	0.0	0.0	0.0	2.2	0.1	0.0	0.6	0.0	1.7	0.0	0.2	0.3	0.4	0.0	0.1	2.5	0.0	0.0	0.3	78.6	0.0	0.0	0.0	0.0	23.5	8.0	1.0	0.0	17.5	0.0	1.9	13.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	39.6	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.7	2.2	0.0	0.1	0.1
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 249.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 158.3;NK-cells: 178.2;T-cells: 476.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 421.8;MAIT T-cell: 403.1;memory CD4 T-cell: 610.2;memory CD8 T-cell: 714.1;naive CD4 T-cell: 316.3;naive CD8 T-cell: 486.2;NK-cell: 1108.0;T-reg: 655.2"	"Group enriched"	"Detected in all"	10	"NK-cells: 1108.0;T-cells: 714.1"	"Group enriched"	"Detected in some"	25	"HDLM-2: 224.1;JURKAT: 145.8;MOLT-4: 166.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"prognostic favorable (4.36e-4)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.46e-5)"	"unprognostic (9.32e-3)"	"unprognostic (1.61e-2)"	"prognostic favorable (3.97e-5)"	"prognostic favorable (7.72e-4)"	"unprognostic (4.18e-2)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (6.16e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.63e-3)"	4.6	4.6	0.6	51.3	0.7	11.4	7.6	0.6	1.0	5.8	0.8	13.9	17.2	3.7	2.8	8.4	4.2	16.8	2.6	0.5	0.8	2.5	7.8	21.0	119.6	1.7	0.7	2.8	2.9	0.9	0.7	1.0	1.1	5.2	16.0	0.0	8.6	2.3	1.4	3.5	28.4	4.4	1.0	44.1	24.1	1.8	1.0	249.8	3.8	1.7	79.1	20.8	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.1	0.0	0.4	0.0	0.0	0.0	0.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.1	0.5	0.0	0.0	166.9	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.4	0.0	11.3	5.2	1.6	421.8	3.7	403.1	3.8	610.2	714.1	95.4	2.5	316.3	486.2	14.1	1108.0	2.8	21.0	655.2	565.1	0.6	0.7	0.6	1.0	0.5	0.8	1.7	0.7	1.1	1.0	1.0	1.1	5.0	3.2	17.5	0.0	12.3	5.0	0.4	0.0	2.2	0.0	4.0	4.7	2.1	0.0	2.5	3.7	0.0	0.1	158.3	0.2	0.0	0.5	23.5	1.1	1.0	2.9	3.0	24.0	0.0	0.0	0.0	2.5	10.7	0.9	5.1	0.0	8.2	1.5	0.6	0.0	0.0	0.0	0.0	10.9	16.6	7.8	0.6	19.1	1.8	1.0	15.5	0.0	178.2	0.0	0.0	0.0	0.0	0.4	42.3	0.1	0.0	1.7	0.0	0.0	0.0	2.9	4.1	0.3	0.2	0.4	3.7	0.0	476.8	0.0	0.5	0.2
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 34.2;placenta: 22.8"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 15.6;Langerhans cells: 14.7;Macrophages: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;monocytes: 1.4"	"Cell line enriched"	"Detected in single"	14	"THP-1: 3.3"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		3100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	34.2	3.9	0.3	8.6	0.6	0.4	4.4	1.3	3.0	4.0	5.7	10.5	14.3	1.4	1.0	4.8	2.5	8.6	4.5	0.3	0.7	2.1	3.3	4.9	18.1	1.0	0.6	1.0	1.0	0.8	0.7	22.8	0.8	0.8	13.9	0.1	2.1	1.9	0.9	1.4	19.3	10.6	0.9	2.4	4.1	2.1	0.6	5.4	1.4	1.5	2.3	20.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.4	0.3	0.6	1.3	3.0	0.3	0.7	1.0	0.6	0.8	0.9	0.6	0.8	0.3	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	15.6	14.7	0.3	0.0	12.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.1
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 141.3;lymphoid tissue: 230.2;ovary: 132.8"	"Group enriched"	"Detected in many"	7	"B-cells: 143.6;granulocytes: 95.8;Granulosa cells: 51.3;Oligodendrocytes: 91.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.6;naive B-cell: 120.3"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 280.6;REH: 83.8;U-698: 219.9;WM-115: 50.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002418, HPA024353, HPA066523"	Enhanced					NA	NA		13000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.7	5.5	39.2	75.3	66.8	13.6	1.7	42.8	58.4	2.7	17.8	4.9	2.3	3.7	2.5	2.2	30.9	4.1	1.3	42.7	53.2	2.1	1.5	7.4	219.2	63.3	53.8	132.8	0.6	0.7	2.1	1.8	60.3	2.9	6.4	0.0	3.5	1.1	0.2	0.3	53.4	2.1	37.8	161.6	7.0	3.8	55.8	11.4	6.3	0.4	230.2	5.7	1.6	141.3	0.9	1.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.4	0.0	5.1	280.6	5.6	0.3	15.0	0.5	0.0	0.0	0.1	1.5	0.0	0.0	0.2	2.2	0.1	0.3	12.4	0.0	0.0	0.2	4.1	0.1	0.0	0.0	1.5	0.1	2.6	0.5	0.1	0.0	0.1	0.4	0.4	83.8	0.3	0.2	0.0	0.0	0.0	0.0	0.3	1.4	6.6	0.2	0.5	0.1	0.3	2.6	1.5	0.0	0.0	0.0	0.1	219.9	2.2	0.9	50.1	0.1	0.1	0.1	0.0	1.1	0.0	97.6	0.0	0.0	4.6	120.3	0.0	0.0	1.0	0.2	0.7	3.8	0.0	4.9	39.2	66.8	42.8	58.4	42.7	53.2	63.3	53.8	60.3	37.8	55.8	141.3	1.7	3.2	3.0	0.0	143.6	0.3	0.4	0.0	0.0	0.0	1.0	3.3	0.7	0.0	0.6	0.0	0.0	0.2	4.1	0.1	0.0	0.0	0.6	0.2	0.4	2.1	0.0	2.7	0.3	0.2	1.3	2.8	0.5	0.5	95.8	51.3	3.3	0.2	6.8	0.0	0.3	0.0	0.0	5.6	2.0	0.2	3.7	6.9	1.8	0.0	0.9	0.0	1.0	0.0	91.5	0.2	0.1	0.7	2.3	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.4	1.1	0.0	0.4	0.1	4.1	12.2	0.0	0.1
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 52.1;Macrophages: 24.4;Microglial cells: 22.5;NK-cells: 90.6;Oligodendrocytes: 26.6;T-cells: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"HEL: 100.0;HMC-1: 42.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.1	0.6	1.1	5.7	6.4	4.4	1.5	1.5	2.4	1.1	0.0	1.8	2.3	1.3	0.5	1.6	1.3	3.0	0.5	0.7	2.0	1.5	4.2	4.2	9.7	3.1	3.3	0.9	0.5	62.4	0.6	0.5	3.2	1.0	2.4	1.4	1.5	0.4	0.7	0.3	3.1	1.6	2.2	20.2	3.2	1.2	5.5	6.4	0.7	0.6	7.1	3.1	0.4	3.2	0.0	0.1	0.3	0.3	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.4	0.2	5.3	0.1	100.0	0.3	0.1	0.0	0.7	42.6	0.0	1.1	0.2	0.6	0.2	0.0	0.9	0.3	9.3	0.4	0.0	0.8	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.5	0.8	0.3	0.1	0.2	11.5	0.4	0.0	0.3	0.2	0.5	0.3	0.1	1.2	36.6	1.0	13.4	0.8	28.8	22.5	2.9	0.1	15.8	17.3	1.6	29.7	1.3	0.1	11.3	13.2	1.1	6.4	1.5	2.4	0.7	2.0	3.1	3.3	3.2	2.2	5.5	3.2	0.6	3.2	3.6	3.3	3.2	0.0	0.3	0.0	0.0	3.4	0.5	0.8	2.5	0.0	0.7	0.0	0.0	0.1	52.1	0.2	0.0	0.0	8.4	0.9	1.7	1.0	0.0	3.2	4.6	0.4	0.0	1.3	3.1	0.5	13.9	1.3	3.3	0.4	1.6	0.0	3.1	0.1	0.0	16.7	2.7	8.2	0.9	24.4	0.0	22.5	14.7	0.8	90.6	2.0	26.6	0.2	0.1	0.7	13.4	0.3	0.0	0.3	1.5	3.6	0.0	1.8	0.6	0.4	0.8	0.0	0.4	0.0	43.2	0.5	0.1	0.2
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	3.2	1.7	2.3	25.3	2.3	49.0	1.9	2.2	2.5	1.9	1.9	4.3	7.1	2.3	3.1	2.1	1.8	5.5	1.3	2.3	2.3	2.0	5.4	10.9	57.7	2.3	2.2	0.8	0.8	0.5	0.8	1.4	2.2	1.8	4.6	0.2	2.4	1.6	1.4	1.1	14.3	1.5	2.1	40.2	7.0	0.4	2.9	179.4	2.5	0.9	36.4	7.3	1.9	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	155.9	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.1	0.0	0.0	167.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	8.3	1.0	0.4	376.4	1.4	208.9	9.3	190.0	219.7	1.5	4.9	237.8	195.1	8.7	225.3	1.2	2.8	254.5	231.2	2.3	2.3	2.2	2.5	2.3	2.3	2.3	2.2	2.2	2.1	2.9	2.5	3.4	3.2	16.0	3.3	8.2	1.5	0.1	0.0	0.6	0.4	3.5	3.2	0.6	1.5	1.3	0.0	0.0	0.1	492.1	0.4	0.0	0.5	0.2	0.7	0.8	1.8	0.0	14.7	8.8	0.0	0.1	2.2	6.1	1.1	6.3	0.4	7.1	1.4	0.3	3.3	9.4	0.5	0.0	7.8	1.4	0.2	0.0	5.9	3.6	14.0	7.6	0.1	727.1	0.5	3.7	0.0	1.2	0.0	51.9	0.1	0.2	1.3	2.2	0.2	0.0	0.9	1.2	0.1	2.5	1.4	0.6	0.1	247.2	0.0	0.1	0.1
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 34.1;T-cells: 52.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 360.6;RPMI-8226: 173.2;U-266/70: 294.1;U-266/84: 283.7"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"	4.0	0.3	0.0	14.9	0.1	3.3	0.8	0.1	0.1	1.1	0.9	1.7	1.1	0.7	0.3	0.9	0.5	4.1	0.6	0.1	0.1	0.5	1.3	1.9	28.0	0.1	0.0	0.3	0.5	0.2	0.1	14.8	0.1	1.0	1.9	0.1	0.6	0.8	0.3	0.3	3.0	1.4	0.1	7.2	2.5	0.7	0.2	30.8	0.5	0.1	18.6	4.6	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.7	2.0	0.0	360.6	0.2	0.0	19.9	0.0	0.1	0.0	0.0	0.1	0.3	173.2	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.3	294.1	283.7	2.9	0.3	0.1	0.0	1.7	0.6	1.0	8.3	0.5	50.6	0.3	54.5	26.1	0.1	0.3	48.1	18.6	13.8	0.2	0.5	0.2	101.9	14.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.5	0.0	1.3	0.0	2.4	2.9	0.1	0.0	0.6	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.2	3.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	1.0	2.0	0.1	1.3	0.0	0.0	0.1	34.1	0.0	0.0	0.0	0.0	0.8	5.3	0.2	0.0	4.4	0.0	1.0	1.5	0.0	2.1	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.2	1.6	0.1	52.6	0.0	0.0	0.0
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.7;lung: 8.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	5	"granulocytes: 15.2;Hofbauer cells: 32.1;Kupffer cells: 26.3;Langerhans cells: 15.3;Macrophages: 36.1;monocytes: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.3;non-classical monocyte: 242.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.1;HMC-1: 33.1;THP-1: 6.5;U-937: 16.2"					"Low region specificity"	"Detected in some"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	4.0	1.3	0.7	6.8	1.1	9.7	0.8	0.8	5.5	0.6	1.1	1.3	1.1	0.6	0.1	0.6	0.7	2.0	0.9	0.7	1.4	0.7	1.5	8.4	2.1	1.7	1.8	0.3	0.6	0.4	0.4	2.9	2.1	0.5	1.3	0.0	0.7	0.5	0.3	0.4	1.2	3.1	1.4	7.3	0.7	0.3	2.7	1.0	1.0	0.2	1.1	3.8	0.4	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	3.3	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.6	0.0	0.0	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.5	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	16.2	0.0	51.8	142.1	7.0	0.7	228.3	0.4	2.7	0.3	0.3	158.8	2.4	0.2	0.2	5.2	43.9	242.7	10.5	0.2	64.6	0.7	1.1	0.8	5.5	0.7	1.4	1.7	1.8	2.1	1.4	2.7	2.2	0.1	0.0	1.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.3	0.1	0.0	0.0	15.2	0.0	0.0	0.2	32.1	0.0	0.0	0.0	0.0	26.3	15.3	0.1	0.0	36.1	1.8	1.0	19.6	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	1.3	0.0	0.0	0.0
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609885-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.1;lymphoid tissue: 37.5"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 71.8;Macrophages: 112.4;monocytes: 100.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"thalamus: 3.7"	"Group enriched"	"Detected in some"	6	"classical monocyte: 88.0;intermediate monocyte: 135.1;non-classical monocyte: 148.5"	"Lineage enriched"	"Detected in many"	7	"monocytes: 148.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA015570	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	14.1	0.8	0.5	37.5	0.2	48.1	0.8	1.3	1.7	0.5	2.5	1.2	0.5	0.6	0.1	0.5	3.2	3.7	1.9	0.3	0.4	1.7	2.5	16.8	1.1	0.4	0.6	0.4	0.9	0.2	0.3	3.1	0.7	0.6	0.9	0.5	0.6	0.2	1.3	0.7	0.6	10.2	0.1	11.0	1.0	0.5	3.7	0.7	0.5	0.3	0.7	18.1	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	88.0	0.6	0.2	135.1	0.1	0.1	0.1	0.1	21.8	0.1	0.1	0.0	1.9	0.1	148.5	0.6	0.1	53.9	0.5	0.2	1.3	1.7	0.3	0.4	0.4	0.6	0.7	0.1	3.7	0.4	0.3	6.4	15.9	0.0	2.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.6	1.8	0.0	0.1	2.9	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	4.0	0.5	0.0	3.8	0.0	0.4	0.4	4.1	0.0	0.2	0.0	0.0	71.8	13.0	0.1	0.0	112.4	1.8	0.0	100.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.5	1.5	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.6	0.4	2.3	0.0	0.0	0.0
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.4;lymphoid tissue: 23.9"	"Group enriched"	"Detected in some"	6	"granulocytes: 76.0;Hofbauer cells: 78.8;Kupffer cells: 131.2;Langerhans cells: 41.4;Macrophages: 53.5;monocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.5;intermediate monocyte: 122.0;myeloid DC: 213.5;non-classical monocyte: 57.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.5;monocytes: 166.5"	"Cell line enhanced"	"Detected in some"		"HEL: 86.1;HL-60: 115.6;HMC-1: 82.4;NB-4: 55.2;RPMI-8226: 62.5;THP-1: 67.0;U-937: 84.1"									"CAB011442, HPA035832, HPA064807, CAB079996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		3400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane"		"CAB011442: , CAB079996: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	7.9	3.4	1.1	11.2	1.2	32.4	2.5	1.5	1.6	3.0	2.5	3.2	3.3	1.7	1.3	2.0	2.5	6.6	2.0	1.1	1.8	1.4	5.5	12.6	10.1	2.5	1.6	1.4	1.4	1.2	0.9	6.9	2.4	1.4	4.2	0.2	1.8	2.6	0.9	2.7	4.4	7.1	1.9	23.9	2.3	1.0	2.3	3.5	0.9	0.8	3.5	6.2	1.3	3.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.2	0.0	5.5	0.4	0.0	1.3	0.3	0.0	0.2	0.0	0.1	0.1	86.1	0.3	0.0	0.0	115.6	82.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	16.2	21.2	0.2	0.0	0.0	55.2	0.2	0.0	25.9	0.0	4.4	62.5	0.4	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	67.0	0.7	14.0	1.1	1.8	0.1	0.3	7.6	0.2	9.6	84.1	0.4	17.9	166.5	11.0	0.3	122.0	0.4	0.1	0.2	0.5	213.5	0.4	0.3	0.2	20.5	15.5	57.8	6.3	1.1	77.8	1.1	1.2	1.5	1.6	1.1	1.8	2.5	1.6	2.4	1.9	2.3	3.6	0.7	0.0	6.7	0.0	1.0	1.8	0.5	0.0	0.0	0.2	1.4	0.4	0.8	0.0	0.6	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.7	0.1	0.1	3.0	0.0	4.2	0.0	0.0	0.5	1.1	0.0	0.1	76.0	0.1	5.3	0.7	78.8	0.0	0.0	0.0	0.0	131.2	41.4	1.7	0.3	53.5	1.8	11.2	65.0	0.2	1.0	0.5	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.2	0.7	0.6	0.0	1.1	0.3	0.7	0.5	0.0	1.0	0.8	2.5	0.1	0.0	0.4
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD3D	T3D	ENSG00000167286	"CD3d molecule"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"lymphoid tissue: 906.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 231.0;T-cells: 665.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	52	"gdT-cell: 1462.4;MAIT T-cell: 990.0;memory CD4 T-cell: 1206.1;memory CD8 T-cell: 1368.7;naive CD4 T-cell: 1091.4;naive CD8 T-cell: 1338.9;T-reg: 1660.4"	"Lineage enriched"	"Detected in all"	66	"T-cells: 1660.4"	"Group enriched"	"Detected in some"	4	"JURKAT: 621.5;MOLT-4: 1299.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"CAB013055: , HPA071778: "	"prognostic favorable (3.00e-4)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (6.00e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (9.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.16e-4)"	4.1	3.8	0.3	77.5	0.4	28.6	9.9	0.4	1.4	5.2	0.7	18.8	21.7	3.6	5.7	7.6	4.5	15.7	3.7	0.3	0.6	2.3	7.9	20.6	222.7	1.1	0.4	3.2	1.3	0.9	0.8	1.2	0.6	5.9	22.4	0.3	8.3	3.1	2.5	4.0	30.1	3.9	0.7	60.9	23.8	2.4	0.5	906.7	3.8	1.4	166.9	26.7	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	621.5	49.8	0.0	0.0	0.0	1299.8	237.2	1.2	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.2	0.8	0.0	0.5	0.0	1.5	1.1	0.0	0.9	1.1	0.4	0.0	0.1	0.0	10.1	5.3	4.6	1462.4	3.3	990.0	9.6	1206.1	1368.7	5.0	3.7	1091.4	1338.9	25.1	4.2	5.3	6.0	1660.4	1138.7	0.3	0.4	0.4	1.4	0.3	0.6	1.1	0.4	0.6	0.7	0.5	0.8	5.9	6.4	29.6	0.0	18.6	15.3	0.3	0.0	1.8	0.0	5.4	6.7	2.8	7.2	2.6	3.7	0.0	0.4	231.0	0.9	0.0	1.3	0.4	0.8	0.8	5.0	1.2	16.8	0.0	0.0	0.0	8.3	21.4	0.9	12.6	0.0	7.9	3.1	0.6	0.0	0.0	0.2	0.0	14.9	28.4	0.7	0.0	14.2	12.4	1.0	25.0	0.0	32.0	0.0	0.0	0.1	0.2	0.0	21.0	0.3	0.0	3.4	1.5	0.0	0.0	2.5	5.8	0.1	1.2	1.4	11.8	0.3	665.7	0.0	1.1	0.2
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 94.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 139.6;T-cells: 294.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	21	"gdT-cell: 229.0;MAIT T-cell: 135.6;memory CD4 T-cell: 187.3;memory CD8 T-cell: 197.3;naive CD4 T-cell: 192.6;naive CD8 T-cell: 241.7;T-reg: 200.0"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.7"	"Group enriched"	"Detected in some"	52	"JURKAT: 70.9;MOLT-4: 193.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	0.7	0.8	0.6	10.5	0.8	1.3	1.0	1.1	0.8	0.7	1.1	2.3	3.3	0.5	0.6	1.4	0.9	2.5	0.5	0.5	0.4	0.6	1.6	2.8	27.9	0.9	0.6	0.4	0.5	0.2	0.0	0.3	0.8	0.9	2.7	0.4	1.6	0.3	10.5	0.9	4.6	0.6	0.3	11.5	4.1	0.4	0.8	94.7	0.6	0.3	20.4	3.0	0.4	1.9	0.2	0.2	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	70.9	2.5	0.3	0.0	0.6	193.8	1.3	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.7	0.3	0.2	0.2	0.1	9.2	1.2	1.2	229.0	0.6	135.6	0.8	187.3	197.3	0.6	0.9	192.6	241.7	6.4	1.4	1.2	1.5	200.0	90.4	0.6	0.8	1.1	0.8	0.5	0.4	0.9	0.6	0.8	0.3	0.8	1.9	3.2	3.2	6.9	0.0	7.8	2.3	0.1	0.0	1.8	0.2	2.0	2.9	0.8	1.5	1.9	0.0	0.0	0.1	139.6	0.4	0.0	0.3	1.0	0.4	0.4	1.4	0.0	3.4	0.1	0.0	0.0	2.3	13.7	0.4	6.3	0.0	4.2	1.7	0.1	0.0	0.1	0.2	0.0	3.8	5.8	1.4	0.0	7.7	5.4	1.0	8.1	0.0	14.4	0.0	0.3	0.0	0.1	0.0	18.5	0.0	0.0	0.6	0.7	0.8	0.0	1.3	1.6	0.2	0.4	0.6	2.4	0.3	294.0	0.1	0.3	0.0
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 15.5"	"Cell type enriched"	"Detected in some"	8	"T-cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.3;MAIT T-cell: 64.1;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.1"	"Lineage enriched"	"Detected in many"	39	"T-cells: 80.5"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 23.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA	776000	20000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	0.8	0.3	0.1	7.9	0.0	1.9	1.1	0.2	0.2	0.9	0.2	1.9	1.8	0.3	0.2	1.0	0.4	2.0	0.2	0.1	0.2	0.4	1.0	2.4	15.5	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.8	3.1	0.0	0.6	0.3	0.1	0.6	3.8	0.6	0.0	4.9	2.0	0.3	0.1	15.5	0.5	0.2	14.8	2.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.3	26.3	0.1	64.1	0.1	80.5	11.7	0.2	0.0	76.1	0.7	1.3	0.8	0.1	0.1	10.5	13.6	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.2	0.6	0.0	2.4	0.0	2.4	1.3	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.0	0.6	2.6	0.0	1.3	0.0	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.6	4.0	8.9	0.0	2.9	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.1	2.0	0.0	76.6	0.0	0.0	0.1
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102489-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Langerhans cells: 9.3;Muller glia cells: 16.0;T-cells: 57.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 138.2"	"Lineage enriched"	"Detected in many"	33	"T-cells: 138.2"	"Group enriched"	"Detected in some"	66	"JURKAT: 21.0;MOLT-4: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"prognostic favorable (4.05e-4)"	"prognostic favorable (9.16e-5)"	"unprognostic (2.33e-1)"	"prognostic favorable (9.00e-5)"	"unprognostic (1.02e-2)"	"prognostic favorable (7.41e-6)"	"unprognostic (2.45e-3)"	"unprognostic (1.37e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.25e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (8.94e-5)"	"unprognostic (4.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.06e-1)"	1.4	0.9	0.4	22.6	0.4	12.2	1.0	0.1	0.5	0.9	0.0	2.8	3.1	0.7	0.4	2.3	0.8	4.9	0.9	0.6	0.4	0.8	1.5	5.7	38.0	0.2	0.0	0.8	0.4	0.2	0.4	0.3	0.5	1.0	2.7	1.8	6.4	0.3	0.6	1.4	7.1	1.2	0.0	14.1	7.9	0.8	0.3	46.5	1.0	0.3	22.2	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.1	70.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.6	45.9	0.4	32.8	1.5	108.7	72.5	3.7	3.4	88.4	69.8	1.8	0.4	3.4	4.1	138.2	61.5	0.4	0.4	0.1	0.5	0.6	0.4	0.2	0.0	0.5	0.0	0.3	0.0	0.4	0.0	1.7	0.0	4.1	0.9	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	2.7	0.0	0.1	0.2	0.0	1.3	0.3	0.0	0.0	0.9	2.6	0.1	1.3	0.0	1.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	9.3	0.9	0.0	1.8	3.6	0.0	2.1	16.0	1.0	0.0	0.1	0.1	0.3	0.0	6.3	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.6	0.4	0.7	0.2	0.3	0.0	57.0	0.0	0.2	0.2
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110871188-110899922	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 448.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 310.0;dendritic cells: 375.0;Hofbauer cells: 365.7;Kupffer cells: 324.3;Macrophages: 294.8;NK-cells: 383.1;T-cells: 297.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 473.5;HDLM-2: 214.8;HMC-1: 298.4;Karpas-707: 188.1;U-266/70: 251.2;U-698: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	63.4	30.8	10.1	284.4	11.1	126.6	27.0	12.6	16.3	20.8	12.3	41.5	37.9	17.3	10.5	20.0	22.8	58.5	12.2	9.7	13.4	15.1	46.8	114.9	397.9	18.9	16.0	9.2	11.9	6.6	6.2	58.5	18.9	12.8	54.8	2.0	19.3	12.8	4.5	6.7	103.4	55.8	18.3	269.4	44.3	5.7	17.5	144.9	11.3	10.6	448.3	85.1	9.0	31.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	473.5	0.2	0.0	0.2	0.5	0.0	0.0	0.0	214.8	0.0	26.4	0.1	0.0	0.0	60.4	298.4	0.0	0.0	0.0	0.0	0.0	0.0	139.2	11.2	188.1	0.0	0.0	103.1	71.1	0.4	0.0	0.0	98.0	0.7	104.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	88.4	17.2	0.2	0.4	0.1	0.5	251.2	123.2	149.2	1.5	68.7	3.4	1483.0	779.5	479.0	732.4	808.6	658.1	794.0	527.8	649.2	631.9	745.1	377.9	552.5	1144.2	526.6	882.9	517.5	740.3	1621.0	10.1	11.1	12.6	16.3	9.7	13.4	18.9	16.0	18.9	18.3	17.5	31.9	4.2	16.0	24.4	0.7	310.0	7.0	0.6	0.0	0.6	0.0	2.3	5.1	1.0	5.7	8.6	1.8	0.0	2.1	375.0	0.2	0.0	0.5	0.4	0.4	0.5	13.0	0.0	42.9	5.8	0.2	5.4	6.7	7.1	0.6	162.2	0.0	16.4	6.7	365.7	0.0	1.4	0.3	0.0	324.3	161.5	1.9	2.1	294.8	39.2	69.3	156.3	0.1	383.1	1.0	0.6	0.3	0.1	0.4	134.0	0.3	0.0	1.6	4.4	0.6	6.6	1.9	1.8	0.1	0.6	1.1	5.5	4.1	297.0	0.0	0.2	0.3
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.6;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 25.7;NK-cells: 49.4;Plasma cells: 18.5;T-cells: 107.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	33	"gdT-cell: 27.7;MAIT T-cell: 24.7;memory CD4 T-cell: 51.4;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.4;naive CD8 T-cell: 25.2;T-reg: 25.5"	"Lineage enriched"	"Detected in many"	51	"T-cells: 51.4"	"Group enriched"	"Detected in some"	12	"JURKAT: 10.2;MOLT-4: 39.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	NA	NA	5270000	160000	"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB002489: AB_563605, CAB016252: AB_631163"	"prognostic favorable (1.95e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (4.47e-2)"	"prognostic favorable (2.41e-4)"	"unprognostic (2.06e-2)"	"prognostic favorable (5.10e-6)"	"unprognostic (8.45e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.87e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.35e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (1.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (5.96e-2)"	1.4	0.9	1.5	21.9	0.9	11.3	1.2	0.5	1.1	1.3	0.7	3.2	4.0	0.9	0.7	1.8	1.4	3.9	0.5	0.6	1.7	1.0	1.4	6.6	43.1	1.5	2.0	0.9	0.6	0.2	0.4	0.3	1.7	1.1	3.1	0.2	3.2	0.4	0.8	1.3	13.6	0.7	0.9	18.0	6.6	0.7	2.5	39.6	1.4	0.3	29.0	4.8	1.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.2	0.0	0.0	0.0	39.2	0.1	0.2	0.2	0.1	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.7	0.0	24.7	1.0	51.4	48.4	0.3	0.9	34.4	25.2	0.7	0.2	0.0	0.0	25.5	13.8	1.5	0.9	0.5	1.1	0.6	1.7	1.5	2.0	1.7	0.9	2.5	0.9	3.2	0.0	2.5	0.3	10.8	2.0	0.2	0.1	0.0	1.4	0.9	0.8	2.6	1.5	0.1	0.0	0.0	0.2	25.7	0.2	0.0	0.2	0.9	0.4	0.3	1.2	0.0	0.0	0.8	0.6	0.2	1.5	8.2	0.3	0.0	0.1	2.5	0.8	2.0	1.7	0.9	0.0	0.0	1.9	4.4	0.4	0.3	3.4	3.6	1.0	2.4	0.0	49.4	0.0	0.2	0.7	0.2	0.0	18.5	0.0	0.1	0.2	0.1	0.2	0.0	1.0	0.9	0.4	0.9	1.0	1.4	0.3	107.3	0.7	0.5	0.4
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 358.0;lymphoid tissue: 370.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1820.4;Kupffer cells: 701.2;Langerhans cells: 341.5;Macrophages: 791.2;Proximal enterocytes: 335.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3255.5;intermediate monocyte: 3655.9;non-classical monocyte: 3740.6"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1378.6;monocytes: 3740.6"	"Cell line enhanced"	"Detected in all"		"ASC diff: 472.0;U-87 MG: 751.0"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	139.6	78.3	10.4	236.1	9.8	266.2	72.6	11.2	33.4	77.8	14.6	88.8	279.5	26.7	9.0	126.4	43.1	161.1	38.9	8.2	26.7	50.6	156.7	358.0	217.3	45.5	31.2	19.4	22.1	14.2	8.9	173.1	36.0	13.1	91.9	4.8	52.6	19.8	23.0	24.8	240.2	79.0	16.1	370.7	87.5	15.2	58.5	44.2	22.7	21.3	84.2	149.3	50.6	31.6	243.4	48.6	3.2	3.5	472.0	177.6	2.1	75.6	203.9	97.8	113.4	10.1	71.3	2.9	84.2	220.8	174.6	10.6	1.2	47.6	65.9	2.2	9.0	38.8	13.2	59.0	42.0	19.2	207.8	57.1	9.8	205.4	150.4	162.6	26.3	4.3	15.7	24.2	95.5	2.2	1.7	17.2	2.8	63.1	36.0	3.3	4.5	144.4	20.9	10.9	1.6	3.0	63.2	31.3	72.1	2.2	1.6	146.1	82.4	123.7	8.0	125.7	100.1	1.4	2.1	1.9	751.0	46.4	64.0	243.5	3255.5	21.4	9.1	3655.9	11.1	80.2	4.1	6.2	817.3	59.0	5.8	5.1	219.4	18.7	3740.6	1378.6	6.5	3324.3	10.4	9.8	11.2	33.4	8.2	26.7	45.5	31.2	36.0	16.1	58.5	31.6	10.4	0.0	19.7	1.3	20.5	15.7	39.0	58.8	3.4	0.2	7.2	9.8	0.0	12.8	53.2	5.5	0.0	8.9	110.3	22.5	5.9	82.1	0.8	8.3	11.3	15.9	4.9	6.6	0.3	156.8	58.1	45.6	29.6	18.7	43.6	0.9	16.4	23.9	1820.4	0.0	0.4	15.8	16.2	701.2	341.5	2.1	6.5	791.2	39.2	5.6	179.2	0.3	7.2	0.0	0.1	121.0	86.1	1.9	8.5	33.3	335.3	50.2	20.6	1.0	26.3	8.7	11.7	0.5	1.2	12.4	14.3	33.4	10.8	0.5	28.9	99.9
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 121.3;Kupffer cells: 107.8;Langerhans cells: 148.3;Macrophages: 151.8;Microglial cells: 78.7;monocytes: 489.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 79.9;intermediate monocyte: 79.0;memory B-cell: 41.0;myeloid DC: 78.8;naive B-cell: 28.5;non-classical monocyte: 85.2"	"Group enriched"	"Detected in many"	18	"B-cells: 41.0;dendritic cells: 78.8;monocytes: 85.2"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 296.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	7.8	5.3	3.5	34.5	3.4	10.3	4.4	4.0	3.6	3.5	4.8	6.3	3.7	2.4	1.0	4.0	2.1	14.3	2.7	3.2	6.1	1.9	11.2	18.6	28.8	7.2	5.5	2.1	2.6	2.9	1.1	15.0	7.0	2.4	7.7	0.9	2.3	2.5	0.8	2.0	6.8	7.4	5.3	23.4	5.2	3.1	5.0	10.6	1.3	0.8	22.0	14.9	1.0	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	296.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.2	0.0	32.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.4	0.0	0.1	0.0	0.1	15.1	0.6	35.1	0.0	0.9	0.0	0.1	79.9	0.8	0.0	79.0	0.0	41.0	0.2	0.3	78.8	28.5	0.2	0.1	0.9	3.7	85.2	8.3	1.6	33.4	3.5	3.4	4.0	3.6	3.2	6.1	7.2	5.5	7.0	5.3	5.0	10.2	0.9	0.0	7.7	0.3	36.5	3.6	0.1	1.3	0.0	0.0	0.4	1.3	0.3	1.5	3.2	1.8	0.0	1.8	3.3	0.0	0.0	0.2	3.7	0.1	0.0	2.6	0.0	1.3	0.2	3.5	0.8	0.8	0.5	0.0	2.5	0.1	1.8	0.8	121.3	0.0	0.3	0.0	0.0	107.8	148.3	2.7	0.0	151.8	7.2	78.7	489.4	0.0	0.0	0.5	0.1	0.3	0.0	0.0	20.6	0.3	0.0	0.1	0.1	0.4	0.0	0.3	0.7	0.2	0.3	0.2	4.0	1.9	2.1	0.1	0.0	0.3
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 369.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 111.7;T-cells: 242.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 234.4;memory CD8 T-cell: 523.0;naive CD8 T-cell: 476.8"	"Lineage enriched"	"Detected in many"	19	"T-cells: 523.0"	"Cell line enhanced"	"Detected in some"		"JURKAT: 4.0;MOLT-4: 15.2;RPMI-8226: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	5.3	4.6	2.1	21.2	2.8	22.5	4.7	1.9	3.0	3.8	1.4	4.9	11.8	3.0	3.6	4.4	4.0	9.8	2.3	2.1	2.1	1.8	7.4	10.5	45.0	2.8	2.1	2.5	2.6	1.1	1.5	0.6	2.5	3.4	5.9	0.2	8.3	1.9	0.8	1.3	20.7	2.4	2.2	117.1	16.4	1.0	2.3	369.0	4.4	0.4	21.4	9.1	4.0	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.0	0.0	0.2	0.0	0.6	15.2	0.9	0.5	0.1	0.2	0.1	0.7	3.3	0.0	0.3	0.7	1.9	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	30.0	0.3	234.4	0.6	2.3	523.0	0.4	0.6	2.2	476.8	4.3	27.9	0.9	1.2	0.8	152.4	2.1	2.8	1.9	3.0	2.1	2.1	2.8	2.1	2.5	2.2	2.3	2.1	2.2	0.0	4.6	0.0	5.7	2.0	0.2	0.0	0.0	0.3	1.5	1.5	3.4	1.5	0.6	0.0	0.0	0.0	111.7	0.2	0.0	0.2	0.3	0.5	0.3	1.3	0.0	7.8	4.2	0.0	0.0	2.6	8.2	0.4	2.5	0.0	6.4	2.3	0.1	0.0	3.1	0.3	0.0	1.9	11.5	0.2	0.0	6.6	0.0	1.0	5.9	0.1	38.1	0.0	0.2	0.0	0.0	0.0	30.8	0.2	0.0	0.4	1.5	0.4	0.0	1.1	1.4	0.4	0.4	1.1	1.8	0.1	242.4	0.0	0.6	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 53.2;T-cells: 162.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Cell line enriched"	"Detected in some"	60	"RPMI-8226: 1113.4"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.9	1.9	0.4	10.6	0.3	8.3	2.9	1.1	0.6	33.4	0.1	2.1	5.0	1.2	1.1	1.6	1.5	4.3	1.0	0.1	1.2	1.0	1.6	4.2	25.9	5.0	2.1	0.9	0.9	4.6	8.8	0.3	4.8	1.7	3.0	0.0	2.4	1.0	0.6	1.4	15.1	1.1	0.7	15.6	5.1	0.4	2.4	459.6	2.0	0.4	15.1	3.4	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.1	0.2	0.0	1113.4	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	42.0	1.0	0.8	15.7	1.1	79.3	0.7	1.9	601.8	0.6	1.2	4.6	1053.9	6.1	1.1	1.7	1.0	2.2	427.6	0.4	0.3	1.1	0.6	0.1	1.2	5.0	2.1	4.8	0.7	2.4	0.5	1.3	6.4	5.5	0.0	4.4	4.0	2.2	0.0	0.6	0.0	2.2	2.8	1.0	1.5	0.0	0.0	0.0	0.1	53.2	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.0	1.7	0.4	0.0	0.0	2.0	7.1	0.2	0.0	0.0	0.7	0.5	0.1	0.0	0.5	4.6	0.0	4.0	4.3	0.5	0.0	4.1	5.4	5.6	7.5	0.0	10.3	0.0	0.1	0.0	0.1	0.0	10.8	0.7	12.4	0.2	0.0	0.0	0.0	2.0	1.2	0.2	0.1	0.5	2.8	0.0	162.9	0.0	7.5	0.3
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 137.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 321.5;Endothelial cells: 309.2;Hepatic stellate cells: 162.8;Kupffer cells: 156.4;Macrophages: 102.4;monocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 346.0;TIME: 442.2;U-937: 593.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		550000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	81.4	11.9	2.7	43.5	2.6	16.4	41.0	2.8	6.5	23.9	6.5	13.8	9.8	17.8	6.1	19.0	23.4	39.7	34.3	2.7	3.5	25.6	16.3	64.6	14.0	5.4	4.3	6.2	13.2	10.8	6.6	137.6	5.4	11.3	12.1	1.4	9.7	10.9	24.2	12.2	14.5	43.5	4.0	23.4	13.0	4.6	7.1	9.3	21.4	34.4	10.6	41.3	12.8	3.5	0.2	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	346.0	0.0	0.9	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.9	0.2	27.8	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	105.3	442.2	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	593.5	0.1	0.0	25.8	0.4	0.3	16.8	0.0	0.0	0.2	0.1	9.1	0.0	0.0	0.0	27.8	0.1	7.5	1.2	0.5	9.9	2.7	2.6	2.8	6.5	2.7	3.5	5.4	4.3	5.4	4.0	7.1	3.5	321.5	3.2	7.4	0.0	2.4	15.0	1.0	0.0	6.2	0.0	1.0	1.8	14.3	5.7	3.7	0.0	0.0	0.2	5.0	0.0	0.0	0.5	0.4	0.4	0.7	309.2	0.0	1.3	0.0	0.0	0.5	9.8	0.5	0.4	5.1	0.0	162.8	1.9	19.9	0.0	0.2	0.0	0.0	156.4	52.5	0.8	1.8	102.4	8.8	4.7	131.8	0.2	6.2	0.0	0.1	0.1	0.0	27.8	2.1	4.1	0.0	0.3	3.0	0.1	19.7	5.7	8.0	0.0	0.2	1.6	10.1	0.4	2.4	3.0	0.0	4.0
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 96.8;NK-cells: 58.7;T-cells: 199.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.2;memory CD4 T-cell: 67.0;memory CD8 T-cell: 85.3;naive CD4 T-cell: 68.7;naive CD8 T-cell: 81.8;NK-cell: 79.5;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.5;T-cells: 117.2"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;JURKAT: 18.2;MOLT-4: 68.7;RT4: 58.2;U-937: 59.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA066754	Enhanced					NA	NA		85000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA066754: AB_2685714"	"unprognostic (1.06e-3)"	"unprognostic (3.95e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.91e-5)"	"unprognostic (4.72e-3)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.06e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-2)"	"prognostic favorable (5.23e-5)"	5.2	1.7	0.7	12.2	0.8	16.0	2.8	1.2	1.0	3.1	1.8	5.0	6.0	2.6	0.9	1.8	1.9	5.8	0.8	0.8	0.8	1.6	3.7	8.3	26.9	1.8	0.7	0.9	0.4	0.2	0.7	1.0	1.2	2.1	5.9	0.1	2.7	1.1	0.4	1.0	10.1	1.4	0.7	12.8	6.8	0.8	1.2	61.8	3.9	0.1	20.2	11.8	2.6	2.2	0.1	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.3	1.6	0.3	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.0	15.9	0.2	0.2	0.0	0.8	1.3	0.0	0.0	0.1	0.1	1.2	0.0	18.2	0.3	2.0	0.0	0.0	68.7	0.2	0.6	0.0	0.0	0.1	1.9	0.5	0.6	58.2	0.1	0.0	0.2	0.9	0.1	0.3	0.3	0.2	0.0	0.3	1.1	0.3	0.1	5.6	1.9	0.0	0.3	59.0	12.2	2.3	0.5	15.6	74.0	0.3	117.2	10.8	67.0	85.3	0.3	18.8	68.7	81.8	2.7	79.5	0.7	0.5	47.4	46.4	0.7	0.8	1.2	1.0	0.8	0.8	1.8	0.7	1.2	0.7	1.2	2.2	1.5	19.2	19.0	0.0	12.5	3.2	0.8	0.1	1.2	1.6	1.6	1.4	1.0	0.0	9.3	1.8	0.0	0.6	96.8	0.8	0.0	0.1	0.8	2.1	0.8	3.0	0.0	9.3	0.7	0.0	0.2	4.3	8.6	1.6	16.4	0.4	2.2	0.9	0.2	0.0	0.4	0.7	0.0	5.0	6.7	1.1	0.3	6.7	3.6	6.5	2.9	0.5	58.7	0.0	0.1	0.0	1.3	0.0	29.6	0.3	0.0	0.4	1.7	2.1	0.0	0.8	1.0	0.4	0.7	0.6	3.1	1.9	199.9	0.2	0.5	0.6
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDC42BPG	"DMPK2, HSMDPKIN, kappa-200, MRCKgamma"	ENSG00000171219	"CDC42 binding protein kinase gamma"	Q6DT37	11	64823052-64844653	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 14.8;Gastric mucus-secreting cells: 23.0;Paneth cells: 18.3;Squamous epithelial cells: 19.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"cerebellum: 9.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.3;HaCaT: 22.5;MCF7: 30.7;RT4: 18.4;SK-BR-3: 18.4;T-47d: 18.1"	"Region enriched"	"Detected in all"	4	"cerebellum: 10.5"	"Low region specificity"	"Detected in some"			"HPA027382, HPA061836"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA027382: AB_1846378, HPA061836: AB_2684622"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"prognostic favorable (5.99e-13)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.99e-3)"	0.5	4.9	0.2	1.4	0.3	2.1	4.8	9.7	1.2	5.4	5.5	8.8	10.6	0.4	2.0	26.5	3.8	2.8	0.4	0.4	0.3	7.7	0.9	7.8	1.3	0.4	0.7	2.2	14.1	6.4	11.0	4.2	1.0	8.5	4.5	0.3	17.7	3.7	0.2	33.7	9.3	0.2	0.3	1.8	12.2	3.3	0.3	2.4	6.0	0.0	2.0	5.8	13.0	0.3	8.9	1.2	0.8	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	11.7	7.5	0.1	4.3	0.0	0.4	22.5	1.3	8.8	0.0	0.4	3.6	0.7	5.3	3.8	0.0	0.3	2.2	0.0	10.9	0.1	0.1	0.1	0.1	3.5	6.1	0.1	0.0	30.7	0.2	1.7	2.7	8.3	1.3	1.3	0.5	4.3	5.5	18.4	15.6	0.7	2.8	18.4	0.5	4.3	18.1	0.4	0.1	0.0	3.1	0.1	0.1	2.1	2.2	2.2	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	9.7	1.2	0.4	0.3	0.4	0.7	1.0	0.3	0.3	0.3	1.0	9.6	7.9	0.0	1.2	6.5	2.3	3.6	9.6	0.0	5.1	5.8	1.8	2.8	9.6	1.8	0.0	6.4	1.7	14.8	0.0	2.4	0.6	13.2	0.7	0.4	3.6	0.8	0.1	6.2	4.9	0.7	23.0	7.9	1.3	0.4	0.0	0.0	1.0	0.0	0.1	4.8	2.0	0.0	0.4	0.8	0.0	1.3	0.0	0.0	1.2	0.8	1.0	0.0	0.1	2.9	18.3	0.0	0.1	1.6	12.4	0.5	9.5	0.0	0.0	2.2	0.8	1.7	1.3	19.3	8.1	6.7	1.4	0.6	5.7	3.4
CDC42EP3	"BORG2, CEP3, UB1"	ENSG00000163171	"CDC42 effector protein 3"	Q9UKI2	2	37641882-37738468	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 233.5;Langerhans cells: 259.6;Melanocytes: 200.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 607.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034986, HPA061792"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Actin filaments"		"HPA034986: AB_10602207, HPA061792: AB_2732670"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.53e-2)"	55.2	10.3	4.4	21.9	5.4	86.5	38.8	0.4	24.8	50.5	22.2	42.4	6.1	92.7	10.7	21.1	24.3	21.2	59.6	7.2	6.9	24.4	9.0	29.3	25.5	2.8	3.9	23.8	27.2	8.3	6.8	26.3	5.9	93.4	20.6	15.4	14.6	107.0	57.7	15.1	17.3	96.4	2.2	26.8	14.4	41.9	5.5	36.2	15.9	22.0	23.4	45.4	20.3	3.3	100.2	38.0	21.6	1.2	80.6	42.2	33.8	84.2	221.1	127.5	92.2	69.8	39.3	17.6	66.5	198.9	39.2	47.1	27.1	99.6	129.4	68.2	9.5	31.6	37.5	0.0	156.1	7.1	1.8	129.6	91.7	110.1	243.2	206.6	75.6	7.0	5.0	13.8	607.0	0.8	3.4	59.3	44.1	1.2	23.5	2.8	163.8	9.3	93.1	47.4	23.7	69.9	41.6	29.7	50.2	37.7	9.9	58.8	57.5	152.3	40.0	40.2	86.9	27.0	37.9	5.9	63.1	48.4	215.4	54.6	88.2	6.9	69.4	56.7	74.6	24.9	44.5	60.2	30.9	11.0	14.3	37.3	189.4	38.3	119.5	0.9	35.8	61.5	4.4	5.4	0.4	24.8	7.2	6.9	2.8	3.9	5.9	2.2	5.5	3.3	233.5	6.4	50.4	1.6	50.3	37.1	137.3	81.4	5.7	12.3	31.9	40.1	97.5	12.8	28.9	31.3	35.5	30.8	63.8	7.8	9.8	20.8	51.7	49.6	24.4	113.9	41.2	14.5	15.6	15.9	68.2	29.7	14.3	33.6	129.6	9.2	83.2	1.5	12.2	101.0	34.9	59.6	32.6	44.1	259.6	158.0	15.2	86.0	200.9	9.4	78.6	27.5	106.1	4.0	0.5	24.9	3.0	126.7	43.4	32.7	1.1	5.0	73.3	13.2	0.0	29.2	29.4	67.2	13.6	3.1	13.5	12.0	97.7	1.4	6.0	38.5
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479457-19520612	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;lymphoid tissue: 20.4;testis: 23.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Erythroid cells: 29.7;Spermatocytes: 72.3;Spermatogonia: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"K-562: 370.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.5	0.5	0.7	6.2	0.5	25.4	1.5	0.2	0.2	1.1	0.4	4.6	3.5	0.9	0.3	5.3	0.4	0.5	0.3	0.2	0.4	0.3	1.2	0.9	11.3	0.5	0.4	0.2	0.2	0.2	0.1	3.2	0.5	0.4	6.0	0.1	0.9	0.2	0.1	3.3	3.1	1.8	0.2	2.8	2.6	23.4	1.1	20.4	0.3	0.0	11.8	1.9	1.7	0.3	57.4	42.2	56.4	42.9	2.0	5.6	24.4	65.4	31.6	75.5	75.5	35.8	30.5	62.2	23.2	21.0	28.9	51.9	58.2	45.9	59.5	72.3	96.3	82.8	50.1	41.3	3.1	125.0	43.7	1.3	2.4	57.9	26.0	7.0	38.8	63.0	370.6	73.3	44.8	77.2	98.1	56.5	16.7	106.2	34.4	77.1	95.5	26.5	16.9	49.3	72.1	37.0	38.1	40.0	12.0	21.7	26.2	51.0	15.0	60.0	91.6	46.0	62.8	24.6	46.8	67.5	30.1	58.9	82.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.2	0.1	0.5	0.5	0.1	0.3	0.9	0.6	0.7	0.5	0.2	0.2	0.2	0.4	0.5	0.4	0.5	0.2	1.1	0.3	0.2	0.0	0.0	0.0	1.9	2.7	1.7	3.7	0.0	0.0	0.7	0.8	0.4	0.0	0.5	0.0	0.0	11.9	1.4	1.9	0.0	0.8	120.5	0.9	0.7	1.2	0.0	29.7	0.1	0.0	19.8	2.3	1.5	1.0	0.0	5.5	3.6	0.0	7.2	0.0	0.1	1.2	4.1	0.6	1.0	14.4	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.7	12.6	0.2	0.4	0.0	0.3	0.0	6.6	1.5	13.9	72.3	50.7	3.3	1.8	4.9	1.2	0.8	5.1	2.5
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287879-40304657	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2;lymphoid tissue: 17.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.2;Erythroid cells: 37.2;Extravillous trophoblasts: 34.6;Plasma cells: 31.6;Spermatocytes: 69.5;Spermatogonia: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.6;NK-cells: 1.5;T-cells: 2.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 500.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	2.1	1.9	0.5	13.7	0.8	27.2	3.4	0.2	1.9	3.2	0.0	8.4	7.5	2.2	1.1	5.7	1.0	2.8	0.6	1.1	0.1	0.5	3.0	1.4	16.4	0.1	0.0	0.9	1.9	0.8	0.5	9.3	0.3	1.1	8.7	0.5	1.3	1.2	0.3	2.8	6.7	3.7	0.0	3.7	3.6	10.1	0.2	16.7	1.7	0.5	17.1	4.3	1.8	0.6	155.1	119.0	115.1	86.5	6.7	12.7	118.0	159.9	49.0	149.2	166.5	135.8	64.9	123.9	99.6	35.9	85.9	214.0	112.2	76.2	148.9	64.5	98.4	96.2	122.3	134.6	4.4	133.3	55.1	4.7	8.1	156.4	107.1	14.8	46.9	84.2	183.0	109.0	71.9	95.8	199.3	43.3	101.6	96.9	48.7	145.0	286.8	119.9	30.3	184.8	85.6	76.9	146.9	500.3	55.4	100.3	100.8	120.0	34.7	95.5	146.3	170.8	196.1	46.1	103.6	222.8	84.6	93.9	109.2	0.1	0.1	0.0	0.8	0.0	0.5	0.4	0.6	1.1	0.7	0.3	0.4	1.1	0.1	1.5	0.0	3.6	2.4	0.6	0.5	0.8	0.2	1.9	1.1	0.1	0.1	0.0	0.3	0.0	0.2	0.6	2.2	0.0	2.0	0.7	4.9	4.2	1.1	3.7	3.4	0.2	2.1	2.2	0.9	1.5	1.3	0.0	0.0	23.2	2.3	7.8	0.0	1.3	2.2	1.3	2.9	2.1	0.0	37.2	2.0	0.6	34.6	5.6	3.6	5.1	0.0	8.1	1.1	0.9	8.3	0.0	0.7	6.1	0.0	1.3	2.1	1.0	2.8	1.5	0.0	0.0	0.0	0.4	2.1	0.0	0.2	1.5	3.0	0.7	31.6	1.3	0.8	0.2	0.2	0.3	13.1	0.6	4.6	69.5	57.2	9.1	1.6	16.7	3.3	1.9	9.3	2.4
CDCA2	"PPP1R81, Repo-Man"	ENSG00000184661	"Cell division cycle associated 2"	Q69YH5	8	25459199-25507911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.5;lymphoid tissue: 11.4;testis: 19.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 23.3;Early spermatids: 49.9;Erythroid cells: 19.0;Late spermatids: 24.2;Spermatocytes: 66.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA026293, HPA030049"	Enhanced		Supported	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA026293: AB_1846384, HPA030049: AB_10600862"	"unprognostic (2.12e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (9.62e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.47e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.30e-14)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.30e-2)"	0.2	0.0	0.0	2.6	0.0	6.5	0.6	0.1	0.0	0.2	0.1	1.9	1.6	0.3	0.0	1.4	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.2	5.3	0.2	0.2	0.0	0.0	0.0	0.0	1.2	0.2	0.1	2.2	0.1	0.2	0.0	0.0	1.1	1.8	0.8	0.0	0.8	0.9	19.4	0.3	11.4	0.1	0.1	6.7	0.6	0.3	0.1	36.5	30.2	29.4	24.2	2.3	4.5	20.2	37.7	22.6	32.9	32.4	25.7	15.8	42.6	16.0	16.2	34.6	31.6	42.9	20.0	48.5	16.2	12.0	43.2	22.4	15.2	0.6	18.4	19.4	2.5	1.0	23.5	15.8	3.3	24.5	24.5	33.6	45.8	30.6	13.9	54.5	8.7	31.0	24.1	14.5	26.3	33.4	15.2	9.2	18.7	12.0	13.3	33.3	16.1	14.3	14.7	17.4	9.4	16.6	23.9	39.3	44.7	35.6	7.1	16.5	44.4	17.7	24.3	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.3	0.1	0.2	0.0	1.1	0.0	2.7	1.1	0.5	1.7	0.0	0.7	0.9	0.8	23.3	0.0	0.2	0.0	0.0	7.2	0.5	1.8	0.0	0.2	49.9	0.8	1.2	1.1	0.0	19.0	0.2	0.0	13.4	2.5	4.1	1.4	0.0	8.8	1.1	0.1	4.1	0.0	0.1	1.3	0.0	2.9	0.6	24.2	1.2	2.1	0.0	0.0	0.6	0.1	2.1	0.5	0.6	0.2	0.1	0.0	15.8	0.5	0.5	1.2	0.9	0.5	13.1	0.1	2.1	66.6	27.8	10.7	0.9	1.6	2.9	1.3	3.6	0.5
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.4;lymphoid tissue: 27.6;testis: 37.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.5;Extravillous trophoblasts: 38.3;Late spermatids: 116.9;Spermatocytes: 50.4;Spermatogonia: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NK-cell: 2.8;T-reg: 2.0"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.8;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.4	1.2	1.3	10.5	1.3	53.4	2.0	0.8	1.8	1.9	0.9	6.8	5.8	1.3	0.3	9.3	0.9	0.9	0.9	1.5	0.9	0.9	1.3	1.9	17.0	1.6	1.3	0.6	0.7	0.4	0.5	6.5	1.6	0.8	7.7	0.5	1.4	0.5	0.6	4.2	5.8	3.1	0.8	6.6	3.1	37.8	1.8	27.6	0.6	0.4	16.2	2.2	2.8	1.3	131.7	74.9	67.2	57.3	4.5	7.3	57.8	92.7	37.4	103.6	81.5	77.7	75.4	121.3	52.3	29.4	120.8	87.9	110.3	49.5	98.6	122.0	52.2	107.7	54.4	64.1	0.4	116.8	81.8	2.5	4.5	96.3	44.0	10.8	32.6	138.4	126.6	206.6	63.5	109.2	164.7	116.9	107.8	63.0	92.4	140.4	76.8	111.9	21.2	49.6	89.1	68.4	59.3	80.7	62.8	41.6	104.7	54.7	19.9	92.7	97.2	99.5	101.7	106.9	187.8	195.4	37.2	69.5	97.4	0.0	0.1	0.2	0.4	0.0	0.0	0.3	0.5	0.3	0.4	0.5	0.0	0.3	0.0	2.8	0.3	0.3	2.0	0.7	1.3	1.3	0.8	1.8	1.5	0.9	1.6	1.3	1.6	0.8	1.8	1.3	0.9	0.0	0.5	0.0	4.6	3.8	1.2	1.3	0.6	0.6	2.3	4.4	1.0	0.0	0.8	0.0	2.1	19.7	2.2	4.6	1.9	0.8	56.5	1.1	1.5	2.3	0.0	21.8	1.1	0.8	38.3	3.5	3.1	1.5	3.8	14.5	1.1	0.0	11.7	1.7	0.6	4.7	2.0	2.8	1.5	116.9	2.8	1.7	0.0	1.0	2.1	0.9	2.1	0.0	0.6	0.6	0.1	1.5	16.2	1.1	1.1	0.6	0.4	0.2	0.0	0.5	2.7	50.4	31.1	7.1	1.0	3.7	4.2	1.9	9.4	1.6
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692481-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.0	1.1	0.7	7.9	1.0	33.5	2.0	0.2	0.9	1.7	0.0	9.4	8.3	1.3	1.8	9.2	1.0	1.1	0.6	0.5	0.4	0.8	1.3	1.5	19.5	0.6	0.4	0.6	0.8	0.5	0.6	4.4	0.5	0.7	11.3	1.9	1.8	0.5	0.3	6.3	7.3	2.8	0.3	4.9	4.9	22.5	0.6	38.8	0.6	0.5	22.7	2.0	2.9	0.7	108.5	45.5	84.4	62.1	3.6	7.0	57.2	79.6	39.5	137.2	96.6	71.9	78.8	130.2	31.5	50.5	54.5	59.4	97.8	52.4	141.9	86.8	44.9	116.8	49.2	57.3	0.8	113.8	58.4	2.8	3.8	77.1	67.3	15.3	60.9	91.1	100.7	135.6	99.1	47.7	106.1	68.9	98.8	61.7	62.8	102.2	115.6	74.4	31.0	43.8	75.4	33.3	87.5	40.6	52.4	71.7	60.1	42.4	37.3	67.8	70.6	39.2	126.0	91.4	128.1	176.3	31.6	104.7	79.6	0.0	0.7	1.3	1.5	1.6	2.8	1.7	3.6	2.2	0.7	1.4	1.1	2.3	3.0	4.1	3.9	1.2	5.9	1.7	0.7	1.0	0.2	0.9	0.5	0.4	0.6	0.4	0.5	0.3	0.6	0.7	0.8	0.0	0.5	1.3	4.8	3.3	0.8	2.4	1.8	1.3	1.9	1.5	0.7	2.8	0.4	0.0	0.0	17.1	1.9	12.4	0.0	1.2	1.0	1.7	1.6	1.9	3.6	34.1	1.2	0.6	26.0	2.9	6.6	2.5	0.0	12.0	3.6	1.0	11.6	1.7	0.9	8.2	2.0	3.5	1.9	2.8	1.5	3.7	1.8	0.0	1.6	0.1	2.1	0.5	0.9	2.4	4.0	1.2	15.8	1.3	1.9	0.6	4.7	1.0	19.7	0.2	6.3	76.8	42.0	17.1	2.7	2.9	5.5	1.2	13.2	1.2
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDH10		ENSG00000040731	"Cadherin 10"	Q9Y6N8	5	24487100-24644978	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 13.0;prostate: 4.4"	"Group enriched"	"Detected in some"	20	"Astrocytes: 169.4;Excitatory neurons: 423.4;Inhibitory neurons: 216.9;Oligodendrocyte precursor cells: 488.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 7.1;HAP1: 4.6;hTERT-RPE1: 4.2;SuSa: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010651, HPA012085"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		270000		"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	Nucleoplasm	"HPA010651: AB_1078370, HPA012085: "	"unprognostic (4.31e-3)"			"unprognostic (2.77e-1)"	"unprognostic (1.88e-1)"			"unprognostic (3.66e-2)"		"unprognostic (4.48e-1)"	"unprognostic (6.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.59e-7)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-1)"		"unprognostic (8.74e-3)"	0.0	0.7	5.6	0.0	8.4	0.0	0.1	13.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	9.0	0.9	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.1	0.0	0.4	0.0	2.2	4.4	0.2	1.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.1	4.6	0.0	0.0	7.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	11.7	0.0	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.4	13.0	8.7	9.0	0.9	0.3	1.7	2.2	1.2	1.1	4.6	0.0	0.0	0.0	169.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.1	0.0	0.0	423.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	216.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.9	0.0	0.6	0.0	488.6	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127162-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 314.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 569.4;Enteroendocrine cells: 108.4;Intestinal goblet cells: 183.7;Paneth cells: 408.6;Proximal enterocytes: 336.9;Undifferentiated cells: 241.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 16.0"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 98.8;OE19: 430.1;U-266/70: 157.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		7500000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.9	0.2	0.7	28.8	0.5	2.7	0.5	1.1	0.8	0.1	1.9	260.9	314.2	1.3	0.8	1.7	0.3	3.0	0.6	0.5	0.2	0.8	0.3	0.2	1.5	0.3	0.1	0.5	1.7	0.0	0.0	0.2	0.3	1.2	246.7	0.5	0.9	1.6	0.5	0.6	270.6	9.3	0.1	5.5	2.5	0.6	0.2	0.3	0.7	0.1	1.8	0.8	0.1	0.7	0.2	18.5	0.2	0.4	0.0	0.4	1.6	0.2	0.3	0.2	0.3	98.8	3.5	0.3	0.3	0.0	0.1	1.0	0.3	0.3	0.3	0.2	1.1	0.1	0.8	0.6	0.3	0.2	4.3	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.4	1.5	0.1	0.7	0.5	1.3	0.3	430.1	0.5	0.3	0.0	2.8	0.3	0.2	1.3	1.2	0.4	0.4	0.5	0.4	0.7	0.9	0.0	0.6	0.7	1.2	0.5	157.2	0.3	0.2	0.3	0.3	0.6	2.9	0.9	1.4	0.2	0.8	0.1	0.3	0.2	0.1	0.5	0.8	0.2	0.3	16.0	0.7	0.5	0.4	0.2	0.2	0.7	0.5	1.1	0.8	0.5	0.2	0.3	0.1	0.3	0.1	0.2	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	569.4	0.0	0.3	1.0	0.0	0.0	0.0	108.4	0.0	0.5	0.0	0.0	0.1	2.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	183.7	0.0	0.0	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	408.6	0.0	0.2	0.0	336.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.1	0.0	241.6	0.1
CDH19	CDH7	ENSG00000071991	"Cadherin 19"	Q9H159	18	66501083-66604138	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.4;heart muscle: 37.1;intestine: 19.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 60.1;Melanocytes: 44.4;Oligodendrocyte precursor cells: 57.8;Oligodendrocytes: 192.6"	"Cancer enriched"	"Detected in some"	21	"melanoma: 16.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"SK-MEL-30: 35.9;WM-115: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056332	Uncertain					NA	NA		320000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA056332: AB_2683102"	"unprognostic (1.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.26e-2)"		"unprognostic (4.10e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.58e-3)"	"unprognostic (8.16e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-5)"	2.3	4.2	3.3	3.1	11.4	0.1	1.3	4.4	7.2	6.7	0.0	19.4	2.2	0.9	1.6	3.0	1.9	2.6	37.1	4.7	5.3	0.4	4.1	1.2	0.1	8.8	7.4	1.1	1.2	0.1	0.4	2.9	7.5	4.2	2.8	0.1	3.4	4.1	4.2	1.9	5.4	1.7	2.7	2.2	4.9	0.7	7.7	0.1	1.0	1.2	0.0	5.2	5.9	18.4	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	35.9	0.1	1.5	0.0	0.0	0.1	0.3	0.2	0.1	4.0	0.2	0.0	0.1	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	11.4	4.4	7.2	4.7	5.3	8.8	7.4	7.5	2.7	7.7	18.4	0.0	0.0	0.0	1.0	0.0	1.1	0.3	0.2	2.8	0.0	1.1	0.3	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	2.8	0.0	0.0	60.1	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0	0.5	0.0	2.0	0.6	1.0	0.2	5.3	0.1	44.4	0.0	0.0	0.0	0.0	57.8	192.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	3.6	2.7	0.9	0.3	0.3	0.0	0.1	0.0	0.0	0.4
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27932879-28177946	"CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 196.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 217.7;Cardiomyocytes: 368.8;Excitatory neurons: 311.2;Granulosa cells: 312.5;Inhibitory neurons: 198.2;Muller glia cells: 157.9;Oligodendrocyte precursor cells: 267.9"	"Cancer enhanced"	"Detected in all"		"glioma: 39.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.7;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 278.2;BJ: 230.7;fHDF/TERT166: 459.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Cluster 10: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	66.5	27.4	2.6	29.0	0.2	0.3	20.6	31.6	6.6	7.9	4.8	0.8	6.2	1.1	0.4	10.5	3.1	196.0	30.0	31.6	18.1	57.2	1.0	1.9	21.7	26.3	6.7	0.9	29.8	8.1	0.4	20.1	2.4	1.1	60.3	0.4	10.8	0.4	0.3	1.4	6.8	24.1	13.5	5.9	44.4	33.3	3.8	6.2	2.2	1.6	1.1	2.7	22.7	0.3	25.8	278.2	0.3	48.1	7.8	0.2	230.7	72.0	94.9	80.8	0.1	0.4	0.0	128.3	459.1	46.0	36.7	50.0	0.2	130.4	0.4	35.8	0.0	66.8	86.7	48.0	0.0	0.1	4.6	0.4	198.6	37.4	212.9	84.0	15.4	0.0	0.1	77.8	0.0	59.4	0.1	43.8	0.1	30.5	0.2	37.1	45.6	0.1	9.9	83.4	144.4	0.1	0.2	26.8	116.8	0.3	0.5	11.6	206.6	63.6	2.9	181.6	0.2	0.3	0.3	40.6	0.2	163.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	27.4	29.0	20.6	31.6	30.0	31.6	21.7	26.3	20.1	24.1	33.3	22.7	0.8	0.0	0.6	217.7	1.2	0.3	0.0	3.4	0.0	38.7	1.6	0.4	368.8	67.2	1.2	11.0	150.1	0.1	0.0	0.0	0.0	12.9	53.2	1.4	15.2	9.8	0.0	6.1	311.2	0.4	0.0	16.7	0.0	2.6	0.0	312.5	12.5	125.3	0.3	3.3	198.2	0.0	2.0	2.2	0.4	17.7	2.1	1.2	3.6	106.8	0.1	157.9	0.0	267.9	138.6	19.2	0.0	12.8	0.0	0.1	0.0	47.5	1.7	99.9	6.6	0.4	45.8	4.8	24.1	0.0	0.0	0.3	0.6	1.6	0.0	0.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 235.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 311.9;Endothelial cells: 206.1;Hepatic stellate cells: 185.6;Late spermatids: 84.6;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 752.5;TIME: 655.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1300000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	84.5	13.8	16.3	14.9	15.9	0.2	71.4	15.1	16.6	16.2	11.3	16.8	7.9	19.9	8.6	12.4	17.1	29.7	84.4	13.8	14.6	19.1	24.0	95.0	13.1	16.7	16.6	8.1	7.7	10.3	7.4	235.9	17.9	11.6	10.2	1.3	12.0	9.1	41.8	16.7	17.0	27.8	15.5	20.4	13.3	10.5	22.6	5.2	37.5	58.9	7.9	22.1	14.2	15.5	0.5	0.6	4.6	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	119.8	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	752.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	15.7	0.0	2.4	0.0	0.1	655.1	0.0	0.9	0.1	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.3	15.9	15.1	16.6	13.8	14.6	16.7	16.6	17.9	15.5	22.6	15.5	311.9	0.0	6.2	1.3	0.7	4.1	0.0	0.0	1.8	0.0	1.0	2.7	17.9	5.7	0.6	1.8	0.0	6.6	0.5	0.0	0.0	0.2	33.5	0.5	0.6	206.1	0.0	10.7	0.1	0.0	48.9	7.1	0.0	1.3	3.8	0.0	185.6	1.7	2.3	0.0	0.1	0.0	0.0	35.7	6.3	84.6	6.2	1.2	12.4	28.1	0.1	0.3	0.0	0.5	0.1	0.0	0.0	2.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.4	10.9	0.3	0.3	3.0	80.7	1.5	3.0	0.1	0.2
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194537-84219621	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 313.8;skin 1: 214.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 379.5;Rod photoreceptor cells: 240.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	12	"NK-cell: 7.5"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.2;HEK 293: 5.2;HEL: 6.3;K-562: 4.6;NTERA-2: 4.4;RPTEC TERT1: 16.3"	"Region enriched"	"Detected in many"	21	"olfactory bulb: 333.0"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"	NA	NA		55000	"Cluster 15: NK-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.2	1.9	7.4	1.0	18.3	0.4	4.5	2.3	8.7	5.3	46.2	29.2	0.1	0.6	4.4	10.7	0.5	0.4	1.2	6.6	7.5	0.4	0.5	0.2	0.9	13.4	2.3	1.1	0.1	0.0	3.0	0.2	13.9	1.4	53.2	313.8	1.5	4.2	1.0	214.0	12.2	1.2	0.1	7.0	0.2	0.3	3.2	3.3	0.2	0.0	1.1	0.1	3.5	3.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	10.2	2.0	0.0	0.0	5.2	6.3	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.5	4.4	0.0	0.0	0.0	0.0	1.4	16.3	0.0	3.4	0.8	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	7.4	18.3	2.3	8.7	6.6	7.5	13.4	2.3	13.9	0.1	3.2	3.5	0.0	0.0	0.5	1.3	0.1	51.2	0.3	1.4	3.4	24.1	0.0	0.1	1.8	0.0	0.7	0.0	379.5	0.0	2.1	47.9	0.0	0.1	0.0	2.7	0.7	1.8	12.7	0.0	4.9	0.0	0.0	0.6	0.0	3.1	0.0	3.7	0.4	0.4	0.0	5.0	7.7	46.9	0.0	0.3	5.2	0.2	0.0	0.1	3.6	1.0	0.0	26.3	1.0	7.5	4.4	0.0	31.2	0.0	0.7	0.3	23.0	0.2	0.1	240.4	0.0	0.2	0.3	0.6	0.3	3.0	67.5	0.0	3.0	0.3	52.9	0.2
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 275.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	0.8	4.5	0.4	0.2	0.0	0.1	0.7	0.0	0.0	23.2	275.8	0.1	0.0	0.1	0.6	5.0	0.0	1.2	0.4	10.1	30.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	12.6	0.3	0.0	0.0	0.0	0.1	238.3	1.1	0.0	0.1	12.4	4.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	0.7	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 296.8;liver: 129.8"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.6	0.1	0.4	0.5	0.4	0.1	2.2	102.2	241.2	0.2	0.0	0.3	0.3	3.9	0.0	0.2	0.0	44.9	129.8	0.2	0.2	0.2	0.1	0.2	1.8	0.0	0.6	0.0	0.3	0.1	51.9	0.1	0.0	0.1	0.1	0.1	296.8	2.7	0.0	0.1	4.3	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.5	0.4	0.2	0.0	0.2	0.1	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 15.2;ovary: 6.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 27.1;granulocytes: 79.1;Late spermatids: 40.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebellum: 2.4"	"Group enriched"	"Detected in some"	28	"basophil: 1.8;eosinophil: 3.7"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 22.6;BJ hTERT+ SV40 Large T+ RasG12V: 20.7;HBF TERT88: 30.9;HMC-1: 58.4;LHCN-M2: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Golgi apparatus"	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	0.7	0.3	0.0	0.2	0.0	0.0	0.8	2.4	0.4	0.8	0.0	0.5	0.3	0.6	15.2	0.6	0.5	1.9	0.2	0.5	0.0	0.3	0.0	1.0	0.1	0.4	0.1	6.1	0.1	0.2	0.3	0.0	0.4	0.7	0.7	0.0	0.3	0.3	0.9	0.6	0.8	0.4	0.1	0.0	0.7	1.9	0.1	0.2	0.1	0.7	0.1	0.8	0.5	0.3	0.3	0.0	0.0	0.0	1.6	2.8	0.0	5.9	22.6	10.2	20.7	0.0	3.0	0.0	0.0	2.3	0.5	0.0	0.0	0.0	30.9	0.0	0.1	1.9	0.0	0.0	0.3	0.1	58.4	3.4	0.0	2.7	1.5	0.4	0.0	0.0	0.0	0.1	19.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	2.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.3	0.1	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	40.3	0.3	0.1	3.6	1.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.5	0.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486993-32491253	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Early spermatids: 21.2;Excitatory neurons: 36.6;Inhibitory neurons: 31.6;Late spermatids: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"SCLC-21H: 58.1;SH-SY5Y: 15.6;SK-MEL-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"HPA000252: AB_2665953"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	0.8	2.8	37.8	7.1	50.8	5.4	1.2	11.0	63.5	1.5	0.0	0.9	1.4	0.9	0.2	7.5	0.7	0.9	1.1	53.4	21.1	0.8	1.0	0.8	13.9	3.2	10.5	2.6	1.4	0.7	6.9	0.6	4.5	0.6	0.8	10.4	1.1	0.5	2.3	1.9	3.6	0.6	3.5	12.1	1.6	7.2	21.7	4.2	0.5	0.8	14.1	0.8	3.1	34.2	3.9	2.2	9.8	3.1	1.1	1.8	1.1	2.4	1.4	2.9	3.7	5.7	0.9	1.9	2.2	2.0	2.4	1.8	3.8	2.4	3.8	0.7	7.3	0.7	1.1	2.3	0.5	1.3	1.9	1.1	5.8	2.9	2.4	1.1	2.1	6.9	3.9	2.2	6.2	1.6	3.4	1.5	6.2	1.4	2.1	2.9	5.9	7.1	1.4	1.7	58.1	15.6	2.3	1.3	43.8	1.4	2.5	4.4	2.2	4.0	5.9	1.6	6.3	1.1	1.5	1.9	3.4	5.6	9.7	0.0	0.3	0.4	0.8	0.3	0.6	0.2	1.1	0.4	0.0	0.1	1.5	0.9	1.2	0.2	0.1	0.6	0.1	0.6	37.8	50.8	11.0	63.5	53.4	21.1	3.2	10.5	4.5	3.5	21.7	34.2	1.7	0.0	1.5	6.5	13.1	1.5	0.5	1.0	7.4	15.9	3.7	2.3	3.6	0.0	0.8	0.0	45.9	0.6	10.1	0.3	0.0	0.2	21.2	1.1	1.3	1.2	0.0	0.0	36.6	0.6	0.3	1.2	0.5	1.5	0.0	1.6	0.7	0.7	0.9	1.7	31.6	1.4	2.0	3.5	0.5	18.9	0.0	1.3	3.6	2.8	2.0	18.4	10.3	9.5	11.9	1.2	1.2	0.7	0.9	1.2	0.4	1.5	1.0	6.3	0.0	2.9	3.1	6.7	4.3	8.8	1.3	1.1	7.1	1.9	1.1	0.5
CDK5R2	"NCK5AI, P39, p39nck5ai"	ENSG00000171450	"Cyclin dependent kinase 5 regulatory subunit 2"	Q13319	2	218959666-218962155	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 52.2;pituitary gland: 35.2;retina: 26.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 78.8;Cone photoreceptor cells: 20.9;Enteroendocrine cells: 22.8;Excitatory neurons: 17.7;Horizontal cells: 15.2;Rod photoreceptor cells: 50.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.9;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 18.4;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.96e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.85e-5)"	"unprognostic (1.73e-6)"	"unprognostic (3.67e-2)"	"unprognostic (2.83e-4)"		"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.34e-10)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-4)"		"unprognostic (6.46e-2)"	0.0	3.9	17.0	0.3	21.5	0.0	0.0	0.0	52.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	17.4	0.0	0.0	0.0	0.0	7.1	3.6	0.0	1.0	0.0	35.2	0.0	10.7	0.0	0.1	26.3	0.0	0.0	0.0	0.0	0.4	0.1	1.4	0.0	0.9	0.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	2.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.4	13.3	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.2	1.3	0.0	0.3	0.0	0.0	0.0	0.6	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	21.5	0.0	52.2	20.2	17.4	7.1	3.6	10.7	1.4	15.6	20.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	78.8	0.0	0.0	0.5	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	22.8	0.0	17.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.2	11.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	8.1	0.0	2.0	2.6	0.2	1.2	0.0	0.0	0.1	0.1	0.0	0.0	50.9	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803789-88809258	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Disease variant, Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 38.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 51.4;Erythroid cells: 71.3;Extravillous trophoblasts: 92.0;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 149.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA017224: AB_1846468"	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavorable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.7	0.8	0.8	3.8	1.2	38.5	0.7	2.5	1.3	1.7	0.0	3.3	4.1	0.5	0.2	6.7	0.5	0.2	0.5	0.8	2.3	0.7	1.0	1.3	4.8	2.2	1.1	0.4	0.6	1.3	2.1	2.8	1.9	0.7	1.6	0.4	1.1	0.2	0.1	3.6	3.9	0.6	0.7	3.1	2.4	3.5	1.1	8.7	0.6	0.0	3.3	0.5	2.3	1.0	33.6	34.5	16.5	25.3	0.7	3.4	64.2	24.1	6.6	19.4	12.0	79.3	33.8	51.4	24.2	5.5	12.7	46.0	21.6	17.7	6.2	18.2	92.1	51.8	28.8	59.9	0.3	28.8	21.5	1.8	1.4	19.8	4.4	1.6	5.9	60.9	80.8	18.4	7.6	90.6	109.3	149.4	41.8	12.2	31.6	120.3	22.9	42.4	4.3	23.8	36.6	26.2	44.4	13.1	16.9	7.4	39.0	55.9	5.9	24.6	42.6	37.2	35.4	61.4	55.7	73.6	19.3	71.9	31.6	0.2	0.1	0.9	0.3	0.0	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.1	0.7	0.4	0.1	0.1	0.7	0.2	0.8	1.2	2.5	1.3	0.8	2.3	2.2	1.1	1.9	0.7	1.1	1.0	0.4	0.0	1.1	0.7	4.9	11.2	4.3	1.4	7.4	0.7	5.4	7.5	2.2	1.5	1.7	1.8	0.0	51.4	2.2	12.7	1.9	1.1	0.4	1.4	1.4	2.2	2.4	71.3	0.2	0.0	92.0	5.2	9.2	2.2	0.0	29.0	0.4	1.0	19.5	0.0	0.8	16.1	4.1	5.6	5.5	1.2	0.3	2.8	1.8	0.0	1.9	1.5	4.1	0.0	0.6	0.6	2.3	0.4	23.1	2.2	2.0	1.6	2.1	1.9	0.0	2.1	3.4	6.6	37.1	10.8	7.1	24.8	5.4	5.7	30.1	4.4
CDX1		ENSG00000113722	"Caudal type homeobox 1"	P47902	5	150166778-150184558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 131.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 349.6;Intestinal goblet cells: 193.4;Paneth cells: 295.0;Proximal enterocytes: 196.8;Undifferentiated cells: 312.5"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 125.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BJ hTERT+: 6.7;SuSa: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055196	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055196: AB_2682734"	"unprognostic (2.50e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-7)"	"unprognostic (2.10e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.16e-3)"	0.3	0.0	0.1	9.6	0.1	0.0	0.7	0.1	0.4	0.7	0.1	131.3	63.9	0.5	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.2	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.1	124.4	0.0	0.1	0.5	0.0	0.3	94.5	5.2	0.1	0.1	0.5	2.4	0.2	0.1	0.1	0.0	1.7	0.2	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.0	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	349.6	0.0	0.0	0.1	0.0	0.5	0.1	59.5	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.4	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	295.0	1.5	0.0	0.0	196.8	0.2	0.0	0.0	0.0	0.0	1.6	2.8	15.3	0.0	0.3	0.1	0.8	0.1	312.5	0.0
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27960918-27969315	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 41.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 287.5;Intestinal goblet cells: 214.5;Paneth cells: 181.7;Proximal enterocytes: 226.9;Undifferentiated cells: 194.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.1	0.0	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	41.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	31.3	0.0	0.0	0.1	0.0	0.0	35.9	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.7	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	287.5	0.0	28.9	0.0	0.0	0.0	0.0	62.4	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	214.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.9	181.7	0.0	0.0	0.2	226.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.4	0.0	194.4	0.3
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 246.3"	"Group enriched"	"Detected in many"	5	"Basal prostatic cells: 335.2;Distal enterocytes: 731.7;Paneth cells: 585.4;Prostatic glandular cells: 244.9;Urothelial cells: 618.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 43.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"eosinophil: 43.6;neutrophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 43.6"	"Group enriched"	"Detected in many"	5	"CAPAN-2: 30.6;Hep G2: 101.0;OE19: 80.9;RT4: 59.2;SK-MEL-30: 67.4"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	NA	NA		130000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favorable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	11.9	10.6	1.3	31.1	0.8	74.5	13.3	3.2	1.8	16.4	0.0	246.3	53.3	11.1	3.9	64.9	6.0	7.4	4.0	1.9	0.0	31.9	60.5	6.8	4.3	0.4	0.1	1.1	2.4	1.7	3.8	33.1	0.5	20.2	141.2	0.6	58.9	10.3	2.7	3.3	51.0	13.1	0.0	7.9	19.9	3.7	0.2	2.3	3.1	3.1	21.5	37.0	29.2	0.0	0.6	5.6	0.3	0.3	0.0	0.0	14.4	0.0	0.2	1.0	0.5	2.3	30.6	1.7	12.2	0.0	3.2	0.8	0.0	7.9	0.4	0.1	0.5	0.3	0.2	101.0	1.7	0.2	13.3	0.0	0.1	0.1	0.1	0.0	0.7	1.4	0.0	5.0	0.0	3.2	0.3	0.2	0.9	80.9	1.7	2.6	0.0	1.3	0.6	59.2	0.5	0.2	0.0	0.2	67.4	7.3	0.3	0.0	2.1	0.3	1.2	1.4	0.5	1.8	0.0	3.7	0.2	0.4	1.0	0.8	0.0	43.6	0.1	1.7	0.3	3.3	0.9	0.4	0.2	0.8	0.6	0.2	26.3	0.1	3.3	0.1	2.7	0.6	1.3	0.8	3.2	1.8	1.9	0.0	0.4	0.1	0.5	0.0	0.2	0.0	16.7	6.4	8.2	1.0	6.0	1.3	335.2	10.4	2.8	6.0	16.3	12.7	1.8	7.2	14.7	0.0	4.2	2.0	0.7	731.7	0.0	21.3	3.5	5.0	5.2	22.3	17.3	0.4	1.7	16.1	9.4	2.9	12.8	28.7	8.9	4.6	41.4	37.7	1.4	5.0	1.4	46.1	4.1	5.9	3.1	0.2	0.0	2.6	7.2	0.0	0.9	1.3	2.1	0.5	0.6	58.7	585.4	0.7	0.2	244.9	97.5	11.1	3.9	6.4	0.0	2.7	3.1	4.3	3.9	9.2	1.0	0.7	5.5	2.2	33.2	618.9
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 181.5;esophagus: 195.2;intestine: 220.3;lung: 286.7;salivary gland: 177.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 942.3;Club cells: 322.1;Distal enterocytes: 640.1;Paneth cells: 391.1;Urothelial cells: 182.3"	"Group enriched"	"Detected in many"	4	"cervical cancer: 139.4;colorectal cancer: 500.8;lung cancer: 344.1;pancreatic cancer: 437.5;stomach cancer: 231.8"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"OE19: 1799.0"									"CAB008370, HPA011041"	Enhanced					NA	NA		86000000	"Cluster 24: B-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	2.0	0.4	0.3	29.7	1.2	181.5	2.7	0.6	0.6	39.2	0.0	195.0	33.0	0.6	1.8	195.2	8.2	130.1	0.2	0.2	0.0	0.3	0.7	286.7	0.3	0.3	0.1	0.4	5.2	0.1	0.3	0.5	0.2	2.4	220.3	0.0	177.6	1.4	0.1	6.8	24.4	6.6	0.0	2.4	15.5	0.4	0.3	2.1	0.3	0.0	32.5	9.6	79.1	0.4	0.1	162.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.5	4.6	0.0	0.2	0.0	0.5	19.4	0.0	0.0	0.1	0.3	0.2	0.0	0.5	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	0.1	0.0	0.1	11.2	0.1	0.2	0.2	1799.0	4.5	0.1	0.0	0.1	1.0	0.7	1.8	0.1	0.0	4.2	0.0	0.2	0.6	1.9	0.4	0.2	0.3	0.5	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.5	0.1	0.0	3.1	0.3	1.2	0.6	0.6	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.0	942.3	84.5	0.0	2.3	0.0	4.9	17.9	0.0	0.0	3.5	2.0	0.2	75.8	322.1	0.0	0.0	0.0	0.0	640.1	0.0	77.0	0.2	0.4	0.1	1.3	5.4	0.0	0.1	16.3	0.0	1.3	1.5	0.8	7.0	0.0	0.4	0.3	0.0	0.0	0.1	102.3	14.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.7	391.1	0.0	0.0	24.2	5.7	0.0	71.8	0.0	0.0	0.0	9.9	0.0	0.1	15.6	0.0	0.0	1.2	0.0	31.7	182.3
CEACAM7	"CEA, CGM2"	ENSG00000007306	"CEA cell adhesion molecule 7"	Q14002	19	41673303-41706976	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 651.8"	"Group enriched"	"Detected in some"	9	"Distal enterocytes: 1454.0;Paneth cells: 731.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA069621, HPA073910"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Cytosol	"HPA069621: AB_2686162, HPA073910: "	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.6	0.0	0.0	71.4	0.0	0.1	2.9	0.0	0.0	13.3	0.0	595.8	0.5	0.3	0.0	52.6	0.6	39.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	651.8	0.0	4.0	0.8	0.1	1.4	0.7	5.7	0.0	0.2	2.0	0.1	0.0	0.0	0.0	0.0	12.0	23.4	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	1454.0	0.0	116.6	0.1	0.0	0.0	0.5	8.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	1.0	731.2	0.0	0.0	1.4	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	38.4	30.3
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT enhancer binding protein delta"	P49716	8	47736913-47738164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 54.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 54.9;monocytes: 19.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067581			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA067581: AB_2685865"	"prognostic favorable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	251.6	72.0	33.4	62.1	35.2	34.3	168.0	37.2	42.0	99.7	43.9	143.5	26.7	82.8	2.7	85.4	192.0	14.7	136.9	35.8	63.6	106.9	207.8	157.5	8.7	81.5	49.3	265.3	81.9	7.6	117.4	50.0	49.5	151.1	12.1	16.9	89.3	19.4	133.0	106.9	79.6	21.6	46.5	109.7	116.3	14.3	47.4	18.5	103.5	21.6	6.6	168.1	139.9	44.6	9.5	7.4	0.3	0.1	41.5	43.2	51.9	24.1	18.7	6.8	14.4	14.8	14.8	0.1	17.3	6.6	5.8	9.9	1.7	12.9	2.1	0.1	3.9	0.5	6.0	6.3	66.8	4.1	0.0	66.7	33.7	1.6	16.0	4.3	1.4	0.4	4.1	7.3	2.5	2.9	0.1	148.7	2.8	6.2	2.5	0.1	5.1	0.5	20.6	7.8	2.8	1.0	58.7	7.7	6.3	2.6	6.4	33.5	6.2	1.5	3.9	15.6	1.5	0.1	0.1	0.1	7.9	0.1	0.3	2.3	19.9	10.6	2.1	8.4	6.2	0.1	0.3	1.2	7.4	0.6	0.0	0.0	54.9	3.7	3.2	0.2	0.3	2.8	33.4	35.2	37.2	42.0	35.8	63.6	81.5	49.3	49.5	46.5	47.4	44.6	1541.7	102.5	196.3	31.3	14.9	663.5	1435.6	98.7	2487.0	6.0	551.3	617.1	79.2	185.8	76.5	224.3	6.2	189.8	152.8	59.2	217.2	50.7	3.5	287.0	418.9	547.9	23.4	30.3	12.5	77.2	457.9	1377.3	387.3	621.0	5.1	96.4	269.5	157.7	220.3	1.7	2.5	44.3	42.7	520.1	502.0	21.5	435.5	912.6	268.6	29.0	163.5	321.9	150.4	6.0	0.5	53.2	58.4	144.8	34.9	1668.5	127.1	353.4	54.9	17.3	466.8	1386.3	1290.5	3.7	13.9	940.2	817.5	351.9	122.7	85.9	73.2	814.5
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243040-37565827	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 122.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 126.4;Excitatory neurons: 197.7;Horizontal cells: 294.4;Inhibitory neurons: 197.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"SCLC-21H: 46.7;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	0.6	11.5	102.9	1.1	104.8	0.3	0.4	59.5	122.2	0.3	11.1	1.9	0.8	0.4	0.6	0.5	0.4	1.2	1.0	96.4	81.2	1.5	0.3	0.6	0.8	58.3	69.7	1.3	3.9	0.3	28.4	0.8	71.4	0.8	0.4	21.4	1.7	0.2	11.0	1.3	1.2	0.5	34.6	1.1	1.7	3.6	57.4	0.0	1.5	0.2	0.1	0.2	0.5	94.4	0.1	0.1	0.7	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	1.0	0.0	0.2	0.6	0.1	0.0	0.0	0.8	0.4	0.0	1.8	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.8	0.0	0.3	0.1	0.5	1.7	0.0	0.3	0.1	0.0	2.1	0.0	0.1	46.7	11.7	1.1	0.3	0.1	0.3	0.2	0.1	0.0	1.4	0.7	0.3	0.2	2.9	0.5	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.9	104.8	59.5	122.2	96.4	81.2	58.3	69.7	71.4	34.6	57.4	94.4	0.2	0.0	0.0	22.5	0.8	0.4	1.4	0.9	0.0	126.4	0.4	0.5	1.9	0.0	0.3	0.0	41.7	0.3	0.1	0.2	0.0	0.4	46.9	0.7	0.9	4.1	12.7	0.0	197.7	1.1	0.3	1.2	2.0	1.2	0.0	1.8	0.7	0.0	8.6	294.4	197.5	2.5	6.1	0.0	0.0	22.6	0.6	0.3	0.0	14.0	0.0	7.3	0.0	19.1	12.3	2.6	0.2	5.3	0.0	2.7	4.4	6.7	0.3	22.0	0.0	4.3	8.2	12.6	7.6	0.0	0.6	0.3	0.3	1.5	3.5	1.2
CELF5	BRUNOL5	ENSG00000161082	"CUGBP Elav-like family member 5"	Q8N6W0	19	3224661-3297076	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 93.1;Excitatory neurons: 88.7;Inhibitory neurons: 72.8;Oligodendrocyte precursor cells: 22.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;REH: 4.3;SCLC-21H: 4.3;SH-SY5Y: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042012, HPA060336"	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA042012: AB_10796896, HPA060336: AB_2684256"	"unprognostic (1.09e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.07e-2)"	0.0	0.2	13.5	0.0	15.1	0.0	0.5	0.0	21.9	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.5	0.0	0.0	15.7	14.4	0.1	0.2	0.0	0.0	0.0	0.0	4.1	0.5	1.3	0.9	0.0	0.0	0.2	0.1	4.4	0.8	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.3	2.1	6.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.6	0.0	0.0	3.4	1.4	0.0	4.3	0.0	0.0	0.0	0.0	4.3	2.6	0.2	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	15.1	0.0	21.9	15.7	14.4	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	3.3	0.2	0.4	2.1	0.0	0.0	93.1	3.9	6.6	2.2	2.8	0.0	0.0	0.0	0.4	0.2	1.6	0.0	0.6	19.3	0.2	0.2	0.4	1.2	0.0	88.7	0.2	0.1	0.4	0.0	0.6	0.0	12.1	0.0	0.8	0.1	8.4	72.8	1.4	0.0	0.3	0.3	15.5	0.3	0.3	0.0	8.4	0.0	3.4	0.0	22.1	3.2	0.4	0.1	2.2	0.0	2.3	0.1	0.4	0.0	3.7	0.0	1.1	0.8	2.5	7.7	0.0	0.3	0.0	0.3	1.4	1.6	0.9
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787115-790113	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 234.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 94.2;Excitatory neurons: 42.9;Horizontal cells: 75.7;Inhibitory neurons: 45.6;Rod photoreceptor cells: 25.5"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.6;Karpas-707: 31.0;SCLC-21H: 54.1;SH-SY5Y: 20.4;U-266/70: 21.1;U-87 MG: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced	Supported	Approved	Mitochondria		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	0.1	5.5	55.0	1.0	78.8	0.0	0.1	56.9	234.7	0.2	20.0	4.0	0.6	0.9	0.2	0.4	0.1	0.0	1.1	67.4	79.3	1.2	0.3	0.2	0.3	103.8	57.9	0.2	0.2	0.3	26.0	0.0	93.4	3.2	0.1	7.6	0.2	1.5	0.2	0.2	1.4	0.5	21.6	0.3	0.9	0.3	106.3	0.0	0.2	0.0	0.1	0.8	1.1	116.6	0.0	0.7	0.7	1.4	0.2	0.3	0.2	1.3	0.4	0.4	0.6	0.0	0.0	0.0	0.0	0.5	13.6	0.5	0.0	0.0	0.0	8.5	0.3	0.0	0.1	0.0	0.1	0.0	5.3	0.6	0.0	0.8	0.0	0.0	0.2	0.0	0.0	31.0	0.5	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	54.1	20.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	1.2	0.9	21.1	6.2	1.3	28.6	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	55.0	78.8	56.9	234.7	67.4	79.3	103.8	57.9	93.4	21.6	106.3	116.6	0.1	0.0	0.0	17.6	0.5	0.1	0.1	0.0	0.0	94.2	0.0	0.0	0.5	0.0	0.0	0.0	10.4	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.4	0.6	0.0	0.0	42.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	75.7	45.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.5	0.0	6.7	0.0	15.1	10.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	25.5	0.0	0.1	1.7	0.0	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.0
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 45.0;Extravillous trophoblasts: 33.2;Granulosa cells: 24.2;Plasma cells: 17.8;Spermatogonia: 28.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 24.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	0.2	0.3	0.0	4.0	0.0	3.7	0.4	0.1	0.1	0.5	0.0	2.9	4.1	0.7	0.0	3.7	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.4	7.3	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.1	2.6	0.0	0.6	0.0	0.0	3.6	2.9	0.9	0.0	2.0	1.6	2.2	0.1	13.3	0.1	0.0	8.4	0.7	1.1	0.0	86.4	21.0	34.9	19.3	2.4	4.5	24.3	26.2	22.2	37.3	31.5	15.4	30.0	25.7	16.2	10.4	45.7	25.6	28.9	15.3	37.7	77.3	25.6	44.0	11.0	28.6	0.8	26.7	49.0	0.4	1.6	16.1	24.4	6.7	22.1	33.7	36.7	58.5	32.5	30.1	39.0	42.2	26.6	35.3	34.3	45.4	53.6	30.8	17.5	5.5	27.5	26.7	25.7	32.7	23.6	12.9	18.2	27.2	12.6	23.9	54.2	27.9	46.4	51.5	53.5	107.3	11.1	54.7	46.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.2	6.2	0.7	1.9	1.8	0.0	2.0	2.5	2.7	0.0	0.5	0.0	0.0	15.3	1.0	2.3	0.0	0.5	0.6	1.6	1.6	1.5	4.2	45.0	0.1	0.2	33.2	4.9	2.6	3.0	0.0	24.2	3.9	0.6	15.7	0.0	0.1	6.6	0.0	2.9	2.8	0.1	0.9	4.4	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.1	1.4	0.0	17.8	2.1	0.8	0.2	0.1	0.0	0.0	0.6	3.9	16.1	28.6	12.5	5.3	3.4	3.4	1.5	11.1	2.0
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664571	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.8;lymphoid tissue: 33.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 84.4;Erythroid cells: 268.7;Extravillous trophoblasts: 78.8;Granulosa cells: 165.8;Spermatocytes: 107.5;Spermatogonia: 107.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	0.8	1.1	0.1	4.4	0.1	28.8	1.8	0.0	0.3	1.3	0.5	5.8	6.1	1.8	0.1	8.6	0.6	0.7	0.4	0.3	0.0	0.4	0.9	0.9	8.5	0.3	0.5	0.7	0.3	0.2	0.1	3.1	0.3	0.5	5.7	1.0	1.4	0.1	0.2	6.2	4.3	2.5	0.2	2.4	2.6	10.5	0.5	33.0	0.4	0.6	10.0	1.4	2.6	0.3	123.7	68.4	144.3	75.8	5.4	7.2	56.3	74.6	30.3	43.9	42.8	54.6	74.1	116.3	43.1	41.7	39.8	74.7	89.9	49.2	74.1	102.6	56.6	96.0	111.4	78.6	0.8	137.0	50.5	2.7	3.8	63.3	72.3	12.7	46.9	52.6	88.4	68.0	79.4	47.0	81.5	54.3	127.9	36.8	30.0	85.7	203.7	38.6	43.2	30.3	67.4	91.2	100.7	66.2	38.9	76.2	79.1	51.9	61.7	78.9	92.2	66.2	155.9	51.6	60.7	108.7	34.4	96.7	71.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.3	0.5	0.3	0.2	0.5	0.3	3.0	0.0	3.1	0.0	11.5	9.3	2.8	11.2	3.4	4.7	10.0	6.7	1.9	1.5	9.9	0.0	0.0	53.3	10.8	19.1	0.0	2.0	84.4	30.1	19.3	12.4	0.0	268.7	1.3	0.4	78.8	19.0	32.1	25.2	1.3	165.8	8.9	2.6	32.2	1.7	0.8	20.1	14.2	16.6	6.6	19.8	1.2	16.2	1.8	1.0	0.7	1.4	5.2	0.0	0.1	0.5	1.1	3.0	25.9	2.3	2.1	0.1	16.7	3.1	0.0	8.3	23.9	107.5	107.1	44.6	5.5	5.1	23.3	11.7	41.3	3.7
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938737-41947152	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.0;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 116.7;Erythroid cells: 60.0;Plasma cells: 70.8;Respiratory ciliated cells: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.8"	"Group enriched"	"Detected in many"	6	"B-cells: 38.6;T-cells: 50.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042404	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA042404: AB_2677981"	"unprognostic (3.78e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.3	1.5	0.6	9.9	0.6	29.0	1.9	1.8	1.1	2.3	0.3	9.9	8.4	1.7	0.1	9.9	10.8	2.0	0.7	0.5	0.7	2.3	1.6	3.8	25.1	0.8	0.8	0.7	0.7	0.3	0.5	3.2	0.8	1.4	5.3	0.1	3.6	0.3	0.9	8.0	8.3	1.8	0.5	10.6	6.1	12.8	1.0	22.6	0.8	0.4	16.3	2.0	4.0	0.5	79.1	79.0	43.5	28.8	3.3	3.3	18.4	37.8	19.4	65.2	66.2	92.3	41.0	101.5	27.8	20.2	42.2	29.5	32.9	38.8	16.2	29.4	137.4	47.8	82.3	64.9	3.2	91.4	51.9	2.7	2.9	42.1	19.3	6.9	24.8	91.5	36.7	95.0	38.8	121.9	91.9	94.8	23.6	47.5	58.1	86.8	43.4	105.6	26.9	46.5	49.3	9.4	58.5	34.5	20.6	7.2	32.8	58.4	12.5	62.8	93.4	42.0	64.1	50.5	38.0	95.2	21.9	75.9	70.0	1.8	0.3	0.0	6.2	0.2	8.8	27.9	18.6	8.4	0.7	38.6	3.5	4.6	1.1	7.4	0.2	0.4	50.8	7.9	0.6	0.6	1.8	1.1	0.5	0.7	0.8	0.8	0.8	0.5	1.0	0.5	0.4	0.0	3.4	0.3	50.7	2.0	4.8	17.8	1.8	1.9	10.9	10.3	0.6	0.0	7.9	0.0	0.0	39.7	5.4	25.3	17.6	2.1	4.5	116.7	4.2	2.6	7.7	60.0	0.5	0.7	38.9	6.4	10.7	18.0	2.5	15.8	3.6	1.3	43.4	3.3	0.8	34.5	28.5	2.9	3.5	6.7	1.2	5.4	7.2	1.0	1.8	0.1	2.1	1.0	0.2	1.5	8.4	0.4	70.8	2.8	4.0	0.3	102.6	0.6	0.0	0.2	7.0	36.4	29.8	13.3	1.0	8.8	18.5	2.9	36.6	9.0
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496612-93529092	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4;testis: 21.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA023430	Approved		Approved	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	1.3	0.6	0.0	7.6	0.0	5.0	1.4	0.0	0.2	1.7	0.0	7.0	6.7	1.4	0.1	7.3	0.4	1.4	0.3	0.0	0.1	0.3	0.6	1.3	14.7	0.1	0.3	0.2	0.2	0.2	0.3	3.5	0.2	0.3	8.8	0.0	1.2	0.3	0.1	4.5	6.3	5.2	0.0	2.4	4.6	21.7	0.4	27.4	0.5	0.2	15.5	3.1	2.3	0.1	208.5	81.5	53.0	67.7	5.8	12.0	29.6	112.4	78.2	103.5	106.4	87.2	108.6	55.4	48.2	72.8	69.6	115.4	64.8	54.8	123.4	167.2	33.7	21.0	49.2	29.9	0.6	36.3	46.3	2.8	3.8	110.6	133.5	30.7	97.1	89.9	19.3	101.8	118.5	48.3	96.3	54.8	20.9	64.2	58.8	41.3	86.9	30.3	47.1	25.5	21.7	30.7	86.3	26.3	64.9	40.1	68.9	36.4	61.4	65.3	90.6	90.5	186.7	45.1	66.1	66.8	51.0	134.8	59.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.1	0.2	0.0	1.3	0.0	2.7	3.6	0.9	1.9	0.0	0.0	1.8	2.0	0.4	2.8	0.2	0.0	0.0	7.7	0.9	3.3	0.0	0.6	29.4	1.7	2.0	1.5	0.0	2.5	0.5	0.2	17.1	2.3	8.2	3.6	0.0	19.8	2.2	0.3	12.9	0.0	0.3	4.5	4.1	7.0	5.1	8.2	0.3	5.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.4	14.8	1.1	0.4	0.0	0.2	0.0	0.0	0.5	4.5	77.3	17.3	16.1	1.3	1.5	4.3	1.6	7.9	1.7
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 298.6;choroid plexus: 92.2"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 126.6"	"Group enriched"	"Detected in many"	5	"glioma: 13.5;melanoma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	0.9	3.1	206.4	0.8	244.8	0.2	0.6	256.1	216.6	2.1	92.2	3.5	0.1	0.7	0.5	1.0	0.7	2.5	4.3	218.8	200.4	0.8	0.2	0.5	0.0	298.6	233.8	2.8	0.9	2.9	12.8	0.3	240.9	1.4	0.2	4.8	0.9	0.5	21.3	0.6	1.0	1.5	247.7	0.2	1.2	29.3	251.3	0.3	1.0	12.3	0.1	1.7	1.7	248.3	0.2	3.3	19.1	32.1	1.1	0.4	0.8	2.2	0.1	5.4	3.9	15.7	1.2	0.1	22.0	1.4	4.4	0.3	13.8	0.6	2.1	0.0	34.7	0.2	0.7	11.7	2.4	3.4	0.5	1.2	0.2	1.7	0.6	6.0	1.3	0.2	2.2	0.2	3.7	8.4	0.3	39.3	25.2	0.1	0.7	0.2	0.6	0.7	4.1	0.0	17.8	15.8	0.8	0.1	14.1	6.0	5.5	20.5	0.5	0.1	4.3	3.4	4.8	0.7	0.5	0.1	0.2	1.2	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	206.4	244.8	256.1	216.6	218.8	200.4	298.6	233.8	240.9	247.7	251.3	248.3	0.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.6	0.6	1.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	21.1	0.3	0.4	0.6	0.0	0.0	0.0	0.2	0.0	1.0	0.0	1.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	126.6	1.2	0.2	1.8	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	1.6	0.0	1.0	0.4	1.4	2.9	0.0	0.4	0.3	0.1	0.4	0.0	0.0
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961245-66975149	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.2;liver: 52.5;skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.8	0.5	3.1	3.2	2.7	0.9	2.3	2.5	2.9	1.3	1.3	38.2	30.0	0.7	0.2	4.2	2.9	0.9	0.7	3.8	2.0	12.2	52.5	0.7	0.3	3.3	2.7	0.6	4.1	1.0	1.9	0.6	3.5	0.5	31.3	0.6	12.0	0.3	24.7	1.2	23.7	1.2	1.4	0.4	7.7	1.1	2.2	0.2	0.4	1.5	0.2	0.1	0.8	2.2	0.4	3.1	0.3	7.4	0.2	0.2	1.2	0.2	0.2	0.3	0.5	0.5	3.8	8.5	2.4	0.0	0.2	0.6	1.1	0.5	0.1	1.5	5.5	4.3	1.3	2.6	0.0	0.9	0.7	0.3	0.9	0.8	0.1	0.2	0.0	13.5	2.8	1.7	0.3	1.1	1.4	1.4	1.5	2.6	0.4	1.3	0.7	1.3	0.1	0.4	0.4	0.8	0.2	5.8	0.2	0.6	5.0	6.5	0.3	0.4	2.4	0.7	0.2	0.9	3.6	1.3	0.3	7.2	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	3.1	2.7	2.5	2.9	3.8	2.0	3.3	2.7	3.5	1.4	2.2	2.2	0.1	3.2	6.7	0.7	0.4	0.5	0.0	1.3	1.2	0.2	9.1	5.7	1.4	2.8	0.9	0.0	0.0	0.0	0.0	120.1	0.0	0.2	0.5	3.2	0.3	0.2	19.7	0.0	1.8	0.9	0.0	0.2	11.7	4.4	1.3	58.5	0.4	53.4	0.3	0.0	2.9	32.0	0.0	3.2	0.9	5.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	1.5	0.1	1.0	67.0	1.2	0.1	0.1	66.0	9.9	4.8	0.2	0.0	0.6	0.2	2.3	2.9	1.1	0.3	0.0	0.4	0.1	44.3	0.2
CETN2	"CALT, CEN2"	ENSG00000147400	"Centrin 2"	P41208	X	152826994-152830757	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 243.6"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 639.9;Proximal tubular cells: 345.8;Respiratory ciliated cells: 1116.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001470, HPA028956"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA001470: , HPA028956: AB_10601798"	"unprognostic (3.32e-1)"	"prognostic favorable (7.54e-6)"	"unprognostic (7.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.73e-3)"	"unprognostic (9.58e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (5.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.20e-1)"	30.2	41.0	61.8	19.8	62.3	26.2	40.3	58.3	80.4	64.6	90.5	54.6	15.2	57.6	116.2	37.2	243.6	31.7	34.6	60.6	65.8	74.7	31.5	39.8	16.0	68.0	75.8	57.2	24.0	55.7	73.9	21.4	70.4	50.3	25.8	40.1	24.4	77.7	19.6	23.8	21.6	54.8	67.4	16.8	29.3	23.3	64.8	21.0	67.2	20.2	21.9	37.3	36.1	67.1	145.2	65.0	78.8	59.6	102.5	110.5	31.4	61.6	73.8	79.9	60.9	29.5	75.8	51.6	157.8	83.1	128.8	55.3	55.3	76.7	94.1	23.2	40.0	11.5	32.1	86.6	38.5	48.7	12.5	67.0	99.2	74.1	39.1	95.4	64.0	40.3	31.0	20.9	78.3	67.9	36.4	53.0	27.5	119.9	82.6	31.9	57.2	53.2	146.9	35.4	38.5	50.0	41.2	42.2	38.2	70.8	45.4	37.2	59.8	56.0	44.9	111.9	69.9	20.9	29.7	81.0	118.3	28.9	28.0	19.9	11.4	35.9	11.7	13.6	14.2	11.9	11.5	13.1	13.5	9.7	12.2	12.5	10.9	12.3	13.7	20.0	10.5	11.8	61.8	62.3	58.3	80.4	60.6	65.8	68.0	75.8	70.4	67.4	64.8	67.1	21.6	51.3	35.7	3.9	19.2	22.6	52.4	201.6	21.6	13.6	46.1	47.6	37.1	64.3	155.8	169.2	6.2	66.6	16.2	13.8	238.7	100.3	60.1	639.9	65.4	29.6	37.1	33.2	4.2	41.1	69.8	42.9	12.2	68.7	24.6	41.0	44.3	96.5	50.0	13.5	3.5	31.7	150.5	23.7	21.3	72.5	67.7	27.3	37.4	1.9	27.8	104.4	20.6	0.5	2.5	39.6	16.0	111.7	16.6	29.3	15.4	345.8	1116.5	29.4	19.7	22.7	64.2	76.5	70.4	33.7	30.5	41.5	19.7	51.8	29.2	42.4
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34709113-34714823	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 372.8;skeletal muscle: 719.9;tongue: 686.4"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 522.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		47000000	"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: AB_2679383"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (2.16e-5)"	48.7	52.5	71.7	28.6	98.7	18.1	24.6	90.3	116.1	39.8	53.9	92.5	14.3	73.4	19.5	69.0	42.6	24.1	372.8	69.4	85.0	31.4	125.9	24.9	10.7	85.7	83.6	41.2	9.4	24.4	10.9	35.3	88.7	75.4	28.1	41.0	17.1	107.3	719.9	8.2	24.0	115.0	74.7	12.7	36.1	21.7	81.2	10.4	29.4	686.4	9.9	56.8	24.3	130.5	87.1	77.7	49.5	32.0	51.1	185.6	27.9	146.6	170.5	145.6	151.4	61.9	38.5	30.6	58.5	245.2	104.9	17.1	107.4	32.5	268.6	4.2	45.0	6.6	87.4	144.5	81.6	8.2	5.3	139.3	12.4	122.2	67.7	96.8	145.9	4.5	9.9	26.8	186.9	25.5	6.3	4.3	16.3	15.4	118.9	5.4	158.1	4.7	55.1	17.7	10.3	41.7	96.6	21.5	51.2	36.2	47.8	7.5	124.6	140.9	93.0	66.1	72.9	34.3	22.8	11.7	51.7	11.4	34.5	1.8	1.0	1.3	1.9	1.0	3.1	4.9	2.2	2.1	1.6	3.0	1.7	1.8	0.3	1.8	0.4	1.6	2.1	0.9	71.7	98.7	90.3	116.1	69.4	85.0	85.7	83.6	88.7	74.7	81.2	130.5	39.6	105.8	41.6	6.2	17.0	20.0	88.6	31.3	23.9	62.8	19.6	16.6	522.2	22.8	26.3	22.0	20.9	32.2	11.5	0.9	60.7	45.2	2.6	40.3	60.5	45.1	9.5	11.4	9.6	39.7	60.5	69.9	6.1	56.2	5.7	25.8	47.2	112.0	15.6	77.4	14.2	2.4	57.0	15.7	14.4	10.1	57.2	10.6	30.2	11.2	5.7	112.9	15.5	8.0	93.8	24.7	4.0	98.6	60.4	84.0	1.0	101.9	24.7	57.8	32.9	83.9	115.8	49.3	51.9	16.1	19.5	21.3	21.1	47.9	4.6	58.5
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 83.9;lymphoid tissue: 58.4"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 108.1;Kupffer cells: 356.7;Langerhans cells: 164.1;Macrophages: 177.3;monocytes: 473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	8	"classical monocyte: 1167.5;intermediate monocyte: 1273.6;myeloid DC: 994.5;neutrophil: 730.3;non-classical monocyte: 868.9"	"Group enriched"	"Detected in all"	46	"dendritic cells: 994.5;granulocytes: 730.3;monocytes: 1273.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 5.0;HMC-1: 5.5;NB-4: 10.7;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		6200000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	6.0	1.9	0.3	20.5	0.3	83.9	2.1	0.3	0.6	0.6	0.2	2.1	1.2	0.9	0.2	1.6	3.4	2.1	2.6	0.4	0.1	0.8	12.0	9.3	11.7	0.1	0.0	0.7	0.8	0.1	0.8	0.9	0.0	0.7	0.9	0.2	1.0	0.2	1.0	1.5	3.7	5.2	0.0	58.4	1.5	0.6	0.0	5.1	0.9	0.7	4.4	4.9	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	20.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	5.0	0.2	0.0	0.1	1.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.0	10.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	1.0	0.0	0.1	0.5	0.1	0.4	0.4	0.1	0.1	7.2	0.0	131.5	1167.5	39.9	3.0	1273.6	2.3	6.7	15.1	1.8	994.5	2.6	21.8	8.1	730.3	12.3	868.9	30.9	14.1	1071.9	0.3	0.3	0.3	0.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.1	1.0	5.8	4.0	0.1	0.3	1.2	3.4	0.7	0.4	0.9	1.5	2.8	0.0	0.0	0.3	1.7	0.3	0.0	0.2	0.2	0.4	0.4	7.4	0.0	2.5	1.4	0.7	0.5	2.0	1.1	0.6	1.3	4.0	108.1	2.0	17.3	1.7	1.1	0.0	0.0	356.7	164.1	0.3	0.9	177.3	5.4	0.0	473.7	0.3	4.1	2.0	0.3	0.3	0.1	1.2	1.2	0.3	0.1	0.5	7.5	1.9	0.0	1.5	1.2	0.0	0.2	0.5	3.0	0.4	4.8	3.1	0.6	0.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"CF transmembrane conductance regulator"	P13569	7	117287120-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.6;intestine: 42.7;pancreas: 210.7"	"Group enriched"	"Detected in many"	4	"Ductal cells: 485.4;Ionocytes: 252.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.0	0.5	4.7	2.0	0.0	0.4	0.7	1.3	8.5	0.0	42.7	36.2	1.1	1.1	0.8	2.2	54.6	0.1	0.3	0.7	2.1	1.6	8.2	0.0	1.1	0.7	0.0	210.7	0.2	0.1	0.6	0.7	2.2	40.7	0.0	21.5	0.5	0.0	1.9	19.9	2.0	1.7	0.0	3.1	1.7	1.0	0.1	0.1	0.0	0.3	0.7	0.0	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	98.9	0.1	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.7	1.3	0.3	0.7	1.1	0.7	0.7	1.7	1.0	2.9	0.0	6.4	65.6	0.0	0.5	0.0	2.0	2.6	0.0	0.5	0.5	0.0	2.4	55.8	17.8	0.0	0.0	0.0	0.0	45.8	0.0	485.4	3.2	9.6	1.2	0.4	7.2	0.0	2.2	4.5	0.0	0.3	4.1	19.8	1.3	0.1	0.0	0.4	0.0	0.0	1.1	13.9	252.3	0.0	0.0	2.6	0.3	0.1	0.0	1.0	6.7	0.5	0.0	0.5	23.8	14.8	86.4	0.0	0.0	4.0	8.6	0.0	5.6	0.0	0.0	0.0	1.6	2.2	0.5	0.0	0.0	0.0	0.3	0.1	87.3	5.8
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Distal enterocytes: 173.2;Paneth cells: 108.7;Proximal enterocytes: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 91.4;CAPAN-2: 59.1;OE19: 58.6;RT4: 44.0"	"Low region specificity"	"Detected in many"							"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	5.8	1.1	1.9	6.0	3.3	0.4	9.0	8.5	3.3	4.9	6.5	37.2	52.7	1.4	1.5	8.6	13.2	13.6	0.6	2.0	3.7	12.2	32.1	27.3	0.4	5.5	3.0	2.0	24.2	32.1	3.7	1.6	5.6	10.1	25.1	3.7	21.1	7.0	0.2	17.9	56.4	1.5	1.7	0.4	30.4	6.6	3.4	0.7	4.9	0.1	2.3	8.3	6.2	6.7	28.9	3.2	2.7	4.6	0.0	0.0	35.4	0.1	0.1	0.8	0.9	91.4	59.1	1.3	9.4	0.0	4.9	27.0	8.6	5.0	0.6	17.3	6.0	2.4	1.3	1.8	0.0	0.4	3.6	0.0	1.0	1.3	0.7	0.0	0.3	7.8	1.2	8.1	0.0	26.8	5.0	0.6	22.9	58.6	2.5	5.4	2.8	4.3	17.9	44.0	8.9	4.4	1.8	27.1	1.0	10.3	33.5	0.3	0.5	0.3	8.3	0.5	1.2	7.7	8.4	5.2	0.3	3.3	2.4	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.0	1.9	3.3	8.5	3.3	2.0	3.7	5.5	3.0	5.6	1.7	3.4	6.7	0.1	118.6	33.3	2.3	0.2	0.3	3.3	5.9	0.6	4.3	14.9	9.1	0.7	24.3	22.4	3.7	0.0	3.5	0.5	173.2	0.0	21.5	0.3	13.8	2.1	0.6	10.3	2.7	0.8	25.4	0.3	2.3	54.6	27.3	0.0	0.5	0.0	29.6	0.3	0.0	10.4	32.7	8.2	0.0	0.4	1.2	0.6	0.5	3.6	0.0	2.1	13.5	0.0	3.5	11.7	49.5	108.7	0.7	0.5	11.9	88.7	3.0	46.8	1.5	0.0	0.1	1.0	1.5	6.9	4.2	1.8	0.4	0.6	1.8	27.2	18.3
CHADL	SLRR4B	ENSG00000100399	"Chondroadherin like"	Q6NUI6	22	41229510-41240931	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 109.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 40.3;Oligodendrocytes: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.8;Hep G2: 3.4;hTCEpi: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA005696, HPA024654"	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"			"HPA005696: AB_1079724, HPA024654: AB_1846615"	"unprognostic (6.14e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.56e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.67e-8)"	"unprognostic (8.36e-3)"	"unprognostic (4.10e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.09e-2)"	2.6	4.7	25.4	0.5	62.4	1.0	2.6	57.5	43.9	3.5	5.2	12.4	1.5	1.3	1.5	4.2	2.2	2.7	16.5	25.1	32.4	2.1	3.1	2.1	0.8	69.6	51.8	2.6	3.5	0.5	4.3	0.6	61.3	6.5	0.3	1.0	11.3	3.8	2.2	6.1	3.4	0.8	43.4	0.7	5.0	3.5	56.3	1.7	4.4	1.6	0.4	2.9	3.6	109.6	0.6	0.2	0.2	0.3	0.1	0.1	11.8	0.4	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.5	0.0	0.6	0.0	0.1	0.2	0.0	0.3	3.4	0.4	0.1	0.1	1.0	3.4	0.3	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.3	0.2	0.6	0.3	0.3	0.4	0.1	0.5	0.2	0.2	0.3	0.7	0.1	1.3	0.2	0.1	0.0	0.0	1.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	1.6	0.0	0.1	0.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.0	0.0	1.2	0.0	0.3	25.4	62.4	57.5	43.9	25.1	32.4	69.6	51.8	61.3	43.4	56.3	109.6	2.7	6.4	2.2	8.1	0.2	4.0	10.2	1.8	17.6	1.4	7.3	6.5	3.5	2.8	1.7	3.7	0.0	3.0	0.4	0.8	7.9	2.0	18.6	2.5	0.6	1.3	3.0	0.0	2.8	1.2	6.4	5.5	2.6	1.6	0.0	3.2	2.5	2.5	5.1	0.0	2.5	0.8	2.0	0.8	2.1	12.0	3.7	3.4	17.8	1.9	0.4	40.3	0.0	12.5	83.1	0.8	1.0	3.0	0.3	3.7	1.3	5.9	4.1	1.6	0.0	2.5	1.2	0.3	0.8	6.5	3.7	1.5	0.5	0.7	1.4	6.5
CHAT		ENSG00000070748	"Choline O-acetyltransferase"	P28329	10	49609095-49667942	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Acyltransferase, Transferase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 13.0;placenta: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"NB-4: 20.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 20.6"	"Group enriched"	"Detected in some"	7	"basal ganglia: 6.5;pons: 7.0;spinal cord: 12.0"	"CAB002313, HPA048547, CAB079053"	Supported	Supported				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 33: Fibroblasts - ECM organization"			"CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437"					"unprognostic (2.34e-2)"	"unprognostic (6.10e-2)"		"unprognostic (5.28e-2)"		"unprognostic (6.96e-2)"	"unprognostic (2.80e-2)"			"unprognostic (3.98e-1)"	"unprognostic (1.09e-1)"			0.0	0.0	0.6	0.2	2.8	0.0	0.0	0.3	13.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	7.9	5.1	0.0	0.3	0.0	0.0	5.5	9.4	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.8	20.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.8	0.3	13.0	0.1	3.1	7.9	5.1	9.4	1.3	0.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CHL1	"CALL, FLJ44930, L1CAM2, MGC132578"	ENSG00000134121	"Cell adhesion molecule L1 like"	O00533	3	196763-409417	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 223.6;Excitatory neurons: 423.8;Inhibitory neurons: 320.7;Oligodendrocyte precursor cells: 918.4"	"Cancer enhanced"	"Detected in many"		"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.7;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 91.8;WM-115: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003345, CAB026120"	Enhanced				"Secreted in brain"	NA	NA		5800000000	"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB026120: , HPA003345: AB_1078516"	"unprognostic (5.54e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	13.6	4.1	18.6	8.6	33.9	0.3	8.5	2.3	35.5	3.3	0.0	14.7	4.4	3.4	1.6	8.9	2.6	4.8	11.5	35.8	26.7	17.8	0.8	5.1	6.2	12.5	5.3	16.3	1.7	0.5	2.6	0.0	5.7	3.7	7.9	15.9	6.9	6.3	0.3	12.9	6.2	5.4	10.0	3.0	4.0	1.5	10.6	0.7	0.9	1.4	2.9	3.1	5.3	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	33.9	2.3	35.5	35.8	26.7	12.5	5.3	5.7	10.0	10.6	5.0	4.1	0.0	0.0	223.6	8.8	22.9	0.6	2.8	56.9	1.2	0.6	13.6	18.0	1.5	15.8	11.0	0.0	0.0	0.1	0.0	11.7	0.0	2.0	2.9	0.1	2.3	0.0	0.0	423.8	0.0	0.0	33.5	0.0	1.9	1.3	106.2	1.4	1.3	0.0	1.7	320.7	0.0	0.0	0.3	4.4	1.4	2.8	0.6	3.6	22.5	0.0	58.7	0.0	918.4	11.6	0.2	0.0	0.0	1.4	6.2	0.0	19.7	17.8	2.7	0.0	2.7	11.2	3.0	1.3	15.6	12.1	0.0	1.1	12.4	0.0	0.8
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732448-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 71.6;Pancreatic endocrine cells: 78.7;Proximal enterocytes: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 37.2;CAPAN-2: 41.5;hTCEpi: 51.4;hTERT-HME1: 41.6;OE19: 73.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023763, HPA023799"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Microtubules, Cytokinetic bridge"		"HPA023763: , HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.7	5.8	1.2	2.1	1.3	1.2	16.6	1.6	1.3	7.5	2.8	16.2	41.8	2.3	5.8	22.6	8.7	8.0	3.6	1.1	1.0	13.9	7.7	7.2	0.5	1.5	1.4	0.5	20.1	15.8	10.1	5.8	1.5	10.0	14.8	0.2	28.1	7.6	0.2	29.1	31.7	0.8	1.1	8.5	23.7	1.1	1.4	1.9	17.5	0.5	5.2	9.7	14.2	2.0	37.2	7.6	0.0	0.2	0.0	0.0	16.6	1.9	2.2	0.1	0.0	14.3	41.5	0.1	28.8	0.0	6.4	22.1	0.2	15.7	0.0	0.0	17.9	0.7	9.9	13.6	0.8	0.1	0.1	0.0	51.4	0.0	41.6	15.3	0.0	0.0	10.0	12.4	0.0	18.4	0.1	0.3	0.1	73.1	14.9	0.1	0.0	8.3	36.3	22.0	7.9	0.1	9.9	16.3	0.1	8.5	23.9	0.2	0.0	0.1	8.9	0.1	0.2	6.5	4.3	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.9	0.0	0.1	0.0	0.1	1.2	1.3	1.6	1.3	1.1	1.0	1.5	1.4	1.5	1.1	1.4	2.0	5.3	25.6	21.5	0.0	3.2	4.6	35.4	17.1	18.2	0.0	27.2	29.3	4.1	21.5	22.4	5.5	0.0	40.2	0.6	42.0	25.4	47.4	0.4	18.6	2.9	4.0	9.1	1.7	0.1	71.6	38.9	1.0	25.5	31.0	1.3	6.5	4.2	7.6	4.4	0.0	0.1	36.4	12.2	0.3	0.7	1.3	0.0	0.9	8.8	1.0	0.0	0.0	1.0	0.0	0.1	78.7	52.8	0.0	5.7	28.9	80.4	22.6	19.1	0.0	0.0	0.2	7.0	0.3	0.7	25.0	17.5	44.5	1.3	0.1	34.4	33.6
CHODL	"C21orf68, FLJ12627, MT75, PRED12"	ENSG00000154645	Chondrolectin	Q9H9P2	21	17901263-18267373	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;lymphoid tissue: 14.1;testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 38.6;Oligodendrocytes: 50.1;Skeletal myocytes: 28.3;Theca cells: 26.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.8;U-266/70: 2.8;U-266/84: 7.2;U-87 MG: 7.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.9;hypothalamus: 12.3;pons and medulla: 10.9"	"Group enriched"	"Detected in all"	4	"olfactory bulb: 66.4;spinal cord: 38.6"	"HPA017282, HPA057559"	Enhanced		Approved	Centrosome,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	Centrosome	"HPA017282: AB_1846687, HPA057559: "	"unprognostic (3.91e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (6.74e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.02e-1)"	3.3	2.0	1.6	1.1	1.4	0.0	1.1	0.7	1.6	0.2	0.8	2.8	1.6	0.6	1.1	0.9	0.5	0.8	3.7	1.7	5.4	3.6	0.0	0.3	0.4	11.5	2.6	0.6	0.1	0.3	2.5	1.9	10.8	5.6	3.5	0.6	0.5	1.8	0.6	2.3	1.0	0.3	1.6	14.1	0.7	31.0	10.2	0.3	1.1	1.7	1.2	0.7	1.1	3.8	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.4	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.7	0.6	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.8	7.2	0.2	7.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.5	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	1.6	1.4	0.7	1.6	1.7	5.4	11.5	2.6	10.8	1.6	10.2	3.8	1.7	0.0	0.0	5.2	1.0	4.0	0.8	0.8	3.4	1.1	1.0	1.3	0.5	0.0	0.9	0.0	0.0	0.2	0.9	0.0	1.9	0.4	5.0	1.4	38.6	1.5	0.0	0.0	5.5	0.0	0.2	4.6	0.0	0.8	0.0	12.3	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.8	4.0	3.1	0.1	1.8	4.7	0.0	0.4	0.0	12.5	50.1	0.0	0.0	1.9	3.1	0.2	0.0	0.3	0.3	0.1	0.0	28.3	10.5	1.3	1.7	0.5	2.3	0.5	1.3	26.7	0.1	0.3
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23755026-23758935	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"intestine: 305.0;skin 1: 149.7"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 345.0;Paneth cells: 274.0;Proximal enterocytes: 654.2;Undifferentiated cells: 205.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.3;hTERT-RPE1: 10.2;NB-4: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055198, CAB072806"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB072806: , HPA055198: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.4	0.2	1.1	3.8	1.1	2.2	4.3	3.6	1.3	14.0	0.0	146.7	305.0	0.9	1.1	0.6	0.9	0.4	0.4	0.7	1.6	4.1	0.7	0.6	0.8	0.5	0.1	0.4	0.5	0.1	0.0	1.4	0.9	3.8	147.4	1.3	0.8	4.5	1.2	149.7	250.5	6.5	0.1	0.3	1.1	7.3	0.9	0.5	0.6	0.2	0.4	9.0	4.2	2.9	1.0	2.2	0.5	0.6	1.2	1.3	1.2	2.9	1.1	0.3	1.0	0.5	2.3	0.4	0.9	2.5	1.2	1.4	0.4	2.9	0.6	0.7	0.2	0.5	4.1	1.6	1.7	0.3	0.7	0.9	0.8	2.5	7.3	10.2	1.1	0.3	1.2	1.0	1.2	0.1	0.1	8.7	0.3	0.5	2.1	0.2	0.1	1.4	1.1	0.7	0.6	0.7	0.8	0.2	0.0	0.6	0.2	0.2	1.3	0.5	0.6	0.7	0.1	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.1	0.1	0.0	0.0	1.1	1.1	3.6	1.3	0.7	1.6	0.5	0.1	0.9	0.1	0.9	2.9	0.0	0.0	0.0	0.0	0.0	10.3	8.7	6.1	0.0	0.0	0.0	0.1	0.1	0.0	24.4	1.8	0.0	0.9	0.0	345.0	0.0	0.0	0.6	1.3	0.5	0.2	9.1	0.0	0.0	0.0	4.1	0.2	0.0	3.6	4.5	0.7	0.0	0.0	0.1	0.0	0.0	70.0	12.2	0.0	1.6	0.5	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	274.0	0.0	0.0	2.5	654.2	12.9	4.4	0.0	0.0	0.0	0.3	0.0	0.2	0.0	67.5	0.7	0.2	0.2	205.4	29.9
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 27.0;prostate: 29.6;salivary gland: 28.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.9;Breast myoepithelial cells: 3.6;Excitatory neurons: 8.7;Inhibitory neurons: 7.8;Intestinal goblet cells: 3.2;Melanocytes: 3.6;Oligodendrocyte precursor cells: 3.0;Prostatic glandular cells: 4.4"	"Cancer enriched"	"Detected in some"	16	"prostate cancer: 27.9"	"Group enriched"	"Detected in many"	178	"amygdala: 12.4;basal ganglia: 18.7;cerebral cortex: 27.0;hippocampal formation: 22.6;white matter: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 3.7;OE19: 12.3"	"Low region specificity"	"Detected in many"							HPA014101	Enhanced	Supported				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014101: AB_1854210"	"unprognostic (3.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.16e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.57e-4)"	"unprognostic (4.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"		0.0	3.3	12.4	0.3	18.7	0.0	2.7	0.0	27.0	0.0	0.0	0.8	0.4	0.1	0.0	0.3	0.2	0.1	0.1	22.6	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.0	29.6	0.7	0.1	28.8	0.0	0.0	2.8	0.7	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	12.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.4	0.1	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	18.7	0.0	27.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	1.8	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	3.2	0.0	0.0	0.3	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	3.0	1.0	0.0	0.1	0.0	0.0	4.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.5;intestine: 6.8;lymphoid tissue: 15.9;testis: 5.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"basal ganglia: 18.5;cerebral cortex: 4.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 3.4;SCLC-21H: 10.0;U-2 OS: 2.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.8"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.1	0.5	1.6	0.2	18.5	1.7	0.1	0.0	4.6	0.1	0.0	1.5	3.2	0.1	0.0	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.2	1.2	0.0	0.0	0.0	0.1	2.4	0.1	0.0	0.0	2.0	6.8	0.1	0.0	15.9	0.6	5.0	1.7	2.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	2.1	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	0.0	1.8	0.1	1.3	0.1	0.0	1.6	0.2	0.4	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.1	0.4	0.1	0.1	0.0	3.4	0.0	0.0	0.1	10.0	0.2	0.2	0.0	0.1	0.2	0.1	1.7	0.0	0.3	2.8	0.0	0.0	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	18.5	0.0	4.6	1.8	0.1	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5"	"Cell type enriched"	"Detected in some"	19	"Cone photoreceptor cells: 164.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 356.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nuclear speckles"	"HPA029430: AB_10603785"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.48e-1)"	0.3	39.3	4.4	5.1	2.0	0.0	0.1	6.3	1.0	1.0	0.3	8.1	1.5	0.5	0.0	0.1	0.0	0.3	0.4	0.7	2.3	0.0	0.0	0.2	0.3	3.1	6.4	0.1	0.2	0.0	1.1	0.1	10.0	0.2	4.0	53.5	0.1	0.0	0.1	0.7	3.0	3.7	0.3	0.1	2.8	1.0	9.2	65.8	0.2	0.0	0.8	0.2	0.7	1.0	0.1	0.3	0.7	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	8.8	0.0	0.0	0.3	1.4	0.5	0.4	0.1	0.0	0.1	4.0	0.0	0.3	0.0	0.0	0.0	0.0	22.6	0.2	0.0	0.0	0.3	7.1	0.0	1.6	0.1	0.2	0.4	0.3	0.1	0.0	0.4	67.7	356.1	0.3	0.1	0.1	0.5	0.4	0.0	0.0	0.1	1.7	0.1	0.4	0.2	0.7	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	2.0	6.3	1.0	0.7	2.3	3.1	6.4	10.0	0.3	9.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	164.7	0.0	0.0	0.2	1.9	0.0	3.7	0.1	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.7	0.4	3.6	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.3	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.1
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.8;intestine: 9.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8"									"HPA029422, CAB033624"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.3	7.8	1.2	0.4	1.1	0.9	1.0	1.8	1.8	0.4	2.1	1.5	4.4	0.5	0.3	0.3	0.4	0.9	0.5	1.0	4.5	0.4	0.1	0.5	0.7	4.5	3.9	1.6	2.4	6.4	1.0	0.0	7.0	1.2	2.3	2.5	0.5	0.7	0.5	0.3	9.7	0.4	1.5	1.2	6.6	2.5	3.3	0.4	2.2	0.8	0.7	1.5	0.7	1.1	0.0	1.3	2.7	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	1.7	0.6	0.0	2.2	0.0	0.4	1.0	0.0	0.0	0.2	0.0	0.1	0.4	2.5	0.0	0.2	0.3	0.2	0.0	0.2	1.5	3.7	0.0	0.0	4.2	0.3	0.5	12.9	0.5	8.3	0.2	13.3	0.0	0.7	0.0	0.5	1.2	0.0	10.8	0.3	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.2	1.1	1.8	1.8	1.0	4.5	4.5	3.9	7.0	1.5	3.3	1.1	0.5	0.0	0.0	1.0	0.0	0.3	3.0	0.0	7.4	1.8	1.1	1.3	1.1	2.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.1	0.2	0.3	1.5	3.0	0.0	9.0	2.5	0.0	0.4	26.0	0.6	1.3	4.6	0.7	0.0	0.1	16.8	30.7	8.9	0.0	0.0	0.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.5	1.1	1.6	2.9	0.0	0.2	0.7	14.4	0.2	0.0	0.0	0.0	0.4	0.3	0.2	5.9	3.2	0.0	0.0	0.1	0.2	2.0	1.2
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567778-154580013	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.4;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.7;Cone photoreceptor cells: 14.6;Horizontal cells: 42.1;Inhibitory neurons: 7.8;Late spermatids: 11.8;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.7;SH-SY5Y: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.13e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.84e-1)"	0.0	1.0	6.5	0.1	7.5	0.0	0.4	2.2	17.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.7	5.3	0.0	0.0	0.0	0.0	3.8	5.5	0.0	0.6	0.1	3.6	0.0	3.8	0.0	0.1	8.3	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	25.7	25.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.5	2.2	17.4	8.7	5.3	3.8	5.5	3.8	0.3	11.8	6.5	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	12.7	0.1	0.3	1.5	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.2	3.6	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	42.1	7.8	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	1.0	0.0	1.3	0.0	1.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.5	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624111-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;retina: 2.7;testis: 5.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 44.1;Late spermatids: 54.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 30.9;SH-SY5Y: 40.7"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2"					HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.0	2.4	0.2	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.2	1.1	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.5	0.7	1.8	0.1	0.0	0.2	0.4	0.0	1.4	0.0	0.4	2.7	0.1	0.0	0.3	0.1	0.3	0.4	0.0	0.4	0.3	5.8	0.2	3.0	0.1	0.0	0.4	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.9	40.7	0.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.5	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.5	0.7	1.8	1.4	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	44.1	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.5	0.1	0.2	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.1	0.0	0.0	0.0	1.6	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 85.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.5"									"HPA043804, HPA068029"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA043804: AB_10960563, HPA068029: "	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.1	0.2	2.2	1.3	2.0	0.6	0.4	1.9	2.2	0.4	2.2	46.1	85.0	0.4	0.3	0.2	1.1	0.2	0.3	2.2	1.0	0.4	0.1	0.3	0.3	1.9	1.5	0.5	0.1	0.4	0.7	0.2	0.7	0.3	55.3	1.5	0.1	0.3	7.7	0.2	75.6	1.0	1.2	0.4	4.7	0.7	1.8	0.3	0.3	0.8	0.1	0.2	0.1	1.6	0.1	0.3	0.4	0.5	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.6	0.4	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.9	0.2	1.3	0.3	0.0	1.5	0.2	0.1	0.9	0.5	0.1	0.7	1.2	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.5	0.3	0.9	0.1	0.2	0.7	0.0	0.3	0.1	0.3	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.2	0.1	0.0	2.2	2.0	1.9	2.2	2.2	1.0	1.9	1.5	0.7	1.2	1.8	1.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	2.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.6	0.0	8.1	0.0	0.0	0.0	11.6	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185308	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 13.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.0	0.2	0.8	0.1	0.9	0.0	2.9	0.7	2.4	2.8	0.0	1.6	0.2	0.1	0.4	1.6	10.3	3.1	2.6	2.7	1.2	1.6	8.2	4.3	0.0	3.5	2.3	0.0	9.3	0.0	1.9	0.0	1.2	3.5	0.2	7.3	13.8	1.8	0.2	0.1	0.3	0.1	2.0	5.7	0.7	6.9	1.2	1.0	0.0	0.9	0.6	1.5	0.7	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	41.8	0.0	9.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	2.4	2.7	1.2	3.5	2.3	1.2	2.0	1.2	1.9	0.1	0.0	2.7	24.8	0.0	0.6	32.6	56.6	4.6	1.3	8.2	8.0	9.2	35.8	115.2	5.5	0.0	0.4	0.1	0.0	11.7	13.0	7.1	49.9	0.7	0.3	3.5	0.0	10.1	0.6	0.1	4.2	0.0	1.8	5.1	0.1	0.0	10.7	0.3	0.0	29.3	0.1	22.4	0.0	0.0	4.4	0.6	0.5	7.2	1.0	0.0	69.2	0.0	167.4	1.0	1.3	0.0	0.4	0.0	8.9	0.0	0.3	311.6	3.2	0.0	3.2	3.7	0.9	1.3	4.7	0.0	0.3	0.4	0.0	0.0	40.3
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175727-101252048	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	27.5	18.6	10.3	18.5	9.8	23.0	21.7	9.0	11.8	19.5	14.4	7.7	6.0	17.3	9.5	10.8	14.9	22.7	20.1	9.2	10.3	13.7	10.0	23.6	11.6	14.2	13.8	19.7	7.3	7.4	8.5	46.7	11.9	14.4	8.2	7.0	10.1	11.4	6.5	15.0	7.7	20.0	11.5	13.9	10.4	8.7	12.5	10.5	10.0	7.4	10.3	34.8	14.0	9.8	9.1	11.2	36.8	18.7	18.9	25.0	24.5	21.8	19.2	25.8	26.2	9.7	7.1	22.0	12.7	36.3	16.8	24.7	24.5	27.7	28.2	24.6	12.4	43.4	12.2	11.4	23.3	66.9	42.9	23.2	22.8	22.3	20.1	29.3	30.8	9.7	16.2	216.3	19.7	7.9	9.2	46.3	42.5	17.7	7.9	20.6	36.9	32.8	18.1	17.7	6.4	34.6	23.0	11.1	40.8	29.8	12.6	81.6	26.2	41.9	24.1	20.0	46.5	38.2	94.5	12.7	32.5	62.2	32.0	0.0	1.3	2.9	1.5	0.8	1.7	0.9	0.9	1.6	0.8	1.0	0.5	1.0	4.9	0.7	0.9	0.5	1.8	0.6	10.3	9.8	9.0	11.8	9.2	10.3	14.2	13.8	11.9	11.5	12.5	9.8	55.0	0.0	15.7	27.7	11.4	57.9	20.7	10.1	20.5	10.7	41.9	29.8	9.3	5.7	9.4	16.5	6.2	6.1	14.6	1.6	1.9	5.3	1.2	10.0	33.4	45.8	3.0	12.0	34.2	2.2	28.8	40.0	5.1	13.8	25.9	51.9	60.0	5.4	16.6	38.7	36.1	3.6	10.2	17.8	37.1	2.5	55.0	41.2	26.6	59.0	10.2	9.2	10.3	21.1	24.2	5.5	2.5	47.0	9.3	19.3	1.2	2.4	8.1	7.5	46.0	47.9	53.5	3.9	7.5	10.5	62.5	13.8	15.2	23.0	3.9	10.2
CILP	HsT18872	ENSG00000138615	"Cartilage intermediate layer protein"	O75339	15	65194760-65211473	"Disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 30.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003195	Uncertain				"Secreted to extracellular matrix"	NA	NA		13000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA003195: AB_1078524"	"unprognostic (2.21e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-13)"	"unprognostic (5.10e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (4.68e-3)"	49.8	0.8	0.2	9.5	0.2	0.1	21.9	0.3	0.3	44.9	0.1	20.3	2.3	13.8	3.6	11.0	15.8	36.8	27.4	0.2	0.2	1.0	1.6	2.9	1.6	0.2	0.2	7.5	3.0	0.3	0.7	2.5	0.2	3.1	6.9	0.5	9.4	4.8	15.5	14.0	22.6	51.0	0.2	0.6	8.3	12.1	0.2	1.8	2.4	32.9	0.8	26.9	28.1	0.2	0.0	0.0	0.0	0.0	4.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	8.1	0.0	0.0	0.0	0.0	5.2	0.1	0.2	0.0	0.9	0.4	0.5	2.1	0.0	0.4	1.8	0.0	0.0	0.2	0.1	0.0	0.1	1.7	1.2	42.9	1.5	0.0	0.0	0.3	0.0	0.0	138.1	4.1	1.7	0.0	0.1	2.2	0.1	0.1	0.0	0.6	0.1	2.0	0.0	11.9	7.1	231.5	1.7	1.8	1.9	0.0	0.2	0.0	1.0	0.3	0.0	0.0	57.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	14.7	6.6	0.6	0.3	0.1	6.1	0.0	1.6	83.5	0.2	0.0
CIT	"CITK, CRIK, KIAA0949, STK21"	ENSG00000122966	"Citron rho-interacting serine/threonine kinase"	O14578	12	119685791-119877320	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Early spermatids: 72.8;Excitatory neurons: 147.0;Inhibitory neurons: 139.8;Oligodendrocyte precursor cells: 82.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019082, HPA048812, HPA075506"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA019082: AB_1846803, HPA048812: AB_2680528, HPA075506: AB_2686752"	"unprognostic (5.64e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.61e-6)"	"unprognostic (6.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.30e-1)"	0.7	2.2	13.5	1.6	26.2	6.3	0.6	0.0	19.9	0.9	0.0	2.1	1.2	0.4	0.0	2.5	0.5	0.5	0.6	15.2	5.4	2.5	0.3	1.8	1.5	0.2	5.0	0.3	0.2	0.1	1.6	1.4	0.4	0.5	2.5	3.4	0.8	0.2	0.5	1.6	1.9	0.9	0.9	3.0	2.2	4.8	14.2	6.8	0.6	0.3	2.3	0.5	1.3	6.6	26.2	20.6	21.7	15.3	2.4	6.3	10.4	22.0	19.1	21.8	16.6	14.5	10.3	18.4	10.0	14.2	9.3	14.6	14.4	9.5	32.1	13.6	7.5	25.7	13.2	7.1	0.3	12.7	20.6	0.9	1.2	23.7	14.8	7.3	15.5	19.9	14.5	15.2	19.5	12.2	22.4	14.0	10.4	8.7	12.5	19.3	39.8	6.3	5.0	11.1	15.5	8.4	31.9	6.5	16.0	9.6	23.2	10.6	11.5	21.9	21.4	17.2	22.7	9.9	12.6	14.2	16.8	12.5	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.5	26.2	0.0	19.9	15.2	5.4	0.2	5.0	0.4	0.9	14.2	6.6	4.1	6.4	13.0	8.5	1.2	3.3	0.7	1.0	0.6	8.2	1.8	1.5	1.8	0.0	5.6	9.2	87.6	3.5	0.6	1.1	0.0	0.2	72.8	2.4	2.1	2.7	1.8	12.8	147.0	0.8	4.8	2.2	3.1	3.6	1.3	10.5	1.1	0.7	3.6	0.0	139.8	4.4	6.1	3.7	0.8	44.1	1.2	2.0	3.6	7.5	0.0	15.4	1.0	82.4	18.7	0.2	0.1	1.2	4.1	0.4	0.8	7.5	1.7	15.2	0.0	0.6	3.3	33.2	4.2	7.7	1.3	1.0	2.2	4.3	4.4	1.0
CKAP2L	"FLJ40629, radmis"	ENSG00000169607	"Cytoskeleton associated protein 2 like"	Q8IYA6	2	112736349-112764664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 13.1;lymphoid tissue: 12.1;testis: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 25.2;Granulosa cells: 12.5;Spermatocytes: 33.0;Spermatogonia: 35.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039407, HPA040057, HPA070737"	Uncertain		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Microtubules, Mitotic spindle"	Cytosol	"HPA039407: AB_10794091, HPA040057: AB_10794871, HPA070737: AB_2686303"	"unprognostic (2.29e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.59e-2)"	"unprognostic (5.75e-5)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.57e-6)"	"unprognostic (2.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.37e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	0.4	0.1	0.2	2.6	0.2	13.1	0.4	0.4	0.3	0.4	0.0	1.6	1.5	0.3	0.1	2.3	0.1	0.3	0.0	0.2	0.1	0.1	0.3	0.3	5.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.2	0.2	0.3	0.0	0.0	1.5	1.1	1.1	0.0	0.9	1.0	4.5	0.2	12.1	0.2	0.0	5.2	0.8	0.6	0.2	47.9	9.6	35.4	16.2	2.0	3.3	7.2	38.5	32.2	37.9	36.1	8.7	13.3	32.0	15.5	15.1	48.3	18.0	20.4	19.6	64.1	44.8	8.9	53.6	12.7	7.7	0.1	25.2	30.9	0.9	1.9	47.4	27.2	10.1	17.5	22.8	14.3	44.9	31.2	6.9	31.0	10.6	15.4	20.0	29.5	22.3	37.0	8.4	6.9	18.7	19.7	12.7	15.2	12.8	13.3	13.2	12.4	11.8	12.9	42.7	33.7	34.5	28.5	9.9	20.1	26.6	18.5	18.1	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.2	0.6	0.0	1.2	3.3	2.1	2.7	0.6	0.0	0.5	0.8	0.5	1.5	0.4	0.0	0.0	11.1	1.3	1.3	0.0	0.4	2.4	1.1	1.6	1.1	0.0	25.2	0.3	0.4	10.6	2.0	1.5	2.1	0.0	12.5	2.9	0.1	6.6	0.0	0.2	3.1	2.0	1.9	1.4	2.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	5.6	1.1	0.1	0.1	0.4	0.0	0.0	0.4	2.8	33.0	35.7	9.5	1.7	1.0	2.5	0.7	3.8	1.1
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;intestine: 75.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.0;Distal enterocytes: 110.5;Intestinal goblet cells: 53.4;Paneth cells: 57.4;Proximal enterocytes: 94.5;Syncytiotrophoblasts: 94.0;Undifferentiated cells: 92.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 127.5;hTCEpi: 56.8;OE19: 144.3;SK-BR-3: 107.8;T-47d: 100.3"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	1.8	3.8	20.8	7.1	22.1	0.0	7.7	29.3	46.4	10.1	12.6	75.0	70.6	0.5	0.4	83.9	2.1	9.4	0.8	21.9	27.3	6.0	0.2	0.9	0.1	24.9	15.8	0.1	3.5	12.3	8.5	9.5	26.9	4.4	69.4	31.8	31.4	1.1	0.1	38.0	63.1	3.4	10.7	0.1	23.3	0.3	23.0	0.2	2.8	0.0	14.7	8.3	26.1	25.7	0.3	2.9	0.7	0.1	1.3	0.0	31.9	0.0	0.0	0.0	0.0	6.8	22.1	0.1	1.4	0.0	2.4	127.5	22.4	39.0	0.0	0.0	17.1	0.0	2.1	0.7	0.0	0.0	6.1	0.2	56.8	0.0	10.3	0.0	0.0	5.0	5.7	0.1	0.0	34.8	0.0	0.2	10.1	144.3	8.2	0.1	0.0	6.7	6.7	4.7	47.1	20.0	0.0	107.8	8.6	2.9	100.3	0.8	0.0	0.0	2.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	22.1	29.3	46.4	21.9	27.3	24.9	15.8	26.9	10.7	23.0	25.7	0.1	0.0	0.0	2.3	0.3	17.7	10.5	30.3	1.8	6.7	4.2	5.2	0.5	10.0	14.9	1.8	20.9	73.0	0.1	110.5	27.4	4.2	0.0	0.7	0.0	0.3	18.0	0.0	10.6	20.2	23.5	0.4	26.0	0.8	8.9	1.5	0.0	0.0	4.5	6.7	9.0	53.4	12.2	0.0	0.7	0.2	0.0	0.0	5.4	1.0	0.0	4.8	0.0	1.5	1.6	12.9	57.4	0.0	0.0	2.7	94.5	1.0	4.1	11.6	0.0	0.0	0.9	0.0	0.1	16.1	18.5	94.0	0.4	0.0	92.7	20.1
CKMT1B	"CKMT, CKMT1, UMTCK"	ENSG00000237289	"Creatine kinase, mitochondrial 1B"	P12532	15	43593054-43604901	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;esophagus: 74.3;intestine: 80.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.4;Distal enterocytes: 146.4;Intestinal goblet cells: 78.3;Paneth cells: 69.9;Proximal enterocytes: 124.6;Syncytiotrophoblasts: 137.9;Undifferentiated cells: 123.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 139.8;hTCEpi: 69.2;OE19: 156.0;SK-BR-3: 183.1;T-47d: 100.7"									HPA043491	Uncertain				"Intracellular and membrane"	NA	NA		2000000		"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA043491: AB_2678510"	"unprognostic (3.47e-2)"	"unprognostic (9.73e-3)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.36e-2)"	1.9	1.9	24.6	6.3	25.1	0.0	6.0	38.0	58.5	8.0	14.3	80.7	63.4	0.3	0.4	74.3	1.9	8.9	0.7	26.5	31.5	5.3	0.1	0.7	0.1	32.4	25.2	0.1	3.1	11.9	9.5	12.8	34.6	3.1	66.0	23.4	28.5	0.8	0.1	26.7	49.4	4.0	13.8	0.0	29.6	0.2	28.6	0.1	6.2	0.0	13.3	8.4	22.0	22.2	0.3	0.9	0.8	0.0	0.2	0.0	35.3	0.0	0.0	0.1	0.1	7.8	23.8	0.0	1.0	0.0	7.2	139.8	28.4	55.8	0.1	0.8	16.0	0.0	3.0	3.8	0.0	0.1	8.6	0.0	69.2	0.0	6.9	0.0	0.0	5.9	9.1	0.0	0.0	38.2	0.1	0.2	12.0	156.0	14.9	0.0	0.0	0.8	3.0	3.7	55.4	19.5	0.9	183.1	10.9	2.3	100.7	0.0	0.0	0.1	1.8	0.2	2.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	25.1	38.0	58.5	26.5	31.5	32.4	25.2	34.6	13.8	28.6	22.2	0.1	0.0	0.5	2.6	0.1	25.1	10.4	40.5	3.4	7.5	3.8	4.1	0.4	5.7	12.7	5.5	18.8	122.4	0.4	146.4	21.5	4.0	0.0	0.9	0.0	0.5	21.0	0.0	37.6	28.0	26.1	0.5	33.1	0.5	0.0	1.1	0.0	0.0	9.4	6.7	36.5	78.3	10.2	0.0	0.7	0.0	0.0	0.1	3.6	2.8	0.0	2.2	0.0	5.0	2.4	18.6	69.9	0.0	0.1	2.0	124.6	0.9	6.0	12.2	0.0	0.0	0.7	0.0	0.0	17.5	24.7	137.9	0.6	0.0	123.7	19.9
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500259	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 1399.9"	"Cell type enriched"	"Detected in some"	16	"Intestinal goblet cells: 3524.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		77000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			1.1	0.0	0.0	109.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	739.9	909.7	1.2	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1061.8	0.0	0.0	0.5	0.0	0.0	1399.9	15.4	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	3524.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	54.8	0.0	0.0	0.0	213.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	68.3	0.1
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 439.7;breast: 420.9;lung: 398.7"	"Group enriched"	"Detected in many"	10	"Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4"	"Cancer enriched"	"Detected in all"	4	"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 18.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.8"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 85.4;SCLC-21H: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	439.7	16.2	124.1	6.1	101.0	0.3	420.9	111.7	127.4	70.2	205.2	75.9	9.2	86.1	3.0	54.4	83.1	6.5	138.3	93.8	103.3	45.5	16.9	398.7	9.6	124.5	114.0	36.4	20.7	1.5	16.9	12.5	127.8	50.2	3.6	2.0	36.0	3.5	101.6	95.9	71.0	6.4	109.2	44.8	41.4	10.5	160.7	1.8	122.5	14.9	2.2	103.7	75.9	107.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.1	0.1	0.2	1.1	0.0	0.0	0.0	0.0	85.4	0.1	0.7	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.9	0.7	0.1	0.0	0.0	53.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	7.1	0.1	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	18.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	4.6	0.2	5.8	0.0	0.1	0.1	0.0	26.9	124.1	101.0	111.7	127.4	93.8	103.3	124.5	114.0	127.8	109.2	160.7	107.4	2644.3	3.2	7.7	0.7	2.4	32.4	1.1	0.1	3.4	1.8	5.9	7.6	14.8	2.8	0.6	7.3	0.0	0.3	4.2	0.0	0.0	0.7	5.0	8.1	0.7	775.2	2.4	8.0	0.0	0.8	0.1	12.5	0.0	1.0	1.3	0.3	701.4	2.7	0.8	0.0	0.1	0.2	4.1	17.0	33.3	5.5	5.3	46.2	14.2	129.3	0.7	2.4	1.0	0.5	0.3	0.0	0.0	0.7	2.8	4.0	0.0	0.0	0.3	7.3	0.0	61.7	12.1	1.1	1.9	1.2	30.5	0.0	4.6	25.0	0.0	6.7
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 341.3;intestine: 341.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	6.7	8.0	0.4	17.6	0.4	0.2	31.2	0.5	0.6	47.3	0.4	341.0	146.7	4.8	43.9	341.3	41.3	27.4	2.7	0.4	0.4	123.8	40.2	61.8	0.8	0.6	0.5	1.5	108.5	49.0	31.1	14.2	0.6	44.5	128.6	1.1	169.2	30.0	1.5	13.1	248.9	6.2	0.5	5.7	5.2	1.9	0.6	2.4	76.7	0.0	21.2	40.5	96.3	0.9	10.8	1.1	0.2	0.3	0.0	0.6	84.1	0.3	0.3	0.0	0.0	90.2	173.2	0.1	3.2	0.4	0.4	364.9	0.1	11.2	0.0	0.1	1.9	0.1	2.4	0.0	6.5	0.1	0.8	1.5	17.3	0.0	0.6	0.0	8.1	0.1	1.0	0.3	0.1	129.8	0.1	1.2	0.6	139.6	3.4	0.2	0.0	2.5	0.1	0.0	20.4	0.4	1.1	150.2	0.0	6.6	55.0	1.3	16.8	0.2	0.6	0.7	0.2	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	0.0	0.5	0.8	1.3	0.1	0.3	0.8	0.4	0.9	0.9	1.7	0.0	0.7	0.0	0.0	0.3	0.5	0.4	0.4	0.5	0.6	0.4	0.4	0.6	0.5	0.6	0.5	0.6	0.9	4.4	112.2	55.6	0.0	7.4	2.0	295.4	316.3	66.6	0.7	200.4	102.4	0.6	240.2	550.3	321.8	8.4	281.3	3.1	1391.1	39.2	787.5	0.1	210.1	26.6	9.0	326.8	4.0	0.0	790.0	342.7	5.2	15.3	225.5	5.7	0.1	3.6	41.2	33.7	0.0	0.0	741.7	362.2	4.1	6.4	0.2	1.2	11.0	24.9	1.9	11.0	1.6	0.0	0.0	0.0	822.1	1276.4	0.0	0.5	406.5	1390.9	78.6	498.5	6.7	0.0	0.2	38.6	0.4	3.5	366.1	2.6	588.9	10.2	1.0	691.9	975.8
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216097	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 224.3;Distal enterocytes: 110.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.7	0.0	27.2	0.0	0.1	9.3	3.9	1.1	0.0	0.0	0.0	0.0	69.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.5	0.0	7.5	50.8	0.0	40.1	13.9	0.0	8.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	0.3	0.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	10.8	2.7	0.0	0.0	29.9	11.6	0.0	0.0	10.5	224.3	0.0	0.0	0.1	110.2	11.7	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.4	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	15.9	0.6	0.4	20.3	0.0	0.0	0.0	0.3	0.0	0.0	4.6	8.4	0.0	0.4	0.0	18.0	23.1
CLEC14A	C14orf27	ENSG00000176435	"C-type lectin domain containing 14A"	Q86T13	14	38254000-38256093	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Adipocytes: 396.6;Endothelial cells: 272.8;Hepatic stellate cells: 567.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 83.7;HUVEC TERT2: 451.8;TIME: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039468, HPA048119"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA		4100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum, Golgi apparatus"		"HPA039468: AB_2676524, HPA048119: AB_2680270"	"unprognostic (4.02e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.20e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.13e-6)"	"unprognostic (2.55e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.28e-2)"	67.1	9.5	13.6	7.9	13.4	0.1	50.6	13.8	15.2	24.8	10.9	15.2	10.1	31.2	7.6	11.1	22.6	19.0	65.1	11.5	13.3	15.9	9.4	55.5	6.6	15.0	13.9	9.5	7.8	10.5	6.1	25.0	15.4	14.5	7.2	0.8	13.6	9.8	33.2	15.8	18.8	19.8	13.1	16.7	13.8	3.5	14.9	4.6	31.4	43.3	4.2	19.2	16.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	451.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	13.4	13.8	15.2	11.5	13.3	15.0	13.9	15.4	13.1	14.9	15.6	396.6	0.0	3.2	0.0	0.9	3.4	0.2	0.0	1.8	0.1	1.5	2.5	6.4	1.5	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.2	0.5	272.8	0.0	0.0	0.4	0.2	0.1	31.0	0.0	0.3	1.3	0.1	567.2	2.1	0.4	0.0	0.2	0.0	0.0	6.4	3.1	1.0	0.6	1.1	5.4	15.0	0.0	0.2	0.0	4.0	2.9	0.0	0.0	0.4	1.4	0.2	0.0	0.0	0.0	0.5	0.0	14.1	7.5	1.6	0.9	0.9	3.1	0.1	1.3	6.7	0.0	0.3
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 64.7"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 10.6;Macrophages: 11.9;monocytes: 15.1"	"Cancer enriched"	"Detected in single"	50	"testis cancer: 11.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 57.1;neutrophil: 98.7"	"Group enriched"	"Detected in many"	32	"granulocytes: 98.7;monocytes: 57.1"	"Group enriched"	"Detected in some"	5	"NB-4: 2.4;NTERA-2: 9.0;SuSa: 9.1;U-937: 5.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004906	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA004906: AB_1078535"	"unprognostic (1.10e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.81e-1)"	"unprognostic (7.91e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.18e-1)"	2.3	0.2	0.0	7.3	0.1	64.7	0.2	0.0	0.2	3.1	0.3	0.1	0.1	0.1	0.5	0.4	0.7	0.4	0.3	0.0	0.0	0.2	0.5	3.1	0.6	0.1	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.1	0.1	0.6	0.4	0.0	0.1	0.0	0.2	0.8	0.0	7.0	0.2	0.2	0.4	0.3	0.1	0.7	0.3	2.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	9.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.9	57.1	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.4	0.0	0.0	0.1	98.7	0.0	1.2	0.7	0.0	12.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.6	0.8	0.0	0.0	11.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
CLEC4G	"LSECtin, UNQ431"	ENSG00000182566	"C-type lectin domain family 4 member G"	Q6UXB4	19	7728958-7733906	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.9;liver: 53.3;lymphoid tissue: 15.1"	"Cell type enriched"	"Detected in some"	15	"Hepatic stellate cells: 730.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 18.8;myeloid DC: 15.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 15.1;monocytes: 18.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003789, HPA014044"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB003789: , HPA014044: AB_1846916"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.13e-8)"	"unprognostic (5.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.65e-2)"	14.9	0.5	1.9	2.4	1.9	1.2	2.6	4.0	2.9	0.1	2.0	1.4	0.4	0.1	0.3	0.4	4.8	1.6	1.2	2.5	1.9	0.5	53.3	1.0	15.1	2.3	2.1	0.5	0.3	0.0	0.1	1.0	2.1	0.3	0.9	0.0	1.1	0.3	0.4	1.1	2.0	1.0	2.1	3.4	0.9	0.4	4.3	0.2	0.5	0.0	0.3	7.7	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	18.8	0.0	0.0	4.2	0.0	0.3	0.0	0.0	15.1	4.2	0.1	0.0	0.4	0.5	0.5	0.7	0.0	4.5	1.9	1.9	4.0	2.9	2.5	1.9	2.3	2.1	2.1	2.1	4.3	2.1	0.1	0.0	0.0	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	18.7	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	730.3	7.1	0.8	0.0	1.1	0.0	0.0	46.7	2.9	0.0	0.3	2.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.0	0.3	0.3	1.1	0.8	0.0	0.1
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 84.0;lung: 30.9;lymphoid tissue: 44.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.2;Kupffer cells: 415.2;Langerhans cells: 291.5;Macrophages: 255.5;monocytes: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 249.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"Karpas-707: 192.2;U-266/84: 168.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	9.9	5.9	2.2	44.5	2.0	84.0	4.5	2.6	3.7	3.5	3.3	7.5	5.6	3.2	3.7	9.7	5.8	11.1	5.7	1.9	3.3	3.5	11.0	30.9	14.4	5.0	2.7	2.4	2.9	2.0	2.7	7.3	4.0	3.3	7.3	1.7	7.3	3.2	1.3	3.8	8.6	8.7	3.6	34.2	4.6	1.5	3.8	10.0	2.6	2.0	11.9	9.1	4.8	6.1	0.3	0.4	0.1	0.2	0.0	0.0	1.1	0.0	0.5	0.2	0.1	0.1	0.4	0.1	0.1	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.7	0.1	0.8	0.1	0.0	0.2	0.1	0.2	0.0	192.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	5.2	0.3	0.2	0.3	0.6	0.0	1.4	0.4	0.1	0.3	0.1	0.2	0.2	0.2	11.4	168.1	0.1	0.3	1.0	0.2	1.4	122.9	2.2	0.3	137.2	0.5	0.3	0.3	0.2	60.6	0.3	0.3	0.2	249.6	0.4	148.1	1.0	0.4	40.4	2.2	2.0	2.6	3.7	1.9	3.3	5.0	2.7	4.0	3.6	3.8	6.1	2.0	12.8	15.1	0.3	5.9	3.7	0.2	0.9	8.6	0.0	3.1	2.8	0.9	0.0	9.7	0.0	0.0	1.5	2.1	0.2	0.0	0.1	1.7	0.2	0.1	9.3	0.0	0.0	0.1	0.0	14.1	2.4	0.0	0.1	6.3	0.0	6.1	2.1	87.2	0.0	0.1	0.0	4.1	415.2	291.5	2.2	0.3	255.5	3.6	27.2	186.1	0.0	8.2	0.0	0.0	0.0	1.1	0.0	1.1	0.1	0.0	1.3	2.4	0.4	13.1	1.1	1.0	0.1	0.5	13.2	3.0	5.3	4.1	0.0	0.0	0.5
CLMP	"ACAM, ASAM, FLJ22415"	ENSG00000166250	"CXADR like membrane protein"	Q9H6B4	11	123069872-123195248	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 75.7;Fibroblasts: 95.1;Inhibitory neurons: 31.9;Peritubular cells: 57.9;Skeletal myocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8;BJ: 171.8;BJ hTERT+: 160.3;fHDF/TERT166: 126.6;hTEC/SVTERT24-B: 129.1;hTERT-HME1: 155.6;U-138 MG: 232.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.63e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.46e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.02e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.78e-8)"	"unprognostic (3.88e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.69e-2)"	63.2	6.5	0.9	14.7	0.8	0.4	24.5	7.8	2.7	20.5	3.6	41.1	7.3	30.3	4.3	10.1	18.4	23.1	12.9	5.3	0.4	6.0	0.4	8.1	7.4	4.2	2.1	9.1	2.0	0.2	1.9	26.3	1.8	7.4	10.6	0.9	5.4	8.5	1.7	6.5	17.3	36.3	2.0	8.1	16.0	2.6	2.1	0.8	2.4	3.4	5.0	16.7	14.0	5.2	3.0	3.3	7.5	15.2	124.8	108.1	45.5	171.8	160.3	23.9	43.8	7.4	0.2	0.0	0.4	126.6	82.4	0.1	0.3	45.5	27.3	0.9	0.3	0.0	7.1	0.1	40.7	0.0	0.1	61.0	30.6	129.1	155.6	59.7	11.7	0.1	0.0	0.4	33.3	0.1	0.0	0.2	17.4	0.0	20.2	0.1	2.5	0.1	12.6	0.0	20.5	50.3	0.0	0.4	0.1	3.2	0.6	0.0	43.3	232.7	2.3	96.0	21.6	0.1	0.0	0.1	63.1	0.0	7.5	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.9	0.8	7.8	2.7	5.3	0.4	4.2	2.1	1.8	2.0	2.1	5.2	2.3	0.0	3.9	2.0	0.2	1.5	0.3	2.4	0.0	3.8	1.2	14.6	5.1	0.0	0.4	0.0	0.0	9.8	0.3	0.1	0.0	1.9	0.7	2.4	75.7	1.4	6.7	0.0	26.5	1.3	20.4	95.1	0.0	1.4	0.0	5.3	2.2	0.0	3.6	1.7	31.9	0.5	0.0	0.0	1.9	0.7	20.8	0.9	0.0	4.7	0.0	0.5	0.0	1.0	3.6	0.9	0.0	57.9	0.6	2.0	0.1	0.1	0.2	1.1	0.0	65.0	8.5	0.1	0.1	0.4	1.0	10.4	1.1	2.2	0.3	0.5
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892941	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 89.0;kidney: 43.9;liver: 79.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.3;renal cancer: 30.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"OE19: 96.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA014482	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.6	0.1	0.4	5.6	0.4	0.0	0.3	0.3	0.5	0.0	0.3	71.1	73.4	0.1	0.0	0.0	0.0	15.2	0.0	0.4	0.3	43.9	79.9	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.2	0.0	0.4	0.0	70.3	0.0	0.0	0.2	0.0	0.0	89.0	1.7	0.3	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	96.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	102.0	15.6	0.4	0.0	0.2	0.0	0.1	41.5	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	43.0	0.0	0.0	0.1	75.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	95.9	0.0	0.0	0.0	155.4	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.6	0.0
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769978	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.3;lymphoid tissue: 7.9;retina: 6.8;testis: 5.7"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 101.0;Spermatocytes: 281.1;Spermatogonia: 263.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low region specificity"	"Detected in many"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	0.5	0.2	0.7	3.2	0.6	11.3	0.5	0.6	1.4	0.2	0.4	1.4	1.0	0.4	0.7	0.9	0.2	0.3	0.1	1.3	0.3	0.2	0.5	0.4	4.9	0.4	0.4	0.1	0.1	0.2	0.0	1.5	0.6	0.2	2.0	6.8	0.2	0.1	0.6	1.2	1.0	0.9	0.2	1.3	0.9	5.7	0.6	7.9	0.2	0.0	5.2	0.6	0.4	0.9	22.0	17.5	37.8	19.9	2.6	4.8	14.1	43.6	12.0	31.0	41.3	27.9	19.6	45.7	13.9	11.8	22.7	21.4	37.1	14.9	48.1	31.6	16.8	64.5	38.1	12.6	0.1	54.0	36.8	1.0	0.6	53.8	3.7	3.7	16.9	27.1	44.2	30.8	30.3	14.1	56.9	13.1	36.0	14.9	12.2	36.0	57.0	13.8	6.4	35.3	14.0	16.2	37.7	11.6	7.4	25.6	10.0	21.1	12.5	44.6	33.8	27.6	49.3	11.1	29.1	47.1	14.1	37.4	37.0	1.1	0.3	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.2	1.0	0.5	0.2	0.2	0.3	0.3	0.7	0.6	0.6	1.4	1.3	0.3	0.4	0.4	0.6	0.2	0.6	0.9	2.6	0.0	0.5	0.3	6.5	5.6	5.7	4.4	1.2	9.4	2.9	3.8	1.4	2.8	2.7	0.0	12.5	19.7	4.6	12.8	0.0	1.6	7.9	1.0	3.6	3.6	1.2	55.6	1.6	0.6	41.1	5.2	4.6	3.3	1.3	12.0	2.2	0.4	16.9	1.7	1.5	9.4	2.0	3.0	8.2	6.1	2.5	5.8	3.6	0.0	9.1	9.4	4.1	0.0	0.6	1.4	9.5	0.4	32.5	1.8	0.4	0.2	0.0	101.0	6.6	5.3	8.7	281.1	263.3	5.8	2.0	10.4	7.2	1.2	12.0	3.9
CLSTN3	"CDHR14, CSTN3, KIAA0726"	ENSG00000139182	"Calsyntenin 3"	Q9BQT9	12	7129698-7158945	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 161.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 79.4;Inhibitory neurons: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		1700000	"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"				"prognostic favorable (5.08e-4)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.73e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (2.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (8.07e-4)"	12.9	14.5	23.1	13.6	20.8	12.4	13.3	18.6	42.7	13.4	0.0	8.3	6.8	11.0	2.7	6.8	11.7	10.1	7.0	21.1	33.9	21.2	29.2	12.7	14.3	13.5	7.7	25.4	10.4	11.2	30.3	3.7	24.8	9.6	3.9	20.2	11.0	4.4	2.5	10.5	14.2	7.3	0.7	20.7	7.5	4.3	22.3	10.2	12.4	1.6	9.0	9.9	9.6	14.0	6.7	11.2	4.3	10.3	4.7	5.2	30.1	3.9	9.4	7.1	12.1	18.3	10.1	12.1	2.9	6.0	9.1	8.4	6.7	8.0	3.5	10.9	7.5	19.2	19.9	18.6	5.9	2.7	34.6	15.2	5.9	8.5	7.4	30.6	9.1	11.2	19.0	6.6	1.3	2.4	8.3	2.8	12.6	0.6	0.7	5.3	0.1	3.5	10.7	13.8	5.6	9.2	8.4	9.5	1.7	10.4	5.4	7.0	4.6	3.9	13.6	8.6	2.4	8.7	2.2	1.6	7.6	3.2	2.8	1.5	0.0	0.0	3.3	0.0	1.9	0.1	1.5	2.9	0.1	0.1	0.5	1.2	0.2	6.9	0.0	0.0	2.0	1.0	23.1	20.8	18.6	42.7	21.1	33.9	13.5	7.7	24.8	0.7	22.3	14.0	6.0	0.0	3.9	5.2	2.8	4.1	2.3	4.9	7.4	161.2	15.7	7.5	2.3	4.3	3.3	14.7	62.6	5.4	14.1	2.9	0.0	9.2	1.2	3.3	18.0	15.3	29.3	1.3	79.4	7.5	9.3	12.0	7.7	6.3	5.7	8.6	5.7	26.6	1.2	26.9	60.2	4.0	16.2	2.0	7.3	1.9	12.8	3.6	5.4	4.7	1.1	9.5	13.4	10.6	3.1	7.2	3.2	6.4	12.7	1.9	1.3	23.3	3.0	40.3	6.6	5.1	6.8	0.7	1.1	2.7	5.7	3.3	16.6	6.8	3.6	1.8
CLVS1	"C6orf212L, CRALBPL, MGC34646, RLBP1L1"	ENSG00000177182	"Clavesin 1"	Q8IUQ0	8	61057158-61501645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 5.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 113.1;Inhibitory neurons: 158.1;Oligodendrocyte precursor cells: 90.0;Oligodendrocytes: 37.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;SCLC-21H: 3.7;SH-SY5Y: 1.6;U-266/70: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076650	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076650: "	"unprognostic (1.86e-2)"	"unprognostic (3.09e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.96e-7)"	"unprognostic (1.11e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.02e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.25e-3)"	"unprognostic (2.94e-1)"	"unprognostic (5.79e-8)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-2)"	1.5	0.4	5.1	0.3	5.6	0.2	0.5	9.9	8.0	0.2	0.0	0.2	0.1	0.0	0.1	1.5	0.5	0.3	0.3	4.9	6.5	0.2	0.6	0.1	0.5	3.8	2.1	0.1	0.1	0.0	2.4	0.1	4.0	0.2	0.1	5.2	1.2	0.0	0.5	1.5	0.2	0.0	2.0	0.4	0.2	2.0	3.8	0.7	1.2	0.0	0.9	0.1	0.3	4.3	0.2	0.4	0.1	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.4	0.8	0.2	0.2	1.2	1.0	0.1	0.4	0.0	3.7	1.6	0.1	0.2	0.0	0.2	0.2	0.5	0.3	0.1	0.2	0.1	0.1	1.6	0.8	0.2	0.9	0.0	0.0	1.1	0.3	0.2	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.5	0.2	0.3	0.8	0.5	0.1	0.3	0.0	0.3	5.1	5.6	9.9	8.0	4.9	6.5	3.8	2.1	4.0	2.0	3.8	4.3	6.1	6.4	0.5	9.8	0.3	0.0	0.1	0.1	0.0	2.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.4	0.0	0.0	113.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	158.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	19.7	0.0	11.2	0.0	90.0	37.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.0	1.8	0.0	1.0	0.2	0.4	0.6	0.3	0.1	0.8	0.0	0.0	0.0	0.2
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNIH2	"CNIH-2, Cnil, MGC50896"	ENSG00000174871	"Cornichon family AMPA receptor auxiliary protein 2"	Q6PI25	11	66278175-66285301	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 270.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.84e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.95e-8)"	"unprognostic (3.53e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.55e-2)"	0.4	3.3	88.4	0.2	74.6	1.6	0.3	28.8	270.1	0.6	11.0	1.0	0.6	0.4	0.0	0.8	0.6	0.2	0.3	234.9	61.3	0.5	0.4	0.7	0.1	28.3	37.1	0.4	3.4	0.1	45.9	0.5	34.5	0.5	0.2	1.1	0.3	0.0	0.1	1.4	0.6	0.2	30.3	0.6	1.0	5.1	53.4	1.3	0.4	0.0	0.0	0.3	0.5	47.5	0.4	0.8	15.8	13.9	0.2	0.3	2.0	1.0	1.1	2.0	0.1	0.4	0.0	0.1	0.3	0.2	0.9	0.2	3.6	0.0	0.3	1.5	1.4	0.0	0.5	0.0	0.0	0.1	1.1	0.0	0.3	0.1	0.0	0.3	0.0	1.6	0.2	2.1	0.9	13.9	2.1	0.3	15.1	0.0	1.0	6.8	0.0	0.1	0.1	0.8	61.5	28.5	0.1	7.6	0.6	0.7	13.3	0.2	0.0	1.8	0.7	0.5	0.6	0.3	0.4	0.6	4.2	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	74.6	28.8	270.1	234.9	61.3	28.3	37.1	34.5	30.3	53.4	47.5	0.8	0.0	0.5	2.9	0.2	0.6	0.3	1.4	0.6	2.3	1.6	1.3	0.7	1.5	0.8	0.0	0.0	1.4	0.7	0.1	0.0	0.2	75.7	5.7	0.6	0.4	49.6	0.0	17.7	0.2	1.6	0.7	2.0	0.6	0.0	0.5	0.4	0.1	0.2	16.8	11.7	1.5	0.0	0.0	0.3	28.1	0.6	0.4	0.0	1.9	0.1	0.7	0.0	1.5	2.7	0.6	0.1	0.4	0.9	0.3	0.2	0.2	6.8	2.6	0.0	0.9	0.7	6.0	0.9	0.6	0.4	1.2	1.4	0.1	0.4	0.3
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538767-11550323	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 1872.4;intestine: 2657.3;smooth muscle: 2207.8"	"Group enriched"	"Detected in many"	5	"Breast myoepithelial cells: 191.0;Early spermatids: 335.0;Late spermatids: 554.6;Peritubular cells: 221.2;Smooth muscle cells: 180.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1;stomach cancer: 103.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 91.5;BJ hTERT+: 34.9;BJ hTERT+ SV40 Large T+: 48.0;BJ hTERT+ SV40 Large T+ RasG12V: 64.6;HBF TERT88: 71.2;K-562: 35.8;SuSa: 72.5;U-2 OS: 34.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"		No	No				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Actin filaments"		"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	115.6	58.4	6.4	160.6	8.3	0.0	89.7	5.7	14.2	366.9	7.5	2657.3	136.3	1872.4	177.0	677.5	655.6	234.3	274.1	6.8	8.5	42.9	10.6	98.7	7.3	6.1	6.8	114.1	24.2	3.0	9.0	28.4	6.3	676.0	326.4	0.7	61.6	1585.7	21.8	57.8	431.3	2207.8	6.1	22.1	673.7	91.4	7.5	2.6	38.5	11.7	0.9	1386.6	305.7	6.3	0.1	1.3	5.9	1.0	0.6	0.2	3.2	91.5	34.9	48.0	64.6	27.9	0.0	0.4	2.7	26.1	4.4	0.3	0.0	0.0	71.2	0.0	0.2	0.1	0.1	2.3	2.5	0.0	0.4	3.0	0.1	28.7	0.1	1.6	0.0	0.0	35.8	0.0	0.0	0.0	0.3	3.8	2.9	0.0	0.7	0.2	0.6	3.8	0.0	0.0	0.1	1.3	0.1	0.2	0.2	72.5	0.1	0.1	0.4	0.4	34.6	1.2	1.2	0.1	0.4	0.1	3.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	6.4	8.3	5.7	14.2	6.8	8.5	6.1	6.8	6.3	6.1	7.5	6.3	2.4	0.0	0.0	0.0	0.2	4.8	4.1	1.6	0.6	0.0	4.2	191.0	51.4	0.0	0.3	1.8	0.0	0.8	0.7	0.0	0.0	14.5	335.0	3.1	20.7	2.4	0.0	0.0	0.5	0.4	1.0	21.5	0.5	0.7	0.0	0.5	6.8	0.0	2.3	0.0	0.3	0.0	0.0	0.0	9.4	554.6	8.4	0.9	3.6	2.8	0.6	0.5	0.0	0.0	0.1	0.9	0.0	221.2	0.0	4.0	0.0	0.4	0.4	0.0	39.5	1.1	180.9	8.3	19.5	0.4	7.1	0.7	1.1	0.7	0.0	1.1
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020949-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7;placenta: 2.6;salivary gland: 2.0;thyroid gland: 2.0"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 968.9;Inhibitory neurons: 2295.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039492, HPA041223"	Approved				"Intracellular and membrane"	NA	NA		480000		"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	4.7	1.1	0.3	0.0	0.1	0.0	0.0	1.3	0.0	0.2	0.2	0.5	2.6	0.5	0.0	0.0	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	4.1	4.7	1.1	0.0	1.3	0.5	0.0	2.9	0.1	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.5	3.5	0.1	0.0	0.0	0.0	968.9	0.0	0.2	1.1	0.0	0.4	0.0	0.0	1.1	0.0	0.2	0.0	2295.2	0.0	2.0	0.0	0.0	0.4	0.9	0.0	0.0	42.2	0.0	0.1	0.0	112.1	23.2	0.1	0.0	1.9	0.0	0.0	0.0	0.2	12.5	0.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;retina: 14.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 3383.0;Inhibitory neurons: 6845.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	25	"B-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"AF22: 8.0;CACO-2: 6.7;NTERA-2: 12.0;SCLC-21H: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.2	0.8	10.0	0.2	13.8	0.0	0.6	1.4	20.7	0.1	0.0	0.8	0.0	0.0	0.0	0.4	0.6	0.0	0.2	5.6	5.7	0.1	1.9	0.0	0.4	5.7	0.5	1.1	0.2	0.3	3.8	0.5	3.8	4.1	0.4	14.4	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.4	0.2	0.5	1.8	3.7	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	8.0	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.0	0.2	0.0	2.0	1.7	0.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.0	1.4	0.0	0.0	0.0	2.2	0.0	0.0	21.5	1.4	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.0	13.8	1.4	20.7	5.6	5.7	5.7	0.5	3.8	0.0	1.8	0.0	0.1	0.0	0.0	65.6	9.3	0.1	0.3	15.5	1.8	33.9	0.3	0.0	1.2	7.2	4.1	0.0	2.1	40.8	0.0	1.8	0.0	1.4	7.2	0.6	0.0	0.6	2.4	0.0	3383.0	0.7	6.8	1.1	0.5	0.7	0.0	0.2	0.0	8.9	3.3	1031.4	6845.7	3.9	0.0	0.6	2.0	2.7	1.2	0.4	0.0	180.8	0.2	8.2	1.0	429.3	914.7	4.1	2.1	0.0	0.3	7.4	4.7	0.5	0.9	16.7	0.0	0.0	0.9	2.4	12.0	9.1	0.0	6.3	0.0	1.2	6.8	0.2
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein family member 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 7.9"	"Group enriched"	"Detected in some"	49	"Excitatory neurons: 554.6;Inhibitory neurons: 906.4;Oligodendrocyte precursor cells: 760.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;SH-SY5Y: 2.6"					"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: AB_2686083, HPA069356: AB_2686127"				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.0	0.5	2.4	0.0	0.6	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	4.3	5.1	0.1	0.0	0.0	0.0	6.8	6.3	0.0	0.1	0.0	0.0	0.0	7.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	7.9	4.3	5.1	6.8	6.3	7.3	0.0	7.2	0.8	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.1	0.0	0.0	554.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	906.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.4	0.0	1.0	0.0	760.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.2;skeletal muscle: 131.6;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	14	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	3.0	1.0	83.8	1.4	96.7	0.0	14.8	62.0	91.1	4.8	41.6	13.3	18.9	2.2	2.1	13.6	19.1	5.8	54.8	81.8	67.9	12.9	19.6	13.8	0.2	76.6	88.3	2.8	18.4	31.5	12.8	4.7	69.2	14.4	10.9	23.3	47.3	4.2	131.6	27.5	21.5	2.7	66.6	0.3	17.6	3.0	89.8	1.3	8.3	107.9	1.0	1.8	5.8	118.2	12.4	8.8	0.2	0.3	0.0	0.0	33.7	0.0	0.0	0.0	0.0	24.1	18.2	0.0	0.9	0.0	1.4	21.1	12.0	0.0	0.0	0.0	9.6	0.0	57.0	4.7	0.0	0.0	0.1	1.5	2.3	0.0	0.0	0.0	0.0	1.6	6.5	0.2	0.2	7.9	0.1	0.1	9.0	53.4	8.0	0.1	0.5	45.5	17.4	0.0	11.0	0.2	3.2	26.2	3.9	32.6	16.6	0.1	0.0	0.0	9.8	0.3	0.9	0.0	34.1	0.1	0.1	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	83.8	96.7	62.0	91.1	81.8	67.9	76.6	88.3	69.2	66.6	89.8	118.2	1.4	38.5	19.6	48.0	1.0	17.8	3.4	1.2	4.0	2.3	38.0	34.7	76.2	28.6	13.2	9.2	58.4	23.3	4.6	59.4	0.0	21.5	3.8	65.9	3.3	2.2	18.6	0.0	198.7	9.7	9.2	7.7	35.7	74.6	10.1	4.6	0.4	29.7	2.2	0.0	96.6	35.2	4.1	0.8	1.7	3.1	0.6	0.9	16.0	10.3	1.1	94.4	0.0	353.9	548.8	23.2	35.0	0.4	0.2	25.3	76.8	18.6	31.4	73.6	0.0	10.5	1.5	0.7	8.8	6.8	35.7	40.2	1.7	11.2	14.4	7.3
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120373573	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 205.8"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 75.1;Endometrial stromal cells: 97.0;Fibroblasts: 235.9;Smooth muscle cells: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 54.4;hTERT-RPE1: 29.7;RH-30: 123.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		3200000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	69.0	16.2	1.6	42.2	1.9	0.3	58.8	1.5	2.4	205.8	2.9	39.8	7.7	78.2	35.2	50.2	46.2	142.2	45.4	1.5	2.0	32.1	19.5	27.7	12.8	3.4	2.2	83.2	15.7	6.0	4.0	152.7	2.7	43.8	53.9	0.6	13.5	24.9	7.0	13.3	35.3	147.6	3.1	28.4	25.6	5.5	2.4	5.3	43.2	36.1	16.5	108.5	93.0	3.0	0.0	0.0	0.9	0.0	5.4	54.4	0.1	0.1	6.7	0.2	0.1	0.0	0.0	0.6	1.8	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	1.8	0.0	13.2	0.2	0.2	14.4	0.3	2.6	0.0	29.7	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.4	4.2	0.0	0.0	0.0	123.4	0.2	4.8	0.0	0.5	0.2	0.1	0.1	0.1	3.2	0.0	0.1	0.0	1.3	0.3	0.2	2.9	0.4	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.5	2.4	1.5	2.0	3.4	2.2	2.7	3.1	2.4	3.0	8.0	0.0	1.1	0.0	0.1	11.3	0.4	2.1	75.1	0.1	1.8	25.3	13.2	0.0	4.3	1.8	0.0	34.4	0.3	0.0	0.0	0.0	1.0	6.9	97.0	7.8	0.0	0.0	5.6	0.0	4.0	235.9	6.1	11.3	3.8	0.2	18.5	0.0	6.2	0.0	5.2	0.0	0.0	0.0	18.5	1.4	14.6	1.7	5.4	5.6	0.0	0.1	0.0	1.0	3.3	0.0	0.0	15.4	0.5	0.6	0.0	0.0	0.1	0.5	0.0	4.2	118.2	4.4	2.8	3.9	9.7	25.3	2.7	4.5	0.0	0.3
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104085880	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 580.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 585.7;Basal respiratory cells: 136.0;Basal squamous epithelial cells: 299.9;Distal enterocytes: 211.5;Proximal enterocytes: 108.5;Suprabasal keratinocytes: 139.4"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 227.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 204.3;HaCaT: 463.8;HBEC3-KT: 745.8;hTCEpi: 914.1;hTERT-HME1: 783.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	1.5	0.4	0.8	6.6	1.1	12.2	37.3	1.0	1.4	50.1	0.6	37.4	10.7	0.6	6.6	116.6	1.1	0.3	0.5	0.5	0.6	0.3	0.3	0.9	0.1	0.6	0.7	0.2	0.4	0.0	1.2	35.4	0.6	17.9	27.3	0.0	82.2	9.6	0.5	580.3	37.2	1.0	0.5	2.3	19.8	25.4	0.6	42.7	5.1	0.0	19.8	9.9	102.0	0.8	26.3	0.4	1.5	0.2	0.1	0.0	80.6	0.5	0.3	0.1	0.2	0.3	204.3	0.0	5.1	0.3	3.9	463.8	0.7	745.8	0.7	0.0	0.7	0.0	0.3	0.2	0.1	0.0	0.4	0.7	914.1	0.5	783.7	0.2	3.5	0.1	0.1	0.9	0.0	0.0	0.0	0.3	1.7	5.1	2.6	0.0	0.0	0.3	35.9	26.4	0.2	0.3	0.0	0.2	0.9	4.0	0.2	0.0	1.5	0.5	5.0	0.3	5.5	0.1	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	1.0	1.4	0.5	0.6	0.6	0.7	0.6	0.5	0.6	0.8	1.0	0.0	1.1	0.7	0.3	585.7	17.7	136.0	299.9	0.6	1.7	85.5	1.1	0.0	16.5	0.0	0.0	10.2	0.3	211.5	0.0	0.8	14.2	23.7	2.3	3.7	2.4	0.0	0.1	0.9	18.9	2.4	23.0	8.1	0.0	0.1	0.0	0.0	1.3	0.0	0.2	5.7	6.1	0.0	28.9	3.6	0.3	0.7	33.8	0.0	0.0	0.4	0.0	0.0	0.4	78.8	35.7	0.7	1.4	16.6	108.5	0.1	5.9	0.4	0.0	0.4	3.0	22.7	1.5	31.9	139.4	5.6	1.3	0.1	21.6	10.7
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914041	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 39.6;Excitatory neurons: 13.0;Late spermatids: 33.7;Muller glia cells: 25.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;RT4: 12.2;SCLC-21H: 8.1;U-2 OS: 6.8"					"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	7.6	0.6	0.6	1.0	0.0	0.0	2.9	0.5	0.8	0.4	1.0	0.3	1.9	0.2	0.1	0.4	0.3	0.2	0.3	1.4	1.9	0.0	0.0	0.5	2.9	1.2	0.2	0.1	1.4	44.0	0.0	0.6	3.0	0.1	5.2	0.9	2.4	0.7	0.0	0.4	1.6	4.3	0.2	2.2	1.1	2.0	2.1	0.2	1.1	1.2	0.9	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	2.9	0.5	0.3	1.4	2.9	1.2	0.6	4.3	2.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	3.7	2.5	0.0	0.3	0.2	0.3	1.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	39.6	0.1	0.2	0.8	0.0	0.0	13.0	0.2	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.0	5.9	0.0	0.8	0.0	8.2	0.0	0.0	33.7	0.3	0.3	0.0	1.0	0.6	25.5	0.0	0.5	0.3	3.0	0.0	0.0	0.0	4.8	0.0	0.1	0.2	1.6	0.0	0.1	0.3	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.1	1.9
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155537-114312511	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 93.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 60.1;Extravillous trophoblasts: 75.5;Gastric mucus-secreting cells: 43.8;Hepatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;Hep G2: 48.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in all"	19	"cerebellum: 71.0"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	9.2	8.7	4.0	3.5	3.4	0.3	9.1	29.6	4.8	93.7	3.0	11.2	3.9	39.7	16.1	8.1	16.7	7.9	10.9	3.6	4.7	33.1	42.7	7.0	3.1	7.0	7.9	27.6	21.2	1.0	4.1	11.7	6.5	22.5	1.4	1.5	5.4	13.7	5.8	15.7	6.9	10.5	4.9	4.7	11.9	6.4	6.4	9.2	13.5	2.8	2.2	8.1	37.7	4.3	3.8	7.8	17.9	6.6	1.3	1.9	54.8	8.7	5.9	6.3	5.2	8.1	0.2	0.0	2.1	4.3	4.7	9.2	6.2	8.1	3.4	0.0	0.7	0.0	7.5	48.7	1.9	0.0	19.8	4.9	2.3	7.6	3.4	3.6	9.4	7.4	0.0	1.9	3.6	1.8	0.1	3.5	6.5	15.1	2.1	25.9	18.1	3.7	14.6	4.2	0.3	0.2	0.4	0.2	1.1	6.8	1.6	5.8	8.9	5.5	11.1	0.7	13.9	1.0	0.0	0.0	4.5	0.1	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	3.4	29.6	4.8	3.6	4.7	7.0	7.9	6.5	4.9	6.4	4.3	2.9	3.2	23.0	15.0	0.8	27.1	4.9	14.2	18.2	1.2	24.3	22.1	34.4	60.1	6.1	9.2	6.2	1.0	2.0	0.5	3.9	12.8	3.7	3.3	25.3	7.1	4.8	0.0	11.0	5.1	75.5	15.0	43.8	11.5	0.0	6.9	3.6	43.6	6.5	1.7	4.6	1.8	0.0	1.0	4.1	1.6	19.3	0.8	23.2	8.4	0.1	5.6	0.0	25.6	0.8	4.7	2.5	4.5	0.4	10.6	0.3	9.8	0.6	1.4	26.3	4.9	40.1	0.5	2.0	5.8	22.4	2.3	1.4	23.8	2.4	3.2
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513209	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 474.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 313.6;Endometrial stromal cells: 308.3;Endothelial cells: 278.2;Extravillous trophoblasts: 512.9;Granulosa cells: 223.8;Sertoli cells: 374.7;Smooth muscle cells: 338.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1041.3;WM-115: 428.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		2700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	240.5	51.2	15.1	103.5	2.3	0.6	153.5	1.7	5.9	111.6	3.4	282.0	29.5	219.4	10.4	51.8	122.9	84.2	113.0	19.3	1.8	71.7	19.1	181.7	22.8	4.3	7.8	51.9	32.6	25.6	17.5	474.0	6.0	121.3	18.9	2.8	35.0	95.8	44.7	45.2	84.1	226.8	2.6	121.5	96.4	15.7	11.5	7.9	74.9	21.5	7.1	186.2	74.4	2.9	88.9	45.7	218.7	0.6	213.7	99.0	312.8	307.9	97.4	167.3	76.1	2.5	0.7	0.6	1041.3	60.0	75.0	85.4	0.1	82.4	27.3	28.1	46.3	0.2	76.6	0.7	150.5	0.5	1.0	42.8	4.5	114.8	71.2	193.5	158.5	0.0	1.3	0.9	25.4	0.3	0.3	12.1	34.2	0.8	11.7	0.6	87.8	0.4	125.6	0.0	6.4	35.4	0.3	0.9	81.2	84.7	0.6	6.7	327.7	94.9	237.9	2.3	161.9	0.6	3.0	7.4	5.8	0.4	428.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	2.3	1.7	5.9	19.3	1.8	4.3	7.8	6.0	2.6	11.5	2.9	313.6	83.3	5.8	17.9	2.9	9.6	8.0	16.3	1.8	2.4	7.0	56.8	31.8	20.0	1.8	53.3	0.0	77.4	0.1	10.0	1.9	39.0	1.7	19.4	308.3	278.2	0.0	8.0	17.7	4.4	512.9	159.1	5.6	50.1	1.3	223.8	102.1	1.8	30.9	0.0	44.0	7.0	2.0	3.3	13.3	3.4	60.6	3.8	39.2	46.9	2.0	7.3	0.0	5.5	1.1	2.8	1.4	176.0	1.5	12.3	23.9	32.7	2.1	0.3	374.7	64.7	338.9	0.9	8.5	0.7	7.0	67.2	3.6	49.4	5.4	2.4
COL9A3	"DJ885L7.4.1, EDM3, FLJ90759, IDD, MED"	ENSG00000092758	"Collagen type IX alpha 3 chain"	Q14050	20	62816244-62841159	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.7;choroid plexus: 34.4;thyroid gland: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8"					"Low region specificity"	"Detected in all"			"HPA040125, HPA058323"	Supported		Approved	"Nucleoplasm,Intermediate filaments"	"Secreted to extracellular matrix"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Intermediate filaments"	"HPA040125: AB_10805604, HPA058323: AB_2683679"	"unprognostic (1.14e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.67e-1)"	1.6	1.5	17.5	0.7	35.7	0.0	2.8	22.4	21.6	3.3	34.4	12.1	0.7	1.2	0.2	1.3	1.7	0.1	6.3	13.0	16.5	2.9	0.6	0.4	0.2	37.4	31.0	1.7	7.6	0.1	14.0	0.5	24.2	3.2	0.1	1.6	23.6	1.2	0.5	1.9	3.1	0.1	20.5	0.3	2.7	20.7	31.6	0.1	25.4	0.0	0.0	2.8	3.8	39.7	0.2	0.3	0.3	0.2	0.0	0.8	143.4	0.1	0.0	0.1	0.0	1.6	0.2	0.0	13.1	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.9	0.0	8.2	59.6	0.3	0.0	0.5	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.3	0.0	0.0	1.0	0.7	6.4	8.2	0.0	2.5	0.0	1.8	0.0	0.1	0.0	1.5	0.2	0.1	51.1	4.6	0.2	5.4	0.0	0.0	0.7	0.1	1.0	0.2	0.1	0.0	0.2	0.0	57.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	35.7	22.4	21.6	13.0	16.5	37.4	31.0	24.2	20.5	31.6	39.7	1.6	3.2	0.0	1.0	26.1	3.2	2.2	1.2	1.8	0.9	2.1	2.5	1.6	0.0	0.2	5.5	10.4	5.1	0.4	0.7	1.9	3.6	116.6	2.7	0.4	3.7	4.2	1.3	2.5	0.0	46.4	15.3	6.1	0.7	0.0	0.6	2.5	6.8	2.2	0.0	2.0	3.3	0.0	2.2	0.9	401.9	4.1	1.7	3.6	0.0	0.5	95.8	0.0	84.9	68.9	0.1	7.3	1.5	44.0	1.2	2.3	23.7	2.5	3.7	0.0	0.8	1.0	2.9	7.8	0.9	7.0	4.0	1.4	3.7	2.0	1.0
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 568.8;lymphoid tissue: 583.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 523.9;dendritic cells: 588.7;Hofbauer cells: 494.4;Kupffer cells: 395.8;Macrophages: 342.7;monocytes: 583.7;NK-cells: 968.1;T-cells: 663.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 924.0;HL-60: 645.7;HMC-1: 1086.7;JURKAT: 603.0;MOLT-4: 632.5;NB-4: 771.8;RPMI-8226: 980.9;U-698: 618.2;U-937: 829.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		45000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	29.1	20.8	34.4	306.4	37.1	568.8	11.2	24.9	52.0	10.6	23.6	26.8	44.3	10.0	3.1	22.5	17.9	45.0	11.3	36.9	31.9	11.5	13.1	49.5	583.8	37.6	32.0	6.4	8.4	4.3	9.3	18.4	32.2	11.4	15.3	0.9	32.9	7.3	6.7	17.6	111.0	22.2	35.8	321.4	49.0	4.8	33.9	257.6	12.7	8.8	309.1	57.6	10.4	50.0	3.1	3.6	10.9	21.5	0.1	0.1	6.1	2.6	0.7	5.4	3.0	0.7	6.9	924.0	6.1	0.9	1.5	4.4	5.2	10.8	1.3	302.3	2.5	97.9	0.5	15.0	1.7	645.7	1086.7	2.8	0.0	4.3	0.5	0.4	2.0	603.0	1.5	467.6	3.4	80.7	632.5	771.8	4.0	3.1	6.4	340.0	17.5	980.9	1.3	5.1	17.3	13.0	2.2	110.7	2.0	0.2	1.9	373.0	1.6	4.0	9.0	2.7	3.1	348.5	497.7	618.2	3.0	829.6	6.3	797.2	773.6	2671.1	637.5	859.7	597.8	505.5	567.3	625.6	843.2	512.0	537.1	566.2	1318.9	531.0	898.0	482.1	858.7	1647.2	34.4	37.1	24.9	52.0	36.9	31.9	37.6	32.0	32.2	35.8	33.9	50.0	6.3	22.4	32.5	0.3	523.9	11.3	1.2	3.2	2.2	1.2	4.7	5.5	1.5	17.2	6.0	1.8	0.0	4.6	588.7	2.3	0.0	3.5	0.5	1.1	2.0	12.3	6.0	60.2	3.3	0.9	17.4	9.5	18.8	1.3	83.7	0.6	21.8	4.8	494.4	0.0	1.7	2.2	6.1	395.8	197.9	1.2	0.6	342.7	32.0	4.7	583.7	0.8	968.1	1.5	0.4	11.1	47.5	0.0	201.4	0.8	1.0	4.8	3.5	0.9	6.6	2.9	5.1	0.1	0.9	2.4	9.1	4.9	663.0	2.7	3.3	0.9
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 301.4;Paneth cells: 324.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 221.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		960000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	54.4	56.4	20.2	29.7	23.8	20.3	53.4	23.4	27.0	55.7	21.1	70.2	62.9	72.8	14.6	80.2	54.2	44.1	26.1	19.4	22.7	48.2	47.2	53.7	41.9	28.0	23.6	42.7	52.5	24.6	35.1	31.2	25.1	71.0	34.5	6.6	73.2	39.6	13.0	42.4	62.3	36.7	24.2	66.0	77.1	13.9	25.1	21.1	55.8	9.9	18.4	58.3	53.5	26.3	80.9	81.4	37.5	76.0	94.1	81.3	56.6	58.5	118.0	94.2	70.8	134.1	116.0	6.4	111.3	80.8	95.8	67.9	41.9	74.9	16.8	19.4	40.7	54.9	47.3	57.9	148.1	2.3	120.8	110.6	66.3	80.1	37.2	59.7	120.7	49.4	42.7	9.2	54.2	238.4	14.4	11.2	47.7	198.2	73.4	11.2	41.0	14.9	62.6	104.3	40.7	50.8	52.4	139.6	181.6	26.0	178.5	63.0	92.2	63.4	47.4	87.4	35.2	1.6	3.3	14.6	103.4	8.2	66.4	57.3	102.8	8.0	10.9	212.9	8.3	20.0	37.6	14.6	79.0	11.0	21.2	11.4	47.8	11.9	221.8	60.8	55.2	57.8	20.2	23.8	23.4	27.0	19.4	22.7	28.0	23.6	25.1	24.2	25.1	26.3	58.7	3.2	2.2	4.6	53.4	27.9	60.1	90.8	40.9	13.0	53.8	39.0	1.6	50.1	66.4	47.8	8.4	87.8	39.2	301.4	60.7	111.4	8.9	43.6	32.9	52.0	99.0	19.8	1.8	105.0	229.8	35.8	111.1	64.8	28.0	46.7	47.8	22.4	251.8	15.2	2.4	188.6	81.4	138.6	66.4	5.0	39.4	96.3	71.2	10.3	195.3	30.0	41.2	4.5	6.8	136.9	324.9	34.6	64.3	55.6	263.5	84.0	41.2	14.6	52.6	22.1	55.1	8.1	6.6	47.6	31.0	150.5	100.3	54.8	128.0	74.5
CORO1C	"coronin-3, HCRNN4"	ENSG00000110880	"Coronin 1C"	Q9ULV4	12	108645109-108731526	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041737	Approved					NA	NA		13000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA041737: AB_10804115"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (2.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.90e-3)"	68.5	30.6	36.1	49.7	36.1	52.5	36.6	28.1	36.8	49.9	22.1	116.6	28.9	96.1	24.1	67.7	55.9	54.4	33.7	41.3	39.1	25.8	49.1	76.4	31.6	43.9	37.1	30.4	13.0	36.4	22.0	48.2	39.0	35.8	53.3	10.5	24.6	67.3	30.0	52.1	42.9	142.9	38.3	26.1	45.0	22.5	40.8	47.4	14.2	23.6	33.6	71.5	44.7	53.4	188.2	207.2	274.3	140.8	137.3	186.5	117.3	347.8	372.0	443.2	353.6	245.8	81.5	10.6	88.8	547.9	173.2	85.4	153.3	255.1	558.1	82.8	71.4	313.8	95.3	192.7	123.8	76.6	154.1	173.7	120.3	501.0	376.9	262.3	234.1	51.8	157.0	101.0	473.6	68.4	34.7	90.5	70.5	68.7	197.9	53.3	158.6	121.9	176.0	122.5	75.0	66.3	115.6	16.0	156.6	173.0	83.0	58.0	263.7	316.1	165.1	297.7	296.8	99.4	245.7	232.8	246.3	64.0	215.5	42.3	70.7	32.0	7.4	78.1	3.5	24.6	2.9	4.5	75.7	19.1	1.0	3.3	81.9	12.6	75.2	75.9	7.5	44.7	36.1	36.1	28.1	36.8	41.3	39.1	43.9	37.1	39.0	38.3	40.8	53.4	24.5	54.5	20.7	18.3	27.8	138.0	168.2	47.7	66.0	7.1	18.2	14.1	19.0	18.6	34.6	12.9	2.1	28.4	39.1	41.3	3.9	59.7	58.9	33.6	47.2	51.9	30.9	25.5	32.8	22.7	125.3	38.4	20.4	39.1	41.8	43.3	17.2	49.8	122.2	15.2	39.7	23.4	16.2	71.0	181.4	56.4	22.4	108.8	90.7	37.5	81.7	6.7	8.2	46.3	42.6	76.9	29.8	58.6	31.6	92.8	19.0	30.1	10.5	5.3	13.1	42.8	53.2	26.8	22.9	60.6	167.8	46.8	12.0	9.9	30.7	93.2
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
COX7B		ENSG00000131174	"Cytochrome c oxidase subunit 7B"	P24311	X	77899440-77907376	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1122.9;tongue: 756.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 2237.0;Distal tubular cells: 2283.3;Proximal tubular cells: 1865.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058041	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA058041: AB_2683587"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.10e-2)"	"prognostic favorable (6.80e-6)"	"unprognostic (8.58e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.38e-2)"	"prognostic favorable (2.43e-4)"	99.1	94.8	198.6	74.5	200.9	205.6	81.5	218.2	376.7	46.2	228.4	176.5	182.4	50.2	94.4	72.1	55.3	42.0	326.8	202.2	214.7	222.6	181.5	45.7	64.3	203.2	202.9	38.7	49.1	301.3	21.3	53.6	205.4	61.6	158.5	184.1	93.5	65.9	1122.9	42.8	156.7	74.8	205.0	51.3	125.1	19.1	208.4	96.6	54.3	756.7	76.3	87.8	19.6	207.3	242.8	239.4	257.8	214.6	111.8	90.1	179.5	159.7	78.8	101.8	113.1	259.6	213.0	158.6	271.8	96.1	333.1	302.5	298.7	183.6	112.7	138.9	372.7	218.5	441.3	343.5	104.2	441.1	185.5	133.0	137.0	154.2	129.9	173.0	113.0	186.1	186.3	409.8	118.6	282.6	350.6	445.5	253.4	972.4	614.5	250.5	297.0	594.4	344.6	420.8	177.3	158.1	305.8	396.8	334.2	209.0	148.7	295.0	149.7	91.1	222.0	232.6	167.7	157.9	407.0	364.8	212.2	504.2	130.5	212.5	226.7	168.6	152.7	326.5	165.2	213.6	166.5	174.8	303.7	146.3	155.7	185.6	142.8	205.9	316.1	213.2	238.6	261.1	198.6	200.9	218.2	376.7	202.2	214.7	203.2	202.9	205.4	205.0	208.4	207.3	238.9	134.6	178.0	28.1	247.7	297.5	297.2	1151.7	225.9	111.4	204.5	244.9	2237.0	487.6	463.6	369.6	35.5	412.9	272.2	1219.8	2283.3	504.6	20.8	424.0	243.9	210.0	516.0	428.5	11.2	395.7	424.2	227.2	382.8	356.4	226.3	134.7	194.5	1179.5	718.3	47.1	14.8	922.1	734.5	438.9	432.1	43.1	199.4	368.3	538.9	10.3	488.1	214.0	258.5	12.5	19.5	425.5	1090.3	176.4	297.3	307.7	1516.9	1865.2	314.0	174.3	210.4	274.2	315.4	81.4	108.8	583.4	345.5	591.7	258.4	166.9	978.4	472.5
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 308.9;epididymis: 128.6;pituitary gland: 65.6"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.3	239.7	1.0	136.0	0.0	0.1	78.2	291.5	0.0	0.0	3.5	2.1	0.0	128.6	0.1	0.0	0.0	0.2	308.9	62.3	0.1	0.2	1.3	0.0	62.2	98.8	0.2	9.0	0.1	65.6	0.0	50.2	0.2	1.4	19.4	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	19.6	0.1	0.2	0.0	0.0	0.1	0.5	157.7	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.7	136.0	78.2	291.5	308.9	62.3	62.2	98.8	50.2	0.0	19.6	157.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPNE4	"COPN4, CPN4"	ENSG00000196353	"Copine 4"	Q96A23	3	131533555-132285410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 34.3;prostate: 25.3"	"Cell type enriched"	"Detected in some"	10	"Excitatory neurons: 351.2"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 22.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 34.3;cerebral cortex: 15.2;hippocampal formation: 16.8;thalamus: 12.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;AF22: 5.7;Karpas-707: 1.7;RT4: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA032036, HPA078300"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA032036: AB_10600898, HPA078300: AB_2732377"	"unprognostic (7.38e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.51e-1)"	0.6	0.5	4.8	0.1	34.3	0.0	0.2	0.0	15.2	0.2	0.0	0.3	0.7	0.2	0.6	0.3	0.4	0.0	0.9	16.8	3.7	1.0	0.1	0.4	0.0	0.0	4.2	0.0	0.2	1.9	3.0	0.0	0.1	25.3	0.2	2.0	0.4	3.7	0.0	0.2	0.5	0.3	0.5	0.8	0.5	1.4	12.1	0.0	0.3	0.1	0.0	0.1	0.4	1.2	0.0	6.2	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.8	0.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.8	0.4	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.8	34.3	0.0	15.2	16.8	3.7	0.0	4.2	0.1	0.5	12.1	1.2	0.9	0.0	0.0	8.8	0.0	0.3	0.4	0.1	0.0	0.8	0.0	0.0	17.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.6	0.1	0.6	4.9	0.0	351.2	0.0	0.0	0.6	3.6	0.6	0.0	0.2	0.0	0.0	0.1	1.7	33.0	0.1	0.0	0.0	0.3	5.6	0.3	1.1	0.0	8.4	0.6	0.3	0.0	8.5	7.1	0.1	0.0	0.0	0.0	17.0	0.0	2.6	0.3	0.6	0.0	0.0	0.4	1.4	1.1	0.3	0.1	0.0	0.0	0.1	0.0	0.9
CPNE8		ENSG00000139117	"Copine 8"	Q86YQ8	12	38646822-38907430	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 115.5;Microglial cells: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 66.8;THP-1: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038600	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038600: AB_10674690"	"unprognostic (1.57e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.93e-3)"	"unprognostic (6.28e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.40e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.21e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.73e-3)"	12.0	8.3	7.0	5.4	7.6	4.6	9.6	3.1	11.5	7.8	9.2	8.1	3.3	5.1	3.5	5.4	5.0	9.0	12.2	10.1	8.9	11.2	15.5	10.1	5.4	5.0	6.5	5.7	3.2	2.5	3.3	12.0	4.6	3.7	10.2	6.0	3.2	8.9	2.9	6.1	4.6	9.1	8.8	10.6	3.7	5.8	8.0	3.1	7.8	5.3	3.2	10.1	5.3	5.5	3.1	18.7	1.3	18.5	17.0	14.3	8.6	1.6	0.1	0.0	0.0	9.4	18.2	0.0	26.3	12.7	6.8	1.0	10.8	5.6	0.0	0.0	11.3	9.9	26.3	2.2	11.3	0.0	7.8	6.7	14.2	4.2	14.9	12.9	14.3	0.0	6.0	0.0	0.0	0.0	0.0	0.1	13.8	11.5	19.0	0.0	0.0	4.3	66.8	0.5	0.0	0.5	26.0	4.7	14.1	18.8	2.3	38.8	13.6	0.0	12.7	21.6	0.1	6.5	19.3	0.2	17.2	17.8	11.0	2.7	12.0	0.0	1.6	9.4	0.3	0.2	2.1	1.8	7.7	0.6	0.9	1.5	0.7	4.5	6.3	2.5	2.1	2.5	7.0	7.6	3.1	11.5	10.1	8.9	5.0	6.5	4.6	8.8	8.0	5.5	68.8	12.8	8.2	66.3	1.6	31.1	5.9	40.8	19.9	2.1	0.6	6.5	20.3	15.7	23.3	12.9	0.0	29.2	6.9	35.8	15.6	7.6	68.9	2.7	9.4	55.9	11.5	7.4	115.5	4.9	27.2	27.1	0.0	3.0	3.8	18.5	36.0	16.5	25.7	0.0	36.3	9.1	6.1	34.1	42.4	14.5	9.6	19.4	46.2	77.8	19.8	36.4	2.1	25.6	2.9	3.6	51.3	8.2	3.3	7.4	0.0	20.9	17.0	2.7	0.0	24.5	16.9	2.7	2.1	6.1	11.2	7.8	4.3	8.6	8.9	3.5
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703826-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 69.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 12.9;Excitatory neurons: 28.2;Inhibitory neurons: 8.0;Late spermatids: 61.3"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;U-937: 2.0"	"Low region specificity"	"Detected in all"							HPA060813			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA060813: "	"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.1	2.1	10.9	0.2	7.1	1.2	0.1	12.1	23.6	0.1	0.0	0.4	0.3	0.1	0.0	0.1	0.1	0.1	0.1	5.8	19.6	0.2	0.0	0.3	0.2	69.2	19.8	0.1	0.1	0.1	5.3	0.1	65.0	0.1	0.1	1.1	0.1	0.2	0.0	1.7	0.3	0.2	4.2	0.2	0.3	1.3	39.6	0.1	0.1	0.0	0.1	0.1	0.1	12.9	0.0	0.3	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.2	0.3	0.3	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.6	0.5	0.0	0.0	0.2	0.4	0.7	0.9	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.4	0.3	2.0	0.1	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	10.9	7.1	12.1	23.6	5.8	19.6	69.2	19.8	65.0	4.2	39.6	12.9	0.1	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.6	0.8	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.9	0.1	0.1	0.1	0.0	0.0	28.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.4	0.0	1.9	0.0	8.0	0.0	0.0	0.8	0.3	61.3	0.0	0.8	0.0	3.7	0.0	0.7	0.0	2.0	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.9	0.7	0.2	0.4	0.0	0.1	0.0	0.1	0.0
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CPXM2	"CPX2, UNQ676"	ENSG00000121898	"Carboxypeptidase X, M14 family member 2"	Q8N436	10	123706207-123940267	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 81.3;intestine: 75.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 106.8;Late spermatids: 202.5;Oligodendrocytes: 35.6;Peritubular cells: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 18.4;fHDF/TERT166: 71.8;SuSa: 28.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048375	Uncertain				"Secreted - unknown location"	NA	NA		62000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA048375: AB_2680377"	"unprognostic (1.50e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.14e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-3)"	29.1	6.4	3.9	5.9	7.2	0.0	20.8	9.2	2.6	5.8	81.3	75.4	6.2	10.2	59.8	18.4	16.0	11.2	18.0	3.5	7.2	11.2	2.4	7.0	2.7	16.1	10.7	16.7	5.2	2.5	10.9	1.2	11.6	15.1	7.0	0.5	9.3	12.7	3.8	7.3	14.9	56.9	20.0	16.8	19.9	9.6	10.4	7.8	15.0	7.9	6.6	28.3	9.2	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.4	0.7	1.1	0.1	0.0	0.0	0.0	0.0	71.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	28.0	0.5	0.0	0.0	0.1	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.2	9.2	2.6	3.5	7.2	16.1	10.7	11.6	20.0	10.4	18.3	22.3	0.0	0.6	0.3	0.1	2.2	0.0	0.2	6.2	0.0	0.3	0.4	2.4	0.0	0.0	1.8	0.0	8.3	0.1	0.2	1.9	0.4	106.8	0.2	0.2	26.1	0.0	0.0	5.0	0.2	0.3	23.0	1.1	0.3	0.0	0.1	16.8	0.0	0.3	1.7	0.5	0.7	0.0	0.0	2.7	202.5	10.8	0.6	3.6	0.0	0.0	0.0	0.0	1.0	35.6	0.1	0.1	79.0	1.4	0.0	0.4	0.0	0.0	0.1	0.0	1.6	2.0	1.3	1.9	0.6	2.0	5.1	0.2	0.0	2.7	0.2
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 13.2;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 32.6;Erythroid cells: 20.4;Kupffer cells: 59.1;Macrophages: 24.9;monocytes: 13.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.7;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.7"	"Group enriched"	"Detected in some"	9	"HL-60: 9.9;HMC-1: 21.8;NB-4: 9.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		33000000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	13.2	0.8	0.1	27.2	0.5	10.5	0.6	0.1	2.9	1.2	1.3	1.5	1.3	0.5	0.2	0.9	1.4	2.1	0.6	0.2	0.2	2.5	2.6	3.2	20.1	0.7	0.5	0.2	0.3	0.1	0.2	9.1	1.6	0.2	1.5	0.0	0.4	0.4	0.2	0.1	4.4	6.3	0.1	24.4	1.7	0.6	2.1	1.6	0.3	1.0	17.9	6.7	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	9.9	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.7	4.2	17.2	0.0	2.4	0.7	4.5	0.9	0.4	0.3	2.2	0.2	0.1	15.6	0.0	2.3	0.0	0.0	1.3	0.1	0.5	0.1	2.9	0.2	0.2	0.7	0.5	1.6	0.1	2.1	1.8	0.3	0.0	4.2	0.3	32.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.9	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.2	0.2	0.0	20.4	0.3	0.0	0.1	0.6	0.0	0.2	1.3	0.3	0.0	0.4	9.7	0.0	0.4	0.0	0.0	59.1	1.4	0.0	0.0	24.9	0.0	1.9	13.3	0.0	0.0	1.5	4.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.3	0.5	0.0	0.0
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340353-78348225	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 544.1;thyroid gland: 173.2"	"Cell type enriched"	"Detected in some"	24	"Muller glia cells: 4845.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 1022.7;NTERA-2: 307.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4"	"Low region specificity"	"Detected in all"			HPA017203	Enhanced	Supported				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.9	1.7	14.2	2.5	24.8	0.2	56.1	25.6	26.4	1.3	28.5	6.9	0.8	2.3	2.0	0.6	0.3	1.6	0.4	9.6	39.6	15.5	0.0	0.7	0.2	61.7	62.6	0.4	0.7	0.0	27.6	15.0	58.4	2.6	1.7	544.1	1.1	47.4	0.2	26.7	5.0	1.8	23.8	75.2	7.1	0.5	86.2	1.7	173.2	0.2	1.2	0.6	2.5	13.7	0.0	0.2	1022.7	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	65.3	0.9	0.0	6.3	0.0	0.3	0.0	9.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	57.9	0.4	307.4	1.0	0.8	0.0	0.0	0.0	0.0	1.5	85.5	58.0	0.0	0.2	0.1	24.8	1.4	35.9	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	24.8	25.6	26.4	9.6	39.6	61.7	62.6	58.4	23.8	86.2	13.7	1.0	0.0	0.0	0.3	0.8	9.7	0.1	0.0	0.0	31.1	112.6	199.0	0.0	0.0	0.0	0.0	33.3	1.1	2.9	1.1	70.5	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.2	0.0	0.8	11.3	0.0	0.1	0.0	4.2	0.0	0.0	1.5	10.1	1.5	0.4	0.0	0.0	5.3	0.0	0.0	0.5	192.1	0.0	0.0	4845.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.0	91.2	0.0	0.0	1.0	0.1	2.2	0.0	2.6	1.4	0.9	0.0	1.6	0.1
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345550-101387503	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"brain: 27.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 66.0;Inhibitory neurons: 27.6;Oligodendrocytes: 12.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"amygdala: 8.7;basal ganglia: 17.2;cerebral cortex: 26.3;hippocampal formation: 27.8;white matter: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;HaCaT: 6.3;HeLa: 2.5;OE19: 7.1;PC-3: 2.4;RT4: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.0	0.1	8.7	0.0	17.2	0.1	0.0	0.0	26.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	27.8	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.7	9.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	17.2	0.0	26.3	27.8	0.0	1.3	0.0	0.6	0.0	1.4	9.0	0.0	0.0	0.0	2.9	0.0	0.0	0.6	0.5	0.0	0.8	0.1	0.1	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.5	0.0	0.0	66.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.6	0.1	2.0	0.0	0.0	6.5	0.0	0.2	0.0	6.5	0.0	0.8	0.0	2.5	12.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.5	0.0	0.2	0.1	1.5	5.6	0.5	0.0	0.1	0.0	0.2	0.0	1.5
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984505-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 29.4"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA		8200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	2.7	1.3	3.9	2.5	4.0	1.5	29.4	3.4	3.1	6.3	3.4	2.7	0.7	8.6	4.9	5.0	7.4	10.0	8.8	4.3	8.0	2.1	2.1	2.3	2.8	5.8	10.4	5.7	2.4	19.3	1.2	7.8	8.3	24.6	1.6	3.1	19.3	2.6	0.5	2.3	1.2	7.0	6.3	2.0	0.9	3.8	4.1	9.4	15.1	1.2	1.1	2.5	1.1	10.7	0.0	1.7	134.4	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.9	0.8	0.0	0.0	19.0	0.0	2.2	0.1	11.3	0.1	0.0	0.1	5.2	0.2	5.1	0.0	3.0	0.0	1.0	7.2	0.3	0.1	1.0	16.6	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.2	13.9	0.0	5.0	0.0	18.5	0.2	0.0	0.0	0.8	72.0	0.0	0.1	8.0	27.5	10.4	6.4	0.0	3.8	19.6	0.2	0.5	2.4	0.9	0.0	4.6	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.9	4.0	3.4	3.1	4.3	8.0	5.8	10.4	8.3	6.3	4.1	10.7	1.0	3.2	0.0	12.7	0.0	0.8	6.1	1.4	17.6	1.6	10.3	36.1	0.4	0.0	5.4	1.8	0.0	22.7	0.3	0.0	0.0	0.0	15.3	62.2	4.9	3.2	0.0	3.0	15.7	0.0	3.8	9.2	0.0	22.4	3.8	1.8	23.6	0.1	2.0	0.0	11.1	0.0	0.0	0.9	0.0	1.5	4.1	0.4	7.2	1.9	0.0	8.8	0.0	81.4	0.9	0.0	0.0	1.5	0.0	9.4	0.0	0.2	22.5	0.9	0.0	0.4	1.5	1.3	6.0	2.5	1.0	12.0	0.4	6.3	0.0	2.3
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819985-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 87.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 87.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 15.6"	"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	No	No	219000000000		"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nucleoli"		"HPA030054: AB_2732452, HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	113.4	29.0	3.3	46.6	4.9	8.1	64.2	3.9	4.6	112.9	2.6	88.9	10.8	115.7	20.3	39.9	129.0	104.0	36.6	3.7	5.2	40.9	17.1	92.7	7.3	5.9	5.5	80.7	23.5	2.5	19.3	122.7	5.9	98.9	18.1	2.4	18.1	27.7	15.0	36.7	58.5	95.0	4.4	24.9	65.9	21.5	4.3	8.2	47.9	12.2	3.7	119.9	69.8	5.7	0.9	2.2	0.6	6.0	43.7	16.2	69.2	34.5	30.4	27.2	19.1	4.7	2.9	0.1	3.0	30.5	8.0	1.0	0.1	0.1	27.3	0.0	0.2	0.5	0.9	0.1	161.4	0.0	0.3	68.0	0.1	8.0	0.1	9.0	0.2	0.0	0.3	0.3	3.1	1.4	0.3	1.7	2.0	4.6	2.0	0.1	0.3	0.4	0.2	5.5	6.7	0.5	8.1	3.5	0.7	9.4	13.7	0.9	3.8	0.4	1.8	28.3	1.0	0.4	0.1	5.8	0.2	0.5	4.1	14.8	20.2	0.7	0.0	1.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.0	87.2	0.0	0.0	0.1	0.0	4.2	3.3	4.9	3.9	4.6	3.7	5.2	5.9	5.5	5.9	4.4	4.3	5.7	5.9	3.2	2.3	0.7	0.7	46.1	8.6	0.6	9.6	0.5	3.9	7.6	8.6	2.8	1.6	0.0	0.0	7.4	0.8	1.8	0.0	1.4	12.6	7.0	137.3	21.7	3.0	0.0	2.2	0.5	42.4	185.5	27.0	6.3	7.0	11.5	38.6	0.8	4.7	1.7	1.5	4.1	0.0	36.6	39.6	19.6	271.5	14.8	48.0	9.4	41.5	5.1	3.1	54.3	0.6	0.9	0.3	265.9	0.9	17.1	0.2	0.1	0.9	0.7	92.1	146.2	341.2	1.0	1.9	3.7	42.8	9.0	5.4	5.7	2.2	6.5
CRLF2	"CRL2, TSLPR"	ENSG00000205755	"Cytokine receptor like factor 2"	Q9HC73	X	1187549-1212723	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.8;gallbladder: 1.3;lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	4	"monocytes: 100.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (7.84e-2)"	"unprognostic (7.99e-4)"	"unprognostic (6.02e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.31e-6)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.88e-5)"	"unprognostic (7.09e-3)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.62e-1)"	0.2	0.0	0.0	1.5	0.0	1.8	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.1	0.5	0.6	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.5	0.8	0.1	0.3	2.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.9	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.3	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	1.8	0.0	1.0	100.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.6;fallopian tube: 38.2;lung: 50.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008175	Enhanced				"Secreted to extracellular matrix"	NA	NA		550000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favorable (1.51e-4)"	4.4	0.8	8.7	1.1	23.7	0.0	2.4	10.9	20.1	6.4	0.9	11.5	0.5	1.3	3.8	8.3	38.2	0.3	10.6	9.1	8.1	4.3	0.4	50.0	0.4	45.1	10.2	0.7	1.3	0.8	5.3	0.0	45.6	2.3	0.4	11.3	3.4	33.6	1.1	4.1	2.3	0.8	12.6	0.1	1.8	3.9	18.5	0.2	4.7	1.5	0.3	30.2	4.9	15.5	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	3.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.7	1.1	0.5	0.0	7.7	0.3	0.0	0.0	9.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	23.7	10.9	20.1	9.1	8.1	45.1	10.2	45.6	12.6	18.5	15.5	1.9	22.4	119.5	2.9	0.0	1.5	2.7	1.3	5.7	10.1	2.6	2.8	7.1	1.5	36.4	9.2	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.5	0.1	8.8	1.8	0.0	22.9	0.7	0.0	2.3	0.0	0.6	5.1	0.0	5.7	0.1	0.0	0.0	63.6	0.0	0.0	0.6	0.9	0.6	0.0	0.2	8.8	2.8	0.0	14.1	0.0	54.8	6.2	0.6	0.0	0.4	1.2	1.3	0.0	0.0	0.9	5.3	0.0	3.5	0.3	1.5	1.9	13.1	0.4	0.0	0.4	0.0	0.0	1.7
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 63.8;Plasma cells: 16.0;T-cells: 54.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 12.9"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.3	0.3	0.3	2.3	0.5	1.8	0.5	38.2	1.4	0.3	0.3	0.5	0.6	0.8	0.5	0.3	0.3	1.5	0.2	0.2	0.4	0.1	1.0	1.8	8.8	1.1	1.4	0.3	0.1	0.1	0.1	0.2	4.2	0.3	0.6	0.0	0.7	0.2	0.1	0.3	1.2	0.2	0.5	3.6	0.8	0.2	0.7	4.9	0.2	0.0	3.5	0.8	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	4.6	0.6	13.0	5.6	12.9	0.1	1.5	27.0	3.6	0.2	4.3	33.3	1.2	54.0	10.5	0.2	0.1	6.0	0.3	0.5	38.2	1.4	0.2	0.4	1.1	1.4	4.2	0.5	0.7	1.6	1.1	0.0	1.1	0.3	0.8	1.5	0.4	0.1	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.1	63.8	0.1	0.0	0.0	1.2	0.4	0.4	0.3	0.0	0.4	0.5	0.0	0.2	1.6	2.0	0.6	1.3	0.0	0.4	0.2	5.9	0.0	0.7	0.0	0.0	8.8	8.1	1.2	0.0	10.3	3.6	0.0	9.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.3	0.5	0.0	0.9	0.1	54.1	0.0	0.0	0.5
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.2;skin 1: 20.3;vagina: 20.6"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 48.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 11.4;BEWO: 23.2;CACO-2: 39.3;CAPAN-2: 25.7;HaCaT: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	10.2	0.0	2.6	6.5	0.0	0.8	48.2	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	6.0	0.0	0.4	1.9	0.0	6.1	0.0	0.0	20.3	5.9	0.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	4.2	8.4	20.6	0.0	11.4	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.0	0.1	0.1	39.3	25.7	0.3	7.7	0.0	0.1	9.7	0.1	6.9	0.0	0.0	0.2	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	1.9	6.3	0.0	0.0	0.0	0.2	0.4	2.5	0.4	0.0	0.0	4.5	0.0	1.7	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	1.8	0.0	6.7	0.9	0.0	1.9	2.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	1.4	4.4	0.1	0.0	2.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	48.6	1.2	0.0	0.0	0.0
CRYGN		ENSG00000127377	"Crystallin gamma N"	Q8WXF5	7	151428832-151440813	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"thyroid gland: 15.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Breast myoepithelial cells: 1.1;Endometrial stromal cells: 1.4;Oligodendrocyte precursor cells: 1.0"	"Cancer enriched"	"Detected in some"	25	"thyroid cancer: 15.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.1;white matter: 11.4"	"Not detected"	"Not detected"			HPA050788	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA050788: AB_2681239"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.94e-5)"	"unprognostic (2.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.48e-2)"	"unprognostic (8.93e-10)"	"unprognostic (2.55e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.36e-1)"	0.8	0.2	0.9	0.1	0.6	0.1	0.5	0.2	0.7	1.7	1.4	0.9	0.1	0.9	0.1	0.1	0.9	0.2	0.1	0.9	0.3	0.4	0.0	0.1	0.6	0.2	0.1	0.7	0.2	1.3	1.2	0.3	0.1	0.7	0.0	0.2	0.2	3.3	0.0	0.0	0.3	0.1	0.1	1.0	0.2	0.1	0.3	0.1	15.4	0.0	0.0	1.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.6	0.2	0.7	0.9	0.3	0.2	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.3;placenta: 103.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 103.2;Hofbauer cells: 340.4;Kupffer cells: 291.2;Langerhans cells: 73.4;Macrophages: 196.3;Microglial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.6;non-classical monocyte: 646.9"	"Lineage enriched"	"Detected in many"	5	"monocytes: 646.9"	"Group enriched"	"Detected in some"	4	"BEWO: 123.0;SK-BR-3: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	51.3	31.0	19.6	75.1	17.1	5.6	19.3	20.2	21.4	21.6	19.3	21.9	24.3	12.1	5.8	21.0	17.2	40.6	16.6	19.8	33.8	7.1	27.5	36.6	54.4	41.4	35.5	12.7	9.9	11.8	5.7	103.3	40.1	9.1	21.5	1.5	10.1	20.8	3.2	13.4	37.3	41.9	36.6	113.3	21.0	7.0	40.6	14.3	6.0	11.8	21.7	42.6	3.8	67.6	4.5	0.2	0.0	0.0	1.9	0.4	123.0	0.2	0.2	0.0	0.0	3.8	0.0	5.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2	1.1	3.0	0.0	6.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.1	0.1	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.2	0.2	0.0	47.8	0.0	1.9	0.0	20.7	0.0	0.8	0.2	0.1	3.3	0.0	0.3	0.1	6.6	2.6	0.0	3.0	138.4	4.0	0.6	444.6	0.6	0.3	0.2	0.4	139.0	0.2	0.3	0.2	21.6	0.2	646.9	11.1	0.5	132.7	19.6	17.1	20.2	21.4	19.8	33.8	41.4	35.5	40.1	36.6	40.6	67.6	2.0	0.0	3.8	0.0	4.3	2.8	0.0	0.0	1.2	0.0	0.5	2.3	3.1	4.3	0.0	0.0	0.0	6.2	2.8	0.0	0.0	0.0	4.8	0.0	0.1	10.5	0.0	2.5	0.4	0.0	103.2	2.2	1.5	0.2	2.5	8.3	2.9	1.5	340.4	0.0	0.5	0.3	0.0	291.2	73.4	5.4	1.8	196.3	3.6	134.9	39.4	0.0	1.0	1.5	0.3	0.1	1.7	0.0	1.0	0.0	0.0	0.1	0.7	0.5	13.1	1.2	2.0	2.2	0.2	0.4	1.3	26.4	1.3	2.2	0.2	0.0
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 379.7;lung: 136.7;lymphoid tissue: 375.6;placenta: 105.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 230.8;Cytotrophoblasts: 423.8;Kupffer cells: 177.7;monocytes: 197.6;Syncytiotrophoblasts: 1194.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1962.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1962.3"	"Group enriched"	"Detected in some"	18	"BEWO: 70.8;NB-4: 20.3;THP-1: 50.3;U-937: 47.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	NA	NA		150000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	36.2	7.1	5.8	148.2	5.6	379.7	13.0	6.7	19.0	5.2	6.3	6.4	2.6	3.1	0.4	5.6	31.5	15.8	14.6	5.5	7.3	9.7	22.9	136.7	7.3	10.3	7.8	3.2	4.9	1.6	5.5	105.1	11.4	7.5	1.8	0.1	7.4	1.8	3.6	1.6	9.8	12.2	9.6	375.6	9.9	1.2	10.7	5.7	5.8	21.7	2.7	22.2	6.2	11.9	0.0	0.0	0.0	0.0	0.0	0.0	70.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	1.6	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.5	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	47.8	0.0	1.1	280.8	8.7	0.2	56.8	0.6	0.1	0.4	0.2	97.2	0.4	0.1	0.3	1962.3	3.4	24.1	3.3	0.6	158.4	5.8	5.6	6.7	19.0	5.5	7.3	10.3	7.8	11.4	9.6	10.7	11.9	0.7	25.6	230.8	0.0	3.3	1.0	0.5	0.0	0.0	0.0	5.9	4.7	1.8	0.0	10.0	0.0	0.0	423.8	2.9	0.0	0.0	0.0	0.4	0.3	6.4	4.8	0.0	4.6	0.2	0.0	47.3	8.0	1.5	0.2	18.9	1.1	3.9	1.2	64.1	0.0	0.2	0.0	0.0	177.7	39.2	0.7	0.3	111.5	0.0	77.8	197.6	0.2	6.2	0.5	0.3	0.1	0.0	0.0	0.7	0.3	0.0	0.5	6.6	0.2	0.0	0.3	1.0	0.0	0.4	0.2	0.1	1194.8	4.0	0.0	0.0	3.0
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 9.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.0;Inhibitory neurons: 148.9;Oligodendrocyte precursor cells: 314.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 6.8;HEL: 10.5;NTERA-2: 8.1;PC-3: 8.4;U-87 MG: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	0.2	0.5	5.3	0.2	3.2	0.0	0.1	0.7	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.2	7.1	5.5	0.1	0.0	0.1	0.2	2.3	2.7	0.0	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.1	0.3	1.0	0.2	0.1	0.5	9.3	0.0	0.1	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.2	0.7	4.8	7.1	5.5	2.3	2.7	1.8	1.0	9.3	2.5	1.4	6.4	3.0	2.6	0.0	0.3	0.6	0.0	0.0	11.2	0.1	0.0	5.5	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	4.3	3.2	0.2	2.3	1.2	0.0	0.0	159.0	2.9	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	148.9	0.0	0.0	0.0	0.3	6.0	1.5	0.4	0.0	12.2	0.3	0.1	0.0	314.7	52.5	1.4	0.0	3.8	0.0	0.9	0.0	0.1	0.0	1.9	0.0	1.4	0.7	0.3	2.1	0.0	0.4	0.0	0.2	0.2	0.0	0.3
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113436939	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 6.8"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 915.9;Inhibitory neurons: 867.9;Oligodendrocyte precursor cells: 1761.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029007, HPA029008"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA029007: AB_10601802, HPA029008: "	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	0.0	0.0	6.8	0.0	4.3	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	4.8	0.0	0.0	0.0	0.0	1.9	2.7	0.0	0.2	0.0	0.1	0.0	1.6	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	4.3	0.0	6.0	5.7	4.8	1.9	2.7	1.6	0.8	5.0	0.7	0.0	0.0	3.0	21.5	0.2	0.3	0.1	0.0	0.0	7.3	0.0	0.0	1.6	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.5	0.1	0.4	0.0	0.0	915.9	0.0	0.0	0.9	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	867.9	0.0	0.0	0.0	0.8	6.3	0.0	0.3	0.0	19.7	0.0	0.5	0.0	1761.3	92.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.2	17.1	8.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3
CSPG4	"CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.4"	"Group enriched"	"Detected in some"	5	"Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		48000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	29.6	1.8	9.0	7.3	7.1	0.0	18.5	6.6	9.3	16.0	1.8	55.4	2.8	34.5	1.4	8.3	15.0	5.6	14.6	7.5	8.2	4.9	0.9	19.4	0.4	11.7	7.8	8.9	2.1	1.2	2.2	15.5	9.7	14.4	2.2	0.1	4.7	11.2	39.6	7.8	15.3	22.7	6.7	5.6	19.1	1.3	7.7	0.6	5.6	10.0	0.3	30.3	12.6	9.8	11.9	0.1	1.0	7.1	1.6	9.8	0.1	64.7	28.6	44.4	28.8	0.1	45.0	0.0	1.5	45.4	6.2	0.6	0.1	0.3	13.6	0.6	0.2	0.0	19.2	0.0	10.0	0.0	0.1	4.8	0.1	13.5	1.5	16.5	0.0	0.0	0.1	0.1	7.6	0.1	0.0	0.2	1.2	0.0	0.3	0.1	4.0	0.1	0.0	0.0	0.1	0.2	1.7	0.1	146.1	1.2	0.9	1.2	0.1	92.1	17.9	3.6	0.8	0.0	0.2	0.0	20.3	0.5	138.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.0	7.1	6.6	9.3	7.5	8.2	11.7	7.8	9.7	6.7	7.7	9.8	4.9	0.0	0.0	1.0	0.0	2.8	0.7	4.7	0.0	1.4	0.1	0.8	11.4	0.0	0.8	1.8	0.0	0.2	0.5	0.1	0.0	0.0	0.6	0.7	0.7	2.7	0.0	0.0	0.4	0.0	0.6	5.9	1.5	0.4	0.0	1.8	1.1	0.2	1.1	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.3	0.3	12.4	3.7	0.0	0.0	0.0	57.3	0.1	0.0	0.0	0.4	0.0	4.3	0.0	0.1	1.0	0.2	118.3	3.1	47.1	0.0	1.3	0.1	1.8	0.3	0.3	0.1	0.0	0.4
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 193.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	88.9	55.8	13.6	34.0	13.7	193.1	51.7	17.2	22.5	34.7	15.4	35.6	12.0	30.2	6.4	61.7	79.8	67.5	49.9	12.8	18.0	29.2	67.3	80.8	14.9	21.3	16.2	41.5	39.4	23.5	43.3	25.0	15.7	32.7	15.4	5.8	21.3	18.5	36.9	57.1	26.4	64.1	18.3	20.3	48.0	14.7	17.1	34.9	33.8	19.0	8.7	51.6	27.7	15.4	4.4	9.7	2.5	4.8	4.7	4.9	7.8	15.9	22.1	13.0	10.6	13.7	4.0	14.4	3.3	12.1	9.3	4.9	3.0	21.0	6.4	21.6	4.0	16.4	8.0	10.5	5.8	4.1	15.7	2.3	11.3	20.4	3.2	11.6	17.8	3.9	12.7	24.9	10.7	13.9	0.8	6.7	11.4	7.4	8.1	6.8	10.4	23.7	10.3	15.9	7.0	1.1	8.7	64.2	5.5	14.5	7.2	7.5	9.0	6.6	28.2	5.6	11.9	6.3	5.8	6.6	14.4	5.2	8.4	0.1	3.0	3.8	1.7	5.9	2.1	3.6	1.6	2.0	3.3	3.7	2.0	1.3	17.1	2.6	11.0	4.2	2.7	2.3	13.6	13.7	17.2	22.5	12.8	18.0	21.3	16.2	15.7	18.3	17.1	15.4	200.8	48.1	66.3	6.8	75.0	103.2	88.1	40.2	153.1	1.4	121.1	95.8	15.8	37.1	31.2	11.0	0.0	19.7	86.3	77.3	9.8	37.6	54.4	119.6	65.2	92.8	59.3	13.2	3.5	38.5	43.0	98.1	75.4	199.4	96.5	4.2	73.9	40.7	38.7	0.0	1.5	54.7	22.4	36.7	165.2	46.8	1.5	94.5	69.4	4.7	14.8	7.6	7.2	1.5	1.3	49.2	60.9	4.1	74.3	49.4	54.1	6.0	21.0	1.7	13.1	154.4	103.9	0.6	4.7	85.7	79.6	90.7	132.4	8.9	38.0	38.9
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 2743.3;seminal vesicle: 2571.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 341.2;Breast myoepithelial cells: 737.5;Extravillous trophoblasts: 388.5;Smooth muscle cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		11000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	344.5	127.2	713.6	224.5	871.4	41.0	321.8	742.5	717.3	542.4	467.6	2743.3	180.6	1904.4	308.4	884.1	1025.6	152.7	194.2	647.3	735.1	192.5	114.7	386.0	64.9	840.1	837.4	319.0	114.6	188.0	117.0	118.3	719.0	947.2	432.0	24.2	250.1	2571.3	64.0	219.8	503.6	2009.6	713.5	165.6	748.3	44.2	848.5	48.0	186.4	53.8	65.7	1494.5	469.1	766.6	83.0	195.3	52.0	116.4	83.2	107.7	273.6	605.7	514.3	455.3	360.9	211.1	57.7	78.7	36.1	325.0	96.7	144.7	32.7	120.3	321.2	169.5	29.3	90.7	220.1	30.7	387.4	72.1	10.2	99.3	105.3	373.0	163.1	253.1	508.1	34.9	4.5	71.9	302.1	232.9	46.6	11.8	0.8	99.0	73.2	18.3	304.9	266.8	212.6	129.7	27.1	22.5	238.0	503.8	163.9	25.6	87.0	74.3	610.6	303.7	195.7	206.6	250.6	40.5	82.6	30.6	303.5	137.6	202.6	75.5	49.8	65.6	37.4	49.3	36.9	25.0	35.8	34.9	65.0	18.1	20.5	25.2	5.0	34.3	54.2	5.2	54.1	46.5	713.6	871.4	742.5	717.3	647.3	735.1	840.1	837.4	719.0	713.5	848.5	766.6	151.8	38.5	47.8	86.5	21.8	49.2	341.2	24.6	207.7	3.4	123.7	737.5	24.8	21.5	36.9	47.8	0.0	88.8	23.3	96.6	49.0	165.1	21.5	30.1	73.6	86.9	57.9	19.1	2.4	171.7	388.5	86.7	36.7	38.9	27.9	13.9	91.1	28.3	66.0	0.0	2.1	80.0	14.2	29.1	55.8	44.9	41.0	37.0	126.3	10.3	73.5	137.4	15.5	6.6	114.8	140.5	71.4	292.3	61.5	113.8	97.2	28.4	25.2	3.1	144.7	37.7	419.9	2.4	3.2	75.3	34.9	160.9	31.2	30.4	69.7	103.6
CSRP2	"CRP2, LMO5, SmLIM"	ENSG00000175183	"Cysteine and glycine rich protein 2"	Q16527	12	76858709-76879023	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 275.3;Muller glia cells: 625.9;Smooth muscle cells: 268.4;Squamous epithelial cells: 271.2"	"Cancer enhanced"	"Detected in all"		"glioma: 24.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 336.2;BEWO: 177.9;fHDF/TERT166: 184.9;HEK 293: 186.4;NTERA-2: 181.4;WM-115: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain					NA	NA		63000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA045617: AB_2679391"	"unprognostic (9.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (8.52e-4)"	"prognostic unfavorable (4.48e-5)"	"unprognostic (3.55e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.45e-1)"	68.9	8.2	52.7	32.6	55.5	0.3	52.2	56.9	70.0	77.4	54.4	34.2	17.2	54.3	27.1	98.0	55.8	61.6	37.4	51.6	62.6	88.3	45.2	57.7	27.8	55.5	56.6	30.1	16.6	11.6	28.7	84.0	57.7	48.5	16.3	64.9	29.9	15.9	15.3	24.1	39.0	37.2	55.5	19.4	45.8	23.7	61.4	26.9	50.0	34.4	37.5	47.4	62.6	61.4	26.0	23.0	336.2	67.7	15.0	3.3	177.9	43.7	52.5	39.3	108.2	15.3	1.1	0.3	17.5	184.9	30.9	31.4	75.3	44.5	63.0	3.2	186.4	0.3	46.4	14.9	3.7	0.0	0.7	18.0	29.5	31.8	5.6	67.8	8.1	12.9	1.2	1.0	68.8	8.3	3.8	0.3	181.4	1.6	39.1	39.5	90.9	0.3	130.3	61.7	17.4	111.8	74.3	2.7	17.9	92.5	0.1	0.8	1.9	34.3	44.4	8.5	32.6	2.2	1.9	3.7	10.5	0.6	188.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	52.7	55.5	56.9	70.0	51.6	62.6	55.5	56.6	57.7	55.5	61.4	61.4	93.8	0.0	1.7	6.2	1.8	78.5	105.5	24.3	133.7	16.7	12.7	57.0	14.4	20.0	8.5	14.7	10.4	275.3	2.7	0.8	215.2	28.5	35.3	107.1	16.1	119.1	0.0	0.0	4.7	4.4	156.7	116.6	7.7	82.4	0.0	61.7	13.2	25.7	28.8	0.0	2.1	2.5	2.0	1.0	43.7	21.0	3.7	5.3	49.8	13.1	76.1	625.9	0.0	2.5	0.6	5.5	1.4	9.1	8.1	72.7	0.4	140.8	2.7	19.4	210.4	138.0	268.4	81.2	44.8	271.2	61.9	117.9	5.9	25.1	3.8	55.0
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.0;epididymis: 67.0;retina: 80.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3673.8;Early spermatids: 560.8;Excitatory neurons: 1358.5;Inhibitory neurons: 1056.9;Oligodendrocyte precursor cells: 1304.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	96	"basophil: 55.3"	"Lineage enriched"	"Detected in single"	553	"granulocytes: 55.3"	"Cell line enhanced"	"Detected in some"		"AF22: 7.1;Karpas-707: 8.2;NTERA-2: 6.7;SCLC-21H: 3.8;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	0.1	4.7	74.1	0.5	82.5	0.1	0.0	51.8	99.0	0.4	28.5	1.9	0.3	3.3	67.0	0.2	1.9	0.2	0.2	78.8	59.3	0.1	0.1	0.0	0.0	47.0	71.2	0.1	0.8	0.0	7.1	0.0	50.8	1.0	0.9	80.4	0.2	0.7	0.2	0.1	0.7	0.5	36.6	0.0	1.1	17.4	78.9	0.0	0.0	0.0	0.0	0.1	0.4	62.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	3.8	10.7	0.0	0.0	0.5	1.0	0.0	0.6	0.0	0.4	0.7	0.2	0.0	2.3	0.0	0.0	2.7	0.0	2.0	55.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	74.1	82.5	51.8	99.0	78.8	59.3	47.0	71.2	50.8	36.6	78.9	62.0	0.0	0.0	0.0	3673.8	0.0	0.0	0.0	0.0	0.0	17.2	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	560.8	12.9	7.0	0.5	0.0	0.0	1358.5	0.0	0.0	0.1	0.0	34.3	0.0	4.7	0.0	0.0	0.0	5.0	1056.9	0.0	0.0	0.0	0.0	144.4	2.5	0.5	0.0	187.4	0.0	112.1	0.0	1304.4	230.7	0.3	0.0	3.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.2	10.3	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	318.6	734.6	147.0	204.9	181.9	499.0	244.0	186.0	156.5	270.8	672.7	298.0	387.6	170.7	82.8	319.4	171.6	438.4	444.1	187.8	223.6	691.6	464.8	539.6	241.0	247.6	206.6	130.7	284.8	137.3	131.5	180.7	228.6	138.2	153.4	48.3	422.1	231.7	590.3	340.9	398.3	105.0	188.9	442.0	287.2	88.9	334.4	78.1	182.1	178.2	123.1	296.4	307.5	367.1	204.6	578.9	51.4	246.2	586.5	206.3	112.1	149.4	362.2	161.8	182.8	147.5	2596.6	49.2	376.8	285.8	1265.6	1072.2	63.7	142.6	35.8	206.7	222.9	70.4	92.5	196.5	736.2	171.4	787.7	350.9	621.6	82.5	136.9	2780.1	128.2	62.1	89.2	267.6	263.3	832.6	47.0	110.9	153.1	719.7	247.9	62.5	72.5	191.2	586.6	610.8	84.2	94.8	173.3	2488.5	535.0	68.6	1022.8	232.6	170.3	556.8	92.9	79.0	216.7	432.0	382.3	26.8	867.7	468.6	509.6	211.2	578.7	170.1	156.5	309.9	90.6	28.8	72.1	110.3	144.5	18.8	82.5	107.4	319.5	192.3	265.2	120.3	89.2	489.1	147.0	181.9	186.0	156.5	187.8	223.6	247.6	206.6	228.6	188.9	334.4	367.1	139.3	112.2	228.6	48.3	62.8	72.0	223.5	473.2	71.7	168.6	108.9	113.8	251.9	314.5	459.5	548.1	110.5	211.7	156.1	1475.9	109.5	911.4	3.3	118.1	67.4	128.3	159.6	132.6	18.3	370.1	165.0	157.0	237.5	203.4	474.3	119.4	695.7	678.9	3763.5	264.2	25.2	418.2	498.5	1187.8	67.5	14.6	108.4	1512.6	227.7	20.6	382.6	179.0	256.4	27.2	42.2	392.3	832.5	128.2	122.5	111.7	1699.4	311.8	270.3	102.1	111.7	70.7	135.2	26.6	63.5	141.2	82.1	471.3	155.0	96.0	399.1	357.8
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206008535-206023909	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 1168.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"OE19: 1799.1"	"Not detected"	"Not detected"							"HPA012674, HPA012940, CAB032687"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.3	0.0	0.1	9.5	0.1	30.0	0.0	0.5	0.3	0.0	0.1	15.3	229.8	0.3	1.7	0.8	1.1	15.0	0.3	0.1	0.1	0.2	0.2	49.7	0.5	0.3	0.1	0.1	3.7	0.0	1.1	1.3	0.3	0.2	25.7	0.1	0.0	1.6	0.0	0.1	55.5	0.3	0.1	0.6	1168.3	0.1	0.3	0.5	8.9	0.0	10.7	5.8	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	3.8	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.4	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.8	1.5	0.7	1799.1	0.1	0.4	0.0	0.8	0.7	39.4	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.1	0.1	0.3	0.1	0.3	0.1	0.3	0.5	0.0	105.8	27.9	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	10.0	42.3	0.0	0.0	0.0	0.0	34.1	0.0	52.0	0.0	0.3	0.0	0.3	2.4	60.6	0.0	262.8	0.1	14.7	553.5	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	21.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.1	260.0	208.9	0.0	0.7	0.1	4.0	0.1	7.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	10.4	0.4
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573518-24576250	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	154	"bone marrow: 5352.9"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 534.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 8681.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		330000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	23.4	0.1	0.0	13.5	0.0	5352.9	25.4	0.0	0.0	16.6	0.0	25.5	5.8	9.6	10.2	22.1	2.7	25.9	3.7	0.0	0.0	2.3	3.6	11.6	6.5	0.0	0.0	0.5	3.5	1.5	1.0	2.9	0.0	3.7	25.5	0.0	11.5	4.8	1.8	28.0	18.1	7.7	0.0	16.9	4.9	3.2	0.0	26.0	0.8	7.6	6.0	34.8	4.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	303.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	3.6	41.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.2	0.0	3.6	0.0	0.0	8681.4	0.0	0.0	0.3	0.0	5.3	0.0	0.8	2.8	0.0	1287.5	0.1	0.0	6.0	0.0	1.1	1.0	0.0	0.0	0.9	3.4	5.4	0.0	0.0	1.7	7.3	5.0	0.0	6.5	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	33.3	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	534.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	11.1	9.1	0.0	1.5	5.4	0.0	1.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.3	0.3	1.7	0.0	4.0	0.0	5.1	0.0	0.4	0.0
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.3;lymphoid tissue: 42.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 717.8;NK-cells: 867.2;T-cells: 352.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"gdT-cell: 1376.3;MAIT T-cell: 869.4;memory CD8 T-cell: 892.8;naive CD8 T-cell: 636.3;NK-cell: 2276.1"	"Group enriched"	"Detected in all"	39	"NK-cells: 2276.1;T-cells: 1376.3"	"Group enriched"	"Detected in some"	22	"HEL: 156.7;NB-4: 363.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB016345, HPA066903"	Enhanced				"Intracellular and membrane"	NA	NA		270000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB016345: AB_626813, HPA066903: "	"prognostic favorable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.1	2.9	0.8	12.9	0.9	116.3	3.7	1.8	1.6	2.6	0.6	5.6	6.1	6.7	2.8	3.1	4.0	6.2	2.9	0.8	0.9	2.1	6.5	24.0	29.5	1.6	0.7	2.4	1.8	0.5	1.1	3.3	1.2	2.1	6.3	0.0	9.1	3.9	1.3	2.7	6.1	2.7	1.2	42.4	8.3	1.2	1.1	7.8	3.2	0.4	13.9	8.6	2.5	1.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	156.7	0.3	0.0	0.0	11.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	9.1	0.2	0.2	1.9	363.4	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	5.6	0.1	0.0	0.1	0.4	0.1	0.3	0.5	0.0	0.2	9.9	0.3	46.4	3.4	4.8	1376.3	4.0	869.4	5.1	145.3	892.8	37.6	3.7	86.0	636.3	25.7	2276.1	5.4	23.3	23.7	809.3	0.8	0.9	1.8	1.6	0.8	0.9	1.6	0.7	1.2	1.2	1.1	1.1	5.1	0.0	4.2	0.0	9.7	4.6	0.4	0.0	1.8	0.0	2.3	2.2	0.4	2.8	1.4	0.0	0.0	0.4	717.8	0.3	0.0	0.3	2.0	0.9	0.9	1.9	0.0	44.1	0.0	0.0	0.2	4.0	12.8	1.1	71.7	0.1	5.7	1.6	1.9	0.0	0.0	0.2	0.0	5.6	34.1	11.1	0.0	9.9	17.8	0.0	6.1	0.0	867.2	0.0	0.2	0.0	0.0	0.0	57.7	0.3	0.0	1.1	0.8	0.0	0.0	1.6	1.9	0.3	1.2	0.8	6.3	0.3	352.6	0.1	0.3	0.3
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CTXN2		ENSG00000233932	"Cortexin 2"	P0C2S0	15	48178122-48203758	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;choroid plexus: 1.6;pituitary gland: 1.1;retina: 1.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 43.4;Late spermatids: 34.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053168	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA053168: AB_2682066"	"unprognostic (1.90e-1)"			"unprognostic (3.85e-3)"	"unprognostic (7.43e-2)"					"unprognostic (2.18e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"		"unprognostic (4.61e-2)"			0.0	0.1	2.6	0.0	2.4	0.0	0.0	2.3	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	3.1	0.0	0.0	0.0	0.0	2.8	2.7	0.0	0.1	0.0	1.1	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	2.4	2.3	3.9	2.3	3.1	2.8	2.7	3.1	2.2	3.1	2.2	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	43.4	0.4	0.0	0.0	4.9	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	34.0	0.9	0.0	0.0	1.9	0.0	2.0	0.0	5.5	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.0	0.0	8.2	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"	A0A1B0GTU2	15	80195481-80252213	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 30.9;liver: 9.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.6;WM-115: 4.7"	"Region enriched"	"Detected in all"	4	"hippocampal formation: 35.0"											NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.3	3.7	11.4	0.2	9.4	0.0	0.2	4.9	14.0	0.3	3.0	0.9	0.4	0.1	5.4	0.1	0.3	0.1	2.7	30.9	9.8	2.2	9.4	1.5	0.2	7.2	11.1	0.4	0.5	0.0	1.4	0.0	8.4	0.3	0.2	1.4	0.1	0.1	0.5	0.8	0.5	0.0	6.4	1.4	2.6	0.4	14.4	0.0	0.4	0.1	0.2	0.5	0.3	6.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.4	4.9	14.0	30.9	9.8	7.2	11.1	8.4	6.4	14.4	6.0	0.0	0.0	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CWH43	"CWH43-C, FLJ21511, PGAP2IP"	ENSG00000109182	"Cell wall biogenesis 43 C-terminal homolog"	Q9H720	4	48986275-49062081	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.0;prostate: 42.8;skin 1: 25.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 10.4;Endometrial ciliated cells: 41.3;Gastric mucus-secreting cells: 10.7;Glandular and luminal cells: 21.1;Paneth cells: 15.4;Respiratory ciliated cells: 29.5;Undifferentiated cells: 15.0"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA042814, HPA048140"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"	"Golgi apparatus, Plasma membrane"		"HPA042814: AB_2678182, HPA048140: AB_2680280"	"unprognostic (9.38e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.14e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.29e-11)"	"unprognostic (5.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	2.0	0.0	0.0	6.0	0.0	16.9	0.4	0.6	0.4	21.0	14.5	0.0	0.0	0.0	0.0	9.0	0.7	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	42.8	15.6	0.0	3.0	7.7	0.0	25.5	0.0	0.8	0.1	0.0	9.6	0.0	0.1	0.1	10.2	0.0	1.5	2.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.9	0.1	0.8	0.0	0.0	0.6	0.1	0.6	0.0	2.3	7.3	0.0	0.0	0.0	10.4	1.9	0.0	0.2	41.3	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	10.7	21.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	15.4	0.0	0.0	7.6	0.0	2.9	29.5	0.0	0.0	0.0	0.5	0.0	0.5	3.2	9.1	0.0	0.2	0.0	15.0	0.3
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162841-218166962	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 5.1;dendritic cells: 5.2;granulocytes: 2.5;NK-cells: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	14	"neutrophil: 1472.7"	"Lineage enriched"	"Detected in many"	62	"granulocytes: 1472.7"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 5.8"	"Not detected"	"Not detected"							HPA031991	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA031991: AB_2674103"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	13.2	0.5	0.3	25.1	0.5	9.5	0.4	0.3	1.7	0.7	0.5	0.4	0.2	0.2	0.0	1.6	2.9	4.1	1.8	0.3	0.3	0.5	2.0	9.7	0.3	0.4	0.4	0.1	1.5	0.3	0.2	2.6	1.2	0.3	0.2	0.0	0.5	0.1	0.4	0.3	0.6	1.8	0.3	40.5	0.9	0.2	0.5	1.8	0.4	12.0	0.6	5.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.2	2.3	2.9	23.7	0.8	0.3	0.2	2.1	6.1	0.7	0.1	0.4	8.7	1472.7	1.5	3.2	0.9	0.3	8.3	0.3	0.5	0.3	1.7	0.3	0.3	0.4	0.4	1.2	0.3	0.5	0.3	0.0	0.0	5.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.2;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 10.5;dendritic cells: 12.9;granulocytes: 6.3;NK-cells: 40.2;Squamous epithelial cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3273.9"	"Lineage enriched"	"Detected in many"	111	"granulocytes: 3273.9"	"Group enriched"	"Detected in some"	11	"BEWO: 14.5;HL-60: 8.2;HMC-1: 16.5;THP-1: 15.3;U-937: 15.1"					"Low region specificity"	"Detected in all"			"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	13.8	1.5	0.3	40.0	0.6	7.3	0.8	0.2	2.6	4.5	0.1	0.9	0.2	0.4	1.3	27.2	2.9	7.8	1.0	0.3	0.1	0.4	2.4	6.5	0.7	0.6	0.5	0.4	2.9	0.4	0.2	4.6	1.4	0.6	0.7	0.0	3.0	3.8	0.5	4.8	1.2	2.4	0.3	27.3	0.7	0.2	0.5	2.8	0.6	11.6	3.0	7.8	7.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.2	16.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	1.3	0.2	0.0	0.0	0.4	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.5	0.0	15.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	15.1	0.0	63.5	29.5	50.3	28.8	7.4	0.4	0.2	1.3	7.3	13.5	0.2	1.1	9.9	3273.9	6.8	3.6	25.0	0.5	17.4	0.3	0.6	0.2	2.6	0.3	0.1	0.6	0.5	1.4	0.3	0.5	0.4	0.0	0.0	10.5	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.2	0.0	1.9	0.0	0.0	0.7	12.9	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	6.3	3.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	1.6	0.0	0.0	2.8	0.0	1.0	3.7	0.0	40.2	0.0	0.1	0.0	2.2	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.0	11.6	0.1	0.3	4.1	0.1	0.1	1.9
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;intestine: 6.4;lymphoid tissue: 16.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 87.6;NK-cells: 15.5;Plasma cells: 36.5;Proximal enterocytes: 17.6;T-cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 306.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 306.7;NK-cells: 198.9;T-cells: 124.7"	"Cell line enriched"	"Detected in some"	15	"RPMI-8226: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA045942: AB_2679507"	"unprognostic (4.84e-3)"	"unprognostic (3.05e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (3.44e-6)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.01e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.67e-6)"	"unprognostic (4.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.76e-2)"	0.6	0.8	0.1	5.9	0.1	7.2	0.5	0.2	0.3	0.5	0.0	1.6	5.4	0.4	0.0	0.6	0.5	1.4	0.4	0.2	0.0	0.5	0.5	3.3	16.3	0.2	0.0	0.4	0.5	0.0	0.1	0.1	0.0	0.4	1.0	0.0	1.8	0.3	0.1	0.6	6.4	0.4	0.0	7.5	2.9	0.3	0.1	3.0	0.9	0.1	5.3	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.1	0.0	0.4	0.3	0.2	80.4	0.2	40.9	45.3	90.3	124.7	8.4	9.9	5.5	51.6	1.9	198.9	0.2	306.7	89.4	35.3	0.1	0.1	0.2	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	13.9	0.3	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.0	0.0	0.0	0.0	0.0	87.6	3.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	3.2	0.0	0.2	0.0	0.3	3.1	0.3	1.3	0.0	0.7	0.3	0.3	0.0	0.0	1.8	0.0	0.8	6.1	0.0	0.0	4.0	1.8	0.0	2.1	0.0	15.5	0.0	0.0	0.2	5.3	0.0	36.5	0.0	17.6	0.5	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.6	0.1	48.3	1.5	3.1	0.1
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1446.9;dendritic cells: 1015.1;Langerhans cells: 486.2;Macrophages: 513.6;Plasma cells: 534.2;T-cells: 1436.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 580.8;JURKAT: 323.6;Karpas-707: 302.1;MOLT-4: 538.9;REH: 281.0;U-266/70: 648.5;U-698: 677.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	51.8	184.5	11.8	297.9	11.4	1175.1	39.6	14.6	23.8	36.1	20.1	33.2	12.6	35.2	5.5	34.9	64.9	84.5	21.8	10.6	19.7	29.0	52.4	95.5	383.8	24.3	12.8	12.9	10.0	12.3	32.6	57.5	18.2	34.1	48.6	7.8	30.2	11.8	5.2	9.8	246.5	28.1	16.7	346.5	64.0	4.0	15.2	491.2	36.7	12.0	549.3	99.3	26.9	32.3	0.8	0.3	9.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	580.8	1.8	0.0	0.4	0.7	1.7	0.0	0.0	29.6	6.9	35.1	84.3	0.0	0.0	81.5	60.7	0.0	0.0	0.0	0.0	0.0	54.5	323.6	1.0	302.1	0.0	1.5	538.9	72.8	9.3	45.4	2.9	281.0	62.6	102.5	4.5	0.0	30.9	26.1	0.6	2.0	0.3	2.9	0.7	156.7	8.1	0.0	2.0	0.5	0.4	648.5	116.7	677.4	0.1	131.8	0.1	87.0	28.5	117.8	83.8	15.6	67.3	115.6	76.5	79.6	25.7	166.2	113.1	109.5	143.3	17.2	9.1	63.7	76.1	51.9	11.8	11.4	14.6	23.8	10.6	19.7	24.3	12.8	18.2	16.7	15.2	32.3	32.0	16.0	42.2	8.5	1446.9	41.0	5.7	0.3	9.6	8.6	46.1	42.2	5.2	11.5	4.4	3.7	0.0	1.5	1015.1	1.1	13.7	5.1	1.2	20.0	8.9	67.6	1.8	67.5	0.0	0.9	4.2	28.9	52.0	71.0	12.6	9.0	29.6	9.1	159.9	0.0	0.2	2.0	10.2	270.0	486.2	2.9	1.5	513.6	113.8	3.7	189.2	1.0	153.5	0.0	2.0	2.3	1.1	2.6	534.2	3.2	0.0	3.2	2.4	0.8	46.0	99.1	23.1	0.5	7.8	8.5	35.7	6.3	1436.5	4.6	1.8	4.5
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 533.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 15: Hepatocytes - Hemostasis"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.2	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.7	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.1	15.1	533.7	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	1.7	0.8	0.0	0.1	0.2	0.0	6.7	0.6	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.6	0.3	0.3	0.1	0.3	0.1	0.2	0.0	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683729-94736190	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.8;liver: 197.0;stomach 1: 67.2"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;OE19: 1.9"	"Not detected"	"Not detected"							HPA074424			Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	"Plasma membrane"	"HPA074424: "	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.3	0.0	0.0	1.6	0.1	0.0	0.3	0.2	0.1	5.3	0.0	5.9	102.8	0.1	0.0	30.9	0.0	16.3	0.0	0.1	0.0	0.3	197.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.5	0.0	5.4	0.0	0.0	4.4	83.1	0.1	0.1	0.0	67.2	0.1	0.1	0.3	0.0	0.0	7.1	0.2	9.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.3	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.1	17.2	3.2	0.0	0.0	0.1	0.0	6.7	0.0	1.5	0.0	0.6	0.1	0.0	0.0	2.7	0.5	6.9	0.2	0.1	68.8	1.3	0.0	0.0	1.8	124.0	0.0	0.0	0.8	2.1	2.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	3.9	0.0	0.3	0.0	62.5	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	22.8	1.7	1.5	0.1	0.1	5.7	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 177.7;liver: 276.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.3	14.4	0.1	3.8	0.4	0.6	6.5	0.8	0.9	5.1	0.4	28.4	127.3	3.1	3.0	22.1	3.1	32.7	1.0	0.3	0.0	10.6	276.1	9.2	1.4	0.6	0.0	0.8	47.0	0.0	0.9	0.4	0.4	21.6	21.0	0.7	2.9	5.7	0.9	20.5	177.7	1.1	0.0	0.8	86.5	0.4	0.0	2.1	1.0	0.0	3.2	10.4	13.1	0.5	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.1	0.4	0.8	0.9	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.5	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.2;kidney: 40.9;liver: 166.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.1	0.1	0.1	1.1	0.2	0.1	0.3	0.1	0.5	2.2	79.9	0.0	25.8	0.2	0.0	3.3	0.0	0.2	0.1	40.9	166.7	0.0	0.1	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.1	6.6	0.9	0.0	0.0	0.1	0.0	0.8	80.2	0.0	0.3	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112153-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 204.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 169.7;Early spermatids: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 481.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	19.4	58.2	22.3	20.6	24.9	30.3	30.6	39.8	32.3	26.4	21.0	52.7	86.6	21.2	35.8	43.7	16.7	24.3	20.7	24.2	39.0	38.7	204.7	53.2	13.1	60.1	42.3	29.0	48.7	59.6	17.1	21.9	50.6	43.8	41.5	31.4	20.3	17.5	7.9	26.5	40.0	20.4	46.6	13.4	45.1	86.4	31.8	6.6	33.6	11.7	16.6	21.3	26.2	57.0	113.7	54.3	134.0	86.4	92.0	149.6	18.7	37.7	112.7	47.1	128.8	131.8	201.7	98.1	57.9	65.3	481.6	96.2	118.1	237.0	55.3	40.3	82.6	27.9	51.1	99.7	125.7	56.0	39.4	109.1	105.7	185.6	194.0	42.2	49.4	19.8	108.2	217.8	56.4	115.6	12.5	53.8	100.7	45.9	53.4	40.3	27.8	222.8	216.7	187.9	94.1	62.5	80.0	156.3	117.2	60.6	56.9	69.5	59.5	65.0	70.6	95.2	49.8	72.8	70.5	88.1	49.8	75.5	85.2	2.8	11.1	3.9	11.6	16.3	7.7	15.6	8.0	8.9	16.3	12.3	7.1	9.6	1.5	7.8	10.3	14.3	6.7	8.2	22.3	24.9	39.8	32.3	24.2	39.0	60.1	42.3	50.6	46.6	31.8	57.0	3.1	67.3	169.7	35.9	24.0	2.5	1.6	4.6	48.9	2.6	6.7	3.7	1.6	7.2	44.5	1.8	2.1	1.5	8.9	20.3	1.9	10.7	74.4	10.7	8.1	7.7	10.8	11.6	34.3	19.8	1.0	9.1	43.3	16.4	28.5	4.1	5.3	45.2	1.5	0.0	39.6	13.1	2.0	5.6	1.9	34.4	3.7	9.2	0.0	15.9	1.3	2.4	0.0	39.2	53.1	14.2	11.7	1.5	34.3	1.4	9.6	1.5	15.7	1.9	0.0	4.0	6.5	7.8	4.2	51.4	5.4	4.4	12.2	9.3	11.9	2.5
CYYR1	C21orf95	ENSG00000166265	"Cysteine and tyrosine rich 1"	Q96J86	21	26466209-26573286	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 200.0;Endothelial cells: 150.0;Hepatic stellate cells: 79.9;Microglial cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	38	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 31.4"	"Cell line enhanced"	"Detected in some"		"AF22: 14.1;NTERA-2: 39.2;PC-3: 11.0;RH-30: 16.6;SCLC-21H: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034921, HPA067685"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB034921: AB_2089315, HPA067685: AB_2685887"	"unprognostic (5.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-3)"	"unprognostic (9.29e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	36.4	46.4	9.7	8.1	9.0	7.8	30.2	8.7	11.4	16.4	8.4	8.4	6.1	19.2	8.1	9.0	12.9	16.1	22.3	8.1	9.4	12.7	4.8	23.7	6.0	9.9	10.5	4.5	5.5	15.5	3.8	36.3	10.6	9.5	6.6	0.9	6.8	11.4	15.1	8.2	9.6	23.6	9.6	32.5	7.7	1.9	10.8	6.0	14.1	31.8	4.6	12.6	9.5	9.4	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.1	1.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.4	0.0	5.6	0.0	0.0	0.0	2.6	0.0	0.0	0.1	39.2	0.0	11.0	0.0	16.6	0.0	1.7	0.0	33.7	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	31.4	0.0	0.1	9.7	9.0	8.7	11.4	8.1	9.4	9.9	10.5	10.6	9.6	10.8	9.4	200.0	0.0	0.6	1.6	1.5	11.7	2.0	10.2	27.3	0.1	14.9	15.0	6.7	0.0	1.7	14.7	0.0	0.1	14.9	0.0	3.9	0.0	0.7	0.4	6.9	150.0	0.0	11.1	1.6	0.0	0.2	8.3	0.0	0.4	0.0	3.7	79.9	0.4	0.3	0.0	4.6	0.0	2.0	3.2	8.0	1.5	2.1	1.4	7.2	58.1	0.7	0.5	0.0	0.0	0.7	0.1	0.0	0.0	2.5	1.1	0.0	6.8	1.1	0.3	0.0	13.3	4.4	0.2	1.3	4.9	5.4	0.3	1.5	0.4	0.0	0.7
DAB1		ENSG00000173406	"DAB adaptor protein 1"	O75553	1	56994778-58546734	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8;intestine: 22.3;seminal vesicle: 10.0"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 460.3;Inhibitory neurons: 1170.3;Oligodendrocyte precursor cells: 814.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 54.0;HeLa: 18.6;NTERA-2: 23.4;RT4: 32.0;WM-115: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	2.0	1.7	4.3	0.4	5.3	0.0	0.3	16.8	8.8	1.6	0.0	0.8	15.8	0.5	0.4	0.6	1.6	0.7	1.8	10.6	5.4	0.3	7.7	0.4	0.2	2.1	3.9	1.2	0.4	0.0	0.2	0.0	2.0	3.9	0.3	5.4	0.9	10.0	0.1	0.1	22.3	0.3	2.3	0.2	1.0	0.4	5.1	0.1	0.3	0.1	0.1	1.2	0.9	1.9	0.0	0.0	10.6	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.1	23.4	0.0	0.0	6.0	0.0	0.2	0.0	32.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.6	0.1	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	4.3	5.3	16.8	8.8	10.6	5.4	2.1	3.9	2.0	2.3	5.1	1.9	0.7	0.0	0.0	30.0	0.1	0.0	0.1	0.1	0.0	23.7	0.1	0.3	3.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	8.6	8.2	0.6	0.3	0.0	0.0	460.3	0.0	0.0	0.4	4.6	12.8	0.0	0.0	0.7	5.1	0.1	21.9	1170.3	1.9	6.1	0.3	0.0	4.7	3.4	0.1	0.0	22.5	0.0	1.0	1.0	814.8	26.5	0.0	0.0	2.6	0.0	0.1	101.1	0.2	0.0	0.8	0.0	0.1	0.9	0.2	0.5	0.0	0.0	0.7	0.6	0.0	2.1	0.0
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148451-86832604	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.1;epididymis: 3.6;fallopian tube: 3.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 27.0;Granulosa cells: 14.3;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 71.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HAP1: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.2	0.1	4.4	0.0	5.0	0.0	0.1	1.3	5.8	0.3	1.4	0.1	0.2	0.3	3.6	0.0	3.7	0.0	0.0	5.7	7.0	1.0	0.0	0.1	0.0	3.7	3.6	0.5	0.2	0.0	0.5	0.0	3.9	0.4	0.0	2.0	0.5	0.1	0.0	0.0	0.3	0.0	2.0	0.0	0.4	0.0	8.1	0.0	0.1	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	5.0	1.3	5.8	5.7	7.0	3.7	3.6	3.9	2.0	8.1	3.0	0.4	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	2.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.1	3.3	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	4.2	0.0	71.4	4.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
DACT3	"DAPPER3, MGC15476, RRR1"	ENSG00000197380	"Dishevelled binding antagonist of beta catenin 3"	Q96B18	19	46647551-46661182	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 23.9;Oligodendrocytes: 27.2;Smooth muscle cells: 22.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 10.5;SH-SY5Y: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043053	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles	Nucleoplasm	"HPA043053: AB_10794769"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.30e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.03e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.59e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (6.66e-4)"	9.1	3.3	42.1	5.9	42.0	1.4	5.4	41.1	54.4	34.7	3.6	53.9	3.9	48.2	14.3	7.4	37.4	7.2	27.5	48.6	33.4	5.9	2.6	14.0	1.1	45.4	40.1	17.0	1.1	1.9	4.1	1.7	39.9	19.7	6.7	5.8	1.7	24.6	2.2	4.1	13.0	31.6	34.7	6.8	18.0	18.7	46.3	0.5	4.8	2.9	0.9	39.0	15.9	58.0	0.2	0.2	5.6	5.3	1.9	1.5	0.5	3.1	5.2	1.0	1.5	0.2	0.3	0.5	2.0	10.5	1.0	0.3	3.6	0.1	1.0	0.3	1.9	1.2	0.8	0.2	2.7	0.1	2.1	4.9	0.1	1.3	0.1	0.6	0.4	0.7	1.8	1.8	0.9	0.4	0.2	1.4	2.2	0.0	0.8	4.6	1.3	0.3	0.2	0.3	2.1	24.6	0.4	0.2	0.4	5.7	0.4	0.5	0.4	2.6	3.2	2.6	0.5	1.6	0.5	0.8	0.5	0.8	1.9	2.6	0.3	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.5	0.2	0.2	1.6	0.7	0.2	0.3	0.2	0.1	42.1	42.0	41.1	54.4	48.6	33.4	45.4	40.1	39.9	34.7	46.3	58.0	1.9	6.4	5.5	13.7	0.2	2.3	1.5	0.0	0.0	16.5	1.0	2.4	17.8	1.5	0.7	0.0	2.1	5.4	0.5	0.3	0.0	0.0	23.9	0.4	9.3	3.1	1.8	0.0	9.2	0.0	2.6	7.4	0.0	0.8	6.3	0.5	1.8	0.2	1.1	1.7	16.7	0.2	2.0	1.6	9.2	8.6	7.8	1.4	3.6	7.5	1.2	9.2	2.1	15.1	27.2	0.1	1.2	14.7	0.1	1.0	0.2	0.3	0.2	6.3	6.6	2.3	22.9	2.3	2.5	0.4	3.3	9.9	1.0	4.3	0.2	1.0
DBNDD2	"C20orf35, HSMNP1"	ENSG00000244274	"Dysbindin domain containing 2"	Q9BQY9	20	45406057-45410610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1300.9"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 18.8;Gastric mucus-secreting cells: 20.4;Macrophages: 10.7;Smooth muscle cells: 23.6;Squamous epithelial cells: 32.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"dendritic cells: 18.7;monocytes: 12.5;T-cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043991	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA043991: AB_10966212"	"unprognostic (6.33e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.79e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.24e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.48e-1)"	71.5	29.7	627.6	33.6	916.1	7.1	59.4	827.6	1054.5	73.6	462.6	160.9	54.5	106.6	41.7	58.7	102.7	33.1	470.5	645.7	709.8	56.3	10.4	63.1	21.3	871.6	808.2	39.1	39.9	65.3	41.3	42.9	853.0	70.2	91.1	34.9	47.7	89.4	316.2	68.6	78.4	100.9	739.9	30.3	82.2	14.4	822.1	23.2	37.2	248.2	27.3	118.7	69.7	1300.9	78.0	13.6	10.8	76.3	6.8	3.0	15.0	44.7	48.4	36.7	24.8	37.2	103.4	1.1	7.7	44.4	13.9	112.1	74.7	4.0	22.4	0.6	43.9	64.5	57.0	34.3	43.1	3.5	94.0	1.2	12.6	13.9	12.8	63.5	25.3	64.8	4.7	1.5	2.9	99.0	5.6	4.9	14.0	50.8	80.0	0.3	1.0	0.7	105.3	1.4	24.8	12.7	15.6	8.4	99.3	7.6	104.0	19.9	41.1	1.5	72.5	48.8	49.5	1.1	1.6	0.3	5.3	0.6	10.9	0.0	10.4	0.0	9.1	12.5	3.3	0.2	8.0	6.8	7.6	0.3	7.4	6.9	0.5	0.8	7.2	18.7	7.4	4.5	627.6	916.1	827.6	1054.5	645.7	709.8	871.6	808.2	853.0	739.9	822.1	1300.9	0.3	3.2	0.5	0.0	3.3	0.0	0.2	0.1	18.8	0.0	0.6	0.3	1.0	0.0	2.5	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.3	0.4	0.2	2.7	0.0	2.1	0.0	0.0	0.0	7.3	20.4	0.4	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	10.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.5	0.0	3.9	0.4	0.9	0.0	5.3	0.0	0.0	0.6	23.6	0.1	0.0	32.7	0.6	0.0	5.3	0.1	0.4	0.3
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DCTN2	"DCTN-50, RBP50"	ENSG00000175203	"Dynactin subunit 2"	Q13561	12	57529633-57547224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039715, HPA040040"	Enhanced		Supported	Centrosome,Cytosol		NA	NA		630000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome	Cytosol	"HPA039715: AB_10795154, HPA040040: AB_10794870"	"unprognostic (1.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.41e-3)"	85.7	99.7	76.3	40.7	80.5	44.6	76.7	88.6	86.1	91.3	62.5	104.6	44.6	98.3	61.8	120.2	71.9	43.6	102.3	81.4	87.9	84.9	50.7	71.7	43.3	91.1	85.1	75.8	116.0	78.2	75.7	52.4	95.5	66.4	73.5	61.3	82.9	65.4	155.2	103.7	75.9	93.3	82.1	64.2	94.9	51.9	82.7	61.4	69.9	102.7	71.4	79.6	89.8	89.9	94.9	109.4	129.1	90.3	194.7	200.0	69.4	104.7	191.7	205.0	149.6	87.2	79.0	95.5	114.1	172.5	83.8	70.8	106.0	136.4	162.0	108.7	119.1	84.8	48.4	69.9	139.3	58.7	60.0	186.3	213.8	131.5	225.1	245.6	201.9	102.0	127.7	126.6	189.5	107.4	89.3	71.8	62.4	56.2	124.0	77.2	101.0	91.4	158.1	92.3	173.2	125.8	98.3	85.2	96.7	104.0	138.5	54.4	153.5	110.6	95.6	69.1	66.7	94.6	91.6	93.8	106.4	73.8	121.2	47.9	48.5	43.7	38.0	54.2	39.3	32.9	37.9	38.0	49.2	30.3	28.1	34.3	22.5	35.1	50.3	37.5	45.5	62.8	76.3	80.5	88.6	86.1	81.4	87.9	91.1	85.1	95.5	82.1	82.7	89.9	82.6	48.1	30.2	20.2	47.5	64.9	87.2	105.1	58.6	84.3	64.7	76.7	70.9	65.8	60.0	35.0	31.3	118.2	53.5	83.4	80.3	162.7	105.5	42.9	58.6	74.0	49.1	53.6	27.9	227.5	122.1	73.6	80.5	52.4	36.2	70.8	69.9	31.7	102.6	72.3	32.6	70.3	83.4	51.8	54.2	265.5	77.9	52.8	76.5	15.0	153.5	141.9	57.7	23.1	28.2	200.4	85.5	73.0	60.9	85.3	121.1	115.8	40.9	67.8	92.1	59.4	107.6	122.7	37.1	93.6	68.5	163.4	52.6	92.3	94.5	89.5
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DEPDC1	"DEP.8, DEPDC1A, FLJ20354, SDP35"	ENSG00000024526	"DEP domain containing 1"	Q5TB30	1	68474152-68497221	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"GTPase activation, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.1;testis: 8.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.9;Erythroid cells: 31.8;Extravillous trophoblasts: 35.2;Late spermatids: 73.0;Spermatocytes: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB017845	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB017845: "	"unprognostic (2.73e-1)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.70e-5)"	"unprognostic (1.23e-3)"	"unprognostic (3.06e-1)"	"unprognostic (7.73e-3)"	"unprognostic (4.37e-6)"	"unprognostic (3.39e-3)"	"unprognostic (1.57e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.04e-6)"	"unprognostic (2.18e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.11e-1)"	0.3	0.1	0.0	2.6	0.0	5.0	0.6	0.0	0.1	0.4	0.0	2.9	2.5	0.5	0.1	2.4	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.2	4.8	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.1	2.1	3.5	0.0	0.3	0.1	0.0	1.6	2.4	1.5	0.0	0.6	1.2	8.1	0.2	8.1	0.3	0.2	4.8	0.9	0.7	0.2	47.2	21.5	40.0	18.5	2.5	5.6	31.3	58.9	26.9	49.1	42.1	17.9	19.3	0.0	42.8	24.4	78.6	30.8	58.6	30.7	82.4	41.2	38.2	38.3	35.9	10.5	0.6	33.4	0.0	2.1	1.6	56.3	31.2	10.0	36.0	16.5	26.6	36.1	88.3	10.7	0.1	12.5	34.6	19.5	28.9	0.0	118.7	15.3	19.8	12.7	44.8	20.7	59.0	24.9	30.3	25.6	22.5	16.6	21.3	31.5	35.5	56.0	69.2	22.5	52.2	0.5	29.7	11.4	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.3	2.0	3.3	0.8	3.3	1.2	0.4	1.3	1.8	0.8	0.0	0.5	1.8	0.0	20.6	0.4	2.1	0.0	0.2	44.9	4.0	1.6	1.6	0.0	31.8	0.5	0.0	35.2	4.4	8.2	2.0	0.0	17.5	2.2	1.2	8.6	0.0	2.2	5.3	4.1	3.5	1.0	73.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	6.9	2.2	0.5	0.1	0.9	0.2	0.0	0.6	4.0	86.8	19.6	12.2	1.3	2.9	1.6	0.5	8.8	1.7
DEPDC1B	"BRCC3, XTP1"	ENSG00000035499	"DEP domain containing 1B"	Q8WUY9	5	60596912-60700190	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;gallbladder: 21.0;lymphoid tissue: 20.7;testis: 12.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Erythroid cells: 23.8;Extravillous trophoblasts: 21.6;Spermatocytes: 37.2;Syncytiotrophoblasts: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038255, HPA072558"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA038255: AB_10669521, HPA072558: AB_2686534"	"unprognostic (1.38e-1)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.42e-4)"	"prognostic unfavorable (8.55e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (3.08e-4)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (2.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.11e-16)"	"unprognostic (1.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.62e-2)"	0.3	0.2	0.4	3.9	0.7	11.1	0.9	0.5	0.5	0.6	0.1	4.1	6.0	0.6	0.0	2.5	0.2	21.0	0.1	0.3	0.6	2.9	0.4	0.4	9.1	1.2	0.5	0.2	0.1	0.0	0.0	7.5	1.4	0.2	5.5	0.1	0.5	0.1	0.0	2.1	6.4	0.9	0.6	1.6	1.4	12.6	0.6	20.7	1.2	0.0	9.7	1.0	1.1	1.5	61.0	20.3	60.5	37.2	1.3	1.9	66.2	16.1	10.9	27.7	35.8	34.0	37.5	34.6	38.5	5.0	36.0	19.8	49.2	36.1	36.9	49.5	35.5	43.3	22.7	42.6	1.0	36.7	40.3	1.2	3.7	9.0	12.9	5.4	26.1	36.3	31.4	45.8	24.7	38.0	59.8	31.9	44.7	13.0	32.6	65.4	49.2	29.4	22.8	29.9	33.6	15.4	37.7	13.4	17.7	27.0	24.9	28.8	12.1	11.7	34.2	9.5	41.6	23.0	43.3	68.0	14.7	53.2	33.3	1.5	0.1	0.9	0.2	0.0	0.2	0.4	1.0	0.7	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	3.2	0.4	0.4	0.7	0.5	0.5	0.3	0.6	1.2	0.5	1.4	0.6	0.6	1.5	0.2	0.0	1.8	0.0	1.9	4.7	1.0	1.5	0.0	0.1	0.5	0.8	0.1	18.6	0.3	0.0	0.0	7.4	1.1	3.1	0.0	0.3	1.9	3.3	1.4	0.9	0.0	23.8	5.5	0.2	21.6	1.1	2.6	11.7	3.8	5.2	0.0	0.3	6.4	0.0	1.7	2.3	0.0	1.6	2.9	2.4	0.3	1.9	0.0	4.7	0.1	0.2	0.0	2.0	7.0	0.9	5.8	0.0	15.9	0.7	3.7	1.0	0.1	0.1	6.6	0.3	1.4	37.2	12.7	5.8	2.0	46.9	4.5	0.6	7.9	0.9
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1 autophagy regulator"	Q9NTK1	10	44970981-44978809	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 889.5;breast: 697.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 192.0;Ductal cells: 146.3;Exocrine glandular cells: 113.0;Glandular and luminal cells: 87.1;Syncytiotrophoblasts: 300.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 143.2;HDLM-2: 106.7;HHSteC: 258.2;HSkMC: 201.6;HUVEC TERT2: 165.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavorable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	889.5	48.4	62.3	19.4	71.4	4.5	697.2	59.5	71.8	153.0	50.3	145.7	16.7	168.5	16.5	65.7	334.2	68.5	260.6	55.5	71.9	95.4	131.6	508.6	63.0	175.9	72.3	297.8	349.7	23.0	85.2	76.5	93.4	82.6	12.0	28.2	119.7	22.8	165.8	165.0	94.8	68.8	101.6	32.8	104.6	19.3	87.4	25.2	200.5	52.2	47.6	177.6	139.1	90.6	30.2	0.2	0.5	0.4	143.2	69.5	7.4	0.2	10.2	0.4	1.8	1.1	11.2	0.0	1.6	13.5	7.1	1.2	1.2	9.1	0.7	106.7	4.0	0.1	0.1	11.0	258.2	0.1	0.1	201.6	0.4	0.1	1.4	24.9	165.0	0.0	0.2	63.2	0.6	0.0	0.1	1.7	0.2	0.6	0.9	5.1	1.7	25.7	0.5	10.9	5.6	0.3	0.0	1.3	5.8	17.0	0.2	7.0	1.6	7.8	5.6	0.5	7.3	1.7	2.8	0.4	44.2	2.6	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.4	62.3	71.4	59.5	71.8	55.5	71.9	175.9	72.3	93.4	101.6	87.4	90.6	192.0	0.0	24.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	47.0	27.8	0.0	0.0	6.2	31.3	0.0	53.8	1.4	0.0	37.2	146.3	0.0	61.3	33.2	60.0	0.0	0.0	0.0	113.0	14.7	79.3	0.0	87.1	0.0	8.4	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	65.0	0.0	0.0	0.5	0.0	0.0	25.5	5.8	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	300.2	1.8	0.8	0.0	0.0
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122227456	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 31.3;Plasma cells: 29.2;Squamous epithelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	23.8	34.3	29.8	17.3	30.8	32.5	25.3	33.7	36.8	21.4	30.4	28.7	21.7	27.0	36.1	30.8	23.3	18.0	30.3	28.7	32.0	34.5	39.6	21.2	21.0	32.0	31.4	27.8	27.7	32.2	41.4	25.8	32.1	21.9	24.5	27.5	28.9	19.5	37.4	25.4	26.9	20.5	33.6	24.3	26.6	53.2	31.0	26.9	25.8	34.5	24.9	32.0	24.5	33.4	49.0	94.7	65.4	44.7	45.9	44.6	50.2	49.5	48.3	56.9	50.8	82.4	24.9	59.2	45.4	45.2	42.4	47.4	72.2	59.3	67.0	51.1	56.4	65.2	36.6	76.7	65.3	71.0	25.9	62.2	41.3	67.3	100.1	64.4	66.8	57.9	75.9	24.5	56.1	72.4	58.6	103.8	52.9	69.5	88.0	52.3	65.2	65.4	64.4	74.7	61.7	62.6	66.1	26.2	54.8	73.3	87.9	49.2	46.0	43.7	53.6	50.0	45.4	52.8	95.5	84.3	55.8	53.6	58.8	43.3	39.8	39.8	39.9	41.4	37.8	46.3	36.4	37.2	48.3	36.4	35.6	36.1	17.9	45.5	40.1	37.5	46.3	42.0	29.8	30.8	33.7	36.8	28.7	32.0	32.0	31.4	32.1	33.6	31.0	33.4	0.2	0.0	0.6	7.2	19.7	5.0	5.9	7.6	31.3	7.3	0.0	0.0	1.3	10.0	3.3	0.0	4.2	11.3	3.0	8.2	0.0	0.2	6.3	0.0	0.0	3.8	7.3	20.4	14.5	0.0	10.8	7.7	25.5	0.0	4.5	0.0	5.3	2.9	6.5	3.3	14.1	8.8	8.2	3.3	3.6	4.6	5.6	7.1	3.6	3.7	2.7	7.6	9.2	9.0	15.1	0.2	11.9	3.4	29.2	3.9	16.8	0.1	1.7	11.1	6.6	2.6	4.9	19.2	16.3	30.4	4.8	13.4	13.2	0.0	9.9	3.9
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163928	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;testis: 18.9"	"Cell type enriched"	"Detected in many"	5	"Early spermatids: 414.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	0.4	0.1	0.1	1.7	0.2	7.1	0.8	0.3	0.3	0.3	0.2	1.9	1.9	0.6	0.0	2.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	1.2	2.4	0.2	0.3	0.1	0.2	0.1	0.0	3.5	0.2	0.1	2.1	0.0	0.5	0.0	0.0	1.3	1.6	2.6	0.1	0.5	1.6	18.9	0.3	5.4	0.1	0.0	2.4	0.6	0.7	0.2	47.7	15.6	15.8	9.1	2.7	7.1	26.9	65.0	28.7	64.2	55.6	41.7	31.4	15.9	5.2	33.4	16.7	31.7	26.0	25.5	96.9	18.0	17.9	22.7	37.6	9.5	4.1	31.2	17.4	2.8	0.6	39.2	26.3	16.3	29.2	14.0	17.8	21.9	61.8	6.9	28.0	10.2	14.7	22.5	8.9	18.8	38.9	12.9	19.9	9.6	8.3	14.3	33.2	22.8	9.5	33.8	16.7	16.8	29.3	40.5	25.9	13.7	54.5	14.7	17.1	24.4	10.9	15.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.2	0.6	54.5	3.4	39.8	1.9	3.7	0.8	2.1	2.8	0.0	3.9	1.5	1.0	2.8	1.8	0.0	0.0	21.1	1.1	3.8	5.9	1.3	414.4	2.5	3.5	2.1	0.0	26.7	5.6	4.0	30.7	5.8	9.7	9.3	0.0	78.8	1.8	0.4	6.1	0.0	3.3	2.6	2.0	1.0	1.2	56.0	0.6	1.5	0.0	5.6	0.1	3.5	2.1	19.1	1.8	1.5	0.2	0.0	18.9	0.4	1.1	5.4	0.2	0.0	0.0	0.0	7.9	39.2	17.8	11.6	1.1	7.3	2.2	2.8	5.6	1.5
DIPK1A	"FAM69A, FLJ23493"	ENSG00000154511	"Divergent protein kinase domain 1A"	Q5T7M9	1	92832737-92961522	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 30.6;Syncytiotrophoblasts: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015718, HPA017281"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA015718: AB_1848405, HPA017281: AB_1848406"	"prognostic favorable (8.96e-4)"	"unprognostic (1.00e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (1.26e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.66e-2)"	18.8	4.2	20.2	14.5	23.3	10.0	9.9	22.3	29.5	7.8	14.6	15.2	11.7	15.7	4.7	12.0	9.5	14.6	6.7	20.4	21.2	7.9	32.8	6.0	14.9	21.7	20.6	7.5	4.5	15.1	3.9	16.9	22.3	11.8	15.9	8.3	7.5	13.8	11.3	7.4	11.0	25.5	23.1	10.6	11.9	8.6	20.9	16.1	8.0	7.5	12.2	14.8	6.2	31.0	11.2	12.6	4.6	11.5	17.6	33.5	5.9	33.9	69.0	18.6	37.8	6.7	2.3	38.3	6.0	62.1	38.0	13.6	0.9	25.3	30.5	15.7	12.2	1.2	9.2	17.1	6.3	3.4	2.1	19.6	19.8	40.8	9.7	31.8	0.3	22.7	13.4	37.7	24.1	4.0	12.4	3.1	8.6	18.4	4.6	11.4	36.2	11.5	2.6	11.2	11.8	9.5	9.7	9.2	12.7	10.6	4.3	1.1	1.3	22.1	17.0	43.0	12.0	57.7	60.2	44.0	10.4	2.2	2.0	0.1	1.8	0.1	19.3	0.9	15.5	43.4	22.3	15.5	8.6	26.9	25.6	22.2	0.5	24.2	0.6	14.1	21.9	12.3	20.2	23.3	22.3	29.5	20.4	21.2	21.7	20.6	22.3	23.1	20.9	31.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	30.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	25.3	0.7	0.0	0.0	0.0
DIPK2B	"CXorf36, DIA1R, FLJ14103"	ENSG00000147113	"Divergent protein kinase domain 2B"	Q9H7Y0	X	45148373-45200901	"Disease related genes, Predicted secreted proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Adipocytes: 96.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 81.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002806	Uncertain				"Secreted - unknown location"	NA	NA		940000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA002806: AB_1078595"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.51e-3)"	"unprognostic (2.05e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.07e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.98e-1)"	"unprognostic (8.47e-2)"	"unprognostic (3.11e-2)"	40.8	5.3	14.4	6.1	15.0	0.8	36.9	11.7	13.9	19.6	7.8	9.1	2.6	20.5	6.9	6.5	18.0	8.8	27.3	11.4	13.1	7.0	1.4	14.1	5.7	14.4	14.2	6.9	3.5	4.6	3.3	40.5	14.1	11.3	3.8	1.4	6.8	7.2	16.6	7.4	7.7	20.7	12.4	3.1	6.3	1.5	14.8	2.7	18.5	16.6	3.4	14.3	13.9	15.4	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	81.7	0.1	0.0	0.5	0.0	0.1	0.0	0.3	0.1	1.4	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	15.0	11.7	13.9	11.4	13.1	14.4	14.2	14.1	12.4	14.8	15.4	96.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.7"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.4	1.4	5.3	3.1	5.4	2.6	1.9	3.9	5.6	2.1	2.6	1.5	1.1	1.5	0.5	1.3	1.1	2.6	9.0	4.2	4.9	1.1	1.4	1.7	2.4	6.9	5.8	4.4	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.7	2.0	0.9	1.4	1.2	1.3	1.4	5.6	2.9	1.0	0.9	7.3	3.1	1.8	1.1	1.7	1.6	1.3	7.7	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.4	3.9	5.6	4.2	4.9	6.9	5.8	6.9	5.6	7.3	7.7	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DLGAP1	"DAP-1, GKAP, SAPAP1"	ENSG00000170579	"DLG associated protein 1"	O14490	18	3496032-4455307	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 2145.5;Inhibitory neurons: 3599.2;Oligodendrocyte precursor cells: 1264.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 39.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 10.7;HAP1: 3.7;U-2197: 3.3;U-87 MG: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078234			Approved	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA078234: "	"unprognostic (2.50e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (5.87e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.78e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-3)"	"unprognostic (8.93e-2)"	"unprognostic (9.68e-2)"	0.4	4.3	8.3	0.2	18.3	0.0	1.5	4.4	39.4	0.6	0.0	0.3	0.1	0.7	8.2	0.2	6.5	4.1	0.4	24.0	0.0	1.2	0.1	0.7	0.2	0.0	0.0	1.9	0.2	0.0	2.4	0.6	0.0	2.9	0.2	3.2	1.9	10.1	0.1	0.2	0.2	0.3	0.0	0.5	0.1	3.7	0.0	0.1	0.5	0.4	0.1	0.5	0.6	7.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.2	1.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.4	0.8	1.2	0.0	0.1	0.0	0.8	0.2	0.0	0.0	0.0	0.0	1.0	3.3	0.0	0.2	0.0	0.1	2.3	0.0	0.9	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	18.3	4.4	39.4	24.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	1.5	0.0	4.6	309.8	0.3	0.8	0.3	0.3	5.7	23.6	6.6	2.8	3.1	7.2	0.1	1.8	0.0	0.1	0.1	0.4	0.0	0.2	11.4	31.7	8.3	1.9	3.0	0.0	2145.5	0.2	0.1	1.8	0.5	94.6	0.0	0.0	2.2	0.0	0.2	0.0	3599.2	1.7	0.0	0.0	0.7	13.8	0.6	0.6	12.4	72.1	0.1	0.2	0.0	1264.6	31.0	0.2	0.1	0.4	0.0	3.5	0.0	5.4	4.4	1.4	0.0	0.7	2.2	12.9	4.8	1.6	0.1	0.3	0.8	0.1	0.1	0.1
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.9;Excitatory neurons: 39.1;Horizontal cells: 21.9;Inhibitory neurons: 27.9;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;NTERA-2: 4.2;SCLC-21H: 12.5;SH-SY5Y: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026445, HPA027304"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody"		Yes	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Plasma membrane, Midbody"	"HPA026445: AB_1847733, HPA027304: "	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	0.3	0.4	46.9	0.5	41.2	1.1	0.2	0.0	48.2	0.2	0.0	0.3	0.2	0.3	0.0	0.1	0.3	0.1	0.1	36.0	19.1	1.3	0.1	0.2	0.3	0.0	17.8	0.1	1.1	0.2	4.8	0.0	0.0	0.2	0.0	1.8	0.2	0.2	0.1	0.2	0.5	0.0	0.0	1.9	0.3	7.5	51.6	0.3	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	8.0	0.1	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.3	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	12.5	2.4	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	46.9	41.2	0.0	48.2	36.0	19.1	0.0	17.8	0.0	0.0	51.6	0.0	0.2	0.0	0.0	1.0	1.8	0.3	0.9	0.8	1.8	4.1	0.7	0.8	1.0	0.0	0.1	1.8	4.2	0.1	0.9	0.8	3.9	0.4	18.9	0.2	0.1	0.4	1.2	0.0	39.1	0.6	0.2	0.4	0.0	0.1	0.0	0.3	0.4	0.1	10.1	21.9	27.9	0.4	0.0	7.1	0.6	19.3	0.9	4.1	0.0	1.9	0.7	1.5	1.0	8.0	0.7	0.2	0.0	0.0	0.8	0.2	1.3	0.8	0.0	2.2	0.0	0.7	0.4	3.4	4.9	1.1	0.3	0.0	1.3	0.1	0.9	0.6
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191608	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 29.7;lymphoid tissue: 42.0;testis: 17.4"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 92.6;Extravillous trophoblasts: 23.1;Plasma cells: 22.1;Spermatocytes: 68.1;Spermatogonia: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 5.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 5.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	0.8	0.3	1.4	8.1	0.9	29.7	1.4	0.4	1.8	0.8	0.6	5.5	5.0	1.3	0.1	5.2	0.4	0.8	0.2	1.0	1.7	0.2	0.7	0.7	17.9	0.7	1.0	0.2	0.1	0.2	0.0	4.1	0.8	0.2	6.7	0.1	0.8	0.1	0.1	3.1	4.6	2.7	0.3	2.6	3.0	17.4	1.1	42.0	0.4	0.0	18.7	2.0	1.5	3.8	144.8	56.8	140.6	63.7	3.3	13.4	43.8	80.3	52.7	115.3	109.3	45.9	75.8	82.1	44.2	46.9	47.4	85.6	91.5	64.0	150.5	101.9	45.7	84.4	49.9	39.3	0.4	82.7	49.3	2.8	2.2	54.8	27.0	18.9	129.0	82.5	70.5	79.8	109.3	69.2	105.0	42.7	72.6	63.3	57.3	80.8	137.9	39.0	37.9	45.2	71.7	40.7	84.8	31.7	30.8	60.6	71.6	31.6	49.6	52.4	133.3	50.6	94.6	19.4	44.9	108.9	35.9	59.6	83.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.9	1.4	0.3	0.0	0.2	0.1	0.2	1.0	0.0	0.0	5.4	0.7	1.4	0.9	0.4	1.8	1.0	1.7	0.7	1.0	0.8	0.3	1.1	3.8	0.1	0.0	0.5	0.0	4.4	1.1	0.7	3.3	0.0	0.0	1.2	0.9	0.4	0.0	1.3	0.0	0.0	11.6	1.4	3.2	0.0	0.4	19.7	7.2	2.6	2.4	0.0	92.6	0.3	0.0	23.1	4.2	7.7	4.5	0.0	15.8	3.9	0.5	10.5	0.0	0.3	3.6	8.2	4.1	1.6	6.0	0.9	3.7	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.2	1.2	22.1	0.6	0.3	0.1	1.3	0.0	6.6	0.0	3.8	68.1	31.7	11.6	0.4	1.9	4.0	0.9	6.9	1.4
DLL4		ENSG00000128917	"Delta like canonical Notch ligand 4"	Q9NR61	15	40929340-40939073	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.7;Distal enterocytes: 24.2;Endothelial cells: 48.6;Hepatic stellate cells: 30.4;Intestinal goblet cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BJ hTERT+: 59.4;HUVEC TERT2: 15.7;SCLC-21H: 32.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023392	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023392: AB_1847740"	"unprognostic (1.92e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (7.52e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.92e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.51e-3)"	25.2	2.6	6.9	2.9	6.1	0.3	21.2	6.5	7.0	8.0	4.9	7.6	4.0	8.8	1.0	3.7	7.6	3.7	23.8	5.8	6.0	10.0	3.5	22.5	5.0	7.1	6.5	4.1	2.9	2.9	5.6	19.8	7.5	7.9	3.0	0.9	4.3	2.7	10.0	5.5	6.8	4.2	6.6	4.6	4.8	1.5	8.4	5.0	15.4	10.6	1.7	8.7	7.6	6.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.9	59.4	0.2	0.3	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.7	0.0	0.4	1.1	0.1	0.1	0.0	0.6	0.0	0.9	0.0	1.4	0.5	1.6	0.0	0.1	32.5	0.0	0.3	0.7	0.0	0.0	0.0	3.5	0.9	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	6.1	6.5	7.0	5.8	6.0	7.1	6.5	7.5	6.6	8.4	6.2	70.7	0.0	2.7	0.0	1.7	1.3	0.2	0.2	4.0	4.9	1.6	2.8	3.2	1.5	0.9	0.0	0.0	1.5	0.2	24.2	0.0	0.2	0.2	1.9	0.7	48.6	17.4	0.0	0.9	0.2	0.6	3.1	13.3	2.6	2.5	0.0	30.4	0.1	0.2	0.0	0.6	36.3	6.1	1.6	0.8	0.3	0.0	0.8	1.8	11.2	0.0	0.2	0.0	0.5	0.5	0.2	16.7	0.0	3.5	2.3	9.2	0.0	0.2	1.4	0.0	0.9	3.8	0.8	2.0	1.0	1.6	1.9	0.4	0.4	12.0	0.6
DLX5		ENSG00000105880	"Distal-less homeobox 5"	P56178	7	97020396-97024950	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 14.1;placenta: 11.7;skin 1: 21.2"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.9;Endometrial ciliated cells: 217.8;Extravillous trophoblasts: 245.2;Glandular and luminal cells: 191.2;Syncytiotrophoblasts: 314.8"	"Cancer enriched"	"Detected in many"	11	"endometrial cancer: 81.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 53.7;HAP1: 27.2;SuSa: 13.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 13.5;olfactory bulb: 29.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 7.5;olfactory bulb: 18.0"	HPA005670	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA005670: AB_1078681"	"unprognostic (3.99e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.43e-8)"	"unprognostic (1.39e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	1.5	0.3	2.1	0.2	3.9	0.0	0.9	0.2	3.4	7.6	0.4	0.6	0.3	14.1	1.0	1.9	1.3	0.4	0.5	1.5	4.5	0.5	0.0	0.2	1.7	0.2	0.3	1.6	0.0	0.2	0.8	11.7	0.3	1.7	0.0	0.0	3.3	2.8	0.3	21.2	0.1	0.9	0.3	0.1	0.1	0.9	1.5	1.8	1.5	0.0	2.1	0.7	3.0	1.3	0.0	0.0	0.0	8.2	0.0	0.0	53.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.2	27.2	0.0	0.0	0.0	4.6	0.0	0.6	0.4	0.0	0.0	0.0	0.1	8.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.0	3.6	1.5	2.1	0.2	0.0	0.0	13.4	0.0	0.0	0.0	1.7	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.2	3.4	1.5	4.5	0.2	0.3	0.3	0.3	1.5	1.3	1.4	0.0	0.0	0.0	0.0	9.8	1.1	1.7	0.6	0.0	0.3	0.6	0.2	0.0	0.1	0.0	0.0	168.9	0.0	0.0	0.0	0.0	0.2	217.8	13.3	2.9	0.0	0.0	0.1	0.0	245.2	1.5	0.0	191.2	0.0	1.6	0.0	0.0	16.9	0.0	12.8	0.0	0.0	0.0	1.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	59.2	0.2	8.0	4.2	11.6	7.9	20.6	314.8	1.6	0.1	0.0	1.6
DLX6		ENSG00000006377	"Distal-less homeobox 6"	P56179	7	97005553-97011040	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.3;testis: 5.5"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 32.9;Early spermatids: 22.6;Endometrial ciliated cells: 37.3;Extravillous trophoblasts: 70.4;Glandular and luminal cells: 27.5;Syncytiotrophoblasts: 17.4"	"Cancer enriched"	"Detected in many"	8	"endometrial cancer: 12.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 33.4;HAP1: 15.3;SH-SY5Y: 11.0;SuSa: 19.3"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory bulb: 27.0"	"HPA030608, HPA061460"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nuclear bodies"		"HPA030608: AB_10600867, HPA061460: AB_2684529"	"unprognostic (7.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.05e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.12e-7)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.12e-2)"	0.4	0.0	2.1	0.0	7.3	0.3	0.1	0.0	4.3	2.0	0.0	0.2	0.0	2.5	0.8	0.0	0.4	0.0	0.1	0.8	4.7	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	3.0	0.0	0.3	0.0	0.0	1.1	0.9	0.1	1.5	0.0	0.2	0.0	0.1	0.0	5.5	1.2	0.3	0.4	0.1	0.2	0.3	0.2	0.4	0.0	0.0	0.0	10.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	1.9	15.3	0.0	0.0	0.0	3.9	0.0	5.9	7.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	2.6	1.6	0.0	0.0	0.0	0.0	2.2	7.3	11.0	1.0	0.0	0.3	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.9	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	7.3	0.0	4.3	0.8	4.7	0.0	0.0	0.0	0.0	1.2	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	32.9	0.1	0.0	0.0	0.0	22.6	37.3	2.2	0.2	0.0	0.0	0.0	0.0	70.4	0.2	0.0	27.5	0.0	0.0	0.0	0.0	3.3	0.0	8.0	0.0	0.0	0.0	0.0	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.8	6.8	10.2	0.0	0.0	17.4	0.3	0.0	0.0	0.1
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Antiviral defense, Differentiation, Host-virus interaction, Protein transport, Transport"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	19	"intestine: 1651.4;salivary gland: 519.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 192.9;Intestinal goblet cells: 113.4;Paneth cells: 388.2;Proximal enterocytes: 167.8;Undifferentiated cells: 314.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 47.6;stomach cancer: 76.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 9.9;LHCN-M2: 16.4;RH-30: 40.3"	"Not detected"	"Not detected"							HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	NA	NA		5200000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Centriolar satellite"		"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.5	0.2	0.6	45.3	2.9	0.1	0.3	4.4	1.5	12.8	0.0	55.6	1651.4	1.7	0.0	1.6	3.9	45.7	0.1	0.5	2.3	0.1	0.1	58.4	1.0	6.1	5.2	0.1	1.8	0.0	0.2	0.0	7.2	1.7	17.0	0.0	519.1	0.0	0.3	0.1	518.7	15.3	2.3	0.0	3.8	1.5	4.2	0.1	0.0	0.2	0.2	15.4	0.0	7.8	0.2	0.2	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.5	0.2	1.1	0.0	0.4	0.0	0.2	0.0	0.0	3.2	0.5	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.0	1.3	0.5	9.9	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	40.3	6.0	0.0	0.0	0.1	3.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.8	0.5	2.3	5.7	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	4.4	1.5	0.5	2.3	6.1	5.2	7.2	2.3	4.2	7.8	0.0	6.4	192.9	0.7	1.1	0.0	7.0	0.4	0.0	0.0	1.5	0.9	0.7	0.0	3.8	0.0	0.0	0.0	0.0	52.4	0.0	2.1	2.9	1.1	0.2	7.3	0.0	0.0	0.0	15.1	0.0	0.4	0.0	3.5	10.1	0.0	0.0	0.0	0.0	0.0	0.1	113.4	0.0	0.0	0.0	2.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.7	388.2	0.0	0.0	1.7	167.8	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.8	0.0	0.0	0.0	1.8	0.0	314.4	20.3
DNAJB5	Hsc40	ENSG00000137094	"DnaJ heat shock protein family (Hsp40) member B5"	O75953	9	34989641-34998900	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.5;tongue: 218.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"myeloid DC: 5.5;neutrophil: 5.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.5;granulocytes: 5.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023818, HPA050794"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA023818: AB_1847793, HPA050794: AB_2681241"	"unprognostic (1.41e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.53e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-3)"	14.7	12.5	18.5	11.0	18.7	1.5	8.7	23.0	27.7	14.0	14.8	63.0	7.7	56.0	11.8	32.5	29.6	12.7	64.8	24.0	20.1	8.5	4.4	12.3	4.6	20.3	21.0	8.6	6.1	4.0	25.3	2.4	19.4	27.5	12.2	10.1	6.3	52.1	164.5	5.1	17.9	64.3	18.1	12.2	26.8	16.0	19.3	5.8	10.9	218.5	5.0	33.7	11.5	18.8	4.7	3.8	23.7	12.7	13.6	10.4	2.6	20.1	14.5	30.3	26.8	2.8	1.0	4.5	4.9	22.2	31.7	0.6	9.1	15.8	25.5	6.4	2.9	1.6	5.6	1.3	15.6	0.5	14.2	15.2	1.1	18.0	8.9	13.4	19.6	8.3	0.4	9.3	24.7	3.3	7.8	6.7	11.2	2.1	8.1	6.0	24.4	2.5	4.4	0.4	10.1	16.4	10.8	0.6	2.4	20.2	3.8	1.4	8.8	14.4	31.4	7.6	6.3	3.4	2.5	3.3	16.6	1.8	15.9	0.0	1.0	0.0	0.2	0.3	0.9	0.4	0.2	0.0	5.5	0.2	0.3	0.7	5.2	0.4	0.1	0.1	1.0	0.5	18.5	18.7	23.0	27.7	24.0	20.1	20.3	21.0	19.4	18.1	19.3	18.8	1.9	6.4	1.5	8.5	0.9	2.0	2.3	4.7	1.8	6.0	1.7	1.4	42.9	1.5	1.8	0.0	6.2	0.1	0.5	0.5	0.0	2.8	8.0	1.7	4.8	4.5	0.0	0.0	4.9	3.4	0.7	6.7	2.0	2.2	0.0	1.7	3.6	1.2	4.7	1.7	3.3	0.3	2.0	1.9	11.1	6.7	1.5	3.6	5.4	1.9	1.2	12.0	2.1	6.6	3.2	4.3	0.0	7.9	0.7	1.5	1.6	4.4	1.0	2.7	6.6	14.7	16.8	6.3	1.3	1.8	3.0	0.8	1.4	1.5	0.3	0.7
DNAJC14	"DNAJ, DRIP78, FLJ32792, HDJ3, LIP6"	ENSG00000135392	"DnaJ heat shock protein family (Hsp40) member C14"	Q6Y2X3	12	55820960-55830824	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017653	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 10: Non-specific - Unknown function"			"HPA017653: AB_1847799"	"unprognostic (2.54e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.91e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.92e-2)"	14.0	13.2	14.2	15.4	14.8	16.3	15.6	13.4	14.2	16.0	14.2	14.2	13.8	15.4	16.9	11.3	17.4	12.6	12.2	14.0	13.3	16.4	16.9	15.2	16.9	14.5	14.6	12.8	13.5	24.6	11.5	16.2	13.8	14.8	15.0	12.3	15.5	13.4	11.2	13.2	15.0	16.1	13.8	17.6	14.6	18.6	14.6	23.6	17.7	11.3	19.0	14.2	10.4	16.2	25.0	29.7	31.9	32.3	31.3	29.5	36.1	27.6	35.8	35.2	25.5	24.2	41.5	31.5	51.9	31.4	24.3	26.9	28.7	34.4	32.1	50.8	20.6	43.6	28.0	20.4	32.4	26.5	35.9	26.5	28.3	35.4	32.8	52.4	38.7	45.7	34.0	36.4	40.6	29.5	48.8	26.3	25.1	24.8	24.8	39.6	28.5	27.6	32.4	21.3	43.1	40.2	22.2	30.5	21.0	30.6	64.1	40.1	33.6	33.2	30.6	31.2	22.6	43.7	40.7	27.7	33.7	24.1	42.1	14.8	9.5	16.1	12.9	8.4	10.2	10.3	9.6	11.6	9.1	7.4	8.4	10.5	7.8	11.3	11.5	11.6	8.4	11.1	14.2	14.8	13.4	14.2	14.0	13.3	14.5	14.6	13.8	13.8	14.6	16.2	9.2	6.4	7.7	1.6	6.8	4.0	4.0	8.1	5.7	7.1	7.5	4.2	0.8	7.2	9.0	11.0	10.4	10.0	6.7	9.6	3.9	9.8	4.5	7.1	7.7	8.1	7.2	10.8	3.9	7.7	14.1	6.4	7.7	6.8	1.3	9.7	5.3	7.4	9.8	1.7	3.8	5.2	0.0	12.5	10.7	4.7	9.6	9.2	7.2	3.7	8.6	7.9	13.4	1.5	5.5	9.3	7.7	9.1	8.5	5.6	8.0	7.5	6.9	5.2	6.6	7.4	11.5	6.8	10.0	5.1	4.1	13.0	6.3	7.7	7.2	3.5
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346888-49357546	"Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 24.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Distal enterocytes: 36.8;Exocrine glandular cells: 42.9;Hepatocytes: 44.6;Intestinal goblet cells: 26.9;Pancreatic endocrine cells: 27.6;Paneth cells: 26.2;Proximal enterocytes: 59.6;Undifferentiated cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.5;CACO-2: 19.1;EFO-21: 17.2;MCF7: 18.8;OE19: 18.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low region specificity"	"Detected in all"			HPA039953			Approved	Vesicles		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA039953: AB_2676770"	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favorable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.2	0.2	0.5	0.4	0.7	0.2	0.3	1.5	0.8	1.1	0.6	4.0	5.6	0.6	0.3	0.0	0.7	3.1	0.1	0.5	0.5	3.7	24.1	0.1	0.1	1.7	1.4	0.0	5.6	2.0	0.2	0.2	1.8	0.2	2.2	0.2	1.4	0.1	0.0	0.4	5.0	0.2	0.7	0.2	3.0	0.6	0.8	0.0	4.4	0.0	0.0	0.1	0.7	1.1	0.9	5.6	0.0	10.5	0.0	0.0	2.4	0.0	1.9	0.5	1.3	19.1	4.0	0.0	17.2	0.5	0.6	0.2	1.2	0.0	1.5	0.0	3.5	0.2	0.4	6.3	1.1	0.1	1.2	0.2	0.1	0.6	0.1	2.8	0.5	0.1	0.1	0.2	0.6	18.8	0.0	0.1	0.1	18.6	5.8	0.0	3.6	0.1	0.3	0.1	2.6	0.6	0.1	0.3	2.4	0.1	6.7	0.0	0.2	0.6	2.1	0.1	0.6	0.0	0.0	0.0	1.7	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.5	0.8	0.5	0.5	1.7	1.4	1.8	0.7	0.8	1.1	0.2	0.0	1.1	1.0	0.3	0.6	1.5	3.0	0.0	0.3	5.9	3.7	0.5	47.1	2.0	1.8	0.0	0.1	0.3	36.8	0.0	16.0	4.1	6.2	4.5	0.6	21.0	0.0	0.5	42.9	0.3	3.8	10.2	5.9	1.3	4.7	1.4	44.6	0.1	3.3	0.2	26.9	0.0	0.8	0.4	1.9	0.0	0.4	3.6	0.0	0.6	0.6	0.0	0.0	5.7	27.6	26.2	0.7	0.0	0.7	59.6	18.6	5.7	0.5	0.0	0.5	2.1	1.9	1.9	0.0	0.3	0.4	0.5	1.0	26.2	0.4
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637268-170083382	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 61.6;lung: 16.4;lymphoid tissue: 51.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.3;dendritic cells: 78.1;Kupffer cells: 93.2;Macrophages: 78.0;Microglial cells: 173.3;monocytes: 72.5;T-cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 123.4;HDLM-2: 172.7;HL-60: 132.7;HMC-1: 135.8;MOLT-4: 94.5;U-698: 112.4;U-937: 85.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.7	3.6	1.4	34.4	2.4	61.6	3.6	1.9	2.6	3.1	2.8	7.6	5.0	2.3	1.3	3.3	2.4	9.6	1.6	1.8	2.5	1.2	5.5	16.4	42.5	6.4	3.7	1.6	1.9	1.5	0.8	7.3	4.6	1.8	7.8	0.2	2.6	1.9	0.9	1.2	9.6	7.0	4.6	36.5	8.1	1.7	6.3	51.4	1.5	1.4	46.9	9.9	1.1	8.4	0.4	0.3	0.0	0.0	0.0	0.4	0.0	3.3	0.0	8.2	14.3	0.0	0.0	123.4	4.5	13.0	3.9	0.1	0.1	0.6	19.5	172.7	0.3	71.0	3.4	0.0	0.2	132.7	135.8	0.4	0.0	6.3	0.0	5.5	0.5	65.1	1.4	60.3	8.7	0.0	94.5	27.0	0.2	0.0	0.0	59.9	4.8	49.3	3.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	64.8	0.4	5.9	6.8	4.1	9.1	18.6	40.9	112.4	7.3	85.1	0.2	19.7	28.6	22.0	12.3	48.6	12.6	13.2	11.3	12.6	29.8	9.7	7.8	9.5	29.4	13.5	72.1	10.9	11.7	24.0	1.4	2.4	1.9	2.6	1.8	2.5	6.4	3.7	4.6	4.6	6.3	8.4	1.4	0.0	3.9	2.0	53.3	0.9	0.2	0.0	0.0	0.0	0.7	2.3	1.7	0.0	2.5	0.0	0.0	0.3	78.1	0.2	0.0	0.0	5.9	0.3	0.3	1.5	0.0	15.1	9.6	0.0	0.3	1.3	1.5	0.3	33.6	0.8	1.8	1.3	42.6	0.0	4.9	0.0	0.0	93.2	31.1	5.6	0.3	78.0	5.4	173.3	72.5	0.0	47.4	4.0	21.7	0.2	0.1	0.0	39.6	0.1	0.0	0.2	0.7	0.1	6.6	0.7	0.6	2.8	1.4	0.2	2.0	0.8	50.8	0.3	0.1	0.1
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913690	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 25.6;lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.6;Hofbauer cells: 131.8;Kupffer cells: 171.8;Langerhans cells: 288.4;Macrophages: 181.5;NK-cells: 344.0;T-cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1565.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.3;HEL: 54.3;HMC-1: 119.8;JURKAT: 22.3;THP-1: 43.1;U-937: 42.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		220000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	9.5	5.0	1.1	26.5	1.2	19.5	5.0	1.2	2.3	1.9	2.5	5.5	7.0	2.2	0.5	2.3	3.5	6.5	3.5	1.3	1.3	3.0	6.1	25.6	26.3	1.4	1.5	1.4	1.9	0.5	1.1	7.9	1.5	2.3	3.6	0.0	3.4	1.5	2.0	2.3	9.5	6.9	1.2	40.9	6.8	1.6	4.5	16.4	2.4	1.6	7.8	8.4	2.3	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	54.3	0.0	0.1	0.0	0.4	119.8	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.8	5.0	0.0	0.0	0.9	8.7	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.3	0.0	0.1	0.2	0.1	0.2	0.1	0.3	1.4	42.0	0.2	577.6	484.3	1565.6	398.3	624.0	184.5	14.5	274.3	304.8	421.9	6.6	151.0	185.9	37.2	307.6	580.7	7.6	597.2	810.3	1.1	1.2	1.2	2.3	1.3	1.3	1.4	1.5	1.5	1.2	4.5	1.5	2.0	3.2	18.1	0.0	13.2	11.5	0.6	0.0	0.0	0.0	1.2	1.8	2.1	0.0	1.3	3.7	0.0	0.7	130.6	0.3	0.0	0.1	0.2	0.2	0.5	2.8	0.0	10.5	0.1	0.0	1.0	2.6	3.1	0.4	36.3	0.1	5.7	1.1	131.8	0.0	0.0	0.2	0.0	171.8	288.4	0.6	0.3	181.5	19.6	0.0	74.8	0.0	344.0	0.0	0.0	0.0	0.0	0.0	15.4	0.2	0.0	0.7	1.5	0.0	0.0	0.6	2.5	0.2	4.3	0.7	8.5	1.0	147.4	0.0	0.2	0.8
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390808-147510068	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.5;Cone photoreceptor cells: 331.5;Granulosa cells: 261.9;Peritubular cells: 205.7;Rod photoreceptor cells: 125.0"	"Cancer enhanced"	"Detected in all"		"glioma: 109.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 685.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Approved	Cytosol		NA	NA		740000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.23e-4)"	58.4	18.6	63.4	54.4	68.6	0.8	37.5	60.3	55.8	66.1	30.4	142.1	18.4	119.9	73.9	69.0	63.4	65.1	59.2	57.0	116.0	7.7	4.4	45.2	18.1	123.7	94.2	88.0	5.5	2.7	12.7	19.8	81.8	104.6	37.6	163.8	24.5	162.0	68.7	23.8	43.3	217.6	115.2	26.4	40.9	19.9	95.2	7.1	22.4	36.0	27.0	118.0	50.6	105.1	0.5	36.1	63.9	0.1	2.3	63.3	1.6	34.1	163.0	71.4	94.4	114.5	3.1	0.0	9.6	100.1	37.4	3.7	13.1	1.4	79.1	16.3	29.2	0.1	30.0	0.2	63.1	0.3	0.2	12.2	0.6	153.8	60.3	178.7	206.9	0.0	0.0	1.3	41.1	0.3	0.2	0.6	135.9	0.2	53.7	0.2	135.1	0.5	63.0	14.2	47.1	685.4	0.3	0.3	10.8	87.9	0.5	1.0	91.1	51.6	38.5	127.0	127.3	113.9	21.7	0.2	47.5	1.4	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.4	68.6	60.3	55.8	57.0	116.0	123.7	94.2	81.8	115.2	95.2	105.1	59.9	0.0	2.8	101.5	0.0	9.4	3.4	1.5	2.2	14.2	8.1	6.6	7.8	1.5	4.0	0.0	331.5	0.1	0.0	0.2	0.0	9.1	16.8	0.3	4.6	62.6	6.6	0.0	11.3	8.4	0.3	79.8	3.1	1.2	1.3	261.9	57.8	0.4	1.6	5.0	12.9	0.2	24.4	1.2	11.9	19.2	42.9	3.1	19.6	5.6	0.0	28.3	0.0	83.9	0.7	13.7	0.0	205.7	0.3	10.1	0.0	0.1	2.8	125.0	0.0	23.6	40.9	1.8	3.2	3.7	8.2	0.4	1.5	49.6	0.3	4.5
DPYSL5	"CRAM, CRMP-5, CRMP5, CV2, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 111.5"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 85.5;Late spermatids: 134.3;Oligodendrocytes: 331.2"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 141.0;HAP1: 118.7;SCLC-21H: 167.3;SH-SY5Y: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: AB_2686516"	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	0.0	1.9	22.6	0.3	49.4	0.0	0.0	59.4	41.7	0.1	3.8	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	17.6	42.1	0.1	0.0	0.0	0.0	79.6	50.2	0.1	0.0	0.0	7.8	0.0	65.5	0.1	0.2	15.8	0.0	0.0	0.1	0.0	0.3	0.3	54.8	0.0	0.1	7.8	60.2	0.0	0.0	0.0	0.0	0.0	0.1	111.5	0.0	3.0	141.0	0.1	0.6	0.0	3.3	0.0	0.0	0.0	0.0	13.2	0.0	0.0	1.0	0.0	3.9	0.0	118.7	0.0	0.0	0.0	26.2	0.0	0.1	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	31.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	167.3	99.0	3.8	0.2	0.0	3.3	0.0	0.0	0.0	0.0	4.1	0.1	3.8	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	49.4	59.4	41.7	17.6	42.1	79.6	50.2	65.5	54.8	60.2	111.5	0.1	0.0	0.0	13.4	0.1	0.0	0.3	0.0	0.0	12.1	0.1	0.0	6.0	0.0	0.0	0.0	85.5	0.1	0.0	0.0	0.0	0.0	45.6	0.1	0.1	0.4	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.2	2.5	0.2	0.0	0.2	0.1	8.4	40.5	0.0	0.0	0.0	0.7	134.3	1.5	0.2	1.8	2.8	0.1	17.2	0.0	18.1	331.2	0.0	0.0	1.2	0.1	0.2	0.0	0.1	0.0	12.1	0.0	0.7	0.3	2.9	4.6	0.0	0.3	0.0	0.2	0.7	0.0	0.1
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526281	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039158, HPA046763"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA039158: AB_10960125, HPA046763: "	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.0	6.3	16.4	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	5.6	0.0	0.4	0.0	0.0	1.1	13.9	0.5	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	1.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.8	0.1	0.0	0.0	0.5	0.2	18.4	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	15.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.5	0.1	4.5	4.6	0.4	0.1	0.0	0.3	1.5	3.5	0.0	2.1	1.6	0.0	17.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.0	0.6	0.0	0.8	0.6	13.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	13.9	0.0	0.4	0.0	44.2	0.0	5.0	0.9	0.0	0.1	0.1	0.6	0.3	3.1	0.0	1.1	0.1	0.0	12.5	0.2
DRAXIN	"C1orf187, FLJ34999, Neucrin"	ENSG00000162490	"Dorsal inhibitory axon guidance protein"	Q8NBI3	1	11691710-11725857	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.5;NK-cells: 3.1;T-cells: 4.6"	"Group enriched"	"Detected in some"	6	"glioma: 5.1;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"NTERA-2: 27.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA014302	Uncertain				"Secreted in brain"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA014302: AB_1853084"	"unprognostic (5.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.16e-6)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (5.08e-1)"	0.0	0.0	1.6	0.2	1.4	0.5	0.0	1.1	1.3	0.0	0.6	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	1.2	1.0	0.0	0.0	0.1	0.2	2.7	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.3	3.9	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.6	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.0	5.7	0.0	0.2	0.0	0.1	0.0	0.2	2.1	0.3	27.9	0.0	0.1	6.4	0.2	0.0	0.0	0.0	1.8	0.7	0.1	0.0	0.1	4.6	0.0	0.2	0.2	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.4	2.5	0.3	0.1	0.5	0.1	0.2	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.8	0.2	0.2	0.1	0.2	0.1	1.6	1.4	1.1	1.3	1.2	1.0	2.7	0.6	0.5	0.4	3.9	1.3	0.1	0.0	0.5	0.0	1.2	0.5	2.9	0.6	0.0	0.7	0.4	0.4	1.1	1.5	0.1	0.0	2.1	0.1	5.5	0.1	0.0	0.1	0.7	0.4	0.4	0.6	0.0	0.0	0.4	0.2	0.2	0.6	0.0	0.4	1.3	0.1	1.1	0.2	0.4	0.0	0.5	0.7	0.0	0.8	1.9	2.1	0.6	1.2	1.8	0.0	0.3	0.2	3.1	1.5	0.4	0.2	0.2	0.0	1.5	2.1	0.0	0.1	0.0	0.7	0.0	2.3	0.7	0.6	1.7	0.0	0.3	0.0	4.6	0.1	0.1	2.2
DRC1	"C2orf39, CCDC164, CILD21, FLJ32660, MGC16372"	ENSG00000157856	"Dynein regulatory complex subunit 1"	Q96MC2	2	26401920-26456711	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 10.3;fallopian tube: 39.3;testis: 20.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 142.0;Endometrial ciliated cells: 112.8;Late spermatids: 321.2;Respiratory ciliated cells: 260.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in single"		"CAPAN-2: 1.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 6.9"							NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (2.28e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.56e-3)"	"unprognostic (7.02e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.06e-3)"	"unprognostic (8.19e-2)"	"unprognostic (9.91e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-2)"	0.0	0.0	2.3	0.0	2.5	0.7	0.0	1.4	1.4	1.5	10.3	0.1	0.0	0.9	0.1	0.0	39.3	0.0	0.0	2.1	2.8	0.2	0.0	3.1	0.0	5.7	7.3	0.0	0.0	0.0	3.2	0.0	4.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	20.8	2.9	0.3	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	2.3	2.5	1.4	1.4	2.1	2.8	5.7	7.3	4.5	5.0	2.9	4.9	0.2	0.0	1.1	1.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.3	0.5	0.0	17.9	1.8	0.0	0.0	0.0	0.1	0.0	0.0	142.0	112.8	1.2	0.3	0.0	0.0	4.3	0.7	0.0	0.5	0.0	1.5	1.3	0.0	0.0	0.0	0.1	0.0	4.8	0.1	10.2	0.0	0.0	321.2	2.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	1.2	0.4	0.0	0.2	1.3	0.1	260.8	0.0	0.0	0.0	2.4	39.5	1.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847158	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.6;pituitary gland: 4.2;retina: 1.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 4376.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019324, HPA057493"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA019324: AB_2670118, HPA057493: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.0	0.0	5.4	0.0	5.8	0.0	0.1	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.6	4.2	0.0	0.1	0.0	0.0	2.3	2.8	0.0	0.1	0.0	4.2	0.7	3.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.8	0.1	6.6	5.6	4.2	2.3	2.8	3.5	2.9	4.1	4.1	0.0	0.0	0.0	19.9	0.0	0.0	0.1	0.0	0.0	19.6	0.0	0.4	1.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	1083.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	16.8	649.1	0.0	0.0	2.4	0.0	4.2	0.0	0.0	0.0	200.5	0.0	0.7	0.0	4376.6	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.1	1.7	1.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17570075-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 1690.3;SK-BR-3: 1421.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037094	Approved					NA	NA		3700000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	306.9	232.5	134.0	136.7	150.8	53.3	287.0	144.0	178.0	336.8	144.5	1146.3	136.1	636.1	297.1	535.6	449.9	297.4	411.6	150.0	158.2	269.0	141.3	315.8	60.2	146.7	150.3	236.8	268.9	180.0	127.1	162.3	154.4	559.2	306.8	114.0	274.6	758.3	87.2	227.8	285.6	695.0	147.6	75.2	486.8	82.0	140.4	47.8	273.0	111.4	79.0	704.4	312.7	164.1	323.0	431.3	161.5	160.5	399.8	391.5	303.8	397.7	616.4	248.1	221.7	200.4	348.6	50.1	97.7	587.8	458.5	305.3	149.4	606.5	281.9	28.0	125.5	131.9	247.2	295.3	426.2	102.9	86.5	357.9	563.1	239.3	275.9	609.0	360.6	85.4	63.4	65.7	468.1	251.7	42.2	121.6	110.4	1690.3	322.3	28.9	248.4	103.5	686.4	291.9	244.6	72.9	363.0	1421.1	441.9	263.7	654.3	55.9	345.3	294.9	93.2	324.1	276.8	39.7	52.2	134.6	139.9	43.8	250.8	33.8	17.6	59.2	55.9	32.2	46.8	11.9	56.9	52.0	22.1	9.0	37.0	47.0	11.8	48.8	46.4	51.1	46.7	45.3	134.0	150.8	144.0	178.0	150.0	158.2	146.7	150.3	154.4	147.6	140.4	164.1	372.8	1442.3	667.9	25.1	84.9	1151.6	697.0	796.7	542.4	101.5	925.2	762.2	1131.3	739.2	696.8	678.6	50.1	576.4	336.9	549.2	1457.6	1022.2	295.0	558.3	447.3	481.7	546.5	83.1	54.7	1468.6	1165.0	533.5	275.7	540.2	183.8	199.4	425.9	602.4	222.2	176.7	43.1	643.2	533.0	147.8	361.5	111.2	496.8	133.0	610.1	57.1	191.7	779.1	224.6	30.7	44.0	1018.6	572.8	1266.8	172.4	640.3	304.4	1491.4	912.0	153.1	1216.2	271.1	1745.4	390.0	298.9	515.2	1043.5	549.5	161.6	252.0	545.8	680.2
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.5;skin 1: 81.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Group enriched"	"Detected in many"	6	"cerebellum: 12.4;white matter: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.6"	HPA023544	Approved					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	1.5	14.1	0.7	1.0	1.0	0.2	4.5	12.4	1.2	44.5	0.0	1.0	0.6	3.0	50.0	108.5	14.0	3.3	3.3	1.0	0.3	0.7	0.4	70.1	0.3	0.3	0.3	1.8	0.5	5.2	1.3	1.5	0.6	13.8	0.3	0.6	18.7	13.0	0.4	81.7	0.7	0.4	0.1	0.3	64.3	1.6	0.4	1.1	70.4	0.0	14.7	11.1	42.0	3.2	8.3	0.1	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	64.4	0.0	6.1	0.0	0.8	0.4	0.0	0.9	0.1	0.0	0.0	0.3	0.0	30.5	0.0	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.1	0.0	0.0	36.3	0.8	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.0	12.4	1.2	1.0	0.3	0.3	0.3	0.6	0.1	0.4	3.2	0.9	83.3	168.6	4.2	4.5	11.1	14.3	22.8	11.4	21.3	4.7	2.8	2.4	8.6	32.5	3.7	8.4	5.3	7.6	2.5	0.0	3.8	0.7	67.1	9.4	3.8	21.7	2.7	5.1	5.4	0.6	5.1	17.9	88.5	8.2	7.9	7.9	1.5	1.2	6.7	3.9	4.0	16.2	3.1	43.5	0.3	3.4	3.3	16.0	1.0	3.2	3.5	33.0	9.5	10.6	4.7	4.0	3.8	0.1	9.5	6.8	0.5	64.9	4.4	0.0	8.5	4.7	11.5	7.5	36.4	18.0	3.7	4.5	0.4	5.6	30.0
DUOXA1	"FLJ32334, mol, NIP, NUMBIP"	ENSG00000140254	"Dual oxidase maturation factor 1"	Q1HG43	15	45117367-45129938	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 189.0;skin 1: 91.6;thyroid gland: 111.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041578	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041578: AB_10795691"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.36e-2)"	1.1	5.0	0.2	1.3	0.5	0.1	4.0	0.7	1.1	32.1	0.0	0.9	0.8	4.6	49.3	189.0	5.7	4.3	2.1	0.5	0.3	0.8	0.3	64.3	0.1	0.6	0.1	1.1	0.4	5.0	0.7	0.8	0.8	21.6	0.5	0.1	27.5	12.0	0.5	91.6	0.8	0.2	0.1	0.1	43.6	0.2	0.7	0.7	111.1	0.0	17.9	23.3	77.4	2.9	10.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	103.9	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.5	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.1	0.5	0.3	0.6	0.1	0.8	0.1	0.7	2.9	0.0	60.9	118.0	1.0	0.0	9.4	18.8	26.9	18.2	0.6	1.4	1.7	0.5	0.0	35.5	0.0	2.1	2.4	0.0	3.3	0.0	2.0	0.1	28.7	4.0	0.8	3.0	0.0	0.7	3.1	0.1	1.6	8.6	47.7	1.3	0.3	0.0	0.0	0.3	0.0	0.4	0.1	4.1	0.0	1.2	0.0	0.3	0.8	0.0	0.0	0.6	0.1	0.0	0.5	1.8	1.9	3.3	0.0	0.0	13.4	0.0	0.0	36.9	0.1	0.0	0.7	1.1	0.0	0.9	53.6	21.9	3.0	0.6	0.1	0.4	44.2
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	17.0	6.0	7.6	18.6	11.6	129.5	5.5	7.5	55.0	8.1	9.2	4.5	1.6	7.0	7.7	6.8	7.6	12.5	19.5	13.4	6.2	12.7	7.5	18.2	47.1	8.0	6.3	7.8	2.3	1.7	35.1	1.3	6.7	17.6	2.0	0.4	3.9	61.5	2.8	26.0	11.8	3.4	6.7	42.0	7.4	3.6	6.9	47.3	6.7	3.7	24.6	39.5	9.0	9.3	3.2	0.0	0.2	0.2	0.4	0.5	4.4	3.7	0.0	5.3	5.1	8.9	0.6	30.4	10.6	4.1	0.0	2.2	7.5	0.0	1.0	0.5	0.0	0.7	29.7	0.0	1.9	12.8	2.6	0.9	2.0	0.9	0.0	0.1	0.0	27.6	0.0	33.8	0.2	5.2	25.5	29.1	6.5	0.8	10.6	0.0	0.4	24.3	0.2	34.2	29.6	1.5	1.4	0.3	5.6	0.0	2.0	14.4	0.1	0.0	7.9	0.0	1.7	2.3	3.9	43.2	0.0	13.9	0.3	2.3	4.3	1.0	199.3	10.5	95.4	17.5	46.7	176.2	10.7	13.9	32.0	99.3	6.1	148.1	9.1	3.0	16.1	40.5	7.6	11.6	7.5	55.0	13.4	6.2	8.0	6.3	6.7	6.7	6.9	9.3	50.8	0.0	7.7	0.7	303.7	96.7	155.0	31.3	70.6	27.8	65.8	72.0	37.8	2.8	12.0	9.2	22.9	0.9	919.7	20.4	1.9	0.9	0.9	115.6	62.7	28.7	87.8	50.5	5.2	1.4	1.7	22.8	86.6	321.1	104.3	7.4	12.8	3.9	80.2	0.0	1.4	37.5	8.2	40.4	924.0	1.4	1.8	353.9	144.1	1.9	3.4	1.5	90.6	1.0	0.5	1.0	2.5	1.9	268.5	70.4	1.6	1.4	2.7	3.6	0.0	14.7	26.6	0.6	4.8	50.4	109.7	1.6	764.7	3.0	51.6	41.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
E2F7		ENSG00000165891	"E2F transcription factor 7"	Q96AV8	12	77021248-77065569	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lymphoid tissue: 8.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.9;Endometrial ciliated cells: 17.2;Late spermatids: 70.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"midbrain: 5.8;pons: 6.4;thalamus: 11.3"	HPA064866			Supported	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA064866: AB_2685374"	"unprognostic (1.21e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.14e-5)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.67e-5)"	"unprognostic (1.42e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.51e-1)"	0.2	0.1	0.2	1.1	0.2	5.0	0.2	0.0	0.3	0.3	0.3	0.9	0.7	0.2	0.0	1.4	0.6	0.7	0.2	0.2	0.2	0.1	0.2	0.3	1.5	0.7	0.8	0.1	0.2	0.1	0.5	1.0	0.4	0.2	1.5	0.2	0.2	0.1	0.0	1.1	0.8	0.3	0.6	0.3	0.6	2.9	0.2	8.3	0.1	0.1	1.6	0.6	0.5	0.2	20.1	9.4	25.7	10.1	0.8	2.5	31.1	27.6	29.8	14.2	17.0	12.8	6.6	11.2	5.4	5.5	29.5	15.1	15.5	29.8	27.1	4.4	10.4	9.8	27.3	7.3	5.9	8.5	8.8	0.8	7.7	37.4	22.9	8.3	14.2	19.0	10.4	8.9	29.5	10.1	31.9	0.1	18.1	6.7	21.9	23.0	22.2	6.2	3.5	16.8	16.3	10.7	22.9	7.9	6.5	10.9	12.6	8.7	39.3	53.5	26.8	23.0	36.7	9.5	5.8	7.1	19.3	3.8	34.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.8	0.4	0.6	0.2	0.2	0.1	0.0	0.5	2.3	0.5	0.3	1.0	1.4	4.6	0.0	0.6	0.9	2.1	0.0	2.2	0.0	0.0	1.8	0.4	1.5	0.0	0.3	46.9	17.2	0.8	1.5	0.0	7.4	0.4	1.1	3.1	0.8	6.1	3.1	4.5	6.3	0.0	0.0	0.9	0.0	0.2	1.2	2.0	0.3	1.2	70.2	0.3	1.3	0.0	3.7	0.0	1.6	0.0	0.5	0.0	12.0	0.1	0.7	6.9	1.7	0.0	0.0	3.1	0.1	0.0	0.0	1.2	1.2	2.1	6.3	0.6	0.3	0.8	0.4	2.1	4.3
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;lymphoid tissue: 11.8;skeletal muscle: 12.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 34.1;Gastric mucus-secreting cells: 10.2;Plasma cells: 9.7;Squamous epithelial cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: AB_2685381, HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	0.3	0.1	0.0	2.8	0.0	14.2	0.5	0.1	0.1	1.0	0.0	4.0	3.8	0.4	0.0	4.9	0.9	0.4	2.1	0.0	0.0	0.1	0.3	0.3	7.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	5.1	0.0	0.9	0.2	12.6	3.0	3.0	0.6	0.0	1.3	5.6	1.7	0.0	11.8	0.1	0.4	7.3	1.8	1.3	0.1	23.3	7.2	7.1	9.8	0.4	1.1	31.7	13.0	3.7	15.3	16.4	25.4	7.8	23.5	5.5	4.3	9.0	20.2	17.2	1.6	13.5	15.9	14.9	8.0	4.1	7.1	0.0	12.7	19.2	0.3	0.1	3.1	1.0	0.9	21.0	17.2	17.6	22.1	6.3	11.6	25.8	16.6	6.9	26.3	10.1	26.9	12.8	16.0	6.6	16.8	6.0	7.0	5.5	11.3	1.3	4.0	7.7	13.7	4.2	7.3	9.0	18.3	11.8	7.7	16.2	30.6	9.0	24.4	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.1	0.1	1.3	0.0	0.0	0.3	0.1	3.8	0.0	0.5	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.4	3.3	0.8	0.8	1.2	34.1	0.1	0.0	1.7	1.0	10.2	3.3	0.0	3.1	0.0	0.0	2.4	0.0	0.0	3.9	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.2	0.0	9.7	0.1	0.4	0.2	5.6	0.0	0.0	1.5	0.9	4.0	3.1	10.0	0.3	0.3	2.2	0.5	6.3	0.9
EBI3	"IL27B, IL35B"	ENSG00000105246	"Epstein-Barr virus induced 3"	Q14213	19	4229523-4237528	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 147.6"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 485.6;monocytes: 505.7;Syncytiotrophoblasts: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 4.8;memory B-cell: 18.7;naive B-cell: 14.7;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	14	"B-cells: 18.7;monocytes: 6.3"	"Cell line enriched"	"Detected in some"	13	"HDLM-2: 218.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046635	Enhanced				"Secreted to blood"	NA	NA	203000	1400000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA046635: AB_2679729"	"unprognostic (7.26e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.25e-3)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.67e-2)"	4.7	4.7	3.8	14.6	3.3	1.2	1.7	3.4	5.3	1.5	3.2	3.0	4.3	1.1	0.1	1.0	2.4	5.4	1.4	3.8	3.7	2.1	3.3	2.9	20.2	5.7	4.2	1.3	2.5	0.4	1.7	147.6	5.2	1.8	1.6	0.1	1.8	1.4	0.2	0.6	8.4	2.1	4.5	34.0	3.7	0.9	5.8	9.4	0.9	0.4	7.3	4.8	1.0	6.1	0.1	1.7	0.1	0.0	0.0	0.0	7.3	0.7	4.2	0.4	0.2	1.3	1.2	4.2	16.4	0.0	2.0	0.1	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.2	0.3	0.0	7.7	0.4	0.0	2.1	0.6	1.6	0.1	0.0	0.4	0.5	0.1	0.1	0.0	3.0	0.4	0.0	0.0	0.0	0.6	0.3	2.6	0.0	0.2	0.4	0.0	0.0	0.0	2.7	0.2	0.2	0.9	0.3	5.1	0.0	0.2	0.4	0.0	0.2	0.3	0.0	0.6	0.0	0.1	0.0	0.0	4.8	0.0	18.7	0.0	0.0	0.8	14.7	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.6	3.8	3.3	3.4	5.3	3.8	3.7	5.7	4.2	5.2	4.5	5.8	6.1	0.5	0.0	0.5	0.3	8.4	0.4	0.0	13.3	0.0	0.0	0.2	0.6	0.1	1.5	10.7	0.0	0.0	10.6	0.5	0.0	0.0	2.8	0.0	0.3	0.4	1.3	0.0	0.0	0.6	0.9	485.6	0.7	0.0	0.3	11.4	0.0	1.1	0.1	9.6	0.0	0.4	0.0	6.1	102.6	11.3	0.0	0.0	19.0	0.0	5.6	505.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	2.6	0.1	0.0	0.6	1.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	336.4	1.0	0.1	0.0	0.1
ECE2	"KIAA0604, MGC2408"	ENSG00000145194	"Endothelin converting enzyme 2"	P0DPD6	3	184276011-184293031	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 57.8;pancreas: 25.2;pituitary gland: 19.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.5;Extravillous trophoblasts: 51.1;Inhibitory neurons: 63.8;Late spermatids: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"REH: 10.3"															NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (8.41e-5)"	"unprognostic (1.37e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.63e-9)"	"unprognostic (3.66e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.25e-2)"	0.0	9.3	24.8	0.2	24.6	0.0	0.0	22.2	28.0	0.0	8.5	1.3	0.0	0.0	0.5	0.0	0.1	0.0	1.9	16.1	57.8	0.0	0.0	0.0	0.0	29.0	52.5	0.0	25.2	4.2	19.8	0.0	36.1	0.6	0.2	5.5	0.3	0.3	0.0	0.0	0.3	0.2	21.5	0.0	0.7	0.2	54.7	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	24.6	22.2	28.0	16.1	57.8	29.0	52.5	36.1	21.5	54.7	15.2	0.0	0.0	0.0	5.2	3.8	38.2	18.2	15.5	20.5	5.5	0.0	0.0	2.2	10.0	7.2	0.0	2.1	21.6	2.7	6.7	0.0	0.0	79.5	0.0	0.0	3.3	12.2	6.3	5.1	0.0	51.1	3.5	9.2	0.0	0.0	0.0	3.3	35.3	17.2	26.9	63.8	12.8	16.2	4.4	5.7	119.8	3.1	4.1	8.8	1.0	4.6	2.4	5.2	30.2	1.1	0.0	5.9	2.2	12.5	35.1	13.5	0.0	2.2	2.3	6.6	2.6	5.1	43.4	9.7	16.9	39.1	21.5	2.3	0.0	13.8	16.2
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448560-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"Adipocytes: 235.8;Endothelial cells: 214.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	122	"EFO-21: 172.1;HUVEC TERT2: 443.7;TIME: 330.9"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	62.7	12.7	5.5	11.2	5.5	0.2	59.8	5.7	8.5	26.8	5.3	19.4	4.6	29.4	7.4	15.9	33.5	12.1	54.6	5.2	5.9	29.9	6.0	60.1	11.6	6.0	5.9	10.4	6.7	4.7	7.1	33.5	6.3	19.6	8.0	0.8	16.1	7.3	15.1	16.6	20.7	24.4	6.1	23.5	15.2	3.3	6.7	3.5	40.9	17.2	7.2	35.5	26.1	5.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.3	0.0	0.0	172.1	0.3	0.1	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	443.7	0.1	0.0	0.0	1.4	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	330.9	0.4	0.4	0.0	1.7	0.0	0.0	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5	5.7	8.5	5.2	5.9	6.0	5.9	6.3	6.1	6.7	5.9	235.8	0.0	3.9	0.0	1.0	14.9	0.4	0.0	0.0	0.0	1.9	2.5	0.0	0.0	0.6	0.0	0.0	0.2	1.0	0.0	0.0	0.6	0.0	0.4	0.5	214.9	0.0	0.0	0.1	1.2	0.1	3.1	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	18.3	0.0	0.0	1.7	10.6	5.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	13.9	0.3	1.3	0.9	0.0	1.6
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488013-63499239	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 1638.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 347.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Approved	Nucleoli,Cytosol		NA	NA		55000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol	Nucleoli	"CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	0.9	32.7	59.3	1.4	81.3	0.0	1.7	17.1	347.2	2.8	0.0	5.1	0.7	0.3	1.1	9.7	0.4	2.4	358.0	73.4	97.3	1.3	3.0	0.8	0.6	95.0	2.9	0.5	6.5	16.2	111.5	0.0	76.3	9.6	0.4	37.2	19.5	0.8	1638.0	6.8	1.9	0.8	0.0	0.3	8.5	1.2	30.7	0.2	0.7	320.7	0.1	2.2	1.8	125.0	0.5	71.0	0.8	16.8	0.0	0.6	7.9	10.0	1.3	51.6	16.3	9.8	41.5	0.0	110.4	0.5	13.4	38.8	240.0	0.7	115.9	0.5	13.1	0.0	24.1	4.1	2.9	0.0	13.4	1.4	2.2	0.1	1.0	0.2	0.0	0.0	3.4	0.2	0.5	405.9	1.4	0.5	11.4	95.6	96.5	8.0	0.2	10.2	2.4	3.9	187.0	89.9	90.0	12.6	1.6	2.2	157.2	3.8	0.0	0.3	202.9	0.7	1.8	0.3	0.9	1.4	0.9	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	59.3	81.3	17.1	347.2	73.4	97.3	95.0	2.9	76.3	0.0	30.7	125.0	0.1	0.0	0.0	9.4	0.7	0.4	0.9	0.0	0.0	130.8	11.8	4.6	125.5	1.5	0.6	0.0	12.5	0.0	1.1	0.4	0.0	1.3	0.2	0.5	0.3	2.2	0.0	0.0	35.5	0.2	0.2	3.6	4.6	1.4	5.7	1.0	1.1	0.1	0.0	269.2	37.2	0.0	0.0	0.3	0.7	0.5	0.0	0.6	0.0	15.0	0.0	11.7	0.0	14.6	12.7	0.3	0.0	0.0	0.3	2.6	0.0	0.5	0.0	50.9	0.0	49.9	3.4	0.0	0.3	0.0	1.8	0.0	1.5	0.0	0.5	1.1
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1285873-1301431	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 12.3;liver: 12.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.5;Cardiomyocytes: 4.9;Inhibitory neurons: 1.6;Oligodendrocyte precursor cells: 5.0;Paneth cells: 2.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5;stomach cancer: 8.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.3;CACO-2: 6.2;Hep G2: 13.5;NTERA-2: 6.8;OE19: 6.0;REH: 6.8;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Mitochondria, Cytosol"		"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.0	0.0	1.6	1.5	1.7	0.0	0.0	1.2	1.3	0.1	0.3	9.9	9.9	0.0	0.0	0.4	0.0	3.5	0.0	1.4	2.0	0.4	12.9	0.0	0.0	1.7	3.0	0.0	0.1	0.2	0.3	0.2	1.1	0.0	4.4	0.6	0.0	0.0	0.2	0.1	12.3	0.0	1.9	0.0	0.2	0.6	3.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.2	10.3	3.1	0.0	0.0	3.7	0.2	0.0	0.0	0.0	6.2	0.1	0.0	1.8	0.0	0.0	0.0	4.8	0.0	0.0	0.0	1.4	0.0	0.0	13.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.1	6.8	6.0	0.0	6.8	1.0	0.1	0.0	0.4	0.0	13.3	0.7	0.0	0.2	3.5	0.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	1.7	1.2	1.3	1.4	2.0	1.7	3.0	1.1	1.9	3.1	1.4	0.1	0.0	0.0	1.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.2	0.0
EFNB3	"EPLG8, LERK-8"	ENSG00000108947	"Ephrin B3"	Q15768	17	7705202-7711372	"Cancer-related genes, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.6;Early spermatids: 9.2;Excitatory neurons: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 53.9;AN3-CA: 32.3;hTERT-RPE1: 32.6;SH-SY5Y: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001623	Approved					NA	NA		11000		"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA001623: AB_1848026"	"unprognostic (5.17e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.20e-2)"	3.5	2.0	23.1	0.7	25.8	0.0	3.5	0.1	25.3	7.4	5.6	0.7	0.3	10.3	0.5	2.0	5.5	1.2	1.1	23.0	37.3	1.2	1.7	1.0	0.3	9.2	10.7	4.7	1.2	12.0	5.7	1.2	8.7	2.1	0.6	3.6	1.4	0.5	0.3	5.9	0.9	3.7	5.8	0.1	0.8	3.6	38.2	0.4	0.7	0.1	0.9	1.0	2.4	10.7	0.0	1.0	53.9	32.3	1.0	0.7	0.4	0.6	7.2	4.8	3.1	2.0	3.4	0.0	1.1	2.1	0.3	0.4	13.9	6.9	2.8	0.0	6.8	0.2	0.0	0.1	1.5	0.0	0.0	3.1	1.4	1.5	1.1	32.6	0.3	0.5	0.0	0.0	0.9	5.4	0.0	0.0	4.8	0.0	1.0	0.2	0.1	0.0	7.4	0.7	3.4	28.1	0.0	0.0	1.1	9.4	2.9	0.0	0.1	3.2	10.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	25.8	0.1	25.3	23.0	37.3	9.2	10.7	8.7	5.8	38.2	10.7	2.1	0.0	0.0	1.0	0.2	4.1	3.8	4.6	6.8	2.2	5.9	11.6	1.7	1.5	0.9	0.0	0.0	0.3	0.0	0.1	0.0	1.1	9.2	2.5	5.9	1.3	6.7	2.7	9.1	0.2	1.0	4.6	0.0	0.7	1.3	3.3	2.2	0.0	0.4	5.0	6.8	0.3	4.1	0.0	0.4	5.6	4.7	0.2	0.0	1.0	0.0	1.4	0.0	0.5	1.3	0.2	0.0	3.4	0.0	1.6	0.0	0.0	6.0	0.7	0.0	0.0	2.2	0.7	0.7	1.8	2.8	0.3	0.1	1.2	0.0	1.6
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042076-25159135	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.1;skeletal muscle: 20.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 127.0;Excitatory neurons: 58.5;Inhibitory neurons: 110.7;Late spermatids: 46.0;Microglial cells: 54.4;Oligodendrocytes: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.3;BEWO: 12.0;SH-SY5Y: 10.7;SK-BR-3: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	0.8	1.6	23.0	0.6	53.1	0.3	0.5	22.4	29.5	0.5	0.0	1.1	0.4	0.7	5.1	0.3	0.6	0.5	4.5	51.7	19.0	1.3	0.2	2.5	0.3	45.3	24.0	0.8	0.4	3.9	9.3	1.7	47.5	0.5	0.6	11.0	0.3	0.8	20.0	0.6	0.5	1.2	9.8	3.4	0.9	2.5	27.7	0.3	3.4	3.8	0.2	0.5	0.4	12.1	0.2	8.3	9.5	10.3	0.5	0.1	12.0	1.0	0.2	0.5	0.1	6.7	0.4	0.1	0.6	1.4	3.3	0.6	7.5	0.0	0.1	1.6	1.8	1.6	0.3	0.6	0.0	0.1	0.8	0.1	0.0	2.3	0.1	0.7	0.3	0.2	0.1	0.4	0.2	0.9	0.2	0.5	1.9	0.1	6.6	0.8	9.1	0.3	0.1	0.3	4.0	10.7	1.2	18.0	5.9	5.3	0.9	0.1	0.5	0.5	2.7	4.1	2.0	0.7	0.9	0.1	7.3	0.1	1.9	1.3	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.0	23.0	53.1	22.4	29.5	51.7	19.0	45.3	24.0	47.5	9.8	27.7	12.1	3.1	28.9	1.1	127.0	0.0	0.0	0.8	0.0	0.0	9.9	0.3	1.0	9.7	0.0	0.0	9.2	22.9	0.1	0.1	0.7	0.0	0.3	20.6	1.3	0.3	6.7	3.6	0.0	58.5	0.8	0.2	1.0	0.0	0.3	0.0	1.1	2.9	0.0	0.9	5.0	110.7	0.1	0.0	0.0	0.3	46.0	1.2	0.1	0.0	54.4	0.0	22.0	0.0	19.6	51.2	0.7	0.0	2.6	0.1	0.6	0.5	0.1	0.0	10.7	0.0	1.6	1.4	2.4	2.2	0.0	0.1	0.1	0.1	0.2	0.3	0.4
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356403-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 48.9;Squamous epithelial cells: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 73.2;AN3-CA: 39.5;BEWO: 57.7;SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol		No	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	Cytosol	"HPA001581: AB_2666367, HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	19.3	12.6	39.7	5.5	59.6	0.0	22.7	51.7	45.6	47.3	28.0	24.4	3.1	29.2	9.9	44.1	28.6	8.7	15.0	35.6	39.3	10.0	1.8	12.1	3.6	63.0	57.6	41.9	2.2	22.2	8.4	10.4	54.8	36.8	3.3	10.6	26.2	22.5	3.6	59.0	9.6	12.5	44.8	7.6	11.9	5.4	49.9	3.2	17.5	5.1	4.8	25.3	42.9	76.0	4.7	0.0	73.2	39.5	17.1	20.0	57.7	5.3	11.3	2.0	0.9	0.0	0.0	0.0	0.0	30.3	0.3	27.5	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	11.6	18.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	0.0	0.0	22.6	0.1	0.0	24.1	7.8	66.5	15.1	2.6	0.0	8.7	17.6	0.0	0.0	7.6	0.0	19.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	59.6	51.7	45.6	35.6	39.3	63.0	57.6	54.8	44.8	49.9	76.0	2.0	0.0	6.7	17.0	0.0	11.6	11.6	5.6	9.6	5.0	20.3	16.3	0.7	0.0	4.1	0.0	6.2	9.3	0.2	0.0	1.9	0.1	0.9	0.6	18.9	1.8	0.0	0.0	0.2	0.0	14.7	15.7	0.0	0.7	0.0	4.4	1.8	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.7	0.8	20.2	0.4	7.2	1.9	0.0	9.0	0.0	22.1	48.9	0.0	0.0	13.9	0.1	7.6	0.0	0.3	1.1	9.3	6.6	12.6	8.9	2.2	0.5	22.7	13.4	18.1	0.5	0.3	0.0	7.0
EGFL7	ZNEU1	ENSG00000172889	"EGF like domain multiple 7"	Q9UHF1	9	136658856-136672678	"Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 806.1;Endothelial cells: 436.5;Hepatic stellate cells: 511.5;Hofbauer cells: 290.3;Spermatogonia: 179.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.1;eosinophil: 3.5;intermediate monocyte: 6.2;non-classical monocyte: 5.5;plasmacytoid DC: 5.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 5.9;granulocytes: 3.5;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 183.9;HUVEC TERT2: 329.0;RPMI-8226: 136.8;TIME: 312.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050716	Approved				"Secreted to extracellular matrix"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA050716: AB_2732562"	"unprognostic (1.72e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.76e-3)"	"unprognostic (5.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.14e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (5.28e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.49e-2)"	195.6	50.2	108.8	13.4	90.4	14.4	192.3	85.0	144.3	112.9	74.4	49.1	13.4	104.3	9.8	39.8	98.5	27.4	243.3	89.8	86.5	144.3	56.1	204.2	20.8	102.0	96.9	37.8	28.2	18.5	51.3	181.6	100.9	74.9	3.5	1.0	39.4	13.2	60.5	47.8	51.4	13.4	89.9	191.7	40.7	43.3	111.7	5.6	105.5	25.2	2.9	87.5	86.3	85.2	0.1	45.7	14.6	52.7	1.2	1.0	33.4	12.9	2.3	7.3	2.3	16.2	42.4	0.3	183.9	4.3	11.9	6.5	3.7	8.3	0.3	77.2	14.1	28.8	3.4	1.3	11.4	0.0	40.1	1.5	3.2	3.7	0.0	2.5	329.0	2.1	104.9	0.1	2.5	83.5	0.5	0.7	21.1	64.3	2.6	91.4	5.9	136.8	4.6	1.1	9.3	31.0	6.3	5.9	12.2	4.2	15.5	43.6	312.6	1.8	37.2	4.4	2.5	0.4	0.1	0.5	0.2	0.1	38.4	0.0	2.1	3.5	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.8	0.2	5.5	5.9	0.0	2.4	108.8	90.4	85.0	144.3	89.8	86.5	102.0	96.9	100.9	89.9	111.7	85.2	806.1	0.0	26.5	2.3	6.2	11.9	5.6	5.5	9.6	2.0	5.9	6.7	23.7	5.7	4.2	3.7	0.0	3.1	5.9	1.4	7.9	19.4	2.7	1.4	3.4	436.5	1.2	58.9	15.0	2.0	17.8	18.5	0.5	1.9	20.3	2.0	511.5	20.5	290.3	3.3	10.1	4.6	2.0	24.5	14.2	9.2	8.7	18.7	19.6	102.1	1.2	1.9	0.0	3.5	1.8	5.8	3.7	6.0	4.0	19.1	22.5	25.2	0.2	2.3	13.1	13.0	18.4	18.9	179.8	2.7	9.5	6.0	2.9	4.8	0.5	3.5
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164595-32168281	"Metabolic proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Granulosa cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.2;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	13.3	7.2	3.8	0.5	3.5	1.1	13.6	3.6	5.7	23.4	4.1	19.8	0.6	10.0	0.8	12.3	16.3	3.0	14.2	3.9	3.9	16.3	7.4	9.4	0.3	3.8	3.9	31.2	5.1	0.4	8.2	2.9	3.7	16.9	0.5	0.0	7.9	1.4	3.8	12.8	8.8	0.3	3.8	7.9	10.2	4.4	4.1	0.6	8.7	2.5	0.2	13.5	17.2	3.8	0.2	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.5	0.0	0.3	3.2	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.2	0.7	0.5	0.0	0.0	0.6	1.0	1.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	3.4	0.0	1.0	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.5	3.6	5.7	3.9	3.9	3.8	3.9	3.7	3.8	4.1	3.8	1.2	6.4	4.1	0.0	0.3	1.5	0.6	0.3	4.6	1.5	0.5	0.3	0.1	0.0	1.6	1.8	2.1	0.8	0.6	0.2	0.0	0.4	0.1	1.0	1.9	1.7	0.0	1.7	0.0	0.2	0.4	1.5	4.6	1.3	0.0	10.4	3.3	0.3	0.2	0.0	0.0	1.1	0.0	0.6	1.6	0.2	3.7	0.7	0.0	0.0	0.0	0.9	3.1	0.0	0.0	0.3	0.2	1.2	2.1	0.7	0.4	0.1	1.6	1.5	0.0	2.0	1.5	0.5	0.4	4.0	2.3	0.8	0.9	1.5	1.3	0.5
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713422-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 161.9;Leydig cells: 99.1;Peritubular cells: 107.2;Sertoli cells: 236.7;Smooth muscle cells: 139.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 312.2;BJ: 238.5;fHDF/TERT166: 258.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		1500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	195.0	59.9	18.4	32.8	17.6	0.4	133.9	16.5	21.2	110.3	11.9	116.1	14.3	119.9	13.2	53.5	75.4	31.2	85.9	15.9	17.1	24.4	14.4	102.8	9.1	23.3	19.3	68.3	28.2	6.2	12.6	50.3	20.0	62.2	14.7	3.0	34.2	51.1	39.6	54.7	54.5	79.6	17.2	40.3	56.3	11.2	24.1	5.1	49.5	28.2	8.3	112.3	88.8	15.8	62.7	142.7	0.1	1.7	312.2	236.0	0.2	238.5	114.0	86.0	70.0	9.3	31.2	0.0	0.3	258.6	20.3	78.1	1.5	126.5	51.9	0.1	0.8	8.4	78.4	0.7	197.0	0.0	16.6	230.1	109.5	72.5	70.6	113.7	168.4	0.7	26.6	0.2	91.7	11.4	13.3	0.7	1.8	9.2	25.9	1.4	10.0	0.2	69.5	2.9	0.1	0.8	212.5	8.2	6.2	19.1	20.2	4.3	192.6	128.0	27.8	112.5	52.2	0.2	0.2	0.2	119.3	3.3	27.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	18.4	17.6	16.5	21.2	15.9	17.1	23.3	19.3	20.0	17.2	24.1	15.8	161.9	60.9	20.6	10.7	0.3	20.3	29.4	31.0	12.5	5.5	7.3	10.8	11.6	10.0	22.5	5.5	0.0	1.1	0.8	0.1	0.0	21.2	0.6	3.4	60.5	75.4	0.0	8.6	4.0	14.1	1.6	55.8	5.1	4.5	2.5	24.7	48.9	3.1	1.9	0.0	0.9	0.0	2.0	1.3	8.8	4.3	99.1	1.6	8.8	7.5	0.6	1.8	0.0	3.5	0.3	31.1	0.0	107.2	0.1	28.8	0.0	0.1	5.5	0.8	236.7	24.8	139.4	0.9	3.0	15.8	13.5	1.5	1.5	27.2	0.0	33.4
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895933-41972557	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 189.5;Urothelial cells: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 103.8;TIME: 172.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"		NA	NA		440000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	21.6	4.6	3.1	11.8	3.2	10.9	16.4	7.5	3.5	9.4	5.3	12.1	5.5	9.6	10.5	15.0	9.8	15.2	27.8	3.3	3.8	14.3	9.6	15.0	12.8	4.8	4.0	5.6	14.3	12.8	5.8	8.3	4.8	9.5	10.2	6.1	10.4	9.7	4.4	14.3	12.4	12.9	5.2	7.4	9.9	2.8	4.0	5.3	18.4	4.7	8.8	23.8	9.0	6.6	28.7	9.8	9.3	9.6	4.6	6.5	8.1	14.9	31.4	25.9	36.1	41.4	16.1	5.9	39.2	18.8	51.6	28.4	13.9	32.6	19.0	35.7	11.7	8.7	13.5	7.1	11.3	4.0	24.4	5.5	12.6	26.3	28.8	9.9	103.8	8.7	9.2	6.6	21.1	12.2	4.2	4.5	7.1	27.8	33.5	0.1	24.5	9.4	23.4	57.0	15.4	6.5	10.9	23.2	17.0	9.0	22.9	5.6	172.8	8.1	15.7	30.5	73.1	18.1	30.9	12.4	10.3	9.4	71.6	1.1	14.0	9.0	4.0	12.4	6.1	2.1	6.2	5.0	14.9	2.6	2.6	3.8	2.3	4.4	5.2	2.5	7.9	8.0	3.1	3.2	7.5	3.5	3.3	3.8	4.8	4.0	4.8	5.2	4.0	6.6	94.9	6.4	44.2	3.9	20.0	81.6	189.5	68.1	34.1	4.9	31.4	20.1	36.6	30.0	69.0	44.1	31.3	10.1	22.2	96.0	7.9	71.3	16.1	66.1	9.7	114.9	22.6	5.7	1.2	62.6	20.4	21.3	25.5	72.4	61.6	16.2	54.7	8.7	89.0	1.7	0.7	22.5	28.5	35.6	52.7	34.7	7.5	46.3	19.6	12.2	53.5	37.5	4.1	26.7	2.7	75.1	70.9	4.9	31.5	49.9	71.4	4.6	60.8	27.8	13.1	8.0	29.0	5.4	8.2	29.3	79.8	17.4	27.8	21.2	37.3	200.1
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34663288	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 287.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 400.8;Basal respiratory cells: 271.6;Club cells: 323.3;Endometrial ciliated cells: 229.6;Glandular and luminal cells: 281.8;Squamous epithelial cells: 251.1;Urothelial cells: 397.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	11	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 138.4;HaCaT: 95.7;HBEC3-KT: 107.6;OE19: 132.9;RT4: 214.8;T-47d: 213.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.9	1.1	0.9	14.7	1.7	0.2	199.5	0.9	0.6	120.8	1.3	99.3	42.2	13.9	95.0	200.7	129.6	32.2	0.3	1.1	0.8	25.7	1.3	23.4	1.5	2.6	4.0	0.2	41.1	18.5	0.7	0.1	2.8	82.7	126.3	0.8	287.7	153.4	0.2	53.6	34.1	3.5	2.5	1.2	59.5	0.7	1.3	1.3	2.5	0.0	67.3	50.7	79.2	4.7	46.5	26.8	0.0	0.3	0.0	0.0	0.8	0.0	3.9	0.0	0.2	0.4	138.4	0.1	17.1	0.0	0.2	95.7	0.0	107.6	0.5	0.1	0.2	0.0	1.5	0.2	0.0	0.2	0.0	0.0	41.7	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.1	2.6	0.1	0.8	0.2	132.9	1.0	0.0	0.1	1.0	20.2	214.8	0.0	0.2	0.5	14.8	0.2	0.0	213.5	0.5	0.0	0.2	1.2	5.1	0.4	0.5	0.2	0.3	0.3	0.2	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.9	0.6	1.1	0.8	2.6	4.0	2.8	2.5	1.3	4.7	0.8	48.1	97.2	1.3	0.6	109.6	400.8	271.6	133.1	0.0	123.0	51.9	0.9	60.1	323.3	55.2	0.0	0.1	1.1	62.7	15.6	77.8	14.2	229.6	17.7	4.0	23.3	0.0	0.7	86.5	0.0	3.2	53.5	281.8	1.3	0.0	0.0	0.4	0.1	0.0	0.0	82.8	116.0	0.0	17.7	1.0	0.0	5.1	12.4	0.0	5.6	3.8	0.0	0.0	2.4	104.8	30.2	0.0	1.2	173.1	14.1	0.3	204.6	0.0	0.0	0.0	9.6	0.4	0.1	251.1	170.1	1.4	4.9	0.0	74.5	397.3
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
ELAPOR1	"EIG121, KIAA1324, maba1"	ENSG00000116299	"Endosome-lysosome associated apoptosis and autophagy regulator 1"	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 156.7;salivary gland: 166.1;stomach 1: 88.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;dendritic cells: 1.2;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 65.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 20.8;SCLC-21H: 16.8;SK-BR-3: 17.6;T-47d: 59.1;U-87 MG: 12.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.8	3.2	3.6	4.1	4.4	0.5	56.7	0.0	4.9	70.1	0.0	28.3	45.5	12.8	9.7	1.6	23.9	5.6	0.2	4.4	13.2	0.1	0.2	5.1	2.5	0.2	0.1	0.1	156.7	9.2	32.9	0.2	0.7	48.6	27.8	0.4	166.1	0.3	0.0	3.9	35.3	1.1	0.0	0.8	88.2	18.3	10.0	0.8	9.0	0.1	1.9	0.4	0.1	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.5	0.2	0.1	0.2	0.0	0.0	0.5	0.6	0.7	1.3	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.1	1.0	0.0	0.0	0.5	20.8	0.2	0.3	0.5	0.0	0.1	0.1	0.3	1.1	0.1	0.0	16.8	0.4	0.1	17.6	0.0	0.1	59.1	0.0	0.4	0.0	2.1	0.2	0.2	1.3	3.6	0.0	12.4	0.0	0.1	0.0	0.1	0.0	4.6	0.0	7.6	0.4	7.5	3.2	0.0	0.1	3.3	1.5	65.2	0.5	0.0	0.0	9.8	2.2	3.6	4.4	0.0	4.9	4.4	13.2	0.2	0.1	0.7	0.0	10.0	1.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0
ELAVL2	"HEL-N1, HuB"	ENSG00000107105	"ELAV like RNA binding protein 2"	Q12926	9	23690104-23826337	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 31.8;testis: 43.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.2;Excitatory neurons: 135.5;Inhibitory neurons: 390.6;Spermatogonia: 159.2"	"Cancer enriched"	"Detected in many"	5	"testis cancer: 7.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;AF22: 37.2;SCLC-21H: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022222, HPA063001"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"CAB022222: , HPA063001: AB_2684918"	"unprognostic (3.51e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.74e-4)"	"unprognostic (3.98e-1)"	"unprognostic (9.08e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.65e-1)"	0.1	1.3	12.4	0.1	15.8	0.5	0.2	1.5	31.8	0.1	0.0	0.4	0.1	0.5	0.5	0.2	0.1	0.2	0.1	10.9	23.2	0.5	0.0	0.2	0.2	15.7	13.0	1.1	0.0	0.1	1.0	0.1	15.3	0.3	0.5	5.0	0.1	0.1	0.1	0.5	0.2	0.2	0.1	0.1	0.1	43.1	15.0	0.0	0.3	0.0	0.1	0.4	0.2	9.4	25.4	0.3	37.2	0.2	0.1	0.3	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	7.8	9.9	15.9	0.2	0.0	7.1	0.0	0.1	0.3	0.0	0.2	0.6	0.5	9.6	0.0	11.0	0.0	0.3	0.1	0.9	1.2	5.3	0.0	0.1	0.1	9.8	0.0	11.8	0.1	13.3	0.2	0.0	0.0	119.6	11.5	0.3	0.3	0.3	9.4	0.6	1.9	0.0	0.2	7.9	0.2	0.2	0.1	0.1	0.1	1.3	0.1	1.4	1.1	0.3	0.5	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.5	0.3	0.4	1.5	0.4	0.2	0.3	0.2	0.0	12.4	15.8	1.5	31.8	10.9	23.2	15.7	13.0	15.3	0.1	15.0	9.4	0.9	0.0	0.0	7.8	0.0	1.0	0.4	0.4	0.6	8.8	0.9	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	1.4	1.9	0.1	62.2	0.5	0.2	1.8	4.2	0.0	135.5	0.0	0.0	0.8	0.0	0.2	0.0	10.6	0.0	0.0	0.1	16.8	390.6	1.2	0.0	0.0	0.7	39.5	3.1	0.2	0.0	7.5	0.0	2.8	0.0	5.5	5.5	0.0	0.2	1.5	0.0	0.4	0.0	0.1	0.0	10.6	0.0	1.4	1.0	13.9	159.2	0.5	0.9	0.0	0.1	0.7	1.3	0.6
ELAVL3	"DKFZp547J036, HUC, HUCL, MGC20653, PLE21"	ENSG00000196361	"ELAV like RNA binding protein 3"	Q14576	19	11451326-11481046	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.9;Bipolar cells: 26.9;Excitatory neurons: 78.1;Inhibitory neurons: 91.0;Oligodendrocyte precursor cells: 36.2;Oligodendrocytes: 120.1"	"Cancer enriched"	"Detected in some"	10	"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 80.9;SH-SY5Y: 46.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013066	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB013066: AB_221448"	"unprognostic (1.47e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.60e-3)"	0.0	1.2	46.8	0.5	62.8	0.0	0.0	89.7	69.3	0.0	0.0	0.6	0.1	0.1	0.5	0.1	0.0	0.0	0.7	54.1	47.8	0.8	0.1	0.1	0.0	60.0	54.8	0.1	0.1	0.1	5.5	0.0	64.9	0.4	0.2	6.0	0.0	0.2	3.2	0.0	0.2	0.2	50.9	0.1	0.2	0.9	55.6	0.0	0.0	0.1	0.0	0.0	0.1	106.4	0.0	0.2	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	80.9	46.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	62.8	89.7	69.3	54.1	47.8	60.0	54.8	64.9	50.9	55.6	106.4	1.0	0.0	0.0	36.9	0.0	0.6	0.4	0.0	0.6	26.9	1.3	3.3	12.4	0.0	0.0	0.0	4.2	0.2	0.1	0.2	0.0	0.0	3.5	0.2	0.5	1.8	0.0	0.0	78.1	0.0	0.1	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.1	5.0	91.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	4.7	0.0	3.0	1.0	36.2	120.1	0.1	0.0	0.0	0.0	0.5	0.2	0.2	0.0	7.4	0.0	1.7	2.2	2.9	4.2	1.1	0.1	0.0	0.1	0.5	0.2	0.3
ELAVL4	"HUD, PNEM"	ENSG00000162374	"ELAV like RNA binding protein 4"	P26378	1	50024029-50203772	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 52.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 155.5;Excitatory neurons: 158.7;Inhibitory neurons: 109.7;Late spermatids: 159.4;Oligodendrocyte precursor cells: 75.4"	"Cancer enriched"	"Detected in some"	4	"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Cell line enriched"	"Detected in some"	17	"SH-SY5Y: 157.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004442, HPA043047"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Vesicles"		"CAB004442: AB_627765, HPA043047: AB_2732502"	"unprognostic (1.25e-1)"	"unprognostic (6.63e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.83e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.91e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.13e-2)"	"unprognostic (7.43e-2)"	0.1	11.2	13.9	2.4	18.0	0.0	0.2	7.4	52.8	0.0	0.0	2.2	1.4	0.0	0.0	0.2	0.1	0.1	0.2	20.0	18.5	0.1	0.1	0.3	0.2	36.5	14.0	0.0	2.3	0.0	3.4	0.2	31.7	0.1	2.8	3.9	0.2	0.1	0.0	0.4	2.2	1.1	2.0	0.2	1.0	8.5	11.4	0.9	0.0	0.0	0.2	0.1	0.2	17.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.2	157.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	13.9	18.0	7.4	52.8	20.0	18.5	36.5	14.0	31.7	2.0	11.4	17.4	0.1	0.0	0.0	7.2	0.1	0.8	0.0	0.0	0.0	3.9	0.1	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	155.5	0.0	0.0	0.3	32.9	0.0	158.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	109.7	0.1	4.1	4.0	5.0	159.4	1.5	3.1	1.8	22.5	0.0	1.5	0.0	75.4	5.9	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.1	8.9	11.8	0.0	0.9	0.1	0.2	0.0	0.1	0.1
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017183	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1599.6;Gastric mucus-secreting cells: 1390.9;Paneth cells: 1506.1;Proximal enterocytes: 1476.3;Urothelial cells: 1628.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 209.6;CAPAN-2: 296.0;OE19: 196.3;RT4: 215.3;SK-BR-3: 405.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	1.6	0.2	0.2	12.7	0.1	0.8	79.2	0.8	0.4	55.3	0.1	161.3	142.9	12.9	4.5	237.0	35.5	77.6	5.0	0.1	0.2	66.7	79.2	59.8	0.3	0.0	0.0	1.2	120.7	8.4	3.9	6.1	0.1	58.7	127.5	1.0	147.1	14.8	0.2	14.5	145.6	7.3	0.0	0.5	122.7	0.2	0.1	1.6	6.6	0.0	16.0	165.2	93.6	0.2	56.1	209.6	0.0	0.4	0.0	0.0	63.5	0.0	7.9	0.0	0.1	47.3	296.0	0.3	24.0	0.0	1.7	53.8	0.0	0.2	0.0	6.7	0.2	0.0	38.3	9.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	40.7	0.3	0.7	3.3	196.3	17.6	0.1	0.1	3.0	78.3	215.3	0.3	0.4	2.4	405.7	0.2	9.2	28.8	0.0	0.1	0.0	0.7	0.4	0.5	1.2	3.9	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.4	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	2.7	294.9	422.9	0.0	12.2	5.1	691.3	879.7	113.8	1.5	470.3	180.3	1.5	586.2	1130.0	329.2	18.8	76.6	9.5	1599.6	41.1	792.7	0.0	812.3	90.8	16.4	452.2	2.7	0.4	641.0	122.2	15.9	1390.9	1127.5	40.6	0.2	0.4	38.6	9.3	0.0	0.2	1225.3	1102.7	2.5	2.7	0.0	0.0	18.6	8.8	0.0	15.4	2.6	1.0	0.5	0.1	512.5	1506.1	0.0	6.0	1014.2	1476.3	147.1	888.2	67.3	0.0	0.8	46.3	0.0	0.3	418.5	8.4	257.2	18.7	0.3	983.0	1628.9
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.2;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 6.2;Endothelial cells: 5.7;Hepatic stellate cells: 7.1;Hepatocytes: 13.5;Inhibitory neurons: 19.2;Rod photoreceptor cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 31.2;U-138 MG: 18.5;U-2 OS: 27.0;U-2197: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		43000		"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	3.1	0.4	1.5	0.3	2.5	0.0	1.5	1.0	3.4	4.2	0.0	0.6	0.1	2.9	0.1	0.5	1.5	0.4	4.6	1.0	4.4	3.9	14.5	0.6	0.1	3.2	4.6	0.4	0.6	0.1	0.8	0.4	3.2	1.0	0.0	3.0	0.4	0.1	0.7	1.0	0.8	0.2	7.2	1.1	0.6	0.8	2.6	0.7	0.8	0.4	0.0	0.6	1.7	0.8	0.3	0.0	4.6	9.7	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.1	0.5	0.0	4.6	2.1	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	5.7	0.0	4.7	1.9	0.0	1.1	31.2	0.0	3.1	0.0	0.0	4.3	2.0	0.3	0.2	0.0	0.5	0.1	0.3	0.1	18.5	27.0	32.1	0.0	0.0	0.4	8.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.5	1.0	3.4	1.0	4.4	3.2	4.6	3.2	7.2	2.6	0.8	4.8	0.0	0.6	0.0	0.0	0.1	0.3	0.3	2.8	1.3	0.1	0.3	1.8	0.0	0.0	0.0	6.2	0.0	0.0	0.0	3.9	0.1	0.1	0.3	2.0	5.7	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	7.1	13.5	0.1	0.0	19.2	0.0	0.0	0.6	0.7	0.1	0.9	0.1	1.8	1.0	0.0	0.9	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	0.9	0.0	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427479	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 18.2;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 45.5;Excitatory neurons: 11.6;Inhibitory neurons: 16.2;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 18.2;basal ganglia: 13.8;cerebral cortex: 17.5;hippocampal formation: 16.6;white matter: 4.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 12.0;CAPAN-2: 11.2;GAMG: 12.3;RPMI-8226: 11.7;RPTEC TERT1: 21.5;U-2 OS: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	0.0	0.6	18.2	0.0	13.8	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	16.6	0.9	0.2	0.2	0.6	0.0	2.7	2.7	0.0	0.2	0.0	0.0	0.0	1.9	0.6	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.1	1.7	2.2	2.2	0.0	0.0	0.0	0.0	0.0	4.8	12.0	4.9	0.0	0.0	0.0	0.9	0.0	5.3	2.8	1.2	0.1	1.9	11.2	0.2	6.8	3.8	12.3	8.2	0.6	1.1	0.1	0.2	0.1	0.0	5.7	0.0	0.2	0.0	0.1	0.9	0.1	0.4	1.6	4.5	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.3	7.1	10.6	0.1	0.1	11.7	21.5	0.1	1.0	0.0	4.9	6.2	0.0	0.1	0.0	0.1	0.5	0.0	24.1	0.2	3.5	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	13.8	0.0	17.5	16.6	0.9	2.7	2.7	1.9	2.8	2.2	4.8	0.1	0.0	5.1	1.3	0.5	0.1	0.0	0.9	0.0	45.5	0.0	0.0	0.0	1.5	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	0.2	0.0	0.0	11.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	3.3	16.2	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	1.9	0.0	0.9	0.0	36.7	0.9	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.6	2.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ELL	"C19orf17, ELL1, Men, PPP1R68"	ENSG00000105656	"Elongation factor for RNA polymerase II"	P55199	19	18442663-18522116	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 297.2;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004202, HPA046076"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA004202: , HPA046076: AB_2679526"	"unprognostic (9.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	15.1	7.7	4.0	9.0	6.2	29.8	11.8	8.4	7.0	11.2	5.0	10.6	6.5	11.0	2.0	10.3	10.6	5.7	10.5	3.6	4.2	12.6	14.1	16.6	7.6	4.7	4.2	13.0	10.0	4.1	11.3	10.0	3.8	9.9	2.3	1.2	8.3	3.6	20.1	15.3	12.8	3.6	4.0	17.3	10.1	38.5	6.1	6.8	8.2	9.9	4.3	10.5	11.0	3.9	12.7	5.7	3.2	6.8	3.4	4.2	22.7	10.0	8.8	7.5	7.1	7.1	9.8	15.6	11.8	6.7	5.2	8.6	4.7	11.1	3.8	13.3	10.9	9.4	5.9	6.3	5.2	10.3	11.8	8.6	9.3	9.8	7.7	5.6	5.4	8.5	13.5	21.8	4.0	10.3	12.5	11.9	10.6	7.8	16.8	10.9	4.8	17.4	5.3	8.8	5.7	6.4	7.4	12.3	11.0	4.1	6.4	12.4	9.0	8.6	6.6	11.6	9.3	34.8	23.4	11.7	11.4	17.6	12.5	0.3	5.9	4.5	4.5	4.1	7.3	2.9	2.6	3.9	5.0	2.1	1.7	2.7	18.1	2.3	2.1	8.6	3.1	4.1	4.0	6.2	8.4	7.0	3.6	4.2	4.7	4.2	3.8	4.0	6.1	3.9	12.3	6.4	6.1	9.1	16.3	28.0	26.4	11.9	23.3	4.5	19.7	10.7	5.1	11.5	7.2	3.7	4.2	47.5	29.5	15.2	11.7	8.7	297.2	22.9	16.0	11.4	19.7	10.3	9.1	8.0	17.6	17.2	12.8	37.7	11.4	5.1	7.5	15.5	19.3	1.7	11.2	10.1	6.1	12.8	21.7	235.9	6.5	20.4	7.2	9.4	13.8	5.3	4.1	7.1	8.0	10.8	3.7	3.0	53.6	14.2	11.8	7.0	8.4	3.4	19.7	13.0	16.7	18.2	24.7	19.4	30.4	68.7	19.2	5.9	7.1	19.9
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95961851	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 382.9;Plasma cells: 430.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA013569: AB_2668853"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.31e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	49.0	19.5	13.5	28.6	32.3	48.3	37.3	22.9	26.8	24.0	6.8	13.5	14.5	9.1	5.7	61.2	16.0	35.6	39.9	18.4	32.0	16.5	86.8	35.8	14.6	51.1	28.5	24.8	94.3	15.6	25.1	25.3	33.7	39.1	13.1	3.7	96.5	23.0	33.5	58.9	14.5	11.4	21.3	18.0	44.3	15.2	41.4	8.1	17.1	10.7	21.8	33.2	35.7	55.8	31.7	12.3	3.8	0.5	45.0	56.1	4.6	322.3	56.2	105.4	89.7	23.7	7.2	1.4	6.7	173.7	24.6	40.0	10.0	103.5	129.3	291.4	7.6	20.5	53.5	52.3	29.0	4.5	33.3	55.1	70.1	64.0	191.4	63.2	17.0	3.8	11.5	120.3	100.6	3.3	0.1	5.6	4.9	5.0	16.8	3.1	19.2	25.3	20.3	30.0	6.4	2.1	118.6	6.2	7.3	15.1	3.6	3.7	35.5	137.6	27.4	32.0	59.4	84.0	216.0	1.5	71.9	2.1	9.4	7.0	0.8	5.7	0.6	1.0	1.0	3.5	0.8	0.9	0.4	1.7	0.6	0.5	1.8	1.6	0.8	0.3	1.1	0.6	13.5	32.3	22.9	26.8	18.4	32.0	51.1	28.5	33.7	21.3	41.4	55.8	30.9	28.9	94.9	28.1	93.2	183.2	137.3	47.1	134.9	0.6	56.0	37.6	31.6	14.3	61.5	18.4	0.0	2.0	98.6	19.4	5.9	24.6	2.5	46.2	32.4	33.4	107.8	25.7	138.6	91.9	14.8	64.4	85.6	88.6	172.4	11.2	18.5	141.1	36.7	0.0	87.5	18.1	12.2	64.4	52.0	4.3	7.8	126.5	46.2	83.4	25.3	1.2	2.1	49.8	382.9	70.8	14.7	7.2	430.1	134.7	12.7	15.8	35.2	0.5	13.1	213.2	76.8	17.2	9.2	185.8	171.5	25.9	72.4	2.4	14.3	88.8
ELMO1	"CED-12, CED12, ELMO-1, KIAA0281"	ENSG00000155849	"Engulfment and cell motility 1"	Q92556	7	36852906-37449223	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 228.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 236.7;Microglial cells: 519.0;Oligodendrocyte precursor cells: 284.0;Oligodendrocytes: 1412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 129.9;JURKAT: 122.0;Karpas-707: 118.0;U-698: 141.7;U-937: 123.4"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.77e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (4.62e-4)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (3.27e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.16e-3)"	27.5	14.5	77.5	32.4	131.5	59.4	21.9	95.1	108.2	14.9	24.3	11.8	6.6	7.8	4.5	10.9	10.4	21.2	16.6	82.9	88.5	6.9	28.0	28.9	49.2	131.7	108.9	13.4	13.2	4.9	12.0	38.1	124.2	10.8	13.0	12.9	9.4	9.9	7.2	10.1	19.1	15.9	89.5	56.4	9.0	6.5	126.1	29.4	82.0	16.6	51.4	18.7	15.5	228.3	0.2	4.1	7.6	0.0	0.0	0.0	16.4	0.2	0.1	0.0	0.0	0.2	0.0	129.9	2.2	0.0	1.0	0.5	0.0	0.0	0.0	72.7	4.7	94.6	0.3	0.0	0.0	60.5	38.0	1.6	0.0	0.0	0.0	0.0	49.8	122.0	1.5	118.0	0.0	0.8	69.8	84.0	19.4	0.2	0.0	77.5	10.1	72.3	0.2	0.0	8.5	40.3	0.3	24.1	0.5	27.3	0.1	43.3	14.4	0.2	1.4	0.3	0.6	98.8	90.1	141.7	21.1	123.4	6.0	49.9	52.8	164.1	33.2	45.7	33.8	49.8	52.1	36.6	78.2	39.7	47.1	36.3	107.0	41.6	40.6	40.1	47.8	55.6	77.5	131.5	95.1	108.2	82.9	88.5	131.7	108.9	124.2	89.5	126.1	228.3	60.4	0.0	4.8	10.4	53.3	5.0	4.5	0.0	3.4	13.7	2.0	2.8	3.5	7.2	0.6	0.0	0.0	1.5	26.8	0.4	0.0	0.2	1.0	1.8	2.4	44.6	3.6	24.6	236.7	1.1	26.7	14.6	0.0	1.1	34.9	6.9	37.1	15.4	20.4	0.0	106.7	0.9	0.0	50.7	58.3	1.5	6.2	44.8	7.2	519.0	34.6	1.1	41.2	284.0	1412.3	0.6	0.8	24.8	31.7	1.9	0.0	2.0	0.0	1.8	13.1	9.5	2.7	1.4	4.6	0.8	4.3	19.7	35.6	15.2	0.2	1.8
EMCN	MUC14	ENSG00000164035	Endomucin	Q9ULC0	4	100395341-100880126	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Adipocytes: 409.0;Endothelial cells: 261.7;Hepatic stellate cells: 175.3;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005928	Approved				"Intracellular and membrane"	NA	NA		470000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA005928: AB_1078735"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (3.65e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.10e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.75e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.75e-2)"	46.3	20.2	6.7	9.6	7.1	0.2	38.2	7.1	11.2	37.1	7.8	10.3	6.8	27.9	9.9	12.7	19.2	31.4	38.5	6.3	7.5	79.7	7.5	48.4	6.6	8.1	7.0	6.9	6.2	19.2	9.6	0.8	9.0	12.7	8.1	1.5	9.2	25.6	18.5	9.0	8.3	38.8	7.0	3.5	8.2	2.3	9.4	8.7	43.6	40.2	4.9	24.9	13.9	7.4	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	7.1	7.1	11.2	6.3	7.5	8.1	7.0	9.0	7.0	9.4	7.4	409.0	6.4	6.0	0.3	14.0	16.6	0.5	0.1	6.2	0.1	2.1	3.0	14.1	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.0	0.1	0.7	0.6	0.6	261.7	0.0	8.0	1.3	0.0	0.0	16.2	0.0	0.3	0.0	0.1	175.3	1.1	0.2	0.0	0.2	0.0	0.0	5.5	21.4	1.3	1.2	1.7	16.0	111.5	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.4	2.6	1.0	0.0	0.2	0.0	0.4	0.0	5.8	21.4	0.2	0.5	1.1	14.6	0.3	2.4	0.7	0.0	1.0
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
EML1	"ELP79, EMAP, EMAPL, HuEMAP"	ENSG00000066629	"EMAP like 1"	O00423	14	99737693-99942060	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Excitatory neurons: 57.5;Late spermatids: 61.3;Microglial cells: 69.3;Oligodendrocytes: 61.8;Rod photoreceptor cells: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 67.3;HDLM-2: 89.5;U-2197: 104.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033137, HPA049105"	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB033137: AB_2098052, HPA049105: AB_2680633"	"unprognostic (9.86e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-3)"	"unprognostic (7.83e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.81e-3)"	"unprognostic (7.03e-3)"	15.5	6.4	8.6	9.1	25.5	0.3	9.7	7.3	12.7	13.2	15.0	35.5	6.8	16.1	10.8	24.1	15.1	18.6	17.2	8.6	7.9	8.6	5.5	13.2	3.3	9.2	9.0	3.8	8.7	28.3	9.2	27.2	10.7	9.6	14.9	50.1	5.0	16.9	47.5	9.4	10.1	31.0	9.4	3.9	14.9	8.0	8.9	1.3	14.8	34.4	4.4	17.1	10.3	22.8	0.0	44.9	36.8	12.9	20.1	39.5	0.3	35.9	67.3	25.2	8.4	5.1	0.9	0.0	22.2	22.6	30.3	0.2	26.7	3.1	11.5	89.5	13.6	0.0	7.9	0.8	4.8	0.1	0.9	11.6	4.9	31.0	11.7	16.0	44.5	0.7	0.1	0.0	10.4	21.3	0.1	0.1	14.5	0.1	17.2	5.4	13.5	0.2	56.2	0.6	14.1	20.9	11.8	1.8	0.0	24.1	13.7	1.2	42.3	22.8	4.1	104.3	14.9	0.5	0.0	0.3	57.3	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	25.5	7.3	12.7	8.6	7.9	9.2	9.0	10.7	9.4	8.9	22.8	22.8	16.0	7.0	17.3	0.3	2.8	1.2	0.4	1.2	9.2	1.0	1.3	15.0	1.5	4.5	3.7	158.4	2.7	0.1	0.1	0.0	4.6	29.1	15.9	14.2	30.1	0.0	0.0	57.5	4.9	0.6	20.6	4.1	4.7	0.0	1.6	40.0	1.3	1.3	1.7	29.9	0.6	0.0	2.5	4.7	61.3	7.2	1.9	7.2	69.3	0.6	8.8	1.0	17.6	61.8	0.8	0.0	6.0	1.2	1.4	0.0	2.5	11.8	113.6	0.0	20.8	8.7	4.8	11.3	0.4	4.0	2.9	0.7	1.2	0.0	0.7
EML3	"ELP95, FLJ35827"	ENSG00000149499	"EMAP like 3"	Q32P44	11	62602218-62612775	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.08e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.36e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.13e-8)"	"unprognostic (1.42e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.52e-1)"	38.6	21.6	15.3	28.3	15.4	21.5	35.3	13.5	15.1	36.7	13.5	21.0	10.5	29.4	7.8	49.6	31.5	14.5	20.6	14.5	14.9	32.0	31.2	29.0	26.9	19.6	15.8	36.4	22.2	13.4	15.6	12.3	17.5	28.1	9.3	17.4	24.3	13.2	10.1	32.4	26.4	14.7	14.8	44.1	24.5	12.8	18.7	18.7	27.1	4.3	22.6	27.1	32.0	18.9	18.8	13.3	13.9	12.7	19.8	33.8	12.5	17.4	18.7	18.6	11.4	11.3	29.8	33.2	43.3	24.4	14.0	29.8	12.3	31.9	9.6	43.5	12.1	31.1	36.9	9.5	27.4	22.8	26.1	46.5	13.3	15.3	22.9	36.0	37.9	14.5	23.7	32.6	24.9	52.1	16.0	28.2	3.4	22.4	18.5	21.1	12.8	71.2	21.5	21.0	5.4	18.7	12.9	44.0	22.1	12.8	43.9	15.5	42.6	24.3	20.0	19.2	19.6	45.3	27.9	20.8	26.4	15.4	17.8	8.7	4.5	5.7	4.6	4.9	4.6	3.1	4.4	4.8	3.4	3.8	3.9	4.8	2.7	5.6	4.6	2.4	5.5	4.4	15.3	15.4	13.5	15.1	14.5	14.9	19.6	15.8	17.5	14.8	18.7	18.9	29.8	6.4	14.5	15.3	18.5	14.3	12.1	14.5	30.1	7.7	13.9	18.3	4.8	15.7	11.6	11.0	8.4	19.6	14.0	12.5	5.9	9.3	7.4	5.9	8.3	27.0	10.2	11.6	0.3	13.6	15.2	12.8	19.9	7.6	3.8	8.1	37.5	18.5	15.1	1.7	1.1	11.0	12.2	23.2	8.5	26.8	22.4	16.7	5.4	6.5	16.1	6.6	23.7	5.0	4.5	20.1	11.5	18.0	15.9	10.3	9.5	5.5	7.6	22.6	19.7	8.0	12.8	7.3	12.3	74.1	21.6	16.8	23.5	10.2	10.3	14.1
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		15000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	26.3	20.2	30.3	16.5	25.9	0.5	13.4	21.1	20.3	13.5	2.0	30.9	12.5	23.6	13.7	16.2	15.0	23.6	25.2	27.2	35.7	7.0	7.5	17.3	4.7	35.5	34.2	22.6	22.3	17.9	6.5	18.2	28.1	21.4	10.1	8.1	20.9	30.6	20.4	10.6	10.8	57.6	22.4	24.8	23.3	25.0	40.9	9.0	7.3	11.5	4.6	30.1	13.8	28.7	91.6	71.9	87.1	79.0	33.3	43.7	111.9	99.1	47.3	58.4	43.9	46.4	33.0	38.7	256.8	153.9	52.5	79.0	102.7	37.4	55.2	0.6	63.4	40.3	62.4	63.1	99.4	4.8	1.5	67.9	44.2	75.9	96.2	47.8	47.0	10.7	2.7	1.9	58.6	17.7	18.5	4.7	146.8	23.9	64.3	27.6	122.9	1.1	26.9	69.5	85.3	68.9	194.6	73.3	63.3	66.1	87.5	5.9	92.2	150.4	109.8	126.8	198.6	4.2	11.4	25.7	82.7	5.0	78.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.3	25.9	21.1	20.3	27.2	35.7	35.5	34.2	28.1	22.4	40.9	28.7	117.0	12.8	37.3	81.9	3.8	129.0	172.5	64.4	26.2	11.2	96.2	57.9	119.3	54.3	56.5	22.0	62.6	65.0	1.7	14.8	3.9	84.7	74.8	127.2	60.5	79.3	41.4	0.0	86.3	100.5	18.5	71.6	63.2	75.0	5.1	194.2	23.9	12.9	11.2	16.8	155.0	27.3	26.4	1.6	29.7	24.3	58.1	4.3	83.6	41.2	3.8	32.6	3.1	160.4	151.3	61.5	16.5	168.9	1.6	133.1	3.5	19.6	137.8	19.0	92.1	69.4	166.1	13.4	37.2	25.6	134.1	60.5	4.8	220.7	31.3	100.3
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 528.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 407.5;Endothelial cells: 514.4;Extravillous trophoblasts: 294.4;Hepatic stellate cells: 579.0;Leydig cells: 487.1;Peritubular cells: 1421.8;Syncytiotrophoblasts: 376.4;Theca cells: 308.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 263.8;HUVEC TERT2: 487.4;TIME: 1027.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"		NA	NA		280000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (6.61e-4)"	"prognostic favorable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	234.5	92.6	44.4	80.2	41.5	18.8	164.8	45.2	44.5	129.7	50.4	62.4	33.2	111.1	35.1	43.1	122.4	58.7	528.7	36.7	43.1	211.6	60.7	260.7	43.4	50.0	47.1	220.9	47.1	29.7	56.1	93.6	52.8	93.9	17.5	2.1	46.2	73.5	72.3	51.3	76.8	65.7	43.1	226.5	57.6	98.9	59.4	17.3	169.2	54.8	17.7	93.0	95.8	43.6	1.3	1.0	7.1	0.4	117.8	81.0	217.8	147.1	102.0	74.4	43.4	0.5	1.3	1.0	70.2	263.8	56.8	2.4	0.0	23.2	24.5	0.7	0.3	42.3	76.7	4.6	91.7	20.2	0.5	137.6	5.4	97.7	34.9	1.0	487.4	1.4	0.7	1.4	88.1	0.9	0.6	1.8	1.7	0.3	4.2	66.9	12.5	1.4	0.0	0.4	0.8	1.8	78.0	65.3	20.1	4.7	13.8	29.8	1027.5	248.1	13.7	164.7	0.7	5.2	1.2	0.9	67.1	52.0	83.2	0.0	19.9	0.5	1.8	28.2	0.6	0.6	3.0	3.4	10.3	1.4	1.9	3.0	0.5	7.6	22.1	3.8	1.2	8.4	44.4	41.5	45.2	44.5	36.7	43.1	50.0	47.1	52.8	43.1	59.4	43.6	407.5	3.2	16.0	2.0	9.2	12.0	2.3	2.1	2.8	2.8	9.5	9.8	28.4	18.6	2.3	3.7	4.2	30.0	8.6	0.4	0.0	10.2	8.6	7.7	67.9	514.4	2.4	49.2	0.6	1.1	294.4	85.7	3.1	8.1	15.2	0.8	579.0	9.8	132.0	0.0	0.7	1.6	0.0	65.4	29.7	51.4	487.1	56.6	24.9	78.7	36.2	2.0	4.1	1.5	1.1	1.4	0.0	1421.8	2.1	2.0	0.0	0.3	5.1	4.6	72.3	44.0	57.5	4.4	5.2	1.3	8.4	376.4	9.6	308.1	0.5	1.4
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387184-40428744	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;cervix: 21.3;salivary gland: 22.4"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.2	1.3	3.4	1.1	20.8	0.1	2.4	2.0	6.5	21.3	0.8	3.5	1.3	3.1	2.4	6.5	0.9	2.0	0.6	4.5	4.5	2.6	0.1	3.9	0.4	6.2	4.0	1.7	15.8	0.5	2.9	0.5	6.1	3.4	2.8	2.6	22.4	4.0	1.2	2.9	1.4	1.9	2.2	4.2	6.8	0.5	5.3	0.9	5.5	2.5	1.7	13.0	3.6	4.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.6	0.0	13.0	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.0	1.5	18.4	1.8	0.2	0.4	1.1	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.0	3.5	0.2	0.0	3.4	20.8	2.0	6.5	4.5	4.5	6.2	4.0	6.1	2.2	5.3	4.7	5.5	3.2	4.2	4.9	0.2	2.3	1.3	2.3	8.0	0.7	6.1	0.3	0.5	0.0	5.1	0.0	0.0	0.0	1.3	1.0	0.0	2.7	0.4	7.6	2.5	0.7	2.4	0.0	22.6	22.5	0.0	0.4	2.6	14.9	0.0	0.0	0.0	0.0	0.1	0.0	92.6	0.1	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.9	0.0	3.7	0.0	7.1	5.9	6.9	0.0	0.7	0.1	1.4	0.0	0.0	1.9	0.8	19.7	0.6	19.9	0.2	0.1	14.5	2.3	0.0	0.2	0.1	0.2	4.7
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 27.6;liver: 14.5"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	1.4	0.0	0.4	0.4	0.2	0.2	0.6	0.0	21.3	27.6	0.1	0.0	0.3	0.7	3.7	0.0	0.0	0.0	3.1	14.5	0.1	0.1	0.2	0.1	0.1	3.1	0.1	5.1	0.1	0.0	0.4	11.2	0.0	6.3	0.2	0.0	0.1	27.2	0.1	0.0	0.2	8.9	0.5	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	5.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.2	0.0	0.0	5.3	0.7	0.0	0.2	0.5	0.1	0.0	0.1	0.4	2.8	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.7	1.5	0.4	11.5	0.3	20.2	0.0	0.0	0.1	194.5	0.0	1.3	0.0	3.0	0.4	0.1	3.6	0.0	0.0	7.5	0.2	0.1	31.6	4.7	0.0	0.1	0.4	10.1	0.1	0.0	0.0	181.0	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	174.3	0.0	0.2	0.6	167.3	5.9	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.3	0.1	15.6	1.7
EOMES	TBR2	ENSG00000163508	Eomesodermin	O95936	3	27715949-27722711	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Differentiation, Gastrulation, Immunity, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 8.4;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 43.6;Erythroid cells: 16.8;NK-cells: 93.7;T-cells: 31.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Region enriched"	"Detected in single"	13	"cerebellum: 8.4"	"Group enriched"	"Detected in many"	7	"gdT-cell: 16.5;MAIT T-cell: 26.2;memory CD8 T-cell: 19.5;naive CD8 T-cell: 11.9;NK-cell: 33.0"	"Group enriched"	"Detected in many"	107	"NK-cells: 33.0;T-cells: 26.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.4;JURKAT: 8.3;SCLC-21H: 3.9"	"Region enriched"	"Detected in many"	8	"olfactory bulb: 77.5"	"Group enriched"	"Detected in some"	27	"cerebellum: 30.2;olfactory bulb: 12.7"	HPA028896	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA028896: AB_10601370"	"unprognostic (1.53e-4)"	"unprognostic (5.95e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.60e-4)"	"unprognostic (4.13e-2)"	"unprognostic (9.63e-4)"	"unprognostic (4.29e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.49e-2)"	1.0	0.6	0.2	3.2	0.1	1.8	0.6	8.4	0.4	0.4	0.4	0.7	0.4	0.8	0.8	0.3	0.4	1.6	0.3	0.2	0.3	0.4	2.4	2.2	15.0	0.2	0.3	0.5	0.3	0.1	0.2	0.4	0.6	0.5	0.8	1.6	0.9	0.1	0.1	0.2	1.4	0.4	0.3	12.8	1.3	0.4	0.2	1.5	0.5	0.1	5.4	1.3	0.4	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	1.3	0.0	7.4	1.1	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.8	0.0	0.9	0.3	0.0	8.3	0.2	0.0	0.0	2.0	2.0	0.0	0.2	0.2	0.9	1.3	0.0	0.0	0.6	0.0	3.9	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	16.5	0.0	26.2	0.0	3.0	19.5	0.0	0.0	0.2	11.9	0.2	33.0	0.1	0.1	0.0	2.9	0.2	0.1	8.4	0.4	0.2	0.3	0.2	0.3	0.6	0.3	0.2	0.4	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.8	1.5	0.0	0.0	0.0	0.0	43.6	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	16.8	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.3	1.3	1.8	1.0	1.1	0.1	93.7	0.0	0.0	0.0	0.0	0.4	9.8	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	2.0	0.0	0.1	0.0	31.5	0.0	0.0	0.0
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 412.0;placenta: 445.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 831.5;Endothelial cells: 425.8;Hepatic stellate cells: 538.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.6;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 267.3;BJ hTERT+: 266.7;HHSteC: 326.3;RT4: 339.8;TIME: 337.8;U-138 MG: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	296.0	52.1	53.4	66.1	48.6	2.3	166.7	44.6	47.7	72.9	139.1	57.1	46.3	87.9	26.0	72.7	80.1	83.2	122.1	39.2	44.7	89.5	110.1	412.0	47.9	60.5	54.2	34.5	59.6	79.4	25.9	445.6	60.2	51.8	42.6	53.6	40.0	66.3	80.5	42.9	50.9	71.7	45.6	84.6	42.8	20.0	75.4	17.9	138.1	153.6	40.3	94.9	47.8	44.6	32.2	33.5	2.1	2.5	153.8	98.6	267.3	98.7	266.7	55.6	60.1	5.8	5.5	0.1	23.8	188.5	55.2	15.2	0.6	79.0	41.3	0.9	1.6	0.0	10.3	71.8	326.3	0.1	19.8	145.0	106.9	108.7	75.8	41.0	193.1	0.7	3.1	0.2	34.2	27.8	0.9	0.8	1.3	22.4	18.5	1.0	3.7	10.5	34.5	339.8	1.4	68.5	77.4	175.5	21.0	68.3	11.7	14.1	337.8	284.0	8.1	38.3	8.4	0.2	0.2	0.1	207.4	5.4	7.4	20.6	0.1	8.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.1	53.4	48.6	44.6	47.7	39.2	44.7	60.5	54.2	60.2	45.6	75.4	44.6	831.5	76.9	151.7	28.4	4.1	48.2	69.8	108.6	43.9	4.5	27.4	29.5	79.2	32.9	124.9	3.7	10.4	126.2	6.6	112.6	1.9	23.0	12.9	36.1	32.7	425.8	4.2	18.7	1.2	52.4	299.9	76.8	32.1	67.6	41.2	2.3	538.7	78.0	55.5	0.0	1.6	13.9	22.4	60.9	30.3	52.7	12.5	21.4	28.4	155.5	0.6	95.5	0.0	31.2	1.3	26.1	53.7	6.4	3.9	57.8	45.9	30.2	31.7	59.3	282.7	23.3	250.5	1.5	4.6	65.0	33.2	349.7	15.9	4.7	23.6	85.7
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
EPB41L4A	NBL4	ENSG00000129595	"Erythrocyte membrane protein band 4.1 like 4A"	Q9HCS5	5	112142441-112419313	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 64.3;Oligodendrocyte precursor cells: 164.4;Oligodendrocytes: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 30.1;HeLa: 36.5;RT4: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036580	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"	Nucleoplasm	"HPA036580: AB_10669908"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.40e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.65e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-1)"	8.7	4.5	4.8	3.2	5.7	3.6	5.3	4.1	4.8	4.1	9.0	4.0	2.6	4.3	12.7	10.1	7.4	13.8	9.2	6.0	5.1	11.7	3.3	7.7	3.3	5.7	4.6	5.7	4.9	8.0	0.5	9.3	4.8	5.8	4.8	16.0	7.2	5.4	4.2	8.8	3.4	2.7	4.9	4.7	5.6	6.1	4.8	3.6	13.5	4.2	3.6	5.1	2.3	4.8	0.8	5.5	14.3	1.5	0.0	0.0	2.9	2.1	0.0	0.0	0.0	3.0	12.3	6.2	30.1	0.0	0.8	7.4	1.1	6.9	0.0	1.0	5.0	9.8	36.5	2.0	0.1	2.6	3.1	0.0	3.0	0.0	0.0	1.6	9.2	1.7	1.9	5.6	0.0	1.8	4.6	3.5	2.7	1.2	1.1	2.3	10.7	1.3	8.4	21.6	11.8	6.1	10.7	5.2	4.5	9.8	15.9	1.4	15.7	0.7	2.4	1.9	4.4	5.6	1.3	4.6	1.4	5.2	0.8	0.5	0.2	0.1	2.0	0.3	1.1	1.4	0.6	0.6	0.2	1.6	0.9	1.8	0.2	0.1	0.5	0.1	0.6	0.5	4.8	5.7	4.1	4.8	6.0	5.1	5.7	4.6	4.8	4.9	4.8	4.8	55.9	28.9	7.7	17.3	4.7	6.0	16.8	11.2	13.6	5.0	11.2	4.7	8.3	64.3	24.2	14.7	4.2	7.4	4.5	8.5	11.7	15.0	20.8	19.7	3.1	35.2	1.2	2.1	28.6	7.5	0.7	8.4	7.1	17.1	8.8	11.9	34.6	1.7	2.7	1.7	31.8	6.3	16.2	4.6	2.1	23.0	1.8	1.8	3.6	56.2	3.2	8.2	14.4	164.4	65.4	14.1	10.9	1.9	6.5	13.7	1.9	30.4	39.5	32.1	0.0	8.7	6.0	1.8	9.1	16.0	8.1	2.5	3.7	2.2	7.5	19.1
EPB41L4B	"EHM2, LULU2"	ENSG00000095203	"Erythrocyte membrane protein band 4.1 like 4B"	Q9H329	9	109171974-109321059	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.9;pancreas: 149.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 134.8;Excitatory neurons: 79.7;Hepatocytes: 125.2;Proximal enterocytes: 79.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;hTCEpi: 49.8;OE19: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042862	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"HPA042862: AB_10794534"	"prognostic unfavorable (1.02e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.60e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.82e-4)"	"unprognostic (1.46e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.29e-1)"	21.0	9.7	6.0	4.5	8.7	0.0	15.3	2.0	12.2	4.1	11.8	57.6	47.6	1.2	17.9	1.5	10.8	4.2	8.8	10.7	6.4	6.4	88.9	6.3	0.2	2.7	5.3	13.8	149.1	11.1	1.6	2.5	3.7	7.6	56.7	3.0	26.9	9.1	6.1	15.5	51.9	1.9	7.2	0.1	30.6	7.5	10.9	0.6	44.7	0.7	1.6	2.2	3.4	4.3	8.7	10.8	0.7	0.8	0.8	0.0	31.7	1.1	0.4	3.7	1.9	18.5	8.5	0.0	2.3	1.0	8.9	13.9	21.5	11.5	3.9	9.2	5.1	0.0	3.4	26.5	2.2	0.4	0.0	0.3	49.8	1.5	17.0	1.1	0.2	8.0	0.3	0.0	5.2	22.3	0.4	0.2	13.8	62.8	15.7	0.0	0.0	0.6	12.9	13.1	13.1	1.4	3.4	22.2	0.0	6.3	5.2	0.1	0.5	7.5	7.6	2.5	3.1	0.1	0.1	0.0	5.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	8.7	2.0	12.2	10.7	6.4	2.7	5.3	3.7	7.2	10.9	4.3	0.2	6.4	5.1	2.6	0.4	11.5	5.4	6.0	1.2	7.5	22.7	10.4	18.5	20.0	9.6	7.3	0.0	4.1	0.0	134.8	0.0	3.5	11.7	23.8	2.3	0.8	51.6	0.0	79.7	20.8	2.1	2.5	26.0	20.7	0.0	6.2	5.0	125.2	0.6	38.7	58.9	51.4	12.2	1.6	1.5	1.9	13.4	0.4	1.8	3.7	0.0	1.9	0.0	12.1	3.8	10.2	54.4	2.6	0.0	7.2	79.2	0.8	39.2	1.1	0.0	0.8	1.0	1.4	17.2	0.9	24.0	1.9	0.5	6.8	46.5	6.5
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 806.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2317.0;Ductal cells: 999.6;Intestinal goblet cells: 1378.2;Paneth cells: 2437.0;Proximal enterocytes: 2681.1;Undifferentiated cells: 1607.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 538.9;CACO-2: 680.9;CAPAN-2: 944.4;OE19: 911.8;RPTEC TERT1: 398.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA		22000		"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	4.4	12.2	3.1	77.0	4.0	10.2	99.7	1.5	3.1	116.2	1.0	806.0	726.5	33.0	238.9	10.8	114.3	71.1	0.6	3.3	9.2	223.1	3.1	74.7	0.9	2.8	3.2	1.2	125.4	219.5	86.9	1.7	3.4	60.5	751.0	0.6	119.8	52.8	0.1	8.8	769.6	22.2	2.6	1.4	172.4	21.7	10.4	6.4	286.8	0.1	2.8	30.9	4.2	2.6	538.9	5.4	0.4	1.2	0.0	0.0	321.3	0.2	0.0	0.6	0.0	680.9	944.4	0.1	141.5	1.0	0.4	247.3	4.6	62.2	2.0	0.1	56.3	0.3	2.5	261.6	0.1	0.3	0.4	0.0	17.6	0.0	0.0	0.0	0.8	0.0	160.9	0.0	0.3	269.7	0.5	24.0	164.3	911.8	31.4	0.3	0.0	136.9	398.6	231.3	354.0	3.2	4.3	187.7	0.6	132.7	158.3	1.0	0.7	0.3	6.3	2.0	1.1	39.2	0.6	0.8	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.1	4.0	1.5	3.1	3.3	9.2	2.8	3.2	3.4	2.6	10.4	2.6	3.7	310.9	148.1	1.3	7.0	9.3	227.6	127.4	14.2	0.5	184.7	112.9	2.0	243.1	222.8	448.8	0.0	16.4	2.3	2317.0	76.3	999.6	8.6	434.7	35.3	5.8	498.1	23.1	1.1	402.8	6.5	6.3	150.3	445.3	32.5	11.8	1.4	0.6	2.9	0.0	0.4	1378.2	486.2	0.0	5.2	5.6	20.5	5.6	35.6	0.0	11.5	15.7	0.0	0.5	1.2	617.5	2437.0	18.8	1.8	257.9	2681.1	195.9	219.0	0.7	13.1	0.5	13.7	83.5	130.3	33.3	10.4	6.0	9.4	70.3	1607.7	230.7
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;intestine: 13.4;testis: 13.4"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 91.8;Early spermatids: 59.1;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.9;HDLM-2: 19.4;SCLC-21H: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA027497	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.0	0.4	4.2	0.9	4.4	0.3	0.9	0.0	7.6	0.2	0.0	13.4	3.5	0.1	3.9	0.4	0.9	1.0	0.1	4.3	2.1	0.2	0.0	0.1	0.2	1.9	0.4	0.0	2.6	1.3	6.7	0.0	0.7	0.6	6.3	3.1	1.4	0.2	0.0	0.2	6.7	0.4	0.0	0.1	3.1	13.4	4.1	0.1	0.4	0.0	0.1	0.2	0.2	1.8	1.5	1.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.0	19.4	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.7	0.0	1.0	0.0	0.1	0.7	2.0	0.6	0.0	0.0	0.4	0.3	1.7	8.6	0.4	1.1	0.0	0.0	0.2	2.8	0.1	0.0	0.0	0.9	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	4.4	0.0	7.6	4.3	2.1	1.9	0.4	0.7	0.0	4.1	1.8	0.0	0.0	0.5	0.3	0.2	0.1	0.0	0.0	0.0	5.6	1.3	0.9	1.5	0.0	0.1	0.0	91.8	0.0	0.0	23.8	0.0	0.4	59.1	0.0	0.0	0.1	18.7	0.0	24.5	2.5	0.0	0.3	1.5	0.1	0.0	0.1	0.0	0.0	0.0	11.8	15.8	10.5	0.0	0.0	0.0	183.7	1.8	0.1	0.0	1.0	0.0	0.4	0.0	2.5	2.2	2.3	21.1	0.4	0.0	0.2	7.8	0.0	0.0	3.1	0.0	0.0	0.1	18.2	2.6	0.0	0.0	0.0	0.1	0.0	11.0	0.2
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156069	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 147.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.3;Glandular and luminal cells: 182.9;Squamous epithelial cells: 156.3;Suprabasal keratinocytes: 248.3;Urothelial cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"plasmacytoid DC: 9.4"	"Lineage enriched"	"Detected in single"	94	"dendritic cells: 9.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 201.1;PC-3: 229.0;U-251 MG: 242.1;WM-115: 258.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	Yes		12000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	21.4	9.5	3.5	4.8	3.1	0.3	14.6	2.9	3.7	38.2	11.7	12.4	10.0	12.1	1.3	147.9	13.5	28.2	15.8	3.1	3.1	18.7	18.9	17.9	7.6	3.8	3.7	5.8	23.2	3.7	7.4	14.0	3.8	11.2	5.8	6.4	67.7	4.2	4.6	40.3	12.8	3.7	3.6	7.6	15.6	1.8	4.3	3.2	15.2	5.1	11.1	56.1	58.8	3.1	76.9	151.7	41.4	20.1	2.9	3.5	24.3	45.2	63.4	79.9	50.6	63.9	201.1	0.1	189.8	25.9	98.8	30.6	9.9	104.4	27.6	0.4	7.0	0.0	46.7	41.1	51.3	0.1	0.2	4.8	38.1	43.7	95.6	125.0	86.4	0.0	0.3	0.1	51.6	24.3	0.0	0.0	20.0	57.2	229.0	0.1	37.6	0.2	85.1	39.0	0.1	6.4	87.8	21.2	6.1	21.3	3.0	0.9	108.1	28.5	76.7	2.0	242.1	0.0	0.5	0.6	22.0	0.1	258.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	3.5	3.1	2.9	3.7	3.1	3.1	3.8	3.7	3.8	3.6	4.3	3.1	17.1	54.5	38.4	2.0	1.2	202.3	114.3	110.9	66.0	2.7	39.5	43.9	6.5	44.3	113.4	9.2	4.2	9.7	8.9	96.8	0.0	33.8	5.8	104.5	19.2	26.3	3.0	0.0	0.1	14.2	1.2	5.8	68.3	182.9	5.7	0.4	29.3	23.3	1.9	0.0	0.2	42.0	34.6	1.6	17.0	0.2	3.4	3.7	26.6	4.7	1.1	7.1	0.0	0.0	0.0	104.6	111.7	0.0	0.0	60.8	22.4	1.8	89.8	2.5	32.9	11.6	21.2	0.2	0.8	156.3	248.3	7.5	2.6	0.4	42.9	200.4
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532682-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;stomach 1: 37.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 77.9;Distal enterocytes: 27.6;Gastric mucus-secreting cells: 44.9;Intestinal goblet cells: 24.9;Squamous epithelial cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 28.6;HBEC3-KT: 40.3;MCF7: 66.4;OE19: 62.8;RT4: 50.2;SK-BR-3: 25.8;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.2	8.9	2.3	0.8	1.3	0.6	2.3	6.4	6.0	6.5	1.2	7.1	6.8	0.4	3.2	35.9	7.5	5.9	7.1	0.7	2.1	6.0	0.1	0.3	0.0	11.5	5.4	13.5	23.0	21.2	0.8	4.2	13.6	9.9	4.4	0.2	11.1	5.6	0.1	30.5	3.2	0.1	0.5	0.0	37.3	2.8	13.4	3.2	1.1	0.0	3.7	5.5	12.9	1.8	20.5	0.3	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	14.7	12.1	0.0	0.2	0.0	0.1	28.6	0.0	40.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.2	0.1	21.8	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.0	66.4	0.3	0.0	0.0	62.8	0.4	0.0	0.0	0.1	0.2	50.2	0.4	0.0	0.0	25.8	0.0	0.4	57.4	0.2	1.5	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.3	6.4	6.0	0.7	2.1	11.5	5.4	13.6	0.5	13.4	1.8	0.2	0.0	0.0	0.0	0.4	2.3	4.4	4.1	10.8	2.9	6.5	3.4	5.4	8.6	8.3	18.4	0.0	77.9	0.0	27.6	5.9	9.2	1.0	3.8	0.6	0.4	3.6	0.0	1.0	11.5	7.4	0.8	44.9	5.5	0.0	3.1	0.0	0.0	5.9	0.0	1.7	24.9	2.0	0.0	0.0	2.1	2.8	0.5	0.0	1.0	0.6	0.6	0.0	0.0	0.0	3.4	10.3	0.0	1.3	4.9	2.1	0.3	4.3	0.9	0.0	0.0	0.8	0.0	0.5	30.0	5.5	10.7	0.2	12.4	19.3	7.8
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377207-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 114.7;Hepatic stellate cells: 66.8;Hofbauer cells: 42.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	6.5	17.5	6.0	1.4	6.3	22.4	5.0	6.7	8.2	7.1	7.7	2.7	1.4	3.3	13.6	1.3	6.7	2.3	9.7	6.3	6.0	21.6	10.7	6.4	2.2	6.1	6.1	3.1	11.8	23.2	8.2	8.0	6.4	4.6	1.7	3.3	3.3	7.3	2.3	1.6	2.3	1.8	6.0	11.9	7.8	1.8	6.2	1.7	30.2	1.5	1.6	3.1	3.7	6.3	3.7	1.2	3.6	4.2	5.3	3.4	2.1	2.2	7.0	3.6	4.5	1.3	1.4	2.5	4.0	4.1	5.0	0.9	2.8	1.4	4.1	2.1	1.6	14.3	1.3	2.1	3.8	2.9	5.5	2.4	0.5	4.8	3.3	8.5	8.5	5.3	12.5	12.0	4.1	3.3	2.7	3.5	1.9	2.0	9.6	7.2	6.3	5.6	3.4	1.9	1.4	11.0	1.5	2.0	6.4	3.7	3.6	4.9	3.5	1.9	2.6	6.6	2.1	6.0	4.7	2.8	10.5	2.9	2.1	9.3	3.7	3.0	1.7	4.6	3.6	2.0	3.4	2.5	2.1	1.2	3.7	2.2	10.2	0.8	7.3	0.1	3.3	2.4	6.0	6.3	6.7	8.2	6.3	6.0	6.1	6.1	6.4	6.0	6.2	6.3	6.1	19.2	18.8	24.8	11.5	2.3	4.0	2.0	2.8	3.8	3.6	6.1	6.5	5.7	3.1	20.2	0.0	2.2	5.2	1.3	3.9	2.2	0.8	9.9	6.8	13.5	8.4	114.7	2.2	3.3	12.2	9.8	15.3	13.9	26.6	1.2	66.8	3.5	42.4	1.7	3.0	3.5	2.0	17.0	4.0	0.6	2.8	15.4	8.8	7.5	4.6	7.9	11.3	1.0	1.6	3.1	0.4	4.1	3.8	1.8	0.2	1.0	2.9	2.5	19.7	3.8	18.5	5.1	7.7	1.6	1.0	3.0	9.6	2.6	1.8	1.2
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 35.7;intestine: 142.1;stomach 1: 50.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 254.4;Gastric mucus-secreting cells: 80.5;Intestinal goblet cells: 103.4;Late spermatids: 144.6;Paneth cells: 257.8;Proximal enterocytes: 285.3;Undifferentiated cells: 112.6"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 15.6;CAPAN-2: 14.4;Hep G2: 36.2;OE19: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favorable (1.82e-4)"	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.0	0.0	1.3	0.0	77.1	141.8	0.2	0.9	0.1	0.1	35.7	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	77.1	0.0	0.0	0.2	0.0	0.0	142.1	2.9	0.0	0.0	50.7	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.6	14.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	67.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	14.3	0.3	0.0	0.0	0.0	0.0	254.4	0.0	11.6	28.0	0.7	0.1	0.3	51.4	0.0	0.0	23.9	0.0	0.0	80.5	1.0	4.5	0.0	0.0	0.2	0.0	0.0	0.0	103.4	0.0	0.0	0.0	144.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.5	257.8	0.4	0.3	0.0	285.3	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.4	0.6	112.6	1.8
ERG	"erg-3, p55"	ENSG00000157554	"ETS transcription factor ERG"	P11308	21	38380027-38661780	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.4;Endothelial cells: 105.5;Hepatic stellate cells: 69.9;Microglial cells: 88.1"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 18.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 138.3;MOLT-4: 47.7;REH: 151.5;TIME: 113.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018377, HPA046598"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"CAB018377: AB_675518, HPA046598: AB_2679715"	"unprognostic (2.14e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (6.44e-3)"	"unprognostic (8.64e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.03e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.63e-3)"	24.6	4.1	5.1	7.1	5.5	7.6	20.0	5.0	5.5	10.0	3.0	5.4	3.4	11.6	1.9	5.2	9.1	12.0	12.4	4.5	5.1	12.8	6.1	19.6	7.5	5.9	5.4	4.4	4.9	2.4	2.4	24.3	6.2	7.1	3.4	0.5	3.7	4.3	7.9	4.9	6.5	12.0	4.7	26.6	4.6	1.5	7.0	4.1	10.0	9.9	3.7	9.2	6.9	5.4	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.2	22.3	0.0	0.1	0.9	0.0	0.0	138.3	0.1	0.0	0.0	0.0	1.0	47.7	0.0	0.5	0.0	0.0	151.5	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	113.4	0.7	2.2	0.5	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	5.5	5.0	5.5	4.5	5.1	5.9	5.4	6.2	4.7	7.0	5.4	94.4	0.0	3.9	0.3	0.7	3.4	1.7	0.6	3.4	0.0	0.6	4.3	3.8	4.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.7	0.4	105.5	0.0	13.5	13.3	0.0	0.0	5.7	0.0	2.1	24.0	4.4	69.9	1.3	0.3	0.0	1.7	0.4	0.0	5.9	3.4	2.1	0.9	0.9	3.6	88.1	0.2	0.0	0.0	7.1	1.4	0.0	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.1	0.0	2.4	3.7	0.3	1.4	0.5	3.4	0.0	0.6	0.5	0.3	0.6
ERICH1		ENSG00000104714	"Glutamate rich 1"	Q86X53	8	614746-738106	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003725	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA003725: AB_1853023"	"unprognostic (7.19e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.51e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.42e-1)"	15.9	8.7	7.3	17.2	6.5	23.0	13.7	6.4	8.2	10.7	8.3	11.0	8.4	10.1	6.6	10.4	10.5	9.1	10.7	6.9	7.1	22.5	11.6	14.6	21.1	9.0	7.1	11.6	9.0	7.9	11.5	10.1	8.4	9.1	7.2	5.1	9.8	5.8	10.8	13.0	12.4	7.9	6.0	15.3	10.5	8.0	8.4	11.8	13.2	5.5	10.7	12.7	11.6	7.1	15.8	22.2	11.7	14.0	12.4	15.0	24.3	14.9	7.9	13.3	14.6	14.4	9.9	36.0	6.9	12.5	25.3	26.0	21.7	22.9	9.4	15.7	28.1	25.1	15.1	20.8	13.9	15.5	22.6	17.4	14.5	10.1	13.0	13.7	14.7	31.2	26.3	20.2	13.5	13.2	30.0	27.5	18.6	17.6	9.9	27.0	7.6	25.0	14.9	28.7	5.4	15.0	10.9	13.8	20.2	19.2	5.8	18.4	23.7	9.7	4.6	0.6	16.2	13.1	36.7	38.9	19.9	24.6	10.5	24.7	33.0	12.5	8.4	32.3	7.5	17.9	9.7	8.4	17.1	20.1	8.1	7.1	30.0	12.3	29.8	12.7	7.5	10.4	7.3	6.5	6.4	8.2	6.9	7.1	9.0	7.1	8.4	6.0	8.4	7.1	71.0	44.8	36.1	17.9	75.3	36.6	47.0	47.9	32.5	23.3	32.6	32.5	23.0	27.1	31.2	33.1	12.5	62.0	55.4	49.2	109.5	38.4	16.1	35.9	52.2	65.8	19.7	43.9	24.4	36.6	60.4	40.7	66.8	57.4	41.1	48.3	62.4	31.9	41.9	48.8	21.0	50.4	32.6	70.9	68.0	9.2	60.3	69.9	35.6	23.4	126.9	18.2	78.2	11.1	22.5	55.4	54.3	40.6	34.6	51.5	33.3	58.9	26.9	22.1	39.5	33.6	35.6	48.5	58.4	23.2	40.9	54.0	68.3	27.0	39.8	37.0
ERICH3	"C1orf173, DKFZp547I048, RP11-653A5.1"	ENSG00000178965	"Glutamate rich 3"	Q5RHP9	1	74568117-74673792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.3;testis: 24.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 326.4;Endometrial ciliated cells: 139.8;Late spermatids: 326.9;Respiratory ciliated cells: 234.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028655, HPA072916"	Approved					NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 49: Ciliated cells - Cilium organization"			"HPA028655: AB_10961002, HPA072916: "	"unprognostic (4.49e-4)"	"unprognostic (1.02e-2)"		"prognostic favorable (1.56e-5)"	"unprognostic (1.71e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.83e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-4)"	"unprognostic (9.21e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.90e-2)"	0.0	2.5	3.1	0.0	3.5	0.0	0.8	0.2	5.4	5.4	0.0	0.0	0.0	1.0	0.0	0.0	17.3	0.0	0.0	3.4	1.8	0.0	0.0	2.7	0.2	0.0	0.3	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	24.1	3.2	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.5	0.2	5.4	3.4	1.8	0.0	0.3	0.0	0.0	3.2	0.2	0.0	3.2	3.1	3.6	0.3	0.0	0.0	0.0	0.0	3.5	2.8	0.3	0.6	0.0	28.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	326.4	139.8	1.0	0.4	3.5	0.0	56.8	0.0	0.0	0.5	0.0	3.2	1.3	0.0	0.0	0.1	0.0	0.0	51.8	0.0	0.0	0.0	0.0	326.9	3.1	0.7	0.0	1.0	0.0	0.1	1.0	24.6	3.2	0.0	0.0	3.8	0.0	0.6	0.0	0.0	234.6	0.5	6.6	0.0	0.1	32.9	1.5	0.0	0.0	0.1	0.3	0.1	0.0	0.3
ERN2	IRE1b	ENSG00000134398	"Endoplasmic reticulum to nucleus signaling 2"	Q76MJ5	16	23690310-23713226	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 19.5;gallbladder: 17.0;intestine: 28.9;salivary gland: 22.9;stomach 1: 51.9"	"Cell type enhanced"	"Detected in some"		"Club cells: 38.4;Distal enterocytes: 80.2;Gastric mucus-secreting cells: 193.7;Intestinal goblet cells: 143.9;Paneth cells: 37.2;Undifferentiated cells: 70.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 17.0;pancreatic cancer: 19.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 43.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076875	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum, Cytosol"		"HPA076875: "	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-9)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-3)"	0.1	0.4	0.1	3.0	0.1	0.0	0.1	0.6	0.4	19.5	0.2	28.9	12.9	0.0	0.0	0.9	0.4	17.0	0.0	0.1	0.2	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.9	0.0	0.2	0.0	0.2	3.5	23.0	0.0	22.9	0.1	0.0	0.2	12.4	0.9	0.0	0.0	51.9	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	43.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.8	0.0	1.5	6.8	0.0	0.0	0.0	0.0	0.5	20.0	38.4	0.0	0.0	0.5	0.0	80.2	0.0	2.3	0.1	0.5	0.2	0.1	10.8	0.0	0.2	1.9	0.0	0.1	193.7	1.6	4.5	0.1	0.0	0.0	0.1	0.0	0.1	143.9	6.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	33.1	37.2	0.0	0.5	1.3	6.1	0.1	16.9	0.0	0.0	1.7	1.6	0.0	0.2	0.0	0.0	0.1	0.4	0.0	70.9	11.1
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111725	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 37.0"	"Cell type enriched"	"Detected in some"	56	"Syncytiotrophoblasts: 575.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 38.8"									HPA011812			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA011812: AB_1857702"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	0.3	0.4	0.6	0.1	0.4	0.2	0.4	1.8	0.6	0.4	0.0	0.3	0.5	0.3	1.0	0.3	0.2	0.4	0.1	0.6	0.7	0.5	0.2	0.6	0.0	0.6	0.4	0.0	0.0	7.5	0.0	37.0	0.5	0.3	0.2	0.2	0.2	0.2	0.0	0.5	0.5	0.2	0.1	0.0	0.3	0.1	0.6	0.4	0.0	0.4	0.0	0.5	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	1.8	0.6	0.6	0.7	0.6	0.4	0.5	0.1	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	10.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	575.5	0.4	0.5	0.0	0.0
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 405.9;Endothelial cells: 301.0;Hepatic stellate cells: 138.1;Sertoli cells: 151.2;Smooth muscle cells: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.2;naive B-cell: 7.5"	"Group enriched"	"Detected in many"	9	"B-cells: 7.5;granulocytes: 8.2;T-cells: 2.2"	"Group enriched"	"Detected in many"	10	"HEL: 218.8;HUVEC TERT2: 277.9;TIME: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056293, HPA072563"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		82000000	"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Cell Junctions"	Cytosol	"HPA056293: AB_2683089, HPA072563: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	97.5	17.7	38.4	9.0	37.7	1.9	79.4	38.8	46.9	33.3	30.1	20.0	7.0	36.2	7.8	21.8	34.2	20.0	83.0	35.2	38.7	63.6	11.5	112.5	8.7	40.9	38.9	14.4	13.6	13.2	14.8	106.9	44.0	19.8	7.8	2.5	15.6	15.6	27.1	18.2	20.9	29.4	37.3	17.3	23.4	4.3	45.4	5.4	95.9	49.8	8.3	30.8	30.2	37.8	1.2	1.6	0.4	1.2	0.0	0.3	5.1	0.1	0.1	0.0	0.1	2.7	14.1	1.2	3.2	0.0	0.2	0.0	3.7	0.0	0.0	1.8	1.3	218.8	0.1	8.0	0.6	0.4	3.6	0.0	0.0	0.0	0.0	0.2	277.9	0.1	0.2	5.9	0.5	1.8	0.0	0.0	0.6	20.8	2.1	0.0	1.0	0.9	0.0	2.4	0.2	0.8	0.1	16.1	0.0	7.5	3.3	0.8	142.0	0.4	0.4	0.5	0.0	0.2	0.2	0.2	0.1	0.5	0.4	8.2	0.6	0.0	0.1	0.3	0.0	2.1	1.5	0.1	0.4	7.5	2.2	0.8	6.5	0.0	0.0	0.4	0.4	24.8	38.4	37.7	38.8	46.9	35.2	38.7	40.9	38.9	44.0	37.3	45.4	37.8	405.9	38.5	56.0	2.0	4.5	15.2	0.5	0.2	2.8	18.5	2.5	3.2	11.2	0.0	3.0	14.7	4.2	1.8	2.5	3.5	5.9	7.6	5.0	1.1	1.5	301.0	0.0	5.3	1.5	2.4	18.7	13.8	3.6	1.4	3.8	0.1	138.1	1.7	1.1	0.0	0.4	0.4	0.0	5.3	22.1	26.3	0.9	25.7	12.4	20.6	1.2	0.7	0.0	0.5	0.4	46.5	2.1	0.4	2.8	1.8	0.1	0.1	1.9	1.3	151.2	4.6	89.4	0.1	0.9	0.8	10.9	37.1	2.0	2.4	1.6	2.3
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Hearing	Actin-binding	"Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 129.1;retina: 117.8;testis: 145.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.4;thalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	5.7	0.4	2.6	1.0	28.0	9.2	13.4	1.0	30.3	0.2	28.2	90.4	2.4	39.9	34.3	18.6	0.3	0.9	0.4	1.7	63.4	129.1	3.2	0.3	0.6	1.3	0.4	0.9	26.8	42.1	0.9	1.1	10.0	6.8	117.8	9.4	6.2	0.8	91.7	89.5	0.8	0.3	0.9	2.7	145.3	6.1	1.6	0.4	0.0	1.7	1.3	22.3	0.5	14.1	0.7	0.6	0.1	0.0	0.0	48.9	0.0	0.0	0.2	0.0	29.9	1.5	0.5	6.5	0.0	0.1	32.6	2.3	0.1	0.0	2.0	0.7	0.4	0.7	81.5	0.0	0.6	2.7	0.1	0.6	0.0	0.0	0.0	0.0	1.0	17.6	0.0	0.0	28.2	0.2	1.0	0.6	3.8	12.2	0.0	0.4	10.9	0.2	0.1	21.0	0.7	3.7	160.1	5.0	0.3	53.6	7.4	15.6	0.1	0.8	0.6	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	13.4	1.0	0.4	1.7	0.6	1.3	1.1	0.3	6.1	0.5	0.2	0.0	0.6	0.0	0.8	7.8	2.4	4.5	12.5	5.6	10.7	3.9	1.4	11.5	3.8	9.2	68.8	3.0	0.2	175.5	13.7	0.2	137.5	19.1	0.9	0.8	6.0	8.2	0.2	3.1	0.5	0.3	5.6	12.4	0.0	0.0	3.9	109.4	0.2	0.0	0.2	36.3	8.2	3.2	0.9	461.6	3.7	1.5	0.0	0.0	0.0	272.5	0.0	0.0	0.1	0.1	186.3	2.2	0.0	1.6	512.1	102.2	9.0	72.5	0.0	0.0	0.2	12.3	3.9	17.6	22.7	6.6	1.5	0.0	35.3	2.9
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 107.2;Suprabasal keratinocytes: 79.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 138.3;BEWO: 101.1;CAPAN-2: 140.8;hTCEpi: 226.5;OE19: 142.6;RT4: 99.1;T-47d: 108.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.2	0.0	0.0	5.2	0.0	0.0	24.2	0.0	0.0	15.5	0.0	57.1	25.2	3.4	29.6	64.2	21.3	8.5	0.1	0.0	0.0	8.5	0.4	15.8	0.0	0.0	0.1	0.1	42.6	28.4	7.2	12.2	0.0	19.9	62.8	0.0	25.9	10.0	0.1	60.6	22.0	2.5	0.0	0.0	38.6	0.6	0.4	5.2	36.6	0.0	15.3	22.5	28.8	0.0	138.3	0.0	0.0	0.2	0.0	0.0	101.1	0.0	0.0	0.0	0.0	44.6	140.8	0.0	3.8	0.0	0.1	81.6	3.8	70.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	226.5	0.0	1.4	0.0	0.0	10.7	0.0	0.0	0.0	67.3	1.9	0.4	12.4	142.6	3.4	0.0	0.0	18.3	17.4	99.1	35.1	0.3	0.0	21.0	14.0	21.4	108.0	0.9	0.0	0.1	0.2	0.1	0.3	12.0	13.8	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	38.5	36.7	0.0	0.6	44.6	18.9	30.4	35.9	0.0	29.4	18.0	1.0	21.5	32.4	27.6	0.0	55.1	0.5	76.2	13.7	19.6	12.9	47.1	3.7	0.9	33.1	0.0	2.6	27.5	69.1	0.9	58.1	46.5	1.3	0.0	0.4	0.1	6.0	0.0	0.4	107.2	16.2	0.0	3.2	10.3	0.0	0.5	24.9	0.0	0.6	0.0	0.0	0.5	0.4	21.7	48.1	0.7	1.8	25.1	25.5	0.3	35.0	0.0	0.0	0.0	1.2	0.6	0.9	71.3	79.1	62.1	0.8	0.0	73.9	40.1
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229033-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 36.3;Gastric mucus-secreting cells: 44.9;Late spermatids: 82.4;Syncytiotrophoblasts: 58.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 55.5;MCF7: 113.2;RT4: 60.4;SK-BR-3: 59.8;T-47d: 90.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.6	0.1	0.2	2.2	0.1	0.0	9.6	0.5	0.3	7.6	0.7	18.1	9.9	1.1	7.4	55.2	4.9	4.1	0.1	0.2	0.0	9.9	38.8	13.3	0.0	0.1	0.1	0.2	28.9	13.4	3.3	8.0	0.1	11.6	14.7	0.0	17.8	2.6	0.2	36.5	8.2	0.5	0.0	0.0	27.0	10.8	0.3	3.4	16.7	0.0	7.1	13.0	19.2	0.2	38.6	0.2	0.1	0.0	0.0	0.0	55.5	0.2	0.0	0.1	0.2	36.7	19.1	0.0	1.7	0.0	0.0	40.4	0.1	30.1	0.0	0.1	24.1	0.1	12.5	30.9	0.6	0.0	0.2	0.0	43.4	0.0	16.4	0.1	0.0	0.1	0.1	0.0	0.0	113.2	0.0	0.3	4.1	31.4	12.0	0.1	0.0	0.2	14.5	60.4	4.2	0.0	19.6	59.8	0.1	5.4	90.1	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	19.2	17.2	0.0	0.3	6.4	5.3	6.8	5.7	0.8	10.7	6.9	1.0	20.0	11.1	23.9	0.0	36.3	0.3	18.8	0.0	11.0	29.1	7.3	1.4	0.4	8.4	0.0	0.0	14.0	5.5	0.5	44.9	13.8	0.0	0.6	0.4	31.1	2.7	0.0	0.0	25.3	8.2	0.8	0.8	82.4	0.9	0.2	1.8	0.0	0.6	0.3	1.0	0.0	0.0	13.7	8.5	0.0	0.3	7.9	5.1	5.6	4.2	0.2	0.0	0.2	0.7	10.4	1.2	27.2	8.5	58.4	0.5	0.0	18.3	8.9
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144674	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	107.9	39.3	15.2	38.5	14.4	18.7	72.7	18.5	18.9	36.6	19.8	45.9	17.2	53.4	22.2	29.2	47.1	27.8	24.5	13.5	23.0	26.8	46.7	45.0	45.9	34.2	21.7	38.8	39.5	40.7	11.7	38.7	36.2	30.5	36.2	8.9	28.0	47.2	54.2	26.1	30.7	74.4	22.5	37.2	29.3	12.1	23.6	36.6	27.8	33.3	49.8	44.7	32.3	24.0	107.0	78.1	62.2	158.2	90.8	67.3	53.4	117.4	129.3	136.2	94.4	72.4	114.3	40.8	92.2	201.3	50.7	118.7	73.7	120.4	121.6	58.8	54.2	244.7	56.0	58.5	125.9	193.2	371.6	76.7	125.5	147.1	81.3	145.3	117.8	39.2	153.6	263.9	124.4	81.2	70.4	116.4	78.9	44.6	102.5	105.4	85.0	107.3	113.7	89.0	52.4	54.8	174.1	52.9	80.5	71.3	111.1	128.4	154.5	104.8	94.7	59.7	85.7	62.3	99.0	58.7	97.3	79.6	111.7	423.2	37.4	423.0	127.2	69.4	157.2	62.4	129.4	129.5	87.2	48.2	102.3	120.2	9.3	84.2	85.6	29.7	139.6	177.8	15.2	14.4	18.5	18.9	13.5	23.0	34.2	21.7	36.2	22.5	23.6	24.0	44.4	9.6	9.3	4.6	25.9	16.3	19.8	23.5	14.2	5.5	20.5	21.3	8.2	14.3	12.9	31.3	10.4	31.9	22.3	6.1	0.0	36.8	2.0	20.5	15.1	28.2	25.2	17.9	10.2	26.8	18.1	17.6	9.2	19.3	62.7	24.7	27.1	37.8	46.4	0.0	7.1	12.0	22.4	21.3	24.8	2.1	17.4	22.9	35.6	6.5	50.6	5.7	60.8	2.0	4.1	26.2	3.5	25.2	18.5	19.9	2.2	4.4	10.7	5.9	52.6	14.3	22.0	3.9	2.9	18.0	11.9	37.9	40.3	12.5	10.8	12.7
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 328.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 263.1;dendritic cells: 378.9;Endothelial cells: 190.4;Hepatic stellate cells: 213.8;NK-cells: 399.6;T-cells: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 352.9;JURKAT: 362.3;U-698: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	101.2	19.2	11.7	145.7	10.4	35.3	65.4	9.8	14.1	35.9	8.9	31.2	26.9	36.5	9.3	21.8	20.2	62.5	43.0	8.9	11.3	30.4	47.6	76.2	277.1	13.1	14.7	27.0	20.1	28.4	7.8	56.3	13.4	17.1	31.4	1.8	16.5	20.7	25.6	18.1	49.3	38.1	11.6	185.8	46.1	8.0	15.2	328.8	39.8	42.3	250.2	67.9	19.2	11.3	87.7	15.7	72.8	0.3	30.7	49.3	0.2	65.7	140.2	80.9	77.3	5.1	91.7	312.1	65.7	109.5	184.7	29.8	7.0	190.0	169.0	66.6	1.1	352.9	6.4	0.3	82.2	36.7	4.0	97.2	15.0	69.6	252.2	46.1	67.9	362.3	0.6	63.3	98.1	0.0	185.7	27.4	27.0	7.9	55.0	50.4	118.7	24.5	64.2	95.6	0.9	5.0	34.5	0.7	73.6	48.5	0.3	17.7	126.1	180.5	57.1	35.5	109.1	46.7	8.9	462.5	32.2	68.0	162.1	51.2	0.1	6.6	20.4	0.3	28.9	12.3	27.0	25.0	0.2	9.2	32.5	26.1	1.1	27.8	1.0	6.2	33.3	9.5	11.7	10.4	9.8	14.1	8.9	11.3	13.1	14.7	13.4	11.6	15.2	11.3	263.1	25.6	26.5	2.9	125.6	114.8	41.0	12.4	1.8	0.0	8.2	7.2	9.0	4.3	24.3	11.0	0.0	0.2	378.9	13.1	0.0	31.9	6.2	26.3	51.0	190.4	15.5	13.7	2.0	22.6	0.5	45.5	17.3	66.2	19.6	1.3	213.8	5.4	7.3	0.0	25.6	15.0	10.2	18.3	48.2	1.5	14.0	12.5	69.4	65.6	16.8	0.2	399.6	55.3	9.5	99.3	6.6	15.4	129.6	26.8	2.2	4.6	5.9	0.2	105.2	55.5	76.6	0.7	1.8	1.5	63.2	0.4	323.2	40.4	5.8	32.6
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.3;lymphoid tissue: 11.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 7.4;Extravillous trophoblasts: 16.7;Plasma cells: 11.8;Spermatocytes: 9.3;Spermatogonia: 9.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	0.5	0.3	0.2	3.3	0.2	17.3	1.2	0.1	0.7	0.5	0.1	3.2	2.9	0.8	0.0	2.5	0.3	0.4	0.2	0.3	0.1	0.3	0.5	0.6	5.8	0.1	0.2	0.2	0.3	0.7	0.1	3.3	0.2	0.2	3.7	0.0	0.5	0.2	0.1	1.8	2.5	1.2	0.2	1.5	1.6	5.7	0.3	11.1	0.4	0.0	6.4	1.2	0.8	0.4	41.3	26.8	43.4	28.6	2.7	6.7	36.5	53.4	17.7	46.7	50.5	33.9	22.5	44.3	25.3	12.6	25.1	40.0	55.5	22.5	54.8	69.5	48.4	41.5	28.8	17.3	1.0	59.8	29.4	1.7	1.1	46.8	12.5	5.7	14.7	43.4	84.6	57.0	37.8	19.0	65.9	33.6	60.4	49.7	26.0	46.2	40.5	47.5	9.6	25.6	48.1	60.9	34.8	27.9	19.5	20.2	25.8	36.6	5.5	44.9	39.5	42.7	72.9	41.5	59.0	71.3	15.6	48.1	54.9	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.3	0.2	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.4	0.2	0.0	0.0	0.3	0.7	0.8	0.1	0.7	0.0	0.0	0.3	0.5	2.3	0.0	0.1	0.0	0.0	5.3	0.2	1.2	0.0	0.1	9.3	0.3	0.4	0.7	0.0	7.4	1.0	0.0	16.7	0.9	1.1	0.5	0.0	4.6	0.4	0.0	3.3	0.0	2.9	0.5	0.0	0.3	0.8	2.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	11.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	9.3	9.8	2.7	0.1	4.0	0.8	0.8	1.9	0.3
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505435-108593768	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skin 1: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebellum: 67.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 20.9;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	8	"cerebellum: 30.9"							NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favorable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.4	0.1	1.3	0.5	2.5	0.2	2.9	67.7	2.3	2.2	12.8	3.9	0.7	0.7	2.7	7.4	1.7	0.3	0.2	2.1	1.9	2.4	7.7	3.9	0.1	1.5	3.6	0.3	1.0	4.7	0.5	2.8	4.6	1.5	4.4	0.3	4.4	0.3	0.1	25.8	0.8	0.4	1.1	0.2	3.2	0.7	1.7	0.8	1.0	0.2	1.4	0.7	3.8	3.4	3.9	0.4	0.2	0.1	0.0	0.1	3.2	0.2	0.1	0.0	0.6	1.0	5.9	0.0	0.2	0.2	0.9	7.9	5.7	2.1	0.2	0.1	1.7	1.6	0.8	0.0	0.5	0.8	0.1	0.1	3.3	0.0	11.2	0.5	0.0	1.3	3.0	0.0	3.1	0.6	1.0	0.0	0.2	6.4	2.4	0.0	0.1	0.0	0.6	20.5	1.4	0.8	1.0	9.7	0.2	1.1	6.4	0.1	0.1	0.0	2.3	0.0	1.1	0.1	0.0	0.0	0.1	0.4	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.5	0.8	0.9	0.1	0.2	0.0	0.1	1.3	2.5	67.7	2.3	2.1	1.9	1.5	3.6	4.6	1.1	1.7	3.4	0.6	147.4	60.0	18.6	0.9	107.7	12.9	16.6	58.6	0.6	14.1	8.6	5.7	4.3	65.3	20.2	14.6	44.5	2.4	47.9	3.9	5.4	10.3	74.8	7.8	2.5	4.9	3.2	9.0	4.9	4.9	5.6	20.9	89.5	1.3	0.9	0.7	24.2	3.8	0.0	4.9	38.6	14.2	0.6	15.2	2.3	0.6	1.8	5.4	16.9	1.3	0.5	1.0	3.0	0.6	3.6	17.5	0.0	1.5	30.4	1.9	3.7	98.5	1.4	0.0	0.3	2.1	1.1	0.5	46.9	72.2	54.6	2.8	0.4	29.1	19.3
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.3;Spermatocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavorable (8.18e-12)"	"prognostic favorable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	1.5	1.5	1.1	10.1	1.1	47.9	2.7	2.0	1.3	2.7	1.5	7.0	6.4	2.0	1.2	10.8	1.1	1.9	1.2	1.1	1.1	2.1	3.3	2.3	22.1	1.2	1.2	1.6	3.7	1.3	0.5	4.8	1.2	1.3	8.2	3.3	2.8	0.2	2.9	10.7	6.9	2.8	1.0	5.6	4.0	27.8	1.5	43.0	1.3	1.9	21.1	3.5	3.8	1.2	65.6	30.1	99.7	66.9	3.1	5.1	54.6	49.7	19.9	39.9	40.2	45.6	73.2	114.3	23.5	18.7	36.3	39.0	52.1	17.1	50.6	164.9	51.8	48.9	38.4	35.5	8.0	110.1	38.5	4.3	9.6	29.9	15.9	12.1	24.0	108.9	105.9	73.6	36.2	74.0	215.7	91.7	79.6	57.0	39.9	131.3	56.0	70.9	18.6	31.0	95.1	60.3	62.3	46.8	16.5	25.3	34.3	46.7	14.8	42.4	19.8	85.2	90.4	65.7	76.6	115.3	38.6	74.2	84.9	0.4	1.7	1.1	1.2	1.2	0.9	1.1	2.6	2.2	3.8	0.6	1.4	0.9	0.1	7.2	3.6	0.8	8.3	1.2	1.1	1.1	2.0	1.3	1.1	1.1	1.2	1.2	1.2	1.0	1.5	1.2	14.4	0.0	6.7	1.3	14.5	26.5	6.7	6.3	10.2	6.0	15.1	12.2	6.1	2.8	7.1	7.3	35.5	28.8	35.9	14.7	3.9	9.5	109.3	16.3	17.0	9.4	9.0	57.0	6.2	8.5	32.2	9.9	15.8	24.2	21.6	45.9	3.3	2.2	11.9	15.2	9.2	20.5	6.1	9.0	33.6	27.7	3.1	19.1	14.2	14.0	14.9	2.6	12.3	16.6	7.0	12.4	10.5	0.7	37.4	4.8	6.8	1.2	9.7	21.3	6.6	13.8	24.1	142.2	58.2	35.8	29.0	30.5	25.7	4.7	22.1	5.9
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 160.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	21.3	8.5	1.1	1.5	1.2	0.0	11.7	2.5	2.0	53.8	1.4	5.6	10.9	13.2	16.4	8.9	23.9	10.9	40.7	1.1	1.8	4.1	160.0	14.4	3.2	2.6	1.5	27.9	7.1	0.2	4.5	4.4	2.5	12.8	2.0	0.9	5.1	7.1	6.8	20.7	11.9	2.7	1.3	3.2	8.6	10.1	1.4	1.4	8.3	6.6	1.3	11.9	25.8	1.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	2.5	2.0	1.1	1.8	2.6	1.5	2.5	1.3	1.4	1.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 232.8;placenta: 489.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 863.3;Langerhans cells: 205.1;Macrophages: 232.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.1;myeloid DC: 179.6"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.6;granulocytes: 50.2;monocytes: 141.1"	"Cell line enhanced"	"Detected in some"		"AF22: 24.0;LHCN-M2: 8.9;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 4: Macrophages - Innate immune response"			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	232.8	57.9	2.6	52.3	4.2	16.1	46.9	1.3	13.0	50.4	28.5	45.9	9.7	18.5	5.6	51.2	29.1	52.7	39.2	2.1	3.6	21.0	3.0	38.7	30.0	8.3	4.6	10.7	10.0	13.3	8.1	489.2	6.9	8.8	63.9	21.6	18.8	13.4	10.3	22.7	22.0	89.6	2.6	8.8	25.4	17.8	3.7	20.9	17.1	32.8	12.5	144.5	12.1	4.0	0.0	0.1	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	43.8	0.8	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	50.2	141.1	1.4	0.5	25.4	0.6	0.4	0.3	0.4	179.6	0.4	0.4	0.2	32.9	0.3	0.7	12.5	0.3	364.9	2.6	4.2	1.3	13.0	2.1	3.6	8.3	4.6	6.9	2.6	3.7	4.0	2.0	0.0	1.9	0.3	1.8	18.7	0.0	0.0	0.6	0.1	0.3	0.4	10.6	5.7	0.0	0.0	0.0	5.0	4.5	0.0	0.0	0.0	5.1	0.6	10.6	3.8	0.0	1.3	3.9	0.0	5.6	13.7	0.0	0.4	1.3	0.0	2.9	0.9	863.3	0.0	1.4	0.0	0.0	92.4	205.1	5.8	4.4	232.0	19.6	64.6	53.1	0.9	6.2	0.5	0.7	0.1	0.0	0.7	1.2	0.0	0.0	11.0	2.2	6.5	59.2	2.5	3.3	1.6	0.9	1.2	15.2	10.1	2.6	0.4	0.0	0.1
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
F2RL2	PAR3	ENSG00000164220	"Coagulation factor II thrombin receptor like 2"	O00254	5	76615482-76623413	"G-protein coupled receptors, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.9;gallbladder: 6.8"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 2.3;Fibroblasts: 3.9;Hepatic stellate cells: 10.0;Rod photoreceptor cells: 5.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 9.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 53.5;HBF TERT88: 33.8;HEL: 78.4;hTEC/SVTERT24-B: 34.8;hTERT-RPE1: 73.2;U-138 MG: 54.0;WM-115: 69.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.35e-3)"	"unprognostic (5.71e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (6.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-8)"	"unprognostic (7.64e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	0.3	0.4	1.2	1.8	1.5	0.3	3.8	4.4	0.2	1.3	0.1	3.5	1.6	2.3	0.1	0.8	0.3	6.8	1.8	0.2	4.4	0.3	2.0	0.6	0.1	3.9	4.7	0.1	1.0	0.3	0.4	0.2	2.9	0.3	1.7	5.0	3.7	0.1	0.0	2.3	2.3	3.8	2.3	0.3	1.3	0.0	6.9	0.8	0.2	0.5	0.3	1.0	0.3	0.5	0.0	2.0	0.2	0.2	2.3	12.1	0.0	31.3	53.5	8.3	30.0	0.0	0.1	0.0	1.8	0.2	24.8	0.1	0.0	0.2	33.8	0.0	0.1	78.4	0.7	0.2	4.7	0.1	0.1	6.7	0.2	34.8	0.1	73.2	2.9	0.2	0.0	0.1	3.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	54.0	16.2	2.4	0.4	2.7	0.0	0.0	6.4	0.0	69.8	10.4	0.4	0.1	0.7	0.2	0.6	0.1	0.7	0.4	0.1	0.1	0.3	0.7	0.9	1.1	0.1	1.1	0.9	0.0	1.2	1.5	4.4	0.2	0.2	4.4	3.9	4.7	2.9	2.3	6.9	0.5	0.0	0.0	0.0	0.3	0.3	0.9	0.1	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	2.3	1.0	0.0	0.0	0.2	0.0	0.0	3.9	1.1	0.3	0.0	0.0	10.0	0.3	0.1	0.0	0.3	0.0	0.0	1.2	1.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.9	0.0	0.0	0.1
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 53.2"	"Group enriched"	"Detected in many"	10	"Adipocytes: 118.6;Endothelial cells: 120.4;Hepatic stellate cells: 371.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 7.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"	NA	NA		25000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	29.4	15.2	7.8	2.5	8.6	2.1	19.3	7.4	11.2	7.5	9.9	9.6	2.9	10.9	9.1	4.0	7.9	5.0	53.2	8.2	8.5	14.1	20.1	16.7	4.7	8.6	8.4	14.5	11.6	5.6	6.4	3.3	8.6	9.0	3.8	6.2	4.7	7.5	20.6	3.6	5.0	6.3	7.8	17.9	5.7	6.1	8.9	3.2	10.9	28.1	3.7	8.1	3.7	7.8	6.1	4.5	0.9	2.1	6.5	10.1	0.7	2.9	1.8	2.0	3.4	0.3	6.8	12.0	9.5	3.0	4.7	0.8	1.0	1.0	1.8	5.1	1.9	2.4	2.8	0.2	3.0	2.1	5.6	7.2	0.6	1.8	2.4	3.5	1.2	5.7	1.1	9.0	10.0	2.7	1.7	1.9	1.6	1.8	4.5	1.4	1.5	1.8	1.8	1.3	3.7	2.8	7.0	0.8	3.9	1.0	2.1	4.9	1.5	10.3	5.5	16.6	3.7	5.3	5.1	6.0	9.4	12.3	5.5	4.6	2.8	0.9	5.2	2.4	10.3	2.1	3.1	5.5	2.7	1.9	1.6	4.1	4.4	3.3	2.4	0.4	4.6	2.7	7.8	8.6	7.4	11.2	8.2	8.5	8.6	8.4	8.6	7.8	8.9	7.8	118.6	0.0	6.3	13.1	2.3	1.8	2.5	1.6	4.0	8.1	3.7	4.2	17.7	7.2	1.9	3.7	2.1	0.9	2.0	0.6	7.9	3.1	1.4	1.5	1.5	120.4	0.0	8.4	7.2	0.7	0.7	6.8	0.0	1.5	1.3	8.2	371.2	11.8	3.2	6.7	5.0	0.6	0.0	19.9	1.1	3.3	11.5	3.0	0.0	8.4	2.4	6.8	2.1	7.5	6.0	4.5	0.1	5.3	2.0	1.4	0.9	11.4	2.4	3.5	6.6	11.1	13.0	2.3	3.4	1.5	1.1	0.1	4.0	4.3	0.4	2.1
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5501.2;liver: 13065.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	160.2	0.6	0.0	10.7	0.5	1.8	0.7	0.4	5501.2	4751.8	13.0	0.0	2.6	3.9	0.5	0.8	0.6	0.7	727.6	13065.3	0.9	3.7	0.6	0.5	0.9	1.0	0.3	0.8	0.7	0.5	2.6	3416.4	0.1	0.5	8.4	0.9	0.5	4727.6	230.4	0.5	2.8	15.8	1.1	0.6	0.1	0.5	0.4	0.1	0.6	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.8	0.6	0.7	0.6	0.5	0.5	0.5	0.6	0.7	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322138	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"intestine: 550.0"	"Cell type enriched"	"Detected in some"	10	"Proximal enterocytes: 5965.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basophil: 1.6;neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		61000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.2	0.1	0.1	3.1	0.1	0.9	0.0	0.6	0.2	0.0	0.4	28.2	291.0	0.3	0.1	0.1	0.2	0.1	0.6	0.2	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.3	0.0	0.0	0.1	0.4	550.0	1.9	0.0	0.1	0.7	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.1	0.3	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.6	0.4	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.2	4.2	0.4	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.8	0.0	0.0	0.0	242.0	0.0	0.0	0.0	1.4	0.1	0.1	1.2	0.0	0.0	0.2	0.1	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	570.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	383.1	0.0	0.0	0.0	5965.8	17.3	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	222.5	0.0
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483236	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 3787.4;breast: 2195.7"	"Cell type enriched"	"Detected in many"	17	"Adipocytes: 24359.7"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	171	"ASC diff: 4051.5;RT4: 2107.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002188, CAB024961"	Enhanced					NA	NA		22000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	3787.4	42.2	0.8	46.7	1.1	2.8	2195.7	0.9	1.6	9.9	34.8	52.9	2.8	4.6	0.6	15.1	10.9	68.1	121.8	1.2	0.8	7.0	5.1	113.5	13.6	0.8	0.8	4.2	16.6	59.1	1.4	186.9	0.8	4.3	33.5	2.6	58.8	5.0	66.7	65.2	44.7	14.2	0.7	6.7	26.5	1.1	3.8	29.8	83.0	166.7	2.0	242.7	18.9	0.9	0.0	0.0	0.0	0.0	4051.5	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	17.9	0.0	0.1	1.3	0.0	0.4	0.0	0.0	2.0	0.7	0.0	0.0	0.0	0.8	1.2	0.1	3.0	0.0	9.4	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	2107.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.2	5.7	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	1.6	1.2	0.8	0.8	0.8	0.8	0.7	3.8	0.9	24359.7	35.3	64.3	0.0	19.4	14.4	1.1	0.9	4.6	0.5	71.7	196.2	42.1	0.0	26.7	0.0	0.0	0.5	73.6	0.0	0.0	0.2	1.6	0.4	8.8	1132.7	0.0	0.0	0.0	5.6	0.7	53.1	1.1	0.2	27.8	0.1	23.2	0.4	114.2	0.0	0.0	0.0	0.0	50.4	15.7	10.9	1.5	192.7	16.0	0.0	0.6	0.9	0.0	0.0	0.0	0.2	2.2	1.2	2.7	0.5	0.0	0.3	21.9	2.4	716.6	62.2	1364.8	0.0	0.1	1.2	13.9	0.7	18.7	2.3	0.0	55.3
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"intestine: 4531.3"	"Cell type enriched"	"Detected in some"	23	"Proximal enterocytes: 52213.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	NA	NA		890000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.0	14.4	7.9	2.5	8.1	0.1	0.2	8.3	11.7	3.1	8.7	3.3	4.9	1.9	0.0	1.2	53.9	0.2	2.2	7.4	11.2	0.2	0.1	5.3	4.2	8.9	8.5	0.1	0.1	0.0	0.7	0.1	10.4	0.2	0.0	0.9	0.2	0.2	0.0	0.4	4531.3	3.4	9.4	1.5	0.4	3.1	9.4	5.6	0.1	1.4	3.5	2.7	0.4	7.7	0.3	0.6	0.0	0.2	0.0	0.0	11.4	0.0	0.0	0.0	0.0	8.1	1.3	31.6	30.5	0.0	0.3	0.0	0.0	0.0	0.0	13.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	2.3	1.2	0.4	0.0	0.0	0.0	17.0	0.1	0.0	2.9	0.0	1.0	17.2	0.0	15.2	2.8	0.7	0.0	8.8	0.2	0.1	0.2	0.2	0.0	0.0	0.1	15.3	1.7	1.7	6.9	4.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	8.1	8.3	11.7	7.4	11.2	8.9	8.5	10.4	9.4	9.4	7.7	0.0	0.0	1.5	1.3	0.2	0.5	0.3	7.8	0.6	0.2	0.1	0.1	3.4	0.0	21.9	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.4	110.2	0.6	0.1	0.0	0.0	1.6	0.0	0.3	0.6	0.0	1.4	0.0	0.6	0.0	0.0	0.1	1.7	2.2	2244.4	2.0	0.0	4.2	0.2	0.3	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.9	0.3	2080.0	0.0	0.0	0.1	52213.9	0.1	134.9	0.7	0.0	0.0	1.2	0.1	2.1	2.0	0.1	0.0	0.1	1.7	1304.0	1.4
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM110C		ENSG00000184731	"Family with sequence similarity 110 member C"	Q1W6H9	2	38814-46870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 248.8;Basal squamous epithelial cells: 90.0;Endometrial ciliated cells: 85.6;Glandular and luminal cells: 158.2;Urothelial cells: 236.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.3;HBEC3-KT: 10.3;hTCEpi: 10.1;RPTEC TERT1: 17.3;RT4: 24.5;SK-BR-3: 10.9"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 1.9"	"Low region specificity"	"Detected in some"			"HPA036144, HPA036145"	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA036144: AB_10670710, HPA036145: AB_2674968"	"unprognostic (4.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.47e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.07e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.68e-1)"	11.1	3.4	2.0	1.8	3.2	0.1	5.3	0.0	2.5	8.7	3.3	8.4	10.9	3.9	20.7	32.8	8.7	8.4	3.2	2.5	0.5	16.5	17.5	3.3	0.2	1.1	0.5	6.5	14.3	5.3	4.0	0.2	0.7	4.2	10.1	1.1	5.8	19.8	0.1	9.9	9.6	1.8	0.6	0.3	7.5	3.6	1.2	1.9	5.8	0.3	2.2	11.1	15.4	1.7	5.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	8.3	0.0	6.3	0.0	0.3	13.3	0.0	10.3	0.0	0.8	0.4	0.0	1.8	1.1	0.0	0.0	0.0	0.0	10.1	0.0	1.7	0.0	0.0	9.1	0.0	0.0	0.0	9.0	6.0	0.1	1.2	6.1	3.2	0.0	0.0	0.0	17.3	24.5	0.6	0.0	0.0	10.9	0.0	1.0	3.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	2.0	3.2	0.0	2.5	2.5	0.5	1.1	0.5	0.7	0.6	1.2	1.7	0.1	0.0	5.8	2.3	0.2	22.9	248.8	12.1	90.0	0.1	9.5	4.7	5.8	27.1	17.4	35.0	0.0	0.0	0.7	40.1	19.6	13.5	0.2	85.6	14.2	1.6	29.8	0.0	2.7	5.3	0.0	4.4	10.2	158.2	0.0	57.3	0.7	13.4	0.1	3.3	0.7	35.8	6.1	0.3	0.7	0.9	2.1	1.6	0.0	0.0	0.0	2.2	1.0	0.0	0.3	9.0	38.6	1.9	1.4	23.1	14.6	13.3	4.3	0.1	0.0	0.1	3.4	0.5	0.2	71.8	30.1	0.0	2.6	0.1	11.1	236.0
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127412	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 12.8;Erythroid cells: 9.1;Plasma cells: 8.8;Squamous epithelial cells: 7.1;Undifferentiated cells: 10.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 3.3;naive B-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	0.9	0.5	0.5	5.9	0.6	4.8	2.7	2.8	1.8	1.0	0.1	5.6	3.4	1.0	0.5	3.4	0.5	0.8	0.3	0.6	1.1	0.4	2.5	1.1	12.3	0.5	1.0	0.2	0.6	0.9	0.0	1.7	0.7	1.0	5.8	1.3	0.8	0.4	0.4	4.4	4.0	2.0	0.1	1.8	3.2	0.8	0.6	18.0	0.9	0.1	13.3	1.7	1.0	2.1	72.6	18.5	26.6	0.4	2.7	4.9	0.3	53.5	26.7	31.2	46.1	38.7	28.0	89.8	35.4	15.7	26.3	54.7	39.5	36.2	55.2	46.8	9.5	9.8	32.3	16.9	0.1	0.3	11.1	1.2	1.2	30.3	2.4	6.0	16.9	24.1	2.8	81.9	37.2	27.3	57.7	0.6	0.3	43.2	21.0	60.1	39.7	34.7	16.8	61.2	5.2	16.9	44.4	50.8	8.7	9.7	56.2	5.0	9.4	24.1	52.4	73.5	49.6	62.6	48.4	0.6	35.0	0.4	35.4	0.2	0.1	0.1	0.1	0.0	0.1	3.3	0.2	0.3	0.1	2.6	0.1	0.1	1.6	0.0	0.1	0.1	0.7	0.1	0.5	0.6	2.8	1.8	0.6	1.1	0.5	1.0	0.7	0.1	0.6	2.1	0.7	0.0	0.0	0.0	12.8	4.2	2.2	4.2	1.8	0.0	2.5	4.2	0.3	0.0	1.4	0.0	0.0	1.1	1.4	4.0	0.0	0.8	0.0	0.9	1.6	1.2	0.0	9.1	0.0	0.0	0.4	1.5	3.6	1.9	0.0	6.3	0.0	0.2	3.9	0.0	0.0	4.4	2.0	0.3	1.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	1.3	0.0	8.8	0.7	0.5	0.1	1.6	0.0	0.0	1.3	1.8	0.1	1.0	7.1	2.7	0.1	3.2	1.1	10.4	1.6
FAM124B	FLJ22746	ENSG00000124019	"Family with sequence similarity 124 member B"	Q9H5Z6	2	224378698-224402107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 8.5"	"Group enriched"	"Detected in some"	4	"Adipocytes: 13.8;Endothelial cells: 10.8;Erythroid cells: 9.4;granulocytes: 4.5"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 29.5;eosinophil: 17.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"HUVEC TERT2: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070240	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Mitochondria	"HPA070240: AB_2686238"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.80e-3)"	5.2	0.5	1.4	1.1	1.2	4.7	4.3	1.4	1.7	1.5	0.9	0.9	1.0	1.6	0.3	1.4	1.2	1.2	1.8	1.3	1.6	0.6	1.9	2.3	0.7	1.8	1.7	0.4	0.4	2.4	0.2	8.5	1.5	0.5	1.0	0.2	0.8	0.5	1.2	1.8	1.0	2.3	1.6	0.5	0.6	0.3	1.7	1.1	1.0	4.6	0.7	1.5	1.4	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	5.5	0.1	0.0	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	103.4	0.0	4.8	0.2	0.0	0.1	0.0	0.1	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.7	7.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.5	3.0	17.2	0.2	2.3	0.0	0.0	0.7	0.0	7.9	0.0	0.0	0.0	0.1	5.4	0.8	0.0	2.5	1.1	1.4	1.2	1.4	1.7	1.3	1.6	1.8	1.7	1.5	1.6	1.7	1.1	13.8	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	1.2	0.3	0.2	10.8	0.0	9.4	0.2	0.0	0.1	0.4	0.0	0.8	4.5	0.0	2.2	0.4	0.4	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.7	0.0	1.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	0.0
FAM180A	"HWKM1940, UNQ1940"	ENSG00000189320	"Family with sequence similarity 180 member A"	Q6UWF9	7	135728348-135748813	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.1;heart muscle: 15.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Cardiomyocytes: 6.6;Fibroblasts: 19.7;Hepatic stellate cells: 4.6;Langerhans cells: 9.5;Melanocytes: 7.2;Suprabasal keratinocytes: 4.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"U-2197: 259.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA021224	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA021224: AB_1851352"	"unprognostic (3.85e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (5.62e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.88e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.35e-4)"	"unprognostic (6.62e-4)"	3.1	2.7	0.0	0.5	0.1	0.1	3.4	0.1	0.3	2.6	4.2	1.8	0.8	4.7	0.4	4.0	2.0	16.1	15.9	0.3	0.0	4.1	10.2	2.5	0.1	0.0	0.0	7.9	1.3	0.2	0.1	0.2	0.0	0.6	2.0	0.0	1.2	0.2	0.3	3.4	1.3	4.7	0.0	0.6	1.0	0.4	0.0	0.2	2.7	1.3	0.5	4.4	1.3	0.1	0.0	0.1	0.0	0.0	27.8	28.4	0.0	14.9	56.2	0.3	0.2	0.0	0.0	0.0	0.0	57.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.6	0.0	35.6	4.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6	57.1	0.0	259.7	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.8	6.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.8	0.0	0.0	0.3	0.0	0.0	19.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.5	0.0	2.8	0.1	7.2	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	1.8	0.0	0.0	0.1	4.8	0.7	0.2	0.0	0.0	0.0
FAM180B	LOC399888	ENSG00000196666	"Family with sequence similarity 180 member B"	Q6P0A1	11	47586678-47589194	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;brain: 5.9;breast: 5.2;choroid plexus: 5.1;skin 1: 6.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.4;Fibroblasts: 20.4;Langerhans cells: 11.9;Melanocytes: 5.4;Peritubular cells: 4.1;Suprabasal keratinocytes: 6.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA029408	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"			"HPA029408: AB_10601319"	"unprognostic (1.28e-2)"	"unprognostic (4.99e-3)"		"unprognostic (7.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	6.5	0.1	0.8	0.0	2.0	0.1	5.2	5.9	1.7	0.4	5.1	0.6	0.0	0.2	0.0	0.1	0.4	0.4	0.7	0.6	0.8	0.0	0.0	0.2	0.0	1.9	1.3	0.1	0.1	0.0	0.2	0.0	1.5	0.0	0.0	0.1	1.1	0.0	1.0	6.3	0.2	0.1	1.3	0.1	0.5	0.5	1.6	0.7	4.3	2.9	0.1	0.4	0.2	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.0	5.9	1.7	0.6	0.8	1.9	1.3	1.5	1.3	1.6	2.6	0.8	0.0	0.0	1.0	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	20.4	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.9	0.3	2.5	0.3	5.4	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	6.3	0.1	0.3	0.0	0.0	0.0
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729940-82733864	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 56.2;Endometrial ciliated cells: 24.1;Muller glia cells: 18.4;Oligodendrocyte precursor cells: 22.1;Oligodendrocytes: 19.0"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 2.4;SH-SY5Y: 1.2;U-2 OS: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Enhanced		Approved	"Nuclear membrane,Mitochondria"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nuclear membrane"	"HPA066861: AB_2685738"	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	0.5	0.6	18.0	0.2	20.3	0.1	0.4	19.8	14.3	1.3	5.9	1.4	0.2	0.7	0.1	0.3	1.0	0.0	1.7	14.5	14.7	0.7	0.0	0.0	0.0	26.9	20.8	0.8	0.5	0.1	1.2	0.0	16.3	0.6	0.0	0.6	0.8	0.5	0.2	0.3	0.4	0.1	23.9	0.0	0.4	0.2	19.9	0.0	0.8	0.1	0.2	1.1	0.7	23.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.3	1.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	20.3	19.8	14.3	14.5	14.7	26.9	20.8	16.3	23.9	19.9	23.6	0.7	0.0	0.0	56.2	0.0	0.3	0.2	0.1	0.0	0.8	1.0	3.6	2.9	0.0	0.1	5.5	0.0	0.0	0.0	0.0	3.9	0.1	0.0	24.1	1.8	1.3	0.0	0.0	0.4	0.0	0.0	1.2	0.0	2.4	0.0	0.6	0.0	0.0	0.1	0.0	0.6	1.5	0.0	0.0	0.3	0.4	0.6	0.2	1.8	1.9	0.0	18.4	0.0	22.1	19.0	0.0	0.0	0.4	0.0	0.2	0.1	0.4	0.1	1.1	0.0	1.6	7.0	0.1	1.6	0.3	0.0	0.0	0.1	2.2	0.2	0.1
FAM20A	DKFZp434F2322	ENSG00000108950	"FAM20A golgi associated secretory pathway pseudokinase"	Q96MK3	17	68535113-68601367	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 50.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 82.4;Early spermatids: 69.0;Hepatocytes: 66.8;Hofbauer cells: 94.0;Late spermatids: 189.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.1;BJ hTERT+: 27.3;HSkMC: 21.8;U-2197: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048964	Approved				"Secreted in other tissues"	NA	NA		13000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048964: AB_2680575"	"unprognostic (3.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.39e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (9.16e-10)"	"unprognostic (1.25e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.39e-2)"	7.5	1.6	0.4	2.7	0.3	0.6	5.4	0.3	0.6	17.5	2.6	1.6	0.6	12.5	0.1	3.1	6.0	1.3	3.1	0.1	1.1	12.9	50.2	12.6	1.6	0.8	1.7	8.1	1.0	0.3	6.3	2.2	0.7	2.5	0.4	0.1	11.6	0.6	1.6	2.5	2.0	2.3	0.1	4.5	7.8	6.5	3.6	0.4	6.8	0.1	0.5	2.2	5.7	0.7	0.0	0.2	0.0	0.2	1.1	10.1	0.0	0.5	27.3	0.0	0.0	0.0	0.1	0.0	2.0	2.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.0	21.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.1	0.0	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.4	0.3	0.3	0.6	0.1	1.1	0.8	1.7	0.7	0.1	3.6	0.7	1.4	16.0	82.4	0.7	1.1	2.3	0.1	5.2	0.0	3.2	5.3	0.9	5.2	7.2	21.3	44.1	0.0	0.6	0.4	0.0	0.0	1.2	69.0	6.1	44.4	3.6	0.0	2.7	3.8	0.5	2.2	18.1	42.3	9.7	1.3	2.9	7.5	66.8	94.0	42.1	8.2	0.0	2.0	27.4	3.5	189.3	11.1	26.8	1.8	16.9	1.3	0.2	0.0	4.0	2.1	0.8	0.0	14.7	0.2	0.0	0.0	15.3	0.8	2.8	6.6	3.4	3.0	1.2	0.6	1.2	1.8	2.7	1.0	13.6	0.0	0.1
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145454-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 272.0;Alveolar cells type 1: 60.9;Alveolar cells type 2: 69.9;Breast glandular cells: 87.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 41.3;HUVEC TERT2: 28.0"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	16.7	4.1	7.7	5.3	8.6	7.2	11.2	16.6	15.5	2.8	0.5	2.8	2.9	3.8	3.8	4.3	2.3	5.1	7.2	6.7	1.7	4.5	4.6	5.1	5.2	1.6	2.3	2.8	2.2	3.9	1.5	10.8	2.9	3.8	2.8	10.5	8.8	2.9	6.0	6.3	3.4	5.1	0.4	5.0	7.3	6.0	3.9	3.2	4.2	5.0	4.1	5.1	2.5	13.7	6.3	2.4	2.5	2.1	12.5	7.1	3.7	5.3	1.2	1.0	1.6	1.9	7.9	41.3	4.9	2.9	3.5	3.1	3.9	5.5	1.8	19.7	6.6	4.4	6.4	3.4	7.4	10.3	2.7	7.8	8.7	1.5	9.1	2.0	28.0	5.8	8.4	19.6	3.1	6.5	3.8	7.4	3.2	10.3	5.9	8.6	4.2	8.5	4.2	6.1	4.6	3.8	5.0	9.0	2.7	3.6	6.5	4.4	17.9	3.2	9.7	2.1	1.9	8.2	11.3	19.1	7.3	5.1	4.1	2.8	0.6	0.6	0.5	0.5	0.4	0.6	0.5	0.4	0.3	0.9	0.5	0.6	1.5	0.6	0.6	1.0	0.6	0.3	7.7	8.6	16.6	15.5	6.7	1.7	1.6	2.3	2.9	0.4	3.9	13.7	272.0	60.9	69.9	0.0	4.9	0.0	0.0	0.0	0.0	0.0	87.0	42.2	0.0	0.0	36.5	33.1	0.0	1.6	9.2	0.0	7.9	12.0	0.0	4.6	3.9	44.0	0.0	0.0	0.0	17.3	2.8	13.8	0.0	12.0	32.8	0.4	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	28.2	0.0	0.0	4.0	0.0	0.0	3.5	42.3	0.0	0.0	0.0	36.5	0.0	0.0	0.0	0.0	2.5	9.8	1.3	0.0	0.0
FAM3D	"EF7, OIT1"	ENSG00000198643	"FAM3 metabolism regulating signaling molecule D"	Q96BQ1	3	58633946-58666834	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 264.8;intestine: 488.7;salivary gland: 468.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 794.8;Intestinal goblet cells: 1150.1;Paneth cells: 776.7;Proximal enterocytes: 353.1;Undifferentiated cells: 760.0"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 3.7"	"Cell line enriched"	"Detected in some"	65	"OE19: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013844	Approved				"Secreted to digestive system"	NA	NA		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA013844: AB_2668897"	"prognostic favorable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.9	0.1	0.2	29.6	0.1	0.0	18.5	0.0	0.5	31.3	0.1	362.0	89.2	0.6	0.2	264.8	0.8	81.6	0.2	0.2	0.1	1.1	0.2	4.8	0.6	0.1	0.2	0.1	1.7	0.0	0.4	1.0	0.1	14.8	488.7	0.0	468.4	68.4	0.1	2.6	90.4	8.3	0.1	0.2	78.2	0.3	0.3	0.4	1.5	0.0	41.1	12.7	59.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.2	68.5	0.0	0.1	0.1	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.7	0.0	0.3	0.0	0.0	0.4	0.2	0.1	0.0	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.6	0.0	1.1	0.3	3.4	0.0	9.9	223.1	0.0	0.0	29.5	53.8	0.2	47.1	133.4	14.7	0.0	0.0	1.3	794.8	0.0	1.3	0.5	0.0	0.0	2.5	152.1	0.0	0.1	0.0	0.0	0.8	114.2	0.2	8.9	0.0	0.4	0.2	0.3	0.0	0.1	1150.1	18.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	776.7	0.0	0.2	68.2	353.1	1.2	43.1	0.0	0.0	0.0	4.9	0.1	0.6	7.9	0.1	0.4	2.0	0.0	760.0	245.0
FAM78B		ENSG00000188859	"Family with sequence similarity 78 member B"	Q5VT40	1	166057426-166167001	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 87.6;Excitatory neurons: 55.4;Horizontal cells: 82.4;Inhibitory neurons: 85.0;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 3.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HDLM-2: 8.6;RT4: 4.9;SK-MEL-30: 10.1;U-2 OS: 2.6;WM-115: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052789, HPA073246"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA052789: AB_2681949, HPA073246: AB_2686588"	"unprognostic (7.38e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.87e-11)"	"unprognostic (7.41e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.69e-2)"	0.7	0.2	0.9	0.0	0.7	0.0	0.5	0.5	2.6	1.1	0.0	0.5	0.2	0.7	0.0	0.4	0.2	0.1	0.6	1.0	0.1	0.2	0.7	0.2	0.1	0.6	0.1	0.3	0.4	0.1	0.5	0.0	0.1	0.4	0.1	0.8	0.3	0.1	0.7	0.5	0.1	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.4	0.1	0.1	0.8	0.5	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.6	0.0	0.0	0.1	0.3	0.2	0.0	0.4	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	4.9	0.8	0.5	0.0	0.1	10.1	0.0	0.3	0.2	0.1	0.6	2.6	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.5	2.6	1.0	0.1	0.6	0.1	0.1	0.2	0.1	0.5	1.2	0.0	1.7	5.5	0.4	0.5	0.5	0.0	1.8	15.5	1.0	0.8	9.9	2.8	0.0	0.0	87.6	0.0	0.0	0.4	1.9	0.7	2.5	0.1	1.7	1.6	0.0	0.0	55.4	0.2	0.0	1.6	0.0	0.1	0.0	1.1	0.4	1.6	0.0	82.4	85.0	0.6	0.0	0.3	0.6	2.6	1.2	0.1	1.8	5.6	0.6	2.2	0.0	45.8	5.7	0.3	0.3	0.7	0.0	0.2	0.1	1.3	0.0	12.9	0.0	4.5	1.0	0.6	4.4	0.6	0.1	0.0	0.7	0.4	1.1	0.2
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54945099	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 14.5;skin 1: 25.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 33.8;Basal prostatic cells: 32.5;Basal squamous epithelial cells: 43.3;Squamous epithelial cells: 31.9;Suprabasal keratinocytes: 41.1;Urothelial cells: 25.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.3;HaCaT: 18.1;HBEC3-KT: 9.8;hTCEpi: 19.7;hTERT-HME1: 23.8;RT4: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031464, HPA031465"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.0	0.0	0.1	1.0	0.1	0.1	2.2	0.1	0.1	3.8	0.0	8.0	7.4	0.3	1.2	14.5	1.6	2.1	1.1	0.0	0.0	2.5	0.1	0.1	0.0	0.0	0.7	0.0	1.5	0.0	0.0	4.3	0.1	1.8	8.2	0.1	4.7	1.1	0.7	25.9	7.4	0.2	0.0	0.0	3.9	0.6	0.0	2.3	3.6	0.1	3.6	4.3	9.8	0.2	13.3	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	6.5	3.6	0.0	0.0	0.0	0.1	18.1	0.0	9.8	0.1	0.0	2.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	19.7	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	9.1	19.2	0.2	0.0	2.9	0.6	0.0	3.3	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.8	32.5	6.6	43.3	0.0	1.5	3.0	3.1	5.7	6.5	7.3	0.0	11.2	0.1	9.0	0.0	6.1	6.3	8.8	0.8	0.3	1.2	0.0	0.2	3.5	11.9	0.4	9.2	8.1	0.0	0.0	0.4	0.0	0.6	0.0	0.1	5.4	6.1	0.0	1.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	17.4	0.0	0.1	9.1	12.6	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.6	31.9	41.1	18.7	0.1	0.0	8.8	25.4
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48599961-48615076	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;salivary gland: 28.5;stomach 1: 37.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 22.8;Early spermatids: 26.0;Gastric mucus-secreting cells: 74.9;Intestinal goblet cells: 26.9;Paneth cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 2.9;OE19: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049305, HPA075968"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol	Vesicles	"HPA049305: AB_2680705, HPA075968: "	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.1	0.1	0.2	3.7	0.3	0.4	1.4	0.8	0.5	10.6	0.2	32.7	30.0	1.1	0.1	7.0	3.9	6.4	0.2	0.3	0.2	0.8	0.3	8.0	0.2	0.1	0.1	0.0	1.2	0.0	0.2	0.6	0.2	3.2	16.6	0.2	28.5	0.4	2.7	1.9	30.0	1.0	0.0	0.2	37.4	2.2	0.2	0.1	0.1	0.0	1.3	1.2	4.1	0.5	0.4	0.4	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	2.9	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.4	0.1	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.8	1.1	9.4	0.9	0.2	0.1	0.3	0.0	0.2	0.5	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.2	0.5	0.1	0.1	0.2	0.1	1.0	0.1	0.2	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.8	0.5	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.5	0.0	9.6	13.4	1.3	0.4	0.0	1.4	0.8	0.6	0.0	1.8	0.8	2.1	8.6	6.5	1.8	0.0	0.1	0.3	22.8	0.0	0.1	26.0	4.8	0.5	0.2	5.4	0.0	0.3	1.1	0.1	0.2	74.9	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	26.9	2.0	0.0	0.0	9.3	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	1.6	16.5	0.0	0.4	3.3	12.7	0.0	5.1	0.0	0.0	0.2	0.2	0.8	0.5	2.3	0.0	0.1	0.3	0.1	12.8	6.9
FAM83F		ENSG00000133477	"Family with sequence similarity 83 member F"	Q8NEG4	22	39994954-40043534	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 20.3;testis: 40.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 68.1;Proximal enterocytes: 39.9;Suprabasal keratinocytes: 34.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 12.1;HaCaT: 12.8;HBEC3-KT: 15.5;hTCEpi: 37.9;hTERT-HME1: 11.8;OE19: 17.6;RT4: 18.6;SCLC-21H: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051207, HPA064657"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA051207: AB_2681388, HPA064657: AB_2685313"	"unprognostic (2.78e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.36e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.79e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (9.40e-4)"	"unprognostic (3.25e-1)"	"unprognostic (1.10e-7)"	"unprognostic (2.93e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.32e-2)"	1.2	0.1	0.2	0.5	0.1	1.2	4.7	0.3	0.2	2.6	0.1	5.3	3.2	0.2	2.5	20.3	1.2	0.5	2.0	0.2	0.1	4.0	2.9	0.2	0.0	0.1	0.1	0.3	13.5	5.4	1.2	0.1	0.1	9.0	3.2	0.4	8.2	6.6	0.1	18.8	7.6	0.1	0.0	0.0	6.8	40.8	0.3	0.9	5.9	0.2	1.1	2.6	7.0	0.3	8.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.1	2.3	0.0	0.0	0.0	0.0	12.8	0.0	15.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	37.9	0.0	11.8	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.1	2.1	17.6	0.0	0.0	0.0	0.1	0.3	18.6	39.8	0.0	0.3	3.4	0.0	1.3	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.5	28.7	14.5	18.0	23.9	1.2	19.1	10.4	5.2	12.8	7.4	23.9	0.0	0.2	0.0	33.1	3.9	9.6	28.4	6.2	0.5	1.0	13.1	0.4	0.2	15.1	0.2	1.0	10.7	6.5	1.3	0.2	0.0	2.2	0.2	0.0	0.2	21.0	14.2	0.6	2.9	68.1	1.8	0.5	1.8	0.0	0.0	0.9	0.0	0.5	0.1	12.5	21.6	2.2	0.2	16.3	39.9	5.9	6.4	0.6	0.0	1.1	1.3	12.4	1.8	30.6	34.5	1.4	0.8	0.4	15.6	17.8
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143738234	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Biomineralization		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.5;skin 1: 34.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 58.7;hTCEpi: 59.8;MCF7: 118.2;OE19: 62.4;RT4: 70.1;T-47d: 58.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favorable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	2.1	4.0	1.9	2.1	1.7	0.5	4.4	1.2	2.2	11.5	2.6	9.8	8.4	0.8	3.3	70.5	4.7	3.3	0.8	2.0	1.1	11.8	13.5	6.3	0.9	1.6	2.4	0.3	13.9	7.9	5.9	3.5	1.5	7.2	4.3	1.1	17.1	3.8	0.1	34.9	9.1	0.3	1.3	1.7	11.0	2.8	1.5	1.5	14.1	0.0	4.0	8.3	23.2	2.2	47.0	28.3	0.3	0.1	0.1	0.0	16.6	4.0	0.0	2.0	0.7	25.8	53.4	0.0	6.1	1.0	0.0	56.1	3.5	51.9	0.9	0.0	0.2	1.5	58.7	18.3	4.3	0.6	1.7	2.9	59.8	0.2	15.0	0.8	0.0	4.2	22.2	0.1	0.0	118.2	0.8	0.4	4.8	62.4	15.3	0.1	0.1	6.0	16.5	70.1	7.1	0.2	38.3	53.8	7.8	7.5	58.2	8.2	0.3	0.1	7.2	3.9	0.2	0.0	0.0	0.2	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	1.2	2.2	2.0	1.1	1.6	2.4	1.5	1.3	1.5	2.2	0.1	32.1	16.5	0.7	0.6	22.8	17.7	21.9	6.8	2.0	18.2	14.0	4.6	14.3	18.9	29.5	2.1	12.8	0.5	38.5	3.9	22.0	1.2	11.4	2.9	1.0	14.4	0.0	1.3	25.9	17.8	1.6	25.0	25.9	0.0	5.4	0.7	25.5	4.7	10.1	0.5	24.3	16.2	2.8	0.8	0.7	0.0	1.3	1.8	0.0	2.8	6.6	2.1	0.5	0.1	42.7	27.2	0.4	0.4	26.4	23.6	7.0	17.4	2.0	0.0	0.2	1.9	1.7	1.0	38.9	26.9	14.6	0.9	1.2	27.8	33.9
FAM89A	"C1orf153, MGC15887"	ENSG00000182118	"Family with sequence similarity 89 member A"	Q96GI7	1	231018958-231040254	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.0;placenta: 68.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 186.3;Extravillous trophoblasts: 267.5;Rod photoreceptor cells: 102.5;Syncytiotrophoblasts: 278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 145.4;SK-MEL-30: 81.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA059052, HPA059578"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA059052: AB_2683890, HPA059578: AB_2684070"	"unprognostic (7.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.05e-3)"	"unprognostic (4.85e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.26e-2)"	60.0	18.0	16.0	4.8	15.3	5.9	36.5	20.7	16.4	11.0	21.3	4.4	1.7	7.5	1.6	6.5	7.1	5.9	10.6	14.2	23.4	22.2	9.2	19.2	5.9	22.6	21.4	6.0	10.6	6.0	5.8	68.2	20.9	7.1	2.7	17.3	5.3	4.6	5.9	30.6	4.6	4.1	21.2	17.5	7.6	3.0	25.1	2.9	5.5	6.7	4.7	8.9	9.2	19.5	0.9	13.7	6.3	13.4	15.0	3.0	145.4	7.8	5.8	2.8	5.1	21.1	12.1	0.0	1.8	5.1	16.7	8.4	12.0	1.9	2.3	42.4	28.9	6.7	0.3	0.9	57.6	5.0	35.2	50.1	26.6	0.0	13.2	0.1	7.4	15.0	53.4	8.6	2.7	5.0	3.2	8.8	9.4	12.6	4.3	16.6	20.3	16.0	10.1	14.8	5.8	16.1	2.6	1.2	81.6	13.9	0.8	29.2	1.1	22.5	0.1	0.4	14.7	18.3	23.7	11.6	6.7	9.8	45.7	1.4	0.2	0.0	0.2	0.0	0.3	0.3	0.2	0.5	0.0	0.1	0.4	0.9	0.0	0.1	0.0	0.0	0.0	0.2	16.0	15.3	20.7	16.4	14.2	23.4	22.6	21.4	20.9	21.2	25.1	19.5	82.3	0.0	2.6	3.6	4.2	30.1	22.0	0.3	8.0	48.1	3.8	5.2	3.3	7.2	0.7	0.0	77.2	186.3	4.9	0.3	3.9	2.8	1.3	1.3	39.3	44.5	0.0	14.9	1.1	3.3	267.5	11.6	0.5	2.6	4.5	0.5	10.8	11.1	51.0	8.4	10.8	0.6	0.0	19.6	2.1	3.6	2.8	8.5	21.4	22.5	0.5	26.2	1.0	10.1	2.0	4.4	0.5	1.5	1.4	30.2	0.0	5.1	0.1	102.5	0.0	9.9	8.5	4.2	11.6	1.7	32.8	278.3	5.5	0.4	1.3	15.4
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.7"	"Group enriched"	"Detected in some"	14	"dendritic cells: 43.4;NK-cells: 79.3;T-cells: 28.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.1"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.5;T-cells: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	NA	NA	73600		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054959: AB_2682650"	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.3	0.8	0.1	1.0	0.2	2.8	0.6	0.1	0.2	0.4	0.1	0.8	1.9	0.5	0.7	0.3	0.3	1.1	0.3	0.2	0.1	0.3	1.1	2.0	5.7	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.2	0.5	0.9	0.0	0.9	0.3	0.1	0.4	1.4	0.3	0.0	4.1	1.5	0.2	0.1	0.6	0.2	0.0	1.8	0.8	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.1	0.0	58.1	0.2	35.5	0.0	11.5	31.4	0.1	0.0	2.2	25.0	1.9	41.5	0.1	0.0	0.2	14.9	0.1	0.2	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.1	0.4	0.4	0.0	2.5	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	43.4	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.6	1.8	0.0	0.9	0.0	79.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	28.8	0.0	0.0	0.1
FBLL1	LOC345630	ENSG00000188573	"Fibrillarin like 1"	A6NHQ2	5	168529305-168530634	"Metabolic proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.4;pituitary gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cone photoreceptor cells: 6.2;Enteroendocrine cells: 6.7;Horizontal cells: 6.7;Inhibitory neurons: 6.6;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 24.2;SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049546, HPA077724"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA049546: AB_2680811, HPA077724: "	"unprognostic (2.75e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (9.69e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.18e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.2	3.0	22.0	0.1	21.0	0.0	0.6	12.8	35.4	0.5	4.6	0.9	0.4	0.2	0.0	0.2	0.4	0.2	0.3	20.4	32.2	0.6	0.7	0.1	0.0	22.7	21.0	0.7	0.9	0.4	15.5	0.2	26.1	1.0	0.1	1.4	0.9	0.3	0.1	0.5	0.5	0.2	11.4	0.2	0.5	5.9	23.1	0.0	0.2	0.0	0.0	0.3	0.3	20.1	0.0	0.5	1.8	0.3	0.1	0.0	0.9	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.5	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	20.2	2.1	0.0	1.2	0.0	0.0	1.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	21.0	12.8	35.4	20.4	32.2	22.7	21.0	26.1	11.4	23.1	20.1	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.6	8.5	1.4	1.8	1.2	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	1.7	0.9	1.4	0.2	6.7	0.0	4.3	0.2	0.1	0.8	0.0	2.4	0.0	1.6	0.0	0.0	0.1	6.7	6.6	0.4	0.0	0.0	0.0	2.3	0.0	0.1	3.6	1.0	0.0	0.7	0.0	3.0	1.1	0.2	0.0	0.0	0.0	0.3	1.0	0.4	0.0	2.8	6.6	0.2	0.4	3.1	0.4	0.2	0.1	0.0	0.1	1.2	0.3	0.0
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 666.3;Endometrial stromal cells: 628.2;Extravillous trophoblasts: 651.6;Fibroblasts: 1506.5;Syncytiotrophoblasts: 1215.9"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1839.4;ASC TERT1: 809.8;BJ: 1029.3;BJ hTERT+: 1615.9;HSkMC: 1345.8;RT4: 1485.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		21000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavorable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	359.3	123.1	17.3	72.3	29.5	1.7	318.2	27.8	27.5	1131.0	802.4	200.7	75.5	410.6	126.0	305.8	497.6	676.1	773.7	47.0	11.9	61.3	15.7	414.9	16.1	21.8	24.5	214.1	106.3	216.9	90.3	505.7	23.1	466.8	83.6	3.1	121.2	158.5	36.0	296.3	174.5	180.3	15.9	24.9	269.1	21.9	24.7	20.5	195.3	47.5	13.0	704.6	940.5	14.6	17.7	41.6	122.9	258.0	1839.4	809.8	559.8	1029.3	1615.9	89.8	33.8	179.2	5.2	0.4	42.8	38.6	2.5	90.9	78.0	2.7	10.8	0.9	21.0	0.4	209.4	121.5	243.2	1.0	1.0	1345.8	15.8	89.6	32.7	1.8	0.2	1.4	0.9	2.1	63.3	2.4	0.8	3.2	173.8	3.7	15.4	1.4	0.9	2.1	41.1	1485.2	8.7	162.7	127.5	589.6	0.6	344.3	3.7	5.4	8.0	17.4	109.3	465.8	1.0	1.6	0.8	1.4	1.2	1.0	43.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.0	2.4	1.2	0.0	0.1	17.3	29.5	27.8	27.5	47.0	11.9	21.8	24.5	23.1	15.9	24.7	14.6	34.4	6.4	1.3	34.3	1.2	170.9	113.4	54.8	21.1	0.1	5.3	11.6	20.1	10.0	28.3	1.8	0.0	666.3	1.6	0.1	0.0	1.3	10.5	61.5	628.2	34.5	0.0	0.0	0.5	0.2	651.6	1506.5	38.7	256.5	1.3	29.0	22.1	0.6	82.4	0.0	0.8	0.3	6.1	0.0	222.9	25.4	92.2	11.4	170.7	41.2	0.0	0.1	0.0	0.0	0.4	1.0	0.1	30.5	4.5	47.4	0.0	0.3	10.2	0.6	118.3	37.1	81.5	42.2	68.7	23.8	130.3	1215.9	18.2	2.3	0.4	86.9
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408313-48645721	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 60.9;placenta: 76.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		520000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	60.9	4.4	1.4	14.5	5.4	3.4	13.7	2.8	2.8	36.0	9.5	8.3	3.8	15.2	6.3	12.6	12.2	27.3	23.5	0.8	2.0	2.7	2.9	10.0	3.7	5.2	6.0	28.4	3.3	3.0	2.5	76.7	3.7	8.0	11.7	1.3	4.6	13.2	4.5	5.7	6.6	35.7	2.3	6.4	6.0	7.1	4.7	2.9	18.6	21.2	3.5	18.8	9.9	5.0	0.1	5.2	19.8	22.4	215.1	460.7	0.2	175.8	62.9	51.1	32.4	0.1	0.3	0.1	7.9	420.8	0.4	0.7	3.9	0.6	45.9	20.7	1.2	2.0	88.5	0.2	120.7	0.8	0.3	251.3	0.1	135.9	15.6	211.1	55.5	1.6	0.0	0.4	55.6	0.0	1.5	0.2	4.0	0.2	7.1	0.1	17.0	0.2	5.9	0.5	0.2	12.9	0.0	2.2	0.1	15.3	0.2	1.4	106.8	206.9	6.2	305.8	37.6	1.2	1.0	0.0	138.9	0.3	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	5.4	2.8	2.8	0.8	2.0	5.2	6.0	3.7	2.3	4.7	5.0	50.0	0.0	1.3	34.9	0.4	25.6	0.8	1.5	0.6	6.1	1.3	3.4	14.2	0.0	5.8	12.9	0.0	132.4	0.4	0.0	0.0	0.2	8.7	4.2	105.2	36.1	0.0	5.5	82.3	0.6	40.8	388.5	3.1	2.0	1.3	22.5	34.6	0.6	15.3	0.0	123.5	0.0	0.0	0.8	39.0	22.8	236.1	5.7	42.7	30.0	2.3	0.8	0.0	76.9	218.7	1.7	0.0	227.2	1.7	0.7	0.1	0.6	3.3	0.2	26.3	139.5	55.8	3.3	3.4	0.8	20.6	65.8	4.3	51.3	0.0	0.2
FBXL16	"C16orf22, Fbl16, MGC33974"	ENSG00000127585	"F-box and leucine rich repeat protein 16"	Q8N461	16	692498-705808	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 287.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 44.4;Excitatory neurons: 29.2;Horizontal cells: 32.0;Inhibitory neurons: 20.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 155.1;basal ganglia: 287.6;cerebral cortex: 194.9;hippocampal formation: 156.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.4;GAMG: 12.3;MCF7: 15.5;SCLC-21H: 30.2;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 240.8;basal ganglia: 720.4;cerebral cortex: 384.6;hippocampal formation: 362.0"	"HPA039504, HPA056354"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA039504: AB_10794197, HPA056354: AB_2683105"	"unprognostic (5.51e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.34e-5)"	"unprognostic (1.62e-3)"	"prognostic favorable (1.87e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-2)"	0.3	4.6	155.1	0.6	287.6	0.1	0.9	0.0	194.9	0.5	0.0	1.5	0.8	0.1	0.0	2.0	0.5	0.0	0.4	156.5	0.0	1.1	0.3	0.4	0.3	0.0	0.0	0.2	2.4	1.2	32.5	0.0	0.0	0.9	0.0	3.3	4.9	0.9	0.3	4.1	1.3	0.0	0.0	0.6	1.4	11.6	8.8	0.3	2.3	0.0	0.2	0.1	1.0	37.6	0.6	0.9	0.3	18.4	0.0	0.2	0.6	0.6	0.1	3.4	0.2	1.8	0.2	0.3	5.0	0.0	12.3	3.4	1.4	2.0	0.2	9.4	0.4	0.0	4.7	0.8	0.0	1.9	0.4	0.0	2.8	0.0	1.6	1.6	0.0	0.7	1.0	4.5	0.0	15.5	0.4	0.0	0.8	0.2	5.8	0.0	0.0	10.8	0.2	0.0	30.2	22.7	3.1	0.5	0.3	0.0	1.7	0.0	0.0	0.1	6.2	0.0	2.4	0.8	5.6	2.4	2.5	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	155.1	287.6	0.0	194.9	156.5	0.0	0.0	0.0	0.0	0.0	8.8	37.6	0.1	0.0	3.7	6.5	0.8	1.0	0.7	1.1	2.2	44.4	3.8	3.7	1.2	0.0	3.9	11.0	2.1	0.6	1.6	0.3	1.9	0.2	1.2	1.6	0.4	0.2	9.6	0.0	29.2	0.0	0.2	0.8	0.0	3.9	0.0	0.0	0.4	0.0	0.1	32.0	20.2	1.0	2.0	0.0	0.3	0.6	0.6	0.1	0.0	6.5	0.1	3.1	0.0	9.0	2.5	0.3	0.1	0.0	0.4	0.7	1.0	0.2	0.1	5.7	0.0	0.1	0.3	5.0	4.6	2.7	1.6	2.5	3.5	0.0	0.4	0.2
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 60.4;intestine: 60.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli, Cytosol"		"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	3.6	0.9	1.9	2.8	1.7	0.3	1.8	2.7	2.0	15.7	0.2	60.1	2.9	60.4	3.6	7.0	21.2	8.8	17.2	1.6	1.3	1.0	0.5	1.1	0.9	0.8	1.1	4.5	0.7	0.6	0.7	0.9	0.9	16.9	4.8	0.6	3.2	29.4	4.9	1.4	7.3	28.9	0.5	0.6	11.1	3.0	1.8	0.4	1.5	1.8	0.2	26.3	10.1	1.0	0.7	1.2	0.2	0.8	0.5	0.5	0.1	0.2	0.0	0.3	0.0	0.8	0.9	0.3	0.7	0.2	0.4	0.8	0.6	0.4	0.0	0.8	0.6	0.3	1.1	2.2	0.1	0.4	0.1	0.2	0.2	0.1	0.5	0.1	0.2	2.2	0.0	1.1	0.0	4.9	0.7	0.7	1.7	0.8	0.4	0.7	0.0	2.4	0.3	0.3	5.3	0.2	0.6	1.0	0.3	0.0	1.9	0.6	0.8	0.3	1.0	0.5	0.2	0.7	1.5	0.8	0.5	3.7	0.8	0.2	0.0	0.0	0.5	0.0	0.5	0.6	0.6	0.6	0.0	0.4	1.0	0.4	0.1	0.7	0.0	1.6	0.0	0.2	1.9	1.7	2.7	2.0	1.6	1.3	0.8	1.1	0.9	0.5	1.8	1.0	1.4	0.0	0.0	1.0	3.4	0.1	1.8	0.4	0.6	10.1	4.7	8.6	7.7	2.8	0.7	7.3	4.2	0.7	2.7	2.3	9.8	1.2	0.9	3.2	5.8	1.3	4.9	2.5	1.5	1.1	1.2	3.4	7.7	5.8	0.0	0.9	3.9	4.0	0.7	0.0	1.8	6.1	0.0	1.6	0.4	0.5	0.3	1.7	0.0	0.0	0.7	10.6	2.1	1.5	0.5	0.8	3.0	11.3	9.1	1.7	1.9	4.0	0.1	3.8	0.0	6.2	8.1	3.8	3.2	4.4	0.9	0.5	4.4	2.7	4.0	0.8
FBXO2	"Fbg1, Fbs1, FBX2, Nfb42, OCP1"	ENSG00000116661	"F-box protein 2"	Q9UK22	1	11637018-11655785	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 238.9;choroid plexus: 125.3;pancreas: 86.9;pituitary gland: 118.3"	"Cell type enriched"	"Detected in many"	4	"Exocrine glandular cells: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 113.4;HBEC3-KT: 96.9;Hep G2: 239.8;SiHa: 440.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA005472: AB_2667332"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.68e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (5.26e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.64e-1)"	6.8	25.2	217.0	1.8	172.1	0.0	13.5	161.1	216.1	7.2	125.3	4.9	16.4	2.3	6.7	8.9	5.9	2.5	11.6	183.3	238.9	32.8	28.1	5.7	2.0	200.2	196.2	3.6	86.9	29.7	118.3	0.1	201.7	15.1	0.4	7.5	25.1	7.5	4.8	18.1	5.3	0.7	176.0	3.7	9.6	12.0	195.1	10.6	8.4	1.0	3.6	5.1	13.1	192.3	35.7	10.8	0.4	35.1	0.7	0.0	5.3	1.5	3.0	1.1	0.2	113.4	10.0	0.0	40.6	0.3	8.3	0.1	3.6	96.9	0.1	0.8	1.0	0.0	1.7	239.8	4.6	0.1	0.0	3.0	17.0	0.0	0.9	1.1	0.4	0.1	0.3	0.1	0.0	0.5	0.0	0.0	1.3	14.3	1.3	0.1	0.1	0.2	8.2	3.0	3.6	4.7	440.5	0.1	3.9	3.5	21.1	0.0	0.0	0.3	3.1	0.0	0.0	2.4	2.1	1.7	0.7	0.0	1.0	0.0	0.0	0.0	0.9	0.0	1.3	0.7	0.5	1.2	0.0	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.4	0.2	217.0	172.1	161.1	216.1	183.3	238.9	200.2	196.2	201.7	176.0	195.1	192.3	1.2	0.0	1.5	40.8	8.4	19.6	62.3	149.9	90.5	11.3	15.0	75.4	3.7	15.7	33.5	47.8	2.1	0.8	5.9	0.2	86.1	23.2	2.1	1.2	0.7	1.8	1.2	0.0	16.5	685.9	3.9	8.7	6.6	0.7	4.5	0.2	2.5	102.0	0.4	28.6	16.7	0.7	38.7	2.2	2.6	2.4	34.8	1.1	44.4	5.6	3.2	106.6	7.2	6.6	10.4	132.1	2.2	40.6	3.3	39.2	2.0	7.2	44.4	15.8	0.0	1.1	7.7	18.4	12.1	10.0	9.9	1.0	13.0	0.5	0.4	25.0
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 26.1;lung: 10.5;lymphoid tissue: 13.5"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 12.8;Macrophages: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.2;neutrophil: 4.0"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.5	0.3	0.0	1.0	0.0	26.1	0.7	0.0	0.3	0.2	0.0	0.6	0.0	0.2	0.0	0.3	3.4	0.0	1.5	0.0	0.0	0.5	1.7	10.5	0.0	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.4	0.1	0.4	0.1	0.0	13.5	0.8	0.1	0.0	0.0	0.5	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.1	0.3	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	12.8	0.3	0.0	0.0	18.0	0.0	1.0	2.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.7	0.5	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.1
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 441.6;lymphoid tissue: 470.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 726.6;granulocytes: 705.6;Hofbauer cells: 2318.6;Kupffer cells: 1950.8;Langerhans cells: 1526.3;Macrophages: 1971.3;monocytes: 808.9;NK-cells: 1037.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	11	"basophil: 1987.3;classical monocyte: 3240.2;intermediate monocyte: 5333.6;myeloid DC: 2386.3;neutrophil: 1831.0;NK-cell: 1750.9;non-classical monocyte: 6984.5;plasmacytoid DC: 3315.6"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 77.8;HMC-1: 301.7;THP-1: 276.1;U-266/84: 90.1;U-937: 87.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	251.7	86.5	34.0	275.6	33.8	441.6	62.9	35.5	66.0	52.5	47.5	82.7	44.9	30.7	38.7	30.6	72.0	101.5	53.1	33.7	42.0	40.3	177.3	286.6	160.9	53.4	48.7	19.9	22.3	26.8	26.9	211.0	50.1	31.0	113.2	8.3	42.9	38.8	11.9	21.0	60.6	160.3	41.5	470.1	39.4	14.5	49.9	62.7	25.5	34.6	82.5	254.6	21.7	65.4	0.2	0.0	0.7	1.3	1.8	0.7	0.4	0.5	0.2	0.5	0.8	2.2	0.1	0.5	0.7	0.0	0.3	0.2	0.5	0.0	0.4	0.3	1.5	77.8	0.6	14.0	0.3	16.1	301.7	6.0	3.3	2.3	0.2	0.7	0.4	1.8	0.1	7.3	2.4	0.5	1.4	37.9	1.6	0.0	0.0	0.1	6.7	0.2	0.5	0.4	0.3	1.0	0.6	0.1	2.7	1.4	0.2	276.1	0.4	1.8	0.4	0.9	1.1	3.0	90.1	0.9	1.7	87.1	0.5	1987.3	3240.2	307.3	13.6	5333.6	15.9	28.2	10.6	10.6	2386.3	9.0	17.3	45.0	1831.0	1750.9	6984.5	3315.6	21.8	4265.5	34.0	33.8	35.5	66.0	33.7	42.0	53.4	48.7	50.1	41.5	49.9	65.4	12.8	86.6	147.7	0.7	35.9	39.6	1.5	0.2	1.8	0.1	5.2	22.1	6.8	15.7	27.3	18.4	0.0	14.5	726.6	1.0	0.0	1.9	3.0	1.0	0.9	38.6	1.8	79.3	0.1	1.0	18.8	18.3	1.1	1.0	705.6	0.5	41.0	13.6	2318.6	0.0	0.2	0.5	0.0	1950.8	1526.3	9.4	5.3	1971.3	80.0	12.2	808.9	0.2	1037.1	0.0	0.1	1.0	1.4	1.2	10.1	1.3	0.4	5.4	15.3	2.3	72.3	3.8	11.2	1.0	2.5	1.4	35.9	23.7	133.3	0.4	0.6	1.8
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 206.3;lymphoid tissue: 306.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 333.4;Hofbauer cells: 193.1;Kupffer cells: 807.9;Macrophages: 300.0;NK-cells: 579.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1763.5;neutrophil: 1169.8;non-classical monocyte: 3948.7"	"Group enriched"	"Detected in all"	5	"granulocytes: 1169.8;monocytes: 3948.7"	"Not detected"	"Not detected"											"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	52.9	41.9	18.4	99.8	20.4	27.3	14.7	19.3	27.2	8.2	26.5	12.5	5.8	5.9	5.9	4.9	9.1	24.5	22.3	16.9	22.0	7.9	111.5	206.3	37.1	37.7	27.9	6.6	7.8	13.6	11.3	71.0	30.6	6.9	12.6	6.9	14.7	7.6	3.3	2.2	5.7	68.4	31.7	306.8	6.8	7.7	28.8	9.3	7.0	4.3	3.9	32.5	3.5	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.5	26.2	9.6	513.6	1763.5	4.9	3.7	4.7	205.9	175.8	1.4	3.0	184.0	1169.8	136.2	3948.7	4.6	2.6	734.1	18.4	20.4	19.3	27.2	16.9	22.0	37.7	27.9	30.6	31.7	28.8	39.8	2.7	22.4	24.6	0.7	6.5	0.5	0.1	0.0	0.0	0.2	1.4	3.4	0.7	8.6	10.5	3.7	2.1	1.2	333.4	0.0	0.0	0.2	1.4	0.1	0.0	18.9	0.0	16.4	0.0	0.0	1.4	3.9	0.0	0.1	18.9	0.1	8.6	5.3	193.1	0.0	0.1	0.1	0.0	807.9	7.4	3.7	0.3	300.0	0.0	20.6	77.2	0.1	579.9	0.0	0.1	0.0	0.0	0.0	22.1	0.0	0.0	0.8	5.8	1.5	19.7	1.1	0.4	0.0	0.5	0.2	0.0	2.1	88.0	0.0	0.0	0.3
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.6;lymphoid tissue: 82.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 7.2;Club cells: 3.1;dendritic cells: 2.2;Fibroblasts: 2.2;Kupffer cells: 2.2;Macrophages: 4.3;NK-cells: 2.1;Respiratory ciliated cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.7"	"Immune cell enriched"	"Detected in many"	79	"neutrophil: 7208.7"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 7208.7"	"Not detected"	"Not detected"																"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	23.0	2.8	0.6	76.4	1.2	36.6	1.3	0.7	6.7	2.8	1.1	2.1	0.5	0.9	0.0	5.0	5.2	16.4	3.5	0.6	0.7	1.9	7.9	22.0	1.3	1.0	0.8	0.4	4.0	1.4	0.7	9.1	2.7	0.8	0.9	0.0	1.3	0.4	0.8	4.0	2.4	5.6	0.7	82.0	1.8	0.2	1.1	6.1	1.3	23.0	1.5	18.3	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.1	12.5	17.2	30.4	0.6	0.3	0.9	6.9	3.0	0.6	0.5	6.2	7208.7	3.6	90.8	0.4	0.6	18.5	0.6	1.2	0.7	6.7	0.6	0.7	1.0	0.8	2.7	0.7	1.1	1.1	0.0	3.2	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	1.5	3.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.3	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.0	4.3	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 16.8;dendritic cells: 19.1;Oligodendrocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.4;RPMI-8226: 43.3;U-937: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	1.8	24.9	14.7	33.7	20.2	1.5	21.7	32.6	1.0	8.6	2.5	3.2	1.3	1.4	1.1	1.5	4.2	0.8	24.1	25.6	1.4	2.2	3.7	24.3	27.5	28.6	1.7	0.7	1.1	3.9	1.1	29.7	1.0	2.2	3.4	1.3	0.8	0.6	22.2	8.1	1.7	19.9	15.5	3.4	4.4	29.2	17.6	1.0	0.8	17.4	3.0	1.0	59.5	0.9	11.9	7.5	5.2	0.2	0.2	7.5	1.1	0.3	0.3	0.5	1.5	1.4	62.4	17.1	0.5	1.4	2.3	3.7	2.3	0.2	27.6	2.1	4.9	1.4	6.4	0.6	15.7	10.2	0.1	0.3	0.0	0.4	0.4	1.6	30.2	24.9	28.9	0.0	17.4	36.2	27.8	3.6	14.7	28.7	30.2	0.2	43.3	0.2	1.2	1.3	2.5	0.3	5.9	0.9	0.9	6.0	15.4	1.3	0.1	4.1	0.9	0.4	18.2	9.0	33.4	0.9	38.5	0.5	13.2	9.6	10.1	7.0	14.3	6.0	12.4	7.9	6.3	14.5	12.3	7.4	6.1	37.8	6.4	11.5	15.3	7.6	7.4	24.9	33.7	21.7	32.6	24.1	25.6	27.5	28.6	29.7	19.9	29.2	59.5	0.4	0.0	1.5	0.7	16.8	0.0	0.4	0.2	0.6	7.8	2.0	4.3	0.9	2.8	0.4	1.8	0.0	2.9	19.1	2.0	0.0	0.5	1.5	0.8	0.2	2.4	1.2	2.5	15.0	0.0	4.6	2.5	1.5	1.0	9.5	2.9	2.5	0.0	6.8	0.0	13.0	1.7	0.0	8.7	14.3	0.7	2.5	11.0	1.8	6.5	12.3	0.1	13.4	3.0	46.9	2.1	0.5	8.6	4.5	0.3	0.1	0.1	0.7	0.8	0.0	0.2	0.6	0.9	5.5	0.2	0.6	0.8	9.8	12.2	1.8	0.3
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552515	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 36.3"	"Group enriched"	"Detected in some"	5	"B-cells: 102.6;Early spermatids: 63.6;Plasma cells: 190.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"memory B-cell: 13.0;naive B-cell: 14.2"	"Lineage enriched"	"Detected in single"	17	"B-cells: 14.2"	"Group enriched"	"Detected in some"	5	"U-266/70: 3.4;U-698: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	169000000	65000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.30e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.32e-5)"	"unprognostic (2.61e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.51e-10)"	"unprognostic (1.20e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.78e-1)"	0.4	0.4	0.0	13.8	0.0	2.3	2.4	0.0	0.1	0.6	0.0	5.5	5.8	0.1	0.3	0.8	0.4	1.2	0.3	0.0	0.0	0.4	0.3	1.1	24.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	4.4	0.0	3.8	0.3	0.0	0.0	5.0	0.1	0.1	15.1	4.5	0.6	0.0	4.1	0.6	0.0	36.3	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.3	102.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.1	2.9	0.1	0.0	0.0	63.6	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.2	0.3	1.1	0.0	1.3	0.0	0.4	1.8	0.3	0.0	0.1	0.0	0.0	0.3	0.3	10.1	0.3	0.2	23.2	0.0	0.5	0.0	0.0	0.5	0.2	0.0	0.0	0.0	190.5	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.3	1.2	0.1	0.1	0.0	0.7	5.7	0.0	0.6	0.0
FCRL6	"FcRH6, FLJ16056, IFGP6"	ENSG00000181036	"Fc receptor like 6"	Q6DN72	1	159800511-159816257	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;lymphoid tissue: 12.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 60.6;NK-cells: 150.4;T-cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 142.9;memory CD8 T-cell: 134.3;naive CD8 T-cell: 102.8;NK-cell: 51.3"	"Group enriched"	"Detected in many"	26	"NK-cells: 51.3;T-cells: 142.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.64e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.18e-2)"	0.8	1.5	0.3	1.9	0.4	7.9	1.1	0.7	0.4	0.6	0.3	0.7	1.0	1.3	2.3	0.6	1.0	2.2	0.8	0.4	0.5	0.6	3.3	5.7	5.8	0.9	0.5	1.4	0.3	0.3	0.3	0.5	0.6	0.7	0.5	0.0	2.3	0.4	0.5	0.3	1.4	0.9	0.5	12.8	0.8	0.4	0.6	1.3	0.6	0.1	1.9	1.2	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.1	142.9	0.3	3.0	0.1	25.5	134.3	3.7	0.1	10.9	102.8	1.5	51.3	1.4	0.2	0.1	53.6	0.3	0.4	0.7	0.4	0.4	0.5	0.9	0.5	0.6	0.5	0.6	0.9	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.7	0.0	0.0	0.0	60.6	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	2.7	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	1.0	1.1	0.0	150.4	0.0	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 355.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1187.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	73.5	188.2	48.2	66.5	50.4	69.5	68.8	60.1	58.8	63.4	51.1	88.7	167.2	57.5	73.0	142.5	57.4	39.8	72.2	49.9	64.6	78.0	355.7	86.1	76.1	71.1	62.5	45.0	75.7	67.9	40.4	72.5	77.5	56.1	102.9	45.9	82.6	42.7	60.9	107.1	81.1	66.0	53.6	59.3	81.5	42.0	55.0	72.6	46.8	66.7	102.3	47.0	76.8	55.0	293.9	156.2	561.5	204.4	128.7	467.7	199.6	136.8	268.1	213.6	344.2	255.4	677.7	222.3	323.6	120.6	506.9	319.1	338.9	1187.5	198.9	122.4	242.5	129.4	260.1	311.5	210.8	212.1	142.0	335.5	184.6	339.6	168.8	96.4	377.6	322.3	235.1	579.9	225.3	315.1	273.6	205.0	338.9	216.4	225.5	231.6	243.2	620.0	567.7	193.0	217.4	185.6	140.7	253.0	243.0	317.3	182.6	567.6	277.1	118.4	144.3	74.3	254.9	244.3	202.3	401.1	115.3	221.7	191.1	90.6	85.5	124.1	89.2	92.9	79.7	102.8	77.8	91.1	95.6	95.1	69.9	87.1	38.9	115.2	70.0	76.2	113.7	134.7	48.2	50.4	60.1	58.8	49.9	64.6	71.1	62.5	77.5	53.6	55.0	55.0	154.2	73.7	181.6	38.5	68.4	36.8	83.3	927.7	42.1	69.4	84.6	56.9	1.8	97.2	431.5	53.3	62.6	207.8	74.9	343.0	137.0	180.9	216.6	56.7	38.2	161.9	71.4	133.4	30.8	329.9	198.7	59.8	52.0	77.8	62.8	116.6	168.1	361.9	112.0	55.5	28.1	135.7	299.1	54.8	44.4	67.9	60.9	52.8	96.0	15.0	144.7	81.1	87.6	22.6	39.7	256.7	324.3	70.3	91.3	206.1	194.1	145.0	129.6	90.8	72.3	47.0	177.5	42.0	14.2	49.7	59.8	143.5	68.3	230.6	165.4	148.2
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 10.8;stomach 1: 43.1"	"Group enriched"	"Detected in some"	9	"Early spermatids: 15.8;Gastric mucus-secreting cells: 39.3;Intestinal goblet cells: 10.4;Late spermatids: 30.5;Pancreatic endocrine cells: 10.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;ASC TERT1: 1.8;BJ hTERT+: 1.2;PC-3: 1.7;U-87 MG: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054117	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA054117: AB_2682387"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.3	0.0	5.0	2.9	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	4.5	0.1	0.0	0.0	43.1	2.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.4	15.8	0.3	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.4	0.0	0.0	0.0	30.5	0.9	0.0	0.0	1.9	0.0	0.0	0.0	1.0	1.0	10.8	2.2	0.0	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8
FERMT2	"KIND2, mig-2, PLEKHC1, UNC112B"	ENSG00000073712	"Fermitin family member 2"	Q96AC1	14	52857268-52952435	"Predicted intracellular proteins"	"Cell adhesion, Cell shape, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040505, HPA072965"	Uncertain		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		230000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	"Nucleoplasm, Cytosol"	"HPA040505: AB_10673300, HPA072965: "	"unprognostic (4.38e-2)"	"unprognostic (4.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.73e-3)"	148.4	21.2	28.7	38.8	31.6	0.5	57.6	29.0	37.3	44.7	18.0	104.3	13.1	105.1	26.3	46.8	55.7	65.7	66.9	31.0	27.4	55.4	108.3	47.9	15.3	35.7	29.1	43.6	20.6	18.4	13.1	116.5	33.5	69.1	33.3	29.5	22.6	117.9	48.8	13.4	29.3	155.6	30.6	37.6	46.4	15.5	27.6	6.9	35.9	69.6	6.6	77.7	29.1	38.1	22.8	18.9	101.6	46.8	163.7	133.7	84.6	148.4	95.2	172.3	107.9	34.1	17.6	0.1	49.4	153.1	33.8	9.6	80.1	11.1	128.3	0.2	22.6	31.9	83.1	40.3	209.6	0.4	12.6	129.4	23.5	95.3	125.4	78.5	91.2	16.8	0.6	153.4	131.7	28.0	7.7	0.5	64.3	0.2	51.3	3.9	103.8	0.4	60.9	20.6	6.2	130.5	157.8	35.0	37.7	103.3	30.1	1.1	115.2	134.5	92.4	108.2	56.0	22.6	29.4	0.6	30.9	0.2	33.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	31.6	29.0	37.3	31.0	27.4	35.7	29.1	33.5	30.6	27.6	38.1	152.7	76.9	42.0	116.5	1.0	18.6	150.6	15.5	13.6	39.5	33.8	41.4	65.8	24.3	25.6	40.5	37.5	74.8	2.3	0.2	31.3	48.5	68.2	20.1	141.7	110.4	0.0	2.7	13.7	33.2	178.1	103.9	3.6	40.2	58.3	31.6	110.3	82.3	10.4	15.2	16.1	0.5	4.1	8.9	19.5	27.9	74.9	4.4	46.2	29.0	4.8	52.3	1.0	41.2	92.0	27.6	0.1	174.9	4.5	40.0	0.0	44.7	10.1	56.0	151.2	83.4	174.1	4.1	16.2	2.2	8.1	102.6	7.9	12.3	0.4	37.0
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223891	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 180.6;lymphoid tissue: 130.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.3;granulocytes: 96.4;Hofbauer cells: 193.1;Kupffer cells: 95.8;Langerhans cells: 88.0;Macrophages: 232.9;monocytes: 142.9;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 306.9;HL-60: 135.9;HMC-1: 314.2;Karpas-707: 127.6;MOLT-4: 121.8;NB-4: 174.1;U-937: 138.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065231			Approved	Vesicles		NA	NA		160000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	25.1	14.5	9.4	63.3	11.6	180.6	13.0	11.2	18.1	8.5	12.2	17.3	22.0	8.4	0.7	6.4	13.6	15.6	12.0	9.8	11.6	11.1	12.5	46.2	89.2	17.9	12.2	5.1	7.0	1.3	5.9	15.0	13.2	8.2	8.1	0.6	10.7	4.4	6.0	7.1	34.1	9.4	13.3	130.1	29.6	4.5	17.1	48.7	10.0	4.6	41.8	19.8	7.3	15.3	1.2	1.6	0.5	0.9	0.3	0.8	2.0	1.4	0.2	0.4	0.3	2.6	2.3	32.6	3.2	6.3	0.7	2.4	1.0	0.5	0.5	83.9	0.6	306.9	1.6	0.1	10.8	135.9	314.2	1.2	1.1	5.2	0.0	0.5	81.2	77.0	7.3	127.6	8.6	3.5	121.8	174.1	1.2	1.0	2.3	72.4	8.8	0.7	0.3	0.7	1.9	0.5	0.7	4.5	1.7	0.7	2.0	92.6	7.8	1.1	2.5	1.9	0.9	1.5	3.3	59.4	19.5	138.9	86.6	204.1	207.0	236.5	120.0	192.6	114.9	54.5	94.1	112.0	162.0	53.1	60.9	80.6	184.6	102.4	151.2	195.7	120.9	292.6	9.4	11.6	11.2	18.1	9.8	11.6	17.9	12.2	13.2	13.3	17.1	15.3	3.8	9.6	14.7	0.7	52.1	4.7	0.9	0.3	3.4	0.5	3.3	5.2	2.4	4.3	3.9	0.0	0.0	1.2	118.3	6.1	0.0	0.8	0.4	4.3	5.6	7.9	0.0	62.5	1.2	2.4	1.4	5.4	19.9	7.3	96.4	0.4	19.6	1.4	193.1	0.0	1.5	32.1	0.0	95.8	88.0	0.9	0.9	232.9	17.8	5.6	142.9	0.3	93.7	1.0	1.5	4.3	10.9	2.6	35.2	0.9	8.2	0.4	1.0	0.3	6.6	13.7	6.6	1.2	0.8	1.9	4.5	2.6	78.5	1.4	15.0	0.7
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 83.4;lymphoid tissue: 110.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 315.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7"	"Cell line enhanced"	"Detected in many"		"HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	30.8	8.0	9.4	20.2	8.8	83.4	21.3	9.6	10.8	18.1	9.6	12.5	5.8	15.7	2.4	5.9	19.0	14.0	19.6	8.3	8.7	18.9	25.2	30.9	13.8	11.1	9.2	13.5	7.8	2.3	5.6	16.3	10.1	17.9	4.6	1.5	58.3	8.0	6.1	8.0	12.5	10.7	10.4	110.9	9.6	4.5	10.9	4.2	16.0	7.0	5.7	15.1	13.5	9.8	0.4	0.8	0.8	10.3	3.1	8.8	17.9	2.9	0.1	5.1	2.9	2.6	0.1	6.8	0.5	6.0	0.2	1.5	1.7	0.3	1.6	3.3	1.1	63.5	0.0	11.9	6.8	56.9	116.6	8.8	0.1	7.6	0.0	0.0	31.2	9.4	1.8	0.2	0.0	21.3	1.8	76.1	3.2	2.5	0.0	8.6	0.1	0.1	0.0	0.2	0.4	0.1	0.0	2.8	2.3	2.9	0.1	110.8	24.9	0.2	10.4	0.2	0.2	0.1	8.0	2.5	0.3	48.0	2.4	64.4	151.7	315.8	0.5	88.6	0.4	5.2	0.3	0.4	162.6	4.1	0.2	0.3	100.5	51.4	39.8	65.0	0.2	81.5	9.4	8.8	9.6	10.8	8.3	8.7	11.1	9.2	10.1	10.4	10.9	9.8	46.8	3.2	5.8	3.6	5.0	3.8	5.4	0.5	0.6	0.2	4.1	3.8	3.4	8.6	0.5	1.8	0.0	5.3	25.6	0.6	3.9	7.3	1.7	2.0	4.2	29.1	3.0	8.0	2.8	4.3	4.2	9.0	2.0	4.2	29.2	10.7	20.0	15.0	48.7	0.0	0.2	2.0	2.0	92.3	27.9	8.4	9.0	51.9	7.2	5.6	57.8	2.5	26.8	2.0	0.3	2.1	2.0	10.1	4.0	3.1	0.7	1.5	0.2	1.9	13.1	4.6	12.9	4.4	15.9	1.0	2.8	4.5	6.7	3.3	3.7	5.2
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.4;pituitary gland: 11.0"	"Cell type enriched"	"Detected in some"	4	"Intestinal goblet cells: 125.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Uncertain	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	4.1	0.4	1.2	0.7	1.3	0.1	1.3	0.6	1.2	0.1	0.3	8.3	0.5	0.0	0.0	0.2	1.0	0.5	0.3	1.0	1.8	0.1	0.4	3.6	0.2	0.6	0.8	0.0	0.6	0.1	11.0	0.1	0.5	0.1	11.4	0.2	0.1	0.0	0.3	0.9	0.6	0.2	0.3	0.1	0.5	1.5	2.6	0.3	0.1	0.1	0.1	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	1.2	1.3	0.6	1.2	1.0	1.8	0.6	0.8	0.5	0.3	2.6	0.7	0.2	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.8	0.4	7.2	0.6	0.0	0.0	0.2	0.0	28.1	0.0	0.8	27.8	0.1	0.0	0.3	20.9	0.0	3.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	2.0	125.7	0.0	7.2	4.4	16.7	0.6	7.6	1.8	3.7	0.5	0.0	0.0	0.0	0.3	0.9	23.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029069	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;dendritic cells: 29.7;Kupffer cells: 118.2;Langerhans cells: 49.3;Macrophages: 52.0;Microglial cells: 43.1;monocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 22.3;intermediate monocyte: 64.8;memory B-cell: 23.2;myeloid DC: 35.0;naive B-cell: 18.6;non-classical monocyte: 70.5;plasmacytoid DC: 27.4"	"Group enriched"	"Detected in many"	18	"B-cells: 23.2;dendritic cells: 35.0;monocytes: 70.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;Daudi: 11.5;HDLM-2: 11.3;U-698: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	6.1	3.3	1.0	14.8	1.3	6.0	2.6	1.2	1.3	1.5	2.3	3.4	3.7	1.3	1.5	2.4	2.8	4.1	1.6	1.0	1.6	1.4	2.5	8.0	22.5	3.2	1.7	1.0	1.3	0.3	1.1	2.7	1.9	1.5	2.7	0.1	2.3	1.8	0.6	2.1	11.1	4.7	2.1	39.7	3.8	0.6	2.1	5.5	2.7	0.9	9.8	4.5	1.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	22.3	2.3	0.1	64.8	0.1	23.2	0.0	0.0	35.0	18.6	0.0	0.0	0.3	0.4	70.5	27.4	0.1	7.5	1.0	1.3	1.2	1.3	1.0	1.6	3.2	1.7	1.9	2.1	2.1	2.0	0.3	6.4	7.4	0.0	53.7	2.0	3.0	1.0	0.6	0.3	0.7	0.6	3.2	2.8	0.5	0.0	0.0	0.3	29.7	0.3	0.0	2.8	11.9	0.5	0.2	1.2	0.0	1.3	0.1	0.9	0.4	1.0	1.5	1.2	7.6	0.0	2.5	0.6	17.7	0.0	0.2	0.1	4.1	118.2	49.3	2.1	1.5	52.0	1.8	43.1	51.8	0.4	2.1	0.5	0.2	1.0	3.9	0.0	14.2	1.6	0.1	0.2	3.2	0.2	0.0	2.3	0.5	0.0	0.1	3.3	2.3	0.4	3.0	0.1	0.4	5.6
FGF11	"FHF3, FLJ16061, MGC102953, MGC45269"	ENSG00000161958	"Fibroblast growth factor 11"	Q92914	17	7438273-7444937	"Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 31.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.4;Basal respiratory cells: 10.2;Horizontal cells: 18.5;Muller glia cells: 15.2;Suprabasal keratinocytes: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 10.4;HaCaT: 18.4;LHCN-M2: 12.1"	"Low region specificity"	"Detected in all"							"HPA066605, HPA075188"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Centrosome		"HPA066605: AB_2685693, HPA075188: AB_2732283"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.79e-4)"	"unprognostic (9.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.00e-6)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.90e-3)"	"unprognostic (4.97e-3)"	4.0	31.2	7.8	1.5	9.3	0.9	3.4	12.4	6.7	10.9	4.0	1.2	0.6	2.1	0.6	19.9	1.6	1.5	16.5	7.5	6.7	8.1	0.8	1.1	3.5	10.0	9.3	1.7	0.8	0.7	1.5	0.7	9.1	1.6	0.4	14.8	5.8	0.5	7.5	18.5	1.6	1.2	6.5	2.4	1.0	2.4	12.1	2.0	7.0	8.6	5.2	1.4	15.4	6.7	10.4	0.6	5.5	0.1	3.2	0.1	2.7	0.3	3.4	0.4	0.7	0.2	1.1	3.1	0.7	0.2	0.1	18.4	2.1	5.8	1.3	6.4	4.5	5.6	0.7	1.4	0.5	0.2	6.0	0.6	1.6	0.4	0.2	0.6	0.2	2.3	2.2	0.2	12.1	2.4	1.9	2.5	2.0	0.4	0.2	4.9	5.1	1.3	0.7	0.8	1.2	5.7	0.7	0.7	0.5	3.1	0.3	0.4	0.2	0.3	5.7	0.0	0.3	0.4	1.5	0.9	1.4	3.5	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	9.3	12.4	6.7	7.5	6.7	10.0	9.3	9.1	6.5	12.1	6.7	1.8	0.0	0.0	10.4	0.3	5.5	0.4	10.2	7.4	4.7	1.5	1.5	0.4	1.5	4.5	1.8	6.2	0.4	0.5	1.0	3.9	0.6	3.3	1.5	0.9	2.4	0.0	0.0	0.1	0.2	0.4	0.9	0.0	3.9	0.0	2.0	1.4	0.2	0.4	18.5	0.8	0.5	0.0	0.6	2.6	4.6	1.8	0.9	1.8	2.8	0.0	15.2	0.0	5.5	0.3	1.1	0.2	2.2	0.2	0.5	0.8	0.2	7.0	2.8	0.0	2.3	1.6	3.4	2.7	6.3	9.7	0.7	0.5	0.1	0.6	1.2
FGF12	"FGF12B, FHF1"	ENSG00000114279	"Fibroblast growth factor 12"	P61328	3	192139390-192767764	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Growth factor"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 35.8;heart muscle: 131.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 413.7;Excitatory neurons: 1213.5;Inhibitory neurons: 1925.1;Oligodendrocyte precursor cells: 1668.3"	"Cancer enhanced"	"Detected in many"		"glioma: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;NTERA-2: 10.3;SCLC-21H: 23.9;U-251 MG: 14.7;WM-115: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071557			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA071557: AB_2686417"	"unprognostic (1.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.50e-5)"	"unprognostic (1.75e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.87e-7)"	"unprognostic (2.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.99e-2)"	1.9	35.8	8.5	0.2	14.1	0.0	1.3	0.5	21.3	0.5	0.0	1.1	0.7	1.0	0.2	1.7	1.5	0.5	131.3	17.5	14.2	2.5	0.6	1.1	0.2	11.1	1.0	0.8	7.7	1.6	5.3	0.4	9.9	1.3	0.3	15.4	5.9	6.0	1.1	0.3	0.3	0.7	0.0	11.6	0.6	2.1	3.5	0.1	1.5	0.8	0.2	0.5	0.7	2.8	0.1	1.1	15.1	0.0	0.0	0.0	0.1	0.0	0.1	1.4	1.7	0.0	0.1	0.8	7.2	0.3	0.3	0.2	0.0	0.0	1.6	0.1	0.2	3.2	6.3	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	3.7	0.2	0.0	0.1	0.1	0.0	4.4	0.0	0.0	10.3	7.1	0.3	0.0	0.1	0.0	4.7	1.8	23.9	0.0	0.0	0.6	0.0	1.7	1.1	0.2	0.4	6.2	3.2	0.0	14.7	0.2	2.5	0.0	1.3	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	14.1	0.5	21.3	17.5	14.2	11.1	1.0	9.9	0.0	3.5	2.8	17.8	0.0	0.0	42.7	0.1	0.6	4.2	0.0	0.6	100.2	0.9	1.7	413.7	0.0	1.9	5.5	4.2	0.2	0.0	0.0	7.9	0.7	20.9	1.6	1.6	13.2	0.0	0.0	1213.5	13.1	0.4	18.6	0.5	0.5	0.0	9.0	16.4	0.0	0.1	33.7	1925.1	0.0	0.0	0.3	0.3	38.5	6.8	0.1	1.8	46.9	0.0	3.8	0.0	1668.3	28.2	2.7	1.2	1.2	0.5	1.1	0.0	0.4	0.8	14.2	0.0	0.7	4.8	4.0	8.0	0.4	0.1	0.0	0.1	38.7	0.1	1.7
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935577-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 117.1;esophagus: 421.8;vagina: 172.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1044.3;Basal respiratory cells: 596.2;Squamous epithelial cells: 528.5;Suprabasal keratinocytes: 786.2;Urothelial cells: 303.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 117.5;head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 556.3;HBEC3-KT: 968.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.6	0.1	0.0	1.7	0.0	0.1	13.5	0.0	0.0	117.1	0.0	22.1	1.8	0.5	0.1	421.8	1.2	0.3	0.2	0.0	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.2	1.1	0.0	1.7	15.6	0.0	59.7	0.1	0.1	91.2	7.0	1.1	0.0	0.1	2.0	0.0	0.0	0.3	0.7	0.0	38.4	14.9	172.3	0.0	150.7	10.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	189.0	0.0	10.9	0.0	0.2	556.3	0.0	968.2	0.0	0.0	1.2	0.0	2.0	0.0	0.2	0.0	0.4	0.1	141.0	0.0	17.7	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.1	7.9	75.2	0.0	0.0	0.0	93.4	6.7	0.0	0.0	0.2	0.0	0.2	0.0	0.9	0.5	0.1	0.2	0.3	0.0	0.3	0.0	0.1	0.2	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	8.4	0.0	0.3	1044.3	182.5	596.2	217.4	0.0	11.8	3.2	0.1	0.0	223.2	0.0	0.0	0.2	0.2	49.6	0.0	49.7	0.0	52.8	3.3	6.3	0.0	0.0	0.0	7.5	2.4	6.2	0.0	65.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.1	42.7	0.0	60.6	0.0	0.0	0.9	74.7	0.0	0.6	0.0	1.0	0.0	0.0	139.1	50.8	0.0	0.0	90.8	0.7	0.0	56.8	0.0	0.0	0.0	10.4	0.0	0.0	528.5	786.2	2.3	2.1	0.0	26.1	303.6
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960245-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.0;bone marrow: 54.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 486.6;NK-cells: 1627.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 551.3;memory CD8 T-cell: 332.1"	"Lineage enriched"	"Detected in many"	8	"T-cells: 551.3"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 6.9;T-47d: 3.2;WM-115: 1.3"														"Secreted to blood"	NA	NA	346000000	36000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	29.0	1.5	0.9	0.4	1.0	54.6	12.7	0.8	1.5	0.6	0.8	11.8	0.1	0.5	7.2	0.6	0.7	0.9	23.6	1.0	1.1	0.5	1.2	8.5	2.9	0.9	0.8	0.4	0.2	0.3	0.2	0.5	0.9	1.4	0.9	1.1	8.6	0.9	1.1	21.0	2.0	0.3	0.8	14.0	1.7	8.6	0.9	5.3	1.1	3.6	1.0	2.8	1.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.9	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	3.5	0.8	2.4	551.3	1.3	5.2	0.8	128.6	332.1	0.9	0.4	47.3	314.1	8.4	64.9	1.6	2.1	0.9	371.2	0.9	1.0	0.8	1.5	1.0	1.1	0.9	0.8	0.9	0.8	0.9	0.9	2.6	0.0	5.3	0.0	2.6	9.6	0.0	0.2	0.0	0.0	1.5	1.7	1.5	5.7	1.4	5.5	8.4	0.6	486.6	0.1	0.0	0.7	1.3	0.9	0.1	2.2	0.0	3.6	0.0	0.0	0.0	19.9	0.5	0.3	3.8	60.3	6.1	0.6	0.0	0.0	0.0	0.4	0.0	4.9	12.0	3.0	0.0	2.2	46.2	0.0	5.8	1.4	1627.2	0.0	0.1	0.2	0.0	0.4	17.5	0.0	0.0	1.3	1.3	0.4	0.0	1.8	2.5	0.7	0.1	0.1	7.7	1.0	167.2	0.2	0.1	0.0
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 11467.1;tongue: 9770.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 1145.1;Early spermatids: 373.8;Late spermatids: 1206.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 88.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 36.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 19.4;NK-cells: 36.1;T-cells: 18.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 303.7;fHDF/TERT166: 258.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		12000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavorable (2.11e-4)"	938.4	65.8	120.8	75.5	117.2	11.7	441.8	95.9	126.3	315.5	85.8	672.0	83.2	464.6	107.7	538.1	281.6	127.6	1462.3	130.8	144.9	45.2	43.1	285.6	41.7	103.9	125.4	102.8	39.4	196.5	92.9	106.6	115.9	408.8	161.4	76.2	161.3	541.1	11467.1	101.3	235.5	486.5	114.8	43.0	368.4	60.2	130.1	25.1	310.1	9770.8	32.1	469.6	253.1	102.9	0.4	44.3	60.7	57.8	127.2	52.3	1.5	183.7	303.7	34.8	81.3	0.3	12.7	0.7	55.8	258.8	95.0	0.5	119.2	148.0	28.2	0.4	136.7	0.7	34.4	0.0	121.6	0.3	26.8	96.6	24.4	41.2	128.7	14.1	36.6	34.5	0.1	26.0	81.9	2.5	26.1	1.6	19.1	0.2	52.2	69.8	2.6	38.2	1.1	0.1	43.5	63.8	6.6	0.2	12.4	24.1	0.3	2.4	102.5	150.2	71.0	5.9	44.7	6.8	16.0	1.1	11.9	1.4	18.2	0.1	0.7	0.0	5.2	0.1	13.8	5.8	18.2	7.2	3.1	3.6	12.0	4.0	1.2	36.1	0.0	19.4	2.2	11.1	120.8	117.2	95.9	126.3	130.8	144.9	103.9	125.4	115.9	114.8	130.1	102.9	203.0	48.1	11.7	32.0	8.1	56.5	26.9	15.1	14.2	36.2	1.4	8.3	1145.1	0.0	4.9	11.0	8.4	0.6	8.6	0.5	1.9	3.0	373.8	4.3	32.3	61.1	13.8	17.9	70.2	0.2	1.1	236.0	2.0	2.0	15.8	41.0	113.6	6.1	4.3	99.3	55.6	0.8	0.0	5.1	47.0	1206.9	123.9	35.6	32.0	16.9	7.4	209.6	2.1	35.2	8.2	0.6	7.6	152.4	15.5	20.1	0.6	11.6	4.8	19.4	105.2	248.1	235.7	7.4	88.6	2.7	44.8	2.7	15.5	9.6	2.0	2.6
FHL5	"ACT, dJ393D12.2, FLJ33049"	ENSG00000112214	"Four and a half LIM domains 5"	Q5TD97	6	96562548-96616636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.5"	"Group enriched"	"Detected in some"	20	"Early spermatids: 1160.3;Late spermatids: 1540.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"ASC diff: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (4.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.48e-3)"	35.7	10.3	5.4	4.4	8.5	0.0	16.0	5.8	7.5	27.8	6.2	5.8	2.5	15.0	17.6	9.6	21.5	12.9	5.6	4.9	5.3	6.4	0.4	14.0	1.8	6.3	5.8	11.4	4.6	3.3	1.2	0.6	7.1	4.9	5.0	0.4	2.1	11.1	8.9	5.5	5.1	9.6	5.4	3.5	4.0	65.5	7.2	1.2	8.9	14.6	0.8	6.8	10.3	5.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	8.5	5.8	7.5	4.9	5.3	6.3	5.8	7.1	5.4	7.2	5.5	5.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1160.3	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1540.1	52.5	1.1	5.4	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.2	0.0	0.0	0.0	0.0	52.6	1.9	67.4	13.2	4.4	0.0	0.3	0.0	0.6	0.1	0.0	0.2
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 161.3;Inhibitory neurons: 82.9;Oligodendrocyte precursor cells: 309.6;Oligodendrocytes: 129.4;Sertoli cells: 72.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	34	"basophil: 3.3"	"Lineage enriched"	"Detected in single"	34	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"AF22: 18.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	3.1	2.0	3.9	0.4	5.0	0.8	2.0	2.3	4.4	2.4	0.0	2.6	0.4	1.1	1.2	0.6	1.9	1.1	3.3	2.5	5.4	1.9	3.2	1.4	0.6	3.0	4.2	4.6	2.9	0.4	2.6	1.1	3.9	1.6	0.7	1.4	2.6	2.7	1.0	1.0	1.4	0.9	1.8	3.0	1.8	1.1	4.6	0.2	1.1	1.7	0.2	1.7	2.4	5.1	6.4	2.3	18.6	0.0	0.0	0.0	6.8	2.4	1.6	1.7	3.2	0.0	2.2	0.0	6.6	2.6	3.4	0.9	6.2	2.6	1.3	0.0	4.6	0.0	4.7	4.6	1.5	0.0	0.0	0.8	2.2	3.3	9.0	2.6	4.0	0.0	0.0	0.0	5.1	1.6	0.0	0.0	7.9	0.4	2.9	0.0	6.3	0.0	4.2	2.1	2.9	2.5	0.0	1.8	1.7	10.3	2.0	0.0	0.4	7.6	6.8	0.0	5.1	1.1	0.0	0.0	2.3	0.0	4.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.0	2.3	4.4	2.5	5.4	3.0	4.2	3.9	1.8	4.6	5.1	2.9	6.4	7.3	161.3	0.7	1.9	0.1	2.8	1.8	24.4	5.7	2.7	19.4	20.0	3.0	12.9	0.0	21.2	0.2	0.1	1.9	3.7	3.8	0.7	0.7	2.1	0.0	0.0	53.4	1.5	7.4	11.6	4.1	1.6	0.0	23.6	7.9	13.5	1.4	6.7	82.9	0.0	4.1	0.0	1.6	6.4	51.9	0.6	17.8	28.1	0.0	4.3	0.0	309.6	129.4	1.1	0.0	34.3	0.0	1.8	0.0	8.1	4.0	2.1	72.3	16.6	17.8	1.1	1.2	1.0	0.4	16.8	0.2	7.0	0.0	0.0
FKBP14	"FKBP22, FLJ20731"	ENSG00000106080	"FKBP prolyl isomerase 14"	Q9NWM8	7	30010587-30026702	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Isomerase, Rotamase"	"Deafness, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013329, HPA026829"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Golgi apparatus"	"HPA013329: AB_1848613, HPA026829: AB_10601651"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.12e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (6.06e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (4.25e-4)"	6.5	5.1	3.4	7.0	3.5	4.3	6.4	5.4	3.6	9.9	3.1	4.7	3.0	8.5	10.0	4.7	4.3	6.0	6.8	3.2	3.2	3.1	3.2	4.1	3.1	3.3	3.1	5.4	5.8	6.2	7.7	7.9	3.0	6.8	4.8	7.2	4.3	7.5	2.1	4.7	2.9	13.9	3.0	2.7	4.0	2.2	3.5	1.8	3.3	3.2	3.2	8.9	3.8	3.5	7.0	5.2	14.4	33.6	36.8	46.8	6.5	34.9	32.7	12.0	23.3	4.4	4.3	2.4	16.0	31.0	14.7	14.8	8.1	12.8	23.9	1.3	11.6	5.6	9.2	13.1	18.6	4.0	9.3	29.4	13.1	20.9	24.6	28.2	27.0	3.6	9.2	5.0	21.8	2.9	2.1	4.9	7.5	7.7	9.2	0.1	9.6	8.2	11.8	6.1	3.8	12.5	12.2	27.5	8.8	17.0	6.2	5.3	21.7	12.6	14.6	21.8	14.0	7.6	8.3	4.2	18.0	3.8	40.2	0.5	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	0.2	0.0	0.6	0.2	0.1	3.4	3.5	5.4	3.6	3.2	3.2	3.3	3.1	3.0	3.0	3.5	3.5	13.5	19.2	16.0	7.2	7.9	27.4	22.0	15.8	35.9	16.3	13.3	13.0	15.7	5.7	11.7	18.4	27.1	11.6	9.4	5.3	1.9	7.4	0.4	30.4	44.3	12.9	1.2	6.5	19.4	3.7	27.3	40.0	15.3	40.0	2.5	9.1	8.6	6.5	6.0	15.2	12.7	9.7	8.2	2.5	11.2	0.4	13.1	5.7	10.6	10.3	3.6	26.5	2.1	11.6	16.6	5.7	19.0	20.7	43.8	17.8	3.3	2.7	6.0	21.4	6.6	13.8	20.4	1.4	3.4	27.5	18.3	15.7	6.0	20.8	6.1	28.0
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 65.7;Endothelial cells: 84.2;Hepatic stellate cells: 64.6;Kupffer cells: 86.4;Microglial cells: 231.4;monocytes: 68.4;NK-cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 113.9;HUVEC TERT2: 60.5;REH: 49.8;TIME: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	10.2	1.9	3.7	10.9	2.3	12.2	6.0	2.1	2.8	5.7	1.2	3.7	3.2	4.6	1.1	2.8	2.7	6.1	6.2	1.8	2.9	2.1	2.8	10.8	12.3	4.7	2.7	1.2	1.7	3.5	0.7	12.5	4.3	1.9	2.9	0.5	2.2	2.2	2.8	1.7	4.0	5.9	3.5	35.8	4.3	0.9	3.9	17.2	2.9	6.6	10.4	6.7	1.9	2.8	0.2	0.0	5.6	0.0	0.8	1.0	0.1	3.3	9.2	3.8	3.1	0.0	0.0	18.5	31.7	11.1	1.1	0.1	0.8	13.5	4.1	9.0	0.2	113.9	0.5	0.0	6.0	13.7	14.6	0.8	1.1	7.7	17.3	11.1	60.5	25.6	0.0	23.3	0.8	0.0	13.3	8.1	1.8	0.0	3.1	49.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	20.4	63.0	0.7	0.0	0.2	3.5	7.3	16.4	16.6	0.1	31.8	5.2	34.5	15.5	24.5	10.1	15.3	11.9	6.8	8.9	8.2	19.1	6.0	3.7	8.2	11.8	12.3	19.1	3.3	11.1	20.1	3.7	2.3	2.1	2.8	1.8	2.9	4.7	2.7	4.3	3.5	3.9	2.8	53.4	6.4	5.3	0.3	65.7	5.1	0.3	1.7	2.2	0.0	0.7	1.3	5.5	5.7	0.1	1.8	0.0	0.4	43.1	0.0	0.0	0.0	0.5	0.4	0.6	84.2	0.0	23.4	0.3	0.0	0.4	5.9	2.0	0.3	22.8	0.0	64.6	1.3	43.2	0.0	1.5	0.1	0.0	86.4	24.7	0.5	1.8	60.3	7.2	231.4	68.4	0.1	93.7	4.0	0.7	0.0	0.0	0.7	56.9	0.3	0.0	0.4	0.8	0.4	6.6	2.1	3.1	0.2	0.1	0.6	4.1	0.3	52.8	0.9	0.2	0.4
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLRT1	"MGC21624, SPG68"	ENSG00000126500	"Fibronectin leucine rich transmembrane protein 1"		11	64103188-64119173	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 8.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 6.1;Excitatory neurons: 8.8;Inhibitory neurons: 16.1;Muller glia cells: 6.2;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 13.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;SCLC-21H: 5.4;SH-SY5Y: 13.5;THP-1: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054589	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054589: AB_2682533"	"unprognostic (5.13e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.64e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.62e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.29e-3)"	"unprognostic (4.37e-2)"	0.3	4.4	7.0	0.3	8.4	0.0	0.4	1.6	6.8	2.9	0.0	3.9	0.5	1.5	0.0	0.8	0.6	0.5	1.2	7.1	3.0	2.5	0.9	0.2	0.0	1.5	4.3	0.5	1.0	0.0	1.2	0.1	0.6	1.2	0.3	1.6	0.7	0.9	0.2	1.0	0.9	0.5	1.6	0.3	1.1	0.3	8.5	0.0	2.2	0.1	0.0	0.7	1.1	7.4	0.4	0.7	2.7	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.4	0.0	1.1	0.6	3.7	0.0	0.0	0.7	0.2	0.0	0.9	0.1	0.0	2.1	0.3	4.0	0.0	0.5	0.1	0.6	1.2	0.1	0.2	0.8	0.2	0.1	0.0	0.3	5.4	13.5	0.3	0.3	0.4	0.0	0.4	11.3	0.1	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.2	3.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	8.4	1.6	6.8	7.1	3.0	1.5	4.3	0.6	1.6	8.5	7.4	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	6.2	0.0	32.2	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FLRT2		ENSG00000185070	"Fibronectin leucine rich transmembrane protein 2"	O43155	14	85530144-85654428	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 279.5;Excitatory neurons: 549.6;Inhibitory neurons: 321.3;Leydig cells: 219.0;Microglial cells: 432.8;Oligodendrocyte precursor cells: 212.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basal ganglia: 2.1;cerebral cortex: 8.2;hippocampal formation: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.1;HUVEC TERT2: 38.7;TIME: 55.3;U-138 MG: 58.8;U-2197: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		17000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.59e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.34e-2)"	"unprognostic (8.02e-6)"	"unprognostic (1.98e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.50e-5)"	9.2	4.5	0.8	4.5	2.1	0.1	2.9	0.0	8.2	11.0	2.3	2.7	0.9	6.1	3.0	3.5	6.4	9.1	3.8	4.7	0.0	1.4	1.2	2.3	3.5	0.0	0.0	29.6	21.7	1.3	1.9	1.2	0.0	5.1	3.1	3.1	1.9	3.3	7.3	6.1	1.7	5.2	0.0	3.0	2.2	4.6	0.2	1.2	4.9	3.1	2.6	5.3	4.2	0.0	0.0	0.2	8.9	0.0	7.9	14.5	0.0	9.7	6.3	9.0	8.4	0.0	0.0	0.0	0.0	28.5	0.9	2.0	13.6	18.6	21.8	0.0	7.8	0.0	5.3	0.0	25.2	2.1	0.0	8.0	10.6	7.5	60.1	2.7	38.7	0.0	0.0	0.0	21.8	0.0	0.0	0.0	4.2	0.0	0.2	0.0	10.8	0.0	0.0	0.0	2.1	0.0	2.3	0.0	3.2	11.8	0.0	0.1	55.3	58.8	9.9	43.0	17.8	0.0	0.0	0.0	18.5	0.0	5.8	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.0	8.2	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.9	0.0	1.3	279.5	0.1	21.4	1.7	5.2	6.2	7.0	3.9	4.4	4.0	10.0	0.4	1.8	0.0	0.4	0.1	0.1	0.0	66.2	3.1	2.2	65.1	15.9	0.0	0.0	549.6	42.8	0.2	34.3	0.5	1.6	0.0	39.9	66.0	0.2	2.4	10.1	321.3	0.0	0.0	1.3	6.6	7.7	219.0	1.2	1.8	432.8	0.6	13.2	0.0	212.1	9.0	20.4	0.0	124.8	0.0	1.1	0.0	0.2	1.7	1.4	13.1	3.2	8.5	1.1	0.6	1.0	24.0	0.8	0.8	32.3	0.0	0.2
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"placenta: 432.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 411.6;Endothelial cells: 263.1;Extravillous trophoblasts: 815.4;Hepatic stellate cells: 234.9;Microglial cells: 433.8;Syncytiotrophoblasts: 1127.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 71.8;BJ hTERT+: 57.2;HMC-1: 349.2;HUVEC TERT2: 64.9;WM-115: 127.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	87000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	47.6	9.6	37.6	9.1	36.2	1.1	31.2	37.0	43.0	16.4	24.6	9.4	7.5	17.2	3.7	5.9	11.7	16.6	46.0	33.3	39.8	34.9	18.2	25.8	5.3	44.6	40.0	4.4	12.7	30.5	9.0	432.4	50.1	13.9	6.1	52.5	7.0	11.0	19.9	5.9	9.3	17.4	33.4	18.6	10.9	17.4	59.6	3.6	48.9	38.8	5.7	14.0	9.5	38.7	0.1	0.0	0.0	0.6	0.6	0.9	0.3	71.8	57.2	25.8	14.9	0.0	0.2	0.1	0.1	9.6	0.0	0.3	6.7	0.0	45.4	0.0	2.0	0.2	0.1	0.0	0.1	0.0	349.2	0.6	0.0	0.1	1.0	0.1	64.9	6.1	1.7	0.3	0.0	0.3	4.5	3.7	37.5	0.0	0.1	2.9	0.0	0.1	0.1	0.1	8.1	0.6	0.0	0.1	0.2	44.4	0.3	0.2	6.3	0.2	1.2	0.1	0.1	2.1	1.0	0.2	0.4	0.3	127.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	37.6	36.2	37.0	43.0	33.3	39.8	44.6	40.0	50.1	33.4	59.6	38.7	411.6	0.0	6.0	2.0	4.7	4.1	0.7	0.2	3.4	17.8	1.2	1.5	26.5	2.8	2.9	0.0	4.2	197.2	1.4	0.1	1.9	0.6	157.2	0.5	1.5	263.1	0.0	0.0	0.9	0.0	815.4	32.1	0.5	2.1	1.3	0.1	234.9	6.9	30.8	1.7	14.5	0.0	0.0	12.5	23.6	173.8	18.6	15.3	0.0	433.8	0.0	153.2	0.0	9.5	2.0	0.0	0.0	48.5	4.1	1.3	0.0	0.1	1.8	9.7	92.1	11.4	30.1	14.6	4.6	1.0	4.8	1127.1	2.8	1.5	0.0	1.1
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	12.2	5.7	13.7	20.5	13.2	5.2	10.6	13.0	11.2	9.6	3.0	8.0	5.7	11.2	19.2	4.5	6.9	11.1	12.6	11.0	12.6	9.3	2.7	17.4	23.5	21.7	14.6	16.1	3.2	3.6	4.1	14.0	18.2	6.0	5.6	2.7	4.6	4.4	5.6	4.4	10.2	11.5	17.7	13.4	6.6	10.1	20.4	20.1	13.4	6.7	28.3	8.6	6.3	20.4	8.6	2.5	18.4	6.1	5.0	20.1	0.2	10.4	21.0	13.8	12.1	9.7	2.3	18.2	19.5	12.4	15.2	0.4	9.5	4.3	12.6	16.2	3.6	20.1	2.9	0.5	8.8	4.0	25.1	12.7	0.7	21.7	9.1	41.2	37.1	9.0	4.6	13.0	20.5	6.3	16.6	6.0	6.0	0.9	5.5	7.9	23.0	2.8	13.1	1.3	3.0	8.6	6.0	0.8	11.8	9.3	1.5	5.9	47.2	34.2	11.8	0.6	18.2	6.7	0.4	9.8	21.3	12.4	14.7	3.0	0.1	0.8	0.8	0.4	0.4	0.2	0.3	0.5	0.2	1.1	0.4	0.5	0.0	0.6	0.3	5.1	0.1	0.5	13.7	13.2	13.0	11.2	11.0	12.6	21.7	14.6	18.2	17.7	20.4	20.4	35.8	3.2	3.4	6.8	17.5	1.7	0.7	0.4	2.2	11.3	1.3	2.3	3.3	0.0	1.4	1.8	39.6	2.1	48.6	0.1	0.0	0.3	2.0	0.7	2.6	29.7	0.0	1.7	16.0	0.6	0.8	7.1	1.5	2.0	27.8	5.4	15.7	0.8	11.1	3.3	6.5	0.8	0.0	6.9	9.0	4.6	3.7	17.7	5.4	119.0	22.9	0.5	16.5	27.6	5.5	0.8	0.1	6.4	1.8	0.8	0.0	0.2	0.2	2.0	13.1	15.5	10.3	5.9	7.5	0.4	1.4	2.5	13.6	2.6	0.1	0.4
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1123.3"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	27.2	12.4	2.5	0.9	2.7	0.4	6.8	2.5	3.6	1.2	2.3	1.4	1.8	1.3	3.0	5.1	13.3	1.8	4.2	2.3	2.6	14.0	1123.3	18.7	4.9	5.0	2.7	0.3	4.5	4.2	4.3	0.2	3.1	1.1	0.7	0.1	5.1	0.4	4.6	4.3	2.2	1.6	4.0	0.4	3.9	0.5	2.8	1.4	2.6	3.1	9.1	1.0	0.9	2.6	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.7	2.5	3.6	2.3	2.6	5.0	2.7	3.1	4.0	2.8	2.6	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1725.9;placenta: 2928.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2583.6;Fibroblasts: 562.6;Hepatocytes: 1012.4;Smooth muscle cells: 450.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 34405.9;HSkMC: 16044.5;hTERT-HME1: 9585.3;hTERT-RPE1: 10587.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	151.1	31.4	37.8	131.9	44.8	0.6	76.5	36.3	51.2	135.9	85.9	444.0	33.8	156.1	61.3	251.6	174.5	187.1	410.9	38.9	41.1	42.9	1725.9	785.7	37.3	37.7	39.8	110.0	26.0	19.3	26.2	2928.1	43.5	105.6	237.2	6.0	67.0	428.9	37.7	52.7	103.4	722.6	36.2	14.3	127.2	25.8	112.1	133.8	40.4	148.4	23.9	361.7	87.1	35.3	12.5	84.2	104.6	22.8	4456.5	34405.9	4.8	1799.2	1200.2	1765.3	1259.9	1059.2	43.7	1.2	9.7	6331.7	47.2	192.7	17.4	4220.9	946.9	1.0	7.4	0.8	24.7	3607.2	3192.2	1.2	6.6	16044.5	29.3	4136.5	9585.3	10587.1	2177.2	1.0	8.2	5.0	3673.9	17.0	2.9	1.5	52.7	2.4	15.2	1.0	2.4	8.0	47.4	13.7	6.0	25.0	213.7	116.4	1219.8	4649.5	19.4	3.2	4161.0	2553.1	269.9	2837.4	355.6	4.4	1.6	1.6	3161.2	1.0	694.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	44.8	36.3	51.2	38.9	41.1	37.7	39.8	43.5	36.2	112.1	35.3	138.9	67.3	67.8	13.4	2.3	55.1	4.1	227.0	2.2	6.4	4.2	5.2	36.3	30.0	34.0	16.5	0.0	216.6	2.3	3.4	0.0	6.5	1.8	6.5	265.8	215.4	21.0	16.8	9.5	9.8	2583.6	562.6	4.1	5.5	18.9	53.5	227.7	1012.4	365.2	1.7	8.1	10.2	12.2	38.0	73.7	4.6	186.4	85.9	110.3	101.2	1.2	1.9	0.0	11.6	10.7	12.5	1.4	88.4	1.7	17.8	0.0	0.6	23.1	8.7	72.3	401.5	450.2	1.6	7.8	5.0	37.4	205.8	11.3	8.5	23.7	1.7
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	21.8	11.9	51.2	57.8	73.7	40.6	16.4	77.4	53.4	32.5	22.2	107.3	15.0	50.0	17.0	39.4	34.8	27.8	15.1	47.0	62.5	16.4	18.4	25.4	78.1	67.6	69.1	22.1	8.1	10.7	17.7	16.3	65.8	41.4	29.6	12.6	16.3	44.1	24.1	25.9	37.6	46.8	55.9	60.9	29.6	17.3	69.9	111.0	33.4	13.2	74.3	68.4	26.8	86.6	42.5	19.3	34.9	40.8	21.0	25.8	29.5	23.7	20.2	17.6	14.7	20.3	16.2	82.9	20.4	44.5	20.8	20.7	33.0	21.6	17.6	137.7	9.8	22.8	22.8	13.8	35.8	62.3	75.1	18.7	9.3	32.6	19.5	25.6	26.1	143.2	5.4	1.1	16.4	34.0	140.1	60.8	27.5	5.7	32.6	31.9	28.3	24.1	22.1	23.0	5.5	17.6	43.3	42.9	16.5	33.3	30.0	28.3	31.9	16.6	20.7	30.5	15.0	16.4	64.4	3.8	20.0	42.2	25.2	13.2	5.1	9.6	10.8	5.6	9.3	12.7	9.7	10.3	5.8	7.7	8.9	8.6	9.3	6.0	6.5	6.9	10.9	4.5	51.2	73.7	77.4	53.4	47.0	62.5	67.6	69.1	65.8	55.9	69.9	86.6	27.2	35.3	25.2	317.7	180.4	33.1	21.3	12.8	21.6	20.2	42.5	24.6	14.8	15.7	29.8	22.0	52.1	18.6	217.2	28.3	19.6	22.6	1.7	46.2	38.8	38.3	18.1	31.3	65.6	17.3	24.5	38.8	26.5	78.7	80.4	9.2	71.0	18.4	43.6	28.6	107.8	8.7	20.3	221.2	402.9	5.5	46.6	131.1	76.5	95.5	433.2	42.8	223.5	69.4	522.1	21.8	19.8	51.6	147.9	67.8	0.2	15.0	42.3	29.5	59.2	19.9	41.0	26.5	45.4	26.7	41.1	63.9	233.7	7.1	16.2	42.3
FNDC9	"C5orf40, MGC27121"	ENSG00000172568	"Fibronectin type III domain containing 9"	Q8TBE3	5	157341598-157345677	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 36.8;pituitary gland: 11.7"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 5.8"	"Cancer enriched"	"Detected in single"	16	"glioma: 0.8"	"Region enhanced"	"Detected in all"		"hypothalamus: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (2.35e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.93e-1)"		"unprognostic (3.53e-3)"	"unprognostic (4.90e-3)"		"unprognostic (3.40e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.35e-6)"	"unprognostic (3.63e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.12e-3)"	0.0	4.8	5.1	0.3	5.2	0.6	0.0	6.5	9.4	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	36.8	0.1	0.1	0.1	0.1	7.3	7.5	0.0	0.0	0.0	11.7	0.0	5.5	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.1	0.1	0.0	18.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.2	6.5	9.4	4.5	36.8	7.3	7.5	5.5	1.8	18.9	1.5	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
FOLR2	FRβ	ENSG00000165457	"Folate receptor beta"	P14207	11	72216601-72221950	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 168.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1114.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 64.2;intermediate monocyte: 50.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 18.7;monocytes: 64.2"	"Cell line enriched"	"Detected in some"	5	"U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		15000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (2.03e-1)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (8.42e-4)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.98e-3)"	119.1	55.0	10.7	28.2	11.0	10.8	31.7	8.2	18.6	27.9	13.8	36.0	19.5	13.5	12.4	31.6	16.8	80.1	38.6	10.9	9.5	10.8	44.8	39.7	78.5	9.3	10.7	16.0	7.1	7.9	6.1	168.4	11.4	6.1	46.7	0.2	12.8	16.7	5.9	9.8	29.6	46.3	9.3	27.7	21.0	13.0	16.2	28.7	9.1	26.3	29.0	81.3	6.3	16.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.2	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.2	0.0	18.6	0.5	0.8	0.0	0.0	64.2	0.0	0.3	50.6	0.0	9.5	0.0	0.0	18.7	4.0	0.0	0.0	1.1	1.8	13.7	0.2	0.0	20.4	10.7	11.0	8.2	18.6	10.9	9.5	9.3	10.7	11.4	9.3	16.2	16.1	3.4	0.0	0.6	0.0	8.0	7.9	0.1	0.0	1.2	0.0	0.1	1.1	2.2	1.5	0.0	0.0	0.0	7.6	0.6	0.0	0.0	0.0	0.9	0.3	0.1	2.3	0.0	0.0	0.0	0.0	6.0	2.4	0.0	0.5	2.5	0.0	2.2	1.7	1114.8	0.0	0.0	0.0	0.0	229.3	98.8	2.5	1.5	199.4	0.0	15.9	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.1	0.0	0.2	0.0	0.3	0.0	2.5	1.2	0.6	0.7	1.3	5.1	16.0	1.2	0.1	0.0	0.1
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.4;urinary bladder: 84.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 338.0;Basal prostatic cells: 398.5;Basal squamous epithelial cells: 281.1;Prostatic glandular cells: 196.9;Squamous epithelial cells: 210.4;Suprabasal keratinocytes: 339.5;Urothelial cells: 456.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 51.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"myeloid DC: 3.4"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in many"		"PC-3: 829.4;U-2197: 520.1;WM-115: 1123.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	56.4	11.2	1.2	7.7	1.3	26.8	10.5	2.2	4.3	6.0	1.0	7.4	1.0	3.5	0.1	48.9	8.5	29.6	11.9	1.6	1.7	12.6	5.6	16.7	0.3	1.9	1.4	1.7	12.9	0.5	4.8	2.7	2.1	6.4	1.9	0.6	11.0	0.8	4.1	25.2	5.5	4.7	1.0	1.7	21.0	0.9	1.9	2.7	5.3	0.3	2.1	84.3	13.8	1.0	324.3	43.8	5.4	20.4	45.7	44.4	45.0	288.5	257.2	239.7	131.7	14.2	252.6	0.5	65.1	199.7	379.6	60.6	19.6	227.4	210.8	9.7	0.7	20.6	4.5	34.9	57.0	13.3	6.9	18.8	23.1	191.1	297.1	117.9	80.4	0.2	48.8	1.7	320.9	12.3	0.3	26.5	21.5	27.0	829.4	1.5	25.7	1.3	116.7	20.4	0.4	0.5	18.2	0.8	229.0	13.0	1.0	12.1	200.6	282.5	62.7	520.1	423.8	0.3	1.4	0.9	389.7	4.9	1123.6	0.0	0.8	0.0	0.1	0.5	0.0	0.0	0.2	0.1	3.4	0.0	0.2	0.0	0.5	0.0	0.3	0.4	0.0	0.5	1.2	1.3	2.2	4.3	1.6	1.7	1.9	1.4	2.1	1.0	1.9	1.0	15.2	6.4	4.4	0.3	2.0	338.0	398.5	56.2	281.1	0.0	27.6	12.2	1.0	4.3	26.2	0.0	0.0	1.3	4.3	11.8	0.0	25.1	0.3	24.4	12.2	30.1	11.3	0.8	0.1	3.5	4.3	45.8	74.9	56.3	9.5	0.3	6.1	0.4	1.9	0.0	0.1	6.8	10.2	1.0	46.6	0.0	0.3	15.5	44.4	1.0	1.1	0.1	0.0	0.5	0.2	39.0	11.1	0.0	6.2	196.9	1.2	0.2	10.7	0.0	0.0	32.4	26.1	0.4	0.7	210.4	339.5	17.6	6.8	0.1	4.2	456.4
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417317	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 287.6;Langerhans cells: 319.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 36.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 152.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	149.4	169.7	18.8	67.6	18.4	232.1	78.6	18.8	31.8	83.0	17.4	64.3	30.2	77.8	7.0	129.5	85.7	79.6	75.1	34.7	32.2	65.8	30.9	83.4	9.1	36.0	19.3	133.5	37.2	7.5	46.6	46.9	18.8	53.8	40.2	10.7	47.4	26.7	101.7	103.4	52.2	81.5	18.2	32.7	76.6	7.3	23.5	17.2	35.2	33.9	16.6	82.3	112.1	15.0	45.0	30.2	2.0	23.2	23.9	41.6	62.0	37.7	38.0	58.8	51.1	35.9	34.6	0.2	53.9	48.6	59.6	42.0	2.5	49.7	52.6	10.6	3.1	4.6	59.3	6.3	37.3	7.9	18.9	66.9	123.3	69.0	60.5	49.5	31.2	1.5	0.6	12.5	39.7	7.3	0.7	24.3	3.6	45.2	14.8	1.8	57.4	4.3	94.3	152.5	15.7	2.3	61.0	35.2	10.9	16.8	3.8	35.5	93.8	122.8	81.9	72.3	55.2	19.1	7.6	0.2	81.5	43.3	21.6	17.2	9.9	8.7	7.7	7.3	7.4	0.0	1.6	3.8	3.9	0.0	0.4	2.5	36.6	4.6	6.4	1.3	1.2	5.1	18.8	18.4	18.8	31.8	34.7	32.2	36.0	19.3	18.8	18.2	23.5	15.0	183.1	32.1	50.9	4.6	20.2	143.1	86.3	85.8	90.0	0.8	76.4	41.7	27.9	70.1	59.7	167.3	0.0	27.4	287.6	140.6	19.6	58.5	1.3	115.7	88.0	111.0	28.1	4.4	11.9	59.8	148.3	79.7	115.7	193.6	108.3	68.1	56.7	16.5	37.4	0.0	8.1	65.2	40.7	58.0	319.8	4.3	22.4	181.2	85.4	15.0	62.8	2.3	53.5	0.5	0.6	54.1	91.5	24.5	67.0	82.2	124.8	35.1	38.2	1.4	26.3	93.8	122.3	1.6	2.5	157.6	150.7	50.2	142.4	23.6	57.6	152.8
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 17.5;liver: 64.6;pancreas: 48.2;stomach 1: 36.8"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	1.4	0.0	17.5	10.6	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	2.8	64.6	0.3	0.1	0.0	0.0	0.0	48.2	1.1	0.0	0.0	0.0	0.5	17.1	0.0	2.1	0.4	0.0	0.0	12.8	0.7	0.0	0.0	36.8	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609915-1613897	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"salivary gland: 154.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 18.0"	HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	12.3	6.0	7.7	1.2	8.3	0.6	9.0	7.1	9.3	6.3	11.0	1.7	0.9	3.7	1.7	4.8	5.0	7.5	14.0	6.0	6.5	19.9	1.2	3.3	1.7	9.0	7.4	4.7	3.6	1.6	9.5	4.1	8.7	8.6	0.9	0.3	154.4	6.4	2.4	11.1	1.6	2.3	7.1	0.4	1.7	2.0	9.2	8.3	5.6	2.9	2.2	9.4	5.6	7.1	18.0	2.0	0.6	92.4	4.2	4.6	2.9	8.9	10.3	5.4	4.3	6.7	3.7	0.0	10.0	5.2	3.9	19.9	8.8	6.5	4.5	5.7	91.8	3.7	5.3	3.3	2.8	1.4	6.0	15.6	8.7	7.3	8.3	2.8	7.9	0.6	2.7	0.1	2.3	3.8	0.0	2.0	0.3	8.9	7.6	0.0	3.7	0.5	35.9	13.3	3.4	8.0	10.9	0.1	6.4	4.5	2.6	1.5	2.0	11.5	7.1	5.9	9.6	0.4	0.8	0.0	3.2	4.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.7	8.3	7.1	9.3	6.0	6.5	9.0	7.4	8.7	7.1	9.2	7.1	93.7	0.0	0.6	0.0	0.4	17.7	31.9	26.3	13.6	0.0	42.2	59.4	7.1	0.0	23.6	11.0	0.0	5.3	1.9	0.9	1.9	3.9	0.6	8.6	1.1	64.7	0.0	0.0	0.0	17.1	0.6	21.2	1.5	3.8	0.0	0.7	65.7	0.4	1.3	0.0	0.0	1.5	8.2	1.3	5.5	1.4	16.1	2.7	1.8	23.4	0.0	0.3	0.0	0.5	0.1	16.2	0.1	28.2	0.1	9.5	0.0	7.4	34.9	0.0	0.0	19.2	40.4	0.7	3.1	11.2	6.5	0.8	1.1	4.4	0.6	64.9
FOXD3	"Genesis, HFH2"	ENSG00000187140	"Forkhead box D3"	Q9UJU5	1	63322567-63325128	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2"	"Cell type enriched"	"Detected in some"	5	"Melanocytes: 5.4"	"Group enriched"	"Detected in some"	6	"melanoma: 9.9;testis cancer: 3.5"	"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 13.1;SK-MEL-30: 11.2;WM-115: 15.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.4"	"Group enriched"	"Detected in some"	13	"olfactory bulb: 8.6;spinal cord: 2.2"	CAB022455	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"			"CAB022455: "	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.33e-3)"		"unprognostic (4.63e-2)"	"unprognostic (7.79e-2)"		"unprognostic (8.22e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.28e-1)"		"unprognostic (3.00e-2)"	"unprognostic (8.56e-2)"		"unprognostic (5.83e-2)"	0.4	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.8	0.0	5.2	0.2	0.2	0.0	0.4	0.4	0.1	1.6	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.1	0.2	0.1	0.0	0.1	0.0	0.4	1.4	0.2	0.0	0.4	0.5	1.4	0.6	1.3	0.1	0.2	0.0	1.1	1.5	0.0	0.0	0.2	0.2	0.0	1.5	1.5	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.3	0.0	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.7	0.0	11.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.0	0.3	0.2	0.3	0.0	0.0	0.0	0.2	0.0
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 195.3;lymphoid tissue: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 119.6;Kupffer cells: 215.3;Macrophages: 178.5;monocytes: 89.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4199.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4199.5"	"Group enriched"	"Detected in some"	5	"LHCN-M2: 17.2;U-87 MG: 67.1"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	69.6	10.0	3.8	166.0	4.4	195.3	5.3	4.1	8.7	8.2	5.7	4.6	3.1	3.7	0.5	8.9	15.4	28.6	7.5	3.6	8.1	4.5	21.4	50.8	12.7	15.2	8.2	2.4	11.2	5.1	3.5	45.1	11.9	3.1	3.3	2.6	4.1	2.3	1.8	1.3	5.2	42.9	8.6	129.2	5.4	2.2	9.9	8.4	3.1	22.8	10.3	66.9	2.7	18.2	0.5	0.8	0.3	0.4	1.0	2.1	0.5	0.2	0.0	0.5	2.0	0.3	0.7	1.2	0.6	0.0	3.9	0.4	0.0	0.0	0.1	0.1	0.0	0.7	0.9	1.0	6.0	0.3	0.5	4.8	0.2	1.8	1.8	9.2	0.0	0.3	0.1	0.6	17.2	0.9	0.1	0.3	0.4	0.3	0.7	0.3	0.7	0.0	1.5	0.5	0.2	0.3	0.6	0.1	0.5	0.2	1.0	1.1	1.0	2.0	0.4	0.1	3.5	0.2	0.0	0.5	67.1	1.7	0.1	317.1	759.9	204.9	1.6	319.7	1.5	0.7	1.0	0.7	174.1	1.0	1.0	1.2	4199.5	0.4	201.8	8.1	1.3	420.3	3.8	4.4	4.1	8.7	3.6	8.1	15.2	8.2	11.9	8.6	9.9	18.2	0.1	16.0	25.7	0.0	1.8	0.6	0.3	0.0	0.0	1.0	0.1	0.3	0.2	0.0	15.5	0.0	0.0	1.1	0.3	0.0	0.0	0.0	1.8	0.0	0.1	6.3	0.0	2.5	0.2	0.0	1.6	4.7	0.5	0.1	26.5	0.0	2.5	2.1	119.6	0.0	0.1	0.0	0.0	215.3	4.7	2.0	0.3	178.5	0.0	3.7	89.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.4	8.8	0.3	6.6	0.6	0.8	0.6	0.8	0.2	0.0	3.0	2.5	0.0	0.0	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.2"	"Group enriched"	"Detected in some"	15	"Hofbauer cells: 56.5;Kupffer cells: 97.4;Langerhans cells: 223.6;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	44	"dendritic cells: 2.4;monocytes: 6.7"	"Group enriched"	"Detected in some"	5	"HEL: 10.0;hTERT-RPE1: 2.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	10.6	12.1	0.6	23.9	1.1	0.4	5.3	0.5	2.4	5.5	2.2	12.6	11.2	3.7	1.5	5.7	2.0	18.8	3.8	0.6	0.7	3.2	21.3	28.2	13.9	3.1	1.0	1.7	2.3	2.2	0.9	5.6	2.8	2.5	18.2	0.3	2.4	2.9	0.9	2.7	14.4	8.9	1.2	16.3	7.1	2.7	6.0	8.1	2.2	2.0	11.0	17.4	1.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.6	1.1	0.5	2.4	0.6	0.7	3.1	1.0	2.8	1.2	6.0	3.9	0.5	0.0	1.7	0.3	2.7	5.6	0.0	0.0	0.0	0.1	0.1	0.5	0.2	0.0	2.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.1	1.5	56.5	0.0	0.2	0.0	0.0	97.4	223.6	0.2	0.3	66.6	7.2	1.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.4	0.1	0.0	0.0	1.5	0.1	0.0	0.3	0.5	0.0	0.1	0.4	4.5	0.8	0.6	0.0	0.0	0.1
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;lymphoid tissue: 13.1;stomach 1: 5.7;testis: 5.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 68.9;Paneth cells: 167.2"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 1.9;RPMI-8226: 3.0"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA				"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			3.6	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.2	0.0	3.1	0.1	0.0	2.1	5.7	5.1	0.0	13.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.8	0.0	0.0	0.0	68.9	0.0	0.0	15.3	0.0	0.0	0.2	7.8	0.0	0.0	1.8	0.0	0.4	4.6	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	16.0	0.0	0.0	0.0	20.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	1.5	0.0	0.0	19.6	23.8	0.0	0.0	0.0	0.3	0.7	13.4	8.2	0.0	0.0	0.1	0.1	15.2	12.6	0.2
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
FRMD5	MGC14161	ENSG00000171877	"FERM domain containing 5"	Q7Z6J6	15	43870761-44195271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 38.7;heart muscle: 46.6;retina: 20.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 375.2;Inhibitory neurons: 646.2;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 2000.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 26.4;U-251 MG: 21.8;WM-115: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (9.54e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.26e-7)"	"unprognostic (3.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.00e-3)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.01e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.31e-1)"	0.2	8.3	14.8	0.5	24.2	0.8	0.4	18.0	20.5	0.3	4.5	1.4	0.2	0.1	0.4	0.3	1.0	0.4	46.6	15.1	18.9	0.3	0.0	0.1	0.3	22.1	21.2	0.3	0.2	0.8	2.0	0.0	20.6	0.5	0.8	20.0	1.1	0.3	0.0	0.3	0.5	0.2	15.6	0.3	1.3	3.4	19.5	0.0	0.3	0.0	0.0	0.4	0.4	38.7	6.6	3.5	2.3	1.3	2.6	0.2	0.4	1.4	2.1	3.9	7.4	11.2	6.6	0.5	1.3	0.9	10.6	7.3	3.3	7.0	3.3	0.4	3.7	1.0	3.1	4.4	0.3	0.1	0.4	0.0	0.7	10.6	20.8	7.6	26.4	5.7	0.2	0.7	4.1	0.6	1.0	0.1	1.9	21.3	3.8	0.1	4.7	0.0	3.6	2.3	14.3	4.8	0.8	0.1	15.0	1.8	0.2	0.2	1.0	7.1	13.4	1.8	21.8	0.5	2.0	0.8	10.4	0.4	61.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	14.8	24.2	18.0	20.5	15.1	18.9	22.1	21.2	20.6	15.6	19.5	38.7	0.0	0.0	0.0	134.8	0.0	0.4	0.0	0.8	0.6	11.4	0.1	0.3	14.8	0.0	0.1	0.0	2.1	0.0	0.0	0.3	0.0	2.8	14.7	0.3	0.1	0.2	1.2	0.0	375.2	6.0	0.0	1.1	7.1	0.1	0.0	3.9	0.0	0.0	0.1	0.0	646.2	0.8	0.0	0.0	0.3	5.2	0.3	0.0	0.0	14.0	0.0	17.5	0.0	298.6	2000.1	8.6	0.3	0.0	0.3	0.4	0.0	1.0	0.1	4.4	0.0	0.1	0.7	6.6	3.9	0.2	0.0	0.0	0.1	0.0	1.3	0.1
FRMPD1	"FRMD2, KIAA0967"	ENSG00000070601	"FERM and PDZ domain containing 1"	Q5SYB0	9	37650954-37746904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 68.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 47.8;Cone photoreceptor cells: 152.2;Inhibitory neurons: 24.3;Rod photoreceptor cells: 79.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.2;NK-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042934	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA042934: AB_10960422"	"unprognostic (6.41e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (4.04e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.12e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.91e-2)"	0.4	0.5	3.1	0.8	3.8	2.9	0.9	2.9	4.1	0.3	0.4	0.5	0.7	1.0	0.6	1.6	0.8	1.6	0.7	2.6	2.9	0.5	0.5	0.7	1.3	3.1	4.8	0.3	0.9	0.7	0.8	0.4	2.6	0.5	0.5	68.9	4.1	0.5	4.2	6.4	1.1	0.4	2.2	0.4	0.6	9.4	5.5	0.2	1.0	1.2	1.1	0.5	0.1	4.5	0.2	0.3	1.2	0.1	0.0	0.0	1.5	0.5	0.0	0.1	0.1	0.6	0.5	0.3	0.2	0.3	0.5	0.9	0.9	0.5	0.3	0.4	0.3	0.1	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.5	0.2	0.6	0.0	0.9	0.5	0.2	0.2	0.3	0.1	0.2	0.7	0.1	0.6	0.6	1.0	0.1	0.0	0.9	2.5	1.7	0.0	1.6	0.8	0.4	0.8	0.3	0.0	0.3	0.5	0.5	0.4	0.4	0.7	0.6	0.4	0.3	0.4	3.2	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	1.0	1.3	0.4	0.3	0.2	0.1	3.1	3.8	2.9	4.1	2.6	2.9	3.1	4.8	2.6	2.2	5.5	4.5	0.2	3.2	10.5	11.1	0.3	0.1	0.3	0.0	0.0	47.8	0.5	0.3	1.1	4.3	1.8	0.0	152.2	0.2	0.0	0.4	0.0	0.1	4.8	0.2	0.1	1.4	0.0	0.0	3.7	0.2	0.5	0.8	0.0	0.4	5.1	0.2	0.7	0.8	0.1	1.7	24.3	0.3	0.0	1.3	2.1	1.3	0.9	0.8	0.0	1.0	0.3	9.0	0.0	13.6	6.7	0.1	0.1	0.4	0.1	0.2	0.0	0.0	1.5	79.8	0.0	0.8	0.2	0.4	1.7	0.0	0.4	0.7	1.0	0.1	0.1	0.3
FSD1	"MGC3213, MIR1"	ENSG00000105255	"Fibronectin type III and SPRY domain containing 1"	Q9BTV5	19	4304598-4323843	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 16.0;testis: 7.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 12.6;Distal tubular cells: 15.6;Excitatory neurons: 26.6;Horizontal cells: 16.8;Inhibitory neurons: 19.7;NK-cells: 16.5;Spermatogonia: 30.4"	"Group enriched"	"Detected in many"	6	"glioma: 9.2;testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.6;NK-cell: 5.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	35	"dendritic cells: 1.4;NK-cells: 5.4;T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 55.3;SH-SY5Y: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043141	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA043141: AB_10797137"	"unprognostic (8.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.29e-2)"	"unprognostic (9.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.15e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	0.3	0.7	11.9	0.7	12.7	0.7	0.0	9.3	15.6	0.6	2.5	0.6	1.0	0.5	0.1	0.2	0.1	0.3	0.1	13.9	12.1	0.3	0.4	0.2	1.1	14.7	10.4	0.2	0.1	0.0	2.0	0.8	16.0	0.3	0.1	1.8	0.1	0.1	0.0	0.2	0.9	0.4	7.7	0.9	0.3	7.6	15.5	0.9	0.1	0.0	0.4	0.1	0.3	11.7	0.1	6.7	18.6	9.7	0.1	1.8	7.9	7.9	3.2	25.0	19.3	15.6	0.5	24.3	6.7	5.5	13.1	1.6	17.0	12.8	8.0	15.6	24.9	6.8	5.6	0.5	9.9	0.0	1.6	4.2	0.1	14.6	0.9	10.1	13.5	21.5	1.1	0.0	1.2	18.4	11.2	0.0	23.9	0.1	12.7	0.0	8.8	0.0	0.1	0.6	55.3	57.6	2.1	0.9	1.7	3.0	0.2	0.2	15.3	3.9	17.6	7.3	7.3	13.7	18.4	6.1	9.4	0.0	9.7	0.0	0.0	0.0	0.5	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.7	0.2	0.0	5.4	0.0	1.4	0.4	0.7	11.9	12.7	9.3	15.6	13.9	12.1	14.7	10.4	16.0	7.7	15.5	11.7	0.2	0.0	1.1	2.0	0.4	0.1	0.7	0.0	0.0	12.6	0.1	0.0	0.5	0.0	0.6	3.7	2.1	3.2	6.1	0.3	15.6	0.1	4.0	0.1	1.1	0.5	2.4	2.7	26.6	0.0	1.3	1.4	0.5	0.2	2.5	3.5	0.7	0.4	0.8	16.8	19.7	0.4	0.0	0.0	0.0	5.3	0.9	0.3	0.0	3.7	0.1	1.7	16.5	8.5	9.5	0.0	0.1	0.4	0.5	0.3	0.0	0.3	0.0	7.1	0.0	0.9	1.6	3.7	30.4	0.0	0.0	2.7	5.6	0.1	0.3	0.4
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164004	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 68.6;retina: 94.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 306.0;Cone photoreceptor cells: 462.9;Excitatory neurons: 184.7;Inhibitory neurons: 517.7;Rod photoreceptor cells: 139.6"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	5	"cerebellum: 68.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 75.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 57.3"						"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.0	6.0	7.4	0.0	6.9	0.0	0.0	68.6	3.7	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.1	15.2	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.3	0.0	1.2	0.1	14.4	0.0	0.1	94.8	0.0	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.6	9.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	0.0	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	75.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.1	10.8	0.0	0.0	0.7	0.1	0.0	0.3	0.1	0.0	0.0	16.2	0.0	6.2	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	6.9	68.6	3.7	3.1	15.2	12.7	9.9	14.4	6.2	9.6	5.1	0.0	0.0	0.0	47.7	0.0	0.3	0.0	0.0	0.0	306.0	0.0	0.0	0.1	0.0	0.0	0.0	462.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	184.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	28.6	517.7	0.0	0.0	0.3	0.3	4.5	0.6	0.0	1.8	7.5	0.0	20.7	0.0	8.0	75.3	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	139.6	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 158.7;intestine: 72.3;retina: 79.3;salivary gland: 84.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.7;Intestinal goblet cells: 78.7;Pancreatic endocrine cells: 49.0;Paneth cells: 88.9;Proximal enterocytes: 85.2;Undifferentiated cells: 65.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 46.3;hTCEpi: 6.9;OE19: 20.6;RH-30: 14.8;SK-BR-3: 7.1"									HPA046966	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046966: AB_2679879"	"prognostic unfavorable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.5	0.0	0.4	12.6	0.6	0.7	1.2	0.5	0.7	25.9	0.5	72.3	47.7	0.3	0.0	158.7	1.3	22.4	0.2	0.4	1.2	9.8	2.3	5.2	0.1	0.8	0.5	0.1	9.1	0.0	0.6	0.1	0.7	2.2	44.5	79.3	84.2	8.5	0.1	3.2	56.3	2.8	0.2	0.2	20.8	4.0	0.6	0.2	0.0	0.0	15.9	3.0	53.2	0.7	46.3	0.0	0.2	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.6	0.0	0.0	2.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	20.6	0.0	0.0	14.8	1.6	0.0	0.6	0.0	0.2	0.0	7.1	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.1	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.5	0.7	0.4	1.2	0.8	0.5	0.7	0.2	0.6	0.7	0.1	0.0	4.8	0.3	1.1	0.0	3.0	23.6	0.0	1.8	1.7	0.3	0.3	11.5	36.4	0.0	0.0	0.1	0.0	154.7	0.0	43.2	4.9	1.1	0.1	0.5	13.8	0.0	0.1	14.2	0.4	0.0	18.3	0.6	8.9	0.1	0.0	0.4	0.0	0.0	0.0	78.7	14.2	0.0	0.0	8.7	0.0	0.2	0.0	1.0	0.0	1.9	0.0	0.0	0.1	49.0	88.9	0.0	0.1	0.9	85.2	16.5	22.8	34.9	0.0	0.0	1.5	0.5	0.2	6.5	0.0	0.3	0.5	0.0	65.6	27.3
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830408-5839722	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.4;kidney: 36.1;salivary gland: 45.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 35.6;Intestinal goblet cells: 39.4;Paneth cells: 21.5;Proximal enterocytes: 101.4;Proximal tubular cells: 45.3;Undifferentiated cells: 29.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"Hep G2: 10.5;RPMI-8226: 4.0"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		51000	"Cluster 10: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favorable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.1	0.0	0.1	2.6	0.1	0.4	1.7	0.2	0.1	17.3	0.4	17.3	28.6	0.3	0.0	79.4	0.6	9.3	0.0	0.1	0.1	36.1	12.4	0.2	0.1	0.1	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	11.6	2.0	45.7	2.5	0.0	0.1	27.0	0.4	0.1	0.1	4.8	0.2	0.1	0.0	0.0	0.0	6.7	0.0	26.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.2	10.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.7	4.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.5	0.0	0.7	0.0	0.4	3.5	0.0	0.4	3.7	1.9	0.3	18.6	15.7	1.8	0.0	0.2	0.3	35.6	3.9	6.8	0.3	0.6	0.7	0.3	4.9	0.0	0.1	0.4	0.1	0.3	0.0	0.7	0.0	0.2	0.7	5.1	0.1	0.0	0.1	39.4	8.2	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.0	0.9	0.0	0.5	0.1	2.7	21.5	0.0	0.0	0.2	101.4	45.3	6.4	11.5	0.0	0.3	0.7	1.0	0.6	3.6	0.1	0.0	0.5	0.1	29.0	1.7
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169881	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	203.1	39.2	30.8	130.8	31.0	275.2	171.1	31.9	47.2	226.2	36.9	59.0	28.6	75.5	20.1	116.1	103.6	68.8	82.3	29.9	36.6	42.0	40.2	148.5	187.4	43.4	34.7	28.6	28.0	17.2	39.8	91.7	37.9	68.8	43.3	3.5	70.3	46.5	28.6	85.8	106.6	59.8	35.4	238.3	67.9	9.2	40.0	85.0	59.2	32.6	187.8	104.8	183.8	39.9	932.2	216.7	0.2	0.9	310.5	390.2	213.6	521.7	686.4	362.8	269.3	61.9	263.6	212.9	139.3	632.2	130.3	212.3	132.5	321.3	231.4	265.7	87.9	397.7	111.8	0.5	244.3	228.6	378.0	233.6	141.6	265.3	452.2	213.2	348.5	58.0	380.0	989.0	229.5	1.5	27.4	95.1	66.4	853.4	126.0	127.6	45.0	272.7	134.0	5.2	38.8	0.3	287.1	148.6	316.6	115.0	78.0	180.4	494.8	443.6	170.0	487.7	40.2	1.5	16.2	54.4	675.9	524.8	694.4	644.0	596.4	111.1	451.5	628.4	422.0	602.8	756.5	467.4	718.7	545.6	489.2	405.6	140.1	840.8	636.9	325.0	894.6	934.1	30.8	31.0	31.9	47.2	29.9	36.6	43.4	34.7	37.9	35.4	40.0	39.9	291.0	3.2	13.4	0.0	330.7	107.1	73.4	106.3	54.1	0.6	80.2	51.2	5.2	32.9	27.8	99.3	0.0	18.9	349.7	2.9	0.0	156.1	1.7	3.4	63.5	276.5	10.7	111.2	2.2	197.3	462.9	93.1	71.9	2.2	361.5	0.3	323.8	6.1	430.3	0.0	0.4	8.2	4.1	385.9	492.1	4.6	6.5	403.9	209.9	10.3	243.7	0.4	260.6	1.0	0.1	585.0	7.8	0.7	302.5	72.2	0.2	4.4	5.5	0.4	65.7	5.7	107.6	1.6	8.1	24.0	69.2	50.9	459.5	0.7	10.0	100.3
FYB2	"ARAP, C1orf168, FLJ43208, RP4-758N20.2"	ENSG00000187889	"FYN binding protein 2"	Q5VWT5	1	56718789-56819696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 14.5;fallopian tube: 13.7;liver: 17.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 22.4;Collecting duct cells: 31.3;Endometrial ciliated cells: 11.1;Glandular and luminal cells: 10.8;Respiratory ciliated cells: 48.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"T-47d: 5.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Low region specificity"	"Detected in some"									NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (6.12e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.89e-2)"	"unprognostic (9.19e-3)"	"unprognostic (4.77e-3)"		"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.04e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	3.6	14.5	0.2	0.3	0.9	0.3	0.2	13.7	0.0	1.5	1.0	0.1	3.5	17.1	2.0	0.0	0.0	0.0	0.1	1.0	6.3	0.8	0.0	0.0	1.5	0.4	0.0	2.1	1.7	1.5	0.0	0.6	0.0	0.0	0.0	0.4	1.3	0.1	2.5	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	22.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	6.3	0.0	0.0	6.8	31.3	0.0	0.5	0.0	0.0	3.9	0.5	0.0	11.1	0.7	0.0	0.0	0.0	0.0	1.5	0.0	7.3	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	48.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GABRA4		ENSG00000109158	"Gamma-aminobutyric acid type A receptor subunit alpha4"	P48169	4	46918900-46993581	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 7.5;heart muscle: 2.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 124.9;Inhibitory neurons: 160.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	149	"REH: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"						"unprognostic (2.78e-2)"		"unprognostic (6.57e-3)"	"unprognostic (2.46e-1)"			"unprognostic (2.23e-1)"		"unprognostic (3.17e-1)"			"unprognostic (1.11e-1)"	"unprognostic (6.91e-2)"			0.0	0.0	1.8	0.0	7.5	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.5	4.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	7.5	0.0	6.8	4.0	2.6	0.7	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	21.5	0.0	0.5	0.0	0.0	0.6	0.3	0.0	0.6	15.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.9	0.0	1.3	0.0	0.0	0.1	0.0	0.0	124.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	160.1	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	8.4	0.0	6.1	0.0	3.5	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.4	3.8	0.1	0.4	0.1	0.0	0.0	0.0	0.9	0.0
GABRB3		ENSG00000166206	"Gamma-aminobutyric acid type A receptor subunit beta3"	P28472	15	26543546-26939539	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;retina: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 152.4;Excitatory neurons: 519.6;Inhibitory neurons: 258.7;Oligodendrocyte precursor cells: 139.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 68.5;HAP1: 27.9;NTERA-2: 48.3;OE19: 21.6;SCLC-21H: 44.2;U-2 OS: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.05e-1)"	0.6	5.5	16.6	0.5	24.3	0.0	0.8	3.9	29.5	2.3	0.0	1.2	0.8	1.7	1.0	1.2	2.3	13.6	6.2	28.0	18.0	7.3	0.9	0.9	0.1	0.0	1.3	1.9	4.8	2.1	15.7	0.0	0.3	5.0	0.9	31.9	0.5	1.2	0.1	0.7	0.6	1.4	3.1	0.6	5.7	4.0	11.6	1.5	8.7	0.1	0.2	1.1	0.5	13.8	0.0	68.5	10.7	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	27.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	5.4	3.3	0.0	0.0	0.0	0.0	0.0	14.8	2.1	0.1	0.0	0.0	4.8	0.0	48.3	21.6	3.4	0.0	0.0	0.0	4.7	0.0	44.2	16.6	0.0	0.1	0.0	5.0	0.1	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	24.3	3.9	29.5	28.0	18.0	0.0	1.3	0.3	3.1	11.6	13.8	0.4	12.8	3.6	33.3	0.0	0.0	0.8	0.7	1.2	152.4	1.0	0.8	15.3	24.3	1.7	5.5	39.6	0.4	0.0	1.4	0.0	4.6	10.7	1.4	4.0	1.2	10.3	0.0	519.6	0.4	0.0	1.7	2.6	0.6	0.0	1.1	0.7	0.4	0.0	75.7	258.7	1.9	0.0	0.6	0.0	5.6	1.8	0.0	0.0	5.6	0.2	7.9	0.0	139.7	8.7	1.7	0.4	3.4	0.0	3.3	0.2	7.0	13.5	53.7	0.0	1.0	0.9	8.6	29.3	0.7	0.1	0.3	0.1	0.5	0.9	0.4
GABRG2		ENSG00000113327	"Gamma-aminobutyric acid type A receptor subunit gamma2"	P18507	5	162000057-162162977	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;retina: 10.9"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 119.0;Excitatory neurons: 239.9;Inhibitory neurons: 167.8"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.6;granulocytes: 4.5;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.3;Karpas-707: 10.2;RPMI-8226: 13.4;SuSa: 13.0;U-266/70: 20.1;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079060		Supported				NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079060: "					"unprognostic (2.88e-2)"			"unprognostic (1.56e-2)"			"unprognostic (6.31e-3)"			"unprognostic (3.07e-3)"	"unprognostic (1.52e-1)"			0.3	4.7	7.9	0.4	9.0	2.2	0.1	7.2	20.0	0.0	0.0	0.7	1.2	0.3	0.4	0.4	0.5	2.6	0.8	9.6	10.6	0.2	0.4	0.9	0.4	4.7	4.6	0.7	0.1	0.0	1.1	1.9	10.7	0.1	0.5	10.9	0.5	0.1	0.5	2.2	0.9	0.8	0.5	0.4	1.9	0.7	9.3	1.7	0.5	0.5	0.5	0.2	0.0	7.5	3.9	1.7	2.3	0.2	0.0	0.1	1.9	0.7	0.0	0.0	0.0	10.3	5.5	0.5	5.9	0.0	0.2	1.1	1.6	0.0	0.0	1.0	1.0	0.0	1.7	1.2	0.0	0.0	0.6	0.4	0.3	0.0	0.0	0.1	0.0	1.0	2.4	10.2	0.0	2.8	0.5	0.1	7.4	3.1	3.6	0.5	0.1	13.4	0.0	3.1	1.1	0.9	0.3	0.5	4.1	13.0	6.7	6.9	0.1	0.3	5.2	0.4	0.5	20.1	18.7	0.1	0.1	0.5	0.3	4.5	0.1	0.3	0.2	0.1	1.2	1.6	0.3	0.3	0.0	1.4	1.5	0.3	0.7	0.4	0.1	0.3	0.4	0.1	7.9	9.0	7.2	20.0	9.6	10.6	4.7	4.6	10.7	0.5	9.3	7.5	0.0	19.2	23.5	15.3	0.0	0.0	0.0	0.0	0.0	119.0	0.1	0.0	0.4	0.0	10.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	239.9	0.0	0.1	1.4	0.0	0.0	8.8	0.0	0.0	0.0	0.1	16.8	167.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	12.2	0.0	2.6	0.0	12.1	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	6.6	9.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GABRQ		ENSG00000268089	"Gamma-aminobutyric acid type A receptor subunit theta"	Q9UN88	X	152637895-152657542	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 72.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.0;Glandular and luminal cells: 2.8;Spermatogonia: 1.4;Squamous epithelial cells: 2.5;Suprabasal keratinocytes: 1.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.4;SiHa: 11.6;SuSa: 5.0;U-87 MG: 37.2"	"Region enriched"	"Detected in many"	5	"hypothalamus: 52.6"	"Group enriched"	"Detected in some"	4	"hypothalamus: 7.7;midbrain: 20.8;pons: 6.3"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.0	2.2	22.3	0.0	25.3	0.0	0.0	0.1	27.1	7.7	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	17.6	72.4	0.0	0.0	0.0	0.0	9.6	27.9	0.0	0.0	0.0	0.1	0.1	22.2	0.4	0.0	0.2	0.0	0.5	0.0	0.3	0.2	0.8	3.0	0.0	0.0	1.2	41.4	0.0	0.0	0.0	0.1	0.0	0.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	1.6	11.6	2.1	0.0	5.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	25.3	0.1	27.1	17.6	72.4	9.6	27.9	22.2	3.0	41.4	1.7	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.6	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.0	1.4	2.5	1.8	0.8	0.0	0.0	0.0	0.5
GADD45B	"DKFZP566B133, GADD45BETA, MYD118"	ENSG00000099860	"Growth arrest and DNA damage inducible beta"	O75293	19	2476122-2478259	"Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1997.9;Breast myoepithelial cells: 1851.8;Smooth muscle cells: 1753.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 16.3"	HPA029816	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA029816: AB_10601325"	"unprognostic (1.32e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.90e-2)"	"unprognostic (8.27e-3)"	"unprognostic (6.00e-2)"	343.5	75.9	45.3	41.4	52.8	321.4	217.4	51.4	63.8	104.8	55.0	205.1	17.2	83.4	3.3	53.9	190.0	91.4	372.7	45.1	57.8	245.6	408.9	343.2	33.1	56.3	55.5	159.2	92.6	49.2	174.1	45.1	54.9	90.8	9.9	57.1	72.6	28.5	84.1	144.8	67.9	27.3	55.0	75.9	187.3	17.1	59.7	65.9	209.2	30.8	12.7	103.9	100.0	49.5	62.1	12.2	1.4	8.1	44.1	33.6	3.8	61.7	17.7	47.6	24.4	17.1	23.3	29.1	40.7	30.7	17.1	33.8	3.2	20.5	11.5	22.5	11.0	3.2	13.9	6.6	74.3	6.7	19.7	54.8	13.1	14.3	70.2	51.3	19.0	3.1	1.6	76.9	49.5	19.9	7.7	33.0	7.3	6.2	25.7	28.5	22.0	46.6	21.7	11.0	0.6	0.6	68.7	50.6	20.9	26.2	26.9	49.5	78.8	47.2	43.2	34.0	77.9	34.3	27.9	12.5	11.5	20.0	15.7	32.1	33.5	131.2	58.1	40.8	52.3	21.0	40.7	45.2	32.9	30.2	35.5	47.9	92.5	43.3	33.5	36.9	54.6	35.3	45.3	52.8	51.4	63.8	45.1	57.8	56.3	55.5	54.9	55.0	59.7	49.5	1997.9	423.1	571.3	24.5	450.9	341.7	805.4	147.3	376.2	11.9	666.3	1851.8	952.6	173.0	226.3	51.5	6.2	93.0	988.3	213.7	191.7	374.3	1.6	614.2	539.7	800.0	85.3	8.6	3.0	209.8	54.0	1143.0	400.1	1122.9	786.6	53.9	138.8	126.1	430.9	13.5	1.5	164.4	282.8	174.8	1169.6	4.7	74.0	863.0	517.6	1.9	157.1	269.8	33.0	0.5	0.9	292.5	309.0	29.3	416.8	823.3	294.3	142.1	211.4	34.2	177.5	818.8	1753.4	1.4	7.8	399.0	308.9	144.2	514.7	128.4	98.8	301.3
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"brain: 645.9;pituitary gland: 885.8"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 22.2;Ductal cells: 38.9;Endometrial ciliated cells: 64.2;Endometrial stromal cells: 50.8;Exocrine glandular cells: 52.1;Extravillous trophoblasts: 48.7;Glandular and luminal cells: 26.4;Pancreatic endocrine cells: 39.5;Prostatic glandular cells: 82.5;Urothelial cells: 24.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.2"	"Region enriched"	"Detected in many"	13	"hypothalamus: 645.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 267.2;HEK 293: 119.3;K-562: 139.5;NB-4: 493.5;SH-SY5Y: 189.6"	"Region enhanced"	"Detected in many"		"hypothalamus: 82.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000	200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	3.2	0.9	2.8	14.9	2.1	0.7	4.4	1.1	5.2	1.0	0.8	17.6	1.8	0.2	0.0	0.8	1.0	0.2	1.0	2.2	645.9	1.5	0.3	0.5	0.1	48.5	5.1	0.2	2.1	0.1	885.8	0.3	13.8	4.4	4.0	0.0	0.9	0.2	0.4	33.3	4.1	9.9	0.6	0.3	9.7	1.0	19.5	0.7	0.4	0.0	0.0	0.7	2.9	2.6	0.0	11.0	1.1	0.3	0.0	0.0	24.0	36.7	0.0	0.7	0.0	267.2	9.9	0.0	12.7	1.3	0.4	0.1	0.0	0.2	0.0	0.0	119.3	6.4	74.6	0.0	1.3	3.7	0.0	1.7	4.0	0.0	0.1	0.0	6.3	0.0	139.5	0.0	0.2	77.2	0.0	493.5	60.3	2.9	23.7	0.0	0.1	51.1	0.6	0.0	49.8	189.6	25.8	1.5	0.0	26.8	1.5	57.6	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.1	1.1	5.2	2.2	645.9	48.5	5.1	13.8	0.6	19.5	2.6	0.6	0.0	0.0	0.0	0.2	2.0	22.2	0.1	0.0	0.0	3.2	5.8	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.0	38.9	0.1	64.2	50.8	3.4	1.8	4.2	2.1	52.1	48.7	6.6	2.0	26.4	4.5	0.4	0.0	0.0	2.0	0.0	0.2	1.1	4.1	0.0	1.2	0.2	0.0	0.7	1.8	0.0	0.6	0.0	0.0	0.0	0.3	39.5	0.1	0.0	1.0	82.5	0.0	0.4	0.0	0.0	0.0	1.6	6.7	2.2	10.9	1.1	3.4	1.9	0.8	0.0	1.3	24.3
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8;heart muscle: 45.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		370000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	14.4	11.6	25.7	2.0	24.4	0.1	12.0	14.7	28.4	7.6	6.5	6.5	2.2	7.3	2.8	3.6	5.6	3.4	45.0	27.0	35.5	7.7	2.0	3.4	3.2	19.6	22.5	2.1	4.3	2.5	4.7	0.4	19.9	4.0	2.2	1.3	23.5	4.6	4.4	7.5	3.7	8.6	16.4	12.1	3.2	3.5	40.8	2.2	4.9	5.8	1.3	3.1	5.0	21.3	0.0	0.8	8.5	0.3	11.7	5.3	0.0	1.3	0.1	1.5	2.3	0.4	0.0	0.0	0.2	1.4	0.8	0.0	3.0	0.0	0.3	0.1	6.0	0.0	0.2	0.5	0.1	0.0	0.5	0.5	0.0	17.0	0.0	17.2	0.9	0.0	0.0	0.0	2.8	0.5	0.0	0.0	1.7	0.0	0.1	0.0	4.8	0.0	0.5	0.0	8.7	3.0	1.8	0.4	0.0	0.3	0.3	0.0	0.1	1.7	19.9	2.2	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	24.4	14.7	28.4	27.0	35.5	19.6	22.5	19.9	16.4	40.8	21.3	4.0	0.0	0.0	16.6	0.0	4.1	0.4	0.0	0.0	2.8	3.1	3.0	46.7	0.0	0.0	0.0	2.1	0.1	0.2	0.0	3.9	0.1	9.7	0.2	0.4	1.7	0.0	0.0	27.6	0.0	0.0	24.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	23.8	0.1	0.0	0.0	6.1	11.2	0.9	0.3	3.6	5.6	0.0	0.1	0.0	8.0	1.6	0.0	0.0	3.8	0.0	0.5	0.1	0.1	0.0	0.8	6.6	10.1	14.8	0.6	2.1	0.3	3.3	0.0	0.3	11.2	0.6	0.4
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257705-157318491	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.5;lung: 10.2;stomach 1: 12.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 157.0;Distal enterocytes: 48.3;Intestinal goblet cells: 75.5;Pancreatic endocrine cells: 53.5;Prostatic glandular cells: 40.1;Urothelial cells: 115.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 4.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 45.3;BJ: 29.8;BJ hTERT+: 53.5;fHDF/TERT166: 64.5;HaCaT: 51.8;K-562: 30.7;LHCN-M2: 52.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"		NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Cytosol"	"Nucleoli, Vesicles"	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.1	0.0	0.0	0.7	0.0	0.6	1.1	4.0	0.3	1.1	5.2	10.6	2.2	0.1	0.1	4.5	0.0	2.7	0.4	0.4	0.0	0.0	0.0	10.2	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.7	13.5	0.1	8.2	0.1	0.0	0.3	4.1	0.4	0.0	0.1	12.8	0.1	0.1	0.1	0.1	0.1	1.7	4.5	4.6	0.2	45.3	4.8	0.0	0.0	2.0	17.0	0.0	29.8	53.5	0.5	1.1	1.9	24.4	0.0	0.1	64.5	0.0	51.8	0.9	10.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.9	0.0	0.0	0.0	30.7	0.0	52.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	25.4	0.3	0.6	0.1	0.0	0.1	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.3	0.4	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.1	157.0	36.1	0.0	0.1	0.8	13.3	20.2	6.2	0.0	0.5	2.8	0.5	2.8	32.9	0.0	0.0	0.0	0.2	48.3	0.0	1.2	6.9	1.2	0.0	0.6	2.4	5.2	0.8	3.2	0.0	2.1	35.7	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.1	75.5	6.1	0.0	0.7	0.5	0.0	0.3	3.6	0.0	1.6	0.0	0.0	0.0	0.1	53.5	26.4	0.0	1.4	40.1	3.1	0.2	10.0	0.0	0.0	0.5	1.2	2.6	0.5	4.5	0.1	0.0	0.3	0.0	22.7	115.1
GALR1	"GALNR, GALNR1"	ENSG00000166573	"Galanin receptor 1"	P47211	18	77249848-77277900	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.4;brain: 1.9;pituitary gland: 1.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.1;Enteroendocrine cells: 17.6;Oligodendrocyte precursor cells: 42.7;Respiratory ciliated cells: 11.7"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.2"	"Low region specificity"	"Detected in many"			HPA074584			Supported	"Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Plasma membrane"		"HPA074584: "	"unprognostic (1.65e-1)"				"unprognostic (1.56e-2)"	"unprognostic (2.85e-1)"			"unprognostic (3.00e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.34e-3)"	"unprognostic (7.33e-3)"	"unprognostic (9.49e-2)"	"unprognostic (2.18e-1)"		0.1	1.4	0.8	0.1	0.5	0.2	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.7	1.5	0.0	0.2	0.0	0.0	1.1	1.6	0.0	0.0	0.2	1.4	0.0	0.8	0.2	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	1.3	0.0	0.1	0.1	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.8	0.7	1.5	1.1	1.6	0.8	1.3	1.9	0.8	4.2	0.0	3.6	0.0	0.0	0.0	1.1	0.0	0.0	4.2	0.0	0.0	0.6	0.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.1	0.3	0.1	0.3	17.6	0.0	1.4	0.0	0.0	1.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.3	0.0	0.0	0.1	0.2	1.0	42.7	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.1	11.7	0.4	0.0	3.1	0.2	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.2
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		23000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	93.9	73.7	31.8	88.2	34.5	83.7	92.8	36.6	36.7	112.6	51.6	104.7	95.6	102.1	151.7	66.4	106.9	75.3	67.9	31.7	41.2	98.5	171.7	86.8	81.7	38.5	34.9	115.5	88.1	130.6	21.8	141.8	38.1	97.5	116.8	79.4	101.8	111.1	39.4	74.7	90.5	126.0	36.5	86.7	85.2	66.1	39.8	105.2	132.6	53.0	94.8	90.7	34.2	43.4	298.2	245.9	318.2	552.0	464.1	389.0	332.9	312.4	480.4	436.2	362.1	222.2	515.9	201.2	616.0	572.5	337.8	376.4	375.2	376.7	443.8	155.8	191.3	202.9	317.8	125.6	389.0	325.7	248.7	397.2	248.4	433.6	475.3	533.0	422.3	199.6	278.5	352.9	398.2	313.6	167.6	193.4	262.3	236.6	237.7	209.5	368.7	513.1	285.7	230.3	168.6	221.2	451.1	308.2	370.8	321.6	380.9	304.8	311.6	430.0	272.2	342.9	309.9	360.8	423.8	152.2	473.9	173.1	421.7	23.9	19.3	19.1	23.8	23.4	23.1	15.9	17.2	20.0	20.8	14.9	20.9	21.3	8.9	29.8	22.2	18.4	17.3	22.6	31.8	34.5	36.6	36.7	31.7	41.2	38.5	34.9	38.1	36.5	39.8	43.4	42.7	12.8	20.7	17.3	29.8	28.3	29.4	45.8	13.6	31.4	57.4	53.8	7.8	52.9	24.2	68.0	60.5	81.7	33.4	40.1	5.9	47.0	18.5	31.4	59.1	42.2	31.8	25.0	12.6	42.6	137.3	45.9	27.5	46.5	11.4	72.8	48.2	98.0	57.9	35.3	16.0	48.9	34.6	45.8	25.1	16.4	58.4	32.7	35.6	15.9	38.9	36.5	38.1	11.1	16.5	39.5	29.3	68.1	50.4	34.0	47.8	27.0	26.3	41.4	32.9	36.4	34.7	25.3	47.4	21.2	31.3	80.2	25.2	63.1	56.3	32.4
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GARRE1	KIAA0355	ENSG00000166398	"Granule associated Rac and RHOG effector 1"	O15063	19	34254552-34355566	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 126.8;Cardiomyocytes: 15.7;Cytotrophoblasts: 23.8;Extravillous trophoblasts: 25.1;Syncytiotrophoblasts: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	18.8	5.6	5.0	7.2	6.7	3.4	16.8	7.3	4.5	10.8	6.7	7.8	5.4	11.0	3.0	8.0	10.1	9.5	12.0	3.6	5.6	8.2	7.3	12.4	9.1	7.0	7.0	9.4	10.4	10.8	7.7	23.3	6.6	8.3	5.6	8.1	7.4	6.4	15.4	10.3	8.2	8.6	5.2	16.1	6.6	7.1	7.1	8.5	10.9	17.0	7.5	8.0	9.9	10.3	3.4	10.2	8.9	4.6	6.0	5.7	11.6	7.6	6.2	5.7	8.4	8.1	3.9	7.7	16.4	7.1	7.1	2.4	6.6	3.6	6.2	11.0	5.8	4.7	3.9	6.2	7.6	2.1	3.7	6.7	6.2	7.5	11.0	22.6	23.7	4.3	14.4	3.8	6.2	1.8	1.4	1.9	6.8	4.6	3.7	3.4	6.2	4.1	4.8	3.8	10.3	8.5	8.7	33.9	10.9	12.9	2.7	3.8	19.7	19.5	7.2	5.0	8.1	6.4	9.5	2.4	3.7	0.8	9.7	0.0	0.7	0.0	0.8	1.4	1.3	2.3	1.8	0.8	0.8	2.8	1.6	1.0	2.2	1.5	2.1	1.1	3.0	0.8	5.0	6.7	7.3	4.5	3.6	5.6	7.0	7.0	6.6	5.2	7.1	10.3	126.8	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	23.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	25.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	34.1	2.3	0.0	0.0	0.0
GAS7	"KIAA0394, MGC1348"	ENSG00000007237	"Growth arrest specific 7"	O60861	17	9910606-10198606	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 133.6;Fibroblasts: 79.6;Inhibitory neurons: 76.6;Late spermatids: 73.4;Oligodendrocytes: 163.3"	"Group enriched"	"Detected in all"	4	"glioma: 15.7;melanoma: 54.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 26.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 17.1;monocytes: 26.2"	"Cell line enriched"	"Detected in many"	9	"WM-115: 533.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004838, HPA064678"	Enhanced		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA004838: AB_2667263, HPA064678: AB_2685319"	"unprognostic (1.68e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.94e-3)"	"unprognostic (6.48e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (6.89e-4)"	27.3	8.5	34.9	23.7	68.9	31.1	15.3	75.4	79.8	29.9	0.0	26.3	7.3	13.3	4.3	23.8	17.8	16.3	46.1	61.9	8.4	1.7	2.3	17.1	9.1	23.4	24.1	7.8	3.4	1.1	2.6	16.2	15.8	8.5	12.0	30.1	7.8	10.8	5.8	33.7	11.9	24.0	14.3	16.1	8.9	17.4	32.9	9.3	4.6	6.8	10.3	18.3	19.5	85.3	0.1	0.5	0.6	1.0	16.5	22.5	0.3	0.8	0.0	2.6	1.1	0.1	0.2	6.6	1.9	6.6	0.3	0.3	0.0	0.0	1.6	0.0	1.5	0.0	1.3	0.7	5.3	1.8	48.7	4.3	0.3	5.1	0.1	0.0	0.0	42.7	0.0	0.6	0.0	0.0	54.3	15.4	2.6	2.1	0.0	14.3	0.1	49.6	0.0	0.2	0.1	3.0	0.2	0.2	60.1	21.0	2.8	24.7	0.0	0.2	3.4	0.1	0.1	0.4	0.0	0.0	0.4	35.1	533.8	0.6	26.2	17.1	2.8	6.9	0.9	0.5	0.3	1.4	5.3	0.6	0.2	1.4	16.4	4.5	4.9	1.0	0.0	7.7	34.9	68.9	75.4	79.8	61.9	8.4	23.4	24.1	15.8	14.3	32.9	85.3	2.9	0.0	4.2	6.8	3.3	8.3	4.5	1.5	1.2	34.6	1.6	2.3	13.3	0.0	1.1	5.5	27.1	1.0	14.5	0.0	0.0	1.0	62.3	17.7	12.8	5.7	0.0	0.4	133.6	0.0	1.8	79.6	0.0	26.3	17.2	7.9	5.0	0.9	39.2	0.0	76.6	0.0	0.0	66.7	32.2	73.4	10.2	54.3	33.8	52.5	57.2	9.5	18.6	11.1	163.3	0.2	0.0	1.9	5.5	2.0	0.0	0.1	16.3	31.7	0.0	67.0	7.1	1.6	6.7	1.0	16.6	1.9	7.4	0.2	0.0	4.9
GASK1B	"C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155"	ENSG00000164125	"Golgi associated kinase 1B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 206.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0"	"Group enriched"	"Detected in many"	41	"dendritic cells: 15.1;monocytes: 50.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA		13000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	73.9	206.2	29.0	39.8	29.2	2.8	47.3	21.8	23.3	47.0	11.9	23.4	13.3	77.7	21.8	17.2	19.4	37.1	77.9	28.7	29.6	9.5	8.6	14.1	11.2	51.7	33.0	140.3	14.2	11.5	2.8	29.0	26.9	23.6	23.3	0.8	23.6	30.0	12.4	7.3	18.5	70.2	34.1	20.8	11.8	10.4	35.5	5.7	17.7	16.7	6.8	43.2	9.2	33.0	12.5	9.9	6.1	1.1	77.0	143.3	11.4	3.1	2.4	0.6	3.7	13.3	4.9	0.1	0.3	5.0	5.1	0.2	70.7	18.9	1.8	0.1	0.2	1.0	0.0	37.0	51.4	0.6	0.3	166.4	4.6	24.2	2.6	8.0	193.3	0.0	13.0	0.0	35.7	0.8	0.0	0.2	0.4	43.4	0.2	0.1	0.5	0.2	0.0	27.5	0.4	0.1	0.0	27.8	8.2	33.4	5.4	0.3	9.3	16.0	17.1	9.6	6.1	0.0	0.1	44.8	2.5	0.3	74.3	0.1	50.6	0.0	0.1	28.8	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.7	0.1	14.0	0.6	0.0	17.8	29.0	29.2	21.8	23.3	28.7	29.6	51.7	33.0	26.9	34.1	35.5	33.0	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	1.2	14.5	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786562-48794311	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 59.9"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 165.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 471.7"	"Lineage enriched"	"Detected in single"	1877	"granulocytes: 471.7"	"Group enriched"	"Detected in some"	9	"HEL: 221.5;HMC-1: 211.9;K-562: 238.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.2	0.1	0.0	0.1	0.2	59.9	0.1	0.2	0.1	0.2	0.0	0.2	0.5	0.3	0.0	0.2	0.1	0.6	0.1	0.0	0.2	0.2	0.3	2.0	0.1	0.3	0.2	0.0	0.0	0.0	0.2	1.0	0.2	0.3	0.3	0.4	0.1	0.1	0.0	0.3	0.5	0.3	0.2	2.0	0.5	1.4	0.2	0.1	0.1	0.4	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	221.5	0.0	0.0	0.0	0.2	211.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	238.9	0.4	0.0	0.0	0.1	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	83.6	0.2	471.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.0	0.0	4.4	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.0	0.0	1.3	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	165.6	0.1	0.0	0.5	0.3	0.0	0.0	37.9	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.4	31.5	0.0	9.2	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	1.2	0.2	0.0	0.0
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2099.3;liver: 2804.2;pancreas: 2935.3"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.4	21.4	133.9	12.4	138.4	1.8	25.4	152.5	216.5	9.9	94.3	19.6	175.5	8.4	10.5	25.1	11.6	47.7	57.2	131.1	140.9	2099.3	2804.2	7.3	18.4	148.0	135.4	165.2	2935.3	2.7	8.3	74.7	153.4	12.4	11.5	7.5	57.5	15.1	142.5	137.6	110.2	14.5	149.2	33.6	99.2	78.2	140.4	12.6	63.0	46.9	29.7	18.0	15.5	181.2	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	133.9	138.4	152.5	216.5	131.1	140.9	148.0	135.4	153.4	149.2	140.4	181.2	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.2;NK-cells: 75.2;Plasma cells: 22.9;T-cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;NB-4: 10.0;U-266/70: 20.7;U-937: 31.5"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.7	3.3	0.4	73.9	0.5	34.9	4.6	0.4	1.7	3.1	1.5	6.9	5.8	2.3	1.4	2.6	3.1	11.5	2.0	0.4	0.5	2.0	11.1	19.1	54.4	2.9	0.7	2.7	1.1	0.7	1.0	2.8	1.2	2.3	8.0	0.2	4.8	1.2	0.7	1.0	9.0	6.1	0.5	42.7	9.2	4.0	0.8	12.4	2.3	0.9	23.3	12.7	1.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	1.2	1.2	0.0	0.1	0.1	6.5	5.3	2.6	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.9	0.6	3.0	0.3	0.0	0.0	10.0	1.4	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.6	1.3	0.1	0.0	0.0	4.0	0.1	0.5	0.5	0.0	2.2	20.7	0.5	0.1	0.2	31.5	0.0	0.9	15.3	1.1	97.5	38.0	150.4	4.8	63.1	89.3	6.7	6.0	23.2	35.8	97.9	53.4	44.9	0.7	243.8	38.4	0.4	0.5	0.4	1.7	0.4	0.5	2.9	0.7	1.2	0.5	0.8	0.7	2.1	6.4	5.1	0.0	12.4	0.0	0.2	0.5	0.6	0.0	0.4	0.4	0.7	1.5	4.2	0.0	4.2	0.1	39.2	0.1	0.0	0.0	0.4	3.7	0.4	2.8	0.0	0.8	0.0	1.1	0.0	1.5	2.0	3.9	10.8	0.2	4.6	0.6	4.0	0.0	0.7	0.0	0.0	18.9	1.4	0.2	0.0	17.1	0.0	2.8	10.4	2.9	75.2	0.0	0.0	1.3	0.0	0.0	22.9	0.4	0.0	0.3	8.0	0.4	0.0	0.9	0.9	0.1	2.9	0.9	0.0	0.1	72.9	11.0	0.1	0.1
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142882-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 1943.6"	"Cell type enriched"	"Detected in some"	23	"Enteroendocrine cells: 5457.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Region enriched"	"Detected in single"	55	"medulla oblongata: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.5"	"Region enriched"	"Detected in some"	5	"spinal cord: 13.7"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000	420000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				20.3	0.1	0.0	3.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	84.4	3.4	0.6	0.0	5.3	0.0	4.1	2.5	0.0	0.0	41.9	0.0	0.2	3.5	6.2	0.0	0.1	1943.6	0.0	0.0	0.1	0.1	0.8	151.9	0.0	0.3	0.0	0.0	37.2	130.2	0.8	0.0	0.2	41.2	0.0	0.0	0.4	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	186.8	0.2	12.1	0.0	5.6	44.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.2	0.0	0.0	0.3	0.1	5457.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	230.9	8.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.9	0.0
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.2	0.7	0.2	11.9	0.2	0.5	0.4	0.6	0.4	19.2	0.2	142.9	97.5	2.0	0.0	15.8	4.2	75.5	0.1	0.2	0.1	17.9	0.4	0.7	0.9	0.1	0.4	0.1	2.1	0.9	0.1	0.1	0.2	1.2	123.2	0.1	55.8	0.3	0.2	0.3	123.3	4.6	0.0	0.1	25.8	4.3	0.2	1.3	2.1	0.0	10.6	9.1	29.9	0.4	0.1	147.4	0.0	0.2	0.0	1.0	0.2	0.1	7.7	0.0	0.0	6.3	6.0	0.6	24.6	0.0	9.5	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.5	30.3	0.0	0.2	0.2	0.3	3.5	0.7	0.0	0.1	0.0	0.2	0.0	0.4	1.4	0.6	0.1	0.2	0.2	75.9	0.3	0.4	0.0	0.6	10.2	1.2	0.2	0.2	0.0	0.2	0.4	0.1	0.1	0.0	0.1	0.2	0.4	7.3	0.1	0.2	0.5	0.8	8.9	0.3	0.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.1	0.0	0.2	0.2	0.6	0.4	0.2	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.0	0.0	2.2	0.0	1.0	0.0	18.3	8.9	0.0	0.0	0.5	0.0	0.7	11.5	40.5	104.8	0.0	0.0	0.1	360.1	0.0	92.6	9.8	23.3	8.6	0.3	7.8	0.0	0.0	14.9	0.0	0.2	27.5	75.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	26.9	8.2	0.6	0.0	19.2	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	58.4	163.2	0.0	0.1	8.0	85.5	4.4	9.8	0.0	6.6	0.6	1.5	3.0	0.3	1.4	0.0	0.0	0.8	0.0	48.5	52.4
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.4;prostate: 5.5"	"Cell type enriched"	"Detected in some"	24	"granulocytes: 223.3"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.4"	"Immune cell enriched"	"Detected in single"	661	"basophil: 227.7"	"Lineage enriched"	"Detected in single"	661	"granulocytes: 227.7"	"Group enriched"	"Detected in some"	71	"HEL: 151.8;HMC-1: 564.8"					"Low region specificity"	"Detected in all"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA027507: AB_10600756, HPA027510: AB_2672309"	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	0.5	0.2	0.4	0.8	0.4	1.8	1.0	6.4	0.7	0.7	0.4	1.2	1.5	0.8	0.5	1.1	0.3	1.4	0.2	0.3	0.4	0.1	0.2	2.1	0.3	0.4	0.3	0.1	0.4	0.1	0.0	0.3	1.2	5.5	1.5	1.2	0.3	0.4	0.2	0.7	1.4	0.6	0.1	0.4	0.9	3.4	0.4	0.7	0.3	0.7	0.2	0.7	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.8	0.8	0.2	0.1	0.0	0.1	151.8	0.2	0.0	0.0	0.3	564.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.3	0.3	5.0	0.2	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.4	0.0	0.0	0.3	0.2	0.0	2.3	0.1	0.4	227.7	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.4	0.4	6.4	0.7	0.3	0.4	0.4	0.3	1.2	0.1	0.4	1.2	0.0	0.0	4.4	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.9	0.0	9.1	0.0	0.1	0.6	0.0	5.0	0.4	0.0	0.0	0.3	0.0	0.0	223.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.7	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.3	1.7	0.0	0.6	0.0	1.4	0.1	0.0	0.2
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDAP1	"CMT2K, CMT4, CMT4A"	ENSG00000104381	"Ganglioside induced differentiation associated protein 1"	Q8TB36	8	74320613-74518007	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.9;Cone photoreceptor cells: 47.9;Excitatory neurons: 75.7;Horizontal cells: 47.1;Inhibitory neurons: 67.3;Oligodendrocyte precursor cells: 67.8;Rod photoreceptor cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014266, HPA024334"	Enhanced		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Cytosol	"HPA014266: AB_1849581, HPA024334: AB_1849583"	"unprognostic (3.19e-2)"	"unprognostic (1.52e-3)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (2.68e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.17e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.73e-1)"	2.7	9.6	19.0	3.3	22.5	1.2	4.0	15.2	26.0	2.9	4.9	2.5	2.4	3.9	1.9	4.0	2.8	2.5	2.1	25.3	19.7	4.2	1.5	2.4	3.3	14.5	17.0	6.0	7.4	12.4	20.6	1.2	18.1	4.1	2.4	19.0	2.4	4.1	2.7	1.7	2.3	2.8	12.2	1.9	2.0	4.7	16.7	4.5	6.6	3.1	2.8	3.9	2.6	20.5	3.5	16.8	17.7	4.8	1.2	1.6	1.5	1.8	8.2	8.3	9.5	7.8	5.0	14.8	2.5	1.2	10.6	6.6	12.4	7.0	16.2	19.7	3.6	7.4	8.9	14.0	0.7	7.6	15.8	4.7	2.3	5.3	8.2	0.9	1.1	7.3	3.4	0.3	4.8	5.7	12.6	0.4	20.1	24.5	17.9	8.7	9.2	3.2	2.9	15.3	18.2	38.9	13.1	3.4	9.7	4.9	14.9	2.6	0.0	11.7	6.2	2.9	5.5	9.3	15.7	6.8	7.3	0.3	13.8	0.5	0.9	1.0	0.8	3.1	1.0	1.4	0.8	1.3	0.8	1.3	0.6	0.6	1.8	0.7	5.5	0.2	4.0	0.8	19.0	22.5	15.2	26.0	25.3	19.7	14.5	17.0	18.1	12.2	16.7	20.5	6.4	6.4	5.1	27.1	5.9	1.8	7.4	4.2	6.2	46.9	6.2	6.1	5.9	5.7	3.6	3.7	47.9	0.4	3.9	2.1	9.8	5.2	5.4	15.4	7.0	6.7	20.4	2.1	75.7	5.8	0.3	4.8	3.1	2.8	17.2	2.1	6.4	1.8	4.7	47.1	67.3	1.7	12.2	6.3	2.5	1.3	4.1	4.6	1.8	15.0	2.9	23.5	4.1	67.8	41.9	3.7	1.4	5.7	2.6	2.6	3.6	6.6	4.9	47.7	0.0	8.0	5.5	14.7	13.1	3.7	1.3	0.0	3.1	6.5	1.7	3.8
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280947	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 30.7;pituitary gland: 17.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.4;Early spermatids: 9.8;Excitatory neurons: 20.9;Horizontal cells: 15.2;Inhibitory neurons: 23.4;Late spermatids: 30.4;Oligodendrocyte precursor cells: 10.1"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 12.5;SCLC-21H: 32.3;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA054182: , HPA063265: AB_2684972"	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	0.1	2.2	21.6	0.2	27.0	0.1	0.1	14.2	30.7	1.1	0.1	0.6	0.0	0.6	0.0	0.0	0.2	0.0	1.6	26.6	15.4	0.1	0.1	0.0	0.0	17.0	10.5	2.7	0.5	0.9	17.7	0.0	15.8	0.2	0.0	5.7	0.0	0.0	0.0	0.3	0.3	0.1	6.2	0.0	0.7	3.5	14.0	0.0	0.2	0.0	0.0	0.1	0.3	21.2	0.0	0.0	3.8	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	14.8	0.0	0.1	1.5	0.2	0.0	3.9	0.1	1.1	0.7	0.3	0.0	0.0	0.2	0.8	1.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	27.0	14.2	30.7	26.6	15.4	17.0	10.5	15.8	6.2	14.0	21.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.1	0.2	0.0	0.0	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	23.4	0.4	0.0	0.0	0.0	30.4	0.6	0.0	0.0	6.5	0.0	1.1	0.0	10.1	3.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;lymphoid tissue: 59.2;skin 1: 47.8"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 56.7;Distal enterocytes: 30.4;Muller glia cells: 29.9;Proximal enterocytes: 92.2"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.0	0.0	10.4	0.5	9.8	0.1	0.9	7.6	10.3	0.0	8.9	4.8	11.1	0.0	4.9	0.2	0.2	0.2	0.7	8.5	11.0	0.5	0.0	0.0	0.0	9.4	14.4	0.1	0.0	0.0	3.2	0.1	10.4	0.0	3.9	3.6	1.0	0.3	0.5	47.8	20.8	0.1	9.0	59.2	1.8	0.0	12.4	0.0	0.0	0.0	0.0	0.7	0.1	10.8	0.0	0.0	9.2	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	9.8	7.6	10.3	8.5	11.0	9.4	14.4	10.4	9.0	12.4	10.8	0.0	0.0	0.0	12.7	0.0	56.7	0.0	0.6	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.0	7.0	0.0	30.4	0.0	0.0	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.0	3.5	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	92.2	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	12.1	3.3	0.2	0.0	3.1	0.2
GFI1	"GFI-1, GFI1A, ZNF163"	ENSG00000162676	"Growth factor independent 1 transcriptional repressor"	Q99684	1	92473043-92486925	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 53.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.2;Intestinal goblet cells: 12.4;NK-cells: 11.3;Plasma cells: 8.6;T-cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HL-60: 61.9;HMC-1: 47.5;NB-4: 64.7;THP-1: 127.7;U-937: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011197	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB011197: AB_532302"	"unprognostic (5.67e-4)"	"unprognostic (8.67e-3)"	"prognostic favorable (5.68e-5)"	"unprognostic (4.88e-3)"	"unprognostic (3.57e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.26e-3)"	"unprognostic (4.47e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.80e-6)"	"unprognostic (2.63e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.37e-2)"	1.0	0.5	0.1	5.1	0.2	53.7	0.9	0.1	0.1	0.6	0.3	3.6	4.7	0.6	0.5	0.5	0.7	1.9	0.3	0.1	0.1	0.5	1.0	2.8	6.9	0.3	0.1	0.5	9.4	0.2	0.5	0.2	0.2	0.8	4.5	0.0	1.0	0.3	0.2	0.3	5.7	0.4	0.2	7.0	3.2	0.9	0.2	31.2	0.9	0.0	4.4	1.7	0.6	0.2	1.4	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.1	0.1	1.0	10.3	0.1	0.7	0.0	0.5	0.4	1.2	0.0	0.2	0.0	2.5	1.6	0.2	5.3	0.1	61.9	47.5	0.0	0.0	0.1	0.1	0.3	0.1	17.1	0.4	15.3	0.1	2.1	39.5	64.7	0.0	0.1	0.2	7.8	2.7	3.4	0.0	0.7	0.1	0.1	0.3	0.1	0.3	0.1	0.0	127.7	0.0	0.0	1.5	0.1	0.2	22.2	1.6	4.0	0.0	261.3	0.0	0.0	0.0	0.4	2.1	0.0	1.0	0.0	0.9	1.4	0.0	0.0	0.3	1.9	0.0	0.1	0.0	0.8	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.9	0.0	0.1	1.1	0.2	0.0	0.1	1.4	0.0	0.1	0.0	0.1	12.4	0.0	0.8	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	11.3	0.0	0.1	0.4	0.0	0.0	8.6	0.0	0.7	0.1	0.1	0.0	0.0	0.1	0.2	0.5	3.9	0.0	0.0	0.0	16.4	0.1	0.4	0.0
GFRA3	GFRa-3	ENSG00000146013	"GDNF family receptor alpha 3"	O60609	5	138252380-138274621	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Enteroendocrine cells: 53.1;granulocytes: 26.7;Late spermatids: 20.9;Spermatogonia: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 11.9"	"Region enriched"	"Detected in single"	8	"cerebellum: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SH-SY5Y: 32.0"	"Not detected"	"Not detected"							HPA020731	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		150000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Plasma membrane"	Cytosol	"HPA020731: AB_1849635"	"unprognostic (1.22e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.90e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.23e-2)"	1.8	1.6	0.0	2.1	0.2	0.0	1.6	2.5	0.3	7.4	0.0	13.0	2.7	0.5	2.5	2.3	1.2	1.9	5.7	0.1	0.2	0.5	0.5	2.0	0.1	0.1	0.1	1.3	3.7	0.0	2.0	0.0	0.2	4.1	3.8	0.0	3.2	5.9	0.2	3.1	3.3	2.0	0.1	0.0	6.3	4.2	0.1	0.5	0.8	0.4	0.1	5.1	7.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.1	0.0	0.0	2.0	1.2	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	32.0	0.5	0.0	0.3	0.2	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	1.8	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	8.7	0.0	0.0	0.0	53.1	0.0	0.2	0.2	0.2	0.5	0.0	0.0	26.7	0.3	0.0	0.0	0.1	0.0	0.1	0.2	6.1	0.0	0.2	20.9	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.8	8.4	0.1	0.0	0.3	0.0	0.1	0.0	0.1
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.8;intestine: 53.4;salivary gland: 55.8;skin 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 208.5;Intestinal goblet cells: 69.4;Paneth cells: 135.8;Proximal enterocytes: 130.9;Undifferentiated cells: 86.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"RT4: 58.5;SK-BR-3: 19.4;T-47d: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		72000	"Cluster 6: Non-specific - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.6	0.4	5.0	0.5	0.2	9.0	0.7	0.7	7.9	0.4	53.4	44.5	0.4	41.1	53.8	8.5	5.3	0.0	0.5	0.3	39.2	0.4	3.5	0.0	0.5	0.4	0.5	46.8	0.0	0.5	0.0	0.5	6.5	34.0	0.1	55.8	6.4	0.4	56.2	38.4	0.8	0.2	0.1	23.7	0.7	0.4	0.7	0.2	0.0	9.0	18.4	18.8	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	6.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	58.5	0.2	0.2	0.0	19.4	0.0	0.0	60.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.7	0.7	0.5	0.3	0.5	0.4	0.5	0.2	0.4	0.9	0.1	35.3	6.9	0.0	1.1	4.1	14.7	12.5	5.2	0.0	17.9	11.0	0.2	20.0	38.0	23.9	2.1	0.0	0.3	208.5	21.5	23.8	0.1	7.4	0.3	0.5	6.0	0.0	0.0	38.2	0.0	0.9	24.5	2.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	69.4	12.2	0.0	1.8	0.2	0.6	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.0	10.6	135.8	0.0	0.0	5.5	130.9	39.5	45.9	0.3	0.0	0.4	2.3	0.0	0.1	30.6	20.9	0.0	1.0	0.0	86.1	26.7
GIMAP1	"HIMAP1, IAN2, IMAP1, IMAP38"	ENSG00000213203	"GTPase, IMAP family member 1"	Q8WWP7	7	150716606-150724284	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 189.8;Endothelial cells: 109.9;Hepatic stellate cells: 117.8;Kupffer cells: 109.1;monocytes: 74.9;NK-cells: 185.3;T-cells: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 14.7;MOLT-4: 9.2;TIME: 3.9"	"Low region specificity"	"Detected in many"							"HPA044887, HPA053441"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA044887: AB_10960351, HPA053441: AB_2682152"	"unprognostic (1.60e-2)"	"unprognostic (6.58e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.09e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-1)"	9.8	2.5	3.0	11.0	3.0	1.0	7.9	2.9	3.5	3.8	3.0	3.7	3.5	4.6	1.1	2.1	4.4	3.2	9.3	2.8	2.9	3.5	2.4	8.9	19.6	3.5	3.2	1.5	1.4	1.5	1.1	7.1	3.4	2.3	2.2	0.1	2.5	2.0	5.4	2.5	6.9	3.8	3.5	24.7	3.3	0.8	3.6	6.6	5.3	7.1	8.4	3.5	3.0	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.7	1.9	0.0	0.0	0.0	0.0	9.2	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	32.2	0.1	43.8	29.6	51.1	0.3	47.5	54.2	13.5	0.6	68.2	56.2	2.7	42.6	30.6	0.8	34.0	35.0	3.0	3.0	2.9	3.5	2.8	2.9	3.5	3.2	3.4	3.5	3.6	3.2	189.8	3.2	1.5	0.0	5.1	5.5	0.6	0.0	1.2	0.6	1.9	3.6	5.9	2.8	0.6	0.0	0.0	0.3	51.5	0.1	0.0	0.3	0.3	0.4	0.6	109.9	0.0	10.5	0.0	0.4	0.3	3.7	1.5	0.2	8.2	0.2	117.8	2.0	37.9	0.0	0.0	0.0	0.0	109.1	7.6	1.3	1.5	48.0	8.8	0.0	74.9	0.3	185.3	0.0	0.0	0.1	0.1	0.0	7.6	0.7	0.2	0.5	0.0	1.0	0.0	2.5	3.5	0.3	0.5	0.7	3.1	0.4	97.3	1.0	0.0	0.7
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567369-150573953	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 127.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 195.2;Hepatic stellate cells: 222.0;Kupffer cells: 197.2;Macrophages: 110.0;monocytes: 176.0;NK-cells: 344.0;T-cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 326.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019135, HPA019137, HPA027198"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Vesicles, Cytosol"		"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	46.1	18.3	15.0	75.1	15.6	4.2	31.8	16.2	21.2	19.7	16.3	21.2	16.5	23.0	9.6	12.0	18.7	24.6	31.3	14.3	16.0	17.3	29.9	50.8	127.7	19.2	18.0	7.7	6.7	9.6	6.0	48.7	18.0	10.2	22.4	1.5	11.2	13.3	17.5	8.4	25.0	38.3	18.8	115.6	18.0	4.2	16.4	30.5	21.1	48.1	85.1	31.1	11.6	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	326.4	3.4	0.1	0.3	0.0	0.0	0.4	0.2	0.4	0.0	0.0	12.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	370.2	5.2	325.8	390.9	404.2	3.0	408.0	402.8	122.1	1.3	424.3	361.9	339.7	263.4	320.4	5.3	312.1	776.9	15.0	15.6	16.2	21.2	14.3	16.0	19.2	18.0	18.0	18.8	16.4	18.7	182.3	3.2	12.4	0.3	7.3	6.8	0.2	0.0	3.4	0.1	2.2	4.7	9.9	5.7	1.8	11.0	0.0	0.6	82.6	0.0	0.0	0.2	0.6	0.3	0.4	195.2	0.0	9.7	0.5	0.2	0.8	9.0	2.0	0.3	6.3	0.0	222.0	3.7	96.4	0.0	0.1	0.0	0.0	197.2	20.9	1.7	5.0	110.0	10.6	18.7	176.0	0.2	344.0	0.0	0.1	0.1	0.0	0.0	14.7	0.4	0.0	1.9	0.7	0.4	13.1	3.9	7.9	0.0	0.8	1.1	6.1	0.8	186.2	0.8	0.0	0.3
GIMAP5	"HIMAP3, IAN4L1, IAN5"	ENSG00000196329	"GTPase, IMAP family member 5"	Q96F15	7	150722253-150750033	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.1;Basal keratinocytes: 11.1;Endothelial cells: 29.7;Langerhans cells: 13.9;Suprabasal keratinocytes: 10.7;T-cells: 31.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 41.7"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (6.77e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.21e-3)"	"unprognostic (6.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-3)"	"unprognostic (4.13e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.47e-2)"	34.4	13.6	13.3	44.8	14.2	5.2	25.5	13.7	16.8	15.9	12.7	16.6	10.6	17.1	8.8	12.4	18.9	17.9	24.2	12.8	13.2	12.7	23.3	39.7	106.2	15.2	14.1	5.9	8.7	9.1	4.1	26.4	14.8	6.6	16.5	0.8	7.2	9.0	12.4	7.2	22.1	30.5	14.2	64.2	15.6	3.5	14.7	25.1	18.3	43.9	66.4	26.7	6.7	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.3	0.0	1.4	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.4	0.0	3.6	70.5	1.1	260.4	106.3	337.2	1.1	436.3	334.0	8.0	0.6	521.5	280.6	8.3	188.3	43.6	1.6	176.9	510.2	13.3	14.2	13.7	16.8	12.8	13.2	15.2	14.1	14.8	14.2	14.7	13.8	22.1	0.0	1.7	0.0	1.4	11.1	0.3	0.0	1.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	5.8	0.2	0.0	0.0	0.1	0.0	0.1	29.7	0.0	0.4	0.0	0.0	0.4	2.6	0.5	0.1	2.5	0.0	8.9	0.6	3.1	0.0	0.0	0.2	0.0	5.3	13.9	0.1	0.0	7.1	3.6	0.0	2.2	0.0	9.2	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.1	0.1	0.0	0.1	0.0	0.7	3.2	0.2	0.1	0.1	10.7	0.3	31.5	0.1	0.1	0.1
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514872-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 170.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 265.8;Endothelial cells: 263.3;Hepatic stellate cells: 267.4;Kupffer cells: 156.8;monocytes: 140.8;NK-cells: 632.4;T-cells: 255.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"monocytes: 666.6;NK-cells: 1121.0;T-cells: 2269.3"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 92.9;MOLT-4: 78.6"	"Not detected"	"Not detected"							"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	49.8	15.0	16.3	73.6	17.4	6.6	37.4	17.1	21.3	19.2	16.0	20.3	21.1	27.8	19.8	12.6	21.5	22.1	40.1	15.5	17.2	20.9	20.4	61.0	170.1	19.0	17.8	7.4	7.6	10.5	5.6	31.5	19.1	10.9	23.3	1.2	13.7	12.0	27.8	9.3	40.1	33.6	17.6	124.3	22.0	4.5	18.0	52.5	28.2	56.1	99.2	29.6	13.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	92.9	9.4	0.0	0.0	0.0	0.0	78.6	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.7	656.5	9.6	1184.0	595.9	1164.2	6.5	1762.9	1440.6	286.3	6.5	2269.3	1597.2	52.5	1121.0	666.6	16.3	1076.9	2581.7	16.3	17.4	17.1	21.3	15.5	17.2	19.0	17.8	19.1	17.6	18.0	17.6	265.8	0.0	13.2	0.3	13.1	2.4	0.4	0.0	2.8	0.0	2.8	5.6	14.6	5.7	0.6	1.8	0.0	0.2	125.1	0.2	0.0	0.5	1.3	0.9	0.6	263.3	0.0	17.0	0.0	0.7	0.0	8.0	3.1	0.7	13.9	0.0	267.4	5.3	15.5	0.0	0.0	0.1	0.0	156.8	10.6	2.0	2.5	54.9	1.8	22.5	140.8	0.4	632.4	0.5	0.1	0.4	1.2	0.4	19.3	0.2	0.0	1.7	0.7	0.4	0.0	6.0	9.4	0.2	0.9	1.1	3.3	0.4	255.9	0.9	0.2	0.0
GIMAP8	"DKFZp667I133, hIAN6, IAN9"	ENSG00000171115	"GTPase, IMAP family member 8"	Q8ND71	7	150450630-150479393	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 67.4;Endothelial cells: 66.0;Hepatic stellate cells: 86.0;Kupffer cells: 75.1;Microglial cells: 32.8;monocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HUVEC TERT2: 59.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014474, HPA017765"	Supported					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014474: AB_1849685, HPA017765: AB_1849683"	"unprognostic (7.86e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.31e-1)"	20.3	5.7	4.4	21.3	5.0	0.7	16.0	4.7	5.5	9.8	5.5	6.7	6.8	10.4	3.1	4.3	9.0	7.5	17.4	4.1	4.5	8.3	9.4	27.0	23.2	5.4	4.9	3.5	2.8	4.6	2.6	15.4	5.4	4.9	7.2	0.3	4.3	5.3	9.8	4.7	10.5	12.7	5.4	40.6	5.0	2.0	5.1	7.3	11.9	15.1	13.5	8.4	5.6	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.7	0.0	9.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.5	45.2	0.0	15.3	59.0	17.4	0.5	14.8	13.9	13.0	0.0	16.7	13.6	4.8	15.5	57.4	0.7	7.7	26.8	4.4	5.0	4.7	5.5	4.1	4.5	5.4	4.9	5.4	5.4	5.1	5.8	67.4	3.2	5.3	0.3	0.8	3.1	0.5	0.0	1.8	0.0	0.4	0.8	5.5	5.7	0.0	1.8	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.2	0.1	66.0	0.0	1.3	0.1	0.0	0.0	2.3	0.5	0.2	3.8	0.0	86.0	1.6	6.8	0.0	0.1	0.0	0.0	75.1	2.8	0.9	0.3	21.9	0.0	32.8	44.2	0.0	19.6	0.0	0.1	0.0	0.0	0.0	2.2	0.9	0.0	0.2	1.5	0.0	0.0	1.5	1.2	0.2	0.4	0.5	1.7	0.1	11.1	0.2	0.0	0.4
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406147	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-698: 146.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	4.3	7.4	2.0	4.2	4.2	8.4	3.7	3.7	2.6	3.7	2.2	5.8	3.2	2.8	3.7	9.1	2.4	1.5	6.2	2.4	2.5	2.5	2.6	2.1	7.8	3.0	3.5	1.3	1.7	3.7	2.0	3.7	2.7	2.2	4.2	1.8	3.4	4.6	1.8	4.5	2.8	3.8	2.8	5.4	2.6	6.8	3.2	8.8	1.9	4.9	8.0	3.0	6.7	2.7	20.2	22.4	26.5	14.3	2.9	3.7	13.3	22.4	9.8	35.4	26.8	16.9	20.2	35.0	17.5	7.6	26.3	18.7	24.5	18.8	39.6	19.5	30.4	20.4	12.0	20.5	1.6	26.1	33.7	4.2	3.5	18.4	6.3	7.9	24.4	28.9	33.5	14.4	15.0	20.9	48.1	24.2	24.5	17.2	45.3	82.6	29.4	44.4	12.8	12.6	30.3	20.1	37.3	24.3	12.8	10.6	12.9	21.4	10.4	23.5	27.8	14.2	28.4	14.3	20.2	146.3	16.2	26.1	29.3	0.1	1.8	0.1	1.9	1.6	1.5	2.5	1.6	2.9	4.1	4.4	1.5	2.5	0.4	4.1	1.0	8.2	2.4	1.5	2.0	4.2	3.7	2.6	2.4	2.5	3.0	3.5	2.7	2.8	3.2	2.7	3.9	0.0	2.6	9.1	3.2	1.8	4.9	2.7	4.0	1.5	2.0	1.7	4.1	0.0	1.4	0.0	2.1	9.1	4.5	1.6	0.0	3.7	20.7	1.8	2.1	4.3	0.0	12.4	0.6	2.0	7.6	2.5	1.5	7.9	1.3	6.9	3.6	0.8	2.8	5.0	0.2	0.9	0.0	1.6	1.1	9.2	1.5	1.9	1.8	2.8	2.6	1.8	2.1	5.0	1.2	1.9	0.3	1.2	6.2	1.7	0.2	0.5	1.1	1.8	6.6	1.6	3.0	4.6	8.7	13.0	2.4	3.1	2.4	3.2	2.8	4.9
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792999-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	79.4	20.4	10.1	9.3	11.0	0.3	61.5	9.8	15.1	26.6	9.0	14.7	2.8	33.8	5.5	7.5	40.0	17.3	83.6	10.5	9.6	35.8	17.3	40.7	11.3	10.3	10.2	18.0	7.0	10.6	6.4	61.6	10.6	18.8	3.8	0.8	10.1	10.7	34.7	14.8	13.9	15.2	10.2	9.9	12.9	5.4	10.2	2.7	39.8	35.2	5.4	28.1	22.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	11.0	9.8	15.1	10.5	9.6	10.3	10.2	10.6	10.2	10.2	9.9	90.4	0.0	0.0	0.3	0.6	9.7	1.9	0.2	1.2	0.2	1.1	1.5	9.0	1.5	0.6	3.7	0.0	0.2	0.7	0.0	0.0	11.0	0.1	3.1	0.5	81.4	15.6	2.7	0.0	0.0	0.1	7.7	2.6	4.9	0.0	0.5	234.2	1.8	0.3	0.0	0.0	0.0	0.0	6.3	10.7	1.1	0.9	2.2	19.6	1.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	12.8	0.2	3.0	0.0	0.1	1.2	0.7	664.0	4.4	306.3	0.2	1.2	0.7	8.7	0.0	1.3	1.6	0.1	5.2
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761747-48773648	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 5.8;intestine: 10.6;kidney: 11.2;liver: 8.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 45.2;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 2.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA010667	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.3	0.0	4.7	10.6	0.0	5.8	0.1	1.9	0.8	0.0	0.0	0.0	11.2	8.2	1.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.1	0.2	6.1	1.9	0.3	0.3	0.0	0.0	10.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	3.2	2.6	1.3	0.5	0.0	0.3	0.2	0.0	0.6	8.3	1.0	0.0	4.3	0.3	7.3	0.0	0.1	0.0	14.4	13.7	0.6	0.2	3.0	0.1	0.0	1.2	2.7	0.2	0.9	0.1	0.0	0.0	1.1	0.0	0.1	0.0	8.0	0.0	0.0	0.3	7.3	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.5	0.0	0.5	0.5	0.8	13.9	0.0	0.1	0.3	45.2	70.5	2.7	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	8.9	0.7
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 10.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	4.2	0.0	3.4	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.2	0.8	3.6	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.4	0.0	3.0	2.6	4.5	0.8	3.6	0.6	0.9	10.5	0.0	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;liver: 27.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.4"	"Group enriched"	"Detected in some"	7	"MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted to blood"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	2.5	0.2	7.0	6.8	7.3	28.1	0.2	1.5	9.8	2.4	5.6	0.4	0.1	3.6	1.0	0.5	3.0	1.7	0.8	7.1	11.1	0.8	27.6	2.8	0.3	2.9	2.6	0.2	0.8	0.6	1.4	0.7	3.1	0.8	0.3	5.7	0.2	1.5	9.0	1.1	0.3	3.1	1.2	12.7	0.3	15.5	4.3	0.9	1.7	9.6	0.4	1.4	0.5	6.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.5	3.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	36.4	0.0	2.0	2.3	0.0	1.6	7.0	7.3	1.5	9.8	7.1	11.1	2.9	2.6	3.1	1.2	4.3	6.8	0.0	0.0	0.0	1.6	0.4	0.9	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.0	4.7	0.0	0.0	0.1	14.6	0.6	2.3	0.1	0.0	0.0	37.6	0.0	0.0	0.4	0.0	4.8	0.0	0.1	1.1	10.4	1.4	0.0	30.2	0.0	0.0	8.5	0.0	41.7	0.3	9.4	1.8	6.5	12.4	10.4	1.0	34.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.3	0.0	0.2	0.2	4.0	0.6	0.0	0.3	0.1	0.2	0.0	0.0	0.0
GNG2		ENSG00000186469	"G protein subunit gamma 2"	P59768	14	51826195-51979342	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 113.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 251.8;Early spermatids: 714.4;Late spermatids: 1146.4;NK-cells: 246.1"	"Cancer enhanced"	"Detected in all"		"glioma: 15.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 77.2;fHDF/TERT166: 140.2;MOLT-4: 112.5;SH-SY5Y: 89.2;WM-115: 249.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003534, CAB018380"	Uncertain	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		170000	"Cluster 46: Basophils - DNA binding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane"	Vesicles	"CAB018380: AB_631547, HPA003534: AB_1079004"	"unprognostic (6.11e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.90e-6)"	"unprognostic (9.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.59e-2)"	51.3	22.0	38.5	41.1	44.8	64.0	21.0	0.8	55.4	11.9	10.9	24.1	15.2	12.2	5.1	14.1	5.8	17.3	13.5	54.1	75.2	7.5	12.7	19.0	47.7	10.6	20.5	14.4	7.3	3.5	14.9	19.5	27.2	10.6	19.6	15.0	8.1	9.0	5.6	7.8	21.2	19.8	13.6	61.7	15.9	113.4	46.4	62.0	5.7	13.1	45.4	22.2	5.3	22.2	0.0	3.1	77.2	48.6	11.6	15.0	1.2	12.9	15.9	6.1	4.9	6.4	0.2	0.2	1.8	140.2	8.9	0.3	10.4	0.0	4.2	36.4	1.2	0.0	0.7	0.0	6.0	7.4	0.3	25.1	0.0	6.2	0.5	32.2	0.0	67.9	0.0	6.5	39.7	0.0	112.5	12.0	41.1	0.0	9.5	39.4	6.1	2.0	6.4	0.0	11.5	89.2	0.3	0.1	34.5	2.7	0.0	0.3	0.0	18.7	3.1	0.3	9.9	0.2	0.0	5.5	15.5	39.2	249.0	379.4	64.0	177.1	162.8	111.9	110.5	38.1	88.9	134.2	65.8	36.2	55.5	98.5	185.2	25.2	177.3	28.0	143.2	158.6	38.5	44.8	0.8	55.4	54.1	75.2	10.6	20.5	27.2	13.6	46.4	22.2	11.6	6.4	7.2	3.3	101.3	11.5	0.4	0.0	2.2	18.7	1.5	1.9	1.0	1.5	0.0	3.7	2.1	0.6	251.8	0.8	1.9	0.2	714.4	0.5	2.7	11.7	175.8	20.4	66.2	0.0	0.6	23.9	11.7	0.8	32.3	0.2	11.0	0.9	51.1	0.0	59.6	2.4	0.0	94.1	60.0	1146.4	9.9	84.0	55.2	24.4	33.3	0.7	246.1	96.0	3.2	0.5	0.1	6.0	62.7	0.2	0.1	0.9	0.0	2.2	39.5	10.2	12.2	11.2	4.6	1.3	6.7	0.7	191.5	2.2	0.5	0.2
GNG3		ENSG00000162188	"G protein subunit gamma 3"	P63215	11	62707676-62709201	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 295.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.8;Early spermatids: 27.6;Excitatory neurons: 23.3;Inhibitory neurons: 20.7;Late spermatids: 123.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 12.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 16.9;naive B-cell: 17.1"	"Lineage enriched"	"Detected in single"	31	"B-cells: 17.1"	"Group enriched"	"Detected in many"	7	"Karpas-707: 149.4;SCLC-21H: 292.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.43e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.68e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.37e-5)"	"unprognostic (3.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.00e-1)"	0.3	14.8	168.3	1.9	183.3	1.1	0.3	132.0	295.7	0.3	62.2	8.3	1.3	0.2	1.0	0.4	0.2	0.3	0.6	203.9	207.0	0.6	0.8	0.4	0.4	146.2	148.2	0.6	0.7	0.9	48.4	0.1	179.5	0.7	2.6	35.3	0.6	0.7	0.6	0.6	3.2	1.2	106.6	0.3	1.5	11.3	152.4	0.0	0.4	0.1	0.2	0.3	1.2	201.3	0.5	1.0	7.3	0.5	0.0	0.0	3.2	0.6	0.0	0.5	0.0	2.4	1.4	0.4	0.8	0.0	0.3	1.0	0.0	0.0	0.0	2.2	0.5	0.8	0.9	2.1	0.2	1.3	0.6	0.3	0.0	0.1	0.0	1.3	0.0	1.1	1.7	149.4	0.0	1.3	0.3	3.9	33.2	0.7	0.1	2.0	1.3	0.8	0.5	2.4	292.9	2.5	0.8	1.0	0.2	1.5	1.7	0.7	0.4	1.7	2.9	0.9	0.5	0.9	2.4	0.8	1.5	1.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.1	0.1	0.1	17.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	168.3	183.3	132.0	295.7	203.9	207.0	146.2	148.2	179.5	106.6	152.4	201.3	0.1	0.0	0.0	5.9	1.2	0.0	0.4	0.0	0.0	39.8	0.4	0.9	0.1	0.0	0.0	0.0	4.2	0.2	0.0	0.2	0.0	0.1	27.6	0.5	0.0	0.1	0.0	0.0	23.3	0.4	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.3	5.0	20.7	0.2	0.0	0.0	0.4	123.0	0.9	0.1	0.0	2.8	0.6	5.3	0.0	8.0	7.4	0.0	1.2	0.0	0.0	0.0	0.1	0.3	0.0	14.1	0.0	0.0	0.1	4.4	3.0	0.0	0.3	0.0	0.1	0.4	0.1	0.2
GNG4		ENSG00000168243	"G protein subunit gamma 4"	P50150	1	235547685-235650754	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.9;ovary: 32.1;pituitary gland: 32.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 24.4;Enteroendocrine cells: 43.0;Inhibitory neurons: 43.3;Intestinal goblet cells: 16.2;Oligodendrocyte precursor cells: 25.1;Prostatic glandular cells: 24.1;Proximal enterocytes: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 151.4;SCLC-21H: 158.4;SH-SY5Y: 222.8;U-2197: 67.2"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 469.3"											NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.50e-3)"	"unprognostic (8.33e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.56e-9)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.01e-3)"	1.4	11.3	20.0	1.7	25.6	0.1	0.6	7.9	21.0	4.7	3.1	3.6	2.5	9.5	0.1	14.4	3.3	0.5	0.1	15.4	40.9	1.9	0.3	0.1	5.7	21.3	28.2	32.1	5.1	0.0	32.0	1.7	25.4	22.6	3.0	2.4	2.0	0.7	0.1	0.5	5.3	6.6	18.9	0.1	3.1	1.7	33.6	4.9	0.3	0.0	3.4	1.0	2.4	7.3	37.2	2.0	26.4	0.0	0.0	1.3	2.4	0.1	0.4	3.3	4.5	0.1	1.5	0.0	0.3	11.2	9.0	3.3	28.4	1.2	6.7	19.4	10.2	0.1	0.7	14.4	0.4	0.2	12.1	2.4	0.2	0.4	0.9	0.0	0.0	2.0	0.3	0.1	2.1	0.1	7.6	1.2	151.4	0.1	0.1	0.0	13.8	0.7	0.0	1.1	158.4	222.8	0.9	0.3	3.2	1.7	0.2	5.3	0.0	1.7	5.0	67.2	5.2	3.5	0.2	0.0	4.9	0.1	44.5	1.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.0	0.1	0.1	20.0	25.6	7.9	21.0	15.4	40.9	21.3	28.2	25.4	18.9	33.6	7.3	0.1	0.0	0.0	2.9	0.2	0.5	2.6	0.3	0.0	2.3	0.2	0.9	0.5	0.0	1.0	0.0	0.0	7.7	2.7	1.6	0.0	0.0	1.1	1.5	24.4	1.4	43.0	0.0	2.3	9.0	10.0	1.7	0.0	0.8	0.0	3.8	0.0	0.0	0.9	1.7	43.3	16.2	4.1	0.0	3.6	1.0	0.3	1.1	0.0	4.7	1.0	0.4	0.0	25.1	0.8	1.6	1.3	0.4	0.1	24.1	24.5	4.9	0.2	1.3	0.0	0.2	1.6	1.8	4.4	0.0	0.0	6.3	1.1	0.3	4.6	1.5
GNRH1	"GNRH, GRH, LHRH"	ENSG00000147437	"Gonadotropin releasing hormone 1"	P01148	8	25419258-25424654	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Hormone	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 9.9;Peritubular cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 19.7;hypothalamus: 12.1;olfactory bulb: 6.7"	"Group enriched"	"Detected in some"	23	"basal ganglia: 14.1;hypothalamus: 32.3"	HPA027532	Supported				"Secreted to blood"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA027532: AB_10612111"	"unprognostic (6.49e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.53e-4)"	"unprognostic (7.80e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.08e-9)"	"unprognostic (7.98e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.68e-2)"	5.1	2.3	5.4	1.4	8.8	3.0	4.9	7.7	7.2	9.0	6.4	6.7	1.9	4.2	4.7	5.7	6.2	1.8	7.7	5.4	15.8	6.0	3.2	6.8	2.2	6.5	6.2	8.6	4.0	0.6	4.7	1.4	6.8	8.3	1.7	9.2	5.4	1.7	3.1	8.6	5.9	1.0	5.2	7.0	4.3	4.6	6.7	1.9	4.4	1.0	1.7	5.7	8.5	8.1	1.0	1.5	4.0	2.2	1.4	4.7	1.7	3.7	1.4	1.1	1.7	1.5	1.1	1.3	0.8	2.1	2.6	3.8	1.2	0.3	2.7	1.7	3.3	1.4	5.9	1.5	1.1	0.2	1.4	2.6	2.1	0.8	0.7	3.6	0.9	1.3	1.5	1.1	1.8	0.6	1.4	3.2	1.4	1.2	0.5	0.9	0.6	0.6	1.0	0.7	21.1	0.7	1.1	0.7	1.4	1.5	0.7	1.8	3.4	3.1	1.5	3.8	1.5	0.3	0.2	1.8	1.5	1.0	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	5.4	8.8	7.7	7.2	5.4	15.8	6.5	6.2	6.8	5.2	6.7	8.1	2.4	0.0	0.5	3.3	1.1	5.0	1.9	1.7	5.2	3.6	2.5	1.3	1.8	1.5	1.4	3.7	4.2	0.1	1.0	2.3	0.0	0.2	0.3	0.7	0.6	2.1	1.8	0.0	3.0	0.6	0.4	3.1	0.0	1.0	0.0	1.0	1.4	0.3	0.5	0.0	2.8	0.5	0.0	0.8	2.2	0.5	9.9	0.4	3.6	2.8	0.8	0.6	4.1	1.5	1.7	0.6	0.6	9.8	1.8	3.7	1.8	0.2	0.9	3.9	0.0	2.4	1.9	1.8	1.2	3.4	2.4	0.1	1.4	0.5	1.4	1.8
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 215.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 775.5;Intestinal goblet cells: 211.6;Paneth cells: 420.3;Proximal enterocytes: 266.1;Undifferentiated cells: 147.2"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 24.2;T-reg: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 24.2"	"Cell line enriched"	"Detected in some"	8	"OE19: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.4	0.0	0.0	18.5	0.0	0.7	0.2	0.0	0.2	0.0	0.4	215.9	150.0	0.3	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.1	0.0	7.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	196.2	0.0	0.0	0.4	0.3	0.0	136.9	7.2	0.0	0.9	1.5	0.2	0.2	2.3	0.0	0.1	1.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.3	1.8	14.4	0.0	0.0	0.8	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	3.8	1.6	0.2	10.9	5.7	2.7	2.2	24.2	3.5	0.2	0.2	2.6	0.0	19.5	6.8	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.3	775.5	0.0	0.0	3.9	0.0	0.0	0.1	26.1	0.8	0.4	0.0	0.0	0.0	0.5	0.0	4.5	0.0	0.0	0.0	0.5	0.0	0.3	211.6	0.0	1.9	1.3	2.3	0.3	1.8	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.1	420.3	0.0	0.0	0.0	266.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.1	0.0	3.1	0.0	147.2	0.2
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435663-240468076	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 226.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 199.8;Syncytiotrophoblasts: 102.7;Urothelial cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		9500000		"Cluster 31: Skin - Epidermis development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	36.8	78.5	42.8	9.0	37.0	0.4	30.7	25.3	64.4	44.5	3.1	36.7	5.8	37.1	9.3	88.4	30.8	8.5	145.2	41.7	28.5	47.6	35.7	21.9	1.4	29.2	30.4	45.1	25.8	9.8	55.7	29.0	26.3	67.8	3.5	5.0	35.2	22.5	134.2	226.0	17.4	16.4	11.3	15.6	23.0	48.7	46.0	9.1	15.7	35.3	6.6	35.1	62.3	24.8	69.0	92.9	21.6	56.7	64.3	61.5	87.3	161.5	78.8	18.3	21.2	33.3	74.9	1.8	21.8	172.0	100.1	186.0	11.7	114.7	3.8	33.3	9.8	0.1	80.7	41.7	92.2	1.6	6.2	54.3	73.4	41.2	21.3	38.1	9.7	3.4	0.4	3.3	47.5	36.0	1.3	0.6	33.7	7.7	20.5	12.3	98.2	16.1	15.0	109.6	21.5	14.4	105.7	91.9	10.1	19.3	29.1	7.0	45.6	97.3	162.3	46.9	67.8	0.7	0.4	0.8	69.4	1.7	111.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	37.0	25.3	64.4	41.7	28.5	29.2	30.4	26.3	11.3	46.0	24.8	1.2	16.0	6.1	45.7	0.7	45.9	69.6	62.2	56.3	22.4	8.3	18.2	53.2	21.5	34.0	25.8	2.1	73.7	0.3	3.7	7.9	27.8	0.9	6.2	24.7	2.8	0.0	0.0	53.0	10.8	199.8	21.0	1.5	8.9	4.5	49.4	11.0	26.3	9.1	25.2	45.0	7.0	16.2	0.6	7.7	3.8	19.0	1.2	35.6	5.6	1.6	24.9	1.0	18.6	8.9	17.6	0.9	7.5	0.9	67.0	0.5	2.3	30.2	6.4	26.3	33.9	38.2	2.2	9.9	44.8	46.2	102.7	1.9	14.5	3.6	110.5
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226807-94408020	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Excitatory neurons: 333.6;Inhibitory neurons: 496.1;Oligodendrocyte precursor cells: 691.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5;HSkMC: 70.8;hTERT-RPE1: 64.3;SuSa: 39.5;U-87 MG: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	9.1	2.2	0.8	8.9	1.9	0.1	2.2	1.7	1.5	3.6	1.1	6.3	2.3	2.4	2.4	5.2	4.1	17.0	6.2	1.3	3.1	7.7	17.7	3.5	0.4	1.7	2.4	7.3	1.6	1.8	2.9	1.3	2.3	6.2	6.5	5.6	3.1	15.1	0.6	1.1	4.3	7.8	2.0	2.2	5.4	2.0	1.9	1.7	1.7	1.9	0.9	11.6	2.4	2.1	0.0	4.7	10.2	4.5	62.5	19.5	0.0	7.2	0.0	4.9	6.4	0.0	0.0	0.2	0.0	16.0	0.0	0.0	5.7	1.2	9.1	0.0	4.1	0.0	0.1	20.2	37.8	0.1	0.1	70.8	0.5	11.7	8.1	64.3	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.1	6.4	0.0	3.4	0.0	1.6	0.1	5.5	0.0	4.1	16.8	0.0	1.9	0.0	39.5	14.0	0.0	0.0	26.9	22.6	25.4	12.3	15.9	0.1	0.0	52.8	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	1.9	1.7	1.5	1.3	3.1	1.7	2.4	2.3	2.0	1.9	2.1	0.6	0.0	0.5	163.2	0.0	0.6	0.5	0.5	0.6	50.3	0.6	1.9	1.7	4.3	0.7	7.3	10.4	0.2	0.0	0.1	0.0	0.3	6.7	1.6	25.9	1.1	0.0	0.0	333.6	0.0	0.1	31.2	0.0	3.1	0.0	36.0	5.7	41.2	0.5	0.0	496.1	0.1	2.0	1.3	1.0	5.0	4.7	0.5	1.8	31.9	0.0	2.7	0.0	691.6	13.2	0.1	0.0	1.9	0.1	1.6	0.0	14.5	0.0	115.0	0.0	34.4	20.9	4.2	2.7	0.5	0.4	0.1	0.7	11.9	0.1	0.2
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13770939-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 743.2;choroid plexus: 180.7;retina: 207.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 633.3;Excitatory neurons: 361.3;Melanocytes: 357.5;Muller glia cells: 1722.4;Oligodendrocyte precursor cells: 408.1;Oligodendrocytes: 1476.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 192.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	220	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in single"	268	"dendritic cells: 77.7"	"Cell line enhanced"	"Detected in many"		"AF22: 154.8;AN3-CA: 150.1;ASC TERT1: 74.2;HSkMC: 110.0;SK-MEL-30: 154.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002913	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	7.5	9.3	418.4	6.0	518.8	1.1	26.4	540.4	521.1	27.1	180.7	33.8	5.0	6.3	12.1	11.5	6.5	5.9	15.8	447.8	463.6	7.7	1.1	16.8	2.8	596.3	459.3	4.4	3.2	0.6	17.2	1.3	580.5	21.8	7.8	207.7	14.8	35.2	2.5	13.9	9.2	5.4	533.4	14.5	11.7	3.5	419.9	0.8	5.0	7.5	1.9	9.1	19.7	743.2	0.4	0.4	154.8	150.1	41.6	74.2	0.4	0.9	6.9	0.1	0.0	0.4	0.5	0.7	0.3	0.0	0.6	1.3	7.6	0.8	0.0	0.6	25.2	0.4	10.0	0.4	1.5	0.5	0.9	110.0	0.9	0.0	1.9	0.6	0.0	3.0	0.4	6.8	1.5	0.6	3.4	0.7	48.5	0.1	2.5	2.0	13.7	23.9	0.0	0.5	7.8	4.4	0.8	4.4	154.4	41.9	0.7	3.6	0.3	1.0	1.3	0.3	2.0	0.5	0.3	0.3	1.4	0.3	12.4	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	77.7	0.1	0.7	418.4	518.8	540.4	521.1	447.8	463.6	596.3	459.3	580.5	533.4	419.9	743.2	13.8	0.0	5.1	633.3	15.8	33.0	22.7	5.9	6.8	74.4	37.1	47.1	1.3	1.5	7.8	22.0	87.6	5.0	50.7	3.0	0.0	5.4	1.5	45.8	32.7	12.5	1.2	5.3	361.3	3.7	3.7	54.2	0.0	30.4	4.5	19.7	10.8	0.4	1.2	26.9	144.0	5.0	8.2	1.9	33.5	3.2	24.2	3.7	357.5	40.3	4.6	1722.4	50.4	408.1	1476.6	2.3	6.0	32.0	7.3	26.5	6.1	1.1	11.0	151.4	46.0	137.7	43.6	9.6	13.3	7.0	17.0	13.7	20.5	8.6	3.2	14.8
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 581.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 327.1;Fibroblasts: 285.8;Hofbauer cells: 814.1;Macrophages: 328.9;Melanocytes: 597.7;Suprabasal keratinocytes: 359.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.1;intermediate monocyte: 3.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.9"	"Cell line enriched"	"Detected in many"	6	"ASC diff: 5015.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 9.7"	"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		33000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	152.9	25.9	20.9	41.7	20.9	6.6	135.6	19.0	70.9	303.9	77.6	78.8	22.5	180.9	43.8	111.8	72.8	270.7	323.5	21.2	23.1	32.7	52.5	215.8	169.0	32.2	21.5	77.7	20.6	15.3	12.8	148.6	31.0	30.4	92.9	2.9	66.1	55.8	15.4	581.2	48.5	151.5	27.3	31.9	37.1	26.2	34.6	89.5	51.5	72.4	103.4	190.9	151.0	66.5	19.2	0.8	0.1	0.6	5015.0	908.0	0.4	33.6	564.1	27.9	116.2	0.2	0.8	0.7	1.4	109.5	49.1	118.3	0.7	0.7	14.2	1.3	1.3	0.1	0.9	2.5	61.5	1.5	0.6	630.3	134.8	46.3	4.7	734.9	0.3	1.4	0.3	0.6	150.2	3.5	0.7	0.7	0.6	0.5	0.5	0.4	1.4	7.6	71.2	443.4	2.4	0.6	0.1	175.6	841.5	1.3	2.3	2.8	0.1	163.0	17.8	297.8	5.5	5.1	8.6	1.2	56.3	2.6	166.1	0.6	2.1	0.1	0.0	3.9	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.1	0.1	0.4	0.0	0.5	20.9	20.9	19.0	70.9	21.2	23.1	32.2	21.5	31.0	27.3	34.6	66.5	18.0	19.2	24.3	0.3	3.2	327.1	7.1	58.5	150.2	0.4	6.6	24.5	204.2	2.8	16.0	75.4	0.0	7.2	2.2	0.1	3.9	0.6	3.0	2.5	44.0	15.0	0.0	0.0	0.5	0.8	4.6	285.8	12.2	2.5	22.7	0.1	4.6	5.1	814.1	1.7	1.2	0.0	12.2	188.4	100.7	5.5	129.8	328.9	597.7	12.2	3.2	0.2	1.0	55.8	0.1	0.6	0.0	108.0	10.2	1.9	0.0	1.2	3.4	0.6	0.0	20.6	53.4	3.9	1.4	65.3	359.7	28.9	5.7	0.1	0.0	11.9
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 12.2"	"Group enriched"	"Detected in some"	6	"Extravillous trophoblasts: 12.3;Granulosa cells: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.7;HHSteC: 133.9;hTCEpi: 61.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	1.5	2.7	0.1	0.2	0.9	0.0	0.7	0.5	0.3	2.6	12.2	0.3	0.1	0.5	0.2	4.5	0.5	1.2	1.6	0.6	0.3	0.4	0.0	0.2	0.8	0.0	0.0	1.3	0.0	0.4	0.2	3.9	0.0	0.2	0.3	0.7	0.9	0.1	0.7	4.8	0.3	1.0	0.0	0.0	0.1	0.9	0.2	0.0	0.3	2.4	0.3	1.0	5.6	0.0	2.2	0.2	1.8	0.0	0.4	7.5	0.6	14.4	24.7	8.8	7.4	0.0	0.0	0.0	0.8	7.3	0.6	0.2	0.7	0.0	2.9	0.0	0.3	0.0	4.2	0.0	133.9	0.0	0.0	5.5	61.8	12.5	20.0	10.2	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	6.9	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	6.1	2.9	0.0	0.0	1.6	0.1	0.0	0.3	10.5	4.8	12.5	1.1	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	12.3	4.5	0.0	0.0	0.0	42.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.9	1.2	0.0	0.0	0.8	1.0	0.7	0.5	0.0	0.0	0.4
GPR155	"DEP.7, DEPDC3, FLJ31819, PGR22"	ENSG00000163328	"G protein-coupled receptor 155"	Q7Z3F1	2	174431571-174487094	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 83.4;stomach 1: 52.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 125.1;Excitatory neurons: 99.4;Inhibitory neurons: 131.1;Melanocytes: 152.9;Oligodendrocyte precursor cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 14.6;WM-115: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036159, HPA057384"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies, Cytosol"		"HPA036159: AB_10671835, HPA057384: AB_2683424"	"unprognostic (3.91e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.11e-4)"	"unprognostic (5.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.54e-2)"	4.3	9.7	8.7	5.9	16.3	2.3	2.4	6.5	12.1	2.4	83.4	10.2	3.8	1.9	12.3	5.9	1.6	5.7	7.0	12.2	5.3	20.1	7.3	3.0	6.3	5.5	5.3	2.5	18.2	8.9	2.3	4.4	5.2	7.5	3.7	10.0	3.6	8.4	4.7	13.2	4.0	6.1	3.5	5.4	52.6	2.2	7.1	3.0	8.3	4.4	3.6	4.1	2.7	6.1	0.7	0.3	0.8	2.0	4.9	2.7	0.5	3.8	1.3	0.6	2.1	0.3	0.2	2.2	1.2	2.8	1.3	0.2	1.3	1.1	2.1	0.8	1.5	2.3	1.1	0.2	0.9	0.7	1.1	3.9	3.1	1.9	0.6	4.0	1.0	3.0	0.3	5.5	4.2	0.6	1.6	0.8	0.4	2.3	1.5	1.9	5.6	1.0	2.0	1.3	5.9	5.0	1.2	0.8	2.0	2.5	0.3	0.3	2.6	2.7	1.0	3.9	0.5	14.6	2.2	0.3	3.0	0.6	9.9	1.3	2.2	0.1	1.8	4.0	1.6	1.1	3.1	2.9	0.6	1.0	2.5	3.9	7.3	3.6	5.7	0.3	5.5	1.4	8.7	16.3	6.5	12.1	12.2	5.3	5.5	5.3	5.2	3.5	7.1	6.1	18.5	12.8	3.6	31.3	9.8	42.7	4.0	4.0	29.0	34.9	5.8	6.1	26.0	2.8	6.8	11.0	125.1	1.5	12.2	0.6	1.9	1.9	0.7	1.4	24.1	9.8	12.7	15.2	99.4	6.0	1.2	9.7	9.7	0.6	1.3	4.0	16.1	16.1	6.1	50.5	131.1	0.8	2.0	50.4	23.0	1.8	14.9	27.0	152.9	8.4	34.3	16.7	11.3	130.2	21.2	3.5	0.1	32.0	14.3	3.1	0.4	41.7	0.5	25.8	0.0	16.9	9.5	3.3	3.2	7.5	28.6	0.8	25.7	52.4	1.0	1.8
GPR158	KIAA1136	ENSG00000151025	"G protein-coupled receptor 158"	Q5T848	10	25174802-25602229	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 367.4;Horizontal cells: 144.7;Inhibitory neurons: 301.9;Oligodendrocyte precursor cells: 419.7;Oligodendrocytes: 101.6"	"Cancer enhanced"	"Detected in many"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 21.3;T-47d: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013185	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013185: AB_2113957"	"unprognostic (4.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.66e-5)"	"unprognostic (5.67e-2)"	"unprognostic (9.37e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-6)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (3.90e-1)"	0.0	0.7	2.6	0.1	12.7	0.0	0.0	24.9	8.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	2.4	0.0	0.0	0.0	0.0	8.5	4.7	0.0	0.0	0.2	1.4	0.3	8.8	0.1	0.1	4.5	0.0	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.5	7.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	21.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.5	1.1	1.9	0.0	5.6	0.0	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	12.7	24.9	8.6	3.5	2.4	8.5	4.7	8.8	2.3	7.0	4.3	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	19.9	0.0	0.1	0.1	0.0	0.0	367.4	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.7	301.9	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	10.3	0.0	26.2	0.0	419.7	101.6	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.8	0.0	0.1	0.1	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
GPR173	SREB3	ENSG00000184194	"G protein-coupled receptor 173"	Q9NS66	X	53048789-53080615	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 43.4;Excitatory neurons: 19.7;Inhibitory neurons: 14.1;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003905			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	"Plasma membrane"	"HPA003905: AB_1078922"	"unprognostic (2.68e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.95e-3)"	"prognostic unfavorable (2.88e-6)"	"unprognostic (3.87e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.08e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.95e-2)"	2.2	2.7	12.6	1.4	11.7	1.0	2.0	14.5	12.5	6.6	4.6	4.2	0.6	5.5	2.1	1.0	6.4	1.4	4.0	12.3	14.2	2.9	0.4	2.6	1.0	10.9	13.6	12.0	0.8	1.1	18.4	2.1	13.3	4.0	1.1	7.0	1.3	2.3	2.4	1.7	2.1	1.9	9.3	3.3	1.9	1.5	14.5	1.5	1.8	1.0	0.4	3.2	3.6	12.0	0.0	0.0	7.8	0.8	4.1	2.4	0.3	1.4	2.7	2.0	2.3	0.8	0.1	0.2	1.9	2.6	5.9	0.8	9.5	0.0	1.7	0.9	1.3	0.6	9.3	0.3	6.0	0.5	0.2	5.8	0.0	3.0	4.1	6.6	3.2	0.2	0.0	5.4	2.9	4.6	0.2	0.1	6.2	0.4	3.5	0.2	2.6	0.7	0.4	0.4	5.8	7.9	0.0	0.8	0.0	4.7	1.2	0.2	5.7	3.4	5.0	2.6	1.1	0.2	0.7	0.8	2.5	0.0	1.8	3.3	0.1	0.2	0.4	0.1	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.2	0.6	0.8	0.2	0.3	0.1	0.0	12.6	11.7	14.5	12.5	12.3	14.2	10.9	13.6	13.3	9.3	14.5	12.0	0.5	0.0	0.0	43.4	0.2	0.3	0.4	0.6	0.0	6.6	0.1	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	5.2	1.1	3.5	0.0	19.7	0.0	0.0	1.5	0.0	0.3	0.0	7.1	1.8	0.1	0.2	6.7	14.1	0.4	0.0	0.3	0.7	0.0	3.1	0.2	1.8	11.2	0.0	3.2	0.0	49.3	42.3	0.1	0.0	4.5	0.0	0.3	0.0	0.1	0.1	3.1	0.0	2.0	2.5	0.1	0.2	0.0	0.0	0.1	0.1	2.8	0.1	0.2
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GPR19		ENSG00000183150	"G protein-coupled receptor 19"	Q15760	12	12660890-12696207	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3;pituitary gland: 7.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.8;Excitatory neurons: 15.2;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 15.6;Oligodendrocytes: 5.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.9;T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.9;NTERA-2: 39.7;SuSa: 28.5;WM-115: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013955	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013955: AB_1849287"	"unprognostic (1.92e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.62e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-1)"	"unprognostic (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.67e-12)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.60e-1)"	0.3	0.8	7.2	2.0	7.3	0.9	0.3	9.1	10.3	0.1	3.6	0.5	0.3	0.1	0.1	0.5	0.2	0.3	0.1	7.0	9.1	0.1	0.2	0.2	1.8	6.3	6.8	0.0	0.3	0.1	7.8	0.3	6.9	0.1	0.6	2.0	0.1	0.1	0.0	0.8	0.5	0.3	7.0	0.7	0.4	4.3	7.6	2.8	0.1	0.0	2.4	0.3	0.1	6.9	1.6	0.6	16.6	0.4	0.0	0.0	7.0	1.6	1.7	2.9	2.5	6.6	10.1	6.8	2.5	1.2	2.3	1.3	2.7	0.3	4.8	39.9	0.3	1.6	0.7	1.1	0.0	1.7	0.6	0.1	0.0	3.1	1.9	1.2	0.5	0.7	0.3	13.8	0.6	2.4	0.6	1.0	39.7	1.7	3.0	4.4	2.5	0.2	0.2	1.4	5.4	5.0	0.7	1.4	13.4	28.5	0.9	1.7	0.0	0.8	7.2	1.3	3.9	7.6	7.2	13.3	3.1	4.7	20.4	0.0	0.0	0.0	1.2	0.0	0.8	0.2	2.4	1.4	0.0	0.1	0.4	0.9	2.9	0.3	0.0	0.0	6.5	0.3	7.2	7.3	9.1	10.3	7.0	9.1	6.3	6.8	6.9	7.0	7.6	6.9	0.2	0.0	0.0	7.8	0.4	0.1	0.1	0.0	0.0	1.8	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	4.7	0.1	0.2	0.1	0.0	2.7	15.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	15.6	0.1	0.0	0.3	0.3	1.6	0.3	0.2	0.0	2.8	0.0	1.7	0.0	15.6	5.9	0.2	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.8	3.6	0.6	0.0	0.0	0.1	1.2	0.0	0.3	0.1
GPR22		ENSG00000172209	"G protein-coupled receptor 22"	Q99680	7	107470018-107475684	"G-protein coupled receptors, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;cervix: 2.1;heart muscle: 8.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.3;Cardiomyocytes: 57.9;Excitatory neurons: 49.9;Inhibitory neurons: 51.2;Oligodendrocyte precursor cells: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	27	"SH-SY5Y: 2.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"hippocampal formation: 60.4"							NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.52e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.00e-1)"		"unprognostic (4.27e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.76e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.85e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"	0.0	0.9	1.0	0.0	1.9	0.0	0.0	2.5	2.7	2.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.5	2.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.9	0.1	0.3	0.0	0.0	0.0	15.3	0.0	0.0	57.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.5	1.8	0.4	0.0	0.0	49.9	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.1	5.0	51.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	6.5	0.0	0.7	0.0	12.5	7.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0
GPR3	ACCA	ENSG00000181773	"G protein-coupled receptor 3"	P46089	1	27392622-27395814	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;heart muscle: 5.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Basal squamous epithelial cells: 2.8;Cardiomyocytes: 2.8;Enteroendocrine cells: 4.8;Horizontal cells: 5.0;Inhibitory neurons: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB006254	Uncertain					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"			"CAB006254: AB_425462"	"unprognostic (4.42e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.30e-3)"	"unprognostic (6.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-2)"	1.9	0.6	1.5	0.7	1.7	1.0	1.3	4.2	7.8	0.6	0.4	0.7	0.2	0.5	0.0	0.5	0.8	0.7	5.4	2.2	3.1	1.5	0.4	2.2	0.2	4.0	3.1	0.4	0.6	0.5	4.4	0.4	3.9	0.9	0.2	1.5	0.5	0.1	0.5	0.6	0.5	0.6	2.5	0.2	0.8	0.2	2.2	0.2	1.8	1.5	0.1	0.8	0.4	2.5	1.9	1.0	5.3	5.9	0.2	0.6	0.7	3.4	4.0	5.2	3.8	1.6	1.1	0.3	0.8	1.6	5.3	1.3	1.4	4.2	4.0	0.1	0.2	1.5	0.3	3.4	0.6	3.4	4.5	0.7	0.0	7.3	1.6	0.5	1.6	2.3	4.3	5.8	6.4	2.7	0.7	4.8	7.8	2.7	8.4	9.2	4.2	2.5	2.2	0.4	1.0	2.5	1.7	0.7	6.6	2.2	0.1	0.7	1.0	3.9	7.1	23.0	4.2	0.7	4.3	0.5	5.9	1.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	4.2	7.8	2.2	3.1	4.0	3.1	3.9	2.5	2.2	2.5	5.5	0.0	0.0	0.7	0.1	0.1	2.3	1.0	2.8	1.6	0.7	0.5	2.8	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.6	0.3	1.4	4.8	0.0	2.6	0.0	0.3	1.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	5.0	4.6	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	1.7	1.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.5	0.4
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 251.4;Kupffer cells: 173.3;Macrophages: 100.6;Microglial cells: 54.4"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 339.6;eosinophil: 117.9"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 339.6"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	28.2	17.1	5.2	15.1	5.2	0.9	21.5	6.1	5.8	14.0	5.6	12.0	6.5	6.7	2.7	8.2	7.8	17.0	8.3	5.0	7.6	5.0	8.5	10.9	20.0	10.6	7.9	7.3	5.4	5.3	1.4	42.7	11.4	3.2	13.1	0.6	3.6	8.8	0.8	1.0	14.6	16.3	9.9	15.6	7.8	2.7	9.7	6.9	3.7	4.6	16.7	13.3	1.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	339.6	9.7	117.9	0.0	12.9	0.4	1.5	0.4	0.1	2.0	1.2	0.1	0.3	1.1	14.3	7.0	0.3	0.6	2.8	5.2	5.2	6.1	5.8	5.0	7.6	10.6	7.9	11.4	9.9	9.7	18.8	0.9	0.0	2.8	1.0	2.0	0.6	0.2	0.0	0.0	0.0	0.5	2.3	1.2	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.6	0.1	0.1	5.0	1.2	0.4	0.7	0.0	1.6	1.0	0.5	0.0	37.3	0.0	2.9	0.8	251.4	0.0	0.9	0.0	0.0	173.3	13.6	1.9	0.9	100.6	1.8	54.4	7.1	0.1	1.0	3.5	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.1	0.0	0.8	19.7	0.6	0.3	0.0	0.2	0.4	1.0	2.5	7.2	0.1	0.1	0.0
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.5;retina: 39.0"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.3	0.1	65.3	0.0	0.5	53.8	43.4	0.3	5.2	0.6	0.0	1.6	0.2	3.7	0.6	0.2	0.1	31.2	40.4	0.3	10.0	0.2	0.1	62.8	56.3	0.0	1.5	0.1	0.2	5.1	62.5	0.5	0.3	39.0	0.9	0.5	0.6	2.3	0.6	1.2	45.2	2.1	1.3	10.6	47.8	0.0	0.0	0.1	0.0	1.4	0.6	109.5	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	65.3	53.8	43.4	31.2	40.4	62.8	56.3	62.5	45.2	47.8	109.5	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GPR4		ENSG00000177464	"G protein-coupled receptor 4"	P46093	19	45589764-45602212	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 26.7;Endothelial cells: 26.4;Hepatic stellate cells: 24.7;Sertoli cells: 6.6;Smooth muscle cells: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HUVEC TERT2: 18.7;TIME: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014278	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA014278: AB_1849300"	"unprognostic (2.49e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (9.19e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (6.46e-3)"	"unprognostic (1.93e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.49e-3)"	40.6	6.9	7.0	3.3	6.2	0.5	22.1	6.0	8.8	4.9	6.2	4.2	0.9	7.4	0.7	2.6	6.0	3.3	23.8	5.6	5.9	24.6	3.6	28.6	0.9	8.0	7.5	3.5	3.7	1.4	5.9	4.0	8.6	5.8	0.7	0.9	2.9	0.9	5.7	2.9	5.1	2.5	6.5	4.1	5.6	1.7	10.7	0.5	18.2	2.5	0.6	7.0	4.9	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.1	0.0	0.1	0.0	2.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.8	0.0	0.0	0.3	0.3	0.0	18.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.3	0.1	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	6.2	6.0	8.8	5.6	5.9	8.0	7.5	8.6	6.5	10.7	6.3	26.7	0.0	0.5	0.7	0.1	2.4	0.2	0.0	1.2	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.1	0.3	26.4	0.0	0.0	0.1	0.0	0.0	1.5	2.0	0.2	0.0	0.0	24.7	0.1	0.3	0.0	0.2	0.0	0.0	1.2	1.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	6.6	0.6	16.8	0.0	0.2	0.1	1.3	0.0	0.1	0.3	0.0	0.3
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 490.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 197.7;Late spermatids: 269.9;Oligodendrocytes: 171.0"	"Cancer enhanced"	"Detected in all"		"glioma: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 92.5;HHSteC: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	25.3	7.0	249.1	4.4	428.3	0.1	19.6	365.2	263.4	12.8	13.1	8.1	5.7	13.1	14.8	8.1	20.1	15.3	40.7	245.8	278.4	22.4	3.2	5.8	7.8	379.4	327.1	22.6	21.7	45.9	14.1	15.7	333.0	9.6	2.4	17.4	40.1	17.7	72.7	7.5	11.1	7.5	262.7	2.5	41.3	34.0	315.0	3.2	13.8	73.8	3.4	12.8	8.6	490.3	1.2	29.9	29.0	5.2	29.3	2.0	5.3	0.3	7.4	2.9	1.8	28.0	1.0	0.0	92.5	1.0	18.9	1.6	21.6	0.2	1.7	0.2	8.6	0.0	0.1	0.0	60.3	0.0	0.0	2.5	0.0	4.9	0.0	7.9	14.3	0.7	6.6	0.6	6.7	1.5	0.1	0.1	31.8	0.0	15.6	8.9	0.0	0.2	1.1	13.8	22.9	1.9	3.6	1.9	27.2	9.1	0.1	0.6	2.9	0.0	3.5	14.4	0.8	0.4	0.1	0.3	1.4	0.3	1.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	249.1	428.3	365.2	263.4	245.8	278.4	379.4	327.1	333.0	262.7	315.0	490.3	71.4	0.0	3.0	75.4	1.2	1.3	5.3	2.6	9.1	30.7	22.5	16.3	15.7	40.0	7.2	31.3	0.0	5.0	0.3	0.2	1.9	65.3	197.7	4.1	20.7	44.8	0.0	0.0	2.4	64.5	1.4	14.8	31.6	13.7	0.0	0.4	9.3	0.2	4.1	0.0	13.5	0.0	38.7	1.6	2.6	269.9	23.9	2.2	16.0	7.5	1.0	24.8	0.0	51.8	171.0	72.8	0.0	26.7	1.3	12.3	0.0	0.3	3.3	6.0	13.1	3.3	13.0	4.9	1.6	2.4	1.7	2.5	0.8	7.0	0.2	1.6
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610156	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.1;pituitary gland: 8.1;retina: 6.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 12.8;Excitatory neurons: 7.5;Horizontal cells: 21.9;Inhibitory neurons: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 56.5;SCLC-21H: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Vesicles	"HPA036478: AB_2675145, HPA070892: AB_2686321"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	0.5	1.6	16.9	0.8	15.9	0.2	0.3	6.8	19.5	0.3	0.0	1.1	3.8	0.4	0.0	0.8	0.1	0.3	0.4	22.1	15.7	0.6	0.4	0.4	0.8	4.3	3.5	0.0	0.6	0.1	8.1	0.3	5.1	0.2	0.4	6.9	0.3	0.0	0.3	1.0	3.2	0.7	3.3	0.4	0.8	1.5	14.8	0.9	0.2	0.2	1.1	0.3	0.2	6.6	7.5	7.9	9.8	14.1	2.1	4.6	8.3	9.8	5.1	7.5	9.7	9.6	4.8	17.0	19.6	5.3	22.0	6.5	6.3	6.8	6.5	56.5	4.3	0.3	4.1	3.4	0.9	0.4	4.2	2.3	5.1	8.1	1.2	1.5	5.5	3.8	9.1	24.0	6.3	19.7	1.8	0.0	9.9	5.0	15.4	31.7	10.9	10.1	8.4	7.7	59.5	34.1	11.4	3.2	17.7	1.2	7.4	6.5	6.8	13.8	16.0	5.3	14.5	0.4	2.3	4.8	11.9	0.8	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	15.9	6.8	19.5	22.1	15.7	4.3	3.5	5.1	3.3	14.8	6.6	0.4	0.0	0.0	0.3	0.5	2.4	0.1	0.3	0.6	12.8	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.3	1.9	0.4	0.0	0.5	0.6	1.0	1.8	0.0	7.5	1.8	0.9	0.4	0.0	1.2	0.0	0.3	0.0	0.0	0.9	21.9	8.0	0.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	1.9	0.1	1.1	1.0	2.5	0.3	1.6	0.1	0.0	0.8	0.2	0.0	0.3	0.4	3.1	0.0	1.5	0.3	0.7	2.7	0.4	1.4	0.1	0.3	0.4	0.2	0.1
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.5;skin 1: 17.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Distal enterocytes: 30.4;Exocrine glandular cells: 20.2;Intestinal goblet cells: 30.8;Late spermatids: 20.6;Proximal enterocytes: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 10.2;A549: 13.1;SiHa: 3.7;SK-BR-3: 12.0"	"Low region specificity"	"Detected in many"							"HPA038129, HPA070760"	Approved		Approved	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA038129: AB_2675846, HPA070760: "	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.1	0.0	1.7	0.6	1.6	0.0	0.9	5.9	2.1	0.9	0.4	6.2	3.6	0.0	0.0	4.4	0.3	0.2	0.0	0.6	6.7	5.7	0.3	10.5	0.0	5.5	4.9	0.1	5.7	2.1	4.2	0.0	5.7	1.9	3.4	0.1	2.8	1.1	0.1	17.4	8.0	0.1	1.8	0.0	5.1	3.0	9.7	0.0	3.4	0.0	0.5	0.6	2.0	1.0	10.2	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.0	1.7	0.3	0.3	0.1	3.7	12.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	5.9	2.1	0.6	6.7	5.5	4.9	5.7	1.8	9.7	1.0	0.0	19.2	3.7	0.0	0.0	1.7	2.8	1.9	2.8	0.3	1.4	1.0	0.2	7.2	2.1	3.7	0.0	0.0	0.0	30.4	0.0	11.3	9.3	0.0	0.0	0.1	6.6	0.0	0.7	20.2	0.0	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	30.8	0.0	0.0	0.3	20.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.6	13.1	0.4	0.0	2.1	21.7	4.0	1.8	0.1	0.0	0.0	0.2	2.9	0.8	2.4	6.1	0.0	0.1	0.0	7.3	1.3
GPSM1	"AGS3, DKFZP727I051"	ENSG00000160360	"G protein signaling modulator 1"	Q86YR5	9	136327476-136359605	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.1;Bipolar cells: 37.2;Cone photoreceptor cells: 22.9;Muller glia cells: 36.0;Rod photoreceptor cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"REH: 82.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042199, HPA060736"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA042199: AB_10959329, HPA060736: "	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.07e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.48e-2)"	13.0	21.7	32.6	4.2	30.6	4.5	12.4	50.9	44.4	38.7	12.7	18.5	3.3	23.3	7.2	6.0	20.3	4.7	74.9	30.5	26.7	19.6	4.7	35.4	2.1	34.9	29.8	38.1	42.3	3.8	19.7	6.6	28.7	30.6	1.2	18.7	8.6	5.9	2.7	17.0	9.3	4.0	25.1	19.9	17.2	29.4	28.6	2.0	12.4	0.7	1.1	15.1	24.4	28.6	3.9	6.2	14.5	25.4	8.1	14.1	12.1	43.0	17.6	11.8	6.4	12.5	4.1	0.0	17.8	26.0	9.9	2.9	2.3	8.8	2.6	35.1	25.5	5.0	23.4	2.3	34.7	0.3	6.1	23.0	5.8	10.8	6.2	14.5	12.0	5.9	13.5	0.2	7.9	14.2	2.4	4.9	15.5	1.4	22.5	82.3	26.2	12.7	3.2	2.8	35.6	44.4	8.0	1.0	13.7	5.6	17.7	8.6	20.0	21.7	17.5	25.7	8.9	7.6	0.3	0.1	13.0	0.0	21.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	32.6	30.6	50.9	44.4	30.5	26.7	34.9	29.8	28.7	25.1	28.6	28.6	4.7	3.2	3.3	26.1	0.6	4.2	2.3	0.8	0.0	37.2	2.5	5.8	12.4	0.0	0.8	0.0	22.9	0.6	1.6	0.0	11.7	3.3	0.6	2.7	18.1	3.9	1.8	2.5	9.0	1.9	0.8	9.1	0.5	5.5	5.7	14.2	3.6	0.0	1.1	10.1	11.6	0.0	0.0	0.3	2.8	1.3	10.5	1.5	8.8	6.5	0.5	36.0	0.0	9.5	10.4	7.3	0.0	9.4	0.3	10.6	0.0	0.1	0.6	43.0	0.0	5.8	6.0	0.4	3.7	0.1	3.3	0.3	1.1	3.3	0.0	4.0
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 179.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		17000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	22.6	2.4	2.2	4.6	1.9	2.3	12.5	3.3	4.7	0.7	3.5	36.0	18.3	0.5	0.4	2.4	1.3	2.4	40.3	2.1	0.4	13.9	179.6	0.4	0.3	0.8	0.5	1.1	10.3	1.4	2.9	0.1	0.6	1.8	5.8	0.6	14.6	1.2	50.1	17.1	18.0	0.4	0.2	0.6	15.0	2.6	0.9	0.0	0.9	24.3	0.2	0.6	1.3	0.9	0.2	0.8	0.2	0.5	0.4	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.9	0.4	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.7	1.3	0.3	1.5	2.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	2.8	0.0	1.3	0.4	0.4	0.3	0.6	0.5	0.5	0.1	1.5	0.0	0.9	0.5	0.8	0.2	0.7	0.1	0.1	1.9	0.1	0.2	0.1	0.6	0.7	0.1	2.9	0.2	0.2	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.2	1.9	3.3	4.7	2.1	0.4	0.8	0.5	0.6	0.2	0.9	0.9	0.2	0.0	0.0	14.4	5.3	1.7	1.3	1.2	0.6	0.9	14.1	4.6	8.5	34.3	1.8	7.3	0.0	0.0	0.4	176.9	21.5	1.1	16.5	0.5	0.4	1.1	2.4	43.2	0.8	2.4	3.3	0.3	51.0	0.7	8.9	0.3	14.3	237.3	0.1	3.3	0.5	30.4	0.0	14.4	2.1	48.1	0.6	1.2	1.8	1.0	0.1	15.6	0.0	2.0	0.0	1.3	88.4	0.4	0.1	1.2	139.7	164.9	0.5	2.0	0.0	2.0	0.4	1.0	0.6	2.4	4.5	0.0	1.8	0.4	62.1	1.6
GPX2	GSHPX-GI	ENSG00000176153	"Glutathione peroxidase 2"	P18283	14	64939152-64942905	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 497.7;intestine: 453.8;liver: 634.0;stomach 1: 374.6;urinary bladder: 350.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 386.1;Distal enterocytes: 436.6;Gastric mucus-secreting cells: 912.3;Hepatocytes: 753.4;Intestinal goblet cells: 438.6;Paneth cells: 463.0;Undifferentiated cells: 776.8;Urothelial cells: 1062.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 493.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 4748.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.2"	"Low region specificity"	"Detected in some"			HPA003545	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA003545: AB_10962695"	"unprognostic (3.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.90e-3)"	"unprognostic (4.75e-3)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (2.96e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.66e-4)"	"unprognostic (1.73e-2)"	1.9	0.2	0.1	53.8	0.3	0.3	5.3	0.5	0.3	23.5	0.1	333.5	96.7	0.7	1.7	187.7	4.9	497.7	0.3	0.2	0.5	30.6	634.0	2.6	0.1	0.4	0.2	0.2	24.5	0.0	1.2	0.2	0.4	43.3	453.8	0.0	71.8	24.9	0.3	25.4	175.7	9.7	0.1	0.6	374.6	2.5	0.3	3.3	0.5	0.0	1.2	350.5	108.2	0.7	0.0	1152.6	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	36.9	9.6	0.0	6.0	0.0	1.9	303.7	0.6	4.8	0.0	0.2	0.1	0.1	1.1	1048.6	0.0	0.1	0.4	0.0	9.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	5.6	0.6	0.3	1.3	4748.8	0.2	0.5	0.2	0.2	0.1	727.5	324.2	0.2	0.1	13.4	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.2	0.5	0.4	0.2	0.4	0.1	0.3	0.7	0.1	0.0	0.0	0.3	6.9	9.9	169.4	104.5	42.1	0.2	0.6	4.1	0.4	386.1	17.1	23.9	0.0	0.1	0.0	436.6	11.7	272.8	13.8	3.8	0.5	3.5	115.2	50.8	0.2	260.6	0.1	2.1	912.3	2.8	13.4	0.1	17.5	753.4	0.0	0.0	0.2	438.6	36.7	26.1	0.8	66.6	0.9	3.5	0.0	1.9	3.2	0.0	0.0	0.0	0.4	163.7	463.0	0.0	2.4	100.7	68.1	31.4	9.0	0.7	0.0	0.0	3.6	0.4	0.0	315.5	9.7	0.0	5.9	0.1	776.8	1062.0
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 340.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	55.7	58.0	66.1	98.3	64.8	127.1	40.3	56.6	66.1	35.9	49.9	54.7	57.3	46.4	31.5	51.0	39.5	43.2	53.3	71.0	68.7	50.5	54.0	65.5	116.9	64.1	64.8	39.3	35.0	39.8	42.6	64.5	61.5	41.8	52.6	24.1	40.6	45.8	48.8	36.3	60.6	58.9	67.5	92.2	44.6	18.5	68.5	83.1	37.6	39.1	107.3	67.5	36.1	72.3	98.6	87.7	58.9	71.1	64.1	54.5	129.5	91.2	70.5	89.3	87.3	75.8	66.7	128.9	57.9	97.0	77.5	58.5	84.0	76.1	89.8	63.4	76.5	137.2	55.7	111.8	57.3	162.8	259.0	55.2	78.0	112.9	55.8	62.3	128.3	125.3	95.5	88.8	64.9	127.4	160.3	160.5	40.5	98.9	81.3	113.7	123.8	94.9	82.7	75.0	66.6	101.1	83.7	85.4	114.7	102.8	94.4	264.9	83.4	100.0	71.0	81.8	104.9	161.1	127.3	205.5	79.1	125.8	75.3	134.5	136.1	164.9	52.3	160.9	45.0	94.5	48.0	52.2	101.2	96.5	46.8	47.8	273.8	51.5	185.1	71.9	56.5	102.9	66.1	64.8	56.6	66.1	71.0	68.7	64.1	64.8	61.5	67.5	68.5	72.3	73.5	60.9	62.2	18.3	210.5	47.0	45.7	31.0	67.7	35.7	45.6	37.5	59.7	41.5	46.9	16.5	31.3	71.9	137.6	74.4	52.8	64.8	3.0	52.9	56.4	60.9	41.9	55.5	41.5	63.4	340.9	47.2	47.9	57.6	124.4	30.0	41.7	42.3	260.3	35.3	41.1	46.4	22.4	182.0	243.8	5.6	25.1	259.9	46.2	81.5	237.0	47.1	73.2	31.7	41.5	77.2	69.6	41.8	236.3	63.3	60.1	69.9	55.1	46.4	6.6	34.6	50.5	27.4	49.9	76.3	44.8	87.2	109.0	59.7	44.9	92.7
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.2;kidney: 61.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 77.1;Basal squamous epithelial cells: 104.7;Prostatic glandular cells: 79.0;Squamous epithelial cells: 124.7;Syncytiotrophoblasts: 98.6;Urothelial cells: 79.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"OE19: 1706.0"	"Region enhanced"	"Detected in many"		"cerebellum: 8.3"	"Low region specificity"	"Detected in many"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	5.9	0.1	0.0	0.7	0.4	0.0	14.2	5.6	0.4	13.5	4.5	8.1	11.8	3.3	3.8	60.2	22.3	9.5	1.2	0.2	0.0	61.5	11.1	10.6	0.1	0.0	0.4	1.0	32.7	11.4	6.9	11.9	0.5	14.5	10.0	0.1	25.2	11.6	0.3	39.9	10.8	1.0	0.0	0.5	16.9	1.2	0.1	1.1	6.6	0.1	8.7	7.5	26.2	0.3	12.6	14.4	0.0	0.0	0.0	0.0	19.1	0.0	0.8	0.1	0.5	44.7	24.3	0.0	4.2	0.4	0.9	24.1	0.0	16.1	0.0	0.0	2.1	0.0	6.4	38.5	0.0	0.0	0.0	0.0	15.1	0.2	3.7	2.5	0.1	0.0	0.0	0.0	0.0	11.5	0.2	0.1	4.9	1706.0	3.4	0.1	0.0	18.6	18.5	14.0	9.5	0.1	18.4	370.7	0.1	17.3	14.0	0.0	0.0	0.0	1.1	0.2	0.0	0.2	0.1	1.0	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.6	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.5	22.4	15.1	0.0	0.9	38.2	77.1	20.0	104.7	0.2	48.2	30.5	2.5	17.2	18.2	22.0	0.0	35.7	0.7	25.6	9.8	35.6	0.0	30.2	5.3	2.6	14.4	0.0	0.3	19.4	27.4	3.1	27.0	41.8	1.3	0.5	0.4	5.1	2.8	0.0	0.0	19.7	40.7	0.0	2.3	0.0	2.8	1.3	5.4	0.0	1.6	0.4	0.0	0.0	0.0	26.7	26.0	1.2	0.3	79.0	28.3	13.8	20.9	0.1	0.0	0.9	2.1	0.4	0.3	124.7	41.9	98.6	1.4	0.0	21.1	79.7
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492439-101669726	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 32.1;Respiratory ciliated cells: 28.8;Squamous epithelial cells: 27.1;Suprabasal keratinocytes: 26.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 39.3;CACO-2: 28.0;HaCaT: 46.3;hTCEpi: 35.5;MCF7: 32.7;OE19: 37.9;RT4: 68.9;T-47d: 79.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.1	0.0	0.0	1.0	0.0	0.0	12.3	0.0	0.3	6.9	0.0	8.0	4.0	1.7	16.1	20.4	8.5	3.3	0.0	0.0	0.0	6.3	0.4	5.6	0.0	0.0	0.0	0.0	11.1	9.3	0.8	6.7	0.0	23.2	9.2	0.0	14.8	7.2	0.0	28.6	4.3	0.4	0.0	0.1	9.8	0.3	0.0	2.9	10.2	0.0	4.6	7.7	10.4	0.0	39.3	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	28.0	18.9	0.0	0.0	0.1	0.0	46.3	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.0	0.3	0.2	37.9	0.0	0.0	0.0	0.1	0.0	68.9	1.9	0.0	0.0	15.0	0.0	4.4	79.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	32.1	13.0	0.3	0.0	24.3	10.5	7.6	20.5	0.0	14.4	6.1	0.7	17.2	20.8	11.0	0.0	14.0	0.2	10.3	5.9	7.5	2.4	20.0	1.5	0.8	1.2	0.0	0.8	5.5	7.1	0.8	15.3	20.7	0.0	0.0	0.0	0.0	1.4	0.0	1.3	9.8	2.0	0.0	1.1	9.3	0.0	0.3	1.8	0.0	0.6	0.0	0.0	2.0	0.5	8.8	8.5	0.0	1.3	9.3	5.7	0.1	28.8	0.0	0.0	0.5	1.0	0.1	0.0	27.1	26.0	19.8	0.3	0.1	11.0	6.3
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GRID2	"GluD2, GluR-delta-2"	ENSG00000152208	"Glutamate ionotropic receptor delta type subunit 2"	O43424	4	92303966-93810157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 40.2;testis: 34.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 380.6;Excitatory neurons: 787.2;Inhibitory neurons: 982.0;Late spermatids: 674.2;Microglial cells: 382.2;Oligodendrocyte precursor cells: 2319.7;Oligodendrocytes: 453.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.8"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 7.7;U-266/70: 3.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 68.3"	"HPA056253, HPA058538"	Enhanced					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA056253: AB_2683079, HPA058538: AB_2683747"	"unprognostic (2.78e-1)"			"unprognostic (1.29e-4)"	"unprognostic (7.23e-3)"			"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.38e-3)"		0.0	2.2	5.6	0.0	6.2	0.0	0.0	40.2	4.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	3.1	10.7	0.1	0.0	0.0	0.0	4.6	5.3	2.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	4.9	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.1	34.0	14.2	0.0	0.0	0.2	0.0	0.1	0.1	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	3.5	0.0	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.2	40.2	4.0	3.1	10.7	4.6	5.3	4.8	3.4	14.2	3.8	0.0	0.0	0.0	86.8	0.0	0.0	0.0	0.0	2.2	108.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	380.6	0.0	0.1	1.5	0.0	0.0	787.2	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.1	28.6	982.0	0.0	0.0	0.0	0.0	674.2	5.0	0.2	0.0	382.2	0.0	115.3	0.0	2319.7	453.5	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	7.7	6.6	0.0	1.2	3.7	2.9	0.2	0.0	0.0	0.0	6.4	0.0	0.0
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	101181257-102070083	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"brain: 93.3"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 724.6;Inhibitory neurons: 2376.0;Oligodendrocyte precursor cells: 1234.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.9"	"Region enhanced"	"Detected in all"		"cerebellum: 93.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.4;BJ hTERT+: 26.6;fHDF/TERT166: 20.8;HAP1: 10.2;SiHa: 11.1;WM-115: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"	"unprognostic (1.43e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-4)"	0.2	1.8	18.7	0.4	20.3	0.3	0.2	93.3	25.2	1.4	0.0	0.5	0.6	0.4	1.1	0.4	0.3	0.5	4.5	20.7	28.4	0.8	0.1	0.1	0.1	1.0	6.8	0.4	2.6	0.0	1.6	2.4	7.9	0.9	0.4	4.2	0.7	1.2	0.9	1.6	0.6	0.3	1.6	0.4	0.3	0.7	19.8	0.0	3.4	0.1	0.0	0.5	0.4	7.6	0.1	0.1	3.1	0.2	3.6	0.1	0.0	16.4	26.6	0.8	0.5	0.0	0.3	0.1	0.0	20.8	0.0	5.1	10.2	0.0	0.3	0.0	0.0	1.7	8.5	0.0	0.9	0.0	0.2	0.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.2	2.7	0.0	0.2	0.1	0.4	0.1	0.7	0.0	3.3	7.0	11.1	0.0	0.5	0.5	0.0	0.8	0.0	2.1	0.5	0.1	1.3	0.1	0.0	0.1	1.5	0.0	24.6	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	18.7	20.3	93.3	25.2	20.7	28.4	1.0	6.8	7.9	1.6	19.8	7.6	0.2	0.0	0.5	54.9	0.0	0.6	1.0	0.1	0.6	11.4	0.1	0.0	5.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.8	3.4	1.9	0.4	1.8	0.0	724.6	0.6	0.0	1.8	0.0	0.5	0.0	13.0	0.0	0.0	0.1	0.0	2376.0	0.0	0.0	0.0	0.0	7.7	0.3	0.1	1.8	38.4	0.0	0.5	0.0	1234.0	40.5	0.1	1.1	0.4	0.0	0.8	0.1	0.0	2.2	1.1	0.0	0.7	4.6	0.0	0.5	0.1	0.6	0.0	0.0	4.3	0.1	0.9
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034515	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;intestine: 7.8;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 39.1;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 72.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 13.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.60e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.08e-2)"	0.5	1.9	12.1	0.6	10.3	0.0	2.4	3.2	5.4	1.0	0.0	7.8	0.7	0.2	1.8	1.2	0.3	0.8	1.1	11.2	9.9	0.1	0.0	0.1	0.1	15.7	9.0	0.3	0.5	0.6	9.2	0.0	17.0	1.6	1.3	4.4	0.8	2.4	0.1	0.3	2.2	0.6	1.8	0.2	1.5	0.7	8.4	0.0	0.2	0.4	0.4	1.0	0.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.4	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	10.3	3.2	5.4	11.2	9.9	15.7	9.0	17.0	1.8	8.4	8.3	0.1	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.7	1.9	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	39.1	0.0	0.0	0.7	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	108.1	0.0	0.0	0.0	0.3	6.9	0.3	0.0	1.8	1.0	0.0	14.3	0.0	72.9	1.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 132.6;Inhibitory neurons: 134.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	0.0	0.1	15.7	0.2	46.4	0.0	0.2	0.0	186.7	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	35.9	0.0	0.0	0.0	0.1	0.1	1.3	19.5	0.0	0.1	0.2	0.7	0.0	3.8	0.7	0.0	3.7	1.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.4	0.0	1.9	0.0	2.5	0.0	0.0	5.2	3.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	46.4	0.0	186.7	35.9	0.0	1.3	19.5	3.8	0.0	0.0	35.6	0.0	0.0	0.0	8.5	0.0	0.0	0.3	0.1	0.0	28.0	1.2	0.9	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.9	0.2	0.1	0.2	1.8	0.0	132.6	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.7	134.4	1.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	9.4	2.0	1.7	0.0	10.1	7.6	0.2	0.1	0.0	0.0	0.7	0.5	0.1	0.3	7.8	0.0	0.0	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345246-44353106	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1420.7;Kupffer cells: 892.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 2057.5;intermediate monocyte: 1122.4;myeloid DC: 1534.2;neutrophil: 851.2;non-classical monocyte: 548.1;plasmacytoid DC: 1331.9"	"Group enriched"	"Detected in all"	9	"dendritic cells: 1534.2;granulocytes: 851.2;monocytes: 2057.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	138000000	110000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	158.9	123.2	61.5	160.4	67.2	478.5	120.7	67.7	97.3	156.7	73.9	189.8	130.9	108.3	134.0	534.0	87.1	157.3	153.0	61.0	69.7	167.4	118.9	309.5	183.2	81.0	71.5	73.8	108.9	87.8	84.4	183.2	87.6	111.7	110.3	12.5	262.9	100.6	60.6	189.7	179.0	91.9	71.8	349.8	127.9	59.4	94.3	67.8	127.7	45.9	107.8	150.0	198.3	97.3	119.3	197.5	52.7	159.5	443.2	231.8	181.2	147.3	447.5	231.6	309.8	86.3	294.0	364.0	299.4	217.6	312.9	185.3	68.6	334.5	75.8	55.8	186.8	38.4	93.8	175.2	245.5	61.6	493.6	332.4	450.5	188.1	106.0	391.2	269.8	64.3	75.1	51.3	148.8	183.1	32.8	172.8	44.3	110.5	334.0	97.7	180.8	433.0	248.2	145.9	54.7	74.7	201.0	92.7	360.9	138.0	209.4	229.0	340.7	437.6	104.6	300.5	97.8	116.3	313.9	122.3	268.1	149.6	124.2	215.1	2057.5	176.5	35.1	1122.4	27.8	174.0	37.1	31.1	1534.2	112.2	27.8	26.5	851.2	30.6	548.1	1331.9	55.4	1613.4	61.5	67.2	67.7	97.3	61.0	69.7	81.0	71.5	87.6	71.8	94.3	97.3	113.0	86.6	83.3	12.7	82.8	112.7	151.1	574.2	97.9	23.6	85.7	69.7	90.7	133.0	332.7	218.8	18.8	429.1	195.7	494.8	9.8	447.7	2.1	103.8	83.8	170.9	124.3	38.7	6.8	307.3	324.1	149.4	83.6	372.5	75.5	90.0	207.8	84.7	1420.7	47.1	6.6	214.6	146.5	892.0	360.8	6.8	60.9	699.2	208.1	20.6	501.6	58.9	20.6	11.1	11.8	285.3	581.7	57.2	65.8	70.7	312.1	120.5	70.0	11.8	85.5	45.4	83.3	25.1	72.2	255.5	96.5	640.0	30.8	89.6	274.5	175.6
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787528-28063714	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.5;heart muscle: 23.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 8.3;THP-1: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.2	0.2	15.6	0.1	19.4	0.2	0.1	9.4	19.5	0.2	4.4	0.4	0.3	0.3	0.3	0.1	1.5	0.0	23.0	17.9	11.0	0.3	0.4	0.4	0.1	21.8	20.0	0.1	0.1	0.0	0.5	0.9	19.0	0.2	0.1	2.4	0.2	0.1	0.3	0.8	0.4	0.0	12.5	0.3	1.1	1.6	22.5	0.0	0.3	0.0	0.0	0.4	0.1	11.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	3.2	0.7	0.0	0.5	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	19.4	9.4	19.5	17.9	11.0	21.8	20.0	19.0	12.5	22.5	11.8	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.1	8.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	7.4	0.1	0.0	0.0	26.0	0.0	0.0	1.8	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	7.4	0.4	0.0	0.0	0.0	3.6	0.0	0.1	0.0	4.7	0.0	0.2	0.0	89.5	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.7	0.3	0.5	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 2486.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1649.5;Fibroblasts: 4145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 1135.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1313.9;HaCaT: 533.6"	"Region enriched"	"Detected in all"	4	"white matter: 869.2"	"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	NA	NA	112000000000	240000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: AB_2682347"	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.79e-5)"	1892.9	162.5	169.7	109.7	317.4	175.0	1244.6	291.2	213.0	577.4	155.6	867.4	152.0	767.7	108.2	435.1	663.2	226.1	2486.9	163.4	219.8	153.1	40.6	308.7	93.2	380.9	284.6	303.8	140.7	70.9	260.6	79.0	354.7	344.0	204.6	57.8	508.7	400.9	420.4	612.9	384.1	350.0	270.6	136.5	469.7	78.1	279.0	99.7	702.6	687.8	87.3	897.2	655.5	376.1	38.4	60.9	39.0	129.8	1313.9	351.8	26.4	130.9	264.7	30.1	56.5	64.2	130.1	3.0	36.6	182.8	48.5	533.6	3.2	84.3	16.9	6.5	7.6	31.2	57.1	167.5	32.0	7.0	146.0	140.0	84.9	51.7	34.4	83.1	120.4	6.1	10.4	5.3	137.0	81.1	0.4	304.4	12.7	76.2	45.1	8.4	13.1	4.3	156.4	63.4	7.7	10.4	60.9	62.5	197.2	84.6	245.3	158.8	217.4	100.0	33.2	10.4	12.8	1.8	2.0	3.2	105.3	18.2	278.1	302.9	122.0	1135.9	1.9	84.9	0.8	17.6	0.8	1.4	345.3	6.7	0.8	0.7	307.1	217.8	23.7	243.2	4.2	105.4	169.7	317.4	291.2	213.0	163.4	219.8	380.9	284.6	354.7	270.6	279.0	376.1	1649.5	147.4	55.7	82.3	22.7	341.2	278.1	252.7	103.0	7.5	120.8	212.0	272.0	85.8	354.3	121.4	77.2	55.8	74.9	557.7	105.7	258.5	9.9	141.9	163.1	724.8	63.1	17.2	17.1	202.3	94.3	4145.2	322.7	220.6	104.0	31.8	273.5	16.5	492.6	1.7	9.0	762.9	512.7	139.0	798.7	20.2	588.7	273.7	537.2	155.5	487.5	220.6	55.6	33.2	443.1	315.8	590.5	671.8	24.1	91.4	77.4	39.8	583.7	86.5	611.4	362.4	740.4	8.7	13.7	175.9	299.1	84.0	58.7	34.3	52.2	144.7
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296870-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 11.2;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 52.2;Extravillous trophoblasts: 31.2;Granulosa cells: 27.1;Spermatocytes: 73.6;Spermatogonia: 27.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	0.6	0.6	0.2	5.1	0.2	11.2	0.5	0.5	0.3	0.7	0.2	2.4	4.1	0.8	0.0	3.6	0.2	0.5	0.3	0.2	0.3	0.3	0.4	0.6	9.2	0.4	0.3	0.2	0.2	0.1	0.1	2.6	0.4	0.2	2.6	0.1	0.7	0.1	0.1	2.5	2.9	1.2	0.1	2.4	1.9	7.2	0.5	19.6	0.2	0.2	8.7	1.0	1.2	0.4	59.5	27.6	53.2	42.2	1.1	3.0	25.5	50.3	23.5	71.7	58.8	29.3	21.9	55.7	13.0	19.4	32.8	30.3	48.0	12.7	45.7	33.7	52.0	37.4	38.9	22.8	0.1	67.5	43.8	0.6	1.0	30.9	15.6	7.5	31.2	39.7	29.0	67.8	43.4	33.1	60.9	33.0	37.2	24.2	30.7	59.6	59.7	36.3	11.7	10.7	27.5	37.5	48.1	30.7	21.5	23.8	26.2	25.8	25.1	40.6	75.8	33.4	53.7	38.6	19.7	56.3	25.8	32.2	60.5	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.4	0.3	0.2	0.2	0.2	0.5	0.3	0.2	0.3	0.4	0.3	0.4	0.1	0.5	0.4	1.1	0.0	0.0	0.7	7.0	2.8	1.1	2.1	0.6	0.7	2.8	3.4	1.6	0.0	0.5	0.0	0.0	19.2	6.8	7.6	0.0	0.9	5.6	2.1	4.7	3.9	1.2	52.2	0.3	0.2	31.2	5.1	16.8	4.3	0.0	27.1	6.4	1.2	19.9	0.0	0.5	9.4	2.0	7.5	4.0	3.9	0.3	4.7	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.8	0.2	0.7	19.1	1.8	0.5	0.5	0.2	0.3	6.6	2.6	5.4	73.6	27.8	11.7	2.6	1.5	5.0	1.2	13.8	1.6
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162690-42164745	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"intestine: 927.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 3728.7;Paneth cells: 17085.1;Proximal enterocytes: 12113.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 52.1"	"Not detected"	"Not detected"							HPA018215	Enhanced				"Secreted to blood"	NA	NA		18000000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.8	0.1	0.0	3.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	716.9	56.5	0.9	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.4	0.2	1.2	0.7	0.0	0.0	0.1	1.2	0.0	0.2	7.3	0.0	0.1	725.9	0.0	0.0	2.0	0.1	0.0	927.5	17.2	0.0	0.2	0.7	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3728.7	0.0	2.6	0.1	0.0	0.0	0.0	47.7	0.0	0.0	1.1	4.4	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17085.1	0.0	0.0	0.0	12113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	3.8	0.0	206.6	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153410-42155820	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 143.1"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 18841.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 1.4;CACO-2: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"						"Secreted to blood"	NA	NA	77700	1200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	89.4	36.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	5.5	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	23.3	0.0	0.0	0.6	0.0	0.1	143.1	0.6	0.0	0.0	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1098.8	0.0	0.9	1.0	0.0	0.0	0.0	22.8	0.0	0.0	47.9	0.3	0.0	0.0	0.0	22.3	0.0	0.4	3.1	0.1	0.0	0.0	107.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	18841.5	0.0	0.0	0.0	2568.9	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	55.3	0.9
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.0;JURKAT: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	5.6	6.0	0.9	16.7	0.9	35.3	7.2	0.9	2.5	7.6	1.2	14.7	29.2	14.7	8.8	4.8	4.6	14.0	4.0	0.8	1.0	3.2	15.2	21.9	68.1	1.6	0.9	4.5	1.0	1.3	1.0	3.1	1.1	3.1	17.8	0.0	7.1	3.0	1.7	1.6	27.6	7.2	1.1	51.1	11.7	2.0	1.1	12.4	2.9	1.3	19.2	13.5	2.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	3.8	941.4	2.3	926.2	3.4	250.0	922.7	3.1	1.3	48.5	494.1	19.9	718.8	4.0	3.2	33.1	712.7	0.9	0.9	0.9	2.5	0.8	1.0	1.6	0.9	1.1	1.1	1.1	1.1	5.1	3.2	18.1	0.0	12.3	0.4	0.1	0.0	2.8	0.0	2.7	2.4	1.6	5.7	3.1	0.0	0.0	0.4	739.3	1.4	0.0	1.6	0.0	1.7	2.7	2.8	0.0	36.2	0.0	0.0	0.2	7.8	20.4	2.1	7.6	0.0	17.9	2.8	0.3	0.0	0.1	1.5	0.0	25.8	2.6	0.0	0.0	12.3	3.6	0.0	12.6	0.0	1543.8	0.0	0.1	0.0	3.9	0.0	40.8	0.1	2.8	3.3	2.9	0.0	0.0	2.6	2.6	0.0	0.1	1.1	1.4	0.7	709.4	0.0	1.8	0.0
GZMH	"CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2"	ENSG00000100450	"Granzyme H"	P20718	14	24606480-24609699	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.9;lymphoid tissue: 25.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 575.2;NK-cells: 492.3;T-cells: 302.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 1678.5;memory CD4 T-cell: 490.7;memory CD8 T-cell: 1389.6;naive CD8 T-cell: 1214.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 1678.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.0"					"Low region specificity"	"Detected in many"			HPA029200	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA029200: AB_10602908"	"unprognostic (3.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.00e-6)"	"unprognostic (8.80e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.77e-3)"	3.4	5.2	1.2	3.1	1.3	33.9	4.6	1.3	2.4	2.6	1.6	2.7	2.4	2.0	5.0	3.6	3.5	7.0	2.5	1.1	1.3	1.2	6.7	15.9	25.2	2.0	1.2	2.8	0.8	0.7	2.4	1.6	1.5	1.4	2.5	0.0	7.9	2.1	1.9	0.6	2.8	3.4	1.3	24.4	4.7	0.8	1.4	3.8	1.5	0.6	4.5	7.5	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.2	31.6	3.4	1.7	1678.5	3.6	30.2	7.6	490.7	1389.6	3.3	4.6	155.1	1214.0	18.6	250.8	5.4	44.6	4.5	1436.5	1.2	1.3	1.3	2.4	1.1	1.3	2.0	1.2	1.5	1.3	1.4	1.3	2.9	0.0	4.6	0.0	3.3	1.1	0.1	0.0	0.0	0.0	1.7	1.5	1.4	8.6	0.0	0.0	0.0	0.1	575.2	0.0	0.0	0.1	0.1	0.3	0.3	1.5	0.0	8.6	0.0	0.0	0.0	1.2	1.1	0.4	1.3	0.0	7.5	1.2	0.1	0.0	0.0	0.0	0.0	9.3	3.4	0.2	0.0	4.5	3.6	1.9	3.1	0.0	492.3	0.0	0.1	0.0	0.0	0.0	43.7	0.2	0.0	2.6	0.7	0.0	0.0	1.9	1.3	0.1	0.0	0.4	1.8	0.0	302.2	0.0	0.1	0.1
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024256-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 99.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.3;T-cells: 301.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 741.6;NK-cell: 505.5"	"Group enriched"	"Detected in many"	199	"NK-cells: 505.5;T-cells: 741.6"	"Cell line enriched"	"Detected in single"	10	"JURKAT: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	3.0	3.9	0.1	19.4	0.1	10.5	4.9	0.1	0.4	4.3	0.3	3.4	1.6	4.0	4.5	3.0	2.0	11.6	2.0	0.1	0.2	1.7	10.7	5.9	99.6	0.5	0.2	2.7	1.0	0.8	0.5	0.5	0.3	3.2	4.6	0.0	4.6	1.0	0.2	0.6	7.3	2.2	0.2	30.4	6.5	1.2	0.3	11.9	2.3	0.3	27.8	8.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.9	1.1	164.3	1.0	741.6	0.5	100.2	457.3	0.5	0.5	4.9	77.4	3.1	505.5	0.9	0.9	7.0	95.5	0.1	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.3	0.2	0.3	0.3	3.8	3.2	7.0	0.0	10.7	1.5	0.1	0.0	1.8	0.0	1.5	1.7	0.1	2.8	0.6	0.0	0.0	0.0	136.3	0.1	0.0	0.0	1.3	0.8	0.4	0.8	0.0	4.4	0.0	0.0	0.0	1.2	4.1	0.8	2.5	0.0	8.6	1.5	0.2	0.0	0.0	0.0	0.0	10.3	2.5	1.2	0.0	6.4	1.8	0.0	5.1	0.0	29.9	0.0	0.1	0.0	0.0	0.0	45.1	0.1	0.2	0.8	0.0	0.0	0.0	1.8	1.7	0.0	0.3	0.2	0.6	0.3	301.9	0.0	0.0	0.1
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.6;lymphoid tissue: 22.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 385.8;NK-cells: 810.5;T-cells: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 583.9"	"Group enriched"	"Detected in all"	33	"NK-cells: 194.9;T-cells: 583.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HDLM-2: 1.7;HMC-1: 2.1;JURKAT: 3.5;MOLT-4: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015624	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015624: AB_2669245"	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	2.2	1.1	0.9	10.0	0.9	21.6	1.1	3.6	2.0	1.4	0.3	1.5	2.1	0.8	0.2	0.8	1.3	1.8	0.8	0.9	0.9	1.0	3.3	5.3	19.2	1.0	0.8	0.7	0.4	0.0	0.9	0.4	1.0	1.3	0.3	0.2	2.8	0.4	0.7	0.8	6.2	0.2	0.7	22.7	3.7	1.8	0.9	8.7	1.6	0.1	3.8	1.5	1.4	1.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.1	0.0	0.4	1.3	0.6	0.3	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.1	0.5	0.1	0.3	0.1	9.1	1.4	1.3	583.9	1.7	366.5	0.9	189.2	471.3	1.5	4.0	182.8	379.2	11.9	194.9	2.3	3.6	99.1	227.5	0.9	0.9	3.6	2.0	0.9	0.9	1.0	0.8	1.0	0.7	0.9	1.0	3.4	0.0	0.0	0.3	5.7	3.1	0.1	0.0	0.6	0.5	2.4	2.2	0.1	1.5	0.0	0.0	0.0	0.2	385.8	0.1	0.0	0.4	0.9	0.6	1.5	1.4	0.0	12.0	0.3	0.4	0.4	2.2	13.3	1.1	0.0	0.1	3.6	1.4	0.2	0.0	0.2	0.4	0.0	3.7	4.7	1.6	0.0	5.9	1.8	1.0	8.6	1.6	810.5	0.5	0.3	0.3	0.0	0.0	35.8	0.1	0.0	1.2	0.0	1.4	0.0	1.5	1.2	0.5	1.1	0.9	1.4	0.5	243.6	0.2	0.1	0.1
HACD1	"CAP, PTPLA"	ENSG00000165996	"3-hydroxyacyl-CoA dehydratase 1"	B0YJ81	10	17589032-17617374	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Developmental protein, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 73.0"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 143.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"T-reg: 55.7"	"Lineage enriched"	"Detected in many"	12	"T-cells: 55.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.73e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.10e-1)"	"unprognostic (5.67e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.49e-2)"	9.7	7.0	3.1	5.0	3.5	8.0	8.8	10.7	4.6	6.8	2.9	31.9	2.8	22.1	3.3	7.8	10.3	3.6	73.0	3.0	6.5	5.0	1.6	9.7	1.3	5.5	5.2	4.3	2.7	0.5	3.7	1.6	5.0	11.9	3.8	2.3	2.7	16.7	36.5	3.0	6.9	25.4	2.4	1.7	15.0	3.5	4.7	2.6	7.6	16.5	1.2	18.1	6.8	8.4	29.3	24.6	6.8	33.4	30.1	5.8	0.6	40.5	24.4	51.9	48.5	16.4	34.6	0.2	5.9	66.4	74.5	7.1	17.3	12.3	28.6	19.1	10.4	67.1	18.4	45.6	39.0	0.3	4.8	14.0	17.2	29.9	11.6	39.8	10.1	35.1	0.6	1.3	69.0	21.0	50.4	6.7	14.6	2.2	6.6	44.7	7.1	0.8	20.5	5.6	7.5	19.1	34.6	0.6	58.9	21.2	24.2	16.7	9.8	30.3	17.4	18.7	18.8	0.9	0.8	0.3	22.3	7.7	4.3	4.7	0.9	0.7	1.2	0.1	0.3	0.4	5.0	1.0	3.0	1.3	0.9	0.7	2.6	3.3	0.3	1.5	55.7	1.3	3.1	3.5	10.7	4.6	3.0	6.5	5.5	5.2	5.0	2.4	4.7	8.4	2.4	28.9	15.0	0.3	0.4	0.0	23.1	0.0	8.0	0.8	6.9	21.6	143.7	10.0	2.5	31.3	0.0	0.5	4.4	0.4	3.9	16.5	11.1	5.6	8.0	5.4	3.6	29.2	10.4	8.0	1.9	7.1	8.2	12.4	6.3	17.5	20.7	1.0	5.4	0.0	11.7	2.5	0.0	2.2	0.0	2.7	1.8	3.6	0.0	5.6	0.8	0.5	1.0	2.5	31.8	15.6	0.8	0.7	0.6	23.9	0.5	2.3	0.7	0.6	0.0	5.7	32.5	7.4	5.2	17.7	0.0	3.0	2.9	10.8	3.5	6.2
HAPLN3	"EXLD1, HsT19883"	ENSG00000140511	"Hyaluronan and proteoglycan link protein 3"	Q96S86	15	88877294-88895597	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 966.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 50.9"	"Lineage enriched"	"Detected in all"	5	"T-cells: 50.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.7;U-2 OS: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039237	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA039237: AB_10805357"	"unprognostic (1.67e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.21e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.13e-3)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.18e-13)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.12e-1)"	10.3	1.9	2.1	11.5	2.0	3.1	8.6	1.9	2.7	5.1	2.1	3.2	0.6	4.3	0.1	6.1	6.2	2.7	4.6	2.1	2.0	6.1	0.9	9.7	11.7	2.4	2.1	2.7	1.4	0.5	2.2	1.4	2.5	5.7	0.4	4.2	6.0	0.7	3.6	6.2	4.6	2.7	2.3	5.7	3.5	1.0	2.4	2.9	4.6	0.6	3.2	6.9	5.6	2.1	2.0	7.0	1.3	15.4	4.4	4.2	4.7	4.4	1.0	1.6	2.0	4.4	6.4	0.0	11.9	5.4	2.5	1.7	14.7	1.9	0.0	34.7	12.9	4.9	0.3	0.0	0.6	0.0	0.1	1.6	0.8	3.0	0.2	0.2	7.1	0.6	0.1	9.3	0.8	0.2	0.1	0.0	11.2	0.0	0.2	0.0	0.6	11.5	2.9	0.1	0.1	4.2	0.9	0.7	6.1	1.9	0.0	0.6	1.3	10.8	31.2	8.1	0.7	1.1	0.1	0.1	3.8	0.0	9.3	1.4	1.1	0.0	1.2	0.8	5.4	0.2	18.3	7.4	2.2	1.5	18.3	8.6	0.3	10.1	0.2	0.8	50.9	5.9	2.1	2.0	1.9	2.7	2.1	2.0	2.4	2.1	2.5	2.3	2.4	2.1	16.0	0.0	3.4	1.3	4.0	32.0	10.8	13.5	4.6	2.5	47.1	42.4	9.3	1.5	10.4	1.8	10.4	5.8	3.2	0.5	0.0	5.3	0.0	6.3	3.7	29.4	0.0	0.0	1.3	2.0	966.2	8.5	1.5	12.1	1.3	2.5	3.3	0.1	19.3	0.0	0.1	0.9	6.1	0.3	22.0	0.2	0.9	3.0	17.8	2.8	9.7	3.8	3.1	0.5	0.1	9.9	0.1	0.7	0.5	10.4	0.0	0.2	2.7	103.8	13.1	7.2	24.5	0.3	2.1	6.3	24.2	20.4	9.4	0.2	0.5	7.8
HASPIN	GSG2	ENSG00000177602	"Histone H3 associated protein kinase"	Q8TF76	17	3723903-3726699	"Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 5.3;testis: 7.3"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA027422, HPA030698"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA027422: AB_10601812, HPA030698: AB_2673575"	"unprognostic (1.15e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.75e-3)"	"unprognostic (3.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.65e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	0.2	0.1	0.0	1.8	0.2	6.0	0.4	0.0	0.1	0.2	0.2	1.1	1.5	0.2	0.1	1.3	0.3	0.2	0.1	0.0	0.0	0.1	0.1	1.4	4.2	0.1	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	1.0	0.0	0.4	0.0	0.6	0.7	1.8	0.4	0.0	1.7	0.9	7.3	0.2	5.3	0.3	0.1	5.1	0.3	0.5	0.2	11.3	12.2	11.1	12.5	0.7	1.4	9.3	10.2	7.8	19.7	19.3	9.6	4.6	27.7	5.7	5.7	7.9	18.0	20.1	9.9	18.7	0.1	16.7	13.8	9.9	5.8	0.5	8.1	13.7	0.9	0.8	14.9	9.2	2.4	9.1	21.6	12.4	23.7	10.1	5.9	16.4	4.8	9.8	8.7	8.3	16.8	13.9	7.4	3.0	7.8	4.4	6.5	8.9	6.1	3.5	9.6	6.1	7.5	4.7	8.7	9.9	9.8	18.1	4.5	5.4	13.4	5.1	11.5	10.7	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.2	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
HAVCR2	"CD366, FLJ14428, Tim-3, TIM3, TIMD3"	ENSG00000135077	"Hepatitis A virus cellular receptor 2"	Q8TDQ0	5	157085832-157142869	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.6;granulocytes: 80.6;Hofbauer cells: 148.3;Kupffer cells: 89.1;Langerhans cells: 67.8;Macrophages: 83.2;monocytes: 49.5;NK-cells: 70.0;Proximal tubular cells: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 53.8;intermediate monocyte: 57.9;myeloid DC: 137.9;NK-cell: 97.1;non-classical monocyte: 36.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 137.9;monocytes: 57.9;NK-cells: 97.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.8;Daudi: 6.4;HDLM-2: 26.3;HMC-1: 6.0;RPMI-8226: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB026003	Enhanced					NA	NA		9900000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB026003: "	"unprognostic (2.50e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.34e-1)"	14.2	8.2	9.5	19.7	11.1	13.9	5.3	11.1	13.3	4.9	10.4	5.4	4.0	3.2	6.0	3.7	3.3	12.8	2.5	9.1	11.8	26.8	9.8	22.6	32.1	18.0	13.7	1.7	3.0	2.8	1.8	16.9	16.9	2.1	6.8	1.2	2.9	2.9	1.7	2.2	4.9	7.9	16.1	24.1	4.7	2.0	17.5	9.1	1.6	2.1	14.0	13.1	1.2	27.2	0.0	0.2	0.1	0.2	7.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	6.4	0.3	0.0	0.2	0.1	0.0	0.0	0.0	26.3	0.0	1.1	0.1	0.0	0.0	0.0	6.0	0.4	0.4	0.0	0.2	0.0	0.0	0.7	0.1	2.3	0.0	0.1	0.1	3.9	0.2	0.0	0.0	0.1	3.0	21.5	0.3	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.2	0.3	0.0	0.9	0.3	0.3	0.0	0.3	1.8	0.2	0.1	0.7	0.1	16.7	53.8	0.1	14.6	57.9	3.0	1.2	5.9	7.9	137.9	0.5	7.0	9.5	2.5	97.1	36.1	16.4	11.5	43.1	9.5	11.1	11.1	13.3	9.1	11.8	18.0	13.7	16.9	16.1	17.5	27.2	1.2	6.4	6.5	2.0	5.9	1.0	0.2	0.1	0.0	0.9	0.7	1.5	1.1	0.0	1.9	0.0	0.0	0.6	87.6	0.3	7.9	0.1	11.1	0.1	0.1	3.7	0.0	1.3	2.1	0.0	0.8	0.9	0.5	0.1	80.6	0.1	1.1	0.5	148.3	0.0	1.7	0.3	0.0	89.1	67.8	7.8	0.3	83.2	3.6	31.9	49.5	0.1	70.0	1.0	4.8	0.1	0.1	0.0	16.3	0.5	0.1	57.7	0.0	0.2	6.6	0.7	0.5	0.3	0.4	0.1	1.3	1.1	26.3	1.5	0.2	0.3
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052197-32101856	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 112.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 150.7;Kupffer cells: 155.5;Langerhans cells: 89.2;Macrophages: 170.1;Microglial cells: 52.5;monocytes: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 575.0;eosinophil: 707.8;intermediate monocyte: 1059.1;myeloid DC: 336.3;neutrophil: 801.3;non-classical monocyte: 1251.7"	"Group enriched"	"Detected in all"	16	"dendritic cells: 336.3;granulocytes: 801.3;monocytes: 1251.7"	"Group enriched"	"Detected in some"	9	"THP-1: 69.3;U-937: 199.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB005195, HPA035534, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane, Cytosol"	"CAB005195: AB_631619, HPA035534: , HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	24.8	9.2	4.7	100.0	5.0	55.2	6.0	5.5	6.0	5.5	13.7	12.8	15.2	3.1	2.6	6.7	7.6	14.4	4.8	4.7	6.2	4.7	14.1	46.0	38.6	9.9	6.8	2.5	4.5	2.1	3.1	20.9	8.3	4.0	13.6	0.5	5.1	4.7	1.6	5.8	17.8	25.3	8.1	112.1	6.7	2.3	8.4	14.5	2.8	6.9	39.3	32.8	4.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.1	0.1	1.3	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	15.6	0.0	0.1	0.1	4.9	0.4	0.0	0.0	0.4	0.2	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.7	0.0	69.3	0.0	0.0	0.3	0.0	0.1	1.9	0.3	10.3	0.0	199.6	0.0	6.4	575.0	707.8	1.1	1059.1	1.3	48.4	1.1	1.1	336.3	43.0	1.1	0.9	801.3	11.0	1251.7	30.4	1.2	566.4	4.7	5.0	5.5	6.0	4.7	6.2	9.9	6.8	8.3	8.1	8.4	12.0	0.6	6.4	14.0	0.0	17.1	3.1	4.0	0.2	0.6	0.1	0.4	1.3	2.0	1.5	3.9	7.3	0.0	0.9	12.1	0.2	1.9	0.1	2.5	0.1	0.1	3.7	1.8	1.7	1.2	0.6	0.9	1.3	4.6	0.1	6.3	0.1	1.1	2.3	150.7	0.0	1.0	0.5	22.4	155.5	89.2	0.3	0.0	170.1	1.8	52.5	222.0	0.0	4.1	1.5	0.6	0.0	0.0	0.0	0.7	0.5	0.1	0.3	1.5	0.1	0.0	0.6	0.5	0.2	0.3	0.2	1.1	1.6	3.0	0.2	0.9	3.7
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 153.6;lymphoid tissue: 300.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 175.7;Kupffer cells: 666.3;Macrophages: 269.0;monocytes: 245.7;NK-cells: 216.3;T-cells: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 265.6;HMC-1: 362.3;RPMI-8226: 256.5;THP-1: 262.8;U-266/70: 361.6;U-698: 371.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		870000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	67.0	32.9	14.6	147.2	14.7	153.6	25.5	15.4	18.7	20.7	15.8	29.2	21.2	13.7	6.4	15.7	21.5	37.8	18.4	14.3	17.0	21.5	39.1	52.7	207.6	21.6	17.5	9.4	11.9	7.7	14.6	51.4	20.8	15.8	31.4	2.3	16.0	11.1	7.3	11.1	68.7	34.6	18.5	300.3	27.1	4.5	18.2	140.3	15.4	18.8	242.8	53.0	13.7	23.0	0.8	0.0	0.2	0.1	20.9	11.5	5.7	4.1	4.0	0.8	1.6	0.1	0.0	265.6	124.6	0.0	0.2	0.3	6.9	9.9	1.1	120.6	0.0	172.6	0.0	0.0	11.6	192.4	362.3	2.2	0.5	0.0	1.5	0.0	153.4	106.2	35.1	235.9	0.0	0.0	137.9	162.9	0.3	0.2	4.5	137.1	0.2	256.5	0.0	68.0	0.3	0.2	0.2	0.4	0.6	0.6	0.1	262.8	203.5	0.0	2.0	0.3	0.9	361.6	118.1	371.5	1.9	181.5	0.2	357.3	713.1	1180.9	405.3	870.4	333.0	345.7	334.2	376.8	636.2	313.1	279.3	326.2	1619.2	280.0	997.1	197.4	494.2	1427.9	14.6	14.7	15.4	18.7	14.3	17.0	21.6	17.5	20.8	18.5	18.2	23.0	23.0	9.6	31.8	1.0	175.7	3.2	1.0	7.8	0.6	0.5	2.7	5.1	2.3	4.3	13.1	0.0	0.0	122.4	139.5	0.8	0.0	0.3	1.1	8.8	1.6	23.3	0.0	50.5	1.4	0.2	60.0	7.0	8.6	3.1	73.4	0.7	27.8	7.7	126.9	0.0	0.7	0.4	4.1	666.3	105.8	1.5	3.4	269.0	19.6	26.2	245.7	0.4	216.3	0.5	0.3	0.2	0.2	1.2	148.6	0.4	0.1	0.9	24.7	0.8	13.1	3.7	6.7	0.6	0.6	1.3	4.4	145.4	181.4	2.4	0.5	2.2
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 17.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		0.0	0.4	1.8	0.0	2.5	0.1	0.0	2.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.4	7.2	2.5	1.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	24.5	0.0	0.1	0.1	0.0	0.0	29.4	0.0	0.0	7.4	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	671.7	0.7	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	6.7	766.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.5	0.0	14.8	0.0	21.1	14.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	199.4	0.0	0.3	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589881-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 146.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 60.4;Horizontal cells: 40.4;Inhibitory neurons: 18.7;Oligodendrocytes: 62.1;Rod photoreceptor cells: 14.9"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 29.9;HeLa: 15.8;MCF7: 28.4;U-138 MG: 20.2;U-87 MG: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	0.1	4.2	34.9	0.2	58.1	0.4	0.1	84.7	111.8	0.1	0.0	0.6	0.1	0.1	0.2	1.6	0.0	0.1	11.6	38.2	56.6	1.3	0.2	0.2	0.3	86.6	76.7	0.1	0.3	3.4	12.8	0.1	84.9	0.3	0.0	7.5	0.3	0.1	0.1	0.9	0.4	0.1	38.2	0.4	0.4	3.1	146.0	0.1	0.1	0.0	0.3	0.1	0.4	66.9	0.1	29.9	0.3	1.0	3.1	2.1	1.0	2.1	2.4	0.8	0.2	4.3	0.3	0.0	6.5	2.9	2.1	0.2	0.6	0.1	0.1	5.1	12.6	0.0	15.8	0.4	2.2	0.3	5.6	5.6	0.5	0.2	0.1	0.9	0.1	0.7	1.8	0.2	2.1	28.4	0.1	0.0	1.4	0.7	0.8	0.2	0.1	0.7	0.5	0.9	11.3	5.8	7.3	0.1	2.3	0.5	5.9	1.0	2.8	20.2	3.0	0.4	8.4	0.5	0.4	0.2	41.7	1.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	58.1	84.7	111.8	38.2	56.6	86.6	76.7	84.9	38.2	146.0	66.9	0.5	0.0	0.0	2.0	0.6	0.6	0.0	0.0	1.2	60.4	0.7	0.9	4.1	0.0	0.0	0.0	2.1	0.0	1.6	0.3	0.0	0.1	0.1	0.6	0.4	0.9	1.2	2.7	12.8	0.0	0.3	0.2	0.0	1.2	0.0	0.2	0.7	0.1	0.1	40.4	18.7	0.0	0.0	1.3	0.3	0.4	0.0	1.1	0.0	2.8	0.0	2.7	0.0	5.5	62.1	0.1	0.0	0.7	1.4	0.1	0.0	0.3	0.0	14.9	0.0	0.1	0.5	0.1	1.7	4.5	0.6	0.3	1.2	0.1	0.1	0.1
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50265965	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 102.9;epididymis: 46.1"	"Cell type enriched"	"Detected in some"	12	"granulocytes: 596.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.9;testis cancer: 2.7"	"Region enriched"	"Detected in many"	6	"hypothalamus: 102.9"	"Immune cell enriched"	"Detected in single"	2140	"basophil: 686.2"	"Lineage enriched"	"Detected in single"	2140	"granulocytes: 686.2"	"Group enriched"	"Detected in some"	4	"HEL: 460.8;HMC-1: 1051.3"	"Region enriched"	"Detected in many"	5	"hypothalamus: 43.9"	"Group enriched"	"Detected in some"	10	"hypothalamus: 16.5;midbrain: 4.2"	HPA038891	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	2.3	0.4	0.0	3.5	5.6	4.7	1.4	0.0	0.2	2.3	0.7	3.8	4.1	2.5	46.1	4.8	0.8	11.2	0.7	0.2	102.9	0.4	0.5	6.9	0.9	0.0	13.7	0.1	1.2	0.5	0.4	0.4	0.0	1.7	3.6	0.8	1.3	0.9	0.3	2.3	4.6	2.5	0.0	0.5	12.9	1.3	17.8	0.9	0.1	0.8	1.0	3.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	460.8	0.2	0.0	0.0	1.2	1051.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	181.8	0.3	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.2	0.4	686.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	1.6	0.0	5.6	0.0	0.2	0.2	102.9	0.0	13.7	0.0	0.0	17.8	0.1	0.0	12.8	47.5	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	10.9	0.3	0.0	0.0	2.3	9.2	0.0	596.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.8	0.4	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	3.5	0.0	0.1	0.1
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188534-93226469	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 96.2"	"Group enriched"	"Detected in some"	11	"Enteroendocrine cells: 218.2;Intestinal goblet cells: 387.5;Ionocytes: 349.9;Paneth cells: 318.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.4;pancreatic cancer: 10.7;renal cancer: 10.6;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SCLC-21H: 172.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		Yes	NA		210000		"Cluster 9: Intestine - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Vesicles, Mitotic spindle"	Nucleoplasm	"HPA012381: AB_1853037"	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favorable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.1	0.0	2.3	0.0	2.5	8.9	0.0	0.1	0.0	0.0	64.3	30.1	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	15.2	0.0	0.1	0.0	0.1	0.1	0.0	4.3	0.4	7.3	0.2	0.0	0.8	96.2	0.0	2.6	1.4	0.0	0.0	48.0	1.5	0.1	0.1	10.1	3.2	0.0	0.1	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	172.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.4	0.3	1.1	0.7	0.0	0.0	15.1	6.6	0.2	0.0	0.9	5.5	0.0	0.0	0.0	17.2	9.8	0.1	2.5	0.0	0.0	0.1	218.2	18.7	0.5	0.0	0.0	0.1	27.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	387.5	349.9	0.0	0.0	2.4	0.0	0.0	7.2	1.0	0.0	0.0	0.0	0.0	2.2	0.0	318.1	0.0	0.1	0.9	11.5	0.0	0.3	0.0	0.0	0.0	0.1	5.6	1.2	0.0	0.1	0.1	0.1	0.0	19.7	0.3
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.9;smooth muscle: 82.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		3700000		"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	8.2	19.1	18.2	14.7	25.0	0.0	8.3	20.8	19.2	23.8	8.7	81.9	79.0	34.7	14.4	11.9	14.2	38.7	36.0	16.7	21.2	8.1	3.5	12.3	3.6	22.3	24.4	22.1	2.3	1.4	3.7	1.3	20.4	24.3	77.6	15.0	7.6	31.8	0.8	4.8	81.6	82.7	18.8	11.1	12.4	3.5	21.7	1.3	5.1	3.2	2.6	19.5	10.1	21.0	0.0	0.0	28.5	2.3	0.0	0.1	0.8	7.3	0.4	0.0	0.0	17.4	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	25.4	0.0	0.0	0.3	0.2	0.1	36.0	0.0	0.0	0.0	9.9	0.0	0.0	72.5	0.6	28.5	0.0	0.0	0.6	14.1	4.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	68.6	0.0	0.0	0.7	16.2	1.2	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	25.0	20.8	19.2	16.7	21.2	22.3	24.4	20.4	18.8	21.7	21.0	2.5	0.0	0.0	78.0	0.5	0.9	0.0	0.0	0.0	1.0	0.9	6.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	211.0	0.0	0.3	0.6	1.3	15.1	4.1	40.8	0.0	0.3	1.1	0.0	12.6	0.0	1.2	0.0	1.1	6.4	0.0	0.2	0.0	2.9	95.6	0.0	0.0	1.9	1.5	11.5	0.3	0.0	6.5	0.0	26.1	0.0	3.5	36.2	5.0	96.9	29.7	0.0	0.3	156.2	0.0	0.7	1.3	6.6	4.4	9.8	0.0	0.3	0.3	0.6	0.0	0.5	6.9	72.4	0.2
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.7;skin 1: 16.9;vagina: 18.8"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 48.9;Late spermatids: 45.3;Paneth cells: 33.0;Squamous epithelial cells: 58.5;Syncytiotrophoblasts: 99.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 17.0;head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 19.7;HaCaT: 37.6;HBEC3-KT: 32.3;hTCEpi: 18.3;PC-3: 13.4;TIME: 55.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039462	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039462: AB_10673533"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.1	0.0	0.2	0.8	0.2	0.4	0.8	0.4	0.4	9.8	0.2	6.1	0.3	0.3	0.6	33.7	2.6	0.1	0.1	0.3	0.2	1.1	0.1	1.1	0.1	0.3	0.2	0.1	0.0	0.3	0.2	6.7	0.4	1.6	4.6	1.2	3.7	0.1	0.1	16.9	1.3	0.3	0.1	0.1	0.1	2.9	0.2	0.3	0.0	0.1	1.7	0.3	18.8	0.7	1.8	0.6	0.0	0.2	0.3	0.1	19.7	0.0	0.0	0.1	0.0	0.5	0.3	0.1	3.5	0.2	0.2	37.6	1.0	32.3	0.0	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.2	0.1	18.3	0.1	0.7	0.0	9.8	0.0	0.3	0.3	0.1	2.9	0.1	1.6	0.0	2.0	13.4	0.1	0.0	0.2	0.3	0.5	0.2	0.0	1.9	10.3	0.3	1.9	1.4	0.7	55.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	3.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	1.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.4	0.3	0.2	0.3	0.2	0.4	0.1	0.2	0.7	0.4	9.6	3.9	0.0	0.4	6.5	8.7	10.5	8.0	1.8	2.0	1.5	9.1	0.0	12.7	1.8	4.2	3.6	0.4	17.3	0.0	1.1	19.4	10.3	1.2	1.5	3.0	0.0	0.0	0.0	4.6	1.1	0.0	9.9	1.3	0.2	1.4	0.2	0.9	0.0	0.0	48.9	6.1	0.6	4.8	45.3	0.3	1.2	1.8	0.0	0.1	1.0	1.0	0.0	0.0	0.5	33.0	0.7	0.3	10.9	9.2	6.6	16.8	6.1	0.0	1.4	0.9	5.8	4.8	58.5	19.6	99.3	0.8	0.1	13.1	23.2
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 200.3;liver: 752.6"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.9	0.5	12.5	0.6	0.8	27.4	1.5	16.7	31.6	3.1	13.0	0.4	4.2	61.7	0.3	0.5	0.4	200.3	752.6	0.8	0.4	0.4	0.4	0.2	31.2	7.0	0.2	0.2	0.4	44.5	20.3	0.7	4.2	4.2	0.1	0.9	25.6	0.5	0.4	0.6	25.5	0.1	0.5	0.7	55.1	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.9	0.6	0.8	0.5	0.4	0.4	0.4	0.4	0.4	0.5	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.7;liver: 91.2;thyroid gland: 102.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	16.2	18.5	5.0	22.2	5.4	84.7	11.2	5.6	8.8	7.1	5.1	7.8	6.4	6.4	3.5	4.1	6.1	27.4	6.1	4.8	5.2	7.0	91.2	16.9	39.1	6.3	5.4	3.0	38.1	1.9	2.2	14.6	6.4	4.7	6.5	0.3	3.5	4.0	2.9	4.6	19.0	5.8	6.2	39.9	5.2	2.4	6.0	4.4	102.1	6.3	30.4	12.7	5.0	6.7	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	5.4	5.6	8.8	4.8	5.2	6.3	5.4	6.4	6.2	6.0	6.7	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HHLA2	"B7-H5, B7-H7, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 129.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 274.7;Paneth cells: 64.2;Proximal enterocytes: 186.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;HDLM-2: 4.0;Karpas-707: 2.8"					"Low region specificity"	"Detected in all"			HPA055478	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.4	0.2	0.5	5.6	0.4	1.1	0.2	0.7	1.3	0.0	0.0	87.9	86.8	0.3	0.8	0.5	3.7	29.2	0.2	0.6	0.7	7.6	0.1	5.7	0.6	0.7	0.3	0.1	2.9	0.1	0.2	0.1	0.6	0.2	83.0	1.2	0.2	0.3	0.5	0.3	129.9	2.0	0.2	0.3	9.4	3.3	0.6	0.4	0.2	0.0	0.3	0.0	0.0	0.8	0.2	0.3	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.7	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.0	0.0	4.0	0.1	0.1	1.4	0.2	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.8	0.0	0.2	0.4	1.5	0.5	0.2	0.3	0.3	0.1	0.8	0.0	0.1	0.7	0.7	0.7	0.0	0.1	0.5	0.1	0.2	0.1	0.1	0.7	0.2	0.2	1.3	0.7	0.3	0.0	0.4	0.1	0.5	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	1.8	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.5	0.4	0.7	1.3	0.6	0.7	0.7	0.3	0.6	0.2	0.6	0.8	0.0	0.0	2.0	0.7	0.4	0.0	0.1	0.7	0.0	0.0	0.7	0.3	0.2	27.1	1.6	0.0	0.0	0.0	0.0	274.7	0.0	8.5	3.3	3.2	0.0	0.3	1.8	0.0	1.3	37.6	0.1	0.3	2.6	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.5	12.5	2.0	0.0	0.7	4.2	0.3	0.3	0.0	0.0	1.1	0.0	0.0	0.5	0.9	35.7	64.2	0.0	0.0	0.1	186.8	20.4	19.4	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.1	0.5	0.0	17.7	0.1
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777998	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"brain: 397.5"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 463.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 27.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favorable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.8	9.2	253.4	6.9	359.7	15.0	10.3	124.8	187.0	4.3	39.4	6.6	7.4	6.0	4.1	9.2	8.8	4.7	30.3	146.3	235.5	25.5	14.9	10.7	4.1	253.8	268.7	5.5	11.5	11.5	8.9	10.1	192.5	9.3	4.8	27.8	12.1	5.7	23.5	3.0	6.3	3.9	187.4	6.9	14.5	1.9	318.3	6.9	9.3	17.0	4.2	6.0	5.2	397.5	11.7	51.4	23.2	14.3	55.2	39.4	2.7	6.4	6.3	7.0	7.3	3.8	6.3	0.0	14.3	12.1	43.2	0.6	10.7	16.6	17.5	120.9	4.3	53.7	8.7	18.4	31.0	14.9	14.0	60.3	10.5	32.4	47.9	16.5	17.6	10.0	31.7	14.4	54.3	8.9	18.9	10.6	5.9	6.6	34.3	22.1	12.7	1.6	31.5	2.0	14.1	12.9	14.4	0.5	7.0	4.3	7.9	6.0	59.5	24.5	11.6	28.5	31.4	68.7	44.3	10.2	49.4	7.7	13.4	27.5	1.3	3.5	0.2	1.1	0.3	0.6	0.5	0.2	0.6	0.5	1.6	0.5	1.7	0.2	4.1	0.2	0.1	0.7	253.4	359.7	124.8	187.0	146.3	235.5	253.8	268.7	192.5	187.4	318.3	397.5	107.8	16.0	31.2	82.6	45.8	9.3	30.6	24.9	16.5	116.0	65.6	32.6	213.9	55.8	35.6	64.4	152.2	8.8	72.0	38.4	35.2	32.5	3.1	39.1	12.2	80.3	67.2	18.5	17.8	67.0	1.5	28.1	70.8	41.7	44.9	24.3	151.0	145.2	15.7	222.1	36.3	32.2	63.1	119.5	10.9	4.0	13.1	53.2	44.4	49.6	47.6	78.0	95.8	145.3	463.7	63.4	24.6	18.8	97.9	118.9	22.5	75.0	48.7	62.9	46.0	96.6	60.8	2.7	4.8	42.5	9.5	9.6	30.5	20.1	29.3	43.9
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.4;Erythroid cells: 38.3;Extravillous trophoblasts: 16.1;Granulosa cells: 14.8;Spermatocytes: 37.5;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	0.6	0.6	0.0	5.5	0.1	47.4	1.1	0.1	0.2	0.8	0.1	3.9	4.1	0.9	0.2	5.6	0.3	0.5	0.3	0.1	0.1	0.4	0.8	1.4	12.6	0.1	0.3	0.2	0.2	0.1	0.1	3.0	0.1	0.4	5.2	0.1	1.0	0.1	0.2	3.6	3.8	1.9	0.0	4.1	2.4	11.1	0.3	30.4	0.3	0.0	12.0	1.4	2.0	0.2	54.5	73.6	68.4	32.7	2.6	5.4	42.8	79.5	37.9	55.2	59.9	51.3	57.6	17.1	9.0	31.4	98.0	61.7	54.9	40.9	72.6	40.0	21.6	65.5	61.4	50.9	0.3	54.1	43.2	1.8	1.5	45.1	30.9	15.7	35.5	51.3	56.6	40.8	103.0	55.3	76.4	59.7	58.9	42.2	49.1	58.4	103.0	30.3	28.6	32.3	39.4	24.7	45.8	34.2	31.7	31.0	25.7	42.1	26.0	59.6	64.6	44.3	87.2	38.6	32.7	67.9	35.7	39.3	151.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.5	0.0	2.9	1.3	0.5	1.9	0.0	0.0	0.7	0.5	1.2	0.0	2.1	0.0	0.0	8.2	0.5	5.6	0.0	0.2	17.4	0.3	1.3	1.1	0.0	38.3	0.0	0.0	16.1	2.0	5.1	1.3	0.0	14.8	2.2	0.3	7.1	0.0	0.0	3.5	0.0	3.0	2.9	9.0	0.6	3.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	11.4	1.0	0.5	0.1	0.1	0.0	0.0	0.1	1.9	37.5	16.3	8.9	0.9	1.5	2.3	0.3	7.6	0.9
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220332-69267552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.5;retina: 46.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 31.5;Distal enterocytes: 29.0;Ductal cells: 32.6;Endometrial ciliated cells: 50.0;Glandular and luminal cells: 55.2;Muller glia cells: 126.9;Proximal enterocytes: 56.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 3.1;naive CD4 T-cell: 5.8;naive CD8 T-cell: 2.3;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	23	"T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;CACO-2: 57.5;CAPAN-2: 111.4;EFO-21: 33.9;GAMG: 45.4;Hep G2: 33.6;RPTEC TERT1: 81.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 11.9"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.1	0.0	1.1	2.7	1.3	0.0	0.0	1.4	1.0	1.1	1.4	6.8	53.5	0.9	0.0	0.1	4.6	6.8	0.0	1.0	1.1	13.3	4.6	1.5	1.0	1.3	2.1	0.0	6.2	0.0	0.3	0.0	1.7	0.0	4.2	46.8	0.1	0.0	0.0	0.1	48.0	0.5	1.4	0.3	1.1	1.0	1.0	5.2	9.3	0.0	0.2	0.0	0.1	1.2	1.2	40.1	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.1	57.5	111.4	0.0	33.9	0.3	45.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	33.6	2.7	0.0	0.0	0.0	0.3	0.4	3.2	0.6	0.0	11.3	0.0	0.0	0.7	0.1	0.2	0.1	0.0	11.9	1.3	0.0	1.2	0.1	81.9	0.1	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.4	1.6	0.2	0.8	0.0	0.1	0.0	8.1	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.5	0.0	3.1	1.0	0.0	0.0	5.8	2.3	0.0	0.2	0.0	0.0	5.4	1.0	1.1	1.3	1.4	1.0	1.0	1.1	1.3	2.1	1.7	1.4	1.0	1.2	0.0	3.2	4.8	11.8	0.7	0.0	0.0	0.3	0.0	1.9	0.0	0.0	1.0	31.5	1.0	16.5	0.0	0.0	0.2	29.0	1.9	32.6	0.6	50.0	4.5	0.5	0.0	0.0	0.4	7.3	0.0	0.2	1.5	55.2	0.0	0.0	0.0	0.4	0.1	3.3	0.5	5.6	0.0	0.3	0.0	0.2	0.3	0.4	0.0	0.0	0.0	126.9	0.0	0.0	0.5	25.5	12.7	0.0	0.3	0.0	56.3	15.7	0.3	5.1	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	1.3	0.1	5.6	0.3
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"	P13747	6	30489509-30494194	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 109.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.3;U-266/70: 284.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	724.7	217.2	9.6	173.7	10.0	410.3	578.9	10.9	109.5	360.1	7.3	329.4	0.6	313.5	119.3	330.9	336.5	186.1	356.0	7.7	13.1	375.2	332.8	1144.6	336.3	16.6	22.7	213.2	156.6	95.8	121.8	117.3	16.1	251.2	116.8	12.4	252.5	93.0	179.2	518.3	428.9	89.0	10.0	1007.2	259.5	41.1	11.7	86.0	381.9	0.0	137.5	295.0	366.3	14.2	100.7	16.7	6.8	57.0	212.3	166.4	0.9	0.0	0.0	0.1	0.3	40.0	189.1	65.6	98.7	92.7	148.3	121.6	12.8	53.1	0.0	67.6	32.7	78.6	18.7	0.0	0.0	0.2	38.3	135.4	94.4	67.7	0.0	0.0	0.2	34.6	9.8	0.9	54.5	0.2	0.3	0.8	0.5	32.0	0.0	20.6	0.2	97.4	82.7	58.4	0.3	4.8	63.3	56.9	0.3	1.2	0.0	132.7	102.0	60.7	0.1	0.5	14.7	284.8	171.6	29.4	0.3	62.1	149.2	1140.0	335.4	1153.0	723.3	550.2	602.2	449.1	539.9	709.2	158.5	450.3	531.5	547.8	1916.1	512.9	648.0	138.3	611.7	1441.6	9.6	10.0	10.9	109.5	7.7	13.1	16.6	22.7	16.1	10.0	11.7	14.2	2347.3	310.9	411.0	8.1	950.6	484.6	386.6	284.2	183.8	2.7	238.7	204.0	108.3	231.6	270.0	123.2	6.2	88.2	1304.6	603.0	17.6	484.9	5.0	157.7	157.9	1554.7	216.2	172.3	0.1	677.2	277.0	402.8	233.4	325.6	531.6	59.2	1647.8	120.1	700.6	5.0	0.1	545.3	248.2	1220.4	512.2	11.0	132.0	821.6	466.0	105.9	740.5	100.2	1874.4	2.0	0.5	682.2	559.1	76.3	716.6	436.9	473.9	79.9	214.7	9.5	177.5	535.1	350.1	10.6	7.0	170.0	426.5	359.0	1162.1	196.5	285.0	544.4
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734391-186190949	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"olfactory bulb: 9.9"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	9.7	1.4	1.3	0.6	1.2	0.0	8.4	0.9	1.1	3.7	1.3	9.0	0.9	1.9	2.5	5.4	1.8	6.5	8.4	0.8	1.1	2.5	7.8	20.3	0.4	1.5	1.9	3.9	0.9	0.9	3.2	4.8	1.5	7.5	2.8	0.6	7.7	1.4	4.8	4.1	3.1	4.3	1.4	8.4	1.7	2.6	1.7	0.8	3.2	7.0	2.4	1.8	3.8	0.9	0.2	0.1	1.6	0.0	4.7	4.7	0.0	0.5	0.9	0.3	0.5	0.0	0.1	1.9	0.2	22.3	1.6	5.0	0.1	0.2	0.1	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	4.7	0.0	5.6	0.4	20.1	2.8	0.0	0.2	0.0	0.0	76.5	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	50.2	4.5	0.1	0.0	0.0	13.7	1.3	0.0	5.1	0.2	0.0	0.3	2.7	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	1.2	0.9	1.1	0.8	1.1	1.5	1.9	1.5	1.4	1.7	0.9	33.8	3.2	7.0	0.3	0.0	3.2	0.2	4.9	2.2	1.7	1.2	1.8	2.8	0.0	0.8	0.0	0.0	0.1	0.2	0.3	0.0	0.0	8.3	0.6	1.5	21.4	0.0	0.0	1.1	0.0	0.8	22.2	0.0	0.9	0.0	5.2	7.9	1.9	0.1	26.9	3.8	0.0	0.0	0.3	2.8	2.7	3.7	0.4	5.4	45.0	0.0	0.1	0.0	3.0	1.5	0.0	0.0	2.2	1.2	0.1	0.0	0.2	1.0	0.0	0.0	2.5	7.7	0.5	0.1	0.4	1.7	0.0	0.4	0.1	0.0	0.2
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2434.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000		"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.0	0.3	0.0	7.3	0.0	0.0	222.4	0.0	0.0	0.1	5.2	366.7	165.6	1.4	0.4	4.3	0.4	4.3	36.6	0.0	0.1	64.9	2434.1	2.2	0.1	0.0	0.1	0.1	20.1	0.1	0.1	0.4	0.0	34.0	228.0	0.1	50.8	0.6	6.9	14.2	151.8	23.7	0.0	0.6	101.2	35.6	0.0	0.4	0.6	3.1	0.0	36.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.6;lymphoid tissue: 27.3;testis: 27.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.2;Erythroid cells: 133.3;Extravillous trophoblasts: 55.1;Late spermatids: 60.9;Spermatocytes: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	0.8	0.7	0.2	10.1	0.3	20.6	2.1	0.3	0.4	1.1	0.1	6.6	7.4	0.8	0.2	4.0	0.5	0.9	0.8	0.2	0.2	0.7	1.7	0.9	18.1	0.5	0.3	0.2	0.3	0.9	0.2	6.2	0.4	0.5	8.8	0.8	0.8	0.2	1.2	4.2	6.5	2.9	0.3	2.9	3.6	27.5	0.7	27.3	0.7	0.4	17.7	2.2	1.4	0.5	77.0	47.2	94.5	50.8	5.0	9.0	70.3	71.4	34.9	88.0	78.9	96.8	145.1	127.5	66.0	22.2	118.5	86.3	112.4	69.0	148.6	116.1	34.4	76.7	32.3	48.4	1.4	68.7	67.3	2.4	4.1	82.8	64.0	14.7	50.6	85.7	73.2	101.0	93.2	28.5	72.3	38.8	81.9	51.2	51.6	78.0	126.3	63.9	34.8	20.4	78.8	43.8	106.3	32.8	38.6	45.1	97.3	54.5	32.9	63.2	52.4	50.6	97.2	53.7	96.3	102.4	41.4	104.2	61.1	0.2	0.2	0.0	0.1	0.1	0.3	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.6	1.5	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.5	0.3	0.4	0.3	0.7	0.5	0.4	0.0	1.1	1.3	6.0	2.5	1.8	4.5	2.8	0.6	3.2	3.7	2.5	4.3	3.2	0.0	0.0	37.3	2.3	5.3	0.0	0.8	86.2	3.8	3.1	3.1	1.2	133.3	0.6	0.2	55.1	4.6	11.7	5.7	0.0	21.6	5.3	3.8	22.2	0.0	0.4	7.8	6.1	8.8	2.7	60.9	2.1	7.6	0.0	0.0	2.3	0.1	1.0	0.5	1.2	0.2	0.3	0.7	22.9	1.5	1.3	2.6	2.8	1.0	6.6	0.6	3.8	100.9	23.3	14.1	1.4	4.5	5.2	1.6	15.6	3.0
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lymphoid tissue: 612.2"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 327.1;Extravillous trophoblasts: 285.2;Hofbauer cells: 494.9;Kupffer cells: 954.1;Macrophages: 271.5;Syncytiotrophoblasts: 502.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 98.8;intermediate monocyte: 238.8;non-classical monocyte: 329.2"	"Lineage enriched"	"Detected in all"	7	"monocytes: 329.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 869.1;GAMG: 631.2;U-138 MG: 506.2;U-87 MG: 489.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		170000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	150.2	48.9	40.9	64.6	48.8	99.3	20.6	42.4	66.3	28.2	46.4	35.2	106.0	10.4	7.6	48.4	40.7	52.6	18.2	40.6	46.6	96.2	136.5	113.6	57.2	52.3	46.5	139.0	41.7	7.4	9.6	72.2	56.3	6.7	31.1	1.7	15.1	4.0	107.1	74.1	64.5	38.7	45.9	612.2	19.9	17.8	60.7	25.1	11.3	21.4	49.4	46.2	29.2	56.2	12.2	179.1	1.8	37.7	170.9	49.6	869.1	83.2	57.6	42.9	48.6	82.1	11.3	0.1	18.3	83.3	631.2	10.1	11.4	1.9	16.1	308.6	9.2	4.3	51.5	179.3	218.9	11.5	54.8	146.3	4.2	282.3	19.7	74.6	130.9	0.5	0.0	87.4	152.5	6.9	0.2	4.3	18.1	130.4	20.7	1.2	15.6	28.4	35.2	104.5	2.7	2.4	215.8	19.1	15.5	92.5	8.9	3.0	44.3	506.2	22.1	82.5	82.5	53.5	77.0	9.3	489.4	5.7	8.6	11.3	98.8	7.7	1.1	238.8	0.4	24.8	0.7	1.7	44.6	2.9	0.1	0.5	47.1	5.3	329.2	1.1	1.8	70.9	40.9	48.8	42.4	66.3	40.6	46.6	52.3	46.5	56.3	45.9	60.7	56.2	19.3	3.2	19.0	0.0	11.5	16.4	27.5	11.0	10.8	0.0	25.0	9.1	2.9	24.3	10.5	5.5	0.0	50.5	3.5	59.1	21.5	13.6	2.1	39.6	12.9	327.1	16.0	5.7	0.2	1.5	285.2	64.1	9.2	74.6	11.4	98.4	23.6	23.6	494.9	0.0	0.4	8.3	18.3	954.1	175.8	4.1	31.1	271.5	35.6	1.9	184.7	0.4	9.2	0.5	1.4	8.3	26.1	5.3	2.5	110.6	61.5	157.9	7.1	0.6	0.0	40.8	52.7	0.9	4.4	5.5	15.6	502.0	6.8	6.9	6.1	118.3
HMX2	NKX5-2	ENSG00000188816	"H6 family homeobox 2"	A2RU54	10	123148136-123150672	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 2.2;kidney: 1.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.9"	"Region enhanced"	"Detected in some"		"midbrain: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"REH: 38.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.3"	"CAB013268, CAB022752"	Approved					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"CAB013268: , CAB022752: "	"unprognostic (3.98e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.18e-2)"		"unprognostic (2.73e-2)"		"unprognostic (7.64e-2)"	"unprognostic (3.29e-1)"		"unprognostic (2.10e-3)"	"unprognostic (5.29e-1)"		"unprognostic (5.01e-2)"			"unprognostic (2.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	38.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	2.2	0.7	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135970-123139423	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 6.9"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;HEL: 6.1;HeLa: 7.0;K-562: 17.9;NB-4: 13.4;SiHa: 7.0;THP-1: 5.7"	"Region enriched"	"Detected in single"	4	"hypothalamus: 1.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.4;hypothalamus: 4.8"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Centriolar satellite"	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				0.9	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.0	0.1	1.3	6.9	0.0	0.1	0.0	0.2	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	8.1	0.0	0.0	0.7	0.4	6.1	7.0	0.2	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	17.9	0.1	0.0	0.0	0.0	13.4	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	7.0	0.0	0.1	0.0	0.0	5.7	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	1.6	0.3	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.3	0.9	0.4	0.2	0.4	0.2	0.1	0.4	0.1	0.3	0.1	0.1	6.5	1.3	6.9	2.4	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HNF1B	"HNF1beta, LFB3, MODY5, TCF2, VHNF1"	ENSG00000275410	"HNF1 homeobox B"	P35680	17	37686431-37745105	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.1;pancreas: 33.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Collecting duct cells: 57.0;Distal tubular cells: 45.0;Ductal cells: 42.0;Early spermatids: 32.3;Glandular and luminal cells: 41.7;Pancreatic endocrine cells: 31.7;Proximal tubular cells: 38.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 32.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 139.3"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in single"			"HPA002083, CAB068192"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Vesicles	"CAB068192: AB_2665649, HPA002083: AB_1080232"	"unprognostic (2.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.29e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.49e-2)"	"prognostic favorable (2.51e-6)"	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.7	0.0	9.9	6.9	1.5	7.5	0.0	5.7	15.1	0.0	0.0	0.1	61.1	12.9	6.8	0.0	0.0	0.0	0.0	33.0	3.5	0.0	0.0	0.0	2.3	7.1	0.0	0.0	4.4	0.0	0.0	8.6	0.1	0.0	0.0	8.2	3.9	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	2.2	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	139.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.6	14.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	78.6	1.9	57.0	0.0	0.0	0.0	15.4	45.0	42.0	32.3	18.5	3.6	0.4	14.4	0.0	0.2	25.4	0.0	0.2	13.7	41.7	5.7	0.0	0.0	5.1	0.1	0.0	0.2	13.5	0.0	0.3	0.0	11.6	0.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.1	31.7	11.4	0.0	0.0	2.6	14.3	38.2	3.7	0.0	0.0	0.0	0.3	3.0	2.5	0.0	0.0	0.0	0.6	0.0	20.4	2.7
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 102.4;kidney: 43.3;liver: 117.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	5.9	0.2	0.1	0.1	0.2	0.2	0.0	8.4	58.6	102.4	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.3	117.1	0.1	0.1	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	44.1	0.1	0.0	0.1	0.2	0.0	82.6	1.8	0.0	0.0	22.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 114.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.2	2.5	0.5	0.0	1.0	0.2	0.3	2.3	0.1	20.6	100.5	0.4	1.2	0.3	1.0	12.1	0.0	0.3	0.3	17.4	12.9	0.2	0.1	0.4	0.5	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.6	0.0	0.4	0.4	0.0	0.0	114.6	0.9	0.4	0.1	8.1	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.3	0.3	0.4	0.5	0.3	0.4	0.3	0.3	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HOOK1	HK1	ENSG00000134709	"Hook microtubule tethering protein 1"	Q9UJC3	1	59814786-59876322	"Predicted intracellular proteins"	"Differentiation, Protein transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 52.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 611.0;Late spermatids: 942.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 35.4;OE19: 24.4;RPTEC TERT1: 32.9;SK-BR-3: 32.1"	"Low region specificity"	"Detected in all"							"HPA018537, HPA018820"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA018537: AB_1850907, HPA018820: AB_1850910"	"unprognostic (9.82e-3)"	"unprognostic (4.29e-1)"	"prognostic favorable (4.53e-6)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.79e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.23e-1)"	0.9	5.4	3.6	3.3	4.3	3.6	11.3	6.8	5.2	4.7	6.1	15.4	12.0	2.0	5.7	13.4	6.9	3.8	2.2	4.3	2.0	16.0	30.9	3.7	2.8	0.6	1.3	0.5	18.4	28.0	8.6	2.3	0.7	6.2	13.5	52.8	17.8	4.9	0.2	11.0	15.9	0.5	0.3	1.4	10.5	16.5	2.7	2.3	13.7	0.0	4.7	3.3	5.5	2.7	17.0	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	14.4	0.1	35.4	0.0	0.1	9.5	3.6	7.3	0.0	0.5	16.0	0.3	4.8	17.7	0.0	0.1	3.7	0.0	15.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	7.1	0.0	0.0	13.6	24.4	6.5	0.0	0.0	18.5	32.9	17.3	13.6	5.6	0.2	32.1	0.4	13.8	19.1	0.3	0.0	0.0	0.1	0.0	0.0	21.9	17.4	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	1.7	1.1	1.8	0.4	0.0	2.2	6.6	2.0	0.0	1.8	0.0	0.0	0.3	0.7	3.6	4.3	6.8	5.2	4.3	2.0	0.6	1.3	0.7	0.3	2.7	2.7	0.2	16.0	29.9	3.9	10.4	39.6	18.1	17.0	51.8	134.4	30.9	16.8	19.0	32.9	51.3	20.2	79.2	21.9	4.6	42.5	31.3	28.2	611.0	46.9	6.7	1.7	36.5	5.9	51.5	34.4	3.0	5.4	25.5	93.6	0.0	10.0	1.1	56.1	1.6	79.1	46.2	36.0	22.4	0.6	1.8	942.1	5.0	1.9	16.0	4.7	0.7	154.4	1.0	2.0	2.6	18.7	41.0	3.4	14.0	24.7	52.7	59.9	50.4	100.3	0.0	2.5	2.2	33.2	9.3	45.4	49.7	35.8	6.8	0.0	51.0	19.7
HOPX	"HOP, LAGY, NECC1, OB1, SMAP31"	ENSG00000171476	"HOP homeobox"	Q9BPY8	4	56647988-56681899	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 716.7;skin 1: 1439.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 750.0;Alveolar cells type 2: 569.2;Basal keratinocytes: 414.6;dendritic cells: 345.3;NK-cells: 1150.4;Suprabasal keratinocytes: 377.2;Syncytiotrophoblasts: 321.8"	"Cancer enhanced"	"Detected in many"		"glioma: 43.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 518.2;NK-cell: 781.6"	"Group enriched"	"Detected in all"	15	"NK-cells: 781.6;T-cells: 518.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2;HUVEC TERT2: 66.9;RT4: 50.5;TIME: 76.2;U-266/70: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018632, HPA030180"	Enhanced		Approved	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"	Cytosol	"CAB018632: AB_2120833, HPA030180: AB_10603770"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.30e-5)"	"unprognostic (3.40e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.10e-2)"	"unprognostic (5.33e-2)"	9.5	33.7	212.8	27.7	235.6	12.1	112.2	215.4	322.0	250.1	239.2	30.5	17.2	19.1	541.4	716.7	10.5	35.1	48.8	237.4	212.0	24.0	2.9	372.8	18.4	237.6	211.6	9.4	5.3	13.3	11.7	59.6	218.5	26.9	7.0	22.1	172.0	64.7	19.2	1439.9	11.3	115.6	238.8	11.9	33.9	45.3	215.0	15.8	224.5	31.8	190.4	34.1	368.6	234.2	0.0	0.0	0.0	0.0	5.0	15.7	5.9	0.0	0.0	1.4	1.0	0.0	0.0	12.6	0.7	0.3	2.3	2.2	1.4	0.0	1.9	31.2	0.2	0.1	0.0	0.0	2.0	0.0	0.1	2.6	11.9	3.6	0.0	3.4	66.9	0.0	0.0	0.5	3.2	0.5	0.1	1.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	50.5	1.0	0.6	0.0	0.0	0.0	4.6	0.0	0.0	76.2	0.0	0.2	0.5	0.1	26.0	0.1	0.1	3.2	0.0	0.0	5.7	1.1	2.0	518.2	3.5	282.0	43.4	123.6	227.6	2.6	36.5	20.9	150.8	11.2	781.6	4.5	3.6	9.1	365.6	212.8	235.6	215.4	322.0	237.4	212.0	237.6	211.6	218.5	238.8	215.0	234.2	14.5	750.0	569.2	38.2	23.3	414.6	42.2	8.7	59.7	3.5	3.4	3.0	14.8	2.8	125.6	1.8	0.0	2.3	345.3	0.8	1.9	0.4	33.3	2.8	4.0	28.7	8.4	30.5	62.2	0.2	5.5	16.7	5.6	5.2	10.1	99.5	5.3	1.2	4.0	0.0	7.9	11.1	4.1	11.4	30.9	45.9	3.1	7.9	35.6	14.0	41.4	166.4	1150.4	7.1	6.7	1.7	0.0	3.0	9.6	31.3	1.2	0.6	12.5	5.6	32.9	3.7	104.8	3.3	15.3	31.6	377.2	321.8	219.9	0.1	1.4	28.8
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130780	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.6;Basal squamous epithelial cells: 31.9;Distal tubular cells: 15.6;Hepatic stellate cells: 16.8;Proximal tubular cells: 13.1;Squamous epithelial cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"medulla oblongata: 19.3;pons: 16.1;spinal cord: 15.6;white matter: 14.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 29.0;HEK 293: 22.2;REH: 21.0;WM-115: 29.1"	"Region enriched"	"Detected in single"	46	"pons and medulla: 11.3"					HPA060088	Approved		Supported	"Nuclear bodies"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA060088: AB_2684200"	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	16.2	10.0	0.0	2.1	0.0	0.7	10.5	0.1	0.1	5.5	0.0	13.2	4.9	5.9	13.0	15.3	22.1	3.6	1.9	0.0	0.0	16.3	1.5	14.7	1.3	19.3	1.6	6.8	1.9	25.8	0.0	0.1	16.1	5.9	2.4	0.0	0.6	5.8	18.8	4.9	8.2	4.6	15.6	6.9	13.4	1.6	0.0	1.9	3.7	8.2	0.4	7.7	4.6	14.1	9.5	3.1	0.0	29.0	0.0	0.0	1.9	0.9	0.9	3.0	3.0	5.9	1.9	2.5	0.1	2.8	2.7	4.0	1.1	0.4	2.3	0.1	22.2	0.0	0.9	13.7	3.3	3.3	5.4	3.2	2.4	10.2	0.8	0.0	10.3	0.8	0.0	0.0	10.0	2.5	0.0	11.2	0.0	3.3	7.2	21.0	4.4	0.2	14.6	2.2	1.4	0.0	2.9	0.0	11.2	1.0	0.7	1.7	13.5	0.0	4.6	7.6	0.2	0.0	0.0	1.0	6.1	5.1	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	19.3	1.6	16.1	15.6	0.0	14.1	11.6	0.0	0.0	0.0	0.1	0.9	3.1	0.0	31.9	0.0	3.6	7.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	1.7	15.6	0.0	0.4	0.2	2.6	5.2	3.0	0.8	0.0	0.0	0.9	5.4	0.5	0.1	0.0	0.4	16.8	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.3	0.4	0.0	0.9	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.7	1.4	0.7	1.0	13.1	0.0	0.0	0.0	8.3	5.8	0.4	3.2	12.5	1.3	0.1	0.8	1.4	2.0	2.5
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 87.9;intestine: 26.3;kidney: 22.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Region enhanced"	"Detected in single"		"spinal cord: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	1.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	11.4	0.0	26.3	0.0	0.9	87.9	0.0	0.3	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.3	0.0	0.0	15.8	0.1	0.1	13.4	1.3	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.7	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691485	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 39.2;Distal tubular cells: 11.7;Excitatory neurons: 16.4;Inhibitory neurons: 20.0"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 3.0;naive CD4 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	30	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7;SH-SY5Y: 9.1;SK-MEL-30: 2.9;U-2 OS: 1.9;U-266/70: 2.4;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA053808: AB_2682270"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	0.0	10.1	75.1	0.8	89.6	0.4	0.0	38.1	89.3	0.0	0.0	0.3	0.2	0.0	0.3	5.2	0.0	0.2	1.1	91.2	38.0	4.7	0.0	0.6	1.0	16.8	29.8	2.9	4.9	0.2	2.1	0.0	30.1	0.3	0.1	10.9	0.1	0.1	3.2	0.1	0.4	0.0	28.1	0.3	0.6	4.6	58.1	0.2	0.1	1.2	0.8	0.1	0.1	43.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	1.4	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.8	9.1	0.2	0.0	2.9	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	2.4	3.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	3.0	0.5	0.1	0.0	2.6	0.9	0.0	0.0	0.0	0.0	2.2	0.9	75.1	89.6	38.1	89.3	91.2	38.0	16.8	29.8	30.1	28.1	58.1	43.8	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	39.2	0.1	0.1	1.5	0.0	0.6	1.8	0.0	0.0	0.0	0.0	11.7	0.0	3.4	0.1	0.0	0.1	0.0	0.0	16.4	0.8	0.0	0.6	0.0	0.7	0.0	0.2	0.0	0.0	0.0	1.7	20.0	0.0	0.0	0.0	0.0	1.2	1.2	0.1	0.0	1.0	0.0	4.9	0.0	1.5	1.3	0.2	0.0	1.5	0.3	0.0	0.0	0.1	0.0	1.4	0.0	0.3	0.1	2.8	0.7	0.0	0.0	0.0	0.9	0.1	0.0	0.0
HPGDS	"GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS"	ENSG00000163106	"Hematopoietic prostaglandin D synthase"	O60760	4	94298535-94342876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 18.7"	"Group enriched"	"Detected in many"	18	"granulocytes: 1056.2;Hofbauer cells: 631.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	28	"basophil: 18.1"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 18.1"	"Group enriched"	"Detected in some"	8	"HEL: 46.2;HMC-1: 13.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA024035	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		250000	"Cluster 46: Basophils - DNA binding"	"Cluster 19: Lung - Lung function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Cytosol"	Nucleoplasm	"HPA024035: AB_1855743"	"unprognostic (5.71e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.01e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.75e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.14e-2)"	3.4	1.9	2.2	1.1	2.1	1.1	4.0	2.3	3.1	3.5	2.1	5.1	5.8	2.4	2.3	2.9	1.4	6.9	1.8	2.3	2.3	1.5	0.8	9.4	0.6	2.7	2.6	0.5	0.5	0.8	0.4	18.7	2.9	2.6	5.3	0.1	1.5	1.3	0.5	3.3	5.6	3.3	2.6	0.3	2.8	0.7	3.1	2.0	0.3	1.7	0.9	4.8	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	3.5	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.1	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.2	2.1	2.3	3.1	2.3	2.3	2.7	2.6	2.9	2.6	3.1	3.5	0.3	12.8	44.7	1.0	0.2	4.1	0.8	0.0	0.6	0.0	0.2	0.8	0.3	0.0	3.7	0.0	0.0	3.6	0.7	0.5	0.0	0.5	0.1	0.2	0.0	2.0	7.1	12.2	0.8	0.0	3.0	3.0	3.6	0.0	1056.2	0.0	0.0	0.0	631.9	0.0	0.6	0.0	0.0	11.4	13.1	0.0	0.3	16.3	3.6	32.8	0.1	0.0	0.0	0.0	0.5	0.1	1.2	0.4	2.1	3.9	0.0	0.0	1.5	0.1	0.0	0.6	0.4	0.0	0.1	0.0	5.4	5.5	20.5	0.3	0.9	0.2
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13494032-13601929	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"medulla oblongata: 5.9"	"Immune cell enhanced"	"Detected in some"		"T-reg: 2.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 2.2"	"Group enriched"	"Detected in many"	4	"PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.3"	"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	0.4	2.0	0.1	1.9	1.0	1.0	0.4	0.0	0.6	4.5	3.2	1.2	1.4	0.7	0.1	4.6	1.3	0.3	2.5	0.2	0.0	1.4	1.9	1.2	2.6	5.9	1.4	8.1	0.3	0.0	0.7	2.7	1.1	3.1	0.3	1.3	2.0	4.9	0.1	0.7	1.2	0.2	3.5	6.4	0.6	2.3	0.1	0.3	0.3	0.0	1.6	0.5	3.4	0.5	0.1	0.3	3.3	0.0	2.7	6.8	5.1	18.2	4.4	3.2	2.0	0.0	0.6	0.0	2.6	11.2	0.0	0.0	0.1	0.0	3.1	1.1	18.3	4.9	1.5	2.0	1.6	0.0	1.2	4.9	0.1	8.5	2.2	5.5	0.0	0.2	19.2	0.0	3.8	2.5	0.1	3.3	3.5	0.0	40.9	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	2.0	0.1	0.6	0.2	3.1	0.4	0.1	123.0	0.0	0.0	0.0	73.2	0.0	9.1	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.5	0.0	0.0	0.5	0.5	0.2	0.3	0.0	1.7	2.2	0.3	0.1	1.0	0.0	0.6	0.2	0.0	5.9	1.4	1.1	3.5	0.1	0.5	0.2	0.0	0.0	9.8	0.0	0.6	0.0	0.0	5.7	0.3	0.0	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.4	0.3	1.1	0.0	0.0	1.8	0.2	0.0	4.7	0.0	0.2	0.0	11.6	7.1	0.0	1.6	26.9	4.1	0.0	0.0	0.8	0.3	0.1	13.7	0.0	0.0	1.9	0.0	2.4	0.0	0.5	0.2	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	4.0	0.3	0.4	9.3	0.6	0.1	0.1	0.0	0.0	0.0
HS3ST4	3OST4	ENSG00000182601	"Heparan sulfate-glucosamine 3-sulfotransferase 4"	Q9Y661	16	25691959-26137685	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 38.1"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 431.4;Microglial cells: 536.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.95e-1)"		"unprognostic (2.24e-1)"	"unprognostic (1.43e-3)"		"unprognostic (1.27e-1)"		"unprognostic (3.84e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.71e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.67e-2)"	0.0	0.0	19.0	0.0	17.5	0.0	2.2	7.0	15.8	0.3	3.3	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	33.2	12.2	0.0	0.0	0.0	0.0	18.2	11.8	0.0	0.0	3.6	0.3	0.0	19.0	0.8	0.0	2.0	0.1	0.0	0.0	0.5	0.0	0.0	7.5	1.6	1.7	0.5	38.1	0.2	0.0	0.0	0.0	0.2	0.5	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	17.5	7.0	15.8	33.2	12.2	18.2	11.8	19.0	7.5	38.1	18.5	0.0	0.0	0.0	7.5	0.1	0.0	0.4	0.1	0.0	26.0	2.6	2.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	431.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	536.8	0.0	0.4	0.0	6.6	9.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;skeletal muscle: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 102.5;Excitatory neurons: 154.8;Inhibitory neurons: 130.9;Oligodendrocytes: 606.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 4.6;RT4: 6.8;SCLC-21H: 14.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.0	0.3	3.5	0.1	9.7	0.2	0.0	3.6	4.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.0	7.2	7.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.1	1.1	0.0	1.3	3.2	0.2	0.1	0.1	6.5	0.0	0.2	0.1	7.6	0.0	0.0	1.4	0.0	2.2	0.0	6.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.9	4.6	0.0	0.8	0.0	0.0	6.8	14.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	4.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.7	3.6	4.4	2.8	4.5	7.2	7.0	7.3	6.5	7.6	6.0	0.0	0.0	0.0	102.5	0.0	1.3	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	11.0	18.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	154.8	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	130.9	0.4	0.0	0.0	0.0	0.8	3.7	0.0	0.0	9.4	0.0	0.0	0.0	11.6	606.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	7.9	0.1	1.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 968.3"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000	"Cluster 35: T-regs - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	22.4	7.7	9.8	14.6	15.4	0.3	12.0	23.0	22.0	2.8	8.1	4.2	1.2	4.2	15.7	2.1	5.1	8.0	7.5	11.0	16.0	24.3	968.3	39.9	4.3	14.3	21.4	59.9	3.2	0.2	8.8	72.5	16.3	27.8	3.3	0.6	2.5	13.0	5.5	33.8	5.0	12.9	9.4	7.3	7.1	7.2	12.8	0.6	5.2	10.6	1.9	27.9	6.3	17.5	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	9.8	15.4	23.0	22.0	11.0	16.0	14.3	21.4	16.3	9.4	12.8	17.5	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 249.9;kidney: 335.2;salivary gland: 260.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 191.3;Distal enterocytes: 476.1;Intestinal goblet cells: 288.8;Paneth cells: 226.2;Proximal enterocytes: 270.2;Syncytiotrophoblasts: 114.5;Undifferentiated cells: 170.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 62.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.4;OE19: 29.0;RPMI-8226: 13.9;RT4: 13.9;SCLC-21H: 14.9;SK-BR-3: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	2.1	5.4	1.6	13.4	4.6	0.1	14.0	2.8	2.8	15.5	0.7	249.9	40.0	11.8	4.0	10.9	10.4	6.8	1.9	1.6	1.3	335.2	5.5	3.2	1.0	2.7	1.3	9.3	7.4	3.6	0.5	13.0	3.3	12.9	102.2	0.0	260.2	6.2	0.9	66.1	141.8	18.3	1.5	7.0	9.8	2.5	2.0	0.4	11.1	0.2	0.9	5.3	23.6	2.4	3.6	1.1	0.4	1.4	0.1	1.7	3.6	0.0	0.0	0.1	0.1	6.1	1.3	0.0	2.7	0.1	0.1	7.8	5.1	0.5	0.0	0.0	1.8	0.0	0.7	6.6	0.6	0.7	0.0	1.7	3.0	0.3	0.1	0.0	0.0	4.6	0.4	0.0	0.0	3.8	0.2	0.2	11.4	29.0	1.0	0.0	0.2	13.9	0.5	13.9	14.9	1.0	0.8	13.4	0.6	1.3	6.5	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.6	2.8	2.8	1.6	1.3	2.7	1.3	3.3	1.5	2.0	2.4	0.7	0.0	0.5	0.0	1.1	1.5	7.2	1.3	1.2	0.0	4.8	2.2	0.5	30.0	2.3	191.3	0.0	1.2	0.3	476.1	45.0	2.1	0.2	17.4	25.2	0.5	26.9	0.0	1.1	3.0	0.7	7.1	7.1	43.5	8.9	43.4	1.1	1.2	1.4	0.0	0.8	288.8	4.1	0.3	0.5	0.5	25.4	0.7	1.8	0.0	0.0	0.0	0.0	0.5	0.3	0.6	226.2	6.8	0.2	13.5	270.2	16.3	0.4	0.0	13.1	0.3	3.9	0.2	1.6	3.5	3.4	114.5	1.2	16.7	170.9	10.5
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 429.0;liver: 217.9;placenta: 381.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	1.6	0.0	0.4	4.2	0.2	0.7	26.4	0.9	0.4	4.3	0.2	74.8	429.0	1.2	0.1	9.6	0.1	21.1	0.2	0.3	0.2	9.6	217.9	2.3	0.3	0.1	0.0	0.3	23.2	0.0	1.2	381.8	0.1	2.0	56.9	17.4	22.1	0.2	0.1	4.2	188.6	2.4	0.0	0.2	20.1	0.3	0.1	0.4	0.1	0.0	3.4	78.6	1.4	0.3	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.9	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.3	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452473-119637199	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 320.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 225.1;Oligodendrocytes: 221.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 75.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		450000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	74.4	85.0	37.2	41.9	50.2	19.7	44.4	51.1	50.0	68.8	47.2	64.5	79.3	34.1	53.0	50.9	39.1	52.5	68.6	34.9	50.7	84.4	320.0	75.6	33.2	50.6	49.5	34.8	55.2	75.5	26.5	53.4	49.2	56.8	65.9	27.2	44.9	79.0	59.8	51.8	87.6	39.5	44.7	36.6	53.8	20.9	49.9	31.9	133.9	52.8	39.7	57.7	31.5	56.3	68.8	59.8	104.1	143.7	261.8	120.3	57.9	63.4	80.3	57.3	103.0	49.4	112.8	84.4	128.0	70.6	81.0	68.7	77.0	144.4	84.3	94.6	79.8	118.1	62.0	96.9	65.8	38.0	169.9	110.0	56.3	64.9	54.7	69.3	103.9	59.4	41.0	48.9	64.2	64.0	59.2	23.6	82.1	161.1	43.1	68.7	103.0	104.8	92.2	192.7	81.1	70.6	149.0	23.4	78.7	93.3	88.7	68.2	67.6	52.7	38.1	66.5	53.1	26.3	55.3	32.6	63.7	104.4	56.7	75.5	27.3	49.9	6.5	15.5	7.3	11.1	5.8	5.3	21.3	10.3	5.5	5.2	4.9	6.9	17.1	13.8	4.1	12.2	37.2	50.2	51.1	50.0	34.9	50.7	50.6	49.5	49.2	44.7	49.9	56.3	38.9	73.7	125.2	47.3	28.2	14.9	42.5	43.2	24.5	19.7	31.1	22.1	76.4	64.3	52.3	36.8	14.6	64.3	19.1	40.0	84.1	39.9	8.8	29.0	48.9	32.3	33.0	42.1	92.9	35.8	29.3	35.6	48.4	35.8	68.4	25.3	32.2	225.1	77.9	15.2	102.8	45.8	22.4	51.8	13.8	13.4	34.5	46.7	8.8	49.6	85.7	47.3	9.2	78.4	221.5	20.5	29.6	51.1	23.1	24.8	85.7	65.4	33.8	18.6	6.6	29.2	32.2	30.6	22.7	34.7	17.2	65.0	15.7	57.2	55.3	39.7
HSPA12A	"FLJ13874, KIAA0417"	ENSG00000165868	"Heat shock protein family A (Hsp70) member 12A"	O43301	10	116671192-116850251	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 205.0;Inhibitory neurons: 186.4;Leydig cells: 63.3;Peritubular cells: 68.4;Theca cells: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.3;naive B-cell: 1.7;T-reg: 1.0"	"Group enriched"	"Detected in many"	14	"B-cells: 1.7;T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011273, HPA073244"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus, Cytosol"		"HPA011273: AB_1851190, HPA073244: AB_2686586"	"unprognostic (7.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.31e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.62e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (2.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.55e-4)"	15.8	21.9	10.9	1.5	13.5	0.0	8.8	11.2	28.2	13.7	7.9	12.4	0.7	9.2	12.5	3.9	10.3	2.3	9.6	16.6	11.1	17.4	1.6	3.0	2.7	17.3	12.2	20.5	2.7	20.0	7.9	0.8	16.4	5.6	1.9	11.0	2.6	5.5	4.9	5.7	4.1	4.6	2.7	3.8	4.7	6.2	27.3	2.1	9.4	3.4	2.8	7.9	10.0	14.7	8.0	10.0	0.1	7.1	6.6	4.4	0.1	5.5	10.1	1.9	1.0	10.0	2.8	0.0	4.1	7.6	5.2	6.1	8.4	0.7	4.9	0.0	3.2	0.0	0.8	5.5	1.9	0.0	1.0	1.7	6.6	7.3	0.9	13.9	0.0	3.3	0.0	0.0	2.1	4.0	0.0	0.0	1.2	0.0	0.1	0.0	1.0	1.2	22.1	1.8	5.3	12.7	4.0	2.9	3.0	2.4	3.2	0.0	0.0	1.4	5.5	12.3	10.2	0.1	3.2	0.0	3.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.9	13.5	11.2	28.2	16.6	11.1	17.3	12.2	16.4	2.7	27.3	14.7	2.1	6.4	3.6	27.7	1.0	11.1	1.6	0.5	2.8	35.8	5.2	6.9	7.8	2.8	2.0	12.9	22.9	0.1	0.1	1.6	15.6	4.2	4.4	12.5	16.1	3.1	0.0	0.0	205.0	3.5	0.1	17.8	0.0	4.4	0.0	2.4	2.9	0.4	0.1	30.3	186.4	0.3	0.0	0.0	5.2	9.7	63.3	0.5	26.6	9.4	0.0	35.8	0.0	27.6	54.8	2.4	0.0	68.4	0.1	2.1	0.0	25.4	11.3	10.2	13.1	14.7	14.9	1.0	5.2	0.5	5.1	0.3	0.8	82.0	0.3	0.7
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302673-76304295	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 5909.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 2482.8;MCF7: 3979.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	964.4	856.4	810.6	329.6	835.1	52.3	560.5	821.6	1798.8	2123.4	864.3	2043.6	208.7	2824.2	131.7	5909.6	993.8	217.2	2981.9	776.6	944.5	986.4	554.9	790.9	99.0	894.1	838.7	731.6	751.7	221.1	303.3	324.3	870.8	979.0	73.8	10.2	1075.3	522.5	3669.8	2258.3	523.8	1066.9	808.2	224.5	770.3	99.8	840.0	218.7	627.1	628.1	279.3	1579.4	3398.4	869.5	1251.1	902.4	79.5	576.8	487.3	447.5	5.1	514.9	249.8	260.9	325.8	84.8	660.7	8.5	389.1	599.1	514.1	1094.2	359.0	279.6	76.5	690.9	106.4	41.5	611.4	345.5	267.9	69.9	466.5	542.8	2482.8	370.0	50.5	436.6	831.3	169.5	459.4	1079.7	276.5	3979.7	117.1	508.9	407.4	212.7	800.6	417.3	195.8	974.5	342.8	423.2	7.6	529.1	363.8	1323.3	456.0	224.5	1674.9	551.6	504.2	778.8	1200.3	221.7	1310.1	85.7	145.9	10.7	575.9	247.2	579.5	19.7	13.6	10.9	58.8	78.2	28.1	115.0	92.4	62.1	31.5	105.5	102.1	88.2	5.8	79.7	112.8	56.5	64.5	46.7	810.6	835.1	821.6	1798.8	776.6	944.5	894.1	838.7	870.8	808.2	840.0	869.5	708.2	272.4	186.4	78.4	145.4	1849.8	16589.4	3603.0	1728.4	243.4	312.5	174.4	822.3	264.5	1899.4	1144.0	323.2	161.7	62.0	824.2	1500.7	2021.4	11.9	1181.8	1060.9	1038.7	422.0	136.1	4.3	6539.7	399.4	998.5	219.2	1227.1	216.7	136.3	725.7	234.7	1199.8	70.7	2.2	433.0	1245.1	147.7	2828.9	30.8	299.5	1024.8	2056.2	35.6	188.0	171.4	50.4	8.0	2.7	2719.4	1417.1	534.5	296.9	3854.8	95.3	2324.4	1253.9	29.2	611.4	551.2	2129.1	20.3	105.5	6300.1	2241.7	2432.7	758.2	68.2	390.5	13091.2
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754566-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 2969.8;tongue: 1759.1"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 165.7;Fibroblasts: 125.2;Leydig cells: 271.8;Peritubular cells: 220.4;Smooth muscle cells: 102.6;Theca cells: 311.0"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1774.3;ASC TERT1: 742.0;HHSteC: 599.9;HSkMC: 700.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		310000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	650.0	414.0	37.3	45.4	40.6	0.4	394.9	32.5	49.2	581.9	26.1	699.9	28.1	565.1	101.6	112.3	495.1	97.9	1463.9	30.0	43.6	69.0	42.3	126.6	5.7	76.7	48.5	455.2	50.5	4.2	17.5	40.2	73.7	271.2	44.0	21.1	115.9	194.7	2969.8	39.1	180.0	278.2	50.8	15.7	362.1	60.6	53.8	6.2	99.5	1759.1	2.7	537.3	290.6	49.3	0.6	0.7	2.1	2.5	1774.3	742.0	1.2	83.0	1.3	4.9	9.3	1.1	0.4	0.7	0.6	252.4	0.0	0.2	0.4	0.7	3.9	0.9	0.5	0.4	1.3	0.5	599.9	0.2	0.9	700.3	0.0	19.1	0.9	2.2	5.4	0.3	0.5	1.0	0.2	0.3	0.4	1.9	1.2	2.3	0.6	1.5	0.5	0.7	0.0	0.1	0.8	0.7	0.1	0.2	0.7	0.3	0.3	0.5	0.1	153.2	0.9	17.3	0.6	1.0	2.8	0.3	20.5	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	40.6	32.5	49.2	30.0	43.6	76.7	48.5	73.7	50.8	53.8	49.3	11.1	3.2	0.6	1.6	0.1	1.8	0.4	0.0	3.4	7.8	0.5	0.5	29.7	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	0.1	27.0	4.9	165.7	3.6	0.0	5.2	0.2	0.0	2.5	125.2	4.1	3.5	0.0	3.6	17.5	0.3	5.0	0.0	0.5	0.0	0.0	0.3	3.6	18.9	271.8	2.7	1.8	0.0	0.6	44.5	0.0	0.0	0.1	0.2	0.0	220.4	0.1	0.4	0.0	0.4	0.0	2.8	26.3	38.0	102.6	2.3	1.4	1.9	2.0	4.8	1.8	311.0	0.0	0.5
HSPB7	cvHSP	ENSG00000173641	"Heat shock protein family B (small) member 7"	Q9UBY9	1	16014028-16019594	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 4135.3;skeletal muscle: 2417.8;tongue: 1229.5"	"Cell type enriched"	"Detected in some"	32	"Cardiomyocytes: 2389.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"fHDF/TERT166: 315.1"	"Not detected"	"Not detected"							HPA027639	Approved		Approved	Nucleoplasm		NA	NA		130000		"Cluster 38: Heart - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA027639: AB_10601756"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.28e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.35e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.19e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (1.26e-4)"	306.8	123.4	3.9	32.1	4.4	0.2	119.7	8.8	5.1	49.6	8.6	138.3	5.1	179.5	7.5	44.2	64.8	18.7	4135.3	4.1	5.6	38.5	3.2	22.1	1.7	13.1	7.9	25.4	9.2	38.8	5.3	7.1	12.0	43.0	8.0	3.1	35.1	24.4	2417.8	19.3	34.0	189.2	5.3	4.5	71.4	20.2	4.7	0.6	14.1	1229.5	0.7	99.2	30.5	6.7	0.0	0.0	0.0	1.5	70.7	3.2	1.8	18.4	1.1	0.0	0.2	0.0	0.1	0.0	0.0	315.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	3.4	0.0	0.0	2.1	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.6	0.1	0.1	0.0	0.1	5.3	3.3	0.0	0.0	0.0	1.3	0.0	11.8	0.0	1.3	0.1	1.1	0.0	14.1	0.6	1.9	0.0	10.3	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.4	8.8	5.1	4.1	5.6	13.1	7.9	12.0	5.3	4.7	6.7	0.5	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.8	0.2	0.4	2389.7	0.0	0.0	3.7	0.0	2.8	0.0	0.0	13.7	1.4	55.5	0.1	0.7	26.6	0.0	0.0	0.0	0.2	1.4	46.3	0.0	0.1	0.0	0.4	0.0	0.0	1.6	1.7	0.1	0.0	0.0	0.0	4.6	74.2	14.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.2	0.0	0.0	6.8	0.0	0.5	0.0	0.2	0.0	0.6	0.0	20.2	42.6	1.9	0.9	0.1	2.6	3.3	0.5	3.0	0.0	0.1
HSPB8	"CMT2L, E2IG1, H11, HSP22"	ENSG00000152137	"Heat shock protein family B (small) member 8"	Q9UJY1	12	119171555-119224855	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Stress response"	Chaperone	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 897.3"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015876	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	Nucleoplasm	"HPA015876: AB_1850458"	"unprognostic (1.52e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (2.98e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.17e-2)"	57.0	13.9	172.2	34.4	172.6	0.0	33.4	179.5	141.8	58.1	147.0	381.0	8.9	114.4	10.1	163.2	58.7	43.1	469.3	147.8	231.0	63.3	4.8	95.7	11.4	188.3	206.1	23.4	30.8	183.1	17.5	92.1	193.0	143.5	35.8	28.2	50.8	289.0	897.3	70.5	50.5	114.1	211.5	56.2	110.4	12.0	193.6	40.3	29.2	448.5	98.7	239.2	100.1	235.5	21.1	16.1	0.3	0.0	14.4	11.5	60.2	32.5	28.7	5.9	0.3	40.0	0.6	0.1	89.6	42.4	48.0	2.4	0.3	0.0	0.6	0.1	1.2	0.0	66.0	3.2	11.2	0.0	0.1	14.1	4.1	22.3	1.3	21.6	12.3	0.0	0.2	0.0	13.0	130.5	0.0	0.2	5.7	0.0	23.0	0.0	22.9	2.9	38.3	6.2	0.4	1.0	13.5	1.6	6.8	50.5	29.0	0.2	20.4	15.8	39.8	21.7	1.7	0.0	0.2	0.2	67.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	172.6	179.5	141.8	147.8	231.0	188.3	206.1	193.0	211.5	193.6	235.5	2.7	44.8	48.2	42.1	0.7	102.3	108.5	4.5	126.3	0.7	95.2	17.5	599.1	7.2	5.4	5.5	8.4	149.1	1.0	0.0	0.0	59.7	12.2	98.1	20.2	27.4	0.0	0.0	6.2	11.4	17.5	82.2	5.6	142.7	1.3	0.0	25.4	0.0	19.4	1.7	6.6	0.0	2.0	1.0	9.4	11.0	1.5	1.6	12.4	2.8	1.0	51.7	0.0	0.0	0.9	12.9	0.0	0.4	0.3	24.6	0.0	52.0	3.1	2.1	6.6	39.8	76.9	0.9	0.2	38.0	28.7	1340.0	3.5	0.1	0.2	72.7
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822244-21937310	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.8;Endothelial cells: 322.9;Granulosa cells: 776.0;Hepatic stellate cells: 600.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 293.0;HUVEC TERT2: 620.8;TIME: 504.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009820, HPA018892, CAB020718, HPA072690"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		1400000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (2.82e-4)"	140.7	54.7	3.8	36.1	5.2	1.7	96.2	3.7	4.8	65.9	18.8	153.1	18.3	151.9	6.6	44.1	85.0	53.4	156.6	3.6	2.9	37.6	10.6	49.0	14.2	5.6	4.6	31.3	31.7	13.1	11.8	30.3	5.7	60.3	8.6	0.3	45.0	56.5	65.1	41.0	54.9	96.2	4.0	37.4	76.1	9.0	7.6	6.7	69.1	40.8	3.5	110.2	59.7	4.7	44.0	40.7	13.8	45.9	131.0	99.4	51.5	70.2	17.8	21.1	18.7	50.5	86.7	3.3	293.0	112.9	0.8	26.9	3.1	31.9	5.4	0.6	4.3	15.7	46.0	35.7	27.0	0.0	4.1	61.6	9.4	19.9	6.0	28.1	620.8	0.3	21.4	5.7	32.4	11.8	0.0	20.0	11.7	19.6	17.9	6.3	87.8	6.1	35.1	6.5	1.3	4.1	51.4	20.0	28.7	14.0	8.1	7.2	504.3	41.1	51.8	29.7	2.3	0.5	7.3	2.6	9.7	0.1	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	5.2	3.7	4.8	3.6	2.9	5.6	4.6	5.7	4.0	7.6	4.7	366.8	70.5	28.6	3.6	3.9	26.4	13.5	81.1	21.1	0.6	6.2	21.5	5.8	38.6	30.3	92.0	0.0	11.0	3.4	52.9	0.0	76.1	1.4	24.2	47.7	322.9	2.4	22.9	0.8	25.0	89.0	141.3	62.2	39.8	23.4	776.0	600.4	6.6	6.8	3.3	0.8	12.6	16.2	22.1	19.2	5.8	75.2	4.6	60.5	15.9	1.8	1.6	0.0	2.5	4.3	87.5	29.9	69.2	4.6	19.3	19.2	0.9	28.7	0.6	32.9	82.5	69.8	0.3	4.8	10.0	17.8	9.3	5.0	83.3	20.1	11.8
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23194729	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 12.4;intestine: 9.4"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 5.7;Proximal enterocytes: 6.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.5;hTERT-RPE1: 9.8;OE19: 14.3;TIME: 26.4;U-2 OS: 8.4"															NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.73e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.87e-3)"	"unprognostic (8.88e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.28e-6)"	"unprognostic (9.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.02e-3)"	0.0	0.0	1.9	0.2	5.7	0.2	0.1	0.3	3.8	0.0	0.1	0.2	9.4	0.1	0.0	0.0	0.5	1.6	0.0	1.4	1.3	0.0	0.0	0.1	0.0	0.6	12.4	0.0	0.2	0.1	0.1	0.2	1.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	8.2	0.1	2.0	0.1	0.1	0.2	4.4	0.0	0.1	0.0	0.1	0.1	0.0	0.7	3.2	10.5	0.1	0.0	0.0	0.2	0.9	0.0	0.8	0.3	0.4	0.7	7.5	0.0	3.0	0.4	5.2	2.2	2.1	0.0	0.5	0.0	0.9	0.0	6.0	0.1	0.4	0.0	0.0	0.1	0.2	1.3	0.4	9.8	6.1	0.1	0.1	0.0	0.2	1.3	0.0	0.0	2.5	14.3	0.1	0.0	0.0	0.0	0.2	0.0	2.5	0.0	7.0	0.4	0.1	0.8	0.1	0.0	26.4	0.0	8.4	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	5.7	0.3	3.8	1.4	1.3	0.6	12.4	1.7	2.0	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.7
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937528-87016679	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;ovary: 4.2"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 125.4;Inhibitory neurons: 104.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"PC-3: 1.7;SH-SY5Y: 6.6"					"Low region specificity"	"Detected in many"			HPA004931	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.0	0.0	1.7	0.0	3.0	0.0	0.0	0.0	4.2	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.2	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.0	0.0	4.2	2.6	1.3	0.2	0.3	0.1	0.0	1.2	2.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	1.1	0.0	0.0	0.0	125.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	104.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.0;salivary gland: 5.0"	"Group enriched"	"Detected in some"	11	"Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	15	"memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	127	"B-cells: 13.8;dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5"	HPA069442	Supported					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"			"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.0	0.4	0.7	2.1	1.2	0.0	0.0	0.4	1.0	0.0	0.4	2.1	0.6	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.5	0.1	0.0	0.0	6.5	0.4	0.5	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	5.0	0.0	0.0	0.7	1.7	0.7	0.4	0.5	0.8	0.1	0.5	0.4	0.0	0.0	8.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.7	1.2	0.4	1.0	1.1	0.5	0.4	0.5	0.4	0.4	0.5	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	3.0	0.1	0.0	23.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HTR3B	5-HT3B	ENSG00000149305	"5-hydroxytryptamine receptor 3B"	O95264	11	113904677-113949078	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.4;Oligodendrocytes: 1.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 2.5"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039559	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA039559: AB_10672779"					"unprognostic (1.60e-2)"	"unprognostic (8.37e-2)"			"unprognostic (2.84e-1)"	"unprognostic (3.28e-1)"				"unprognostic (1.71e-1)"	"unprognostic (2.46e-1)"			0.0	0.1	0.0	0.2	0.5	0.5	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.4	0.1	0.3	0.2	0.1	0.0	0.5	0.0	2.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155087392	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 8.7;Excitatory neurons: 7.6;Inhibitory neurons: 10.0;Late spermatids: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							CAB017467	Approved					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.0	0.0	1.7	0.0	1.6	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	3.6	2.8	1.3	1.6	0.6	2.7	1.8	0.2	1.2	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronidase 2"	Q12891	3	50317790-50322782	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 282.8"	"Group enriched"	"Detected in many"	5	"Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 363.3;TIME: 502.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	97.4	62.6	24.7	29.1	23.0	3.1	93.9	24.9	28.3	51.6	24.3	34.0	17.9	66.1	10.3	39.7	55.6	47.5	92.2	22.3	24.8	85.1	32.2	186.8	40.0	26.0	24.9	29.1	27.9	25.7	41.6	87.4	27.5	37.2	11.5	3.3	37.5	22.0	30.9	37.1	38.7	37.4	27.1	282.8	38.6	22.0	28.1	9.5	80.9	35.7	14.6	47.0	45.8	24.9	26.8	38.5	63.0	64.1	38.2	32.9	39.6	29.8	41.2	42.0	32.6	44.6	77.3	7.0	102.4	43.6	82.5	27.4	24.6	58.7	12.0	14.2	19.6	9.7	34.9	69.2	33.0	8.1	24.4	51.9	48.8	42.1	13.8	38.1	363.3	18.2	17.6	8.0	35.4	37.0	17.7	16.6	72.0	23.2	55.7	15.5	12.4	26.1	52.4	24.2	16.6	53.3	30.4	31.2	31.8	21.2	34.4	20.3	502.9	50.0	49.7	33.5	47.5	13.9	24.1	21.6	29.4	25.5	73.0	0.0	9.5	10.7	1.4	14.1	3.0	1.1	1.3	3.8	5.3	1.5	0.4	0.7	9.2	2.8	13.6	4.0	1.9	3.3	24.7	23.0	24.9	28.3	22.3	24.8	26.0	24.9	27.5	27.1	28.1	24.9	497.6	19.2	9.9	5.2	3.6	13.0	28.6	45.2	11.4	7.8	17.6	16.6	7.3	32.9	30.9	33.1	6.2	33.6	4.1	13.5	11.7	53.0	4.7	8.5	19.8	216.3	7.3	10.1	1.6	38.7	38.4	26.6	16.8	13.8	0.0	31.5	253.1	9.1	46.2	8.4	1.9	13.0	42.7	12.6	9.3	5.0	24.5	9.4	17.8	15.9	7.6	19.7	5.2	4.0	3.4	45.6	13.5	22.2	4.2	45.3	16.1	11.8	11.0	6.1	39.5	11.2	26.0	11.2	56.0	24.9	12.6	32.7	4.1	50.0	16.6	33.3
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 341.8;Endothelial cells: 180.8;Hepatic stellate cells: 128.5;NK-cells: 106.1;Plasma cells: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 1260.8;TIME: 319.0"	"Low region specificity"	"Detected in all"							HPA071155			Approved	"Plasma membrane,Cytosol"		NA	NA		730000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	97.4	11.3	39.6	30.4	39.6	20.7	78.7	40.3	48.3	20.3	34.6	26.3	14.1	24.4	6.7	12.1	22.2	18.8	99.7	38.2	40.5	44.3	14.6	84.5	60.5	42.1	40.9	12.7	15.4	9.0	12.4	79.3	42.9	16.1	18.2	1.2	16.0	8.6	37.9	16.3	34.2	29.5	41.4	168.1	18.8	3.5	44.6	31.5	33.6	55.9	41.8	33.0	21.4	40.6	0.0	0.0	0.0	0.0	11.3	10.8	3.2	1.1	0.7	0.3	1.1	2.7	52.2	92.9	16.6	0.0	0.3	0.4	1.2	0.0	1.7	22.3	0.0	82.9	4.4	10.0	1.8	14.2	0.3	0.4	0.0	0.8	0.2	0.0	1260.8	78.8	67.7	50.5	0.3	0.0	101.8	11.8	0.1	0.7	0.0	60.3	0.2	128.7	6.7	12.8	0.0	0.8	0.0	0.2	0.0	0.1	0.0	10.3	319.0	0.2	0.8	6.2	0.0	47.6	18.7	83.4	0.1	17.7	0.0	444.8	191.8	62.1	282.8	464.6	326.0	265.6	371.2	270.7	203.6	328.9	400.3	253.3	23.1	188.5	525.8	67.2	450.8	502.0	39.6	39.6	40.3	48.3	38.2	40.5	42.1	40.9	42.9	41.4	44.6	40.6	341.8	0.0	8.4	0.0	47.8	7.4	4.0	5.2	0.6	0.1	6.1	11.3	0.5	1.5	4.5	7.3	0.0	0.5	41.7	1.7	0.0	1.2	0.6	1.2	2.4	180.8	1.2	28.2	0.1	1.4	0.3	13.8	1.1	0.8	12.0	0.7	128.5	1.9	20.0	0.0	0.0	2.2	2.0	55.6	13.4	1.3	0.3	56.9	28.4	21.5	25.7	0.4	106.1	0.5	0.2	6.8	4.7	1.9	114.4	3.8	0.6	0.5	4.1	0.5	6.6	7.4	11.6	0.2	0.3	0.7	5.4	1.0	60.1	6.5	4.2	2.8
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289952-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 40.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Cardiomyocytes: 33.9;Erythroid cells: 8.2;Excitatory neurons: 17.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	239	"amygdala: 13.6;basal ganglia: 15.4;cerebral cortex: 26.2;hippocampal formation: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 16.3;K-562: 13.2;RPMI-8226: 14.7;U-266/70: 17.5;U-87 MG: 9.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	14	"amygdala: 40.8;basal ganglia: 45.1;cerebral cortex: 50.7;hippocampal formation: 76.2;olfactory bulb: 27.4"	"HPA008943, HPA009083, CAB025178"	Enhanced					NA	NA		3300000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.3	0.0	13.6	0.0	15.4	0.6	0.2	0.0	26.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	1.2	40.2	0.0	1.0	0.0	6.2	0.2	0.0	0.0	2.1	0.0	0.1	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	3.5	0.0	0.0	7.4	0.0	0.0	0.3	5.0	0.8	0.2	0.5	0.0	0.1	5.6	2.3	0.0	0.0	6.5	0.2	0.0	0.0	0.2	1.0	16.3	6.1	0.5	0.1	0.0	3.1	0.0	0.6	0.1	0.0	0.0	0.0	2.0	13.2	0.1	0.0	0.8	0.0	2.3	0.0	0.3	4.9	0.1	0.0	14.7	0.2	0.0	0.9	0.1	2.3	0.2	0.5	0.0	2.7	0.0	0.0	1.5	0.0	0.9	0.0	17.5	3.1	3.5	9.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	15.4	0.0	26.2	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.4	2.8	1.6	0.4	0.3	0.2	0.3	1.8	0.7	1.6	5.2	33.9	0.0	1.3	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.5	0.6	0.5	2.8	0.0	8.2	17.7	0.0	0.1	1.1	1.1	1.3	2.5	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.3	1.7	0.0	0.0	2.1	0.0	2.8	0.3	0.0	0.0	1.5	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.4	0.5	0.0	0.0	0.7	1.7	1.7	1.3	0.4	0.1	0.1	0.7	0.1	0.2	0.2
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	12	"T-cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Group enriched"	"Detected in some"	8	"HEL: 4.6;MOLT-4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"	0.5	0.1	0.0	7.7	0.0	16.5	0.3	0.0	0.0	0.2	0.0	0.7	0.7	0.2	0.1	0.5	0.3	1.4	0.2	0.0	0.0	0.2	0.4	2.6	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.2	2.3	0.4	0.0	3.3	1.3	0.2	0.0	20.2	0.4	0.0	16.2	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.2	0.0	15.1	6.8	0.0	0.0	15.7	7.2	0.1	0.5	0.0	0.0	29.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	3.1	2.9	0.0	0.0	0.0	0.0	1.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.1	2.0	0.2	6.3	0.0	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.8	4.7	0.1	0.0	3.1	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	1.8	0.1	81.2	0.0	0.0	0.1
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 425.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria		NA	NA		5200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favorable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	32.8	10.5	56.5	60.2	67.8	161.1	51.1	57.1	59.8	36.6	76.6	95.9	97.2	29.0	12.5	140.6	32.7	31.7	492.6	47.2	55.0	208.3	274.7	32.0	77.1	61.0	61.3	13.6	128.7	104.0	15.5	87.3	54.4	76.2	84.1	5.4	163.1	90.4	1302.3	61.8	84.3	79.8	52.9	36.8	175.7	5.3	71.6	148.7	16.0	1611.3	66.0	53.3	49.4	57.6	61.3	33.5	169.9	169.8	23.3	28.3	144.5	74.5	110.8	68.0	72.6	16.1	51.1	72.7	21.0	61.2	65.1	20.8	25.1	22.4	32.0	143.8	16.9	122.9	12.7	119.7	28.1	85.1	118.2	59.7	12.7	16.3	13.0	82.1	141.0	246.4	18.9	59.3	53.0	175.3	425.0	131.2	51.8	81.9	14.3	352.0	122.4	213.7	105.6	71.3	244.5	125.3	92.1	359.8	29.9	94.2	290.9	256.9	34.0	120.4	17.0	16.1	34.9	101.5	20.5	9.0	38.4	175.0	71.2	45.0	112.8	75.6	105.9	199.1	53.2	70.1	77.0	120.1	136.9	47.7	42.9	71.8	22.9	99.9	252.1	79.4	72.4	163.4	56.5	67.8	57.1	59.8	47.2	55.0	61.0	61.3	54.4	52.9	71.6	57.6	16.9	6.4	21.0	40.1	64.2	39.9	98.8	91.6	12.5	6.2	90.5	48.1	445.9	114.4	95.8	75.4	10.4	732.5	84.0	70.0	1168.0	252.8	5.6	96.4	25.7	41.6	61.7	193.8	11.8	288.8	586.7	44.7	88.2	50.9	31.6	29.2	38.2	283.1	263.7	10.1	8.3	158.3	229.9	77.7	101.1	3.2	14.0	79.0	58.7	5.6	85.3	20.9	119.4	16.6	27.3	116.6	105.0	35.3	185.9	170.3	69.6	205.0	167.9	5.4	13.1	60.8	73.4	0.6	15.6	113.3	67.1	573.0	88.1	14.7	305.1	140.1
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA002134, CAB016293, HPA073514"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099, HPA073514: "	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	95.7	37.9	13.5	114.5	17.5	35.5	72.8	14.3	14.1	56.8	9.1	38.3	23.8	76.5	22.7	63.6	54.2	100.6	35.0	13.7	20.3	30.1	27.7	68.2	140.6	29.9	22.7	76.8	16.7	9.7	9.3	66.7	27.0	26.5	45.0	7.7	63.7	32.0	16.8	58.8	47.9	87.3	23.6	107.8	30.7	18.8	23.8	116.8	37.4	32.6	133.1	113.6	52.8	26.2	43.5	3.2	14.4	0.6	97.4	319.5	0.4	89.9	238.0	245.7	324.2	0.0	54.1	251.7	75.4	55.3	79.2	122.2	2.2	91.1	97.7	78.4	1.1	64.9	17.2	0.1	181.8	22.8	4.2	302.4	159.5	126.5	177.8	117.8	262.8	218.1	1.4	179.4	138.6	0.0	302.2	21.1	38.4	0.0	32.5	140.6	91.4	295.0	34.4	16.1	6.6	0.1	117.7	1.0	259.5	56.9	0.4	26.3	150.2	63.1	29.7	179.9	38.2	165.8	82.8	235.5	181.2	72.7	155.7	9.1	67.7	0.4	57.5	66.4	51.9	88.4	54.3	59.4	68.3	94.6	33.9	43.3	164.4	91.6	65.3	51.1	82.1	63.8	13.5	17.5	14.3	14.1	13.7	20.3	29.9	22.7	27.0	23.6	23.8	26.2	378.4	38.5	54.6	4.2	217.8	95.0	110.7	197.6	174.8	0.4	47.8	43.8	10.7	37.1	130.7	42.3	0.0	3.4	278.3	7.9	1.9	38.0	4.9	41.9	219.1	286.8	12.1	38.7	1.3	47.8	2.9	207.8	9.7	68.0	138.3	27.7	137.4	3.0	214.2	0.0	2.2	19.9	79.3	163.8	135.0	9.8	117.4	187.2	83.6	116.2	202.4	30.8	329.6	37.2	20.7	47.1	23.5	53.0	143.3	32.6	7.9	4.9	76.6	1.4	85.5	185.3	132.7	2.4	13.2	92.6	68.2	3.3	219.2	70.6	26.4	107.5
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30 lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 572.7;lymphoid tissue: 708.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 155.9;Kupffer cells: 205.4;Langerhans cells: 139.3;Macrophages: 426.2;monocytes: 144.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 9509.8;eosinophil: 3890.4;intermediate monocyte: 14243.6;myeloid DC: 5699.9;non-classical monocyte: 9865.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 5699.9;granulocytes: 3890.4;monocytes: 14243.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 655.7;RPMI-8226: 717.7;SK-BR-3: 457.4;U-266/84: 794.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	132.4	121.0	18.4	708.3	20.8	283.8	58.6	20.3	104.5	40.8	48.7	129.0	197.3	22.2	26.9	38.7	57.3	109.6	31.2	18.0	23.3	80.3	148.2	572.7	370.7	32.0	24.9	14.8	61.3	75.0	27.9	128.8	40.5	31.6	148.0	2.6	66.3	22.0	12.6	55.0	153.6	165.0	26.8	385.3	112.2	16.0	69.4	91.9	54.2	9.0	221.0	215.7	19.6	49.8	115.5	59.2	0.4	37.9	11.2	19.9	102.6	11.8	17.2	34.6	91.8	132.3	193.1	655.7	96.6	39.7	175.2	85.1	69.9	30.1	3.7	182.5	55.2	8.1	98.1	188.9	111.8	20.1	46.9	70.4	60.4	59.8	19.7	4.4	2.0	23.8	96.8	394.8	16.6	217.3	9.9	2.5	21.2	380.6	68.7	65.8	4.5	717.7	101.1	3.7	5.3	8.0	200.5	457.4	11.3	7.4	31.6	8.8	4.2	55.2	34.2	120.7	12.0	14.6	794.7	368.5	154.1	133.5	8.5	106.9	9509.8	3890.4	40.8	14243.6	38.8	952.6	28.5	31.1	5699.9	708.1	19.7	24.3	2102.8	70.2	9865.9	173.2	41.5	11082.7	18.4	20.8	20.3	104.5	18.0	23.3	32.0	24.9	40.5	26.8	69.4	49.8	6.4	9.6	38.8	0.0	54.2	3.6	2.5	2.1	2.2	0.4	8.6	13.2	1.1	4.3	18.3	12.9	0.0	5.6	4.0	8.3	1.9	1.8	0.3	2.5	1.7	8.4	0.0	4.6	0.1	1.1	14.8	8.1	6.6	4.1	13.9	0.2	3.6	1.3	155.9	0.0	0.1	14.9	2.0	205.4	139.3	0.2	0.3	426.2	5.4	1.0	144.1	0.7	5.2	0.0	0.1	1.2	3.4	0.0	47.7	4.6	5.9	5.4	8.9	0.7	0.0	2.6	1.8	0.2	0.7	3.7	3.3	12.0	9.6	1.5	9.6	1.2
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFNAR2	IFNABR	ENSG00000159110	"Interferon alpha and beta receptor subunit 2"	P48551	21	33229901-33265675	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 211.2;U-266/70: 261.6;U-266/84: 145.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.00e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-3)"	"unprognostic (8.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.42e-1)"	"prognostic unfavorable (7.54e-7)"	"unprognostic (9.70e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.12e-3)"	"unprognostic (1.85e-2)"	21.3	9.0	13.2	33.2	13.6	29.1	16.4	11.5	14.8	12.7	9.7	16.7	17.4	11.7	8.2	8.0	11.7	21.0	13.4	11.0	14.3	14.3	28.7	22.6	33.5	16.7	14.0	11.8	10.0	12.5	10.1	22.9	15.1	10.1	17.4	8.3	13.7	11.3	9.0	7.0	16.2	18.3	13.6	41.0	14.8	5.3	15.8	33.9	10.7	10.8	36.4	38.2	9.0	14.0	17.0	18.4	9.9	23.7	11.9	27.3	16.2	18.1	45.1	14.2	15.7	24.4	20.8	28.3	12.8	25.4	22.8	10.9	15.2	9.2	15.0	18.3	19.9	100.9	19.1	22.2	17.5	17.5	38.0	20.7	8.7	16.8	18.5	24.8	46.0	41.5	30.2	211.2	13.7	9.1	44.0	19.6	18.3	24.2	11.7	14.9	53.4	50.7	30.8	31.9	26.6	14.2	29.5	28.2	23.9	10.4	4.4	30.5	32.2	15.3	9.3	12.5	10.1	261.6	145.3	64.3	20.5	60.3	37.5	44.5	38.5	63.8	31.2	65.0	32.2	25.7	37.9	29.3	36.6	17.1	27.5	30.8	101.2	35.2	73.4	101.0	65.8	41.3	13.2	13.6	11.5	14.8	11.0	14.3	16.7	14.0	15.1	13.6	15.8	14.0	35.6	60.9	16.1	19.6	49.4	6.8	43.8	41.7	2.8	6.6	11.4	12.4	2.2	20.0	23.6	11.0	6.2	28.9	64.4	6.0	3.9	67.5	3.0	6.7	10.0	39.0	3.0	27.6	44.4	62.7	72.1	15.4	4.6	8.5	31.7	11.8	44.6	19.6	44.9	20.2	42.3	4.4	4.1	73.5	17.1	3.3	7.5	58.5	19.6	74.9	47.9	6.4	89.6	51.3	29.4	73.8	5.9	9.1	188.8	89.5	17.3	10.2	35.2	5.6	0.0	16.8	12.5	4.2	19.9	4.3	5.7	23.5	43.9	2.5	4.9	83.2
IGF1	"IGF, IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 86.7;cervix: 89.0"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 1279.3;Leydig cells: 1103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.4"	"Lineage enriched"	"Detected in single"	24	"B-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.9;HDLM-2: 49.6;K-562: 22.4;Karpas-707: 11.3;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048946	Approved				"Secreted to blood"	NA	NA	103000000	330000000	"Cluster 24: B-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA048946: AB_2680566"	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	86.7	5.1	1.2	27.1	1.8	0.9	38.7	0.3	2.3	89.0	1.3	6.9	5.4	46.9	10.6	6.6	13.0	21.5	15.1	2.2	1.0	3.1	83.5	11.6	6.5	2.5	1.1	9.0	3.9	1.4	1.2	24.2	2.0	38.5	6.7	5.4	7.6	33.4	8.5	4.9	5.7	74.3	1.2	9.8	7.7	7.6	2.0	3.1	25.4	5.9	3.7	21.3	22.7	0.9	0.3	0.0	0.0	0.0	37.9	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	22.4	11.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.2	0.2	1.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.4	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	1.8	0.3	2.3	2.2	1.0	2.5	1.1	2.0	1.2	2.0	0.9	11.8	3.2	2.2	1.0	8.5	2.5	0.7	0.0	1.8	168.1	4.0	6.2	0.4	2.8	0.7	0.0	0.0	1.1	0.6	0.2	0.0	0.0	17.5	35.8	1279.3	38.9	0.0	5.3	1.2	0.6	1.5	259.7	2.6	34.5	0.0	0.3	6.4	243.0	122.0	0.0	123.9	0.0	16.2	25.8	12.5	58.0	1103.2	42.0	14.2	27.2	3.6	4.4	0.0	0.5	0.9	0.1	0.0	193.4	66.9	1.2	0.0	1.4	0.1	9.0	0.0	139.3	19.6	1.9	1.2	1.6	2.7	1.2	9.1	69.4	0.2	0.4
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IGHA1		ENSG00000211895	"Immunoglobulin heavy constant alpha 1"	P01876	14	105703995-105708665	"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 7411.2;lymphoid tissue: 6397.6;salivary gland: 8904.9;stomach 1: 6664.9"	"Group enriched"	"Detected in many"	10	"B-cells: 17763.5;Plasma cells: 34095.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	203	"memory B-cell: 2571.8;naive B-cell: 1114.6"	"Lineage enriched"	"Detected in many"	284	"B-cells: 2571.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.4;RPMI-8226: 34.7;SH-SY5Y: 22.3;U-266/70: 78.2;U-266/84: 24.0"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		130000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (8.87e-5)"	"unprognostic (5.36e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.75e-2)"	"prognostic favorable (3.81e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.83e-7)"	"unprognostic (8.10e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	200.6	41.7	1.4	1121.1	1.0	918.5	953.5	0.7	6.5	214.3	4.2	5973.6	7411.2	79.9	3.5	641.9	203.5	662.9	73.8	0.6	1.3	278.5	327.7	1305.3	1420.6	3.5	1.1	40.6	115.1	3.5	38.3	6.7	1.1	202.5	1338.5	0.0	8904.9	69.0	10.8	56.7	3788.8	69.5	1.4	6397.6	6664.9	23.2	1.0	131.0	447.3	0.4	1949.0	1616.2	302.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.8	0.0	0.0	3.6	0.0	0.0	0.0	17.4	0.0	3.7	0.0	0.0	0.0	5.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.0	0.0	4.1	14.4	5.5	0.0	0.0	3.8	4.3	34.7	0.0	0.0	9.7	22.3	2.6	0.0	0.0	0.0	0.0	1.6	5.1	0.0	3.9	4.2	3.2	78.2	24.0	2.2	0.0	2.4	0.0	3.8	3.0	0.6	1.3	0.3	1.0	2571.8	0.7	1.1	1.5	1114.6	0.4	1.0	9.0	0.9	0.9	1.7	1.0	508.3	1.4	1.0	0.7	6.5	0.6	1.3	3.5	1.1	1.1	1.4	1.0	1.9	11.8	131.4	783.5	0.0	17763.5	0.0	26.0	0.0	1.2	0.0	22.4	4.6	4.7	22.8	46.4	0.0	0.0	0.7	55.5	20.8	0.0	0.0	0.0	0.1	0.1	26.5	28.4	167.0	0.0	0.0	0.5	56.5	99.4	0.1	584.8	0.0	353.8	225.1	1.6	0.0	0.0	13.6	0.0	57.8	0.0	0.0	0.0	34.6	0.0	0.0	6.7	0.0	11.3	0.0	0.0	0.0	12.8	0.0	34095.8	33.2	0.0	1.4	16.0	0.0	0.0	2.0	13.6	0.0	0.0	0.8	0.0	6.0	2514.2	0.0	27.9	1.2
IGHA2		ENSG00000211890	"Immunoglobulin heavy constant alpha 2 (A2m marker)"	P01877	14	105583731-105588395	"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 5017.7;salivary gland: 3728.4"	"Group enriched"	"Detected in many"	22	"B-cells: 3713.4;Plasma cells: 10918.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	876	"memory B-cell: 279.6;naive B-cell: 123.8"	"Lineage enriched"	"Detected in single"	1214	"B-cells: 279.6"	"Group enriched"	"Detected in some"	42	"U-266/70: 181.9;U-266/84: 63.9"	"Not detected"	"Not detected"							"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	NA	NA		67000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001217: AB_1079120, HPA006013: AB_1079119"	"prognostic favorable (1.98e-9)"	"unprognostic (3.20e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.40e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.50e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.47e-1)"	24.3	3.7	0.0	14.2	0.0	12.4	329.7	0.0	0.0	47.6	0.0	5017.7	15.3	8.9	0.0	219.7	35.0	0.9	4.8	0.0	0.0	49.7	35.1	134.2	6.8	0.0	0.0	5.3	30.3	0.0	4.9	0.3	0.0	37.7	8.8	0.0	3728.4	0.1	2.1	17.8	2261.3	1.0	0.0	700.9	670.1	1.1	0.0	22.4	59.8	0.0	13.0	93.4	67.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	2.8	2.8	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.9	181.9	63.9	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	279.6	0.0	0.1	0.1	123.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.2	12.4	0.0	3713.4	0.0	2.4	0.0	2.8	0.0	1.4	0.3	1.2	5.7	0.6	0.0	0.0	0.1	3.2	3.7	0.0	0.0	0.0	0.0	0.0	15.6	8.5	56.2	0.0	0.0	0.0	8.0	10.7	0.0	15.2	0.0	78.9	6.0	0.3	0.0	0.0	2.9	0.0	10.8	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	10918.5	0.3	0.0	0.1	0.0	0.0	0.0	0.1	23.6	0.0	0.0	12.3	0.0	0.4	325.4	0.0	4.8	0.2
IGHD	"FLJ00382, FLJ46727, MGC29633"	ENSG00000211898	"Immunoglobulin heavy constant delta"	P01880	14	105836765-105845678	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 330.9"	"Group enriched"	"Detected in some"	47	"B-cells: 261.8;Plasma cells: 588.1;T-cells: 474.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 58.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	63	"memory B-cell: 279.1;naive B-cell: 815.9"	"Lineage enriched"	"Detected in many"	93	"B-cells: 815.9"	"Group enriched"	"Detected in some"	7	"Daudi: 82.3;U-698: 95.8"									CAB012703	Approved				"Immunoglobulin genes"	NA	NA		14000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB012703: AB_10554307"	"prognostic favorable (1.49e-6)"	"unprognostic (1.84e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.30e-2)"	2.8	0.4	0.0	35.4	0.0	39.2	9.3	0.0	0.4	0.9	0.0	2.2	3.4	5.0	0.2	2.8	0.6	19.0	5.7	0.0	0.0	2.1	3.5	34.1	111.6	0.2	0.0	0.3	0.4	0.2	0.0	0.3	0.0	6.4	1.9	0.0	67.1	1.2	0.4	1.5	17.6	0.9	0.0	146.7	43.3	0.3	0.1	8.3	1.3	0.0	330.9	20.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	82.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	12.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	2.7	0.5	0.3	0.4	0.3	0.2	279.1	0.3	0.8	0.7	815.9	1.0	0.3	3.3	0.3	0.5	8.7	0.4	39.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	261.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.7	0.0	9.2	0.0	0.0	0.0	0.0	0.0	588.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	474.2	0.0	0.0	0.0
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 11451.9;urinary bladder: 3998.0"	"Group enriched"	"Detected in many"	16	"B-cells: 3900.5;Plasma cells: 9883.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.7"	"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 766.8"	"Lineage enriched"	"Detected in many"	123	"B-cells: 766.8"	"Group enriched"	"Detected in many"	9	"Karpas-707: 157.8;U-698: 392.7"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	NA	NA		230000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.25e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.36e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.49e-9)"	"unprognostic (3.12e-1)"	"unprognostic (3.52e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.61e-2)"	526.0	696.8	0.7	1661.1	0.6	681.1	203.2	0.5	4.5	518.2	2.8	302.1	103.7	210.6	18.4	334.4	661.5	312.9	143.2	0.4	2.2	491.7	356.1	962.4	3281.1	4.7	3.2	407.0	38.5	7.9	35.8	2.3	2.3	209.8	85.1	0.3	391.6	250.8	13.1	28.5	1008.8	27.6	12.7	11451.9	608.9	172.8	1.2	1773.7	1277.9	0.1	5826.8	3998.0	267.2	1.8	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.7	0.0	0.0	2.3	0.0	0.0	0.0	8.4	0.0	5.3	0.0	0.0	0.0	22.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	157.8	0.0	0.0	1.7	2.1	2.6	0.0	0.0	2.9	15.1	3.7	0.0	0.0	18.2	17.0	3.1	0.0	0.0	0.0	0.0	0.2	10.8	0.0	3.2	3.3	4.5	4.9	0.3	392.7	0.1	3.7	0.0	0.2	0.3	0.1	0.3	0.0	0.2	766.8	0.6	0.3	0.4	134.9	0.0	0.1	6.2	0.1	0.1	0.1	0.2	96.2	0.7	0.6	0.5	4.5	0.4	2.2	4.7	3.2	2.3	12.7	1.2	1.8	2.9	73.7	378.5	0.0	3900.5	0.0	8.1	0.0	0.0	0.0	0.5	0.0	2.8	22.8	9.3	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.5	0.0	0.1	8.5	13.9	83.4	0.0	0.0	0.0	13.6	8.2	0.0	209.4	0.0	46.1	52.9	0.1	0.0	0.0	5.0	0.0	62.8	0.0	0.9	0.0	9.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	5.4	0.0	9883.3	9.1	0.0	10.9	1.5	0.1	0.0	0.0	1.5	1.9	1.0	0.0	0.0	0.0	415.6	0.0	13.6	0.1
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4319.4"	"Group enriched"	"Detected in some"	8	"B-cells: 2050.1;Plasma cells: 2918.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	447	"memory B-cell: 339.0;naive B-cell: 119.3"	"Lineage enriched"	"Detected in single"	661	"B-cells: 339.0"	"Group enriched"	"Detected in some"	4	"RH-30: 9.6;RPMI-8226: 25.1"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		250000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"prognostic favorable (3.53e-4)"	"unprognostic (6.88e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (3.30e-6)"	"unprognostic (1.06e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (4.72e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.40e-2)"	109.5	11.0	1.3	170.0	1.4	34.8	56.0	0.2	4.1	59.9	0.8	202.8	7.5	55.8	0.8	90.2	51.5	20.7	15.2	0.2	1.1	157.5	98.2	171.0	65.4	0.9	0.2	16.3	8.0	0.1	8.2	0.0	0.5	64.2	9.4	0.0	201.2	1.2	3.5	13.3	330.7	1.0	1.5	4319.4	87.2	2.3	0.3	16.7	134.4	0.0	226.0	100.4	104.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	25.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	339.0	0.5	0.0	0.3	119.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	34.5	1.3	1.4	0.2	4.1	0.2	1.1	0.9	0.2	0.5	1.5	0.3	1.8	0.2	54.5	305.3	0.0	2050.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	2.8	13.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.2	4.1	0.0	32.5	0.0	0.0	0.0	3.1	0.0	0.0	126.1	0.0	8.2	5.1	0.1	0.0	0.0	0.9	0.0	12.4	0.0	0.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2918.6	0.7	0.0	3.5	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	0.1	305.5	0.0	0.7	0.0
IGHG3		ENSG00000211897	"Immunoglobulin heavy constant gamma 3 (G3m marker)"		14	105764503-105771405	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 1289.1"	"Group enriched"	"Detected in many"	7	"B-cells: 2548.4;Plasma cells: 4543.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	415	"memory B-cell: 211.0;naive B-cell: 64.4"	"Lineage enriched"	"Detected in single"	636	"B-cells: 211.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.8;Karpas-707: 18.7;U-698: 49.1"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (8.49e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.92e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.36e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (8.46e-11)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.80e-2)"	"unprognostic (6.79e-2)"	63.6	17.6	0.1	90.8	0.3	65.4	23.8	0.1	1.5	37.9	1.0	30.0	11.6	22.8	0.3	32.2	104.4	8.4	6.7	0.1	0.6	72.8	42.4	194.9	346.3	2.8	0.1	13.4	6.3	0.1	6.8	0.1	0.4	41.4	8.8	0.0	69.9	12.7	1.9	2.3	100.9	1.6	1.2	1289.1	65.4	31.7	0.1	27.1	87.6	0.0	929.0	87.3	29.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.0	3.9	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	49.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	211.0	0.0	0.0	0.0	64.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.7	0.1	0.3	0.1	1.5	0.1	0.6	2.8	0.1	0.4	1.2	0.1	1.0	1.9	57.7	363.7	0.0	2548.4	0.0	9.7	0.0	0.0	0.0	0.5	0.1	1.9	18.6	11.2	0.0	0.0	0.0	2.0	7.0	0.0	0.0	6.5	0.1	0.2	5.3	13.2	24.5	0.0	0.0	0.0	9.1	2.6	0.0	195.5	0.0	22.9	64.2	0.1	0.0	0.0	7.4	0.0	62.8	0.0	16.4	0.0	7.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.6	0.0	4543.8	13.3	0.0	0.5	2.2	0.0	0.0	0.0	0.7	4.7	0.7	0.0	0.0	0.0	467.3	0.0	13.5	0.1
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2478.2"	"Group enriched"	"Detected in some"	10	"B-cells: 964.5;Plasma cells: 2099.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 122.7;naive B-cell: 73.7"	"Lineage enriched"	"Detected in single"	571	"B-cells: 122.7"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 339.7"									HPA001245	Approved				"Immunoglobulin genes"	NA	NA		170000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA001245: AB_1079121"	"unprognostic (7.29e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.16e-4)"	"unprognostic (4.58e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (9.09e-8)"	"unprognostic (2.84e-2)"	"unprognostic (4.23e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.72e-2)"	80.0	2.1	0.4	2478.2	0.6	42.2	5.8	0.5	1.0	33.9	0.3	40.6	85.5	10.8	0.2	401.2	28.5	101.3	19.2	0.3	0.4	44.0	43.7	49.4	136.5	0.6	0.4	3.9	4.2	0.5	1.9	0.2	1.3	31.2	44.3	0.1	16.4	4.1	0.8	4.7	186.2	1.8	1.1	831.6	57.4	2.2	0.4	49.9	108.3	0.0	872.5	588.7	29.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	43.2	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.6	339.7	0.0	0.0	3.5	3.7	0.3	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.3	1.5	0.6	0.1	57.5	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	122.7	0.0	0.0	0.1	73.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	19.6	0.4	0.6	0.5	1.0	0.3	0.4	0.6	0.4	1.3	1.1	0.4	0.3	1.3	6.4	118.8	0.0	964.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.0	8.6	3.7	0.0	0.0	0.0	0.3	11.5	0.0	0.0	0.2	0.0	0.4	2.5	27.8	26.7	0.0	0.0	0.0	4.3	0.0	0.0	50.4	0.0	16.4	36.7	0.0	0.0	0.0	10.5	0.0	51.9	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	2099.3	0.2	0.0	10.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	152.3	0.0	12.8	0.1
IGHJ2		ENSG00000211904	"Immunoglobulin heavy joining 2"		14	105865199-105865250	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	6	"cervix: 48.7;intestine: 127.5;lymphoid tissue: 174.5"	"Cell type enriched"	"Detected in single"	6	"Plasma cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"medulla oblongata: 3.8"	"Group enriched"	"Detected in some"	18	"MAIT T-cell: 49.0;naive B-cell: 12.6"	"Group enriched"	"Detected in many"	45	"B-cells: 12.6;T-cells: 49.0"	"Group enriched"	"Detected in some"	25	"Daudi: 3.8;K-562: 1.1"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.03e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.27e-2)"		"prognostic favorable (1.05e-4)"		"unprognostic (7.40e-2)"	"unprognostic (6.38e-2)"		"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.33e-6)"	"unprognostic (4.31e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.60e-1)"	2.0	0.0	0.2	0.0	0.5	13.3	20.5	0.2	2.0	48.7	0.1	87.2	0.0	5.4	17.9	18.0	2.1	0.8	0.1	0.2	0.4	1.2	12.0	0.0	7.6	3.8	0.8	7.7	18.9	0.6	0.0	0.0	0.5	15.0	127.5	0.0	0.0	7.1	0.0	0.0	0.0	5.8	0.6	18.8	18.2	0.1	0.5	19.6	5.1	0.0	174.5	6.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	49.0	1.3	0.4	1.6	0.4	12.6	0.0	0.2	0.2	0.0	0.6	0.0	0.0	17.1	0.2	0.5	0.2	2.0	0.2	0.4	3.8	0.8	0.5	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ3		ENSG00000242887	"Immunoglobulin heavy joining 3"		14	105864587-105864635	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"esophagus: 36.4;intestine: 57.9;pancreas: 61.6"	"Cell type enriched"	"Detected in single"	48	"Plasma cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basophil: 9.0;naive B-cell: 29.1"	"Group enriched"	"Detected in many"	7	"B-cells: 29.1;granulocytes: 9.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;RPMI-8226: 6.1;TIME: 8.0;U-251 MG: 2.6"															NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (8.67e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-2)"		"prognostic favorable (3.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.30e-1)"	16.2	3.0	0.6	0.0	0.9	0.0	0.0	0.2	2.5	1.9	0.5	0.0	0.0	0.0	0.0	36.4	0.7	9.1	0.0	0.6	0.9	0.9	10.2	17.3	0.0	1.5	0.4	11.3	61.6	0.0	0.0	0.0	1.7	7.5	57.9	0.1	0.0	4.3	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.3	0.7	0.0	2.4	0.0	0.0	5.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.2	0.0	0.9	0.0	0.7	1.1	2.6	29.1	1.5	1.2	0.0	0.4	0.7	0.0	1.2	0.0	0.6	0.9	0.2	2.5	0.6	0.9	1.5	0.4	1.7	1.4	0.7	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGHJ4		ENSG00000240041	"Immunoglobulin heavy joining 4"		14	105864215-105864260	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 416.7;lymphoid tissue: 1568.0;urinary bladder: 551.2"	"Cell type enriched"	"Detected in single"	148	"Plasma cells: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	187	"memory B-cell: 6029.7;naive B-cell: 2618.0"	"Lineage enriched"	"Detected in all"	261	"B-cells: 6029.7"	"Cell line enriched"	"Detected in some"	87	"U-698: 3990.3"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"																					0.0	0.0	7.2	0.0	2.9	0.0	240.0	0.9	10.8	0.0	3.6	377.5	0.0	0.0	0.0	200.2	7.4	4.1	12.3	0.9	2.5	0.0	39.1	0.0	0.0	8.9	30.7	0.0	0.0	13.6	0.0	2.5	22.3	7.0	416.7	0.0	0.0	0.0	0.0	20.7	0.0	0.0	2.0	45.4	7.3	3.7	3.1	32.3	3.9	0.0	1568.0	551.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	14.0	17.5	0.0	0.0	0.0	0.0	6.8	3.6	0.0	0.0	0.0	0.0	0.0	8.9	0.0	45.8	0.0	0.0	6.2	0.0	3990.3	0.0	12.2	0.0	13.9	3.6	5.4	5.0	1.3	3.0	6029.7	13.2	4.0	23.1	2618.0	1.5	6.0	20.1	3.3	6.0	0.0	6.6	1048.2	7.2	2.9	0.9	10.8	0.9	2.5	8.9	30.7	22.3	2.0	3.1	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ5		ENSG00000242472	"Immunoglobulin heavy joining 5"		14	105863814-105863862	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"adipose tissue: 33.5;breast: 73.2;intestine: 72.3;prostate: 32.7"	"Cell type enriched"	"Detected in single"	397	"Plasma cells: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	263	"memory B-cell: 1081.0"	"Lineage enriched"	"Detected in many"	263	"B-cells: 1081.0"	"Group enriched"	"Detected in some"	11	"HL-60: 10.5;REH: 14.0;RH-30: 18.0"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"																					33.5	0.0	0.7	0.0	3.7	0.0	73.2	0.7	2.0	0.0	2.0	72.3	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.9	4.2	4.5	29.4	17.1	0.0	3.1	1.0	0.0	4.7	0.0	0.0	0.0	1.9	32.7	0.2	0.2	0.0	0.0	0.0	7.9	0.0	0.0	1.6	0.0	0.0	0.4	1.3	0.0	4.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	2.1	1.2	0.7	1081.0	0.4	0.6	4.1	0.0	2.6	0.9	2.3	0.7	0.6	0.0	1.1	316.0	0.7	3.7	0.7	2.0	0.9	4.2	3.1	1.0	1.9	1.6	1.3	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHJ6		ENSG00000211900	"Immunoglobulin heavy joining 6"		14	105863198-105863258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"cervix: 142.4;intestine: 38.6;lung: 47.0;testis: 151.4;urinary bladder: 113.5"	"Cell type enriched"	"Detected in single"	56	"Plasma cells: 39.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory B-cell: 316.2;naive B-cell: 112.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 316.2"	"Cell line enhanced"	"Detected in some"		"U-266/84: 1.3;U-937: 1.2"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"																					0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.1	0.9	142.4	0.0	2.6	38.6	1.0	0.0	0.0	2.1	0.5	0.9	0.3	0.0	3.0	2.4	47.0	0.4	0.4	0.1	0.0	0.0	3.7	0.0	0.0	0.3	3.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	151.4	0.3	0.0	0.7	0.0	10.7	113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.2	0.0	3.5	3.5	0.8	0.3	0.0	0.2	316.2	0.5	0.6	0.5	112.7	0.6	0.3	14.8	0.2	1.0	0.0	0.1	89.2	0.0	0.0	0.1	0.9	0.3	0.0	0.4	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHM		ENSG00000211899	"Immunoglobulin heavy constant mu"	P01871	14	105851705-105856218	"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 1315.0;lymphoid tissue: 4112.3"	"Group enriched"	"Detected in many"	14	"B-cells: 3757.1;Plasma cells: 9906.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	16	"memory B-cell: 4278.4;naive B-cell: 6731.2"	"Lineage enriched"	"Detected in all"	19	"B-cells: 6731.2"	"Group enriched"	"Detected in many"	9	"Daudi: 4983.6;U-698: 4905.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			CAB008643	Uncertain				"Immunoglobulin genes"	NA	NA		110000000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB008643: AB_1617732"	"unprognostic (2.91e-3)"	"prognostic favorable (6.49e-4)"	"unprognostic (9.30e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.70e-6)"	"unprognostic (9.61e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (5.20e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.28e-3)"	52.0	9.0	0.4	373.7	0.4	395.3	56.6	0.2	1.7	67.9	1.8	446.8	1204.9	11.1	10.2	66.8	38.5	141.7	50.5	0.2	0.4	48.4	84.7	180.6	3192.1	1.9	0.3	9.7	44.5	0.6	8.7	3.6	0.7	15.1	201.4	0.0	325.1	6.1	2.7	1.7	1315.0	7.9	1.0	4112.3	528.9	70.9	0.7	117.3	37.0	0.7	497.1	128.0	10.5	0.5	4.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	4983.6	2.9	0.0	0.0	0.8	0.0	0.0	0.0	21.6	0.0	3.0	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	1.7	28.7	1.2	0.0	0.0	580.2	2.2	6.9	0.0	0.0	4.0	5.8	3.0	0.5	1.2	0.0	0.2	3.8	6.5	0.0	13.8	1.2	2.5	1.5	1.5	4905.9	0.0	2.4	0.0	10.8	5.4	5.6	3.1	1.2	2.3	4278.4	5.5	6.8	5.4	6731.2	4.5	3.8	25.4	11.4	4.5	346.1	11.4	815.2	0.4	0.4	0.2	1.7	0.2	0.4	1.9	0.3	0.7	1.0	0.7	0.5	1.0	38.5	254.5	0.0	3757.1	0.0	0.2	0.0	1.2	0.0	2.2	0.8	0.3	31.5	14.2	0.0	0.0	0.0	63.8	1.8	0.0	0.0	0.0	0.0	0.1	4.2	6.7	474.1	0.0	0.0	0.0	10.8	27.5	0.0	152.6	0.0	56.7	147.9	0.1	0.0	0.0	2.2	0.0	158.1	0.0	0.0	0.0	12.4	0.0	0.0	5.2	0.0	11.3	0.0	0.0	0.0	1.2	0.0	9906.5	0.3	0.0	2.2	1.5	0.0	0.0	0.4	16.8	0.0	0.0	0.2	0.0	0.0	415.0	0.3	4.1	0.1
IGHV1-18		ENSG00000211945	"Immunoglobulin heavy variable 1-18"	A0A0C4DH31	14	106184901-106185394	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.2;lymphoid tissue: 486.7;salivary gland: 234.3"	"Cell type enriched"	"Detected in some"	259	"Plasma cells: 13773.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	21	"memory B-cell: 73.2"	"Lineage enriched"	"Detected in many"	21	"B-cells: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HL-60: 3.0;RPMI-8226: 2.9;TIME: 1.6"														"Immunoglobulin genes"	NA	NA		4700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.47e-4)"	"unprognostic (2.53e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.56e-2)"	"unprognostic (9.67e-3)"	"prognostic favorable (8.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.26e-1)"	"prognostic unfavorable (5.84e-7)"	"unprognostic (3.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.44e-2)"	22.0	3.5	0.0	0.0	0.3	0.0	22.9	0.0	0.6	54.6	0.0	223.2	0.0	8.9	4.5	162.5	24.3	7.7	2.3	0.0	0.0	16.2	14.3	58.3	0.0	0.6	0.1	8.5	3.2	1.9	1.3	0.2	0.4	10.8	0.0	0.0	234.3	0.0	0.4	1.3	103.2	2.6	0.0	486.7	84.0	0.5	0.1	0.0	33.9	0.2	0.0	156.1	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.6	0.5	0.8	0.0	0.0	1.1	1.2	2.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.4	1.0	0.5	0.0	0.3	0.0	1.4	0.0	3.4	0.0	0.1	0.0	0.0	0.1	73.2	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	53.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13773.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	3.2	0.0	0.1	0.0
IGHV1-2	V35	ENSG00000211934	"Immunoglobulin heavy variable 1-2"	P23083	14	105986582-105987083	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 462.7;lymphoid tissue: 1157.3"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 609.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	52	"memory B-cell: 285.2;naive B-cell: 347.4"	"Lineage enriched"	"Detected in many"	57	"B-cells: 347.4"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 14302.7"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.63e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.46e-2)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.67e-5)"	"unprognostic (9.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (2.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.17e-2)"	16.7	43.1	0.3	364.1	0.2	76.0	84.1	0.0	1.2	41.5	0.5	462.7	223.7	13.1	1.3	34.5	58.5	54.4	26.2	0.0	0.1	13.7	18.9	60.7	404.9	0.4	0.0	36.5	3.0	0.6	1.3	0.6	0.2	23.2	283.8	0.0	222.4	52.5	0.4	4.5	121.9	7.5	0.2	393.2	216.1	35.0	0.1	72.1	33.7	0.0	1157.3	255.5	8.9	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.0	0.0	2.3	0.4	2.8	0.0	0.0	3.1	0.6	0.5	0.0	0.0	1.3	1.8	0.1	0.0	0.6	0.0	0.0	0.2	0.3	0.0	1.5	0.0	1.3	14302.7	1755.5	0.5	0.0	0.4	0.0	0.3	0.6	0.1	0.3	0.0	0.2	285.2	1.6	0.7	0.2	347.4	1.5	0.6	6.1	0.2	0.3	0.5	1.1	34.0	0.3	0.2	0.0	1.2	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.6	0.0	0.0	1.3	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	4.6	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	609.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0
IGHV1-24		ENSG00000211950	"Immunoglobulin heavy variable 1-24"	A0A0C4DH33	14	106276548-106277043	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 186.8;salivary gland: 76.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 231.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HL-60: 1.8;JURKAT: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		3100000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (9.01e-4)"	"unprognostic (2.67e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.93e-3)"		"prognostic favorable (3.61e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.10e-1)"	"prognostic unfavorable (2.07e-7)"	"unprognostic (5.43e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.78e-2)"	6.8	1.4	0.1	33.7	0.0	0.0	8.5	0.0	0.3	56.3	0.1	30.5	0.0	5.7	0.0	46.2	6.5	4.6	1.8	0.0	0.1	7.0	6.4	17.7	0.0	1.2	0.1	19.6	1.4	0.1	0.4	0.3	0.0	3.1	14.0	0.0	76.3	0.0	0.1	0.8	24.0	2.1	0.0	186.8	37.0	14.2	0.0	0.4	14.5	0.0	18.4	63.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.8	0.1	0.0	0.0	2.8	0.1	0.2	0.0	0.0	0.0	0.0	0.1	3.6	0.1	0.0	0.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	231.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0
IGHV1-3	VI-3B	ENSG00000211935	"Immunoglobulin heavy variable 1-3"	A0A0C4DH29	14	106005095-106005574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 223.2;lymphoid tissue: 629.4"	"Cell type enriched"	"Detected in some"	335	"Plasma cells: 13473.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"memory B-cell: 52.8;naive B-cell: 27.8"	"Lineage enriched"	"Detected in many"	9	"B-cells: 52.8"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 148.5"														"Immunoglobulin genes"	NA	NA		2600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.39e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.93e-2)"		"unprognostic (7.41e-3)"		"unprognostic (2.42e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (5.67e-7)"	"unprognostic (7.02e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.26e-1)"	10.6	59.3	0.0	207.8	0.0	36.4	46.7	0.0	0.5	41.6	0.3	193.3	218.5	4.8	15.3	45.5	6.5	85.4	3.2	0.0	0.1	8.2	8.9	40.9	171.8	0.2	0.0	8.4	7.0	0.3	0.6	0.1	0.1	6.0	223.2	0.0	120.6	23.5	0.6	0.9	140.9	11.2	0.0	246.6	189.1	0.4	0.1	57.8	24.2	0.0	629.4	92.1	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	14.1	1.0	148.5	0.0	0.0	0.8	1.1	0.1	0.0	0.0	0.0	0.7	0.7	0.0	0.0	10.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	2.8	1.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	52.8	0.6	0.2	0.0	27.8	1.6	0.5	0.0	0.0	0.0	5.8	1.7	6.1	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13473.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.9;lymphoid tissue: 125.7;salivary gland: 67.4"	"Cell type enriched"	"Detected in some"	201	"Plasma cells: 8432.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;RPMI-8226: 1.2;SH-SY5Y: 1.2;TIME: 2.3;U-266/70: 1.1;U-266/84: 1.2"														"Immunoglobulin genes"	NA	NA		2900000000	"Cluster 24: B-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.28e-4)"	"unprognostic (2.49e-2)"	"prognostic favorable (7.34e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.76e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-1)"	"prognostic unfavorable (1.56e-6)"	"unprognostic (6.19e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.13e-1)"	5.1	1.3	0.0	0.0	0.0	0.0	7.2	0.0	0.1	6.2	0.0	67.9	0.0	2.5	1.0	4.9	3.5	0.7	5.0	0.0	0.0	3.2	4.2	15.3	0.0	0.1	0.0	3.0	5.3	0.1	0.3	0.3	0.1	1.9	45.1	0.0	67.4	0.0	0.1	0.7	34.2	0.0	0.0	125.7	25.1	0.2	0.0	0.0	10.5	0.2	0.0	5.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.0	0.5	1.2	0.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.3	0.0	0.1	1.1	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	1.9	41.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8432.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
IGHV1-69D		ENSG00000280411	"Immunoglobulin heavy variable 1-69D"	A0A0B4J2H0	14	106762092-106762588	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2878.6;stomach 1: 989.1"	"Group enriched"	"Detected in some"	6	"Plasma cells: 5.8;T-cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	225	"memory B-cell: 184.5;naive B-cell: 433.4"	"Lineage enriched"	"Detected in many"	316	"B-cells: 433.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HL-60: 2.3;MOLT-4: 4.2;RPMI-8226: 2.5;U-266/70: 3.3;U-698: 7.9"														"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (3.32e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.49e-4)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.66e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.72e-8)"	"unprognostic (5.14e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.08e-2)"	26.1	95.3	0.1	462.7	0.1	113.1	146.7	0.0	0.7	37.5	1.0	628.2	491.2	15.0	16.8	98.6	16.0	78.0	20.2	0.0	0.1	17.5	46.6	149.6	2878.6	1.1	0.0	35.9	3.3	0.6	1.1	0.4	0.1	16.5	406.2	0.0	385.0	100.0	0.5	5.2	121.3	43.8	0.2	452.7	989.1	6.8	0.0	135.7	38.3	0.0	2219.2	295.4	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.2	0.3	1.3	0.0	0.0	0.9	0.8	2.5	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.6	0.4	3.3	0.1	7.9	0.0	0.7	0.0	0.8	0.3	0.1	0.0	0.0	0.2	184.5	0.3	0.0	0.2	433.4	0.4	0.1	0.4	0.2	0.4	1.3	0.2	33.5	0.1	0.1	0.0	0.7	0.0	0.1	1.1	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGHV2-26		ENSG00000211951	"Immunoglobulin heavy variable 2-26"	A0A0B4J1V2	14	106301396-106301862	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 128.8;lymphoid tissue: 98.5;urinary bladder: 227.1"	"Group enriched"	"Detected in some"	39	"B-cells: 8.3;Plasma cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	14	"memory B-cell: 13.9"	"Lineage enriched"	"Detected in single"	140	"B-cells: 13.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.3;RH-30: 1.4"														"Immunoglobulin genes"	NA	NA		190000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 57: B-cells - Immune response"				"unprognostic (9.39e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.66e-3)"	"unprognostic (2.94e-2)"		"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (6.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.09e-2)"	6.2	7.7	0.0	59.0	0.0	21.6	14.0	0.0	0.3	15.5	0.2	35.0	61.5	4.2	0.0	31.5	3.8	128.8	5.6	0.0	0.4	2.3	6.0	20.7	3.5	0.2	0.6	0.5	1.6	0.0	0.3	0.0	0.1	6.3	86.5	0.0	44.2	0.9	0.1	0.5	55.1	4.4	0.2	98.5	65.1	0.0	1.1	0.0	6.8	0.0	21.8	227.1	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.2	1.1	0.2	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV2-5		ENSG00000211937	"Immunoglobulin heavy variable 2-5"	P01817	14	106037902-106038365	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 465.8;lymphoid tissue: 1426.6;stomach 1: 707.9"	"Cell type enriched"	"Detected in some"	333	"Plasma cells: 9414.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"memory B-cell: 66.7;naive B-cell: 67.3"	"Lineage enriched"	"Detected in many"	22	"B-cells: 67.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.8"														"Immunoglobulin genes"	NA	NA		700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.38e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.62e-3)"		"prognostic favorable (1.41e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.56e-1)"	16.9	5.0	0.0	183.0	0.2	112.8	106.0	0.0	0.5	45.0	0.2	465.8	266.6	7.5	2.5	27.9	10.7	65.0	5.8	0.0	0.1	20.9	16.4	83.9	188.0	0.5	0.2	13.8	9.3	1.0	1.1	0.3	0.7	9.4	296.3	0.0	201.4	8.8	0.4	2.9	177.0	17.4	0.3	351.0	707.9	2.3	0.0	121.5	27.6	0.0	1426.6	249.3	12.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.6	0.4	0.0	0.1	1.2	1.8	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.4	0.6	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	66.7	0.0	0.0	0.1	67.3	0.1	0.1	3.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.0	0.5	0.0	0.1	0.5	0.2	0.7	0.3	0.0	0.4	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	27.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9414.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0
IGHV2-70		ENSG00000274576	"Immunoglobulin heavy variable 2-70"	P01814	14	106770577-106771020	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 727.6;stomach 1: 502.1"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Group enriched"	"Detected in some"	241	"memory B-cell: 24.6;naive B-cell: 23.5"	"Lineage enriched"	"Detected in single"	247	"B-cells: 24.6"	"Cell line enriched"	"Detected in some"	8	"U-698: 12.4"														"Immunoglobulin genes"	NA	NA		170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (8.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.38e-2)"		"unprognostic (1.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (9.10e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.93e-2)"	"unprognostic (2.91e-1)"	7.3	25.7	0.0	96.2	0.0	69.2	86.1	0.0	5.2	62.3	0.0	86.7	53.2	4.1	0.0	44.3	8.1	37.5	2.5	0.0	1.4	4.8	13.2	69.9	82.7	0.1	1.1	5.0	1.0	0.9	0.3	0.2	0.1	6.8	82.8	0.0	94.5	14.1	0.1	0.9	42.1	2.5	2.2	156.4	502.1	1.2	0.0	59.5	8.5	0.0	727.6	50.4	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.4	0.8	0.0	0.0	0.8	0.6	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.7	0.0	0.1	0.0	12.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	5.2	0.0	1.4	0.1	1.1	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-11		ENSG00000211941	"Immunoglobulin heavy variable 3-11"	P01762	14	106116635-106117204	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 220.1;lymphoid tissue: 613.1;stomach 1: 206.7"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1655.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	445	"memory B-cell: 43.1;naive B-cell: 45.7"	"Lineage enriched"	"Detected in single"	458	"B-cells: 45.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.1;SH-SY5Y: 1.2"														"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.07e-3)"	"unprognostic (4.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (3.42e-5)"	"unprognostic (4.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.30e-1)"	9.3	25.9	0.0	175.0	0.0	38.0	66.0	0.0	0.5	34.7	0.2	220.1	193.4	6.8	12.3	38.6	6.6	43.7	8.6	0.0	0.0	6.8	10.5	29.1	123.7	0.8	0.0	7.8	2.0	0.2	0.8	0.0	0.1	4.0	167.9	0.0	119.7	3.7	0.3	0.7	116.8	11.2	0.1	219.2	206.7	1.3	0.4	44.9	17.0	0.0	613.1	109.4	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1655.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
IGHV3-15		ENSG00000211943	"Immunoglobulin heavy variable 3-15"	A0A0B4J1V0	14	106153624-106154163	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 183.3;lymphoid tissue: 380.2;salivary gland: 177.7;stomach 1: 112.8;urinary bladder: 172.6"	"Cell type enriched"	"Detected in some"	112	"Plasma cells: 6281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 21.6;memory B-cell: 24.4"	"Group enriched"	"Detected in many"	9	"B-cells: 24.4;T-cells: 21.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;Daudi: 1.9;HL-60: 2.1;K-562: 2.0;NB-4: 2.4;RH-30: 1.9;RPMI-8226: 4.1;SH-SY5Y: 3.7"														"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (8.85e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.62e-2)"	"prognostic favorable (3.34e-5)"	"unprognostic (5.20e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (6.85e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (3.63e-1)"	12.2	36.8	0.0	24.7	0.5	1.8	23.2	0.0	1.2	13.0	0.1	183.3	4.5	5.0	0.9	11.7	16.3	29.6	1.4	0.0	0.2	9.1	10.6	40.0	0.0	1.0	0.0	5.8	19.1	0.4	1.3	0.4	0.3	9.5	14.6	0.0	177.7	23.0	0.8	4.2	107.2	0.3	0.0	380.2	112.8	0.5	0.0	0.0	14.9	0.0	10.4	172.6	9.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	2.4	0.7	0.0	0.0	0.0	1.9	4.1	0.0	0.0	0.0	3.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	1.6	0.0	0.2	0.0	0.3	0.0	0.2	0.2	0.1	0.1	0.0	21.6	24.4	0.1	0.2	0.2	0.0	0.2	0.1	2.5	0.0	0.0	0.2	0.1	1.8	0.0	0.5	0.0	1.2	0.0	0.2	1.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	56.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.1	8.2	0.0	0.0	0.1	1.1	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6281.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0
IGHV3-20		ENSG00000211946	"Immunoglobulin heavy variable 3-20"	A0A0C4DH32	14	106210936-106211453	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.2;lymphoid tissue: 216.6;stomach 1: 122.5;urinary bladder: 81.9"	"Cell type enriched"	"Detected in some"	24	"Plasma cells: 142.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	242	"memory B-cell: 28.5;naive B-cell: 19.8"	"Lineage enriched"	"Detected in single"	286	"B-cells: 28.5"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.2"														"Immunoglobulin genes"	NA	NA		2200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.45e-2)"		"prognostic favorable (2.93e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	2.8	2.1	0.0	36.3	0.2	22.6	23.7	0.0	0.1	17.4	0.2	64.8	99.2	1.8	0.0	10.1	2.2	20.7	3.1	0.0	0.0	1.5	4.7	10.5	58.0	0.1	0.0	2.7	0.4	0.1	0.2	0.0	0.0	1.2	62.5	0.0	43.1	1.4	0.0	0.3	37.7	2.0	0.0	59.6	122.5	1.1	0.0	16.6	2.8	0.0	216.6	81.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	142.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
IGHV3-21		ENSG00000211947	"Immunoglobulin heavy variable 3-21"	A0A0B4J1V1	14	106235064-106235594	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 209.7;lymphoid tissue: 398.1;salivary gland: 213.2"	"Cell type enriched"	"Detected in some"	86	"Plasma cells: 3885.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.1;NB-4: 2.1;NTERA-2: 1.2;RH-30: 2.3;TIME: 1.9"														"Immunoglobulin genes"	NA	NA		37000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.30e-4)"	"unprognostic (1.21e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.51e-2)"	"unprognostic (9.16e-3)"	"prognostic favorable (9.34e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.05e-1)"	"prognostic unfavorable (9.31e-8)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-1)"	18.1	2.7	0.3	0.0	0.3	0.0	24.8	0.2	1.1	16.8	0.3	209.7	0.0	7.1	0.9	17.4	30.9	0.0	2.0	0.2	0.3	15.4	10.7	55.3	0.0	0.4	0.3	2.9	16.2	2.3	1.3	0.6	0.4	7.2	0.0	0.0	213.2	0.3	0.4	4.3	111.3	0.8	0.4	398.1	83.0	0.4	0.3	0.0	25.6	0.0	0.0	27.7	10.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	1.2	0.0	0.0	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.2	1.1	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.0	21.4	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3885.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGHV3-23		ENSG00000211949	"Immunoglobulin heavy variable 3-23"	P01764	14	106268606-106269140	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1683.1;lymphoid tissue: 2989.8"	"Cell type enriched"	"Detected in some"	139	"Plasma cells: 15979.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	406	"memory B-cell: 548.5;naive B-cell: 336.7"	"Lineage enriched"	"Detected in many"	503	"B-cells: 548.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;HL-60: 3.3;NB-4: 4.1;RH-30: 3.0;RPMI-8226: 9.0;SH-SY5Y: 5.8"														"Immunoglobulin genes"	NA	NA		42000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.34e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (3.26e-1)"	"unprognostic (4.79e-1)"	"unprognostic (7.26e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.79e-7)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.42e-2)"	66.5	189.3	0.4	912.2	0.4	185.5	343.1	0.1	2.1	80.1	1.5	1683.1	1640.8	37.0	9.8	342.6	30.1	231.2	46.4	0.1	0.3	27.3	56.4	248.7	859.5	0.8	0.1	42.6	31.0	1.5	2.7	0.9	0.4	35.3	1087.1	0.1	697.8	53.4	0.9	15.0	886.8	40.0	0.8	802.7	1058.8	35.0	0.2	197.5	52.3	0.1	2989.8	993.6	27.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	4.1	0.7	0.0	0.0	0.6	3.0	9.0	0.0	0.0	2.7	5.8	0.8	0.1	0.0	0.0	0.0	0.0	1.8	0.0	1.3	1.3	1.1	1.5	0.0	0.3	0.0	0.9	0.0	0.4	0.4	0.1	0.2	0.0	0.1	548.5	0.2	0.3	0.3	336.7	0.1	0.2	1.0	0.2	0.2	0.2	0.8	62.4	0.4	0.4	0.1	2.1	0.1	0.3	0.8	0.1	0.4	0.8	0.2	1.4	0.1	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	12.0	0.0	0.0	0.0	1.6	19.4	0.0	1.3	0.0	1.8	2.0	0.2	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15979.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.1	0.0
IGHV3-30		ENSG00000270550	"Immunoglobulin heavy variable 3-30"	"P01768, P0DP03"	14	106335082-106335613	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 534.0;lymphoid tissue: 1294.8;salivary gland: 459.9;stomach 1: 572.6;urinary bladder: 378.9"	"Cell type enriched"	"Detected in some"	184	"Plasma cells: 14426.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	409	"memory B-cell: 164.0;naive B-cell: 136.6"	"Lineage enriched"	"Detected in single"	446	"B-cells: 164.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 1.7;NB-4: 2.3;RPMI-8226: 1.7;SCLC-21H: 1.7;SH-SY5Y: 3.0;U-266/70: 1.3"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.12e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (3.23e-5)"	"unprognostic (7.43e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (1.65e-7)"	"unprognostic (1.32e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.96e-2)"	25.3	38.5	0.1	320.5	0.2	119.7	143.9	0.0	0.4	49.3	0.5	534.0	265.5	13.3	0.0	134.6	44.8	146.5	30.3	0.4	0.2	29.2	25.1	128.2	374.9	0.6	0.2	23.0	12.3	0.7	3.3	0.7	0.2	18.6	254.9	0.0	459.9	20.4	0.9	3.5	296.1	23.6	0.1	797.4	572.6	5.9	0.1	158.2	76.6	0.1	1294.8	378.9	34.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	164.0	0.2	0.0	0.1	136.6	0.3	0.1	0.3	0.0	0.0	0.2	0.0	24.4	0.1	0.2	0.0	0.4	0.4	0.2	0.6	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	5.4	16.3	0.0	1.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14426.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.4	0.0
IGHV3-33		ENSG00000211955	"Immunoglobulin heavy variable 3-33"	P01772	14	106359793-106360324	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1066.7;lymphoid tissue: 2371.2;stomach 1: 1778.8"	"Cell type enriched"	"Detected in some"	26	"Plasma cells: 556.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"Group enriched"	"Detected in many"	101	"memory B-cell: 378.9;naive B-cell: 364.1"	"Lineage enriched"	"Detected in many"	103	"B-cells: 378.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;HL-60: 5.3;RPMI-8226: 7.7;SH-SY5Y: 3.8;U-266/70: 8.1"														"Immunoglobulin genes"	NA	NA		7500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.04e-3)"	"unprognostic (2.38e-2)"	"unprognostic (8.95e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (6.84e-2)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.18e-1)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (6.23e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.92e-2)"	27.9	67.4	1.0	513.8	0.8	117.8	289.5	0.2	4.0	53.6	2.4	1066.7	882.1	16.2	14.5	127.5	18.9	141.9	32.9	0.2	0.4	15.7	41.8	210.1	795.2	1.4	0.2	110.0	29.4	1.9	1.7	0.8	0.4	23.2	775.6	0.0	619.6	39.5	0.5	3.6	343.9	37.3	0.5	476.1	1778.8	29.4	0.7	296.8	42.2	0.1	2371.2	379.8	18.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	5.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.1	0.8	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.8	2.9	7.7	0.0	0.0	1.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.3	0.7	8.1	0.0	0.2	0.0	0.8	0.0	0.2	0.6	0.1	1.1	0.0	1.9	378.9	3.6	0.9	0.3	364.1	1.4	0.6	1.0	0.2	0.1	0.2	0.5	44.6	1.0	0.8	0.2	4.0	0.2	0.4	1.4	0.2	0.4	0.5	0.7	0.7	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.0	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	556.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-43		ENSG00000232216	"Immunoglobulin heavy variable 3-43"	A0A0B4J1X8	14	106470264-106470800	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 211.9;stomach 1: 312.2;urinary bladder: 153.0"	"Cell type enriched"	"Detected in some"	28	"Plasma cells: 557.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	321	"memory B-cell: 29.4;naive B-cell: 39.0"	"Lineage enriched"	"Detected in single"	366	"B-cells: 39.0"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.8;SH-SY5Y: 2.3"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.31e-4)"	"unprognostic (2.22e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.87e-3)"		"prognostic favorable (8.20e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.63e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.73e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.75e-2)"	9.3	2.3	0.0	23.7	0.3	11.5	43.7	0.0	0.3	46.0	0.0	101.8	102.5	2.0	0.0	10.2	3.5	10.7	0.4	0.0	0.0	2.7	9.8	10.8	4.3	0.7	0.0	4.2	2.2	1.0	0.3	0.1	0.2	2.7	66.1	0.0	58.1	5.4	0.1	1.0	48.3	4.4	0.0	83.7	312.2	0.2	0.1	0.0	3.8	0.0	211.9	153.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	557.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0
IGHV3-48		ENSG00000211964	"Immunoglobulin heavy variable 3-48"	P01763	14	106537810-106538344	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 516.4;lymphoid tissue: 858.8;stomach 1: 404.9"	"Cell type enriched"	"Detected in some"	100	"Plasma cells: 5878.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	527	"memory B-cell: 187.1;naive B-cell: 97.5"	"Lineage enriched"	"Detected in single"	693	"B-cells: 187.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.6"														"Immunoglobulin genes"	NA	NA		49000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (9.19e-3)"	"unprognostic (1.87e-2)"	"unprognostic (5.12e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (4.88e-8)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	8.7	22.9	0.0	232.6	0.0	81.2	56.4	0.0	1.3	25.9	0.2	434.1	516.4	8.1	0.1	33.4	12.1	38.6	6.9	0.0	0.0	10.8	18.6	32.3	125.3	0.3	0.0	12.2	8.8	0.9	0.9	0.1	0.7	6.8	253.2	0.0	164.6	16.0	0.6	1.6	134.4	17.7	0.1	271.1	404.9	27.9	0.0	36.3	16.0	0.0	858.8	248.6	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.4	0.0	0.0	0.0	0.8	0.9	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	187.1	0.0	0.0	0.1	97.5	0.0	0.1	0.1	0.0	0.0	0.0	0.2	22.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	58.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.7	17.9	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5878.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
IGHV3-49		ENSG00000211965	"Immunoglobulin heavy variable 3-49"	A0A0A0MS15	14	106556936-106557477	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 210.7;lymphoid tissue: 373.5;stomach 1: 182.3"	"Cell type enriched"	"Detected in some"	46	"Plasma cells: 717.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	187	"memory B-cell: 59.4;naive B-cell: 42.2"	"Lineage enriched"	"Detected in single"	219	"B-cells: 59.4"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"														"Immunoglobulin genes"	NA	NA		1600000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (7.16e-4)"	"unprognostic (7.91e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.34e-6)"	"unprognostic (4.47e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.00e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.00e-1)"	20.8	7.1	0.0	112.3	0.0	45.7	42.5	0.0	0.5	11.5	0.3	210.7	184.4	4.6	3.9	20.0	5.1	10.9	9.4	0.0	0.2	5.0	12.8	43.2	108.6	0.7	0.0	26.5	1.7	0.2	0.4	0.0	0.3	3.0	139.3	0.0	88.5	12.1	0.2	0.4	88.2	11.5	0.1	183.1	182.3	1.8	0.1	21.4	9.7	0.0	373.5	100.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.4	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.4	0.0	0.0	0.0	42.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	717.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0
IGHV3-53		ENSG00000211967	"Immunoglobulin heavy variable 3-53"	P01767	14	106592676-106593347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.5;lymphoid tissue: 129.5;stomach 1: 43.3"	"Cell type enriched"	"Detected in some"	22	"Plasma cells: 176.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	99	"memory B-cell: 54.7;naive B-cell: 52.7"	"Lineage enriched"	"Detected in single"	101	"B-cells: 54.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.41e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-3)"	"prognostic favorable (5.66e-4)"		"prognostic favorable (3.95e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (2.04e-5)"	"unprognostic (1.79e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.72e-1)"	2.9	0.8	0.0	37.1	0.0	7.9	15.5	0.0	0.1	4.7	0.0	66.5	81.5	1.0	0.3	4.1	1.9	6.7	1.4	0.0	0.0	1.8	2.8	7.7	38.5	0.1	0.0	3.2	1.3	0.1	0.1	0.0	0.0	1.1	74.0	0.0	32.2	1.9	0.0	0.3	33.9	2.3	0.0	66.9	43.3	1.6	0.0	8.2	4.6	0.0	129.5	10.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	54.7	0.0	0.0	0.0	52.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV3-64		ENSG00000223648	"Immunoglobulin heavy variable 3-64"	A0A075B6Q5	14	106657725-106658258	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.9;lymphoid tissue: 32.1;salivary gland: 21.0"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 88.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"memory B-cell: 11.1"	"Lineage enriched"	"Detected in single"	111	"B-cells: 11.1"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.1"														"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.09e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-2)"		"unprognostic (1.39e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.07e-2)"	1.7	0.1	0.0	2.0	0.0	8.6	7.2	0.0	0.4	0.7	0.0	17.9	6.9	0.9	0.0	1.2	1.9	4.1	1.2	0.0	0.0	0.8	2.2	4.3	0.0	0.1	0.0	3.3	3.6	0.0	0.1	0.0	0.0	0.5	1.2	0.0	21.0	0.4	0.0	0.1	11.3	1.3	0.0	32.1	6.0	0.0	0.0	0.0	1.5	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGHV3-64D		ENSG00000282639	"Immunoglobulin heavy variable 3-64D"	A0A0J9YX35	14	106088122-106088573	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 145.2;lymphoid tissue: 272.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	301	"memory B-cell: 43.3;naive B-cell: 18.7"	"Lineage enriched"	"Detected in single"	420	"B-cells: 43.3"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		2500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 7: Non-specific - Mitochondria"																					8.3	0.5	0.2	140.3	0.1	10.9	84.2	0.0	0.8	12.9	0.3	130.9	20.4	3.3	1.4	35.4	7.8	46.3	4.8	0.5	0.0	1.5	4.2	36.7	48.8	0.1	0.0	5.1	8.1	0.1	0.1	0.1	0.0	4.1	145.2	0.0	28.9	11.5	0.0	3.8	68.8	3.6	0.1	67.4	74.8	0.5	0.0	16.5	2.9	0.0	272.7	40.5	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.3	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.2	0.1	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV3-66		ENSG00000211972	"Immunoglobulin heavy variable 3-66"	A0A0C4DH42	14	106675017-106675544	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 47.3;intestine: 59.5;urinary bladder: 103.9"	"Cell type enriched"	"Detected in some"	107	"Plasma cells: 958.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"memory B-cell: 39.7"	"Lineage enriched"	"Detected in single"	137	"B-cells: 39.7"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;U-2 OS: 2.3"														"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.43e-6)"	"unprognostic (2.48e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.31e-3)"		"unprognostic (2.20e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (3.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.19e-1)"	3.8	0.9	0.0	0.0	0.1	11.1	3.9	0.0	0.4	15.3	0.3	59.5	0.0	1.4	1.2	27.0	3.2	47.3	0.3	0.0	0.0	1.3	3.5	13.1	41.1	0.2	0.0	5.6	0.4	0.0	0.1	0.0	0.0	3.9	32.3	0.0	16.1	5.7	0.0	1.5	10.1	1.3	0.0	31.8	6.3	0.6	0.0	0.0	2.5	0.0	39.7	103.9	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.7	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	958.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 461.3;lymphoid tissue: 971.3"	"Cell type enriched"	"Detected in some"	255	"Plasma cells: 20463.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 18.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	147	"memory B-cell: 134.0;naive B-cell: 107.0"	"Lineage enriched"	"Detected in single"	163	"B-cells: 134.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;HL-60: 3.1;K-562: 3.0;NB-4: 3.0;RPMI-8226: 5.8;SH-SY5Y: 4.8;TIME: 2.9"														"Immunoglobulin genes"	NA	NA		39000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.29e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.37e-2)"			"prognostic favorable (1.47e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.35e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.70e-2)"	47.8	10.1	0.7	50.1	1.0	71.1	202.7	0.3	0.8	87.4	0.6	461.3	154.1	37.7	8.2	17.8	13.4	37.0	2.2	0.2	0.4	17.6	20.3	56.4	102.5	1.6	2.8	24.7	4.8	2.9	1.8	0.3	2.3	9.2	303.5	0.0	265.5	22.9	1.3	9.6	206.0	3.6	3.9	610.4	230.4	13.2	0.4	0.0	21.1	0.1	971.3	42.9	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.4	2.6	5.8	0.0	0.0	2.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.7	0.0	1.2	1.6	0.0	0.1	0.0	0.6	0.0	0.4	0.8	0.2	0.1	0.0	0.2	134.0	0.2	0.2	0.3	107.0	0.1	0.1	0.1	0.1	0.2	0.6	0.2	12.6	0.7	1.0	0.3	0.8	0.2	0.4	1.6	2.8	2.3	3.9	0.4	1.3	0.0	0.0	0.0	0.0	80.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	30.5	0.0	5.3	0.0	0.0	0.0	4.4	31.1	0.0	0.0	0.0	2.2	1.9	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20463.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.0	0.0	0.0	7.4	0.0	0.5	0.0
IGHV3-74		ENSG00000224650	"Immunoglobulin heavy variable 3-74"	A0A0B4J1X5	14	106810442-106811131	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 103.9;lymphoid tissue: 327.0;salivary gland: 102.6"	"Cell type enriched"	"Detected in some"	454	"Plasma cells: 19404.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	861	"Daudi: 2948.0"														"Immunoglobulin genes"	NA	NA		27000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.47e-4)"	"unprognostic (9.70e-2)"	"prognostic favorable (8.33e-4)"	"unprognostic (6.96e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (7.79e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (4.70e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-1)"	11.3	1.2	0.1	0.0	0.2	0.0	12.6	0.0	1.5	9.3	0.0	103.9	0.0	2.1	1.9	87.3	2.6	1.3	0.7	0.0	0.3	4.7	6.6	22.2	0.0	0.6	0.0	2.5	1.9	0.6	0.8	0.1	0.2	6.5	0.0	0.0	102.6	0.0	0.5	3.2	74.1	0.0	0.3	327.0	27.5	0.2	0.1	0.0	7.7	0.0	0.0	46.4	5.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	2948.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	1.1	0.2	0.0	0.0	0.1	1.2	0.0	0.1	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.7	0.3	0.4	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.9	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	0.3	0.6	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.0	42.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	1.4	27.5	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	19404.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.3	0.0	0.1	0.3
IGHV4-28		ENSG00000211952	"Immunoglobulin heavy variable 4-28"	A0A0C4DH34	14	106324254-106324760	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 44.8;lymphoid tissue: 87.4;salivary gland: 39.9;stomach 1: 30.7;urinary bladder: 122.6"	"Cell type enriched"	"Detected in some"	230	"Plasma cells: 346.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"spinal cord: 1.3"	"Group enriched"	"Detected in some"	206	"memory B-cell: 28.7;naive B-cell: 12.5"	"Lineage enriched"	"Detected in single"	288	"B-cells: 28.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		2500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.64e-3)"		"prognostic favorable (2.63e-4)"	"unprognostic (1.58e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (4.79e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-1)"	1.8	11.3	0.0	40.9	0.0	6.0	12.9	0.0	0.2	3.3	0.1	44.8	44.8	1.0	0.0	12.5	1.9	7.7	1.2	0.0	0.0	1.8	2.4	8.9	10.0	0.0	0.0	3.5	0.4	0.0	0.2	0.0	0.0	0.8	44.1	0.0	39.9	1.7	0.0	0.5	30.2	2.0	1.3	42.3	30.7	0.5	0.0	5.8	4.3	0.0	87.4	122.6	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.7	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	346.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGHV4-31		ENSG00000231475	"Immunoglobulin heavy variable 4-31"	A0A087WSY4	14	106349283-106349792	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 467.7;urinary bladder: 190.8"	"Cell type enriched"	"Detected in some"	183	"Plasma cells: 1651.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"spinal cord: 1.6"	"Group enriched"	"Detected in some"	48	"memory B-cell: 43.6;naive B-cell: 19.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 43.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.4;SH-SY5Y: 1.0"														"Immunoglobulin genes"	NA	NA		710000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.53e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.74e-4)"		"prognostic favorable (4.64e-5)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (2.00e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.09e-1)"	4.3	1.7	0.0	48.0	0.0	5.4	37.6	0.0	0.3	15.4	0.0	103.8	72.1	6.5	1.5	32.2	5.3	105.2	11.7	0.0	0.7	3.9	6.3	19.1	104.0	0.2	0.2	58.0	4.7	0.2	0.5	0.0	0.1	11.4	24.9	0.0	53.2	8.4	0.1	1.3	90.4	3.1	1.6	138.6	87.8	1.3	0.2	76.0	15.7	0.0	467.7	190.8	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.6	0.1	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.7	0.2	0.2	0.1	1.6	0.2	0.1	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1651.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGHV4-34		ENSG00000211956	"Immunoglobulin heavy variable 4-34"	P06331	14	106373663-106374145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 283.3;urinary bladder: 278.5"	"Cell type enriched"	"Detected in some"	197	"Plasma cells: 15696.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	602	"U-698: 5353.4"														"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.34e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.34e-3)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.77e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.61e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.51e-2)"	7.9	3.0	0.0	0.0	0.3	0.0	9.8	0.1	1.5	12.0	0.1	83.5	0.0	5.5	0.9	7.3	22.5	0.0	2.3	0.0	0.2	7.2	7.0	33.4	0.0	0.6	0.2	22.0	1.3	0.4	0.9	0.3	0.3	3.8	2.2	0.0	82.1	0.0	0.3	2.8	54.2	0.3	0.1	283.3	48.0	0.3	0.1	0.0	19.3	0.0	0.0	278.5	4.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	2.6	3.2	0.0	0.0	1.4	0.0	4.1	0.0	0.3	0.0	0.6	3.7	0.0	0.1	8.8	0.4	1.8	0.0	0.8	5353.4	0.0	3.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.5	0.0	0.8	0.0	0.3	0.1	1.5	0.0	0.2	0.6	0.2	0.3	0.1	0.1	1.4	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15696.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0
IGHV4-39		ENSG00000211959	"Immunoglobulin heavy variable 4-39"	P01824	14	106421711-106422218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 251.6;lymphoid tissue: 474.9;salivary gland: 247.1;urinary bladder: 541.3"	"Cell type enriched"	"Detected in some"	432	"Plasma cells: 48104.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;Daudi: 1.8;HL-60: 2.4;NB-4: 2.2;RH-30: 2.1;RPMI-8226: 1.4;U-266/70: 2.1;U-698: 2.0"														"Immunoglobulin genes"	NA	NA		5000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.33e-2)"	17.8	6.5	0.5	378.0	0.5	14.5	33.2	0.1	0.8	24.0	1.5	251.6	4.4	12.5	2.5	19.1	17.7	0.0	11.4	0.1	0.2	13.8	13.8	54.9	0.0	0.8	1.2	17.6	3.7	1.2	1.4	0.0	0.6	7.1	5.0	0.0	247.1	9.5	0.5	12.1	143.6	2.0	0.1	474.9	108.1	1.3	0.4	2.8	37.2	0.0	5.3	541.3	13.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	1.1	2.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.2	0.2	0.0	2.1	0.0	2.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.2	1.6	0.1	0.1	0.1	1.7	0.5	0.1	1.1	0.1	0.1	0.2	0.1	0.0	0.5	0.5	0.1	0.8	0.1	0.2	0.8	1.2	0.6	0.1	0.4	0.3	0.0	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	111.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48104.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.3	0.0
IGHV4-4		ENSG00000276775	"Immunoglobulin heavy variable 4-4"	A0A075B6R2	14	106011922-106012420	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 567.7;urinary bladder: 768.4"	"Cell type enriched"	"Detected in some"	285	"Plasma cells: 2624.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"midbrain: 4.8"	"Group enriched"	"Detected in some"	23	"memory B-cell: 56.6;naive B-cell: 31.2"	"Lineage enriched"	"Detected in many"	30	"B-cells: 56.6"	"Cell line enriched"	"Detected in some"	18	"Karpas-707: 34.5"														"Immunoglobulin genes"	NA	NA		3800000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.03e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"			"prognostic favorable (1.60e-6)"		"unprognostic (2.24e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.69e-5)"	"unprognostic (3.16e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.05e-1)"	9.4	2.5	0.0	131.4	0.0	17.8	63.6	0.0	0.2	37.5	0.1	205.2	159.9	3.8	0.8	59.8	53.4	104.9	0.9	0.0	0.1	5.5	6.6	36.9	173.2	0.3	4.8	10.0	6.0	0.4	0.4	0.0	0.1	4.0	140.2	0.0	78.2	15.0	0.3	3.8	78.6	13.4	0.4	186.4	175.0	1.6	0.1	31.8	16.7	0.0	567.7	768.4	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	34.5	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	56.6	0.2	0.2	0.0	31.2	0.6	0.0	0.0	0.0	0.0	1.9	0.6	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	4.8	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2624.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
IGHV4-59		ENSG00000224373	"Immunoglobulin heavy variable 4-59"	P01825	14	106627249-106627825	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 525.9;lymphoid tissue: 911.2;urinary bladder: 702.5"	"Cell type enriched"	"Detected in some"	301	"Plasma cells: 12374.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"spinal cord: 2.0"	"Group enriched"	"Detected in some"	37	"memory B-cell: 169.0;naive B-cell: 77.2"	"Lineage enriched"	"Detected in many"	51	"B-cells: 169.0"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.1;SCLC-21H: 2.0;SH-SY5Y: 4.2"														"Immunoglobulin genes"	NA	NA		5500000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.62e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (9.18e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.41e-7)"	"unprognostic (6.04e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.76e-1)"	23.9	3.2	0.0	260.5	0.3	95.5	89.3	0.0	1.1	40.4	0.8	525.9	301.0	12.1	2.7	89.6	17.9	168.0	27.9	0.0	0.6	13.8	20.6	89.9	148.0	0.3	0.1	23.5	10.3	1.7	1.5	0.3	0.2	12.6	456.0	0.0	225.7	8.8	0.5	3.6	222.6	19.5	2.0	465.3	260.5	15.0	0.2	86.4	44.1	0.0	911.2	702.5	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.0	8.1	1.0	0.3	0.3	0.0	0.8	1.0	0.7	0.0	0.0	2.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.4	0.4	0.1	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	169.0	0.0	0.2	1.4	77.2	0.1	0.0	0.0	0.0	0.1	3.3	0.1	11.9	0.0	0.3	0.0	1.1	0.0	0.6	0.3	0.1	0.2	2.0	0.2	0.3	0.0	0.0	0.6	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12374.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	3.6	0.0	0.5	0.0
IGHV5-10-1	IGHV5-A	ENSG00000282651	"Immunoglobulin heavy variable 5-10-1"	A0A0J9YXX1	14	106107972-106108464	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 316.6;lymphoid tissue: 568.1"	"Cell type enriched"	"Detected in single"	36	"B-cells: 3.6"					"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"memory B-cell: 74.8;naive B-cell: 66.7"	"Lineage enriched"	"Detected in many"	16	"B-cells: 74.8"	"Group enriched"	"Detected in some"	6	"Daudi: 9.4;U-698: 4.8"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA006014: "																		4.5	28.4	0.0	229.8	0.0	38.7	102.0	0.0	0.9	68.9	0.1	274.0	0.9	10.8	0.0	111.5	20.0	92.5	6.2	0.0	0.0	5.5	7.3	128.3	121.2	0.1	0.0	54.0	5.7	0.4	0.3	0.2	0.2	6.9	316.6	0.0	75.5	19.0	0.1	1.6	51.6	10.9	0.0	203.8	148.3	0.1	0.0	39.3	7.3	0.0	568.1	196.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.0	4.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.8	0.0	0.0	0.0	66.7	0.0	0.0	4.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGHV5-51		ENSG00000211966	"Immunoglobulin heavy variable 5-51"	A0A0C4DH38	14	106578744-106579236	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 245.7;lymphoid tissue: 547.1;salivary gland: 224.5;urinary bladder: 353.3"	"Cell type enriched"	"Detected in some"	87	"Plasma cells: 5993.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.7;K-562: 2.4;NB-4: 1.7;TIME: 3.3"									HPA006014	Approved				"Immunoglobulin genes"	NA	NA		2700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA006014: "	"unprognostic (2.03e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.80e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.17e-1)"	20.0	4.8	0.3	0.0	0.0	0.0	25.9	0.1	1.7	17.8	0.7	245.7	0.0	8.6	6.3	19.1	15.2	27.1	2.1	0.1	0.7	15.4	15.0	56.2	0.0	0.9	0.0	8.8	17.1	1.0	2.2	0.6	0.2	11.2	0.0	0.0	224.5	0.0	0.7	3.2	144.8	1.7	0.6	547.1	99.9	4.8	0.1	0.0	25.6	0.0	0.0	353.3	14.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	1.3	1.2	0.8	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.7	0.1	0.7	0.9	0.0	0.2	0.6	0.1	1.3	0.0	0.0	0.0	0.0	68.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	44.9	0.0	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5993.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0
IGHV6-1		ENSG00000211933	"Immunoglobulin heavy variable 6-1"	A0A0B4J1U7	14	105939756-105940253	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 441.3;lymphoid tissue: 159.0"	"Cell type enriched"	"Detected in some"	175	"Plasma cells: 2295.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in single"	53	"B-cells: 19.7"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		930000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.35e-4)"	"unprognostic (9.66e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.26e-1)"		"prognostic favorable (1.85e-5)"		"unprognostic (1.84e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (3.69e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	13.0	2.1	0.3	0.0	0.1	0.0	7.5	0.0	0.4	4.2	0.2	441.3	0.0	1.2	0.0	17.9	4.3	1.5	2.7	0.0	0.1	3.2	6.2	13.6	0.0	0.3	0.1	0.9	11.5	0.0	0.3	0.0	0.1	1.6	0.0	0.0	56.7	8.6	0.1	2.0	40.9	11.2	0.3	159.0	19.5	0.3	0.2	0.0	6.8	0.0	0.0	3.7	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.1	19.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.1	0.3	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2295.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0
IGKC	HCAK1	ENSG00000211592	"Immunoglobulin kappa constant"		2	88857161-88857683	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"intestine: 35196.7;lymphoid tissue: 63075.6"	"Group enriched"	"Detected in many"	12	"B-cells: 72318.1;Plasma cells: 96515.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	21	"memory B-cell: 39143.0;naive B-cell: 35081.5"	"Lineage enriched"	"Detected in all"	23	"B-cells: 39143.0"	"Group enriched"	"Detected in many"	6	"Daudi: 9909.1;U-266/70: 10337.6;U-266/84: 3927.9;U-698: 12154.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB015377	Uncertain				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB015377: AB_2251264"	"prognostic favorable (6.59e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.82e-3)"	"prognostic favorable (1.18e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (2.17e-9)"	"unprognostic (1.85e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.59e-1)"	1025.4	2379.8	13.1	20500.0	13.3	6315.2	11287.7	11.3	33.6	3649.2	26.7	35196.7	24515.5	877.3	474.1	5708.4	1137.6	5995.3	810.4	11.4	16.7	1176.6	1580.5	5824.2	21356.1	25.1	18.2	2214.9	462.9	72.6	101.8	22.2	15.3	843.6	30618.3	4.0	19606.1	2123.2	32.9	250.8	17061.1	1259.7	43.5	26904.1	22740.5	1083.9	13.4	8576.0	2151.1	8.1	63075.6	24817.5	705.0	20.2	17.1	0.0	0.0	0.0	0.0	0.0	103.7	0.0	0.0	0.1	0.0	0.0	0.0	9909.1	15.3	0.0	1.0	22.2	0.0	0.0	0.0	510.2	0.0	30.9	0.0	0.0	0.0	67.8	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.4	0.0	0.0	18.3	83.2	28.8	0.0	0.0	16.7	56.4	1509.5	0.6	0.0	79.6	146.1	19.6	1.5	6.0	0.5	0.5	17.2	66.7	0.0	56.9	24.3	44.0	10337.6	3927.9	12154.4	0.0	28.9	0.0	47.5	55.6	31.6	24.6	11.2	21.7	39143.0	28.3	18.3	46.6	35081.5	15.2	16.8	65.2	24.1	29.1	1735.4	23.7	8567.0	13.1	13.3	11.3	33.6	11.4	16.7	25.1	18.2	15.3	43.5	13.4	20.2	58.6	336.5	1863.8	0.0	72318.1	0.0	189.2	0.0	2.2	0.0	8.8	7.0	5.7	163.0	88.5	0.0	0.0	48.0	452.1	39.8	3.9	0.0	2.8	0.7	0.3	72.8	77.8	1658.9	0.0	0.2	37.3	186.5	64.7	0.4	849.0	15.5	340.2	334.8	8.9	0.0	0.0	35.1	0.0	496.3	0.0	11.0	0.0	64.4	0.0	0.0	26.4	0.0	59.8	0.0	0.0	0.0	25.9	0.4	96515.7	193.2	0.3	45.2	12.4	0.0	0.0	3.7	38.4	0.3	0.2	5.9	0.0	49.4	6505.3	0.1	50.2	1.9
IGKJ1	J1	ENSG00000211597	"Immunoglobulin kappa joining 1"	A0A0A0MT89	2	88861886-88861923	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	5	"intestine: 3082.3;lymphoid tissue: 3301.5;salivary gland: 1202.6;stomach 1: 2816.8;urinary bladder: 1106.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	418	"memory B-cell: 38345.4;naive B-cell: 32121.1;plasmacytoid DC: 14778.6"	"Group enriched"	"Detected in all"	390	"B-cells: 38345.4;dendritic cells: 14778.6"	"Cell line enriched"	"Detected in many"	4	"U-266/70: 21925.7"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"																					70.6	227.2	1.9	3301.5	1.5	424.8	363.1	1.3	9.2	71.7	5.0	1960.8	3082.3	41.6	0.0	278.0	18.1	157.4	31.0	3.2	2.2	31.7	92.0	382.5	839.3	3.4	2.4	127.7	50.3	2.0	0.0	6.3	2.9	50.4	1743.7	0.2	1202.6	16.4	6.9	8.8	2231.5	61.2	3.4	1516.0	2816.8	31.2	2.1	115.3	6.2	0.0	2770.1	1106.5	0.0	2.9	22.9	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	7.4	0.0	9.9	2.5	0.0	0.0	14.6	0.0	0.0	0.0	851.1	0.0	10.1	0.0	0.0	0.0	34.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	10.3	12.1	11.8	0.0	0.0	23.1	0.0	4365.8	0.0	0.0	10.3	18.7	0.0	0.0	4.9	0.0	0.0	31.0	0.0	0.0	9.7	2.4	34.6	21925.7	5461.9	93.7	0.0	6.3	0.0	48.3	44.8	22.7	19.1	17.9	25.4	38345.4	27.2	13.8	57.2	32121.1	20.1	20.9	68.0	38.9	26.9	14778.6	29.9	3897.0	1.9	1.5	1.3	9.2	3.2	2.2	3.4	2.4	2.9	3.4	2.1	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ2	J2	ENSG00000211596	"Immunoglobulin kappa joining 2"		2	88861525-88861563	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 2670.6;lymphoid tissue: 2226.1;salivary gland: 1187.7;stomach 1: 1719.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 22200.6;naive B-cell: 20663.6"	"Lineage enriched"	"Detected in all"	52	"B-cells: 22200.6"	"Group enriched"	"Detected in many"	7	"HDLM-2: 213.9;RPMI-8226: 179.1"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"																					67.9	154.0	0.6	1862.6	0.9	296.5	312.9	0.1	4.0	158.7	0.7	1762.7	2670.6	37.5	0.0	308.3	14.3	114.1	19.6	0.6	0.6	27.0	61.7	236.7	693.3	4.3	1.4	71.6	72.5	1.9	0.0	1.1	1.2	46.0	1364.3	0.0	1187.7	20.2	2.9	5.2	1974.3	28.2	1.5	1097.1	1719.7	44.8	0.9	73.5	5.1	0.0	2226.1	494.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	3.5	0.0	0.0	0.0	213.9	0.0	9.7	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	8.0	3.6	0.0	0.0	7.4	2.5	179.1	0.0	0.0	3.2	17.5	4.8	0.0	0.0	0.0	0.0	29.6	10.7	0.0	3.4	3.7	7.6	5.3	0.0	29.0	0.0	1.8	0.0	19.7	33.6	12.8	10.3	7.7	12.8	22200.6	15.0	8.1	23.3	20663.6	9.5	9.6	42.6	10.8	18.6	430.3	17.4	2451.2	0.6	0.9	0.1	4.0	0.6	0.6	4.3	1.4	1.2	1.5	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKJ3		ENSG00000211595	"Immunoglobulin kappa joining 3"		2	88861221-88861258	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 1010.8;lymphoid tissue: 997.2;stomach 1: 710.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	12	"spinal cord: 18.3"	"Group enriched"	"Detected in all"	26	"memory B-cell: 8663.4;naive B-cell: 7153.9"	"Lineage enriched"	"Detected in all"	28	"B-cells: 8663.4"	"Group enriched"	"Detected in some"	6	"HDLM-2: 105.2;RPMI-8226: 89.2;U-698: 41.2"															NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						15.1	19.6	0.8	886.7	0.7	115.0	111.2	0.3	1.3	19.2	0.5	587.3	1010.8	7.6	0.0	68.8	7.9	44.8	9.3	0.9	0.6	14.3	41.1	101.9	490.2	1.2	0.5	31.1	0.0	0.0	0.0	1.9	1.5	18.2	546.6	0.6	362.3	12.6	8.7	2.5	726.3	19.9	18.3	548.6	710.1	9.7	0.9	53.9	5.1	3.9	997.2	236.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	105.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	89.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	41.2	0.0	0.0	0.0	17.0	8.6	57.9	1.9	1.1	9.2	8663.4	3.0	3.3	5.9	7153.9	5.7	5.1	61.8	7.1	15.2	309.9	7.8	660.0	0.8	0.7	0.3	1.3	0.9	0.6	1.2	0.5	1.5	18.3	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ4		ENSG00000211594	"Immunoglobulin kappa joining 4"		2	88860886-88860922	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3282.9;lymphoid tissue: 2905.5;stomach 1: 2295.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	42	"memory B-cell: 36413.7;naive B-cell: 27723.7"	"Lineage enriched"	"Detected in all"	48	"B-cells: 36413.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.9;Daudi: 23.5;HDLM-2: 58.4;RPMI-8226: 43.3;SH-SY5Y: 27.6;U-698: 25.7"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"																						80.0	268.7	0.6	2905.5	0.7	407.6	414.6	0.3	4.1	110.0	0.5	1844.1	3282.9	29.5	62.5	433.0	33.3	138.1	34.8	0.6	1.1	48.2	104.6	481.3	932.6	2.9	0.7	117.5	29.3	1.7	0.0	1.3	1.3	56.4	1849.6	0.3	1142.3	54.8	3.9	17.3	2184.0	78.1	2.6	1246.0	2295.9	39.7	1.8	113.5	11.4	0.0	2661.5	645.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	9.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.0	10.4	0.0	0.0	0.0	0.0	9.1	43.3	0.0	0.0	6.7	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	7.3	8.5	3.3	0.0	25.7	0.0	0.0	0.0	114.4	64.9	20.3	24.9	9.5	16.8	36413.7	15.8	15.2	32.5	27723.7	22.7	16.1	60.0	21.5	25.4	759.9	22.8	3519.3	0.6	0.7	0.3	4.1	0.6	1.1	2.9	0.7	1.3	2.6	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKJ5		ENSG00000211593	"Immunoglobulin kappa joining 5"		2	88860568-88860605	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	4	"intestine: 1221.3;lymphoid tissue: 1365.8;salivary gland: 643.7;stomach 1: 1066.6;urinary bladder: 436.6"	"Cell type enriched"	"Detected in single"	13	"B-cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	24	"memory B-cell: 9254.1;naive B-cell: 8737.5"	"Lineage enriched"	"Detected in all"	25	"B-cells: 9254.1"	"Cell line enriched"	"Detected in some"	24	"U-698: 3392.4"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (4.92e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (9.30e-3)"		"prognostic favorable (1.83e-4)"		"unprognostic (1.12e-1)"			"unprognostic (3.22e-1)"		"prognostic unfavorable (5.49e-6)"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"		"unprognostic (2.02e-1)"	25.2	42.2	0.5	1365.8	0.7	164.5	236.5	0.6	4.5	73.7	0.3	1194.4	1221.3	13.4	5.8	130.7	8.8	78.5	26.1	0.9	0.7	18.0	30.8	157.6	529.7	1.6	0.6	63.3	29.2	6.6	0.0	4.1	1.2	22.8	1171.9	0.0	643.7	17.1	0.0	5.8	1078.7	40.6	4.9	672.7	1066.6	12.4	0.7	61.5	4.3	0.0	1213.5	436.6	0.0	0.9	17.7	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	142.3	0.0	0.0	0.0	0.0	0.0	7.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	58.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.3	3.5	11.4	3.2	1.9	3392.4	0.0	8.1	0.0	3.3	10.1	10.2	3.8	1.3	2.2	9254.1	18.4	3.5	7.4	8737.5	9.5	3.4	9.4	7.6	3.4	373.6	8.8	1167.3	0.5	0.7	0.6	4.5	0.9	0.7	1.6	0.6	1.2	4.9	0.7	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1-12	"IGKV112, L19"	ENSG00000243290	"Immunoglobulin kappa variable 1-12"	A0A0C4DH73	2	89040224-89040745	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 395.8;lymphoid tissue: 788.8"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 12442.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	820	"memory B-cell: 259.8;naive B-cell: 164.2"	"Lineage enriched"	"Detected in single"	1005	"B-cells: 259.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;Daudi: 2.1;RPMI-8226: 1.9;SH-SY5Y: 1.9"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		13000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (6.09e-4)"	"prognostic favorable (1.59e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.74e-2)"		"prognostic favorable (3.85e-5)"		"unprognostic (5.89e-2)"	"unprognostic (5.74e-1)"	"unprognostic (7.13e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (6.59e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.71e-1)"	13.6	144.8	0.0	201.7	0.2	73.1	116.8	0.0	0.4	50.8	0.2	395.8	240.6	7.3	0.0	57.1	16.2	69.6	9.9	0.1	0.1	13.7	17.8	65.3	238.6	0.6	0.0	18.1	7.2	0.2	1.4	0.0	1.1	7.2	278.6	0.0	219.0	5.4	0.4	2.8	231.2	11.2	1.2	360.5	254.9	6.7	0.0	69.5	32.7	0.0	788.8	243.3	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.0	259.8	0.0	0.1	0.1	164.2	0.0	0.1	0.2	0.1	0.1	0.1	0.1	24.3	0.0	0.2	0.0	0.4	0.1	0.1	0.6	0.0	1.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	1.8	1.6	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12442.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.3	5.0	0.0	0.0	0.0
IGKV1-16	"IGKV116, L1"	ENSG00000240864	"Immunoglobulin kappa variable 1-16"	P04430	2	89099859-89100361	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 279.7;lymphoid tissue: 597.8;urinary bladder: 260.3"	"Cell type enriched"	"Detected in some"	559	"Plasma cells: 18463.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	523	"memory B-cell: 164.7;naive B-cell: 112.8"	"Lineage enriched"	"Detected in single"	621	"B-cells: 164.7"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		10000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.63e-4)"	"unprognostic (7.81e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.35e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.84e-2)"	"unprognostic (5.82e-2)"	11.8	4.7	0.1	159.1	0.1	40.0	75.9	0.0	0.8	76.0	0.6	279.7	199.4	6.3	0.5	34.3	6.6	99.0	11.4	0.0	0.1	9.2	14.9	40.5	155.0	0.2	0.0	17.7	2.0	0.1	3.6	0.1	0.1	5.6	235.6	0.0	126.9	30.9	0.8	0.7	143.6	11.8	0.1	315.4	158.9	2.0	0.1	45.7	18.4	0.0	597.8	260.3	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	164.7	0.0	0.0	0.1	112.8	0.0	0.1	0.2	0.0	0.0	0.0	0.0	16.9	0.1	0.1	0.0	0.8	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	21.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18463.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0
IGKV1-17	"A30, IGKV117"	ENSG00000240382	"Immunoglobulin kappa variable 1-17"	P01599	2	89117342-89117844	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 375.0;lymphoid tissue: 454.4"	"Cell type enriched"	"Detected in some"	113	"Plasma cells: 4510.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	425	"memory B-cell: 105.7;naive B-cell: 82.2"	"Lineage enriched"	"Detected in single"	478	"B-cells: 105.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;K-562: 1.2;RPMI-8226: 2.0;SH-SY5Y: 1.4"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (7.72e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.37e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.08e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (3.12e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.28e-2)"	12.8	26.5	0.1	183.7	0.2	27.7	87.1	0.0	0.7	11.9	0.4	358.5	294.8	6.6	4.1	54.7	12.4	55.7	10.9	0.0	0.1	10.3	14.2	36.5	95.7	0.6	0.0	12.4	3.3	1.1	1.0	0.1	0.2	5.5	375.0	0.0	134.3	31.0	1.3	1.2	152.7	4.7	0.1	306.1	159.7	2.4	0.3	45.6	25.8	0.0	454.4	182.6	6.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.8	2.0	0.0	0.0	0.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	105.7	0.0	0.0	0.1	82.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	12.6	0.1	0.2	0.0	0.7	0.0	0.1	0.6	0.0	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4510.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0
IGKV1-27	"A20, IGKV127"	ENSG00000244575	"Immunoglobulin kappa variable 1-27"	A0A075B6S5	2	89213423-89213928	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 268.0;lymphoid tissue: 347.1;salivary gland: 177.6"	"Cell type enriched"	"Detected in some"	126	"Plasma cells: 4951.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	683	"memory B-cell: 152.7;naive B-cell: 185.3"	"Lineage enriched"	"Detected in single"	748	"B-cells: 185.3"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.8"					"Not detected"	"Not detected"			HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.56e-5)"	"unprognostic (6.50e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.99e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (8.84e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.67e-2)"	17.2	9.2	0.0	133.5	0.0	28.5	70.0	0.0	0.4	16.8	0.1	268.0	183.3	6.2	7.7	30.4	6.9	37.5	10.7	0.1	0.1	11.8	9.7	55.2	124.7	0.7	0.3	8.8	4.9	0.2	1.0	0.0	0.1	6.4	212.3	0.0	177.6	8.8	0.6	0.9	200.2	5.1	0.2	276.9	91.9	1.0	0.0	46.9	19.4	0.0	347.1	87.7	6.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	152.7	0.1	0.1	0.1	185.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	15.8	0.0	0.0	0.0	0.4	0.1	0.1	0.7	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	12.2	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4951.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0
IGKV1-33	"IGKV133, O18"	ENSG00000242076	"Immunoglobulin kappa variable 1-33"	P01594	2	89266494-89268506	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1727.5;stomach 1: 627.3;urinary bladder: 623.3"	"Cell type enriched"	"Detected in some"	131	"Plasma cells: 2044.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.5"	"Region enriched"	"Detected in many"	7	"spinal cord: 12.0"	"Group enriched"	"Detected in some"	378	"memory B-cell: 369.6;naive B-cell: 441.5"	"Lineage enriched"	"Detected in many"	411	"B-cells: 441.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;SCLC-21H: 9.1;SH-SY5Y: 8.8;U-251 MG: 3.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (1.76e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.52e-2)"			"prognostic favorable (4.58e-5)"		"unprognostic (5.06e-2)"		"unprognostic (8.55e-3)"	"unprognostic (2.31e-1)"			"unprognostic (1.63e-2)"	"unprognostic (2.57e-1)"		"unprognostic (4.66e-1)"	50.5	21.9	0.1	266.2	0.5	139.5	320.5	0.6	1.0	129.8	0.4	471.5	296.2	20.7	2.8	106.2	33.4	187.2	23.2	0.2	1.6	36.7	37.9	130.4	529.5	0.4	1.0	37.0	8.3	1.9	2.7	0.4	0.7	18.7	511.9	0.2	476.4	127.7	0.7	2.5	175.9	14.5	12.0	820.8	627.3	13.5	0.2	381.9	53.9	0.2	1727.5	623.3	26.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.1	1.9	2.7	0.0	0.0	9.1	8.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.4	3.5	0.7	0.0	0.2	0.0	0.6	0.0	0.4	0.3	0.4	0.1	0.0	0.1	369.6	0.2	0.1	0.3	441.5	0.2	0.1	1.0	0.2	0.3	0.3	0.2	39.5	0.1	0.5	0.6	1.0	0.2	1.6	0.4	1.0	0.7	12.0	0.2	1.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2044.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0
IGKV1-39		ENSG00000242371	"Immunoglobulin kappa variable 1-39"	P01597	2	89319625-89320146	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.5;lymphoid tissue: 254.9;salivary gland: 151.2;stomach 1: 83.2"	"Cell type enriched"	"Detected in some"	151	"Plasma cells: 16225.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 13.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	388	"memory B-cell: 1069.8;naive B-cell: 935.1"	"Lineage enriched"	"Detected in many"	415	"B-cells: 1069.8"	"Cell line enriched"	"Detected in some"	21	"Daudi: 194.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.76e-4)"	"unprognostic (5.10e-3)"	"unprognostic (4.71e-2)"			"prognostic favorable (1.70e-5)"		"unprognostic (2.38e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"		"unprognostic (6.62e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.25e-1)"	10.9	9.1	0.0	54.7	0.1	14.2	17.7	0.0	0.1	21.8	0.0	108.5	70.5	5.7	0.0	11.6	12.5	14.3	1.5	0.2	0.0	10.9	6.8	27.2	36.5	0.0	0.0	1.8	3.2	0.0	0.5	0.0	0.2	4.2	13.3	0.0	151.2	0.9	0.2	1.3	74.4	1.2	0.0	254.9	83.2	0.3	0.0	5.9	31.0	0.0	42.5	17.5	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	194.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	1.8	0.0	9.0	0.0	0.0	0.0	0.9	1.0	0.7	0.3	0.3	0.3	1069.8	0.5	0.4	1.1	935.1	0.3	0.6	2.5	0.4	0.6	1.3	0.8	136.4	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.7	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16225.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	4.9	0.0	0.3	0.0
IGKV1-5		ENSG00000243466	"Immunoglobulin kappa variable 1-5"	P01602	2	88947301-88947957	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 777.1;lymphoid tissue: 1459.2;urinary bladder: 945.2"	"Cell type enriched"	"Detected in some"	240	"Plasma cells: 39194.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	364	"memory B-cell: 859.0;naive B-cell: 860.5"	"Lineage enriched"	"Detected in many"	364	"B-cells: 860.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.0;HL-60: 2.4;RPMI-8226: 5.0;SCLC-21H: 2.9;SH-SY5Y: 4.5"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		8400000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.19e-4)"	"unprognostic (1.26e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.59e-2)"	"prognostic favorable (3.47e-4)"	"unprognostic (7.60e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (4.36e-8)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-2)"	35.8	82.0	0.2	639.7	0.2	115.4	233.9	0.1	1.6	115.8	0.6	777.1	528.7	17.1	2.0	146.2	86.9	124.8	18.7	0.1	0.5	36.2	32.0	125.3	387.2	1.0	0.2	60.8	10.8	0.5	3.0	0.4	0.3	16.7	745.0	0.0	392.2	34.8	0.9	3.2	429.7	24.4	1.3	915.4	456.3	11.5	0.2	155.3	58.4	0.0	1459.2	945.2	28.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.4	1.6	0.5	0.0	0.0	0.3	1.0	5.0	0.0	0.0	2.9	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.7	0.4	0.6	0.1	0.4	0.0	0.6	0.0	0.7	1.2	1.3	0.5	0.2	0.4	859.0	2.3	0.3	1.0	860.5	0.2	0.3	1.4	0.4	0.6	0.7	0.6	113.5	0.2	0.2	0.1	1.6	0.1	0.5	1.0	0.2	0.3	1.3	0.2	0.5	0.0	0.0	0.6	0.0	163.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	7.0	89.7	0.0	0.0	0.0	0.7	3.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39194.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	11.8	0.0	0.2	0.0
IGKV1-6		ENSG00000239855	"Immunoglobulin kappa variable 1-6"	A0A0C4DH72	2	88966262-88966767	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 155.5;lymphoid tissue: 606.3"	"Cell type enriched"	"Detected in some"	33	"Plasma cells: 877.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	801	"memory B-cell: 123.6;naive B-cell: 85.7"	"Lineage enriched"	"Detected in single"	946	"B-cells: 123.6"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		12000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (3.44e-5)"	"unprognostic (5.25e-3)"	"unprognostic (3.78e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.23e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.86e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (5.23e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.54e-1)"	8.2	1.7	0.1	84.1	0.1	37.0	50.3	0.0	0.4	16.5	0.1	155.5	110.5	4.0	4.1	23.5	5.0	18.1	5.3	0.0	0.0	7.7	6.3	20.0	82.3	0.1	0.1	4.0	1.8	0.0	1.1	0.0	0.0	4.3	145.9	0.0	95.0	2.2	0.2	0.6	59.1	5.1	0.2	209.5	130.3	0.7	0.0	22.7	16.4	0.0	606.3	144.8	8.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	123.6	0.0	0.0	0.1	85.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.1	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	877.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0
IGKV1-8	"IGKV18, L9"	ENSG00000240671	"Immunoglobulin kappa variable 1-8"	A0A0C4DH67	2	88992409-88992931	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 29.7;lymphoid tissue: 55.0;salivary gland: 21.2;stomach 1: 18.6;urinary bladder: 41.7"	"Cell type enriched"	"Detected in some"	40	"Plasma cells: 622.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	311	"memory B-cell: 131.0;naive B-cell: 136.4"	"Lineage enriched"	"Detected in single"	317	"B-cells: 136.4"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		6100000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.64e-4)"	"unprognostic (1.56e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.41e-3)"		"prognostic favorable (5.13e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (4.14e-7)"	"unprognostic (6.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.98e-1)"	2.1	2.5	0.0	13.5	0.0	7.1	6.7	0.0	0.1	2.0	0.0	29.7	12.0	1.3	0.0	2.9	1.4	5.4	1.5	0.0	0.0	3.3	2.1	4.8	13.7	0.0	0.0	0.5	0.9	0.0	0.1	0.0	0.0	1.4	19.3	0.0	21.2	0.7	0.0	0.1	13.9	0.6	0.0	51.3	18.6	0.3	0.0	7.0	3.3	0.0	55.0	41.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	131.0	0.0	0.4	0.1	136.4	0.1	0.0	0.1	0.1	0.1	0.0	0.1	12.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0
IGKV1-9	"IGKV19, L8"	ENSG00000241755	"Immunoglobulin kappa variable 1-9"	A0A0C4DH69	2	89009982-89010515	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 428.1;lymphoid tissue: 671.3;stomach 1: 283.7"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 7178.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	705	"memory B-cell: 300.5;naive B-cell: 296.8"	"Lineage enriched"	"Detected in single"	709	"B-cells: 300.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;NB-4: 1.0;RPMI-8226: 2.9;TIME: 1.2"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.10e-7)"	"unprognostic (1.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.70e-2)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (6.04e-8)"	"unprognostic (4.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.40e-1)"	12.6	12.6	0.2	184.3	0.4	53.6	202.8	0.0	1.3	15.8	0.4	428.1	267.0	8.3	0.8	52.9	78.3	30.0	13.9	0.1	0.1	15.4	17.9	40.1	201.8	0.3	0.1	20.7	2.5	0.5	1.3	0.1	0.2	12.8	348.6	0.0	221.3	13.3	0.5	1.6	182.8	13.3	0.4	313.1	283.7	35.1	0.1	85.1	34.2	0.0	671.3	187.5	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.9	2.9	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.2	0.4	0.1	0.2	0.0	0.1	300.5	0.1	0.0	0.3	296.8	0.0	0.1	0.3	0.2	0.2	0.1	0.3	34.5	0.2	0.4	0.0	1.3	0.1	0.1	0.3	0.1	0.2	0.4	0.1	0.3	0.0	0.0	0.0	0.0	61.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7178.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0
IGKV1D-13		ENSG00000276566	"Immunoglobulin kappa variable 1D-13"	"A0A0B4J2D9, P0DP09"	2	90154073-90154574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 103.7;lymphoid tissue: 317.6"	"Cell type enriched"	"Detected in some"	141	"Plasma cells: 6195.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	733	"memory B-cell: 480.8;naive B-cell: 331.6"	"Lineage enriched"	"Detected in single"	868	"B-cells: 480.8"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.0"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA		370000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (4.68e-6)"	"unprognostic (4.10e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.71e-3)"		"unprognostic (3.01e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.60e-2)"	4.8	0.4	0.0	101.2	0.0	34.8	34.3	0.0	0.0	46.6	0.0	85.6	21.7	5.4	0.0	17.9	10.2	2.5	3.5	0.0	0.0	8.1	6.4	39.4	317.6	0.0	0.0	1.0	1.9	0.0	0.4	0.0	0.1	3.1	78.3	0.0	54.2	1.4	0.0	1.1	103.7	6.8	0.0	102.8	20.3	2.7	0.0	29.0	7.2	0.0	223.2	45.9	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.3	0.1	0.1	0.2	480.8	0.2	0.1	0.5	331.6	0.0	0.0	0.4	0.1	0.1	0.2	0.1	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6195.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV1D-16		ENSG00000241244	"Immunoglobulin kappa variable 1D-16"	P01601	2	90100236-90100738	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 79.1;intestine: 92.0;lymphoid tissue: 165.5"	"Cell type enriched"	"Detected in some"	249	"Plasma cells: 1994.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 17.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	327	"memory B-cell: 57.6;naive B-cell: 120.1"	"Lineage enriched"	"Detected in single"	442	"B-cells: 120.1"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		9000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (2.41e-4)"	"unprognostic (4.41e-3)"	"unprognostic (3.96e-3)"	"unprognostic (5.39e-2)"		"unprognostic (1.35e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (4.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.84e-1)"	2.4	0.4	0.0	30.2	0.0	15.0	18.9	0.0	0.4	11.0	0.1	92.0	39.0	1.6	0.0	13.8	2.5	79.1	1.3	0.0	0.0	1.7	3.9	10.0	27.5	0.0	0.0	2.5	0.9	0.6	0.1	0.0	0.1	3.6	50.3	0.0	30.3	0.9	0.0	0.2	34.4	1.0	0.3	56.6	26.7	0.4	0.0	9.9	2.7	0.0	165.5	23.5	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.1	120.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1994.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
IGKV1D-33		ENSG00000239975	"Immunoglobulin kappa variable 1D-33"	P01593	2	89913982-89916052	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7;lymphoid tissue: 63.0;salivary gland: 73.3"	"Cell type enriched"	"Detected in some"	410	"Plasma cells: 5131.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	116	"memory B-cell: 6.3;naive B-cell: 16.8"	"Lineage enriched"	"Detected in single"	169	"B-cells: 16.8"	"Not detected"	"Not detected"											HPA048721	Approved				"Immunoglobulin genes"	NA	NA		4900000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"unprognostic (5.10e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.11e-2)"			"unprognostic (2.03e-4)"		"unprognostic (7.90e-2)"		"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"			"unprognostic (4.54e-2)"	"unprognostic (4.23e-2)"			2.8	0.5	0.0	3.8	0.1	2.3	8.3	0.0	0.1	3.6	0.1	32.7	1.3	1.4	0.0	4.6	2.7	2.6	0.2	0.2	0.2	4.0	2.2	17.9	6.8	0.0	0.2	0.4	0.5	0.0	0.1	0.0	0.0	1.6	2.0	0.0	73.3	8.6	0.0	0.5	19.1	0.0	0.5	63.0	21.2	0.1	0.0	4.7	3.3	0.2	9.1	16.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5131.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
IGKV1D-39		ENSG00000251546	"Immunoglobulin kappa variable 1D-39"	P04432	2	89862482-89862981	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2922.1;lymphoid tissue: 6491.8;stomach 1: 2259.8"	"Cell type enriched"	"Detected in some"	298	"Plasma cells: 7890.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 12.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	226	"memory B-cell: 470.5;naive B-cell: 733.0"	"Lineage enriched"	"Detected in many"	275	"B-cells: 733.0"	"Group enriched"	"Detected in some"	36	"Daudi: 731.4;U-698: 516.7"									HPA048721	Approved				"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA048721: "	"prognostic favorable (1.88e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.14e-3)"			"prognostic favorable (5.99e-5)"		"unprognostic (3.84e-1)"		"unprognostic (4.34e-2)"	"unprognostic (1.28e-1)"			"unprognostic (9.06e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-1)"	147.3	181.1	0.6	1609.8	0.8	466.1	990.4	0.5	4.2	369.0	2.1	2922.1	2055.2	80.0	52.5	611.3	132.1	629.8	87.5	0.4	2.0	82.3	171.8	685.1	1968.9	2.6	0.8	214.9	26.5	3.5	5.5	1.3	3.6	80.9	2261.1	0.4	1229.7	148.4	2.3	33.2	1255.9	88.7	4.2	1712.0	2259.8	27.6	1.3	770.5	209.3	0.0	6491.8	1816.1	46.9	2.5	0.3	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	731.4	0.5	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.0	0.0	5.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	2.3	6.6	2.4	0.0	0.0	1.0	2.9	10.3	0.0	0.0	11.1	17.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	2.5	0.0	0.1	516.7	0.0	1.6	0.0	0.5	0.4	0.8	0.6	0.2	0.4	470.5	0.3	0.3	0.4	733.0	0.5	0.2	2.6	0.8	0.4	0.4	0.3	47.6	0.6	0.8	0.5	4.2	0.4	2.0	2.6	0.8	3.6	4.2	1.3	2.5	0.0	0.0	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7890.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	14.0	0.0	0.0	0.0
IGKV2-24		ENSG00000241294	"Immunoglobulin kappa variable 2-24"	A0A0C4DH68	2	89176328-89177160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 272.7;lymphoid tissue: 474.9;urinary bladder: 935.2"	"Cell type enriched"	"Detected in some"	252	"Plasma cells: 5620.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"memory B-cell: 48.1"	"Lineage enriched"	"Detected in single"	482	"B-cells: 48.1"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.3"														"Immunoglobulin genes"	NA	NA		840000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.74e-6)"	"unprognostic (4.92e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	13.7	14.6	0.1	65.8	0.1	27.4	91.8	0.0	0.6	11.5	0.4	272.7	250.8	3.2	1.1	82.0	6.6	24.1	14.7	0.2	1.0	7.8	8.6	30.0	131.7	0.6	0.1	6.3	5.6	0.2	0.9	0.2	0.9	5.4	180.6	0.0	219.3	3.3	0.3	3.3	98.5	7.9	1.1	474.9	106.8	1.2	0.2	23.7	11.1	0.0	235.6	935.2	14.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.6	0.2	1.0	0.6	0.1	0.9	1.1	0.2	0.3	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5620.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGKV2-28		ENSG00000244116	"Immunoglobulin kappa variable 2-28"	A0A075B6P5	2	89221698-89222461	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1044.6;lymphoid tissue: 1735.3"	"Cell type enriched"	"Detected in some"	92	"Plasma cells: 1868.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 11.1"	"Lineage enriched"	"Detected in single"	13	"B-cells: 11.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;Daudi: 2.8;HL-60: 3.6;K-562: 2.0;NB-4: 2.7;RPMI-8226: 4.5;SCLC-21H: 2.1;SH-SY5Y: 1.7"														"Immunoglobulin genes"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.03e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.34e-1)"			"prognostic favorable (3.32e-4)"		"unprognostic (2.12e-2)"		"unprognostic (6.32e-3)"	"unprognostic (3.14e-1)"			"unprognostic (3.71e-2)"	"unprognostic (5.21e-2)"		"unprognostic (2.64e-2)"	36.2	40.2	0.2	402.4	0.2	180.2	425.2	0.1	1.1	56.6	0.9	1044.6	756.7	38.2	4.9	662.7	29.0	130.8	22.3	0.1	0.3	46.2	40.2	157.6	584.6	0.6	0.9	87.9	19.5	3.8	3.3	0.5	0.3	21.1	709.6	0.1	732.4	95.0	1.8	7.1	425.6	23.9	0.8	1207.7	530.0	161.9	0.2	167.6	84.8	0.0	1735.3	494.1	30.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	1.1	4.5	0.0	0.4	2.1	1.7	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	11.1	0.2	0.1	0.8	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.1	1.1	0.1	0.3	0.6	0.9	0.3	0.8	0.2	0.9	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1868.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0
IGKV2-30		ENSG00000243238	"Immunoglobulin kappa variable 2-30"	P06310	2	89244781-89245596	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 631.0;lymphoid tissue: 670.2;stomach 1: 323.1"	"Cell type enriched"	"Detected in some"	365	"Plasma cells: 25365.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	316	"memory B-cell: 561.0;naive B-cell: 325.4"	"Lineage enriched"	"Detected in many"	400	"B-cells: 561.0"	"Cell line enriched"	"Detected in some"	388	"U-698: 8426.0"														"Immunoglobulin genes"	NA	NA		6800000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.84e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-1)"		"prognostic favorable (6.78e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.53e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.50e-1)"	15.0	9.4	0.1	160.7	0.2	75.9	237.0	0.1	1.3	19.6	0.7	631.0	394.3	5.6	0.8	37.8	11.5	35.0	17.9	0.1	0.1	15.1	29.6	67.3	176.7	1.4	0.1	15.8	7.8	0.1	2.3	0.2	0.2	7.8	324.5	0.0	220.5	23.3	0.6	2.0	260.2	19.1	0.6	670.2	323.1	21.2	0.1	40.9	18.8	0.0	600.3	207.5	21.5	1.1	5.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	13.1	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.3	0.0	0.0	0.1	2.7	1.9	0.0	0.4	0.0	0.9	3.8	0.0	2.6	0.0	0.0	5.6	0.0	0.0	21.7	0.1	2.6	0.3	1.7	8426.0	0.0	2.7	0.0	0.5	0.4	0.2	0.2	0.0	0.2	561.0	0.1	0.2	0.4	325.4	0.0	0.2	1.4	0.2	0.3	0.7	0.3	53.3	0.1	0.2	0.1	1.3	0.1	0.1	1.4	0.1	0.2	0.6	0.1	1.1	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	30.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25365.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.3	0.0
IGKV2D-28		ENSG00000242534	"Immunoglobulin kappa variable 2D-28"	P01615	2	89959979-89960754	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 221.6;lymphoid tissue: 462.7;salivary gland: 259.7"	"Cell type enriched"	"Detected in some"	98	"Plasma cells: 4332.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	224	"memory B-cell: 3054.0;naive B-cell: 2203.9"	"Lineage enriched"	"Detected in all"	260	"B-cells: 3054.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.0;RPMI-8226: 2.0;SCLC-21H: 1.9;SH-SY5Y: 4.3;U-698: 4.4"														"Immunoglobulin genes"	NA	NA		3500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.88e-3)"	"unprognostic (2.68e-2)"				"unprognostic (2.51e-3)"		"unprognostic (1.22e-1)"		"unprognostic (1.13e-1)"	"unprognostic (4.17e-1)"			"unprognostic (1.13e-1)"	"unprognostic (2.66e-1)"			9.9	4.8	0.1	162.1	0.2	23.3	35.2	0.0	1.5	7.6	0.3	203.7	221.6	8.3	1.2	113.5	14.0	26.1	4.8	0.3	0.4	11.5	13.3	40.6	166.6	0.7	0.2	2.8	1.9	0.1	0.9	0.4	0.4	11.1	65.9	0.0	259.7	19.2	0.3	1.4	143.3	8.7	0.2	462.7	186.4	5.7	0.2	40.9	37.8	0.3	192.0	157.9	8.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.1	0.0	0.0	0.0	5.0	0.0	1.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.1	0.0	0.0	0.7	0.0	2.0	0.0	0.0	1.9	4.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.6	1.3	0.0	4.4	0.0	1.1	0.0	11.7	7.8	1.2	1.2	0.5	1.3	3054.0	1.3	0.9	2.0	2203.9	0.2	0.9	2.2	1.0	1.5	1.4	1.3	248.7	0.1	0.2	0.0	1.5	0.3	0.4	0.7	0.2	0.4	0.2	0.2	0.3	0.0	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4332.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	31.5	0.0	0.1	0.0
IGKV2D-29		ENSG00000243264	"Immunoglobulin kappa variable 2D-29"	A0A075B6S2	2	89947512-89948279	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 252.2;lymphoid tissue: 464.7"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 184.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Group enriched"	"Detected in some"	253	"memory B-cell: 360.5;naive B-cell: 489.4"	"Lineage enriched"	"Detected in many"	292	"B-cells: 489.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.5;HDLM-2: 1.2;TIME: 2.1;U-698: 2.2"														"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.31e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.76e-2)"		"prognostic favorable (8.34e-4)"	"unprognostic (4.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.80e-2)"	11.3	1.0	0.0	73.7	0.1	29.4	49.4	0.1	1.3	12.6	0.8	252.2	97.0	3.9	0.0	9.5	6.5	14.2	3.8	0.1	0.2	3.6	8.4	41.4	139.4	0.3	0.0	9.8	2.8	0.2	0.3	0.0	0.2	3.6	110.9	0.0	106.8	10.3	0.4	3.0	67.9	2.9	0.4	170.2	126.0	1.0	0.1	38.0	7.8	0.0	464.7	35.1	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.2	0.1	0.0	2.2	0.0	0.1	0.0	0.3	0.4	0.2	0.1	0.0	0.2	360.5	0.2	0.1	0.6	489.4	0.0	0.1	1.6	0.2	0.4	0.2	0.2	42.2	0.0	0.1	0.1	1.3	0.1	0.2	0.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0
IGKV3-11		ENSG00000241351	"Immunoglobulin kappa variable 3-11"	P04433	2	89027171-89027731	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1373.3;lymphoid tissue: 2812.9;urinary bladder: 1822.6"	"Cell type enriched"	"Detected in some"	129	"Plasma cells: 27475.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"spinal cord: 19.8"	"Group enriched"	"Detected in many"	292	"memory B-cell: 1729.8;naive B-cell: 1401.2"	"Lineage enriched"	"Detected in many"	323	"B-cells: 1729.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;Daudi: 2.0;SCLC-21H: 3.7;SH-SY5Y: 4.6"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		18000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"unprognostic (3.97e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	45.8	60.5	0.4	733.2	0.3	189.1	385.3	0.2	2.1	136.2	0.6	1373.3	701.6	32.1	11.5	143.5	34.0	253.5	18.9	0.2	0.6	44.4	55.2	227.4	575.7	0.6	0.7	120.8	13.7	1.9	3.2	0.9	0.9	30.1	1090.9	0.1	496.0	60.9	1.2	14.2	536.0	59.5	19.8	1100.0	788.6	22.2	0.3	261.9	88.8	0.9	2812.9	1822.6	33.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.4	1.8	1.5	0.0	0.0	3.7	4.6	0.4	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.7	0.7	0.6	1.8	0.3	0.1	0.0	1.4	0.0	1.9	1.3	1.2	2.0	0.2	0.7	1729.8	0.8	0.6	1.6	1401.2	0.8	0.8	5.3	0.9	1.1	1.2	1.3	186.7	0.4	0.3	0.2	2.1	0.2	0.6	0.6	0.7	0.9	19.8	0.3	1.0	0.0	0.0	0.5	0.0	211.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	82.6	0.0	0.0	0.0	2.5	1.9	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27475.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	62.0	0.0	0.3	0.0
IGKV3-15		ENSG00000244437	"Immunoglobulin kappa variable 3-15"	P01624	2	89085177-89085787	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 785.8;lymphoid tissue: 1996.3;urinary bladder: 784.8"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 22923.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	561	"memory B-cell: 2243.8;naive B-cell: 1651.4"	"Lineage enriched"	"Detected in all"	646	"B-cells: 2243.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;K-562: 1.3;NB-4: 1.9;RH-30: 1.2;RPMI-8226: 2.2;SCLC-21H: 1.4;SH-SY5Y: 2.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		7200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.57e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.02e-3)"	"unprognostic (3.89e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.06e-3)"	"unprognostic (5.36e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.15e-7)"	"unprognostic (2.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.17e-1)"	47.9	114.5	0.0	603.8	0.1	131.0	174.3	0.0	1.5	141.8	0.3	785.8	431.4	19.4	34.7	120.0	30.0	144.4	14.8	0.1	0.3	35.2	36.7	184.8	500.9	0.7	0.3	55.4	9.3	2.5	3.0	0.5	0.3	18.3	649.4	0.0	399.3	114.2	1.0	2.7	335.8	29.5	1.5	1020.7	629.8	64.8	0.2	250.2	77.7	0.0	1996.3	784.8	28.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	1.9	0.6	0.0	0.0	0.0	1.2	2.2	0.0	0.0	1.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.4	0.7	0.5	0.0	0.0	0.0	1.0	0.0	1.8	3.4	0.8	1.0	0.4	0.8	2243.8	1.0	1.1	1.8	1651.4	1.0	1.1	1.9	1.0	1.3	1.7	1.5	193.1	0.0	0.1	0.0	1.5	0.1	0.3	0.7	0.3	0.3	1.5	0.2	1.0	0.0	0.0	0.0	0.0	269.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.6	73.4	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22923.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	252.5	0.0	0.0	0.2	0.0	0.0	28.2	0.0	0.0	0.0
IGKV3-20		ENSG00000239951	"Immunoglobulin kappa variable 3-20"	P01619	2	89142574-89143160	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3080.6;lymphoid tissue: 5246.5"	"Cell type enriched"	"Detected in some"	138	"Plasma cells: 52154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	329	"memory B-cell: 1602.7;naive B-cell: 1222.4"	"Lineage enriched"	"Detected in many"	373	"B-cells: 1602.7"	"Group enriched"	"Detected in many"	215	"U-266/70: 3769.9;U-266/84: 1732.3"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		20000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.86e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (7.35e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.70e-2)"	104.8	56.4	0.9	1791.2	0.9	380.3	736.4	0.5	4.2	326.9	2.6	3080.6	1714.2	59.0	7.8	302.1	105.2	637.2	55.7	0.5	1.6	106.2	113.5	454.0	2815.6	2.1	8.4	153.5	32.8	5.8	9.6	1.8	1.4	56.1	2731.8	0.2	1270.5	224.5	3.3	13.4	1355.8	82.8	10.4	2699.1	1412.9	24.7	1.2	671.5	224.3	1.8	5246.5	1644.0	70.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.5	0.0	2.1	0.0	0.0	0.0	6.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	2.0	5.9	2.8	0.0	0.0	3.0	6.0	10.4	0.0	0.0	7.7	12.8	1.4	0.0	0.1	0.0	0.0	0.8	4.4	0.0	2.0	1.5	4.3	3769.9	1732.3	1.8	0.0	2.3	0.0	4.0	1.2	0.7	0.7	0.4	0.8	1602.7	0.8	0.6	3.5	1222.4	0.4	0.7	4.2	0.8	1.0	0.9	0.8	196.9	0.9	0.9	0.5	4.2	0.5	1.6	2.1	8.4	1.4	10.4	1.2	1.5	0.1	3.2	1.3	0.0	376.9	0.0	0.0	0.0	5.2	0.0	0.1	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.4	0.0	0.0	0.0	55.3	124.4	0.0	1.3	0.0	3.6	5.0	0.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	52154.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	0.0	0.0	26.7	0.0	0.2	0.0
IGKV3-7		ENSG00000243063	"Immunoglobulin kappa variable 3-7 (non-functional)"	A0A075B6H7	2	88978468-88979081	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.6;lymphoid tissue: 22.2;salivary gland: 15.9;stomach 1: 10.2"	"Group enriched"	"Detected in some"	37	"B-cells: 1.5;Plasma cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	61	"memory B-cell: 27.8;naive B-cell: 24.3"	"Lineage enriched"	"Detected in single"	65	"B-cells: 27.8"	"Not detected"	"Not detected"											HPA047702	Approved				"Immunoglobulin genes"	NA	NA		850000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (1.17e-4)"	"unprognostic (3.07e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.28e-2)"		"unprognostic (1.20e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-2)"	0.3	0.4	0.0	15.0	0.0	4.2	3.9	0.0	0.0	2.1	0.0	18.6	15.1	0.3	0.1	1.5	0.1	1.3	0.0	0.0	0.0	0.2	0.5	1.8	2.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	13.6	0.0	15.9	0.1	0.0	0.0	11.2	0.7	0.0	4.9	10.2	0.0	0.0	1.4	0.1	0.0	22.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	24.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGKV3D-11		ENSG00000211632	"Immunoglobulin kappa variable 3D-11"	A0A0A0MRZ8	2	90172802-90173414	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.6;lymphoid tissue: 58.5;stomach 1: 27.7"	"Cell type enriched"	"Detected in some"	34	"Plasma cells: 196.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	468	"memory B-cell: 152.5;naive B-cell: 146.1"	"Lineage enriched"	"Detected in single"	478	"B-cells: 152.5"	"Cell line enhanced"	"Detected in single"		"U-266/70: 2.1"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		6700000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.40e-5)"	"unprognostic (7.90e-3)"	"unprognostic (1.91e-2)"	"unprognostic (2.24e-3)"		"prognostic favorable (5.58e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.24e-2)"	1.3	0.7	0.3	35.9	0.2	8.9	6.4	0.0	0.1	1.7	0.0	38.6	32.2	0.8	0.0	2.4	2.1	2.7	0.5	0.0	0.1	2.1	1.3	12.4	13.0	0.1	0.3	1.5	0.5	0.0	0.1	0.0	0.1	0.7	26.6	0.0	18.8	0.3	0.0	0.1	23.6	0.7	0.2	29.9	27.7	0.2	0.0	4.2	2.3	0.0	58.5	17.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.8	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	152.5	0.0	0.0	0.1	146.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	30.2	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0
IGKV3D-20		ENSG00000211625	"Immunoglobulin kappa variable 3D-20"	A0A0C4DH25	2	90038848-90039479	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 131.8;lymphoid tissue: 275.4"	"Cell type enriched"	"Detected in some"	38	"Plasma cells: 289.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	1042	"memory B-cell: 197.3;naive B-cell: 99.0"	"Lineage enriched"	"Detected in single"	1388	"B-cells: 197.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 19.5"									HPA047702	Approved				"Immunoglobulin genes"	NA	NA		11000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA047702: "	"prognostic favorable (6.82e-4)"	"unprognostic (4.70e-3)"	"unprognostic (3.16e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (7.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	4.0	6.3	0.0	81.2	0.0	16.0	32.4	0.0	0.6	12.2	0.1	131.8	55.9	2.7	0.0	15.3	4.2	16.2	6.4	0.0	0.1	3.0	6.4	20.6	73.5	0.2	0.1	7.1	3.3	0.0	0.3	0.1	0.1	3.7	88.1	0.0	64.0	3.3	0.1	2.6	77.7	6.0	0.3	88.4	82.5	1.2	0.0	16.2	5.2	0.0	275.4	38.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.5	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	197.3	0.0	0.1	0.1	99.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	289.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
IGKV4-1	"B3, IGKV41"	ENSG00000211598	"Immunoglobulin kappa variable 4-1"	P06312	2	88885397-88886153	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1805.7;lymphoid tissue: 3169.0"	"Cell type enriched"	"Detected in some"	219	"Plasma cells: 46306.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	588	"memory B-cell: 3036.3;naive B-cell: 3070.9"	"Lineage enriched"	"Detected in all"	591	"B-cells: 3070.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;RPMI-8226: 10.4;SH-SY5Y: 6.9;U-266/70: 7.5"														"Immunoglobulin genes"	NA	NA		8500000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (6.41e-5)"	"unprognostic (9.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.42e-3)"	"unprognostic (2.08e-2)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.19e-1)"	55.9	296.3	0.4	1054.1	0.9	342.1	665.2	0.4	3.4	145.2	2.4	1805.7	1769.7	46.8	19.4	195.7	41.3	188.2	51.9	0.4	1.2	35.0	76.1	302.3	816.8	1.9	0.8	86.5	28.3	2.5	2.8	1.0	3.5	43.9	1318.2	0.1	701.8	89.6	1.0	8.6	1023.0	66.4	3.6	972.3	1125.7	125.7	0.7	405.1	51.0	0.1	3169.0	758.2	19.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.6	3.6	0.3	0.0	0.0	1.4	2.2	10.4	0.0	0.0	4.0	6.9	2.3	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.8	1.1	1.0	7.5	0.2	0.8	0.0	1.2	0.0	3.9	3.2	5.1	1.6	0.9	1.7	3036.3	1.9	1.1	2.8	3070.9	2.1	1.3	2.4	1.6	2.4	2.3	1.7	344.9	0.4	0.9	0.4	3.4	0.4	1.2	1.9	0.8	3.5	3.6	0.7	1.5	0.0	0.0	0.0	0.0	210.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.0	0.0	0.0	0.0	17.0	40.2	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46306.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	15.7	0.0	0.1	0.0
IGKV6-21	"A26, IGKV621"	ENSG00000211611	"Immunoglobulin kappa variable 6-21 (non-functional)"	A0A0C4DH24	2	89159751-89160366	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.3;lymphoid tissue: 141.0"	"Cell type enriched"	"Detected in some"	142	"Plasma cells: 1715.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	194	"memory B-cell: 28.8;naive B-cell: 9.8"	"Lineage enriched"	"Detected in single"	289	"B-cells: 28.8"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 10.5"														"Immunoglobulin genes"	NA	NA		250000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.82e-4)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.32e-2)"		"unprognostic (1.51e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.32e-2)"		"unprognostic (4.74e-2)"	"unprognostic (8.91e-2)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	2.2	0.4	0.0	41.6	0.0	12.0	37.4	0.0	0.1	3.3	0.0	97.3	38.8	1.8	0.6	8.4	1.9	5.9	0.5	0.0	0.0	2.7	2.6	11.9	64.4	0.2	0.0	2.1	0.8	0.0	0.1	0.0	0.0	1.5	79.3	0.0	43.5	9.0	0.0	0.5	38.5	5.0	0.1	63.8	36.3	0.9	0.0	10.2	3.5	0.0	141.0	37.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1715.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
IGKV6D-21	"A10, IGKV6D21"	ENSG00000225523	"Immunoglobulin kappa variable 6D-21 (non-functional)"	A0A0A0MT36	2	90021567-90022185	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"intestine: 67.0;lymphoid tissue: 152.7;urinary bladder: 227.3"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 234.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	154	"memory B-cell: 14.2;naive B-cell: 16.5"	"Lineage enriched"	"Detected in single"	166	"B-cells: 16.5"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.95e-4)"	"unprognostic (5.47e-3)"	"unprognostic (2.85e-3)"			"prognostic favorable (5.25e-5)"		"unprognostic (1.51e-1)"		"unprognostic (1.86e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.07e-1)"	1.1	0.4	0.0	17.2	0.0	17.2	11.8	0.0	0.1	5.4	0.0	67.0	38.8	1.6	0.0	22.1	0.8	2.7	2.1	0.2	0.0	1.6	2.4	6.3	19.8	0.6	0.0	1.1	1.1	0.0	0.0	0.0	0.1	0.8	31.8	0.0	21.1	17.3	0.0	1.2	37.8	1.0	0.0	45.3	13.4	3.4	0.0	9.1	1.4	0.0	152.7	227.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	234.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLC1	IGLC	ENSG00000211675	"Immunoglobulin lambda constant 1"		22	22895375-22895834	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 3264.2;lymphoid tissue: 5586.9;stomach 1: 2335.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 37.3;granulocytes: 15.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	743	"memory B-cell: 5729.2;naive B-cell: 5821.4"	"Lineage enriched"	"Detected in all"	749	"B-cells: 5821.4"	"Cell line enriched"	"Detected in many"	5	"U-266/70: 600.3"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"																					132.3	163.1	2.2	1208.8	1.9	641.9	903.4	1.7	7.0	190.8	4.4	3038.0	3264.2	63.1	2.1	535.0	113.2	640.0	104.5	1.7	2.2	148.2	114.7	470.6	2372.4	3.9	1.7	135.6	69.8	8.0	13.2	1.9	2.2	71.5	2133.6	0.7	2047.0	124.0	4.9	28.8	1389.9	78.0	2.6	3332.0	2335.3	23.7	2.3	873.2	224.5	0.0	5586.9	1948.8	79.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	1.0	0.0	1.9	0.2	0.0	0.0	6.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	9.1	0.0	0.0	1.1	10.2	2.0	0.0	0.0	2.3	8.9	33.4	0.0	0.0	6.3	11.1	1.4	0.0	0.0	0.0	0.0	0.3	2.5	0.0	1.3	4.3	2.6	600.3	119.9	36.5	0.0	3.5	0.0	4.2	7.7	2.0	3.7	1.7	2.9	5729.2	3.8	2.5	6.0	5821.4	0.9	2.2	7.6	2.8	4.8	5.2	3.4	897.2	2.2	1.9	1.7	7.0	1.7	2.2	3.9	1.7	2.2	2.6	2.3	3.4	0.0	6.4	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0
IGLC2	IGLC	ENSG00000211677	"Immunoglobulin lambda constant 2"	P0DOY2	22	22900976-22901437	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9734.6;lymphoid tissue: 19988.7;stomach 1: 10849.9"	"Group enriched"	"Detected in many"	40	"B-cells: 24632.2;Plasma cells: 18795.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	36	"memory B-cell: 11361.1;naive B-cell: 10650.3"	"Lineage enriched"	"Detected in all"	37	"B-cells: 11361.1"	"Group enriched"	"Detected in many"	190	"RPMI-8226: 62032.1;U-266/70: 102644.1;U-266/84: 83511.6"														"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.76e-5)"	"unprognostic (2.29e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.02e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.96e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (4.47e-9)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	386.6	782.7	7.7	3871.2	6.2	2741.4	2183.6	4.6	14.9	815.5	11.4	8217.0	9734.6	194.3	207.0	1690.0	231.5	2091.8	318.3	4.6	5.7	301.6	382.3	1442.8	5543.4	11.1	5.0	540.2	112.7	16.8	31.0	7.5	6.6	264.0	5055.4	0.7	5934.2	384.9	8.6	74.2	5290.6	306.2	6.6	7090.0	10849.9	256.0	5.4	2071.4	491.7	0.6	19988.7	6482.1	176.7	10.7	120.6	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	221.4	12.0	0.0	0.0	61.9	0.0	0.0	0.0	30.5	0.0	7.7	0.0	0.0	0.0	19.2	343.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	64.7	0.0	0.0	70.1	27.7	52.3	0.0	0.0	45.3	436.2	62032.1	0.0	0.0	46.7	45.7	5.6	43.0	17.3	0.0	17.7	57.2	11.7	0.0	38.9	23.4	78.2	102644.1	83511.6	298.8	0.7	21.9	0.7	9.9	18.6	5.6	5.8	3.0	5.7	11361.1	5.8	4.5	10.9	10650.3	3.5	4.7	118.0	5.8	8.7	303.3	6.5	2385.6	7.7	6.2	4.6	14.9	4.6	5.7	11.1	5.0	6.6	6.6	5.4	10.7	4.1	32.1	121.0	0.0	24632.2	0.0	0.3	0.0	1.2	0.0	16.1	3.0	3.9	44.3	8.1	0.0	0.0	0.3	8.0	28.0	0.0	0.0	0.0	0.0	0.1	86.3	62.5	222.4	0.0	0.0	0.3	42.5	14.8	0.0	65.6	0.0	222.8	539.9	2.1	0.0	0.0	21.5	0.0	134.5	0.0	0.0	0.0	8.5	0.0	0.0	11.4	0.0	15.5	0.0	0.0	0.0	20.6	0.0	18795.5	0.0	0.0	1.4	1.5	0.0	0.0	0.2	10.2	0.0	0.0	2.8	0.0	0.1	538.6	0.0	23.7	0.0
IGLC3	IGLC	ENSG00000211679	"Immunoglobulin lambda constant 3 (Kern-Oz+ marker)"	P0DOY3	22	22906342-22906803	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 4115.7;lymphoid tissue: 8175.8;stomach 1: 4130.0;urinary bladder: 3726.3"	"Group enriched"	"Detected in many"	35	"B-cells: 12202.8;Plasma cells: 5357.3;T-cells: 3582.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	34	"memory B-cell: 7254.6;naive B-cell: 6119.2"	"Lineage enriched"	"Detected in all"	37	"B-cells: 7254.6"	"Cell line enriched"	"Detected in many"	15	"RPMI-8226: 10741.3"									"CAB000050, CAB016533"	Supported				"Immunoglobulin genes"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB000050: , CAB016533: AB_629719"	"prognostic favorable (2.32e-4)"	"unprognostic (1.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.54e-2)"	"unprognostic (8.41e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.45e-2)"	"unprognostic (4.59e-2)"	"unprognostic (8.77e-2)"	"prognostic favorable (4.58e-4)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (1.04e-9)"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.97e-2)"	156.2	550.9	2.6	2377.2	2.7	840.6	1388.6	1.4	9.1	220.4	7.1	4115.7	4046.3	115.2	33.2	508.5	88.0	707.7	63.7	1.3	2.8	178.6	171.7	1081.6	2745.8	7.2	1.4	247.8	47.6	7.0	19.0	3.2	2.0	134.0	2268.4	0.3	2264.0	177.1	5.8	20.7	2373.2	113.9	3.4	4261.5	4130.0	55.4	2.1	426.9	232.0	0.9	8175.8	3726.3	111.5	6.4	0.6	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	60.1	0.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	18.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	338.0	0.0	0.0	10.8	15.0	2.8	0.0	0.0	700.2	9.3	10741.3	0.0	0.0	16.6	25.1	4.4	20.8	0.0	0.0	4.9	0.8	11.1	0.0	6.3	7.2	5.0	88.0	103.4	36.1	1.2	5.3	0.5	6.4	9.1	3.9	6.0	2.0	27.3	7254.6	5.1	3.6	6.9	6119.2	2.6	3.3	60.7	4.3	4.6	195.3	4.7	1415.5	2.6	2.7	1.4	9.1	1.3	2.8	7.2	1.4	2.0	3.4	2.1	6.4	2.0	22.4	97.3	0.0	12202.8	0.0	0.7	0.0	0.0	0.0	5.4	0.5	15.3	8.6	3.7	0.0	0.0	0.2	8.8	5.0	0.0	0.0	0.0	0.0	0.1	7.4	12.2	54.8	0.0	0.0	0.0	22.1	5.6	0.1	47.9	0.0	195.9	127.7	0.2	0.0	0.0	3.5	0.0	23.1	0.0	0.0	0.0	5.6	0.0	0.0	2.0	0.0	2.1	0.0	0.0	0.0	3.1	0.0	5357.3	0.2	0.0	1.1	2.2	0.0	0.0	0.0	4.2	0.0	0.0	0.8	0.0	0.1	3582.0	0.0	6.3	0.9
IGLC7		ENSG00000211685	"Immunoglobulin lambda constant 7"		22	22922594-22923034	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 88.1;lymphoid tissue: 107.7;salivary gland: 70.1;stomach 1: 113.1"	"Cell type enriched"	"Detected in some"	10	"B-cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	341	"memory B-cell: 128.8;naive B-cell: 133.0"	"Lineage enriched"	"Detected in single"	346	"B-cells: 133.0"	"Cell line enriched"	"Detected in some"	913	"Karpas-707: 122629.0"														"Immunoglobulin genes"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.20e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.16e-2)"		"prognostic favorable (2.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (9.60e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (2.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-2)"	5.6	4.7	0.0	27.9	0.0	19.9	15.6	0.0	0.4	5.1	0.0	54.1	88.1	4.4	0.5	8.4	4.3	10.7	1.4	0.0	0.5	2.3	3.5	8.3	40.8	0.3	0.0	2.5	1.7	0.1	0.2	0.0	0.2	4.4	23.1	0.0	70.1	0.6	0.1	0.2	23.1	0.9	0.0	107.7	113.1	0.8	0.1	20.0	5.7	0.0	104.2	19.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	112.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122629.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	134.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.7	3.0	0.6	111.2	0.0	47.3	0.3	0.1	0.0	0.0	0.1	0.0	128.8	0.0	0.0	0.1	133.0	0.0	0.2	0.1	0.0	0.1	0.3	0.1	25.5	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.4	3.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0
IGLJ1		ENSG00000211674	"Immunoglobulin lambda joining 1"	A0A0A0MT76	22	22893692-22893818	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"intestine: 95.1;lymphoid tissue: 50.0;salivary gland: 32.5;stomach 1: 40.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 19.6;naive B-cell: 11.0"	"Lineage enriched"	"Detected in single"	31	"B-cells: 19.6"	"Group enriched"	"Detected in some"	6	"Daudi: 274.6;U-266/70: 310.0;U-698: 88.7"														"Immunoglobulin genes"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"					"unprognostic (4.18e-4)"							"unprognostic (4.80e-3)"						"unprognostic (6.97e-2)"	"unprognostic (4.68e-1)"			2.3	0.6	0.1	43.3	0.1	9.8	1.8	0.2	0.6	0.0	0.4	17.1	95.1	0.8	0.0	2.0	0.4	5.1	0.2	0.0	0.1	0.2	0.1	2.7	50.0	0.5	0.1	0.5	0.0	0.0	0.0	0.2	0.3	0.6	13.5	0.0	32.5	0.0	0.0	0.0	43.4	2.6	0.2	31.5	40.8	1.3	0.2	5.2	0.0	0.0	34.5	4.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	274.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	310.0	37.0	88.7	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	19.6	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.1	0.1	0.2	0.6	0.0	0.1	0.5	0.1	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLJ2		ENSG00000211676	"Immunoglobulin lambda joining 2"		22	22899481-22899655	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 260.8;lymphoid tissue: 189.8;stomach 1: 212.7"	"Cell type enriched"	"Detected in single"	5	"Plasma cells: 1.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.9;endometrial cancer: 21.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"memory B-cell: 876.1;naive B-cell: 864.5"	"Lineage enriched"	"Detected in many"	12	"B-cells: 876.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.8;HMC-1: 34.1;RH-30: 89.7;U-698: 19.8"															NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (6.99e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.13e-2)"		"unprognostic (5.94e-7)"		"unprognostic (1.51e-2)"			"unprognostic (3.63e-2)"			"unprognostic (3.66e-2)"	"unprognostic (5.17e-2)"		"unprognostic (2.92e-1)"	8.4	54.9	0.2	173.0	0.0	25.4	11.2	0.1	0.8	6.1	0.1	134.5	260.8	2.9	4.2	13.5	1.0	12.5	2.9	0.1	0.2	2.1	6.9	21.5	94.5	0.3	0.0	4.7	5.9	0.1	0.0	0.0	0.9	4.0	31.1	0.0	75.6	4.2	0.0	0.2	206.0	1.9	0.1	128.3	212.7	2.3	0.0	15.5	0.3	0.0	189.8	60.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.7	89.7	1.3	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	0.0	0.6	19.8	0.0	0.5	0.0	1.4	1.9	0.6	0.4	0.2	0.7	876.1	0.3	0.3	0.9	864.5	0.2	0.4	9.3	0.7	0.8	71.8	0.5	136.5	0.2	0.0	0.1	0.8	0.1	0.2	0.3	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLJ3		ENSG00000211678	"Immunoglobulin lambda joining 3"		22	22904850-22905025	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"intestine: 552.2;lymphoid tissue: 227.6;salivary gland: 149.1;stomach 1: 462.5;urinary bladder: 147.8"	"Group enriched"	"Detected in some"	44	"B-cells: 4.5;Plasma cells: 4.3"	"Group enriched"	"Detected in some"	13	"colorectal cancer: 5.1;endometrial cancer: 10.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Group enriched"	"Detected in many"	24	"memory B-cell: 1223.9;naive B-cell: 1139.6"	"Lineage enriched"	"Detected in many"	25	"B-cells: 1223.9"	"Group enriched"	"Detected in some"	7	"Daudi: 53.6;REH: 69.6;U-266/70: 42.8;U-266/84: 22.5"															NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"						"unprognostic (1.19e-1)"	"unprognostic (2.06e-3)"				"unprognostic (2.05e-1)"						"unprognostic (1.37e-1)"	"unprognostic (5.00e-1)"			5.7	29.4	0.4	212.4	0.3	37.4	32.5	0.1	1.5	9.7	0.4	130.1	552.2	3.2	0.0	40.0	4.0	32.7	3.1	0.1	0.1	2.9	9.9	41.7	132.1	0.4	0.2	31.1	1.9	0.0	0.0	0.1	0.1	9.6	71.4	0.0	149.1	1.6	0.0	1.5	205.9	6.1	0.0	207.6	462.5	6.1	0.1	23.2	0.8	0.0	227.6	147.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	69.6	2.5	6.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	1.0	42.8	22.5	4.3	0.0	0.0	0.0	0.8	1.6	0.7	0.9	0.3	4.3	1223.9	0.8	0.5	1.3	1139.6	0.4	0.5	8.5	0.6	1.2	49.2	0.8	193.9	0.4	0.3	0.1	1.5	0.1	0.1	0.4	0.2	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGLON5	LOC402665	ENSG00000142549	"IgLON family member 5"	A6NGN9	19	51311848-51330354	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2;retina: 13.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Horizontal cells: 79.1;Inhibitory neurons: 17.6;Spermatogonia: 9.7"	"Group enriched"	"Detected in many"	5	"glioma: 9.2;ovarian cancer: 3.5;testis cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 35.0;NTERA-2: 16.0;SH-SY5Y: 23.0;SuSa: 9.9;U-2 OS: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041994	Approved				"Secreted in brain"	NA	NA		15000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA041994: AB_10794641"	"unprognostic (2.09e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.47e-4)"	"unprognostic (6.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (5.62e-7)"	"unprognostic (1.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.86e-3)"	1.7	1.7	11.5	0.2	9.0	0.7	0.9	23.4	21.6	0.5	1.1	0.6	0.1	0.1	0.7	4.2	0.1	0.2	0.3	11.7	17.1	0.4	1.9	0.2	0.0	47.2	19.1	1.2	0.2	1.8	1.2	0.4	44.9	0.2	0.0	13.9	0.7	0.7	0.0	0.6	0.3	0.1	16.5	0.1	0.2	8.0	22.2	0.0	0.2	0.0	0.0	0.4	1.2	10.8	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.4	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	16.0	0.2	0.0	0.0	0.0	3.5	0.0	0.1	0.1	23.0	0.0	0.0	0.0	9.9	0.2	2.2	0.0	0.0	6.4	0.1	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	9.0	23.4	21.6	11.7	17.1	47.2	19.1	44.9	16.5	22.2	10.8	2.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.8	0.1	0.3	79.1	17.6	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.7	0.0	2.5	0.0	5.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.9	0.9	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLV1-36		ENSG00000211655	"Immunoglobulin lambda variable 1-36"	A0A0B4J1U3	22	22431958-22432465	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 268.7;stomach 1: 122.4;urinary bladder: 86.4"	"Cell type enriched"	"Detected in some"	13	"Plasma cells: 59.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 33.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	625	"memory B-cell: 60.9;naive B-cell: 85.8"	"Lineage enriched"	"Detected in single"	731	"B-cells: 85.8"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		980000000	"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.55e-4)"	"unprognostic (5.15e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (2.60e-4)"		"unprognostic (1.11e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (2.99e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-1)"	1.8	0.3	0.0	19.6	0.0	14.4	23.7	0.0	0.1	6.0	0.0	28.2	21.6	0.7	0.6	10.5	9.1	7.3	6.0	0.0	0.0	3.3	3.3	8.7	16.6	0.0	0.0	1.7	1.1	0.0	0.1	0.0	0.0	1.6	44.7	0.0	37.3	3.0	0.0	0.6	12.3	0.8	0.0	108.1	122.4	0.3	0.0	30.5	2.8	0.0	268.7	86.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	60.9	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
IGLV1-40		ENSG00000211653	"Immunoglobulin lambda variable 1-40"	P01703	22	22409766-22410282	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1291.5;stomach 1: 1287.4"	"Cell type enriched"	"Detected in some"	358	"Plasma cells: 43406.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Group enriched"	"Detected in some"	496	"memory B-cell: 666.4;naive B-cell: 576.7"	"Lineage enriched"	"Detected in many"	532	"B-cells: 666.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.5;RPMI-8226: 2.2;SH-SY5Y: 3.4;TIME: 2.3"														"Immunoglobulin genes"	NA	NA		2300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.64e-3)"	"unprognostic (4.68e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.37e-3)"	"unprognostic (9.60e-3)"	"prognostic favorable (5.74e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.43e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	43.4	13.0	0.8	203.5	0.5	114.3	138.5	0.1	3.0	68.1	1.1	553.8	551.6	14.8	0.6	125.4	21.5	236.0	15.2	0.2	0.2	28.8	28.3	115.4	282.5	0.3	0.2	56.6	10.0	1.1	3.4	0.6	0.6	46.1	336.7	4.2	413.8	19.7	1.2	3.1	287.2	14.3	0.2	1029.8	1287.4	7.2	0.3	179.2	61.2	0.0	1291.5	464.8	19.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	1.0	1.1	0.0	0.0	0.2	0.8	2.2	0.0	0.0	1.3	3.4	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.4	0.7	0.7	1.1	1.1	0.8	0.0	0.3	0.0	0.4	0.7	0.2	0.3	0.1	0.6	666.4	0.3	0.3	0.6	576.7	0.1	0.2	1.2	0.3	0.3	0.6	0.4	53.7	0.8	0.5	0.1	3.0	0.2	0.2	0.3	0.2	0.6	0.2	0.3	1.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.2	8.0	0.0	0.0	0.0	28.6	64.2	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	43406.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	7.4	0.0	0.1	0.0
IGLV1-44		ENSG00000211651	"Immunoglobulin lambda variable 1-44"	P01699	22	22380766-22381347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 589.7;lymphoid tissue: 1918.7;stomach 1: 534.3"	"Cell type enriched"	"Detected in some"	108	"Plasma cells: 12023.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	840	"memory B-cell: 968.8;naive B-cell: 850.4"	"Lineage enriched"	"Detected in many"	894	"B-cells: 968.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;RPMI-8226: 5.5;SCLC-21H: 4.1;U-698: 15.2"														"Immunoglobulin genes"	NA	NA		4000000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.88e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.81e-3)"	"prognostic favorable (4.71e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.55e-8)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.48e-2)"	"unprognostic (5.49e-2)"	33.9	2.0	0.1	297.2	0.0	133.4	110.2	0.0	0.8	14.3	0.0	378.7	589.7	11.8	0.0	80.1	19.5	78.7	17.5	0.0	0.0	18.7	17.1	122.2	519.5	1.3	0.2	15.3	3.6	0.0	2.6	0.0	0.4	13.8	263.1	0.0	273.0	9.4	0.7	2.4	236.5	21.4	0.0	608.7	534.3	11.6	0.1	117.8	35.1	0.0	1918.7	240.5	16.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.5	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	968.8	0.0	0.0	0.7	850.4	0.0	0.0	0.0	0.0	0.1	1.0	0.1	100.0	0.1	0.0	0.0	0.8	0.0	0.0	1.3	0.2	0.4	0.0	0.1	0.8	0.0	0.0	0.6	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.7	0.0	0.0	0.0	3.5	48.4	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12023.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.3	0.0
IGLV1-47		ENSG00000211648	"Immunoglobulin lambda variable 1-47"	P01700	22	22357739-22358260	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 706.6;lymphoid tissue: 1804.0;stomach 1: 625.5"	"Cell type enriched"	"Detected in some"	114	"Plasma cells: 10777.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	638	"memory B-cell: 1518.1;naive B-cell: 819.6"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1518.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.1;RH-30: 2.1;RPMI-8226: 4.2;SCLC-21H: 2.7;SH-SY5Y: 2.4;U-698: 7.1"														"Immunoglobulin genes"	NA	NA		3000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (5.19e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.12e-8)"	"unprognostic (5.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.15e-2)"	36.0	216.0	0.6	323.0	0.4	162.3	200.5	0.4	2.3	82.1	0.7	706.6	704.7	23.8	3.0	163.7	21.3	112.7	27.2	0.2	0.5	23.2	31.8	126.7	689.2	2.6	0.4	43.5	8.9	4.9	2.1	0.5	1.2	22.5	531.5	0.2	526.6	70.2	0.7	4.7	332.8	34.7	0.5	813.7	625.5	9.8	0.4	260.1	34.1	0.0	1804.0	367.0	10.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.7	2.1	4.2	0.0	0.0	2.7	2.4	0.5	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.0	0.1	0.6	0.0	7.1	0.0	0.9	0.0	0.7	1.2	0.5	0.7	0.1	0.5	1518.1	0.7	0.6	1.0	819.6	0.3	0.6	0.6	0.5	0.5	1.8	0.6	159.6	0.6	0.4	0.4	2.3	0.2	0.5	2.6	0.4	1.2	0.5	0.4	2.4	0.0	0.0	0.0	0.0	94.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.7	29.0	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10777.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0
IGLV1-51		ENSG00000211644	"Immunoglobulin lambda variable 1-51"	P01701	22	22322472-22322969	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 1318.8;lymphoid tissue: 3027.3;urinary bladder: 1584.8"	"Cell type enriched"	"Detected in some"	312	"Plasma cells: 34336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 275.9;naive B-cell: 178.3"	"Lineage enriched"	"Detected in many"	10	"B-cells: 275.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.9"														"Immunoglobulin genes"	NA	NA		1700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.85e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.61e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (3.55e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.40e-5)"	"unprognostic (1.21e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.07e-1)"	43.5	318.8	1.1	484.8	1.9	274.1	627.0	4.6	7.1	73.2	2.0	1318.8	1139.1	38.0	16.9	287.4	52.8	238.0	70.2	1.4	1.6	32.7	53.3	179.1	343.1	4.0	1.4	185.0	39.0	5.8	4.1	1.5	4.2	34.4	930.0	3.1	695.2	49.5	1.9	13.1	702.1	49.8	1.9	934.5	956.7	11.7	1.5	274.0	63.0	1.7	3027.3	1584.8	17.7	2.7	1.3	0.6	1.6	3.8	3.5	1.7	5.9	1.4	3.2	3.1	2.0	2.3	1.0	8.8	1.6	0.8	1.1	3.1	1.9	3.8	2.2	1.4	17.9	3.9	4.5	2.4	0.7	3.4	1.7	5.2	1.0	2.7	0.3	0.4	3.1	0.9	3.9	0.9	3.0	1.6	2.6	3.8	3.0	2.8	4.1	2.3	2.7	8.8	3.6	1.4	8.3	4.9	2.0	1.4	1.8	0.9	2.7	0.3	4.3	4.4	9.2	1.0	1.2	2.0	2.0	2.0	0.4	2.8	0.8	0.1	0.5	0.0	0.2	0.2	26.3	275.9	0.2	0.3	0.1	178.3	0.7	0.5	0.4	0.1	0.3	0.2	0.2	26.4	1.1	1.9	4.6	7.1	1.4	1.6	4.0	1.4	4.2	1.9	1.5	2.7	0.0	0.0	0.5	0.0	109.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	4.8	35.7	0.1	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34336.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	19.3	0.0	0.0	9.4	0.0	0.0	0.0
IGLV2-11		ENSG00000211668	"Immunoglobulin lambda variable 2-11"	P01706	22	22792491-22793007	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1542.6;lymphoid tissue: 2926.9"	"Cell type enriched"	"Detected in some"	85	"Plasma cells: 7693.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	37	"memory B-cell: 1402.5;naive B-cell: 850.1"	"Lineage enriched"	"Detected in many"	46	"B-cells: 1402.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 75.0;U-266/70: 20.9;U-266/84: 15.3"														"Immunoglobulin genes"	NA	NA		980000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (9.76e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.46e-3)"	"unprognostic (7.67e-3)"	"unprognostic (2.82e-3)"	"prognostic favorable (4.74e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.38e-7)"	"unprognostic (3.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.27e-1)"	33.6	7.3	0.6	344.7	0.3	157.3	447.8	0.1	2.7	27.7	0.8	1455.8	1542.6	18.4	0.5	212.0	30.0	191.3	44.6	0.2	0.7	22.4	41.1	179.8	680.1	1.5	0.2	30.5	22.4	0.6	2.1	0.5	1.1	17.0	868.3	0.0	425.0	36.0	1.7	2.9	713.8	21.3	0.6	637.7	876.1	75.4	0.5	286.4	62.2	0.0	2926.9	661.1	14.8	2.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	75.0	0.0	0.0	0.9	4.6	1.1	0.0	0.0	0.8	2.8	8.3	0.0	0.0	2.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.1	0.3	1.6	20.9	15.3	0.0	0.3	1.1	0.0	1.2	1.0	0.7	11.5	0.2	1.4	1402.5	1.5	5.9	0.9	850.1	1.0	4.6	30.2	11.1	0.8	0.9	0.8	149.8	0.6	0.3	0.1	2.7	0.2	0.7	1.5	0.2	1.1	0.6	0.5	2.2	0.0	0.0	0.0	0.0	89.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	15.8	0.0	0.0	0.0	1.4	11.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7693.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
IGLV2-14		ENSG00000211666	"Immunoglobulin lambda variable 2-14"	P01704	22	22758700-22759218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2622.2;lymphoid tissue: 5374.9;stomach 1: 2530.1"	"Cell type enriched"	"Detected in some"	179	"Plasma cells: 58316.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	50	"memory B-cell: 3655.3;naive B-cell: 2657.4"	"Lineage enriched"	"Detected in all"	58	"B-cells: 3655.3"	"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 22672.4"														"Immunoglobulin genes"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.23e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.69e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.97e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.87e-2)"	83.9	192.1	0.8	754.9	1.7	357.8	749.8	0.5	6.4	119.7	3.8	2622.2	2470.7	47.8	20.7	245.2	49.0	442.1	45.2	0.6	1.0	54.3	102.1	399.3	3320.0	1.6	0.6	75.3	52.1	4.5	5.6	1.2	1.0	71.0	1074.1	0.1	797.3	119.4	2.7	21.3	1262.7	62.0	1.4	1580.6	2530.1	13.9	1.3	586.1	116.5	0.5	5374.9	1165.2	35.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4453.2	0.0	0.0	8.7	8.0	1.7	0.0	0.0	4.9	3.7	22672.4	0.0	0.0	11.8	11.1	0.4	17.3	0.0	0.0	7.1	0.0	5.1	0.0	4.1	5.7	1.1	20.4	37.7	1.4	12.1	1.7	5.0	3.9	5.3	1.7	47.1	1.0	28.8	3655.3	9.6	53.9	3.3	2657.4	1.4	12.7	11.6	62.5	2.4	2.2	2.1	451.3	0.8	1.7	0.5	6.4	0.6	1.0	1.6	0.6	1.0	1.4	1.3	2.1	0.0	0.0	0.0	0.0	324.1	0.0	0.0	0.0	1.2	0.0	0.3	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	14.7	0.0	0.0	0.0	9.9	121.8	0.0	0.0	0.0	1.4	1.7	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	58316.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	36.6	0.0	0.8	0.0
IGLV2-23		ENSG00000211660	"Immunoglobulin lambda variable 2-23"	P01705	22	22697789-22698407	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 691.1;lymphoid tissue: 1598.0;stomach 1: 672.8"	"Cell type enriched"	"Detected in some"	132	"Plasma cells: 12487.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	369	"memory B-cell: 2072.7;naive B-cell: 2596.0"	"Lineage enriched"	"Detected in all"	410	"B-cells: 2596.0"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 85411.7"														"Immunoglobulin genes"	NA	NA		540000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.43e-5)"	"unprognostic (7.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.50e-7)"	"unprognostic (8.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.42e-2)"	16.0	38.9	0.7	306.7	0.3	103.6	184.7	0.1	1.5	45.2	0.6	634.1	691.1	16.2	1.3	78.7	25.5	66.8	19.9	0.2	0.1	18.6	26.2	160.8	623.2	1.0	0.1	16.3	8.2	0.6	1.7	0.6	0.4	10.8	457.1	0.0	356.7	38.1	0.5	2.1	517.3	16.1	0.3	530.5	672.8	5.9	0.2	277.6	39.1	0.4	1598.0	274.5	11.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	65.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	82.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	85411.7	0.0	0.0	2.2	4.2	0.5	0.0	0.0	0.7	1.9	8843.9	0.0	0.0	2.1	4.5	0.0	4.7	0.0	0.0	1.9	0.0	1.0	0.0	1.1	3.4	0.7	213.9	81.1	0.5	92.6	0.2	35.5	1.8	3.1	1.0	1.6	0.9	1.3	2072.7	1.6	0.8	2.6	2596.0	0.6	0.9	6.3	1.6	1.7	0.9	1.3	231.7	0.7	0.3	0.1	1.5	0.2	0.1	1.0	0.1	0.4	0.3	0.2	0.3	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.7	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12487.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.5	0.0	0.2	0.0
IGLV2-8		ENSG00000278196	"Immunoglobulin lambda variable 2-8"	P01709	22	22822658-22823289	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1141.8;lymphoid tissue: 1012.4"	"Cell type enriched"	"Detected in some"	80	"Plasma cells: 5288.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	125	"memory B-cell: 1439.0;naive B-cell: 2097.3"	"Lineage enriched"	"Detected in all"	149	"B-cells: 2097.3"	"Group enriched"	"Detected in many"	617	"U-266/70: 64161.5;U-266/84: 56786.5"														"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (2.92e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.07e-5)"	"unprognostic (2.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.62e-1)"	18.7	7.0	1.1	325.0	0.6	96.0	155.2	0.3	2.4	26.0	1.7	1141.8	977.0	9.4	3.5	91.4	7.9	132.4	30.5	0.3	0.3	15.4	24.3	59.2	228.2	0.8	0.3	57.2	30.3	1.4	1.4	0.2	0.7	9.0	250.6	0.0	255.5	60.3	0.6	1.9	451.5	20.1	0.8	437.7	433.9	3.4	0.3	90.6	23.7	0.0	1012.4	259.0	10.3	1.0	62.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.6	0.0	0.0	23.1	0.0	0.0	0.0	22.3	0.0	0.5	0.0	0.0	0.0	0.7	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	0.0	0.0	11.3	1.9	14.8	0.0	0.0	97.9	0.9	10.1	0.0	0.0	1.4	2.8	0.2	0.0	9.3	0.0	0.0	29.5	0.9	0.0	9.8	0.6	38.9	64161.5	56786.5	20.4	0.0	10.1	0.0	1.2	2.4	0.6	2.1	0.7	0.9	1439.0	1.3	1.5	1.9	2097.3	0.4	1.0	14.1	1.3	1.4	0.6	0.7	174.0	1.1	0.6	0.3	2.4	0.3	0.3	0.8	0.3	0.7	0.8	0.3	1.0	0.0	3.2	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	2.5	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5288.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.2	0.0
IGLV3-1		ENSG00000211673	"Immunoglobulin lambda variable 3-1"	P01715	22	22880706-22881396	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1234.9;lymphoid tissue: 3325.7;stomach 1: 1460.4"	"Cell type enriched"	"Detected in some"	321	"Plasma cells: 56277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	725	"memory B-cell: 779.5;naive B-cell: 1038.5"	"Lineage enriched"	"Detected in many"	828	"B-cells: 1038.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;RPMI-8226: 4.5;SCLC-21H: 9.1;SH-SY5Y: 9.9"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		4300000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (9.70e-5)"	"unprognostic (9.06e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.13e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (9.06e-9)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	44.5	70.9	0.3	485.2	0.2	332.4	317.1	0.2	2.0	192.0	0.9	1234.9	643.4	39.2	0.0	217.7	19.2	310.4	28.1	0.1	0.4	26.3	70.1	176.2	1117.0	1.0	0.3	34.1	7.6	2.7	2.0	0.7	1.5	21.9	684.4	0.2	627.3	19.6	1.2	4.1	481.7	37.2	0.4	654.2	1460.4	56.0	0.3	335.5	35.9	0.0	3325.7	679.7	30.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.0	0.0	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	2.4	0.8	0.0	0.0	0.5	3.0	4.5	0.0	0.0	9.1	9.9	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	1.7	1.8	1.2	2.8	0.0	0.3	0.0	0.7	1.1	0.5	0.3	0.4	0.4	779.5	0.6	0.2	1.2	1038.5	0.2	0.3	0.6	0.4	0.8	0.5	0.5	52.3	0.3	0.2	0.2	2.0	0.1	0.4	1.0	0.3	1.5	0.4	0.3	0.9	0.0	3.2	0.0	0.0	111.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.5	0.0	0.0	0.0	0.0	0.0	10.7	174.8	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56277.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	11.7	0.0	0.2	0.0
IGLV3-10		ENSG00000211669	"Immunoglobulin lambda variable 3-10"	A0A075B6K4	22	22811747-22812281	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 317.0;lymphoid tissue: 707.7;stomach 1: 288.7"	"Cell type enriched"	"Detected in some"	52	"Plasma cells: 1090.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.3;medulla oblongata: 1.8"	"Group enriched"	"Detected in some"	786	"memory B-cell: 548.7;naive B-cell: 315.0"	"Lineage enriched"	"Detected in single"	998	"B-cells: 548.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;HL-60: 1.0;RH-30: 1.6"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		2000000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"unprognostic (6.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.99e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (7.40e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (9.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.04e-2)"	33.3	112.9	0.5	144.0	0.4	65.5	111.1	0.1	3.3	41.3	0.6	308.0	176.3	7.6	4.5	56.3	7.9	43.5	20.5	0.1	0.2	12.2	20.8	48.0	230.5	1.8	0.2	14.6	10.8	0.9	0.8	0.4	0.6	11.0	317.0	0.0	139.7	10.8	0.2	8.1	94.9	5.8	0.1	217.1	288.7	97.4	0.2	25.9	8.6	0.0	707.7	140.2	7.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.2	0.0	0.2	548.7	0.1	0.2	0.2	315.0	0.0	0.2	0.3	0.1	0.1	0.3	0.1	43.2	0.5	0.4	0.1	3.3	0.1	0.2	1.8	0.2	0.6	0.1	0.2	0.2	0.0	0.0	0.6	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1090.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0
IGLV3-19		ENSG00000211663	"Immunoglobulin lambda variable 3-19"	P01714	22	22720623-22721145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1026.7;lymphoid tissue: 1979.7;stomach 1: 1240.2"	"Cell type enriched"	"Detected in some"	61	"Plasma cells: 3121.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	355	"memory B-cell: 618.3;naive B-cell: 503.7"	"Lineage enriched"	"Detected in many"	391	"B-cells: 618.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.2;SCLC-21H: 9.4;SH-SY5Y: 10.7;U-251 MG: 4.2"														"Immunoglobulin genes"	NA	NA		1200000000	"Cluster 37: B-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (5.92e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.60e-3)"	"prognostic favorable (6.11e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.58e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (9.37e-10)"	"unprognostic (2.10e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.52e-2)"	49.1	20.1	0.1	402.2	0.3	185.1	313.5	0.1	2.4	69.2	0.3	1026.7	713.6	19.0	263.4	154.0	65.8	182.4	36.9	0.1	0.3	26.0	57.5	192.2	464.9	1.5	0.4	44.9	11.5	1.3	2.7	0.4	0.4	17.2	912.2	0.0	304.9	62.4	0.9	4.8	385.2	34.9	0.6	714.2	1240.2	6.0	0.4	435.0	55.4	0.0	1979.7	642.5	13.6	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	2.7	0.3	0.0	0.0	0.1	0.9	6.2	0.0	0.0	9.4	10.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	4.2	0.8	0.5	0.7	0.0	0.5	0.0	0.4	0.4	1.0	0.5	0.3	0.7	618.3	0.2	0.3	0.5	503.7	0.4	0.3	1.5	0.3	0.4	0.6	0.4	36.2	0.1	0.3	0.1	2.4	0.1	0.3	1.5	0.4	0.4	0.6	0.4	1.1	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.4	15.8	0.0	1.3	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0
IGLV3-21		ENSG00000211662	"Immunoglobulin lambda variable 3-21"	P80748	22	22711689-22713203	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1812.1;urinary bladder: 773.9"	"Cell type enriched"	"Detected in some"	59	"Plasma cells: 5013.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	339	"memory B-cell: 432.0;naive B-cell: 224.7"	"Lineage enriched"	"Detected in single"	445	"B-cells: 432.0"	"Cell line enriched"	"Detected in some"	103	"REH: 282.7"														"Immunoglobulin genes"	NA	NA		4700000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.75e-3)"	"unprognostic (6.04e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.06e-3)"	"prognostic favorable (3.26e-7)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (9.54e-8)"	"unprognostic (7.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.52e-2)"	17.6	63.4	0.3	321.9	0.2	248.2	120.7	0.1	1.6	110.0	1.6	357.4	350.4	12.9	0.5	63.1	10.2	120.4	10.8	0.1	0.2	21.5	36.4	108.6	272.7	1.0	0.1	35.6	5.7	0.7	1.4	0.4	0.4	16.8	230.8	0.0	260.8	20.2	0.5	2.3	150.7	9.0	0.3	421.0	504.5	14.4	0.3	171.6	19.9	0.0	1812.1	773.9	17.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.5	0.2	0.0	0.0	282.7	1.8	2.0	0.0	0.0	1.6	1.8	0.1	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.5	0.5	0.1	0.2	0.0	0.2	0.0	0.2	0.2	0.1	0.1	0.0	0.1	432.0	0.1	0.1	0.3	224.7	0.1	0.1	0.9	0.1	0.1	0.2	0.1	36.6	0.3	0.2	0.1	1.6	0.1	0.2	1.0	0.1	0.4	0.3	0.3	1.3	0.0	0.0	0.0	0.0	84.4	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	20.4	0.0	0.0	0.0	3.3	2.5	0.1	0.0	0.0	0.0	0.0	1.3	0.0	4.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5013.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.2	0.0	0.0	1.8	0.0	0.2	0.0
IGLV3-25		ENSG00000211659	"Immunoglobulin lambda variable 3-25"	P01717	22	22686726-22687271	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2440.7;stomach 1: 1015.7"	"Cell type enriched"	"Detected in some"	41	"Plasma cells: 17441.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	45	"memory B-cell: 545.0;naive B-cell: 794.2"	"Lineage enriched"	"Detected in many"	53	"B-cells: 794.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.6;RPMI-8226: 2.7;SCLC-21H: 4.6;SH-SY5Y: 5.1"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		3200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (5.55e-4)"	"unprognostic (8.28e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.43e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (3.78e-7)"	"unprognostic (1.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	56.8	163.2	0.2	293.2	0.2	243.2	430.9	0.1	1.7	151.9	1.3	847.4	338.9	20.8	2.1	161.5	49.8	177.1	29.8	0.2	0.3	17.1	45.7	870.5	1024.7	1.8	0.2	21.8	14.5	1.7	1.7	0.5	0.6	18.9	467.5	0.0	532.3	116.5	0.7	2.4	228.9	34.1	0.4	543.5	1015.7	59.8	0.5	155.9	23.1	0.0	2440.7	779.6	20.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.7	0.4	1.7	0.0	0.0	1.6	1.5	2.7	0.0	0.0	4.6	5.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.1	0.8	1.8	0.2	0.7	0.0	1.3	0.0	0.8	0.4	0.3	0.7	0.1	0.2	545.0	0.4	0.1	0.5	794.2	0.2	0.1	14.9	0.3	0.6	0.3	0.3	76.5	0.2	0.2	0.1	1.7	0.2	0.3	1.8	0.2	0.6	0.4	0.5	0.6	0.0	0.0	0.0	0.0	84.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0	1.9	40.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17441.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	417.4	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0
IGLV3-27		ENSG00000211658	"Immunoglobulin lambda variable 3-27"	P01718	22	22668288-22668806	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 401.6"	"Cell type enriched"	"Detected in some"	135	"Plasma cells: 1406.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	719	"memory B-cell: 194.0;naive B-cell: 367.8"	"Lineage enriched"	"Detected in single"	941	"B-cells: 367.8"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		720000000	"Cluster 24: B-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (3.45e-2)"	"unprognostic (1.87e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.30e-3)"		"prognostic favorable (3.60e-7)"	"unprognostic (8.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.56e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (4.95e-9)"	"unprognostic (1.82e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	8.8	1.8	0.1	16.4	0.0	29.4	29.7	0.0	0.5	23.7	0.1	56.7	19.3	2.2	0.0	10.3	5.1	10.5	3.1	0.0	0.0	3.7	3.7	29.3	64.3	0.4	0.0	2.9	0.3	0.2	0.4	0.0	0.1	2.4	26.9	0.0	40.6	0.8	0.0	0.5	24.4	0.6	0.0	103.9	59.8	24.2	0.0	47.6	2.8	0.0	401.6	27.4	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	194.0	0.2	0.0	0.3	367.8	0.0	0.0	0.2	0.0	0.1	0.1	0.1	11.8	0.1	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1406.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV3-9		ENSG00000211670	"Immunoglobulin lambda variable 3-9"	A0A075B6K5	22	22819010-22819756	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 313.9;stomach 1: 117.3"	"Cell type enriched"	"Detected in some"	9	"Plasma cells: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	51	"memory B-cell: 64.7;naive B-cell: 168.7"	"Lineage enriched"	"Detected in many"	74	"B-cells: 168.7"	"Cell line enriched"	"Detected in some"	5	"U-266/70: 41.3"									HPA003285	Approved				"Immunoglobulin genes"	NA	NA		1500000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003285: AB_1079122"	"prognostic favorable (2.59e-4)"	"unprognostic (6.52e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.40e-2)"		"prognostic favorable (9.80e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.47e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-1)"	1.8	23.5	0.1	84.6	0.0	27.8	14.9	0.0	0.1	7.3	0.1	87.1	58.7	2.0	0.0	20.8	1.8	18.6	7.6	0.0	0.0	3.2	6.2	17.1	139.8	0.7	0.0	3.9	2.4	0.2	0.1	0.0	0.1	1.4	64.0	0.0	46.2	3.1	0.1	1.5	60.3	5.2	0.0	64.6	117.3	1.6	0.1	35.0	3.8	0.0	313.9	72.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.3	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	0.3	0.0	41.3	5.8	0.7	0.0	3.9	0.0	0.0	0.1	0.0	1.2	0.0	2.2	64.7	1.3	1.4	0.0	168.7	0.4	1.8	0.1	0.5	0.1	0.0	0.1	6.5	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
IGLV4-69		ENSG00000211637	"Immunoglobulin lambda variable 4-69"	A0A075B6H9	22	22030934-22031472	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 430.3;lymphoid tissue: 461.2;salivary gland: 116.6;stomach 1: 285.6;urinary bladder: 204.0"	"Cell type enriched"	"Detected in some"	140	"Plasma cells: 4593.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	4	"medulla oblongata: 1.1"	"Group enriched"	"Detected in some"	302	"memory B-cell: 331.7;naive B-cell: 224.0"	"Lineage enriched"	"Detected in single"	361	"B-cells: 331.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;NB-4: 1.0;REH: 1.3;RPMI-8226: 5.4;SH-SY5Y: 1.3"														"Immunoglobulin genes"	NA	NA		320000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.02e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.34e-3)"	"unprognostic (2.67e-2)"	"prognostic favorable (4.04e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (9.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.08e-2)"	15.6	9.7	0.0	172.4	0.1	43.2	64.1	0.1	0.2	27.9	0.1	325.8	430.3	5.7	0.2	52.2	5.5	44.1	15.1	0.0	0.0	6.2	14.5	72.1	450.4	1.1	0.0	10.6	8.5	0.3	1.1	0.1	0.2	6.3	209.5	0.0	116.6	6.3	0.2	0.7	219.6	3.4	0.0	305.9	285.6	1.4	0.2	82.1	9.8	0.1	461.2	204.0	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	1.3	0.0	5.4	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.1	331.7	0.2	0.1	0.2	224.0	0.0	0.1	0.9	0.1	0.1	0.1	0.2	32.3	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	11.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4593.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0
IGLV5-45		ENSG00000211650	"Immunoglobulin lambda variable 5-45"	A0A087WSX0	22	22375986-22376505	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 40.5;intestine: 43.5;lymphoid tissue: 97.5;salivary gland: 49.0"	"Cell type enriched"	"Detected in some"	116	"Plasma cells: 6697.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 1.2;naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.2"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		160000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (4.62e-4)"	"unprognostic (6.18e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.58e-3)"	"unprognostic (2.77e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (5.95e-6)"	"unprognostic (6.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.36e-2)"	2.2	0.3	0.0	0.0	0.0	0.4	5.5	0.0	0.4	3.3	0.0	43.5	0.0	0.7	0.0	40.5	2.0	0.0	0.2	0.0	0.0	2.5	3.1	9.6	0.0	0.1	0.0	0.6	0.6	0.0	0.2	0.0	0.1	1.1	0.2	0.0	49.0	0.0	0.1	0.7	42.1	0.0	0.0	97.5	14.1	0.4	0.0	0.0	4.0	0.0	1.4	14.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.8	57.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6697.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0
IGLV6-57		ENSG00000211640	"Immunoglobulin lambda variable 6-57"	P01721	22	22195799-22196276	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1814.6;urinary bladder: 675.2"	"Cell type enriched"	"Detected in some"	72	"Plasma cells: 10791.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 353.9;naive B-cell: 292.4"	"Lineage enriched"	"Detected in many"	13	"B-cells: 353.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 148.0;RPMI-8226: 40.6;U-266/70: 21.6;U-698: 47.3"														"Immunoglobulin genes"	NA	NA		1900000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (1.92e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (1.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.30e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	15.6	9.1	0.0	220.8	0.1	191.7	215.5	0.0	0.6	82.3	0.4	485.0	351.3	19.1	4.4	171.4	38.2	75.8	39.2	0.1	0.0	10.7	26.8	97.0	237.6	0.6	0.1	20.3	7.7	17.8	1.1	0.4	0.5	17.2	318.8	0.0	249.6	12.7	0.3	3.2	174.3	11.5	0.1	276.6	437.6	15.9	0.1	139.7	15.3	0.0	1814.6	675.2	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.2	1.0	40.6	0.0	0.0	2.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.2	0.4	21.6	15.2	47.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.3	353.9	0.1	0.1	0.2	292.4	0.1	0.1	27.9	0.1	0.1	1.2	0.2	27.6	0.0	0.1	0.0	0.6	0.1	0.0	0.6	0.1	0.5	0.1	0.1	0.3	0.0	0.0	0.6	0.0	148.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.3	1.8	26.7	0.0	0.0	0.0	4.4	67.8	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10791.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	6.2	0.0	0.5	0.0
IGLV7-43		ENSG00000211652	"Immunoglobulin lambda variable 7-43"	P04211	22	22395018-22395489	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 161.9;lymphoid tissue: 238.7;stomach 1: 115.9"	"Cell type enriched"	"Detected in some"	57	"Plasma cells: 1304.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	325	"memory B-cell: 132.0;naive B-cell: 54.2"	"Lineage enriched"	"Detected in single"	461	"B-cells: 132.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RPMI-8226: 1.4;U-698: 1.5"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		130000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (6.49e-6)"	"unprognostic (7.85e-3)"	"prognostic favorable (7.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.62e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (7.63e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (6.29e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	8.0	0.8	0.0	31.2	0.1	15.8	45.7	0.0	0.5	4.9	0.0	161.9	132.8	3.6	0.5	7.9	3.3	22.1	3.5	0.0	0.1	3.1	4.2	13.0	59.0	0.0	0.0	4.1	2.2	0.0	1.0	0.2	0.1	2.3	129.3	0.0	72.5	4.7	0.1	0.5	57.1	17.7	0.0	168.6	115.9	0.5	0.0	31.3	6.4	0.7	238.7	31.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	132.0	0.0	0.0	0.0	54.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1304.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.2	0.0
IGLV7-46		ENSG00000211649	"Immunoglobulin lambda variable 7-46"	A0A075B6I9	22	22369614-22370087	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 400.6;lymphoid tissue: 459.1;stomach 1: 250.7;urinary bladder: 444.0"	"Cell type enriched"	"Detected in some"	180	"Plasma cells: 6758.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.6"	"Group enriched"	"Detected in some"	377	"memory B-cell: 183.6;naive B-cell: 82.3"	"Lineage enriched"	"Detected in single"	521	"B-cells: 183.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.0;RPMI-8226: 2.8;U-698: 6.6"									HPA003182	Approved				"Immunoglobulin genes"	NA	NA		270000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA003182: "	"prognostic favorable (3.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.25e-3)"	"unprognostic (4.68e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.02e-1)"	15.1	3.8	0.0	59.8	0.3	44.2	171.7	0.1	0.9	4.1	0.1	400.6	162.4	4.4	0.0	43.7	3.0	56.0	5.2	0.0	1.6	5.7	7.7	44.9	82.2	0.4	0.0	9.0	6.2	0.1	0.8	0.1	0.2	2.5	298.6	0.0	107.2	5.2	0.5	0.8	133.1	12.1	0.1	248.1	250.7	0.7	0.2	57.3	8.7	0.0	459.1	444.0	3.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.3	0.0	6.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	183.6	0.1	0.0	0.1	82.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	15.2	0.0	0.3	0.1	0.9	0.0	1.6	0.4	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6758.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0
IGLV8-61		ENSG00000211638	"Immunoglobulin lambda variable 8-61"	A0A075B6I0	22	22098700-22099212	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 805.8;lymphoid tissue: 984.2"	"Cell type enriched"	"Detected in some"	4	"B-cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Group enriched"	"Detected in some"	630	"memory B-cell: 257.8;naive B-cell: 529.3"	"Lineage enriched"	"Detected in single"	848	"B-cells: 529.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.2;RPMI-8226: 3.6;SH-SY5Y: 1.8;U-266/70: 6.6"					"Low region specificity"	"Detected in all"								"Immunoglobulin genes"	NA	NA		620000000	"Cluster 24: B-cells - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.07e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (3.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-1)"	9.4	4.9	0.1	125.5	0.2	63.9	78.3	0.1	3.5	43.5	1.0	201.1	805.8	22.7	0.8	10.6	5.6	46.4	11.7	0.1	0.2	5.3	13.7	82.2	257.2	0.2	0.1	9.2	13.4	1.3	0.8	0.0	0.7	10.5	191.0	0.0	108.6	1.0	0.2	4.0	161.6	13.0	0.8	275.7	179.2	3.3	0.1	16.5	11.5	0.0	984.2	247.8	3.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.0	0.2	3.6	0.0	0.0	1.0	1.8	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.3	6.6	1.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.2	0.1	257.8	0.3	0.0	0.4	529.3	0.0	0.0	0.2	0.1	0.4	0.1	0.2	32.7	0.1	0.2	0.1	3.5	0.1	0.2	0.2	0.1	0.7	0.8	0.1	1.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
IGLV9-49		ENSG00000223350	"Immunoglobulin lambda variable 9-49"	A0A0B4J1Y8	22	22343187-22343732	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 125.5;lymphoid tissue: 118.0"	"Cell type enriched"	"Detected in some"	20	"Plasma cells: 46.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	672	"memory B-cell: 70.3;naive B-cell: 88.1"	"Lineage enriched"	"Detected in single"	747	"B-cells: 88.1"	"Not detected"	"Not detected"																"Immunoglobulin genes"	NA	NA		43000000	"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"		"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (3.04e-5)"	"unprognostic (4.30e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.61e-2)"		"prognostic favorable (2.00e-5)"	"unprognostic (6.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (1.12e-8)"	"unprognostic (1.66e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.16e-2)"	2.4	125.5	0.0	14.7	0.0	9.8	6.1	0.1	0.5	3.3	0.0	33.6	36.5	2.2	0.0	6.0	3.2	1.1	1.2	0.2	0.0	1.2	4.4	43.8	118.0	0.2	0.0	3.3	1.4	0.0	0.1	0.1	0.2	0.9	15.1	0.0	29.7	1.0	0.1	0.1	28.2	0.4	0.0	65.9	46.3	2.0	0.0	14.0	3.4	0.1	97.9	39.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IGSF10	"CMF608, FLJ25972"	ENSG00000152580	"Immunoglobulin superfamily member 10"	Q6WRI0	3	151425384-151458709	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Osteogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 17.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 170.5;Horizontal cells: 60.6;Late spermatids: 34.1;Microglial cells: 61.8;Syncytiotrophoblasts: 30.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 44.1;HL-60: 23.3;REH: 17.2;RPMI-8226: 55.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA012655, HPA012921"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		540000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA012655: , HPA012921: AB_1851526"	"unprognostic (1.78e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.47e-7)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.84e-4)"	"unprognostic (9.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.52e-4)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.57e-4)"	3.9	4.0	1.4	0.9	0.7	0.6	6.1	0.3	1.0	0.5	3.2	1.3	0.5	1.4	1.6	2.9	4.3	9.7	4.3	2.8	1.1	0.2	0.3	8.6	1.4	0.1	1.0	17.7	0.7	1.3	1.7	0.7	0.3	0.1	1.3	0.2	5.2	0.2	0.1	1.9	1.2	1.5	0.0	0.9	0.7	0.9	3.6	1.3	1.5	0.5	2.5	2.2	0.3	0.3	0.0	0.1	0.3	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.4	0.0	0.0	0.3	0.3	7.5	44.1	0.0	1.6	23.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.2	0.1	55.1	0.1	0.1	1.0	0.0	5.9	0.0	0.0	0.2	0.0	0.2	0.0	0.1	1.1	0.0	0.0	2.4	0.0	0.0	0.2	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.7	0.3	1.0	2.8	1.1	0.1	1.0	0.3	0.0	3.6	0.3	2.0	0.0	0.5	1.0	0.6	2.4	1.2	0.5	2.8	15.8	0.6	0.9	1.6	2.8	6.3	1.8	4.2	21.7	2.7	0.2	0.0	0.1	170.5	11.4	4.0	0.9	6.0	3.4	2.4	1.3	2.9	20.4	0.5	0.5	0.0	0.0	0.0	0.1	1.3	60.6	2.8	0.7	4.1	0.8	3.2	34.1	6.8	2.9	3.6	61.8	1.1	25.6	0.0	0.5	0.7	0.4	0.1	1.2	0.3	0.7	0.0	0.3	12.5	2.4	0.0	0.5	2.2	10.7	7.9	0.8	2.4	30.9	0.6	2.5	0.1	0.2
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IGSF9	"IGSF9A, KIAA1355, Nrt1"	ENSG00000085552	"Immunoglobulin superfamily member 9"	Q9P2J2	1	159927039-159945613	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.8;retina: 34.8;skin 1: 23.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Distal enterocytes: 83.5;Gastric mucus-secreting cells: 37.8;Rod photoreceptor cells: 145.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 24.9;HaCaT: 37.0;NTERA-2: 18.9;SCLC-21H: 32.9;SH-SY5Y: 16.8;T-47d: 18.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.9;cerebellum: 5.5"	HPA037753	Uncertain				"Intracellular and membrane"	NA	NA		140000		"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA037753: AB_10672915"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.30e-2)"	"unprognostic (6.06e-3)"	"unprognostic (8.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	4.4	0.0	0.1	0.6	0.4	0.2	2.1	0.1	0.3	2.6	0.0	9.8	7.4	0.8	2.0	10.0	4.6	0.4	0.9	0.1	0.5	1.4	32.8	0.5	0.0	0.2	0.2	0.7	1.7	1.6	0.6	0.2	0.2	6.0	4.3	34.8	5.7	3.5	0.0	23.3	9.6	0.3	0.0	0.2	12.8	5.0	0.5	1.8	1.4	0.0	0.7	1.8	6.3	0.2	8.6	0.0	3.3	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	12.1	4.2	0.0	0.3	0.1	0.0	37.0	1.8	5.1	0.0	0.0	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.5	0.0	0.0	1.5	0.4	0.0	0.0	15.9	0.3	0.0	18.9	14.4	4.0	0.0	0.0	1.5	0.0	11.6	32.9	16.8	1.1	14.3	0.0	3.3	18.6	0.0	0.0	0.0	6.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.1	0.5	0.2	0.2	0.2	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.1	13.4	3.7	8.2	6.8	11.6	5.6	6.2	1.8	10.0	3.4	0.0	93.8	1.3	0.0	83.5	0.0	4.5	19.8	7.8	0.9	1.3	8.3	0.0	0.0	33.8	3.2	1.2	37.8	13.7	0.0	1.9	0.4	19.6	0.2	1.7	0.0	7.9	4.1	0.3	2.8	3.4	0.3	0.4	0.0	0.0	0.0	5.1	0.0	0.0	0.1	29.0	12.5	0.0	0.1	2.1	24.1	0.1	3.4	145.8	0.0	0.2	0.4	0.6	1.8	6.4	12.5	0.7	0.2	0.7	7.4	1.7
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog signaling molecule"	Q14623	2	219054424-219060921	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 14.0;intestine: 22.3;stomach 1: 15.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.5;Enteroendocrine cells: 49.2;Granulosa cells: 122.4;Intestinal goblet cells: 34.7;Proximal enterocytes: 18.8;Undifferentiated cells: 23.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8;endometrial cancer: 30.9"	"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 16.4;OE19: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		23000000		"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.1	2.4	4.9	0.0	22.3	12.2	14.0	0.0	0.3	0.9	0.7	0.0	0.0	0.0	2.4	3.5	1.3	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.1	0.4	2.4	12.4	0.0	0.0	0.7	0.0	0.0	12.9	0.7	0.2	0.0	15.0	0.1	0.1	0.0	1.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.3	0.1	0.4	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.8	0.0	1.8	0.0	0.0	0.4	31.5	0.0	0.1	0.0	6.0	0.5	0.1	49.2	0.0	0.0	3.3	0.0	0.1	12.2	8.9	0.0	122.4	0.0	0.6	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	14.0	0.0	0.0	1.8	18.8	3.2	0.9	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	23.6	0.3
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 28.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in all"		"BJ: 206.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	14.0	7.1	2.3	15.3	2.8	5.1	10.1	2.3	3.1	12.6	5.0	6.6	4.1	10.3	5.8	4.8	6.7	12.9	9.3	2.3	2.9	8.3	10.3	11.0	12.6	3.2	2.7	5.9	5.8	4.2	7.7	26.8	3.2	6.8	7.0	1.2	6.1	7.4	2.6	3.1	5.7	16.0	2.9	11.8	5.6	4.6	3.1	11.6	9.3	4.8	9.6	17.1	7.4	3.7	13.0	39.8	43.5	28.4	102.8	105.8	39.4	206.0	124.7	53.3	67.2	8.8	12.4	42.4	35.5	128.7	37.1	26.7	17.5	80.5	90.1	12.4	26.7	16.2	23.9	59.8	39.3	30.2	31.1	81.1	16.6	62.4	54.5	95.3	75.3	7.8	25.5	16.0	133.3	11.8	14.0	68.7	16.9	10.2	33.5	11.9	64.0	21.7	88.9	14.6	6.6	20.8	58.9	4.1	34.1	73.6	13.1	37.0	71.6	115.7	41.3	50.5	53.9	17.2	20.1	31.8	33.3	27.2	85.1	11.4	6.4	19.3	2.8	4.9	3.3	5.9	1.8	2.9	5.4	3.8	2.0	2.0	28.1	5.0	5.7	3.7	2.6	1.8	2.3	2.8	2.3	3.1	2.3	2.9	3.2	2.7	3.2	2.9	3.1	3.7	44.9	12.8	15.7	1.6	34.4	7.6	15.5	55.6	21.6	2.8	7.9	22.4	3.0	0.0	18.7	3.7	4.2	35.5	32.5	2.3	11.7	10.5	2.8	7.9	47.4	47.7	0.0	19.8	5.9	5.8	65.3	47.0	2.6	4.4	20.8	32.7	44.3	8.4	45.7	3.3	3.3	4.8	12.2	31.2	34.1	3.6	30.7	35.4	14.2	14.0	40.4	2.0	37.0	11.6	2.2	5.1	3.1	17.0	74.8	7.6	1.0	10.1	6.3	2.6	39.5	27.8	46.8	32.1	16.0	9.0	7.2	10.1	23.6	25.3	2.9	6.5
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 120.5;dendritic cells: 221.4;Erythroid cells: 89.8;Microglial cells: 91.8;monocytes: 106.6;NK-cells: 150.4;Plasma cells: 128.9;T-cells: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 140.4;HDLM-2: 258.6;HMC-1: 220.4;JURKAT: 128.9;MOLT-4: 184.3;REH: 192.3;U-698: 342.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	5.0	3.2	3.5	53.0	3.4	173.0	4.4	4.0	3.9	3.6	3.3	7.6	7.0	2.5	2.3	4.8	2.2	7.7	1.5	3.0	4.0	1.4	4.9	11.6	87.1	7.7	5.2	1.6	0.8	0.8	0.6	3.6	7.5	2.3	6.8	0.2	4.6	1.9	1.0	2.0	15.6	4.0	7.3	48.6	12.0	1.7	8.7	112.5	2.1	1.2	73.8	9.6	1.8	10.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	258.6	0.2	52.1	0.0	0.0	0.0	84.5	220.4	0.0	0.0	0.0	0.0	0.0	0.0	128.9	72.4	15.4	0.0	0.0	184.3	80.9	2.4	0.0	0.0	192.3	0.3	39.6	0.0	0.0	1.6	2.0	0.8	1.0	0.8	0.4	0.2	112.1	0.2	0.0	1.9	0.2	0.4	80.8	49.4	342.7	0.5	89.5	0.5	21.2	14.2	25.0	35.4	43.9	29.1	46.7	36.3	35.0	15.1	40.7	48.2	35.7	20.2	24.3	43.3	23.4	32.6	26.4	3.5	3.4	4.0	3.9	3.0	4.0	7.7	5.2	7.5	7.3	8.7	10.3	2.8	3.2	12.2	0.7	120.5	2.8	0.1	0.0	0.0	0.0	2.8	1.9	1.5	2.8	1.8	1.8	0.0	0.4	221.4	0.3	0.0	0.4	3.8	0.5	0.4	2.6	0.0	89.8	0.2	0.0	0.4	2.5	4.6	0.6	23.4	0.2	3.9	2.0	30.6	0.0	0.3	0.0	0.0	64.3	61.0	5.3	0.0	72.1	19.6	91.8	106.6	0.0	150.4	1.0	0.3	0.1	0.4	0.0	128.9	0.1	0.0	1.0	1.5	0.1	0.0	1.5	1.6	0.1	2.1	0.5	2.7	0.7	182.8	0.1	0.1	0.1
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	4	"B-cells: 108.1;dendritic cells: 76.5;granulocytes: 47.9;NK-cells: 121.5;Plasma cells: 80.2;T-cells: 99.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.0;Karpas-707: 35.6;U-266/70: 41.7;U-266/84: 50.0;U-698: 108.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"	1.0	0.8	0.3	18.8	0.2	5.9	1.8	0.7	0.6	1.5	0.6	3.3	3.5	1.0	0.7	1.5	0.7	3.0	0.5	0.7	0.1	0.6	2.0	3.1	36.5	0.5	0.1	0.7	0.4	0.1	0.2	0.3	0.4	1.0	3.1	0.3	2.2	0.3	0.5	0.9	12.1	0.8	0.1	22.3	6.2	1.6	0.4	23.0	0.9	0.3	41.0	4.5	0.7	1.0	0.2	0.2	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.3	69.0	0.1	0.0	0.1	0.3	0.1	0.2	0.0	15.6	0.3	4.2	0.4	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	4.1	1.8	35.6	0.0	0.2	6.2	2.4	0.2	3.9	0.1	0.3	0.2	12.7	0.0	4.2	0.4	0.2	1.2	0.5	0.1	0.1	0.2	0.8	0.3	0.3	0.5	0.2	0.1	41.7	50.0	108.1	0.1	0.2	0.1	1.0	0.2	0.8	26.3	0.1	28.8	13.2	11.0	20.3	0.1	11.9	4.5	12.2	1.1	4.5	0.3	0.6	18.9	8.7	0.3	0.2	0.7	0.6	0.7	0.1	0.5	0.1	0.4	0.1	0.4	1.0	1.1	9.6	21.8	0.3	108.1	0.1	2.2	0.0	0.0	1.7	1.2	0.9	4.0	1.5	5.6	1.8	0.0	0.1	76.5	0.2	0.0	0.1	12.8	1.9	0.9	2.4	0.0	4.0	0.6	0.0	0.4	2.3	3.1	3.9	47.9	0.4	4.2	1.2	0.1	0.0	0.4	0.1	0.0	6.3	0.0	11.8	0.0	4.4	0.0	2.8	3.3	0.2	121.5	0.0	0.1	1.2	0.1	0.0	80.2	1.8	0.0	0.3	0.7	1.7	0.0	4.0	1.2	6.3	2.3	0.6	0.1	0.3	99.9	0.1	0.0	1.6
IL17B	"IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7"	ENSG00000127743	"Interleukin 17B"	Q9UHF5	5	149371324-149404202	"Cancer-related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 44.8;Peritubular cells: 13.2;Sertoli cells: 26.3;Smooth muscle cells: 7.6;Theca cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HEL: 1.3;Karpas-707: 1.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042441	Uncertain				"Secreted to blood"	NA	NA	75000		"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA042441: AB_10797014"	"unprognostic (2.83e-4)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-3)"	"unprognostic (9.22e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.30e-3)"	"unprognostic (3.22e-1)"	"unprognostic (6.98e-8)"	"unprognostic (2.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.10e-1)"	1.4	2.2	0.0	1.0	0.0	0.2	2.9	0.5	0.1	3.2	0.0	3.1	0.3	4.3	0.0	1.5	1.1	0.4	1.1	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	2.4	0.1	0.4	2.8	2.1	0.3	0.9	1.3	2.2	0.0	0.6	0.8	3.7	0.0	0.0	0.1	0.2	0.0	1.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.8	44.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.6	1.3	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	1.0	1.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.6	7.6	0.1	0.1	0.0	0.3	0.0	0.0	9.9	0.0	0.1
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.9;Kupffer cells: 81.4;Macrophages: 61.4;monocytes: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 59.9;NB-4: 52.5;THP-1: 74.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		62000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	9.1	5.6	5.5	9.6	11.3	31.8	6.9	5.7	7.5	5.4	6.8	4.7	3.8	5.4	5.0	5.2	6.0	3.6	4.6	6.3	5.5	3.7	5.7	10.0	6.9	9.8	7.3	4.5	5.2	3.9	3.8	3.5	8.9	5.0	3.4	1.5	5.2	2.8	1.8	6.9	6.2	5.3	7.7	16.6	5.6	2.0	7.7	15.4	4.2	2.6	5.6	4.6	4.7	9.6	7.9	4.5	4.1	5.1	8.0	4.6	5.1	11.5	7.4	5.3	6.8	4.4	5.1	7.1	4.6	11.6	6.9	12.4	5.6	5.4	3.7	11.6	6.6	0.0	2.6	2.8	9.2	59.9	17.8	6.8	7.9	4.7	3.7	5.2	5.7	5.6	3.0	7.3	5.5	6.7	7.2	52.5	2.2	10.1	4.3	1.6	0.8	1.3	5.1	5.8	2.8	0.1	8.0	6.7	5.7	4.6	5.3	74.7	15.9	4.1	5.8	6.1	4.3	5.8	3.4	3.3	6.0	28.3	4.5	8.5	7.4	7.2	1.1	3.4	0.9	0.5	1.5	1.2	3.9	0.4	2.4	1.8	16.5	1.5	3.5	1.8	1.0	2.6	5.5	11.3	5.7	7.5	6.3	5.5	9.8	7.3	8.9	7.7	7.7	9.6	14.0	12.8	14.1	2.9	13.8	8.8	6.6	10.2	10.8	3.9	7.2	5.8	6.1	10.0	8.6	5.5	8.4	6.1	18.7	23.6	0.0	8.7	4.0	7.2	8.1	13.7	13.2	9.2	8.3	12.6	11.9	13.6	29.0	9.7	7.6	58.9	17.5	11.1	34.0	3.3	6.4	13.9	6.1	81.4	16.2	2.1	9.0	61.4	8.8	41.2	114.2	4.3	28.8	12.5	11.4	12.2	12.4	4.5	10.3	9.1	14.7	3.4	8.0	2.9	13.1	10.4	10.0	3.0	13.4	9.0	6.8	6.4	25.4	8.1	12.4	9.6
IL22RA1	"CRF2-9, IL22R"	ENSG00000142677	"Interleukin 22 receptor subunit alpha 1"	Q8N6P7	1	24119771-24143140	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 199.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.8;Exocrine glandular cells: 12.0;Pancreatic endocrine cells: 11.3;Paneth cells: 33.4;Proximal enterocytes: 44.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 11.3;Hep G2: 8.1;OE19: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.68e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.78e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.64e-2)"	0.7	0.4	0.0	1.2	0.0	0.0	2.0	0.3	0.3	4.0	0.0	11.4	20.0	0.2	0.1	17.8	1.5	2.6	0.3	0.5	0.1	2.1	7.0	0.8	0.0	0.1	0.0	0.3	199.3	0.0	2.1	0.1	0.1	0.7	10.0	0.2	2.9	0.4	0.4	40.1	28.3	0.4	0.1	0.0	3.5	0.4	0.0	0.0	2.3	0.0	2.4	0.3	7.0	0.1	2.9	2.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	1.3	1.5	11.3	4.8	0.0	0.9	0.3	4.7	5.0	0.6	3.0	0.4	3.7	0.0	0.0	1.4	8.1	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.1	18.7	1.0	0.0	0.0	0.1	0.0	0.6	0.1	0.1	1.4	0.0	1.6	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	4.2	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.9	0.4	0.7	2.8	0.0	0.1	0.3	0.3	1.5	0.2	0.0	0.0	0.0	0.0	34.8	0.0	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.2	12.0	0.0	0.3	3.6	0.5	0.0	0.5	0.0	5.8	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.1	11.3	33.4	0.0	0.0	0.2	44.0	1.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.3	1.1	0.0	0.0	0.0	7.0	0.2
IL27RA	"CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1"	ENSG00000104998	"Interleukin 27 receptor subunit alpha"	Q6UWB1	19	14031762-14053218	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 49.1;dendritic cells: 56.6;Kupffer cells: 41.1;Langerhans cells: 44.2;NK-cells: 69.0;T-cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA073441			Approved	Vesicles		NA	NA		4900000	"Cluster 32: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA073441: "	"prognostic favorable (1.74e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (2.58e-10)"	"unprognostic (5.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.87e-3)"	7.8	1.7	2.4	8.7	2.3	2.7	6.5	2.2	2.7	2.7	2.2	3.1	2.3	2.4	0.7	2.6	3.3	2.3	7.7	2.8	2.9	6.1	1.5	8.0	12.6	2.5	2.5	1.0	2.8	5.6	0.8	1.3	2.7	3.6	2.1	0.2	3.0	1.2	2.0	2.2	8.1	1.9	2.5	14.7	2.8	2.0	3.1	11.1	4.0	2.4	16.5	3.9	2.8	2.4	7.7	3.3	3.2	4.4	0.2	1.6	1.3	3.5	7.3	6.3	9.0	1.6	6.1	0.1	3.6	3.1	2.9	1.4	5.1	2.1	4.8	14.8	3.5	18.6	0.7	2.7	0.5	9.0	0.2	1.6	0.8	3.0	0.6	5.1	2.5	4.6	13.1	13.5	0.3	10.7	6.8	19.5	4.2	4.5	2.2	5.8	1.9	7.1	3.9	1.8	2.8	1.5	4.5	0.3	5.2	1.7	5.6	5.4	4.0	0.6	7.7	6.4	3.8	13.9	7.2	6.7	0.6	18.2	4.2	7.9	22.5	0.6	24.3	18.4	21.4	15.6	24.0	20.2	20.7	12.8	26.1	20.6	1.6	22.9	9.5	7.6	23.1	21.4	2.4	2.3	2.2	2.7	2.8	2.9	2.5	2.5	2.7	2.5	3.1	2.4	30.4	0.0	10.0	0.0	49.1	1.9	13.3	8.5	3.4	0.3	14.0	11.9	5.4	5.7	5.7	3.7	0.0	0.6	56.6	0.7	0.0	10.7	0.4	1.9	1.2	22.8	2.4	7.2	2.4	2.7	1.4	4.0	3.6	1.5	17.7	1.4	22.9	0.7	21.4	1.7	2.1	0.9	4.1	41.1	44.2	0.5	3.4	32.8	5.4	1.0	22.8	0.3	69.0	1.0	0.6	3.8	0.8	3.4	26.0	12.4	0.0	0.9	2.0	0.0	0.0	1.9	2.2	0.1	11.5	2.6	1.3	0.1	63.5	0.4	2.4	3.5
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 118.0;lymphoid tissue: 346.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 186.1;dendritic cells: 199.0;Distal enterocytes: 202.0;NK-cells: 310.0;Paneth cells: 133.2;Plasma cells: 221.2;T-cells: 289.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"Karpas-707: 2316.2"									"HPA046641, HPA049691"	Enhanced		Approved	Vesicles		NA	NA		13000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Vesicles		"HPA046641: AB_2679733, HPA049691: AB_2680851"	"unprognostic (2.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (8.25e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.28e-7)"	"unprognostic (1.73e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.54e-2)"	12.8	6.2	2.7	132.2	2.4	87.3	14.1	2.5	6.3	10.2	4.0	98.9	50.4	7.5	7.5	15.1	6.8	28.2	4.6	2.3	2.8	7.1	20.6	51.7	235.6	3.6	2.7	4.9	4.1	1.9	1.5	16.9	4.2	7.8	118.0	0.5	19.0	5.9	2.6	15.4	82.8	12.3	3.1	119.4	41.4	2.2	3.0	346.4	5.8	6.3	306.9	46.4	5.5	3.8	1.2	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	4.7	9.1	187.3	13.5	0.0	0.7	1.7	0.4	0.0	0.0	160.3	0.2	23.6	0.3	0.3	0.2	99.3	4.0	0.0	0.0	0.0	0.1	0.1	0.0	220.5	43.3	2316.2	0.0	0.0	356.4	193.7	0.4	0.9	0.1	79.5	0.8	20.0	0.0	0.7	0.2	0.3	2.3	0.1	0.5	0.0	0.0	3.5	0.4	0.0	1.0	0.0	0.5	132.1	242.2	119.6	2.1	397.4	0.9	540.5	102.2	169.7	1204.7	239.5	1179.9	604.7	1086.3	1250.7	243.5	603.0	742.0	943.1	773.0	1190.3	177.0	368.9	1422.2	1494.0	2.7	2.4	2.5	6.3	2.3	2.8	3.6	2.7	4.2	3.1	3.0	3.8	3.3	3.2	11.2	0.0	186.1	8.2	8.1	13.1	1.2	0.0	1.5	1.7	0.9	4.3	4.2	0.0	0.0	0.5	199.0	202.0	0.0	1.2	0.1	0.8	0.7	5.8	77.7	27.1	0.0	2.3	0.3	4.2	13.7	0.7	39.3	0.4	6.1	2.1	31.1	0.0	0.0	24.5	4.1	25.2	116.7	0.0	0.0	45.4	42.7	1.0	91.1	0.1	310.0	0.0	0.1	28.0	133.2	0.4	221.2	4.3	88.8	1.1	2.3	0.4	0.0	1.3	2.6	0.0	0.1	1.8	6.8	0.3	289.5	0.0	18.6	8.9
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.3;skin 1: 62.0"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 18.3;Peritubular cells: 40.6;Sertoli cells: 19.7;Suprabasal keratinocytes: 20.5;Theca cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	13	"eosinophil: 18.5"	"Lineage enriched"	"Detected in single"	185	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;Hep G2: 2.7;HSkMC: 2.4;NTERA-2: 5.3;U-138 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	57100		"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.76e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	4.4	22.9	17.1	3.9	18.1	0.1	8.6	8.5	23.3	9.6	23.1	4.0	5.1	2.9	1.0	25.5	3.2	6.7	4.4	22.5	14.5	5.7	2.5	5.0	9.1	13.0	11.7	1.6	1.9	1.0	12.5	0.5	14.1	6.2	2.2	1.2	16.0	3.8	9.6	62.0	6.4	2.5	10.1	106.3	2.4	3.5	19.0	3.9	5.1	2.5	5.0	4.8	13.4	11.6	0.0	0.6	0.1	0.1	0.2	2.1	0.2	0.1	1.8	0.2	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.9	0.0	1.6	2.4	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	3.6	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	1.4	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	18.1	8.5	23.3	22.5	14.5	13.0	11.7	14.1	10.1	19.0	11.6	2.8	0.0	1.8	2.9	0.1	8.3	1.6	3.4	2.2	1.2	15.7	14.7	0.4	1.5	4.9	0.0	4.2	0.1	0.5	0.0	0.0	7.4	0.2	0.5	0.3	6.1	0.0	0.0	12.7	2.0	0.9	9.0	0.0	0.1	0.0	0.0	3.6	0.1	3.8	5.0	11.4	0.1	2.0	0.0	4.2	0.3	18.3	0.4	12.4	5.6	0.0	15.2	0.0	1.5	1.0	0.8	0.1	40.6	0.1	2.4	0.2	0.3	1.2	0.8	19.7	2.0	8.1	0.1	0.4	7.8	20.5	0.8	0.3	18.8	0.5	1.9
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.0;dendritic cells: 137.5;Endothelial cells: 83.2;Langerhans cells: 47.6;monocytes: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2665.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2665.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.8;NB-4: 24.9;RPMI-8226: 54.1"									"HPA003539, CAB018374"	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	25.2	2.9	7.1	15.8	13.6	25.0	20.6	16.1	11.7	6.4	0.2	8.1	5.5	8.7	1.6	5.4	8.0	11.3	13.0	5.9	8.1	9.2	1.8	25.0	25.1	11.7	10.6	8.8	5.4	3.4	2.8	6.2	11.1	7.0	6.6	22.0	9.5	3.2	12.1	12.7	9.2	12.3	7.5	11.1	6.9	3.5	10.1	4.4	10.3	8.6	13.0	12.4	6.3	20.5	0.2	9.4	3.6	1.3	0.1	0.0	1.1	1.2	0.3	0.0	0.1	0.9	1.5	1.2	7.2	0.2	0.6	9.6	0.0	0.0	0.0	128.8	3.9	0.6	2.1	0.4	0.0	0.8	15.6	0.0	0.0	0.0	0.0	4.1	8.2	0.9	0.3	6.1	0.0	1.4	0.7	24.9	3.1	0.8	0.5	1.4	4.2	54.1	0.0	1.4	0.6	0.4	0.6	0.3	2.8	1.8	1.2	17.8	0.4	0.5	1.5	0.5	0.3	12.5	3.9	1.1	9.8	2.8	0.1	2665.0	5.6	83.9	0.6	31.7	1.0	2.5	0.9	0.5	14.9	8.9	0.7	0.7	4.6	14.2	42.5	628.5	0.5	12.0	7.1	13.6	16.1	11.7	5.9	8.1	11.7	10.6	11.1	7.5	10.1	20.5	79.0	3.2	1.8	11.8	6.8	5.9	0.7	0.9	1.2	2.3	0.5	0.9	2.2	1.5	1.0	0.0	10.4	0.1	137.5	4.7	0.0	0.4	0.2	2.7	1.4	83.2	0.0	3.0	7.3	0.2	0.1	4.3	0.5	1.5	11.4	0.4	24.3	0.7	4.6	0.0	14.3	7.3	0.0	2.8	47.6	0.1	0.3	32.9	8.8	13.1	72.6	0.6	1.0	6.0	18.2	0.1	3.4	0.7	4.0	0.7	0.2	0.0	0.4	3.2	0.0	3.6	3.2	0.1	0.7	0.7	5.5	0.3	1.6	1.3	0.6	2.1
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066324-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.0;fallopian tube: 10.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 28.0;granulocytes: 19.0;Plasma cells: 9.9;Respiratory ciliated cells: 13.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	192	"basophil: 178.4;eosinophil: 355.1"	"Lineage enriched"	"Detected in many"	255	"granulocytes: 355.1"	"Cell line enriched"	"Detected in some"	28	"HMC-1: 71.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		910000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.2	0.2	0.8	0.6	0.7	0.6	1.0	0.6	0.3	1.0	9.0	0.7	1.7	0.4	0.2	0.5	10.7	0.7	1.0	0.8	1.2	0.4	0.1	2.7	0.4	5.0	4.6	0.1	0.4	0.0	1.5	0.1	3.2	1.8	1.1	0.0	0.7	0.1	0.4	0.1	1.6	0.3	4.5	1.8	1.1	1.1	1.2	0.5	0.2	0.0	1.5	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	2.5	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	178.4	0.1	355.1	0.9	0.1	0.1	0.4	1.0	0.7	0.1	1.3	0.3	0.7	1.0	0.0	0.1	0.1	0.1	0.7	0.8	0.7	0.6	0.3	0.8	1.2	5.0	4.6	3.2	4.5	1.2	0.9	0.2	0.0	2.5	0.0	4.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	2.3	1.5	1.4	0.0	0.0	0.1	2.8	0.0	0.0	0.0	2.4	28.0	0.3	0.1	0.0	0.8	0.7	0.0	0.0	0.2	0.0	0.5	19.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.3	5.7	0.0	0.1	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	9.9	0.8	0.0	0.1	13.9	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.1
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 217.6;urinary bladder: 281.3"	"Group enriched"	"Detected in many"	4	"Adipocytes: 188.5;Endometrial ciliated cells: 163.9;Endothelial cells: 287.4;Fibroblasts: 593.3;Glandular and luminal cells: 322.2;Smooth muscle cells: 449.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	44	"memory B-cell: 3.9;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	48	"B-cells: 4.8"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 2214.7;GAMG: 1447.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	5700		"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	217.6	13.9	3.6	30.8	3.8	46.8	31.3	3.7	6.0	4.7	9.2	22.1	1.9	5.7	0.0	34.9	18.9	41.6	55.1	3.8	3.8	17.7	13.0	114.9	9.1	4.0	4.3	6.2	19.5	10.0	38.3	11.3	4.9	16.5	17.3	1.4	12.0	2.0	7.8	7.6	8.3	19.5	3.9	7.0	18.0	1.2	4.7	6.3	14.2	4.1	3.7	281.3	5.7	4.1	0.1	0.0	0.0	0.0	0.7	2.2	7.5	8.9	2214.7	43.2	151.0	0.0	0.6	0.2	71.6	15.2	1447.6	1.7	0.0	0.3	59.9	94.2	0.2	0.0	3.7	0.0	47.3	0.0	0.6	5.6	0.0	413.8	63.1	44.2	18.2	0.0	10.6	0.5	1.9	0.1	0.0	0.3	1.6	0.7	0.5	0.0	0.0	0.0	124.2	0.0	0.0	0.0	144.5	0.1	0.6	7.9	0.1	0.1	14.5	15.2	1.4	28.2	4.7	0.0	27.8	0.4	98.5	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	3.8	3.7	6.0	3.8	3.8	4.0	4.3	4.9	3.9	4.7	4.1	188.5	6.4	22.7	0.0	27.0	44.6	3.4	28.5	1.8	0.1	1.4	1.1	1.4	0.0	17.7	3.7	0.0	1.1	0.4	0.1	0.0	9.8	0.4	163.9	44.6	287.4	0.0	0.0	0.0	2.8	4.0	593.3	0.0	322.2	6.3	0.0	3.6	0.1	4.1	0.0	0.0	0.0	0.0	9.3	76.5	0.2	0.0	27.4	40.9	2.8	4.2	0.0	0.0	0.0	0.1	4.3	0.1	0.0	0.9	16.4	0.0	0.0	8.1	0.0	0.0	28.9	449.0	0.0	0.1	0.4	33.4	1.4	8.6	0.2	0.0	20.6
IL7R	"CD127, IL7RA"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 183.7"	"Group enriched"	"Detected in many"	4	"monocytes: 271.8;T-cells: 973.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2"	"Group enriched"	"Detected in all"	33	"NK-cells: 113.2;T-cells: 369.5"	"Cell line enhanced"	"Detected in many"		"BJ: 99.8;BJ hTERT+ SV40 Large T+: 87.7;fHDF/TERT166: 187.7;HBF TERT88: 168.3;REH: 406.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		610000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	11.2	14.4	1.5	137.6	1.8	14.0	20.4	7.4	2.7	12.0	1.0	17.3	15.0	3.9	1.6	11.0	5.7	32.4	2.2	2.0	2.5	4.5	12.5	63.9	139.4	1.8	0.5	2.2	5.3	0.8	1.7	2.9	1.6	8.7	20.4	0.9	3.3	3.1	4.1	3.8	56.8	5.6	0.6	70.1	34.1	4.7	4.4	183.7	7.6	1.7	123.0	48.0	7.1	6.2	0.6	0.4	0.7	0.4	0.7	0.6	0.6	99.8	50.6	87.7	51.3	0.5	0.6	9.6	0.3	187.7	15.9	16.0	0.2	6.0	168.3	8.6	1.1	3.2	10.3	0.0	1.5	0.6	7.2	1.6	0.0	18.7	4.3	2.4	2.6	0.7	0.7	0.9	71.3	0.2	2.3	1.0	0.3	0.3	4.6	406.2	5.2	0.6	0.0	5.3	0.4	0.2	15.9	1.7	0.2	0.3	0.6	0.4	7.0	34.5	58.4	14.8	13.4	0.6	0.2	10.4	17.4	9.2	27.8	4.3	1.6	1.0	102.1	1.2	369.5	1.5	213.8	151.1	0.7	2.1	179.5	124.6	7.3	113.2	1.5	1.8	39.7	87.7	1.5	1.8	7.4	2.7	2.0	2.5	1.8	0.5	1.6	0.6	4.4	6.2	8.9	16.0	16.0	0.0	47.4	11.6	2.7	0.0	5.2	0.0	8.6	6.1	4.9	0.0	2.5	0.0	0.0	0.2	136.0	0.6	0.0	1.0	0.1	1.1	0.4	13.2	0.0	16.4	0.0	2.0	0.2	11.6	53.5	1.2	19.6	0.2	13.2	4.4	10.6	0.0	0.0	0.5	0.0	10.6	98.5	0.8	0.0	58.8	21.4	2.8	271.8	0.0	11.3	0.0	0.0	0.1	1.4	0.0	93.5	1.4	0.0	0.8	5.8	0.0	0.0	5.5	7.9	0.2	0.1	1.5	10.4	0.3	973.8	0.4	0.4	3.5
ILDR1	"DFNB42, MGC50831"	ENSG00000145103	"Immunoglobulin like domain containing receptor 1"	Q86SU0	3	121987323-122022247	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Club cells: 14.7;Collecting duct cells: 20.2;Cytotrophoblasts: 16.6;Distal enterocytes: 17.5;Glandular and luminal cells: 13.5;Respiratory ciliated cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;HDLM-2: 8.2;MCF7: 5.1;RT4: 7.5;T-47d: 5.3;U-266/70: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018207	Approved				"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA018207: AB_1851742"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.46e-3)"	"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.37e-1)"	"prognostic favorable (5.79e-9)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.21e-2)"	0.0	0.7	0.2	1.3	0.1	0.3	2.9	0.2	0.3	11.7	0.1	8.2	3.3	1.0	12.8	3.8	5.1	3.3	0.0	0.1	0.0	6.5	0.2	2.9	1.1	0.1	0.1	0.0	6.7	15.7	2.4	1.8	0.1	6.9	7.2	0.2	8.0	10.6	0.1	1.2	2.4	0.3	0.0	0.6	0.8	0.6	0.1	0.8	7.3	0.0	2.2	2.2	1.1	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	6.3	1.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	2.4	2.8	7.5	0.2	0.0	0.0	0.7	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.1	1.4	1.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	12.8	7.4	0.3	1.3	0.0	0.8	7.5	0.0	0.0	4.2	2.4	0.7	4.3	14.7	20.2	0.0	16.6	0.1	17.5	1.9	7.5	0.2	6.3	1.6	0.1	3.5	0.0	0.5	3.7	0.5	0.1	1.1	13.5	0.0	0.2	0.0	0.1	1.2	0.0	0.5	7.9	8.2	0.6	0.0	0.0	0.0	0.3	1.8	1.9	0.0	0.0	0.0	0.0	0.2	2.6	8.9	0.0	2.1	2.2	2.5	2.1	13.7	0.0	0.0	0.0	0.6	0.0	0.1	5.9	0.6	5.1	0.1	0.0	7.8	3.5
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		30000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	108.0	77.2	49.8	85.1	52.4	43.7	91.8	51.7	50.6	151.6	55.0	398.2	66.4	359.1	81.8	115.5	164.2	88.0	175.9	47.4	50.7	78.8	65.9	107.9	72.4	51.8	50.6	101.0	89.3	73.2	47.1	98.8	50.9	182.7	116.8	28.3	69.5	412.2	90.8	61.5	117.4	364.7	51.1	95.5	149.7	26.5	53.7	45.8	72.0	92.0	70.5	226.7	118.8	51.9	127.8	94.4	148.9	51.8	224.8	159.4	67.2	182.2	360.0	211.9	256.0	102.7	145.7	47.0	47.0	304.1	206.9	99.5	84.4	155.6	213.0	83.5	74.3	69.1	84.9	82.8	150.8	55.9	74.7	153.2	72.8	143.8	108.9	217.7	206.9	40.5	63.7	55.0	282.8	97.1	49.4	97.4	94.3	107.5	110.8	51.0	77.8	50.5	160.3	100.8	25.6	57.4	86.0	118.4	103.6	144.0	82.2	62.2	238.8	263.9	118.0	111.1	90.7	38.9	25.9	67.1	195.6	82.8	125.3	314.9	260.0	417.6	127.3	258.1	124.9	96.9	114.4	122.3	242.7	92.9	70.2	88.5	165.5	257.8	254.8	98.5	142.8	402.8	49.8	52.4	51.7	50.6	47.4	50.7	51.8	50.6	50.9	51.1	53.7	51.9	79.5	44.8	17.9	24.2	33.6	50.5	73.7	100.6	24.5	21.5	43.1	68.2	0.5	70.1	49.7	57.0	8.4	119.8	46.0	71.9	58.7	136.1	64.6	33.2	78.1	69.4	37.9	53.7	14.6	125.0	177.7	83.2	50.4	52.5	30.4	41.6	76.4	31.4	127.4	8.4	17.1	50.1	69.2	51.5	97.7	143.7	71.4	115.9	85.4	30.9	143.0	54.3	77.2	15.6	15.3	117.1	60.0	147.4	35.1	42.0	74.5	98.6	31.0	32.9	157.8	53.3	165.8	31.7	17.1	32.3	43.2	110.0	49.3	65.0	50.1	43.9
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277138-103290346	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 160.7;pituitary gland: 41.4;retina: 97.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	0.2	12.1	34.2	1.2	35.5	0.0	0.0	63.3	160.7	0.0	0.0	3.3	0.6	0.0	0.0	0.6	0.0	0.1	0.0	31.8	109.5	0.0	0.0	0.2	0.1	107.9	37.5	0.0	2.0	0.4	41.4	0.1	98.1	0.2	1.2	97.3	0.1	0.0	0.0	0.8	1.1	0.8	25.3	0.0	1.1	2.7	72.8	1.7	0.1	0.0	0.2	1.1	0.5	51.9	0.0	25.4	11.8	0.0	0.1	0.0	19.3	13.3	3.3	3.1	0.3	0.0	0.0	0.0	5.4	0.9	1.5	1.9	11.0	0.0	0.7	24.6	4.9	0.0	6.8	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	13.6	0.0	53.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	103.3	58.7	71.6	0.1	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	3.4	3.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	35.5	63.3	160.7	31.8	109.5	107.9	37.5	98.1	25.3	72.8	51.9	0.1	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	62.4	0.0	0.4	0.5	0.0	0.0	0.0	22.9	0.2	0.0	0.1	0.0	0.1	41.4	0.4	0.2	0.9	7.8	0.0	28.7	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.5	45.4	39.8	0.0	0.0	0.0	0.0	26.5	0.3	0.1	0.0	2.8	0.0	8.7	0.0	1.0	5.4	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	48.2	0.0	0.0	0.6	20.3	4.1	1.0	0.4	0.1	0.1	0.1	0.0	0.6
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915742	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.2;intestine: 55.4;skin 1: 47.0"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 33.3;Endometrial ciliated cells: 26.8;Exocrine glandular cells: 45.5;Glandular and luminal cells: 25.1;Pancreatic endocrine cells: 118.6;Proximal tubular cells: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;CAPAN-2: 49.6;HaCaT: 66.0;OE19: 57.8;RPMI-8226: 54.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511, HPA079622"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nuclear bodies"	"HPA027499: AB_10599708, HPA027511: AB_10600334, HPA079622: "	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.1	0.0	1.4	4.0	1.4	4.5	1.7	0.8	1.3	8.8	1.8	33.8	47.3	1.1	0.5	44.2	4.2	16.3	0.2	1.4	1.4	15.3	0.4	3.5	0.4	1.1	1.4	0.1	13.2	0.1	0.3	1.9	1.0	7.0	30.1	0.4	12.3	2.6	0.2	47.0	55.4	1.1	1.0	0.3	27.3	1.1	1.5	0.9	0.1	0.0	5.7	17.1	20.3	1.0	27.5	40.8	23.3	0.0	0.0	0.0	60.3	0.0	0.0	0.7	0.5	43.4	49.6	0.0	13.3	0.0	1.1	66.0	0.0	17.4	0.5	0.0	5.0	3.8	1.8	17.2	0.1	8.5	0.8	0.0	26.1	0.4	1.1	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.1	1.4	45.2	57.8	9.2	0.2	9.7	54.0	24.4	34.9	0.1	2.8	2.6	41.5	0.0	27.3	17.1	7.9	0.0	0.1	10.1	0.1	2.9	46.2	20.6	0.0	0.1	8.6	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.4	1.4	0.8	1.3	1.4	1.4	1.1	1.4	1.0	1.0	1.5	1.0	0.6	12.8	7.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.5	3.3	0.0	0.0	5.0	14.7	0.0	7.6	0.1	0.0	5.9	33.3	0.0	26.8	2.2	0.7	0.0	0.0	0.0	45.5	13.2	0.4	0.0	25.1	1.3	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	0.0	26.0	4.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.5	0.3	0.0	0.0
INHBB		ENSG00000163083	"Inhibin subunit beta B"	P09529	2	120346136-120351803	"Cancer-related genes, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 52.5;breast: 43.3"	"Group enriched"	"Detected in many"	7	"Adipocytes: 200.5;Granulosa cells: 653.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 44.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 47.6;ASC diff: 63.1;BJ hTERT+ SV40 Large T+ RasG12V: 38.5;MCF7: 58.4;PC-3: 91.7;SK-BR-3: 163.4;T-47d: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		130000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.57e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (1.76e-2)"	52.5	3.7	5.6	0.9	5.5	0.2	43.3	8.0	4.0	6.9	3.4	3.4	1.3	7.4	2.6	2.5	6.2	2.5	6.4	3.9	4.8	4.3	20.2	4.4	1.1	9.7	7.4	2.5	4.2	6.3	8.0	1.2	6.0	8.2	0.3	1.0	16.4	0.8	10.4	17.1	2.4	2.2	6.2	0.5	3.6	17.1	7.9	0.4	20.9	2.4	0.7	8.2	6.4	4.2	24.5	47.6	0.2	0.0	63.1	4.9	0.0	3.3	3.8	20.7	38.5	1.0	0.0	0.0	8.3	1.2	0.1	0.1	3.7	0.0	28.9	0.1	0.8	0.0	0.0	1.2	1.0	0.0	0.1	2.6	3.5	0.7	0.0	0.3	0.4	0.0	0.0	0.0	0.1	58.4	0.0	0.1	0.0	4.7	91.7	0.0	0.0	1.2	5.6	0.0	5.4	0.0	0.2	163.4	0.0	0.0	39.2	0.5	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	5.5	8.0	4.0	3.9	4.8	9.7	7.4	6.0	6.2	7.9	4.2	200.5	3.2	2.2	8.1	0.2	4.0	2.2	5.5	0.0	0.1	53.7	24.4	0.7	8.6	9.2	1.8	25.0	0.1	0.7	0.1	0.0	0.4	0.6	9.2	1.6	24.3	0.0	2.7	0.1	0.0	0.2	9.8	0.0	12.5	0.0	653.3	24.7	19.4	0.1	0.0	1.3	0.0	8.2	1.3	6.6	3.6	11.8	1.3	1.8	1.0	0.0	0.2	0.0	2.5	0.0	0.2	0.0	6.8	0.3	8.9	0.0	0.0	30.0	0.6	0.0	37.3	3.1	0.8	6.0	0.6	3.0	0.1	0.6	0.2	0.0	3.2
INSC		ENSG00000188487	"INSC spindle orientation adaptor protein"	Q1MX18	11	15112424-15247208	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"parathyroid gland: 25.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.9;Early spermatids: 4.6;Exocrine glandular cells: 3.1;Oligodendrocyte precursor cells: 8.0;Pancreatic endocrine cells: 10.9;Proximal tubular cells: 8.9"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;hTERT-HME1: 6.0;Karpas-707: 3.3;LHCN-M2: 3.6;TIME: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039769	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039769: AB_10697556"	"unprognostic (1.64e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.88e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.00e-2)"	0.2	0.8	0.2	1.0	0.1	0.6	0.2	0.1	0.2	1.1	0.1	4.7	2.1	0.1	0.1	0.5	0.3	0.6	1.2	0.1	0.2	0.3	0.2	0.9	0.0	0.3	0.2	0.1	0.9	25.3	0.2	0.0	0.2	1.0	1.8	0.0	0.5	1.0	0.0	0.1	3.0	0.5	0.2	0.1	2.4	0.7	0.1	0.2	0.3	0.1	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.3	11.7	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.4	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.5	0.6	6.0	0.0	0.0	0.0	0.0	3.3	3.6	0.0	0.0	0.2	0.0	0.1	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	1.0	0.0	0.0	1.5	0.2	0.0	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.9	0.1	4.6	0.2	0.0	0.1	1.8	0.0	0.5	3.1	0.0	0.9	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	0.0	10.9	0.0	0.0	0.1	0.2	0.0	8.9	0.0	0.0	0.0	0.0	1.1	1.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	106	"intestine: 128.9"	"Cell type enriched"	"Detected in some"	365	"Enteroendocrine cells: 8836.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA030100, CAB033849"	Enhanced				"Secreted to blood"	NA	NA	38500000			"Cluster 37: Intestine - Unknown function"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.8	1.1	0.0	1.2	75.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.8	0.5	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.2	0.0	0.9	0.1	128.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.8	1.1	0.8	0.8	1.1	1.0	0.9	0.9	0.8	0.9	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.3	0.0	0.0	8836.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	22.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	11.4	0.0
IQANK1		ENSG00000203499	"IQ motif and ankyrin repeat containing 1"	A8MXQ7	8	143734139-143790645	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.2;skin 1: 28.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.4;Breast myoepithelial cells: 6.3;Collecting duct cells: 7.3;Cytotrophoblasts: 8.8;Endometrial ciliated cells: 23.2;Extravillous trophoblasts: 6.0;Respiratory ciliated cells: 12.4;Syncytiotrophoblasts: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.5;HaCaT: 29.4;hTCEpi: 35.4;MCF7: 72.3;OE19: 68.6;RT4: 30.3;SK-BR-3: 30.0;T-47d: 64.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.45e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.40e-2)"	0.2	0.3	0.8	0.6	1.2	0.8	6.1	1.2	1.0	8.3	2.2	1.8	1.3	0.8	21.5	41.2	13.6	1.3	0.2	1.1	0.4	3.0	0.5	3.5	0.2	1.5	2.9	0.2	4.7	3.3	1.9	3.5	1.0	7.2	2.4	1.9	8.0	2.0	0.3	28.7	0.9	0.2	0.7	0.3	4.1	8.4	0.6	0.6	2.6	0.0	3.9	6.3	18.5	1.0	17.6	1.1	0.2	0.8	0.1	0.2	19.5	0.3	0.0	0.1	0.2	9.2	26.5	0.1	2.0	0.1	0.1	29.4	0.9	3.4	0.2	0.2	0.8	0.1	2.8	2.1	0.5	0.2	0.2	0.3	35.4	0.2	0.7	0.4	0.0	0.6	1.3	0.2	0.0	72.3	0.1	0.2	1.5	68.6	1.1	0.2	0.1	0.6	1.9	30.3	9.8	0.2	2.6	30.0	1.1	2.3	64.4	0.4	0.2	0.3	1.0	0.5	0.1	0.5	0.2	0.2	0.1	0.3	0.5	0.8	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	1.4	0.2	0.2	0.2	0.0	0.0	0.8	1.2	1.2	1.0	1.1	0.4	1.5	2.9	1.0	0.7	0.6	1.0	0.1	0.0	3.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.4	6.3	0.0	0.0	3.7	7.3	0.0	8.8	0.0	0.0	0.0	2.0	0.0	23.2	0.7	0.3	0.0	0.0	0.0	1.6	6.0	0.4	0.0	5.2	1.3	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.3	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.1	0.2	0.0	0.0
IQCJ-SCHIP1		ENSG00000283154	"IQCJ-SCHIP1 readthrough"	B3KU38	3	158962235-159897366	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 165.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 7.3;Basal squamous epithelial cells: 12.5;Bipolar cells: 11.5;Excitatory neurons: 11.3"					"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA003243, HPA003445"	Approved		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA003243: AB_1079877, HPA003445: AB_1079875"																		22.0	5.1	82.3	9.7	90.6	2.2	15.4	84.9	165.9	9.2	56.6	49.8	4.5	19.6	6.3	15.4	18.2	12.5	57.2	83.9	73.9	17.8	14.3	19.6	2.2	93.5	88.0	4.4	2.7	1.1	7.3	23.6	92.0	17.7	6.8	14.2	6.5	20.4	27.6	5.7	12.8	25.9	81.5	4.3	18.3	4.7	87.2	2.5	5.7	3.2	1.8	35.8	10.8	110.5	87.9	14.8	28.9	34.4	6.6	6.3	25.1	73.6	17.3	59.4	40.5	55.6	20.9	4.4	46.4	24.6	22.6	34.8	11.3	24.9	48.5	72.7	27.6	0.1	31.2	2.8	7.7	4.2	0.5	6.5	20.8	26.5	31.1	49.3	44.5	4.9	0.0	0.3	27.7	3.9	0.3	0.0	24.2	7.0	31.9	10.2	58.4	0.0	57.6	4.7	5.8	26.8	39.8	16.7	21.8	32.9	9.8	0.8	37.6	34.0	47.5	22.9	101.5	0.3	0.5	0.4	19.1	12.4	92.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	82.3	90.6	84.9	165.9	83.9	73.9	93.5	88.0	92.0	81.5	87.2	110.5	4.7	6.4	0.0	1.0	0.1	1.5	7.3	0.8	12.5	11.5	0.3	0.9	0.6	0.0	1.4	1.8	6.2	0.0	0.1	0.3	0.0	0.9	2.0	2.1	0.8	5.7	0.0	0.0	11.3	0.6	0.0	3.1	0.0	2.3	2.5	0.0	1.8	0.6	0.0	0.0	4.7	0.2	0.0	0.3	1.2	0.6	0.3	1.2	0.0	0.0	0.6	0.5	0.0	0.0	0.6	1.2	0.0	1.2	0.0	1.3	0.0	4.2	2.4	0.6	0.0	2.5	5.4	0.1	0.4	3.5	0.9	0.0	0.5	0.0	0.2	1.6
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 11.2;Late spermatids: 26.6;Undifferentiated cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	0.7	0.7	0.2	2.2	0.4	15.5	0.6	0.0	0.6	1.1	0.2	4.1	6.6	0.5	1.1	5.2	0.2	0.7	0.4	0.5	0.1	0.6	0.6	1.6	1.6	0.9	0.4	0.1	0.2	0.1	0.1	2.8	0.9	0.4	5.0	0.0	1.0	0.1	0.3	3.7	5.7	2.9	0.0	0.8	4.6	3.8	0.6	3.4	0.2	0.0	2.2	0.9	2.1	0.4	59.2	28.4	25.6	18.1	1.6	4.0	12.4	43.1	28.3	41.0	36.6	32.4	52.5	5.2	15.6	25.2	21.6	54.6	17.5	22.1	36.3	0.1	15.7	7.8	62.6	16.1	0.2	9.7	0.1	1.2	2.5	34.3	50.0	10.0	24.1	12.5	16.1	8.1	30.2	31.2	5.7	13.7	18.6	57.7	28.0	18.9	28.8	6.1	10.4	20.3	16.3	25.2	38.7	44.9	14.9	29.8	35.8	25.6	16.8	36.8	43.7	30.4	51.4	4.0	2.1	2.4	12.4	15.1	42.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.2	0.4	0.0	0.6	0.5	0.1	0.9	0.4	0.9	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.4	1.3	0.1	0.4	0.6	0.0	1.4	1.3	1.0	2.8	0.1	0.0	0.0	2.2	0.1	3.9	0.0	0.3	6.5	0.5	0.7	0.6	1.2	6.5	0.7	0.0	3.6	0.9	11.2	1.4	0.0	4.4	2.5	0.4	3.9	0.0	0.2	3.7	0.0	1.3	6.1	26.6	0.3	1.9	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	0.4	0.8	0.4	0.0	0.0	0.0	0.0	1.4	6.4	2.6	3.6	1.0	0.8	0.2	0.3	7.4	0.4
IRAG1	"IRAG, JAW1L, MRVI1"	ENSG00000072952	"Inositol 1,4,5-triphosphate receptor associated 1"	Q9Y6F6	11	10573091-10693988	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Cardiomyocytes: 7.4;Hofbauer cells: 11.1;Smooth muscle cells: 28.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 24.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 20.8;BJ: 15.3;BJ hTERT+: 17.6;fHDF/TERT166: 6.9;REH: 6.8"	"Region enriched"	"Detected in many"	5	"thalamus: 7.6"	"Low region specificity"	"Detected in all"			HPA008704	Uncertain		Approved	"Nuclear bodies,Cytosol"		NA	NA		220000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Nuclear bodies"	"HPA008704: AB_1079413"	"unprognostic (2.18e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-3)"	"prognostic favorable (5.78e-4)"	"unprognostic (5.30e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (9.70e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-3)"	29.7	8.0	64.6	18.2	85.8	1.5	16.1	50.4	53.4	55.4	17.7	67.6	8.5	60.8	16.1	37.5	45.6	33.2	10.1	54.5	54.3	9.3	2.1	13.3	3.7	65.8	71.4	20.2	2.9	2.7	3.8	11.8	54.4	37.9	17.3	1.7	4.1	39.5	6.7	9.3	22.0	69.1	55.2	7.1	33.7	8.2	89.8	2.3	10.2	8.1	1.8	43.8	21.9	48.8	0.1	0.0	4.2	0.0	20.8	4.1	0.2	15.3	17.6	0.0	0.0	0.4	1.7	0.0	0.1	6.9	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.7	0.0	0.1	0.2	0.0	0.2	4.8	0.4	0.0	0.1	0.0	1.2	0.0	0.6	0.1	0.3	0.0	0.1	0.3	0.5	0.0	0.1	6.8	0.0	0.3	0.0	0.0	0.0	3.1	0.0	2.6	0.0	4.4	0.0	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	6.0	0.0	0.7	2.2	1.7	0.0	3.9	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	24.0	0.0	5.7	0.1	0.0	0.7	64.6	85.8	50.4	53.4	54.5	54.3	65.8	71.4	54.4	55.2	89.8	48.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785617-209806175	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 95.4;skin 1: 114.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 387.2;Basal prostatic cells: 253.9;Basal squamous epithelial cells: 217.9;Squamous epithelial cells: 251.9;Suprabasal keratinocytes: 552.4;Urothelial cells: 290.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 10.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 61.9;HaCaT: 210.7;HBEC3-KT: 80.5;hTCEpi: 170.1;hTERT-HME1: 82.2;RT4: 78.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.6	11.4	1.6	3.2	1.5	2.8	35.9	10.9	1.8	21.6	5.2	27.1	26.9	5.9	49.3	95.4	21.7	10.8	29.7	1.7	1.4	17.0	33.3	8.8	0.9	1.9	2.9	1.9	19.7	26.4	6.5	20.4	1.9	32.4	31.5	2.4	39.0	26.4	0.5	114.0	25.0	2.0	2.1	2.1	24.8	2.9	2.3	20.3	17.1	2.7	23.0	40.5	46.8	1.2	61.9	0.0	0.0	0.0	0.4	0.0	20.9	0.1	0.5	0.1	0.3	13.6	20.7	0.0	0.1	0.1	0.0	210.7	0.0	80.5	0.0	0.0	1.3	0.1	0.2	0.0	0.2	0.0	0.2	0.1	170.1	0.1	82.2	0.0	3.7	0.0	0.1	0.2	0.0	8.3	0.0	0.3	1.2	17.0	0.2	0.0	0.0	0.3	7.7	78.8	18.7	6.1	1.4	34.1	1.9	3.8	24.1	0.3	0.0	0.0	0.1	0.0	0.3	0.8	15.8	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	1.6	1.5	10.9	1.8	1.7	1.4	1.9	2.9	1.9	2.1	2.3	1.2	1.9	16.0	10.4	0.3	1.0	387.2	253.9	154.0	217.9	0.1	47.2	33.3	26.0	32.9	70.4	35.0	0.0	94.2	1.3	95.5	27.4	36.7	1.1	120.2	9.5	6.0	59.9	0.4	0.0	19.2	25.4	4.5	53.0	121.7	2.5	0.0	1.1	35.9	8.3	0.0	0.1	74.9	38.7	1.0	30.1	0.7	0.6	2.3	35.6	1.9	1.0	6.5	0.0	0.0	0.0	49.2	43.8	0.0	2.5	153.9	49.5	11.9	82.1	0.6	0.0	0.4	7.4	8.2	3.7	251.9	552.4	161.6	2.5	0.7	44.5	290.3
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"intestine: 37.5"	"Group enriched"	"Detected in some"	32	"Distal enterocytes: 24.2;Enteroendocrine cells: 19.4;Intestinal goblet cells: 16.0;Paneth cells: 19.4;Proximal enterocytes: 32.7;Undifferentiated cells: 23.8"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 1.6;Hep G2: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	37.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.0	0.0	0.0	0.0	0.0	0.0	27.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.2	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.1	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.8	0.0
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 182.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 45.4;granulocytes: 35.5;Hofbauer cells: 47.2;Kupffer cells: 117.7;Langerhans cells: 45.5;Macrophages: 83.2;Microglial cells: 41.2;monocytes: 87.4;NK-cells: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 50.0;NB-4: 19.9;U-937: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		1000000	"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	13.4	4.7	3.4	24.7	3.5	182.8	3.0	4.5	4.2	3.3	4.8	3.0	2.2	2.0	0.7	2.6	2.3	5.9	2.9	3.6	5.1	1.0	3.5	16.4	7.4	6.7	5.7	1.6	2.3	1.3	0.1	7.7	7.3	1.5	3.4	0.3	2.4	2.2	1.4	1.7	3.5	11.2	6.5	13.1	3.1	1.4	8.6	5.2	1.0	3.1	10.4	8.0	0.2	10.8	0.8	1.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.5	0.8	1.3	0.9	0.0	0.4	0.1	0.0	0.4	0.0	7.6	0.0	1.0	0.0	0.0	0.0	1.8	50.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	19.9	0.0	0.0	0.0	0.3	0.1	1.0	0.0	2.2	0.0	0.0	0.0	0.5	0.4	0.0	0.2	4.3	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	22.6	0.1	93.3	55.7	70.2	31.1	20.9	1.9	4.8	3.3	9.5	9.5	1.0	0.9	7.7	58.4	54.4	3.2	0.6	1.2	27.0	3.4	3.5	4.5	4.2	3.6	5.1	6.7	5.7	7.3	6.5	8.6	10.8	1.4	3.2	9.8	0.7	9.3	1.1	0.3	1.5	0.0	0.0	1.8	3.8	2.3	4.3	1.8	0.0	0.0	0.3	45.4	0.0	0.0	1.2	0.5	0.3	0.4	1.6	3.6	9.4	1.0	0.0	0.7	1.1	1.1	0.5	35.5	0.5	2.2	1.2	47.2	0.0	1.0	0.1	0.0	117.7	45.5	1.8	0.3	83.2	0.0	41.2	87.4	0.0	75.2	3.0	0.3	0.9	0.0	0.0	4.5	0.5	0.0	0.2	0.9	0.0	13.1	1.2	0.5	0.7	0.9	0.5	1.0	0.8	14.9	0.0	0.3	0.2
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301750-71305371	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 89.4;skeletal muscle: 46.1;tongue: 52.9"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 80.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040721			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA040721: AB_10805827"	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.6	0.5	1.5	0.6	1.5	0.5	1.0	0.9	2.4	0.5	6.5	1.0	16.6	3.0	4.1	3.3	2.5	89.4	0.6	0.6	0.8	1.4	1.0	0.9	0.6	0.6	1.6	0.5	0.0	0.5	0.3	0.6	6.0	1.8	1.8	1.3	10.3	46.1	0.6	2.1	16.3	0.5	1.1	2.0	1.3	0.6	1.0	0.7	52.9	0.6	5.5	1.5	0.7	0.5	1.4	2.1	1.8	0.1	0.1	0.4	0.7	1.0	0.5	0.5	0.9	1.1	2.1	0.2	1.1	0.5	0.9	1.9	0.6	1.1	0.7	0.9	1.3	1.5	0.4	0.2	0.4	9.3	1.1	0.7	0.2	0.3	0.4	0.8	2.2	1.0	0.5	1.1	0.4	0.8	2.3	3.1	1.4	0.9	1.4	1.6	0.8	1.0	1.3	1.0	0.3	0.5	0.1	0.6	1.4	0.5	0.3	0.0	0.9	1.8	0.1	0.4	1.8	2.8	3.1	0.2	1.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.0	0.9	0.6	0.6	0.6	0.6	0.6	0.5	0.6	0.7	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	1.7	0.3	0.3	80.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.6	0.1	0.2	0.2	0.8	0.0	0.4	0.2	0.0	0.1	2.3	0.0	0.2	0.0	0.4	1.1	0.8	0.2	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.1	8.6	0.0	0.3	0.1	0.5	0.3	1.1	0.0	0.6	2.5	0.5	0.4	0.0	0.3	0.0	0.1	0.6	0.3	0.1
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 376.2;lymphoid tissue: 175.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 417.6;Hofbauer cells: 652.4;Kupffer cells: 485.9;Langerhans cells: 259.1;Macrophages: 527.4;monocytes: 463.8;NK-cells: 959.9;T-cells: 254.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"THP-1: 812.4;U-937: 615.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		3300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	54.5	23.2	8.2	175.2	9.5	376.2	15.4	13.1	9.3	15.5	11.7	25.2	23.8	8.5	2.8	16.2	17.0	36.4	11.8	7.7	14.2	8.4	23.4	78.0	169.1	29.5	19.9	7.2	11.3	5.1	4.6	44.4	28.1	8.8	13.9	1.1	19.5	9.2	6.8	9.3	32.8	46.4	23.9	137.2	29.1	5.9	26.2	87.2	7.3	7.6	68.4	46.3	5.9	50.4	1.9	4.8	0.0	0.0	0.0	0.3	1.7	0.0	2.7	0.1	0.0	0.4	0.4	17.9	128.1	0.2	0.6	0.5	0.0	0.2	0.0	1.5	1.4	18.2	0.0	3.2	0.1	106.6	27.5	1.6	0.1	0.5	0.3	0.1	0.3	58.0	0.7	1.4	7.0	4.0	117.8	126.1	0.4	0.4	2.4	1.5	23.2	64.6	4.7	0.0	0.6	1.3	3.4	2.5	1.7	0.0	0.4	812.4	2.5	0.2	6.6	0.4	3.7	0.8	5.9	2.9	0.1	615.0	0.9	186.6	1848.8	1224.1	726.7	1144.9	326.6	86.1	349.7	506.5	1031.4	115.2	233.1	396.5	1386.1	585.5	1183.5	165.5	288.0	3034.2	8.2	9.5	13.1	9.3	7.7	14.2	29.5	19.9	28.1	23.9	26.2	50.4	7.1	16.0	29.6	0.3	81.7	5.5	0.5	9.6	0.6	0.0	4.1	6.5	4.0	14.3	18.6	5.5	0.0	4.0	417.6	0.3	0.0	3.4	1.0	0.6	0.5	16.8	0.0	19.6	0.5	0.4	4.8	5.3	2.6	0.7	24.1	8.2	9.7	8.6	652.4	0.0	0.3	0.2	2.0	485.9	259.1	2.8	0.6	527.4	5.4	27.2	463.8	0.4	959.9	0.0	0.2	0.6	0.1	1.5	50.5	0.6	1.8	4.2	3.6	0.8	6.6	2.1	3.2	0.2	1.0	0.9	5.1	5.6	254.5	0.0	0.3	0.7
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 45.1;dendritic cells: 62.3;NK-cells: 134.9;Plasma cells: 115.9;T-cells: 62.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	99	"Karpas-707: 4821.4;RPMI-8226: 3980.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042277			Approved	"Plasma membrane,Cytosol"		NA	NA		130000	"Cluster 52: Eosinophils - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.6	1.4	1.7	20.0	1.8	15.5	1.9	1.7	2.2	2.7	2.0	9.7	11.7	1.6	2.8	6.4	2.9	3.9	0.8	1.5	2.0	4.7	5.3	6.6	29.2	2.3	1.8	0.7	1.2	0.7	1.3	0.5	2.0	1.7	9.5	1.0	4.1	2.3	0.7	11.9	17.3	2.4	1.9	30.0	8.2	0.6	2.8	8.6	3.1	0.6	26.5	6.2	2.9	2.1	0.1	0.0	0.0	0.3	0.1	0.7	1.4	0.5	0.0	0.0	0.5	0.0	2.1	44.5	0.8	0.0	0.0	9.4	0.0	0.3	0.0	16.5	0.0	1.5	0.0	0.0	0.0	1.0	18.5	1.0	1.8	0.2	0.1	0.6	0.0	2.2	0.4	4821.4	0.0	1.6	0.9	7.0	0.3	41.7	0.1	1.8	0.0	3980.8	0.0	1.2	1.9	0.6	0.1	1.8	0.5	0.0	0.8	10.4	0.0	0.3	0.6	0.9	0.0	8.9	17.9	3.8	3.8	2.6	1.6	80.7	5.6	97.7	52.0	1.4	38.2	28.1	51.8	63.0	44.5	29.8	44.5	44.4	1.5	23.7	0.4	11.9	71.8	17.3	1.7	1.8	1.7	2.2	1.5	2.0	2.3	1.8	2.0	1.9	2.8	2.1	1.0	3.2	5.5	1.3	45.1	2.2	0.3	1.7	3.4	0.1	1.3	1.0	0.5	2.8	1.3	7.3	4.2	0.1	62.3	0.6	7.9	0.3	0.0	1.2	0.4	0.9	0.0	2.1	0.0	0.5	0.1	1.3	2.6	2.4	29.2	0.1	0.4	2.2	13.3	0.0	0.1	0.5	0.0	3.7	10.3	0.3	0.0	17.3	7.2	1.9	13.3	7.0	134.9	0.0	0.5	0.9	1.7	0.0	115.9	0.2	0.0	7.6	0.2	0.8	0.0	1.0	8.2	0.2	1.4	3.3	3.7	0.1	62.5	0.1	1.2	1.4
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9;choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	133	"basophil: 16.5"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	3.8	2.6	25.7	4.2	41.8	0.3	9.6	53.9	19.2	15.4	39.4	3.7	3.2	7.7	14.0	6.4	7.5	8.7	2.9	19.5	37.5	21.6	0.8	2.4	0.5	38.9	48.4	4.7	13.3	5.1	5.4	5.2	42.7	6.7	2.8	4.6	13.6	9.0	0.2	6.3	4.2	3.0	39.7	0.0	4.2	6.5	35.6	0.8	2.1	0.9	6.9	7.2	9.0	48.6	28.2	1.1	44.3	5.6	3.7	15.2	0.0	0.1	0.5	0.2	1.5	0.3	6.9	0.0	54.6	2.0	1.7	30.1	1.9	4.5	0.5	0.0	0.7	0.0	23.1	0.0	1.8	0.0	0.1	1.8	12.6	0.5	2.4	27.1	2.4	0.0	0.0	8.3	0.8	0.1	0.0	0.0	3.3	0.4	4.8	0.0	3.7	0.0	88.1	2.5	0.7	1.9	8.6	0.2	23.5	0.8	0.7	0.1	3.0	11.2	7.1	3.2	5.8	10.2	0.1	0.0	2.7	0.0	127.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	25.7	41.8	53.9	19.2	19.5	37.5	38.9	48.4	42.7	39.7	35.6	48.6	0.7	12.8	4.8	106.4	2.5	33.1	117.2	39.4	34.7	13.3	26.3	18.7	3.0	38.6	57.9	38.6	0.0	20.0	0.4	5.0	7.9	26.3	3.0	376.2	150.6	5.2	34.0	0.0	28.1	17.4	1.2	15.5	7.7	551.9	1.3	0.9	1.4	0.2	3.3	1.7	8.2	7.4	34.6	1.0	4.7	6.5	44.1	9.8	3.6	4.7	31.6	24.3	0.0	192.0	119.2	35.8	6.1	44.8	2.0	149.7	14.5	76.7	100.1	1.4	0.0	4.8	7.0	1.4	1.1	34.6	12.4	4.9	5.5	1.9	9.6	150.7
ITK	"EMT, LYK, PSCTK2"	ENSG00000113263	"IL2 inducible T cell kinase"	Q08881	5	157142933-157255185	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 57.9"	"Group enriched"	"Detected in some"	6	"dendritic cells: 51.7;granulocytes: 31.8;NK-cells: 42.2;Plasma cells: 34.0;T-cells: 115.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	23	"gdT-cell: 39.6;MAIT T-cell: 26.4;memory CD4 T-cell: 55.6;memory CD8 T-cell: 54.9;naive CD4 T-cell: 78.2;naive CD8 T-cell: 65.0;NK-cell: 29.3;T-reg: 73.2"	"Group enriched"	"Detected in many"	23	"NK-cells: 29.3;T-cells: 78.2"	"Group enriched"	"Detected in some"	10	"JURKAT: 62.2;MOLT-4: 23.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043670			Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA043670: "	"unprognostic (2.08e-3)"	"unprognostic (6.57e-4)"	"unprognostic (5.06e-3)"	"unprognostic (4.96e-5)"	"unprognostic (1.52e-2)"	"unprognostic (1.12e-4)"	"unprognostic (8.45e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.52e-6)"	"unprognostic (3.64e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.26e-2)"	1.0	0.3	0.0	15.9	0.0	3.7	0.9	0.0	0.0	1.0	0.0	1.4	0.7	0.4	0.0	1.4	0.4	4.2	0.2	0.0	0.0	0.3	1.6	3.1	29.3	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	1.5	0.0	0.3	0.1	0.0	0.2	4.0	0.5	0.0	10.5	3.1	0.5	0.0	57.9	0.5	0.0	24.6	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	3.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	62.2	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	39.6	0.0	26.4	0.0	55.6	54.9	0.1	0.0	78.2	65.0	1.3	29.3	2.3	0.1	73.2	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	6.2	0.0	4.0	2.7	0.6	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.6	1.8	0.0	0.1	51.7	0.1	0.0	0.1	8.5	0.2	0.3	0.8	0.0	1.7	0.2	0.0	0.0	1.1	7.7	0.4	31.8	0.1	1.8	1.0	0.0	0.0	0.2	0.0	0.0	1.6	5.1	6.7	0.0	2.9	1.8	1.0	2.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	34.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.2	3.4	0.1	115.7	0.0	0.1	0.6
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876540-160885180	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 757.3;intestine: 1247.8"	"Cell type enriched"	"Detected in many"	14	"Intestinal goblet cells: 1818.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 9.2;non-classical monocyte: 24.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 24.1"	"Group enriched"	"Detected in some"	4	"HEL: 2.6;HL-60: 1.9;OE19: 7.2;U-937: 7.1"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	NA	NA	294000000	6400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764"	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	757.3	0.3	0.0	26.4	0.0	2.6	0.5	0.0	0.0	0.3	0.0	444.2	272.7	0.5	2.1	0.4	6.2	0.8	233.8	0.0	0.0	35.5	3.1	40.3	0.3	0.0	0.0	9.7	3.3	0.0	0.4	1.3	0.0	0.6	1247.8	0.0	24.9	3.3	0.7	0.2	415.7	7.7	0.0	2.5	15.9	2.0	0.0	0.7	0.6	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.2	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	24.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.6	71.4	2.1	3.7	0.0	0.1	0.1	46.4	0.0	37.7	0.8	0.0	0.0	4.3	18.0	4.0	0.0	3.6	1.4	87.8	8.6	0.0	1.3	1.4	60.7	1.9	0.8	0.0	0.0	1818.6	0.0	124.7	0.0	0.7	14.6	1.8	0.0	0.0	0.3	0.0	1.0	0.0	0.0	7.3	17.7	3.0	0.0	0.3	15.4	0.1	0.8	0.0	0.0	0.0	10.8	0.1	0.9	0.0	0.0	0.3	2.1	15.3	59.4	0.1
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;intestine: 18.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.6;OE19: 18.2"	"Low region specificity"	"Detected in all"							HPA040454	Enhanced	Approved	Approved	"Vesicles,Plasma membrane"		No	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Plasma membrane"	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.2	7.3	21.4	0.7	26.7	0.4	0.2	13.8	36.5	1.3	10.9	10.7	17.6	0.3	0.1	0.3	0.5	0.2	2.6	28.7	12.4	0.2	1.7	0.5	0.1	10.9	12.0	0.3	1.9	2.0	0.4	0.3	11.6	0.8	2.7	0.3	1.4	0.3	4.4	0.4	18.1	0.3	11.3	0.2	10.9	10.4	12.1	0.0	0.2	0.0	0.0	0.6	0.9	20.4	7.1	1.9	0.3	7.9	0.0	2.5	14.3	4.3	3.4	2.8	2.9	16.3	0.3	0.0	3.5	0.4	6.3	0.8	3.4	0.3	0.2	6.6	4.3	9.9	4.7	33.6	12.6	3.4	0.5	0.2	0.2	2.7	0.8	1.6	0.2	1.3	12.9	1.9	1.0	4.7	0.3	6.5	0.9	18.2	5.6	1.7	1.4	0.6	0.3	0.4	0.7	1.5	3.2	0.0	0.3	0.0	0.9	5.0	0.3	6.9	7.1	7.7	11.8	1.0	10.8	0.0	12.6	13.2	2.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	21.4	26.7	13.8	36.5	28.7	12.4	10.9	12.0	11.6	11.3	12.1	20.4	0.1	0.0	0.0	3.3	0.5	0.1	0.3	0.1	0.0	0.0	0.3	0.0	1.4	0.0	0.1	0.0	0.0	0.6	0.1	51.4	0.0	0.1	45.4	0.3	2.4	0.5	0.0	0.8	23.7	0.7	0.5	0.3	34.1	0.3	0.0	1.0	0.4	0.3	0.2	0.0	0.8	12.0	0.0	0.0	0.0	166.4	2.5	0.4	0.0	1.9	0.0	7.9	0.0	1.5	2.9	0.8	16.1	1.5	0.1	0.1	35.8	0.1	0.1	0.2	6.6	0.3	0.5	14.4	4.9	0.0	0.0	0.1	0.4	0.1	18.7	0.2
ITPKC	"IP3-3KC, IP3KC"	ENSG00000086544	"Inositol-trisphosphate 3-kinase C"	Q96DU7	19	40717112-40740860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 96.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 151.4;Glandular and luminal cells: 139.3;Squamous epithelial cells: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050760, HPA053003"	Approved		Supported	"Nuclear speckles"		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Nuclear speckles"		"HPA050760: AB_2681227, HPA053003: AB_2682011"	"unprognostic (4.27e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.31e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.81e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.32e-1)"	45.3	13.9	11.2	10.8	9.6	3.5	29.4	9.4	10.7	32.6	11.6	16.8	11.7	18.6	4.7	96.7	25.0	23.0	19.3	10.0	10.7	18.8	17.7	41.8	6.0	15.0	11.5	12.9	22.8	10.3	22.0	10.3	11.6	27.1	6.8	5.5	31.1	10.5	18.4	51.0	16.9	16.3	10.8	14.5	26.3	6.0	15.2	8.7	17.2	8.9	13.9	22.4	42.0	9.3	12.9	12.0	7.3	11.5	32.2	27.8	11.6	7.5	15.7	7.6	6.7	17.3	13.1	3.5	8.5	9.7	5.7	13.3	7.3	32.6	3.1	6.7	7.5	2.7	4.5	12.3	31.8	3.0	3.6	38.8	46.4	7.2	26.5	10.3	18.9	5.0	10.6	6.1	7.5	15.7	4.4	4.5	3.7	29.4	5.4	4.7	3.6	4.9	12.0	21.5	5.2	6.5	7.6	30.5	7.2	8.4	14.1	7.6	12.2	4.9	7.3	3.3	5.1	3.5	0.9	3.7	7.6	3.1	5.4	0.9	0.7	0.4	0.8	0.3	0.3	0.3	0.6	0.4	0.3	0.7	0.4	0.5	0.3	0.2	0.5	0.5	0.6	0.4	11.2	9.6	9.4	10.7	10.0	10.7	15.0	11.5	11.6	10.8	15.2	9.3	75.4	86.6	35.2	6.5	2.7	60.4	72.4	17.4	39.9	10.0	88.4	44.4	4.1	7.2	29.7	3.7	0.0	7.7	2.8	57.7	1.9	13.9	2.1	67.5	23.2	26.4	16.7	3.2	7.4	12.3	5.5	20.1	151.4	139.3	3.8	4.3	25.7	6.8	2.9	5.0	6.0	27.2	2.0	7.8	9.6	2.2	11.8	6.8	19.6	6.5	3.1	3.7	3.1	9.0	3.5	23.2	50.8	7.5	1.2	65.3	28.7	4.4	29.4	6.2	0.0	7.1	10.1	1.9	2.0	160.8	53.4	16.8	5.2	4.6	18.0	98.6
ITPRIPL1	KIAA1754L	ENSG00000198885	"ITPRIP like 1"	Q6GPH6	2	96325317-96330517	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Group enriched"	"Detected in many"	10	"Early spermatids: 170.7;Late spermatids: 145.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 12.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 12.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.9;HEL: 32.0;MOLT-4: 34.5;RPMI-8226: 33.0;U-698: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (4.78e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.56e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.41e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (6.39e-2)"	3.4	0.4	0.5	2.9	1.0	1.1	3.8	3.2	0.7	0.9	0.3	0.9	1.2	0.5	0.5	1.5	0.8	1.6	1.3	0.5	0.5	0.5	0.5	1.4	3.9	0.9	0.5	0.4	1.4	0.5	0.4	1.2	0.8	2.0	0.9	0.9	7.5	1.5	1.5	0.8	1.7	1.0	0.6	2.6	1.2	27.8	0.6	5.1	0.7	2.0	4.2	1.5	1.2	0.8	0.0	0.0	7.3	0.1	0.8	1.9	8.3	1.6	8.7	7.2	14.1	3.3	0.3	0.0	0.1	3.1	0.1	0.7	25.4	0.0	8.1	15.7	30.9	32.0	0.2	14.4	3.9	0.1	0.0	5.4	0.0	8.3	0.0	0.0	4.7	20.4	0.0	10.6	0.2	0.0	34.5	5.0	10.5	0.0	0.0	22.7	23.1	33.0	0.3	0.0	21.2	14.2	0.0	0.0	0.1	4.4	0.0	5.3	2.4	0.0	0.8	0.1	0.1	15.4	21.4	35.3	4.1	0.0	6.8	0.4	0.2	0.0	10.2	0.2	12.9	1.6	3.3	9.7	1.2	0.4	0.7	4.1	0.1	2.7	0.0	0.5	6.3	2.3	0.5	1.0	3.2	0.7	0.5	0.5	0.9	0.5	0.8	0.6	0.6	0.8	9.4	3.2	0.0	0.0	2.3	0.3	4.8	1.8	2.2	0.7	3.6	2.9	0.7	2.8	3.5	0.0	4.2	0.9	6.9	1.0	0.0	0.1	170.7	0.2	0.6	2.7	0.0	1.7	0.2	0.2	2.3	0.9	0.5	0.1	0.0	0.8	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	2.4	145.2	1.2	1.8	1.8	0.0	0.3	4.3	11.3	0.0	0.0	0.3	0.1	0.7	7.6	3.3	0.0	0.3	0.8	1.7	6.6	0.6	2.9	3.6	2.8	1.7	1.0	0.4	14.8	0.3	0.4	1.3
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
JAG2		ENSG00000184916	"Jagged canonical Notch ligand 2"	Q9Y219	14	105140982-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.1;Basal respiratory cells: 30.9;Basal squamous epithelial cells: 27.3;Breast myoepithelial cells: 26.4;Endothelial cells: 34.2;Horizontal cells: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.6;HBEC3-KT: 21.0;SCLC-21H: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol		NA	NA		370000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178"	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	7.2	1.0	4.0	1.3	3.6	0.1	9.6	0.9	5.0	4.6	0.5	3.1	1.1	5.3	0.4	8.8	5.3	1.8	12.8	3.5	7.4	4.3	0.9	5.1	0.7	4.6	4.4	1.5	6.8	1.5	17.4	3.0	6.8	8.1	0.2	0.8	7.8	2.8	9.7	19.5	4.0	1.1	2.5	2.0	3.0	3.2	6.5	1.6	4.7	2.8	0.6	5.2	6.8	1.6	16.8	6.7	0.4	1.7	0.0	0.0	20.0	0.2	0.1	0.0	0.0	5.6	20.1	0.0	13.8	0.0	0.1	62.6	4.0	21.0	0.0	2.3	9.7	0.0	20.0	0.0	0.2	0.1	3.9	0.2	9.9	0.0	2.3	0.2	5.1	0.9	4.1	0.0	0.0	7.6	0.0	0.0	2.0	2.1	2.3	5.3	3.9	7.2	0.1	4.4	31.4	1.0	5.6	1.3	0.2	0.3	15.8	2.5	17.2	0.1	1.7	0.0	0.2	0.9	0.1	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.6	0.9	5.0	3.5	7.4	4.6	4.4	6.8	2.5	6.5	1.6	56.1	6.4	3.2	1.0	0.2	23.3	7.6	30.9	27.3	2.7	3.8	26.4	6.7	2.8	7.6	0.0	25.0	2.2	2.2	2.7	0.0	3.9	0.1	16.5	0.9	34.2	0.0	0.0	12.1	2.7	1.0	1.8	2.0	7.4	0.0	1.1	7.9	0.6	0.7	26.9	9.9	3.6	4.1	0.8	2.9	1.0	1.5	1.1	7.2	15.0	1.3	0.6	1.0	0.5	1.1	3.3	2.1	0.7	0.9	4.4	8.2	0.3	11.5	4.8	0.0	3.7	3.7	0.8	13.5	6.0	6.8	1.4	3.4	0.3	2.7	1.5
JAKMIP1	"FLJ31564, Gababrbp, JAMIP1, MARLIN1"	ENSG00000152969	"Janus kinase and microtubule interacting protein 1"	Q96N16	4	6026199-6200591	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.1;pituitary gland: 10.2;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.6;dendritic cells: 17.6;Excitatory neurons: 82.9;Inhibitory neurons: 53.6;Muller glia cells: 61.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"gdT-cell: 25.3;MAIT T-cell: 11.2;memory CD4 T-cell: 11.2;memory CD8 T-cell: 22.6;naive CD8 T-cell: 10.1;T-reg: 36.7"	"Lineage enriched"	"Detected in many"	33	"T-cells: 36.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;JURKAT: 14.3;MOLT-4: 45.2;SCLC-21H: 18.6;U-266/70: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044570	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA044570: AB_2678995"	"unprognostic (4.79e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.86e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.25e-4)"	"unprognostic (7.14e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-8)"	"unprognostic (1.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.96e-3)"	0.3	4.8	21.4	1.0	31.1	1.3	0.1	5.0	30.4	0.2	0.1	1.0	0.2	0.1	0.1	0.3	0.2	0.5	0.1	21.6	22.0	0.2	0.3	0.9	3.0	9.0	13.5	0.5	0.6	0.0	10.2	0.0	12.8	4.2	0.2	17.0	0.7	0.1	0.1	0.1	1.1	0.2	7.1	2.6	0.6	5.2	16.2	0.3	0.7	0.0	0.6	0.7	0.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.6	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.4	45.2	0.0	3.4	0.0	2.6	2.3	0.0	0.7	0.0	0.0	18.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.3	0.0	11.2	0.3	11.2	22.6	0.0	0.2	0.8	10.1	0.1	1.1	0.0	0.1	36.7	5.4	21.4	31.1	5.0	30.4	21.6	22.0	9.0	13.5	12.8	7.1	16.2	20.3	0.2	0.0	0.0	35.6	0.8	0.0	0.0	0.0	0.0	1.5	0.2	0.1	0.8	0.0	0.0	0.0	2.1	0.0	17.6	0.0	0.0	0.0	1.5	0.1	0.2	0.1	0.0	0.4	82.9	0.0	0.0	0.5	2.6	0.8	0.0	0.2	0.0	0.0	0.1	3.3	53.6	0.0	0.0	1.3	0.5	2.4	0.0	0.5	0.0	7.5	0.3	61.2	12.3	7.1	3.1	0.1	0.0	0.0	2.3	1.3	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.9	4.6	0.0	0.1	0.0	16.2	0.4	0.0	0.0
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639258-25717562	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Astrocytes: 81.6;Endothelial cells: 148.7;Hepatic stellate cells: 112.8;Microglial cells: 82.4;Oligodendrocyte precursor cells: 76.9"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.5;BJ hTERT+: 16.5;HDLM-2: 16.7;hTERT-RPE1: 22.5;U-138 MG: 18.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	20.5	15.8	16.6	3.7	21.5	0.3	16.8	24.0	21.8	16.8	12.8	17.8	6.1	18.5	11.2	7.1	16.1	12.9	19.2	19.2	22.0	9.2	2.2	15.5	3.6	25.9	23.1	16.1	2.8	4.3	8.1	63.5	21.3	9.4	7.9	7.1	6.1	15.4	7.8	5.5	10.7	19.6	26.8	1.6	10.2	17.6	25.2	2.6	10.3	13.2	5.0	11.6	13.2	23.0	0.0	0.0	25.5	0.1	1.0	0.2	0.5	0.8	16.5	2.0	7.6	0.0	0.0	0.1	0.0	0.2	9.7	0.1	2.2	0.0	4.6	16.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.4	0.0	1.8	0.1	22.5	0.0	0.6	0.0	0.2	8.0	0.0	0.4	0.1	8.1	0.2	0.0	3.2	5.3	0.1	0.0	0.0	0.4	3.7	0.2	0.3	0.0	0.3	0.9	0.2	0.0	18.1	1.7	0.1	2.5	1.8	0.1	0.0	13.4	0.1	0.7	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.4	0.6	0.1	0.4	0.0	0.1	16.6	21.5	24.0	21.8	19.2	22.0	25.9	23.1	21.3	26.8	25.2	23.0	173.8	0.0	2.3	81.6	0.9	7.5	1.4	0.0	2.2	1.4	1.4	9.1	33.2	0.0	0.0	3.7	14.6	0.3	0.5	0.0	0.0	0.2	16.5	1.0	4.7	148.7	0.0	0.0	15.2	0.2	5.3	28.5	0.5	2.1	0.0	4.5	112.8	0.5	1.3	0.0	45.0	0.0	0.0	1.8	10.7	15.6	9.9	2.8	16.0	82.4	0.0	1.8	0.0	76.9	4.1	0.1	0.0	24.5	1.2	1.5	0.0	0.0	0.7	5.2	0.0	5.7	7.0	6.7	4.4	0.8	6.7	0.8	1.6	2.1	0.0	1.2
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 3028.0;intestine: 7979.6;stomach 1: 5916.2"	"Cell type enriched"	"Detected in many"	16	"Plasma cells: 101294.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	121	"memory B-cell: 4173.0;naive B-cell: 2555.1;plasmacytoid DC: 3578.1"	"Group enriched"	"Detected in all"	137	"B-cells: 4173.0;dendritic cells: 3578.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 3953.8;Karpas-707: 2117.6;RPMI-8226: 4469.2;U-266/70: 8794.0;U-266/84: 3519.2;U-698: 4949.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	NA	NA		2200000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favorable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	130.2	76.6	0.7	1089.0	0.8	76.3	3028.0	0.4	3.0	205.2	3.1	7979.6	6145.8	94.2	25.0	654.4	115.0	492.4	45.6	0.4	1.4	43.3	116.8	620.2	1033.5	1.9	1.0	183.5	78.3	2.1	2.0	2.4	0.8	90.2	6426.5	0.3	2420.5	258.4	4.2	13.2	4277.1	200.3	7.0	819.4	5916.2	40.0	0.8	155.3	19.4	0.8	1746.7	1059.4	11.6	2.8	8.9	0.0	0.0	0.0	0.0	0.0	15.5	8.2	1.5	0.1	0.1	0.0	0.0	3953.8	3.3	12.7	0.1	6.6	0.0	0.0	0.6	2.1	0.0	3.3	0.0	0.0	0.0	3.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.4	2117.6	0.1	0.0	6.1	14.9	4.9	0.0	0.0	4.8	2.6	4469.2	0.0	0.0	3.3	15.7	3.7	2.6	2.7	0.0	0.8	6.8	3.9	9.9	11.8	4.9	6.3	8794.0	3519.2	4949.0	2.1	5.2	1.2	25.1	7.5	2.6	4.0	1.5	19.1	4173.0	2.5	3.8	6.6	2555.1	2.1	2.1	28.3	4.5	2.5	3578.1	2.6	1310.4	0.7	0.8	0.4	3.0	0.4	1.4	1.9	1.0	0.8	7.0	0.8	2.8	3.0	22.4	101.3	0.0	6154.9	0.0	28.2	0.0	8.6	0.0	11.7	1.9	2.2	15.7	8.1	0.0	0.0	0.1	700.0	5.1	0.0	0.0	0.5	0.0	0.1	38.1	7.3	139.0	0.0	0.0	0.1	48.8	228.8	0.0	79.5	0.1	66.4	24.6	0.3	0.0	0.0	5.3	0.0	35.8	0.0	0.3	0.0	42.0	0.0	0.0	3.9	0.0	6.2	0.0	0.0	0.0	5.1	0.0	101294.9	32.7	0.0	5.4	3.6	0.0	0.0	0.6	88.4	1.4	0.3	24.3	0.0	0.3	1487.8	0.0	3.5	0.6
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
JPH4	"JPHL1, KIAA1831"	ENSG00000092051	"Junctophilin 4"	Q96JJ6	14	23568035-23578790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 126.2;pituitary gland: 66.5"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 191.4;Horizontal cells: 410.5"	"Cancer enhanced"	"Detected in some"		"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.8;myeloid DC: 3.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.2;monocytes: 2.8"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 14.2;SH-SY5Y: 35.4;U-2 OS: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045022			Approved	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA045022: "	"unprognostic (3.30e-2)"	"unprognostic (1.91e-3)"	"unprognostic (5.05e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-3)"	"unprognostic (5.98e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.96e-3)"	1.5	11.7	83.7	1.0	88.5	0.2	1.0	25.2	126.2	8.4	0.0	1.7	0.8	24.3	5.2	0.4	13.7	0.5	0.3	115.4	29.3	3.0	0.3	2.5	1.0	14.5	11.0	13.6	0.5	1.8	66.5	0.5	11.2	12.3	0.6	12.5	0.3	36.8	0.2	0.9	1.3	12.9	7.2	2.6	0.9	1.4	31.7	0.3	0.4	0.5	0.6	1.6	6.6	57.2	0.0	0.0	0.7	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	14.2	35.4	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	83.7	88.5	25.2	126.2	115.4	29.3	14.5	11.0	11.2	7.2	31.7	57.2	0.3	0.0	0.6	0.7	0.0	0.0	0.2	0.0	0.0	191.4	0.2	0.1	1.3	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.3	0.3	5.7	1.7	1.8	0.0	22.1	0.0	0.0	1.4	0.0	0.1	5.1	1.2	1.8	0.0	2.0	410.5	18.3	0.2	0.0	1.3	9.3	0.2	10.8	0.9	0.0	0.0	0.1	1.6	0.0	15.6	0.4	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	7.7	13.1	0.1	2.3	0.5	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 81.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2;testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 81.3"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	1.3	0.3	5.0	0.7	7.4	0.0	0.6	11.1	81.3	0.2	0.0	1.6	0.4	0.1	0.3	0.4	0.1	0.3	0.7	4.5	12.5	0.1	0.0	0.1	0.6	28.0	7.5	0.1	0.8	0.0	2.1	0.0	32.0	0.5	0.5	9.6	0.5	0.8	1.0	0.5	0.6	0.4	0.1	0.3	0.7	0.9	27.1	3.0	2.3	2.1	1.5	0.3	0.3	20.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	3.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	5.0	7.4	11.1	81.3	4.5	12.5	28.0	7.5	32.0	0.1	27.1	20.7	0.1	0.0	0.0	49.9	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	36.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	37.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	8.4	0.0	19.8	0.0	36.2	6.8	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	4.2	0.0	0.4	1.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 4.9;T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	0.5	0.9	3.4	6.4	2.0	4.6	0.9	1.1	4.9	1.1	0.0	2.4	2.5	0.5	0.0	0.5	0.3	1.3	0.4	5.0	7.2	0.2	0.8	5.9	9.4	1.1	3.3	0.7	0.4	0.4	0.4	0.7	5.0	0.5	1.9	0.6	1.4	0.2	0.1	0.2	2.6	0.6	0.2	6.0	4.3	0.5	3.3	25.4	0.7	0.1	7.6	2.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	45.6	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.0	9.6	0.0	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	32.6	31.9	11.6	0.0	2.7	0.0	0.0	1.1	0.0	8.9	0.0	10.0	2.8	13.4	14.3	1.4	4.9	10.4	7.9	0.0	1.3	0.1	0.6	13.4	4.4	3.4	2.0	1.1	4.9	5.0	7.2	1.1	3.3	5.0	0.2	3.3	0.0	0.2	0.0	1.9	1.3	11.5	0.4	0.0	0.0	0.0	2.5	0.1	0.0	0.6	0.0	0.0	1.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.3	13.1	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.8	0.0	0.4	0.0	60.2	0.0	0.0	1.6	2.4	0.0	0.0	3.1	3.6	2.8	2.4	0.3	3.1	7.5	1.3	0.0	0.0	0.0	61.6	0.0	0.0	0.1	0.0	0.2	6.6	0.0	0.1	4.3	0.9	0.1	0.6	0.0	20.3	0.0	0.0	0.1
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 6.1;brain: 20.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 62: Horizontal cells - Visual perception"			"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			1.5	6.1	4.7	0.0	20.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	4.7	4.4	0.2	0.0	0.7	0.0	1.6	1.7	0.0	0.0	0.0	1.3	0.2	1.3	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	20.0	0.0	6.5	4.7	4.4	1.6	1.7	1.3	0.1	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.4	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 47.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	1.1	0.1	3.3	0.9	0.2	41.0	47.3	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.5	8.0	0.1	0.2	0.1	0.2	8.8	3.0	0.2	0.4	0.0	2.2	0.0	9.3	0.2	0.0	7.0	0.3	0.0	0.5	0.5	0.3	0.0	1.0	0.2	0.3	1.4	12.3	0.1	0.3	1.2	0.0	0.3	0.5	18.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	1.1	3.3	41.0	47.3	4.5	8.0	8.8	3.0	9.3	1.0	12.3	18.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 46.9"	"Group enriched"	"Detected in some"	51	"Excitatory neurons: 389.6;Inhibitory neurons: 1425.5"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.0	0.0	9.2	0.0	18.4	0.0	1.7	0.0	46.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.5	17.2	0.0	0.2	0.0	0.0	22.3	15.9	0.0	0.0	0.0	7.0	0.0	24.5	2.6	0.0	8.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	45.5	0.0	0.0	0.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	18.4	0.0	46.9	6.5	17.2	22.3	15.9	24.5	0.0	45.5	9.4	0.0	0.0	0.0	17.6	0.0	0.0	2.9	0.0	0.0	15.9	16.7	7.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	0.0	389.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1425.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	2.6	0.0	14.1	14.8	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148510-19535642	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 16.0;pituitary gland: 10.7"	"Group enriched"	"Detected in some"	63	"Oligodendrocyte precursor cells: 331.7;Oligodendrocytes: 989.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;OE19: 1.9;SH-SY5Y: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.0	1.8	7.3	0.3	11.9	0.2	0.5	6.5	16.0	0.3	2.8	0.6	0.4	0.1	0.1	0.1	0.2	0.4	0.2	6.4	8.8	0.1	0.1	0.0	0.8	8.4	8.8	0.0	1.5	0.1	10.7	0.0	8.2	0.7	0.5	3.4	1.1	0.2	0.0	0.4	1.1	0.1	5.8	1.1	1.4	1.7	9.7	0.4	0.2	0.0	0.7	0.1	0.3	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.3	11.9	6.5	16.0	6.4	8.8	8.4	8.8	8.2	5.8	9.7	15.4	0.0	0.0	0.0	2.0	9.7	0.5	1.6	0.0	0.0	4.2	1.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	3.2	0.1	0.1	0.1	3.6	0.0	9.3	0.6	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	10.4	1.5	0.0	0.0	0.0	1.9	0.0	0.1	3.6	1.0	0.0	3.4	0.0	331.7	989.4	0.5	0.2	0.0	0.1	1.5	0.0	0.0	0.0	1.0	0.0	0.2	0.5	1.2	3.4	0.0	0.0	0.1	0.3	0.1	0.6	0.4
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 241.6;thyroid gland: 129.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 197.9;Cholangiocytes: 88.6;Proximal tubular cells: 236.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 29.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	20	"neutrophil: 395.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 395.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 68.7;GAMG: 103.6;HBEC3-KT: 69.6;RPTEC TERT1: 67.5;RT4: 80.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (6.34e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.09e-10)"	"unprognostic (9.46e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (1.95e-4)"	8.7	0.5	0.8	20.7	0.7	14.1	2.8	0.9	6.7	12.7	0.5	0.9	1.5	0.5	11.0	8.5	1.2	30.4	0.8	0.8	0.6	241.6	2.8	42.2	1.2	0.9	0.6	0.3	57.8	0.7	0.4	4.6	1.8	2.6	0.4	0.5	25.5	14.6	0.5	3.0	0.7	2.4	0.3	11.7	40.5	1.8	5.4	1.9	129.5	3.0	1.9	25.1	8.1	1.1	1.6	0.0	0.3	0.6	13.7	68.7	0.6	1.0	4.8	0.0	0.0	0.0	0.6	0.2	0.0	7.5	103.6	23.5	0.0	69.6	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.1	21.0	7.2	17.8	3.8	1.5	3.2	0.1	0.2	0.7	31.6	0.0	0.1	0.2	0.0	0.1	0.7	1.5	0.3	0.7	67.5	80.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.4	3.5	0.2	1.7	0.4	0.1	5.6	4.3	0.4	0.3	19.3	0.1	0.0	0.8	0.0	0.0	0.1	0.0	1.2	0.0	0.2	0.3	395.3	0.0	0.0	0.4	0.0	4.6	0.8	0.7	0.9	6.7	0.8	0.6	0.9	0.6	1.8	0.3	5.4	1.1	2.9	60.9	197.9	0.0	1.1	2.8	10.4	20.7	13.6	0.0	0.5	0.0	1.6	88.6	33.1	31.3	0.0	0.1	0.0	0.0	17.6	27.8	1.9	0.0	0.0	4.6	0.0	0.0	0.3	8.6	0.8	1.5	15.8	0.1	6.3	0.0	0.7	0.4	0.4	0.0	0.1	0.0	2.0	2.9	3.0	2.2	0.6	5.9	1.8	0.0	2.1	0.0	0.0	0.0	0.1	44.7	0.0	0.0	0.1	0.7	0.0	236.9	7.0	0.0	0.0	1.5	0.8	1.1	1.1	16.8	1.6	0.1	1.7	0.1	0.0	9.0
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.3;pancreas: 20.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.3	1.2	0.6	0.9	0.4	0.9	0.6	2.0	1.3	0.2	0.8	0.8	0.3	0.9	1.0	0.9	2.2	8.5	0.7	3.2	5.4	0.4	5.9	1.6	3.7	1.7	0.9	20.4	1.3	11.9	7.3	2.7	1.3	0.7	1.0	0.9	9.6	0.4	0.4	0.5	0.6	1.7	13.6	2.3	1.1	7.9	5.8	0.5	0.4	0.5	1.5	0.4	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.2	0.9	0.6	2.0	0.7	3.2	3.7	1.7	2.7	1.7	7.9	3.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium inwardly rectifying channel subfamily J member 9"	Q92806	1	160081538-160090563	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 65.8;choroid plexus: 20.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.9;Excitatory neurons: 23.5;Horizontal cells: 8.4;Inhibitory neurons: 12.6;Oligodendrocytes: 8.3"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	0.0	0.3	55.2	0.0	57.0	0.0	0.0	64.9	65.8	0.0	20.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	38.6	0.2	0.0	0.0	0.0	38.1	49.8	0.0	0.0	0.0	2.0	0.0	41.5	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.0	0.0	37.2	0.0	0.1	0.4	58.5	0.0	0.0	0.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	57.0	64.9	65.8	56.8	38.6	38.1	49.8	41.5	37.2	58.5	61.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.9	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.0	8.4	12.6	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.7	0.0	1.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNK10	"K2p10.1, PPP1R97, TREK-2, TREK2"	ENSG00000100433	"Potassium two pore domain channel subfamily K member 10"	P57789	14	88180103-88326907	"Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;intestine: 5.1;stomach 1: 2.6"	"Group enriched"	"Detected in some"	4	"dendritic cells: 12.5;Excitatory neurons: 43.8;Inhibitory neurons: 17.0;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 11.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	62	"plasmacytoid DC: 10.0"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 10.0"	"Cell line enhanced"	"Detected in some"		"OE19: 1.5;REH: 1.7;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030462	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA030462: AB_10601919"	"unprognostic (9.52e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.26e-3)"	0.0	0.3	4.0	0.4	3.6	0.2	0.0	5.1	4.1	0.2	0.0	1.3	5.1	0.0	0.0	1.1	0.0	0.0	0.0	4.4	2.9	2.4	0.0	0.1	0.1	4.2	2.9	0.0	1.4	0.0	0.5	0.0	3.5	0.0	0.7	0.1	0.2	0.0	0.0	0.0	2.6	0.1	2.3	0.1	2.6	0.5	2.4	0.0	0.0	0.0	0.4	0.0	0.2	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.1	1.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.1	4.0	3.6	5.1	4.1	4.4	2.9	4.2	2.9	3.5	2.3	2.4	4.6	0.0	0.0	0.0	0.7	0.1	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.5	2.1	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	43.8	0.6	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.0	1.6	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	37.7	11.9	0.1	0.3	0.0	0.0	0.0	1.5	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.2	0.0	0.0	0.1	0.0	1.6	0.1
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 59.2;intestine: 75.1;smooth muscle: 53.1"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 354.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cell line enhanced"	"Detected in some"		"REH: 8.8;SK-BR-3: 2.1;U-937: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	5.7	1.8	2.7	10.5	2.3	1.7	6.9	2.5	2.7	16.8	1.4	75.1	4.3	59.2	6.2	16.6	20.6	7.3	4.2	2.1	2.4	1.4	0.7	4.0	1.7	5.9	4.0	4.0	0.7	0.3	0.5	1.1	6.2	24.5	8.9	1.1	6.8	50.6	1.0	2.9	14.3	53.1	3.4	2.3	21.5	2.7	4.2	1.0	1.4	1.1	1.3	32.6	11.2	3.9	0.1	0.1	1.5	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.3	0.1	1.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	1.2	0.6	0.2	0.0	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.7	0.1	0.7	0.0	0.8	0.3	0.0	0.1	8.8	0.0	0.2	0.0	0.2	0.4	0.2	0.1	2.1	0.0	0.7	0.1	1.0	0.5	0.2	0.3	0.3	0.0	0.4	0.2	0.1	0.1	3.8	0.1	1.3	3.3	0.3	0.1	5.9	0.1	0.2	0.2	0.1	5.7	0.3	0.1	0.1	0.9	0.4	5.1	2.0	0.2	1.0	2.7	2.3	2.5	2.7	2.1	2.4	5.9	4.0	6.2	3.4	4.2	3.9	1.3	0.0	6.3	0.3	1.2	2.0	1.2	0.4	0.0	1.6	2.5	55.1	3.7	4.3	4.5	1.8	6.2	0.5	1.7	0.1	0.0	0.1	0.6	0.6	14.4	3.6	0.0	1.3	0.1	0.4	0.6	9.8	0.0	0.6	19.7	0.4	1.8	0.4	7.4	1.7	0.3	0.2	0.0	18.9	10.9	4.5	38.5	15.6	3.6	4.7	27.8	0.6	2.1	0.0	0.1	0.0	0.0	354.3	0.3	1.3	0.0	0.1	4.5	2.3	46.0	2.2	43.6	0.7	1.2	0.1	1.7	0.5	1.7	1.4	0.0	0.7
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.4;SCLC-21H: 3.3"									CAB022649	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.3	5.1	2.5	0.0	3.0	0.0	0.7	1.5	4.0	1.4	0.9	1.2	0.5	2.9	35.4	0.4	13.9	0.5	5.8	4.0	2.3	3.4	0.2	1.1	0.0	3.0	2.7	12.7	4.0	0.2	1.7	0.1	2.3	0.5	0.3	0.2	0.2	1.1	0.2	0.3	0.5	1.9	2.2	1.3	3.0	0.2	2.1	0.0	0.3	0.2	0.0	0.2	0.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.5	3.3	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	1.5	4.0	4.0	2.3	3.0	2.7	2.3	2.2	2.1	2.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.1	8.7	0.2	0.0	13.8	0.0	311.8	0.0	0.0	2.7	0.0	1.9	0.0	12.7	1.8	0.0	0.0	0.0	791.1	0.0	4.1	0.0	0.0	0.1	2.8	0.1	0.0	12.2	0.0	0.0	0.0	1982.5	6.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	10.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.1
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366290-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.2;choroid plexus: 18.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 95.7;Hepatic stellate cells: 37.1;Inhibitory neurons: 45.0;Oligodendrocytes: 86.9"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 7.7;RH-30: 8.2;RT4: 9.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072287	Enhanced	Approved	Approved	Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA072287: AB_2686507"	"unprognostic (3.90e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.05e-2)"	2.3	14.9	35.3	1.1	39.5	0.2	2.0	29.7	43.5	3.1	18.9	8.6	1.0	1.8	1.1	1.0	1.7	1.4	4.7	36.4	29.7	3.7	0.5	6.1	1.3	38.5	32.2	2.6	0.5	0.2	1.9	2.5	32.1	3.2	1.2	1.9	1.7	2.1	2.4	2.6	3.0	1.2	28.9	1.2	2.1	2.1	38.4	1.3	2.1	1.5	1.0	2.5	2.6	54.2	0.0	0.3	4.9	2.7	0.3	0.2	0.5	0.6	0.9	0.2	0.7	0.2	1.8	2.4	0.3	0.0	1.0	0.0	5.3	0.8	0.2	1.1	3.1	1.3	1.1	2.9	0.0	0.1	0.1	1.4	0.1	0.0	0.0	0.5	0.2	3.5	0.0	0.0	0.9	0.7	1.8	0.4	7.7	0.1	5.6	2.6	8.2	0.2	0.2	9.3	2.4	2.9	0.7	0.9	0.0	7.3	2.7	0.1	0.1	0.3	1.3	0.1	0.3	1.7	0.0	2.5	0.4	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.1	35.3	39.5	29.7	43.5	36.4	29.7	38.5	32.2	32.1	28.9	38.4	54.2	8.5	0.0	0.6	2.6	1.1	3.2	0.2	0.4	0.6	23.1	2.8	1.9	4.3	0.0	0.2	23.9	0.0	0.2	2.1	0.1	0.0	0.1	0.9	4.7	1.1	8.7	0.0	3.2	95.7	0.0	0.4	9.6	0.0	3.4	0.0	7.2	37.1	0.7	1.2	0.0	45.0	0.4	0.0	10.8	2.6	2.2	6.5	2.9	1.8	20.6	0.7	1.5	0.0	13.6	86.9	0.0	0.0	18.0	0.2	0.8	0.0	9.7	0.0	3.0	0.0	12.8	5.1	2.2	7.8	0.2	5.5	0.3	1.4	14.0	0.5	0.0
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 168.8;Skeletal myocytes: 121.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	0.9	1.1	24.9	3.9	24.2	0.3	0.7	15.1	12.8	2.7	0.0	7.4	3.0	4.9	0.6	1.7	5.7	1.5	2.1	16.9	18.5	2.1	0.2	1.5	3.5	14.4	33.1	0.8	0.3	1.1	1.2	0.0	16.5	1.6	2.4	0.3	1.3	1.2	6.1	0.3	2.2	6.0	12.9	3.5	2.4	0.5	25.7	1.0	1.9	5.3	5.5	3.1	1.6	11.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.3	3.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	26.1	0.5	0.0	0.3	0.0	0.1	0.8	0.1	0.0	65.5	0.6	0.1	0.2	0.0	0.8	0.0	2.5	0.0	16.2	18.7	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	62.3	8.8	21.4	0.6	0.0	6.2	4.7	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	24.9	24.2	15.1	12.8	16.9	18.5	14.4	33.1	16.5	12.9	25.7	11.0	8.7	12.8	2.7	168.8	3.9	1.3	0.6	0.7	0.6	0.5	0.1	0.0	3.4	0.0	2.1	0.0	2.1	0.1	0.0	0.0	3.9	0.2	3.4	26.6	0.6	25.9	4.2	0.0	18.2	0.2	0.0	16.3	0.0	5.8	0.0	2.0	13.9	0.3	0.4	0.0	13.6	0.0	4.1	0.0	3.0	7.7	0.3	0.9	0.0	11.2	0.0	2.2	0.0	12.1	5.0	0.0	2.2	0.0	30.9	0.5	0.0	0.3	18.3	0.4	0.0	121.5	1.3	0.7	0.2	0.8	1.7	0.0	0.5	22.5	0.0	0.7
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 91.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	0.0	6.2	55.7	0.1	37.2	0.0	0.0	27.8	91.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.2	68.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	1.1	0.0	19.1	0.0	0.1	1.6	0.0	2.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	10.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	21.2	35.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.6	0.0	8.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.5	0.2	0.0	0.0	0.1	0.0	0.0	67.8	119.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	55.7	37.2	27.8	91.9	68.1	0.0	2.6	0.0	0.1	0.0	1.0	12.9	0.6	0.0	0.0	7.2	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	16.5	0.0	0.1	1.0	0.0	0.0	61.7	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.5	37.5	0.2	0.0	0.0	0.0	8.1	0.6	0.1	0.0	1.0	0.0	0.9	0.0	50.8	2.1	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.1	0.1	7.4	28.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120859-132481095	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 501.5;Inhibitory neurons: 485.6;Microglial cells: 502.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.6;JURKAT: 3.8;RPMI-8226: 2.8;U-2 OS: 4.3;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.3	1.4	9.9	0.5	21.2	0.0	0.9	0.0	23.7	0.3	0.0	0.4	0.2	0.2	0.1	0.1	0.3	0.3	0.7	9.1	4.7	0.7	0.0	1.9	0.1	4.7	8.1	0.1	0.9	0.2	1.9	0.2	7.4	0.4	0.2	2.5	0.3	0.6	0.0	0.4	0.6	0.5	0.0	0.5	0.1	0.2	16.0	0.5	0.5	0.0	0.2	0.4	0.4	8.7	0.2	0.1	0.0	0.0	0.3	1.0	0.0	0.3	1.1	0.0	0.0	0.0	1.0	0.0	1.2	1.5	2.5	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	6.6	0.1	0.0	3.8	0.0	0.1	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	2.8	1.6	0.0	1.3	1.2	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	21.2	0.0	23.7	9.1	4.7	4.7	8.1	7.4	0.0	16.0	8.7	0.4	0.0	14.0	84.5	0.2	0.3	0.0	0.0	0.0	6.7	1.3	0.6	4.6	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.6	0.3	4.2	2.7	0.0	0.0	501.5	6.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	485.6	0.7	0.0	0.3	1.6	2.9	0.0	2.1	0.0	502.2	0.6	0.4	0.0	117.1	31.2	1.8	0.0	0.0	0.0	0.1	4.6	1.6	0.8	0.6	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	0.4	0.1	1.2	0.1
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198853	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.3;skeletal muscle: 21.1;tongue: 12.2"	"Group enriched"	"Detected in some"	30	"Excitatory neurons: 2136.7;Inhibitory neurons: 862.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 28.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.9;HEL: 23.2;HL-60: 31.5;U-251 MG: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.1	1.6	1.2	1.3	7.5	5.1	0.4	0.0	28.3	0.4	0.0	0.4	0.2	0.1	0.0	0.9	0.3	0.3	0.2	4.3	0.0	0.1	0.2	0.3	2.2	17.4	1.0	0.1	0.1	0.0	0.2	0.4	19.4	1.3	0.3	0.2	1.2	0.9	21.1	0.1	0.7	0.3	0.0	1.1	0.3	1.2	0.0	1.7	4.7	12.2	2.0	0.9	0.6	4.6	4.4	1.1	0.0	0.2	0.0	1.5	0.0	34.9	5.2	5.1	4.3	0.0	0.0	21.2	0.0	11.9	0.4	0.7	0.1	2.1	6.1	0.3	7.2	23.2	0.1	0.0	0.9	31.5	0.0	0.3	0.8	14.5	14.9	3.3	0.0	0.0	1.4	14.2	10.2	0.1	0.0	13.5	1.3	0.0	7.1	0.0	1.1	14.4	1.9	0.0	5.8	2.7	0.0	0.1	13.7	0.2	4.3	2.3	0.0	21.0	9.2	0.1	23.4	14.8	0.4	9.3	0.2	14.9	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.1	0.3	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.2	7.5	0.0	28.3	4.3	0.0	17.4	1.0	19.4	0.0	0.0	4.6	0.0	0.0	0.0	38.8	7.6	0.3	3.6	0.7	5.2	0.3	0.4	0.5	3.6	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	5.5	2136.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	862.4	0.0	0.0	0.0	1.5	1.6	0.0	0.2	1.8	49.6	0.0	0.1	1.0	30.2	26.7	0.0	0.0	0.0	7.6	5.7	0.0	0.0	0.0	0.2	0.0	6.0	0.8	0.5	0.5	0.8	0.3	0.3	2.8	0.0	0.0	0.7
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960468	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 32.6;Ductal cells: 29.4;Syncytiotrophoblasts: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	36	"B-cells: 3.4;T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.9;BEWO: 20.8;CAPAN-2: 22.7;HaCaT: 21.4;HBEC3-KT: 30.3;hTCEpi: 38.5;OE19: 39.3;SK-BR-3: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA028634, HPA028639"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Cytosol	"HPA028634: , HPA028639: AB_10599191"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.1	1.1	0.4	1.3	0.3	0.1	10.3	1.6	1.3	4.0	0.3	8.9	12.4	0.9	19.7	20.2	7.4	2.9	0.4	0.4	0.2	11.0	4.7	4.4	0.8	0.3	0.3	0.1	16.2	12.5	10.4	3.9	0.4	7.2	7.1	1.3	12.8	4.6	0.0	17.7	10.5	0.3	0.2	0.6	10.6	2.6	0.3	2.3	10.0	0.0	3.4	4.8	8.3	0.7	24.9	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	12.1	22.7	0.0	0.9	0.0	0.0	21.4	0.0	30.3	0.0	0.1	0.4	0.0	0.0	4.4	0.3	0.0	0.0	0.1	38.5	0.0	3.1	0.0	0.0	0.0	1.4	0.0	0.0	14.7	0.0	0.1	1.7	39.3	0.1	0.0	0.0	3.7	5.5	11.7	14.9	0.0	0.2	25.2	0.1	2.7	16.1	0.4	0.2	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	2.5	4.3	3.0	0.1	3.4	6.2	3.8	0.0	0.0	0.0	0.0	0.2	1.7	0.4	0.3	1.6	1.3	0.4	0.2	0.3	0.3	0.4	0.2	0.3	0.7	0.2	12.8	8.8	0.0	0.8	0.0	14.3	0.0	10.8	0.6	15.1	16.3	0.3	12.8	2.5	14.7	0.0	32.6	1.5	17.2	25.4	29.4	0.4	7.3	0.8	0.7	7.8	0.0	0.2	23.2	26.5	0.6	13.7	8.0	0.0	0.1	0.0	4.4	2.7	0.0	0.1	13.1	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.2	1.1	0.0	0.0	0.1	21.8	25.2	0.0	0.4	16.8	26.2	10.1	5.1	2.5	0.0	0.0	0.3	6.3	7.5	14.4	0.0	29.7	1.2	0.0	16.9	19.0
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KHDRBS3	"Etle, etoile, SALP, SLM-2, SLM2, T-STAR"	ENSG00000131773	"KH RNA binding domain containing, signal transduction associated 3"	O75525	8	135457456-135656722	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 157.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 364.5;Excitatory neurons: 828.6;Inhibitory neurons: 190.8;Microglial cells: 227.7;Oligodendrocyte precursor cells: 578.6;Spermatocytes: 276.1"	"Cancer enhanced"	"Detected in all"		"glioma: 9.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 27.9;cerebral cortex: 50.9;hippocampal formation: 29.8;white matter: 41.1"	"Immune cell enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"REH: 87.8;RPTEC TERT1: 76.0;WM-115: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000275, HPA000500, HPA000981"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA000275: AB_1079183, HPA000500: AB_1079184, HPA000981: AB_2666164"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.31e-3)"	"unprognostic (9.36e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (7.16e-6)"	"unprognostic (6.63e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.33e-3)"	16.8	16.4	21.4	5.6	27.9	2.6	11.5	0.0	50.9	17.0	0.0	12.5	4.1	6.8	22.8	6.2	6.5	11.5	10.3	29.8	0.6	19.3	12.3	8.8	3.0	7.5	1.4	9.3	9.2	7.6	6.8	2.0	0.4	8.4	8.9	21.1	11.0	12.3	32.6	6.4	5.9	8.7	0.0	2.8	6.9	157.7	5.7	9.2	5.6	31.2	4.2	10.6	9.0	41.1	0.5	1.8	30.9	1.7	6.5	12.0	12.4	20.7	28.6	19.2	9.8	11.1	4.4	0.1	10.9	19.8	0.3	2.7	19.5	20.9	26.0	4.4	33.6	0.1	11.2	22.9	5.0	5.8	69.8	2.6	2.8	10.5	16.1	23.2	15.9	36.7	2.6	51.0	34.5	7.5	2.2	1.2	6.3	16.9	34.0	87.8	42.0	22.6	76.0	0.6	39.5	33.4	1.5	4.4	22.6	19.4	1.4	1.8	1.3	23.6	40.7	0.4	45.2	17.9	0.0	0.1	14.3	0.0	85.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	27.9	0.0	50.9	29.8	0.6	7.5	1.4	0.4	0.0	5.7	41.1	15.4	28.9	5.3	20.2	3.1	15.0	14.7	2.3	2.8	160.9	23.8	10.8	12.3	2.8	4.8	7.3	0.0	0.6	0.6	7.0	25.4	14.6	364.5	24.2	21.1	13.7	23.4	0.8	828.6	22.9	1.2	37.2	2.0	40.7	4.5	4.0	5.0	21.8	0.8	6.7	190.8	8.7	10.2	3.5	10.9	142.4	16.1	5.2	14.2	227.7	1.6	7.0	0.0	578.6	34.9	19.8	2.5	8.6	1.1	19.3	2.1	29.0	2.9	16.1	0.0	57.9	34.5	276.1	33.1	3.4	9.2	1.4	2.1	12.7	6.6	12.6
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646191	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.3;pituitary gland: 4.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.0	0.4	10.0	0.2	10.3	0.0	0.1	4.3	10.4	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	9.2	5.8	0.0	0.0	0.6	0.0	7.2	7.4	0.0	1.4	0.1	4.1	0.0	7.6	0.4	0.4	1.2	0.2	0.0	0.0	0.7	0.2	0.1	2.7	0.2	0.8	1.1	12.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.0	2.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	0.0	2.1	0.8	0.3	0.0	0.0	2.4	1.0	0.0	1.9	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	3.8	0.2	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.3	3.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	10.0	10.3	4.3	10.4	9.2	5.8	7.2	7.4	7.6	2.7	12.3	4.8	0.1	3.2	0.5	119.5	0.6	0.0	0.0	0.5	0.0	3.6	0.1	0.1	1.4	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	65.6	2.6	0.1	0.0	10.2	0.0	129.2	0.0	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	72.7	0.8	0.0	0.0	0.0	96.8	0.6	0.2	0.0	5.6	0.6	0.3	0.0	5.0	3.1	0.3	0.1	0.7	0.0	0.2	0.0	0.1	10.9	0.9	0.0	0.1	0.0	1.2	1.5	0.0	0.0	0.7	0.1	0.1	0.3	0.3
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376108-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 26.4;parathyroid gland: 33.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 366.9;Inhibitory neurons: 193.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.4"	"Group enriched"	"Detected in many"	141	"amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		160000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.2	0.4	8.6	0.2	14.9	0.0	0.7	0.0	26.4	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.3	0.1	12.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.3	33.5	0.7	1.1	0.0	0.0	0.1	0.9	0.3	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.7	0.3	0.2	7.9	0.1	1.9	6.1	0.2	1.0	6.5	0.0	24.7	14.4	3.8	2.1	0.0	0.6	18.7	0.3	21.9	19.2	1.4	0.9	7.3	5.7	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.1	6.4	11.0	13.4	16.9	0.5	0.2	20.5	15.1	0.0	0.2	0.0	1.4	0.0	9.1	0.0	1.6	0.0	0.0	9.6	2.2	2.2	0.3	0.0	6.2	0.2	0.0	0.0	42.4	53.8	11.8	1.3	19.6	0.0	0.0	0.0	14.7	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.0	26.4	12.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	18.3	0.1	2.0	0.6	0.6	0.0	5.6	2.2	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.8	1.1	0.2	0.1	0.7	0.0	0.0	366.9	0.0	0.2	1.0	0.0	0.6	0.0	0.2	5.0	0.2	0.3	3.3	193.5	0.0	0.0	0.0	0.9	1.2	0.0	0.1	17.8	18.7	0.0	0.1	0.0	40.2	7.2	1.2	0.0	0.4	0.0	1.2	0.0	0.1	0.1	0.4	0.0	0.1	1.8	0.0	1.8	0.6	0.3	0.0	0.0	0.1	0.0	0.7
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92574105-92655395	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.4;lymphoid tissue: 37.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 39.1;Granulosa cells: 20.7;Spermatocytes: 38.0;Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	1.1	0.7	0.5	8.5	0.7	19.4	2.5	0.4	0.6	1.4	0.5	6.3	5.5	1.8	1.0	6.7	1.0	1.2	0.6	0.5	0.5	1.0	1.1	1.3	17.5	0.6	0.6	0.6	0.5	0.7	0.3	3.9	0.6	1.0	7.4	0.8	1.3	0.7	0.2	6.0	5.3	2.5	0.5	2.9	3.9	11.6	0.4	37.9	1.6	0.3	18.5	2.3	2.3	0.6	103.1	45.2	100.6	94.5	7.3	10.5	24.2	72.6	62.8	78.8	78.1	39.6	67.2	111.1	36.5	34.4	32.9	72.0	72.1	36.5	92.4	68.3	41.3	70.5	41.4	42.4	1.4	116.0	63.0	3.6	3.3	61.4	55.9	18.3	50.0	46.1	51.2	126.4	61.1	41.4	99.3	65.8	40.3	42.5	30.7	106.6	98.8	40.2	21.0	30.1	30.0	42.9	56.4	25.9	29.2	34.1	67.9	37.6	28.6	35.7	51.3	37.1	96.9	35.4	58.3	113.4	29.5	82.3	50.3	0.8	0.0	0.1	0.0	0.3	0.3	0.6	0.4	0.4	0.2	0.1	0.1	0.2	0.2	1.0	0.1	0.1	1.1	0.2	0.5	0.7	0.4	0.6	0.5	0.5	0.6	0.6	0.6	0.5	0.4	0.6	0.4	0.0	2.0	1.3	3.5	2.9	1.1	1.6	3.4	1.0	1.8	1.8	1.7	1.5	2.5	1.8	0.0	6.7	2.3	2.9	1.9	0.5	16.3	3.4	4.3	2.0	0.0	39.1	2.1	0.6	11.4	4.7	9.2	4.9	0.0	20.7	2.2	0.4	8.2	0.0	1.8	4.3	4.1	4.6	3.4	4.4	0.9	4.0	0.0	0.0	1.0	0.7	2.1	2.5	1.1	0.2	0.4	0.7	15.2	0.8	0.5	0.6	3.7	0.4	0.0	1.7	3.7	38.0	23.4	12.6	3.3	1.5	4.5	2.5	8.0	1.7
KIF12		ENSG00000136883	"Kinesin family member 12"	Q96FN5	9	114086126-114099291	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 162.3;pancreas: 85.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 105.8;Collecting duct cells: 90.1;Distal tubular cells: 80.3;Ductal cells: 43.3;Enteroendocrine cells: 64.1;Proximal enterocytes: 60.3;Proximal tubular cells: 79.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;OE19: 17.2;RPTEC TERT1: 44.8;SCLC-21H: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020192, HPA024127"	Uncertain		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Plasma membrane"		"HPA020192: AB_1852467, HPA024127: AB_1852469"	"unprognostic (5.29e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	2.2	1.1	2.1	0.0	25.3	0.4	3.6	11.4	2.8	7.8	25.5	4.2	1.0	0.2	8.0	24.7	0.2	2.0	0.9	162.3	27.7	1.6	0.5	0.6	1.1	0.7	85.4	0.8	0.6	1.1	1.0	7.0	4.2	0.1	3.6	4.8	0.0	1.4	16.1	0.4	0.4	0.2	11.0	2.4	1.3	1.3	31.8	0.0	0.1	0.2	0.3	0.8	0.0	4.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.6	0.2	0.0	5.2	0.0	0.6	0.0	0.2	0.1	0.2	0.0	0.9	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.0	0.4	0.1	17.2	0.6	0.0	0.0	0.1	44.8	0.2	6.6	0.1	0.0	0.9	0.0	0.2	4.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.1	0.4	3.6	2.0	0.9	0.6	1.1	1.0	0.4	1.3	0.8	0.1	0.0	4.4	0.0	1.3	0.0	0.9	0.6	0.0	0.0	20.3	10.8	0.4	105.8	0.0	90.1	0.0	0.1	0.0	7.9	80.3	43.3	7.0	8.3	1.5	0.3	64.1	0.0	0.7	11.8	9.3	0.4	14.8	15.6	0.0	0.0	0.0	10.2	0.3	0.0	0.3	22.0	0.0	0.3	0.0	14.7	0.6	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.7	21.3	0.0	0.0	2.2	60.3	79.1	0.0	0.0	0.0	0.0	0.3	3.2	7.9	0.0	0.0	0.5	0.9	0.3	28.9	0.5
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease variant, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.1;Granulosa cells: 13.2;Spermatocytes: 22.8;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"		Yes	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: AB_2683642"	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.2	0.2	0.1	2.0	0.0	6.5	0.3	0.2	0.3	0.2	0.1	0.9	1.2	0.3	0.0	1.0	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.2	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.2	0.1	0.1	0.0	0.0	1.0	1.1	0.6	0.0	0.6	0.6	2.5	0.1	10.9	0.1	0.0	3.2	0.4	0.3	0.1	29.7	17.3	26.8	15.0	0.8	3.0	14.8	20.0	11.7	18.7	16.8	10.5	15.1	18.0	7.0	9.6	11.6	23.0	21.6	13.3	26.7	22.1	11.3	28.8	24.8	10.3	0.1	45.5	15.7	0.6	0.6	20.9	17.8	4.0	13.5	26.3	44.0	22.6	23.5	12.1	26.9	14.2	22.6	8.7	15.0	24.3	35.4	22.8	6.3	8.3	12.7	14.0	28.3	9.5	11.0	19.8	12.9	11.6	11.1	14.7	17.3	16.2	35.3	8.2	8.9	25.8	8.6	24.0	30.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	1.0	0.0	0.0	0.0	1.9	2.4	1.0	1.1	0.6	2.3	1.5	1.9	0.8	0.0	0.9	0.0	2.1	4.2	0.6	2.5	0.0	0.2	4.1	3.7	2.2	1.6	0.0	27.1	1.1	0.0	7.7	3.3	10.2	5.0	2.5	13.2	2.5	0.9	5.4	0.0	0.9	5.2	0.0	2.9	1.9	2.5	0.6	2.3	0.0	0.0	0.4	0.5	0.0	0.5	0.8	0.3	0.0	0.7	11.3	1.2	0.2	0.1	1.4	0.8	6.6	1.4	2.1	22.8	16.3	8.3	0.9	1.4	2.3	0.7	4.3	1.9
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947773	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 9.0;Extravillous trophoblasts: 3.8;Granulosa cells: 5.9;Oligodendrocyte precursor cells: 7.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.4	0.4	0.3	3.8	0.4	12.7	0.2	0.7	0.3	0.9	0.3	2.0	2.7	0.4	0.0	5.1	0.2	0.4	0.3	0.3	0.4	0.2	0.4	0.8	5.7	0.5	1.1	0.1	0.1	0.0	0.1	1.9	0.6	0.2	1.7	0.1	0.7	0.0	0.4	3.0	2.5	1.1	0.3	2.9	1.5	2.9	0.6	14.4	0.2	0.0	4.7	0.6	1.6	0.5	31.5	41.7	35.3	32.8	0.8	3.0	28.1	25.8	10.3	34.6	26.9	34.0	27.4	28.3	10.9	10.8	21.5	34.0	25.1	11.3	17.9	56.6	36.4	35.4	51.7	22.1	0.0	30.0	30.2	0.7	0.6	29.7	12.2	4.7	17.9	29.2	28.1	48.0	18.2	25.9	60.0	31.1	25.4	30.4	28.9	43.5	51.8	19.2	5.8	16.7	26.2	24.7	18.0	16.1	9.8	17.0	30.2	21.6	11.2	49.9	48.0	28.8	56.8	15.1	15.7	34.4	16.3	22.9	33.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.3	0.4	0.7	0.3	0.3	0.4	0.5	1.1	0.6	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.9	0.4	0.1	0.2	0.0	0.5	0.5	0.4	2.6	0.0	0.0	0.0	0.0	2.4	0.4	1.9	0.0	0.0	0.0	0.3	0.8	0.6	0.0	9.0	0.3	0.0	3.8	1.4	1.5	0.5	0.0	5.9	0.4	0.3	2.3	0.0	0.3	1.6	0.0	2.2	1.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	7.1	0.1	0.1	0.0	0.0	2.1	0.2	0.3	0.0	0.0	0.3	0.0	0.2	0.8	1.1	2.9	2.5	0.4	0.8	1.3	0.3	3.2	0.3
KIF1A	"ATSV, C2orf20, SPG30, UNC104"	ENSG00000130294	"Kinesin family member 1A"	Q12756	2	240713761-240824293	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 115.0;pancreas: 34.1;pituitary gland: 42.1;retina: 58.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 393.8;Cone photoreceptor cells: 419.1;Horizontal cells: 536.7;Muller glia cells: 116.4;Rod photoreceptor cells: 176.8"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 62.5;HAP1: 146.0;SCLC-21H: 276.0;SH-SY5Y: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005442			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Centriolar satellite, Cytosol"		"HPA005442: AB_1079210"	"unprognostic (1.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.90e-2)"	0.2	12.4	54.0	1.1	55.6	0.0	0.1	22.4	113.6	0.1	0.0	2.2	0.7	0.3	0.8	0.0	0.2	0.0	13.7	71.8	25.0	0.2	0.4	0.3	0.0	115.0	47.4	0.7	34.1	0.4	42.1	0.0	107.7	5.4	0.5	58.4	0.2	0.2	0.2	1.0	0.8	0.3	10.2	0.4	2.6	11.2	53.9	0.4	0.9	0.1	0.0	0.1	0.6	99.6	0.0	0.2	1.8	62.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	3.5	0.4	1.4	0.6	146.0	0.0	0.0	8.4	10.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.3	0.0	2.5	0.3	0.0	8.8	0.0	0.0	0.0	0.6	1.2	0.0	0.0	276.0	52.0	0.0	0.8	0.0	0.4	0.4	0.0	2.0	0.0	1.3	0.4	0.0	0.2	0.1	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	55.6	22.4	113.6	71.8	25.0	115.0	47.4	107.7	10.2	53.9	99.6	0.0	0.0	0.0	50.9	0.0	0.9	0.1	0.0	0.0	393.8	0.1	0.3	16.8	0.0	0.0	0.0	419.1	0.0	0.0	0.1	0.0	0.5	2.2	1.1	0.2	1.2	34.2	0.0	57.6	25.1	0.0	2.9	4.1	5.0	0.0	1.5	0.0	0.4	0.1	536.7	72.4	0.8	8.2	0.0	0.4	4.1	0.9	0.1	17.8	9.4	0.0	116.4	0.0	18.1	50.3	14.6	0.0	0.4	0.0	10.4	0.0	0.3	0.0	176.8	0.0	0.0	1.0	46.2	20.5	0.0	0.0	0.0	0.0	3.8	0.1	0.5
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187723	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 24.6;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.0;Erythroid cells: 24.6;Extravillous trophoblasts: 13.1;Granulosa cells: 11.1;Spermatocytes: 21.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 6.6;T-reg: 2.5"	"Group enriched"	"Detected in many"	46	"NK-cells: 6.6;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA036909, HPA036910"	Approved		Uncertain	"Nucleoplasm,Cytokinetic bridge"		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytokinetic bridge"		"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	0.7	0.8	0.0	4.5	0.1	14.1	1.3	0.1	0.1	1.0	0.1	3.3	3.5	1.4	0.0	6.6	0.4	0.8	0.5	0.0	0.1	0.4	0.9	0.9	8.6	0.1	0.2	0.2	0.2	0.1	0.0	5.4	0.1	0.2	5.1	0.0	1.0	0.1	0.1	4.4	2.8	5.8	0.0	1.9	2.1	11.7	0.5	24.6	0.5	0.1	13.1	1.6	2.0	0.1	87.8	59.5	127.8	84.4	6.7	12.3	53.9	75.0	68.9	162.3	121.4	111.9	80.5	38.8	39.2	96.5	60.6	85.9	121.7	142.5	160.9	56.4	57.4	57.2	101.1	70.7	0.3	28.2	25.1	4.8	2.3	86.2	49.5	27.1	106.7	53.9	24.4	70.4	113.9	81.5	47.6	26.7	80.6	51.8	63.7	51.2	128.5	39.5	43.9	42.3	37.8	37.5	144.1	47.9	30.9	161.6	60.8	28.5	51.1	41.6	60.5	38.0	126.4	36.0	37.5	42.0	26.7	81.1	82.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	2.5	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.3	0.0	1.7	0.0	0.8	0.4	0.4	2.9	0.0	0.0	1.1	1.3	0.3	0.0	0.7	0.0	0.0	11.0	0.1	2.8	0.0	0.1	1.0	1.0	1.9	1.7	0.0	24.6	0.0	0.0	13.1	3.1	2.6	1.3	4.5	11.1	3.3	0.4	6.1	0.0	0.0	1.6	6.1	2.2	0.4	2.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.4	3.0	0.3	1.2	0.0	0.9	0.0	0.0	0.5	4.4	21.7	7.5	5.3	0.4	1.0	0.7	0.8	3.4	0.6
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.3;retina: 77.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 308.6;Cone photoreceptor cells: 308.6;Inhibitory neurons: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 7.1;MAIT T-cell: 3.4;memory CD4 T-cell: 4.4;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.8;NK-cell: 3.0;T-reg: 2.2"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.0;T-cells: 7.3"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 187.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: AB_2683717"	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	6.5	12.1	37.4	3.9	40.0	0.9	6.2	41.4	51.2	12.3	8.0	11.9	9.0	9.2	5.5	20.9	33.7	6.1	19.2	38.2	55.7	26.5	20.5	5.9	2.9	67.4	46.6	4.5	13.2	16.6	16.0	5.7	70.3	11.2	13.1	77.6	23.9	3.1	15.3	12.7	10.3	8.7	39.3	6.5	12.5	12.5	46.5	2.2	8.8	9.5	5.3	5.9	11.4	44.3	18.5	23.2	31.8	13.7	6.0	3.0	25.4	4.5	2.2	5.9	4.1	42.2	22.4	0.0	14.1	1.9	9.4	16.0	18.5	11.2	5.4	36.1	14.7	0.2	40.6	38.6	4.6	31.0	0.1	2.0	24.4	7.4	35.3	13.4	7.7	7.8	35.4	36.9	4.8	11.1	4.0	0.0	42.8	0.0	20.0	0.1	0.0	21.1	22.3	30.1	43.0	187.6	17.7	27.7	10.8	32.1	32.2	3.9	5.6	3.4	13.7	1.1	13.1	16.7	6.1	0.0	8.1	4.4	2.9	0.0	0.0	0.0	7.1	0.0	3.4	0.5	4.4	7.3	0.0	0.0	1.0	4.8	0.1	3.0	0.0	0.0	2.2	1.0	37.4	40.0	41.4	51.2	38.2	55.7	67.4	46.6	70.3	39.3	46.5	44.3	4.1	38.5	17.5	205.7	5.3	18.5	25.1	25.9	4.6	308.6	10.9	11.0	121.9	22.8	53.9	12.9	308.6	15.3	36.2	30.0	9.8	27.8	108.4	78.1	30.2	5.5	24.0	2.5	189.9	41.3	100.8	17.2	36.2	27.7	13.4	92.7	12.8	44.2	3.8	138.0	221.0	28.7	22.4	2.5	2.2	79.9	3.1	2.4	14.2	23.4	7.8	112.3	25.7	124.1	160.3	37.2	20.0	2.6	30.7	37.5	20.7	53.3	193.9	186.1	0.0	26.1	17.4	57.2	24.0	30.5	30.7	59.1	33.5	17.7	29.3	21.7
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 25.7;Cone photoreceptor cells: 58.4;Late spermatids: 82.1;Rod photoreceptor cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 41.0;JURKAT: 78.8;Karpas-707: 49.6;RPMI-8226: 43.8;U-266/70: 90.2;U-266/84: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	1.6	0.8	16.1	9.4	16.4	34.1	1.3	0.0	16.5	0.9	0.0	2.4	2.0	0.7	0.4	0.8	1.2	2.1	0.7	21.6	8.3	0.9	1.5	4.8	12.9	5.9	5.7	0.7	0.8	6.0	0.6	0.9	6.5	0.8	1.8	21.4	1.4	0.7	0.3	0.7	6.7	0.8	1.5	12.3	2.5	13.7	9.5	11.8	1.0	0.4	8.0	2.3	0.8	7.9	1.3	1.5	11.8	0.5	0.0	0.0	3.0	0.1	0.0	0.3	0.1	0.7	0.4	39.1	0.5	0.0	3.4	0.3	1.2	0.3	0.4	1.9	0.4	9.7	0.2	0.2	1.0	29.4	41.0	1.0	4.1	0.4	0.7	0.0	1.5	78.8	4.6	49.6	0.0	0.2	24.5	11.2	5.2	3.9	0.0	8.4	0.1	43.8	0.2	0.0	7.2	1.0	0.6	0.5	0.6	2.1	0.2	8.9	2.8	0.0	3.3	0.0	0.2	90.2	44.7	19.3	3.9	12.8	0.3	6.0	0.0	0.6	0.8	0.2	0.9	0.4	0.6	0.8	0.1	0.3	0.5	0.6	1.0	1.3	0.3	0.1	0.6	0.4	16.1	16.4	0.0	16.5	21.6	8.3	5.9	5.7	6.5	1.5	9.5	7.9	1.5	0.0	3.8	22.5	11.0	1.0	0.5	0.2	0.0	25.7	0.4	0.8	1.5	0.0	0.1	1.8	58.4	0.0	17.4	1.2	0.0	0.5	20.4	0.1	0.2	1.8	0.0	4.8	15.6	1.6	0.1	0.6	1.1	0.4	6.3	0.5	1.4	0.3	1.7	1.7	11.8	1.4	0.0	4.4	3.1	82.1	0.9	5.3	0.0	8.4	2.7	20.0	13.4	14.6	4.0	2.4	0.3	0.0	12.0	0.4	0.2	0.0	0.1	26.1	6.6	0.6	1.1	1.9	3.7	0.1	1.0	0.0	18.0	0.1	1.1	2.0
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 33.0;lymphoid tissue: 37.4;testis: 76.5"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1860.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.1"	"Not detected"	"Not detected"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	0.7	0.8	0.7	7.0	0.7	33.0	1.6	2.3	0.7	1.8	1.1	6.2	5.5	1.8	0.7	7.3	0.9	1.3	1.3	0.6	1.1	0.8	0.7	1.3	16.4	1.1	0.9	0.6	0.5	1.3	0.4	5.4	1.4	0.8	7.6	0.8	1.3	0.7	0.9	6.0	5.1	3.2	0.9	3.7	3.5	76.5	0.8	37.4	1.1	0.7	19.2	2.1	2.7	0.8	119.7	45.8	99.6	79.8	5.3	11.6	66.6	86.9	62.1	175.0	151.3	77.6	84.2	136.2	41.3	43.2	121.7	55.2	102.8	59.6	158.2	89.1	44.4	162.1	83.3	65.5	0.6	121.5	71.8	2.7	5.8	125.0	60.3	16.5	57.6	95.4	130.4	113.1	112.4	46.5	127.5	72.9	97.1	58.4	56.5	101.1	149.3	86.4	29.6	42.8	68.3	48.5	116.1	81.6	71.5	71.9	47.2	90.7	34.7	62.9	124.2	69.0	155.6	59.4	65.0	195.3	40.3	115.4	123.9	0.0	0.0	0.0	0.9	0.0	0.0	0.6	1.7	1.2	0.1	0.1	0.3	0.2	0.0	2.0	0.1	0.8	2.9	0.5	0.7	0.7	2.3	0.7	0.6	1.1	1.1	0.9	1.4	0.9	0.8	0.8	0.1	0.0	0.5	1.6	1.3	1.8	0.5	2.4	0.0	1.0	0.9	0.9	1.6	0.0	1.7	1.8	2.1	12.2	1.9	2.9	1.9	0.3	461.1	1.2	1.4	1.6	0.0	34.5	0.8	0.4	23.4	3.2	3.1	2.1	0.0	13.0	2.9	0.2	9.2	0.0	1.0	3.5	0.0	1.9	1.5	1860.6	9.3	3.4	0.0	1.0	4.3	0.4	0.0	0.5	0.2	0.1	0.2	6.8	7.8	0.8	0.3	0.2	0.3	0.2	6.6	0.8	3.4	60.6	36.8	4.6	0.4	3.7	2.7	0.8	7.4	0.7
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57546026-57586633	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease variant, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"brain: 1628.2;choroid plexus: 951.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.7;Early spermatids: 12.2;Endometrial stromal cells: 12.9;Excitatory neurons: 28.4;Horizontal cells: 26.9;Inhibitory neurons: 21.7;Late spermatids: 15.2;Rod photoreceptor cells: 11.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.2;K-562: 15.3;NTERA-2: 17.7;SCLC-21H: 34.4;U-87 MG: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: AB_2686601"	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	0.4	10.6	1198.6	4.6	1243.7	4.2	0.5	1056.4	1628.2	2.5	951.3	4.5	3.6	3.8	1.4	1.4	0.6	0.7	0.6	1242.7	1056.4	0.8	0.2	0.8	0.7	1103.5	1046.7	0.6	2.6	9.0	21.3	0.1	1113.3	0.9	1.9	48.0	1.1	0.6	0.3	1.1	2.5	2.0	1002.7	0.8	1.3	4.8	1052.3	0.1	2.3	0.1	0.4	0.5	1.5	1313.2	0.5	0.1	7.2	5.7	0.0	0.0	0.6	1.4	1.3	2.2	3.5	1.2	0.2	3.2	0.4	1.9	1.3	0.8	3.8	0.1	2.5	33.2	4.1	0.5	1.8	7.0	1.9	1.5	1.3	1.0	0.4	1.6	0.1	0.5	0.5	2.8	15.3	9.4	0.0	0.6	0.8	0.0	17.7	0.0	0.0	0.5	0.2	0.3	1.1	0.5	34.4	9.1	0.0	1.6	0.0	2.0	0.9	0.2	0.9	0.6	5.3	1.1	2.1	5.3	7.7	1.9	14.5	0.1	0.6	0.2	0.4	0.1	1.0	0.5	1.6	0.7	0.7	1.2	0.3	0.5	0.9	2.2	1.1	0.3	1.1	0.3	1.0	0.4	1198.6	1243.7	1056.4	1628.2	1242.7	1056.4	1103.5	1046.7	1113.3	1002.7	1052.3	1313.2	0.1	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	40.7	0.1	0.9	2.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	12.2	0.5	12.9	0.7	0.0	0.4	28.4	0.2	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	26.9	21.7	0.2	0.0	0.0	0.2	15.2	0.0	0.1	0.0	0.0	0.0	6.4	0.0	8.5	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.7	3.3	7.9	0.0	0.1	0.0	0.3	0.0	0.1	0.1
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423358-127003460	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 21.5"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 274.4;Inhibitory neurons: 482.6;Oligodendrocytes: 390.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 8.3"	"Cell line enhanced"	"Detected in some"		"BJ: 25.2;BJ hTERT+: 14.7;BJ hTERT+ SV40 Large T+: 9.3;BJ hTERT+ SV40 Large T+ RasG12V: 9.7;fHDF/TERT166: 18.3;U-138 MG: 11.3;U-251 MG: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	0.2	1.4	17.3	0.5	21.5	0.3	0.1	4.9	19.9	0.6	0.0	3.8	0.4	0.1	0.0	0.4	0.1	0.2	2.1	15.5	8.5	0.2	0.1	0.0	0.6	12.2	14.6	0.5	0.2	0.0	0.1	0.3	7.6	0.3	0.4	2.5	1.4	1.1	0.0	0.1	0.8	0.5	14.0	2.5	0.6	0.2	16.0	0.0	0.1	0.2	0.4	0.6	0.3	17.8	0.4	3.0	0.2	0.0	0.0	0.1	0.2	25.2	14.7	9.3	9.7	0.0	0.1	0.0	0.1	18.3	0.1	0.1	0.0	0.0	5.7	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.7	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	6.1	0.2	0.4	0.5	0.0	0.0	1.3	0.0	0.1	2.8	0.2	0.1	0.2	0.0	0.0	0.1	0.4	0.0	11.3	7.8	4.5	14.1	0.0	0.0	0.0	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	17.3	21.5	4.9	19.9	15.5	8.5	12.2	14.6	7.6	14.0	16.0	17.8	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.2	0.0	17.3	0.1	0.1	2.2	1.5	0.4	0.0	0.0	0.0	5.4	0.9	0.0	0.1	5.2	0.0	0.1	0.2	0.0	0.0	274.4	0.0	0.0	0.5	0.0	0.1	1.3	0.3	0.4	0.0	0.0	0.0	482.6	0.4	2.0	0.0	0.3	12.9	0.0	0.2	1.8	18.7	0.1	0.5	0.0	23.1	390.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.2	0.2	0.2	0.1
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077541	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 242.0;skin 1: 234.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1105.5;Basal squamous epithelial cells: 757.5;Glandular and luminal cells: 678.2;Squamous epithelial cells: 1028.4;Suprabasal keratinocytes: 685.9;Urothelial cells: 1495.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	21	"basophil: 24.0"	"Lineage enriched"	"Detected in single"	140	"granulocytes: 24.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 111.8;HaCaT: 128.8;HBEC3-KT: 112.2;hTCEpi: 156.1;OE19: 246.3;RT4: 136.3;SiHa: 114.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 23.2"	HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	6.5	5.9	4.2	18.0	9.1	63.5	36.2	0.6	3.3	49.9	2.7	161.2	130.4	6.7	6.6	242.0	37.5	55.9	3.3	2.6	3.4	8.5	4.7	29.6	2.0	0.8	3.4	4.5	11.9	0.5	10.9	18.8	0.7	23.1	145.4	0.4	79.8	14.4	19.2	234.9	146.2	6.6	0.5	1.5	82.2	12.0	4.1	12.0	25.7	7.8	53.6	111.5	122.2	1.0	22.3	31.1	0.2	0.4	1.1	1.5	34.1	12.9	29.8	5.6	6.9	28.5	111.8	0.4	68.9	11.4	2.3	128.8	39.0	112.2	8.9	0.9	11.0	0.4	61.9	2.8	7.8	10.5	1.9	8.1	156.1	1.7	61.1	5.7	0.1	3.8	1.6	2.2	25.5	7.9	2.1	0.8	1.4	246.3	43.3	2.0	28.3	2.5	87.3	136.3	2.9	1.3	114.5	18.3	8.5	13.9	2.5	2.5	0.3	7.8	23.1	0.2	5.4	3.7	1.9	3.8	10.8	2.1	9.5	24.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.1	4.2	9.1	0.6	3.3	2.6	3.4	0.8	3.4	0.7	0.5	4.1	1.0	7.8	163.5	123.3	0.7	5.2	518.9	1105.5	185.6	757.5	0.4	79.9	57.0	6.0	91.5	218.5	36.8	2.1	77.8	4.6	420.7	21.5	31.8	448.3	302.1	44.1	12.5	203.2	0.4	1.6	46.1	98.5	33.4	425.1	678.2	3.8	0.9	2.2	4.7	6.1	10.1	11.6	387.4	46.8	0.9	34.6	241.4	6.5	12.4	58.7	1.9	4.3	0.0	1.0	1.0	0.6	88.6	374.9	1.5	15.7	632.1	260.0	3.5	159.3	0.2	0.0	38.4	32.4	8.8	26.3	1028.4	685.9	58.0	17.4	0.5	505.4	1495.5
KLHDC8A	FLJ10748	ENSG00000162873	"Kelch domain containing 8A"	Q8IYD2	1	205336061-205357090	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"ovary: 284.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 50.8;Granulosa cells: 97.0;Muller glia cells: 19.8;Peritubular cells: 21.1;Theca cells: 44.6"	"Group enriched"	"Detected in many"	5	"glioma: 45.7;thyroid cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;HAP1: 8.7;NTERA-2: 2.1;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (1.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.92e-1)"	"unprognostic (8.37e-3)"	"unprognostic (7.39e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-7)"	"unprognostic (4.53e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.20e-2)"	0.1	26.5	9.3	0.4	7.3	6.5	0.5	15.0	14.3	2.4	4.6	2.8	0.8	1.6	0.7	4.5	13.9	0.5	0.6	13.9	13.0	0.5	0.2	0.2	0.2	16.6	11.0	284.0	2.1	0.6	18.0	0.0	17.1	0.4	0.6	26.4	1.4	0.2	0.1	0.5	0.8	2.5	11.0	0.3	6.8	6.4	18.5	0.3	3.4	0.0	1.2	0.4	2.5	4.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.3	15.0	14.3	13.9	13.0	16.6	11.0	17.1	11.0	18.5	4.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	50.8	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	2.1	7.1	11.6	1.2	0.0	0.0	7.6	0.0	0.2	0.0	97.0	0.4	0.0	0.0	5.0	8.9	0.0	0.0	0.0	0.0	0.2	5.3	0.2	0.0	0.0	0.0	19.8	0.0	3.0	0.2	0.3	0.0	21.1	0.5	0.0	0.0	0.2	0.1	4.8	0.0	0.0	8.1	0.8	5.0	0.0	0.0	0.0	0.0	44.6	0.0	0.0
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 31.4"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocyte precursor cells: 206.1"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021196	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.0	0.1	2.9	0.0	1.9	0.0	0.0	2.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.9	0.0	0.0	0.0	0.0	6.8	31.4	0.0	0.0	0.0	0.4	0.0	10.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.9	2.6	1.5	1.0	10.9	6.8	31.4	10.5	4.5	21.6	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	206.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736089	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1;Excitatory neurons: 91.9;Inhibitory neurons: 56.1;Late spermatids: 60.7;Muller glia cells: 46.2;Oligodendrocytes: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 5.8;RT4: 6.1;TIME: 13.5;U-266/70: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051291	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051291: AB_2681423"	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.4	7.1	8.5	2.3	10.6	1.0	3.9	26.7	9.9	5.2	3.4	2.8	1.8	3.3	1.8	2.5	3.7	4.0	16.5	9.5	7.4	8.5	2.5	3.0	3.9	6.8	7.2	5.8	2.4	0.4	8.5	2.3	7.1	3.2	1.6	7.7	2.1	1.5	1.9	2.1	2.9	2.4	5.2	4.2	3.5	6.5	8.3	3.9	9.2	1.6	2.9	3.3	4.7	12.6	0.3	0.3	1.4	0.0	0.8	1.1	0.9	0.3	0.4	0.1	0.2	0.5	5.3	1.3	2.8	0.0	0.0	0.1	0.3	2.5	0.2	1.4	0.6	0.6	1.1	0.0	0.3	0.0	1.0	1.0	0.2	0.6	0.0	2.2	5.8	3.7	0.2	1.1	0.2	0.0	3.0	0.8	2.4	0.0	0.8	2.4	0.0	0.0	0.9	6.1	1.6	0.9	0.3	0.0	0.5	3.8	0.0	0.5	13.5	0.4	0.3	0.0	0.4	7.9	4.7	0.0	5.0	0.1	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.9	0.5	0.0	0.7	0.0	0.4	0.4	0.2	8.5	10.6	26.7	9.9	9.5	7.4	6.8	7.2	7.1	5.2	8.3	12.6	13.3	0.0	2.2	20.2	1.9	1.1	1.7	1.4	1.2	15.6	1.8	1.5	36.4	1.5	1.4	7.3	22.9	0.6	5.6	0.5	1.9	0.8	44.1	7.1	1.8	14.1	15.6	2.7	91.9	0.9	0.1	3.9	9.2	7.1	1.3	6.6	24.7	3.7	0.6	5.0	56.1	1.0	0.0	1.3	1.2	60.7	2.5	0.7	1.8	7.5	1.0	46.2	5.2	30.7	66.4	1.3	0.3	1.9	1.0	0.8	0.5	0.3	2.3	6.6	0.0	3.7	3.9	9.2	8.5	1.8	0.9	0.1	3.2	6.8	1.9	1.2
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819146-50823787	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	84	"pancreas: 9557.9;salivary gland: 5487.3"	"Group enriched"	"Detected in many"	7	"Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 9.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	13	"B-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 43.8"									HPA059690	Approved				"Secreted to digestive system"	NA	NA		10000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA059690: "	"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	1.4	2.4	0.1	4.0	0.0	0.4	1.8	0.0	0.4	1.9	0.0	68.8	9.6	2.0	0.0	1.3	0.6	0.1	3.0	0.3	0.0	89.4	0.6	0.5	0.5	0.0	0.0	4.7	9557.9	0.4	0.2	1.1	0.0	2.7	53.0	0.0	5487.3	0.1	0.2	26.3	9.7	2.8	0.0	3.3	1.4	0.1	0.0	0.2	2.9	0.2	1.5	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.2	0.3	0.5	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	0.1	0.4	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	9.7	0.0	0.1	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.1	4.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	18.9	19.5	1.2	2.9	1.2	0.0	1.0	1.1	0.3	0.0	2.5	0.0	0.0	0.0	0.2	62.2	45.0	3.3	0.6	0.1	1.4	0.4	117.1	0.0	0.0	788.4	0.0	7.7	1.5	0.0	8.9	8.8	0.4	0.0	0.6	0.0	0.0	1317.5	14.2	1.6	5.3	0.3	6.2	1.5	5.4	0.0	6.2	0.0	0.0	0.0	0.0	125.8	134.4	0.0	10.9	9.8	57.1	0.3	0.3	0.0	0.0	0.0	1.1	0.3	0.9	1.7	54.0	0.0	2.1	2.5	148.5	3.8
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.2;salivary gland: 5.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.5;Intestinal goblet cells: 34.6;Late spermatids: 8.8;Spermatocytes: 15.0;Spermatogonia: 9.5"	"Group enriched"	"Detected in some"	4	"prostate cancer: 3.5;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019802	Uncertain				"Secreted to blood"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	1.2	0.0	5.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.5	0.0	0.0	0.1	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	34.6	0.0	0.0	0.0	8.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	9.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 642.3;NK-cells: 1855.8;T-cells: 790.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2177.1"	"Group enriched"	"Detected in all"	140	"NK-cells: 756.7;T-cells: 2177.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"		"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"prognostic favorable (3.51e-5)"	"unprognostic (1.23e-3)"	"unprognostic (7.03e-3)"	"prognostic favorable (1.42e-5)"	"unprognostic (1.69e-1)"	"prognostic favorable (6.99e-5)"	"unprognostic (1.54e-3)"	"unprognostic (7.15e-3)"	"unprognostic (4.12e-1)"	"unprognostic (8.23e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (1.17e-2)"	3.1	1.7	0.7	17.8	0.8	47.4	5.1	0.3	0.8	4.2	0.2	7.7	10.7	1.6	1.4	3.2	1.5	10.7	0.7	0.6	0.7	1.4	11.3	6.7	20.1	0.6	0.6	1.0	0.4	0.2	0.3	1.4	0.6	2.1	8.1	0.1	0.8	1.0	0.7	0.8	20.1	1.6	0.6	28.9	10.1	0.6	0.6	5.7	1.3	0.9	36.4	10.6	1.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.4	0.2	9.5	2.2	1.1	519.7	2.1	2177.1	1.6	307.4	346.1	1.9	1.5	17.1	98.0	10.5	756.7	3.6	3.9	77.9	285.3	0.7	0.8	0.3	0.8	0.6	0.7	0.6	0.6	0.6	0.6	0.6	0.8	6.1	0.0	8.9	0.0	19.0	9.7	0.9	0.0	1.2	0.0	5.2	2.5	1.0	4.3	1.3	0.0	0.0	0.4	642.3	1.7	0.0	0.6	0.0	1.9	1.5	6.2	0.0	118.1	0.4	0.0	0.1	7.9	12.2	2.4	0.0	0.0	45.3	10.1	0.9	0.0	0.6	1.0	0.0	36.2	15.8	0.0	0.0	13.2	24.9	0.0	28.1	0.0	1855.8	2.5	0.1	0.0	3.3	0.0	23.0	1.1	0.9	2.0	0.0	0.0	0.0	1.6	4.1	0.0	0.1	1.2	8.8	1.0	790.5	0.0	2.0	1.3
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.2;NK-cells: 8.2;Plasma cells: 4.7;T-cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7"	"Group enriched"	"Detected in many"	59	"NK-cells: 4.7;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.5;SuSa: 1.8;U-698: 1.7"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"	0.8	0.7	2.0	2.3	2.1	1.7	1.5	0.9	2.0	0.6	0.2	1.2	1.3	0.8	0.6	0.8	0.5	2.2	0.3	1.6	2.0	0.2	1.2	1.8	4.7	2.2	1.6	0.4	0.1	0.0	0.1	0.5	1.8	0.4	1.3	0.1	1.1	0.1	0.0	0.1	2.6	0.5	1.2	9.4	2.3	0.6	1.9	0.6	0.7	0.0	3.2	0.6	0.5	2.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	6.7	0.1	4.7	0.0	0.0	0.0	1.8	2.0	2.1	0.9	2.0	1.6	2.0	2.2	1.6	1.8	1.2	1.9	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.1
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
KNDC1	"bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2, v-KIND, Very-KIND"	ENSG00000171798	"Kinase non-catalytic C-lobe domain containing 1"	Q76NI1	10	133160219-133226412	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0;pituitary gland: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Excitatory neurons: 41.9;Inhibitory neurons: 36.3;Respiratory ciliated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;EFO-21: 1.2;MCF7: 1.1;NTERA-2: 1.4;RPMI-8226: 2.1;SuSa: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039624, HPA056143"	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane, Cytosol"	Vesicles	"HPA039624: AB_10671045, HPA056143: "	"unprognostic (2.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (1.59e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.80e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.41e-2)"	1.5	13.7	31.1	0.1	17.9	0.0	0.2	8.4	44.0	2.3	0.0	0.3	0.0	2.8	0.7	0.2	9.0	0.2	0.3	19.8	9.1	0.8	6.5	2.8	0.0	17.3	13.3	8.5	0.5	0.4	27.5	0.4	10.3	1.1	0.0	0.9	0.6	0.9	0.0	0.2	0.2	0.4	3.0	0.5	0.3	1.8	22.7	0.0	2.5	0.0	0.0	0.2	0.9	13.1	0.2	0.3	0.2	1.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.2	0.0	1.2	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	31.1	17.9	8.4	44.0	19.8	9.1	17.3	13.3	10.3	3.0	22.7	13.1	0.0	0.0	9.0	93.4	0.2	0.0	0.1	0.4	0.0	1.6	0.2	0.0	2.4	1.5	4.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	1.5	0.2	3.0	0.0	41.9	0.0	0.1	1.4	0.0	0.3	0.0	1.5	0.4	4.6	0.2	1.7	36.3	0.0	0.0	1.0	0.4	1.0	3.7	1.2	0.0	5.6	0.3	4.5	0.0	6.6	2.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	25.9	1.0	0.0	0.1	0.5	0.0	1.7	0.0	0.3	0.1	0.4	1.2	0.0	0.0
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.2	0.1	0.1	1.9	0.0	5.3	0.3	0.2	0.2	0.2	0.2	1.3	1.6	0.3	0.2	1.0	0.1	0.3	0.1	0.1	0.1	0.5	0.7	0.4	3.6	0.1	0.3	0.0	0.0	0.3	0.0	1.3	0.1	0.1	1.4	0.2	0.2	0.0	0.0	0.8	1.7	0.7	0.0	0.6	0.9	16.9	0.3	7.4	0.3	0.1	3.4	0.5	0.2	0.1	19.1	9.3	18.0	13.8	0.5	2.6	8.6	20.5	8.1	16.0	13.1	11.6	7.2	11.9	6.1	9.3	12.0	21.9	17.6	9.7	16.3	21.4	5.0	35.5	15.5	3.9	0.0	26.2	17.8	0.5	0.4	10.8	6.4	2.1	13.8	20.9	22.9	19.2	18.3	6.1	23.5	6.1	9.4	11.3	9.5	21.2	25.8	5.9	2.6	15.6	15.9	7.7	17.7	10.6	2.1	5.9	11.1	9.0	13.1	18.7	16.3	21.9	11.7	7.5	27.9	22.3	7.6	18.5	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.3	0.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.1	1.1	0.0	0.0	1.8	1.8	0.0	8.5	2.6	0.0	1.9	0.2	0.0	3.5	3.5	1.9	0.0	0.0	0.0	0.6	11.3	4.2	0.0	2.9	0.0	22.8	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	11.5	0.7	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	3.7	1.9	1.7	0.0	0.0
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952906	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 76.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 76.7"	"Cell line enhanced"	"Detected in many"		"A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 12.1"	"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol		NA	NA		140000000	"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"CAB000008: , CAB000030: , HPA001605: AB_2666381"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	170.3	29.0	2.6	77.5	1.4	1.5	209.8	5.3	1.6	243.5	34.8	424.1	324.3	27.8	226.0	118.4	193.5	180.6	38.3	2.2	6.9	247.2	519.5	177.8	8.6	26.1	4.3	16.4	570.2	79.5	251.9	474.5	30.3	183.3	492.3	0.6	323.4	129.5	2.1	44.5	370.7	23.4	2.5	28.5	289.9	8.3	13.9	10.3	244.1	1.4	27.8	199.7	62.2	2.5	2065.1	5639.4	1.1	7.9	0.7	1.1	3818.0	313.3	349.5	368.4	104.6	6249.4	4576.4	1.4	839.8	318.4	196.5	487.2	79.1	2228.5	217.9	2.6	138.2	19.4	865.7	1743.9	942.1	0.6	1.3	13.6	202.9	323.8	437.1	1046.9	399.0	3.4	511.4	0.2	0.3	8470.0	3.8	37.3	471.0	2740.1	457.9	3.0	0.3	236.1	1803.3	1144.9	65.6	3.7	512.7	4583.8	18.8	2696.0	2446.8	6.6	137.9	5.0	441.8	6.9	68.3	1.1	7.3	4.3	0.9	1.2	36.4	76.7	0.3	2.4	0.6	0.2	2.2	4.6	4.5	1.2	2.2	7.4	11.1	4.1	3.2	2.5	0.0	0.1	0.4	2.9	2.6	1.4	5.3	1.6	2.2	6.9	26.1	4.3	30.3	2.5	13.9	2.5	14.4	862.2	286.4	0.3	29.8	14.8	1605.7	912.1	447.3	0.1	814.6	615.6	5.3	1252.5	877.3	623.5	0.0	3698.8	14.2	1942.9	275.9	6583.8	1.0	462.3	60.3	77.8	642.3	15.4	0.0	4826.1	5496.7	203.5	971.5	742.4	48.9	51.2	57.1	610.9	308.3	1.7	0.0	2492.6	1969.3	9.8	13.8	3.8	10.5	28.3	208.1	1.0	41.5	6.2	0.0	0.0	0.0	6071.5	2164.1	0.0	13.7	1205.1	1912.3	718.5	500.8	0.6	0.0	0.6	298.6	2.7	26.0	395.7	6.7	7643.5	38.1	45.0	1635.0	1512.1
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 889.0;salivary gland: 810.7;urinary bladder: 781.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 7444.0;Club cells: 5055.9;Ductal cells: 4717.9;Extravillous trophoblasts: 6919.3;Pancreatic endocrine cells: 7374.9;Proximal enterocytes: 8623.3;Urothelial cells: 5959.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1945.3;HBEC3-KT: 2945.0;MCF7: 2220.9;RT4: 3146.7;SK-BR-3: 5446.1;T-47d: 3674.2"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		300000000	"Cluster 40: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	89.3	18.7	2.0	61.7	2.4	0.3	403.3	7.9	2.5	250.0	1.6	525.7	348.3	57.9	72.0	889.0	176.1	298.6	13.5	1.5	1.7	141.8	7.7	204.1	0.4	1.6	2.9	74.4	48.8	14.3	15.6	175.1	2.2	208.3	359.2	0.1	810.7	194.2	1.3	141.9	776.1	46.5	1.4	1.2	631.5	3.4	1.8	127.8	28.3	1.6	98.3	781.4	317.0	1.8	2.6	343.4	0.0	6.3	0.7	1.8	1169.3	412.1	0.5	12.8	2.9	992.6	1945.3	0.4	393.3	199.0	1.5	1044.6	0.1	2945.0	2.5	0.8	10.4	0.2	213.4	692.3	30.3	0.0	82.0	0.7	524.9	9.0	0.4	0.2	26.2	0.0	148.4	2.5	0.1	2220.9	5.9	3.0	18.5	1323.5	492.7	2.9	0.1	5.8	1335.4	3146.7	40.0	1.7	3.3	5446.1	0.1	266.5	3674.2	0.3	1.7	3.6	6.1	7.7	0.7	1.1	0.8	2.0	1.5	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	2.4	7.9	2.5	1.5	1.7	1.6	2.9	2.2	1.4	1.8	1.8	10.5	673.1	185.5	0.0	17.8	5.2	4317.3	7444.0	1715.8	0.0	1393.0	867.5	2.9	662.0	5055.9	892.0	0.0	1160.8	20.5	3599.6	1.9	4717.9	0.1	737.2	102.8	41.9	362.5	0.0	0.1	2589.9	6919.3	171.8	1571.4	1010.7	94.6	1.0	1.1	0.7	179.0	0.0	0.1	1382.4	2720.0	2.6	2.5	2.6	37.9	25.5	190.3	1.0	30.0	0.8	0.0	0.0	0.0	7374.9	3399.6	88.8	19.9	2228.8	8623.3	26.7	1954.3	0.0	0.0	0.0	240.0	1.1	1.6	1302.6	1.1	2127.5	36.1	4.8	1619.0	5959.8
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875889-40885242	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 646.9"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 1328.5;Intestinal goblet cells: 421.7;Paneth cells: 1606.6;Proximal enterocytes: 1107.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		NA	NA		30000000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	1.3	0.0	0.0	49.9	0.0	0.0	1.6	0.0	0.0	0.1	0.0	597.7	295.9	2.1	0.0	0.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	480.1	0.0	0.0	1.2	0.0	0.1	646.9	27.0	0.0	0.0	124.9	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.4	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1328.5	0.0	0.1	0.0	0.0	0.0	0.0	43.9	0.0	0.1	0.0	0.0	0.0	115.7	0.1	13.4	0.0	0.0	0.0	0.1	0.0	0.0	421.7	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1606.6	0.0	0.6	1.9	1107.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.6	0.0	160.4	1.4
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371390-30372271	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 12.8"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 31.1;Paneth cells: 27.0;Prostatic glandular cells: 11.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA		1000000		"Cluster 61: Skin - Cornification"		"Cluster 53: Intestinal epithelial cells - Unknown function"												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	12.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	5.4
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968990	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.0;pituitary gland: 7.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 161.8;Excitatory neurons: 284.7;Inhibitory neurons: 234.9;Oligodendrocyte precursor cells: 95.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.5;SCLC-21H: 3.2;TIME: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.0	0.9	2.3	0.0	2.4	0.0	0.2	1.1	10.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.0	7.7	0.0	0.7	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.6	7.9	0.0	0.6	0.1	0.3	1.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.8	0.3	0.0	0.6	0.0	0.1	0.2	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.1	0.4	0.9	3.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	6.9	0.0	0.5	0.0	0.1	0.5	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.4	1.1	10.0	7.7	0.0	0.7	0.0	0.6	0.1	0.3	2.7	0.9	0.0	0.0	17.6	0.5	0.3	1.2	0.1	0.0	55.2	2.8	2.4	2.2	5.7	0.2	161.8	39.6	0.9	0.0	1.3	0.0	2.3	10.8	4.0	0.3	0.5	20.4	5.3	284.7	1.5	0.4	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.1	47.1	234.9	10.3	2.0	0.3	0.4	12.5	0.0	0.0	0.0	5.6	0.0	2.4	0.0	95.0	4.2	0.4	1.5	0.0	0.0	1.4	0.1	0.8	0.3	28.2	0.0	0.3	0.1	0.6	3.1	0.0	0.3	0.3	0.6	0.0	3.0	1.3
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;intestine: 48.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 84.6;Excitatory neurons: 23.7;Horizontal cells: 33.7;Inhibitory neurons: 23.3;Melanocytes: 44.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 372.4;BJ hTERT+ SV40 Large T+ RasG12V: 200.8;HeLa: 258.1;RH-30: 162.6;RPTEC TERT1: 218.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Cluster 24: B-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	3.5	27.2	20.4	7.6	23.0	0.5	2.1	23.0	42.8	8.4	0.0	48.5	4.2	2.4	2.1	4.4	3.4	2.4	12.1	12.6	42.4	18.5	0.9	0.6	3.2	9.0	2.5	1.3	2.2	0.1	14.4	0.6	6.1	8.3	4.7	15.7	4.8	9.0	0.9	9.2	13.0	5.4	0.0	0.9	11.3	0.8	3.2	0.7	2.5	2.1	1.8	6.1	9.6	13.2	95.2	7.2	27.6	0.2	0.0	0.0	11.8	131.6	372.4	123.6	200.8	37.8	1.0	0.0	121.8	0.9	103.2	3.9	3.5	2.3	64.1	0.3	1.0	0.0	258.1	6.1	0.4	0.3	20.4	0.9	1.6	18.7	12.9	0.2	0.1	0.1	0.3	0.3	0.6	127.9	0.4	2.6	6.5	0.4	4.7	0.2	162.6	0.9	218.4	1.9	81.4	53.0	73.4	64.2	54.1	61.0	6.7	1.7	0.3	0.1	52.6	5.8	63.7	1.1	1.6	1.0	0.9	1.1	105.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	23.0	23.0	42.8	12.6	42.4	9.0	2.5	6.1	0.0	3.2	13.2	0.4	0.0	0.0	2.6	1.3	1.1	0.1	0.6	3.4	11.6	0.0	0.4	1.2	0.0	0.0	84.6	4.2	0.3	0.1	0.0	0.0	0.5	0.0	0.3	0.1	1.9	0.0	0.0	23.7	0.0	0.2	1.3	0.0	0.6	0.0	0.0	1.4	0.0	0.1	33.7	23.3	0.0	0.0	0.0	1.1	0.0	0.9	0.3	44.4	5.6	0.0	1.5	0.0	1.5	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	10.4	0.0	2.2	0.6	0.4	0.1	0.0	1.3	0.1	1.5	0.0	0.0	0.1
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201380833-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 362.1;skin 1: 215.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 174.7;Ductal cells: 178.0;monocytes: 248.6;Pancreatic endocrine cells: 227.0;Proximal enterocytes: 214.7;Squamous epithelial cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 159.9;CAPAN-2: 158.5;HaCaT: 220.4;HBEC3-KT: 190.3;hTCEpi: 181.5;MCF7: 218.3;OE19: 246.5;RT4: 164.7;SK-BR-3: 250.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.5	0.1	0.0	15.9	0.1	0.1	15.8	0.0	0.2	65.4	0.0	67.6	75.6	5.0	11.0	362.1	14.7	50.2	8.4	0.2	0.6	38.6	21.6	10.6	2.9	0.0	0.0	0.4	50.7	2.4	0.7	4.1	0.0	15.7	51.0	0.0	51.9	22.6	5.1	215.4	74.5	2.9	0.0	1.4	66.9	0.3	0.0	6.2	3.5	0.2	47.7	71.4	135.2	0.0	159.9	1.3	0.0	0.3	0.0	0.0	57.0	0.0	0.0	0.1	0.1	127.3	158.5	0.0	8.9	0.0	0.0	220.4	0.0	190.3	0.1	0.2	0.0	0.0	0.1	79.3	0.0	0.1	0.2	0.1	181.5	0.1	36.8	0.0	0.1	0.0	0.1	0.7	0.1	218.3	0.2	0.4	3.7	246.5	2.6	0.2	7.4	2.3	126.0	164.7	9.1	0.2	0.1	250.6	3.1	5.4	37.6	0.4	0.0	0.1	0.5	0.5	0.6	0.1	0.4	0.2	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	35.4	0.0	0.9	88.5	112.1	47.2	46.7	0.0	15.4	14.1	2.1	110.1	31.3	31.3	0.0	3.8	0.5	174.7	45.0	178.0	1.1	26.2	2.6	1.6	18.1	0.0	0.0	121.9	5.9	2.6	85.1	34.5	0.0	0.0	0.4	9.0	0.5	0.0	0.0	53.8	18.3	0.6	16.0	3.6	0.0	2.6	10.6	0.0	248.6	0.0	0.0	0.0	0.0	227.0	109.6	0.4	2.9	77.1	214.7	71.8	4.8	0.0	0.0	0.0	3.2	0.0	0.3	265.6	152.7	10.4	1.5	0.0	136.2	150.2
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.1;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 106.6;granulocytes: 109.3;Hofbauer cells: 190.9;Kupffer cells: 100.9;Macrophages: 128.9;NK-cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 7.5;Karpas-707: 19.4;THP-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		350000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	23.3	11.6	0.5	3.0	0.3	4.4	12.3	1.6	1.3	4.1	0.5	6.9	0.4	3.8	0.2	2.6	5.5	0.9	3.8	0.4	0.6	4.6	3.5	28.1	5.8	1.0	0.8	2.2	3.8	0.1	4.4	1.0	1.0	5.4	0.2	0.1	5.8	0.2	1.3	2.1	14.3	2.0	0.4	46.3	5.0	1.7	1.1	3.9	3.3	0.1	0.9	6.3	3.0	0.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	3.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	19.4	0.0	0.0	2.6	1.8	0.0	0.0	0.0	2.6	0.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.9	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	3.2	0.3	13.1	4.2	11.7	7.7	9.8	4.8	2.1	2.3	4.1	0.1	5.8	3.4	4.4	0.7	6.3	11.0	11.2	1.7	3.8	0.5	0.3	1.6	1.3	0.4	0.6	1.0	0.8	1.0	0.4	1.1	0.9	1.9	16.0	25.6	0.3	26.1	0.6	0.6	0.2	0.0	5.6	1.1	2.9	1.5	1.5	11.2	0.0	37.5	5.3	106.6	0.2	0.0	0.1	32.2	0.6	0.7	5.0	0.0	10.9	0.4	0.0	5.2	2.5	0.0	0.7	109.3	0.6	3.6	1.2	190.9	1.7	0.5	0.0	0.0	100.9	17.7	26.1	0.3	128.9	0.0	13.1	22.5	0.9	98.9	0.0	0.6	0.1	0.0	0.0	5.1	0.7	0.3	0.3	11.0	15.4	0.0	0.9	1.3	2.9	1.0	0.4	1.1	10.0	32.1	0.2	0.2	0.9
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652425	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 73.2;urinary bladder: 73.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 370.0;Basal respiratory cells: 447.6;Pancreatic endocrine cells: 853.8;Urothelial cells: 392.7"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 223.9"	"Region enriched"	"Detected in many"	7	"cerebral cortex: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 353.8;HaCaT: 538.2;HBEC3-KT: 1315.0;hTCEpi: 412.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		20000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	10.9	16.0	2.6	13.1	2.9	10.7	20.7	0.9	21.3	13.2	0.5	26.2	31.5	18.0	2.6	47.2	16.4	11.9	6.8	2.9	2.1	16.3	9.3	28.4	1.2	1.5	1.5	1.1	4.2	0.1	1.7	5.8	1.6	25.9	16.6	0.2	41.5	24.1	6.8	42.1	43.7	2.3	1.7	1.0	73.2	1.0	1.9	5.8	1.2	0.3	13.2	73.1	32.6	2.8	178.4	25.8	0.0	0.4	18.1	11.7	1.0	5.1	15.4	6.0	9.1	68.9	353.8	0.1	15.1	3.7	8.9	538.2	0.1	1315.0	9.1	13.1	1.4	1.1	86.9	1.1	2.4	1.0	1.3	2.6	412.8	19.1	253.4	11.7	6.4	0.1	2.5	6.7	1.9	0.3	0.2	1.2	0.6	81.0	74.0	0.2	17.1	165.4	70.9	109.0	0.5	0.5	73.9	8.5	15.4	1.0	2.0	9.7	138.3	29.1	61.3	1.0	104.6	1.7	3.4	0.4	42.2	0.8	2.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.6	2.9	0.9	21.3	2.9	2.1	1.5	1.5	1.6	1.7	1.9	2.8	0.4	221.2	67.7	1.6	1.2	109.7	370.0	447.6	159.9	0.3	11.5	64.4	8.4	4.3	168.5	47.8	0.0	1.1	0.4	247.5	0.0	180.5	6.0	50.8	10.0	3.5	7.8	0.4	2.5	153.0	1.4	7.5	195.7	135.0	18.4	0.2	0.4	3.9	2.0	3.3	2.3	71.7	18.3	0.3	30.0	10.9	1.8	9.9	8.8	0.0	2.1	0.4	0.0	1.0	1.7	853.8	229.1	0.7	2.1	185.0	111.9	2.3	52.2	0.3	0.0	5.3	10.4	0.3	0.6	51.7	26.0	0.5	4.0	0.0	63.1	392.7
LAMP5	"BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46"	ENSG00000125869	"Lysosomal associated membrane protein family member 5"	Q9UJQ1	20	9514358-9530524	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.6;retina: 29.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 78.4;Granulosa cells: 22.2;Horizontal cells: 60.6;Inhibitory neurons: 38.9;Theca cells: 23.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"plasmacytoid DC: 141.3"	"Lineage enriched"	"Detected in many"	31	"dendritic cells: 141.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 469.4;SH-SY5Y: 86.4;THP-1: 169.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004802, HPA070765"	Enhanced		Uncertain	"Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Mitotic spindle, Centriolar satellite"	"HPA004802: AB_10603682, HPA070765: AB_2686309"	"unprognostic (2.78e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.73e-4)"	"unprognostic (5.47e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (6.46e-6)"	"unprognostic (5.12e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.49e-3)"	0.5	4.3	41.7	1.5	96.6	2.3	0.9	11.0	51.8	8.8	3.7	2.2	1.2	4.8	6.3	0.4	10.6	3.1	0.4	39.1	14.3	0.8	0.2	0.9	5.7	47.7	10.1	21.9	1.2	0.7	6.3	0.1	43.7	2.3	1.2	29.6	1.1	3.8	0.1	0.7	1.3	3.9	29.1	1.8	1.4	0.9	35.3	1.4	0.9	0.2	5.2	0.7	1.2	13.6	0.1	0.2	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	469.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	86.4	0.0	0.0	0.1	0.4	0.0	169.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	21.1	0.3	4.2	1.7	0.0	0.0	0.3	0.2	4.5	0.0	0.1	9.5	0.5	0.0	0.0	0.4	0.0	0.0	141.3	0.0	2.4	41.7	96.6	11.0	51.8	39.1	14.3	47.7	10.1	43.7	29.1	35.3	13.6	0.5	0.0	1.1	6.2	3.4	0.1	0.0	0.0	0.0	12.3	0.3	4.3	0.3	0.0	0.0	0.0	8.4	0.0	78.4	0.0	0.0	0.8	5.4	0.2	0.7	0.8	0.0	0.0	10.0	0.0	0.0	8.4	0.0	0.7	0.0	22.2	0.0	0.0	1.3	60.6	38.9	0.0	0.0	0.6	0.8	7.5	0.6	3.5	3.6	4.7	5.4	3.9	0.0	13.0	1.5	0.4	0.0	0.0	5.5	0.5	0.0	0.0	0.0	5.7	0.0	0.3	13.9	0.6	1.1	0.0	0.0	0.0	0.9	23.2	0.1	0.0
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765177-203776372	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 23.2;granulocytes: 82.2;NK-cells: 30.9;Plasma cells: 65.1;T-cells: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	14	"B-cells: 7.5;NK-cells: 5.2;T-cells: 12.0"	"Group enriched"	"Detected in some"	4	"Karpas-707: 22.8;U-266/70: 28.2;U-266/84: 71.9;U-698: 24.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	0.5	0.6	0.2	8.8	0.3	1.6	1.7	0.4	0.4	1.4	0.3	3.7	3.1	0.3	0.3	0.9	0.4	2.6	0.3	0.3	0.2	0.2	0.9	2.7	11.8	0.5	0.2	0.2	0.4	0.1	0.0	0.1	0.5	0.7	3.4	0.1	1.2	0.4	0.1	0.2	2.0	0.7	0.2	7.2	4.5	0.3	0.3	11.1	0.2	0.3	21.2	5.1	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	8.0	0.2	22.8	0.0	0.0	8.7	0.0	0.1	0.0	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.2	71.9	24.9	0.0	1.9	0.0	0.3	0.0	0.5	12.0	0.0	9.1	7.5	7.1	9.4	0.0	2.5	5.5	7.1	0.3	5.2	0.0	0.0	8.1	3.5	0.2	0.3	0.4	0.4	0.3	0.2	0.5	0.2	0.5	0.2	0.3	0.7	0.9	0.0	1.9	0.0	14.6	1.1	0.4	0.0	0.0	0.0	0.3	0.1	2.6	0.0	0.6	0.0	0.0	0.1	23.2	0.1	0.0	0.2	0.0	0.4	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.6	1.5	0.4	82.2	0.0	2.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	1.9	10.6	0.0	0.4	0.0	30.9	0.5	0.0	0.1	0.0	0.0	65.1	0.4	0.6	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.0	0.2	0.4	0.0	29.2	0.1	0.3	0.5
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 283.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	29.5	20.8	29.3	8.3	29.8	4.2	27.2	56.7	37.5	41.4	37.8	30.6	5.0	28.7	9.1	13.4	26.1	11.5	42.0	28.5	32.3	33.2	283.0	36.1	7.5	41.9	32.7	28.5	17.7	8.0	17.5	17.8	31.6	40.0	4.8	2.8	16.9	18.6	13.2	32.0	17.8	12.3	31.9	23.3	16.5	11.3	33.4	9.4	43.2	8.9	4.4	27.5	27.3	32.0	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	29.3	29.8	56.7	37.5	28.5	32.3	41.9	32.7	31.6	31.9	33.4	32.0	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251239-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 343.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 143.9;NK-cells: 272.9;T-cells: 255.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	12	"gdT-cell: 1109.8;MAIT T-cell: 1034.8;memory CD4 T-cell: 1123.8;memory CD8 T-cell: 1201.7;naive CD4 T-cell: 1260.7;naive CD8 T-cell: 1168.7;NK-cell: 641.5;T-reg: 1682.7"	"Group enriched"	"Detected in all"	12	"NK-cells: 641.5;T-cells: 1682.7"	"Group enriched"	"Detected in some"	6	"JURKAT: 365.7;MOLT-4: 536.9;U-698: 302.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"unprognostic (6.38e-3)"	"unprognostic (5.45e-3)"	"unprognostic (8.39e-2)"	"prognostic favorable (2.96e-6)"	"unprognostic (2.20e-2)"	"prognostic favorable (2.91e-4)"	"unprognostic (4.78e-3)"	"unprognostic (1.33e-2)"	"prognostic favorable (5.65e-5)"	"unprognostic (3.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-2)"	3.4	2.2	0.4	50.6	0.5	13.7	2.3	0.4	0.5	2.2	0.7	6.9	7.6	1.7	13.0	3.9	2.1	9.4	1.9	0.5	0.4	3.8	3.8	11.4	111.0	0.8	0.5	1.6	0.9	0.5	0.8	1.1	0.6	2.8	6.5	0.0	4.8	1.4	1.3	1.9	23.1	2.3	0.6	39.9	12.1	1.1	0.5	343.0	3.7	1.4	79.6	13.2	2.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.7	64.1	3.5	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.6	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	365.7	0.2	0.0	0.0	0.0	536.9	0.2	5.9	4.6	0.3	20.6	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.3	0.3	0.4	0.6	0.4	0.0	0.0	1.7	0.1	0.1	0.7	0.3	302.7	0.0	0.1	0.0	12.8	5.2	6.0	1109.8	4.9	1034.8	62.0	1123.8	1201.7	5.2	98.9	1260.7	1168.7	33.6	641.5	6.0	7.7	1682.7	1836.9	0.4	0.5	0.4	0.5	0.5	0.4	0.8	0.5	0.6	0.6	0.5	0.6	4.9	0.0	9.3	0.0	23.4	4.6	1.2	0.4	0.0	0.0	3.5	5.2	1.8	4.3	1.6	3.7	0.0	0.3	143.9	0.9	0.0	0.6	0.1	1.0	0.5	3.4	2.4	10.1	0.2	0.5	0.2	3.1	7.7	0.7	5.1	0.0	4.6	1.5	0.3	0.0	0.2	0.3	0.0	7.8	7.3	0.0	0.0	8.1	3.6	0.0	8.7	0.0	272.9	0.5	0.1	4.7	0.0	0.4	15.7	1.0	0.0	1.4	1.8	0.0	0.0	1.5	2.4	4.5	2.0	0.5	3.1	0.4	255.5	2.9	1.3	1.1
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153453	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 2768.7;gallbladder: 2223.2;salivary gland: 1308.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 4054.2;Club cells: 5757.0;Ductal cells: 6457.0;Pancreatic endocrine cells: 5424.3;Respiratory ciliated cells: 3161.5;Urothelial cells: 7112.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 944.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	88	"basophil: 9.8;neutrophil: 11.9;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	83	"granulocytes: 11.9;monocytes: 4.7"	"Group enriched"	"Detected in many"	11	"CAPAN-2: 3623.8;EFO-21: 1450.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 149.7;spinal cord: 102.4"	"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA	297000000	590000000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favorable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	4.9	3.6	0.0	125.5	0.1	2768.7	22.0	0.1	0.5	810.5	2.0	249.1	34.4	14.2	20.5	677.6	52.6	2223.2	3.1	0.0	0.1	31.6	67.8	76.1	1.1	0.3	0.1	1.1	74.8	7.3	21.2	2.6	0.3	74.5	131.0	0.0	1308.3	13.5	1.2	28.1	157.3	11.9	0.1	82.0	363.9	0.5	0.1	14.2	27.1	0.3	199.1	669.9	480.7	0.1	117.7	35.1	0.0	4.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3623.8	0.2	1450.9	0.0	3.7	236.4	0.0	6.9	0.1	5.3	0.0	30.4	0.0	0.8	0.2	0.0	1.1	0.1	230.4	0.0	12.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	1.9	80.9	0.2	0.2	0.3	0.3	1.0	20.1	0.1	0.1	2.0	65.3	1.0	0.0	8.4	1.8	0.0	2.9	16.9	0.0	2.9	0.6	4.6	4.7	0.2	0.6	2.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	4.7	0.0	0.0	12.1	0.0	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	0.0	20.8	0.0	15.9	0.3	376.6	4054.2	1.8	0.0	38.1	29.3	0.2	1328.2	5757.0	138.0	0.0	0.8	1.2	315.6	0.0	6457.0	2.0	25.6	4.3	11.5	57.9	11.2	0.0	1837.0	0.3	12.2	237.0	52.3	13.4	0.0	2.2	43.2	0.6	0.0	0.0	264.3	956.2	2.7	0.0	15.8	3.4	34.9	0.0	0.0	60.3	0.0	1.0	0.0	0.0	5424.3	183.4	0.0	1.4	420.6	509.8	1.6	3161.5	0.0	0.0	0.0	337.7	0.0	0.3	51.1	0.0	0.3	7.7	0.0	475.5	7112.9
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 709.0;epididymis: 402.7;lymphoid tissue: 605.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 438.4;granulocytes: 309.1;Hofbauer cells: 264.4;Kupffer cells: 401.2;Langerhans cells: 337.6;Late spermatids: 290.9;Macrophages: 466.1;monocytes: 535.7;NK-cells: 471.7;T-cells: 375.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 875.8;HDLM-2: 799.3;HL-60: 850.7;HMC-1: 861.7;JURKAT: 792.7;NB-4: 789.2;THP-1: 840.5;U-698: 1105.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		1800000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	85.9	31.1	11.3	396.9	13.1	709.0	43.9	13.9	30.9	28.5	16.8	54.7	42.4	27.4	402.7	29.5	21.5	76.4	14.5	11.3	14.2	13.1	89.0	173.8	563.5	19.7	18.9	10.0	12.2	12.6	4.3	67.2	21.3	184.5	71.2	4.9	44.4	24.3	7.1	40.6	62.3	60.4	18.6	375.2	53.2	33.2	24.8	499.8	23.6	17.8	605.1	133.0	7.7	29.9	36.1	0.2	1.9	0.0	0.0	0.0	409.8	0.1	1.2	3.9	2.9	237.4	1.4	875.8	179.5	0.0	249.1	1.7	0.1	0.6	3.9	799.3	202.9	187.6	0.4	1.1	0.9	850.7	861.7	2.3	0.1	1.4	1.2	0.3	0.0	792.7	100.4	569.7	0.0	2.8	624.8	789.2	1.0	0.4	8.2	451.6	1.6	638.2	0.0	233.8	2.8	7.5	1.9	91.8	6.4	25.0	6.4	840.5	3.1	22.0	13.6	1.5	25.5	135.3	292.5	1105.7	17.0	530.9	3.6	1007.3	1559.5	810.8	915.7	1806.2	822.0	342.3	539.6	761.2	1134.5	251.6	330.2	560.5	1908.6	650.6	1826.1	297.5	598.1	3644.2	11.3	13.1	13.9	30.9	11.3	14.2	19.7	18.9	21.3	18.6	24.8	29.9	7.4	32.1	73.2	0.3	185.2	12.0	1.2	0.0	1.8	0.4	10.3	11.7	4.2	5.7	18.0	3.7	0.0	9.8	438.4	0.2	0.0	16.9	113.1	4.7	42.8	9.6	1.2	63.9	0.5	16.3	68.3	10.9	19.9	7.0	309.1	0.7	12.5	24.0	264.4	0.0	0.5	0.5	0.0	401.2	337.6	290.9	1.2	466.1	23.2	17.8	535.7	23.7	471.7	0.5	1.5	6.8	2.4	1.9	102.4	42.0	0.1	1.5	13.8	1.2	0.0	3.1	6.2	2.7	1.6	2.2	11.8	13.5	375.3	0.5	0.4	4.0
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.5;Endothelial cells: 194.4;Excitatory neurons: 1314.4;Hepatic stellate cells: 364.8;Inhibitory neurons: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"NK-cell: 2.0"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"AF22: 18.3;fHDF/TERT166: 19.0;HAP1: 34.4;HUVEC TERT2: 65.3;TIME: 17.1;U-138 MG: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		No	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: AB_2686012"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	58.9	15.5	13.7	8.0	19.8	0.4	52.2	3.3	45.9	43.5	7.6	12.7	6.5	65.5	23.4	15.8	28.0	31.2	33.7	23.3	7.3	28.0	26.0	58.2	11.5	4.4	10.9	18.2	7.6	17.0	9.0	58.8	4.7	18.0	8.5	5.3	10.8	13.7	14.0	9.4	12.8	53.8	7.1	50.4	11.5	5.0	7.9	8.3	31.3	24.3	4.8	22.5	22.8	19.7	0.0	0.0	18.3	0.1	10.5	16.9	0.0	10.2	8.0	1.2	2.7	0.0	0.0	0.0	0.0	19.0	0.0	0.0	34.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	9.5	0.0	12.5	0.0	2.7	65.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.7	0.0	0.1	8.8	0.0	0.0	0.8	0.0	0.0	2.3	0.0	0.0	0.0	4.9	0.0	0.0	17.1	25.7	0.1	1.2	0.0	8.3	0.1	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.2	13.7	19.8	3.3	45.9	23.3	7.3	4.4	10.9	4.7	7.1	7.9	19.7	236.5	0.0	5.5	44.7	1.5	8.7	0.3	0.0	2.8	27.1	1.7	2.2	8.7	2.8	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.4	1.3	1.4	36.5	194.4	0.0	8.0	1314.4	0.2	0.2	44.4	4.1	1.1	5.7	0.1	364.8	3.1	0.4	0.0	196.5	0.0	0.0	16.4	13.2	2.6	38.2	1.4	8.8	117.1	0.0	10.4	3.1	120.6	36.7	0.2	0.0	50.4	0.0	0.3	0.0	0.1	0.7	2.1	6.6	2.8	19.3	0.2	0.7	1.3	6.8	0.1	4.9	39.7	0.0	0.5
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089462-11133820	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 112.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 397.4;Alveolar cells type 2: 468.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 46.0"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 46.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		23000000	"Cluster 38: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	43.6	112.1	6.4	27.3	7.5	27.4	15.6	8.6	13.0	27.5	22.0	20.0	23.6	21.6	3.8	50.1	21.6	36.9	19.3	8.4	10.8	15.2	60.4	54.8	4.8	24.3	14.4	37.7	50.7	10.1	6.9	16.6	20.0	20.2	12.2	2.3	19.1	4.6	3.9	25.5	18.3	28.6	9.9	10.5	36.5	8.4	11.7	4.0	7.7	4.0	5.1	22.6	25.8	14.5	113.6	52.2	61.1	29.9	80.5	152.7	21.0	23.5	89.8	41.3	88.6	52.9	105.3	37.2	94.1	46.1	135.6	88.3	31.1	185.6	19.9	27.5	6.1	18.1	34.5	47.1	120.2	19.2	100.9	192.5	67.5	139.6	30.2	28.5	45.8	29.5	38.9	213.8	31.9	41.4	25.3	25.9	66.4	56.0	67.5	17.1	44.9	48.2	103.1	89.5	14.8	15.4	21.1	45.7	3.8	45.2	19.0	44.6	50.8	36.1	26.3	23.2	44.7	26.8	24.4	23.3	42.8	43.7	83.6	46.0	2.9	0.1	5.4	2.6	1.3	0.6	2.2	1.7	1.6	0.5	2.3	2.2	0.8	2.5	0.8	0.5	1.6	3.2	6.4	7.5	8.6	13.0	8.4	10.8	24.3	14.4	20.0	9.9	11.7	14.5	106.3	397.4	468.6	16.3	8.1	143.4	176.8	182.2	85.4	11.4	144.0	108.7	35.9	92.9	205.7	14.7	6.2	18.4	24.7	273.7	1.9	57.9	1.2	95.3	61.7	75.8	61.9	6.6	10.7	89.0	32.1	42.9	195.2	278.6	75.9	32.9	22.9	149.2	14.9	1.7	8.1	157.2	77.3	16.5	26.5	1.6	19.6	47.4	56.9	7.5	2.7	6.8	8.2	7.5	19.4	86.7	209.7	7.2	30.7	142.7	32.5	0.6	99.1	6.6	6.6	133.4	48.4	4.1	2.8	155.3	197.2	48.2	32.8	214.3	110.7	184.2
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Metabolic proteins, Predicted secreted proteins"		"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 68.3;pancreas: 96.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 201.5;Glandular and luminal cells: 175.0;Intestinal goblet cells: 86.1;Paneth cells: 228.9;Undifferentiated cells: 301.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 44.8;endometrial cancer: 36.2;pancreatic cancer: 13.8;testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"basophil: 17.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 17.0"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 50.2"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.3	0.2	2.1	7.8	2.1	0.0	0.4	1.8	2.7	1.4	1.3	68.3	0.2	0.5	6.9	0.1	0.6	0.0	0.4	2.1	1.9	1.7	0.9	0.3	0.0	1.6	1.7	4.1	96.9	0.0	1.0	0.2	1.7	0.9	32.4	0.8	1.5	3.3	0.4	0.2	2.9	0.8	1.6	0.3	1.4	0.8	1.9	0.0	0.1	0.1	0.1	1.5	0.2	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	0.3	0.0	0.0	0.0	4.5	0.1	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	0.0	0.0	0.0	5.4	0.6	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	2.1	2.1	1.8	2.7	2.1	1.9	1.6	1.7	1.7	1.6	1.9	1.9	0.2	0.0	0.0	0.7	1.0	0.4	1.6	0.0	0.0	1.8	0.2	0.3	0.1	14.3	0.0	0.0	0.0	0.0	0.0	51.7	1.9	20.1	1.8	201.5	9.9	0.3	31.5	0.0	2.3	29.6	0.1	1.6	0.0	175.0	0.0	1.6	0.0	0.2	0.0	0.0	2.3	86.1	0.0	0.0	0.0	3.9	1.5	2.1	0.0	0.0	0.0	0.9	0.0	1.5	0.2	0.5	228.9	1.9	0.0	0.8	0.7	6.0	0.0	1.4	0.0	0.0	0.6	2.5	4.2	0.0	0.0	0.0	1.0	1.3	301.0	1.3
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"intestine: 1307.1"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000		"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.1	0.4	0.5	5.5	0.5	0.6	1.4	0.2	1307.1	812.2	3.2	0.2	1.4	2.4	137.1	0.9	0.3	0.3	2.9	79.5	1.2	1.1	0.3	0.3	1.6	31.5	0.0	0.8	0.2	0.3	2.3	933.0	0.2	1.1	2.3	1.6	1.6	691.9	55.2	0.2	4.0	135.2	0.9	0.3	0.3	1.7	0.2	0.4	11.2	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 15.4;intestine: 11.1;stomach 1: 30.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.7;Gastric mucus-secreting cells: 109.1;Intestinal goblet cells: 32.6;NK-cells: 28.8;Paneth cells: 42.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	17	"NK-cell: 12.7"	"Lineage enriched"	"Detected in single"	17	"NK-cells: 12.7"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.5;U-937: 2.8"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	1.6	0.0	8.2	3.3	0.0	0.0	15.4	0.0	7.4	0.0	0.1	0.0	0.0	0.1	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.1	0.0	2.2	0.0	0.0	0.6	3.4	0.3	0.0	0.6	30.9	0.1	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.1	12.7	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	2.3	0.3	1.1	0.6	0.0	0.0	0.0	0.1	1.5	2.2	0.0	0.0	0.0	9.9	17.7	0.0	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	109.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	32.6	2.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	28.8	0.0	0.0	0.6	42.3	0.0	1.2	0.2	7.7	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	2.1	0.0	6.6	0.3
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.3;intestine: 9.3;stomach 1: 11.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.1;Gastric mucus-secreting cells: 194.2;Intestinal goblet cells: 37.9;Paneth cells: 58.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"neutrophil: 1.9;NK-cell: 5.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;NK-cells: 5.5"	"Not detected"	"Not detected"											"HPA046876, HPA047218"	Approved		Approved	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"		"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	9.3	1.1	0.0	0.0	10.3	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	1.6	0.0	0.0	0.2	4.3	0.0	0.0	1.4	11.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	1.9	5.5	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.1	3.4	48.1	0.0	0.2	0.0	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.0	0.0	194.2	0.1	0.0	0.0	0.4	0.1	0.7	0.0	0.0	37.9	4.1	2.2	0.0	0.0	0.0	1.3	0.0	0.0	0.5	0.0	9.2	0.0	0.0	0.4	58.4	0.0	0.2	0.0	13.5	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.1	4.5	0.1	0.0	1.8	0.0	10.8	0.2
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146830-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 112.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 22.2;Excitatory neurons: 17.7;Inhibitory neurons: 23.7;Melanocytes: 40.9;Oligodendrocytes: 58.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;melanoma: 14.3;thyroid cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;SCLC-21H: 1.6;SK-MEL-30: 1.6;WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	0.3	3.4	44.2	0.1	79.7	0.1	0.2	81.1	84.6	2.9	5.2	0.8	0.3	1.2	0.3	6.5	1.6	0.1	2.2	43.4	70.4	0.4	0.1	15.9	0.0	85.8	72.4	0.2	0.8	0.3	2.8	0.0	90.7	1.3	0.1	3.9	1.7	2.8	0.2	15.0	0.5	0.6	57.1	0.1	0.9	0.8	86.3	0.3	13.0	0.1	0.3	0.2	2.5	112.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	79.7	81.1	84.6	43.4	70.4	85.8	72.4	90.7	57.1	86.3	112.6	0.0	0.0	22.2	2.0	0.0	2.3	0.0	0.0	0.0	2.7	0.1	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.8	0.0	17.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.4	0.0	0.3	0.1	40.9	2.8	0.0	1.2	0.0	6.6	58.4	0.1	0.0	7.2	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.6	0.1	0.1	1.4	0.6	0.0	0.0	0.9	0.0	0.0
LGI4		ENSG00000153902	"Leucine rich repeat LGI family member 4"	Q8N135	19	35124513-35142451	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.7;Distal enterocytes: 33.1;Muller glia cells: 95.5;Sertoli cells: 78.9;Smooth muscle cells: 104.4"	"Group enriched"	"Detected in many"	6	"glioma: 4.5;melanoma: 11.5;renal cancer: 13.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	27	"WM-115: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042116, HPA043556"	Approved		Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"HPA042116: AB_2677855, HPA043556: AB_2678550"	"unprognostic (3.79e-1)"	"unprognostic (6.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.84e-7)"	"unprognostic (1.71e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.73e-2)"	"unprognostic (7.13e-2)"	77.6	5.4	71.2	4.1	72.3	0.2	36.1	70.3	98.4	99.9	52.1	100.5	3.6	35.5	2.3	15.0	43.7	5.0	39.4	67.8	61.3	4.7	8.0	14.3	2.1	86.5	68.4	13.3	6.4	1.4	4.4	3.6	70.1	37.2	3.7	7.2	12.2	13.3	39.1	21.2	35.1	4.8	72.8	1.9	27.0	2.7	72.0	0.5	19.1	5.4	0.5	33.5	79.3	81.4	0.1	0.0	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	71.2	72.3	70.3	98.4	67.8	61.3	86.5	68.4	70.1	72.8	72.0	81.4	13.3	0.0	0.0	74.7	0.2	2.5	0.6	0.3	3.4	0.8	1.5	1.5	17.1	0.0	0.8	1.8	2.1	0.0	0.2	33.1	0.0	0.0	0.1	0.2	2.8	5.4	1.8	0.0	21.9	0.0	0.3	12.7	0.0	0.2	0.0	0.0	7.9	2.0	0.1	0.0	2.2	0.9	0.0	0.0	4.6	0.3	14.6	0.7	10.6	5.6	0.1	95.5	0.0	2.0	9.2	0.1	21.8	7.2	0.3	1.2	1.1	0.1	0.9	3.1	78.9	7.9	104.4	2.8	2.8	0.8	2.4	0.0	0.7	0.0	0.7	1.1
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LHX6	LHX6.1	ENSG00000106852	"LIM homeobox 6"	Q9UPM6	9	122202577-122229626	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 77.2;Endothelial cells: 32.1;Inhibitory neurons: 46.0;Late spermatids: 225.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.2;K-562: 9.8;NB-4: 18.4;PC-3: 12.3;U-87 MG: 9.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 6.5;basal ganglia: 7.1;cerebral cortex: 7.7;hippocampal formation: 7.2;hypothalamus: 2.2"	"HPA047854, HPA058319"	Approved		Uncertain	"Nucleoli fibrillar center,Plasma membrane"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA047854: AB_2680183, HPA058319: "	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.72e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.94e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"	"unprognostic (9.14e-2)"	"unprognostic (5.64e-6)"	"unprognostic (1.77e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.51e-2)"	15.9	0.8	10.7	1.9	7.1	0.0	11.8	0.0	6.8	4.5	0.0	3.5	1.1	3.5	0.6	2.1	3.5	2.8	5.9	6.5	9.7	1.6	0.2	3.6	1.0	0.0	0.0	2.0	1.1	0.9	0.3	2.7	0.0	2.5	1.3	0.1	2.3	0.8	2.3	2.7	3.4	3.3	0.2	0.1	2.2	5.6	1.3	0.7	3.3	2.8	1.0	5.6	4.0	3.1	2.7	0.0	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	13.2	3.3	0.0	2.8	0.0	1.1	0.0	1.4	3.6	0.0	0.0	2.1	0.1	1.0	0.6	0.0	2.5	0.6	0.0	0.8	0.0	0.2	0.0	4.7	0.7	9.8	0.0	0.0	2.8	0.0	18.4	2.8	0.4	12.3	0.0	6.2	0.0	2.2	0.0	1.9	0.4	3.3	1.0	3.3	0.5	2.7	0.0	0.8	0.8	1.3	0.0	0.2	0.3	0.2	0.2	9.6	4.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	7.1	0.0	6.8	6.5	9.7	0.0	0.0	0.0	0.2	1.3	3.1	13.7	0.0	0.0	0.7	0.0	0.1	0.2	3.6	1.8	0.0	1.3	1.5	2.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.2	0.2	0.1	32.1	0.0	2.7	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	46.0	0.0	0.0	0.3	0.3	225.9	1.2	0.1	0.0	5.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.9	2.5	6.7	0.5	0.3	0.0	0.0	0.1	0.0	0.2
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.5;lymphoid tissue: 57.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 22.0;Kupffer cells: 79.9;Macrophages: 39.1;monocytes: 48.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 31.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 31.6;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.7;REH: 2.0;THP-1: 4.0;U-937: 9.1"														"Secreted to blood"	NA	NA		140000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	5.2	3.2	0.9	2.8	1.0	15.5	1.8	1.0	1.5	0.9	0.9	1.5	0.2	1.0	0.2	0.9	4.0	0.4	1.9	1.0	1.0	1.4	3.4	10.3	0.2	2.0	1.2	0.8	1.4	0.1	0.8	0.1	2.0	1.4	0.2	0.2	1.7	0.1	0.5	0.7	1.7	0.4	1.1	57.4	1.6	0.8	1.6	0.2	0.8	0.2	0.3	2.2	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.0	5.3	7.6	3.0	0.1	11.6	0.1	0.1	0.1	0.1	3.3	0.3	0.1	0.1	31.6	0.4	11.3	0.7	0.1	6.1	0.9	1.0	1.0	1.5	1.0	1.0	2.0	1.2	2.0	1.1	1.6	1.8	0.2	3.2	3.0	0.0	0.3	0.3	1.6	0.0	0.0	0.9	0.4	0.1	0.5	1.5	1.8	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.0	0.2	0.2	0.6	0.0	0.1	6.3	0.1	0.4	0.4	22.0	0.0	0.0	0.0	0.0	79.9	5.9	0.6	0.0	39.1	0.0	8.4	48.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.0	0.1	1.5	0.6	0.0	2.1	0.3	0.3	0.3	0.0	0.1	0.4	1.4	0.0	0.0	0.6
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.7;lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 76.9;Hofbauer cells: 127.6;Kupffer cells: 118.9;Macrophages: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 37.3"	"Group enriched"	"Detected in many"	44	"dendritic cells: 37.3;monocytes: 10.8"	"Cell line enriched"	"Detected in some"	32	"Karpas-707: 407.8"									HPA052807	Approved					NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA052807: AB_2681958"	"unprognostic (4.09e-2)"	"unprognostic (5.75e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	8.6	4.6	2.2	10.9	2.5	2.0	3.6	2.7	4.2	1.1	2.2	4.1	1.6	0.9	0.3	1.0	4.0	1.7	2.3	2.2	2.8	2.2	2.9	13.7	11.4	3.8	3.2	0.7	1.6	0.1	2.2	1.4	3.5	1.9	2.3	0.1	3.6	0.3	0.5	0.5	6.3	0.7	3.2	18.8	1.7	0.3	3.0	0.6	2.4	0.0	2.1	6.1	0.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	407.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.4	12.8	0.0	0.2	0.0	0.4	0.0	7.8	0.0	0.0	10.8	0.0	0.2	0.0	0.0	11.7	0.5	0.0	0.0	0.1	0.1	8.9	37.3	0.0	3.8	2.2	2.5	2.7	4.2	2.2	2.8	3.8	3.2	3.5	3.2	3.0	3.3	0.6	0.0	4.1	0.0	13.4	0.4	0.0	0.0	0.0	0.2	0.3	1.7	1.0	1.5	1.3	0.0	0.0	0.3	76.9	0.1	0.0	0.0	0.2	0.0	0.0	4.2	0.0	7.8	0.1	0.0	0.9	0.5	0.0	0.0	1.3	0.0	2.2	0.8	127.6	0.0	0.2	0.0	0.0	118.9	12.6	0.6	0.0	104.0	1.8	14.0	29.3	0.2	1.0	0.0	0.0	0.1	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.2	6.6	0.2	0.1	0.0	0.4	0.1	0.1	0.8	2.2	0.0	0.2	0.1
LINC00634		ENSG00000205704	"Long intergenic non-protein coding RNA 634"		22	41952174-41958933	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"brain: 33.2;choroid plexus: 10.7"	"Group enriched"	"Detected in some"	35	"Astrocytes: 5.2;Excitatory neurons: 4.0;Inhibitory neurons: 3.6;Oligodendrocyte precursor cells: 3.5;Oligodendrocytes: 1.6"	"Cancer enriched"	"Detected in single"	13	"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 2.9;SCLC-21H: 2.7"									HPA029815			Approved	"Nuclear speckles,Cytosol"		NA	NA					"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear speckles"	Cytosol	"HPA029815: AB_10601803"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-4)"	"unprognostic (3.93e-4)"	"unprognostic (9.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.11e-6)"	"unprognostic (5.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.17e-1)"	0.0	2.1	27.4	0.0	25.9	0.1	0.0	16.3	33.2	0.0	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.2	22.6	0.0	0.0	0.0	0.0	19.0	23.6	0.0	0.0	0.0		0.0	17.9	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.0	15.6	0.0	0.2	1.0	30.1	0.0	0.0	0.0	0.1	0.0		21.9	0.3	0.0	1.3	1.3	0.0	0.7	0.8	0.0	0.0	0.2	0.3	0.4	1.0	2.4	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	2.1	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.6	0.6	0.0	0.0	2.5	0.1	1.5	0.0	0.6	1.0	1.4	0.3	0.3	2.0	2.9	0.5	0.1	0.0	0.1	2.7	1.8	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.3	0.8	1.7	2.4	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	25.9	16.3	33.2	30.2	22.6	19.0	23.6	17.9	15.6	30.1	21.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552588	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.7;stomach 1: 48.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 144.2;Club cells: 135.5;Distal enterocytes: 312.3;Gastric mucus-secreting cells: 236.5;Intestinal goblet cells: 139.8;Proximal enterocytes: 226.1;Urothelial cells: 158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 74.1;OE19: 17.2;RPTEC TERT1: 36.7;T-47d: 17.6;U-266/84: 18.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049079	Approved				"Secreted to blood"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favorable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.3	0.3	2.8	0.6	0.1	3.8	0.1	0.6	2.8	6.9	36.3	11.1	0.2	7.1	14.7	1.1	12.3	0.4	0.4	1.6	7.8	0.4	18.3	0.1	0.1	0.1	0.5	5.5	0.0	0.3	0.1	0.1	6.8	37.7	0.2	13.2	2.0	0.5	7.4	11.8	0.6	0.0	0.4	48.2	2.7	0.2	0.3	0.2	0.1	3.0	12.2	4.3	0.1	10.3	13.5	0.1	0.1	0.0	0.2	2.9	0.3	0.0	0.3	0.3	1.3	74.1	0.0	7.5	0.2	2.9	3.6	5.6	0.1	0.4	0.1	1.6	1.8	1.8	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	5.4	0.1	0.0	1.3	0.5	0.1	0.7	17.2	1.1	0.0	0.0	1.0	36.7	9.2	0.0	0.0	1.1	12.2	0.3	0.6	17.6	0.3	0.0	0.1	1.1	0.1	0.2	1.2	18.9	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.6	0.4	1.6	0.1	0.1	0.1	0.0	0.2	0.1	0.1	144.2	38.5	2.0	0.8	0.8	16.3	76.5	0.6	0.7	55.6	12.7	0.4	94.4	135.5	68.0	0.0	0.2	1.0	312.3	1.9	57.8	0.2	7.0	0.5	1.8	22.2	0.0	1.7	24.9	0.1	1.1	236.5	5.7	7.0	36.0	1.1	0.3	0.0	0.0	0.9	139.8	38.7	0.3	0.3	0.1	0.0	2.4	16.0	0.0	0.8	0.3	2.1	2.5	0.4	60.4	102.7	0.0	0.3	72.8	226.1	1.6	105.6	0.9	0.0	0.1	5.5	1.1	0.3	6.9	2.0	0.3	0.8	12.0	102.1	158.0
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 32.4;retina: 42.6"	"Cell type enriched"	"Detected in some"	13	"Muller glia cells: 289.4"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Group enriched"	"Detected in some"	13	"RPTEC TERT1: 53.5;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: AB_2683715"	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	0.0	0.3	24.0	0.2	22.3	0.3	0.0	24.7	16.2	0.0	7.1	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	26.6	30.7	3.1	0.0	0.0	0.5	31.1	32.4	0.0	0.0	0.0	1.5	0.4	24.7	1.5	0.3	42.6	0.0	5.8	0.0	0.1	0.2	0.2	32.2	0.1	0.4	0.1	26.1	0.0	4.6	0.0	0.0	0.0	0.0	29.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.1	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	24.0	22.3	24.7	16.2	26.6	30.7	31.1	32.4	24.7	32.2	26.1	29.1	0.0	0.0	0.0	21.2	1.3	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.7	0.0	0.1	12.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	3.3	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	289.4	0.0	0.5	1.4	0.0	0.0	0.0	0.1	0.1	0.0	2.3	0.0	9.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LLGL2	"HGL, Hugl-2"	ENSG00000073350	"LLGL scribble cell polarity complex component 2"	Q6P1M3	17	75525080-75575209	"Predicted intracellular proteins"	"Cell cycle, Cell division, Exocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 297.5;Pancreatic endocrine cells: 249.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;NK-cells: 2.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 92.6;CAPAN-2: 134.2;MCF7: 132.1;OE19: 101.6;RT4: 92.9;SK-BR-3: 127.5;T-47d: 96.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022913	Uncertain		Supported	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA022913: AB_1852930"	"unprognostic (1.18e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.25e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.00e-5)"	"unprognostic (6.22e-3)"	"prognostic favorable (6.14e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.15e-3)"	"unprognostic (1.56e-2)"	3.9	7.8	2.7	14.2	6.0	4.6	9.0	6.2	3.6	16.3	9.5	64.5	54.5	4.1	24.0	55.5	14.9	21.3	3.4	2.1	4.1	56.7	26.9	27.6	5.1	6.0	5.9	4.9	74.5	17.3	11.2	6.3	6.2	14.7	28.4	10.4	43.4	12.5	1.3	34.1	55.4	1.9	4.0	24.5	64.2	6.9	4.5	2.3	17.8	0.9	5.7	9.6	25.9	9.8	60.1	54.7	0.3	10.4	0.0	0.0	22.7	0.4	0.6	1.1	0.6	92.6	134.2	4.0	13.6	0.2	5.0	73.7	10.1	10.1	0.2	5.1	18.1	4.0	16.1	35.1	0.6	0.6	8.5	0.0	13.6	0.2	2.1	1.3	2.0	5.8	7.9	5.4	0.0	132.1	3.5	7.1	7.4	101.6	21.2	6.9	0.2	14.9	28.4	92.9	22.1	4.5	11.8	127.5	4.0	12.2	96.6	9.4	0.5	0.2	0.6	0.2	1.0	6.4	9.3	1.8	0.4	0.3	2.7	0.0	0.1	0.1	3.1	0.3	0.7	0.3	0.7	2.1	0.1	0.3	0.1	1.2	0.1	2.1	0.1	1.1	0.5	0.4	2.7	6.0	6.2	3.6	2.1	4.1	6.0	5.9	6.2	4.0	4.5	9.8	7.7	89.8	51.6	3.6	9.0	10.6	34.7	17.3	12.0	15.5	28.8	20.1	3.8	74.4	40.5	90.1	166.8	3.7	44.7	297.5	31.3	84.1	0.6	88.7	7.2	9.0	95.1	0.8	1.1	138.9	8.5	3.5	158.5	87.7	22.2	7.2	4.6	25.0	6.0	8.4	0.8	113.0	32.6	3.8	6.0	1.0	4.7	4.7	3.6	5.6	5.5	28.1	50.4	0.5	49.9	249.4	159.8	4.1	16.1	37.6	84.5	47.0	53.9	117.5	6.6	1.3	6.4	1.5	18.9	27.5	21.7	4.4	21.8	7.5	136.1	89.7
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501807-8574668	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 573.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 287.6;Ductal cells: 122.0;Endothelial cells: 161.9;Pancreatic endocrine cells: 114.1;Smooth muscle cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 20.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 20.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 88.9;HSkMC: 124.9;hTEC/SVTERT24-B: 93.8;U-2197: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No		6600	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	131.4	14.3	9.5	45.6	9.5	0.1	97.5	13.5	10.8	27.2	38.8	18.1	9.0	90.3	18.4	36.1	57.8	67.2	90.6	14.0	9.7	33.0	9.7	131.7	17.3	14.0	11.0	65.8	37.7	30.0	8.7	54.5	12.1	34.8	7.0	15.2	42.2	16.8	573.4	28.8	20.1	63.3	13.2	55.6	46.4	11.3	12.6	4.7	18.5	260.9	10.2	110.6	31.5	14.8	9.4	52.0	8.6	6.6	62.0	34.6	8.9	37.9	19.4	20.5	50.0	38.8	11.5	0.0	4.2	44.2	8.8	0.8	4.9	9.9	8.4	16.0	3.6	11.6	3.5	7.6	88.9	0.0	1.1	124.9	0.2	93.8	0.7	11.9	10.1	0.0	0.0	0.0	26.8	6.7	0.0	0.1	16.8	12.0	2.3	0.2	28.2	0.1	19.1	3.6	0.3	21.3	6.4	31.1	20.6	23.9	40.7	0.1	5.0	20.4	40.3	83.0	25.9	5.1	6.2	2.6	4.1	2.9	27.0	0.0	0.0	0.0	0.0	0.4	0.1	2.0	2.9	0.6	3.3	0.3	0.0	0.1	0.0	0.0	0.0	1.0	20.5	0.3	9.5	9.5	13.5	10.8	14.0	9.7	14.0	11.0	12.1	13.2	12.6	14.8	287.6	9.6	10.7	2.0	2.1	31.6	42.1	7.4	9.6	13.0	20.4	17.0	14.7	14.3	13.5	5.5	10.4	3.9	1.7	1.4	3.9	122.0	1.1	9.6	77.7	161.9	12.1	0.0	0.8	48.5	4.2	64.5	7.1	4.8	10.2	44.2	30.7	12.6	3.4	97.6	1.2	2.4	4.1	0.8	47.0	2.3	11.5	3.2	53.4	29.0	9.0	38.9	1.0	4.0	8.7	114.1	0.9	32.4	8.0	8.4	0.3	45.5	12.0	8.0	0.0	57.0	112.9	6.4	9.1	29.0	27.1	4.4	5.3	21.5	4.7	7.5
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892076	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.2;Endothelial cells: 144.6;Erythroid cells: 103.7;Hepatic stellate cells: 167.4;Kupffer cells: 65.0;Microglial cells: 64.6"	"Cancer enhanced"	"Detected in all"		"glioma: 30.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.9;granulocytes: 1.5;monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"HEL: 71.8;HL-60: 72.7;K-562: 60.9;NB-4: 27.3;THP-1: 81.6;U-937: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	15.0	5.9	14.9	11.4	13.0	27.7	12.5	14.2	16.6	8.4	13.4	5.0	4.6	6.5	0.7	6.8	8.3	5.4	4.4	14.7	16.0	13.1	2.3	18.2	19.4	19.9	16.3	3.5	2.6	2.3	8.6	6.5	18.5	5.7	1.5	0.6	5.3	2.4	23.4	4.9	6.6	4.8	18.7	19.0	3.9	1.7	19.0	1.8	12.3	4.6	8.4	5.8	7.3	13.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	2.2	1.3	12.8	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.4	71.8	0.0	0.0	0.3	72.7	18.5	0.0	0.0	0.0	0.0	0.0	10.2	0.0	60.9	0.0	0.0	0.3	5.1	27.3	0.9	0.0	0.0	15.3	0.8	0.2	0.0	0.8	4.3	0.0	0.3	0.5	0.1	0.2	0.0	81.6	0.9	0.0	0.2	1.7	0.0	0.0	0.2	0.6	4.7	29.2	0.3	0.6	0.5	1.5	0.0	1.4	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	1.7	0.1	0.0	0.2	14.9	13.0	14.2	16.6	14.7	16.0	19.9	16.3	18.5	18.7	19.0	13.3	109.2	3.2	7.1	8.5	6.6	8.4	7.9	8.0	0.6	1.6	2.8	9.5	2.8	8.6	1.7	5.5	2.1	0.4	1.0	0.8	0.0	3.0	0.5	40.5	11.0	144.6	0.0	103.7	1.3	2.0	3.2	9.8	0.0	39.6	7.6	0.9	167.4	1.7	39.1	0.0	3.8	0.2	2.0	65.0	56.8	1.2	4.1	54.1	10.6	64.6	47.5	1.1	4.1	5.0	1.0	1.0	1.9	0.0	3.0	5.4	0.0	8.8	5.0	2.6	0.0	17.3	3.6	0.3	7.9	0.8	6.0	21.5	1.9	12.4	0.5	25.1
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513935	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 44.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 41.4;Excitatory neurons: 37.0;Inhibitory neurons: 38.8;Urothelial cells: 49.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 9.4;SK-BR-3: 16.4;U-266/70: 9.8;U-266/84: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	0.0	1.7	23.1	0.7	27.5	0.4	0.7	6.1	44.0	0.6	0.0	0.2	3.7	0.1	1.1	0.6	0.3	0.4	0.3	31.7	6.7	1.1	0.0	1.3	1.1	9.9	1.2	0.1	0.8	3.6	5.7	0.6	1.5	1.5	0.0	2.7	2.6	1.1	0.0	0.8	1.9	0.0	0.7	0.6	1.2	0.2	8.4	0.4	0.8	0.0	0.8	0.2	0.0	21.8	6.0	4.4	0.5	0.5	0.0	0.0	5.1	0.1	0.4	0.0	0.2	3.7	5.2	1.6	1.5	0.0	1.4	3.0	0.8	1.9	0.0	0.7	2.8	0.2	2.5	0.9	0.0	0.0	9.4	0.1	1.1	0.3	0.0	2.0	0.0	5.0	1.6	3.6	0.0	7.9	1.1	4.1	1.2	3.4	1.5	4.8	0.0	2.1	1.7	1.2	1.5	2.9	0.2	16.4	0.9	1.2	5.6	0.2	0.1	0.0	1.5	0.1	0.0	9.8	9.3	1.9	0.3	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	23.1	27.5	6.1	44.0	31.7	6.7	9.9	1.2	1.5	0.7	8.4	21.8	0.3	3.2	1.7	11.8	2.1	0.5	13.1	17.0	2.8	15.9	20.5	6.2	2.7	2.8	41.4	7.3	0.0	4.9	0.6	0.4	25.4	21.5	0.1	8.4	0.6	0.5	0.0	0.0	37.0	0.4	2.8	0.9	6.6	8.1	0.0	0.6	1.4	0.4	1.3	18.5	38.8	1.2	8.2	0.6	0.9	0.2	0.6	0.4	3.6	1.9	0.2	6.9	0.0	26.2	9.6	17.2	0.1	0.0	14.5	18.8	3.0	0.6	25.9	2.2	0.0	0.4	3.3	4.0	3.3	7.1	1.8	6.8	1.3	2.9	1.5	49.5
LMX1B	NPS1	ENSG00000136944	"LIM homeobox transcription factor 1 beta"	O60663	9	126613928-126701032	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;salivary gland: 18.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.3;Breast myoepithelial cells: 7.2;Cardiomyocytes: 1.9;Early spermatids: 1.6;Spermatogonia: 2.1"	"Cancer enriched"	"Detected in some"	14	"breast cancer: 12.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HEK 293: 3.6;MCF7: 11.9;OE19: 10.4;T-47d: 8.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 2.3"	"Region enhanced"	"Detected in many"		"midbrain: 5.0"	"HPA073716, HPA075656"			Approved	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm		"HPA073716: AB_2686630, HPA075656: "	"unprognostic (4.17e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.63e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-6)"	"unprognostic (1.13e-2)"	0.6	0.0	0.1	0.0	0.1	0.1	4.1	0.1	5.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	1.0	3.6	0.0	0.1	0.0	3.8	9.2	0.0	0.2	1.1	0.2	0.0	3.3	0.0	0.0	0.0	18.5	0.0	0.1	2.1	0.1	0.0	6.8	0.0	0.1	1.4	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.2	0.6	0.3	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.3	0.0	2.5	0.6	3.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	11.9	0.0	0.0	0.0	10.4	0.0	0.0	2.4	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.2	0.1	8.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	5.6	1.0	1.0	3.8	9.2	3.3	6.8	2.6	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	7.2	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	1.6	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.4"	"Lineage enriched"	"Detected in single"	34	"T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		280000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	12.4	3.1	1.4	5.4	0.8	0.8	6.8	0.2	1.4	12.7	12.3	10.2	1.9	16.0	1.4	4.7	8.3	5.0	27.9	1.7	1.9	8.7	1.5	10.1	4.4	1.4	1.7	8.0	3.3	2.2	9.2	8.0	1.1	15.3	1.4	0.0	7.6	11.9	3.8	6.4	5.6	4.9	0.8	3.2	7.8	2.4	1.9	0.9	5.2	1.9	2.3	16.6	14.8	0.6	3.3	0.0	0.9	0.0	45.6	54.8	2.2	66.5	75.2	27.6	48.7	1.3	1.7	0.0	12.1	49.1	6.9	19.9	0.3	0.2	6.5	0.0	4.3	0.2	2.0	0.3	6.2	0.0	0.1	45.0	0.0	20.8	0.2	73.7	1.0	1.2	0.0	0.3	33.3	2.4	0.4	1.3	6.3	4.4	45.1	0.0	38.7	0.6	2.5	12.0	5.5	0.0	2.0	0.4	0.0	6.5	0.4	0.0	4.9	53.8	47.0	42.8	25.8	0.2	0.0	0.0	61.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.9	0.0	1.3	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	3.4	0.2	1.4	0.8	0.2	1.4	1.7	1.9	1.4	1.7	1.1	0.8	1.9	0.6	4.1	0.0	0.6	3.3	0.1	5.9	7.6	6.0	4.0	0.9	2.3	4.8	92.3	2.8	0.9	9.2	0.0	2.2	0.6	0.1	3.9	5.2	1.7	9.2	8.0	4.1	3.5	0.0	0.5	1.3	145.8	76.0	8.6	9.3	1.3	5.5	12.1	0.1	6.6	0.0	0.4	0.6	2.0	0.0	6.2	1.3	9.9	0.9	10.6	0.0	0.1	6.4	0.0	1.5	0.3	12.2	0.1	21.1	0.1	4.8	0.4	2.5	1.2	0.4	0.0	6.0	32.7	8.9	4.9	2.4	3.4	5.1	3.4	0.3	1.1	5.0
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 358.4;choroid plexus: 122.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 626.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.1;eosinophil: 19.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 19.0;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 582.0;ASC TERT1: 337.0;BJ hTERT+: 426.7;HSkMC: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	30.5	13.3	251.0	18.8	315.0	0.2	25.9	208.8	318.6	57.7	122.2	24.5	13.9	17.0	17.1	15.2	15.8	14.1	24.1	199.5	201.3	9.6	2.6	16.3	17.6	299.6	277.5	12.1	6.6	2.2	5.0	38.8	249.2	21.0	18.3	0.8	16.7	23.6	6.6	20.1	18.3	20.5	224.0	14.8	11.8	6.9	266.2	6.8	16.5	17.5	17.2	27.6	31.7	358.4	11.7	22.2	30.4	0.1	582.0	337.0	0.0	151.6	426.7	104.1	46.8	3.0	1.8	0.0	0.1	157.7	18.6	45.5	0.4	118.5	85.0	0.0	4.1	0.0	1.1	0.0	157.1	0.1	0.2	246.6	6.8	51.4	96.9	62.3	1.8	0.2	0.0	0.2	80.8	0.1	0.0	0.1	5.9	0.0	121.6	0.1	22.4	0.0	23.5	20.6	0.9	7.2	3.1	0.0	0.0	6.2	10.4	0.5	0.1	48.9	1.3	35.3	0.1	1.5	0.0	0.0	7.4	0.0	54.9	1.5	9.1	19.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.9	2.1	1.3	0.2	0.0	2.1	251.0	315.0	208.8	318.6	199.5	201.3	299.6	277.5	249.2	224.0	266.2	358.4	1.9	0.0	1.1	6.2	0.2	13.0	15.5	8.5	4.0	0.0	3.4	6.0	1.4	1.5	9.1	0.0	0.0	0.5	0.3	6.6	1.9	1.8	1.4	3.6	40.4	1.9	0.0	0.0	1.0	2.9	0.4	61.4	6.1	8.7	0.0	0.0	2.5	0.0	3.3	0.0	15.6	3.7	4.1	4.1	15.1	2.7	38.8	3.6	14.2	141.5	12.0	1.0	1.0	1.0	626.8	2.0	2.9	70.7	0.7	12.7	4.5	0.2	3.0	0.2	0.0	13.3	6.3	0.3	2.4	15.2	9.2	0.8	1.2	0.2	4.2	6.7
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 566.5;Late spermatids: 1737.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 97.0;EFO-21: 115.2;U-698: 200.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		2700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	29.3	10.8	6.7	28.4	8.9	9.9	18.8	9.1	9.7	27.5	27.3	73.3	13.8	61.9	11.8	49.4	32.2	21.3	16.7	6.1	11.2	11.5	12.1	19.1	17.2	15.6	7.9	14.7	8.8	9.9	2.9	11.5	12.6	39.0	31.7	2.4	12.0	53.1	12.4	12.0	23.0	81.3	6.6	10.8	32.7	18.6	13.8	8.0	8.8	9.1	21.4	57.0	22.1	7.8	25.6	23.3	16.7	11.3	35.3	36.0	17.9	16.0	20.9	11.8	7.8	42.2	12.1	97.0	115.2	37.3	14.7	10.7	5.2	11.0	29.5	10.7	5.7	4.6	18.4	11.1	15.0	2.0	5.5	25.7	15.3	26.4	22.5	16.9	20.1	5.2	0.2	2.0	21.0	8.1	5.1	2.1	6.6	16.3	7.6	6.2	12.3	0.5	13.1	26.8	1.1	0.3	35.3	11.4	19.2	27.3	9.0	8.8	43.7	27.1	20.8	19.6	41.1	0.2	4.0	200.0	13.6	4.3	24.9	0.8	4.9	2.2	5.1	4.5	3.3	3.3	4.5	3.8	2.6	5.6	2.4	2.9	18.9	4.8	4.6	5.3	1.8	1.9	6.7	8.9	9.1	9.7	6.1	11.2	15.6	7.9	12.6	6.6	13.8	7.8	104.7	89.8	69.8	357.5	48.5	78.0	84.9	65.0	70.0	9.5	141.8	111.5	143.0	100.1	86.2	69.9	14.6	44.7	65.7	207.1	29.4	139.7	566.5	49.3	134.4	91.8	77.5	12.0	132.8	90.9	24.1	124.9	97.9	93.6	18.3	136.6	126.4	94.8	42.5	5.0	191.2	91.7	44.7	65.1	121.0	1737.1	225.3	75.8	80.0	308.2	55.8	24.8	54.6	395.6	214.9	120.2	158.1	476.9	24.6	172.5	127.5	80.2	60.9	7.1	335.2	159.2	368.2	9.8	8.0	64.2	68.2	18.6	55.3	46.8	151.3	149.3
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753120	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"NTERA-2: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.2	0.2	0.6	0.2	0.7	0.5	0.4	0.7	2.6	0.2	1.6	0.5	1.2	0.1	0.3	0.0	0.2	0.5	0.1	0.7	1.2	0.1	2.1	0.3	0.1	1.0	1.1	0.3	0.8	0.2	0.2	0.1	1.3	0.4	0.1	1.0	0.1	0.5	0.8	0.4	1.6	0.1	0.7	0.1	0.3	0.8	0.7	0.0	1.5	0.0	0.1	0.1	0.1	0.9	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	15.3	0.0	0.0	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.6	1.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	1.5	0.2	0.1	0.1	0.8	0.2	0.2	0.2	0.1	2.2	0.6	0.7	0.7	2.6	0.7	1.2	1.0	1.1	1.3	0.7	0.7	0.9	0.2	0.0	4.4	4.6	0.1	1.1	4.4	4.0	0.6	0.5	8.6	9.1	0.3	11.5	1.7	0.0	0.0	0.1	0.3	0.8	3.9	1.2	15.2	0.9	0.5	0.3	0.0	0.0	2.2	0.8	0.1	1.5	2.0	2.2	0.0	104.4	1.4	2.2	0.1	0.0	0.6	0.9	2.0	0.8	2.8	3.2	0.0	0.3	5.4	0.0	0.0	3.9	0.0	1.0	2.2	1.2	0.0	0.0	0.0	2.4	12.3	1.0	0.9	0.8	0.0	1.4	8.1	10.5	4.7	1.4	1.1	0.3	0.6	0.0	1.2	0.6
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391591-40587364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.4;retina: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4;cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 1.7;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.0	0.3	1.6	0.0	6.4	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.7	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	6.4	0.0	5.9	1.3	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.3	0.6	0.0	0.1	0.0	62.6	0.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	4.2	0.0	111.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	62.8	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	3.7	0.0	0.8	0.0	49.8	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.3	0.2	0.0	0.1	0.1
LRIT2	"AC022389.4, LRRC22"	ENSG00000204033	"Leucine rich repeat, Ig-like and transmembrane domains 2"	A6NDA9	10	84220571-84225544	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"retina: 59.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.5;Cone photoreceptor cells: 8.4;Rod photoreceptor cells: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037788	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA037788: AB_10672393"			"unprognostic (3.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.99e-1)"	"unprognostic (9.44e-2)"				"unprognostic (2.36e-1)"			"unprognostic (1.76e-2)"		"unprognostic (2.41e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	59.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.3	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005672	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 36.2;kidney: 42.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 152.3;Paneth cells: 36.0;Proximal enterocytes: 82.1;Proximal tubular cells: 57.0;Undifferentiated cells: 36.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA		190000		"Cluster 87: Intestine & Kidney - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favorable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.0	0.1	0.1	2.7	0.1	0.3	0.0	0.4	0.1	0.0	1.0	36.2	23.4	0.1	0.0	0.0	0.0	5.9	0.0	0.1	0.1	42.8	1.4	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	32.6	0.2	0.0	0.1	0.2	0.2	31.4	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.4	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	18.6	0.0	23.9	0.0	0.0	0.1	152.3	9.8	0.1	0.1	0.4	0.4	0.2	6.0	0.0	0.7	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	3.7	0.0	0.0	0.7	20.3	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	36.0	0.4	0.0	0.0	82.1	57.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	36.0	0.0
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391137-18397622	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 32.4;lymphoid tissue: 61.2"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 47.0;Kupffer cells: 123.6;Macrophages: 90.0;monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.6;eosinophil: 356.2;intermediate monocyte: 512.1;myeloid DC: 229.3;neutrophil: 573.0;non-classical monocyte: 706.7"	"Group enriched"	"Detected in all"	60	"dendritic cells: 229.3;granulocytes: 573.0;monocytes: 706.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.0;HMC-1: 1.8;THP-1: 1.7;U-937: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029459	Approved		Approved	"Endoplasmic reticulum,Microtubules,Cytosol"		NA	NA		630000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Endoplasmic reticulum, Microtubules, Cytosol"		"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	9.4	9.4	2.4	21.8	2.5	32.4	3.1	3.3	2.9	1.8	3.2	3.3	3.7	1.6	0.7	2.3	3.9	5.3	2.5	2.3	3.1	2.4	5.9	11.5	9.9	4.6	4.0	1.5	2.0	0.7	1.2	5.4	4.2	2.0	2.8	0.3	2.6	1.2	3.7	1.0	4.8	6.7	2.8	61.2	2.3	1.2	5.4	3.0	1.2	8.7	4.0	7.0	1.3	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.3	1.0	0.8	0.4	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.7	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.2	1.5	0.1	55.4	320.6	356.2	0.9	512.1	1.9	7.3	0.6	0.7	229.3	8.4	0.5	0.6	573.0	4.6	706.7	32.1	1.3	229.2	2.4	2.5	3.3	2.9	2.3	3.1	4.6	4.0	4.2	2.8	5.4	4.7	0.7	0.0	1.3	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.3	1.0	0.3	0.0	0.7	0.0	0.0	0.1	2.9	0.1	5.9	0.1	1.9	0.2	0.1	0.9	0.0	2.1	0.1	0.0	0.4	0.5	0.0	0.4	10.2	0.0	1.8	0.5	47.0	0.0	0.1	0.0	0.0	123.6	12.5	0.5	0.0	90.0	1.8	1.0	74.9	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	2.4	0.2	0.0	0.2	0.0	0.1	0.4	1.1	0.2	0.1	0.1
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 290.0"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.2	0.3	0.4	0.0	7.3	2.6	0.5	0.4	0.0	11.2	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	53.1	0.5	0.0	290.0	0.5	0.0	5.1	7.2	0.0	0.2	0.1	5.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.2	0.4	2.6	0.5	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839172-169869935	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 21.7;salivary gland: 6.5;stomach 1: 10.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 8.9;Enteroendocrine cells: 10.3;Intestinal goblet cells: 23.5;Paneth cells: 6.0;Undifferentiated cells: 5.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HAP1: 1.4;OE19: 8.8;RPTEC TERT1: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA058013			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA058013: "	"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	1.4	0.0	17.5	8.4	0.1	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	5.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	21.7	0.1	6.5	0.0	0.0	0.0	9.6	0.4	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	1.0	0.3	0.0	10.3	0.0	0.3	0.0	0.0	0.0	3.1	3.0	0.0	0.0	0.0	2.4	0.1	0.0	0.2	23.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	0.4
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 78.0;Endothelial cells: 88.3;Extravillous trophoblasts: 164.2;Hepatic stellate cells: 95.3;Sertoli cells: 39.5;Smooth muscle cells: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 115.0;ASC TERT1: 70.3;HSkMC: 44.0;HUVEC TERT2: 51.4;U-2197: 108.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		98000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA055775: AB_2732600, HPA058434: AB_2732622"	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (2.64e-4)"	104.5	34.3	12.6	10.5	12.6	2.4	63.6	11.2	11.8	56.2	8.4	23.2	8.9	36.4	6.2	10.3	31.6	29.0	55.7	9.6	10.6	64.7	11.3	109.0	4.3	12.2	13.8	13.5	12.0	7.5	16.7	53.0	13.0	24.9	6.1	1.3	12.8	11.0	23.6	26.6	21.4	15.2	10.9	28.9	21.3	3.6	15.0	2.0	42.3	6.2	1.5	36.7	28.8	11.5	0.0	0.0	1.3	0.0	115.0	70.3	1.4	0.4	0.8	0.1	0.1	0.0	0.0	0.2	3.1	1.9	0.0	0.1	0.2	0.0	0.1	0.0	0.0	11.8	0.6	0.0	2.2	0.0	0.1	44.0	0.0	4.1	0.2	0.9	51.4	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	7.6	0.2	0.0	13.8	7.5	0.8	108.3	0.0	0.1	0.0	1.9	5.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	4.3	12.6	12.6	11.2	11.8	9.6	10.6	12.2	13.8	13.0	10.9	15.0	11.5	78.0	0.0	4.3	0.0	1.7	14.5	0.3	0.0	1.8	0.0	0.6	0.6	10.4	0.0	1.3	0.0	0.0	1.9	0.1	0.2	0.0	0.3	1.3	0.1	1.9	88.3	0.0	5.3	0.0	0.0	164.2	26.4	0.5	0.3	2.5	0.5	95.3	0.6	3.6	0.0	0.1	0.4	0.0	3.1	19.0	1.9	9.0	2.9	17.8	14.0	0.0	0.4	0.0	0.0	0.1	0.0	2.2	9.1	0.2	1.4	0.0	0.4	0.7	0.1	39.5	2.1	47.6	0.4	4.7	0.6	12.5	8.3	1.6	0.4	0.1	1.2
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.4;retina: 17.1"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 5497.5"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 19.1;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Supported		Approved	Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol		"HPA054800: AB_2682603, HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	0.7	3.4	11.4	0.8	14.1	0.0	1.4	0.5	15.4	3.0	0.0	2.5	0.4	1.2	0.3	0.4	0.5	0.8	2.1	14.4	9.6	0.3	1.1	0.8	0.7	7.8	10.7	0.6	0.3	1.7	4.0	0.0	5.7	0.6	0.7	17.1	0.6	1.6	0.3	0.2	0.8	1.3	4.6	0.6	0.5	0.2	8.1	0.6	2.3	0.7	0.7	0.7	2.0	9.2	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	20.9	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.1	0.5	15.4	14.4	9.6	7.8	10.7	5.7	4.6	8.1	9.2	0.2	0.0	1.3	498.2	0.2	0.1	0.0	1.4	0.0	35.5	4.2	3.0	1.2	0.0	1.4	0.0	6.2	0.0	0.0	0.0	1.9	0.0	0.9	0.3	10.5	1.4	0.0	0.0	1171.8	0.0	0.0	5.6	0.0	0.9	0.0	0.1	0.0	0.0	0.1	8.4	1274.6	0.0	0.0	0.0	1.9	0.2	2.1	0.4	1.8	49.6	0.0	93.6	0.0	5497.5	221.3	0.3	0.0	1.5	0.1	0.1	0.0	0.7	0.0	99.7	0.0	2.0	0.7	0.3	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 15.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 19.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 105.4"	"Low region specificity"	"Detected in all"			HPA014053	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.4	0.5	4.7	1.0	2.8	0.0	0.1	0.8	3.5	0.1	0.0	0.5	0.3	1.8	0.0	0.0	0.3	0.2	0.3	4.1	6.7	0.3	1.2	0.2	2.1	15.0	11.7	0.0	0.2	0.0	0.0	0.9	3.7	0.0	0.5	0.1	0.6	0.0	0.3	0.1	0.4	1.0	8.4	1.3	0.1	0.2	5.9	0.9	0.1	0.3	0.5	0.0	0.0	6.8	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.8	0.8	3.5	4.1	6.7	15.0	11.7	3.7	8.4	5.9	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 28: Placenta - Pregnancy"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	14.3	7.6	3.8	9.0	4.5	8.0	7.7	4.5	5.8	3.2	11.4	3.2	3.2	7.3	1.9	2.9	2.8	6.6	6.2	4.1	4.1	2.5	3.3	7.7	12.2	4.6	5.0	5.3	1.8	2.8	2.3	6.6	5.1	2.3	3.7	1.6	2.0	2.0	2.7	6.0	3.8	15.8	4.8	9.2	2.9	4.0	4.7	5.6	3.5	8.0	7.7	6.2	2.0	6.0	0.3	3.8	3.0	2.7	9.1	10.2	1.4	19.3	21.6	8.7	8.0	0.0	1.3	6.0	5.3	8.5	14.9	13.1	10.1	29.0	20.9	14.8	6.1	5.7	2.9	0.3	7.4	26.6	1.9	4.4	5.8	18.8	10.0	5.8	35.6	9.2	3.9	7.9	7.5	0.7	3.9	26.2	3.3	0.1	7.8	26.5	1.4	2.0	1.8	3.2	2.3	10.7	7.1	0.7	16.2	4.7	0.2	41.3	29.9	15.3	7.3	5.3	14.9	2.9	2.6	3.1	4.7	19.6	2.6	0.4	6.0	0.0	3.8	5.2	3.3	0.7	6.1	5.1	8.9	0.5	4.8	4.5	0.8	2.0	6.6	0.7	11.3	3.2	3.8	4.5	4.5	5.8	4.1	4.1	4.6	5.0	5.1	4.8	4.7	6.0	73.5	3.2	3.6	31.3	7.6	45.4	3.8	5.6	3.4	2.3	1.7	2.9	6.3	2.8	2.7	0.0	0.0	0.1	24.6	0.3	0.0	1.7	36.3	0.2	1.9	47.3	1.2	4.8	73.6	2.4	1.1	8.7	2.6	0.6	0.0	58.5	28.9	0.1	13.6	1.7	99.2	0.3	2.0	29.5	36.9	21.3	0.0	27.8	26.6	185.5	21.3	0.5	13.4	22.1	85.2	12.8	1.9	0.7	20.8	2.1	0.3	0.6	2.9	1.2	0.0	2.2	24.2	3.9	2.0	1.3	44.9	0.3	27.1	3.4	0.3	2.5
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.4;salivary gland: 12.8"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.5	0.9	6.4	0.3	13.4	0.0	0.1	0.0	10.0	2.2	0.0	3.7	0.6	0.6	0.3	0.3	1.2	0.2	1.3	16.3	5.2	0.3	0.4	0.1	0.0	0.9	9.4	0.3	0.1	0.0	1.9	0.0	2.0	1.0	0.3	0.4	12.8	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.7	0.2	22.4	0.0	1.6	0.1	0.0	0.6	0.8	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.4	0.0	10.0	16.3	5.2	0.9	9.4	2.0	0.2	22.4	4.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRTM4	FLJ12568	ENSG00000176204	"Leucine rich repeat transmembrane neuronal 4"	Q86VH4	2	76747685-77593319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.6;retina: 6.8"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 3972.6;Inhibitory neurons: 2310.6;Oligodendrocyte precursor cells: 3758.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"Karpas-707: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.72e-4)"	"unprognostic (7.20e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.54e-2)"		"unprognostic (7.99e-2)"	0.4	0.6	5.8	0.3	11.4	1.7	0.2	0.1	17.6	0.4	0.0	0.5	0.8	0.4	1.5	0.8	0.2	0.7	0.1	13.5	1.6	0.2	1.3	0.8	0.4	0.2	4.1	0.6	0.5	0.0	1.0	0.9	1.2	0.6	0.5	6.8	0.9	1.5	1.6	0.8	0.5	0.3	0.0	0.5	0.6	0.3	0.0	0.1	0.7	0.3	0.2	0.3	0.5	14.5	1.4	1.7	0.9	0.8	0.0	0.0	0.9	0.3	0.0	0.0	0.0	2.1	0.5	1.0	2.2	0.8	0.7	0.8	0.2	0.0	0.3	0.8	2.5	0.5	4.8	3.1	0.4	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.5	125.8	0.0	2.8	0.5	0.7	12.2	0.2	1.2	0.5	0.1	2.6	0.0	4.1	3.7	1.4	0.8	0.7	0.8	2.0	1.4	0.9	0.0	2.9	3.7	0.1	0.2	0.0	2.4	0.1	2.8	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.1	0.0	0.1	0.0	5.8	11.4	0.1	17.6	13.5	1.6	0.2	4.1	1.2	0.0	0.0	14.5	0.0	0.0	0.5	208.6	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.3	0.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	1.1	0.4	0.2	0.4	0.0	0.0	3972.6	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	2310.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	84.3	0.0	2.8	0.0	3758.4	176.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.7	2.3	6.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836753	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 11.8"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.9;Excitatory neurons: 10.2;Horizontal cells: 11.8;Inhibitory neurons: 7.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 4.3;SCLC-21H: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA055094: AB_2682693, HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	2.9	0.0	11.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	0.0	0.6	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	11.4	0.0	3.8	3.9	3.6	0.6	4.8	0.5	0.2	11.8	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
LSM1	"CASM, YJL124C"	ENSG00000175324	"LSM1 homolog, mRNA degradation associated"	O15116	8	38163335-38176730	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA024601			Approved	"Cytosol,Cytoplasmic bodies"		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Cytoplasmic bodies"	Cytosol	"HPA024601: AB_1853379"	"unprognostic (1.19e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.97e-1)"	30.0	31.9	42.1	27.6	43.0	34.4	28.0	44.1	49.2	25.1	43.4	31.0	25.3	27.5	39.6	27.5	22.9	26.7	61.1	41.5	44.0	36.1	36.7	20.4	33.9	42.8	43.2	20.0	28.3	29.5	22.1	34.6	43.0	27.3	29.4	21.4	32.4	34.1	34.8	24.7	25.4	31.7	43.0	22.4	27.0	20.9	44.1	34.8	28.7	35.0	31.8	37.8	22.5	43.2	66.8	72.1	47.6	54.2	78.1	71.8	41.2	78.6	81.9	74.9	78.3	51.3	45.7	32.2	69.4	96.9	75.3	33.1	61.2	67.0	83.7	49.0	71.8	102.9	52.2	65.4	68.1	36.4	65.3	70.1	60.9	62.0	51.2	57.1	66.1	65.0	83.2	78.7	94.7	66.7	110.7	70.4	68.7	100.9	73.9	53.2	49.2	38.1	102.9	78.8	80.3	67.1	34.3	51.0	98.7	48.3	43.3	76.2	65.1	63.9	77.1	96.0	65.0	82.2	123.2	66.2	74.8	73.7	67.3	161.5	65.7	105.0	58.6	75.0	61.1	59.8	64.6	64.9	66.0	52.4	58.4	67.2	50.5	62.9	78.8	111.1	82.1	78.8	42.1	43.0	44.1	49.2	41.5	44.0	42.8	43.2	43.0	43.0	44.1	43.2	40.8	12.8	24.6	5.2	49.5	66.3	45.6	101.7	26.2	26.6	58.5	42.4	5.9	48.6	61.7	68.0	10.4	109.3	78.4	40.7	180.0	90.6	9.0	65.0	47.1	42.9	46.7	36.2	9.3	119.2	138.9	40.7	25.5	53.0	24.1	29.5	42.5	58.5	84.9	13.5	11.6	48.8	75.3	51.5	46.9	8.4	61.5	58.6	48.0	12.2	104.8	55.0	125.7	7.5	12.4	120.0	54.5	56.8	57.1	92.1	59.8	121.4	51.1	24.1	52.6	39.0	58.0	64.7	129.3	40.8	70.3	102.2	57.8	67.3	49.9	87.3
LSMEM2	"C3orf45, FLJ38608"	ENSG00000179564	"Leucine rich single-pass membrane protein 2"	Q8N112	3	50279087-50288114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.9;skeletal muscle: 16.5"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 283.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA079523			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA079523: "	"unprognostic (2.84e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.71e-1)"	0.4	0.4	2.9	0.1	4.8	0.4	0.3	3.1	3.7	1.3	1.8	0.5	0.3	0.7	0.2	0.5	0.7	0.2	23.9	3.2	3.2	0.8	0.2	0.4	0.0	3.7	3.7	1.2	0.2	0.0	0.1	0.1	3.4	0.4	0.1	0.3	0.2	0.4	16.5	0.2	0.3	0.4	2.7	0.2	0.3	3.9	3.8	0.0	0.2	5.5	0.0	0.4	0.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.8	3.1	3.7	3.2	3.2	3.7	3.7	3.4	2.7	3.8	6.0	1.0	0.0	0.6	0.7	0.3	1.0	0.2	0.2	0.0	0.2	1.5	0.9	4.4	0.0	0.8	1.8	0.0	0.1	0.3	0.9	0.0	0.1	40.5	3.3	0.6	0.8	0.0	0.0	0.2	0.2	0.1	0.4	0.0	10.1	5.1	0.2	0.0	0.3	0.1	0.0	0.2	0.3	0.0	0.3	0.4	283.1	1.2	0.3	1.8	0.0	0.0	0.5	0.0	0.0	2.8	0.2	0.0	0.7	0.0	0.4	1.5	0.1	0.2	0.2	0.0	1.4	4.7	1.8	1.1	0.4	1.3	0.1	0.2	0.1	0.7	0.1
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1087.8;dendritic cells: 183.5;Ductal cells: 280.4;Pancreatic endocrine cells: 296.2;T-cells: 554.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.6;Daudi: 127.4;HDLM-2: 82.2;HMC-1: 38.1;NB-4: 62.3;REH: 58.6;U-698: 90.8"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	3.5	0.7	0.2	82.6	0.3	19.1	1.3	0.1	0.5	1.3	0.2	6.7	8.2	1.2	0.0	4.3	1.2	4.8	1.1	0.1	0.2	10.3	4.8	8.7	103.9	0.4	0.2	0.4	2.5	0.2	0.7	0.9	0.3	2.4	2.7	0.0	4.2	0.3	1.0	2.2	66.7	1.9	0.2	229.2	13.9	0.2	0.3	83.3	3.8	1.4	47.6	8.7	1.4	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	35.6	127.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	82.2	0.0	1.4	0.0	0.0	0.0	0.4	38.1	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	18.5	62.3	0.0	0.0	0.0	58.6	0.0	11.4	32.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.8	90.8	0.0	0.0	0.0	79.2	9.2	542.5	95.7	55.9	646.7	1027.3	924.3	419.4	14.5	1021.9	713.6	317.0	327.8	142.5	94.5	412.0	672.0	308.9	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.2	0.3	0.2	0.3	0.2	3.0	0.0	9.0	1.3	1087.8	16.3	0.5	45.7	2.2	0.7	2.9	3.7	0.5	2.8	4.7	90.1	0.0	0.9	183.5	0.9	1.9	280.4	3.5	2.2	2.0	8.4	0.0	11.2	0.9	113.1	0.3	6.3	3.1	1.5	14.0	0.1	10.8	3.5	10.1	0.0	0.9	0.4	160.7	31.0	112.1	0.2	0.6	49.8	42.7	0.0	72.3	1.8	99.9	0.0	0.3	296.2	1.6	0.0	13.6	3.0	0.0	11.6	0.9	0.2	6.6	1.3	4.3	0.4	1.2	1.2	12.4	0.3	554.0	0.3	3.6	0.3
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498183-74612378	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease variant, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 60.6;Fibroblasts: 59.5;Peritubular cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 240.8;HUVEC TERT2: 129.1;LHCN-M2: 129.4;TIME: 564.5"	"Group enriched"	"Detected in some"	10	"cerebellum: 5.3;olfactory bulb: 2.4"	"Region enhanced"	"Detected in many"		"olfactory bulb: 15.4"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA		14000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.94e-4)"	34.2	4.0	1.1	15.2	2.9	0.6	24.4	4.1	5.6	66.2	9.5	6.6	3.1	22.5	23.9	10.7	11.7	33.1	45.4	1.2	1.1	4.1	2.1	64.9	8.3	2.2	1.1	39.4	8.7	9.6	7.3	28.0	1.4	15.7	2.6	2.3	26.7	19.6	13.6	12.6	6.9	16.0	2.2	3.9	8.5	5.4	1.9	3.1	53.0	21.4	6.1	14.2	21.6	1.0	2.5	4.9	1.2	0.2	36.9	67.7	0.2	47.4	16.2	9.2	5.7	0.0	17.4	0.4	13.8	240.8	4.1	4.8	0.2	17.7	3.8	0.2	0.8	0.8	2.2	2.1	8.8	0.1	0.6	70.2	7.7	50.7	29.1	68.9	129.1	0.1	0.2	0.1	129.4	1.1	0.1	0.3	0.3	0.2	4.5	0.5	1.1	0.1	11.3	6.7	1.0	3.3	33.1	0.1	1.1	3.4	1.1	0.2	564.5	3.3	54.0	17.0	18.0	0.7	0.7	0.1	13.1	0.3	1.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	2.9	4.1	5.6	1.2	1.1	2.2	1.1	1.4	2.2	1.9	1.0	3.8	0.0	2.2	2.3	0.1	5.6	15.1	13.0	13.1	2.1	1.9	60.6	6.4	0.0	6.1	0.0	0.0	0.5	1.2	0.1	5.9	1.4	1.2	0.5	7.9	6.5	0.0	5.7	1.1	0.4	0.3	59.5	1.5	0.9	1.3	1.9	9.3	0.4	4.2	3.3	0.7	0.0	20.3	0.3	5.8	5.8	16.4	3.7	0.0	22.5	0.1	0.4	0.0	1.0	0.3	4.4	0.0	82.4	0.3	10.7	0.0	0.0	0.3	1.0	6.6	3.2	10.8	2.8	3.8	5.2	1.0	1.2	0.9	2.2	0.1	2.1
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.5;intestine: 12.0;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 244.0;dendritic cells: 36.2;Melanocytes: 71.2;Plasma cells: 102.5;T-cells: 44.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 112.9;MAIT T-cell: 113.5;memory B-cell: 56.1;memory CD4 T-cell: 97.6;memory CD8 T-cell: 109.8;naive B-cell: 52.8;naive CD4 T-cell: 109.6;naive CD8 T-cell: 112.3;plasmacytoid DC: 72.8;T-reg: 80.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;JURKAT: 14.1;Karpas-707: 28.0;U-266/70: 70.7;U-266/84: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"		NA	NA		43000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.4	0.9	0.1	13.7	0.2	11.5	2.0	0.1	0.2	0.8	0.2	3.9	4.0	0.6	0.4	0.9	0.9	2.5	0.5	0.1	0.2	1.1	2.3	3.8	30.2	0.3	0.2	0.6	0.2	0.0	0.2	0.3	0.2	1.1	3.8	0.0	7.1	0.4	0.3	0.8	12.0	0.5	0.3	26.7	6.0	0.2	0.2	25.5	1.4	0.2	31.1	3.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	28.0	0.0	0.0	2.3	0.5	0.1	0.8	0.0	1.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	70.7	29.3	0.3	0.0	4.0	0.0	1.2	0.8	0.4	112.9	1.1	113.5	56.1	97.6	109.8	5.2	52.8	109.6	112.3	2.4	22.2	0.8	72.8	80.3	53.5	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.0	1.8	0.3	244.0	1.0	0.5	0.1	0.0	0.0	0.4	0.8	0.9	0.0	0.0	0.0	0.0	0.1	36.2	0.1	0.0	0.0	0.1	0.1	0.1	0.7	1.2	28.0	0.1	0.2	0.0	1.4	0.5	0.1	0.0	0.0	1.8	0.4	1.9	0.0	0.1	0.0	0.0	3.2	31.9	0.0	0.0	6.3	71.2	1.9	2.1	0.0	22.6	0.0	0.1	0.1	0.0	0.0	102.5	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.0	0.1	0.5	1.0	0.1	44.8	0.0	0.3	0.3
LYPD1	"LYPDC1, MGC29643"	ENSG00000150551	"LY6/PLAUR domain containing 1"	Q8N2G4	2	132643286-132671579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;choroid plexus: 15.4;fallopian tube: 53.5;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 73.8;Exocrine glandular cells: 74.5;monocytes: 62.0;Oligodendrocyte precursor cells: 28.1;Pancreatic endocrine cells: 43.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 57.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 41.6;HUVEC TERT2: 32.7;SK-MEL-30: 36.5;U-251 MG: 65.9;WM-115: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA068333			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA068333: "	"unprognostic (9.25e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.60e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	0.6	0.8	24.8	0.3	27.1	0.4	0.8	19.5	25.5	0.3	15.4	8.1	0.1	0.9	0.1	1.5	53.5	1.2	0.8	24.2	29.2	5.9	1.0	1.0	0.6	29.9	30.0	1.3	5.1	0.3	33.7	0.0	27.7	0.7	0.2	1.6	5.5	0.1	0.3	0.3	1.6	0.6	27.3	0.3	0.9	0.7	31.2	2.2	0.9	0.1	1.0	0.8	0.6	21.5	0.4	8.6	11.6	0.2	0.0	0.0	0.0	1.9	1.5	6.3	1.4	0.6	1.1	0.0	18.3	5.1	3.0	7.2	0.0	0.0	2.9	0.1	1.8	0.0	4.0	0.0	0.0	0.0	0.2	0.0	0.1	41.6	0.0	1.7	32.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	11.1	0.2	3.3	0.0	0.0	0.0	15.1	0.2	1.1	2.3	1.8	0.2	36.5	26.8	0.1	0.3	1.5	0.7	17.4	5.9	65.9	0.1	0.0	0.1	10.0	0.0	140.5	0.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	27.1	19.5	25.5	24.2	29.2	29.9	30.0	27.7	27.3	31.2	21.5	0.7	0.0	0.0	8.1	0.2	0.1	0.1	0.4	0.0	1.6	2.0	0.9	0.2	2.8	0.2	5.5	0.0	0.0	0.0	0.5	1.9	73.8	5.6	1.4	0.1	0.2	1.8	0.0	0.8	74.5	0.0	2.2	0.0	0.9	0.0	0.1	0.4	0.0	0.1	15.2	4.7	0.0	0.0	0.8	0.7	9.3	4.1	0.1	0.0	0.0	62.0	1.4	0.0	28.1	4.4	43.4	0.0	0.0	0.0	0.1	0.1	4.8	0.3	0.8	0.0	0.2	3.9	2.6	2.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248739415-248755759	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 215.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 710.5;Paneth cells: 1098.0"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"	"Group enriched"	"Detected in many"	10	"amygdala: 1.1;basal ganglia: 1.6;cerebral cortex: 1.9;hippocampal formation: 1.1;white matter: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.1	0.0	1.1	11.4	1.6	0.5	0.6	0.0	1.9	0.0	0.0	215.9	0.7	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	126.8	0.0	0.0	0.4	0.0	0.0	26.4	3.5	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	1.1	1.6	0.0	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	710.5	1.9	0.0	4.7	0.0	0.0	0.0	31.5	0.0	15.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	166.9	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	1098.0	0.0	0.0	0.1	38.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.3	0.3	0.0	16.6	0.0
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 126.4;placenta: 149.3"	"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 81.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.8"	"CAB025860, HPA042953"	Supported					NA	NA		3300000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	126.4	68.9	2.7	19.3	3.5	0.9	37.3	2.0	5.1	17.6	8.9	19.9	13.3	8.1	5.7	26.2	23.0	20.2	13.5	2.9	2.4	8.1	44.2	23.8	8.4	3.0	2.2	11.8	4.9	2.3	2.7	149.3	3.1	4.0	20.0	0.3	5.4	11.2	5.0	7.1	17.6	67.1	2.1	61.6	10.5	4.3	3.3	1.7	13.5	27.4	3.0	35.1	6.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	81.6	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	3.5	2.0	5.1	2.9	2.4	3.0	2.2	3.1	2.1	3.3	3.2	5.7	0.0	2.8	8.1	2.1	3.7	0.1	0.0	0.0	0.0	0.5	0.3	4.6	8.6	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.0	0.0	0.2	102.7	0.0	5.3	0.8	0.0	5.7	3.4	0.0	0.0	1.3	0.0	238.8	4.5	807.4	0.0	0.4	0.0	0.0	338.1	10.7	2.3	3.7	86.0	7.2	12.2	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.4	2.7	0.2	0.0	0.0	1.5	0.0	13.1	3.4	6.8	0.0	0.0	1.4	3.3	11.1	1.4	0.7	0.0	0.2
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35473789-35476689	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, Nucleotidyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.9;retina: 68.7"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 57.7;Cone photoreceptor cells: 50.1;Horizontal cells: 87.5;Muller glia cells: 151.1;Rod photoreceptor cells: 125.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Region enhanced"	"Detected in many"		"cerebellum: 21.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.6;BJ hTERT+: 29.9;BJ hTERT+ SV40 Large T+: 41.7;HBF TERT88: 44.9;hTERT-RPE1: 86.2;SH-SY5Y: 133.5"	"Group enriched"	"Detected in many"	10	"cerebellum: 40.9;midbrain: 18.6;pons and medulla: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 33.0"	"HPA049324, HPA059864"			Approved	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.3	4.3	1.3	0.5	1.2	0.0	7.5	21.9	2.0	0.4	0.3	2.2	0.5	0.1	0.1	0.2	0.1	0.2	0.7	1.6	0.3	0.1	0.0	0.1	0.8	2.8	6.1	0.9	0.1	0.0	0.3	0.0	3.7	1.4	0.5	68.7	2.9	0.3	5.7	2.0	1.1	0.2	3.2	0.4	0.7	0.1	2.1	0.4	1.2	0.6	0.3	0.8	0.9	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	36.6	29.9	41.7	23.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.6	0.1	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.1	86.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	3.6	133.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	21.9	2.0	1.6	0.3	2.8	6.1	3.7	3.2	2.1	0.6	2.6	0.0	0.0	0.0	0.0	0.8	0.5	0.6	0.0	57.7	0.2	0.9	0.5	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	2.5	1.2	0.7	0.0	0.1	87.5	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.4	1.8	0.0	0.0	151.1	0.0	1.5	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	125.8	0.0	5.6	3.1	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.3
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689236	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 273.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 264.0;Hofbauer cells: 377.6;Kupffer cells: 672.8;Macrophages: 456.7;Squamous epithelial cells: 361.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 88.3;non-classical monocyte: 121.4"	"Lineage enriched"	"Detected in many"	15	"monocytes: 121.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 28.6;hTCEpi: 61.2;SCLC-21H: 16.7;SiHa: 15.6;U-138 MG: 16.4;U-2197: 24.4;U-87 MG: 16.0"	"Low region specificity"	"Detected in many"							HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	35.3	13.8	4.8	37.3	4.9	59.2	27.3	4.4	10.5	16.5	6.9	9.5	7.8	9.3	5.4	33.0	11.3	24.4	10.7	3.7	5.7	17.5	29.3	20.9	27.8	14.3	6.3	6.8	15.8	273.1	3.1	13.2	7.2	8.3	7.2	0.6	18.3	4.7	15.8	85.3	13.2	14.2	9.0	96.3	11.0	3.9	13.1	6.7	50.1	16.7	12.7	13.9	21.9	15.8	0.0	0.0	0.0	2.6	1.5	0.2	0.4	0.3	0.1	0.3	0.1	0.4	0.2	0.0	1.9	0.4	0.0	3.8	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.2	0.9	0.0	0.1	28.6	61.2	0.2	2.1	0.0	0.4	0.0	0.0	0.0	0.1	0.9	0.3	7.4	2.6	6.2	0.0	0.0	0.0	0.0	0.5	0.4	16.7	1.4	15.6	1.5	3.9	5.4	1.5	0.3	0.5	16.4	0.3	24.4	0.0	0.0	0.0	0.0	16.0	0.6	0.0	0.4	24.3	0.0	0.0	88.3	0.0	0.0	0.0	0.1	7.9	0.1	0.0	0.0	2.1	0.0	121.4	0.1	0.0	10.6	4.8	4.9	4.4	10.5	3.7	5.7	14.3	6.3	7.2	9.0	13.1	15.8	70.0	22.4	37.9	1.6	7.8	68.6	50.5	17.1	264.0	12.0	112.2	217.8	208.9	7.2	16.8	51.5	25.0	9.8	7.6	117.1	1.9	2.3	0.8	15.7	64.4	39.1	57.7	4.0	0.8	3.4	2.8	172.7	49.5	27.6	10.8	0.9	34.6	36.1	377.6	3.3	25.4	50.7	6.1	672.8	91.7	2.8	29.5	456.7	21.4	6.5	65.3	21.9	3.1	2.0	1.3	4.9	30.9	24.5	5.6	29.7	89.5	1.3	2.4	8.3	13.1	160.6	102.4	0.8	1.7	361.5	88.2	12.4	9.5	114.6	39.0	19.2
MAFF	hMafF	ENSG00000185022	"MAF bZIP transcription factor F"	Q9ULX9	22	38200767-38216507	"Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 682.0;Syncytiotrophoblasts: 479.1;Urothelial cells: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 23.9;neutrophil: 8.7;NK-cell: 21.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 23.9;NK-cells: 21.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 79.2;SK-MEL-30: 104.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 5.6"	"CAB025341, HPA055371"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Mitochondria	"CAB025341: , HPA055371: AB_2682797"	"prognostic favorable (4.32e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.06e-3)"	"unprognostic (3.42e-3)"	"unprognostic (7.83e-3)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-2)"	102.9	22.8	9.4	12.9	9.0	36.2	69.9	9.3	10.7	37.4	9.4	26.6	8.1	28.8	2.1	53.4	64.2	41.4	53.8	8.2	11.9	32.0	30.8	59.2	4.7	14.5	10.0	53.9	19.7	5.3	19.5	34.5	13.4	39.5	10.3	19.6	28.6	5.5	73.3	45.7	19.6	23.2	10.5	9.3	45.4	3.0	14.1	7.4	25.0	6.9	11.3	53.8	41.4	16.6	20.8	3.3	4.4	6.6	6.9	21.3	20.6	41.4	54.2	19.8	21.0	6.1	16.0	0.7	3.9	16.9	29.5	13.5	1.1	15.7	33.2	3.9	0.6	2.1	2.1	5.2	18.0	1.3	7.1	9.3	25.7	79.2	43.6	17.6	42.1	1.9	4.2	18.6	15.6	4.9	0.8	5.2	3.3	22.0	16.8	1.4	3.8	4.3	19.9	30.6	2.2	3.7	6.1	15.4	104.9	10.7	3.3	1.5	57.9	24.7	19.2	18.8	13.7	7.2	8.0	0.7	37.4	1.4	15.9	23.9	0.4	0.3	2.9	0.7	2.8	0.8	1.7	2.1	1.4	0.5	2.1	1.6	8.7	21.1	3.5	0.2	0.7	1.8	9.4	9.0	9.3	10.7	8.2	11.9	14.5	10.0	13.4	10.5	14.1	16.6	215.4	54.5	43.4	1.0	19.3	125.9	344.1	56.8	169.0	2.9	302.9	214.1	18.6	67.2	49.5	11.0	0.0	37.8	112.5	134.2	7.9	49.9	0.5	284.7	149.3	97.3	104.8	5.7	0.8	24.2	77.5	134.7	132.5	682.0	22.2	11.5	22.1	8.2	26.0	0.0	1.6	112.5	34.6	14.0	131.1	0.4	9.9	113.5	58.7	1.0	10.2	36.0	17.5	1.5	1.3	76.0	181.0	3.8	25.8	258.4	67.6	3.7	37.9	3.6	19.7	265.2	153.1	2.4	1.0	139.5	103.1	479.1	59.0	8.4	75.5	409.2
MAL2		ENSG00000147676	"Mal, T cell differentiation protein 2"	Q969L2	8	119165034-119245673	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 259.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 389.9;Distal enterocytes: 433.3;Pancreatic endocrine cells: 329.8;Suprabasal keratinocytes: 455.8;Urothelial cells: 594.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1042.5;HaCaT: 451.8;OE19: 1132.4;RPTEC TERT1: 385.4;SK-BR-3: 1439.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043831	Uncertain					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043831: "	"prognostic unfavorable (4.57e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.27e-3)"	14.1	1.8	8.5	10.6	13.4	0.0	65.6	15.3	28.0	41.9	0.0	102.9	64.3	6.7	14.2	259.2	54.4	33.1	2.1	22.2	17.0	85.7	47.0	81.6	1.3	0.0	4.2	0.5	37.4	43.5	35.8	12.0	0.0	26.9	94.2	2.6	62.6	41.2	0.4	121.0	53.0	2.6	0.0	0.4	137.6	12.5	8.3	4.3	147.5	0.1	56.0	69.0	102.6	3.4	1042.5	0.0	1.0	0.3	0.2	0.0	92.9	0.1	2.3	1.2	1.6	87.7	329.0	0.3	56.2	0.0	0.4	451.8	0.8	32.9	0.5	0.9	2.6	0.0	13.8	86.1	0.3	0.6	0.3	0.0	225.5	0.0	34.3	1.7	0.3	0.0	0.2	0.5	0.0	244.9	0.8	0.3	8.2	1132.4	309.2	0.6	0.0	0.7	385.4	257.4	56.7	0.3	17.8	1439.4	2.7	6.8	191.4	3.0	0.0	0.6	3.1	1.3	1.9	5.5	0.8	1.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	13.4	15.3	28.0	22.2	17.0	0.0	4.2	0.0	0.0	8.3	3.4	0.5	112.2	130.8	4.2	2.7	114.7	79.9	59.3	19.9	1.5	118.9	50.7	1.6	90.1	119.7	389.9	0.0	25.0	0.4	433.3	109.5	206.0	0.5	71.8	10.3	3.7	41.9	0.0	62.4	178.6	23.5	4.7	149.9	139.4	14.7	0.0	3.6	44.9	2.9	5.0	9.8	145.9	71.2	0.3	14.3	2.2	0.6	2.3	16.0	3.7	3.6	1.0	0.0	3.5	3.6	329.8	252.9	0.0	1.2	285.4	70.2	19.9	107.5	1.0	0.0	0.0	7.0	1.9	9.7	268.8	455.8	9.3	2.8	0.0	122.5	594.5
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.1;lymphoid tissue: 56.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 42.6;dendritic cells: 42.6;Langerhans cells: 27.8;Plasma cells: 30.4;Rod photoreceptor cells: 77.9;T-cells: 43.6"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.2"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 45.2;HDLM-2: 46.4;Karpas-707: 46.9;REH: 25.5;RPMI-8226: 29.8;U-266/70: 36.0;U-266/84: 38.2;U-698: 57.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA007419, CAB007754"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favorable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	2.7	1.5	0.6	14.6	0.7	9.2	1.7	0.7	1.2	1.6	0.7	5.0	2.7	1.3	0.8	2.8	1.8	2.3	1.7	0.7	0.8	2.7	3.0	6.2	32.2	1.0	0.8	0.9	1.2	0.2	1.8	1.8	0.9	2.5	2.3	16.1	2.8	0.5	0.8	1.9	30.1	0.9	0.8	56.9	3.1	1.5	0.9	13.1	3.2	0.2	29.3	2.9	2.1	0.9	0.2	0.3	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	45.2	0.7	0.0	0.0	0.1	0.1	0.0	0.0	46.4	0.3	9.8	0.1	0.1	0.0	3.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	21.3	0.2	46.9	0.1	0.3	11.0	12.0	1.4	0.3	0.1	25.5	0.1	29.8	0.0	0.0	0.4	0.1	0.1	0.2	0.1	0.3	0.2	10.8	0.1	0.1	0.3	0.1	0.1	36.0	38.2	57.8	0.0	13.5	0.1	2.9	4.9	2.0	18.9	9.4	17.4	22.7	15.8	20.1	23.9	15.5	8.6	12.1	0.5	6.1	5.7	22.2	22.2	12.1	0.6	0.7	0.7	1.2	0.7	0.8	1.0	0.8	0.9	0.8	0.9	0.9	0.7	3.2	4.9	0.3	42.6	2.3	0.2	0.4	1.2	6.7	0.7	1.0	0.9	0.0	0.6	0.0	12.5	0.2	42.6	0.1	0.0	0.0	0.0	0.3	0.2	1.6	0.0	5.5	0.7	0.2	0.3	1.5	2.0	0.3	15.8	0.4	1.1	1.1	2.6	1.7	1.0	0.1	0.0	8.8	27.8	0.2	0.0	11.6	3.6	1.9	10.3	11.5	15.5	1.0	0.5	0.0	0.0	0.0	30.4	0.3	0.0	0.2	0.0	77.9	0.0	1.0	0.4	0.7	6.4	0.6	1.0	0.1	43.6	0.3	0.3	0.1
MAP7D1	"FLJ10350, FLJ39022, PARCC1, RPRC1"	ENSG00000116871	"MAP7 domain containing 1"	Q3KQU3	1	36155579-36180849	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 286.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028075	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA028075: AB_10603778"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (6.00e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.32e-3)"	67.9	23.2	41.7	41.5	60.7	36.2	47.1	50.7	52.2	38.9	0.4	84.1	18.9	50.0	3.9	48.8	34.8	28.8	122.4	40.8	43.5	21.8	7.7	53.2	25.0	74.7	58.2	24.8	14.7	12.5	36.5	24.0	78.4	39.5	9.4	13.0	33.5	28.2	286.0	71.6	31.4	34.0	23.3	33.5	39.3	12.6	67.3	22.6	33.1	106.5	17.6	62.1	41.2	96.2	104.8	60.3	92.7	58.9	55.6	41.9	68.3	102.3	102.8	105.4	92.5	33.9	104.6	43.8	85.7	93.5	57.7	112.3	38.3	139.1	34.4	74.9	34.4	29.7	42.5	13.2	87.3	44.0	73.3	73.4	38.6	142.6	87.8	81.5	72.9	59.8	29.1	65.3	59.3	21.0	81.6	37.2	84.7	14.7	33.5	83.8	68.4	41.5	53.0	35.7	35.7	68.6	58.7	32.3	79.6	49.7	21.6	30.9	138.3	123.6	94.4	105.5	140.6	64.4	20.6	52.5	105.8	29.7	75.9	0.1	0.4	0.4	0.3	0.2	0.4	0.0	0.2	0.2	0.2	0.1	0.5	0.2	1.4	0.1	0.1	0.2	0.1	0.0	41.7	60.7	50.7	52.2	40.8	43.5	74.7	58.2	78.4	23.3	67.3	96.2	40.6	44.8	14.4	12.1	26.5	143.1	147.3	18.4	47.8	35.4	44.0	26.3	172.6	17.2	17.9	23.9	10.4	48.3	58.2	39.9	17.6	43.3	36.9	32.1	38.6	46.7	10.1	16.2	17.4	27.4	111.3	48.0	29.6	60.1	12.7	56.3	30.7	9.7	69.9	48.8	35.1	14.9	10.2	40.6	125.3	77.1	30.7	65.1	32.0	9.4	35.9	32.3	75.2	9.5	62.3	66.1	29.2	47.8	53.2	98.5	63.0	14.3	10.0	39.8	19.7	51.6	55.8	17.6	16.1	62.7	141.8	130.2	59.8	17.0	19.5	157.6
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.6;epididymis: 36.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 93.0;Excitatory neurons: 45.5;Inhibitory neurons: 55.2;Spermatocytes: 57.8;Spermatogonia: 134.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;CACO-2: 19.3;HEK 293: 25.0;HeLa: 21.4;Hep G2: 11.4;SCLC-21H: 29.1;SiHa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.2	2.8	11.6	0.3	15.3	0.7	0.4	12.5	66.6	0.3	0.0	0.7	0.7	0.6	36.4	0.2	2.3	0.5	0.4	13.9	16.3	3.5	0.1	0.2	0.2	35.8	7.0	0.3	1.1	0.0	3.9	7.6	28.9	0.8	0.8	14.6	0.2	2.0	0.5	0.9	1.2	0.4	3.0	0.1	8.7	9.6	17.1	2.3	0.1	0.1	0.3	0.1	0.3	20.0	0.0	13.3	1.1	0.1	0.1	0.3	0.0	1.4	0.0	0.2	0.1	19.3	0.5	2.3	2.0	0.0	0.2	0.0	0.0	0.0	0.1	1.0	25.0	0.0	21.4	11.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	5.0	1.0	0.0	0.3	0.0	0.0	1.5	0.0	29.1	5.0	12.8	4.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.5	1.4	0.1	1.4	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	11.6	15.3	12.5	66.6	13.9	16.3	35.8	7.0	28.9	3.0	17.1	20.0	0.2	3.2	0.0	4.6	0.6	1.8	0.3	7.2	0.6	29.1	0.9	1.1	1.2	0.0	2.5	0.0	2.1	93.0	0.8	2.2	3.9	1.3	16.4	0.6	0.2	0.7	9.6	0.0	45.5	0.9	9.2	1.1	28.1	0.7	0.0	12.3	0.0	0.2	6.1	18.5	55.2	0.6	2.0	0.0	0.7	17.8	0.6	0.7	0.0	6.5	0.0	2.8	0.0	11.1	3.6	0.8	4.8	1.9	0.9	1.0	3.5	18.8	6.9	8.1	0.0	0.6	0.8	57.8	134.9	0.9	1.6	30.6	0.4	0.9	1.3	0.5
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.5;Astrocytes: 16.6;Endothelial cells: 21.1;Excitatory neurons: 15.8;Hepatic stellate cells: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069"	Approved		Approved	Mitochondria		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"CAB012961: AB_2533144, HPA045069: AB_2679207"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.96e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (6.02e-6)"	"unprognostic (9.84e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	27.5	6.8	52.3	7.9	56.0	1.1	24.0	48.2	70.9	15.1	40.6	7.3	1.9	15.5	5.8	9.4	16.7	8.7	18.9	55.2	49.6	18.6	4.8	16.8	9.4	48.2	47.2	12.5	5.7	5.4	28.4	8.3	48.2	18.2	2.6	8.6	7.2	7.2	6.4	7.5	8.3	9.4	47.4	16.3	10.9	6.1	50.2	3.5	11.0	5.8	6.1	11.6	12.3	51.0	2.8	6.8	7.4	27.8	9.5	14.3	0.2	10.2	7.4	6.8	2.7	2.8	5.2	0.0	8.7	9.9	11.3	6.9	4.9	4.2	0.5	13.9	3.4	10.1	10.4	0.6	10.9	2.5	15.0	19.9	12.3	1.9	0.8	7.7	15.2	10.6	8.1	26.8	6.9	12.4	0.5	9.4	0.6	8.4	7.7	26.7	0.1	9.9	10.3	0.0	6.8	18.4	9.0	3.7	7.7	0.9	12.2	7.9	24.0	20.4	16.5	1.5	3.7	1.2	3.2	11.8	10.4	2.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.3	56.0	48.2	70.9	55.2	49.6	48.2	47.2	48.2	47.4	50.2	51.0	29.5	0.0	1.1	16.6	2.2	1.9	1.8	3.2	8.0	3.3	1.1	1.5	6.6	1.5	1.7	0.0	6.2	0.0	1.8	0.1	1.9	1.0	4.7	0.6	1.8	21.1	0.0	0.4	15.8	0.2	0.4	2.7	0.5	1.7	0.0	0.1	20.0	2.1	0.3	0.0	3.6	0.2	2.0	1.3	2.1	9.7	3.1	0.5	5.4	13.1	0.1	5.9	0.0	1.0	0.9	0.7	0.0	2.2	1.6	2.9	0.0	1.9	1.3	11.4	0.0	0.6	1.8	1.3	3.2	1.8	1.3	0.0	3.3	0.7	0.1	1.1
MAPK12	"ERK6, p38gamma, PRKM12, SAPK-3, SAPK3"	ENSG00000188130	"Mitogen-activated protein kinase 12"	P53778	22	50245450-50261716	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 279.7;tongue: 120.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 23.1;Astrocytes: 22.9;Endothelial cells: 15.8;Hepatic stellate cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 31.6"	"Low region specificity"	"Detected in all"			"CAB025483, HPA054562"	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	Cytosol	"CAB025483: , HPA054562: AB_2682524"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.16e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.28e-3)"	11.0	2.3	15.6	3.8	16.5	1.3	7.9	15.5	21.2	11.4	9.2	4.7	3.5	19.0	9.8	6.3	11.2	4.4	15.7	15.1	16.5	10.7	1.4	6.8	4.1	17.1	14.9	10.6	1.8	4.3	25.1	4.1	14.6	10.0	1.1	1.4	4.3	6.9	279.7	1.5	4.4	8.6	14.6	4.3	5.0	4.6	15.2	0.9	3.2	120.9	1.4	6.0	5.9	13.9	23.2	13.9	5.3	16.3	12.4	13.5	7.5	17.5	15.1	28.2	18.3	19.6	7.2	45.1	23.4	19.6	16.8	15.4	24.3	3.4	5.5	12.8	34.0	29.2	46.7	24.9	37.7	28.4	54.5	29.8	6.0	7.2	0.0	16.8	33.2	4.0	26.3	38.5	13.4	12.8	0.0	35.4	15.9	7.6	22.5	41.4	14.2	43.9	17.5	3.0	18.0	6.5	13.3	0.5	22.1	4.2	7.1	29.6	18.7	28.5	26.1	6.6	11.2	9.3	7.3	24.5	7.2	24.7	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	15.6	16.5	15.5	21.2	15.1	16.5	17.1	14.9	14.6	14.6	15.2	13.9	23.1	0.0	3.2	22.9	1.6	0.8	0.7	3.3	1.2	5.5	1.2	1.3	8.8	4.3	0.8	0.0	0.0	0.3	0.9	0.3	1.9	0.5	0.3	0.6	10.0	15.8	1.8	1.7	9.8	0.0	2.8	5.3	2.6	0.7	10.8	0.6	20.7	0.9	6.3	1.7	6.5	0.2	8.2	2.2	0.8	1.9	6.5	2.2	0.0	6.5	0.6	8.1	0.0	5.0	0.9	0.5	0.0	3.8	2.8	3.6	0.4	8.0	0.9	2.2	6.6	3.3	3.0	0.7	12.1	0.8	0.6	0.4	2.2	3.2	0.3	0.2
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 166.8;pituitary gland: 118.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.8;Enteroendocrine cells: 40.2;Horizontal cells: 67.3;Late spermatids: 39.2;Muller glia cells: 41.3;Oligodendrocytes: 48.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	4.8	23.3	127.9	2.3	131.0	1.3	4.8	122.0	147.7	8.2	29.6	8.3	1.4	10.9	3.5	2.2	11.3	3.5	5.5	166.8	120.6	11.5	5.6	4.0	0.6	154.9	130.9	9.1	43.1	19.2	118.2	1.4	142.6	11.6	1.2	11.5	11.4	6.1	2.4	4.0	3.7	5.7	124.6	2.3	9.0	27.7	139.3	1.0	7.0	2.5	0.4	6.7	4.8	164.4	0.0	7.1	9.4	26.2	3.4	1.8	0.3	5.1	4.6	9.9	7.2	6.3	1.1	0.4	2.5	5.9	16.8	5.8	10.2	4.8	4.4	4.0	13.1	0.1	8.6	4.1	3.1	0.6	4.4	2.4	1.0	6.4	1.3	6.6	2.2	0.9	11.5	1.6	2.8	3.9	0.4	0.6	24.9	3.3	10.5	0.6	15.4	0.3	4.6	0.2	76.4	28.5	8.4	6.8	10.0	3.6	11.0	0.4	2.1	12.5	19.1	19.0	9.3	1.1	1.3	0.5	7.9	0.2	3.8	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.0	127.9	131.0	122.0	147.7	166.8	120.6	154.9	130.9	142.6	124.6	139.3	164.4	1.7	6.4	4.1	7.2	0.9	2.4	5.8	2.0	2.8	34.4	6.1	5.3	1.1	5.7	3.3	11.0	22.9	1.6	0.4	2.2	13.7	6.9	43.8	23.9	15.9	2.9	40.2	0.0	10.3	28.9	0.6	6.5	4.1	19.9	0.0	2.8	0.4	4.6	0.5	67.3	11.6	1.6	4.1	0.8	3.5	39.2	6.2	1.1	3.6	1.0	1.6	41.3	0.0	3.5	48.7	11.6	0.5	6.4	0.1	6.3	1.4	8.9	10.9	18.3	0.0	14.2	6.0	10.6	8.2	0.9	1.0	5.7	1.3	7.7	0.9	5.5
MAPK8IP2	"IB2, JIP2, PRKM8IPL"	ENSG00000008735	"Mitogen-activated protein kinase 8 interacting protein 2"	Q13387	22	50600793-50613981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 84.0;pituitary gland: 35.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.8;Enteroendocrine cells: 32.3;Horizontal cells: 99.3;Rod photoreceptor cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 19.3;HEK 293: 11.0;SCLC-21H: 15.7;SH-SY5Y: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034780	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034780: AB_10670283"	"unprognostic (7.82e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.78e-3)"	"unprognostic (6.33e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.75e-2)"	1.4	9.2	54.7	0.3	50.2	0.0	1.4	27.5	67.8	1.4	0.0	2.1	0.2	2.1	0.3	1.2	1.5	0.0	0.4	53.7	35.1	0.7	0.5	0.5	0.0	78.0	27.0	7.0	1.8	2.0	35.2	0.3	84.0	1.9	0.1	9.6	2.8	0.2	0.3	1.5	1.0	0.2	18.6	0.8	1.5	7.1	39.4	0.2	1.0	0.1	0.0	0.3	1.0	49.2	0.3	1.1	4.7	4.1	0.4	0.0	3.7	0.0	0.0	1.0	0.6	2.4	0.8	0.6	1.0	0.0	19.3	0.0	6.6	0.0	0.0	0.3	11.0	0.0	0.4	1.2	0.5	0.0	0.8	0.3	5.5	0.0	0.1	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	3.4	0.8	1.8	1.1	0.7	0.0	0.0	0.1	15.7	19.8	3.7	4.6	0.2	0.9	0.9	0.0	0.0	0.1	0.1	0.6	0.0	1.1	3.1	0.5	0.5	0.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	50.2	27.5	67.8	53.7	35.1	78.0	27.0	84.0	18.6	39.4	49.2	0.6	3.2	2.0	6.5	0.1	0.4	1.6	0.5	0.6	57.8	2.3	3.9	2.3	2.8	2.7	0.0	16.7	0.2	0.0	0.5	0.0	3.0	0.6	0.7	1.7	0.7	32.3	0.0	15.6	2.5	1.1	0.7	0.0	1.5	0.0	0.5	0.0	0.3	0.1	99.3	13.1	0.5	4.1	0.0	0.4	1.8	5.9	0.3	7.2	3.7	0.2	11.2	0.0	6.0	3.2	0.7	0.1	0.7	0.1	1.2	0.3	0.7	0.3	26.7	0.0	1.3	1.0	3.4	2.7	0.6	0.6	1.1	0.3	0.5	0.6	0.5
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MARCHF4	"KIAA1399, MARCH-IV, MARCH4, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372483	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	4	"brain: 4.4;pituitary gland: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 69.0;fHDF/TERT166: 43.8;TIME: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014348	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.0	0.7	2.6	0.0	3.9	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.6	0.0	0.0	3.1	2.2	0.0	0.0	0.0	0.0	0.5	4.1	0.0	0.4	0.0	6.2	0.6	1.1	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.5	2.5	0.0	0.0	0.2	1.6	0.0	69.0	23.2	14.5	5.1	0.1	1.0	0.0	10.5	43.8	24.2	0.1	0.0	26.7	14.1	0.0	0.0	5.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	13.3	19.6	9.3	19.0	0.0	0.0	0.0	22.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.4	1.9	0.1	0.0	0.0	2.2	0.0	0.0	32.7	22.7	23.9	0.1	18.6	0.0	0.0	0.0	5.2	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.9	0.0	4.4	3.1	2.2	0.5	4.1	1.1	2.7	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942194-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 94.9;lung: 199.6;lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	6	"Kupffer cells: 1269.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 21.6"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 4.1;thalamus: 12.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 33.7;intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 56.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;THP-1: 2.5;U-2 OS: 2.6;U-266/70: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		30000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"	Vesicles	"HPA063793: AB_2685123"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	64.7	31.1	0.4	87.9	1.4	3.4	7.4	0.7	4.1	0.7	4.4	5.7	2.0	0.7	1.3	2.4	25.5	2.4	19.0	0.9	1.0	1.6	94.9	199.6	17.7	1.2	1.7	7.5	0.8	0.3	1.5	2.8	1.9	1.8	2.1	0.0	4.4	2.3	1.5	2.5	3.1	29.8	1.2	37.1	3.5	2.0	12.6	1.3	1.5	5.0	1.1	25.2	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	2.6	0.4	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	33.7	0.0	0.0	56.5	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.7	0.0	7.2	1.0	0.0	9.2	0.4	1.4	0.7	4.1	0.9	1.0	1.2	1.7	1.9	1.2	12.6	0.7	0.7	25.6	45.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	3.4	1.8	0.4	1.5	16.7	3.7	0.0	0.7	1.4	0.1	0.0	3.9	0.0	0.0	0.0	5.2	0.0	8.0	0.0	0.2	1.1	2.6	0.0	0.0	12.6	0.0	11.4	3.4	169.6	0.0	0.0	0.0	0.0	1269.8	46.4	0.1	0.0	199.3	0.0	2.8	23.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.5	0.1	0.0	0.2	13.1	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.9	1.9	4.1	0.0	0.0	0.1
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.2	0.3	0.5	3.1	0.6	0.6	6.2	1.8	0.9	4.0	6.5	23.6	31.1	1.8	7.3	4.2	4.2	4.8	0.3	1.1	0.5	12.9	5.3	2.4	0.5	0.4	0.5	0.5	17.1	12.5	1.0	5.7	0.5	6.0	18.7	2.1	11.6	2.5	0.8	3.3	33.1	0.6	0.1	0.4	2.8	0.9	0.5	0.9	3.9	0.0	1.7	3.8	2.5	0.9	21.7	0.7	0.5	0.9	0.0	0.1	30.9	0.0	0.0	0.0	0.0	23.6	22.5	0.2	2.3	0.0	0.1	21.4	1.9	10.3	0.1	0.0	12.1	0.0	0.4	6.2	0.0	0.1	0.2	0.9	12.5	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.0	40.8	0.2	0.3	3.5	13.4	0.2	0.0	0.1	8.8	0.3	18.8	3.7	0.2	0.4	18.5	0.0	2.4	26.3	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0.2	1.8	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.2	0.1	0.5	0.6	1.8	0.9	1.1	0.5	0.4	0.5	0.5	0.1	0.5	0.9	0.3	9.6	8.4	0.3	0.8	7.9	28.7	9.6	22.8	7.0	25.4	10.7	0.6	40.0	17.9	9.2	0.0	36.5	1.5	150.1	1.9	29.8	4.4	14.2	1.5	1.0	61.5	0.0	0.6	33.7	2.5	1.5	6.1	19.4	0.0	3.8	0.4	9.1	3.1	0.0	0.6	68.2	14.2	1.0	1.0	3.3	0.3	1.2	0.0	0.0	0.8	1.0	0.0	0.0	0.6	26.3	102.9	0.7	0.0	38.4	199.3	27.6	17.4	19.6	0.0	4.1	1.6	9.6	5.0	19.6	3.7	4.8	1.4	0.0	61.3	44.3
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874952	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 37.7;pituitary gland: 23.3;retina: 15.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 24.7;Cone photoreceptor cells: 43.8;Excitatory neurons: 64.7;Inhibitory neurons: 70.3;Oligodendrocyte precursor cells: 22.1;Rod photoreceptor cells: 20.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.7"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;SCLC-21H: 40.5;SH-SY5Y: 20.2;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	0.0	2.2	6.5	0.3	12.1	0.3	0.1	7.3	37.7	0.2	0.0	1.2	0.3	0.0	0.0	0.2	0.1	0.2	0.2	8.3	2.4	0.1	0.6	0.1	0.1	11.2	1.1	0.3	0.6	0.5	23.3	0.0	9.5	0.2	0.1	15.4	0.2	0.0	0.0	3.7	0.4	0.0	0.0	0.1	0.6	5.0	1.2	0.8	0.1	0.0	0.0	0.2	0.3	3.0	3.6	1.6	1.5	23.3	0.0	0.0	1.9	0.2	0.1	0.3	0.9	0.8	1.5	5.8	2.6	0.0	3.9	0.1	6.8	0.1	0.1	4.1	4.5	0.5	5.8	2.6	0.0	1.3	1.2	0.5	0.1	0.8	0.7	1.3	0.0	15.2	5.2	3.0	0.0	0.8	2.4	0.6	6.9	0.6	7.2	15.9	4.6	8.3	0.3	0.2	40.5	20.2	0.8	1.4	4.3	1.2	3.8	2.1	0.0	2.8	4.2	3.1	0.8	16.7	14.5	3.7	5.1	3.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	6.5	12.1	7.3	37.7	8.3	2.4	11.2	1.1	9.5	0.0	1.2	3.0	0.5	0.0	2.4	7.8	0.2	0.9	1.6	0.6	0.6	24.7	0.8	2.5	1.0	0.0	0.3	0.0	43.8	0.6	0.4	0.6	0.0	0.4	14.0	0.2	0.2	1.3	0.0	0.0	64.7	0.5	0.6	1.3	0.0	0.3	1.3	0.5	1.1	0.5	0.2	15.2	70.3	0.1	0.0	1.0	1.2	8.2	0.6	0.7	5.4	6.5	0.1	3.7	0.0	22.1	3.0	0.3	2.5	1.2	0.0	1.0	0.9	0.2	1.0	20.4	0.0	2.0	0.5	8.0	5.2	0.7	1.4	0.3	1.0	0.4	0.7	1.2
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 128.5;Endothelial cells: 153.5;Muller glia cells: 89.8;Sertoli cells: 322.1;Smooth muscle cells: 384.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 83.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 1121.0;TIME: 1107.4;WM-115: 869.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"		NA	NA		1900000000	"Cluster 13: T-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	332.7	30.0	36.6	68.4	46.1	1.2	180.6	45.7	45.3	96.6	25.3	166.3	29.2	175.8	47.0	89.2	136.4	66.8	118.0	35.3	44.7	42.0	10.5	116.4	19.6	59.4	43.1	60.9	22.0	93.9	17.8	168.0	52.2	78.1	32.2	12.2	39.5	148.0	40.7	50.9	73.0	160.9	36.2	35.4	97.7	9.7	50.2	15.5	58.7	37.4	15.4	174.5	79.8	44.8	0.7	5.1	4.7	0.3	21.5	0.3	23.2	3.2	0.3	29.9	13.3	17.9	0.9	1.2	94.5	10.7	44.7	3.2	38.3	8.1	15.0	56.9	14.5	1.2	102.4	19.8	51.0	0.1	0.4	15.2	0.3	40.8	18.7	1.1	1121.0	7.1	38.7	1.5	6.1	0.0	1.2	9.3	19.9	0.2	4.4	0.9	147.8	32.9	27.1	0.0	12.5	3.9	87.1	2.1	249.2	46.2	4.3	0.9	1107.4	3.1	156.7	0.2	89.1	2.4	2.3	0.6	43.1	0.1	869.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	36.6	46.1	45.7	45.3	35.3	44.7	59.4	43.1	52.2	36.2	50.2	44.8	128.5	0.0	2.3	1.3	1.4	4.7	0.6	11.1	8.0	1.2	9.9	19.7	65.8	18.6	1.1	0.0	22.9	0.5	2.5	0.1	0.0	17.3	1.7	7.8	14.0	153.5	0.0	0.0	1.4	0.4	38.7	14.1	1.5	10.3	0.0	18.2	60.0	0.6	0.8	0.0	3.5	0.0	0.0	1.3	7.0	0.7	0.9	2.4	21.4	14.0	0.6	89.8	1.0	18.6	45.2	1.6	0.0	25.2	3.1	1.7	0.0	0.9	1.3	4.0	322.1	9.9	384.6	2.1	1.6	1.7	3.3	0.4	9.3	4.9	0.1	1.8
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 65.9;lung: 74.2;lymphoid tissue: 35.1"	"Cell type enriched"	"Detected in some"	4	"Macrophages: 147.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Group enriched"	"Detected in some"	5	"classical monocyte: 102.1;neutrophil: 45.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.9;monocytes: 102.1"	"Group enriched"	"Detected in some"	6	"THP-1: 53.7;U-937: 166.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.3"	"Not detected"	"Not detected"			HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	4.0	0.5	0.0	19.7	0.0	65.9	0.5	0.0	2.1	0.1	0.0	0.4	0.2	0.1	0.0	0.5	1.7	0.6	1.3	0.0	0.0	0.7	1.5	74.2	0.1	0.0	0.0	0.2	0.7	0.0	0.2	1.8	0.9	0.5	0.1	0.0	0.8	0.0	0.3	0.1	0.6	5.1	0.0	35.1	0.9	0.2	0.7	0.9	0.4	1.5	0.1	4.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	1.4	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	166.6	0.0	0.0	102.1	2.8	0.2	6.0	0.0	0.0	0.3	0.0	14.9	0.0	0.0	0.3	45.9	0.6	0.4	0.9	0.2	38.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.4	19.2	34.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	11.2	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	2.2	0.0	3.6	0.0	0.0	1.0	2.9	0.0	0.0	7.6	0.0	0.0	0.3	28.8	0.0	0.0	0.0	0.0	28.3	0.0	0.1	0.0	147.5	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.2	5.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.8	2.9	0.0	0.0	0.1
MCF2L	"ARHGEF14, DBS, KIAA0362, OST"	ENSG00000126217	"MCF.2 cell line derived transforming sequence like"	O15068	13	112894378-113099742	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 134.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Bipolar cells: 70.4;Cone photoreceptor cells: 127.2;Endothelial cells: 69.7;Microglial cells: 92.8;Oligodendrocytes: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 35.9;SCLC-21H: 65.3;SH-SY5Y: 29.0;SK-BR-3: 43.9;WM-115: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.56e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (6.01e-4)"	"unprognostic (9.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.36e-5)"	"unprognostic (1.17e-1)"	"prognostic favorable (9.14e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (2.63e-5)"	44.1	7.6	39.0	6.3	35.1	0.9	39.5	134.5	76.1	16.5	0.4	17.5	11.3	19.4	5.1	14.1	17.8	13.4	52.8	32.3	27.7	17.5	7.7	19.0	6.8	51.3	40.6	4.8	18.8	10.3	44.4	8.4	57.6	17.0	13.7	20.0	32.7	8.5	16.5	24.8	18.7	7.1	29.1	3.6	18.1	2.0	49.3	7.1	27.6	16.3	6.0	15.0	16.9	47.7	0.0	1.6	14.9	4.8	0.5	0.9	2.1	0.0	0.0	0.0	0.0	3.8	2.2	0.1	3.7	1.5	2.5	0.3	3.8	0.0	0.0	0.0	7.4	4.3	0.2	9.1	0.5	0.2	3.1	1.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	14.4	5.6	0.5	2.6	4.0	35.9	0.0	0.2	15.0	7.9	5.9	23.6	65.3	29.0	0.0	43.9	0.1	2.4	26.0	0.1	0.6	0.1	12.5	5.4	0.0	7.5	0.4	2.3	23.9	1.0	60.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.4	39.0	35.1	134.5	76.1	32.3	27.7	51.3	40.6	57.6	29.1	49.3	47.7	138.3	0.0	8.4	4.6	2.6	5.5	3.4	1.5	8.0	70.4	12.9	10.0	44.3	12.8	4.6	9.2	127.2	0.0	1.2	10.8	7.9	5.6	0.4	9.9	1.6	69.7	26.5	0.0	58.5	2.6	0.2	7.1	23.0	18.7	1.3	11.2	13.6	3.4	1.4	38.7	60.9	54.6	8.2	2.2	4.6	1.5	0.6	2.5	8.8	92.8	0.1	5.4	0.0	40.7	75.0	1.7	9.8	1.2	3.0	4.2	4.0	10.4	7.2	23.9	0.0	5.2	11.9	0.7	2.7	4.2	9.1	0.1	2.1	0.5	7.4	4.1
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161558-13211110	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.2;lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: AB_2686477"	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	1.2	0.1	0.0	3.3	0.1	9.2	0.8	0.1	0.2	0.4	0.1	1.7	1.5	0.4	0.1	1.9	0.2	0.2	0.1	0.0	0.0	0.1	0.7	0.3	4.8	0.0	0.1	0.2	0.1	0.2	0.1	2.1	0.1	0.1	2.2	0.1	0.3	0.0	0.5	1.1	1.2	0.8	0.0	1.0	0.8	1.5	0.2	8.1	0.3	0.1	4.5	0.6	0.6	0.1	38.0	42.0	48.6	36.9	1.6	2.9	21.2	38.7	5.9	42.7	44.0	41.3	26.4	56.7	17.1	9.9	15.7	43.3	69.0	22.8	39.2	29.7	32.9	70.9	17.6	27.7	0.0	36.6	30.8	0.6	0.8	43.3	4.0	3.5	14.0	45.0	85.2	37.6	23.4	34.0	87.7	15.7	28.9	36.3	10.3	68.3	43.0	34.6	9.8	13.7	9.7	36.6	31.3	22.0	5.9	25.2	27.7	24.9	8.6	27.0	50.3	41.0	42.4	11.7	49.0	74.3	17.2	39.6	21.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.9	0.3	0.1	0.1	0.7	0.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	1.7	0.0	0.0	0.0	1.8	1.7	0.4	0.8	0.0	0.0	0.8	0.5	2.4	0.0	0.8	0.0	0.0	11.8	0.8	2.4	0.0	0.4	1.0	0.3	1.2	1.4	0.0	23.5	0.4	0.2	20.9	1.8	1.1	1.0	0.0	7.2	0.0	0.2	5.3	0.0	0.4	1.2	2.0	0.6	0.4	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.4	15.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	6.4	15.8	12.9	3.6	0.4	3.4	1.2	0.8	3.1	0.4
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.3;brain: 37.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 113.3;Excitatory neurons: 510.6;Inhibitory neurons: 412.2;Oligodendrocyte precursor cells: 263.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	46	"basophil: 37.0;classical monocyte: 28.6;eosinophil: 13.2;intermediate monocyte: 41.4;myeloid DC: 22.3;neutrophil: 40.5;non-classical monocyte: 40.6;plasmacytoid DC: 11.4"	"Group enriched"	"Detected in many"	54	"dendritic cells: 22.3;granulocytes: 40.5;monocytes: 41.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 71.4;RPMI-8226: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	21.3	2.3	12.8	12.5	37.1	45.3	15.9	27.7	19.4	6.0	0.0	7.7	5.1	5.9	2.0	6.4	4.9	17.4	3.8	20.9	10.0	4.4	3.7	12.9	6.1	3.8	0.5	1.7	3.2	1.9	4.0	7.3	5.7	3.5	7.2	1.7	3.7	2.2	3.2	4.3	4.9	11.2	0.5	8.8	5.5	2.1	1.4	7.9	4.6	7.9	4.4	21.3	6.1	13.4	0.3	5.2	3.3	0.1	49.0	19.6	0.2	0.3	25.1	2.3	8.1	0.1	13.3	18.7	19.2	0.0	51.1	0.2	0.4	0.2	2.8	0.0	3.6	11.4	13.3	0.2	6.4	23.6	14.6	7.3	0.0	9.0	32.5	21.2	52.7	7.6	0.3	71.4	18.7	0.6	1.4	17.9	4.1	0.3	20.7	0.9	0.2	73.7	52.7	29.0	10.0	0.5	1.7	0.1	37.1	1.4	0.0	21.8	0.3	9.0	13.9	0.4	4.2	5.0	0.1	0.2	41.8	38.5	9.1	37.0	28.6	13.2	0.1	41.4	0.0	0.6	0.1	0.2	22.3	0.3	0.4	0.0	40.5	0.3	40.6	11.4	0.0	8.5	12.8	37.1	27.7	19.4	20.9	10.0	3.8	0.5	5.7	0.5	1.4	13.4	113.3	3.2	10.8	15.3	3.2	18.1	0.2	6.9	3.4	2.2	1.7	1.1	3.1	0.0	6.6	3.7	0.0	0.3	9.8	0.1	0.0	0.0	27.8	5.5	1.2	97.9	0.0	5.0	510.6	0.2	0.2	18.5	5.6	11.6	63.3	0.1	2.2	0.3	12.2	3.3	412.2	0.0	4.1	42.4	76.5	16.2	0.6	63.5	12.4	67.5	32.9	3.2	2.1	263.4	9.0	1.3	0.0	0.0	2.4	0.8	0.0	0.5	3.5	3.5	0.0	1.8	2.0	1.8	1.4	0.7	13.4	0.3	3.7	0.3	0.0	0.6
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1349.1;tongue: 1843.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1926.9;Proximal tubular cells: 1428.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol		NA	NA		49000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: AB_2682434"	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	274.6	213.6	235.9	86.7	249.7	79.1	137.9	245.9	353.6	89.6	230.2	167.7	154.7	82.0	161.3	125.3	114.5	87.2	1349.1	253.2	261.5	371.6	266.3	89.8	131.9	248.5	218.3	80.4	69.9	411.8	107.2	92.5	253.3	125.5	190.9	240.7	122.0	142.0	792.5	87.7	133.1	171.5	215.7	71.6	192.6	70.5	259.1	170.4	125.5	1843.8	165.4	131.5	62.8	237.7	268.2	219.5	257.8	173.2	369.6	280.9	282.3	215.1	295.9	300.6	304.1	252.5	215.4	355.2	112.8	264.1	358.8	214.3	303.0	355.0	425.5	207.6	253.1	337.0	173.2	376.8	202.1	384.1	223.9	277.7	241.3	271.5	152.7	236.2	235.3	308.1	183.7	217.3	395.1	157.8	300.6	317.5	158.0	376.3	266.5	235.2	349.7	310.5	460.9	251.0	249.9	153.6	182.5	257.7	384.1	205.6	191.9	341.9	149.6	220.3	211.9	187.1	252.9	264.6	264.8	407.6	266.2	312.2	184.1	271.3	186.3	200.2	202.7	267.8	218.8	258.5	236.6	224.6	241.0	258.5	230.3	221.6	28.1	214.6	253.4	184.3	320.9	321.2	235.9	249.7	245.9	353.6	253.2	261.5	248.5	218.3	253.3	215.7	259.1	237.7	44.4	60.9	54.3	54.9	78.7	81.6	109.4	562.9	50.7	165.4	81.0	86.7	1926.9	95.8	227.2	134.3	70.9	248.7	78.4	128.4	630.0	186.2	12.4	116.1	72.6	61.0	62.8	62.9	120.2	108.1	257.0	134.7	112.7	68.8	80.5	95.0	36.0	153.2	397.0	122.8	130.0	115.9	380.5	85.2	65.8	15.1	100.0	98.4	177.9	43.1	155.0	136.3	73.2	51.3	58.8	91.3	99.8	109.1	82.1	48.8	177.4	1428.3	224.5	164.1	59.2	68.3	167.8	58.0	65.6	82.7	84.0	149.5	84.3	137.4	167.8	102.6
MEGF10	"KIAA1780, SR-F3"	ENSG00000145794	"Multiple EGF like domains 10"	Q96KG7	5	127290796-127465737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis, Phagocytosis"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 52.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 218.4;Oligodendrocyte precursor cells: 97.5;Oligodendrocytes: 381.7;Skeletal myocytes: 62.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 31.6;RH-30: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		73000000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.02e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-3)"	"unprognostic (8.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-4)"	"unprognostic (5.28e-3)"	"unprognostic (2.59e-1)"	"unprognostic (9.36e-4)"	"unprognostic (1.17e-1)"	0.2	1.7	18.0	0.1	34.9	0.0	0.7	29.4	19.9	0.3	0.0	0.8	0.1	0.7	0.4	0.1	0.1	0.0	0.4	15.6	18.2	0.0	0.4	0.0	0.0	26.6	26.8	0.1	0.0	0.0	1.7	0.1	29.4	0.7	0.2	8.0	1.9	1.1	3.0	0.3	0.2	0.3	21.2	0.1	0.1	0.4	23.8	0.6	0.1	4.8	0.2	0.0	0.1	52.6	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.8	0.0	0.2	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.7	0.0	0.1	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	34.9	29.4	19.9	15.6	18.2	26.6	26.8	29.4	21.2	23.8	52.6	0.0	0.0	0.0	218.4	0.0	0.0	0.1	0.0	0.0	2.0	0.7	1.5	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	6.5	1.3	0.2	0.0	0.0	4.5	0.0	0.0	0.4	0.0	15.4	0.0	0.7	0.0	0.2	0.0	8.4	3.5	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	29.0	0.0	38.9	1.0	97.5	381.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	2.0	0.0	62.9	0.2	0.4	0.7	0.0	0.1	0.0	0.1	5.1	0.0	0.1
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3487951-3611508	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 20.6;Basal keratinocytes: 18.4;Basal squamous epithelial cells: 23.3;Melanocytes: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 51.1;HeLa: 56.3;hTERT-RPE1: 69.7;U-2197: 55.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted to blood"	Yes	No		1700000	"Cluster 52: Eosinophils - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	25.9	4.3	2.9	3.9	2.7	10.8	20.0	2.6	2.8	14.5	1.4	14.1	2.1	9.6	1.4	13.2	28.9	11.2	14.2	1.9	3.2	5.9	5.0	22.1	5.5	3.5	5.8	18.0	6.5	0.4	4.1	2.8	3.6	26.5	1.1	1.8	19.3	4.7	4.8	44.6	10.0	1.4	2.1	10.7	10.1	3.3	3.7	3.4	11.6	1.9	3.4	11.0	22.8	1.9	11.6	14.1	4.3	6.6	0.4	0.3	1.0	51.1	14.1	5.2	1.6	3.3	10.4	0.0	13.8	24.6	4.4	6.7	0.0	0.5	1.7	0.0	0.4	0.0	56.3	3.3	0.0	0.2	0.9	0.1	0.6	0.4	0.8	69.7	5.6	0.1	0.0	0.0	0.1	6.0	0.0	10.9	2.7	3.3	0.9	2.2	3.0	6.2	1.1	3.8	3.8	3.1	18.8	1.1	6.4	11.4	4.9	1.5	2.2	19.6	1.7	55.6	3.9	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.8	0.0	0.0	0.0	0.8	0.1	2.9	2.7	2.6	2.8	1.9	3.2	3.5	5.8	3.6	2.1	3.7	1.9	5.0	22.4	20.6	8.8	2.7	18.4	7.1	3.9	23.3	0.8	3.6	3.0	3.3	5.7	4.4	1.8	0.0	0.2	0.4	0.6	0.0	3.6	0.2	1.4	0.6	7.0	0.0	4.8	6.5	1.4	1.3	9.4	6.6	5.0	1.3	9.8	16.8	0.9	1.0	0.0	7.2	1.4	0.0	0.3	7.5	0.5	11.5	2.8	19.6	5.6	0.7	14.7	1.0	4.5	5.2	4.5	0.1	3.4	0.4	4.0	0.5	1.2	0.3	1.2	0.0	0.5	2.7	0.3	1.1	7.6	11.4	0.4	3.6	0.1	1.1	2.7
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 21.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.1;Erythroid cells: 15.2;Extravillous trophoblasts: 44.1;Spermatocytes: 23.2;Spermatogonia: 21.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA017214	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	0.9	0.5	0.0	5.7	0.0	10.0	1.4	0.0	0.1	1.3	0.0	6.8	5.2	1.0	0.0	7.9	0.3	0.6	0.2	0.0	0.0	0.3	0.7	0.9	10.0	0.0	0.1	0.2	0.3	0.1	0.0	5.3	0.1	0.3	8.5	0.0	1.2	0.1	0.0	3.4	4.4	2.4	0.0	2.0	3.2	9.2	0.3	21.0	0.3	0.1	11.7	1.7	2.3	0.0	123.4	62.1	81.6	48.5	11.1	18.8	47.1	88.8	62.2	121.5	148.2	47.8	47.3	40.9	27.8	43.8	106.5	41.0	71.7	55.5	133.1	112.3	28.6	32.0	69.1	48.1	4.3	50.2	39.0	6.9	9.8	93.9	53.0	15.6	62.2	61.9	41.7	63.2	100.9	40.9	63.1	23.4	65.1	55.1	47.9	57.4	54.9	25.8	37.7	40.7	55.1	40.8	47.4	45.3	28.6	45.2	38.0	23.7	30.8	65.4	81.8	56.1	82.3	12.3	47.9	60.7	41.2	36.8	91.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	1.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.7	1.9	4.6	0.9	3.5	0.0	0.0	0.9	0.8	0.4	0.0	2.0	0.0	0.0	16.1	0.7	4.5	0.0	1.1	2.8	2.9	1.4	1.3	0.0	15.2	0.8	1.1	44.1	3.3	4.6	2.1	0.0	7.8	1.4	0.7	10.1	0.0	0.7	4.7	4.1	1.6	3.0	2.7	1.2	1.9	0.0	0.0	3.1	0.0	2.1	1.0	0.4	1.7	2.7	0.0	10.2	0.5	0.6	0.1	2.0	0.0	0.0	0.0	3.7	23.2	21.3	9.3	1.7	8.9	2.7	0.7	8.9	2.3
MEOX1	MOX1	ENSG00000005102	"Mesenchyme homeobox 1"	P50221	17	43640389-43661922	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 36.0;breast: 26.1;heart muscle: 24.9"	"Group enriched"	"Detected in some"	9	"Adipocytes: 63.5;Endothelial cells: 41.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"T-reg: 17.5"	"Lineage enriched"	"Detected in single"	48	"T-cells: 17.5"	"Cell line enriched"	"Detected in some"	14	"HeLa: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045214, HPA063788"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA045214: AB_10959299, HPA063788: "	"unprognostic (1.36e-3)"	"unprognostic (2.15e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-2)"	"unprognostic (5.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.44e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.47e-3)"	36.0	0.5	0.0	4.7	0.0	0.0	26.1	0.0	0.1	8.0	0.0	4.7	1.6	5.5	1.1	3.7	9.0	5.7	24.9	0.0	0.0	0.2	0.1	1.4	6.6	0.0	0.0	1.0	1.5	1.2	0.5	0.1	0.0	2.6	2.4	0.0	4.9	1.9	8.3	6.6	5.1	10.6	0.0	10.8	3.0	1.1	0.0	3.0	1.9	17.1	5.3	7.7	7.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	1.8	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.3	2.7	0.0	0.0	1.7	0.5	0.0	0.3	0.0	0.0	17.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.5	0.0	0.0	1.0	0.3	4.1	0.0	0.0	1.2	0.0	0.4	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	41.3	0.0	0.0	0.7	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.0	0.0	0.1	0.3	1.8	0.1	1.5	0.3	0.0	0.0
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793389-46839778	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"intestine: 467.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2"									"CAB025163, HPA029416"	Enhanced					NA	NA		2100000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.2	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	115.6	269.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	4.2	0.0	0.0	0.5	0.1	0.1	102.5	0.0	0.0	0.2	0.0	0.0	467.7	2.6	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	309.4	0.0	0.0	7.7	0.1	0.0	0.0	15.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	87.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.0	156.9	0.4	0.0	0.0	902.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	45.8	0.0
METRN	"C16orf23, MGC2601"	ENSG00000103260	"Meteorin, glial cell differentiation regulator"	Q9UJH8	16	715118-719655	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 299.3;choroid plexus: 238.6"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 1153.9"	"Cancer enhanced"	"Detected in all"		"glioma: 69.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5"	"Region enhanced"	"Detected in all"		"cerebellum: 612.9"					HPA051164	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted in brain"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA051164: AB_2681369"	"unprognostic (1.60e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	16.1	36.3	238.0	4.0	233.8	1.5	14.1	203.7	299.3	15.5	238.6	30.7	4.1	17.3	3.0	10.4	37.0	2.5	56.8	209.7	210.3	29.2	49.9	16.8	2.1	258.1	239.0	5.2	46.1	5.5	88.0	3.7	208.5	25.4	1.2	3.0	25.2	13.1	23.3	11.9	12.0	2.9	244.4	12.3	22.2	15.3	258.3	2.4	30.6	5.1	1.8	20.5	11.3	237.4	8.9	73.4	14.2	72.4	24.6	13.8	22.9	17.5	8.7	6.9	4.4	11.0	21.5	1.5	39.6	12.4	26.3	32.6	2.1	17.0	1.1	4.7	32.0	2.9	13.3	57.1	15.1	6.5	9.2	33.3	18.3	2.1	4.2	21.3	2.3	20.3	5.3	1.7	5.2	178.2	2.4	22.0	5.2	9.8	133.1	24.3	16.4	24.4	18.4	2.6	22.5	28.5	6.9	18.9	93.5	1.6	28.6	12.6	8.0	19.4	36.8	22.7	15.4	11.0	3.3	1.7	30.3	4.8	46.6	0.0	0.1	0.2	0.8	0.3	0.5	1.2	0.4	0.8	0.0	0.1	0.2	0.5	0.0	0.5	0.3	0.2	1.0	0.1	238.0	233.8	203.7	299.3	209.7	210.3	258.1	239.0	208.5	244.4	258.3	237.4	46.7	0.0	2.2	91.4	8.5	3.8	17.1	3.3	0.0	45.5	79.5	75.8	16.3	48.6	1.8	16.5	14.6	0.6	26.7	29.0	50.9	8.4	8.0	230.7	54.8	21.5	27.4	2.7	6.6	5.1	2.1	15.1	5.6	14.4	0.0	2.7	20.0	39.5	6.4	70.7	5.7	10.7	2.0	7.8	6.5	25.8	11.1	6.6	10.6	8.4	1.1	1153.9	23.7	44.2	57.6	5.3	26.7	9.4	7.9	27.7	6.2	55.6	9.5	37.9	26.3	11.8	26.7	4.6	11.7	1.4	3.0	0.4	12.7	5.2	9.2	16.2
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 14.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	29	"T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	1.8	1.6	1.4	1.6	2.3	0.0	1.7	2.1	1.9	3.9	8.1	5.9	1.4	7.5	2.2	4.0	6.0	5.8	3.0	1.7	1.8	3.9	0.9	1.6	0.1	1.6	2.2	5.6	1.3	2.5	2.1	0.4	1.4	4.9	4.2	1.4	0.4	7.1	0.0	0.5	2.1	14.2	2.0	0.7	2.4	2.1	1.8	1.0	1.3	1.1	0.6	4.7	1.6	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.3	2.1	1.9	1.7	1.8	1.6	2.2	1.4	2.0	1.8	1.2	0.0	0.0	0.0	30.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.4	1.5	0.1	0.0	0.0	23.8	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.7	28.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.7	0.0	0.6	0.0	31.7	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	2.1	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.5;choroid plexus: 88.8"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 5.7;eosinophil: 1.8;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.5;RT4: 38.0;SK-BR-3: 34.3;SuSa: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.0	3.4	32.9	0.9	61.0	3.2	12.0	49.1	34.4	13.0	88.8	2.7	0.6	5.1	38.9	0.8	4.2	2.6	1.7	35.2	40.1	30.0	37.4	2.7	0.9	46.3	58.3	0.6	1.5	6.5	4.1	3.0	48.5	2.8	2.0	25.0	2.1	12.8	5.1	24.5	1.0	4.1	38.8	1.5	1.3	46.3	54.9	0.6	2.8	2.3	0.5	10.1	1.8	65.5	0.4	5.7	3.0	3.1	2.6	1.3	1.1	6.2	0.9	2.8	2.5	1.9	0.4	0.0	0.2	9.6	5.4	2.9	10.9	1.4	1.2	0.0	4.7	0.0	6.7	2.4	1.4	0.0	22.5	1.8	3.4	0.3	1.0	1.5	0.3	3.5	0.9	1.1	5.8	3.4	1.0	0.8	3.1	0.7	4.7	0.0	1.8	0.0	8.1	38.0	2.5	5.5	5.1	34.3	11.6	19.1	1.9	0.0	0.2	2.9	11.2	5.5	11.9	0.6	0.0	0.0	7.5	1.2	11.4	5.7	0.1	1.8	0.6	0.7	0.3	0.0	0.5	0.1	0.2	0.0	0.2	0.1	3.5	0.0	0.0	0.5	0.1	4.6	32.9	61.0	49.1	34.4	35.2	40.1	46.3	58.3	48.5	38.8	54.9	65.5	1.0	0.0	5.6	112.6	0.6	2.5	0.4	0.1	2.8	12.2	8.5	9.7	3.4	0.0	0.2	36.8	20.9	3.1	0.2	0.6	5.9	0.5	417.5	8.5	1.1	2.0	2.4	11.2	36.3	1.1	1.0	0.6	0.0	12.4	4.5	11.0	3.3	49.1	1.2	3.3	25.0	0.3	0.0	1.0	0.7	1840.0	5.3	13.5	7.2	3.7	1.5	2.9	2.1	53.8	127.6	1.4	0.3	9.1	0.5	0.9	0.3	24.0	0.3	15.8	19.7	1.7	4.2	17.6	13.2	0.3	8.4	9.4	0.6	1.4	0.8	2.2
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFSD1	"FLJ14153, Minerva, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 214.4;Kupffer cells: 289.7;Macrophages: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 254.5;granulocytes: 246.0;monocytes: 288.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	39.7	27.4	11.0	38.1	12.9	35.9	26.9	20.2	15.8	22.5	23.8	31.1	25.7	16.1	19.4	35.0	21.4	32.3	17.2	15.7	14.5	30.3	39.5	40.5	34.5	15.8	12.2	17.9	31.5	36.0	7.5	30.7	16.4	26.8	22.2	8.4	48.4	23.4	11.1	23.4	23.2	26.2	11.5	42.0	36.1	18.0	16.1	16.1	27.9	16.9	21.5	40.0	19.6	17.3	83.3	28.9	9.1	26.3	51.0	45.0	35.9	109.7	61.8	46.5	45.9	10.3	82.8	19.7	73.5	81.9	24.1	37.0	22.0	26.7	40.9	68.2	33.7	57.2	24.0	6.7	52.1	206.0	135.7	59.3	38.5	39.7	9.5	15.9	38.0	14.0	39.9	32.9	85.1	19.2	11.3	83.2	8.5	29.9	50.9	19.8	11.3	170.9	18.1	16.3	18.2	29.8	76.7	70.0	25.0	8.3	56.9	100.1	102.8	58.6	23.2	87.3	60.5	98.3	94.4	9.6	74.1	162.0	39.7	102.4	288.8	246.0	36.6	223.4	35.3	54.2	30.3	33.9	254.5	44.5	32.2	35.5	97.1	32.9	187.8	81.8	38.9	252.1	11.0	12.9	20.2	15.8	15.7	14.5	15.8	12.2	16.4	11.5	16.1	17.3	28.5	19.2	34.0	12.1	39.6	21.4	46.2	38.4	33.0	11.8	33.3	19.7	22.2	20.0	51.6	22.0	6.2	27.5	24.1	33.3	19.6	34.0	5.3	13.6	22.7	28.2	22.8	56.0	14.6	28.5	33.6	33.7	23.9	17.2	48.8	8.9	37.1	34.4	214.4	18.5	15.2	28.6	34.6	289.7	90.7	6.7	12.2	212.3	32.0	16.9	88.7	26.0	25.7	15.1	29.4	29.0	29.9	11.3	32.9	30.0	27.1	31.8	59.3	10.5	13.1	11.8	23.8	11.6	8.7	61.2	26.0	56.0	22.3	19.4	28.3	58.4
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.8;pancreas: 4.0;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.4	0.0	0.2	1.5	11.8	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.6	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MGAT2	GNT-II	ENSG00000168282	"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	Q10469	14	49620799-49623481	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043721, HPA056824"	Approved		Supported	"Golgi apparatus"		NA	Yes		5100000	"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043721: AB_2678636, HPA056824: AB_2683248"	"unprognostic (1.20e-2)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.59e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-2)"	16.8	17.6	5.9	24.3	5.8	10.3	13.3	6.9	6.8	17.4	9.0	23.6	23.1	12.7	21.7	11.8	11.9	15.2	11.7	5.6	6.7	14.2	40.7	13.8	25.3	6.4	6.3	13.1	23.8	8.2	7.9	22.0	6.6	14.1	21.9	8.2	15.8	13.7	5.0	9.3	22.5	16.0	6.9	20.2	21.0	24.3	7.2	16.4	13.3	5.6	25.1	20.9	8.8	7.3	63.5	30.7	23.2	39.2	53.6	51.7	15.1	68.6	67.7	62.2	55.8	37.5	47.1	63.7	56.9	62.9	36.0	49.5	32.9	39.7	66.7	65.5	29.1	40.7	21.7	37.2	42.3	94.5	91.2	39.8	31.2	36.8	51.8	45.5	75.5	31.4	31.7	170.4	66.3	24.2	32.9	60.1	23.8	22.2	49.1	36.7	67.1	55.6	49.3	36.2	24.0	25.6	49.3	12.9	39.8	22.2	39.1	63.6	78.9	56.1	60.8	41.1	49.6	182.8	94.6	56.7	27.3	46.5	38.6	49.4	38.6	39.3	36.6	34.1	39.3	25.1	33.3	33.1	39.9	15.9	19.3	26.8	11.6	22.3	39.8	47.2	31.6	44.8	5.9	5.8	6.9	6.8	5.6	6.7	6.4	6.3	6.6	6.9	7.2	7.3	17.4	12.8	8.6	2.0	31.7	15.7	25.7	28.8	14.2	13.7	15.5	8.9	0.1	24.3	18.0	11.0	4.2	26.4	46.9	34.6	9.8	31.0	7.9	12.5	20.7	20.8	12.1	19.0	3.0	34.4	40.3	24.3	13.7	11.7	17.1	27.7	27.1	63.0	37.2	18.5	4.3	20.5	40.7	34.5	28.8	6.0	17.4	26.3	21.4	2.8	40.6	16.7	63.8	6.0	4.5	36.5	25.1	22.2	77.1	27.0	26.7	15.2	23.5	15.8	6.6	15.8	34.6	56.4	13.0	15.2	14.1	5.3	31.5	23.2	20.0	25.5
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"epididymis: 3.7;pituitary gland: 3.1;testis: 4.7;thyroid gland: 6.2"	"Group enriched"	"Detected in some"	8	"Astrocytes: 876.3;Excitatory neurons: 988.4;Inhibitory neurons: 1438.9"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 6.0;SCLC-21H: 2.5;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016418	Approved		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane"	"Centriolar satellite"	"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	0.3	0.8	1.7	0.0	2.0	0.1	0.0	0.2	1.4	0.1	0.0	0.4	0.0	0.0	3.7	0.0	0.1	0.1	1.7	1.0	1.8	0.0	0.1	0.1	0.0	1.0	2.4	0.0	0.1	0.0	3.1	0.0	1.6	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.7	2.3	0.0	6.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.2	1.4	1.0	1.8	1.0	2.4	1.6	1.1	2.3	0.7	0.1	6.4	1.1	876.3	0.0	0.1	0.2	1.5	0.0	11.2	0.0	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	123.9	0.1	0.1	4.2	0.0	0.0	988.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1438.9	0.0	4.1	0.0	0.0	98.9	16.1	0.3	0.0	34.7	0.2	0.5	0.0	32.2	17.2	0.4	0.0	4.1	0.0	0.3	0.0	0.1	0.0	1.8	0.0	0.4	0.2	3.8	1.5	0.0	0.1	0.0	0.5	6.2	0.0	0.3
MGST1	"GST12, MGST-I"	ENSG00000008394	"Microsomal glutathione S-transferase 1"	P10620	12	16347142-16609259	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1096.9;adrenal gland: 1137.3;liver: 3104.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1205.9;Club cells: 1308.7;Hepatocytes: 4345.6;Proximal tubular cells: 1265.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 170.2;myeloid DC: 123.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 123.5;monocytes: 170.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 5391.4;ASC TERT1: 2078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044840	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA		19000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria	"Endoplasmic reticulum"	"HPA044840: AB_10965550"	"unprognostic (4.57e-2)"	"unprognostic (4.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.92e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (9.90e-2)"	"unprognostic (4.61e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (4.19e-1)"	1096.9	1137.3	139.2	76.1	143.9	79.3	574.8	131.4	200.7	69.7	111.9	315.5	128.9	32.7	43.9	195.3	78.4	200.8	135.1	133.9	165.4	392.9	3104.7	177.2	3.5	156.5	155.7	11.4	131.3	0.8	52.6	14.2	166.6	161.2	212.8	7.0	155.3	55.8	25.5	88.8	119.5	44.7	146.4	7.3	131.4	20.2	147.5	14.0	272.3	43.3	7.7	267.9	114.7	132.9	1.4	495.2	115.6	139.4	5391.4	2078.4	1.5	408.5	418.5	220.6	339.1	186.0	838.6	0.4	48.5	535.8	694.2	2.4	317.0	663.5	202.9	1.1	41.4	175.7	256.6	664.8	1252.0	350.4	1.2	1375.9	714.7	671.2	710.5	540.4	393.1	0.1	126.7	0.6	486.3	101.2	0.3	137.0	987.6	0.7	391.2	0.4	69.3	229.3	503.3	982.1	21.8	17.1	645.8	411.8	17.5	630.1	442.5	190.8	248.0	226.1	30.5	447.3	541.1	0.6	1.7	1.5	748.1	538.5	7.1	11.3	170.2	1.8	0.1	26.3	0.5	1.0	0.2	0.1	123.5	0.0	0.1	0.1	5.9	0.2	5.9	34.1	1.1	55.9	139.2	143.9	131.4	200.7	133.9	165.4	156.5	155.7	166.6	146.4	147.5	132.9	39.6	266.0	651.3	130.2	14.0	25.6	130.2	1205.9	91.0	0.0	383.8	262.6	5.1	574.7	1308.7	71.7	0.0	2.9	9.8	288.1	181.9	26.9	25.4	299.9	198.2	19.6	45.6	92.8	4.4	434.1	218.1	404.5	153.9	947.9	34.1	26.3	67.5	4345.6	160.2	0.0	0.5	280.5	740.6	176.4	52.0	17.9	33.2	75.7	39.2	6.5	224.4	1.0	5.2	1.0	0.8	322.7	175.0	113.2	6.0	467.2	209.5	1265.6	526.1	1.3	0.0	11.3	124.3	0.7	2.3	510.3	17.6	7.9	22.1	152.4	534.1	883.3
MIA	CD-RAP	ENSG00000261857	"MIA SH3 domain containing"	Q16674	19	40771648-40777490	"Cancer-related genes, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.9;pituitary gland: 76.2;salivary gland: 43.3;stomach 1: 65.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 51.4;Breast myoepithelial cells: 171.7;Melanocytes: 103.2;monocytes: 30.0;Pancreatic endocrine cells: 66.8;Respiratory ciliated cells: 53.9"	"Cancer enriched"	"Detected in many"	5	"melanoma: 58.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.7"	"Group enriched"	"Detected in some"	29	"AN3-CA: 90.1;CAPAN-2: 80.6;SK-MEL-30: 271.9;WM-115: 247.7"									HPA042369	Approved				"Secreted to blood"	NA	NA	8270000	64000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 4: Stomach - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA042369: AB_10794420"	"prognostic favorable (2.08e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.02e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-1)"	"unprognostic (3.29e-8)"	"unprognostic (5.88e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	2.6	2.9	4.9	6.9	5.9	2.9	57.9	5.7	7.5	8.3	5.4	16.9	2.0	1.2	2.0	6.6	3.7	2.9	5.3	4.4	4.8	2.4	2.7	1.9	2.0	5.3	5.0	7.0	1.4	0.0	76.2	2.1	5.6	6.4	4.2	0.4	43.3	3.3	0.7	9.6	5.9	7.6	4.8	7.0	65.8	1.7	5.5	2.4	2.9	1.7	1.6	4.0	5.2	7.9	0.3	0.9	1.5	90.1	1.3	1.2	1.0	0.0	0.0	0.0	0.5	0.5	80.6	0.2	0.0	0.0	0.3	0.2	0.4	4.9	0.1	2.9	0.9	0.0	1.0	0.1	0.4	0.2	0.4	0.7	4.2	0.0	1.5	1.4	0.0	1.4	0.0	0.9	0.0	0.0	0.1	0.0	0.2	5.9	0.3	0.1	0.2	0.0	2.5	0.0	0.2	0.1	0.1	0.0	271.9	3.4	0.5	1.2	0.0	0.2	3.4	0.1	1.0	0.0	0.2	0.9	0.1	0.4	247.7	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	4.9	5.9	5.7	7.5	4.4	4.8	5.3	5.0	5.6	4.8	5.5	7.9	1.0	0.0	0.5	0.0	0.3	5.2	0.1	11.2	0.6	0.0	51.4	171.7	0.6	0.0	4.9	0.0	0.0	0.8	0.5	1.7	0.0	0.5	0.0	0.9	0.0	1.4	0.0	0.0	0.0	3.2	0.1	1.1	14.3	0.2	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.1	4.1	0.0	0.7	0.3	0.6	0.2	103.2	0.0	30.0	0.0	0.0	0.0	0.0	66.8	5.1	0.0	0.1	0.8	0.4	0.0	53.9	0.0	0.0	0.2	1.3	0.1	0.6	6.1	1.3	0.7	0.3	0.8	4.1	0.5
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MIDN		ENSG00000167470	Midnolin	Q504T8	19	1248553-1259140	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 455.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 11.8"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042018, HPA049432"	Uncertain		Approved	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA042018: AB_2677800, HPA049432: AB_2680765"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	71.4	61.9	25.6	25.2	25.0	82.6	42.7	24.9	32.3	48.0	16.1	53.9	22.3	34.2	6.3	99.2	64.6	31.4	72.9	21.1	32.1	46.9	50.5	67.0	19.1	44.8	30.1	61.4	37.4	8.2	81.9	15.5	29.8	39.2	12.0	12.4	46.6	11.5	141.6	79.1	52.6	12.4	29.8	50.3	56.1	19.6	32.4	19.0	35.0	17.4	15.1	42.2	55.7	23.1	14.7	31.8	53.5	25.0	11.2	19.0	39.2	25.0	14.9	12.6	8.9	41.8	16.1	23.3	26.6	18.9	6.8	29.6	16.3	26.5	4.9	32.9	30.0	32.8	21.8	33.3	22.7	33.3	46.9	29.4	24.4	15.1	14.3	19.5	20.8	27.3	42.7	24.0	13.5	58.9	44.6	13.6	117.6	28.6	21.1	68.8	15.2	10.7	23.8	17.2	42.7	55.9	52.9	50.1	33.7	27.7	20.2	37.7	26.2	22.9	25.4	106.2	27.3	22.4	13.2	32.2	43.9	14.6	79.5	1.6	1.0	1.1	1.0	1.0	0.7	0.2	0.3	0.7	0.4	0.3	0.2	0.5	11.8	1.3	1.1	0.4	0.1	0.7	25.6	25.0	24.9	32.3	21.1	32.1	44.8	30.1	29.8	29.8	32.4	23.1	330.7	38.5	60.5	17.3	101.1	98.9	128.3	114.4	175.8	53.9	290.6	224.2	84.3	117.2	86.2	134.3	31.3	15.8	184.8	455.8	19.6	125.5	34.7	220.6	84.5	186.1	164.5	19.4	8.0	155.5	47.3	84.0	132.0	294.7	61.5	60.6	197.4	80.9	77.9	21.9	5.6	219.5	59.0	100.0	134.9	33.3	49.7	150.9	42.7	24.4	49.7	77.8	96.8	32.2	10.3	259.0	306.8	33.1	69.9	190.9	242.1	35.8	109.6	35.7	39.5	219.8	142.4	3.3	12.0	227.3	148.0	81.3	122.9	33.2	167.8	190.7
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751112-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"intestine: 196.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 793.4;Intestinal goblet cells: 230.9;Paneth cells: 646.7;Proximal enterocytes: 1115.2;Undifferentiated cells: 220.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 121.4;HaCaT: 90.2;hTCEpi: 82.6;MCF7: 63.2;OE19: 76.9;SK-BR-3: 134.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	1.3	0.0	0.3	12.1	0.3	0.0	0.9	0.5	0.4	4.4	0.1	95.5	171.0	0.7	0.0	0.3	9.8	11.3	0.0	0.4	0.3	8.8	0.1	9.3	0.1	0.5	0.5	0.3	1.7	0.0	8.1	1.2	0.5	5.6	48.4	0.0	1.0	0.5	0.0	0.6	196.6	3.3	0.2	0.0	22.9	0.5	0.3	0.3	0.1	0.0	0.0	9.0	0.6	0.2	30.4	121.4	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	42.1	44.2	10.8	11.5	0.0	0.1	90.2	0.0	37.7	0.0	0.0	0.1	0.0	47.0	13.3	0.0	0.0	1.9	0.0	82.6	0.3	4.5	0.0	0.0	0.0	0.0	0.4	0.2	63.2	0.1	0.7	0.1	76.9	24.6	0.2	0.4	1.0	30.1	33.7	1.4	0.4	42.9	134.3	0.1	0.1	29.3	0.0	0.0	0.0	14.8	1.8	0.2	0.6	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.4	0.4	0.3	0.5	0.5	0.5	0.2	0.3	0.2	0.1	38.5	8.0	0.3	2.9	0.1	4.5	22.5	0.0	0.0	4.7	2.3	0.5	10.0	39.7	11.0	0.0	0.6	0.0	793.4	1.9	39.9	0.6	40.5	1.5	0.8	58.0	0.0	0.2	46.0	6.0	2.4	56.6	14.3	8.9	0.0	0.0	0.0	0.1	0.0	0.3	230.9	28.5	0.0	0.0	0.9	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.2	157.7	646.7	0.0	0.1	41.6	1115.2	27.5	41.3	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.3	2.1	1.6	0.0	220.7	62.1
MKI67	"MIB-1, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126423	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.3;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 232.9;Extravillous trophoblasts: 86.1;Granulosa cells: 87.0;Plasma cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	0.9	0.7	0.0	8.5	0.1	46.3	1.7	0.0	0.1	1.2	0.2	8.1	6.2	1.0	0.0	10.0	0.3	0.9	0.3	0.1	0.1	0.4	0.8	1.4	14.9	0.1	1.0	0.2	0.2	0.1	0.1	4.1	0.6	0.4	9.2	0.0	1.4	0.1	0.0	6.6	5.8	2.6	0.0	4.8	4.2	2.3	0.9	52.7	0.4	0.1	16.4	1.8	2.8	0.3	204.6	101.5	103.2	73.6	4.3	8.7	32.1	75.7	55.3	70.3	62.3	83.9	82.3	152.6	21.3	51.9	46.4	120.7	109.3	56.8	104.7	161.8	53.1	131.0	79.4	52.7	0.1	186.0	68.0	2.0	2.5	72.2	73.2	17.2	69.8	69.5	61.2	142.1	70.5	80.9	111.7	56.6	41.3	52.7	45.7	82.2	135.1	20.3	25.6	56.2	35.9	38.9	107.1	38.0	17.3	33.9	31.4	39.3	65.0	37.0	73.6	53.0	206.8	64.2	54.9	177.2	30.7	83.3	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.6	0.0	0.9	0.3	0.6	0.0	5.4	0.0	16.0	6.4	1.6	5.3	0.6	0.0	3.9	3.2	1.6	1.5	5.3	0.0	0.0	30.6	7.4	25.0	0.0	0.8	4.2	2.3	10.2	6.7	6.7	232.9	0.0	0.0	86.1	13.5	34.7	13.2	1.3	87.0	5.7	1.7	42.1	0.0	0.0	22.4	2.0	12.9	13.7	0.9	0.3	16.6	3.6	0.0	0.2	0.0	8.2	0.0	0.0	0.1	3.0	0.4	107.4	4.6	2.6	0.1	1.6	0.0	0.0	0.5	13.6	8.1	24.1	50.4	3.0	7.8	23.0	2.7	47.1	4.8
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565674-23630075	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.1;retina: 8.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"JURKAT: 26.3;K-562: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	0.3	0.1	4.5	0.4	7.7	1.8	0.5	4.8	6.7	0.1	2.4	0.5	0.2	0.4	1.6	3.4	3.1	0.1	0.1	5.2	5.1	0.3	0.1	0.2	0.7	7.0	6.1	0.2	0.4	0.0	1.1	3.3	7.0	0.3	0.1	8.9	3.1	0.2	0.8	0.4	0.3	0.1	4.0	0.6	0.2	2.4	6.6	2.4	0.2	0.8	0.8	0.2	0.2	14.1	8.5	2.9	6.1	5.6	0.0	0.0	13.0	0.9	0.0	4.3	4.5	14.7	0.0	0.1	0.1	0.0	11.8	12.5	2.4	0.0	2.7	0.1	0.5	15.3	17.0	0.9	0.4	18.6	10.2	0.6	0.0	5.8	0.0	2.8	0.0	26.3	30.6	12.9	3.5	0.0	20.3	7.3	0.0	9.6	12.1	10.7	2.5	7.5	0.0	0.1	1.6	4.4	0.0	7.7	0.1	0.2	4.2	5.2	0.1	13.5	9.9	0.9	9.6	16.8	24.5	8.6	7.9	0.1	0.1	0.6	0.2	0.1	0.6	0.0	0.3	0.2	0.2	0.4	0.0	0.2	0.6	2.3	0.4	0.1	0.1	0.3	0.1	0.3	4.5	7.7	4.8	6.7	5.2	5.1	7.0	6.1	7.0	4.0	6.6	14.1	0.0	0.0	0.0	0.7	0.1	0.5	1.2	0.0	0.0	13.8	0.3	0.0	0.7	0.0	0.1	0.0	25.0	0.8	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.6	0.5	0.0	0.1	1.8	1.0	0.1	3.4	0.0	6.0	9.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	7.4	0.0	0.7	1.6	2.6	0.9	1.8	0.0	0.5	0.2	0.1	0.0	0.4
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MLLT11	AF1Q	ENSG00000213190	"MLLT11 transcription factor 7 cofactor"	Q13015	1	151060397-151069544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 54.1;Early spermatids: 76.9;Excitatory neurons: 57.9;Late spermatids: 215.6"	"Cancer enriched"	"Detected in all"	4	"glioma: 29.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 216.7;EFO-21: 164.9;SH-SY5Y: 238.6;U-698: 207.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000540	Uncertain		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA000540: AB_2666024"	"unprognostic (2.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.25e-12)"	"unprognostic (5.66e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-3)"	5.3	19.0	59.4	4.7	61.8	2.0	2.5	41.1	109.3	4.5	8.8	7.2	1.6	10.7	1.3	4.0	6.2	6.0	38.1	66.2	80.6	3.8	2.0	3.8	2.1	63.1	50.5	8.2	3.1	16.2	10.4	1.0	66.1	4.3	3.6	35.6	3.8	1.5	11.3	2.6	4.9	13.8	29.9	4.6	5.1	2.8	49.7	20.6	3.8	10.8	2.1	4.0	3.9	57.1	6.3	31.0	216.7	34.4	3.5	5.8	1.4	11.6	15.2	13.2	24.0	3.0	12.6	10.0	164.9	10.6	35.9	4.5	54.3	13.0	7.6	65.8	14.5	28.9	17.7	0.9	6.9	0.8	1.0	9.9	1.6	73.5	2.9	42.2	100.1	43.3	30.8	2.3	43.6	1.4	106.4	19.0	95.7	0.6	4.4	99.8	28.1	0.6	25.5	1.7	132.8	238.6	0.8	1.3	6.9	142.5	5.3	2.7	65.9	27.0	29.0	9.2	24.7	2.4	3.2	207.1	70.0	0.6	51.7	1.1	0.3	1.4	5.9	0.6	2.7	2.5	3.9	6.2	0.7	1.9	5.3	9.1	1.6	4.0	0.9	1.4	4.1	3.2	59.4	61.8	41.1	109.3	66.2	80.6	63.1	50.5	66.1	29.9	49.7	57.1	1.4	0.0	1.1	11.8	4.2	3.6	5.0	14.6	4.6	54.1	2.5	4.8	10.2	1.5	2.2	3.7	8.4	2.9	15.3	0.1	17.6	3.9	76.9	0.8	11.3	5.2	10.7	6.3	57.9	1.2	2.5	17.5	2.0	0.9	4.5	4.3	4.2	0.4	6.0	37.0	40.6	0.1	16.2	6.6	14.5	215.6	2.1	12.3	5.4	10.3	33.3	20.6	19.6	16.1	14.4	3.0	0.2	3.8	4.8	1.3	0.2	2.4	0.6	26.3	0.0	3.4	30.0	8.6	12.3	2.8	3.4	7.4	9.9	3.0	0.2	4.3
MMP17	MT4-MMP	ENSG00000198598	"Matrix metallopeptidase 17"	Q9ULZ9	12	131828393-131851783	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.2"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 47.0;Inhibitory neurons: 14.3;Melanocytes: 28.4;Oligodendrocyte precursor cells: 26.7"	"Cancer enriched"	"Detected in many"	10	"melanoma: 29.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"REH: 29.6;SK-MEL-30: 60.4;WM-115: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (9.11e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.66e-4)"	"unprognostic (7.68e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.26e-10)"	"unprognostic (1.15e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.81e-2)"	3.9	0.8	9.9	1.2	16.6	0.9	4.0	0.0	37.2	10.8	0.0	6.4	0.3	3.7	0.0	1.7	2.4	1.0	2.2	31.7	9.2	1.0	1.0	2.0	0.9	0.0	0.2	11.6	2.0	0.1	1.5	0.1	0.3	2.9	0.1	0.1	3.1	0.5	0.9	4.7	2.7	0.3	0.0	1.7	1.6	3.2	6.3	0.0	1.7	0.0	0.2	2.7	4.7	8.8	0.3	11.5	0.0	0.5	2.3	2.9	0.1	7.2	7.9	2.1	3.3	0.0	1.4	0.0	5.2	1.8	1.4	3.8	1.3	1.5	0.0	0.0	0.7	1.1	3.8	0.0	3.6	0.0	7.2	2.7	1.2	2.4	0.0	0.5	4.0	0.0	2.0	0.0	1.0	8.3	0.0	11.5	4.6	1.6	7.3	29.6	0.0	3.9	0.0	0.0	3.7	2.0	1.0	0.2	60.4	0.5	7.4	12.8	5.8	0.7	0.9	6.3	0.6	0.0	0.0	0.0	2.4	0.3	87.5	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	9.9	16.6	0.0	37.2	31.7	9.2	0.0	0.2	0.3	0.0	6.3	8.8	0.6	0.0	0.0	2.9	2.3	2.5	0.1	1.7	0.6	1.0	2.3	1.8	1.2	1.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.5	0.0	0.0	47.0	0.2	0.2	5.4	0.0	0.4	0.0	0.7	1.1	0.0	0.6	3.3	14.3	0.0	2.0	2.6	1.0	0.4	0.9	3.4	28.4	3.7	2.4	0.1	0.0	26.7	2.9	0.0	0.0	1.9	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.8	1.4	0.4	0.4	0.1	1.1	0.0	0.2	5.3	0.0	0.2
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.4;Fibroblasts: 52.8;Hofbauer cells: 30.8;Kupffer cells: 35.7;Langerhans cells: 100.7;Macrophages: 61.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 75.6"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 7.2"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	58.5	3.6	0.0	11.4	0.1	0.7	18.3	0.0	0.3	10.4	0.5	7.3	1.2	20.7	0.5	2.3	17.2	25.6	8.8	0.1	0.1	5.7	2.7	25.4	2.8	0.1	0.1	11.9	7.2	0.5	0.8	10.8	0.2	3.3	3.3	0.1	3.1	2.3	0.9	5.5	8.7	8.7	0.1	27.4	9.6	0.4	1.3	2.9	4.4	0.6	6.9	9.6	6.2	0.1	1.5	0.0	0.2	0.0	7.8	12.4	75.6	10.1	10.6	3.9	4.4	0.6	0.6	0.0	0.0	12.8	0.3	0.0	0.0	3.0	4.0	0.8	0.0	0.0	0.3	0.1	6.5	0.0	0.6	12.1	0.4	1.9	2.4	6.2	0.7	0.0	0.2	0.1	11.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.8	0.0	1.7	4.7	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.2	15.7	2.2	5.0	0.2	0.3	0.1	0.0	0.0	8.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.1	1.3	0.1	2.8	0.0	4.6	0.7	1.3	7.1	0.3	1.9	0.6	0.4	0.3	0.3	0.7	11.5	3.3	0.0	4.2	18.6	0.7	0.0	0.0	0.3	0.5	2.4	20.8	1.5	0.0	0.0	0.2	0.5	54.4	52.8	1.1	1.7	2.5	0.4	3.6	0.7	30.8	0.0	0.2	0.1	0.0	35.7	100.7	0.9	5.9	61.2	12.4	1.9	22.5	0.4	0.0	0.0	0.3	0.1	0.0	5.3	1.0	0.3	0.0	0.1	1.5	1.7	0.0	3.8	7.6	0.2	0.2	1.0	4.3	18.7	0.9	0.2	0.0	0.4
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 40.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	3.4	1.0	6.1	0.5	5.8	0.7	0.5	40.0	8.1	0.7	3.5	0.7	2.1	1.3	0.1	0.3	2.2	0.6	0.6	6.0	5.6	7.8	0.5	4.7	0.4	4.4	5.6	0.4	5.8	0.3	3.8	0.2	5.4	1.7	0.2	2.5	0.5	4.2	0.3	1.2	1.4	2.0	2.7	0.4	0.6	0.4	7.2	0.0	0.7	0.1	0.0	0.4	0.3	4.8	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.1	5.8	40.0	8.1	6.0	5.6	4.4	5.6	5.4	2.7	7.2	4.8	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MMP27		ENSG00000137675	"Matrix metallopeptidase 27"	Q9H306	11	102691487-102705769	"Enzymes, Predicted intracellular proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 4.7;salivary gland: 1.9;skin 1: 2.4"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 1.2;Fibroblasts: 4.2;Langerhans cells: 1.8;Suprabasal keratinocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069097	Approved				"Intracellular and membrane"	NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 50: Fibroblasts - ECM organization"			"HPA069097: AB_2686085"	"unprognostic (3.99e-2)"	"unprognostic (2.37e-4)"				"unprognostic (1.25e-3)"			"unprognostic (1.63e-1)"					"unprognostic (4.60e-1)"				1.2	0.0	0.0	0.0	0.0	1.3	4.7	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.4	2.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Adipocytes: 229.3;Endothelial cells: 127.1;Hepatic stellate cells: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 89.2;HUVEC TERT2: 196.6;TIME: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020741			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		84000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	63.2	13.9	14.0	10.1	12.7	1.5	54.5	11.5	12.5	20.6	11.0	14.2	10.5	28.1	13.8	16.9	22.7	16.6	38.8	11.4	11.9	22.0	8.6	32.1	9.7	13.6	12.4	23.1	10.5	10.6	7.6	73.8	13.7	14.1	8.9	3.0	26.6	28.7	26.8	38.9	13.8	27.3	13.2	34.6	11.9	15.3	15.8	6.5	25.8	32.5	13.3	32.3	19.1	12.0	11.4	2.9	0.4	0.2	1.2	6.3	7.1	4.1	11.1	4.8	6.8	6.4	89.2	0.1	39.5	7.6	11.6	21.9	0.0	5.2	6.4	8.1	0.0	2.3	10.2	0.2	0.9	0.0	4.6	1.5	26.4	5.7	38.6	13.0	196.6	2.4	2.1	35.0	1.8	7.1	0.4	4.4	2.0	0.4	4.9	0.2	0.1	0.1	2.0	17.5	4.8	0.0	3.1	3.7	1.4	0.9	14.9	1.2	237.1	1.9	11.0	1.9	0.1	2.6	4.0	0.1	5.8	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	12.7	11.5	12.5	11.4	11.9	13.6	12.4	13.7	13.2	15.8	12.0	229.3	0.0	5.8	1.6	0.3	9.4	0.9	0.0	4.6	0.2	1.4	2.0	13.2	5.7	0.7	1.8	0.0	0.7	0.4	0.0	0.0	0.1	1.0	0.3	0.4	127.1	0.0	2.7	0.9	0.0	0.1	8.1	0.0	0.5	0.0	0.2	182.0	4.1	1.7	0.0	1.2	0.0	0.0	6.5	4.4	2.8	2.5	0.7	3.6	15.9	0.0	0.7	0.0	1.0	0.1	0.0	0.0	3.0	0.1	0.6	0.5	0.2	0.0	0.6	6.6	3.9	9.4	1.8	2.3	2.2	7.7	0.3	0.8	3.6	0.2	1.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.2;liver: 25.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	13.9	44.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.6	0.0	0.2	0.2	0.0	0.6	48.2	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201038	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 24.4;liver: 18.9"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"CACO-2: 2.9;Hep G2: 10.7"									HPA011940	Approved		Approved	Centrosome		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.1	0.1	0.5	1.7	0.4	0.9	0.1	1.4	0.7	0.0	0.2	13.4	24.4	0.2	0.2	0.2	0.1	0.2	0.1	0.5	0.2	1.2	18.9	0.1	0.2	0.3	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.1	7.2	0.4	0.1	0.1	0.5	0.4	23.8	0.8	0.0	0.2	0.2	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.9	0.8	0.1	0.4	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	10.7	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.0	0.3	0.4	0.4	0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.6	0.6	0.1	0.6	0.3	0.2	0.1	0.0	0.6	0.3	0.8	0.8	0.2	0.3	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.4	0.2	0.3	1.6	0.5	0.2	0.3	0.1	0.1	0.5	0.4	1.4	0.7	0.5	0.2	0.3	0.1	0.4	0.0	0.4	1.1	0.3	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	81.9	0.0	0.1	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.1	7.4	0.0	0.0	0.0	14.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.3	0.0	0.0	0.2	88.9	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.5	0.1	26.3	0.4
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212927	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 207.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 204.9;monocytes: 290.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046801	Approved				"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	29.2	15.8	1.5	112.4	1.6	21.3	13.5	1.7	2.4	11.6	3.2	32.9	40.9	10.9	3.7	12.6	6.9	36.2	10.3	1.4	2.1	6.0	41.1	35.4	96.3	3.3	1.9	4.9	4.6	4.6	1.6	35.8	2.5	8.0	43.4	0.3	7.3	9.3	3.9	7.1	52.8	28.2	2.9	207.4	19.2	4.5	4.0	42.8	5.9	8.3	75.2	42.7	2.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	290.5	8.4	0.5	209.9	0.5	12.6	0.3	0.2	144.7	14.0	0.2	0.1	38.5	1.2	245.2	204.9	0.6	214.5	1.5	1.6	1.7	2.4	1.4	2.1	3.3	1.9	2.5	2.9	4.0	4.0	0.7	0.0	7.9	0.0	33.8	1.1	0.0	0.0	1.2	0.0	0.3	0.9	1.7	1.5	0.6	0.0	0.0	0.3	156.0	0.1	0.0	0.0	0.2	0.0	0.1	1.7	0.0	4.4	0.0	0.0	0.6	0.8	0.5	0.1	2.5	0.0	4.6	3.7	52.4	0.0	0.0	0.0	0.0	409.8	48.0	0.6	0.0	174.6	1.8	10.3	218.2	0.2	7.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	6.6	0.7	0.4	0.0	0.0	0.3	1.6	0.3	2.7	0.0	0.0	0.1
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB, P0"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309968	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Skeletal myocytes: 9.3"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"WM-115: 139.3"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 2.9;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	10	"spinal cord: 2142.4"	HPA068925	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	19.1	6.9	2.1	2.1	3.0	1.1	12.6	2.5	2.7	8.3	1.4	22.3	1.6	2.0	2.0	4.4	5.3	2.4	15.2	1.9	3.9	6.3	5.4	2.9	1.1	3.0	2.2	3.1	2.3	0.6	6.2	0.6	9.9	12.2	2.7	1.2	15.8	8.0	5.1	9.1	8.5	0.8	3.3	4.4	7.6	2.4	2.0	1.4	3.7	18.4	0.9	9.5	15.9	2.2	0.4	0.0	0.3	0.1	2.7	1.3	0.3	0.3	0.5	0.1	1.6	0.0	0.1	2.3	1.5	0.4	0.5	0.1	1.8	0.6	0.1	1.1	0.0	1.0	0.4	31.0	1.2	4.7	3.7	4.2	0.0	6.2	0.3	0.0	2.8	1.9	9.9	0.0	4.3	0.0	0.7	7.6	1.4	0.0	0.0	0.3	0.2	1.4	0.3	0.1	2.0	0.3	0.0	0.0	14.0	0.8	0.1	9.5	2.7	0.3	0.4	2.7	0.2	0.9	0.9	1.2	4.8	17.5	139.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	3.0	2.5	2.7	1.9	3.9	3.0	2.2	9.9	3.3	2.0	2.2	1.7	3.2	0.6	1.0	2.1	0.5	3.1	0.4	4.0	2.5	0.4	1.3	0.7	0.0	0.5	3.7	2.1	0.5	1.6	0.1	0.0	0.2	5.5	0.3	0.2	1.5	1.8	1.3	1.7	1.2	0.7	2.5	0.0	0.1	0.0	0.8	1.8	1.0	1.6	1.7	2.2	0.7	2.0	1.9	0.8	1.8	1.5	2.0	3.6	1.0	3.8	0.5	0.0	0.5	1.6	0.1	0.1	0.4	1.4	0.9	0.3	1.0	0.6	1.1	6.6	9.3	3.9	0.4	0.6	1.1	0.4	0.3	1.6	0.4	0.4	2.0
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 122.3"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 128.9;Hepatic stellate cells: 397.7;Hofbauer cells: 176.1;Kupffer cells: 361.4;Macrophages: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 19.3;TIME: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		170000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	54.4	28.7	0.8	24.0	1.7	0.7	16.3	0.3	3.5	17.2	9.2	16.1	9.9	7.2	1.7	13.1	11.9	27.7	10.2	1.1	0.7	7.6	40.9	122.3	15.2	1.4	0.9	6.2	8.1	4.6	1.5	54.3	1.1	2.2	18.5	0.1	4.9	8.0	1.8	2.8	17.5	30.3	0.7	50.6	9.7	7.5	2.8	8.0	5.5	8.7	3.0	29.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	19.3	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.8	1.7	0.3	3.5	1.1	0.7	1.4	0.9	1.1	0.7	2.8	1.3	4.0	32.1	43.5	1.3	3.5	0.4	0.0	0.0	0.0	0.0	128.9	1.7	3.6	11.5	7.4	0.0	0.0	0.9	1.0	1.4	0.0	0.1	27.3	0.0	0.1	39.0	0.0	3.2	0.8	0.4	1.4	2.5	0.0	0.1	13.9	0.1	397.7	13.1	176.1	0.0	1.3	0.9	0.0	361.4	46.8	19.4	1.5	316.5	0.0	60.9	0.5	0.0	0.0	0.5	0.5	0.1	1.5	0.0	1.0	0.0	2.2	0.1	5.8	0.0	32.9	3.0	2.2	0.4	2.3	1.2	0.4	2.1	4.7	1.7	0.8	0.1
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MRGPRX2	MRGX2	ENSG00000183695	"MAS related GPR family member X2"	Q96LB1	11	19054455-19060717	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skin 1: 1.0"	"Cell type enhanced"	"Detected in single"		"Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055220	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA055220: AB_2682743"						"unprognostic (1.56e-2)"											"unprognostic (1.79e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MRTFB	"FLJ31823, MKL2, MRTF-B"	ENSG00000186260	"Myocardin related transcription factor B"	Q9ULH7	16	14071319-14266773	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	170	"amygdala: 9.4;basal ganglia: 15.1;cerebral cortex: 21.4;hippocampal formation: 21.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011286	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA011286: AB_1853973"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.62e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.20e-4)"	"unprognostic (5.22e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.96e-2)"	21.4	7.3	9.4	8.6	15.1	3.8	18.3	0.0	21.4	19.0	0.0	9.9	9.7	14.9	9.1	14.5	14.0	13.3	11.8	21.7	0.0	8.4	5.9	13.2	7.6	0.0	0.0	7.1	12.1	22.2	4.9	21.7	0.0	15.5	10.8	8.6	11.6	15.2	11.9	16.6	7.9	15.6	0.0	5.1	10.1	17.5	0.0	10.3	16.9	14.5	8.1	11.3	12.2	0.0	17.6	17.8	17.8	13.2	5.9	11.0	8.0	4.9	13.3	7.4	10.6	7.7	16.4	9.4	12.4	8.4	9.3	13.8	12.9	14.4	13.5	23.1	7.0	6.0	13.6	13.3	8.2	4.2	5.4	8.4	14.6	12.8	8.3	7.8	14.7	12.2	7.9	9.7	5.6	15.1	13.4	2.8	6.0	4.7	4.8	20.5	13.7	8.1	7.3	17.3	6.2	10.8	23.9	10.2	4.9	8.2	18.0	3.5	9.4	15.3	14.9	4.4	6.4	6.6	8.8	8.4	16.6	7.1	11.7	0.2	0.5	0.0	1.1	0.7	1.7	3.7	1.9	0.9	0.7	1.5	2.4	1.3	0.3	1.1	0.8	1.7	0.9	0.6	9.4	15.1	0.0	21.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	9.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	10.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	10.4	0.4	0.0	0.0	0.0
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"intestine: 254.3"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 1139.3"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.2	0.0	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	234.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	254.3	0.0	0.0	0.5	0.0	0.0	0.3	4.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1139.3	0.0	0.0	0.4	0.1	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.6	0.1	27.8	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.6"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.6	0.2	0.3	2.4	0.3	0.9	2.7	0.5	0.5	6.3	0.6	4.9	5.5	4.2	3.7	4.8	0.9	8.2	0.6	0.3	0.3	0.5	0.4	12.6	1.1	0.4	0.3	0.1	0.5	0.3	0.1	0.3	0.4	3.0	5.4	0.0	1.8	2.4	2.9	2.5	6.7	4.1	0.3	0.2	5.3	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.3	0.5	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MS4A4A	"CD20L1, MS4A4, MS4A7"	ENSG00000110079	"Membrane spanning 4-domains A4A"	Q96JQ5	11	60185657-60318080	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 63.1"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 376.8;Kupffer cells: 445.0;Macrophages: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 61.2;myeloid DC: 27.6;non-classical monocyte: 82.9;plasmacytoid DC: 27.7"	"Group enriched"	"Detected in many"	30	"dendritic cells: 27.7;monocytes: 82.9"	"Cell line enhanced"	"Detected in some"		"HEL: 35.6;HMC-1: 45.8;K-562: 154.9"									HPA029323	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"			"HPA029323: AB_10601866"	"unprognostic (7.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.56e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.21e-2)"	42.8	24.7	3.5	16.5	3.6	6.1	12.3	3.7	8.6	14.1	4.4	14.0	5.2	4.9	3.4	8.9	11.6	25.8	8.4	3.5	3.9	4.8	15.4	28.0	31.3	4.2	3.4	4.1	4.0	3.3	3.3	63.1	3.6	3.4	16.1	2.0	7.6	4.9	2.3	2.9	13.5	20.0	2.5	33.3	6.6	3.0	5.5	11.5	3.7	10.4	7.5	28.0	3.3	4.3	0.3	0.1	0.1	0.6	0.0	0.2	0.7	0.6	0.0	0.2	0.4	0.3	0.9	0.8	0.4	0.0	0.4	0.3	0.5	0.1	0.6	1.6	0.0	35.6	0.7	0.6	0.1	1.2	45.8	0.4	0.3	0.2	0.8	0.2	0.0	0.4	154.9	4.2	0.6	0.7	0.6	0.9	0.7	0.3	0.1	0.7	0.0	2.5	0.1	1.5	0.5	0.5	0.3	0.3	0.1	0.7	0.7	8.9	0.8	1.5	0.6	0.4	0.2	6.0	0.7	0.5	0.2	0.8	0.2	0.1	9.9	0.0	0.1	61.2	0.2	1.0	0.1	0.1	27.6	0.3	0.2	0.1	0.9	1.8	82.9	27.7	0.1	6.0	3.5	3.6	3.7	8.6	3.5	3.9	4.2	3.4	3.6	2.5	5.5	4.3	2.3	0.0	7.9	0.0	3.0	1.8	0.1	0.0	0.6	0.0	0.3	2.2	3.4	2.8	2.5	0.0	0.0	1.8	7.5	0.0	0.0	0.0	0.7	0.0	0.0	5.7	0.0	13.0	0.1	0.0	2.0	1.6	0.0	0.0	7.6	0.0	47.5	4.6	376.8	0.0	0.1	0.0	0.0	445.0	24.9	1.0	0.9	264.6	3.6	10.3	8.3	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	13.1	1.2	1.1	0.1	0.2	0.7	1.8	3.6	1.5	0.1	0.0	0.1
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 580.8;Hofbauer cells: 376.8;Kupffer cells: 1649.6;Langerhans cells: 470.0;Macrophages: 675.9;monocytes: 429.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 406.4;classical monocyte: 1095.3;intermediate monocyte: 345.6;myeloid DC: 638.8;plasmacytoid DC: 454.4"	"Group enriched"	"Detected in all"	74	"dendritic cells: 638.8;granulocytes: 406.4;monocytes: 1095.3"	"Cell line enriched"	"Detected in some"	8	"THP-1: 47.9"									"HPA011391, HPA076623"	Approved		Approved	Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA011391: AB_10603876, HPA076623: AB_2686809"	"unprognostic (1.17e-1)"	"prognostic favorable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	72.6	42.3	10.7	57.5	10.9	33.5	40.0	10.8	22.5	28.1	14.7	41.0	27.8	14.3	9.6	25.7	16.8	61.4	22.8	10.0	11.8	11.5	108.6	56.4	109.1	15.8	13.7	12.3	7.8	8.7	9.8	65.2	14.8	12.4	54.9	1.4	16.0	18.3	5.3	7.3	45.1	52.6	12.4	121.5	24.5	7.8	13.6	32.2	10.0	17.7	47.6	59.9	8.6	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.1	0.0	406.4	1095.3	8.2	1.6	345.6	3.4	9.6	2.2	1.4	638.8	1.5	1.0	1.0	72.8	2.1	24.4	454.4	1.9	752.8	10.7	10.9	10.8	22.5	10.0	11.8	15.8	13.7	14.8	12.4	13.6	17.6	5.3	6.4	22.9	0.0	16.1	9.3	0.6	0.0	1.2	0.3	2.2	8.0	3.3	17.2	2.5	3.7	0.0	2.0	220.6	0.3	0.0	0.0	2.2	0.4	0.2	12.8	0.0	43.9	0.1	0.0	2.7	4.3	2.6	0.2	13.9	0.1	580.8	20.5	376.8	0.0	0.1	0.1	0.0	1649.6	470.0	5.1	1.5	675.9	14.2	40.3	429.2	0.0	11.3	0.5	0.1	0.0	1.2	0.0	2.0	0.2	0.0	0.5	1.5	0.6	46.0	3.0	4.4	0.5	1.1	2.4	8.0	2.1	10.4	0.1	0.2	0.3
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378485-60395951	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 196.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 311.4;Kupffer cells: 1060.3;Macrophages: 567.5;monocytes: 184.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 747.4;non-classical monocyte: 1486.0"	"Lineage enriched"	"Detected in many"	12	"monocytes: 1486.0"	"Cell line enriched"	"Detected in some"	25	"THP-1: 114.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA017418, CAB026387"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	46.9	37.6	6.3	50.9	5.0	10.7	30.7	4.5	13.7	18.2	13.9	21.4	17.6	7.6	4.1	12.7	6.6	46.8	9.9	4.2	8.7	8.0	66.5	75.7	23.2	12.8	10.4	6.0	6.0	9.0	4.7	43.9	11.4	4.9	23.3	1.2	6.7	9.0	1.9	2.3	25.1	15.9	7.4	196.6	14.8	4.7	17.1	18.2	7.3	4.1	18.6	41.2	3.9	18.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.1	1.1	0.1	0.1	0.0	2.8	0.0	0.1	0.1	0.8	0.5	0.0	0.0	114.2	0.0	0.1	0.1	0.1	0.1	0.2	0.2	3.0	0.0	3.1	0.0	8.3	188.0	2.5	0.8	747.4	1.1	22.3	0.6	0.5	120.9	19.7	0.8	0.4	9.3	0.8	1486.0	3.2	0.9	137.8	6.3	5.0	4.5	13.7	4.2	8.7	12.8	10.4	11.4	7.4	17.1	18.3	5.0	12.8	31.4	0.0	30.6	2.7	0.8	0.0	0.6	3.6	14.7	9.9	2.1	0.0	3.7	9.2	0.0	1.0	1.4	0.3	0.0	0.0	2.4	0.1	0.0	12.2	0.0	10.1	0.1	0.2	1.7	3.9	1.5	0.1	13.9	0.1	11.0	4.7	311.4	0.0	0.2	0.0	0.0	1060.3	93.4	1.2	1.2	567.5	1.8	59.0	184.8	0.4	4.1	0.0	0.3	0.1	1.1	0.0	1.8	1.1	0.0	0.7	7.3	0.5	19.7	2.2	1.2	0.0	0.4	0.9	1.8	1.9	5.3	0.3	0.1	1.0
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699585-60715807	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 129.7;intestine: 197.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 376.4;Enteroendocrine cells: 473.4;Ionocytes: 140.4;Proximal enterocytes: 694.6;Respiratory ciliated cells: 502.8"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.9;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007319	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.0	0.8	1.6	3.5	1.3	0.0	0.0	0.0	1.1	25.6	5.4	18.2	189.8	8.2	0.0	0.3	129.7	10.8	0.0	0.6	0.4	0.1	0.0	16.6	0.2	0.0	0.2	0.3	2.2	0.7	7.5	0.1	0.0	1.7	16.9	0.0	0.6	7.1	4.6	0.0	197.7	1.0	0.0	0.0	45.7	0.5	0.9	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	0.0	1.1	0.6	0.4	0.0	0.2	0.0	0.0	0.9	0.0	0.0	6.4	6.4	0.0	0.2	0.0	0.2	11.9	0.0	0.0	0.0	0.0	0.3	18.6	58.8	1.8	0.0	0.0	0.0	15.0	0.0	0.3	1.3	376.4	3.2	0.3	473.4	0.0	0.4	2.5	0.0	2.0	14.3	11.6	1.3	0.0	0.0	0.0	0.0	0.0	0.1	42.5	140.4	0.0	0.0	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	46.1	0.0	0.0	1.7	694.6	0.2	502.8	0.0	0.0	0.0	3.5	0.3	0.7	0.0	0.0	0.0	0.5	0.2	24.7	0.4
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938229-1943293	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 234.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1414.9;neutrophil: 3051.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 3051.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	28.1	15.1	26.2	31.8	27.3	96.3	21.3	27.8	28.4	17.5	25.8	36.7	29.4	29.5	11.2	45.3	33.5	23.2	47.3	25.6	26.8	80.3	234.2	30.4	17.7	29.3	28.0	16.4	149.6	14.8	14.5	13.2	27.1	32.0	17.4	2.7	16.5	29.2	76.0	31.1	27.5	36.8	27.5	67.0	33.3	17.7	28.5	13.7	12.5	93.6	12.2	40.8	20.1	27.1	23.6	59.1	21.3	50.4	39.9	17.0	36.4	27.8	36.0	41.2	35.6	96.2	25.5	22.7	90.6	33.5	36.0	37.9	36.3	25.2	12.8	127.7	41.1	17.5	20.5	154.9	36.1	49.3	40.3	32.0	21.9	29.6	6.0	12.9	41.9	28.8	28.2	12.3	22.3	131.2	28.2	82.7	29.2	42.7	33.5	40.3	29.3	106.0	66.0	37.2	20.5	26.9	32.3	35.6	17.3	13.9	38.7	87.9	24.8	12.3	33.7	24.3	16.7	32.0	53.4	42.4	12.5	47.4	22.0	493.5	412.0	1414.9	31.9	194.8	32.2	28.0	26.5	26.7	171.2	28.3	20.5	22.7	3051.8	42.2	182.9	73.2	45.9	226.7	26.2	27.3	27.8	28.4	25.6	26.8	29.3	28.0	27.1	27.5	28.5	27.1	24.9	9.6	13.4	3.9	10.0	6.5	9.1	21.5	8.0	6.5	27.9	21.3	36.1	32.9	14.9	33.1	4.2	33.3	12.3	69.1	93.9	65.9	5.9	23.9	13.4	15.4	60.3	21.5	0.8	111.2	121.4	13.7	11.7	17.0	4.5	12.2	20.7	275.6	63.5	8.4	1.2	38.6	34.6	59.2	21.2	13.9	9.3	37.9	16.0	2.8	178.7	22.5	25.7	1.5	2.9	66.0	62.8	23.0	13.0	16.3	97.3	496.8	37.9	4.2	0.0	8.1	22.8	28.9	8.7	11.1	9.5	38.6	10.6	14.8	33.5	21.9
MSRB2	"CBS-1, CBS1, CGI-131, MSRB, PILB"	ENSG00000148450	"Methionine sulfoxide reductase B2"	Q9Y3D2	10	23095579-23122013	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 269.1;Proximal tubular cells: 463.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027933	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA027933: AB_10601867"	"unprognostic (4.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.07e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	16.2	17.3	29.0	6.6	30.8	7.7	11.0	29.5	40.5	13.2	26.8	22.7	9.4	15.8	16.8	10.8	17.6	7.7	61.6	29.5	32.2	19.0	31.0	9.8	3.9	30.4	30.9	11.9	5.4	23.1	14.4	8.2	30.5	14.3	11.4	13.1	9.1	19.5	42.2	5.5	11.9	16.3	29.1	9.3	11.4	3.9	30.8	8.4	14.1	51.7	4.1	17.1	11.0	29.4	7.3	10.4	19.0	11.6	19.3	17.3	5.7	11.5	6.4	7.2	8.3	7.2	15.5	5.9	10.0	24.6	10.9	4.6	6.3	8.6	5.9	40.3	7.0	4.3	17.7	4.1	27.2	0.9	5.0	22.2	14.3	8.4	2.0	15.7	10.4	11.5	5.9	10.3	16.0	21.9	7.0	5.5	10.5	41.4	6.0	8.0	10.9	1.5	9.1	2.8	3.8	26.1	14.2	12.4	23.9	15.9	8.4	17.1	7.7	6.2	5.8	14.0	6.9	13.3	4.4	0.2	8.8	12.7	5.3	0.9	1.4	2.3	0.3	1.1	0.3	0.2	0.3	0.2	0.8	0.0	0.6	0.4	3.4	0.2	0.8	1.6	0.4	0.2	29.0	30.8	29.5	40.5	29.5	32.2	30.4	30.9	30.5	29.1	30.8	29.4	29.0	0.0	16.4	27.1	11.4	18.2	52.1	33.1	59.2	68.2	69.6	79.1	269.1	80.1	21.1	90.1	22.9	116.1	10.6	86.7	176.1	130.4	1.4	49.3	71.6	34.4	55.7	30.7	9.5	63.4	61.2	70.7	23.4	46.5	29.2	114.0	42.1	195.4	109.6	112.7	16.9	54.8	26.4	70.5	25.1	4.4	49.7	54.2	72.9	11.2	29.7	126.6	7.2	14.6	26.1	90.3	79.6	62.4	24.7	34.9	80.8	463.9	24.3	57.5	59.2	52.6	71.6	4.4	7.7	66.7	17.5	69.6	13.5	60.9	71.0	54.3
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 2801.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 41.6"	"Lineage enhanced"	"Detected in many"		"granulocytes: 41.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 126.1;hTERT-RPE1: 110.6;U-937: 106.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	44.9	10.7	12.9	20.9	13.6	21.2	26.3	12.5	12.8	29.5	18.8	108.0	11.9	85.8	20.1	63.0	41.4	33.2	90.8	11.9	18.3	10.1	3.8	30.6	5.7	15.9	15.2	16.9	5.8	3.2	6.8	25.2	13.8	52.7	27.8	12.5	10.8	103.0	104.0	9.7	25.6	123.9	14.6	13.6	36.2	5.8	18.2	4.1	14.5	69.2	3.9	60.9	23.7	11.8	8.8	19.2	16.4	75.9	71.6	63.0	0.5	87.0	92.9	33.2	19.8	0.7	1.0	0.0	18.3	126.1	10.5	1.9	7.7	22.1	30.0	0.2	15.9	0.0	16.7	0.9	46.6	47.1	0.3	33.4	11.9	28.1	39.0	110.6	68.2	0.1	0.3	0.3	76.8	2.9	0.0	11.0	5.4	0.2	10.4	0.2	22.0	0.5	7.5	1.0	0.4	7.9	30.0	1.8	21.9	16.8	14.1	44.5	78.9	42.3	22.8	19.5	34.2	8.0	6.7	0.2	11.5	106.7	26.9	15.0	0.6	41.6	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.3	0.2	0.2	6.8	8.3	0.4	10.8	0.1	1.4	12.9	13.6	12.5	12.8	11.9	18.3	15.9	15.2	13.8	14.6	18.2	11.8	55.3	12.8	3.4	76.7	0.8	6.4	16.4	11.4	4.0	22.7	2.2	45.3	2801.7	4.3	1.2	3.7	0.0	0.4	8.3	0.0	0.0	9.3	5.7	0.9	16.7	154.2	0.0	17.4	37.1	1.0	0.4	108.8	1.1	0.4	2.5	7.4	28.2	0.2	0.5	21.9	56.6	0.0	0.0	0.0	13.7	2.2	12.5	4.0	10.6	62.8	1.6	44.4	2.1	37.7	1.4	1.6	0.0	116.6	0.3	14.8	0.0	0.4	6.8	10.6	105.2	37.7	218.7	4.2	4.7	0.8	4.5	0.7	2.4	10.3	0.0	2.9
MSTN	GDF8	ENSG00000138379	Myostatin	O14793	2	190055700-190062729	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Cytokine, Growth factor, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 10.1;tongue: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.7;Cone photoreceptor cells: 4.2;Early spermatids: 17.8;Late spermatids: 4.2;Muller glia cells: 19.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"LHCN-M2: 25.9;RH-30: 52.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB009963	Approved				"Secreted in other tissues"	NA	NA		7600000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB009963: AB_2148798"	"unprognostic (8.45e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.86e-4)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-3)"	"unprognostic (7.72e-3)"	"unprognostic (1.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.67e-4)"	0.4	0.9	0.6	0.0	0.6	0.0	0.3	0.7	0.9	1.2	0.1	0.6	0.2	0.8	0.5	1.1	0.3	0.1	0.3	0.7	0.5	0.5	0.1	0.2	0.0	0.6	0.6	0.4	0.2	0.0	0.6	0.0	0.6	0.4	0.4	3.1	0.4	0.1	10.1	0.5	0.2	0.3	0.4	0.2	0.2	0.3	0.5	0.0	0.4	15.3	0.0	0.2	0.5	0.5	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.9	0.7	0.5	0.6	0.6	0.6	0.4	0.5	0.5	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.1	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	17.8	0.1	0.1	0.1	0.0	0.0	1.4	0.2	0.0	1.4	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	19.1	0.0	0.5	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.7	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 488.0;liver: 430.8"	"Group enriched"	"Detected in many"	6	"Adipocytes: 797.9;Fibroblasts: 244.1;Hepatocytes: 343.8;Skeletal myocytes: 561.9;Smooth muscle cells: 889.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 33.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.4;ASC TERT1: 27.9;HHSteC: 19.7;HMC-1: 29.5;hTEC/SVTERT24-B: 80.2;NTERA-2: 40.1"					"Low region specificity"	"Detected in single"			"CAB002161, CAB013056"	Approved					NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	488.0	64.3	9.8	10.8	12.3	0.0	208.1	9.8	14.1	62.0	8.2	28.9	7.7	13.6	1.3	33.4	68.7	30.2	63.3	9.3	10.7	136.8	430.8	115.2	0.6	10.6	10.8	19.8	90.3	2.1	25.9	0.7	11.7	33.1	13.1	4.4	18.9	2.9	100.0	26.1	23.4	16.9	11.5	3.4	42.9	8.4	10.8	6.1	67.7	6.1	0.7	34.0	22.6	9.7	0.0	6.2	0.0	0.1	18.4	27.9	0.4	1.9	7.9	1.2	1.5	2.3	4.8	0.0	2.4	1.1	0.0	0.5	0.0	0.4	2.9	0.0	0.0	0.0	2.5	9.9	19.7	0.2	29.5	8.2	0.0	80.2	0.0	0.0	7.7	0.0	0.7	0.0	5.5	0.0	0.0	0.1	40.1	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.9	0.0	0.3	6.3	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	9.8	12.3	9.8	14.1	9.3	10.7	10.6	10.8	11.7	11.5	10.8	9.7	797.9	9.6	1.7	0.7	1.8	27.4	11.3	1.9	5.7	0.0	11.7	15.4	5.4	8.6	5.1	0.0	0.0	1.1	1.0	11.1	13.7	2.7	0.1	11.9	6.9	63.2	3.6	29.5	0.0	1.8	12.8	244.1	5.1	23.8	3.8	0.3	15.7	343.8	0.3	0.0	0.0	32.3	0.0	10.4	39.6	0.7	55.0	12.4	33.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.6	12.8	1.2	27.9	86.5	16.1	3.0	0.0	26.3	561.9	889.5	0.0	0.3	2.1	19.5	0.5	6.6	0.4	34.7	13.7
MT1M	"MT1, MT1K"	ENSG00000205364	"Metallothionein 1M"	Q8N339	16	56632659-56633981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 398.9;liver: 562.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1333.5;Distal enterocytes: 906.4;Glandular and luminal cells: 1180.5;Hepatocytes: 1549.5;Paneth cells: 1204.8;Proximal enterocytes: 933.2;Smooth muscle cells: 680.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 181.8"															NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.83e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.19e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (4.67e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.71e-2)"	398.9	27.7	214.3	32.8	233.5	0.1	145.6	240.4	316.0	31.2	183.0	134.0	21.2	14.8	4.1	83.4	95.4	42.6	36.6	207.3	219.5	47.6	562.4	116.5	4.5	225.3	226.8	16.1	145.8	2.6	10.4	2.7	232.6	57.5	140.9	24.7	31.5	6.7	48.2	44.6	113.6	37.3	217.6	7.7	98.5	3.9	246.4	5.2	64.3	4.0	2.5	33.4	26.1	213.6	0.0	0.0	0.0	0.0	39.1	27.3	0.5	1.2	9.9	1.2	2.4	0.4	0.6	0.0	7.9	6.3	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.2	0.1	3.1	0.0	14.8	0.0	23.7	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.2	13.4	0.0	1.3	0.0	0.1	0.2	181.8	0.0	0.2	0.5	0.0	0.0	0.0	1.7	0.0	2.7	5.5	0.1	0.0	1.8	0.0	0.1	0.0	0.2	4.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	214.3	233.5	240.4	316.0	207.3	219.5	225.3	226.8	232.6	217.6	246.4	213.6	1333.5	12.8	7.2	49.6	9.3	27.5	19.0	3.1	27.9	0.0	13.7	52.7	7.9	121.5	6.0	14.7	0.0	0.3	4.9	906.4	37.2	58.9	0.1	413.6	114.7	141.3	32.7	131.0	0.1	117.0	70.5	308.1	25.5	1180.5	15.9	11.9	82.8	1549.5	1.7	0.0	0.1	397.5	0.0	65.9	39.9	1.5	47.8	35.2	88.9	5.6	24.3	0.0	0.0	6.0	0.3	64.1	1204.8	12.0	29.4	152.4	933.2	258.6	5.2	0.0	78.9	587.1	680.1	0.0	0.5	4.7	20.2	1.0	15.5	1.2	559.6	7.9
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 485.8;stomach 1: 1064.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1370.0;Collecting duct cells: 491.1;Exocrine glandular cells: 1164.9;Gastric mucus-secreting cells: 640.6;Pancreatic endocrine cells: 1074.8;Respiratory ciliated cells: 555.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 1146.1;OE19: 548.3;RPTEC TERT1: 870.2;T-47d: 383.6"	"Not detected"	"Not detected"							"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	15.2	6.3	5.3	21.9	5.7	9.4	78.2	4.7	8.6	194.2	4.7	176.0	21.4	40.2	61.6	209.9	120.0	125.8	6.8	5.1	5.7	485.8	3.9	321.5	1.8	7.8	6.3	9.8	358.5	1.0	14.1	3.3	6.0	43.9	103.6	1.3	135.0	34.4	1.9	20.6	35.2	20.0	6.1	5.4	1064.7	47.9	6.8	1.2	54.8	0.7	18.8	102.0	50.0	5.2	15.3	8.2	5.1	4.8	3.9	4.2	1.7	5.6	12.2	6.2	15.2	0.2	1146.1	0.0	81.9	9.5	2.7	23.2	1.0	0.3	1.8	10.4	0.8	1.8	101.5	0.0	2.4	0.4	36.1	9.5	2.1	2.8	2.2	12.7	2.1	1.9	9.2	15.4	4.3	120.0	1.6	1.2	3.5	548.3	2.1	2.3	0.6	29.3	870.2	0.9	5.1	2.1	28.0	48.3	1.5	4.1	383.6	5.6	2.2	3.9	6.7	10.5	1.2	17.7	9.8	0.2	5.9	1.1	1.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.2	0.1	5.3	5.7	4.7	8.6	5.1	5.7	7.8	6.3	6.0	6.1	6.8	5.2	2.3	432.7	1370.0	5.9	6.4	0.6	18.5	126.4	0.0	1.3	219.2	48.5	0.4	327.5	374.9	491.1	4.2	0.5	1.5	271.8	35.2	177.3	32.7	245.2	28.8	8.0	30.6	1.3	0.3	1164.9	1.1	7.0	640.6	282.8	48.0	0.3	1.8	0.9	0.2	1.7	0.3	351.5	164.8	2.2	1.0	81.0	2.5	7.2	5.4	1.0	24.3	1.7	0.0	0.5	0.1	1074.8	60.5	1.5	1.3	16.3	6.8	1.3	555.3	0.2	0.0	2.0	22.0	5.8	0.8	3.5	1.1	0.3	10.3	0.1	220.8	154.5
MUC12	MUC11	ENSG00000205277	"Mucin 12, cell surface associated"	Q9UKN1	7	100969623-101018949	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 67.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1187.9;Intestinal goblet cells: 132.3;Paneth cells: 550.8;Undifferentiated cells: 265.8"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 13.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA023835	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023835: AB_1854199"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.33e-7)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	49.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	67.9	0.0	0.0	0.1	0.0	0.0	2.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	8.2	3.8	13.1	2.2	0.0	0.0	0.1	0.0	2.7	0.0	2.7	1.8	0.0	0.4	1.4	1187.9	0.0	7.9	13.0	17.2	16.6	1.2	47.5	0.0	3.0	2.8	2.2	15.6	9.2	0.6	8.9	1.6	0.7	0.1	1.9	0.0	0.7	132.3	4.1	1.6	16.0	5.7	0.9	4.0	3.6	1.0	0.0	0.0	0.0	0.0	0.3	8.3	550.8	3.4	2.8	9.5	53.1	0.2	15.7	0.0	0.0	2.2	4.4	11.5	3.8	0.1	3.0	0.5	5.7	5.3	265.8	5.3
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 614.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 853.2;Intestinal goblet cells: 418.5;Paneth cells: 641.9;Proximal enterocytes: 422.5;Undifferentiated cells: 207.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"OE19: 220.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045163, HPA079663"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045163: AB_10960396, HPA079663: "	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavorable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.8	0.8	0.0	62.0	0.0	0.1	0.5	0.0	0.1	0.8	0.0	304.6	614.6	1.5	0.0	0.8	2.8	47.9	0.1	0.0	0.0	17.5	3.7	0.3	0.4	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.3	2.1	301.3	0.0	0.0	0.8	0.0	0.1	503.8	10.9	0.0	0.1	35.3	0.3	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.1	6.4	13.6	0.0	0.8	0.2	0.1	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.1	0.0	0.0	1.0	0.0	220.9	1.1	0.0	0.1	2.7	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	25.8	0.8	0.0	0.0	0.0	0.0	853.2	0.0	24.7	0.9	120.0	1.5	0.4	153.8	0.0	0.1	31.4	0.0	0.0	36.7	6.1	8.9	0.0	0.0	0.0	0.0	0.0	0.2	418.5	0.0	0.3	0.0	4.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.8	641.9	0.7	0.0	1.5	422.5	7.7	10.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	1.5	0.0	207.9	1.4
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058859	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	62	"intestine: 42.7"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 320.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031634	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	42.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.9	14.8	0.0	0.0	0.1	320.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	22.0	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	12	"intestine: 133.8"	"Cell type enriched"	"Detected in some"	12	"Intestinal goblet cells: 745.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 93.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			CAB016275	Enhanced				"Intracellular and membrane"	NA	NA						"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.6	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.8	31.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	91.7	0.0	0.0	0.5	0.0	0.0	79.9	4.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.0	0.0	0.0	60.3	0.0	0.3	0.0	0.1	0.0	0.6	14.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	745.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	31.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	34.3	0.0
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195811973	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 19.2;intestine: 31.1;prostate: 14.8;vagina: 15.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 3.4"	"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	5.4	0.0	31.1	0.0	0.0	0.0	19.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.8	0.0	7.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	1.2	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	6.4	15.6	0.3	2.1	0.0	18.5	82.1	0.6	0.0	25.7	2.9	2.5	0.0	193.7	0.0	0.0	0.1	0.3	185.1	0.0	1.6	3.5	6.2	0.2	0.7	16.4	0.0	0.9	5.2	4.3	0.6	163.1	5.1	2.5	0.1	0.0	0.0	0.1	0.0	1.0	193.3	40.7	0.0	0.0	0.7	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	37.5	64.3	0.4	0.8	12.4	1.1	0.2	336.1	0.0	0.0	0.5	11.1	2.1	1.9	0.4	0.0	0.1	1.2	2.3	174.5	319.4
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"salivary gland: 2621.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 443.2;Distal enterocytes: 158.4;Intestinal goblet cells: 210.1;Undifferentiated cells: 183.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 113.9;PC-3: 120.0"	"Not detected"	"Not detected"							"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		1300000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.7	0.2	2.0	0.1	0.0	1.3	0.0	0.4	229.4	0.0	58.0	0.1	0.3	0.0	101.0	1.1	221.3	0.1	0.0	0.0	0.1	2.4	7.5	0.0	0.1	0.0	0.1	9.8	0.0	0.4	0.0	0.0	0.6	17.1	0.0	2621.9	0.0	0.3	0.4	2.6	0.6	0.0	0.0	6.9	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	17.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.2	0.0	113.9	120.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	2.3	0.0	0.0	6.7	0.6	0.0	6.4	4.3	12.4	443.2	64.0	0.0	0.0	0.1	0.0	158.4	0.0	0.9	0.0	1.4	0.8	0.9	24.5	0.0	0.1	0.0	0.1	1.1	12.8	7.2	4.5	0.0	0.0	1.2	0.2	0.0	0.0	210.1	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	53.4	0.0	1.4	1.3	0.1	0.2	24.5	0.0	0.0	0.0	3.0	0.0	0.5	1.6	0.0	0.1	0.7	0.1	183.1	1.1
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 203.7;Muller glia cells: 365.7;Rod photoreceptor cells: 163.8;Theca cells: 218.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 663.8"									"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	189.2	244.3	111.9	53.4	175.1	13.5	133.5	114.5	136.5	149.4	263.7	310.7	37.5	268.3	208.8	157.0	181.0	103.6	526.4	123.4	118.4	83.0	29.9	124.9	31.8	130.3	122.7	185.4	90.3	235.7	48.8	102.8	125.3	154.3	76.1	514.6	62.0	314.8	68.8	73.0	89.4	284.4	122.1	149.7	124.0	115.7	115.4	44.6	272.1	75.9	33.3	250.5	123.1	120.4	19.1	56.1	82.4	155.3	424.0	384.4	41.0	263.8	212.8	188.8	182.8	75.1	2.9	0.5	116.8	368.0	196.8	75.7	92.5	146.5	306.4	1.4	91.7	48.7	39.2	126.8	258.4	22.9	5.9	241.1	171.2	219.3	178.7	421.8	282.0	12.3	35.2	1.2	440.8	5.3	2.9	15.9	26.5	30.0	156.7	43.2	322.2	16.5	153.1	4.8	28.8	207.3	78.5	1.0	152.6	231.6	51.5	29.3	348.5	422.7	90.1	174.3	282.6	24.5	4.9	1.4	663.8	9.9	62.5	1.3	2.8	0.5	4.0	0.8	3.1	2.3	2.1	4.5	2.1	0.4	1.3	2.9	1.1	5.4	0.3	2.4	0.5	3.4	111.9	175.1	114.5	136.5	123.4	118.4	130.3	122.7	125.3	122.1	115.4	120.4	128.3	16.0	14.6	8.5	2.0	10.3	27.0	15.0	13.6	142.0	9.4	42.5	117.3	2.8	10.3	31.3	95.9	1.4	62.6	1.3	1.9	25.5	3.5	48.7	203.7	56.1	6.7	0.8	19.3	4.1	8.1	97.2	2.0	63.9	2.5	64.7	52.5	4.2	3.5	111.0	27.9	7.5	10.2	5.0	13.3	12.4	101.2	7.4	14.2	10.3	1.3	365.7	6.2	15.1	8.9	6.5	0.3	143.3	11.0	21.2	1.6	8.1	10.2	163.8	13.1	132.1	83.6	2.3	10.7	6.0	8.8	0.8	19.7	218.5	1.5	21.1
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53864763-53876435	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 207.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056301			Approved	"Nuclear speckles"		NA	NA		27000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	179.4	25.7	21.5	66.5	20.2	196.3	82.4	3.1	21.6	97.4	24.6	155.6	48.9	248.6	22.2	76.8	146.5	124.6	92.3	16.7	22.2	19.8	46.4	110.7	37.2	16.9	24.7	73.4	101.1	31.1	17.9	89.6	13.7	75.0	39.9	3.6	48.8	100.9	36.7	45.2	63.8	180.9	6.4	42.5	79.5	28.4	17.3	37.1	57.8	21.1	15.2	104.6	64.8	18.8	28.8	231.6	29.2	23.3	96.2	66.0	45.3	145.9	105.9	57.0	58.7	94.4	84.1	2.6	53.7	187.4	61.6	56.4	14.6	56.7	48.5	34.9	34.2	38.0	35.8	75.6	219.2	78.4	131.3	72.3	12.7	73.4	10.5	93.4	52.0	14.9	41.5	68.7	36.4	32.0	21.4	60.9	27.9	104.3	65.3	82.1	31.0	13.3	63.8	3.0	0.4	43.8	1.2	44.6	14.1	58.4	44.4	66.8	105.5	125.8	44.5	17.0	66.2	44.7	29.9	0.6	78.4	37.1	2.1	74.3	48.1	165.5	20.9	27.1	19.6	5.4	13.4	15.2	59.5	7.1	12.5	11.0	207.4	17.8	23.5	22.3	5.4	20.0	21.5	20.2	3.1	21.6	16.7	22.2	16.9	24.7	13.7	6.4	17.3	18.8	125.9	163.5	59.1	2.9	138.9	103.0	173.3	73.1	96.8	4.1	141.0	105.8	67.1	97.2	91.5	20.2	4.2	46.2	143.3	43.8	0.0	106.6	2.7	97.0	164.1	117.2	202.4	35.7	9.1	51.8	243.9	279.7	83.1	195.5	347.6	27.0	182.8	18.5	73.5	10.1	8.3	203.9	24.4	120.4	217.2	2.2	90.1	180.3	60.5	11.2	68.0	4.0	19.6	7.1	13.9	71.4	54.7	116.6	189.9	56.6	2.7	0.5	57.0	1.4	151.2	340.1	199.0	35.9	14.5	19.7	59.8	49.5	221.5	20.5	93.8	75.0
MYBL2	"B-MYB, BMYB"	ENSG00000101057	"MYB proto-oncogene like 2"	P10244	20	43667019-43716495	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;lymphoid tissue: 55.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 295.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 91.5"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 91.5"	"Cell line enhanced"	"Detected in many"		"MCF7: 763.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017114, HPA030530, HPA055416"	Uncertain		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811"	"unprognostic (9.75e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.20e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.11e-7)"	"unprognostic (2.66e-3)"	"unprognostic (9.23e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	1.6	0.6	0.1	24.2	0.1	91.8	1.6	0.1	0.2	1.1	0.2	8.6	7.0	1.4	0.1	10.1	0.4	1.0	0.4	0.1	0.1	0.6	1.1	1.8	55.5	0.1	0.1	0.3	11.2	0.1	0.2	5.7	0.1	0.5	6.9	0.0	1.6	0.2	0.1	4.2	7.8	2.1	0.1	27.8	6.1	15.6	0.4	33.3	0.5	0.0	53.5	3.5	2.5	0.1	195.8	121.8	105.4	109.6	1.0	3.5	136.2	87.0	29.0	265.6	194.6	600.2	118.8	393.6	49.2	37.8	55.8	116.1	192.1	59.6	98.8	74.2	124.1	183.2	118.7	164.2	0.2	168.6	121.7	2.4	5.1	101.6	22.9	5.9	72.2	189.6	188.1	470.3	23.8	763.7	346.0	236.3	121.8	155.4	105.4	237.3	216.3	222.1	49.6	39.7	96.7	140.6	255.6	253.3	26.1	110.4	167.2	183.1	34.0	16.3	264.3	118.3	151.5	162.1	363.8	606.5	34.2	142.3	103.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.2	0.0	91.5	1.3	0.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	33.0	4.2	0.8	0.8	0.0	0.0	2.5	3.4	2.0	1.5	0.1	0.0	0.0	14.4	32.6	3.4	0.0	0.4	5.9	0.9	1.3	1.8	0.0	82.3	0.4	0.9	32.3	4.8	10.2	2.9	0.0	18.9	0.7	1.4	13.5	0.0	0.3	5.1	0.0	2.4	2.6	14.1	0.0	3.2	1.8	0.0	0.0	0.0	1.0	0.0	0.5	0.7	1.1	0.0	139.6	0.3	0.5	0.0	0.0	0.0	0.0	0.1	3.9	7.0	33.6	8.2	2.4	3.7	3.0	1.2	8.6	2.4
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
MYD88		ENSG00000172936	"MYD88 innate immune signal transduction adaptor"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 75.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 172.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favorable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	20.1	14.2	6.9	43.5	7.4	51.8	15.0	7.2	7.5	15.2	8.0	30.3	32.2	12.1	18.6	36.6	14.4	23.5	9.4	6.7	7.7	13.7	61.1	42.6	35.2	9.5	7.5	11.4	11.6	11.6	9.2	22.6	8.0	14.3	31.7	2.1	18.0	12.0	3.2	17.7	32.2	24.5	8.6	40.7	27.6	7.7	9.2	38.3	9.4	8.8	41.6	47.4	20.3	8.5	25.1	34.2	5.9	33.2	25.0	32.0	10.8	23.6	39.0	68.1	72.9	22.7	30.9	52.8	13.8	44.7	15.8	30.9	43.2	24.2	22.1	39.5	8.7	28.5	16.6	36.6	21.4	36.2	72.0	38.4	26.6	39.2	15.3	13.2	39.9	40.3	13.3	22.3	36.8	25.7	61.3	12.2	22.1	52.8	35.7	24.8	7.0	23.1	37.6	58.9	3.0	12.0	33.4	172.1	22.3	4.8	25.8	40.8	35.5	13.8	7.9	60.6	24.0	28.9	32.9	38.5	25.0	63.0	28.9	288.5	236.9	296.9	67.2	333.6	58.1	43.7	60.6	69.3	203.6	35.2	42.1	59.5	284.7	54.6	436.1	99.9	87.4	257.3	6.9	7.4	7.2	7.5	6.7	7.7	9.5	7.5	8.0	8.6	9.2	8.5	13.4	6.4	15.2	2.0	19.5	14.4	13.5	12.7	14.2	1.0	11.3	10.8	1.6	5.7	16.4	5.5	0.0	14.6	35.3	40.8	7.9	24.5	1.4	10.9	30.2	15.9	9.6	9.7	0.2	27.3	24.4	10.8	23.9	18.6	24.1	10.0	10.4	33.2	32.2	0.0	0.4	14.9	10.2	75.4	40.5	0.9	13.7	61.5	3.6	1.9	58.1	4.1	28.8	2.5	0.3	64.0	34.8	10.5	12.9	16.0	28.0	12.2	12.1	0.1	13.1	4.3	7.2	8.6	0.6	15.1	17.2	12.0	19.6	10.2	15.9	49.4
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703135-15857028	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3322.6;seminal vesicle: 1665.5;urinary bladder: 2048.3"	"Group enriched"	"Detected in many"	8	"Peritubular cells: 1669.7;Sertoli cells: 624.5;Smooth muscle cells: 964.6"	"Group enriched"	"Detected in many"	5	"prostate cancer: 173.2;stomach cancer: 125.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;RPMI-8226: 1.4;U-698: 7.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"midbrain: 39.8"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		23000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	172.9	38.6	5.0	109.1	17.2	0.2	78.4	5.5	14.5	372.3	11.1	3322.6	95.4	1074.6	219.7	759.7	606.1	250.6	74.8	5.3	5.2	27.9	9.2	108.9	9.5	9.0	7.0	144.0	10.7	2.8	11.6	68.2	7.1	762.7	293.2	0.4	83.3	1665.5	41.2	68.5	487.4	1053.2	5.8	46.0	832.5	60.9	7.2	2.9	46.0	34.6	5.3	2048.3	314.2	6.3	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.2	7.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	5.0	17.2	5.5	14.5	5.3	5.2	9.0	7.0	7.1	5.8	7.2	6.3	7.6	0.0	1.8	0.0	4.4	13.3	2.1	1.7	5.7	2.7	5.3	122.3	40.5	0.0	1.9	0.0	8.4	0.3	3.4	0.4	0.0	0.2	50.2	4.7	19.5	12.8	1.2	0.8	0.8	0.4	0.3	22.2	0.0	3.4	0.0	27.3	6.4	0.1	1.1	0.0	5.2	0.5	0.0	2.2	17.3	46.2	42.9	2.8	12.4	15.9	3.7	0.3	3.1	1.5	10.7	0.4	0.2	1669.7	2.4	5.6	0.1	0.2	2.5	1.9	624.5	4.3	964.6	3.1	8.8	3.5	18.6	0.0	5.7	34.7	0.4	2.6
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310542	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease variant, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 191.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 487.2;Paneth cells: 306.4;Proximal enterocytes: 376.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 48.6;CAPAN-2: 59.4;HaCaT: 119.0;MCF7: 59.0;OE19: 61.7;RT4: 147.8;SK-BR-3: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		NA	NA		9600000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (3.97e-8)"	"prognostic favorable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	12.6	1.0	24.1	7.0	35.0	0.0	8.8	38.2	23.3	13.3	22.0	64.5	83.8	1.5	0.2	63.7	15.4	3.6	41.3	20.0	30.9	10.2	25.4	24.4	0.1	38.7	35.6	0.4	17.3	16.7	18.5	0.4	35.7	8.8	19.5	5.1	44.0	5.7	191.3	87.7	76.7	1.3	29.5	0.1	45.5	2.6	34.4	1.5	33.2	35.1	6.1	11.0	31.8	37.4	48.6	5.0	0.0	25.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	33.1	59.4	0.2	30.1	0.0	3.7	119.0	0.1	0.0	0.0	0.1	8.7	0.0	0.0	25.7	0.0	0.0	17.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	59.0	0.0	0.3	0.8	61.7	0.7	0.1	29.4	0.7	0.0	147.8	0.1	0.2	2.9	51.8	0.0	0.2	9.7	1.9	0.0	0.1	11.7	0.2	0.1	0.9	11.2	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	35.0	38.2	23.3	20.0	30.9	38.7	35.6	35.7	29.5	34.4	37.4	0.1	80.1	36.5	23.5	2.8	3.3	18.7	29.3	0.0	3.7	17.9	9.3	21.8	44.3	50.9	57.0	2.1	0.1	0.3	487.2	0.0	53.2	0.9	58.1	6.0	1.2	51.6	0.0	10.9	27.2	0.1	1.1	85.1	70.7	14.7	0.0	2.9	45.8	0.1	16.8	21.7	109.4	22.4	0.8	1.6	0.8	0.3	1.3	5.4	2.8	0.0	19.7	0.0	23.6	27.5	67.5	306.4	0.0	0.3	30.8	376.1	7.6	80.6	11.5	0.0	17.7	3.5	0.5	4.6	30.8	21.0	0.0	2.0	0.0	122.8	86.2
MYL6	"ESMLC, MLC1SM, MLC3NM"	ENSG00000092841	"Myosin light chain 6"	P60660	12	56158346-56163496	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046859, HPA063034"	Approved					NA	NA		60000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA046859: AB_2679842, HPA063034: AB_2684927"	"unprognostic (1.10e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.01e-1)"	2247.0	1427.5	830.7	1207.0	830.7	1756.5	1977.9	864.2	962.6	1767.3	901.0	5900.2	1027.9	2971.8	1635.0	1777.8	2197.9	905.8	1153.9	809.9	863.8	1915.8	1172.0	1946.7	882.9	900.5	874.9	1155.2	1032.8	1466.7	747.7	1441.7	869.2	2037.5	2360.3	927.1	1167.6	2912.2	411.1	1090.1	1867.5	4209.9	858.5	1547.8	2128.0	494.6	899.3	1151.3	1316.7	578.7	1404.7	3041.7	1685.0	869.9	1924.9	1739.1	3199.3	958.8	2063.5	2065.5	1755.8	4056.4	4162.8	5469.7	3191.3	2738.5	1720.0	735.0	2274.3	5778.4	1417.7	1222.8	1995.9	2846.0	3556.8	1423.1	666.5	1311.5	2481.7	1536.9	1512.2	913.8	2304.1	2389.9	2013.5	3242.3	1263.1	4706.8	4854.4	867.2	708.1	2121.5	4585.6	2052.1	1291.6	1402.8	1629.5	1071.6	1746.1	1027.3	1265.3	932.9	5125.1	2361.7	1169.2	862.9	4456.0	1380.0	760.4	2312.4	2148.7	2383.0	5212.3	1486.3	1011.6	2077.3	2746.8	635.3	1150.3	867.7	1953.3	1168.9	1578.1	11449.4	4509.8	13302.4	3191.2	5016.0	2404.9	2844.7	2828.6	2994.0	4747.3	2558.5	2020.7	2528.3	8440.7	2233.9	6531.2	5167.0	4209.8	14776.8	830.7	830.7	864.2	962.6	809.9	863.8	900.5	874.9	869.2	858.5	899.3	869.9	2044.5	1733.9	1161.8	16.0	704.4	2114.0	2470.4	2988.3	746.1	278.4	896.3	1394.8	672.8	946.5	2016.5	1475.0	316.9	1704.4	1144.5	2568.2	2406.5	4126.7	292.4	1134.2	1714.2	1628.1	1017.3	857.4	15.6	4820.4	2604.5	1264.0	871.6	1676.6	994.3	1307.8	1328.6	887.8	3370.3	80.8	19.8	1572.3	1845.3	1148.3	2472.8	910.7	1064.0	1872.2	1469.2	39.4	4426.3	820.8	1195.7	17.6	31.3	6222.1	2715.8	2775.1	892.8	1762.1	3007.9	2956.9	1870.9	763.7	1735.5	685.8	3305.2	76.2	115.0	1139.6	2066.1	1929.9	1191.9	1039.1	1406.1	2558.6
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541497-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 8015.9"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 860.2;Cardiomyocytes: 1856.1;Peritubular cells: 1891.9;Sertoli cells: 2143.1;Smooth muscle cells: 2525.7;Theca cells: 881.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.2;neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 783.3;BJ: 1047.3;fHDF/TERT166: 844.3;hTERT-RPE1: 645.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 76.1"	"HPA039262, HPA045244, HPA059197"	Supported					NA	NA		34000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	944.6	948.6	61.6	347.0	76.7	5.2	649.5	63.3	132.2	1083.0	104.6	8015.9	270.5	2897.3	238.2	999.8	1643.3	364.3	2294.5	61.4	63.1	352.2	116.6	617.9	56.4	66.3	66.3	717.2	82.0	45.4	91.2	160.3	66.1	2347.4	345.8	22.8	200.7	2248.7	164.3	289.2	1287.7	2107.8	62.0	274.3	1946.4	260.7	66.5	27.4	431.7	111.4	23.2	4176.1	943.6	63.3	79.4	1.3	60.3	1.2	783.3	298.6	264.5	1047.3	450.9	541.3	349.9	612.3	9.1	0.2	535.6	844.3	120.6	29.4	0.2	2.4	125.7	0.9	0.2	16.7	114.4	57.3	500.4	0.4	17.7	420.8	54.4	359.9	1.6	645.9	19.2	0.0	2.4	28.0	461.7	0.2	0.3	7.8	24.0	16.1	5.6	0.4	0.0	5.8	4.6	5.8	0.6	4.1	11.1	26.6	0.6	257.5	232.9	15.6	137.0	510.9	220.1	75.5	1.0	0.8	4.0	2.3	194.3	0.8	0.6	0.0	0.1	2.2	0.0	0.0	0.0	0.9	0.0	0.1	0.3	0.2	0.0	0.0	1.9	0.2	0.0	0.4	0.0	7.2	61.6	76.7	63.3	132.2	61.4	63.1	66.3	66.3	66.1	62.0	66.5	63.3	325.3	394.2	52.3	0.0	6.6	60.7	320.2	167.1	21.6	1.4	36.8	860.2	1856.1	24.3	50.8	90.1	0.0	37.0	6.3	0.1	27.4	310.3	9.3	13.1	419.9	179.7	0.0	5.7	0.2	116.0	78.3	410.4	10.2	9.3	15.2	234.3	169.9	2.7	32.0	1.7	0.1	1.2	14.2	5.0	76.6	55.4	331.8	111.7	72.9	30.9	19.4	230.4	6.2	0.0	0.5	47.9	2.5	1891.9	6.4	156.9	105.5	42.1	31.8	6.1	2143.1	65.9	2525.7	16.3	9.5	6.5	53.4	26.8	14.7	881.1	2.0	61.9
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 1700.3;smooth muscle: 2137.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 728.5;Hepatocytes: 208.7;Peritubular cells: 690.5;Sertoli cells: 276.1;Smooth muscle cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 200.0;BJ hTERT+: 298.2;fHDF/TERT166: 260.2;hTERT-RPE1: 202.7;RPTEC TERT1: 291.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		1500000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	143.6	57.4	37.6	188.7	64.8	3.3	163.4	72.1	42.4	281.3	14.1	551.5	110.9	669.2	232.9	420.6	289.8	250.4	33.6	33.6	46.7	64.4	67.2	85.2	33.6	104.6	64.8	95.9	15.3	11.6	2.6	70.2	99.3	907.6	299.1	13.6	140.1	1700.3	10.0	20.1	125.1	2137.7	55.6	89.5	122.7	50.5	52.2	8.0	22.2	14.9	19.1	505.7	84.8	112.1	14.4	38.4	10.8	7.8	10.8	1.9	4.7	200.0	298.2	137.3	92.1	8.1	7.4	0.6	42.5	260.2	67.0	4.8	5.2	1.8	149.0	0.2	0.7	102.4	0.9	28.9	56.1	0.6	9.8	36.9	3.5	24.4	34.4	202.7	8.9	1.3	1.2	0.5	90.9	1.7	0.2	2.5	12.0	0.5	5.1	13.5	6.8	36.7	291.9	8.5	1.4	6.4	21.8	1.9	3.1	25.0	1.0	0.3	33.4	39.5	13.9	10.3	30.7	3.4	4.2	0.3	104.0	1.0	9.6	7.4	1.6	0.4	0.1	0.2	0.0	0.2	0.0	0.0	3.5	0.1	0.2	0.1	5.0	0.0	0.0	3.3	0.2	20.9	37.6	64.8	72.1	42.4	33.6	46.7	104.6	64.8	99.3	55.6	52.2	112.1	45.9	16.0	38.3	43.4	2.5	20.5	27.2	24.8	1.2	2.9	19.9	728.5	25.2	37.1	5.7	27.6	125.1	0.8	3.5	88.1	3.9	6.0	40.7	45.9	46.6	56.9	11.4	3.2	25.2	3.9	0.8	40.1	3.1	54.4	2.5	3.2	45.3	208.7	4.9	3.3	3.4	3.9	8.2	7.9	37.0	33.8	104.7	20.8	19.6	8.4	1.2	4.7	0.0	5.5	37.0	4.0	18.7	690.5	3.3	8.6	14.2	17.2	17.6	19.9	276.1	5.6	448.7	4.7	4.6	1.3	20.2	2.5	3.2	4.5	4.2	3.7
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 330.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 174.5;Proximal enterocytes: 690.2"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in many"		"white matter: 8.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 43.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.2	0.2	0.1	5.1	0.4	0.1	0.1	0.8	0.2	0.0	0.7	68.3	330.0	0.4	0.0	0.2	0.1	4.1	0.0	0.1	0.2	0.1	0.1	0.2	0.3	2.1	2.0	0.0	0.2	0.0	0.1	0.2	1.8	0.1	65.7	0.1	0.0	0.2	0.1	0.1	309.8	3.0	3.7	0.1	16.3	1.0	0.6	0.4	0.0	0.0	0.1	0.0	0.1	8.3	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	8.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.5	0.1	43.3	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.8	0.2	0.1	0.2	2.1	2.0	1.8	3.7	0.6	8.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.9	4.3	0.1	0.0	0.0	0.0	0.0	174.5	0.0	0.1	0.7	0.3	0.0	0.1	24.7	0.0	0.1	0.0	0.0	0.1	26.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	85.4	0.0	0.3	1.0	1.2	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.3	66.8	0.0	0.1	0.0	690.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	0.4	0.1	0.0	0.4	0.0	102.3	0.1
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 255.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 330.2;Hepatocytes: 414.2;Sertoli cells: 203.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 360.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	42.9	7.3	9.2	15.4	7.8	0.6	27.4	3.5	11.4	13.3	5.8	23.7	13.2	16.2	16.6	15.9	9.2	26.7	19.1	7.1	5.3	25.6	255.5	74.9	11.3	4.2	8.9	14.0	49.3	34.6	5.8	48.4	6.0	15.1	22.0	21.5	12.8	17.7	9.2	15.3	13.4	20.1	3.9	8.2	12.2	9.6	13.2	17.4	19.3	13.6	10.5	25.4	14.3	6.7	102.5	51.7	82.6	24.9	22.4	95.0	74.6	190.8	93.9	129.0	127.4	63.9	8.9	0.1	31.0	220.5	52.1	221.0	27.4	164.3	161.1	0.3	23.9	0.2	22.6	82.3	52.1	2.2	0.6	38.6	111.1	135.0	360.0	47.6	23.8	42.4	0.2	0.4	120.7	43.5	39.7	12.4	53.9	6.7	81.2	50.5	52.6	7.7	51.0	42.8	41.8	109.0	64.5	11.1	57.9	70.2	10.1	3.1	29.1	122.7	61.5	75.0	22.7	0.9	0.5	1.1	74.4	0.4	69.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	7.8	3.5	11.4	7.1	5.3	4.2	8.9	6.0	3.9	13.2	6.7	95.8	330.2	112.5	1.6	3.6	76.7	58.2	78.7	31.9	1.4	29.0	22.9	7.9	45.8	84.3	69.9	0.0	5.2	0.8	30.4	0.0	120.4	2.9	13.0	20.2	60.5	58.5	10.7	22.3	44.6	26.5	40.3	18.3	18.1	3.8	129.1	5.0	414.2	4.2	0.0	38.0	24.6	34.6	10.5	10.0	3.8	5.0	2.3	26.6	70.3	1.0	72.2	0.0	1.0	0.8	38.1	54.1	9.1	0.4	112.2	4.5	1.2	48.2	2.7	203.8	32.6	160.1	2.4	21.0	13.9	28.1	3.4	3.3	44.9	38.0	47.1
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492686	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		3800000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	169.3	27.0	12.4	34.4	11.8	4.9	115.9	13.3	12.7	77.4	17.1	104.9	47.4	97.1	21.5	64.7	66.4	46.1	97.5	10.2	14.7	56.8	39.5	87.2	24.1	14.8	11.2	43.6	69.3	34.3	22.9	56.9	14.6	69.9	41.7	2.1	91.7	58.2	49.5	57.7	65.6	65.7	11.9	30.8	76.3	17.1	13.7	21.3	60.6	35.8	25.1	86.3	67.8	10.8	169.8	182.1	19.3	79.5	88.8	87.6	74.2	168.6	138.9	108.7	91.0	122.3	90.7	16.9	118.7	261.1	72.7	139.9	29.2	117.2	56.3	75.2	74.5	16.2	96.4	46.2	131.7	1.6	81.5	68.7	57.3	100.2	57.3	99.5	141.7	10.5	13.1	13.7	93.5	129.5	1.9	1.4	12.4	105.8	34.0	6.9	26.4	30.7	100.5	86.9	7.8	43.0	105.9	152.6	67.4	47.5	125.3	8.7	187.9	156.6	119.1	77.7	147.8	10.7	9.1	7.2	124.7	4.1	138.8	0.1	0.9	0.0	0.9	2.0	0.4	4.8	2.1	0.9	1.1	3.8	0.7	0.4	0.5	0.0	1.7	1.0	1.9	1.5	12.4	11.8	13.3	12.7	10.2	14.7	14.8	11.2	14.6	11.9	13.7	10.8	133.7	125.0	35.9	5.5	20.8	39.8	38.2	27.8	31.9	4.1	44.0	33.0	75.4	48.6	36.3	86.5	0.0	57.8	2.5	159.0	21.5	62.3	17.4	26.3	44.4	78.0	39.5	13.5	2.5	52.0	28.4	51.8	66.3	75.5	12.0	25.4	83.6	38.5	20.0	5.0	3.8	111.8	14.2	14.5	43.4	11.4	42.3	16.7	64.0	15.0	20.3	5.6	0.0	2.5	1.0	92.8	88.7	48.5	12.8	64.7	92.8	15.4	12.9	2.1	118.3	37.7	90.6	9.4	7.5	39.5	42.6	47.6	10.0	10.6	88.1	39.2
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822789-50195147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 147.3;Inhibitory neurons: 90.5;Pancreatic endocrine cells: 106.6;Proximal enterocytes: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 65.5;HaCaT: 100.3;RH-30: 152.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	3.2	1.7	1.0	7.9	3.3	0.1	13.7	0.5	3.6	17.7	15.9	45.3	60.2	2.6	18.5	37.4	12.2	11.3	2.7	4.4	10.4	19.7	18.7	11.9	2.6	0.5	3.4	0.5	16.6	23.0	13.4	3.8	1.6	10.1	43.6	40.9	25.4	7.1	0.4	27.4	62.0	3.1	0.4	1.7	33.3	11.4	1.9	3.1	29.4	0.2	13.0	14.2	21.6	1.4	65.5	17.3	0.3	0.3	0.0	0.0	34.0	0.3	2.6	1.4	0.1	45.8	27.2	0.1	15.6	0.1	5.0	100.3	22.6	27.3	1.3	0.2	6.9	0.2	7.5	32.8	0.0	0.2	0.2	0.0	23.6	0.6	16.2	5.1	2.3	0.3	0.5	24.7	2.7	25.3	0.0	0.2	4.6	37.8	7.0	0.0	152.5	11.0	56.8	13.2	33.7	0.7	24.4	28.3	0.0	8.6	16.8	0.2	1.5	0.0	34.0	0.4	6.8	16.7	11.2	0.1	1.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	3.3	0.5	3.6	4.4	10.4	0.5	3.4	1.6	0.4	1.9	1.4	0.1	54.5	15.8	2.6	1.6	0.4	9.0	7.9	2.2	7.7	14.3	7.7	3.5	15.7	21.5	7.3	10.4	4.4	0.3	147.3	5.9	49.0	22.4	38.5	3.1	1.1	6.7	5.3	4.4	47.3	1.1	3.7	48.4	29.1	0.0	27.1	0.0	18.4	0.9	0.0	90.5	35.4	2.0	1.3	0.8	4.5	0.9	1.0	3.6	3.7	2.0	31.9	0.0	2.0	9.0	106.6	70.7	0.7	1.4	60.1	177.6	18.9	38.1	30.2	0.0	0.9	2.3	9.5	6.7	8.3	6.5	4.7	0.7	0.1	46.7	56.2
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652688	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 110.8"	"Cell type enriched"	"Detected in some"	6	"Fibroblasts: 244.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA027364	Uncertain				"Secreted to extracellular matrix"	NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	47.1	1.1	0.0	0.0	0.0	0.0	19.2	0.2	0.0	1.8	0.0	13.0	3.5	16.5	4.9	19.6	15.3	1.5	18.3	0.0	0.1	0.2	0.1	7.4	0.1	0.5	0.1	1.3	3.0	0.1	0.2	0.2	0.2	5.3	3.5	0.0	14.0	6.4	33.8	4.7	4.8	2.9	0.0	0.0	50.2	1.4	0.1	14.1	28.7	110.8	0.2	22.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.2	0.0	0.1	0.1	12.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.1	3.1	0.0	0.0	0.1	0.0	0.0	244.4	11.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	1.0	8.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.6	2.4	0.1	0.0	0.0	0.0	0.0	0.0	15.1	6.3	0.1	0.1	1.1	0.0	0.0	1.1	0.2	0.0	0.0
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 412.8;skeletal muscle: 845.6;tongue: 435.6"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.1	2.2	7.5	1.3	9.0	0.6	4.1	7.8	6.4	3.0	3.4	14.1	1.9	6.4	2.9	14.1	6.8	14.6	412.8	5.7	11.5	1.5	24.7	1.5	1.3	11.1	12.0	2.9	11.5	0.4	1.6	1.6	11.3	12.4	2.4	2.0	5.3	4.5	845.6	1.6	4.6	11.9	8.6	0.9	3.2	5.7	8.0	0.8	2.8	435.6	0.7	7.6	2.4	8.6	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.5	9.0	7.8	6.4	5.7	11.5	11.1	12.0	11.3	8.6	8.0	8.6	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
MYOT	"LGMD1, LGMD1A, TTID"	ENSG00000120729	Myotilin	Q9UBF9	5	137867858-137887851	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"skeletal muscle: 2183.8;tongue: 2038.6"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 40.9;Skeletal myocytes: 42.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037733, HPA037734"	Enhanced					NA	NA		9100		"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 37: Myocytes - Muscle contraction"			"HPA037733: AB_10697082, HPA037734: AB_2675638"	"unprognostic (5.85e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.85e-4)"	"unprognostic (8.03e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.56e-4)"	"unprognostic (1.72e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	0.8	1.7	5.7	1.4	9.3	0.0	0.8	5.8	9.8	3.3	3.9	8.0	2.1	0.4	0.5	34.6	0.7	0.7	17.0	5.4	5.8	0.9	0.4	0.2	0.1	6.2	7.2	0.4	0.4	1.1	0.5	0.0	6.0	20.0	1.6	0.5	19.4	3.7	2183.8	1.0	3.1	1.0	5.3	0.6	1.9	0.2	6.8	0.2	1.0	2038.6	0.3	2.3	3.7	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	9.3	5.8	9.8	5.4	5.8	6.2	7.2	6.0	5.3	6.8	7.8	0.0	0.0	0.0	0.3	0.2	0.3	0.6	0.0	1.2	0.0	0.0	0.1	40.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	0.0	2.3	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.5	3.6	0.0	0.0	0.0	0.0	2.0	8.2	0.0	0.1	0.0	0.1	0.3	0.3	0.2	0.1	0.8	0.0	42.0	1.3	0.2	0.2	0.2	0.0	0.0	0.3	0.1	0.5	0.1
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.6;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 31.9;Cone photoreceptor cells: 60.5;Horizontal cells: 26.9;Oligodendrocyte precursor cells: 112.1;Rod photoreceptor cells: 29.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 7.6;SCLC-21H: 23.1;SH-SY5Y: 6.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 17.5"	HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.2	3.5	5.8	0.2	3.8	1.1	0.1	24.6	4.3	0.0	0.0	0.2	0.8	0.1	0.2	0.0	0.2	0.1	0.1	3.8	6.6	0.1	0.1	0.1	0.1	5.0	5.6	0.1	0.6	0.3	5.5	0.1	5.2	0.1	0.2	8.3	0.0	0.1	0.0	0.1	0.2	0.1	2.7	0.2	0.6	0.7	5.9	0.1	0.6	0.0	0.1	0.1	0.0	3.6	0.0	0.1	0.8	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.7	0.3	0.1	0.3	0.0	2.4	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.7	0.0	0.1	1.8	0.1	0.9	0.0	0.5	7.6	0.2	0.2	0.0	0.1	23.1	6.0	0.0	0.2	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	2.2	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	3.8	24.6	4.3	3.8	6.6	5.0	5.6	5.2	2.7	5.9	3.6	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	31.9	0.1	0.0	1.2	4.3	0.0	0.0	60.5	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.4	2.4	2.7	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.5	26.9	5.8	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	5.0	0.0	112.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	29.0	0.0	0.4	0.1	1.6	8.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0
MYT1L	"KIAA1106, NZF1, ZC2H2C2, ZC2HC4B"	ENSG00000186487	"Myelin transcription factor 1 like"	Q9UL68	2	1789113-2331664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 45.8;pituitary gland: 14.8"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 582.4;Inhibitory neurons: 635.5;Oligodendrocyte precursor cells: 265.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 45.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 18.6;SH-SY5Y: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060245			Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA060245: AB_2732643"	"unprognostic (9.90e-3)"	"unprognostic (3.74e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.61e-3)"	"unprognostic (7.17e-2)"		"unprognostic (3.73e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	0.0	1.4	7.8	0.2	14.1	0.1	0.0	4.2	45.8	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	17.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	14.8	0.1	0.0	0.1	0.1	5.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	18.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	7.8	14.1	4.2	45.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.1	6.4	6.1	16.6	0.0	1.8	0.5	0.0	0.0	46.7	0.5	0.4	4.5	0.0	3.1	1.8	2.1	0.1	0.2	0.1	0.0	0.0	5.0	0.4	0.1	1.3	0.0	0.0	582.4	0.0	0.2	1.3	0.0	0.2	6.3	0.1	0.7	0.4	0.1	117.8	635.5	0.0	0.0	0.6	0.8	4.7	0.0	0.8	0.0	18.7	0.0	1.5	0.0	265.4	11.1	0.1	0.0	1.5	0.1	0.4	0.0	0.2	1.5	7.4	6.6	1.5	0.4	50.0	31.4	0.0	1.0	0.3	0.9	0.1	0.0	0.6
MZB1	"HSPC190, MEDA-7, MGC29506, PACAP, pERp1"	ENSG00000170476	"Marginal zone B and B1 cell specific protein"	Q8WU39	5	139387467-139390081	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 89.8;lymphoid tissue: 272.2"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 4000.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 160.4;plasmacytoid DC: 569.3"	"Group enriched"	"Detected in many"	116	"B-cells: 160.4;dendritic cells: 569.3"	"Group enriched"	"Detected in some"	5	"Karpas-707: 581.5;RPMI-8226: 2193.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043745, HPA052694"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		350000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA043745: AB_10960359, HPA052694: AB_2681919"	"unprognostic (4.97e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.23e-2)"	"prognostic favorable (7.27e-4)"	"unprognostic (2.21e-2)"	"prognostic favorable (4.60e-5)"	"unprognostic (6.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.45e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.15e-8)"	"unprognostic (7.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.46e-2)"	"unprognostic (7.36e-2)"	4.4	9.1	0.0	87.4	0.1	33.0	21.0	0.0	0.7	18.3	0.2	70.1	89.8	1.8	0.4	10.1	5.7	14.3	2.3	0.0	0.0	5.9	5.8	15.9	123.2	0.1	0.0	4.9	1.3	0.0	0.7	0.0	0.1	5.1	39.9	0.0	56.7	4.9	0.1	0.4	47.8	2.1	0.4	272.2	66.6	2.4	0.1	147.3	9.1	0.0	117.8	58.7	3.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	256.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	144.6	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	128.5	0.5	581.5	0.0	0.0	227.8	2.2	0.0	0.0	0.0	90.1	0.3	2193.9	0.0	0.0	0.3	0.8	0.0	11.4	0.0	0.0	3.1	0.1	0.6	0.0	1.8	0.1	0.0	262.0	16.7	223.0	0.1	0.4	0.0	0.0	0.1	0.1	1.5	0.1	3.0	160.4	0.6	1.1	0.5	75.6	0.1	0.2	3.1	2.7	0.0	569.3	0.2	26.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.3	0.4	6.4	10.1	0.0	665.7	2.5	1.3	0.1	0.0	0.0	3.7	3.2	1.1	4.3	2.0	0.0	0.0	0.1	235.0	0.9	0.0	0.1	0.1	1.8	0.4	2.0	1.2	49.3	0.0	0.0	0.1	2.0	6.1	0.4	2.5	0.1	11.4	14.0	0.1	0.0	0.0	1.1	0.0	7.1	3.4	1.1	0.0	4.7	540.7	0.0	1.0	0.0	4.1	0.0	0.0	0.1	0.4	0.0	4000.1	3.0	1.2	1.9	1.2	0.0	0.0	1.7	2.1	0.1	0.1	0.4	2.4	2.2	100.7	0.5	9.7	0.4
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.1"	"Group enriched"	"Detected in some"	10	"Astrocytes: 125.4;Excitatory neurons: 265.8;Inhibitory neurons: 277.4;Oligodendrocyte precursor cells: 324.7;Oligodendrocytes: 477.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 14.2;HHSteC: 14.4;hTERT-RPE1: 11.0;TIME: 19.8;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	0.5	4.3	7.5	0.4	9.8	0.6	2.7	6.4	10.3	1.5	0.0	0.4	0.6	0.5	1.5	0.2	1.0	2.3	3.3	8.6	10.2	0.3	1.2	1.1	0.3	8.2	5.8	2.8	1.3	2.9	6.8	3.0	7.0	0.3	0.6	6.1	0.8	1.0	0.3	0.5	0.5	0.5	6.8	0.4	0.7	0.6	8.3	0.0	2.4	0.2	0.1	0.5	0.2	13.1	0.1	7.8	1.4	0.2	0.7	0.3	0.1	0.8	0.8	1.8	0.4	0.2	8.9	0.0	0.3	3.6	0.8	14.2	0.0	2.2	5.5	0.0	1.2	0.4	3.8	0.1	14.4	0.2	0.3	0.4	0.5	1.7	4.6	11.0	8.2	0.1	0.1	0.4	5.9	0.0	0.1	0.0	0.4	1.3	1.8	0.0	0.0	0.0	4.6	1.9	1.2	0.6	0.1	0.0	0.8	0.9	0.2	0.1	19.8	0.4	0.1	0.3	1.8	0.1	0.1	0.1	11.4	0.1	0.3	2.6	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	7.5	9.8	6.4	10.3	8.6	10.2	8.2	5.8	7.0	6.8	8.3	13.1	0.1	0.0	0.0	125.4	0.0	0.3	0.0	0.3	0.6	15.4	3.5	4.6	6.2	0.0	0.1	0.0	6.2	1.0	0.0	0.0	0.0	0.8	4.5	0.1	0.2	0.6	0.0	0.0	265.8	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	26.9	277.4	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	23.4	0.0	2.0	0.0	324.7	477.4	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	2.6	0.0	3.6	0.5	0.2	0.8	0.0	0.1	0.5	0.0	0.1	0.0	0.0
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248298-106285966	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 279.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 279.2"	"Cell line enhanced"	"Detected in all"		"HHSteC: 387.5;U-87 MG: 434.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	308.5	74.2	14.4	360.5	15.6	312.5	103.3	15.2	35.4	47.3	21.7	62.5	38.5	38.6	6.9	228.2	107.6	113.7	103.1	15.2	20.9	82.9	317.9	218.5	23.2	75.7	24.9	58.4	80.9	25.9	30.1	87.3	30.3	70.1	30.3	17.2	126.0	13.4	135.9	54.1	55.9	48.0	21.3	88.2	102.4	11.7	46.3	15.6	42.2	44.4	39.9	283.3	86.7	21.5	103.6	41.0	14.6	16.8	85.8	95.0	34.4	26.1	194.7	57.0	90.6	25.7	38.7	77.7	78.8	32.1	131.5	58.2	38.8	88.1	93.8	50.5	51.7	35.8	17.2	22.6	387.5	61.3	49.4	94.8	94.2	114.9	115.0	70.6	187.3	32.0	70.5	225.6	68.1	49.4	58.1	19.4	36.6	33.6	59.7	25.8	30.4	147.6	46.2	60.8	33.4	19.3	46.0	61.1	107.9	43.0	25.4	9.4	168.2	75.6	52.9	105.9	51.9	212.1	142.7	115.7	434.3	69.3	105.6	39.6	6.5	16.0	1.8	21.8	2.4	3.9	2.2	2.7	7.0	3.4	2.8	2.2	279.2	4.4	30.5	5.5	7.1	4.8	14.4	15.6	15.2	35.4	15.2	20.9	75.7	24.9	30.3	21.3	46.3	21.5	323.8	131.4	245.7	12.1	78.0	207.6	321.0	105.7	169.0	23.8	184.2	132.0	94.8	197.3	161.4	42.3	12.5	26.2	67.5	105.8	46.9	320.6	12.2	128.0	160.8	192.8	25.1	29.5	25.3	141.3	58.9	239.6	132.0	296.5	188.4	18.8	159.5	580.0	107.0	40.4	28.8	51.9	63.1	390.3	1123.7	6.9	40.4	947.3	161.9	46.9	102.7	22.6	9.2	12.1	22.4	138.1	49.7	31.2	93.7	364.0	112.8	50.7	94.1	30.8	26.3	264.6	185.6	30.5	65.8	98.3	207.8	25.3	110.3	38.4	79.4	334.5
NAP1L3	"MB20, MGC26312, NPL3"	ENSG00000186310	"Nucleosome assembly protein 1 like 3"	Q99457	X	93670930-93673578	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.4;retina: 40.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Excitatory neurons: 27.9;Horizontal cells: 62.2;Inhibitory neurons: 57.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Group enriched"	"Detected in many"	25	"NK-cells: 3.1;T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"AF22: 13.6;HAP1: 13.2;NTERA-2: 24.0;SuSa: 20.7;U-2197: 16.1"	"Low region specificity"	"Detected in all"							HPA026075			Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA026075: AB_1854301"	"unprognostic (7.18e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.83e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.23e-4)"	2.5	13.4	65.2	2.8	53.3	1.2	2.6	46.9	103.4	19.3	11.2	3.2	1.5	12.1	5.6	1.3	10.0	5.4	11.3	50.5	62.9	3.3	1.3	1.8	2.5	45.3	62.7	16.7	1.3	1.0	18.1	1.5	54.4	4.4	2.4	40.9	1.4	5.3	0.4	1.7	2.0	8.2	40.6	4.6	1.4	16.6	46.9	1.1	5.6	1.2	1.3	3.5	2.8	47.5	0.0	0.2	13.6	9.9	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	7.6	0.3	0.1	13.2	0.0	0.0	0.0	0.3	6.4	0.0	0.2	0.7	0.0	0.4	6.1	0.0	0.6	6.2	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	24.0	0.0	5.7	0.0	10.5	0.0	0.4	0.1	0.1	1.4	0.0	0.0	0.2	20.7	0.0	0.7	0.0	7.5	10.9	16.1	0.7	10.2	4.5	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.7	0.0	2.6	0.9	0.0	0.0	4.1	2.9	0.1	3.1	0.0	0.0	0.8	0.9	65.2	53.3	46.9	103.4	50.5	62.9	45.3	62.7	54.4	40.6	46.9	47.5	0.8	0.0	0.0	11.8	0.3	0.6	0.3	0.0	0.0	41.8	0.2	1.9	8.3	0.0	0.6	0.0	6.2	0.2	0.8	0.0	17.6	0.1	1.2	0.3	9.9	1.4	0.0	1.3	27.9	0.0	0.2	7.6	0.0	0.3	5.7	7.4	1.1	0.0	0.4	62.2	57.1	0.0	0.0	0.0	0.9	2.2	11.8	0.3	5.4	9.4	0.2	16.6	0.0	16.6	21.2	0.2	0.0	19.5	0.1	0.0	0.0	0.5	1.5	12.9	0.0	6.6	4.0	5.7	7.4	0.0	0.4	0.3	1.6	16.4	0.0	0.0
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391282-18401218	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 33.5;liver: 128.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 14.8;Hepatocytes: 59.0;Paneth cells: 15.9;Proximal enterocytes: 36.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.0;RT4: 1.6;SCLC-21H: 2.2;SK-BR-3: 1.4"									HPA043704	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"			"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.1	0.1	0.2	1.6	0.2	0.0	1.1	0.2	0.6	0.5	0.1	15.0	33.5	0.9	0.7	0.1	0.2	0.2	0.2	0.2	0.2	1.9	128.6	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.1	0.4	13.2	0.0	0.0	0.5	0.0	0.0	25.6	1.6	0.2	1.3	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	1.0	1.6	2.2	0.0	0.0	1.4	0.0	0.1	0.3	0.2	0.5	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.0	0.0	14.8	5.9	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	59.0	0.2	0.0	0.0	7.4	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	2.6	0.0	0.0	36.0	0.8	0.3	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	4.4	0.1	0.8	6.7	0.1
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"	43.5	0.7	56.1	0.1	46.4	0.0	1.6	42.9	99.0	0.0	0.6	0.2	0.1	0.3	1.3	0.1	0.9	0.1	0.8	45.8	29.0	5.3	0.0	0.0	0.2	52.3	46.4	0.2	2.3	0.9	1.8	0.1	57.5	1.0	0.1	3.7	2.3	1.6	5.7	1.0	0.2	0.2	33.0	0.3	0.4	9.0	88.8	0.2	0.3	2.5	0.0	0.0	0.0	38.9	0.1	9.2	4.9	10.0	0.9	0.0	5.7	0.2	0.0	0.2	0.0	4.1	0.3	0.0	1.9	0.0	1.5	0.1	11.1	0.0	0.1	0.0	13.2	0.1	2.1	6.6	1.5	14.5	6.9	0.0	0.2	0.0	0.0	1.8	0.0	3.4	11.5	0.0	0.4	6.2	0.2	20.8	14.1	0.0	4.1	0.7	2.3	0.4	0.2	0.5	25.8	8.6	6.6	0.0	21.4	0.8	0.7	8.3	0.0	0.0	3.3	0.1	5.6	0.0	0.0	0.2	0.0	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	56.1	46.4	42.9	99.0	45.8	29.0	52.3	46.4	57.5	33.0	88.8	38.9	0.5	0.0	0.0	126.7	0.0	0.3	0.0	0.0	0.0	14.5	1.4	2.2	2.6	0.0	0.0	1.8	6.2	0.0	5.4	0.0	0.0	4.6	1.1	1.7	0.1	0.4	1.8	0.0	46.0	0.6	0.1	0.2	0.0	1.0	0.0	21.9	0.0	0.0	0.8	80.8	37.6	0.0	0.0	0.0	0.3	3.8	0.0	0.7	10.6	17.8	0.0	25.0	0.0	23.1	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.8	0.5	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211958-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"brain: 73.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 195.5"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.0;SCLC-21H: 2.3;SH-SY5Y: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"	NA	NA		790000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	0.0	0.1	52.8	0.0	53.1	0.0	0.0	15.2	73.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	44.2	0.0	0.0	0.0	0.0	33.3	32.3	0.0	0.0	0.0	0.3	0.0	38.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.9	61.5	0.1	0.0	0.0	0.0	0.0	0.0	49.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.8	53.1	15.2	73.6	55.6	44.2	33.3	32.3	38.1	21.5	61.5	49.4	0.0	0.0	0.0	195.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	15.5	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	29.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810979-17844865	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 15.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"white matter: 1.6"	"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes		9500	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	0.7	0.5	0.1	4.1	0.1	13.9	0.9	0.5	0.1	0.7	0.2	3.0	3.8	0.6	0.0	3.5	0.2	0.9	0.3	0.0	0.2	0.2	0.7	0.6	8.7	0.6	1.2	0.2	0.2	0.1	0.1	3.0	0.7	0.3	2.4	0.3	0.7	0.0	0.2	3.5	3.2	1.0	1.2	2.1	1.9	5.6	0.3	15.8	0.3	0.1	8.7	1.2	1.0	0.2	45.1	28.3	63.8	42.2	4.0	7.8	23.1	56.8	22.2	55.0	55.8	36.3	26.8	66.8	11.3	16.0	47.6	19.9	54.5	22.1	74.8	30.5	27.0	53.6	37.3	29.8	0.2	38.4	20.3	1.5	1.5	40.7	18.6	8.8	27.9	28.9	53.1	74.1	55.0	13.4	44.1	36.9	32.8	26.1	27.9	42.8	57.4	28.0	16.6	13.9	50.0	29.7	51.2	10.9	15.7	27.2	25.6	21.3	23.2	52.5	23.6	30.0	78.9	23.2	23.3	56.1	21.7	39.1	35.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.4	0.1	0.1	0.5	0.1	0.0	0.2	0.6	1.2	0.7	1.2	0.3	0.2	0.3	0.0	1.1	0.0	3.3	2.4	0.6	1.9	1.2	0.2	0.6	0.6	0.2	0.0	0.8	0.0	0.0	11.7	1.6	2.9	0.0	0.1	15.8	0.9	1.9	1.7	1.8	59.3	0.2	0.0	26.6	3.8	7.1	2.3	1.3	14.2	2.2	0.5	9.5	0.0	0.4	3.1	2.0	2.6	2.9	9.5	0.6	3.7	1.8	1.0	0.7	0.3	3.1	0.5	0.5	0.2	0.1	0.0	20.4	0.4	0.2	0.0	0.0	0.2	0.0	0.2	4.3	63.7	24.3	11.0	1.1	2.2	3.7	0.7	5.6	1.3
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335766-96377091	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.2;lymphoid tissue: 37.4;testis: 35.4"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 26.3;Spermatocytes: 89.3;Spermatogonia: 29.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 6.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.2	0.7	0.3	9.9	0.4	35.2	1.8	0.9	0.9	1.3	0.1	7.7	5.6	0.9	0.2	6.3	0.5	1.6	0.4	0.3	0.2	0.4	1.0	1.1	20.3	0.1	0.0	0.3	0.3	0.5	0.2	5.2	0.3	0.4	9.3	1.8	1.5	0.2	0.3	4.7	6.2	2.8	0.0	3.7	3.6	35.4	0.1	37.4	0.4	0.1	22.0	2.6	2.0	0.3	134.1	52.0	115.1	60.6	3.9	6.1	80.8	58.7	40.3	115.1	118.4	93.5	71.5	121.0	41.8	26.6	106.2	57.2	100.2	39.6	117.2	110.0	63.4	123.7	49.3	74.5	0.7	112.2	101.3	1.8	4.2	89.1	35.9	10.2	46.6	89.7	89.5	88.8	53.0	59.5	183.8	104.2	85.9	57.6	56.6	133.4	106.7	95.5	23.6	49.6	71.2	52.3	34.8	46.5	19.9	42.4	36.6	80.0	24.1	83.5	126.3	76.9	101.9	44.4	70.1	134.0	33.7	111.5	95.3	3.8	0.0	0.2	0.8	0.9	0.1	0.9	1.2	1.0	0.4	0.9	0.0	0.4	0.3	0.1	0.0	0.0	6.2	0.5	0.3	0.4	0.9	0.9	0.3	0.2	0.1	0.0	0.3	0.0	0.1	0.3	4.9	0.0	0.0	0.0	3.5	0.6	0.7	1.9	1.2	0.4	1.0	0.8	0.5	0.0	1.6	0.0	8.4	9.4	2.0	2.1	0.0	0.5	5.9	1.7	0.9	1.8	0.0	16.4	0.4	0.0	16.3	1.8	4.1	1.2	1.3	5.5	1.4	0.4	8.5	0.0	0.3	2.8	0.0	3.8	3.7	4.9	0.9	2.2	1.8	0.0	0.2	8.5	0.0	0.5	1.0	0.2	0.1	0.4	26.3	0.7	0.4	0.0	1.6	2.3	0.0	0.2	3.5	89.3	29.4	8.8	0.9	1.9	5.1	0.6	5.7	1.1
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 424.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.7;Inhibitory neurons: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	10.7	23.9	197.0	9.4	424.1	4.9	9.8	51.0	360.4	20.5	0.0	16.9	5.3	17.1	6.5	12.1	16.1	9.7	23.1	364.2	118.3	13.4	10.3	11.8	9.6	114.1	115.9	18.9	10.0	10.6	38.7	6.7	112.0	17.2	3.4	21.3	11.0	11.3	14.6	10.1	10.6	9.6	168.3	11.4	14.9	15.3	215.9	7.4	16.6	9.0	6.6	16.2	15.9	191.3	17.3	20.5	16.8	26.6	23.8	29.4	11.6	22.3	22.9	23.0	18.3	20.6	24.8	19.6	21.1	20.7	16.5	26.0	16.6	27.1	8.4	19.2	34.3	24.4	32.2	10.7	33.0	22.3	26.9	28.2	22.2	40.7	16.3	18.9	12.3	11.6	26.9	30.4	18.9	31.0	20.5	14.2	75.7	19.1	35.6	16.6	9.4	25.4	15.6	19.0	20.9	30.0	25.4	23.2	32.1	13.3	22.2	14.4	17.0	29.1	20.9	21.5	30.9	42.4	32.6	14.7	36.3	35.1	27.1	0.0	2.6	0.4	1.6	1.5	2.0	3.7	2.5	2.5	1.5	1.4	3.3	2.9	0.3	1.8	2.6	0.9	1.5	3.8	197.0	424.1	51.0	360.4	364.2	118.3	114.1	115.9	112.0	168.3	215.9	191.3	3.8	3.2	12.0	15.7	1.9	3.4	0.5	4.0	1.8	4.7	5.8	7.1	13.8	2.8	12.6	7.3	0.0	5.6	2.0	2.9	1.9	3.7	2.5	3.9	8.1	4.4	3.6	2.1	39.7	4.4	2.6	6.1	8.6	5.1	3.8	6.5	3.3	4.3	3.5	6.7	35.0	3.5	6.1	6.7	1.0	1.4	6.5	2.6	5.4	12.2	1.7	2.1	2.1	9.5	16.4	3.8	2.1	4.1	6.5	0.6	0.8	4.7	14.7	2.9	0.0	1.7	5.4	5.1	2.2	2.7	3.0	5.6	4.9	8.0	1.7	0.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555562-183590876	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.9;lung: 74.6;lymphoid tissue: 78.8"	"Group enriched"	"Detected in many"	5	"Ductal cells: 68.6;Hofbauer cells: 212.0;Kupffer cells: 137.9;Langerhans cells: 129.5;Macrophages: 194.4;monocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 26.4;HMC-1: 21.4;hTERT-HME1: 51.6;RPMI-8226: 20.0;U-2 OS: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA		12000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	29.9	5.8	2.7	76.9	3.0	191.9	7.0	3.2	14.6	9.5	4.5	10.4	8.5	4.1	1.6	7.6	8.0	23.8	5.6	2.3	3.9	3.7	12.7	74.6	17.3	6.2	4.2	2.1	4.6	2.8	2.7	39.7	6.8	2.9	12.5	0.8	6.6	3.5	3.7	15.9	12.4	20.4	4.5	78.8	5.8	2.1	12.0	11.3	3.0	11.5	16.9	24.2	5.9	7.8	26.4	0.8	0.0	0.0	0.0	0.0	0.3	1.9	2.4	3.4	1.6	0.2	0.8	3.2	4.3	0.8	0.6	14.3	0.1	19.0	3.1	16.2	0.0	0.0	7.3	6.0	0.0	2.0	21.4	0.0	4.1	3.4	51.6	2.2	0.0	0.1	0.0	5.6	5.8	0.2	0.2	1.1	0.4	1.5	1.5	7.0	2.2	20.0	0.8	0.2	0.0	0.1	0.3	0.1	0.9	1.7	2.8	9.1	1.2	0.1	50.2	0.0	4.9	0.9	1.4	0.6	0.4	10.3	0.0	199.5	489.2	1313.6	1.0	348.8	1.6	14.1	4.0	1.6	246.0	10.8	2.2	1.3	799.7	2.1	326.1	13.5	11.1	298.9	2.7	3.0	3.2	14.6	2.3	3.9	6.2	4.2	6.8	4.5	12.0	7.8	0.7	9.6	15.7	0.0	8.4	5.5	0.2	13.7	1.8	0.3	0.1	0.3	1.3	7.2	17.3	0.0	0.0	1.0	9.6	0.1	3.9	68.6	1.1	1.9	0.5	3.5	0.0	1.7	0.3	3.9	1.1	2.0	0.5	1.3	7.6	0.0	3.3	1.0	212.0	0.0	0.3	0.2	26.4	137.9	129.5	2.9	0.6	194.4	7.2	3.7	223.6	0.0	6.2	0.0	0.2	27.3	2.6	0.0	3.2	0.6	0.0	0.3	32.0	0.7	13.1	0.7	6.8	0.1	0.6	0.6	4.3	1.9	3.7	0.2	0.0	1.2
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	10	"B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7"					"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	0.5	0.0	0.0	2.9	0.0	4.0	0.2	0.0	0.1	0.1	0.0	0.4	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	1.0	1.8	5.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.2	5.6	0.0	0.0	16.1	0.4	0.7	0.1	2.0	0.3	0.0	4.9	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.5	0.0	98.8	0.1	274.3	65.2	12.1	53.9	0.3	51.8	5.7	30.1	0.9	76.6	0.6	0.6	20.3	31.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	1.9	0.0	43.6	3.4	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.0	1.3	0.0	0.0	0.1	110.4	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	2.7	0.0	0.0	0.2	0.3	0.5	0.1	8.9	0.0	1.4	0.4	0.4	0.0	0.0	0.0	0.0	2.5	2.9	0.2	0.3	1.2	3.6	0.0	1.6	0.0	166.9	0.0	0.1	0.0	0.1	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.1	1.7	0.1	55.5	0.0	0.1	0.0
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172404-130237303	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 272.0;intestine: 123.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.9;Horizontal cells: 112.7;Inhibitory neurons: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		10000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	8.3	26.2	183.3	13.4	96.0	8.4	5.1	0.0	227.7	22.6	0.0	123.6	5.2	70.7	5.7	40.6	29.3	13.9	12.6	272.0	20.8	17.6	2.8	9.5	1.9	17.0	23.4	10.8	4.9	2.3	14.5	1.7	16.6	36.1	10.1	8.5	8.1	65.1	3.1	18.3	19.8	58.6	2.3	1.2	25.1	3.1	75.5	4.2	32.8	1.9	3.8	63.8	20.8	85.8	25.6	50.8	25.9	51.9	15.9	35.3	12.3	64.3	29.6	48.2	32.0	24.3	12.8	0.1	22.8	81.6	56.5	45.2	42.5	56.3	21.5	75.3	13.0	0.1	32.3	26.5	24.4	2.2	30.2	41.2	28.0	54.7	34.4	42.9	46.2	9.9	18.8	0.3	70.8	73.1	4.9	25.6	39.6	13.7	21.2	0.1	81.5	17.3	47.4	15.9	67.9	63.9	39.5	18.7	37.7	19.4	34.8	16.2	36.7	92.9	75.4	75.5	84.1	0.1	0.1	0.2	108.7	7.1	102.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	183.3	96.0	0.0	227.7	272.0	20.8	17.0	23.4	16.6	2.3	75.5	85.8	0.5	0.0	0.0	26.1	0.1	9.7	10.5	16.6	15.4	7.7	3.0	10.0	2.9	1.5	6.3	11.0	4.2	0.1	5.3	0.8	5.9	7.9	0.4	27.8	10.5	1.0	1.2	14.7	40.9	2.9	1.6	9.1	1.1	12.4	3.8	4.4	0.7	0.5	3.7	112.7	42.5	1.0	0.0	0.6	5.8	0.9	1.2	2.5	5.4	2.8	9.8	19.2	0.0	8.0	7.8	5.3	0.1	1.5	1.3	11.0	0.2	17.3	9.7	4.3	0.0	4.2	19.0	0.0	1.9	6.0	7.0	0.5	2.6	1.2	0.5	3.3
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237175-133302022	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 613.9"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 571.9;Distal enterocytes: 405.4;Horizontal cells: 588.9;Suprabasal keratinocytes: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 606.9;hTERT-HME1: 1226.9;U-87 MG: 772.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol		NA	NA		200000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	161.2	72.9	299.1	55.9	523.6	130.0	107.6	413.5	300.2	169.4	132.8	130.0	242.2	92.9	34.3	343.1	106.4	87.8	99.8	254.5	316.6	192.4	49.6	116.6	38.7	523.2	500.0	126.1	52.8	69.1	82.2	110.8	476.8	354.3	77.8	86.0	130.8	60.0	28.2	262.6	258.1	61.9	333.7	39.4	154.0	28.1	423.1	55.1	80.5	44.6	88.1	105.5	273.8	613.9	191.6	24.0	1.7	0.8	116.3	86.8	26.0	13.7	103.0	9.8	52.5	12.5	27.6	1.5	133.0	58.0	21.9	62.4	1.7	316.8	18.0	13.3	226.8	1.9	55.6	14.7	46.3	7.0	4.6	79.2	606.9	51.2	1226.9	124.2	45.2	27.9	2.0	138.3	17.2	11.0	19.1	20.8	3.0	69.8	155.8	1.7	19.4	86.2	29.7	28.0	13.8	13.0	31.0	312.1	73.3	48.6	1.3	20.0	58.5	84.4	43.6	40.7	10.4	96.3	280.3	0.8	772.5	69.5	161.5	10.9	4.3	0.0	5.8	3.4	9.1	1.6	5.3	6.9	6.0	1.4	3.9	3.1	4.0	1.5	4.2	13.0	8.1	3.7	299.1	523.6	413.5	300.2	254.5	316.6	523.2	500.0	476.8	333.7	423.1	613.9	123.0	144.2	47.4	14.4	23.6	571.9	141.3	207.3	42.1	68.8	28.6	31.2	20.6	80.1	102.9	187.6	2.1	12.8	68.1	405.4	33.2	33.2	5.3	57.4	59.0	217.7	22.1	17.4	7.7	13.7	138.2	90.5	151.4	167.7	22.2	41.0	112.8	64.0	16.5	588.9	5.7	140.9	83.4	31.1	109.5	5.9	49.0	42.7	101.4	28.1	25.7	81.2	14.4	20.6	136.2	62.9	155.9	44.0	23.5	264.3	402.5	87.5	38.7	40.3	46.0	65.2	44.3	1.2	7.1	113.0	667.4	43.4	45.7	32.6	124.7	280.8
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 380.7;heart muscle: 352.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 433.0;Horizontal cells: 516.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 32.5;GAMG: 28.6;hTERT-RPE1: 26.8;HUVEC TERT2: 21.0;SCLC-21H: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	16.4	128.8	122.7	2.9	136.0	0.1	11.4	239.4	248.6	25.3	0.0	6.5	3.7	25.5	6.8	20.8	8.0	3.6	352.7	195.0	170.4	1.6	1.0	17.7	4.1	379.4	113.0	1.8	2.7	12.0	71.6	2.0	380.7	3.1	3.2	115.5	5.3	30.2	8.7	21.5	3.9	13.3	41.6	21.9	4.1	48.1	190.9	4.5	2.7	3.6	4.0	3.7	57.5	91.7	0.2	16.9	15.8	3.1	0.4	2.9	1.3	5.2	8.2	2.5	1.7	6.5	4.3	0.4	32.5	4.0	28.6	1.5	1.2	0.9	2.2	0.0	3.3	0.7	3.3	4.7	4.4	0.3	0.3	3.6	0.3	1.6	0.0	26.8	21.0	0.1	0.3	0.2	2.4	4.3	1.7	0.2	1.4	0.6	12.4	0.4	4.4	0.4	0.7	10.6	49.2	18.4	0.5	1.4	0.1	2.0	0.6	0.2	7.7	2.1	6.0	0.6	0.8	0.9	0.5	5.7	11.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.7	136.0	239.4	248.6	195.0	170.4	379.4	113.0	380.7	41.6	190.9	91.7	8.9	0.0	1.9	53.5	0.2	2.0	6.8	0.6	1.2	52.3	0.7	1.5	433.0	0.0	0.3	0.0	4.2	0.0	0.1	0.6	0.0	4.0	5.9	4.0	5.6	17.0	1.8	0.0	95.7	0.2	0.1	10.1	1.5	11.5	0.0	13.6	29.3	0.3	0.0	516.5	94.3	0.1	2.0	1.0	1.2	10.8	4.4	0.3	7.2	22.5	0.0	82.6	0.0	29.7	14.1	3.7	0.0	2.6	0.0	4.9	0.0	0.2	0.2	33.4	6.6	3.5	6.7	4.8	6.5	14.5	5.8	0.0	0.3	0.3	0.0	8.8
NDUFA4	"CI-9k, COXFA4, MLRQ"	ENSG00000189043	"NDUFA4 mitochondrial complex associated"	O00483	7	10931943-10940153	"Disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 513.5;skeletal muscle: 525.0;tongue: 652.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4615.5;Distal tubular cells: 3960.0;Proximal tubular cells: 3331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055323, HPA078265"	Approved		Supported	Mitochondria		NA	NA		50000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA055323: , HPA078265: "	"unprognostic (1.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (4.61e-8)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.08e-1)"	78.6	90.1	188.7	40.8	196.2	67.5	76.0	192.9	263.4	54.7	192.8	84.1	74.2	74.2	81.1	66.9	69.5	36.2	513.5	201.9	205.0	156.6	140.3	62.8	42.5	194.4	189.6	60.1	61.3	251.9	23.3	31.6	197.6	66.0	56.6	128.4	108.6	84.4	525.0	58.3	58.8	60.9	194.1	59.6	107.0	24.3	194.3	64.0	66.3	652.5	46.1	73.7	54.1	200.1	55.3	90.9	155.0	176.8	84.0	78.4	70.3	68.2	63.2	61.3	53.6	115.2	144.7	104.6	63.0	96.7	168.0	94.1	102.1	79.4	66.5	52.2	74.0	88.2	93.4	108.6	73.2	123.3	84.3	84.8	78.4	75.4	66.0	116.7	86.6	92.7	133.2	139.0	129.8	103.8	56.2	109.3	169.2	364.2	181.6	74.7	108.6	118.6	158.0	115.4	95.2	99.7	106.9	303.7	64.7	210.3	191.6	149.6	76.8	73.3	102.0	107.0	115.0	84.6	115.8	120.5	101.3	130.8	232.5	236.7	110.2	160.6	74.3	135.8	88.3	95.7	103.3	93.9	138.9	74.6	106.1	93.3	25.3	79.4	146.4	131.2	131.6	192.8	188.7	196.2	192.9	263.4	201.9	205.0	194.4	189.6	197.6	194.1	194.3	200.1	422.2	490.4	470.7	52.9	366.9	407.1	605.8	1642.7	307.9	521.0	742.3	936.0	4615.5	843.6	879.3	952.7	266.9	875.9	357.5	543.8	3960.0	865.1	160.6	626.2	471.6	447.0	209.7	358.3	54.1	955.5	763.9	557.9	404.7	477.7	576.4	507.5	656.1	1887.5	964.5	158.2	72.7	780.8	1373.2	589.0	589.8	106.8	493.6	517.6	916.0	49.6	596.6	721.5	374.9	36.7	57.9	776.6	626.7	784.3	467.9	696.6	596.2	3331.1	803.0	666.0	335.2	546.5	846.5	172.7	295.5	581.7	482.9	658.8	389.1	443.5	712.4	803.2
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968244-84002776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 106.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	66	"neutrophil: 55.4"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2"	"Low region specificity"	"Detected in all"							"HPA013998, HPA014144, CAB068211"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	0.9	0.5	67.8	0.6	73.0	0.5	0.7	20.3	106.4	2.0	24.9	1.3	1.2	1.2	0.3	0.1	0.4	0.5	1.2	80.5	62.0	11.1	26.0	0.5	0.2	32.1	50.7	0.5	1.9	6.7	16.2	0.3	80.2	0.3	0.2	3.1	0.1	0.1	0.2	0.2	1.2	0.4	24.9	1.6	1.8	10.5	59.4	0.2	0.5	0.2	0.0	0.3	0.2	31.4	0.2	4.4	10.1	0.0	0.0	1.4	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.0	1.6	0.2	0.8	0.0	1.9	0.0	0.0	0.1	2.9	0.0	0.0	0.5	0.1	0.0	1.7	0.5	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.0	6.8	0.0	0.0	5.0	0.4	0.6	0.1	0.0	0.6	0.0	0.0	37.6	1.5	0.0	0.2	3.1	1.4	5.2	1.4	0.3	0.2	2.8	0.4	0.0	0.1	0.0	0.0	12.2	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.1	67.8	73.0	20.3	106.4	80.5	62.0	32.1	50.7	80.2	24.9	59.4	31.4	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	16.6	0.0	0.1	0.1	7.2	0.0	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	10.7	3.4	0.0	22.2	0.0	0.0	0.0	0.0	49.2	0.3	0.3	0.0	3.7	0.2	17.8	0.0	4.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	27.8	0.0	0.3	0.0	0.1	0.0	2.1	3.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889223	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 136.6;Ductal cells: 215.6;Exocrine glandular cells: 154.2;Glandular and luminal cells: 126.1;Pancreatic endocrine cells: 241.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 10.4"	"Lineage enhanced"	"Detected in many"		"granulocytes: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"		NA	Yes		5900000	"Cluster 52: Eosinophils - Transcription"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	71.4	79.1	30.8	32.1	28.4	15.8	66.0	29.8	34.3	41.7	44.3	42.3	55.3	45.0	58.2	76.3	43.9	52.5	71.3	29.2	33.1	79.6	118.5	72.9	15.8	35.8	33.0	41.7	55.0	61.5	39.1	77.2	32.9	69.2	32.8	16.7	62.6	30.4	20.1	52.5	47.5	31.3	31.8	58.1	75.4	65.8	34.7	6.9	57.4	17.7	25.3	55.8	49.3	28.9	73.8	89.3	118.3	140.6	59.3	35.8	123.7	62.6	83.9	120.4	136.6	194.8	171.0	0.6	79.2	79.0	61.1	98.5	106.6	55.6	91.7	3.2	53.2	43.0	30.8	128.6	145.0	0.7	117.9	64.9	22.5	56.2	44.8	123.2	149.3	3.0	71.1	0.7	59.2	146.4	0.6	5.6	92.8	249.8	27.7	4.3	37.7	3.2	139.5	100.1	5.4	15.2	74.9	127.0	28.7	210.4	97.2	47.1	140.1	31.3	105.5	23.7	48.6	9.0	25.8	0.6	57.3	10.0	83.0	1.8	2.0	10.4	0.0	0.7	0.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.8	0.0	0.4	0.3	0.0	0.7	30.8	28.4	29.8	34.3	29.2	33.1	35.8	33.0	32.9	31.8	34.7	28.9	136.6	35.3	31.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	108.4	54.9	0.0	0.0	6.8	58.8	0.0	109.3	2.6	0.0	3.9	215.6	0.0	73.8	66.3	58.8	0.0	0.0	0.0	154.2	97.8	30.4	0.0	126.1	3.8	75.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	80.1	0.0	0.0	0.0	0.0	241.8	0.0	0.0	0.1	0.0	0.0	27.1	3.6	0.0	0.0	0.0	42.9	0.0	0.0	0.0	0.0	101.8	2.2	58.3	0.0	0.0
NEFH	"NF-H, NFH"	ENSG00000100285	"Neurofilament heavy"	P12036	22	29480218-29491390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 544.0;prostate: 245.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 20.9;monocytes: 34.6;Prostatic glandular cells: 44.0;Spermatogonia: 29.5;Theca cells: 49.7"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 130.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.7"	"Cell line enriched"	"Detected in many"	5	"SiHa: 182.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 1241.2"	"CAB007786, HPA061615"	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"CAB007786: AB_598179, HPA061615: AB_2684568"	"prognostic favorable (2.33e-6)"	"unprognostic (6.17e-3)"	"unprognostic (9.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.47e-1)"	0.6	21.1	17.7	1.6	18.9	0.6	1.4	143.1	544.0	0.6	0.0	1.4	0.4	0.5	0.7	0.3	0.5	0.4	0.4	7.8	57.3	0.9	0.3	0.4	0.9	494.1	56.2	20.0	0.3	0.9	15.4	0.6	376.1	245.9	0.5	39.6	0.9	0.6	0.3	0.2	0.9	1.0	58.3	1.2	0.6	7.7	172.9	0.7	0.3	0.3	1.0	0.4	1.2	147.3	0.0	0.0	2.4	0.6	0.1	0.3	1.8	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.9	9.5	0.1	0.0	0.0	0.0	9.0	34.2	0.1	24.2	0.0	1.4	0.2	10.5	3.5	0.0	0.5	0.0	0.0	1.3	0.0	28.0	0.0	11.7	0.0	12.0	1.2	17.4	0.0	0.0	0.1	0.1	1.9	0.0	0.0	1.5	19.5	182.2	0.1	0.0	5.9	0.0	9.9	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.0	0.4	2.7	0.8	0.1	0.5	0.4	0.6	0.0	0.1	0.5	0.0	0.2	4.7	0.1	0.2	0.6	17.7	18.9	143.1	544.0	7.8	57.3	494.1	56.2	376.1	58.3	172.9	147.3	0.7	0.0	0.0	3.9	1.0	0.1	1.0	0.1	2.2	3.2	1.4	5.3	0.9	1.5	0.0	1.8	2.1	1.4	1.6	0.5	0.0	0.2	0.4	0.3	7.7	1.0	0.0	5.9	13.6	0.4	1.1	2.4	0.0	0.8	1.3	8.8	0.0	0.0	5.6	8.4	20.9	0.0	0.0	4.2	2.3	1.0	5.9	5.2	1.8	5.6	34.6	3.6	0.0	2.0	2.6	0.3	0.0	3.0	1.7	44.0	0.2	1.0	0.0	9.9	6.6	1.3	2.0	4.4	29.5	3.0	0.1	0.4	1.7	49.7	0.2	0.7
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24956721	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 675.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 32.7;Distal tubular cells: 103.7;Enteroendocrine cells: 33.3;Excitatory neurons: 64.6;Horizontal cells: 30.3;Rod photoreceptor cells: 110.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2"	"Lineage enriched"	"Detected in single"	113	"T-cells: 11.2"	"Group enriched"	"Detected in some"	4	"HEK 293: 456.2;PC-3: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nucleoplasm,Intermediate filaments,Midbody"		Yes	NA		200000	"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Intermediate filaments"	Midbody	"HPA014850: AB_1854397, HPA015021: AB_2669135"	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.1	18.0	35.4	1.3	36.7	0.0	0.0	103.6	675.9	2.0	0.0	2.5	0.6	0.1	0.3	5.4	1.3	0.1	0.1	50.9	75.6	5.0	0.0	0.0	0.1	425.7	41.1	0.2	0.2	0.1	4.0	0.0	231.3	1.8	1.5	89.5	0.0	15.6	0.0	0.9	1.9	1.1	33.9	0.2	0.8	1.7	216.1	12.7	0.7	0.1	0.3	0.0	1.4	184.0	0.0	0.6	68.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.6	0.0	0.0	456.2	0.0	0.0	0.0	21.6	0.0	1.0	8.3	2.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	18.8	0.0	145.4	0.0	0.0	0.0	31.7	4.2	30.9	31.6	11.2	0.0	1.9	2.2	0.0	0.0	0.0	2.2	31.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.2	1.5	35.4	36.7	103.6	675.9	50.9	75.6	425.7	41.1	231.3	33.9	216.1	184.0	0.1	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.6	32.7	0.0	0.0	3.2	0.0	0.0	0.0	8.4	0.0	0.1	0.1	103.7	0.1	0.4	0.1	0.3	3.7	33.3	0.0	64.6	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	30.3	29.1	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	27.2	0.1	27.8	0.0	14.6	18.4	0.0	0.1	9.4	0.0	0.0	0.0	0.2	0.0	110.0	0.0	0.1	0.2	0.0	13.2	1.5	0.0	0.0	1.6	1.4	0.0	0.0
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913758-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 689.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.6;Excitatory neurons: 46.6;Late spermatids: 114.6;Rod photoreceptor cells: 69.1;Spermatocytes: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	25	"HEK 293: 3890.8"									"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA		220000		"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	0.3	19.5	61.1	0.9	27.9	0.0	0.1	150.0	689.9	9.6	0.0	2.8	0.1	4.0	0.0	4.0	5.3	0.2	0.2	57.7	54.0	1.9	0.1	0.2	0.1	610.3	89.1	1.7	2.0	0.0	17.9	0.2	487.1	1.5	0.7	90.8	0.3	27.6	1.7	0.6	1.3	2.5	86.8	0.1	0.9	18.9	430.5	1.7	0.1	0.7	0.5	0.4	6.5	203.6	0.0	0.0	154.3	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3890.8	0.0	0.0	0.0	79.4	0.0	0.1	2.4	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.2	5.9	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	3.7	32.6	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	27.9	150.0	689.9	57.7	54.0	610.3	89.1	487.1	86.8	430.5	203.6	3.1	0.0	0.0	12.4	0.0	1.3	0.2	0.1	9.1	30.9	1.1	21.2	2.4	0.0	0.6	0.0	6.2	0.0	3.2	0.1	0.0	0.1	92.6	0.7	19.5	2.9	3.5	0.0	46.6	0.2	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	20.2	17.5	0.0	0.0	0.0	0.7	114.6	0.9	0.7	1.8	13.1	0.0	22.8	0.0	9.5	13.6	0.0	0.0	4.5	0.4	0.3	0.0	0.4	0.0	69.1	0.0	3.3	5.7	43.8	1.0	14.0	0.3	0.0	4.1	0.0	0.1	0.4
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309874-177362936	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 6.6;lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 14.7;Granulosa cells: 4.8;Plasma cells: 6.1;Squamous epithelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 72.1;HL-60: 79.1;Karpas-707: 99.1;MOLT-4: 80.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.3"	HPA065761			Enhanced	Nucleoplasm		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.1	0.0	0.0	1.7	0.0	6.6	0.3	0.0	0.1	0.2	0.0	1.1	1.1	0.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	2.3	1.3	0.5	0.0	0.4	0.6	1.5	0.1	23.6	0.0	0.0	3.5	0.4	0.4	0.0	19.3	15.8	16.4	8.2	1.8	3.3	8.0	23.4	8.6	25.3	14.9	5.8	16.5	21.2	3.4	6.2	25.1	8.8	17.4	9.3	36.6	72.1	11.4	14.7	11.9	15.2	0.5	79.1	9.7	0.3	0.5	26.2	5.6	5.2	9.9	53.9	15.3	99.1	16.7	8.4	80.7	30.2	7.5	5.7	11.5	16.2	11.2	6.8	6.8	2.6	12.8	8.9	11.7	13.4	6.3	7.2	10.9	20.4	4.7	15.2	11.8	7.8	24.0	6.8	4.8	33.5	10.1	27.8	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.4	1.2	0.0	0.2	0.1	0.4	0.0	1.3	0.0	0.0	2.6	1.6	0.5	0.0	0.0	0.1	0.1	0.6	0.3	0.0	14.7	0.1	0.2	3.3	0.9	0.0	0.5	0.0	4.8	0.4	0.0	1.5	0.0	0.1	1.0	0.0	1.3	0.4	0.2	0.0	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	6.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.5	2.7	2.4	4.5	1.3	0.3	1.0	0.5	1.2	0.2
NEK2	"NEK2A, NLK1, PPP1R111, RP67"	ENSG00000117650	"NIMA related kinase 2"	P51955	1	211658657-211675630	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.9;lymphoid tissue: 19.2;testis: 67.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 76.1;Spermatocytes: 244.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.7"	"Low region specificity"	"Detected in all"			"CAB017530, HPA064967"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Centrosome"		"CAB017530: AB_1126558, HPA064967: AB_2685393"	"unprognostic (1.28e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (9.47e-6)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.09e-3)"	"unprognostic (8.49e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.21e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.71e-1)"	0.7	0.4	0.5	5.3	0.4	17.9	1.5	0.9	0.6	1.1	0.6	5.9	7.4	1.3	0.5	4.4	2.2	0.8	0.4	0.5	0.3	0.3	0.7	0.7	9.0	0.4	0.2	0.4	0.1	0.1	0.0	3.2	0.3	2.5	7.6	1.5	0.8	0.2	0.4	4.3	6.9	2.0	0.2	1.7	2.7	67.1	0.6	19.2	0.4	0.2	10.6	1.3	1.6	0.9	86.0	60.5	45.3	32.6	2.6	4.5	49.7	32.4	30.1	55.4	47.5	32.3	81.7	45.1	15.2	25.2	35.1	44.5	39.9	24.2	69.6	69.5	33.2	21.6	51.4	44.2	0.4	43.2	28.3	1.4	2.9	42.9	45.9	13.4	36.3	45.2	59.9	76.9	56.0	23.6	47.3	28.8	43.0	55.0	30.5	46.2	69.2	68.7	19.7	24.2	41.0	45.0	46.6	51.5	39.3	38.4	79.4	25.1	19.0	27.6	54.1	54.8	88.3	31.6	62.6	59.6	24.1	32.6	46.8	1.2	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	0.4	0.3	0.2	0.7	1.5	0.1	0.2	1.6	0.3	0.5	0.4	0.9	0.6	0.5	0.3	0.4	0.2	0.3	0.2	0.6	0.9	0.1	0.0	0.5	0.3	1.7	2.9	0.7	3.8	0.6	11.3	1.9	2.2	0.5	0.0	2.9	0.0	0.0	9.4	0.8	1.9	0.0	0.2	76.1	15.2	0.7	0.8	0.0	39.6	0.8	0.2	14.1	1.4	5.6	1.5	0.0	3.6	3.6	0.7	5.8	3.3	0.0	3.2	10.2	2.5	1.1	39.0	2.5	2.1	0.0	0.0	0.0	1.6	2.1	0.0	0.1	0.0	2.5	0.7	5.4	0.7	2.1	0.1	5.2	1.8	6.6	0.0	1.5	244.2	26.1	8.6	1.7	1.4	2.0	0.9	9.5	1.4
NELL1	"FLJ45906, IDH3GL"	ENSG00000165973	"Neural EGFL like 1"	Q92832	11	20669551-21575686	"Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.2;kidney: 16.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 279.0;Inhibitory neurons: 175.8;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051535	Approved				"Secreted in other tissues"	NA	NA		160000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051535: AB_2681524"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.35e-4)"	"unprognostic (3.78e-4)"	"unprognostic (1.67e-2)"		"unprognostic (3.91e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.23e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.29e-1)"	0.3	0.1	4.5	0.1	5.5	0.0	0.0	0.0	8.2	0.3	0.0	0.2	0.0	0.3	1.6	0.6	0.1	0.4	0.0	10.2	2.0	16.6	0.0	0.4	0.0	2.4	1.9	0.1	0.0	0.0	3.5	0.0	2.5	5.1	0.3	0.8	0.4	2.5	0.0	0.6	0.1	0.1	0.0	0.1	0.6	1.0	1.5	1.2	0.0	0.3	0.7	0.1	0.6	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.0	0.0	0.7	0.0	0.0	0.1	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	5.5	0.0	8.2	10.2	2.0	2.4	1.9	2.5	0.0	1.5	4.2	0.1	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.8	0.7	0.0	0.0	1.8	0.0	0.8	0.0	0.0	5.9	0.0	28.8	0.8	0.1	0.0	0.0	0.0	279.0	0.0	0.0	0.2	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	175.8	0.0	0.0	0.0	0.0	22.3	0.3	0.0	0.0	13.1	0.0	0.0	0.0	323.2	7.6	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.2	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.2
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 105.5;choroid plexus: 59.5;fallopian tube: 60.1;retina: 85.2"	"Cell type enriched"	"Detected in many"	6	"Excitatory neurons: 652.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Group enriched"	"Detected in many"	15	"amygdala: 48.9;basal ganglia: 60.0;cerebral cortex: 105.5;hippocampal formation: 89.6;white matter: 42.0"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 70.4;naive CD8 T-cell: 111.1"	"Lineage enriched"	"Detected in many"	10	"T-cells: 111.1"	"Cell line enhanced"	"Detected in some"		"AF22: 104.6;HEK 293: 27.5;NTERA-2: 41.2;SCLC-21H: 75.6;U-266/70: 27.5;U-266/84: 29.5;U-698: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA		6400000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA035714: AB_2674746, HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	4.6	16.9	48.9	10.9	60.0	7.3	1.9	1.3	105.5	23.1	59.5	2.0	26.3	2.2	0.4	1.2	60.1	1.9	0.4	89.6	4.5	1.2	1.0	5.0	20.7	0.0	0.0	0.8	0.9	0.2	34.6	0.3	0.0	27.2	2.1	85.2	1.4	2.0	0.3	13.4	15.3	2.8	0.0	6.2	2.9	3.0	0.8	8.7	6.5	0.6	15.7	4.1	4.2	42.0	0.3	0.1	104.6	3.5	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	8.3	12.4	0.0	0.0	0.2	25.3	0.2	0.0	0.0	27.5	0.4	8.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	1.6	0.2	0.4	0.0	0.4	0.2	0.4	41.2	0.0	14.0	0.2	12.7	0.2	0.0	0.0	75.6	1.8	0.0	0.4	0.0	1.3	0.1	0.7	0.0	0.4	3.8	0.1	2.1	27.5	29.5	40.3	0.2	0.2	0.4	0.2	0.2	0.0	5.0	0.1	24.9	0.2	30.3	52.9	0.1	0.1	70.4	111.1	0.5	11.0	0.1	0.1	0.4	26.7	48.9	60.0	1.3	105.5	89.6	4.5	0.0	0.0	0.0	0.0	0.8	42.0	0.3	0.0	1.3	48.0	1.0	1.1	0.0	0.0	5.7	35.4	0.4	0.6	0.5	2.8	6.2	0.0	33.3	0.1	2.5	5.8	0.0	0.0	0.4	0.7	0.8	0.7	0.0	0.0	652.4	0.2	0.3	3.7	0.0	0.3	0.0	49.4	0.0	0.0	0.1	1.7	108.4	0.9	0.0	0.0	1.5	1.0	0.0	0.4	0.0	18.7	1.3	7.9	1.0	74.4	16.5	0.4	0.4	0.4	0.5	0.3	18.5	0.2	21.9	58.3	0.0	4.1	4.6	1.9	4.2	0.2	1.1	0.1	23.4	0.1	2.9	0.1
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 75.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.9	0.2	2.3	0.1	2.5	3.5	0.2	2.2	4.4	0.5	0.6	15.5	10.7	0.2	0.0	0.0	0.7	0.4	0.3	2.1	2.5	1.8	75.8	0.4	0.0	5.0	2.8	0.3	0.1	0.0	1.1	0.0	2.7	0.4	2.2	0.1	0.8	0.0	9.0	0.1	9.2	0.0	2.6	0.3	0.1	0.7	2.7	0.0	0.3	0.8	0.0	0.1	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.5	2.2	4.4	2.1	2.5	5.0	2.8	2.7	2.6	2.7	2.9	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 146.9;tongue: 60.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"intermediate monocyte: 45.1;non-classical monocyte: 112.0"	"Lineage enriched"	"Detected in many"	19	"monocytes: 112.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	0.5	4.6	25.5	3.8	29.6	2.2	0.4	20.8	37.4	14.1	0.0	15.2	10.9	25.8	15.1	4.3	2.6	1.9	0.5	32.2	7.2	2.4	1.2	0.9	0.8	1.7	4.1	1.9	18.8	8.3	15.9	4.6	1.3	1.4	10.3	39.5	2.9	1.3	146.9	1.8	17.2	5.2	0.0	1.9	5.2	13.0	5.0	1.1	0.5	60.5	0.5	18.7	2.6	17.2	0.9	0.2	1.3	0.0	0.2	0.1	13.7	0.5	0.9	0.2	0.1	0.3	0.2	0.4	0.7	0.1	0.9	0.6	0.4	0.2	0.1	0.4	0.8	0.2	8.6	0.3	0.0	0.3	6.9	0.2	0.5	0.1	0.7	0.2	0.0	7.4	2.3	0.5	0.2	1.2	1.4	0.9	0.0	0.5	4.2	0.2	0.7	1.5	0.0	0.5	17.1	5.9	8.8	0.0	0.4	2.5	0.7	1.7	0.0	0.1	0.9	0.3	0.2	1.0	0.2	0.3	0.5	0.0	0.4	0.8	2.8	0.5	0.7	45.1	1.1	1.1	1.0	1.1	5.8	0.7	1.2	0.8	2.3	0.6	112.0	4.7	0.4	4.1	25.5	29.6	20.8	37.4	32.2	7.2	1.7	4.1	1.3	0.0	5.0	17.2	0.3	0.0	0.6	1.3	1.5	0.5	1.5	0.2	0.0	53.2	2.0	2.7	1.6	0.0	0.2	0.0	93.8	4.6	3.1	7.9	0.0	12.0	128.7	0.0	0.8	2.2	78.3	4.6	47.9	0.7	12.9	2.2	13.3	0.1	0.0	1.2	0.0	0.2	4.5	3.3	32.9	105.4	32.6	4.6	2.4	461.2	5.6	4.8	0.0	0.0	5.5	9.0	2.1	1.0	4.2	0.5	183.4	5.3	0.6	1.3	7.2	0.0	0.2	88.0	6.6	2.4	1.0	56.6	33.6	0.0	1.8	113.4	1.7	8.4	9.4	0.7
NEXN	"NELIN, nexilin"	ENSG00000162614	"Nexilin F-actin binding protein"	Q0ZGT2	1	77888513-77943895	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 404.8;skeletal muscle: 676.9;tongue: 548.9"	"Cell type enriched"	"Detected in many"	6	"Cardiomyocytes: 2329.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 152.2;LHCN-M2: 135.1;RH-30: 108.5"	"Region enhanced"	"Detected in all"		"basal ganglia: 40.4"	"Group enriched"	"Detected in all"	4	"basal ganglia: 9.0;midbrain: 13.4;pons: 10.0;thalamus: 25.2"	"HPA011185, HPA011904"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA		2900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA011185: AB_1854409, HPA011904: "	"unprognostic (9.73e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.25e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.68e-2)"	42.8	22.3	2.3	24.5	3.1	0.6	16.2	1.7	1.6	21.9	2.5	89.2	10.2	79.0	10.7	49.4	47.5	28.7	404.8	1.3	1.8	8.0	5.6	25.2	5.6	1.4	3.3	15.2	10.0	1.5	1.4	10.6	1.5	62.5	15.7	0.6	11.5	69.8	676.9	6.8	26.7	70.6	1.2	8.6	44.1	5.7	4.7	2.1	10.3	548.9	1.8	49.7	19.5	1.7	26.0	1.5	4.5	0.2	79.5	75.3	12.3	152.2	65.5	29.8	20.2	4.6	0.2	0.0	8.6	54.7	34.4	3.4	3.3	14.3	53.3	0.7	3.4	6.2	7.5	1.5	59.3	1.3	0.2	56.6	3.3	40.7	23.8	65.2	22.8	6.0	0.3	0.0	135.1	0.0	29.9	1.8	23.8	0.0	18.6	24.3	108.5	0.2	35.5	1.2	0.1	1.1	13.3	0.0	1.0	29.9	0.0	3.5	23.4	71.7	53.6	31.2	76.1	0.2	0.2	0.1	4.0	2.8	0.2	0.0	1.7	0.0	0.2	1.0	0.0	0.7	0.1	0.2	0.9	0.5	0.3	0.1	1.4	0.3	0.8	0.6	0.0	3.6	2.3	3.1	1.7	1.6	1.3	1.8	1.4	3.3	1.5	1.2	4.7	1.7	8.3	105.8	4.9	11.4	2.1	1.8	0.9	4.6	1.2	2.7	1.4	33.1	2329.6	0.0	5.4	0.0	4.2	0.8	4.1	0.4	1.9	15.3	24.0	2.6	24.2	17.4	0.0	1.7	26.6	32.4	4.0	93.2	1.1	3.2	1.3	29.7	38.6	1.5	1.2	1.7	27.6	0.5	0.0	4.4	2.2	9.0	73.3	44.9	0.0	16.9	5.8	0.7	0.0	24.6	27.3	21.8	0.1	346.1	0.3	1.3	5.3	0.7	0.4	3.8	216.9	70.4	177.2	0.7	3.6	0.8	0.9	0.3	2.3	13.0	2.1	0.4
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380407-42432403	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.9;lymphoid tissue: 19.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 11.4;Hofbauer cells: 17.0;Kupffer cells: 53.9;Macrophages: 27.2;monocytes: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 90.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 90.4;monocytes: 48.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 37.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031812	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	6.3	1.9	1.5	12.4	1.9	30.9	1.1	1.5	2.2	1.8	2.0	1.5	1.3	0.6	0.6	1.3	2.0	2.3	1.3	1.8	2.4	1.2	2.3	7.5	5.5	3.1	2.2	0.3	0.8	0.3	0.6	2.9	2.9	0.9	1.2	0.1	0.8	1.4	0.4	1.4	2.3	2.9	2.3	19.9	1.1	0.7	2.9	2.1	0.7	1.5	2.1	3.1	0.7	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	5.8	0.0	0.0	0.1	0.0	0.4	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.3	48.2	2.8	0.1	32.5	0.2	0.0	0.1	0.0	16.5	0.1	0.0	0.0	90.4	0.0	31.1	0.3	0.0	25.4	1.5	1.9	1.5	2.2	1.8	2.4	3.1	2.2	2.9	2.3	2.9	3.0	0.4	0.0	3.7	0.0	0.5	0.9	0.7	0.9	0.6	0.2	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.8	0.4	0.2	0.5	1.2	0.0	0.7	0.2	0.1	0.5	0.0	0.3	11.4	0.0	0.7	0.6	17.0	0.0	0.6	0.0	0.0	53.9	8.2	5.6	0.3	27.2	0.0	8.4	44.6	0.0	0.0	2.0	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.5	0.5	0.8	0.7	0.0	1.0	0.3	1.3	0.4	0.0	0.5
NFE2	NF-E2	ENSG00000123405	"Nuclear factor, erythroid 2"	Q16621	12	54292111-54301015	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 112.5;lymphoid tissue: 45.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 265.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 1489.2;neutrophil: 810.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1489.2"	"Group enriched"	"Detected in some"	5	"HEL: 376.9;K-562: 168.1;NB-4: 118.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001914	Enhanced		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Actin filaments"		"HPA001914: AB_1079475"	"unprognostic (2.68e-4)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.90e-6)"	"unprognostic (1.81e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.46e-2)"	3.8	0.3	0.5	6.2	0.7	112.5	0.6	0.5	1.0	1.4	1.4	0.4	0.5	0.3	0.1	0.8	2.4	1.2	1.9	0.5	0.5	1.4	2.6	13.0	0.3	0.7	0.6	0.2	0.7	1.1	0.9	4.0	0.7	0.5	0.2	0.0	0.5	0.1	1.3	4.8	0.6	1.9	0.5	45.3	0.8	1.2	0.6	1.4	1.4	3.7	0.1	2.3	0.5	0.6	0.3	0.3	0.0	0.0	0.0	0.5	1.4	1.1	6.9	0.7	0.9	5.5	10.0	0.1	0.9	0.9	0.4	0.3	0.0	0.0	0.3	0.0	0.1	376.9	0.9	9.1	0.0	5.8	48.5	0.5	0.1	0.3	0.2	4.4	0.0	0.1	168.1	0.1	0.0	0.1	15.3	118.8	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.2	0.6	1.8	1.0	18.9	0.3	0.2	0.4	1.1	0.1	0.0	0.0	0.1	0.4	23.4	0.0	1489.2	241.7	232.3	0.6	66.7	1.0	0.3	0.8	0.5	156.7	0.5	1.0	0.7	810.6	1.1	42.0	2.7	0.2	160.2	0.5	0.7	0.5	1.0	0.5	0.5	0.7	0.6	0.7	0.5	0.6	0.6	0.0	0.0	3.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.1	5.9	0.1	0.0	0.0	0.0	265.6	0.0	0.0	0.5	0.4	0.0	0.1	3.8	0.1	0.4	0.2	1.0	0.0	0.0	0.0	0.0	22.8	0.2	19.0	0.0	44.3	1.8	0.0	33.9	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.3	1.3	0.0	0.3	1.2	1.1	0.0	0.1	0.1
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423832	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 57.9;neutrophil: 26.9"	"Lineage enriched"	"Detected in many"	35	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	149.8	84.1	11.1	37.5	12.1	211.2	80.2	16.5	17.0	75.6	14.0	55.3	18.1	62.0	15.0	22.9	94.0	47.5	60.9	11.9	13.8	36.2	121.6	68.7	9.4	15.7	14.6	92.6	30.3	15.9	31.6	47.4	14.7	59.9	21.8	33.6	22.9	16.4	133.5	59.5	29.3	52.5	13.2	20.0	44.1	18.5	13.7	18.2	26.7	24.9	11.6	61.2	64.9	12.9	18.3	10.7	12.8	7.1	152.6	117.9	62.1	21.3	61.1	23.8	35.8	7.4	8.9	7.9	12.9	17.8	69.5	11.7	14.9	21.4	27.1	179.1	6.4	8.7	10.2	62.2	124.4	12.1	50.8	120.3	141.2	21.5	149.2	13.5	10.8	20.2	14.3	89.6	15.8	9.2	1.3	16.1	9.8	31.3	9.7	29.3	13.9	11.7	29.5	8.7	16.0	11.8	14.9	13.2	21.5	22.6	7.4	15.8	11.6	52.0	11.5	45.2	10.9	76.3	18.9	3.5	27.8	11.3	9.4	57.9	1.6	10.3	1.2	0.7	0.6	0.4	0.0	0.3	0.9	0.1	0.1	0.2	26.9	0.1	1.0	0.6	0.0	0.6	11.1	12.1	16.5	17.0	11.9	13.8	15.7	14.6	14.7	13.2	13.7	12.9	60.1	22.4	32.4	1.3	7.8	46.1	14.7	15.2	22.2	17.7	31.7	28.6	81.8	8.6	16.4	0.0	16.7	9.6	75.6	23.7	9.8	10.5	24.1	122.0	127.4	34.3	16.1	1.3	5.1	9.8	24.9	55.0	9.7	152.6	9.5	27.5	13.9	29.4	10.6	20.2	5.6	9.5	6.1	25.3	78.0	6.4	10.8	75.4	33.8	2.8	15.4	17.8	6.2	3.5	2.9	7.8	9.1	11.7	24.3	25.6	17.7	10.0	10.3	15.5	6.6	60.2	83.8	0.8	3.9	23.3	39.5	23.1	22.6	6.8	9.6	13.1
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 57.9;pituitary gland: 16.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 6.1;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042615, HPA058596"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.1	7.5	20.6	0.2	17.2	0.0	0.0	11.8	26.8	0.0	10.7	5.5	0.2	0.0	0.1	0.1	1.3	0.0	0.0	15.2	57.9	0.0	0.0	0.0	0.0	24.8	29.0	0.0	5.0	0.0	16.9	0.0	29.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.0	0.1	15.5	0.0	1.0	0.5	40.9	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	17.2	11.8	26.8	15.2	57.9	24.8	29.0	29.9	15.5	40.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878701-233013256	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 56.2;brain: 129.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.0;Excitatory neurons: 105.9;Proximal enterocytes: 66.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 22.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 129.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 53.9;HDLM-2: 45.3;HeLa: 21.6;PC-3: 57.0;T-47d: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 167.6;cerebral cortex: 133.8;hippocampal formation: 73.0"	HPA008160	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	1.1	56.2	16.3	2.2	129.6	0.1	1.9	0.0	59.4	4.1	0.0	14.2	42.7	5.0	4.1	10.3	4.8	3.1	2.2	19.8	0.0	7.0	35.5	0.7	0.2	0.0	0.0	2.0	6.0	11.9	2.7	0.3	0.0	1.8	10.5	1.4	2.0	0.7	0.9	30.3	31.3	6.7	0.0	0.4	10.7	3.7	0.2	0.0	0.9	0.7	0.3	1.8	5.2	29.4	53.9	15.4	0.6	0.2	0.2	8.2	0.9	0.9	0.1	0.4	0.0	0.7	5.2	0.0	15.2	10.9	5.5	6.9	11.6	3.0	0.4	45.3	3.8	0.1	21.6	16.7	0.2	0.0	0.3	0.0	0.2	3.5	0.6	0.2	1.9	0.2	0.2	0.2	0.5	4.0	0.0	0.1	1.3	0.2	57.0	0.0	0.0	0.1	1.0	1.4	1.9	0.4	6.6	3.3	0.1	2.0	32.2	0.4	0.0	0.5	4.5	0.3	1.0	0.5	0.2	0.0	3.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	129.6	0.0	59.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	10.4	0.0	9.9	1.2	1.2	2.8	0.3	2.1	1.4	2.4	4.3	0.5	0.0	0.0	0.1	0.0	38.0	0.0	3.9	0.7	9.1	0.9	0.4	4.9	0.0	105.9	10.5	0.3	0.7	17.3	2.0	0.0	0.3	0.4	20.4	0.1	1.7	12.8	14.6	0.0	0.3	0.6	2.0	0.0	0.3	1.8	6.5	0.0	5.5	0.0	4.5	6.0	12.1	23.5	1.2	0.1	0.5	66.7	9.8	2.5	0.2	0.0	0.2	0.3	1.1	0.8	3.8	7.5	0.0	0.2	0.5	20.2	1.1
NIM1K	"MGC42105, NIM1"	ENSG00000177453	"NIM1 serine/threonine protein kinase"	Q8IY84	5	43192071-43280850	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.7;choroid plexus: 7.9;pituitary gland: 6.5;retina: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 29.7;Excitatory neurons: 56.0;Horizontal cells: 18.5;Inhibitory neurons: 44.2;Oligodendrocyte precursor cells: 43.7;Oligodendrocytes: 20.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HDLM-2: 2.3;PC-3: 2.5;U-87 MG: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007695			Approved	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA007695: AB_2667897"	"unprognostic (7.97e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (8.84e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-5)"	"unprognostic (2.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.46e-3)"	"unprognostic (4.98e-3)"	0.4	1.2	11.9	0.4	12.5	0.0	0.4	8.9	13.7	0.9	7.9	1.6	0.1	0.2	0.3	0.4	0.5	0.3	0.8	12.5	11.6	0.3	0.3	1.3	0.2	9.9	10.8	0.2	0.3	1.2	6.5	0.4	9.5	0.8	0.4	10.3	0.8	0.6	0.8	0.6	0.5	0.2	10.4	0.2	1.2	0.4	11.3	0.2	0.9	0.6	0.1	0.6	0.8	11.7	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.4	1.5	0.5	2.0	0.0	0.0	0.2	0.2	0.4	0.7	0.1	0.3	0.0	1.2	2.3	0.1	0.0	0.3	0.0	0.7	0.1	0.3	0.8	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	2.5	0.1	0.1	0.2	0.0	0.3	0.4	0.0	0.8	0.2	0.1	0.1	0.2	0.7	0.0	0.4	0.3	0.3	0.3	0.7	0.2	0.1	2.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	11.9	12.5	8.9	13.7	12.5	11.6	9.9	10.8	9.5	10.4	11.3	11.7	0.4	0.0	4.4	29.7	0.0	0.5	0.1	0.4	1.8	7.6	0.1	0.0	0.3	0.0	0.1	0.0	6.2	0.1	0.1	0.0	0.0	0.0	1.3	0.0	1.0	0.2	0.0	0.0	56.0	0.0	1.4	1.0	0.5	0.3	0.0	0.1	0.0	0.1	0.1	18.5	44.2	0.0	0.0	0.3	0.0	1.8	0.0	0.2	0.0	1.0	0.6	9.9	0.0	43.7	20.3	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	6.6	0.0	1.2	0.6	0.4	0.4	0.2	0.4	0.0	0.4	0.4	0.0	0.1
NIPAL1	"DKFZp686A06115, NPAL1"	ENSG00000163293	"NIPA like domain containing 1"	Q6NVV3	4	47914142-48040173	"Predicted membrane proteins"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.8;skin 1: 25.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 42.0;Collecting duct cells: 42.3;Distal enterocytes: 56.2;Squamous epithelial cells: 44.4;Undifferentiated cells: 38.6;Urothelial cells: 55.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.3;CAPAN-2: 11.6;HaCaT: 15.3;HBEC3-KT: 11.1;RT4: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036765	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA036765: AB_10672366"	"unprognostic (3.03e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.03e-7)"	"unprognostic (2.55e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-1)"	0.3	0.1	0.1	1.7	0.3	0.2	3.6	0.3	0.3	2.0	0.3	14.1	5.4	0.3	7.3	21.8	2.1	1.4	0.1	0.1	0.4	3.3	16.2	0.4	0.1	0.2	0.2	0.0	1.9	3.7	0.6	1.8	0.2	2.1	13.3	1.8	5.1	1.2	1.6	25.7	7.1	0.5	0.1	0.2	7.1	0.6	1.0	0.3	1.6	0.1	3.0	7.7	4.8	0.1	13.3	0.2	0.0	0.0	0.0	0.0	2.1	2.4	2.3	1.8	3.2	7.8	11.6	0.0	1.7	0.0	3.3	15.3	2.2	11.1	4.7	0.1	2.8	0.0	0.1	0.5	0.0	0.1	0.1	0.1	4.0	0.2	2.6	3.1	0.6	0.8	0.1	0.0	2.6	5.1	0.1	0.1	1.9	9.1	3.4	0.0	0.0	0.0	6.4	17.9	1.1	0.3	1.2	4.3	1.9	1.0	2.7	0.0	5.0	0.1	4.5	0.0	0.3	0.1	0.2	0.0	0.2	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.4	0.2	0.2	0.2	0.1	1.0	0.1	0.3	9.6	6.1	0.0	0.4	14.4	42.0	6.4	4.6	0.2	9.9	5.0	2.8	4.3	12.6	42.3	0.0	2.1	0.2	56.2	0.0	15.7	0.7	7.3	1.1	1.1	11.5	0.0	0.9	6.7	1.4	1.5	11.2	14.2	0.0	0.3	0.4	18.5	0.4	0.0	1.0	27.5	4.1	1.2	2.1	0.3	0.0	0.6	1.8	1.0	0.6	0.7	0.0	0.5	0.1	16.1	31.2	0.0	1.4	27.4	31.8	1.0	3.2	5.1	0.0	1.9	2.8	1.3	2.8	44.4	33.0	3.6	1.0	0.1	38.6	55.2
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415802-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	8.4	7.4	49.6	8.4	67.3	8.4	12.9	67.7	58.5	9.6	25.8	13.8	11.3	6.2	11.7	15.9	14.6	8.9	12.8	43.6	58.1	13.8	3.5	13.9	11.6	61.8	58.6	7.2	17.1	21.9	7.3	3.5	65.0	55.9	14.4	27.7	15.2	7.6	5.9	14.0	12.7	12.3	56.1	7.8	14.8	4.9	65.0	13.2	29.2	11.9	13.1	8.0	10.4	88.5	32.4	12.1	1.1	4.2	18.9	20.7	4.5	101.8	71.7	35.0	26.2	4.5	36.4	15.4	30.2	55.2	7.3	31.5	12.5	37.1	37.3	29.5	38.1	16.0	18.5	5.4	17.7	14.2	14.4	20.7	36.1	22.3	75.7	34.8	12.2	27.5	9.5	9.7	22.4	7.2	11.5	6.6	8.3	15.4	34.0	5.5	0.1	17.1	41.6	10.1	44.6	4.3	13.1	19.5	26.9	8.6	26.0	10.6	17.9	31.5	6.7	10.9	22.9	29.4	24.1	5.4	21.4	26.8	28.8	16.9	5.8	7.9	16.7	5.7	16.9	22.1	28.8	22.5	11.2	20.1	38.9	24.8	2.5	15.6	4.2	14.6	31.8	16.0	49.6	67.3	67.7	58.5	43.6	58.1	61.8	58.6	65.0	56.1	65.0	88.5	17.1	48.1	27.5	8.8	15.4	9.2	13.5	25.7	14.8	50.3	15.9	12.2	25.9	15.7	24.7	40.5	110.5	3.8	32.1	25.0	3.9	13.1	3.6	11.0	3.5	10.2	18.7	26.1	29.3	15.5	4.7	7.4	16.8	18.3	13.3	10.5	9.3	3.8	4.5	13.5	32.2	16.7	16.2	7.0	7.8	8.0	4.1	5.5	14.2	10.3	8.6	18.7	23.7	24.6	91.8	22.6	22.6	5.3	16.0	34.5	33.2	4.5	16.5	53.6	0.0	4.4	5.9	2.6	6.0	20.0	16.3	4.2	25.3	8.2	17.2	20.9
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;brain: 19.9;skeletal muscle: 19.4;tongue: 11.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.2	8.1	0.2	15.6	0.0	0.4	17.3	11.6	0.3	3.1	0.3	0.1	0.6	3.4	0.6	0.1	0.0	0.0	11.5	10.6	0.2	0.0	0.0	0.0	17.9	16.4	0.1	0.2	0.6	2.2	0.3	19.9	1.0	0.1	1.5	0.4	0.3	19.4	1.7	0.1	0.2	6.8	0.0	0.1	0.3	12.2	0.2	0.0	11.9	0.0	0.0	0.5	18.6	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	15.6	17.3	11.6	11.5	10.6	17.9	16.4	19.9	6.8	12.2	18.6	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372701	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 602.6;lymphoid tissue: 154.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3163.4;NK-cells: 7721.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8"	"Group enriched"	"Detected in all"	44	"NK-cells: 4796.8;T-cells: 6827.0"	"Group enriched"	"Detected in some"	5	"NB-4: 180.8;THP-1: 54.5;U-937: 46.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"	12.5	7.9	3.7	23.2	3.6	602.6	7.7	3.6	6.3	5.9	4.2	9.5	11.0	12.5	6.1	7.2	7.9	21.4	6.7	3.5	3.6	6.5	23.5	49.2	136.4	4.9	3.9	4.2	2.2	2.2	3.2	7.9	4.2	4.9	7.3	0.4	9.6	4.5	6.5	2.7	14.6	7.7	4.1	154.6	10.6	3.3	4.3	9.4	6.6	3.3	21.9	16.7	4.4	4.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.9	7.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.6	0.6	2.0	0.8	0.2	0.0	20.1	3.6	0.0	0.0	0.3	0.0	0.2	0.0	2.5	0.5	0.8	0.0	0.0	2.4	180.8	0.0	0.2	0.3	4.4	9.4	0.4	0.0	0.0	0.1	0.2	0.4	0.1	0.1	0.3	0.0	54.5	0.4	0.1	0.2	0.6	0.1	2.6	0.9	0.9	0.1	46.6	0.0	76.9	34.1	15.2	6827.0	131.7	2871.2	37.9	811.1	4295.0	87.1	15.4	261.0	3114.2	111.7	4796.8	104.8	67.1	17.5	4929.2	3.7	3.6	3.6	6.3	3.5	3.6	4.9	3.9	4.2	4.1	4.3	4.2	17.2	3.2	8.0	0.0	24.5	5.0	0.1	0.0	0.0	0.0	5.7	3.7	0.7	28.6	1.3	5.5	0.0	1.0	3163.4	1.9	3.9	1.0	0.2	2.7	3.6	7.1	0.0	186.5	0.0	0.0	0.8	5.2	17.3	4.2	24.1	0.2	55.3	9.9	15.0	0.0	0.0	0.5	0.0	132.9	10.2	0.3	0.0	55.5	17.8	1.0	49.4	0.0	7721.0	0.0	0.2	0.0	1.2	0.0	120.4	0.0	0.6	9.2	0.7	0.0	0.0	6.4	4.7	0.0	0.5	1.1	6.5	1.1	1321.5	0.0	1.1	0.1
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.1;seminal vesicle: 12.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.6;Inhibitory neurons: 12.7;Oligodendrocyte precursor cells: 92.0;Oligodendrocytes: 43.7;Peritubular cells: 17.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.7;NTERA-2: 5.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	0.5	6.6	10.1	0.8	8.5	1.4	0.4	6.4	11.1	1.9	0.0	1.8	0.2	2.7	6.4	0.6	4.3	1.4	1.1	10.3	10.2	0.3	0.1	0.6	0.4	7.3	7.0	4.4	0.3	0.5	1.0	0.6	4.8	6.0	0.5	1.9	0.6	12.5	0.1	0.7	0.7	1.9	5.5	0.6	0.6	2.6	7.3	0.4	0.4	0.4	0.2	0.7	1.2	9.7	0.0	0.5	6.7	0.2	1.6	0.6	1.2	0.0	0.0	0.0	0.1	0.1	0.3	0.5	0.5	0.1	0.0	0.1	0.2	0.0	0.1	0.4	0.9	0.4	0.4	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.0	0.3	0.1	2.0	0.5	1.5	0.0	0.3	0.5	1.2	5.3	0.0	0.0	0.6	0.2	0.3	0.0	0.8	1.7	2.5	0.2	0.0	0.6	0.8	0.0	0.3	0.1	0.1	0.8	0.2	0.0	1.1	1.1	0.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	10.1	8.5	6.4	11.1	10.3	10.2	7.3	7.0	4.8	5.5	7.3	9.7	0.3	0.0	0.0	19.6	0.0	0.6	0.3	0.2	1.2	2.6	0.3	0.9	0.4	0.0	0.1	0.0	0.0	1.0	0.2	0.2	0.0	0.1	1.3	0.2	1.1	0.5	0.0	0.0	11.3	0.0	0.2	1.3	0.0	0.4	0.0	1.0	0.7	0.0	0.1	0.0	12.7	0.0	0.0	0.0	0.8	3.9	2.1	0.2	0.0	2.8	0.1	2.5	0.0	92.0	43.7	0.2	0.1	17.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.6	0.2	0.0	0.1	0.4	0.3	0.2	4.5	0.1	0.3
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.8	1.8	10.1	0.0	2.2	9.8	12.7	5.1	0.0	3.4	1.3	2.3	0.4	0.7	2.0	2.5	4.5	14.8	28.5	0.3	1.3	1.1	0.8	6.5	5.6	11.6	0.4	5.2	1.7	3.6	4.4	1.1	1.9	9.2	0.8	1.9	0.3	0.6	2.6	3.7	1.6	2.2	1.1	2.6	8.9	14.3	0.7	0.2	0.5	2.1	1.4	4.2	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.1	9.8	12.7	14.8	28.5	6.5	5.6	4.4	1.6	8.9	4.2	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	8.1	10.7	4.9	4.7	5.0	6.5	7.0	4.7	5.5	10.5	6.4	10.8	4.8	10.1	3.4	43.2	9.8	5.2	17.0	4.7	4.6	8.8	9.1	5.5	5.0	5.3	5.1	4.0	9.6	6.0	4.8	4.2	5.4	8.3	3.4	2.7	10.3	6.8	24.1	21.5	6.4	5.8	5.1	8.1	7.3	3.5	5.1	4.7	7.9	13.7	10.5	9.6	16.5	5.2	5.3	15.6	1.6	12.2	5.1	5.9	2.4	7.0	8.0	3.4	5.9	0.9	13.0	9.5	21.0	8.9	5.1	13.1	4.7	4.0	1.1	12.5	5.0	12.6	5.5	8.6	7.7	4.4	7.0	6.6	16.4	4.5	8.7	6.9	7.0	12.5	0.1	6.2	3.6	14.2	7.5	10.7	7.5	6.9	8.6	14.6	2.1	3.1	8.2	6.8	2.3	7.9	10.4	5.5	4.5	2.4	17.7	13.0	8.2	6.8	6.0	6.1	3.6	2.2	2.6	3.3	1.0	13.4	4.9	2.8	3.5	15.4	0.8	1.5	1.0	0.5	0.8	1.2	2.1	0.4	0.9	1.0	8.1	1.4	1.4	0.9	1.4	2.3	4.9	5.0	4.7	5.5	4.7	4.6	5.3	5.1	5.4	5.1	5.1	5.2	3.0	0.0	7.9	5.9	3.2	2.5	1.7	4.5	2.8	1.3	4.1	4.2	12.8	2.8	4.2	7.3	2.1	3.6	1.4	7.3	1.9	7.1	2.0	8.7	2.8	3.8	2.4	3.8	5.9	3.8	2.2	3.5	8.2	4.1	0.0	5.7	5.3	10.2	6.5	0.0	4.0	3.7	2.0	6.0	1.8	4.7	1.2	4.0	1.8	2.8	6.2	6.1	5.2	5.5	2.8	5.5	7.6	1.2	1.8	1.6	3.9	5.3	7.2	3.2	0.0	2.9	2.7	1.9	2.0	10.8	4.7	0.5	2.8	2.1	5.5	1.2
NMNAT2	"C1orf15, KIAA0479, PNAT2"	ENSG00000157064	"Nicotinamide nucleotide adenylyltransferase 2"	Q9BZQ4	1	183248237-183418380	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.5;heart muscle: 18.3;pituitary gland: 18.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 54.3;Excitatory neurons: 195.5;Inhibitory neurons: 265.4;Oligodendrocyte precursor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 26.2;SCLC-21H: 80.6;SuSa: 25.1;U-2197: 45.8;U-87 MG: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015708, HPA061714"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015708: , HPA061714: AB_2732669"	"unprognostic (3.70e-1)"	"unprognostic (7.98e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.02e-1)"	8.5	5.9	13.1	0.8	14.8	0.0	5.1	17.2	45.5	2.1	0.0	2.3	0.4	1.2	1.4	0.8	2.3	2.8	18.3	15.6	21.4	0.4	0.0	0.7	0.6	0.7	0.8	0.4	1.7	0.2	18.4	0.9	6.7	0.2	0.9	6.5	0.5	2.5	0.5	0.9	0.9	1.5	0.0	0.1	1.1	8.9	0.8	0.5	6.0	1.4	0.6	0.7	0.8	10.0	1.4	0.5	5.5	0.0	3.1	12.5	4.6	3.4	8.9	1.8	0.6	2.7	5.4	0.0	14.2	0.8	1.5	2.2	0.2	0.1	3.3	0.0	0.1	0.0	2.2	0.0	0.5	0.0	0.1	26.2	1.1	2.1	0.5	11.1	0.5	0.0	0.0	0.1	2.1	0.1	0.0	0.5	9.7	0.1	5.4	0.0	0.2	0.0	5.9	4.5	80.6	6.2	0.7	0.3	0.0	25.1	0.7	1.5	3.0	2.5	0.9	45.8	3.3	0.6	0.0	0.0	35.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	14.8	17.2	45.5	15.6	21.4	0.7	0.8	6.7	0.0	0.8	10.0	21.4	0.0	1.5	3.9	0.0	0.8	0.2	0.6	0.6	12.1	0.2	0.1	35.2	0.0	2.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	54.3	2.7	0.3	5.2	0.0	0.0	195.5	0.0	12.9	5.7	0.0	7.4	0.0	0.2	0.0	0.0	0.7	20.2	265.4	0.0	4.1	1.0	0.0	42.3	0.0	0.5	1.8	11.2	0.0	0.3	0.0	98.5	6.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	3.4	2.9	19.7	0.3	12.0	0.4	0.2	0.1	0.3	1.4	0.2	0.0	0.0	0.0
NOD1	"CARD4, CLR7.1, NLRC1"	ENSG00000106100	"Nucleotide binding oligomerization domain containing 1"	Q9Y239	7	30424527-30478784	"Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.3;Microglial cells: 26.2"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 11.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074367			Approved	Mitochondria		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria		"HPA074367: AB_2686683"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (6.62e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (2.64e-1)"	10.6	2.9	3.0	8.8	3.2	6.8	9.5	2.5	2.6	5.3	4.6	5.3	2.2	6.1	2.6	4.7	6.5	5.4	7.3	2.4	3.2	3.9	2.2	11.9	6.1	7.6	4.9	10.3	1.8	2.7	2.9	12.2	4.7	4.0	4.3	0.6	6.2	3.2	4.0	5.9	5.4	7.3	3.6	11.1	4.8	1.9	5.6	3.5	10.8	4.0	5.0	7.3	5.0	2.8	4.8	2.5	3.5	10.5	2.2	10.3	5.3	3.3	2.3	5.5	7.0	2.2	5.7	6.9	3.8	4.2	6.1	11.2	3.5	5.8	3.7	3.6	3.0	9.7	7.7	2.2	2.8	4.3	7.0	9.6	2.5	3.5	3.0	4.9	18.3	10.1	5.2	2.4	5.0	2.8	6.2	7.7	4.1	5.3	4.5	7.4	4.0	6.3	1.8	3.8	0.6	12.4	4.2	10.7	3.7	4.8	3.6	9.6	7.7	4.8	7.6	6.0	4.5	2.2	8.0	0.3	3.5	15.1	5.1	13.7	3.7	13.5	8.1	5.0	8.9	7.5	5.5	5.3	3.3	10.9	4.9	4.0	2.8	8.5	6.6	8.0	4.8	2.6	3.0	3.2	2.5	2.6	2.4	3.2	7.6	4.9	4.7	3.6	5.6	2.8	19.3	3.2	15.1	7.2	6.6	0.8	0.5	1.0	5.2	2.4	2.9	2.9	4.9	1.5	5.0	5.5	0.0	5.0	6.7	4.5	0.0	1.3	0.2	4.4	1.7	12.0	0.0	3.4	5.3	2.1	2.3	8.2	1.1	4.6	2.5	7.8	13.6	1.3	4.6	0.0	1.4	5.5	2.0	3.1	3.7	0.0	0.6	4.3	5.4	26.2	4.0	0.6	6.2	2.5	1.1	1.7	1.7	1.9	3.1	0.2	1.6	0.5	2.9	0.2	0.0	2.5	5.6	0.0	0.6	5.4	1.8	1.5	5.3	1.0	5.6	0.8
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 23.0;skeletal muscle: 36.9;tongue: 57.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 10.0;Hepatic stellate cells: 18.2;Inhibitory neurons: 32.1;Oligodendrocyte precursor cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.6;RH-30: 9.4;RPTEC TERT1: 5.8;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.1	0.1	12.7	0.4	12.4	0.2	0.1	5.7	7.0	0.3	0.0	2.2	0.1	0.1	0.2	0.8	0.3	0.0	0.0	4.0	16.2	1.3	0.0	0.8	0.1	12.1	11.0	0.0	1.4	0.0	0.9	0.0	12.2	0.9	0.4	0.3	3.4	0.1	36.9	1.9	0.4	0.3	2.3	0.0	0.2	0.5	23.0	0.0	0.1	57.2	0.1	0.0	0.7	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	9.4	0.0	5.8	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.7	12.4	5.7	7.0	4.0	16.2	12.1	11.0	12.2	2.3	23.0	3.3	0.0	0.0	0.0	1.3	0.0	3.8	10.0	2.4	4.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.0	3.0	5.1	0.4	3.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	8.4	0.0	0.0	18.2	0.0	0.0	0.0	32.1	0.2	0.0	0.3	0.7	0.6	0.3	0.2	1.8	1.9	0.0	0.0	0.0	48.2	5.7	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.1	1.8	0.1	0.6	0.0	0.2	0.0	0.0	1.0
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150991017-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 62.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 20.4;Early spermatids: 81.9;Endothelial cells: 32.6;Hepatic stellate cells: 29.3;Late spermatids: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.1;HUVEC TERT2: 44.7;K-562: 16.6;TIME: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	19.3	6.3	8.4	5.8	6.8	0.8	13.2	5.7	6.7	7.3	3.4	5.9	2.6	9.7	0.4	5.8	8.1	4.7	20.6	5.7	6.1	24.2	4.3	11.2	2.7	9.2	7.7	3.2	2.9	1.2	7.2	4.8	8.6	7.6	1.2	0.8	4.4	1.7	3.9	4.2	6.7	3.7	7.5	62.4	5.4	7.2	11.0	0.6	9.1	3.5	1.2	9.7	7.4	6.0	0.4	0.1	1.3	4.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	2.2	0.4	2.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.4	2.2	0.3	6.4	0.6	0.5	10.4	0.1	0.2	0.0	0.0	0.1	44.7	5.1	16.6	3.6	0.0	0.0	0.2	0.5	1.7	0.7	0.1	3.0	0.0	1.8	0.0	0.3	0.5	0.4	0.2	1.4	0.0	0.4	0.1	1.4	82.5	0.2	0.7	0.4	0.1	2.4	8.9	2.2	0.0	7.5	0.0	0.2	0.1	0.1	1.1	0.2	0.7	0.3	1.7	0.9	0.2	0.5	2.3	0.9	0.3	0.2	0.2	0.2	2.1	0.5	8.4	6.8	5.7	6.7	5.7	6.1	9.2	7.7	8.6	7.5	11.0	6.0	20.4	9.6	2.2	0.3	0.7	0.9	0.1	0.1	0.0	0.2	0.2	0.3	3.1	0.0	0.7	0.0	0.0	0.2	0.7	0.1	0.0	1.0	81.9	4.9	0.7	32.6	0.0	0.0	0.2	0.0	0.1	2.9	0.5	3.2	5.7	0.7	29.3	0.7	0.4	0.0	0.2	0.4	0.0	0.6	0.5	29.3	0.9	0.4	0.0	7.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	1.2	1.5	0.4	0.1	0.2	2.2	0.3	0.0	0.6	2.6	6.9	5.3	0.2	0.6	3.6	1.6	0.9	0.1	0.9
NOSTRIN	MGC20702	ENSG00000163072	"Nitric oxide synthase trafficking"	Q8IVI9	2	168786539-168865514	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 167.0;Endothelial cells: 129.6;Hepatic stellate cells: 172.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.1;HEL: 41.9;K-562: 31.8;OE19: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044384, HPA076885"	Approved		Approved	Vesicles,Cytosol		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	Vesicles	"HPA044384: AB_2678922, HPA076885: "	"unprognostic (4.74e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.02e-6)"	"unprognostic (4.89e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.14e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.98e-2)"	32.6	20.4	6.1	4.6	5.8	0.3	31.4	5.0	7.6	17.5	4.2	15.3	14.0	14.9	4.3	5.1	16.4	14.0	16.1	4.9	5.6	32.6	7.3	30.8	4.6	6.6	6.0	10.6	22.6	3.8	3.8	25.4	6.5	13.3	16.4	0.8	48.9	6.8	5.1	7.3	14.3	12.8	5.5	5.5	23.0	14.4	6.6	1.9	13.5	3.6	3.0	8.1	11.3	5.0	0.0	3.6	1.1	0.0	0.0	0.0	10.1	0.4	0.0	0.0	0.0	6.3	6.5	0.1	4.3	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	41.9	1.8	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	31.8	0.0	0.0	0.1	0.1	0.1	0.1	20.5	0.3	0.4	1.9	0.0	3.4	1.6	0.0	0.1	0.2	1.9	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.2	0.6	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	5.0	7.6	4.9	5.6	6.6	6.0	6.5	5.5	6.6	5.0	167.0	9.6	10.3	2.0	1.6	1.0	0.6	0.3	0.6	0.1	20.0	11.0	7.1	15.7	3.3	3.7	0.0	18.9	0.4	57.3	13.7	8.0	26.6	16.3	3.3	129.6	11.4	2.7	0.4	21.8	7.0	6.1	41.3	23.2	0.0	72.4	172.5	1.0	1.6	0.0	0.5	35.9	0.0	6.3	0.9	60.9	8.7	1.2	24.9	55.3	0.7	1.6	0.0	2.0	0.0	17.7	53.4	5.7	0.2	3.3	43.1	59.0	1.5	0.3	72.3	1.3	11.3	13.7	1.8	0.4	0.4	26.3	0.9	71.9	20.7	1.2
NOTCH4	INT3	ENSG00000204301	"Notch receptor 4"	Q99466	6	32194843-32224067	"Human disease related genes, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.2;breast: 19.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 263.8;Endothelial cells: 121.0;Hepatic stellate cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA		6400000		"Cluster 82: Adipose tissue - ECM organization"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	24.2	4.0	0.0	0.5	0.0	0.0	19.8	0.0	0.0	5.8	0.0	3.6	0.5	7.2	3.2	2.7	5.8	0.0	15.8	0.0	0.0	8.5	2.5	18.5	0.4	0.0	0.1	2.8	2.6	0.0	3.0	1.4	0.0	6.0	0.1	0.0	2.6	0.0	5.6	2.8	3.9	0.0	0.0	2.6	3.9	0.9	0.0	0.0	9.6	0.0	0.1	5.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	263.8	0.0	6.1	0.0	6.0	5.2	32.1	9.9	13.6	2.7	2.6	6.6	8.7	0.0	4.2	5.5	4.2	0.4	11.9	0.6	0.0	2.6	46.0	2.6	3.1	121.0	6.0	12.0	0.2	1.1	0.3	4.7	0.0	1.0	0.0	1.8	188.8	2.3	1.7	6.7	0.2	0.8	4.1	9.3	5.2	35.6	7.2	6.8	3.6	10.3	1.6	21.0	0.0	0.0	0.5	0.4	0.3	5.3	0.7	18.0	1.0	0.9	3.1	3.6	0.0	7.8	9.3	5.5	1.9	1.9	1.6	0.3	3.6	3.7	0.9	5.6
NOVA2	"ANOVA, NOVA-2, NOVA3"	ENSG00000104967	"NOVA alternative splicing regulator 2"	Q9UNW9	19	45933734-45974044	"Human disease related genes, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 39.4;Bipolar cells: 56.7;Endothelial cells: 32.0;Excitatory neurons: 21.8;Hepatic stellate cells: 42.5;Horizontal cells: 21.9;Inhibitory neurons: 20.9"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.7;HDLM-2: 11.0;HUVEC TERT2: 16.9;SH-SY5Y: 5.6;TIME: 25.8;U-2 OS: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045607	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"HPA045607: AB_10962628"	"unprognostic (9.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.02e-3)"	"unprognostic (6.42e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.31e-2)"	6.7	1.9	12.4	0.7	15.1	0.0	5.7	0.5	16.7	3.2	0.0	1.8	0.6	3.4	0.6	1.4	2.9	1.4	6.7	16.0	5.8	4.7	1.0	9.3	0.5	4.6	3.0	1.2	1.1	1.0	6.2	3.9	3.6	2.3	0.5	5.6	1.1	0.8	2.3	1.1	1.7	2.0	0.6	1.5	1.5	2.0	4.6	0.4	4.5	2.5	0.2	2.5	2.0	9.8	0.0	0.1	9.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	1.3	0.0	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	15.1	0.5	16.7	16.0	5.8	4.6	3.0	3.6	0.6	4.6	9.8	39.4	0.0	0.0	5.9	0.1	0.6	0.2	0.0	0.6	56.7	0.1	0.5	3.4	1.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.1	32.0	0.0	0.0	21.8	0.2	0.0	1.2	0.0	0.1	0.0	0.1	42.5	0.5	0.1	21.9	20.9	0.0	0.0	1.6	1.5	3.5	0.0	0.1	0.0	9.4	0.0	1.3	0.0	11.6	9.5	0.2	0.0	0.4	1.2	0.3	0.0	0.0	0.0	3.3	0.0	0.6	0.6	2.4	2.3	0.3	0.1	0.0	0.5	0.4	0.0	0.3
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874359	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"intestine: 71.7"	"Group enriched"	"Detected in some"	8	"Distal enterocytes: 45.8;Intestinal goblet cells: 21.4;Paneth cells: 29.1;Undifferentiated cells: 64.8"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 30.9;OE19: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favorable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.3	0.5	0.0	2.9	0.0	0.0	0.1	0.1	0.1	0.1	0.0	58.9	0.5	0.3	0.0	0.5	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	71.7	0.3	0.2	2.4	0.1	0.7	1.6	1.6	0.0	0.1	0.1	0.2	0.1	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.4	1.1	0.4	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	30.9	0.4	0.4	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1.4	0.5	0.6	0.9	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.3	0.0	0.3	1.3	1.2	0.8	11.6	1.1	0.7	0.7	0.5	0.0	1.1	0.5	0.6	0.7	0.3	0.7	0.3	0.2	1.0	0.3	0.4	0.3	0.5	0.8	0.3	0.7	0.3	0.8	1.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	64.8	0.6
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.0;parathyroid gland: 39.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nucleoli"		"HPA041070: AB_2677285"	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.6	18.4	11.0	0.1	16.9	1.2	2.1	7.4	40.0	4.9	2.2	1.1	2.2	5.0	0.9	1.0	3.2	1.9	2.3	12.4	9.2	6.6	1.6	1.8	0.6	7.5	7.6	1.5	11.0	39.2	18.5	0.5	10.0	6.6	1.0	5.7	2.7	1.4	0.3	2.2	1.2	3.6	2.3	12.5	1.9	5.1	7.1	2.9	25.3	0.3	0.4	2.0	2.3	13.5	3.9	0.5	0.2	0.2	0.9	0.0	1.5	0.5	0.5	2.4	4.9	1.6	3.6	0.0	1.1	0.0	0.2	17.7	0.5	0.0	1.4	0.1	0.5	14.5	1.0	32.4	3.1	1.9	1.3	0.5	2.3	0.0	0.3	3.7	0.0	9.5	0.5	0.0	0.1	0.0	0.2	3.9	0.7	6.4	0.4	0.3	1.4	0.8	5.6	0.1	3.8	0.2	0.0	0.1	4.6	0.0	0.7	11.2	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.7	0.0	0.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	11.0	16.9	7.4	40.0	12.4	9.2	7.5	7.6	10.0	2.3	7.1	13.5	0.1	0.0	1.1	1.0	0.7	0.1	9.7	3.7	0.6	29.4	3.1	5.2	2.1	5.7	8.8	0.0	20.9	0.1	0.5	0.6	3.9	9.4	15.1	1.1	0.3	0.6	11.4	0.4	21.3	8.0	0.2	1.7	1.5	1.1	0.0	1.4	2.5	0.5	4.6	6.7	21.9	2.1	2.0	0.0	0.3	14.4	0.6	0.9	10.6	1.9	1.0	0.9	0.0	2.5	1.6	4.3	0.8	0.4	0.6	3.4	0.5	14.6	7.7	4.2	0.0	0.4	1.6	0.5	0.9	1.1	1.1	0.3	2.7	7.6	1.2	5.8
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208636-155217078	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.3;breast: 1.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5"	"Group enriched"	"Detected in many"	5	"amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 14.2"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.3	0.2	2.0	0.2	1.1	0.0	1.6	0.1	2.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.5	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.5	0.2	0.7	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.1	2.4	5.3	3.5	1.5	0.6	0.6	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
NSG1	"D4S234E, NEEP21, P21"	ENSG00000168824	"Neuronal vesicle trafficking associated 1"	P42857	4	4348140-4419058	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.7;pituitary gland: 135.1;skin 1: 120.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 222.4;Cytotrophoblasts: 120.2;Granulosa cells: 128.8;Melanocytes: 291.7;Suprabasal keratinocytes: 178.2"	"Cancer enriched"	"Detected in many"	4	"melanoma: 61.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 45.2;MAIT T-cell: 61.9;memory CD4 T-cell: 42.2;memory CD8 T-cell: 37.1;naive CD8 T-cell: 27.6"	"Lineage enriched"	"Detected in many"	57	"T-cells: 61.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 84.7;SCLC-21H: 168.6;SH-SY5Y: 82.5;SK-MEL-30: 80.9;TIME: 204.6;U-698: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"				"unprognostic (3.21e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (9.49e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.41e-2)"	5.0	25.3	29.0	4.2	33.1	1.0	6.0	59.6	50.7	17.1	5.3	7.9	6.8	7.8	2.1	30.7	20.1	1.3	5.9	18.4	95.7	4.4	0.5	1.5	3.2	57.1	64.8	46.3	1.8	0.1	135.1	18.3	58.8	22.8	7.1	32.3	6.7	18.2	0.7	120.9	5.8	6.9	24.2	2.2	8.0	16.0	45.4	9.5	0.5	3.0	3.5	13.3	30.1	24.2	0.2	0.1	0.8	0.5	0.0	0.0	14.6	0.3	0.0	0.2	0.0	1.3	0.4	0.0	10.4	0.5	3.3	2.4	84.7	5.5	0.4	0.0	3.0	0.0	0.2	0.0	4.1	0.0	0.0	0.1	12.0	0.0	2.3	0.0	14.6	22.3	0.0	0.1	1.3	0.0	6.8	0.5	10.1	0.1	0.4	0.1	0.0	0.4	0.0	4.8	168.6	82.5	0.6	0.2	80.9	7.0	0.9	0.3	204.6	0.0	13.0	0.2	0.3	0.1	0.4	75.9	0.1	0.2	0.4	0.2	0.1	0.1	45.2	0.1	61.9	0.1	42.2	37.1	0.1	0.1	10.4	27.6	1.0	0.9	0.2	0.1	4.5	15.7	29.0	33.1	59.6	50.7	18.4	95.7	57.1	64.8	58.8	24.2	45.4	24.2	1.6	9.6	0.0	5.9	0.4	86.8	83.4	47.9	31.3	222.4	0.7	24.3	0.0	0.0	13.2	0.0	4.2	120.2	6.0	0.0	0.0	0.0	31.2	10.3	1.4	2.1	2.4	0.0	16.6	0.0	15.2	24.9	0.0	16.4	1.3	128.8	1.8	0.0	8.2	8.4	32.2	0.0	4.1	0.0	13.6	44.2	3.1	1.3	291.7	6.5	0.4	6.4	20.6	1.5	4.0	0.1	0.2	5.7	0.7	19.9	0.0	20.4	1.7	24.3	0.0	0.2	10.8	2.9	14.4	44.8	178.2	76.8	17.0	96.0	0.3	77.0
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 321.8;choroid plexus: 89.2;retina: 74.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 608.9;Astrocytes: 2164.2;Cone photoreceptor cells: 950.8;Excitatory neurons: 651.0;Inhibitory neurons: 1056.6;Oligodendrocyte precursor cells: 1930.7;Oligodendrocytes: 1257.6;Rod photoreceptor cells: 1415.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	175	"plasmacytoid DC: 17.4"	"Lineage enriched"	"Detected in single"	175	"dendritic cells: 17.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 122.4;U-138 MG: 47.7;U-2 OS: 81.8;WM-115: 166.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"	NA	NA		58000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	17.9	4.7	137.2	2.3	138.8	0.0	2.9	165.1	321.8	1.6	89.2	12.0	2.5	1.3	0.6	9.4	0.9	9.6	30.5	136.9	131.5	2.3	0.3	25.8	0.4	144.0	135.4	0.3	0.9	22.1	0.9	0.7	143.6	1.9	3.8	74.8	2.7	2.8	0.9	6.1	4.6	4.5	135.0	0.5	2.0	0.6	154.2	0.5	1.1	5.0	0.4	3.5	1.8	158.4	0.1	0.0	7.5	0.1	0.9	22.2	0.0	36.7	19.5	11.7	6.8	0.1	0.0	0.0	0.0	20.3	0.0	0.3	0.0	43.6	12.6	0.1	0.4	0.0	0.0	0.4	0.4	0.0	0.2	2.0	0.0	38.0	45.0	29.0	7.5	0.0	0.0	0.3	122.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	3.9	20.8	0.0	2.4	3.8	0.0	0.0	0.2	1.3	0.0	0.1	8.1	47.7	81.8	2.2	31.6	0.0	0.0	0.2	0.1	0.0	166.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	137.2	138.8	165.1	321.8	136.9	131.5	144.0	135.4	143.6	135.0	154.2	158.4	1.2	608.9	27.6	2164.2	0.0	1.8	0.0	1.5	2.2	225.3	0.9	4.4	13.7	0.0	29.7	20.2	950.8	0.0	5.4	0.4	0.0	0.6	10.9	0.0	0.5	2.9	0.0	2.7	651.0	0.0	0.0	22.2	0.5	0.0	53.0	0.1	0.7	0.0	0.1	40.4	1056.6	0.1	0.0	0.0	3.8	2.2	0.3	0.7	3.6	139.6	0.0	30.5	0.0	1930.7	1257.6	0.1	0.2	0.4	0.1	0.1	0.0	0.1	1.5	1415.0	0.0	20.6	7.5	0.4	0.9	0.5	4.8	0.0	0.8	0.0	0.8	0.1
NUAK1	"ARK5, KIAA0537"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063345-106138954	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 111.7;Excitatory neurons: 150.5;Hepatic stellate cells: 136.3;Microglial cells: 93.7;Oligodendrocytes: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 58.0;EFO-21: 55.1;RH-30: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"		Yes	No				"Cluster 47: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: AB_2683349"	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavorable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	17.5	3.6	12.6	2.3	17.5	0.6	12.1	9.4	25.4	9.8	0.0	4.1	2.2	9.5	3.1	3.5	9.0	4.9	18.8	17.4	5.6	4.2	4.0	9.3	3.2	6.1	5.9	6.1	3.2	17.5	2.7	4.5	8.3	6.0	3.9	5.4	3.4	6.0	20.6	20.8	4.3	10.2	5.5	0.8	3.8	2.6	5.5	3.3	4.3	17.2	2.3	4.8	8.1	31.8	13.0	8.3	58.0	0.6	23.7	2.5	27.0	14.2	9.5	9.9	8.0	4.3	2.1	0.0	55.1	27.4	5.0	11.9	12.6	11.2	4.8	0.2	3.4	0.0	9.7	4.7	5.0	0.1	0.1	11.0	8.1	6.0	1.7	19.2	21.2	0.1	0.0	40.3	7.8	1.3	0.2	0.6	11.1	0.2	3.3	0.1	77.7	10.5	6.6	13.3	6.8	0.4	6.9	1.9	0.5	37.2	2.9	0.4	16.6	9.4	29.7	3.3	17.0	0.0	0.0	0.7	2.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.6	17.5	9.4	25.4	17.4	5.6	6.1	5.9	8.3	5.5	5.5	31.8	56.4	0.0	2.4	15.7	0.6	13.5	32.9	29.8	10.2	32.3	2.1	4.2	48.9	10.0	7.2	7.3	0.0	0.8	13.5	0.9	3.9	6.2	0.4	5.1	6.6	111.7	0.0	5.3	150.5	9.6	5.2	17.9	2.0	3.8	0.0	2.9	136.3	12.1	8.0	40.4	55.4	2.3	12.2	8.4	8.8	2.6	4.1	1.3	10.6	93.7	0.6	1.9	1.0	15.6	73.5	18.4	0.5	3.0	3.2	10.6	0.2	1.8	2.2	2.9	0.0	7.1	26.4	1.0	5.5	2.5	15.9	0.3	2.7	0.4	0.8	5.2
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334121	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		7300	"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	11.1	5.0	3.3	6.0	3.5	1.3	9.5	3.7	4.2	7.7	3.1	5.5	2.8	7.2	5.2	5.7	6.9	4.8	6.6	3.3	3.5	7.8	6.4	7.0	9.3	3.7	3.6	6.3	6.9	5.8	4.2	15.1	3.4	5.9	6.7	4.7	6.1	6.8	6.1	4.3	5.1	7.9	4.1	7.3	5.8	13.0	3.4	10.1	9.0	9.3	8.5	11.4	6.8	3.8	28.9	16.7	24.7	13.7	13.1	18.0	13.1	20.6	24.8	57.8	54.4	17.6	21.8	18.5	13.1	22.5	16.3	17.1	36.3	34.3	79.8	23.6	12.6	28.8	9.9	19.6	27.2	13.7	10.6	12.7	18.4	28.1	40.3	18.3	53.0	22.7	32.2	9.5	49.5	23.3	33.3	15.1	17.3	59.7	22.7	21.4	20.4	18.3	35.6	14.8	20.5	18.1	9.4	26.1	21.6	25.6	19.2	9.9	14.2	28.2	17.2	12.1	17.6	6.9	9.4	22.3	10.4	22.2	24.1	0.0	0.4	0.5	0.8	1.3	1.4	1.2	1.0	1.6	1.4	1.1	1.1	1.6	0.0	1.7	1.7	0.9	1.5	0.7	3.3	3.5	3.7	4.2	3.3	3.5	3.7	3.6	3.4	4.1	3.4	3.8	25.4	3.2	10.0	6.2	11.3	17.7	24.4	19.4	10.2	5.0	7.4	6.3	11.3	2.8	23.2	3.7	6.2	23.4	9.7	2.5	7.9	17.1	122.3	11.2	19.2	26.5	9.0	14.5	22.9	11.0	21.2	16.2	5.6	10.2	17.7	11.8	8.9	6.2	9.8	5.0	23.5	5.7	14.2	4.7	11.5	22.5	13.1	8.7	7.2	13.1	16.9	4.4	5.2	15.1	15.3	14.1	4.7	6.8	12.1	29.6	3.4	13.0	15.4	9.0	0.0	13.7	15.8	53.3	36.4	8.9	16.8	8.2	9.5	12.5	9.9	22.7
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2 component of NDC80 kinetochore complex"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 28.4;lymphoid tissue: 26.0;testis: 53.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 60.8;Spermatocytes: 208.2;Spermatogonia: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	0.8	0.6	0.5	6.9	0.8	28.4	1.2	0.5	0.8	1.0	0.4	4.2	4.3	1.1	0.3	5.8	0.4	1.0	0.3	0.6	0.6	0.3	0.7	0.9	18.2	0.9	0.8	0.4	0.2	0.6	0.2	4.7	0.9	0.4	5.3	1.5	0.9	0.3	0.1	4.1	4.3	2.3	0.7	3.6	2.6	53.5	0.8	26.0	0.5	0.2	16.7	1.8	1.8	1.0	90.8	30.8	80.5	33.9	2.5	8.1	43.6	55.9	39.3	88.9	77.3	23.7	77.7	77.4	45.5	22.6	37.0	51.6	49.6	21.0	111.5	81.4	35.6	30.3	34.8	34.4	0.3	53.0	60.2	1.0	2.0	45.0	31.6	16.8	41.1	74.5	58.1	103.9	85.0	17.6	97.3	70.6	43.9	66.1	47.0	65.0	70.3	68.4	25.3	12.4	59.9	68.9	29.9	32.2	30.6	49.7	49.3	109.5	29.4	65.9	73.8	50.1	115.1	73.9	111.5	148.9	22.0	42.9	74.7	1.4	0.1	1.3	1.2	0.0	0.5	0.6	1.8	1.2	0.2	0.7	1.2	1.0	0.4	1.8	0.1	0.3	4.3	0.4	0.5	0.8	0.5	0.8	0.6	0.6	0.9	0.8	0.9	0.7	0.8	1.0	0.5	0.0	0.5	1.3	5.3	5.9	1.9	4.2	1.2	1.2	1.3	2.7	0.9	0.0	3.3	0.0	0.0	21.7	3.6	2.6	0.0	0.8	17.7	2.5	2.5	1.8	0.0	60.8	1.1	0.2	29.7	3.4	5.6	3.0	4.5	18.3	3.3	0.4	14.0	0.0	1.4	3.3	0.0	5.2	3.6	21.4	2.5	3.1	0.0	1.0	0.9	2.0	6.2	0.5	3.6	0.2	0.1	2.2	17.8	0.8	0.9	0.2	0.7	2.3	6.6	0.9	4.2	208.2	40.3	10.6	2.4	4.0	5.0	1.7	9.0	3.8
NUSAP1	"ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41320794-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 88.6;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 10.7;T-reg: 7.7"	"Group enriched"	"Detected in many"	15	"granulocytes: 10.7;T-cells: 7.7"	"Low cell line specificity"	"Detected in many"											"HPA042904, HPA074847"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		Yes	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli, Nucleoli fibrillar center"		"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	1.8	14.1	0.2	7.8	0.2	88.6	1.5	0.3	0.4	3.6	0.3	6.1	7.0	1.1	0.1	17.7	1.1	1.0	1.1	0.2	0.2	2.6	5.0	3.8	28.7	0.3	0.4	4.4	1.3	0.0	0.6	6.5	0.3	1.1	8.0	0.1	3.6	0.6	5.4	9.4	7.4	2.7	0.2	7.8	4.5	10.9	0.3	101.5	0.9	0.1	31.5	1.9	6.4	0.3	146.0	38.3	165.1	64.6	3.5	5.9	37.0	107.4	74.6	138.9	130.6	58.4	67.0	63.5	42.5	44.4	99.1	107.6	104.2	46.2	132.4	98.5	62.3	149.6	102.0	50.7	0.2	67.3	57.2	0.9	1.3	69.1	37.3	21.7	72.0	104.2	70.1	237.5	105.7	30.7	147.5	82.2	59.8	139.8	55.0	136.5	156.5	67.5	42.4	29.3	85.7	55.2	129.8	88.5	25.7	46.0	106.2	76.1	33.7	89.9	104.8	101.5	206.2	81.3	145.8	200.5	42.1	163.6	171.2	10.7	0.1	0.5	0.1	0.0	0.0	0.3	0.5	0.5	0.3	0.6	0.0	0.3	0.2	0.4	0.0	0.3	7.7	0.5	0.2	0.2	0.3	0.4	0.2	0.2	0.3	0.4	0.3	0.2	0.3	0.3	1.9	0.0	1.5	1.3	14.2	38.5	10.3	21.2	31.9	0.9	9.9	13.7	1.1	17.2	5.0	0.0	0.0	72.2	13.4	14.4	3.9	2.3	33.2	10.7	11.6	7.3	3.0	266.7	1.4	0.5	121.2	14.6	25.5	21.8	7.0	93.3	10.8	3.9	36.7	0.0	1.5	15.5	24.4	13.8	22.7	14.6	0.3	17.5	3.6	1.9	6.1	1.9	4.1	1.0	1.3	1.5	0.4	1.9	57.2	5.3	2.6	5.4	1.1	1.0	0.0	2.8	12.1	99.6	59.9	69.5	24.9	19.3	22.9	38.8	30.0	10.3
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 79.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 27.0;Early spermatids: 73.6;Intestinal goblet cells: 35.1;Late spermatids: 53.5;Paneth cells: 18.1;Undifferentiated cells: 36.2"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049133	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.0	0.0	0.0	4.9	0.1	0.0	0.1	0.0	0.2	0.0	0.0	64.9	1.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.3	79.7	0.0	1.2	0.0	0.0	0.0	3.5	2.3	0.1	0.0	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.4	0.1	0.2	0.3	0.0	0.0	0.0	2.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	73.6	0.0	0.0	0.0	3.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	35.1	0.0	0.0	0.0	53.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	18.1	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	36.2	0.1
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595786	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 119.6;salivary gland: 77.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 95.5;Intestinal goblet cells: 88.1;Paneth cells: 41.8;Undifferentiated cells: 115.8"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA042801	Approved				"Secreted to digestive system"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.1	0.0	0.1	7.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	114.2	0.6	0.2	6.8	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	5.3	119.6	0.0	77.2	0.2	0.0	0.0	0.7	5.2	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.5	0.0	0.0	0.5	0.0	0.0	0.0	17.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	88.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	41.8	0.0	0.1	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	115.8	0.2
NXPH2	NPH2	ENSG00000144227	"Neurexophilin 2"	O95156	2	138669157-138780390	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.1;kidney: 4.1;ovary: 8.1"	"Cell type enriched"	"Detected in some"	6	"Inhibitory neurons: 156.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	6	"medulla oblongata: 11.7;midbrain: 7.6;pons: 13.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.4;SiHa: 3.0;SuSa: 2.1;U-2 OS: 4.7;U-251 MG: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034759	Approved				"Secreted in brain"	NA	Yes				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034759: AB_10669732"	"unprognostic (5.83e-2)"				"unprognostic (8.83e-2)"			"unprognostic (1.41e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.80e-1)"							0.2	0.0	1.8	0.1	1.7	0.0	0.1	1.0	1.8	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.0	0.4	4.1	0.0	0.0	0.0	11.7	7.6	8.1	0.0	0.0	0.1	0.1	13.1	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.6	3.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.7	1.0	1.8	1.0	0.4	11.7	7.6	13.1	1.9	1.1	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ODAM	"APin, FLJ20513"	ENSG00000109205	"Odontogenic, ameloblast associated"	A1E959	4	70196496-70204576	"Cancer-related genes, Predicted intracellular proteins"	Biomineralization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"salivary gland: 371.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 4.2;Breast glandular cells: 10.3;Ductal cells: 6.5;Exocrine glandular cells: 8.2;Gastric mucus-secreting cells: 6.6;Glandular and luminal cells: 10.5;Theca cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 31.7;OE19: 21.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036279, HPA036543, HPA070297"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Cytosol	"HPA036279: , HPA036543: AB_10669797, HPA070297: "	"unprognostic (2.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"		"unprognostic (3.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-2)"		"unprognostic (3.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"		"unprognostic (2.72e-1)"		"unprognostic (1.86e-2)"	"unprognostic (2.50e-2)"	0.0	0.8	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.3	0.1	3.6	1.0	0.1	0.6	0.2	0.1	0.5	0.0	0.0	0.8	1.2	0.0	2.4	0.3	1.2	0.7	0.0	0.5	3.6	0.5	0.3	0.0	1.8	0.8	0.0	371.5	1.4	0.0	0.0	0.7	7.3	0.0	0.0	9.8	0.0	0.2	0.0	4.1	0.0	1.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.2	0.0	0.1	3.2	4.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	10.3	0.4	0.0	1.5	1.3	1.8	0.0	0.4	0.0	0.0	0.0	6.5	0.0	2.3	0.9	0.1	0.0	0.0	0.0	8.2	0.0	0.0	6.6	10.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	4.2	0.5	0.4
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase L"	Q9ULD0	10	49734641-49762379	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 98.5;kidney: 121.8;liver: 80.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.7;renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.2	11.6	23.1	0.3	23.4	0.0	0.0	23.7	41.1	0.7	98.5	1.4	1.0	2.2	0.5	0.1	1.0	0.4	5.8	24.4	36.9	121.8	80.0	0.0	0.2	38.4	25.6	1.6	4.3	50.5	29.3	0.1	38.9	1.6	0.3	18.7	17.1	6.3	0.1	0.1	1.1	0.7	15.4	0.3	1.0	2.3	33.8	0.5	23.0	0.8	0.6	0.5	0.5	24.3	0.0	0.0	4.7	21.3	0.0	0.0	2.7	0.1	0.1	1.1	0.2	10.5	2.3	0.0	11.4	0.0	3.4	0.4	7.4	0.2	0.4	0.0	0.4	0.0	0.2	5.3	0.2	0.0	1.6	0.3	0.0	0.0	0.0	0.6	0.0	5.4	0.5	0.0	0.0	3.2	8.2	7.3	2.0	0.8	1.0	0.0	0.0	0.0	43.4	0.7	12.0	16.3	0.1	16.2	1.1	6.1	4.5	2.9	0.0	0.0	10.6	0.0	0.7	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	23.4	23.7	41.1	24.4	36.9	38.4	25.6	38.9	15.4	33.8	24.3	0.0	0.0	0.0	20.2	0.8	0.0	0.9	0.4	0.0	30.4	0.1	0.1	4.4	2.8	0.1	29.5	31.3	0.0	0.0	0.4	92.0	1.1	0.2	0.9	0.2	0.3	4.8	0.0	16.8	0.0	0.1	0.3	0.0	1.6	0.0	0.7	1.4	55.3	0.1	30.3	21.4	0.5	2.0	1.3	0.0	0.5	0.0	0.5	0.0	1.0	0.0	5.4	0.0	3.5	1.8	0.1	1.1	0.0	0.0	0.3	0.0	84.7	0.0	18.1	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.1	0.6	0.4	0.3	0.3
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802560-101996926	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 12.0;retina: 7.4"	"Group enriched"	"Detected in some"	17	"Excitatory neurons: 653.3;Inhibitory neurons: 174.6"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AF22: 5.7;HAP1: 3.9;HEL: 3.6;SCLC-21H: 2.2;SH-SY5Y: 2.2"	"Region enhanced"	"Detected in all"		"cerebellum: 177.3"	"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.0	1.3	2.9	0.3	5.0	0.0	0.0	6.9	12.0	0.0	0.0	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	6.4	3.9	0.4	0.0	0.0	0.0	1.2	1.9	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.5	7.4	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.2	0.1	3.7	0.0	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	6.9	12.0	6.4	3.9	1.2	1.9	1.2	0.0	3.7	4.6	0.1	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	23.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	653.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	174.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.7	0.0	8.5	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	6.5	0.0	0.0
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028813-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1296.1;pancreas: 671.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 497.1;Exocrine glandular cells: 900.9;Intestinal goblet cells: 791.9;Pancreatic endocrine cells: 933.7;Paneth cells: 556.9;Undifferentiated cells: 2419.9;Urothelial cells: 1989.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;BJ hTERT+: 18.8;HaCaT: 26.4;OE19: 10.4;RPMI-8226: 6.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted to digestive system"	Yes	NA		9300		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	1.9	0.1	0.2	195.4	0.5	126.0	6.8	0.1	0.5	7.9	0.2	451.6	1211.9	5.5	3.5	0.8	8.3	10.4	0.8	0.2	0.4	26.9	0.9	3.8	1.4	0.1	0.2	0.2	671.4	0.0	0.5	0.6	0.2	92.4	568.7	0.4	16.2	0.9	0.6	0.4	1296.1	52.6	0.2	18.0	16.1	0.3	0.2	4.2	0.4	2.1	0.2	127.0	285.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	5.4	2.4	18.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	26.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	10.4	0.0	0.0	0.8	6.2	0.2	0.0	1.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.6	0.9	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.5	0.2	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.3	3.8	0.1	168.5	0.3	0.0	0.0	9.8	2.5	0.5	0.0	11.9	139.8	0.0	0.0	0.0	98.7	1.9	497.1	0.2	13.5	0.5	1.4	92.3	0.8	1.0	900.9	0.0	1.5	0.0	17.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	791.9	2.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	10.3	4.0	0.0	0.0	0.2	933.7	556.9	0.0	0.4	209.4	300.6	0.0	0.5	0.2	0.0	2.1	9.2	0.0	0.1	0.0	0.0	0.0	3.1	0.2	2419.9	1989.0
OLFML1	UNQ564	ENSG00000183801	"Olfactomedin like 1"	Q6UWY5	11	7485388-7511377	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 52.3;Leydig cells: 39.7;Peritubular cells: 39.5;Sertoli cells: 26.3;Smooth muscle cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 31.2;U-2197: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058824	Approved				"Secreted - unknown location"	NA	NA		260000	"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA058824: "	"unprognostic (3.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (3.13e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.72e-3)"	21.6	6.2	1.4	5.2	1.8	0.3	12.5	2.2	1.9	27.2	7.5	8.4	5.0	19.0	21.3	8.2	17.5	23.8	14.8	1.8	1.9	6.4	10.8	18.9	9.3	2.0	1.5	48.6	2.8	2.3	3.1	7.3	1.7	14.1	10.2	0.2	5.6	18.3	5.2	8.3	7.2	18.0	1.2	14.7	5.4	4.1	2.1	3.2	8.2	12.1	5.6	14.9	17.7	2.0	0.0	0.0	0.4	0.0	1.9	1.9	31.2	0.3	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.2	0.1	0.1	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.2	0.1	20.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.8	0.1	0.0	0.0	1.4	1.8	2.2	1.9	1.8	1.9	2.0	1.5	1.7	1.2	2.1	2.0	6.1	0.0	0.0	1.0	0.4	5.2	0.0	0.0	1.2	0.1	0.2	0.3	1.0	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	13.3	2.9	0.0	0.0	0.1	0.0	2.0	52.3	0.0	0.4	0.0	0.0	5.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	6.1	0.7	39.7	0.4	7.2	2.8	0.0	0.0	0.0	0.5	1.4	0.1	0.0	39.5	0.2	0.1	0.0	0.3	0.0	0.0	26.3	9.4	16.3	0.3	0.1	0.2	3.7	0.3	0.7	5.0	0.0	0.1
OMD	"osteoadherin, SLRR2C"	ENSG00000127083	Osteomodulin	Q99983	9	92412380-92424471	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Fibroblasts: 66.8;Hepatic stellate cells: 26.4;Leydig cells: 97.9;Peritubular cells: 110.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"ASC diff: 6.1;ASC TERT1: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069948			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		21000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	"Nucleoli fibrillar center"	"HPA069948: AB_2732144"	"unprognostic (1.18e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.31e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.81e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.08e-3)"	13.9	6.9	2.4	0.3	3.2	0.2	12.6	3.0	6.0	15.5	4.1	4.8	0.8	7.6	7.5	4.3	9.4	8.1	20.0	2.4	2.3	1.9	1.1	4.6	0.9	2.3	2.4	12.0	1.7	0.8	3.9	2.8	2.5	5.0	1.9	0.1	2.2	3.4	1.3	3.3	3.2	8.4	2.3	0.4	4.4	3.1	2.4	0.9	8.9	11.3	2.8	5.5	3.9	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.4	0.4	0.4	0.0	0.3	0.6	0.5	0.2	0.2	0.1	0.3	0.5	0.4	2.4	3.2	3.0	6.0	2.4	2.3	2.3	2.4	2.5	2.3	2.4	2.2	4.4	0.0	0.0	0.0	0.3	2.7	0.4	0.1	0.0	0.9	0.1	0.1	1.3	4.3	0.6	1.8	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.3	11.4	7.8	0.0	0.0	1.7	0.0	0.2	66.8	2.0	0.3	0.0	0.1	26.4	0.0	0.3	0.0	1.5	0.0	0.0	0.3	3.3	3.2	97.9	0.2	1.8	9.4	0.0	0.0	0.0	1.0	1.6	0.0	0.0	110.2	0.8	0.2	0.0	0.1	0.0	1.6	0.0	2.2	2.9	0.2	0.1	0.3	2.7	0.0	0.4	0.1	0.0	0.2
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812142-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.7;Excitatory neurons: 11.8;Inhibitory neurons: 15.7;Skeletal myocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 16.4;SCLC-21H: 6.4;SH-SY5Y: 6.5;WM-115: 22.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070831	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070831: AB_2732167"	"unprognostic (1.44e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-3)"	"unprognostic (6.28e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.95e-3)"	"unprognostic (4.28e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-7)"	"unprognostic (1.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-3)"	0.1	0.5	1.4	0.1	1.6	0.4	0.0	0.0	3.2	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.1	4.4	0.1	0.1	0.3	0.0	0.1	0.1	4.7	0.1	0.1	0.5	0.2	0.0	1.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	16.4	0.1	0.0	0.1	6.4	6.5	0.0	0.1	1.1	0.3	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.4	22.0	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.2	0.0	0.0	1.4	1.6	0.0	3.2	1.9	0.0	4.4	0.1	4.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	3.7	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	11.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	2.6	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	1.2
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OR2L13	OR2L14	ENSG00000196071	"Olfactory receptor family 2 subfamily L member 13"	Q8N349	1	248095184-248101103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	6	"brain: 6.7;retina: 2.2"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 140.4;Inhibitory neurons: 106.7;Oligodendrocyte precursor cells: 68.3;Oligodendrocytes: 139.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.39e-2)"				"unprognostic (1.53e-1)"				"unprognostic (9.89e-2)"	"unprognostic (3.66e-1)"		"unprognostic (7.01e-2)"			"unprognostic (2.44e-2)"	"unprognostic (1.14e-1)"		0.0	0.6	2.1	0.0	2.9	0.0	0.2	2.7	6.7	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	2.0	2.8	0.0	0.0	0.0	0.1	3.9	2.7	0.0	0.0	0.0	0.6	0.0	4.1	0.5	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.7	2.7	0.0	0.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.9	2.7	6.7	2.0	2.8	3.9	2.7	4.1	2.8	2.7	5.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	140.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.8	0.0	0.8	0.0	68.3	139.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9 endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 3551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		10000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	151.0	93.0	61.1	118.6	59.3	149.0	113.4	60.7	60.8	135.6	94.3	158.1	149.9	101.2	141.4	105.2	109.6	106.2	111.0	58.4	71.5	114.8	264.5	130.0	89.7	64.5	62.8	124.6	270.0	171.6	71.5	141.3	63.5	116.4	132.6	75.5	189.0	102.1	59.6	119.8	143.2	110.2	60.8	106.0	137.2	38.9	66.7	72.6	129.4	65.5	94.2	119.7	103.5	63.7	86.8	170.8	86.2	214.4	440.4	295.6	190.5	211.9	268.4	153.4	154.6	180.2	274.5	110.0	345.3	255.2	118.5	152.9	81.3	137.5	121.2	142.0	97.6	124.0	115.3	164.8	287.1	196.9	307.3	273.7	217.6	150.7	152.6	529.4	258.6	71.7	96.0	427.9	162.2	149.5	53.7	239.7	97.7	172.0	121.2	69.8	3551.9	281.5	116.5	210.6	88.4	116.4	300.3	205.5	176.6	158.1	245.4	381.0	238.9	206.0	122.3	140.4	136.4	253.4	234.6	112.9	173.8	141.6	290.4	175.7	241.2	274.6	72.9	213.0	68.5	50.5	61.1	65.0	172.6	54.3	46.8	54.1	246.4	58.8	182.4	149.0	74.4	218.9	61.1	59.3	60.7	60.8	58.4	71.5	64.5	62.8	63.5	60.8	66.7	63.7	83.3	86.6	116.7	22.2	65.8	57.7	85.4	103.3	43.9	44.1	61.2	46.6	14.1	80.1	111.8	73.5	77.2	142.4	64.5	153.0	9.8	144.8	6.7	34.0	73.3	90.2	103.6	53.4	19.5	110.1	124.6	113.6	65.7	60.0	91.1	61.6	81.4	161.1	144.8	50.5	27.0	167.3	107.8	121.1	99.1	10.7	113.4	106.1	119.2	29.0	125.0	87.2	53.5	23.6	24.4	94.7	155.4	79.0	141.1	56.5	154.0	53.9	74.0	50.9	92.1	68.3	66.9	38.1	46.4	51.3	51.6	197.7	59.5	64.9	102.4	65.0
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796540-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	2.6	1.2	3.6	6.8	4.2	4.1	3.9	2.8	5.9	10.2	3.8	5.9	9.3	2.2	0.8	7.6	5.1	5.0	2.6	3.9	4.4	16.0	1.2	8.6	11.3	3.8	3.7	5.2	1.9	14.1	2.0	3.9	3.5	2.2	6.0	1.3	3.7	2.5	3.3	10.3	7.6	3.7	3.1	6.8	8.5	2.8	4.5	8.3	9.8	2.0	14.4	13.3	6.5	5.1	40.2	10.7	7.8	14.4	17.3	34.5	17.5	44.5	49.3	20.4	32.1	27.0	52.0	22.2	6.2	47.8	26.9	34.6	23.6	33.4	31.4	13.5	9.8	5.3	16.4	20.4	24.5	15.3	113.8	17.0	27.2	26.7	31.8	26.0	31.0	19.0	28.4	30.1	34.9	0.0	9.4	18.7	15.3	38.1	13.7	7.5	21.6	9.1	20.4	28.2	1.6	16.1	30.3	21.5	6.7	23.0	11.1	1.5	37.1	9.1	17.9	49.4	33.7	20.7	32.8	55.6	19.5	24.7	102.0	5.8	1.9	1.5	8.5	1.7	7.3	3.3	5.3	5.6	3.3	1.6	1.8	3.5	0.4	7.7	1.2	2.3	9.5	2.5	3.6	4.2	2.8	5.9	3.9	4.4	3.8	3.7	3.5	3.1	4.5	5.1	2.2	0.0	26.1	123.1	18.3	12.1	8.0	8.8	21.6	0.3	3.8	4.4	5.5	5.7	22.2	25.8	0.0	8.4	13.2	3.8	3.9	3.5	0.3	24.6	2.3	3.6	1.8	11.1	176.1	3.9	2.1	3.1	19.4	31.9	0.0	0.4	3.6	0.5	10.8	0.0	272.2	1.7	20.3	12.7	9.3	0.3	0.6	13.2	16.0	94.6	7.8	4.8	14.4	44.2	3.6	24.4	4.5	0.0	91.7	5.2	3.3	0.5	53.1	0.2	0.0	3.4	4.6	0.5	5.0	16.5	8.0	4.0	18.5	20.3	4.5	16.5
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Cytokine, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 118.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 74.4;Macrophages: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"basophil: 65.2;neutrophil: 34.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 65.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.7;HL-60: 3.8;HMC-1: 11.1;Karpas-707: 3.5;NB-4: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	39700		"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	7.2	3.6	0.8	14.3	1.0	118.2	0.8	0.8	4.2	1.2	2.0	1.0	0.5	1.1	0.1	0.8	2.3	6.2	1.4	0.6	1.5	2.0	1.9	7.8	1.6	1.8	0.9	0.5	1.2	0.9	1.5	5.5	1.7	1.0	0.5	0.1	1.1	0.2	0.2	0.2	0.7	3.1	1.6	5.0	0.9	0.4	4.7	2.6	0.8	2.9	0.8	12.7	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.0	0.3	0.0	0.0	0.0	3.8	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	3.5	0.0	0.0	0.5	6.6	0.0	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.3	0.0	65.2	0.5	2.0	2.0	0.3	6.5	0.0	4.8	2.6	0.8	0.2	0.9	2.4	34.9	4.3	0.1	0.2	1.4	1.6	0.8	1.0	0.8	4.2	0.6	1.5	1.8	0.9	1.7	1.6	4.7	2.9	0.9	9.6	10.6	0.0	3.2	0.8	0.2	0.0	0.0	0.0	0.7	1.8	0.6	0.0	3.7	0.0	0.0	0.8	13.2	0.0	0.0	0.1	0.1	0.6	0.2	1.9	0.0	1.3	0.1	0.0	0.9	1.4	0.0	1.1	15.2	0.0	0.4	0.0	74.4	0.0	0.1	0.1	0.0	6.1	12.4	0.0	0.0	51.6	0.0	0.0	1.8	0.1	1.0	0.0	0.1	0.1	0.1	0.0	2.5	0.1	0.0	0.1	0.7	0.2	0.0	0.7	0.4	0.0	0.0	0.3	0.3	0.8	14.2	0.1	0.0	0.0
OSTF1	"bA235O14.1, OSF, SH3P2"	ENSG00000134996	"Osteoclast stimulating factor 1"	Q92882	9	75088514-75147265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 329.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 302.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020514	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA020514: AB_2670461"	"unprognostic (1.41e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (3.67e-5)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.68e-3)"	"unprognostic (3.76e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.36e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	44.3	36.9	27.8	65.7	35.0	56.3	34.9	32.0	37.2	34.1	25.4	42.5	38.2	22.7	38.2	104.8	20.0	42.8	32.0	28.3	33.2	34.6	57.7	56.4	74.9	31.0	32.5	16.0	19.4	72.1	19.1	69.9	33.1	22.7	45.8	12.3	38.5	19.6	9.5	63.1	47.8	28.8	30.8	87.0	40.6	18.0	31.0	47.8	29.0	16.0	85.0	55.3	53.9	35.1	69.1	16.0	7.7	11.2	45.4	41.7	81.3	71.9	46.9	26.9	24.4	8.2	50.8	70.9	35.3	59.2	34.6	111.8	12.9	51.9	77.0	302.0	16.0	39.3	24.8	42.5	36.7	71.5	141.6	29.1	49.2	31.6	21.8	23.7	91.2	59.4	13.4	158.4	65.4	35.9	107.5	44.8	14.5	161.5	30.8	20.1	52.3	63.0	57.0	97.1	6.5	0.6	53.1	74.1	36.2	58.2	97.4	79.9	86.4	55.8	19.4	108.3	30.8	30.1	52.5	26.7	67.1	81.9	46.4	359.5	177.7	464.8	158.6	199.3	169.6	101.2	110.5	131.5	148.7	87.4	62.1	109.8	495.2	168.4	256.8	110.6	163.0	283.0	27.8	35.0	32.0	37.2	28.3	33.2	31.0	32.5	33.1	30.8	31.0	35.1	113.4	22.4	24.4	8.1	90.8	82.2	61.2	78.2	61.5	2.9	38.6	23.2	7.8	28.6	51.2	33.1	6.2	125.5	162.1	64.8	76.3	49.7	11.9	42.8	59.4	60.5	27.2	23.3	32.0	52.3	252.9	42.1	31.1	51.1	137.6	4.2	71.7	32.2	233.1	10.1	12.6	31.9	69.2	167.4	181.5	6.0	23.9	155.7	76.5	43.1	329.9	6.0	268.8	30.2	67.3	60.5	97.7	15.4	83.2	34.1	64.1	63.0	27.3	8.6	19.7	15.9	45.0	6.7	17.8	141.4	114.5	133.9	163.8	37.6	38.2	91.6
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.1"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	1.4	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787063-65797214	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 57.2;skin 1: 51.0;testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 113.2;Squamous epithelial cells: 130.8;Syncytiotrophoblasts: 348.9;Urothelial cells: 114.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 52.2;CACO-2: 13.6;HaCaT: 31.4;MCF7: 12.6;RT4: 31.2;SK-BR-3: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003984	Uncertain		Approved	Nucleoplasm		Yes	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favorable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.1	0.0	0.0	1.0	0.1	0.1	2.8	0.2	0.1	13.6	0.0	10.3	15.5	0.5	0.1	57.2	0.6	0.9	0.0	0.1	0.0	7.4	0.2	0.3	0.0	0.0	0.0	0.0	9.1	15.0	0.1	6.9	0.0	1.4	8.3	0.1	8.8	1.0	0.1	51.0	9.1	0.3	0.0	0.1	1.6	35.5	0.0	0.4	1.3	0.0	5.5	27.4	21.3	0.1	19.0	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.0	0.0	0.0	13.6	5.0	0.0	0.1	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.1	1.4	31.2	0.2	0.1	0.0	24.0	0.2	5.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.3	2.3	26.6	62.6	14.5	54.1	0.0	59.4	25.4	0.5	7.2	13.0	3.7	0.0	19.5	1.3	57.6	0.0	2.5	81.9	76.2	11.7	1.8	31.6	0.0	0.1	3.8	14.0	0.9	0.0	113.2	2.5	0.0	0.0	0.1	2.1	0.0	0.1	54.9	20.3	0.0	1.4	87.2	1.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	44.5	1.9	3.0	34.1	39.1	6.7	11.3	0.0	0.0	0.0	1.1	83.9	4.8	130.8	57.4	348.9	1.7	0.0	52.0	114.9
OVOL2	"bA504H3.3, CHED, CHED1, HOVO2, ZNF339"	ENSG00000125850	"Ovo like zinc finger 2"	Q9BRP0	20	17956979-18059188	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Corneal dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 7.1;stomach 1: 7.9"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 24.4;Spermatocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.6;CACO-2: 4.1;CAPAN-2: 7.3;HaCaT: 5.4;OE19: 10.0;SCLC-21H: 8.3;SK-BR-3: 5.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.9;hippocampal formation: 3.3"	HPA038531	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA038531: AB_10673012"	"unprognostic (2.85e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.41e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-4)"	"unprognostic (4.77e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.76e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	2.8	0.0	0.1	1.5	0.0	3.5	2.9	0.3	0.5	5.3	1.0	0.3	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	4.5	0.4	1.2	0.1	0.0	4.1	1.3	0.0	7.1	0.7	0.0	6.7	2.3	0.0	0.0	0.0	7.9	1.4	0.0	0.1	3.3	0.0	0.2	1.2	3.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.1	7.3	0.0	1.0	0.0	0.3	5.4	1.0	1.3	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	10.0	0.1	0.0	0.0	2.1	0.1	2.6	8.3	0.0	0.0	5.4	0.0	0.1	2.8	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.4	8.4	0.3	0.1	8.3	11.4	4.8	4.0	0.0	14.6	11.7	1.4	8.6	8.8	1.8	0.0	1.7	0.2	17.1	0.0	8.4	18.6	24.4	1.3	0.3	3.6	0.0	3.3	10.9	3.2	0.2	17.9	18.4	0.0	0.0	0.0	0.0	0.1	1.7	1.7	15.5	10.2	0.0	0.7	7.4	0.3	0.5	0.0	0.0	0.0	0.7	0.0	1.0	0.3	16.9	10.5	0.4	0.0	12.9	12.0	1.6	6.4	0.0	0.0	0.0	0.7	37.9	0.7	4.9	9.8	0.1	0.4	0.0	12.3	15.1
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870425	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 245.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 243.7;Distal tubular cells: 187.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 238.7;SiHa: 319.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		440000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	52.7	15.8	30.4	16.6	34.9	13.3	18.5	23.9	32.7	13.5	15.9	19.2	8.3	14.9	17.6	26.8	12.4	15.2	245.9	36.2	27.1	53.1	1.3	8.0	21.7	19.5	21.4	13.8	5.3	48.6	14.7	5.0	20.0	25.5	21.1	23.6	18.9	29.8	28.5	23.1	12.8	36.6	19.3	11.0	34.2	13.2	25.7	76.8	27.3	42.6	25.9	15.1	13.8	24.5	35.3	1.6	27.9	33.6	84.7	45.0	0.1	62.1	38.9	50.3	30.4	5.7	23.5	91.2	15.0	47.5	25.8	20.5	77.5	55.9	58.5	78.5	9.1	63.9	238.7	11.9	36.8	125.8	20.9	42.7	15.3	49.3	82.2	24.6	46.4	81.6	13.3	114.0	58.1	4.5	105.5	6.1	6.4	0.0	24.5	82.8	78.9	68.7	41.7	2.9	27.9	28.8	319.5	0.3	38.3	2.5	0.4	27.4	28.3	39.7	51.9	68.6	50.6	18.6	16.5	3.6	59.9	90.9	30.9	1.4	1.4	4.7	11.6	1.5	13.8	10.0	11.5	12.7	6.3	7.5	13.6	10.9	0.4	11.3	2.5	2.4	21.5	6.6	30.4	34.9	23.9	32.7	36.2	27.1	19.5	21.4	20.0	19.3	25.7	24.5	8.4	6.4	9.2	37.5	19.2	14.8	11.7	12.4	17.6	14.1	18.8	14.2	243.7	7.2	14.3	11.0	2.1	7.0	18.3	5.0	187.9	5.4	19.1	11.7	18.8	9.8	13.2	23.1	71.5	0.7	11.9	21.3	20.4	31.2	9.5	8.7	6.8	0.3	38.2	13.5	84.2	18.6	12.2	1.3	7.0	8.6	6.2	5.2	16.0	26.2	4.4	11.8	10.3	66.4	46.8	4.8	5.3	7.5	31.3	12.1	2.9	27.4	5.6	21.6	13.1	9.7	24.6	35.6	19.7	27.6	21.6	6.8	26.6	8.6	18.1	9.0
OXNAD1	MGC15763	ENSG00000154814	"Oxidoreductase NAD binding domain containing 1"	Q96HP4	3	16265160-16350299	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.0;Inhibitory neurons: 62.8;T-cells: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 81.0"	"Lineage enriched"	"Detected in all"	4	"T-cells: 81.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036830, HPA059160"	Approved		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA036830: AB_2675338, HPA059160: AB_2683936"	"unprognostic (4.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.38e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.08e-2)"	"prognostic favorable (1.00e-7)"	"unprognostic (2.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-3)"	"prognostic favorable (7.63e-4)"	5.8	4.0	2.0	11.4	3.3	8.9	4.8	2.4	3.7	2.7	3.7	8.5	12.2	3.0	2.5	5.4	3.4	5.0	9.0	1.8	2.4	8.7	16.9	4.2	17.0	2.3	2.4	3.0	3.7	7.3	2.4	3.6	2.5	2.9	7.2	4.6	4.4	2.6	14.9	4.1	14.1	2.8	1.3	7.1	7.3	4.4	2.8	18.1	5.6	10.1	12.1	5.4	3.3	3.4	8.3	12.0	7.6	12.0	8.8	7.8	29.7	8.8	6.5	11.8	9.5	17.2	8.2	11.8	5.4	5.5	6.5	5.9	15.9	14.3	11.2	21.6	10.5	17.4	9.6	9.3	9.1	28.3	10.2	5.8	10.5	19.2	9.2	3.7	9.3	12.0	24.1	27.3	5.2	14.7	16.6	14.8	16.3	12.4	13.8	14.6	9.3	20.7	8.0	9.9	5.4	7.5	9.8	16.3	14.0	8.2	10.4	16.1	4.2	7.7	9.8	8.5	14.4	9.9	19.0	19.0	9.1	24.3	10.5	0.1	3.8	3.1	22.6	5.4	30.3	5.5	34.6	24.5	6.0	4.3	81.0	61.8	3.4	19.3	5.4	4.6	20.4	19.3	2.0	3.3	2.4	3.7	1.8	2.4	2.3	2.4	2.5	1.3	2.8	3.4	4.9	0.0	8.6	35.6	8.9	2.4	5.4	7.9	6.2	5.8	5.7	3.4	12.8	7.2	4.7	7.3	6.2	10.2	29.4	8.9	31.3	9.8	40.2	3.9	5.5	4.4	3.0	16.2	67.0	6.2	8.1	5.1	11.2	3.9	20.8	5.8	3.9	23.3	8.5	3.3	62.8	7.6	6.1	5.2	3.6	31.7	3.1	6.3	5.4	17.8	10.2	5.8	41.2	36.2	42.1	7.5	2.9	1.9	20.8	5.0	21.2	15.7	7.2	11.7	6.6	6.1	6.8	9.0	11.7	7.5	3.4	5.1	90.0	7.8	11.5	6.5
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622388	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Hearing, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;epididymis: 21.8;prostate: 14.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.6;Endometrial ciliated cells: 2.6;Fibroblasts: 8.3;Gastric mucus-secreting cells: 1.1;Peritubular cells: 3.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Group enriched"	"Detected in many"	7	"amygdala: 9.2;cerebral cortex: 11.3;hippocampal formation: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MCF7: 5.1;T-47d: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	1.1	0.1	9.2	0.6	0.4	0.1	0.2	0.3	11.3	0.7	0.0	2.4	1.1	0.2	21.8	7.2	9.3	0.1	0.0	10.1	1.5	2.5	0.4	4.9	1.9	0.1	0.2	0.3	0.5	0.7	1.3	0.4	0.1	14.1	0.3	0.0	0.1	9.0	0.0	0.2	4.3	0.1	0.0	3.2	1.7	1.5	1.0	0.4	0.2	0.0	0.8	1.0	1.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	5.1	0.1	0.3	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.9	0.0	0.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.4	0.3	11.3	10.1	1.5	0.1	0.2	0.1	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.1	0.1	0.0	0.0	0.1	0.0	0.1	8.3	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1
P2RX3	P2X3	ENSG00000109991	"Purinergic receptor P2X 3"	P56373	11	57338352-57372396	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;liver: 1.7;testis: 5.2"	"Group enriched"	"Detected in some"	28	"Early spermatids: 34.5;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057776	Uncertain					NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA057776: AB_2683526"	"unprognostic (5.44e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-3)"		"unprognostic (2.24e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-7)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.29e-1)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RY10	P2Y10	ENSG00000078589	"P2Y receptor family member 10"	O00398	X	78945332-78963727	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 79.3;granulocytes: 29.2;Langerhans cells: 38.5;monocytes: 32.5;Plasma cells: 32.6;T-cells: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 256.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 121.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036757, HPA065766"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA036757: AB_10696786, HPA065766: AB_2685556"	"unprognostic (3.02e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-6)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-4)"	"unprognostic (3.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.99e-2)"	0.8	0.5	0.4	14.6	0.5	8.2	0.9	1.4	1.1	1.0	0.0	2.7	3.1	0.8	0.3	1.1	0.4	3.2	0.4	0.4	0.1	0.4	1.6	2.4	27.4	0.2	0.0	0.4	1.5	0.0	0.1	0.3	0.2	1.3	3.6	0.6	1.2	0.2	0.2	0.6	6.4	0.7	0.0	16.6	3.9	0.3	0.2	10.3	0.6	0.1	25.8	5.4	0.4	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	121.8	0.0	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	9.9	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.2	0.1	0.0	26.5	0.1	1.4	0.2	0.3	0.1	256.1	0.2	158.1	12.6	0.9	11.4	73.1	28.0	25.5	4.0	74.1	25.7	19.5	27.9	18.1	10.9	2.8	41.7	13.2	0.4	0.5	1.4	1.1	0.4	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.7	0.0	1.7	0.0	79.3	1.8	0.0	0.0	0.0	0.0	0.3	0.3	1.2	0.0	0.6	0.0	0.0	0.0	15.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.8	0.5	0.1	29.2	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.6	38.5	0.0	0.0	3.6	8.8	0.0	32.5	0.0	9.2	0.0	0.0	0.0	0.0	0.0	32.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.0	0.0	55.1	0.0	0.0	0.3
PABPC1L2A	RBM32A	ENSG00000186288	"Poly(A) binding protein cytoplasmic 1 like 2A"	Q5JQF8	X	73077276-73079512	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;prostate: 2.5"	"Group enriched"	"Detected in some"	10	"Early spermatids: 14.3;Late spermatids: 48.5"	"Cancer enriched"	"Detected in single"	15	"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.5"									HPA041573	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA041573: AB_2677556"					"unprognostic (4.30e-2)"							"unprognostic (2.19e-1)"			"unprognostic (3.22e-1)"			0.0	1.0	4.6	0.0	3.9	0.0	0.0	2.3	6.3	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.7	6.1	0.0	0.0	0.0	0.0	2.6	2.7	0.0	0.0	0.1	2.0	0.0	2.5	2.5	0.0	1.1	1.8	0.2	0.0	0.0	0.1	0.0	0.8	0.2	0.0	1.7	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.9	2.3	6.3	3.7	6.1	2.6	2.7	2.5	0.8	4.3	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	48.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	3.0	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PABPC1L2B	RBM32B	ENSG00000184388	"Poly(A) binding protein cytoplasmic 1 like 2B"	Q5JQF8	X	73002939-73006106	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.2;pituitary gland: 2.1;prostate: 2.7;salivary gland: 2.1;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.7;Excitatory neurons: 2.2;Inhibitory neurons: 2.7;Oligodendrocytes: 1.7"	"Cancer enriched"	"Detected in single"	23	"prostate cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"									HPA041573	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041573: AB_2677556"					"unprognostic (1.73e-1)"							"unprognostic (2.26e-1)"			"unprognostic (3.31e-1)"			0.0	0.6	2.6	0.0	1.7	0.0	0.0	0.2	5.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.3	3.4	0.0	0.0	0.0	0.0	1.6	1.0	0.0	0.0	0.0	2.1	0.0	0.8	2.7	0.0	0.4	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.7	0.2	5.2	1.3	3.4	1.6	1.0	0.8	0.1	2.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PAGR1	"C16orf53, GAS, MGC4606, PA1"	ENSG00000280789	"PAXIP1 associated glutamate rich protein 1"	Q9BTK6	16	29816152-29822489	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 166.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Plasma cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041440, HPA043608"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"			"HPA041440: AB_10795541, HPA043608: AB_10797144"	"unprognostic (2.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.09e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.39e-2)"	23.5	27.8	10.2	5.5	10.8	6.5	23.2	18.4	12.3	120.8	8.9	48.9	8.7	55.3	7.1	25.7	68.4	6.1	32.0	10.1	9.9	30.4	28.1	23.0	8.7	10.9	10.7	166.5	26.3	7.4	128.9	3.7	10.8	69.3	5.7	6.8	21.4	8.8	24.6	18.0	30.8	4.7	10.5	23.6	26.4	31.2	10.6	9.3	30.2	9.0	6.8	50.7	73.8	12.5	16.7	24.1	13.9	8.7	7.0	6.7	11.8	12.7	11.5	14.5	12.7	17.1	16.9	33.4	12.7	9.1	7.2	15.4	15.2	19.1	9.2	14.8	31.1	14.8	16.4	16.1	7.3	23.6	26.9	7.5	15.1	10.2	10.0	13.4	12.1	31.0	20.1	10.4	9.9	45.2	18.6	27.6	19.3	14.2	20.4	35.4	24.5	24.9	10.8	7.8	34.9	13.2	9.6	22.4	9.7	10.5	20.9	15.0	9.2	12.0	10.9	15.2	12.9	19.4	21.3	13.1	15.8	24.2	15.0	22.5	16.9	33.0	19.7	17.0	22.1	19.7	16.8	20.0	21.3	19.5	21.7	20.1	11.0	13.9	19.6	21.5	12.7	15.2	10.2	10.8	18.4	12.3	10.1	9.9	10.9	10.7	10.8	10.5	10.6	12.5	1.3	0.0	9.8	66.6	15.2	0.0	0.3	0.1	18.2	3.5	4.7	2.9	0.6	14.3	6.9	1.8	0.0	5.6	5.3	5.9	0.0	27.9	0.5	1.0	1.3	3.8	14.6	10.7	16.2	21.7	8.2	4.4	13.3	0.8	7.6	0.3	6.1	2.0	7.5	5.0	16.5	11.1	0.0	5.6	0.0	0.6	0.9	7.7	0.0	9.4	22.5	1.9	4.1	11.6	8.6	13.5	15.8	3.4	34.5	0.7	20.7	2.1	3.0	3.3	0.0	0.9	5.0	3.1	1.6	16.7	0.4	6.7	10.9	0.2	13.2	0.2
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537370-9839076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 12.0;retina: 4.7"	"Group enriched"	"Detected in some"	4	"Breast myoepithelial cells: 6.5;Glandular and luminal cells: 2.0;Granulosa cells: 5.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 4.6;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.0	1.9	3.6	0.0	4.8	0.0	0.4	12.0	8.4	0.1	0.0	0.0	0.0	0.2	0.6	0.2	0.0	1.2	0.0	5.5	0.7	0.2	0.7	0.0	0.0	0.3	1.4	0.0	1.3	0.0	1.2	0.0	0.4	0.4	0.0	4.7	0.3	0.4	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.2	2.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	4.8	12.0	8.4	5.5	0.7	0.3	1.4	0.4	0.2	2.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0
PALMD	"C1orf11, FLJ20271, PALML"	ENSG00000099260	Palmdelphin	Q9NP74	1	99646113-99694541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 130.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 537.2;Cardiomyocytes: 157.6;Endothelial cells: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 155.2;LHCN-M2: 49.5;TIME: 220.5;U-87 MG: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017959, HPA030549"	Supported		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Actin filaments"	"Plasma membrane, Focal adhesion sites"	"HPA017959: AB_1854949, HPA030549: AB_2673518"	"unprognostic (1.48e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.05e-2)"	"prognostic favorable (9.42e-4)"	"unprognostic (7.67e-2)"	"prognostic favorable (5.90e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.70e-1)"	"unprognostic (8.08e-2)"	130.8	43.0	14.6	7.1	11.7	0.0	77.6	10.5	15.3	27.4	45.8	9.5	3.4	33.0	6.1	38.2	22.8	14.6	91.2	13.7	12.7	11.0	57.1	28.4	3.9	12.0	11.8	18.8	4.9	9.2	10.5	43.2	11.5	18.0	6.5	7.5	71.0	7.9	112.6	48.9	8.6	31.4	11.1	6.3	6.1	11.0	14.1	8.0	7.2	66.2	8.6	14.5	15.9	10.4	0.0	0.3	0.4	0.2	7.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	39.2	2.5	0.6	10.8	0.0	0.5	0.1	0.1	0.1	0.0	18.6	26.4	0.0	0.0	0.1	3.9	2.0	0.0	0.0	4.3	155.2	0.0	22.7	0.0	49.5	0.6	0.0	0.0	0.0	1.6	6.8	0.0	38.2	0.1	0.0	8.0	0.9	0.5	0.0	9.9	0.0	1.0	2.3	0.0	220.5	0.0	0.4	16.8	0.0	0.0	0.0	0.1	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	11.7	10.5	15.3	13.7	12.7	12.0	11.8	11.5	11.1	14.1	10.4	537.2	6.4	5.6	0.3	0.5	38.5	11.4	49.6	22.2	2.0	20.0	31.8	157.6	32.9	35.9	3.7	0.0	0.4	1.6	0.1	5.9	8.1	74.9	78.7	71.9	219.4	1.8	2.7	1.4	0.2	0.3	19.2	2.0	17.7	1.3	0.0	96.0	57.3	0.6	3.3	1.8	0.0	14.2	2.2	5.5	12.2	9.3	1.7	24.9	73.1	0.0	55.0	0.0	0.5	0.2	4.1	0.0	24.0	0.0	5.9	0.0	0.4	111.5	3.3	0.0	91.3	12.7	0.5	0.6	27.5	46.5	0.3	1.4	110.1	0.1	3.3
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153791-116402321	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 72.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		78000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.1	1.5	0.7	1.8	0.2	0.0	0.8	0.5	0.9	4.2	2.2	2.0	0.3	3.9	0.6	2.5	3.1	2.0	2.6	0.3	1.6	3.8	0.3	1.9	1.2	2.5	2.5	2.5	0.8	9.1	0.4	72.3	2.0	1.1	1.5	1.0	0.4	2.1	0.3	0.9	0.9	4.2	0.4	0.3	1.1	0.8	1.6	0.8	1.0	1.4	1.0	4.5	2.4	1.3	0.0	14.9	22.3	0.0	50.0	37.8	0.0	12.2	21.4	3.3	5.6	0.0	0.0	0.0	0.0	8.6	1.1	1.7	0.0	0.0	15.6	0.0	0.0	2.6	12.8	0.1	24.3	0.0	0.0	137.4	0.0	16.4	1.9	26.9	0.1	0.0	0.5	0.0	3.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.1	1.2	1.8	0.0	0.0	6.8	0.0	0.0	28.9	36.3	1.8	1.0	1.4	0.0	0.0	0.0	25.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.9	0.3	1.6	2.5	2.5	2.0	0.4	1.6	1.3	0.2	0.0	1.5	3.9	1.0	2.9	0.2	4.0	92.2	17.6	0.8	0.4	3.4	0.0	1.6	165.5	12.5	0.5	0.1	0.1	9.8	5.9	20.1	4.7	101.3	1.4	0.0	0.0	10.0	0.9	19.5	31.8	0.5	2.6	1.3	10.4	4.6	0.1	0.4	0.0	19.6	0.0	0.0	0.0	5.8	17.9	14.3	1.0	1.8	7.5	0.0	2.5	1.0	15.1	2.9	0.3	0.0	8.6	1.2	1.2	0.2	51.5	1.6	2.9	0.0	3.3	10.9	2.2	0.6	19.7	1.1	14.0	1.3	0.2	0.1	0.3
PAPPA2	"PAPP-A2, PAPPE, PLAC3"	ENSG00000116183	"Pappalysin 2"	Q9BXP8	1	176463171-176845601	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 56.8"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 140.7;Extravillous trophoblasts: 71.9;Muller glia cells: 41.4;Oligodendrocytes: 37.6;Syncytiotrophoblasts: 74.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8;renal cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-87 MG: 19.8"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"cerebellum: 5.6"	"HPA018412, HPA018430"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted in female reproductive system"	NA	NA		2000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum, Vesicles"		"HPA018412: AB_1854962, HPA018430: AB_1854961"	"unprognostic (2.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.52e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.18e-4)"	"unprognostic (4.35e-2)"	0.6	0.0	0.5	0.3	0.3	0.0	2.5	0.3	0.4	6.6	0.0	0.6	0.0	0.6	0.3	0.0	0.2	1.8	0.3	0.5	0.2	6.3	0.6	0.1	0.0	0.5	0.5	0.0	2.5	0.0	1.1	56.8	0.6	0.2	0.5	3.7	0.1	0.6	0.0	0.1	0.2	0.5	0.4	0.0	1.6	0.4	0.3	0.0	0.5	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	4.3	2.1	3.5	0.9	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.5	0.5	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.3	1.6	1.3	0.1	0.6	0.3	0.4	0.0	19.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.4	0.5	0.2	0.5	0.5	0.6	0.4	0.3	0.4	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.8	0.0	0.0	5.5	0.0	1.5	0.0	0.1	11.7	0.0	2.6	0.2	0.1	0.3	140.7	0.0	16.3	0.2	71.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	10.8	0.2	0.0	0.0	0.0	1.9	11.5	0.0	0.0	2.8	0.0	41.4	0.0	5.0	37.6	0.8	0.0	10.9	0.0	0.0	0.0	0.5	0.0	2.4	6.6	0.0	1.2	1.3	2.2	0.0	0.0	74.0	0.0	0.0	0.2	0.1
PAQR6	"FLJ22672, PRdelta"	ENSG00000160781	"Progestin and adipoQ receptor family member 6"	Q6TCH4	1	156243320-156248117	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"brain: 674.6;choroid plexus: 196.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 44.1;Muller glia cells: 70.9;Oligodendrocytes: 65.1"	"Cancer enriched"	"Detected in all"	6	"glioma: 34.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 5.7"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"RT4: 14.8;T-47d: 17.8;U-266/70: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.64e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (7.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.50e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (1.99e-4)"	"prognostic unfavorable (1.58e-8)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.82e-2)"	"prognostic favorable (1.86e-4)"	1.9	1.8	275.4	0.8	321.1	6.1	2.7	319.1	674.6	3.2	196.2	7.9	1.3	0.9	0.4	4.8	3.4	1.3	2.3	240.1	271.1	6.3	7.2	2.6	0.4	413.7	327.9	1.8	1.9	0.4	11.8	0.7	397.2	7.0	0.8	6.7	3.1	1.0	1.5	11.2	3.7	0.5	369.6	4.7	3.3	4.2	320.9	0.6	3.7	0.3	0.7	1.9	4.2	380.4	1.7	1.5	3.8	3.1	0.8	0.5	9.9	0.3	0.6	0.2	0.2	1.3	6.7	3.7	2.0	0.7	0.4	7.5	0.0	1.6	0.5	2.2	2.6	2.4	2.6	1.5	0.5	1.2	7.5	1.6	4.3	2.8	3.0	3.7	0.2	8.6	2.4	9.4	0.5	7.4	0.5	1.1	5.3	1.1	1.3	1.8	0.9	2.4	3.0	14.8	3.3	6.8	0.5	1.3	5.0	6.9	17.8	1.7	0.6	1.2	6.2	2.0	0.8	27.4	7.7	2.4	0.5	10.5	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.6	0.0	0.1	275.4	321.1	319.1	674.6	240.1	271.1	413.7	327.9	397.2	369.6	320.9	380.4	0.6	0.0	0.5	44.1	1.7	1.3	0.5	1.8	0.0	3.9	1.8	2.0	3.5	1.5	1.3	0.0	0.0	0.1	1.0	0.9	0.0	0.7	0.4	1.3	0.6	0.7	4.2	3.2	1.5	3.4	0.2	1.3	4.6	1.7	1.3	1.1	0.7	0.9	0.6	6.7	1.4	0.5	2.0	1.3	0.4	0.8	0.3	0.9	0.0	3.7	0.6	70.9	0.0	6.0	65.1	1.8	0.0	2.2	3.5	0.7	0.8	0.4	2.3	11.2	0.0	0.6	0.5	1.3	0.5	0.6	1.4	0.3	2.3	0.5	1.1	0.5
PARP15	"ARTD7, FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577628-122639047	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 19.2;B-cells: 88.4;dendritic cells: 38.6;granulocytes: 19.6;NK-cells: 21.6;Plasma cells: 18.6;T-cells: 31.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.6;JURKAT: 5.1;REH: 3.5;THP-1: 3.7;TIME: 8.9"					"Low region specificity"	"Detected in single"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	3.7	1.2	3.1	25.7	2.7	23.1	1.8	4.2	3.8	1.7	1.2	3.8	2.6	1.9	1.3	2.0	2.0	4.4	1.7	2.1	1.2	1.7	3.2	9.0	44.4	1.8	2.3	0.7	0.8	0.2	0.7	2.5	1.7	1.8	4.8	2.2	2.2	1.1	6.0	1.2	42.1	1.9	0.7	67.2	4.1	2.5	2.0	8.3	3.0	1.9	50.3	4.5	1.6	3.6	0.3	0.2	0.3	0.3	0.1	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.7	0.3	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.1	7.6	0.5	0.3	0.1	0.5	0.3	1.5	0.1	0.3	0.1	0.2	1.7	5.1	0.2	1.3	0.0	0.3	2.3	0.4	0.4	0.1	0.1	3.5	0.2	0.3	0.0	0.6	0.5	0.3	0.1	0.1	0.1	0.3	0.5	3.7	8.9	0.2	0.6	0.3	0.2	0.6	0.4	1.6	0.4	0.2	0.1	1.8	0.2	0.1	7.2	0.3	5.8	9.4	4.4	5.4	0.8	9.3	3.8	4.8	0.5	3.9	0.7	1.0	4.2	2.2	3.1	2.7	4.2	3.8	2.1	1.2	1.8	2.3	1.7	0.7	2.0	3.6	0.8	19.2	15.9	0.0	88.4	0.5	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.0	2.1	0.0	0.0	0.1	38.6	0.1	0.0	0.0	0.2	0.3	0.1	1.2	0.0	7.4	0.1	0.0	0.1	2.7	2.6	0.3	19.6	0.0	2.2	0.6	8.3	0.0	0.2	0.0	0.0	5.1	1.4	0.2	0.0	6.4	1.8	6.5	4.7	0.0	21.6	0.0	0.1	0.1	0.0	0.0	18.6	0.0	0.0	0.1	10.5	0.0	0.0	0.7	0.4	0.1	1.6	0.4	0.0	0.3	31.1	0.0	0.0	0.0
PARVA	"FLJ10793, FLJ12254, MXRA2"	ENSG00000197702	"Parvin alpha"	Q9NVD7	11	12377563-12535356	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cell shape, Chemotaxis, Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 229.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005964	Approved		Supported	"Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		7300000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Actin filaments, Focal adhesion sites"	Cytosol	"HPA005964: AB_1079569"	"unprognostic (3.87e-2)"	"unprognostic (7.38e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.38e-2)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-2)"	61.8	17.6	9.3	22.7	9.0	0.1	40.9	7.2	10.1	53.9	16.5	92.4	17.5	71.8	16.7	42.8	38.8	31.9	34.3	9.8	11.6	23.0	16.9	28.8	6.4	11.0	7.3	31.9	36.0	16.9	11.7	35.9	8.4	50.6	38.4	8.9	20.9	68.9	8.1	14.0	26.1	95.5	11.3	11.3	42.5	6.8	8.6	4.6	17.9	11.7	9.1	55.0	28.2	11.0	34.0	33.1	30.2	39.4	147.8	110.6	69.1	126.5	130.1	87.7	81.6	24.7	51.8	0.0	41.1	229.5	9.9	20.7	0.4	66.4	104.0	0.6	14.9	0.1	42.4	18.7	114.7	0.1	0.9	91.3	22.3	37.1	57.4	107.5	110.9	0.0	0.1	0.3	131.8	20.4	0.0	0.2	14.2	20.2	26.4	0.0	75.2	0.2	44.9	32.8	4.8	0.1	97.6	39.1	65.5	66.9	18.4	0.9	138.2	105.1	43.8	57.2	35.4	0.1	0.1	0.2	58.5	0.1	118.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	9.0	7.2	10.1	9.8	11.6	11.0	7.3	8.4	11.3	8.6	11.0	37.0	99.3	33.0	47.3	1.1	13.8	25.0	29.3	20.5	4.3	24.4	24.8	45.1	18.6	27.0	27.6	0.0	39.9	0.7	39.6	39.2	56.1	0.9	26.9	62.5	33.3	27.1	0.0	31.4	67.1	92.2	59.1	24.5	35.9	5.1	34.8	39.7	19.1	6.5	0.0	34.9	26.2	18.3	1.8	8.8	2.5	41.0	2.0	46.2	36.5	1.0	25.3	0.0	30.7	1.0	51.7	25.4	51.9	0.2	33.5	23.1	38.1	54.8	2.5	52.6	32.6	60.6	1.1	3.4	20.2	8.9	19.0	2.3	25.1	32.4	25.1
PATL2	Pat1a	ENSG00000229474	"PAT1 homolog 2"	C9JE40	15	44665732-44711316	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.7;lymphoid tissue: 17.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 21.6"	"Cell line enriched"	"Detected in some"	28	"U-266/70: 124.9"	"Not detected"	"Not detected"													NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.28e-2)"	"unprognostic (8.59e-3)"	"unprognostic (3.30e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.00e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.69e-4)"	0.9	1.1	0.8	7.7	1.1	7.7	1.3	0.6	0.8	0.3	1.5	2.1	2.4	1.1	1.7	0.6	1.4	2.3	0.7	0.7	0.8	0.5	1.7	3.9	17.2	1.8	1.1	0.9	0.6	0.4	0.2	1.0	1.1	0.8	2.5	0.1	2.5	0.6	0.3	2.7	3.2	0.8	0.9	13.9	3.2	0.5	1.2	3.6	0.7	0.0	10.8	2.1	0.2	1.4	0.2	0.0	0.0	0.1	0.0	1.1	2.8	0.1	0.4	0.9	0.9	0.6	1.2	0.9	0.1	0.3	1.8	1.3	0.1	0.2	0.5	2.1	0.0	1.2	0.0	0.1	0.5	0.5	0.7	1.2	0.1	0.5	0.3	0.2	0.0	1.4	0.2	4.5	0.3	0.3	0.1	1.4	0.4	0.1	0.1	1.8	0.0	0.5	0.1	0.4	0.1	0.0	0.0	1.3	0.1	0.2	0.1	0.9	0.6	0.3	0.0	0.8	0.0	124.9	4.3	0.4	1.2	3.1	0.4	1.5	0.3	2.6	21.6	0.7	3.2	3.3	6.0	17.7	0.7	3.5	3.6	12.8	1.6	2.7	0.5	0.6	0.9	3.7	0.8	1.1	0.6	0.8	0.7	0.8	1.8	1.1	1.1	0.9	1.2	1.4	1.4	3.2	1.7	1.6	29.2	0.9	0.6	0.5	0.6	0.0	0.6	0.6	11.7	0.0	0.4	0.0	0.0	0.2	19.1	2.0	0.0	0.4	0.3	2.4	1.0	1.8	0.0	3.0	0.3	0.6	0.5	1.9	8.2	0.8	0.0	1.2	1.4	1.0	2.0	0.0	0.4	1.4	0.0	4.8	2.3	0.0	0.3	5.6	0.0	3.7	5.2	0.0	51.5	0.5	1.3	0.4	0.3	0.0	15.7	0.6	2.2	0.4	8.5	0.0	0.0	1.0	2.6	0.1	0.4	1.4	0.9	0.3	29.8	1.8	0.9	1.3
PAX4	MODY9	ENSG00000106331	"Paired box 4"	O43316	7	127610292-127618142	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Cell type enriched"	"Detected in some"	7	"Enteroendocrine cells: 85.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"						"unprognostic (1.52e-1)"								"unprognostic (9.71e-2)"			"unprognostic (4.86e-3)"	"unprognostic (1.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	85.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809624-27838082	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 22.8;testis: 70.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 364.9;Spermatocytes: 436.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 282.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.7;white matter: 13.9"	"Not detected"	"Not detected"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	1.1	0.6	0.1	6.6	0.1	9.1	2.3	0.0	0.1	1.1	0.0	8.9	8.4	1.2	0.0	6.6	0.6	0.7	0.2	0.1	0.1	0.4	1.1	0.7	12.8	0.1	0.3	0.2	0.4	0.2	0.0	5.1	0.2	0.4	10.1	0.0	0.9	0.0	0.2	4.8	8.1	2.7	0.1	1.5	3.6	70.3	0.3	22.8	0.5	0.1	12.4	1.6	2.1	0.1	282.8	94.2	94.4	57.9	8.3	15.7	36.9	129.5	63.0	133.2	112.3	33.7	51.2	156.4	43.3	51.7	150.2	76.4	87.6	44.7	145.7	35.8	48.0	35.0	64.6	49.2	0.6	25.7	54.1	4.4	36.0	62.6	32.8	24.3	68.5	75.9	54.3	100.6	160.4	34.5	87.7	29.1	15.6	80.1	80.0	54.4	126.9	41.2	51.2	44.9	36.1	53.2	48.2	56.0	75.0	26.2	58.0	37.3	40.6	85.6	207.3	111.5	141.5	15.4	39.4	70.1	54.0	43.4	188.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.2	0.0	0.0	0.0	4.2	8.9	2.8	10.8	0.0	0.0	2.9	2.4	0.5	2.8	2.6	0.0	0.0	29.8	1.3	5.5	0.0	0.6	364.9	2.5	2.2	2.4	0.0	61.7	0.1	0.0	49.3	6.7	6.6	3.5	0.0	13.5	5.7	1.7	5.0	0.0	0.1	9.4	6.1	1.9	1.6	76.8	8.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	3.0	14.0	2.0	1.5	0.3	0.1	0.0	6.6	0.1	5.8	436.4	38.1	9.4	2.4	6.7	1.9	2.4	18.7	3.8
PCBP4	"LIP4, MCG10"	ENSG00000090097	"Poly(rC) binding protein 4"	P57723	3	51957454-51974016	"Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 391.4"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 374.5;Cone photoreceptor cells: 654.7;Rod photoreceptor cells: 592.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"B-cells: 5.2;granulocytes: 7.0;T-cells: 12.0"	"Cell line enhanced"	"Detected in all"		"SH-SY5Y: 160.4;SK-MEL-30: 140.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057754			Supported	Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol		"HPA057754: AB_2683517"	"unprognostic (7.17e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.94e-2)"	"unprognostic (4.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.72e-2)"	25.7	26.9	86.3	9.2	111.6	2.6	27.7	100.8	106.8	41.6	75.1	40.2	18.3	39.3	13.4	16.0	31.9	13.0	68.4	87.7	92.1	30.1	20.0	31.2	8.3	116.1	106.6	33.8	20.1	24.1	48.7	8.6	101.9	55.5	9.3	391.4	24.7	22.1	154.1	21.7	24.1	16.8	91.3	22.3	33.3	24.4	106.5	5.7	35.0	96.3	6.5	38.2	30.4	139.9	35.1	11.8	46.3	67.8	20.6	36.6	7.9	78.7	38.1	46.4	29.8	44.2	12.4	1.1	11.5	62.6	41.0	8.1	43.4	27.5	21.7	55.4	7.0	4.4	41.3	46.1	33.2	4.5	32.7	49.8	50.6	29.6	12.9	57.5	23.5	20.1	2.2	15.2	75.3	16.5	1.9	5.4	22.5	22.2	31.5	24.5	22.4	6.2	16.5	24.7	90.3	160.4	21.5	11.6	140.2	12.2	21.5	17.0	47.2	49.3	92.6	15.7	42.8	10.1	7.0	7.2	57.2	9.9	73.5	7.0	0.1	3.8	11.1	0.0	7.8	5.2	10.6	10.9	0.3	2.6	4.8	3.7	0.0	0.1	0.0	0.1	12.0	3.4	86.3	111.6	100.8	106.8	87.7	92.1	116.1	106.6	101.9	91.3	106.5	139.9	14.9	3.2	3.2	27.7	3.8	8.7	16.2	14.2	9.1	374.5	12.4	15.7	7.3	1.5	5.6	9.2	654.7	1.5	6.3	7.7	17.6	31.4	49.8	2.2	15.8	17.3	62.0	0.4	15.0	23.4	1.2	13.0	6.6	4.2	1.3	7.8	15.7	3.6	1.1	42.1	20.8	9.4	16.2	1.0	5.1	101.2	22.4	1.5	23.2	5.6	0.9	88.8	9.2	40.7	65.0	42.3	16.6	16.1	5.3	19.8	21.2	10.7	1.5	592.7	6.6	11.6	17.9	1.4	6.0	4.4	11.8	0.5	9.6	3.6	6.1	11.1
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 28.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 18.2;Excitatory neurons: 24.8;Inhibitory neurons: 18.6;Muller glia cells: 25.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 28.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.0	0.0	5.8	0.0	12.1	0.0	0.0	0.0	19.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	4.5	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	1.4	0.0	1.3	1.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	5.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	12.1	0.0	19.7	28.4	4.5	1.1	1.2	1.3	5.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.1	2.1	0.0	0.0	18.2	0.4	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	24.8	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	3.7	0.0	25.8	0.0	2.5	2.2	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.4	0.1	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.1
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 159.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4339.5;Excitatory neurons: 5259.8;Inhibitory neurons: 2489.4;Oligodendrocyte precursor cells: 6313.8;Oligodendrocytes: 14117.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 4.5;memory B-cell: 5.3;naive B-cell: 17.3"	"Group enriched"	"Detected in many"	9	"B-cells: 17.3;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 25.1;LHCN-M2: 41.6;TIME: 48.9;U-698: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		2900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	3.8	2.2	37.1	0.4	84.0	3.3	1.0	41.5	53.2	0.9	0.0	1.2	0.2	0.2	1.2	0.3	0.4	1.5	4.9	37.8	51.3	2.5	1.5	1.5	0.7	49.9	52.1	0.6	1.3	0.0	2.0	0.0	56.8	1.6	0.5	9.4	0.3	4.2	1.3	0.2	0.5	0.5	27.1	0.9	1.9	0.9	76.1	2.2	1.0	1.1	0.6	0.7	1.0	159.3	0.0	19.3	25.1	0.0	6.6	5.1	0.0	3.8	0.2	2.7	1.0	0.1	0.1	5.7	0.1	2.9	0.9	0.0	2.1	0.6	1.2	0.0	10.1	0.3	0.2	0.0	6.3	0.7	0.3	12.1	0.7	3.1	5.0	0.6	2.1	2.2	0.6	0.3	41.6	1.6	12.2	0.0	0.2	0.5	2.5	18.2	0.8	0.0	0.5	0.0	3.2	1.3	0.0	0.1	0.3	0.6	0.0	0.1	48.9	1.4	1.2	5.9	2.0	7.3	0.0	64.2	10.6	0.0	5.0	4.5	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	17.3	0.1	0.1	0.1	0.9	0.0	1.2	0.0	0.2	37.1	84.0	41.5	53.2	37.8	51.3	49.9	52.1	56.8	27.1	76.1	159.3	5.6	19.2	68.0	4339.5	29.1	1.9	2.5	0.0	1.8	318.8	9.2	14.7	152.5	0.0	4.4	5.5	20.9	0.2	4.3	0.9	9.8	1.9	3.6	0.3	6.4	4.7	62.4	2.5	5259.8	0.0	0.2	76.3	11.7	0.3	1.3	1.0	19.2	8.6	0.3	198.5	2489.4	1.4	0.0	1.9	1.4	3.0	29.5	3.7	10.6	237.0	0.3	87.8	2.1	6313.8	14117.8	0.3	1.2	14.7	1.4	2.0	0.0	0.8	0.0	27.1	6.6	27.9	25.4	6.8	5.4	1.2	0.3	0.0	2.7	3.7	0.8	0.8
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926299-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 29.8"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;EFO-21: 2.5;hTCEpi: 5.9;PC-3: 4.2;SCLC-21H: 2.9"	"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles		No	No				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: AB_2681942"	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.4	0.4	0.6	0.5	0.7	0.0	0.1	4.5	1.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	1.0	0.0	0.5	0.5	0.2	0.1	0.7	1.2	2.0	3.1	0.0	1.2	29.8	0.7	0.0	2.3	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.7	0.7	0.0	0.9	0.0	0.6	0.0	0.0	0.6	0.0	5.7	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.2	0.0	0.0	0.0	0.1	0.3	2.9	1.7	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	4.5	1.0	0.5	0.5	2.0	3.1	2.3	0.0	0.7	0.6	0.1	6.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.2	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHAC2	PCDH-ALPHA-C2	ENSG00000243232	"Protocadherin alpha subfamily C, 2"	Q9Y5I4	5	140966470-141012347	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;parathyroid gland: 42.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 1.3;Hepatic stellate cells: 2.2;Respiratory ciliated cells: 1.6;Rod photoreceptor cells: 1.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076190			Approved	Nucleoplasm,Mitochondria		NA	NA		1100000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA076190: AB_2686785"	"unprognostic (1.47e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.31e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.46e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-3)"	0.6	1.1	4.0	0.5	4.6	0.0	0.1	3.5	6.6	0.9	0.0	0.3	0.1	0.6	0.1	0.0	0.2	2.6	0.7	4.9	1.7	0.4	0.7	2.2	2.1	0.8	16.9	0.1	0.4	42.9	1.6	1.8	6.0	0.3	0.3	9.7	0.6	0.1	0.0	0.1	0.2	1.0	0.0	1.7	0.5	1.6	2.8	0.0	1.2	0.0	0.6	0.2	0.0	2.3	0.0	13.1	1.2	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	3.7	0.0	2.5	0.1	1.3	6.9	0.0	0.0	0.2	0.0	13.7	0.0	0.8	0.0	0.0	0.2	8.8	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.0	2.3	0.0	0.0	0.0	1.7	0.1	2.7	10.6	0.0	0.0	0.1	1.2	2.6	0.4	0.0	1.1	1.2	0.0	0.6	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.6	3.5	6.6	4.9	1.7	0.8	16.9	6.0	0.0	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PCDHB1	PCDH-BETA1	ENSG00000171815	"Protocadherin beta 1"	Q9Y5F3	5	141051374-141059346	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"skeletal muscle: 1.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Cardiomyocytes: 2.7;Respiratory ciliated cells: 2.2;Skeletal myocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA053921	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Plasma membrane"	"HPA053921: AB_2682310"	"unprognostic (5.54e-2)"	"unprognostic (1.60e-2)"		"unprognostic (9.01e-4)"	"unprognostic (8.65e-2)"			"unprognostic (8.00e-2)"		"unprognostic (7.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-5)"	"unprognostic (3.38e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-4)"	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.9	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0.1	0.4	0.2	0.3	0.1	0.1	0.2	0.4	0.3	0.1	0.4	0.3	0.5	0.1	0.4	0.1	0.0	0.5	0.2	0.0	1.4	0.3	0.2	0.0	0.1	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.9	0.5	0.4	0.2	0.4	0.3	0.4	0.1	0.3	0.4	0.0	0.0	1.1	0.0	0.4	0.0	0.9	0.0	0.0	0.3	0.1	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	2.2	0.4	0.0	1.2	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094606-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Endometrial stromal cells: 7.2;Spermatocytes: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 23.7;AN3-CA: 51.0;EFO-21: 28.7;U-138 MG: 22.2"	"Low region specificity"	"Detected in many"							HPA007548	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA007548: AB_2667859"	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.84e-4)"	2.7	0.9	0.7	0.4	1.2	0.1	2.6	0.9	2.6	1.8	0.0	2.3	0.6	2.3	0.6	0.9	1.3	1.4	1.9	2.4	1.0	1.0	0.2	2.2	0.2	0.9	0.9	1.7	1.0	0.1	1.8	0.7	0.7	1.5	0.9	1.4	1.7	0.4	1.0	2.0	0.9	1.4	0.9	0.6	0.8	5.5	0.8	0.2	1.3	1.3	0.1	1.2	1.3	1.8	0.4	3.4	23.7	51.0	6.7	3.1	10.8	0.9	3.7	0.0	0.0	0.6	0.2	0.9	28.7	1.7	5.6	0.0	1.2	0.3	0.0	0.3	0.8	0.0	0.1	6.9	0.0	0.0	2.4	1.6	0.0	0.0	0.4	1.0	0.5	2.9	0.8	0.7	7.1	0.2	6.9	0.0	10.5	0.3	6.7	0.0	17.6	0.2	2.6	0.0	13.1	3.6	0.0	3.4	7.6	13.2	14.6	4.3	2.8	22.2	6.6	10.5	3.4	0.3	0.1	0.2	4.8	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.9	2.6	2.4	1.0	0.9	0.9	0.7	0.9	0.8	1.8	5.1	0.0	0.5	0.0	0.0	0.8	1.1	0.6	4.0	3.1	1.8	1.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.6	2.1	7.2	2.5	1.2	0.0	0.0	0.4	0.0	3.7	0.5	1.3	0.0	0.7	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.3	1.0	1.2	0.1	3.6	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	1.5	0.0	0.8	0.0	0.3	0.8	1.4	0.0	3.0	1.9	9.9	4.0	0.7	0.4	0.0	0.1	0.1	0.1	0.7
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 432.1;liver: 681.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.2	1.1	0.8	1.7	0.8	0.0	29.8	0.7	1.6	0.0	0.6	57.8	110.4	1.2	0.2	0.4	0.9	5.0	1.0	0.7	1.4	432.1	681.4	0.2	0.3	0.7	0.9	1.6	0.4	0.0	21.1	0.3	0.8	0.2	79.8	0.5	1.1	0.2	0.4	0.9	143.9	2.9	0.6	0.3	0.9	0.0	1.3	0.1	0.8	6.5	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.6	0.7	1.4	0.7	0.9	0.8	0.6	1.3	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PCLAF	"KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15"	ENSG00000166803	"PCNA clamp associated factor"	Q15004	15	64364304-64387687	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 128.6;lymphoid tissue: 73.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"T-reg: 23.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 23.6"	"Low cell line specificity"	"Detected in all"											HPA047929			Supported	Centrosome		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA047929: AB_2680215"	"unprognostic (5.34e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (4.38e-3)"	"unprognostic (1.91e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-3)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (9.77e-15)"	"unprognostic (5.59e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.22e-1)"	2.1	1.4	0.9	22.9	1.0	128.6	3.9	1.4	1.1	1.7	0.8	19.0	14.7	4.5	1.2	15.2	1.3	2.5	0.4	0.9	0.6	1.2	3.6	2.5	49.5	1.0	0.8	0.4	1.9	0.8	0.5	8.7	0.9	2.0	22.6	0.3	2.3	0.3	0.4	6.7	15.8	5.0	0.5	7.4	8.1	1.1	1.0	73.8	2.2	0.1	47.1	7.9	4.9	1.9	212.6	165.8	154.4	140.8	15.9	60.9	134.4	146.2	84.8	185.4	276.4	198.4	202.1	343.7	46.4	57.4	64.8	153.6	340.7	83.1	235.3	192.5	124.8	352.5	202.5	209.8	1.5	285.3	153.8	20.0	7.9	156.4	31.9	52.3	168.9	175.9	201.3	104.4	248.1	187.8	268.0	605.5	73.9	179.9	73.4	416.6	353.8	247.1	115.9	200.2	19.1	86.7	112.8	105.2	69.3	78.9	153.8	365.3	36.3	158.4	308.6	177.8	386.7	65.5	223.4	229.0	67.7	512.9	108.5	2.4	0.3	0.9	1.4	0.2	0.2	2.0	4.4	4.2	2.8	0.6	0.5	1.0	2.7	5.7	0.4	0.3	23.6	2.3	0.9	1.0	1.4	1.1	0.9	0.6	1.0	0.8	0.9	0.5	1.0	1.9	0.5	9.6	11.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	27.5	25.5	0.0	0.0	5.0	1.8	0.0	82.2	8.3	0.0	1.9	6.5	0.0	18.6	10.4	8.5	0.0	0.0	0.0	3.0	160.2	25.4	0.0	13.8	3.8	48.8	0.0	0.0	110.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.3	0.0	0.0	3.0	3.6	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	42.1	5.8	7.6	0.0	0.0
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754012-83162930	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 25.6;pituitary gland: 11.1;retina: 21.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 655.4;Inhibitory neurons: 746.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 25.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	28	"REH: 263.3;U-2 OS: 284.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"		NA	NA		6000000		"Cluster 58: Brain - Synaptic function"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	1.8	4.2	4.0	0.2	5.5	0.0	2.4	25.6	22.4	1.5	0.0	2.1	1.5	0.3	3.8	2.3	1.0	0.9	1.4	7.8	1.7	4.4	0.1	0.8	0.1	0.0	0.0	0.8	3.9	4.4	11.1	0.3	0.0	2.5	1.7	21.7	2.5	2.5	0.1	2.0	1.7	0.1	0.0	0.5	1.5	3.7	1.3	1.2	4.6	0.1	0.2	0.6	2.6	4.2	1.2	1.6	1.9	0.0	0.8	0.1	0.0	0.7	0.7	0.5	1.0	0.3	0.7	0.0	0.0	0.8	7.7	0.6	5.7	2.4	2.4	0.3	0.8	0.0	1.2	0.1	0.0	0.8	0.2	0.4	1.8	0.0	9.6	0.5	0.0	0.1	0.0	0.0	0.8	0.8	0.2	0.0	2.0	1.0	4.7	263.3	4.2	0.0	1.9	0.9	4.9	3.4	0.2	2.7	0.6	1.2	3.4	0.6	0.0	0.0	284.5	1.2	0.6	0.2	0.0	0.5	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	5.5	25.6	22.4	7.8	1.7	0.0	0.0	0.0	0.0	1.3	4.2	0.6	9.6	17.9	40.5	0.0	2.5	9.0	3.2	13.6	121.9	11.0	9.7	31.2	22.8	12.6	1.8	131.3	1.9	0.0	22.9	7.9	6.4	13.0	7.4	6.7	2.5	60.1	0.0	655.4	4.9	0.4	2.4	20.4	13.5	0.0	24.2	0.0	0.2	1.7	85.8	746.4	15.0	2.0	0.0	0.0	7.9	2.8	0.4	0.0	50.6	0.0	16.2	0.0	73.9	73.7	2.5	21.9	6.4	0.0	3.9	13.5	23.0	7.7	86.9	0.0	0.3	3.2	5.0	19.5	19.3	3.4	0.7	0.3	37.5	9.3	6.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 68.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 19.1;hypothalamus: 68.3;pons: 30.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.7	6.3	5.5	4.7	3.7	0.1	1.4	1.0	19.1	0.9	0.0	2.4	5.2	0.1	0.0	0.1	0.2	0.2	0.8	3.0	68.3	0.4	0.0	0.3	0.1	6.6	7.7	0.4	7.6	0.0	12.1	0.0	30.0	0.4	2.3	8.7	2.7	0.1	0.3	1.1	3.6	0.6	4.0	0.1	5.7	0.1	6.6	0.2	1.9	0.0	0.0	2.0	0.5	5.3	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.7	1.0	19.1	3.0	68.3	6.6	7.7	30.0	4.0	6.6	5.3	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831096-48835610	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 642.6;pituitary gland: 1243.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 3045.7;Horizontal cells: 437.4;Paneth cells: 628.8;Proximal tubular cells: 1601.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 2.4;memory CD4 T-cell: 5.0;memory CD8 T-cell: 4.9;naive CD4 T-cell: 2.0;naive CD8 T-cell: 6.4;T-reg: 1.8"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 58.9;PC-3: 148.5;SCLC-21H: 58.2;SH-SY5Y: 53.8;SiHa: 52.1;U-266/84: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		3300000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	2.2	29.5	177.1	0.5	135.6	0.0	2.0	21.6	212.8	18.2	118.8	19.2	9.6	34.1	2.9	0.9	6.9	0.2	16.0	105.6	642.6	152.1	1.3	2.9	0.1	290.3	257.1	2.3	54.0	11.1	1243.7	0.2	193.0	14.4	0.5	2.5	6.7	0.8	0.8	8.8	13.7	0.6	95.5	1.1	21.9	19.7	264.9	0.0	3.3	0.0	0.0	1.2	6.5	51.8	0.1	5.4	0.2	14.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	5.3	0.1	0.0	10.4	0.0	4.2	0.8	0.0	1.1	0.0	0.0	58.9	0.0	0.0	9.3	0.0	0.0	3.7	0.0	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.5	7.9	0.0	148.5	0.0	0.0	0.4	1.4	0.2	58.2	53.8	52.1	0.2	4.9	0.7	0.2	0.1	0.1	0.1	22.7	0.2	5.0	13.3	73.6	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.8	0.0	2.4	0.0	5.0	4.9	0.0	0.0	2.0	6.4	0.0	0.0	0.0	0.0	1.8	0.7	177.1	135.6	21.6	212.8	105.6	642.6	290.3	257.1	193.0	95.5	264.9	51.8	0.8	0.0	0.0	29.0	12.5	15.8	1.3	4.3	0.6	139.6	11.4	14.9	1.4	2.8	4.3	389.9	52.1	1.0	1.0	18.2	277.8	8.6	12.8	44.3	8.7	3.6	3045.7	2.7	64.8	0.7	69.0	17.2	112.1	35.2	0.0	2.5	0.0	0.5	1.7	437.4	118.8	218.9	54.9	0.3	17.2	52.9	3.4	10.5	56.9	22.5	0.4	96.2	1.0	72.9	26.0	23.1	628.8	7.2	4.5	30.4	21.6	1601.1	24.8	148.2	0.0	0.3	12.6	32.5	82.2	0.2	11.5	1.9	20.1	0.2	15.6	3.7
PCSK7	"LPC, PC7, PC8, SPC7"	ENSG00000160613	"Proprotein convertase subtilisin/kexin type 7"	Q16549	11	117204337-117232525	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8400	"Cluster 15: NK-cells - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (7.11e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	31.8	16.4	16.4	27.9	17.6	25.7	24.0	15.9	20.9	27.5	16.7	69.5	29.2	72.4	7.6	24.0	35.7	12.9	20.1	19.9	16.6	15.7	19.6	25.6	31.6	18.1	17.0	17.5	29.7	11.8	16.6	13.5	18.0	35.4	37.5	10.0	15.9	11.2	15.6	20.7	35.4	13.5	15.7	30.7	45.1	12.5	18.3	25.0	18.1	10.7	29.2	39.4	22.2	20.2	14.6	27.5	19.1	21.4	23.3	19.0	15.0	48.5	22.2	24.1	23.9	38.3	82.6	24.8	33.5	38.6	31.1	48.0	25.2	34.7	15.5	34.2	24.2	36.7	40.7	17.5	26.1	23.2	49.4	32.9	22.5	33.0	26.4	12.4	41.2	28.0	22.5	22.0	34.8	19.0	31.5	24.3	17.6	63.4	28.1	19.1	16.9	29.5	30.1	33.7	24.9	32.3	39.6	51.1	7.5	14.8	32.3	18.6	36.4	36.4	16.4	31.5	34.3	13.4	8.7	14.0	18.6	33.1	33.3	7.9	7.1	9.0	38.1	9.8	33.0	23.5	29.7	35.6	7.6	18.5	20.8	24.7	5.3	41.0	11.5	8.8	42.8	20.6	16.4	17.6	15.9	20.9	19.9	16.6	18.1	17.0	18.0	15.7	18.3	20.2	47.4	48.1	36.2	44.4	93.3	70.1	50.0	35.2	19.4	124.1	31.2	23.5	8.1	35.8	42.5	47.8	246.0	50.7	97.4	204.9	5.9	27.4	6.4	21.0	40.3	47.5	62.4	27.4	47.2	54.5	39.0	38.5	110.6	36.5	34.1	30.2	77.4	27.8	32.4	87.5	41.4	91.2	24.4	60.6	83.9	7.5	33.5	39.2	53.4	25.3	54.6	21.8	310.0	48.2	62.0	73.7	132.2	39.9	58.7	39.0	98.2	9.2	22.9	178.8	72.3	87.5	107.7	64.4	24.5	27.4	94.3	62.5	127.3	42.7	110.3	53.3
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.7;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"Plasma cells: 9.5;T-cells: 34.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cell line enhanced"	"Detected in some"		"JURKAT: 1.5;MOLT-4: 2.4;RPMI-8226: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favorable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"	1.2	0.3	0.0	3.2	0.2	0.9	0.4	0.0	0.1	0.6	0.2	0.8	0.3	0.4	0.0	0.8	0.6	0.3	6.7	0.1	0.1	0.7	0.4	1.8	16.1	0.1	1.4	0.2	0.3	0.0	1.5	0.0	0.2	0.7	0.1	0.0	1.0	0.2	0.1	0.3	3.8	0.2	0.1	7.0	1.8	0.3	0.4	3.1	1.5	0.0	4.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	4.8	0.2	8.7	12.4	0.0	0.0	0.8	1.2	0.0	0.0	0.0	0.0	4.3	2.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	1.4	0.2	0.1	0.4	0.2	0.4	0.0	0.6	0.0	3.6	0.4	0.3	0.0	0.0	0.0	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.6	0.0	34.7	0.0	0.0	0.1
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857953-149944793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"retina: 1119.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 2946.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.1	0.7	0.5	0.2	0.5	0.9	0.2	1.4	0.7	0.1	0.2	1.2	0.2	0.1	16.3	0.9	0.2	0.2	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.2	1.7	0.1	0.5	0.3	0.9	1119.5	0.4	0.2	0.3	0.6	0.1	0.1	0.2	0.2	0.2	1.5	0.6	0.0	0.4	0.0	0.2	0.0	0.1	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.2	0.3	0.4	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.1	0.4	0.4	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.5	0.5	1.4	0.7	0.5	0.5	0.3	0.3	0.5	0.2	0.6	1.2	0.9	0.0	5.8	0.0	0.4	1.1	0.6	0.8	0.0	150.5	0.5	0.4	6.7	0.0	2.8	0.0	244.0	1.1	1.6	14.3	0.0	0.1	18.4	1.5	0.5	11.6	0.0	0.0	1.2	0.2	2.2	1.2	0.0	2.5	3.8	1.9	2.2	0.6	0.3	75.7	0.6	0.4	2.0	1.9	0.4	5.5	1.2	1.5	0.0	0.0	1.4	263.1	5.2	0.5	0.2	0.1	2.8	0.4	0.3	0.4	0.4	0.1	3.2	2946.4	0.0	1.0	1.2	2.3	0.8	5.4	0.6	2.9	1.5	2.2	2.7	0.2
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		580000	"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	15.4	8.5	29.3	7.9	36.8	1.7	17.0	36.6	32.4	18.1	20.5	29.2	20.2	26.1	11.2	9.6	21.2	11.4	21.1	27.0	27.5	22.2	8.5	24.9	3.5	46.4	37.5	7.7	71.6	6.6	10.2	26.8	40.7	23.3	14.8	5.2	20.3	11.2	95.2	12.5	25.9	10.2	35.8	16.3	32.1	4.5	36.5	6.6	10.0	15.1	2.4	17.8	15.9	58.8	22.9	15.3	1.5	21.6	4.1	0.7	50.7	5.0	2.9	6.4	4.4	23.8	25.3	0.6	8.7	4.3	2.9	56.6	1.5	69.0	3.4	12.9	2.3	0.3	13.3	8.7	26.9	2.4	2.2	3.0	26.8	3.3	21.3	8.5	12.5	1.3	2.3	3.1	15.8	28.7	3.5	5.0	40.1	8.9	3.3	11.6	1.5	2.5	9.0	5.3	2.1	1.8	76.5	4.2	13.3	47.5	10.7	2.6	37.3	13.6	37.8	8.0	31.0	0.9	1.4	0.8	12.3	7.1	311.4	11.3	1.6	2.4	1.6	1.9	2.2	1.9	1.6	1.5	1.5	1.8	1.9	2.0	4.9	3.4	3.3	2.1	1.8	2.1	29.3	36.8	36.6	32.4	27.0	27.5	46.4	37.5	40.7	35.8	36.5	58.8	15.2	89.8	11.9	11.1	1.5	28.0	20.2	12.1	59.7	15.7	12.7	154.9	29.9	15.7	11.0	14.7	8.4	8.8	1.7	76.9	5.9	15.8	0.3	49.0	4.2	19.4	13.1	0.0	7.7	53.3	5.4	12.3	41.8	35.7	10.8	18.1	21.0	1.0	2.0	32.0	5.9	40.5	2.0	1.3	10.4	0.1	2.1	14.8	14.2	6.5	1.5	0.7	1.0	5.0	27.5	72.6	97.0	6.4	4.4	29.4	47.2	8.5	4.5	2.1	39.5	48.9	110.3	0.5	1.8	9.4	9.8	2.9	3.9	0.2	32.1	18.2
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244982	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 75.0;Endothelial cells: 60.6;Langerhans cells: 44.3;Macrophages: 25.5;Pancreatic endocrine cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 10.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;EFO-21: 69.2;HUVEC TERT2: 52.6;SK-BR-3: 53.5;TIME: 68.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	4390000	950000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	32.6	6.4	14.7	7.1	10.7	0.4	24.0	10.3	22.2	7.5	4.8	20.6	4.9	8.9	5.2	6.2	7.2	11.7	31.2	12.0	9.8	17.0	3.7	28.1	7.4	13.6	12.4	3.8	8.8	8.9	4.0	40.2	12.0	7.6	3.5	0.8	10.6	5.2	18.7	10.3	9.1	9.2	10.6	6.6	7.9	3.4	16.0	2.1	16.1	11.0	1.6	8.5	6.6	9.4	33.8	2.6	8.4	0.0	0.0	0.0	9.9	0.1	0.4	0.2	0.0	13.0	10.3	0.0	69.2	0.0	3.1	12.4	0.5	2.8	0.0	0.1	0.2	0.7	1.1	4.8	4.3	0.0	18.1	0.0	0.3	0.0	0.4	0.9	52.6	0.0	1.3	6.1	1.9	13.7	0.1	0.1	3.2	8.1	3.4	0.0	0.3	22.8	27.7	0.1	0.2	0.0	0.6	53.5	0.2	6.0	24.3	0.1	68.1	0.1	6.4	0.1	7.5	0.1	0.4	0.3	0.1	1.5	31.3	0.0	0.0	0.0	7.3	0.1	10.0	0.0	4.3	5.6	0.0	0.0	3.6	1.9	0.1	0.0	0.4	1.3	2.3	2.1	14.7	10.7	10.3	22.2	12.0	9.8	13.6	12.4	12.0	10.6	16.0	9.4	75.0	0.0	1.1	0.0	0.6	2.8	1.2	3.8	1.2	0.7	5.1	7.1	3.1	0.0	1.3	7.3	0.0	7.3	4.0	0.1	0.0	20.0	1.3	4.0	0.7	60.6	1.8	0.0	2.8	3.6	6.5	1.6	0.0	5.6	0.0	13.1	16.8	1.4	7.7	0.0	0.9	0.7	4.1	2.6	44.3	0.1	0.6	25.5	1.8	14.0	1.1	0.3	0.0	0.0	0.2	54.7	0.0	0.0	0.0	2.7	0.1	1.9	0.9	0.1	6.6	4.7	9.6	0.3	1.6	1.1	1.4	4.5	2.0	1.2	0.1	0.6
PDHB	PDHE1B	ENSG00000168291	"Pyruvate dehydrogenase E1 subunit beta"	P11177	3	58427630-58433857	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 299.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 300.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033794, HPA036744, HPA036745"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No		61000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (2.79e-8)"	"unprognostic (2.67e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.85e-2)"	59.9	76.5	48.7	42.2	50.2	25.7	42.9	53.9	62.7	43.3	63.6	56.8	42.5	38.5	44.6	57.4	37.7	35.9	175.0	49.7	52.3	100.8	110.7	36.4	53.1	51.7	49.4	26.5	36.4	88.8	44.1	57.0	51.5	48.5	60.4	30.7	45.9	52.1	272.6	36.8	37.6	63.8	51.6	42.8	53.9	42.3	53.1	53.1	40.8	299.4	56.0	49.7	35.9	54.3	66.5	90.9	92.3	69.8	91.7	111.1	110.4	81.6	101.3	117.9	120.6	165.1	62.6	140.3	44.9	103.8	109.0	37.6	113.2	74.9	90.0	81.7	83.0	125.4	163.7	126.0	92.5	103.0	67.9	97.9	67.7	95.5	55.8	137.5	103.1	114.2	65.9	61.5	129.5	63.1	98.2	107.8	127.2	69.2	101.3	46.3	71.8	136.1	188.1	89.1	63.7	70.2	75.6	107.2	85.4	131.3	159.0	108.7	76.3	62.9	83.7	66.8	94.2	85.2	129.9	99.2	96.2	120.8	60.7	57.8	98.9	98.7	83.2	115.1	87.9	102.2	81.7	80.5	141.1	103.4	90.9	82.4	19.6	129.4	109.7	94.7	113.2	124.1	48.7	50.2	53.9	62.7	49.7	52.3	51.7	49.4	51.5	51.6	53.1	54.3	57.8	60.9	34.5	5.9	45.3	27.9	40.7	142.0	26.7	31.8	29.4	31.6	300.6	48.6	96.0	35.0	25.0	174.1	35.3	41.0	230.9	95.9	76.3	37.0	37.3	58.0	58.0	22.5	10.9	72.2	101.6	54.1	29.6	34.2	39.3	48.5	46.1	76.1	84.6	57.2	13.3	50.4	162.8	37.9	26.6	16.9	60.3	37.2	56.9	9.4	76.5	61.7	70.0	9.0	13.6	55.9	43.0	51.1	38.8	19.1	45.8	146.8	70.7	45.9	65.7	30.8	72.3	98.2	88.3	42.8	29.8	157.2	44.7	224.4	53.0	37.7
PDIA2	"PDA2, PDI, PDIP, PDIR"	ENSG00000185615	"Protein disulfide isomerase family A member 2"	Q13087	16	283164-287215	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 2509.7"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 294.9"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 28.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 7.9;Hep G2: 6.7;Karpas-707: 2.9;MCF7: 4.6;SH-SY5Y: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051692, HPA053492"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA051692: AB_2681575, HPA053492: AB_2682169"	"unprognostic (3.46e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.58e-14)"	"unprognostic (3.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.87e-2)"	2.8	0.6	64.4	0.4	70.1	0.6	0.8	80.5	96.0	0.6	61.2	2.7	23.9	0.3	0.9	0.9	0.7	0.1	4.4	64.2	66.7	0.6	0.6	0.7	0.2	76.6	67.1	1.5	2509.7	0.0	7.6	2.5	73.2	1.0	0.3	2.4	1.0	0.1	0.6	0.4	7.1	0.0	69.9	0.3	191.7	1.0	68.7	0.0	0.4	0.0	0.5	0.5	0.6	88.5	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.5	0.0	7.9	0.0	0.3	6.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.3	2.9	0.1	4.6	0.1	0.4	0.2	1.6	0.0	0.1	0.0	0.9	0.0	0.0	1.6	3.7	0.0	0.1	0.0	0.5	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	70.1	80.5	96.0	64.2	66.7	76.6	67.1	73.2	69.9	68.7	88.5	0.0	0.0	0.5	1.6	1.9	0.5	0.0	0.0	0.0	4.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.1	0.3	0.1	0.0	0.0	12.4	294.9	1.3	5.5	65.7	0.1	0.0	0.1	0.0	0.0	0.4	0.0	14.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	1.6	0.6	0.0	2.0	22.2	25.5	1.4	0.4	0.2	0.0	3.9	1.1	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	1.4	0.0
PDIA5	"FLJ30401, PDIR"	ENSG00000065485	"Protein disulfide isomerase family A member 5"	Q14554	3	123067025-123225227	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 12.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030353, HPA030355"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"	"Intracellular and membrane"	NA	NA		4700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA030353: AB_10599734, HPA030355: AB_10602200"	"unprognostic (8.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-2)"	"prognostic favorable (4.55e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.09e-11)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.06e-3)"	17.9	23.6	0.3	15.2	0.3	17.9	13.8	0.2	1.4	14.5	2.7	20.1	13.9	12.4	30.2	6.1	14.0	19.6	9.9	0.6	0.8	14.5	80.2	17.7	11.1	0.5	0.6	11.5	26.6	10.7	12.7	47.4	0.4	32.3	25.0	4.2	13.7	7.9	4.2	8.8	12.8	17.0	0.3	10.1	33.4	15.3	0.9	4.5	30.8	4.3	12.0	17.9	9.5	0.7	24.0	14.6	17.7	21.5	80.3	71.9	95.0	44.9	74.5	24.5	66.9	47.8	21.6	0.0	57.6	69.9	15.7	12.5	7.8	27.4	25.7	1.1	8.8	10.4	3.9	56.7	33.2	26.5	1.4	62.3	40.2	16.6	34.5	26.1	84.0	10.1	13.6	60.4	16.9	29.6	7.2	31.3	13.1	54.5	15.6	6.7	13.0	67.5	20.7	13.9	19.3	11.4	22.0	24.0	40.4	28.7	21.4	32.3	47.2	6.2	19.5	29.4	12.3	18.1	5.0	10.8	20.2	21.0	21.5	0.0	9.3	0.3	1.4	2.4	2.3	3.5	1.0	0.8	5.5	1.1	0.6	0.6	0.2	0.5	0.5	12.8	0.0	2.3	0.3	0.3	0.2	1.4	0.6	0.8	0.5	0.6	0.4	0.3	0.9	0.7	17.2	19.2	30.7	2.6	5.6	5.0	6.0	6.4	3.4	13.1	6.9	4.7	2.7	35.8	11.3	5.5	39.6	41.8	3.1	5.4	0.0	32.2	1.6	5.4	13.1	24.3	8.4	5.5	9.6	28.6	133.6	20.7	30.5	21.1	3.8	7.3	37.5	50.1	12.1	0.0	7.1	36.9	0.0	7.8	5.5	2.0	24.2	4.4	8.8	5.6	5.0	2.3	0.0	1.0	2.5	11.9	7.6	22.2	40.1	18.1	3.5	5.3	6.4	28.4	13.1	3.6	17.6	1.3	1.5	3.4	4.1	50.2	3.1	23.3	15.1	4.5
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 1202.1;Plasma cells: 883.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		15000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.20e-4)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	118.3	112.3	54.5	155.8	64.6	140.8	124.9	57.1	66.7	178.8	71.2	156.0	122.4	131.6	418.5	98.2	133.5	96.7	113.4	55.9	60.8	130.3	260.5	103.8	118.1	61.1	55.4	99.8	252.1	149.7	74.0	171.3	60.7	127.4	171.6	48.0	184.1	135.5	59.3	64.3	121.5	155.5	60.9	107.4	155.4	55.1	62.6	86.6	363.3	59.4	153.7	130.9	75.7	66.4	287.0	304.6	425.7	672.6	535.6	459.4	753.4	677.8	625.9	348.3	465.1	435.1	548.5	460.9	464.7	668.9	674.1	228.0	324.1	568.3	371.1	363.2	253.4	374.2	228.4	713.2	577.5	387.9	268.9	334.2	428.4	338.1	603.3	642.1	798.0	171.8	328.0	963.6	348.7	338.8	150.5	400.8	356.6	923.4	236.4	355.7	433.0	846.4	498.3	339.9	272.0	543.2	267.6	387.0	396.2	547.8	136.8	648.5	395.0	324.4	409.8	296.3	399.1	900.0	596.6	297.1	438.5	479.6	464.8	276.1	200.0	95.5	198.4	210.9	219.0	197.6	154.2	187.6	215.0	161.0	74.3	125.1	35.0	241.6	161.4	268.9	174.4	319.2	54.5	64.6	57.1	66.7	55.9	60.8	61.1	55.4	60.7	60.9	62.6	66.4	217.1	57.7	124.2	17.6	193.9	103.0	294.2	552.8	61.5	69.1	121.1	91.7	35.9	148.7	264.6	196.8	29.2	456.3	164.6	125.8	43.0	338.6	8.2	146.5	382.9	176.2	157.7	89.2	47.4	240.6	1202.1	228.2	138.1	255.0	131.3	210.6	211.3	355.6	413.1	42.1	30.5	276.3	170.9	155.7	149.8	16.2	121.2	145.9	199.3	15.0	132.1	106.5	142.2	32.6	25.3	175.4	131.2	135.1	883.2	385.4	99.9	149.6	145.8	60.1	85.5	96.9	225.3	98.5	117.9	95.4	102.6	554.1	125.7	254.3	248.3	265.3
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535507	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"skeletal muscle: 4781.7;tongue: 1519.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 228.9;Ductal cells: 332.7;Melanocytes: 124.5;Peritubular cells: 196.0;Skeletal myocytes: 428.3;Smooth muscle cells: 131.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 115.6;RH-30: 26.9;U-266/70: 111.2;U-266/84: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol		NA	NA		240000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.78e-3)"	36.3	11.5	12.7	25.7	13.3	0.0	34.5	16.8	14.8	22.7	10.9	201.2	20.8	235.3	59.1	216.2	97.5	40.1	314.0	12.0	15.7	13.9	7.7	55.2	10.7	19.9	14.2	38.1	18.7	0.8	20.7	18.8	13.8	87.0	32.5	11.2	56.3	148.1	4781.7	12.1	69.0	127.6	17.9	24.5	95.8	8.2	14.6	4.1	32.7	1519.6	26.2	141.1	40.8	14.2	0.0	0.0	0.9	0.0	0.3	0.0	0.8	0.0	0.0	0.3	1.0	1.2	0.4	0.0	0.0	0.0	6.0	0.0	0.0	0.2	0.0	0.0	15.1	0.0	0.8	4.7	13.5	0.0	0.0	8.7	0.0	2.6	0.0	12.3	9.1	0.0	0.0	0.0	115.6	0.0	0.0	0.1	2.4	0.0	1.0	0.0	26.9	0.3	0.0	0.0	17.6	13.3	0.0	0.0	7.3	2.8	0.6	0.0	7.9	0.0	7.6	0.1	7.1	111.2	34.8	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	13.3	16.8	14.8	12.0	15.7	19.9	14.2	13.8	17.9	14.6	14.2	22.4	9.6	6.0	37.2	2.6	8.9	11.4	0.7	12.5	12.1	72.8	105.7	228.9	5.7	2.2	0.0	12.5	2.5	0.6	0.2	0.0	332.7	0.4	1.4	0.8	39.0	3.5	0.0	2.5	16.7	2.7	82.9	1.1	1.1	0.0	1.3	67.5	0.9	1.6	5.0	0.5	0.5	2.0	1.8	11.7	2.6	19.6	2.3	124.5	1.0	3.2	36.4	0.0	6.6	2.6	31.2	0.0	196.0	7.3	12.2	0.0	0.2	3.2	44.3	105.2	428.3	131.4	4.0	12.6	2.4	7.1	12.2	2.5	2.4	0.3	3.9
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920000-27926313	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 41.8;pancreas: 13.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Ductal cells: 13.3;Enteroendocrine cells: 13.8;Exocrine glandular cells: 9.8;Gastric mucus-secreting cells: 4.6"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 8.4;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;HEK 293: 2.3;HeLa: 5.9;OE19: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	41.8	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	13.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.0	2.3	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	15.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	13.8	0.0	0.0	9.8	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 19.3;kidney: 17.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 93.4;Gastric mucus-secreting cells: 30.5;Paneth cells: 74.8;Proximal enterocytes: 79.1;Proximal tubular cells: 29.5;Undifferentiated cells: 21.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.3;renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077887	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	17.1	0.0	0.0	0.0	1.0	2.8	0.1	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.3	8.6	0.0	0.0	6.2	0.0	0.0	93.4	3.9	0.1	0.0	0.2	0.1	0.2	1.2	0.0	0.0	0.2	0.0	0.4	30.5	0.1	0.0	0.1	1.1	0.1	0.2	0.0	0.0	8.5	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	74.8	0.0	0.2	0.1	79.1	29.5	0.7	0.7	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	21.0	0.1
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183582-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 1047.0"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 5516.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 148.8;RPTEC TERT1: 501.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	20.9	8.2	0.6	24.6	0.8	43.2	36.4	0.4	1.2	29.9	0.7	44.4	21.6	10.7	2.9	205.9	25.7	197.6	1.4	0.5	0.7	1047.0	6.8	29.5	0.4	0.4	0.5	0.7	99.9	0.0	1.1	3.9	0.7	12.1	30.9	0.0	203.4	8.6	1.6	153.1	66.4	3.1	0.4	3.7	63.4	1.4	0.9	1.9	1.5	0.6	60.2	20.0	66.6	0.4	54.8	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	41.5	0.0	148.8	0.0	0.0	0.7	0.0	0.5	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	2.6	501.3	0.0	0.0	0.0	0.5	4.3	0.0	0.0	1.4	0.0	0.0	0.1	1.2	0.1	0.4	0.3	0.6	0.3	0.1	0.1	0.0	0.0	3.4	0.3	0.6	1.1	0.2	0.0	0.0	0.0	1.7	0.4	0.2	0.0	6.6	0.7	0.1	1.5	1.1	144.5	0.6	0.8	0.4	1.2	0.5	0.7	0.4	0.5	0.7	0.4	0.9	0.4	1.6	76.9	47.4	0.0	31.2	14.1	13.3	489.8	7.4	0.0	152.9	105.5	0.1	303.1	413.3	233.6	0.0	0.1	1.7	118.8	414.8	1175.8	0.0	6.1	3.3	4.5	39.6	148.4	0.0	760.0	0.0	6.6	36.7	38.1	10.8	0.2	5.0	1.7	0.3	0.0	0.0	143.3	52.9	0.3	2.1	0.0	3.4	59.3	8.8	0.0	13.6	0.6	2.1	0.0	0.0	1115.2	91.0	0.0	0.1	38.9	106.2	5516.6	147.6	0.0	0.0	0.1	28.7	0.0	0.1	30.7	54.0	0.8	22.0	0.0	150.5	68.5
PEAK3	"C19orf35, FLJ45778"	ENSG00000188305	"PEAK family member 3"	Q6ZS72	19	2274631-2282175	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.3;lymphoid tissue: 4.1"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.5;Hofbauer cells: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 41.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 12.2"					"Group enriched"	"Detected in some"	5	"basal ganglia: 6.7;cerebellum: 3.1"	HPA057806	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"HPA057806: AB_2683534"	"unprognostic (9.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.40e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.90e-1)"	0.5	0.4	0.5	1.3	0.9	2.3	0.3	0.5	1.6	0.2	0.1	0.4	0.2	0.2	0.0	0.2	0.5	0.2	0.7	0.4	0.5	0.3	0.2	1.1	0.4	1.4	1.0	0.1	0.2	0.0	0.2	0.1	1.0	0.3	0.2	0.0	0.2	0.0	0.3	0.3	0.8	0.1	0.9	4.1	0.3	0.1	0.8	0.1	0.2	0.0	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	10.5	4.4	11.7	1.6	5.7	0.2	0.2	0.1	0.2	1.8	0.4	0.1	0.3	41.0	4.5	1.9	0.2	0.0	1.1	0.5	0.9	0.5	1.6	0.4	0.5	1.4	1.0	1.0	0.9	0.8	0.6	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 455.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 702.3"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HUVEC TERT2: 773.0;TIME: 537.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"		NA	NA		110000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoli	"HPA004690: AB_1078462, HPA004871: "	"unprognostic (2.79e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.68e-2)"	"prognostic unfavorable (8.98e-5)"	"unprognostic (9.72e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.16e-2)"	195.6	21.4	20.3	78.9	21.4	35.5	128.5	21.9	25.3	54.9	21.7	37.9	29.7	51.1	9.2	54.3	45.1	88.6	70.3	18.0	22.2	43.6	22.4	204.9	68.0	24.7	23.1	10.7	21.3	29.9	9.7	455.1	24.1	23.5	37.7	4.0	33.4	24.5	35.7	36.2	39.4	83.5	26.3	94.9	30.9	5.0	28.1	62.4	69.8	97.0	60.4	84.0	35.7	22.2	0.1	0.3	1.3	0.1	1.1	1.5	0.4	0.2	0.3	0.0	0.1	4.7	0.1	4.2	121.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	95.0	1.8	2.2	3.7	0.5	0.3	0.3	0.0	0.8	0.2	1.6	773.0	34.1	2.3	57.8	0.1	0.4	33.3	8.1	0.1	0.0	9.1	1.4	15.3	3.8	0.0	0.1	0.4	0.3	1.8	0.0	0.1	0.2	0.0	48.5	537.8	0.8	0.5	0.9	0.2	3.4	6.3	6.8	1.6	6.7	0.1	54.8	263.9	219.2	19.8	419.6	18.9	26.7	2.2	46.6	154.0	32.7	36.3	68.6	392.0	40.3	702.3	88.6	2.1	224.2	20.3	21.4	21.9	25.3	18.0	22.2	24.7	23.1	24.1	26.3	28.1	22.2	672.9	16.0	37.9	0.7	24.4	0.0	0.5	0.0	4.0	0.0	4.8	4.6	23.3	1.5	3.1	9.2	0.0	0.5	50.1	0.0	0.0	0.8	0.9	1.1	1.1	468.2	0.0	17.9	1.2	0.2	4.0	22.0	0.0	1.6	8.8	0.0	275.3	3.0	45.8	0.0	1.2	0.0	0.0	110.4	0.0	1.1	2.5	143.9	0.0	47.8	93.8	0.3	26.8	0.5	1.3	0.1	0.0	1.9	109.1	1.3	0.0	0.5	7.3	1.2	0.0	6.9	15.8	0.1	0.5	1.6	0.0	0.8	21.2	4.3	0.1	1.0
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245035-140303113	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavorable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	74.1	50.9	73.9	37.7	75.6	60.2	50.0	82.2	88.4	41.4	70.8	59.2	40.2	50.8	54.3	52.3	41.9	35.7	93.3	77.2	79.7	61.6	38.5	46.9	46.1	82.9	77.2	37.2	34.7	52.8	39.4	50.8	80.5	44.8	42.9	35.1	45.4	43.7	149.0	46.2	39.8	61.4	79.1	36.6	40.7	29.9	79.3	51.5	42.4	86.4	51.6	45.9	40.9	81.2	172.4	79.6	137.7	80.9	89.7	91.8	133.8	229.6	114.9	174.6	192.6	172.1	107.9	114.9	224.1	124.3	180.0	62.6	102.0	228.7	204.2	122.6	102.9	102.4	76.5	113.0	105.1	213.5	76.4	98.2	119.8	148.5	156.3	112.6	196.0	132.8	93.7	73.1	149.8	78.5	146.0	147.6	92.0	70.3	119.2	101.3	195.9	86.3	197.1	77.9	78.2	81.8	172.1	148.6	136.8	128.5	102.1	122.3	249.1	121.8	119.6	71.9	208.0	70.3	198.6	299.2	122.5	138.5	144.1	149.5	84.7	130.3	86.2	131.1	91.8	106.0	98.6	100.4	100.5	97.9	97.3	88.4	14.0	114.7	130.3	93.0	129.3	115.5	73.9	75.6	82.2	88.4	77.2	79.7	82.9	77.2	80.5	79.1	79.3	81.2	87.9	67.3	33.0	16.3	57.4	38.0	65.9	96.2	30.7	42.5	50.1	57.3	81.3	52.9	62.1	66.2	45.9	116.1	53.1	56.6	123.3	121.9	3.9	58.0	56.6	73.8	46.6	62.9	31.2	101.7	86.6	55.4	35.2	70.9	54.4	53.6	72.1	56.9	85.4	25.2	29.3	43.6	48.8	61.1	37.7	12.9	52.2	63.4	74.7	37.5	90.4	84.9	71.1	24.1	39.3	128.9	55.1	52.3	35.5	45.4	80.9	147.3	45.3	42.9	65.7	39.6	63.7	23.7	61.8	40.8	34.9	85.6	45.2	42.9	47.3	63.6
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 5241.0;monocytes: 4824.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037134, CAB037140"	Enhanced		Approved	Cytosol		NA	NA		660000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	573.1	365.8	278.0	1133.4	302.0	1613.0	397.0	323.2	333.0	393.7	289.2	970.2	764.0	734.4	346.4	582.7	500.9	372.7	343.8	281.8	301.5	460.9	661.6	559.2	1357.9	347.3	325.4	247.7	246.4	311.3	198.9	581.1	348.6	419.4	808.4	71.8	346.9	601.4	337.9	449.8	772.9	1034.7	315.2	910.8	675.1	116.2	366.2	1197.6	269.2	238.7	1440.0	842.6	425.0	355.2	3019.5	4276.8	1461.5	1205.2	778.8	977.1	1972.7	2416.8	1970.4	2568.6	1923.7	1684.1	1181.1	2476.9	1892.0	2542.0	1453.6	1825.4	1383.6	3040.5	2049.6	3560.1	2355.1	2516.6	2034.3	2225.8	2144.0	1630.4	5006.0	1152.4	1331.9	1957.6	1939.8	1477.6	2361.3	1646.4	1488.6	1736.7	3150.5	1815.0	2469.9	3448.0	2095.2	1474.7	2297.3	2451.9	2035.1	1494.6	2491.7	1909.8	564.0	1586.2	1910.5	1180.9	1679.7	1226.8	1121.0	1359.7	2731.7	2136.6	1675.1	1512.3	3969.3	931.3	1070.7	1799.3	1834.4	1949.7	3316.4	8100.1	8206.3	13914.4	9850.0	10858.8	6780.3	5722.0	8185.7	9586.6	9920.0	4970.0	5238.0	7604.7	9387.0	9112.1	13547.4	7809.7	11245.6	23570.1	278.0	302.0	323.2	333.0	281.8	301.5	347.3	325.4	348.6	315.2	366.2	355.2	561.8	112.2	176.1	12.1	1070.6	1806.0	873.2	3658.3	1003.3	25.0	767.4	914.1	147.6	457.5	1020.0	741.2	0.0	1911.0	1725.6	1733.8	992.0	1866.6	19.7	313.4	546.1	806.6	603.7	713.5	7.1	1625.2	5241.0	599.9	733.4	422.7	486.5	291.2	637.5	754.3	4094.2	38.7	6.4	1399.7	1452.6	1434.3	2934.8	31.0	263.8	1854.7	873.4	21.5	4824.7	99.8	3216.3	9.0	37.2	2933.5	1585.7	375.0	927.8	1238.2	1472.2	1671.2	559.4	17.8	506.2	282.3	1838.4	97.4	355.4	1170.1	1513.5	1682.8	1804.7	410.7	1355.5	1177.9
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426191-97433444	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 791.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Supported	Nucleoplasm		NA	NA		120000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA042528: AB_2678039, HPA060483: AB_2684292"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	149.0	294.7	228.7	153.6	249.7	180.0	122.1	252.9	265.0	184.3	275.1	162.9	151.5	153.7	98.6	436.7	117.2	106.6	275.7	256.1	266.0	167.6	182.5	121.7	165.7	241.7	242.7	133.3	81.8	191.3	150.8	156.6	280.9	107.3	141.9	420.7	164.7	156.5	56.5	206.9	141.4	177.9	228.3	139.6	133.2	87.5	278.8	124.9	86.9	70.2	229.7	186.6	233.3	224.7	1160.6	538.9	364.0	697.9	336.7	307.7	494.1	722.4	938.4	830.2	1148.3	589.4	335.4	609.1	482.7	619.2	333.4	706.8	639.8	1051.4	998.1	567.2	611.7	393.6	386.4	667.5	248.4	570.0	503.9	303.2	422.5	552.7	408.7	1118.9	610.8	447.2	262.0	334.0	884.8	478.3	514.7	697.8	559.0	331.8	637.8	384.2	333.6	484.0	646.0	431.1	79.1	370.1	388.6	229.2	381.2	564.9	625.0	472.9	463.8	441.5	385.2	394.8	844.0	499.0	593.1	556.1	1023.3	937.5	209.3	242.5	433.5	572.7	217.0	366.6	192.3	134.8	183.8	216.9	309.7	114.7	117.5	164.9	312.6	149.4	422.7	110.5	265.6	580.2	228.7	249.7	252.9	265.0	256.1	266.0	241.7	242.7	280.9	228.3	278.8	224.7	92.9	44.8	44.4	23.8	122.2	187.0	173.1	394.2	124.1	403.5	77.8	76.7	22.9	85.8	140.8	106.7	77.2	495.8	122.3	233.9	358.1	321.8	15.1	50.2	113.7	145.9	48.1	71.1	29.4	205.8	791.9	146.0	68.8	72.0	103.4	109.5	96.8	193.7	395.1	387.0	35.7	116.7	152.5	170.0	129.1	27.0	149.5	174.6	131.6	16.9	376.9	404.4	174.0	14.1	19.9	295.7	132.9	234.3	254.9	175.2	283.0	274.8	72.1	300.5	203.8	73.1	199.9	38.0	114.7	253.3	204.7	372.6	138.0	257.8	176.4	269.6
PGBD5	"DKFZp761A0620, FLJ11413"	ENSG00000177614	"PiggyBac transposable element derived 5"	Q8N414	1	230314490-230426332	"Disease related genes, Predicted intracellular proteins"	Transposition	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;pancreas: 20.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Excitatory neurons: 83.3;Inhibitory neurons: 78.4;Oligodendrocytes: 48.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 17.7;basal ganglia: 18.5;cerebral cortex: 35.9;hippocampal formation: 41.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 30.7;GAMG: 15.0;NTERA-2: 30.3;RH-30: 16.4;SCLC-21H: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065010			Supported	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA065010: AB_2685402"	"unprognostic (2.00e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (8.78e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.51e-1)"	0.4	9.4	17.7	0.4	18.5	0.1	0.4	1.1	35.9	18.1	0.0	1.0	0.5	4.6	0.0	1.2	4.9	1.7	13.1	41.8	0.0	1.0	3.1	1.3	0.5	0.9	0.0	0.3	20.3	1.3	5.8	2.1	1.4	0.8	0.7	6.9	5.2	0.7	2.6	0.7	0.5	2.4	0.0	2.2	1.1	5.2	0.1	3.0	5.2	5.1	4.6	0.9	2.6	6.6	0.0	0.0	7.6	0.1	0.1	0.0	0.6	0.5	0.0	0.2	0.0	6.8	0.0	30.7	2.8	0.1	15.0	5.7	2.4	0.0	0.0	0.1	2.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.2	1.5	0.3	6.2	30.3	0.0	0.2	0.0	16.4	4.9	3.5	0.0	41.4	7.7	1.0	0.1	0.4	0.6	0.4	10.5	0.0	0.0	2.5	0.0	2.5	12.7	10.3	0.0	0.1	2.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.7	18.5	1.1	35.9	41.8	0.0	0.9	0.0	1.4	0.0	0.1	6.6	0.3	0.0	1.9	18.9	0.3	0.1	0.7	0.1	0.0	26.6	1.3	0.6	9.0	4.3	0.4	0.0	20.9	0.1	0.3	0.4	0.0	10.3	0.9	1.4	3.0	0.3	9.1	0.0	83.3	5.8	0.2	0.8	0.0	2.9	10.8	1.9	0.4	4.1	11.5	21.9	78.4	0.4	0.0	3.8	0.3	0.9	0.0	0.9	1.8	4.7	0.1	2.8	0.0	16.1	48.0	5.5	0.3	0.0	0.0	2.1	0.0	0.8	0.9	10.8	0.0	6.4	0.8	0.7	1.8	0.0	0.0	0.3	0.5	2.8	0.6	1.9
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420511	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 400.2;esophagus: 572.4"	"Cell type enhanced"	"Detected in all"		"monocytes: 214.9;Squamous epithelial cells: 496.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1074.7;monocytes: 321.0"	"Cell line enhanced"	"Detected in all"		"A549: 1445.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		No	No		41000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	115.8	51.0	49.5	59.8	49.2	400.2	89.0	52.9	49.3	75.9	52.5	52.9	91.6	23.1	41.9	572.4	30.0	94.2	34.3	47.4	54.3	53.2	81.3	88.5	38.1	57.0	54.6	35.7	32.0	52.7	43.8	47.4	55.4	30.4	46.3	49.1	133.7	22.9	34.7	50.0	70.7	35.0	49.7	110.4	61.4	68.3	59.2	53.6	71.8	28.2	73.8	61.8	126.9	52.0	191.5	1445.2	319.3	340.6	445.4	274.0	71.8	124.8	185.9	144.4	195.3	219.2	190.4	163.5	151.0	109.2	202.4	148.0	225.6	192.1	96.4	127.5	199.9	227.8	264.3	452.1	136.3	390.9	249.7	196.5	92.2	229.4	55.5	186.9	344.0	223.0	305.3	145.7	183.5	202.5	321.4	179.4	194.7	221.0	109.1	252.7	298.1	312.2	199.6	105.5	178.0	154.1	99.1	153.5	137.5	196.7	173.3	308.5	369.3	81.1	149.6	98.3	134.5	111.6	256.0	323.5	175.1	393.9	73.6	1060.2	321.0	1074.7	23.2	137.7	26.5	33.1	21.4	20.8	144.6	23.3	21.1	22.3	332.6	19.7	105.6	98.7	23.1	225.0	49.5	49.2	52.9	49.3	47.4	54.3	57.0	54.6	55.4	49.7	59.2	52.0	7.4	19.2	35.0	11.8	24.9	13.0	30.8	78.0	70.6	7.8	30.4	18.5	11.0	50.1	73.2	20.2	18.8	134.6	29.8	24.3	52.8	52.1	10.9	17.8	18.6	22.6	23.4	55.7	8.6	40.3	40.7	37.5	41.8	24.5	25.9	53.9	16.1	66.2	134.6	1.7	12.6	30.2	59.0	163.8	30.9	13.4	17.1	150.9	17.8	4.7	214.9	16.5	10.3	13.6	9.0	38.7	26.7	10.5	41.9	43.5	66.6	55.1	46.2	20.2	19.7	23.4	21.5	41.5	38.4	496.0	16.6	81.3	19.4	27.3	51.7	76.1
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 677.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 520.4;Theca cells: 907.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		1200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	108.0	171.3	97.9	37.5	102.5	25.1	106.0	83.8	115.5	135.4	96.3	98.2	109.3	154.5	273.3	57.0	149.0	56.9	38.6	102.3	127.0	235.4	677.4	62.1	27.6	97.2	109.3	93.3	40.2	113.9	59.1	44.9	126.1	127.6	87.3	80.5	71.4	200.4	15.7	53.2	131.9	85.2	106.1	41.4	77.1	46.5	112.8	33.4	89.0	27.0	29.3	77.3	65.0	116.9	165.6	102.4	196.3	227.7	414.2	196.9	127.1	243.0	281.0	126.1	155.7	124.5	196.6	47.3	259.5	253.8	147.3	128.3	216.5	102.1	168.8	50.8	248.7	53.7	88.5	141.0	69.0	88.4	27.5	204.7	56.5	153.8	79.2	93.5	82.6	55.7	57.2	28.8	150.3	176.5	66.9	64.7	515.8	179.4	170.3	78.5	123.1	68.5	168.7	123.9	182.9	81.7	178.1	291.7	98.9	188.2	67.4	56.2	64.2	87.6	127.7	312.6	233.6	29.9	59.2	51.0	238.8	138.6	170.6	21.0	20.1	20.4	8.7	19.9	11.8	5.8	12.0	12.9	17.0	5.5	12.0	10.1	9.1	8.8	18.4	12.0	13.4	50.2	97.9	102.5	83.8	115.5	102.3	127.0	97.2	109.3	126.1	106.1	112.8	116.9	109.1	125.0	91.4	16.0	19.0	94.1	131.3	67.4	81.4	199.1	110.8	95.1	17.1	120.1	76.7	73.5	68.8	88.2	25.8	170.5	68.4	93.0	4.2	119.7	264.2	81.9	57.7	37.6	36.5	73.0	138.6	153.1	50.4	122.4	40.5	197.0	66.4	520.4	51.8	65.6	58.5	85.0	81.4	35.0	51.2	9.0	172.1	111.1	103.2	15.0	26.5	109.8	18.6	108.6	91.3	68.9	144.7	181.7	22.6	118.8	375.5	295.1	105.4	92.4	105.2	99.2	111.1	68.2	77.2	69.3	87.7	62.1	32.1	907.9	137.6	127.9
PGS1	DKFZP762M186	ENSG00000087157	"Phosphatidylglycerophosphate synthase 1"	Q32NB8	17	78378649-78425114	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022526	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA022526: AB_1855271"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.46e-3)"	"prognostic favorable (7.33e-5)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (9.94e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.72e-2)"	16.1	10.0	12.6	17.9	14.9	39.6	15.4	13.3	25.3	14.2	15.8	13.0	11.7	14.9	6.0	10.8	14.0	13.2	11.1	13.0	16.6	13.8	7.0	23.5	16.9	18.0	15.4	13.9	10.9	11.5	11.5	19.7	15.6	12.4	7.8	6.6	11.9	10.8	13.5	11.5	14.7	10.3	12.9	19.8	11.4	8.9	18.8	14.0	16.4	7.6	11.6	14.5	12.0	18.1	19.9	16.7	17.8	13.5	14.6	23.0	18.8	18.3	17.2	19.3	21.2	17.8	15.8	20.2	10.8	10.8	19.4	15.5	19.8	12.5	15.1	30.3	24.1	22.2	25.0	17.5	15.2	17.7	16.9	23.6	16.1	14.6	12.6	19.1	37.8	15.9	26.0	14.2	13.2	10.8	39.5	19.5	17.4	8.5	15.9	19.4	29.6	16.8	21.0	19.5	21.4	33.2	15.4	16.4	18.5	17.8	17.4	23.8	22.8	24.9	16.6	13.5	15.4	16.0	9.5	15.2	19.1	19.0	18.7	2.1	17.7	19.3	11.0	15.0	13.6	10.3	11.6	11.7	20.6	11.9	14.5	10.6	33.9	11.2	7.2	9.4	15.1	12.0	12.6	14.9	13.3	25.3	13.0	16.6	18.0	15.4	15.6	12.9	18.8	18.1	25.9	12.8	16.8	10.1	11.6	4.5	12.0	16.3	7.4	13.0	6.4	8.8	5.8	4.3	12.0	12.9	2.1	20.2	11.2	7.7	3.9	5.8	20.0	9.0	8.7	21.5	4.2	5.5	14.8	7.0	8.1	9.7	12.2	6.7	7.6	13.3	15.0	3.9	15.4	20.2	15.0	6.1	6.1	13.9	8.3	10.8	10.5	19.2	5.4	17.8	12.1	11.0	10.3	11.6	20.4	7.2	15.6	8.6	9.4	9.2	8.0	5.2	14.4	11.4	32.9	6.8	10.8	17.9	18.4	5.8	3.8	19.3	10.8	14.7	8.5	10.9
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 2541.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"OE19: 833.5"									HPA068787	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA068787: AB_2686035"	"prognostic favorable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	3.7	0.4	0.1	88.8	0.2	0.2	11.1	0.3	0.1	0.8	0.0	2541.0	881.0	1.2	0.0	2.0	3.5	0.3	0.3	0.1	0.1	1.9	1.0	0.2	1.2	0.1	0.1	0.5	1.9	0.0	0.5	0.0	0.1	2.5	370.7	0.0	0.3	3.0	0.4	3.7	2320.2	17.3	0.1	0.4	177.1	0.3	0.1	0.0	0.4	0.0	0.0	5.6	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.0	0.1	833.5	0.3	0.1	0.0	10.8	0.0	1.5	61.5	7.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	46.0	0.0	0.2	0.3	0.0	0.0	40.2	38.0	0.0	117.2	0.0	0.0	0.0	0.0	0.1	19911.4	0.0	2.5	0.1	0.0	0.0	0.2	1938.2	0.0	0.0	0.2	0.0	0.5	884.8	0.1	213.9	0.0	0.0	0.6	0.0	0.0	0.0	8220.0	20.3	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	9497.7	0.0	2.1	1.1	51149.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	4881.6	1.0
PHOX2A	"ARIX, CFEOM2, FEOM2, PMX2A"	ENSG00000165462	"Paired like homeobox 2A"	O14813	11	72239077-72245664	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 19.9;brain: 18.3"	"Cell type enriched"	"Detected in single"	4	"Spermatogonia: 2.9"	"Cancer enriched"	"Detected in some"	9	"ovarian cancer: 9.3"	"Region enriched"	"Detected in some"	9	"pons: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	226	"SH-SY5Y: 569.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA053810, HPA065621, HPA078004"	Enhanced		Supported	Nucleoplasm		No	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367"			"unprognostic (5.84e-2)"		"unprognostic (8.51e-2)"					"unprognostic (5.07e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.13e-1)"	"unprognostic (9.92e-4)"	"unprognostic (3.03e-2)"			0.3	19.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	0.0	0.2	0.0	0.5	0.0	18.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.3	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	569.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.9	18.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PHOX2B	"NBPhox, PMX2B"	ENSG00000109132	"Paired like homeobox 2B"	Q99453	4	41744082-41748725	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 8.6;brain: 15.2"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"medulla oblongata: 10.1;pons: 15.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	89	"SH-SY5Y: 132.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.6"	"Group enriched"	"Detected in some"	18	"medulla oblongata: 1.4;pons: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	8.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	3.7	15.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174902-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2267.8;lymphoid tissue: 2103.1;vagina: 1595.8"	"Group enriched"	"Detected in many"	10	"Basal respiratory cells: 5354.5;Club cells: 2170.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Group enriched"	"Detected in some"	22	"cerebral cortex: 12.0;pons: 7.3;thalamus: 19.0"	"Immune cell enriched"	"Detected in some"	1021	"neutrophil: 1763.3"	"Lineage enriched"	"Detected in single"	4377	"granulocytes: 1763.3"	"Group enriched"	"Detected in many"	5	"EFO-21: 89.3;HaCaT: 109.8;OE19: 103.7;PC-3: 189.9"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		1400000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	6.1	0.7	0.2	101.9	0.5	1.8	8.8	0.2	12.0	180.1	1.2	124.3	1.9	2.3	1.1	2267.8	4.8	56.6	1.7	0.2	0.4	1.5	3.3	32.5	0.4	0.3	0.3	0.7	1.6	0.2	2.8	1.1	7.3	11.7	43.3	0.0	460.8	3.5	0.6	78.6	42.3	7.5	0.3	20.0	9.0	0.5	19.0	90.6	0.8	1.9	2103.1	44.7	1595.8	0.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	7.7	0.4	0.0	3.1	2.1	1.4	89.3	0.0	1.1	109.8	0.0	23.2	0.1	1.2	0.0	0.5	6.3	0.9	0.0	0.7	0.0	0.0	21.7	17.8	1.9	0.0	0.1	0.0	1.3	0.2	0.0	0.0	0.1	0.1	0.2	103.7	189.9	0.0	1.0	0.0	21.9	0.4	0.0	0.0	15.7	2.1	0.1	0.0	0.0	0.0	0.8	1.0	10.9	0.3	0.9	0.3	1.8	0.4	14.3	0.7	0.1	0.3	0.4	1.7	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1763.3	0.0	0.1	0.1	0.1	0.6	0.2	0.5	0.2	12.0	0.2	0.4	0.3	0.3	7.3	0.3	19.0	0.3	0.1	0.0	8.6	0.0	7.4	0.1	4.7	5354.5	0.0	0.0	39.4	8.4	0.2	8.6	2170.2	18.4	0.0	0.2	0.5	375.4	0.0	46.6	0.1	3.7	0.7	3.0	16.6	0.0	0.0	317.3	0.0	0.8	2.6	6.9	4.5	0.0	0.0	0.0	0.1	0.0	0.0	31.8	197.4	0.0	0.4	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	231.8	219.6	0.0	0.2	29.1	33.9	0.2	152.9	0.0	0.0	0.0	50.5	0.0	0.0	36.2	3.8	0.0	2.5	0.1	154.1	150.4
PID1	"FLJ20701, NYGGF4"	ENSG00000153823	"Phosphotyrosine interaction domain containing 1"	Q7Z2X4	2	228850526-229271287	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 135.0;Inhibitory neurons: 142.2;Langerhans cells: 210.4;Microglial cells: 179.9;Oligodendrocyte precursor cells: 543.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 71.1;intermediate monocyte: 79.4;myeloid DC: 83.6"	"Group enriched"	"Detected in many"	53	"dendritic cells: 83.6;monocytes: 79.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;hTEC/SVTERT24-B: 86.1;LHCN-M2: 57.3;REH: 62.3;RH-30: 90.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036103	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA036103: AB_10602144"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.91e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.34e-2)"	"unprognostic (9.61e-6)"	31.2	29.5	18.8	13.9	20.8	2.9	25.8	9.0	21.2	30.2	9.0	37.6	5.5	22.9	8.9	12.0	33.9	12.7	17.0	20.6	15.5	5.6	62.2	24.4	4.4	14.8	30.5	31.0	13.8	1.5	8.8	26.1	13.6	19.2	21.5	3.8	10.2	14.8	13.1	20.0	25.1	16.7	11.8	20.3	25.5	5.5	21.4	3.4	16.6	20.8	3.6	30.9	27.0	13.8	0.0	1.9	0.0	0.0	54.5	10.5	0.1	9.2	34.7	5.8	7.1	0.7	0.0	0.0	0.2	13.0	18.0	1.7	0.0	1.7	7.8	0.0	0.0	0.0	4.0	0.1	22.3	0.0	0.1	19.8	15.5	86.1	14.0	16.1	0.0	0.0	0.0	0.1	57.3	0.1	0.1	0.0	0.9	7.6	5.2	62.3	90.7	0.1	1.1	0.0	1.8	2.3	19.4	1.8	0.1	0.7	0.2	0.0	0.0	22.3	8.3	21.1	8.8	0.1	0.0	0.0	29.3	0.1	3.7	0.0	71.1	0.0	0.0	79.4	0.4	0.2	0.0	0.2	83.6	0.0	0.0	0.0	1.5	0.0	16.7	0.4	0.3	28.4	18.8	20.8	9.0	21.2	20.6	15.5	14.8	30.5	13.6	11.8	21.4	13.8	4.0	6.4	70.9	53.8	1.6	15.6	6.1	13.5	6.8	5.7	0.9	1.7	2.6	8.6	11.1	0.0	0.0	1.9	0.2	75.7	0.0	2.5	0.1	1.4	37.8	4.1	4.9	0.4	121.0	4.0	31.5	107.3	1.1	4.4	6.3	7.8	4.2	135.0	3.3	0.0	142.2	11.9	4.1	42.5	210.4	1.9	88.0	50.1	21.4	179.9	35.2	14.0	1.0	543.4	3.5	1.6	24.2	75.2	0.5	21.9	39.5	0.3	2.5	1.3	0.0	4.8	8.7	0.4	2.1	1.4	14.5	4.8	2.4	41.0	36.0	1.4
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928522-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 2641.0;salivary gland: 1645.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 7090.1;Intestinal goblet cells: 2361.1;Paneth cells: 3208.3;Proximal enterocytes: 1558.6;Undifferentiated cells: 4954.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"EFO-21: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Secreted to digestive system"	NA	NA		1300000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favorable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	2.4	0.5	0.4	187.3	0.2	0.3	131.0	0.5	0.4	547.0	0.2	1693.4	2641.0	20.5	0.2	12.4	3.6	455.0	0.5	0.4	0.2	108.9	34.5	101.6	1.7	0.2	0.2	0.6	13.3	0.1	1.3	0.3	0.4	13.6	1222.6	0.1	1645.1	5.3	0.3	0.6	809.8	39.1	0.1	0.8	414.6	0.3	0.6	0.4	0.2	0.0	0.6	80.3	0.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	36.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	1.9	0.3	0.0	0.0	0.2	0.0	6.9	0.2	1.7	0.8	2.5	0.0	6.8	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.3	0.6	0.3	0.4	1.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.3	0.8	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.4	0.2	0.5	0.4	0.4	0.2	0.2	0.2	0.4	0.1	0.6	0.6	2.1	93.0	604.3	0.0	22.1	0.3	4.0	106.6	0.0	0.0	392.4	192.0	1.4	876.4	638.4	108.5	0.0	0.1	2.5	7090.1	17.6	92.5	0.0	65.9	14.6	5.4	426.4	2.7	0.0	64.5	0.0	4.7	482.1	120.1	52.0	0.0	1.8	28.0	0.4	0.0	0.0	2361.1	59.0	2.2	1.1	0.0	0.0	5.7	1.8	0.0	0.6	0.0	0.0	0.0	0.0	221.5	3208.3	0.0	0.7	53.9	1558.6	328.4	415.4	0.0	0.0	0.0	21.0	0.0	0.0	6.9	0.0	0.0	15.6	0.1	4954.6	761.3
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593315-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lymphoid tissue: 62.3;salivary gland: 73.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;Hepatocytes: 70.7;Kupffer cells: 127.0;Macrophages: 89.8;Microglial cells: 60.9;monocytes: 57.4;NK-cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 44.7;memory B-cell: 48.3;naive B-cell: 44.5;non-classical monocyte: 123.0"	"Group enriched"	"Detected in all"	6	"B-cells: 48.3;monocytes: 123.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;NB-4: 62.1;REH: 183.5;THP-1: 92.9;U-698: 114.7;U-937: 95.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	8.1	4.5	2.1	51.1	2.0	47.5	4.7	2.4	3.2	2.8	2.7	7.3	6.8	2.1	1.7	2.4	2.2	24.8	2.5	1.9	2.9	11.8	83.2	16.7	61.2	6.5	4.6	6.0	22.8	2.0	1.4	14.1	5.3	2.8	8.6	3.1	73.6	2.4	0.7	1.0	7.7	8.3	4.7	62.3	6.9	3.0	5.7	8.7	4.1	3.1	57.8	15.2	0.6	7.6	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.2	2.8	1.5	85.3	8.5	0.0	1.3	0.1	17.7	0.0	0.6	48.0	3.0	13.0	0.0	1.7	0.1	36.1	6.7	0.0	0.0	0.1	0.0	0.1	0.0	3.1	0.9	0.1	0.1	0.4	1.1	62.1	0.8	24.3	1.0	183.5	4.3	20.0	0.2	0.1	3.6	2.0	0.2	0.2	1.1	0.3	0.2	92.9	0.0	0.0	2.8	0.1	0.7	0.7	0.2	114.7	0.0	95.2	0.0	6.1	16.0	10.5	13.3	44.7	4.7	48.3	0.3	4.1	12.9	44.5	0.1	3.3	13.5	14.0	123.0	11.3	0.5	14.4	2.1	2.0	2.4	3.2	1.9	2.9	6.5	4.6	5.3	4.7	5.7	7.6	0.5	3.2	3.9	1.3	53.7	1.5	0.1	0.1	0.6	0.6	2.2	2.3	2.6	32.9	2.2	1.8	2.1	0.5	41.5	8.1	1.9	40.0	4.3	0.3	0.1	1.8	1.8	10.3	0.8	29.1	0.9	0.7	0.0	0.2	14.0	0.2	5.7	70.7	47.7	0.0	0.8	2.8	4.1	127.0	32.5	1.0	1.2	89.8	5.4	60.9	57.4	0.2	58.7	1.0	0.3	16.4	21.2	2.2	9.4	0.4	1.6	18.3	1.1	3.4	0.0	0.6	0.8	0.8	0.2	0.3	1.1	2.3	18.3	0.4	3.8	0.3
PIK3R3	p55	ENSG00000117461	"Phosphoinositide-3-kinase regulatory subunit 3"	Q92569	1	46040140-46133036	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 199.0;Endothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.8;monocytes: 2.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"RT4: 76.1"					"Low region specificity"	"Detected in all"			"HPA005751, HPA071988"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Nucleoplasm	"HPA005751: AB_1855350, HPA071988: AB_2686479"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-3)"	"unprognostic (8.04e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (6.32e-2)"	"prognostic favorable (3.62e-4)"	"unprognostic (4.88e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.99e-3)"	"unprognostic (2.87e-2)"	"unprognostic (9.74e-2)"	"unprognostic (6.71e-2)"	"unprognostic (8.22e-3)"	31.2	12.2	13.0	7.2	11.2	0.7	28.0	35.9	14.8	15.3	14.0	7.5	3.2	15.9	10.3	7.1	10.1	10.7	35.2	11.4	14.9	16.2	4.0	18.5	6.2	16.7	17.3	4.1	4.7	12.1	8.5	13.3	16.8	12.0	4.9	17.9	12.5	6.1	12.0	6.4	8.6	11.5	15.5	11.2	9.9	25.4	15.9	10.8	14.2	18.5	5.3	14.8	7.4	11.4	10.9	3.6	47.4	24.4	4.6	2.0	15.2	6.3	4.6	8.2	10.1	2.1	3.2	14.3	18.9	2.5	9.9	6.4	16.9	5.8	5.3	11.1	15.0	9.3	41.8	1.6	1.5	8.3	11.8	5.8	3.3	8.7	3.2	7.8	17.3	32.8	3.5	10.0	11.8	16.7	33.4	5.1	16.9	3.1	9.6	42.0	12.7	17.0	20.4	76.1	34.4	24.9	20.5	53.5	5.7	28.5	14.9	7.3	32.4	8.7	8.0	1.5	6.2	14.1	15.8	8.5	6.9	10.9	4.5	0.0	0.2	5.8	2.0	0.3	1.9	0.3	0.4	1.8	0.0	0.0	0.1	1.1	0.0	0.0	2.4	0.3	2.3	0.6	13.0	11.2	35.9	14.8	11.4	14.9	16.7	17.3	16.8	15.5	15.9	11.4	199.0	0.0	8.4	15.7	3.1	2.5	5.4	42.1	14.8	48.3	32.0	30.1	21.1	0.0	28.8	18.4	45.9	4.4	13.9	21.7	0.0	0.6	11.8	13.9	21.0	83.3	7.8	5.9	26.2	1.2	1.1	16.2	55.5	26.2	9.5	6.1	0.0	0.0	1.7	3.3	55.9	8.6	38.7	0.0	4.4	19.9	1.2	8.4	5.4	60.9	0.9	33.5	3.1	22.1	7.1	1.4	1.5	7.9	10.1	7.2	4.5	4.2	26.7	42.8	0.0	13.3	18.0	35.9	31.7	8.0	1.8	1.4	15.7	19.2	6.6	5.0
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.9;Kupffer cells: 35.7;Langerhans cells: 40.5;Macrophages: 36.8;Microglial cells: 79.6;NK-cells: 32.0;Plasma cells: 24.7;T-cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 39.2;HMC-1: 5.7;JURKAT: 13.7;U-937: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	6.5	3.6	1.4	19.7	1.3	87.4	2.7	1.3	7.5	2.1	1.6	3.3	3.3	1.4	0.8	2.5	3.0	6.6	1.8	1.3	1.7	1.4	2.9	14.1	13.7	4.0	2.7	0.8	1.3	0.8	0.8	3.1	3.6	1.5	2.6	0.0	2.1	1.0	0.7	1.5	9.5	3.9	2.8	22.4	3.6	2.2	6.8	12.3	1.7	0.9	8.9	6.5	1.4	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.4	1.5	0.0	0.0	0.0	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	1.5	2.5	0.6	0.0	0.0	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	9.5	16.1	5.7	18.1	14.3	11.8	4.3	10.1	15.6	11.5	5.7	7.5	12.0	34.4	8.6	19.0	9.0	13.2	16.2	1.4	1.3	1.3	7.5	1.3	1.7	4.0	2.7	3.6	2.8	6.8	5.4	0.2	0.0	6.1	0.7	11.7	1.0	0.0	0.0	0.0	0.0	0.2	0.3	2.1	1.5	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.1	4.5	0.1	0.1	0.7	0.0	4.0	0.3	0.0	0.3	0.5	1.5	0.1	5.1	0.0	1.4	0.4	18.3	0.0	0.5	0.0	0.0	35.7	40.5	12.2	0.3	36.8	1.8	79.6	19.8	0.0	32.0	1.0	0.3	0.0	0.0	0.0	24.7	0.1	0.0	0.2	0.0	0.0	0.0	0.4	1.4	0.6	0.4	0.1	0.9	0.4	25.7	0.0	0.0	0.0
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802722-8867677	"Metabolic proteins, Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.5;granulocytes: 47.4;Hofbauer cells: 7.6;Late spermatids: 20.6;Microglial cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 21.9;eosinophil: 75.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 75.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 148.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	0.4	0.0	1.1	1.8	1.6	2.2	0.4	0.9	1.1	0.6	0.8	0.8	1.5	0.9	0.1	0.5	0.2	1.2	1.3	1.0	1.1	0.0	0.3	1.2	2.1	1.4	1.5	0.0	0.4	0.1	0.0	0.6	1.6	0.3	0.6	0.0	0.2	0.3	0.5	0.8	2.2	0.7	1.1	2.9	1.0	0.4	1.9	2.1	0.0	0.3	1.5	1.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	19.4	0.0	0.0	0.0	0.0	148.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	2.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	21.9	7.2	75.8	0.5	9.6	0.4	2.7	0.1	0.3	10.8	0.3	0.1	0.2	1.1	1.5	7.8	0.0	0.0	3.3	1.1	1.6	0.9	1.1	1.0	1.1	1.4	1.5	1.6	1.1	1.9	1.6	0.2	0.0	1.3	0.3	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	11.5	0.0	0.1	2.6	0.0	0.4	0.6	0.0	0.1	0.2	0.5	0.0	47.4	0.0	0.4	0.0	7.6	0.0	0.5	0.0	0.0	4.4	1.6	20.6	0.0	3.9	1.8	7.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	1.6	0.1	0.0	0.0
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444441-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.9"	"Group enriched"	"Detected in some"	6	"Fibroblasts: 5.5;Granulosa cells: 21.5;Hofbauer cells: 7.2;Smooth muscle cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 161.8"	"Region enhanced"	"Detected in many"		"white matter: 5.7"	"Low region specificity"	"Detected in single"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			"Cluster 22: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	0.5	2.5	0.3	1.3	0.0	2.5	0.8	1.1	0.4	0.9	0.0	3.3	3.0	0.8	0.0	3.3	0.3	0.7	0.3	0.1	0.1	0.3	0.3	0.7	1.5	0.2	0.0	0.8	0.2	0.1	0.1	0.6	0.0	0.3	4.1	0.4	0.7	0.1	0.0	2.7	3.1	2.0	0.0	6.0	1.2	0.3	0.1	13.9	0.4	0.0	2.1	1.3	1.3	0.2	42.1	54.1	161.8	73.1	1.5	4.5	12.6	47.9	29.8	78.6	52.5	32.8	17.9	0.0	18.8	39.8	39.9	29.9	82.6	21.6	41.9	64.6	33.9	0.1	33.8	41.2	0.2	1.7	48.9	2.4	1.5	32.2	12.4	8.0	24.8	36.8	10.1	23.0	49.9	30.5	9.2	0.5	70.9	34.0	37.8	74.9	64.8	29.6	12.9	6.4	36.5	51.3	41.7	42.5	39.1	20.4	19.9	4.0	11.9	59.9	48.4	36.0	80.7	8.2	31.5	0.2	23.6	20.4	94.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.1	0.2	1.0	0.1	0.0	0.3	0.3	0.3	0.0	1.1	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.2	0.0	0.4	1.2	0.6	0.0	0.0	0.0	0.0	0.6	5.5	0.0	0.7	1.3	21.5	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.0	0.0
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822470-10838087	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.0"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 2.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.0	2.5	7.5	1.1	8.7	0.0	0.0	11.5	6.8	0.0	1.7	4.0	1.0	0.0	0.0	0.1	0.2	0.1	0.0	5.4	11.6	0.0	0.0	0.0	0.0	22.4	16.5	0.0	0.0	0.0	0.0	0.0	14.0	0.1	2.6	0.2	0.0	0.0	0.0	0.3	1.9	0.8	11.8	0.0	1.4	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.5	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.7	11.5	6.8	5.4	11.6	22.4	16.5	14.0	11.8	24.0	10.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PITPNC1	"RDGB-BETA, RDGBB, RDGBB1"	ENSG00000154217	"Phosphatidylinositol transfer protein cytoplasmic 1"	Q9UKF7	17	67377281-67697261	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1255.9;Inhibitory neurons: 330.9;Oligodendrocyte precursor cells: 281.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA026563, HPA031250"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	Nucleoplasm	"HPA026563: AB_1855409, HPA031250: AB_2673808"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.17e-2)"	"prognostic favorable (4.85e-5)"	"unprognostic (6.57e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-2)"	25.7	8.9	27.2	5.6	30.1	3.8	18.6	23.5	26.9	8.7	13.2	7.6	1.5	7.8	3.8	9.8	10.9	3.8	13.3	22.7	31.2	21.8	9.8	15.1	8.8	38.4	41.0	15.2	23.1	1.8	13.7	6.0	28.2	11.9	2.2	15.0	14.1	4.4	5.4	4.9	8.7	3.5	28.7	9.4	12.6	2.5	42.7	8.4	9.0	5.0	7.4	12.0	9.2	20.1	4.2	1.0	4.5	6.8	2.8	5.1	3.9	6.0	2.9	0.8	0.4	0.0	6.4	4.6	1.4	3.6	1.7	2.0	6.7	6.0	1.1	9.3	3.0	0.7	7.6	3.4	0.7	1.4	9.8	3.6	2.2	0.9	2.5	0.5	3.2	6.5	0.3	16.9	2.3	7.0	10.9	2.8	6.6	1.8	7.7	15.2	0.9	4.2	9.7	5.4	4.7	13.0	1.7	3.3	4.1	4.8	3.0	4.7	3.7	1.8	1.0	2.4	2.9	13.2	6.2	3.7	14.4	4.6	1.6	0.7	1.4	10.3	11.1	2.6	5.7	0.5	6.9	9.2	0.9	1.3	8.2	8.3	1.7	5.2	4.1	0.1	2.8	4.1	27.2	30.1	23.5	26.9	22.7	31.2	38.4	41.0	28.2	28.7	42.7	20.1	102.6	9.6	1.1	1255.9	9.6	5.4	55.6	4.6	8.0	15.2	7.7	4.1	6.9	21.5	4.6	0.0	2.1	7.9	84.0	5.8	21.5	43.3	0.2	13.7	5.7	59.8	6.0	4.0	88.4	49.1	13.6	18.9	8.2	30.9	5.1	7.7	21.4	10.1	13.8	74.0	330.9	1.3	4.1	21.4	22.3	1.4	5.0	17.7	10.6	103.0	20.2	34.6	84.5	281.5	9.7	38.7	4.4	14.7	28.0	32.9	0.1	21.2	3.4	21.8	26.3	66.5	25.7	0.4	3.8	9.0	4.3	3.4	75.7	2.7	3.8	54.3
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.4;intestine: 90.8;parathyroid gland: 63.7;placenta: 60.4"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 70.4"	"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 34.8"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 34.8"	"Cell line enhanced"	"Detected in many"		"AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7"	"Region enhanced"	"Detected in all"		"cerebellum: 63.0"	"Region enhanced"	"Detected in all"		"cerebellum: 45.0"	HPA030156	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	2.2	5.8	4.4	9.0	3.9	0.2	23.3	70.4	5.2	4.9	3.4	90.8	15.5	3.4	3.4	5.2	5.5	5.7	0.5	5.9	6.9	2.8	8.2	4.1	2.2	13.9	7.4	0.8	6.3	63.7	22.1	60.4	14.6	6.2	62.4	56.1	8.5	2.4	0.7	9.1	28.3	3.9	3.9	3.2	34.4	4.2	6.8	3.7	1.1	0.6	4.1	5.4	1.2	5.0	0.1	2.8	71.8	0.3	0.6	0.3	62.4	0.0	0.8	0.3	1.2	0.4	3.0	0.0	0.4	0.0	3.8	0.3	0.0	1.5	0.8	0.4	3.7	1.2	3.9	1.7	0.2	0.0	12.3	0.3	1.2	1.2	15.3	34.0	0.3	0.5	22.3	0.4	0.2	84.9	0.3	0.4	29.6	91.2	112.5	0.6	10.8	0.4	187.1	10.6	157.7	0.2	0.0	17.1	2.0	39.4	12.0	1.8	5.7	0.2	47.3	0.2	6.2	0.2	0.3	0.2	46.7	1.5	0.4	0.0	0.6	0.0	0.0	3.2	0.7	0.0	0.0	0.0	34.8	0.1	0.4	0.1	0.1	1.9	0.3	0.5	0.4	0.7	4.4	3.9	70.4	5.2	5.9	6.9	13.9	7.4	14.6	3.9	6.8	5.0	3.0	3.2	3.9	17.0	4.6	19.8	2.3	2.5	2.8	23.6	94.8	53.3	0.3	2.8	10.2	1.8	4.2	542.7	0.9	750.2	19.6	22.6	106.0	5.3	1.6	3.9	98.0	4.0	5.5	35.8	420.5	6.9	52.0	5.5	38.7	0.3	1.1	3.8	53.1	6.7	15.5	94.9	14.2	75.5	251.9	251.1	1.2	51.2	44.4	9.4	25.5	15.2	0.0	6.0	8.5	50.4	355.4	0.4	1.2	13.8	255.0	26.9	58.3	54.8	6.6	0.3	2.7	3.3	5.8	12.4	17.0	959.8	3.5	0.2	92.9	8.3
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980479	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;testis: 56.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: AB_2686050"	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (8.33e-4)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	1.1	1.0	0.4	6.8	0.5	27.6	0.6	1.6	1.4	2.2	0.2	3.9	2.8	0.6	0.3	11.5	0.4	0.6	0.9	0.5	0.2	0.9	1.6	2.0	8.0	0.7	0.6	0.3	1.8	0.1	1.0	3.1	0.8	1.0	1.3	17.4	1.9	0.1	2.4	4.4	4.0	1.0	0.5	5.6	3.3	56.9	0.7	9.6	0.5	0.0	4.5	0.7	3.3	0.8	84.2	57.0	22.0	31.2	0.3	0.9	64.0	65.5	15.1	40.0	38.4	45.0	49.3	54.2	29.2	7.9	24.2	106.7	15.7	20.7	7.2	71.7	56.7	27.9	52.7	40.0	0.0	31.2	73.6	0.7	1.8	24.0	6.5	5.0	8.4	57.6	80.6	87.0	13.5	127.5	83.6	88.0	37.9	39.3	34.4	93.7	51.2	100.7	7.8	17.7	42.6	46.7	31.9	77.7	23.9	12.1	44.7	56.9	7.7	53.2	69.7	77.3	68.0	67.6	54.2	94.0	19.4	40.0	61.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.3	0.4	0.5	1.6	1.4	0.5	0.2	0.7	0.6	0.8	0.5	0.7	0.8	0.0	0.0	1.1	0.0	1.9	2.5	1.3	2.1	0.6	0.4	1.5	1.3	0.6	1.5	1.6	1.8	6.2	16.0	1.3	5.0	0.0	0.8	20.0	0.6	0.8	0.8	1.8	29.0	0.4	0.6	52.0	2.5	3.1	1.9	0.0	4.5	0.0	0.4	11.8	0.0	0.2	3.6	6.1	2.1	1.8	8.6	0.3	1.9	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.6	0.3	0.4	22.9	0.7	0.3	0.1	0.2	7.1	0.0	0.1	2.6	114.7	46.1	11.2	0.6	7.4	4.2	0.5	8.6	2.0
PKN3	"PKNbeta, UTDP4-1"	ENSG00000160447	"Protein kinase N3"	Q6P5Z2	9	128702503-128720916	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 27.1;Breast glandular cells: 15.3;Endothelial cells: 17.9;Microglial cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 78.0;REH: 42.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045390, HPA058305"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"HPA045390: AB_2679308, HPA058305: AB_2683674"	"unprognostic (4.36e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.73e-3)"	"unprognostic (6.18e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.36e-1)"	12.6	2.7	6.1	2.6	5.8	2.6	13.2	7.3	6.8	6.3	4.7	5.1	4.7	7.6	0.6	5.2	7.0	2.3	15.9	5.0	5.2	9.0	4.1	11.1	2.1	6.1	5.9	2.8	5.3	2.2	1.8	3.3	6.0	5.4	0.9	0.1	11.5	2.0	3.6	5.4	6.2	2.8	5.4	9.5	7.0	2.6	7.2	2.8	6.9	3.4	1.1	6.9	6.3	5.3	2.9	14.1	11.3	17.2	0.1	0.3	27.7	8.7	2.7	12.6	13.0	0.1	10.1	0.1	8.4	4.7	2.6	19.0	13.8	2.1	2.9	9.0	26.0	17.1	78.0	20.5	2.1	2.1	3.0	0.6	0.7	6.8	1.9	2.7	25.1	5.0	39.6	1.9	2.3	26.9	2.6	9.2	10.5	13.1	4.1	42.4	21.3	3.8	5.3	1.7	1.9	8.5	6.6	3.5	6.5	6.1	12.3	13.6	21.9	0.1	10.3	20.0	6.7	6.2	2.9	5.7	1.6	2.2	8.0	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	6.1	5.8	7.3	6.8	5.0	5.2	6.1	5.9	6.0	5.4	7.2	5.3	27.1	0.0	2.0	0.3	1.2	1.0	1.7	1.7	3.4	0.2	15.3	3.6	1.8	4.3	2.1	0.0	0.0	2.2	2.0	1.5	0.0	1.9	0.2	2.2	1.1	17.9	0.0	5.0	0.3	2.6	6.1	1.8	5.1	4.9	0.0	5.0	9.3	0.4	1.9	0.0	0.2	1.7	0.0	0.8	2.3	0.9	1.5	0.8	0.0	13.1	1.2	0.3	4.1	0.0	0.1	3.3	1.5	0.7	1.6	1.1	2.6	0.6	0.5	0.2	0.0	0.7	1.3	2.8	6.6	2.8	1.0	1.4	1.9	1.4	2.5	1.7
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 36.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.3;Early spermatids: 46.8;Excitatory neurons: 132.9;Inhibitory neurons: 137.4;Oligodendrocyte precursor cells: 85.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 39.1;AN3-CA: 9.6;hTEC/SVTERT24-B: 7.8;LHCN-M2: 11.6;SK-MEL-30: 7.8;WM-115: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	3.6	3.3	2.6	2.0	5.8	0.0	1.2	1.4	12.7	3.2	8.1	2.8	0.9	3.3	2.7	1.4	6.1	1.8	7.3	4.8	0.6	3.0	0.5	10.0	1.4	3.0	0.3	14.9	3.9	0.9	5.6	8.4	1.3	6.3	1.4	2.8	2.5	5.1	15.0	2.4	1.7	2.6	2.6	2.3	2.3	4.8	0.8	3.1	12.1	36.3	1.1	3.1	2.7	3.1	0.0	0.0	39.1	9.6	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	11.6	0.3	0.0	0.0	3.9	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	6.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	5.8	1.4	12.7	4.8	0.6	3.0	0.3	1.3	2.6	0.8	3.1	0.6	0.0	0.0	31.3	0.0	0.9	0.0	0.0	0.0	0.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	1.4	46.8	0.0	1.1	0.5	0.0	0.0	132.9	0.2	0.0	3.1	0.0	0.0	0.0	12.2	1.8	0.0	0.3	8.4	137.4	0.0	0.0	0.0	0.3	9.6	5.0	0.0	8.8	22.5	0.0	2.9	0.0	85.5	3.8	0.1	0.0	17.7	0.0	1.9	0.0	0.1	0.0	0.3	6.6	8.8	2.9	1.2	0.4	0.0	0.4	0.1	0.0	6.9	0.0	0.0
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 294.4;skin 1: 223.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 345.0;Extravillous trophoblasts: 176.8;Paneth cells: 248.9;Proximal enterocytes: 195.6;Undifferentiated cells: 142.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 151.3;CAPAN-2: 102.6;HaCaT: 199.1;hTCEpi: 126.9;MCF7: 94.9;SK-BR-3: 148.0"	"Region enriched"	"Detected in single"	37	"cerebellum: 8.9"	"Low region specificity"	"Detected in all"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	1.1	0.1	0.3	3.7	0.2	0.0	9.1	0.2	0.6	50.2	0.1	34.3	31.1	1.4	4.7	294.4	7.5	4.9	0.8	0.3	0.3	4.2	0.8	9.7	0.1	0.6	0.2	0.3	27.4	9.1	15.8	10.9	0.6	19.8	10.2	0.0	52.8	5.0	1.0	223.0	28.6	0.5	0.2	0.2	29.1	0.7	0.3	2.5	12.8	0.1	8.8	9.2	104.3	0.3	151.3	28.8	0.0	0.6	0.1	0.2	60.3	1.2	1.0	3.1	1.6	59.2	102.6	0.1	6.0	1.1	6.4	199.1	0.0	75.1	0.5	0.1	36.9	0.1	18.0	41.7	0.6	0.0	0.3	0.5	126.9	0.5	30.8	0.5	0.5	0.0	45.3	0.9	0.4	94.9	0.5	0.2	0.3	75.6	49.1	0.8	0.3	0.6	1.6	29.9	41.1	0.7	42.7	148.0	0.2	1.8	53.8	0.4	5.4	1.0	5.2	2.7	0.8	0.2	0.4	0.1	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.6	0.3	0.3	0.6	0.2	0.6	0.2	0.3	0.3	0.2	16.0	13.0	0.0	1.1	72.1	52.0	56.1	54.7	0.2	27.7	26.5	1.1	11.5	36.8	12.9	0.0	133.8	0.4	345.0	0.0	83.8	0.0	16.1	1.8	1.8	21.7	0.0	0.2	62.9	176.8	2.3	91.3	27.4	13.4	0.4	0.0	0.3	13.2	0.0	0.0	95.1	36.7	0.3	6.5	0.4	0.9	0.9	1.8	0.0	2.0	0.6	0.0	0.0	0.0	140.2	248.9	0.0	0.2	63.5	195.6	0.9	17.9	0.2	0.0	0.0	2.8	0.2	1.7	114.1	88.7	109.7	1.6	0.0	142.9	60.4
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 27.3;pancreas: 10.5;stomach 1: 41.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 280.1;Exocrine glandular cells: 116.3;Gastric mucus-secreting cells: 116.2;Intestinal goblet cells: 137.7;Paneth cells: 225.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 6.4;HaCaT: 2.2;MCF7: 2.3;OE19: 5.9;SK-BR-3: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.2	1.3	0.1	27.3	7.6	0.1	0.0	0.2	4.5	3.4	0.0	0.1	0.1	0.1	0.0	4.7	0.2	0.1	0.1	0.0	10.5	0.0	0.0	0.3	0.1	0.4	23.6	0.0	0.1	0.0	0.0	0.0	7.0	0.6	0.1	0.0	41.9	2.2	0.1	0.0	0.0	0.0	0.3	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.5	6.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	35.3	23.1	0.7	0.3	0.0	0.9	3.7	0.6	0.0	0.7	0.5	0.1	5.7	17.9	1.8	0.0	0.6	0.1	280.1	0.0	2.6	0.3	25.1	3.5	0.2	12.7	0.0	0.5	116.3	56.7	0.1	116.2	45.7	0.0	0.4	0.0	0.0	0.9	0.0	0.3	137.7	24.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	225.3	0.0	0.7	1.3	16.1	0.0	60.1	0.0	0.0	0.0	2.0	1.1	1.2	1.7	0.0	0.5	0.5	0.0	57.3	14.6
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 1302.4;intestine: 1973.9;placenta: 756.7;urinary bladder: 813.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 645.0;OE19: 2384.4"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	680000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	1302.4	7.0	0.1	280.2	0.1	0.0	27.4	0.1	0.7	5.4	2.9	1474.0	786.8	4.3	3.3	29.3	14.8	57.7	137.4	0.0	0.2	6.6	238.6	16.8	5.4	0.6	0.7	44.1	7.8	0.9	2.5	756.7	0.2	203.9	1668.0	0.1	24.6	6.1	6.0	18.1	1973.9	164.4	0.1	0.4	11.6	36.8	1.3	1.7	11.1	114.2	15.0	813.6	12.1	0.1	0.0	0.0	1.6	0.0	248.3	0.0	8.5	0.0	0.1	0.1	0.0	11.2	0.0	0.0	1.1	0.0	0.8	18.7	0.0	0.0	0.0	0.1	0.3	0.0	0.3	645.0	0.0	0.1	1.1	2.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.4	2384.4	0.0	0.0	0.0	7.6	0.0	198.2	1.0	4.7	0.0	20.1	0.0	31.1	0.1	0.0	0.0	0.0	0.0	44.7	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.2	0.6	0.7	0.2	0.1	1.3	0.1	20.6	6.4	6.7	0.0	9.1	13.9	10.8	0.2	0.6	0.9	1.0	0.8	14.9	12.8	9.3	0.0	0.0	3.6	0.4	536.5	1.9	0.7	4.0	0.7	43.1	6.9	62.3	13.5	0.0	1031.5	4.6	656.0	6.1	0.6	4.5	0.0	30.0	310.9	9.5	0.0	0.0	393.6	2.0	18.8	31.1	11.6	171.2	3.5	14.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	574.1	1.2	2.6	921.1	328.2	0.2	1.9	0.0	0.0	2.4	37.8	0.9	1.5	4.9	16.8	6.8	6.2	0.1	861.9	32.2
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091911	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.7;ovary: 47.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053361	Approved				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	8.9	1.5	8.7	1.4	10.9	0.0	3.4	10.5	14.4	1.2	22.1	33.7	0.7	1.8	0.9	4.4	6.4	2.0	132.7	9.1	9.7	0.1	6.1	8.0	0.6	10.2	10.9	47.6	0.9	0.0	0.8	4.7	9.2	14.9	2.3	18.9	2.7	7.7	0.5	1.7	3.0	3.3	9.5	1.6	6.3	10.1	11.8	0.0	2.4	0.3	1.2	17.6	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	10.9	10.5	14.4	9.1	9.7	10.2	10.9	9.2	9.5	11.8	8.6	0.7	0.0	0.5	25.8	0.0	0.4	0.0	0.0	0.0	11.6	0.2	1.3	75.3	0.0	0.0	0.0	70.9	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.1	30.8	0.0	0.0	0.0	6.7	10.8	0.1	0.3	0.0	0.2	0.0	0.0	1.2	0.7	4.9	81.4	0.5	0.0	1.9	0.0	30.8	0.0	0.5	0.1	0.0	0.0	73.4	0.0	1.3	0.0	0.0	0.0	32.1	263.0	0.5	63.1	0.6	0.7	0.0	0.4	0.3	0.1	0.0	0.0	0.1
PLAAT2	"FLJ20556, HRASLS2, PLAAT-2"	ENSG00000133328	"Phospholipase A and acyltransferase 2"	Q9NWW9	11	63552770-63563379	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 67.9"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.3;naive B-cell: 8.2"	"Lineage enriched"	"Detected in many"	10	"B-cells: 17.3"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 128.9"									HPA058997	Approved		Approved	Mitochondria		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.3	0.0	0.6	0.8	0.6	0.1	9.1	0.5	0.9	0.9	0.3	11.2	67.9	0.3	1.2	1.5	4.7	0.6	0.2	0.5	0.5	8.6	4.6	3.6	0.3	0.7	0.6	0.2	0.0	0.0	0.2	0.2	0.6	0.4	13.7	0.0	0.9	0.5	0.0	0.3	42.5	0.3	0.5	0.7	12.4	0.5	0.6	0.3	0.9	0.0	0.3	1.3	0.2	1.1	0.4	1.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.3	15.6	0.0	0.9	0.0	0.4	1.0	0.6	0.2	0.1	0.2	0.0	0.1	1.0	0.1	0.2	0.0	0.1	0.1	1.2	0.3	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.3	0.1	8.7	1.9	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.1	4.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	128.9	16.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.9	17.3	0.2	1.0	0.1	8.2	0.2	0.7	0.1	1.6	0.0	0.9	0.0	3.9	0.6	0.6	0.5	0.9	0.5	0.5	0.7	0.6	0.6	0.5	0.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1118.2;Distal enterocytes: 1514.4;Extravillous trophoblasts: 572.2;NK-cells: 1103.0;Paneth cells: 865.7;Respiratory ciliated cells: 549.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 183.2;CAPAN-2: 510.7;HL-60: 329.1;NB-4: 160.1;RPMI-8226: 238.2;THP-1: 187.8;U-937: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	9.2	2.0	1.8	81.3	2.0	365.9	3.8	2.8	2.4	32.8	1.4	236.0	78.9	2.7	1.2	92.0	18.7	6.5	2.8	1.5	1.7	2.6	35.4	41.2	93.8	7.8	2.7	1.0	1.6	0.5	2.0	33.7	5.5	3.7	163.3	1.1	6.6	2.3	2.0	1.0	88.5	18.5	2.3	155.1	117.5	0.8	2.4	40.5	2.6	0.8	137.5	11.0	5.8	3.7	183.2	1.3	0.5	1.1	0.0	0.2	28.6	4.6	1.1	11.1	13.7	3.5	510.7	30.7	1.5	52.3	17.0	18.7	3.2	1.4	41.6	0.2	0.6	0.8	33.4	15.2	1.8	329.1	1.7	0.9	3.6	1.8	2.4	0.3	0.8	16.0	0.4	2.6	29.5	0.8	62.6	160.1	1.0	14.4	0.9	8.0	10.6	238.2	0.9	5.4	25.8	0.5	1.2	29.1	0.6	9.0	1.6	187.8	1.3	1.1	31.7	0.9	0.9	1.8	0.4	81.7	2.3	149.7	0.2	49.2	139.2	95.9	392.1	635.8	299.4	523.8	185.1	229.2	129.5	481.1	225.9	263.4	29.7	1053.3	358.9	2310.7	13.8	577.1	1.8	2.0	2.8	2.4	1.5	1.7	7.8	2.7	5.5	2.3	2.4	3.7	4.3	195.5	39.2	0.3	247.4	0.4	1.7	77.3	0.0	0.3	0.9	1.4	0.5	2.8	119.1	0.0	0.0	18.5	1118.2	1514.4	0.0	0.3	0.5	45.6	1.1	95.0	86.8	58.4	0.1	3.6	572.2	3.1	119.8	2.9	26.6	0.6	141.0	8.4	21.7	1.7	0.1	231.2	67.1	384.5	7.4	0.6	0.0	213.3	7.2	1.0	157.3	1.2	1103.0	0.0	0.2	99.0	865.7	0.0	35.7	1.1	374.4	1.4	549.6	0.3	6.6	0.7	8.0	0.2	0.8	10.1	0.1	14.2	150.6	0.1	104.2	9.0
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 51.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 149.0;Pancreatic endocrine cells: 179.8;Suprabasal keratinocytes: 90.6;Theca cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 91.0;CAPAN-2: 94.4;HBEC3-KT: 177.4;PC-3: 64.1;TIME: 69.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	0.8	51.1	0.3	5.5	0.3	12.7	3.9	0.8	0.6	3.9	0.1	25.1	29.6	1.5	32.4	16.4	1.7	3.9	0.3	0.4	0.2	9.7	29.7	1.6	0.2	0.3	0.2	0.6	7.9	7.0	1.3	1.5	0.3	7.7	28.7	0.1	6.8	4.2	0.3	26.5	32.6	1.3	0.2	0.6	20.6	3.1	0.4	22.9	23.5	0.2	5.5	12.1	7.9	0.4	91.0	13.4	0.0	0.1	0.0	1.0	8.4	17.9	2.7	4.2	5.2	48.8	94.4	0.0	17.3	2.5	0.2	42.4	0.1	177.4	9.6	0.1	0.7	0.0	19.4	0.4	3.8	0.0	0.0	1.9	12.3	4.6	55.4	0.0	14.8	0.0	0.4	0.4	3.0	28.9	0.0	0.2	0.3	57.4	64.1	0.0	0.1	14.0	30.0	2.4	0.7	0.2	17.0	7.9	5.2	0.9	11.6	0.9	69.3	0.0	54.1	0.3	0.4	0.3	0.2	0.3	10.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.4	0.0	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	0.8	0.6	0.4	0.2	0.3	0.2	0.3	0.2	0.4	0.4	0.1	0.0	1.1	1.0	0.6	149.0	29.0	69.9	37.0	0.0	4.9	6.0	0.5	10.0	11.8	5.5	0.0	1.0	0.0	25.0	3.9	42.1	0.1	2.3	0.2	2.0	8.4	16.0	0.8	46.3	5.5	4.2	37.2	2.2	0.0	24.0	0.0	11.5	6.8	0.0	0.6	68.5	26.4	1.3	57.1	0.3	0.3	7.4	21.4	0.0	5.2	0.0	0.0	0.5	0.3	179.8	23.9	0.0	0.0	15.8	47.9	3.2	4.5	0.0	0.0	0.0	4.6	0.4	2.3	21.2	90.6	1.5	1.3	107.7	54.8	25.5
PLEKHB1	"KPL1, PHR1, PHRET1"	ENSG00000021300	"Pleckstrin homology domain containing B1"	Q9UF11	11	73646178-73662819	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 1531.3;choroid plexus: 728.4;retina: 758.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 344.0;Early spermatids: 145.6;Late spermatids: 184.4;Muller glia cells: 496.6;Rod photoreceptor cells: 460.4"	"Cancer enhanced"	"Detected in all"		"glioma: 59.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 83.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 83.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 77.2;OE19: 53.3;U-266/84: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (1.20e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (3.59e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.44e-2)"	2.7	6.7	1011.3	7.7	1362.5	1.3	10.4	1275.8	1156.9	6.9	728.4	52.9	11.6	3.0	15.0	4.7	24.3	10.3	14.7	914.2	1059.3	12.3	2.1	15.2	8.9	1472.5	1259.8	3.0	22.9	88.1	135.2	0.9	1433.2	13.2	9.0	758.1	59.0	8.6	9.4	5.2	19.8	3.0	1263.6	4.2	20.5	20.2	1172.4	5.6	28.8	11.9	7.6	8.2	5.5	1531.3	0.7	2.0	4.8	3.8	2.0	0.6	0.2	0.2	0.1	0.3	0.3	8.5	16.2	0.1	20.0	0.5	0.6	0.4	2.6	0.4	0.4	11.0	12.5	0.0	1.0	77.2	1.2	0.0	0.2	0.7	0.0	0.3	0.0	4.1	0.1	19.4	0.3	10.5	0.3	6.3	5.3	0.3	3.1	53.3	1.0	3.8	0.1	2.6	0.7	1.4	11.8	2.8	0.0	0.3	1.7	3.5	5.6	1.0	0.0	0.0	2.2	0.1	1.6	17.5	30.4	11.3	2.8	0.0	0.8	0.2	0.5	1.1	17.1	0.0	41.5	18.3	41.4	30.6	0.5	7.9	83.7	47.3	0.9	4.3	0.1	0.9	26.9	27.4	1011.3	1362.5	1275.8	1156.9	914.2	1059.3	1472.5	1259.8	1433.2	1263.6	1172.4	1531.3	0.7	6.4	13.5	25.5	5.3	0.4	1.1	1.7	0.6	53.6	19.1	11.8	8.1	25.8	4.5	7.3	344.0	0.5	1.9	0.8	11.7	30.6	145.6	27.4	0.5	3.9	62.8	0.0	1.1	0.8	0.1	2.0	13.7	3.7	11.4	10.4	1.8	0.2	2.7	20.2	0.6	11.2	22.4	0.3	0.3	184.4	2.5	0.9	10.6	7.5	1.6	496.6	6.2	15.6	96.4	2.9	3.9	0.7	1.0	4.0	0.9	13.9	42.8	460.4	0.0	2.5	1.8	2.6	1.7	0.3	0.1	0.1	9.7	0.1	6.5	1.6
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 33.9;intestine: 43.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 117.9;Extravillous trophoblasts: 56.2;Paneth cells: 67.5;Proximal enterocytes: 62.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 153.2;CACO-2: 50.1;CAPAN-2: 27.3;OE19: 48.0;RT4: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	15.1	0.3	1.3	4.3	1.2	2.7	12.8	1.5	2.0	7.5	2.1	31.0	36.5	0.5	0.5	33.9	1.0	5.0	0.3	1.0	0.9	2.7	4.5	1.3	0.6	1.4	1.4	0.2	5.6	7.9	5.2	8.5	1.0	3.0	17.9	0.2	13.3	1.3	0.4	12.1	43.4	1.1	0.7	0.5	11.0	0.8	1.3	0.7	3.9	0.2	2.5	15.7	15.0	1.5	0.7	6.0	0.8	0.1	2.9	0.2	153.2	0.3	0.0	0.4	0.3	50.1	27.3	0.3	0.4	0.0	0.2	13.0	0.0	0.4	0.2	0.1	0.1	0.2	1.5	10.2	0.5	0.5	0.4	0.0	0.7	0.2	0.0	0.5	0.1	0.2	0.4	0.3	0.0	7.9	0.0	0.7	12.7	48.0	1.0	0.2	0.2	0.3	0.1	53.2	0.3	0.2	1.2	23.1	0.3	10.9	7.5	0.0	1.2	0.2	0.5	0.6	0.2	0.0	0.1	0.1	0.8	0.7	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	1.1	0.0	0.0	1.3	1.2	1.5	2.0	1.0	0.9	1.4	1.4	1.0	0.7	1.3	1.5	0.6	0.0	0.0	0.0	0.2	5.0	7.0	2.8	20.5	0.0	4.6	2.9	0.4	8.6	2.5	1.8	0.0	17.6	0.4	117.9	0.0	12.1	1.4	2.9	1.1	0.8	8.4	0.0	0.2	1.8	56.2	1.5	16.3	4.2	0.0	0.5	0.4	2.3	2.7	0.0	0.2	19.3	0.0	0.0	0.7	2.0	2.5	0.3	0.0	0.0	0.2	0.8	2.1	0.0	0.1	2.2	67.5	0.7	0.2	8.4	62.6	0.8	3.0	0.1	0.0	4.7	3.1	0.2	0.5	14.2	7.0	23.9	0.3	0.0	27.9	21.6
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867694	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Supported	"Lipid droplets"		NA	Yes		11000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	30.8	69.9	23.3	41.4	39.6	70.8	29.5	44.2	27.5	50.4	25.9	37.6	70.8	22.6	14.4	124.7	22.9	34.5	25.3	22.1	28.6	38.0	26.5	25.7	29.1	51.1	36.1	40.0	20.3	9.8	9.3	33.3	48.9	28.0	20.9	1.7	45.9	21.0	112.0	87.5	73.9	23.9	36.2	32.3	28.5	34.3	39.1	28.0	24.8	36.4	33.0	37.5	55.4	66.0	138.2	79.1	53.6	50.5	59.8	189.8	24.1	196.8	178.9	152.0	142.9	52.6	124.9	72.5	43.3	242.2	82.1	61.3	25.1	108.2	88.2	82.7	35.4	79.1	43.0	97.8	41.4	56.7	112.9	147.1	46.2	107.4	23.6	90.5	81.2	23.5	122.4	31.3	192.1	57.1	78.3	72.9	42.5	63.3	127.7	136.2	74.9	40.2	133.8	31.7	2.3	26.3	62.5	55.5	49.5	43.2	70.4	125.9	125.1	83.3	80.5	333.8	102.9	44.1	58.9	50.8	250.7	79.6	97.3	128.3	141.7	64.8	13.8	100.4	14.6	46.3	24.7	15.9	109.1	36.3	19.4	12.4	173.9	39.5	76.7	82.8	34.1	86.4	23.3	39.6	44.2	27.5	22.1	28.6	51.1	36.1	48.9	36.2	39.1	66.0	19.2	19.2	25.6	5.5	28.5	142.2	62.9	58.8	90.0	0.4	108.0	43.1	2.3	14.3	51.3	11.0	2.1	152.2	34.4	169.7	37.2	114.7	9.7	65.2	50.9	27.7	40.7	18.5	0.8	86.8	77.3	62.9	33.1	78.4	55.8	112.9	26.0	18.2	101.2	0.0	1.1	67.0	28.5	57.8	103.4	14.0	35.8	74.7	55.2	2.8	62.3	23.9	15.5	5.0	17.1	243.4	223.0	53.0	37.1	39.3	268.8	38.8	65.2	0.7	52.6	37.8	66.2	75.1	14.6	109.0	229.3	194.8	20.3	193.4	54.8	69.2
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
PLP1	"GPM6C, PLP, SPG2"	ENSG00000123560	"Proteolipid protein 1"	P60201	X	103773718-103792619	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 7004.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 4822.5"	"Group enriched"	"Detected in many"	22	"glioma: 160.5;melanoma: 75.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SK-MEL-30: 241.0;WM-115: 139.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004128	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA004128: AB_1079635"	"unprognostic (5.72e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.95e-2)"		"unprognostic (2.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-5)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.16e-2)"	7.3	15.7	2252.5	4.2	4296.1	0.1	5.4	4251.8	3472.7	17.8	1056.0	73.9	6.3	6.8	6.7	9.9	7.3	9.6	30.1	2314.1	2859.4	2.9	2.0	1.2	0.4	5976.3	3571.3	5.7	2.5	83.1	6.4	0.0	5342.5	21.1	14.9	7.5	6.7	30.0	2.4	24.4	22.4	22.7	3919.9	0.5	15.4	33.5	3592.5	3.8	3.4	6.8	0.4	12.9	21.8	7004.9	0.2	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.8	1.9	0.0	0.0	0.2	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	4.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	37.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	241.0	6.3	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.3	0.2	4.0	0.0	139.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2252.5	4296.1	4251.8	3472.7	2314.1	2859.4	5976.3	3571.3	5342.5	3919.9	3592.5	7004.9	0.5	0.0	0.0	23.8	0.1	15.9	0.3	0.0	6.2	1.7	0.2	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	9.7	0.0	0.0	13.3	0.0	0.0	0.0	188.3	3.3	0.0	0.1	0.0	11.2	0.0	0.0	0.0	5.8	3.1	7.5	0.8	396.6	17.8	0.0	30.7	0.0	31.2	4822.5	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.0	1.1	0.0	3.1	2.4	0.6	0.3	0.8	2.6	0.0	0.2	5.6	0.0	0.1
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120457227-120592065	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 12.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 14.2;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.0	0.0	2.9	0.1	3.5	0.4	0.1	6.4	2.8	0.2	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	5.3	8.9	0.8	0.1	0.0	0.0	11.0	5.3	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	4.3	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.2	0.0	0.3	0.1	0.0	1.7	1.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	14.2	1.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.9	0.2	0.0	2.8	1.7	1.2	0.1	10.4	0.0	0.0	0.0	2.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.9	3.5	6.4	2.8	5.3	8.9	11.0	5.3	12.2	4.3	3.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.3	10.9	0.1	2.5	0.0	0.0	9.7	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.2	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	7.9	0.0	0.5	0.0	9.0	0.0	0.0	0.0	0.0	4.9	1.5	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4
PLPPR5	"LPPR5, PAP2, PAP2D, PRG5"	ENSG00000117598	"Phospholipid phosphatase related 5"	Q32ZL2	1	98890245-99005032	"Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;retina: 1.6;testis: 2.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9"	"Group enriched"	"Detected in some"	13	"glioma: 2.7;renal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 11.9;SH-SY5Y: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018072, HPA059085"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA018072: AB_1854958, HPA059085: AB_2732631"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.07e-1)"		"prognostic unfavorable (6.22e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.28e-1)"		"unprognostic (2.33e-1)"	0.0	0.4	5.2	0.0	5.8	0.0	0.0	0.1	6.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	4.5	0.0	0.0	0.0	0.0	1.3	3.9	0.0	0.4	0.0	0.2	0.0	2.8	0.0	0.1	1.6	0.0	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	2.0	7.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.9	0.0	0.0	0.0	0.5	0.1	0.4	21.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	5.8	0.1	6.6	6.1	4.5	1.3	3.9	2.8	2.0	7.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.1	0.1	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596393-142713664	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 315.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 471.4;Intestinal goblet cells: 147.9;Paneth cells: 200.5;Proximal enterocytes: 335.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 36.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;NK-cells: 3.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"A-431: 90.0;BEWO: 112.3;OE19: 166.4;RPTEC TERT1: 143.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055744, HPA061936"	Enhanced					NA	NA		56000000	"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	1.6	3.9	0.8	18.8	1.3	7.4	5.7	2.7	2.2	10.1	11.7	144.2	191.6	3.3	3.1	9.6	7.7	27.7	1.2	1.1	1.4	26.7	27.5	14.8	1.7	3.3	0.3	0.9	12.2	15.7	6.2	1.5	3.2	3.1	139.1	24.9	9.1	1.9	0.9	3.6	315.6	4.3	0.3	0.9	45.8	7.5	0.4	5.9	7.7	0.9	2.9	19.6	3.7	1.4	90.0	69.2	4.8	10.4	0.7	0.0	112.3	1.7	2.3	9.4	20.1	31.7	68.8	15.2	35.8	0.1	31.9	18.9	18.8	28.7	20.0	5.5	27.0	27.2	10.2	11.4	0.9	13.0	1.7	0.1	4.7	17.8	11.4	14.8	4.5	16.4	11.8	1.7	1.1	21.0	21.4	7.0	18.9	166.4	25.9	8.7	20.3	12.7	143.6	81.7	24.1	9.7	10.0	7.0	7.8	13.3	55.6	2.2	1.2	1.1	11.3	3.5	21.3	12.7	12.6	18.1	3.2	12.8	3.5	1.9	0.2	2.6	1.5	0.2	2.0	0.3	1.8	2.0	0.4	0.3	2.2	2.6	1.8	3.2	0.2	0.5	1.3	1.0	0.8	1.3	2.7	2.2	1.1	1.4	3.3	0.3	3.2	0.3	0.4	1.4	0.6	54.5	38.0	1.3	1.6	2.9	4.1	23.2	2.8	3.4	9.7	4.2	3.1	54.3	46.8	44.1	16.7	5.8	0.7	471.4	21.5	21.8	64.3	22.2	1.8	0.7	53.9	5.9	18.7	34.0	1.9	1.1	50.0	26.8	8.9	32.3	1.1	31.5	0.6	5.0	25.2	147.9	24.4	1.6	1.0	20.5	1.2	1.4	1.8	5.6	0.8	2.8	0.0	4.0	3.1	70.2	200.5	0.0	2.8	6.8	335.1	40.6	42.2	13.4	0.0	1.2	1.9	4.6	4.1	7.6	3.3	1.4	1.8	1.3	85.2	20.7
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351450-17377342	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 436.2"	"Group enriched"	"Detected in many"	4	"Adipocytes: 439.2;Endothelial cells: 344.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 35.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 35.2"	"Cell line enriched"	"Detected in some"	27	"EFO-21: 549.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA		53000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	283.0	51.1	2.7	54.6	3.1	1.7	210.5	2.9	4.2	102.7	18.2	95.7	86.7	90.0	5.1	48.9	83.3	139.2	92.5	3.3	3.1	153.0	6.9	31.0	50.5	3.7	3.5	16.7	96.1	98.6	64.3	48.8	3.6	68.4	22.3	0.0	77.9	38.0	32.7	58.9	103.3	50.5	3.6	166.7	116.6	4.4	3.5	18.9	436.2	12.9	16.2	104.4	80.8	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	549.1	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	9.5	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.1	20.0	0.0	2.3	0.1	0.3	0.5	2.2	2.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	35.2	0.0	0.6	2.7	3.1	2.9	4.2	3.3	3.1	3.7	3.5	3.6	3.6	3.5	4.1	439.2	6.4	0.0	0.3	0.7	22.9	1.0	0.0	8.0	0.0	2.7	3.3	3.7	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	1.7	3.6	0.4	0.3	344.9	0.0	0.4	0.4	2.5	0.1	48.9	0.0	0.3	0.0	0.4	79.6	0.2	1.8	0.0	0.3	0.0	0.0	3.5	28.8	0.8	0.0	5.5	23.2	6.5	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	7.6	1.5	0.0	0.0	0.0	0.1	0.0	1.4	6.1	0.5	0.7	2.9	16.8	0.1	1.4	0.7	0.0	2.3
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA		94000	"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: AB_2683872"	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.5	7.0	5.7	3.5	6.4	1.7	6.0	7.5	7.2	10.7	5.3	7.5	3.6	8.1	4.3	5.3	8.7	3.9	7.1	5.5	8.6	5.8	2.8	8.4	3.8	6.4	7.3	17.0	7.6	2.0	24.8	3.6	7.2	10.5	2.2	1.5	12.0	3.4	1.7	10.1	7.8	2.6	4.6	8.0	5.5	3.7	9.0	2.2	10.2	1.1	2.6	7.4	9.7	8.6	11.2	2.2	6.3	16.1	6.5	8.3	8.4	15.6	3.3	3.6	4.9	8.2	4.6	2.0	8.2	16.9	8.4	9.6	6.4	7.6	1.3	0.9	4.8	2.0	29.0	4.5	5.2	1.0	8.8	11.3	5.5	5.4	0.4	12.4	4.1	3.2	5.2	1.6	5.7	13.8	1.9	8.4	2.0	3.4	4.9	7.2	0.5	0.7	4.8	7.2	13.2	6.8	5.7	10.3	2.6	4.4	6.2	2.4	10.4	7.8	7.0	0.8	6.7	1.2	0.2	2.9	14.5	1.5	2.1	0.7	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	5.7	6.4	7.5	7.2	5.5	8.6	6.4	7.3	7.2	4.6	9.0	8.6	5.2	12.8	7.7	13.4	9.8	8.7	9.0	7.3	9.6	18.7	13.9	10.3	6.5	2.8	6.8	11.0	12.5	3.0	10.3	15.9	0.0	11.5	0.1	14.4	23.2	3.9	7.2	0.0	6.5	5.8	7.2	11.0	17.9	30.4	8.8	21.3	2.9	1.6	8.5	5.0	5.4	15.1	0.0	3.5	9.2	0.8	11.5	10.5	14.2	6.5	4.7	6.5	4.1	6.0	4.1	13.6	11.4	8.6	8.5	10.3	9.4	1.5	10.9	7.8	13.1	26.5	9.4	0.9	2.3	8.1	7.4	9.3	13.2	2.5	9.6	8.2
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 110.8"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 339.6;Muller glia cells: 325.9;Pancreatic endocrine cells: 827.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 157.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"naive B-cell: 6.3;plasmacytoid DC: 23.9"	"Group enriched"	"Detected in many"	8	"B-cells: 6.3;dendritic cells: 23.9"	"Cell line enhanced"	"Detected in many"		"SiHa: 206.1;U-2 OS: 129.9;U-251 MG: 481.8;WM-115: 237.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavorable (7.60e-4)"	50.5	14.5	24.2	14.2	75.5	1.3	25.1	38.8	29.9	94.8	1.8	30.7	6.5	48.4	7.1	7.6	19.9	26.0	29.2	24.0	28.3	16.2	3.8	21.8	7.4	32.9	34.1	14.9	31.3	5.0	13.5	3.9	38.8	110.8	8.4	23.6	30.5	20.6	33.2	18.1	12.6	28.8	27.0	6.6	12.2	5.3	36.1	2.4	13.6	13.6	8.9	13.1	29.6	26.2	32.2	75.4	2.3	3.9	2.4	0.0	0.8	4.9	0.2	1.7	0.8	1.5	97.4	0.2	17.7	7.4	51.8	121.1	1.6	100.8	1.3	1.0	4.1	0.0	23.2	0.1	1.5	0.3	0.8	1.2	55.8	4.4	12.1	16.5	13.0	67.8	0.8	1.2	6.2	66.1	3.8	0.7	9.4	15.0	9.6	0.3	36.0	11.3	24.2	0.0	17.7	13.7	206.1	120.3	15.1	5.6	18.8	4.1	33.1	17.9	129.9	1.9	481.8	5.9	0.8	0.5	8.1	1.1	237.1	0.0	0.4	0.0	0.0	0.0	0.0	2.6	0.8	0.2	0.1	6.3	1.8	1.2	0.1	0.0	0.1	23.9	0.5	0.6	24.2	75.5	38.8	29.9	24.0	28.3	32.9	34.1	38.8	27.0	36.1	26.2	59.4	57.7	32.3	4.9	32.7	167.0	143.1	120.6	30.7	59.0	38.0	23.0	23.2	125.8	31.7	11.0	2.1	0.2	27.8	57.3	3.9	339.6	1.2	33.4	88.8	55.6	10.1	0.0	19.1	62.5	4.1	40.5	5.1	80.2	59.8	17.5	24.7	0.5	6.1	1.7	32.7	16.9	14.2	3.5	68.0	2.7	3.1	13.4	32.0	31.9	5.8	325.9	0.0	17.6	9.0	827.5	54.2	21.8	25.3	203.1	6.2	2.7	10.1	11.5	72.3	43.8	155.2	0.2	8.8	10.0	178.4	0.1	17.8	9.1	19.3	87.5
PMP2	"FABP8, M-FABP, MP2"	ENSG00000147588	"Peripheral myelin protein 2"	P02689	8	81440326-81447439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	50	"brain: 278.7;choroid plexus: 97.2"	"Group enriched"	"Detected in some"	16	"Astrocytes: 84.9;Muller glia cells: 48.5;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 90.3"	"Cancer enriched"	"Detected in some"	59	"glioma: 239.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	9	"spinal cord: 1313.6"							NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"					"unprognostic (5.87e-2)"			"unprognostic (5.81e-2)"	"unprognostic (1.12e-2)"		"unprognostic (1.95e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.43e-2)"		"unprognostic (7.21e-2)"	"unprognostic (4.41e-1)"		"unprognostic (3.27e-3)"	1.8	1.4	155.1	1.4	168.0	0.0	0.7	231.4	193.1	1.3	97.2	1.4	0.4	0.1	1.8	0.8	0.3	1.1	2.0	146.1	206.4	0.4	0.2	0.1	0.0	278.7	243.1	0.2	0.4	0.0	0.7	0.0	257.4	1.8	0.7	0.2	1.0	3.7	0.3	0.3	0.6	0.3	247.1	0.0	0.6	0.1	214.0	0.0	0.3	0.8	0.0	0.9	1.1	275.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.1	168.0	231.4	193.1	146.1	206.4	278.7	243.1	257.4	247.1	214.0	275.2	1.4	0.0	0.0	84.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.7	0.0	48.5	0.0	88.4	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504701-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;retina: 24.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.2;Horizontal cells: 30.3;Inhibitory neurons: 92.0;Muller glia cells: 26.9"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 78.4;JURKAT: 43.3;SH-SY5Y: 44.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	10.8	52.2	1.2	55.1	0.4	1.9	1.3	73.4	3.5	0.0	1.4	0.8	0.8	1.0	0.5	2.5	3.9	4.9	55.1	88.4	3.2	0.9	6.8	0.4	29.0	25.7	0.8	3.9	2.7	15.4	0.5	28.7	0.8	0.9	24.5	0.3	0.9	0.5	0.6	1.1	1.9	16.5	0.5	2.8	1.7	67.0	0.2	2.7	0.2	0.3	2.2	0.8	29.2	0.0	11.7	63.0	0.6	12.2	2.6	0.1	3.2	17.2	7.8	2.6	0.5	8.4	0.0	2.3	1.2	19.3	0.2	39.5	0.0	6.0	0.0	7.0	0.0	8.7	0.1	0.9	0.0	0.4	4.2	0.0	33.4	0.2	78.4	37.7	43.3	0.0	0.1	4.9	0.3	19.3	0.1	34.7	0.7	0.1	0.1	12.8	0.0	18.7	4.3	30.7	44.9	0.0	0.1	2.1	4.5	0.2	1.2	18.6	0.8	12.7	16.1	2.6	5.9	4.6	0.1	36.1	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	52.2	55.1	1.3	73.4	55.1	88.4	29.0	25.7	28.7	16.5	67.0	29.2	0.4	3.2	13.0	20.5	0.6	0.0	0.1	0.2	0.0	6.5	0.9	1.1	0.5	0.0	3.7	0.0	2.1	0.0	0.0	0.1	0.0	0.3	5.4	1.0	4.5	1.0	10.8	0.0	71.2	0.0	0.1	3.6	0.0	1.5	1.3	0.0	0.4	0.1	0.1	30.3	92.0	0.5	0.0	1.6	0.8	1.5	11.1	0.1	1.8	12.2	0.0	26.9	0.0	19.1	11.5	2.7	0.0	12.0	0.0	0.0	0.0	5.4	2.9	6.2	0.0	0.2	4.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.2
PNMA8C		ENSG00000277531	"PNMA family member 8C"	A0A1B0GUJ8	19	46424697-46428951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.9;pituitary gland: 8.6"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.3;Endometrial ciliated cells: 1.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 1.1;HMC-1: 2.4;SH-SY5Y: 3.7"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (3.25e-2)"			"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"			"unprognostic (4.91e-3)"		"unprognostic (2.58e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.92e-2)"		0.0	1.1	12.3	0.1	13.0	0.1	0.2	1.6	11.4	0.0	1.5	0.2	0.0	0.1	2.0	0.0	1.2	0.2	0.1	11.0	15.1	0.0	0.0	0.1	0.0	5.9	10.2	0.1	0.0	0.1	8.6	0.0	7.1	0.3	0.0	2.0	0.0	0.4	0.7	0.1	0.1	0.1	5.9	0.0	0.0	0.6	15.9	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	12.3	13.0	1.6	11.4	11.0	15.1	5.9	10.2	7.1	5.9	15.9	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B actin binding protein"	Q8WVV4	X	85277396-85379717	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.2;skin 1: 123.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.8;Gastric mucus-secreting cells: 48.9;Intestinal goblet cells: 61.1;Paneth cells: 62.5;Proximal enterocytes: 73.6;Squamous epithelial cells: 39.2;Undifferentiated cells: 51.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Group enriched"	"Detected in some"	5	"OE19: 179.0;RT4: 78.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA		200000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.7	0.3	0.1	6.1	0.1	0.2	11.0	0.8	0.3	6.4	0.0	54.2	34.4	0.2	0.5	33.1	6.2	9.0	10.6	0.1	0.0	1.4	0.4	1.8	0.5	0.0	0.0	0.1	6.9	0.0	0.3	1.0	0.0	2.9	50.9	0.4	8.5	1.3	0.8	123.9	43.4	2.0	0.0	3.5	23.7	0.2	0.0	0.5	0.5	0.0	12.0	14.3	14.7	0.0	3.7	22.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.5	23.9	12.0	3.3	0.0	0.1	23.7	5.1	0.4	0.0	2.4	0.1	4.4	0.1	0.1	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.3	0.7	3.9	0.0	9.6	0.1	0.2	0.0	179.0	0.0	0.2	1.0	0.1	0.0	78.2	0.1	0.1	0.0	6.0	0.0	1.8	2.4	1.0	0.2	0.1	0.1	0.2	0.3	2.0	4.8	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	1.2	9.1	4.9	7.9	12.0	0.0	2.5	0.8	24.2	8.6	10.2	5.5	0.0	3.2	0.0	129.8	0.0	13.8	0.0	0.3	0.0	1.7	22.8	0.0	0.4	15.6	0.6	3.4	48.9	0.2	0.0	0.0	0.4	0.2	0.3	0.0	0.4	61.1	6.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.4	24.8	62.5	0.0	0.2	3.9	73.6	0.1	9.5	0.0	0.0	0.1	0.9	0.0	0.1	39.2	28.6	5.3	0.3	0.0	51.1	17.1
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;lymphoid tissue: 4.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 16.4;Excitatory neurons: 9.5;Granulosa cells: 12.6;Inhibitory neurons: 7.8;Plasma cells: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.5"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.1	0.2	0.0	1.6	0.1	6.0	0.4	1.0	0.2	0.2	0.0	1.2	1.2	0.2	0.0	2.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	2.0	0.0	0.3	0.0	0.0	1.4	0.9	0.4	0.0	0.8	0.5	2.2	0.0	4.5	0.0	0.0	2.3	0.3	0.5	0.0	18.2	12.1	10.2	7.2	0.9	1.2	9.2	8.5	3.2	9.7	12.9	9.8	6.6	21.5	3.7	4.6	11.7	14.0	12.2	5.4	16.4	6.3	6.7	13.8	8.0	6.1	0.1	15.1	12.1	0.2	0.4	8.9	5.4	1.7	4.9	7.9	9.3	15.9	10.3	7.1	13.7	8.8	9.7	5.5	5.9	11.4	12.2	7.6	3.1	10.3	5.5	5.0	9.8	5.2	3.4	8.8	4.8	14.8	3.8	8.6	11.2	3.4	11.1	8.0	6.9	21.8	4.1	11.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	1.6	0.7	0.9	0.5	0.6	0.0	0.9	0.6	0.6	1.6	0.0	2.0	0.0	0.0	3.1	0.6	1.6	0.0	0.1	0.4	0.9	1.0	0.5	0.0	16.4	9.5	0.0	3.3	1.2	4.6	1.0	0.0	12.6	0.0	0.2	2.3	0.0	7.8	1.6	2.0	1.3	1.2	0.7	0.3	1.7	0.0	1.0	0.6	0.4	0.0	1.5	1.3	0.2	1.2	0.0	12.2	0.5	0.2	0.1	2.4	0.2	0.0	0.1	1.0	6.8	3.4	4.9	0.1	0.3	1.8	0.9	3.2	0.8
POLR2F	"HRBP14.4, RPB6"	ENSG00000100142	"RNA polymerase II, I and III subunit F"	P61218	22	37952607-38041915	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	4	"melanoma: 1.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000827, CAB009882"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009882: AB_2299942, HPA000827: AB_1079834"	"unprognostic (8.27e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.73e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.11e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.86e-2)"	52.5	61.1	73.4	34.6	92.3	38.9	50.8	77.5	90.2	59.5	56.9	64.9	37.7	53.2	24.8	58.7	50.2	19.5	91.8	74.2	91.2	58.2	118.6	41.6	31.0	87.9	83.9	60.9	47.5	76.5	62.7	30.2	82.6	47.7	28.7	16.8	56.1	39.6	111.0	45.8	42.3	28.8	75.3	36.4	57.6	48.8	86.8	36.7	54.7	68.4	26.3	53.1	52.7	123.7	150.7	176.2	120.6	128.7	141.1	81.7	109.4	138.0	81.0	141.4	130.5	210.0	51.8	117.4	99.1	120.3	138.3	106.4	166.9	135.7	67.1	143.0	303.7	107.3	181.3	289.1	125.9	213.6	67.0	112.4	99.8	186.3	72.1	71.2	118.7	130.4	208.9	93.7	101.9	220.2	168.4	258.2	174.3	175.4	134.7	162.3	110.4	134.5	77.4	94.8	180.6	67.2	129.5	88.9	215.3	69.6	62.9	144.3	110.5	119.8	173.9	150.4	158.1	106.0	178.0	247.9	122.4	107.9	138.4	118.9	92.9	140.8	83.8	90.4	78.5	95.8	71.9	81.8	86.3	71.3	63.1	63.7	122.8	113.7	78.5	123.3	103.4	85.3	73.4	92.3	77.5	90.2	74.2	91.2	87.9	83.9	82.6	75.3	86.8	123.7	82.6	38.5	85.9	9.4	73.2	204.3	113.9	205.4	63.7	26.7	133.8	168.7	0.3	101.5	122.5	121.4	25.0	243.5	70.5	148.7	193.7	160.0	117.0	96.0	117.2	94.8	117.2	109.6	9.9	159.5	303.4	97.4	58.1	82.4	90.0	90.0	98.6	304.4	178.5	28.6	10.7	143.1	116.0	94.2	102.9	42.0	159.7	65.9	225.9	2.8	102.3	99.4	111.2	9.5	99.0	182.4	152.9	151.2	65.7	137.3	196.6	306.5	114.3	33.3	157.8	90.1	197.1	237.0	241.0	106.0	224.3	211.9	82.4	82.7	145.7	121.2
POLR3G	"C31, RPC32, RPC7"	ENSG00000113356	"RNA polymerase III subunit G"	O15318	5	90471748-90514557	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.8;Inhibitory neurons: 21.2;Oligodendrocytes: 70.8;Spermatogonia: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 84.5"									"CAB010109, HPA052658, HPA074330"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB010109: AB_2165718, HPA052658: AB_2681904, HPA074330: "	"unprognostic (4.31e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.19e-6)"	"unprognostic (2.17e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.21e-14)"	"unprognostic (3.86e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.17e-5)"	1.8	0.6	3.5	2.4	4.5	3.0	2.0	6.3	5.9	1.3	0.7	1.6	1.8	1.5	4.7	4.3	1.2	1.3	1.8	3.6	6.0	0.9	2.2	1.6	4.7	5.7	4.4	1.9	2.4	2.0	0.9	1.8	6.8	1.7	1.5	3.3	2.3	0.5	3.0	4.3	1.4	0.8	1.9	1.8	1.2	4.5	4.2	0.8	3.2	0.8	1.9	2.0	1.7	6.3	24.1	13.0	18.8	5.3	5.9	8.2	7.7	11.9	4.3	19.8	16.8	9.0	18.8	63.7	4.2	5.3	20.0	11.6	20.8	23.2	69.2	29.6	19.6	26.2	8.1	15.1	9.5	19.4	6.2	6.7	8.1	32.7	25.8	4.6	27.2	26.5	35.8	6.4	8.3	13.2	19.1	14.1	78.1	4.0	63.2	16.5	7.4	40.2	5.9	3.2	22.0	6.4	3.7	9.6	35.1	7.7	5.4	6.2	29.1	10.3	21.2	13.2	48.3	13.5	36.7	50.0	22.1	23.7	84.5	3.3	0.2	0.2	1.5	0.4	0.7	1.7	0.5	0.9	0.4	0.9	1.1	1.2	0.7	2.9	1.5	1.0	0.2	0.3	3.5	4.5	6.3	5.9	3.6	6.0	5.7	4.4	6.8	1.9	4.2	6.3	3.2	6.4	2.2	11.8	2.8	3.6	1.6	1.5	1.8	3.0	2.8	3.7	5.2	0.0	0.7	1.8	8.4	0.8	0.7	0.9	3.9	2.4	4.5	1.6	2.3	2.0	6.7	8.8	24.8	4.4	5.4	3.8	0.5	1.2	7.0	1.6	4.6	2.6	1.7	3.3	21.2	1.4	0.0	0.3	0.3	1.0	0.3	1.2	1.8	5.6	0.0	1.1	1.0	14.6	70.8	4.1	3.0	1.2	5.4	6.1	0.4	1.5	3.0	0.8	0.0	1.1	1.8	7.2	26.6	6.3	8.5	0.8	1.7	6.5	2.0	0.8
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPP1R12A	"M130, MBS, MYPT1"	ENSG00000058272	"Protein phosphatase 1 regulatory subunit 12A"	O14974	12	79773563-79935460	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 353.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041296, HPA071956"	Approved		Supported	"Actin filaments,Cytosol"		NA	NA		270000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Actin filaments, Cytosol"		"HPA041296: AB_2677394, HPA071956: AB_2732192"	"unprognostic (3.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	31.5	18.6	21.2	32.3	26.6	57.5	21.7	25.3	65.3	34.1	15.0	73.3	22.8	66.2	31.1	71.2	40.9	36.6	28.0	27.7	20.3	18.2	14.2	24.6	31.9	14.3	14.5	27.4	11.0	18.5	11.2	41.6	14.2	67.6	35.4	14.6	19.0	84.8	20.5	17.6	27.6	83.7	14.1	30.8	29.2	23.5	20.7	34.3	24.9	27.2	27.8	64.5	27.7	27.0	42.9	36.5	49.3	28.5	36.8	36.2	45.8	84.0	46.5	53.1	35.2	34.9	20.7	36.9	33.4	113.8	21.4	33.4	38.6	32.9	63.8	51.3	24.3	98.2	40.5	24.1	29.1	64.8	59.5	30.7	24.3	53.6	49.1	60.1	37.2	36.7	41.1	43.0	57.0	27.7	71.4	34.3	39.1	18.8	25.2	57.9	54.4	27.8	31.4	66.6	23.8	17.9	66.3	23.2	28.5	45.1	32.4	30.9	56.8	56.3	29.9	40.1	48.2	28.3	27.8	48.6	19.2	36.3	49.3	155.1	44.4	197.4	62.8	47.5	56.5	56.8	59.7	66.8	41.8	52.8	47.3	61.3	187.2	98.2	70.4	35.3	69.6	46.3	21.2	26.6	25.3	65.3	27.7	20.3	14.3	14.5	14.2	14.1	20.7	27.0	108.4	76.9	65.9	168.5	79.7	84.5	69.0	59.1	57.5	82.2	30.7	69.0	127.4	32.9	61.5	53.3	35.5	66.7	113.4	44.9	15.6	50.9	111.3	47.5	113.6	93.6	44.9	66.3	240.4	40.0	82.0	82.4	42.8	81.2	121.4	66.6	55.0	27.5	78.0	102.6	135.4	37.7	44.7	57.5	100.8	64.2	86.3	92.8	60.5	132.1	112.0	52.2	120.5	353.9	132.9	55.9	42.7	147.4	60.7	52.0	34.3	26.3	41.0	61.4	210.4	74.6	332.7	133.4	89.8	50.9	81.1	83.7	119.7	81.5	41.3	63.6
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 356.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 836.8;Excitatory neurons: 225.7;Granulosa cells: 438.3;Oligodendrocytes: 647.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	40.0	11.1	5.1	36.0	12.6	8.3	17.8	8.9	9.9	51.8	15.5	151.0	24.1	222.0	30.5	150.1	52.6	72.5	356.9	5.5	6.5	14.3	8.4	24.8	18.6	17.2	15.3	38.3	7.2	6.2	5.0	34.4	18.0	142.8	64.8	7.6	20.0	198.6	84.1	11.0	30.9	246.4	16.2	30.8	41.5	7.1	9.2	7.7	10.9	80.5	15.1	86.7	23.0	27.3	2.2	4.4	3.3	3.2	4.6	3.3	5.4	1.7	1.7	1.8	1.7	1.9	3.9	2.5	0.8	3.2	4.3	7.0	5.0	2.7	1.9	3.3	3.1	2.5	7.1	1.2	1.1	5.4	2.8	2.6	3.0	2.5	2.6	9.1	1.5	2.8	3.9	2.9	3.1	1.7	4.1	3.4	2.3	2.4	0.9	2.6	8.5	3.7	1.4	8.1	4.0	3.1	3.3	3.9	1.9	4.4	3.4	2.4	1.9	2.5	1.5	1.9	1.5	4.2	4.3	2.7	2.4	4.4	10.2	2.4	1.7	1.5	1.6	1.0	1.4	2.0	1.1	1.0	1.5	2.1	1.3	1.0	16.2	0.7	1.5	1.7	1.7	0.5	5.1	12.6	8.9	9.9	5.5	6.5	17.2	15.3	18.0	16.2	9.2	27.3	12.5	12.8	19.8	181.5	6.0	17.3	49.0	35.6	8.6	59.3	11.1	20.6	836.8	11.5	23.0	12.9	75.0	18.1	8.6	52.9	11.7	10.1	39.2	19.3	16.1	15.2	24.0	5.2	225.7	12.9	8.4	51.4	17.3	7.6	18.9	438.3	16.4	9.6	9.4	26.9	205.0	17.2	63.1	23.5	10.9	13.1	12.2	8.2	8.8	102.1	7.8	10.2	5.2	102.5	647.4	6.3	21.1	51.1	9.6	24.3	12.8	7.1	27.4	30.4	32.9	38.6	162.7	19.3	13.9	7.1	10.9	25.4	10.7	14.2	33.9	28.4
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256532	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 492.0;intestine: 450.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 332.5;Granulosa cells: 435.0;Leydig cells: 341.1;Peritubular cells: 656.0;Sertoli cells: 979.5;Smooth muscle cells: 465.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 299.4;naive B-cell: 283.9;plasmacytoid DC: 246.9"	"Group enriched"	"Detected in many"	24	"B-cells: 299.4;dendritic cells: 246.9"	"Group enriched"	"Detected in some"	4	"A549: 164.1;EFO-21: 112.2;K-562: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		880000	"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: AB_2677846, HPA054534: AB_2682518"	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.25e-5)"	"prognostic unfavorable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	134.0	144.2	175.2	22.1	347.5	2.9	111.9	321.5	226.5	149.7	63.2	450.3	18.6	273.5	5.2	47.6	153.7	14.8	94.6	175.2	219.6	53.3	17.9	163.1	2.6	402.3	322.9	125.1	31.1	2.8	12.6	34.1	336.3	142.0	12.6	0.3	19.0	86.1	27.5	28.6	82.1	57.2	222.0	101.2	140.3	77.6	365.3	1.7	25.8	12.3	1.4	301.6	106.1	492.0	0.0	164.1	0.4	0.0	1.0	0.0	6.1	10.8	0.0	0.1	0.0	12.8	0.2	0.0	112.2	1.0	0.0	0.5	13.6	0.2	0.0	1.4	0.0	25.5	0.0	0.0	4.6	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	64.5	0.3	0.0	0.8	0.0	0.3	4.9	0.0	0.0	0.2	2.4	0.4	0.4	0.0	3.5	0.2	0.0	0.0	0.1	9.2	0.0	0.4	0.4	0.0	0.8	0.4	0.0	0.4	0.0	0.5	0.2	0.0	0.1	11.3	0.6	1.2	0.1	0.7	0.2	299.4	0.2	0.4	44.3	283.9	0.6	0.1	1.7	8.7	0.2	246.9	0.2	21.6	175.2	347.5	321.5	226.5	175.2	219.6	402.3	322.9	336.3	222.0	365.3	492.0	332.5	0.0	1.1	1.3	29.9	9.6	3.0	1.2	3.4	0.4	8.8	209.8	19.6	2.8	0.7	0.0	0.0	48.3	48.7	32.7	0.0	0.7	14.1	15.4	239.5	108.5	1.8	34.7	0.5	10.9	7.4	66.8	2.0	10.8	3.8	435.0	224.5	2.3	9.5	0.0	0.6	0.4	0.0	5.6	24.6	42.1	341.1	41.4	8.8	14.0	66.1	0.5	4.1	3.5	155.6	2.2	2.6	656.0	4.8	2.4	3.8	0.3	0.0	1.6	979.5	8.7	465.2	9.9	46.2	0.6	8.0	26.4	3.7	66.0	0.4	1.2
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143044-150250392	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.5;skeletal muscle: 66.5;skin 1: 97.2;thyroid gland: 58.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 53.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044667, HPA047907"	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB044667: , HPA047907: "	"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.4	0.2	5.1	1.4	6.6	0.2	6.0	5.9	8.0	10.2	6.0	12.5	10.4	1.4	0.9	18.4	16.0	0.1	75.5	7.8	5.0	9.5	0.0	12.3	0.3	5.6	5.4	0.1	0.7	5.1	1.7	3.4	5.6	1.3	8.6	0.6	3.2	0.2	66.5	97.2	2.7	0.9	4.4	0.1	0.8	6.7	5.0	0.5	58.7	8.5	5.8	0.5	22.0	5.0	27.9	0.1	11.7	0.1	0.1	0.6	0.0	3.7	0.0	0.0	0.1	1.3	3.8	0.7	8.0	5.3	1.8	40.7	6.1	86.1	0.0	0.0	36.2	0.3	0.0	0.0	0.0	0.0	1.1	0.0	103.0	0.2	41.1	0.0	0.0	0.5	23.6	0.0	0.0	3.8	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	35.5	1.5	6.2	0.0	0.6	37.7	2.2	0.7	0.2	1.9	0.0	0.1	20.4	32.5	9.5	0.0	0.0	0.0	14.2	16.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.6	5.9	8.0	7.8	5.0	5.6	5.4	5.6	4.4	5.0	5.0	0.3	19.2	41.1	1.3	0.5	280.2	17.9	19.6	12.0	1.1	6.5	4.3	79.5	0.0	17.1	14.7	0.0	0.1	0.4	24.5	1.9	3.8	0.2	37.9	0.6	3.0	28.2	0.0	28.0	0.2	0.1	6.7	0.0	5.1	1.3	4.1	0.0	0.0	3.0	1.7	13.3	3.1	14.2	0.0	19.7	1.6	0.0	0.6	30.2	2.8	1.1	0.0	0.0	37.2	2.5	12.8	41.5	0.4	0.0	16.6	5.0	38.6	61.5	0.5	0.0	80.9	4.3	0.5	1.8	14.7	336.6	1.9	1.4	0.5	8.7	1.9
PPP1R14D	"CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016"	ENSG00000166143	"Protein phosphatase 1 regulatory inhibitor subunit 14D"	Q9NXH3	15	40815451-40828709	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 111.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 334.5;Paneth cells: 338.1;Proximal enterocytes: 412.4;Undifferentiated cells: 108.9"	"Cancer enriched"	"Detected in many"	4	"colorectal cancer: 45.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;RPMI-8226: 3.1;RT4: 1.9;SK-BR-3: 1.2;T-47d: 1.1;U-266/84: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041846	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041846: AB_10794307"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.11e-2)"	0.1	0.0	0.1	9.6	0.1	0.0	0.5	0.5	0.1	0.3	0.1	107.1	111.1	0.2	1.9	0.2	0.3	15.6	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.2	0.0	0.3	0.4	0.1	0.1	0.1	0.7	92.5	0.2	0.7	0.4	0.0	1.0	82.3	3.6	0.1	0.0	1.7	0.2	0.1	0.0	0.6	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.1	0.0	1.9	0.4	0.3	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.3	0.0	0.0	0.5	0.9	0.0	5.7	0.3	1.8	0.0	0.4	0.1	334.5	0.0	1.3	0.0	0.1	0.0	0.0	61.3	0.0	0.1	5.3	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.2	58.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	338.1	0.0	0.0	0.1	412.4	52.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.9	0.0	108.9	0.2
PPP1R9B	"PPP1R6, PPP1R9, SPINO, Spn"	ENSG00000108819	"Protein phosphatase 1 regulatory subunit 9B"	Q96SB3	17	50133737-50150677	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 96.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022461	Approved					NA	NA		420000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB022461: "	"unprognostic (4.71e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.11e-4)"	"unprognostic (8.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.29e-1)"	23.5	30.0	61.4	28.6	58.6	33.7	20.2	39.3	96.7	25.4	4.6	17.6	14.9	22.0	8.4	28.9	19.6	15.5	24.3	90.2	30.3	23.3	11.9	39.9	36.8	25.7	40.1	27.8	18.3	15.2	20.6	14.6	24.0	21.5	8.9	7.9	17.6	10.6	11.8	24.2	30.2	11.8	22.2	52.4	17.8	24.0	47.7	22.5	22.0	14.8	28.0	20.4	22.6	48.9	25.9	45.2	24.0	60.5	31.2	19.8	56.9	36.4	33.1	31.5	22.9	38.3	19.9	48.6	57.8	42.2	30.7	25.2	24.9	25.8	19.6	125.7	37.2	79.9	35.4	26.2	30.3	35.1	121.2	22.2	44.4	34.6	21.7	60.5	31.2	15.4	43.0	35.7	21.0	47.7	13.0	50.2	9.4	33.0	40.9	26.5	32.5	34.6	21.6	15.0	15.1	44.5	23.0	35.6	29.5	19.3	47.7	68.8	25.5	66.4	48.7	46.0	48.8	65.4	16.2	35.2	30.5	34.8	32.4	4.2	1.8	2.9	1.3	1.6	1.1	1.6	1.0	0.9	1.4	2.0	0.4	0.9	4.1	2.2	2.0	2.0	0.5	0.8	61.4	58.6	39.3	96.7	90.2	30.3	25.7	40.1	24.0	22.2	47.7	48.9	18.1	0.0	2.2	6.2	23.6	23.6	3.6	5.8	13.6	18.8	7.8	5.3	7.7	4.3	3.2	16.5	2.1	2.3	29.0	10.9	5.9	9.7	2.6	4.0	9.5	20.9	12.0	20.2	6.6	9.1	3.5	10.5	5.6	6.3	2.5	9.6	18.2	8.7	27.7	16.8	6.5	10.8	10.2	48.6	34.6	5.1	20.2	30.2	12.4	2.8	42.1	3.2	34.0	2.5	2.7	9.1	10.2	15.4	15.4	7.8	18.1	9.8	3.4	2.6	13.1	7.0	9.1	5.5	5.7	16.9	22.4	1.0	14.9	10.0	10.7	5.4
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190048-52229518	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (1.76e-4)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	98.5	300.7	305.0	60.5	311.1	58.1	98.7	292.0	394.2	126.9	261.4	115.7	91.5	126.8	101.0	164.4	126.8	63.2	322.8	342.6	299.4	156.9	106.0	87.5	72.7	308.9	301.1	163.7	100.7	129.9	123.9	69.1	312.8	123.3	82.2	89.8	99.8	92.2	239.7	119.3	98.5	96.0	280.1	87.6	106.0	67.2	331.7	76.9	107.9	170.7	90.0	123.5	121.9	299.2	153.6	248.4	210.9	182.0	166.9	173.4	105.3	130.3	173.2	174.1	151.1	129.3	122.1	132.5	91.0	213.9	95.7	108.8	228.0	197.9	100.6	101.3	562.8	99.6	126.9	148.2	152.6	105.6	93.1	234.3	163.8	163.5	149.2	162.9	167.9	92.1	114.3	96.8	196.3	178.6	159.6	215.4	204.6	162.2	218.4	148.6	118.3	152.5	285.0	251.7	153.3	161.3	149.0	160.1	100.3	136.3	141.9	197.3	153.1	133.2	120.5	65.7	154.2	96.9	151.5	160.0	143.1	109.7	170.5	172.6	172.0	169.4	143.9	212.2	131.0	143.1	126.3	134.3	192.8	157.1	101.6	119.6	103.7	228.6	199.0	119.7	177.5	255.6	305.0	311.1	292.0	394.2	342.6	299.4	308.9	301.1	312.8	280.1	331.7	299.2	55.3	44.8	35.4	21.5	76.0	70.4	99.0	178.0	56.9	114.0	64.5	71.1	100.2	74.4	99.5	119.5	25.0	203.7	47.3	157.0	117.4	213.5	4.4	77.5	79.7	72.4	107.0	39.7	27.4	155.7	259.9	85.7	77.5	100.7	68.5	96.7	65.0	52.8	146.2	144.7	39.5	128.8	144.5	68.1	39.3	10.4	72.4	58.0	53.4	17.8	103.7	118.0	62.8	25.6	29.9	168.2	189.0	85.4	60.3	88.3	147.5	135.3	80.6	61.5	78.9	49.2	90.3	16.5	68.8	74.4	63.2	182.0	64.2	99.7	185.2	104.2
PPP2R2C	"B55gamma, IMYPNO, MGC33570, PR52, PR55G"	ENSG00000074211	"Protein phosphatase 2 regulatory subunit Bgamma"	Q9Y2T4	4	6320578-6563600	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 106.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 61.0;Early spermatids: 67.4;Excitatory neurons: 203.3;Inhibitory neurons: 82.8;Late spermatids: 182.5;Oligodendrocytes: 94.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 31.4;A549: 46.1;CAPAN-2: 28.2;GAMG: 68.4;MCF7: 36.2;PC-3: 38.9;SCLC-21H: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042122, HPA042770, HPA060473"	Approved		Approved	Cytosol		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA042122: AB_2677859, HPA042770: AB_2678155, HPA060473: AB_2684291"	"unprognostic (9.39e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.70e-4)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.36e-13)"	"unprognostic (2.52e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.90e-3)"	0.8	6.2	72.9	0.6	86.7	0.0	1.4	42.1	106.2	18.0	0.0	1.1	0.8	27.0	7.4	35.9	9.9	0.4	2.5	85.7	44.5	0.3	0.1	0.1	0.3	52.5	52.7	0.6	0.7	1.5	22.6	0.1	55.1	5.0	0.3	10.9	5.3	14.5	0.8	34.0	1.2	11.9	62.3	0.3	0.8	7.3	66.9	2.7	0.1	0.9	3.1	0.9	11.5	91.2	31.4	46.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	19.0	0.0	68.4	13.7	20.0	0.7	0.0	0.0	2.4	0.0	3.2	3.7	0.7	0.0	0.1	6.6	11.4	0.0	0.0	0.0	0.1	4.2	0.0	0.1	6.6	36.2	0.0	0.1	2.2	0.6	38.9	0.0	0.0	1.2	0.0	0.1	39.1	7.5	1.5	0.1	0.0	1.1	18.9	0.1	0.0	0.2	22.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.9	86.7	42.1	106.2	85.7	44.5	52.5	52.7	55.1	62.3	66.9	91.2	0.2	0.0	0.0	61.0	0.0	14.7	0.4	0.8	4.6	11.0	1.9	0.4	4.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	67.4	0.8	5.7	0.6	0.0	0.0	203.3	0.2	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.1	3.3	82.8	0.0	0.0	0.0	1.1	182.5	6.8	0.0	0.0	4.7	0.0	6.5	0.0	14.1	94.6	2.4	0.0	4.5	0.0	1.3	0.0	0.2	0.0	3.1	0.0	0.0	2.5	2.3	1.6	6.5	22.0	0.0	0.2	0.1	0.0	0.2
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1135.4;liver: 675.2"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	6.5	74.6	1053.8	0.8	0.1	0.4	0.7	2.6	0.3	0.6	0.4	145.4	675.2	0.2	1.5	1.2	0.7	0.4	0.1	0.1	0.8	0.1	1.1	0.3	35.7	0.0	1.7	0.3	0.2	1.3	1135.4	1.7	0.4	0.8	2.7	12.2	0.6	0.3	0.2	0.3	0.1	0.3	0.2	0.8	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.7	1.1	0.4	0.6	0.8	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966040-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.9;testis: 55.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 34.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 34.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	7.4	6.2	6.4	10.0	6.1	89.9	6.4	10.3	8.4	8.1	5.0	16.3	10.6	5.7	2.3	37.6	6.0	3.0	6.9	5.6	4.9	5.6	4.8	9.0	16.9	4.8	5.2	8.1	8.9	2.6	3.6	15.3	5.2	4.9	16.5	4.9	9.5	1.5	4.1	20.1	13.0	9.4	4.9	12.5	11.7	55.0	4.2	43.0	4.3	2.3	24.9	4.8	13.7	5.6	167.9	199.9	164.8	113.6	16.8	28.7	87.5	237.8	139.3	257.2	195.3	134.6	158.5	65.5	91.4	151.9	156.9	220.9	188.8	101.2	240.6	118.7	206.4	135.6	263.5	123.5	4.1	71.4	109.0	7.7	12.8	145.8	146.9	56.6	146.4	100.5	114.0	132.4	241.1	144.4	66.9	98.5	66.6	216.4	84.9	69.7	205.1	86.3	115.3	123.6	151.2	118.9	225.4	121.9	82.7	112.3	149.1	127.1	91.2	168.2	146.0	140.5	345.1	43.5	127.7	80.0	74.5	162.0	265.3	34.4	0.6	2.9	0.6	0.1	0.4	1.1	1.3	1.3	2.4	0.5	1.2	0.4	0.4	3.0	0.3	2.6	8.0	1.0	6.4	6.1	10.3	8.4	5.6	4.9	4.8	5.2	5.2	4.9	4.2	5.6	2.5	0.0	3.1	1.3	6.8	16.6	6.6	8.0	2.2	6.4	3.4	4.3	3.2	0.0	7.6	3.7	0.0	45.5	2.8	16.5	0.0	3.2	41.5	4.5	4.0	4.7	5.4	142.9	5.0	2.9	68.3	7.2	16.3	6.8	8.9	13.2	9.3	2.1	21.5	3.3	5.2	17.0	10.2	8.7	15.0	15.4	3.7	5.2	3.6	1.9	5.5	3.8	4.1	2.0	1.7	2.3	3.2	1.9	17.5	5.9	2.0	0.1	3.2	4.6	6.6	7.4	10.9	136.4	74.2	38.0	14.2	14.6	6.8	0.4	24.1	6.7
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	105993463-106109939	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.5;T-cells: 34.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 3.6"	"Low region specificity"	"Detected in many"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	6.6	2.1	1.6	20.0	1.6	20.3	6.8	5.5	1.8	15.7	3.1	15.2	9.2	17.2	1.3	55.2	5.5	12.7	1.7	1.5	2.8	2.5	4.5	10.1	15.9	3.2	1.8	4.9	1.9	2.5	1.4	5.1	2.7	3.4	17.2	1.3	9.3	2.4	4.3	9.1	12.6	5.5	2.4	13.6	15.2	1.2	2.9	4.2	9.0	2.2	27.8	19.6	20.2	3.4	1.4	0.5	1.1	0.0	1.6	2.1	0.2	7.2	23.3	2.3	3.7	1.4	9.2	2.0	0.4	13.8	0.3	0.5	0.0	3.6	2.5	21.7	0.1	0.4	4.9	0.0	3.6	0.8	1.6	2.3	11.6	3.3	9.7	0.7	2.9	1.0	1.4	212.1	0.4	0.0	0.1	0.5	0.8	1.4	0.0	0.5	0.0	42.4	2.1	0.3	0.0	0.3	1.0	0.9	0.0	1.6	1.0	2.4	1.5	3.1	1.8	2.1	7.2	81.5	57.0	4.9	5.1	1.3	2.1	2.4	0.8	11.1	22.1	1.2	34.0	2.5	20.5	20.2	0.5	1.0	1.8	11.3	12.5	4.7	0.3	0.4	29.4	2.6	1.6	1.6	5.5	1.8	1.5	2.8	3.2	1.8	2.7	2.4	2.9	3.4	93.1	0.0	5.1	0.3	42.1	19.5	8.6	15.0	3.4	0.6	2.8	3.4	1.5	0.0	19.1	3.7	52.1	0.7	199.8	129.8	0.0	0.3	0.9	15.9	101.0	41.1	1.8	6.1	1.8	0.2	0.7	18.5	19.4	62.6	3.8	9.9	6.4	2.5	19.8	0.0	19.2	15.0	10.2	38.0	199.2	0.3	0.0	64.5	37.4	23.4	30.4	0.5	89.6	0.5	0.1	7.8	103.7	1.2	786.9	4.0	3.2	0.3	13.0	1.1	0.0	5.3	30.1	0.5	2.3	43.9	41.5	0.7	184.3	1.6	8.7	91.9
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167720-119178812	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1060.4;Proximal tubular cells: 937.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488, CAB079909"	Enhanced		Supported	Mitochondria		NA	NA		1600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB008656: AB_1620979, CAB079909: AB_2809998, HPA041488: AB_2677508"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	165.7	335.3	92.4	96.0	92.6	82.3	138.3	101.3	116.0	103.4	139.2	133.3	137.8	87.0	120.8	83.3	116.7	88.0	278.2	95.2	104.5	385.7	571.2	74.9	108.4	97.2	97.1	74.9	96.2	223.8	60.0	126.3	99.0	126.7	139.8	52.5	132.1	131.7	376.0	38.0	132.1	130.0	100.4	76.3	97.5	48.3	98.6	98.3	176.7	402.7	104.0	112.8	65.1	102.7	350.6	392.2	234.1	267.3	241.7	259.8	145.9	244.8	414.8	364.5	380.7	303.4	339.9	407.2	208.8	290.8	173.4	155.5	391.5	296.1	408.8	401.5	411.4	183.7	149.7	542.4	252.5	347.8	212.7	306.8	186.4	292.1	269.7	261.2	268.6	245.2	230.0	82.5	338.7	140.2	265.1	292.7	218.9	264.0	229.3	276.5	339.7	281.5	623.8	164.6	103.0	149.2	259.8	346.1	332.2	201.0	179.6	411.5	190.5	118.3	178.1	170.9	323.1	128.0	200.7	327.0	185.7	507.4	107.3	144.4	429.1	246.9	110.5	369.5	142.7	179.9	145.6	134.6	382.1	149.8	149.5	134.0	239.9	132.8	333.9	214.8	205.7	510.2	92.4	92.6	101.3	116.0	95.2	104.5	97.2	97.1	99.0	100.4	98.6	102.7	61.4	48.1	74.5	14.4	65.1	69.8	117.8	274.0	81.4	27.5	145.2	105.2	236.5	131.5	119.0	147.1	10.4	328.4	50.6	84.5	1060.4	124.5	5.0	105.1	76.0	78.3	110.9	132.8	15.4	75.1	212.0	100.8	116.7	77.3	52.6	131.0	73.2	390.0	247.6	40.4	15.4	132.5	221.8	164.2	96.0	10.5	77.3	127.9	133.4	10.3	158.4	76.9	39.1	12.5	18.8	63.8	99.3	101.2	153.7	95.1	176.1	937.8	163.4	24.8	72.3	63.1	105.3	11.2	23.2	146.4	52.6	155.0	56.1	440.0	207.0	119.6
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788485	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.7"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 35.5;Oligodendrocytes: 54.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 5.2;Hep G2: 3.3;NTERA-2: 2.3;SCLC-21H: 8.3;SH-SY5Y: 8.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavorable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	5.8	3.0	6.1	2.9	11.3	0.0	3.8	10.8	12.3	17.5	2.5	53.7	2.1	13.9	2.1	8.0	18.3	1.6	8.8	5.2	7.9	2.5	0.8	1.0	0.1	17.1	11.3	5.4	1.3	0.0	0.7	1.0	14.7	15.6	3.7	5.7	5.0	5.0	0.9	3.4	21.6	8.1	12.7	0.2	20.0	1.7	9.1	0.2	1.7	1.4	2.3	11.0	14.4	18.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.3	8.2	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	11.3	10.8	12.3	5.2	7.9	17.1	11.3	14.7	12.7	9.1	18.4	0.2	0.0	0.0	1.3	0.0	0.5	1.0	0.3	0.6	2.6	0.4	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.4	0.2	0.0	0.0	0.2	0.0	0.0	3.4	2.6	0.6	0.0	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.2	2.8	0.1	0.0	0.0	0.0	35.5	0.0	2.0	54.7	0.1	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.3	0.0	4.9	0.3	0.7	1.4	0.6	0.3	0.0	0.0	0.0	0.0	0.1
PRKCH	"PKC-L, PKCL, PRKCL"	ENSG00000027075	"Protein kinase C eta"	P24723	14	61187559-61550976	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 128.4;Microglial cells: 267.9;NK-cells: 229.6;T-cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"gdT-cell: 116.5;MAIT T-cell: 91.3;memory CD4 T-cell: 88.0;memory CD8 T-cell: 137.0;naive CD4 T-cell: 106.9;naive CD8 T-cell: 105.5;NK-cell: 117.1;T-reg: 79.8"	"Group enriched"	"Detected in all"	14	"NK-cells: 117.1;T-cells: 137.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 81.8;HUVEC TERT2: 108.7;MOLT-4: 75.8;RT4: 46.4;TIME: 72.0"	"Group enriched"	"Detected in all"	6	"basal ganglia: 28.0;thalamus: 17.9"	"Low region specificity"	"Detected in all"			"HPA026294, HPA053709"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"HPA026294: AB_10603988, HPA053709: AB_2682237"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.73e-3)"	26.6	7.8	21.1	21.9	30.2	24.2	21.9	12.4	15.7	20.6	9.5	8.9	9.5	14.5	10.9	30.0	13.6	19.7	19.2	13.2	13.9	14.5	10.3	35.3	55.2	19.3	21.7	5.9	8.4	14.2	15.0	32.5	19.4	15.8	8.8	3.1	28.3	11.4	14.2	23.7	16.6	18.1	18.6	38.5	9.6	7.5	29.9	65.8	21.1	18.1	38.5	25.3	21.7	15.5	18.1	6.3	0.8	4.9	2.8	0.6	81.8	0.3	1.5	0.8	0.8	1.9	10.5	0.3	12.4	0.1	1.6	12.3	0.6	13.5	1.4	2.2	7.9	0.1	2.0	0.7	1.2	0.0	2.4	2.2	13.8	0.7	9.4	1.2	108.7	35.4	0.2	0.4	6.2	32.7	75.8	0.7	1.4	12.9	8.4	6.3	3.2	0.2	0.2	46.4	3.2	5.1	2.1	16.2	10.2	14.5	15.9	1.4	72.0	2.1	14.0	2.1	0.9	1.4	0.2	0.6	3.1	1.1	3.6	0.8	3.0	2.4	116.5	1.9	91.3	2.2	88.0	137.0	9.2	1.4	106.9	105.5	5.9	117.1	1.1	3.0	79.8	84.0	21.1	30.2	12.4	15.7	13.2	13.9	19.3	21.7	19.4	18.6	29.9	15.5	59.7	6.4	11.4	2.0	6.6	18.7	16.4	8.3	15.9	0.4	15.0	9.3	9.0	10.0	15.5	0.0	0.0	27.6	128.4	0.6	3.9	6.0	32.6	10.3	2.1	70.8	11.9	18.1	1.7	6.8	21.2	5.0	7.1	20.9	1.3	15.4	68.9	2.0	6.0	0.0	3.1	2.7	2.0	14.4	6.9	6.0	1.8	15.4	16.0	267.9	8.9	7.0	229.6	4.5	1.8	5.4	4.3	6.8	26.6	14.7	4.6	1.2	9.2	0.5	0.0	4.4	5.2	0.1	2.4	18.1	26.7	48.3	130.5	1.6	1.3	26.0
PRKD2	"DKFZP586E0820, HSPC187, PKD2"	ENSG00000105287	"Protein kinase D2"	Q9BZL6	19	46674275-46717127	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Cell adhesion, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-266/84: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021490, HPA056727"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA021490: AB_1855708, HPA056727: AB_2683217"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.06e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.21e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (9.15e-4)"	29.0	11.5	7.2	23.6	7.3	29.4	29.3	5.4	7.7	26.6	12.5	20.3	17.1	21.8	4.7	27.5	24.1	11.2	13.8	6.1	6.0	19.2	13.8	34.3	31.1	10.0	6.3	21.8	19.1	8.3	24.0	11.1	6.8	23.9	7.1	4.4	24.7	10.0	8.0	46.8	29.9	6.0	6.0	54.3	20.3	6.6	7.7	25.6	28.9	4.8	21.2	19.5	26.9	6.6	19.6	34.5	12.8	16.6	7.3	6.4	15.1	11.5	13.2	19.6	19.7	19.7	21.0	22.3	16.3	13.2	13.2	27.5	9.5	26.0	5.9	19.8	17.5	25.9	11.5	10.2	12.8	21.2	34.7	11.0	15.8	12.7	9.8	12.8	30.1	21.5	14.6	35.4	7.0	23.8	32.7	53.1	9.7	27.4	17.4	25.8	5.8	37.5	11.4	32.7	7.7	22.4	18.8	18.8	4.6	10.6	11.6	7.5	17.6	8.7	18.8	7.1	10.0	31.8	149.1	13.5	8.5	17.7	11.0	0.6	0.7	2.6	3.9	0.7	3.3	4.3	3.9	4.3	0.3	4.1	3.3	3.3	5.3	2.2	0.5	0.0	2.9	1.5	7.2	7.3	5.4	7.7	6.1	6.0	10.0	6.3	6.8	6.0	7.7	6.6	37.8	9.6	9.9	5.9	46.5	22.0	32.0	13.2	22.8	6.4	13.9	11.3	17.2	12.8	13.0	9.2	0.0	13.8	17.5	43.6	7.9	18.6	1.2	15.3	6.7	37.2	21.6	4.0	6.5	28.2	13.8	9.6	23.4	15.0	14.5	14.1	37.1	8.5	9.0	1.7	2.8	21.7	4.1	12.3	11.4	3.1	11.8	8.3	12.4	11.2	9.3	6.5	42.2	4.0	3.1	29.5	35.1	6.8	47.0	22.9	34.1	9.3	15.6	4.4	13.1	6.1	7.6	2.9	17.9	21.2	26.7	29.7	31.9	6.6	15.3	30.2
PRKX	PKX1	ENSG00000183943	"Protein kinase X-linked"	P51817	X	3604340-3713649	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 33.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 108.3;Endometrial ciliated cells: 164.0;Glandular and luminal cells: 179.5;NK-cells: 139.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015324	Supported		Supported	Nucleoplasm		No	No			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	5.5	1.6	10.0	9.8	12.9	7.7	7.9	12.6	8.8	7.8	12.7	6.5	5.1	4.6	9.6	13.9	19.4	4.4	3.7	8.3	14.3	15.6	1.8	9.0	12.8	18.1	13.8	4.0	4.4	3.1	2.0	5.3	15.8	3.8	6.1	1.7	6.1	5.9	2.2	12.0	6.3	3.7	14.5	12.4	4.0	6.8	15.3	15.4	33.8	3.2	9.9	4.5	12.4	17.1	9.1	8.3	22.4	16.7	4.2	5.6	20.5	5.3	2.1	2.6	3.5	12.4	6.1	0.7	5.3	4.3	5.4	6.2	21.1	16.1	4.5	10.2	14.7	10.0	6.7	0.2	4.4	13.0	74.7	3.8	16.8	2.8	10.3	7.1	25.7	12.3	11.8	12.7	8.6	8.0	15.0	11.7	15.0	7.0	9.4	27.7	21.5	17.2	20.6	7.6	14.9	9.6	5.6	3.6	5.5	35.1	2.8	10.3	14.2	2.2	3.8	3.7	3.6	0.3	0.7	11.6	1.3	11.6	5.8	11.0	2.0	1.2	2.3	2.4	2.4	1.6	2.4	2.2	1.6	1.5	1.9	2.1	0.5	2.4	3.2	1.9	1.8	1.2	10.0	12.9	12.6	8.8	8.3	14.3	18.1	13.8	15.8	14.5	15.3	17.1	32.0	3.2	9.4	7.8	35.5	21.4	22.3	9.7	21.6	1.8	14.4	9.1	1.6	30.0	10.1	5.5	0.0	30.8	108.3	8.8	13.7	10.8	11.9	164.0	23.8	19.7	4.8	7.2	1.3	3.1	5.8	10.4	6.1	179.5	85.1	11.8	13.2	2.3	16.9	1.7	20.2	13.5	24.4	19.4	24.1	49.2	19.9	29.0	5.4	39.4	53.4	2.2	139.0	11.1	7.0	5.6	13.1	21.8	38.2	29.0	10.7	6.1	18.0	0.6	32.9	46.4	12.4	1.3	21.6	34.1	26.9	7.8	63.5	10.6	23.6	20.4
PRMT8	"HRMT1L3, HRMT1L4"	ENSG00000111218	"Protein arginine methyltransferase 8"	Q9NR22	12	3381349-3593973	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.8;retina: 3.9;testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 21.7;Cone photoreceptor cells: 16.7;Early spermatids: 22.8;Excitatory neurons: 60.5;Inhibitory neurons: 63.8;Late spermatids: 15.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"hTERT-HME1: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039747, HPA069769"	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA039747: AB_2732482, HPA069769: AB_2686193"	"unprognostic (3.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.80e-3)"	"unprognostic (9.41e-2)"		"unprognostic (3.41e-5)"	"unprognostic (5.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.49e-2)"	0.0	0.0	3.2	0.0	7.8	0.0	0.0	3.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	5.4	1.5	0.6	0.0	0.8	0.0	2.1	3.0	0.0	0.6	0.0	0.1	0.0	0.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	4.0	1.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	48.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.8	3.8	7.2	5.4	1.5	2.1	3.0	0.7	0.3	4.0	3.6	0.0	6.4	1.7	1.6	0.1	0.0	0.0	0.0	0.0	21.7	0.1	0.0	1.3	0.0	5.0	0.0	16.7	0.0	0.0	0.1	0.0	0.0	22.8	2.2	0.1	0.3	0.0	0.0	60.5	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.0	63.8	0.0	4.1	0.0	4.2	15.4	0.6	0.4	0.0	1.0	0.0	0.7	0.0	3.0	1.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	7.5	1.6	0.0	0.0	0.2	3.5	1.5	0.0	0.0	0.0	0.2	0.0	0.1	0.2
PROKR1	"GPR73, GPR73a, PKR1, ZAQ"	ENSG00000169618	"Prokineticin receptor 1"	Q8TCW9	2	68643579-68658251	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.6;epididymis: 3.5"	"Cell type enhanced"	"Detected in single"		"Adipocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 2.0"					"Low region specificity"	"Detected in all"			HPA029396	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA029396: AB_10610285"	"unprognostic (5.46e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.72e-2)"	"unprognostic (8.96e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.19e-1)"	"unprognostic (7.22e-2)"	1.6	1.1	0.0	0.2	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.7	0.6	0.4	0.5	0.4	0.1	0.1	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.6;intestine: 21.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Group enriched"	"Detected in many"	5	"medulla oblongata: 51.9;pons: 53.6;white matter: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.1	14.5	0.9	7.5	1.1	0.0	1.8	0.3	1.8	3.3	0.4	21.0	4.7	0.8	0.1	0.5	3.1	0.6	1.2	0.9	2.2	0.9	0.1	0.9	0.2	51.9	8.0	0.7	1.3	0.1	2.9	0.3	53.6	2.3	2.1	1.5	0.5	1.5	0.4	1.1	8.9	2.0	7.8	1.2	5.2	13.2	0.9	0.1	0.5	0.2	0.1	1.5	8.3	15.7	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	1.8	0.9	2.2	51.9	8.0	53.6	7.8	0.9	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563835-29567293	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 62.6;intestine: 81.4;stomach 1: 49.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 263.0;Granulosa cells: 194.2;Proximal enterocytes: 122.4;Respiratory ciliated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.7;HaCaT: 45.1;OE19: 97.7;RT4: 34.5;SK-BR-3: 74.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	6.5	0.7	0.6	4.8	0.4	1.1	9.2	0.1	0.7	62.6	0.0	81.4	72.3	18.1	21.6	1.0	9.0	7.8	1.3	0.4	1.0	16.9	0.3	2.3	0.4	0.6	0.4	5.9	3.0	1.4	3.0	4.8	0.5	2.5	52.6	0.0	7.5	3.1	0.2	0.3	72.4	2.3	0.6	0.2	49.3	0.9	1.3	0.1	1.1	0.0	0.7	16.6	0.5	0.6	16.8	23.3	0.0	0.0	8.7	10.7	29.3	0.7	1.1	0.4	0.2	20.5	38.7	0.0	4.1	5.5	0.6	45.1	4.9	0.0	0.0	0.0	3.3	1.3	4.5	22.7	2.8	0.0	0.1	0.1	7.3	0.0	1.7	0.0	0.1	1.5	0.0	0.0	0.0	3.9	0.6	3.2	3.5	97.7	18.5	0.1	0.0	21.4	26.5	34.5	0.5	0.3	2.3	74.9	0.0	12.8	5.4	0.0	19.9	0.5	0.0	0.1	0.9	1.8	3.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	0.7	0.4	1.0	0.6	0.4	0.5	0.6	1.3	0.6	1.8	0.0	0.5	0.0	0.4	0.1	1.2	11.0	0.0	0.0	10.0	7.1	0.5	12.8	16.4	38.6	0.0	14.2	0.2	263.0	29.4	6.9	0.8	31.3	2.3	1.2	8.4	0.0	0.1	21.8	9.9	1.3	16.8	34.7	0.0	194.2	0.4	0.2	2.7	0.0	0.0	45.3	26.4	0.0	0.3	0.1	1.5	2.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.4	58.5	2.2	0.1	3.0	122.4	14.4	63.1	0.0	0.0	0.0	7.8	0.0	0.4	1.2	0.0	6.3	0.6	0.4	56.9	23.3
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 178.4;pancreas: 103.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 203.0;Distal tubular cells: 170.2;Intestinal goblet cells: 127.8;Paneth cells: 226.4;Proximal enterocytes: 263.7;Undifferentiated cells: 100.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 205.6"	"Not detected"	"Not detected"							HPA022918	Approved		Approved	Cytosol		No	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (6.29e-13)"	"prognostic favorable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	2.2	0.1	0.0	7.9	0.1	0.1	38.8	0.2	0.2	13.4	9.5	111.2	178.4	1.4	18.3	12.9	26.5	22.0	0.4	0.8	0.0	28.0	1.9	21.7	0.2	0.1	0.0	0.3	103.9	0.8	8.5	0.0	0.0	17.7	124.3	0.0	51.8	15.8	0.1	10.0	128.5	3.3	0.0	0.0	84.4	2.5	0.0	0.4	67.8	0.0	2.0	2.7	6.7	0.1	3.8	0.6	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	8.6	5.8	0.2	0.3	0.0	0.0	20.5	0.0	0.1	0.0	0.4	0.7	0.2	0.0	2.6	0.0	0.4	0.4	0.0	4.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	19.7	0.4	0.4	0.0	205.6	0.7	0.3	0.0	1.4	1.1	2.6	11.7	0.5	0.0	35.7	0.0	0.0	24.1	0.0	0.1	0.3	0.0	0.7	0.1	0.1	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	22.4	19.8	0.3	0.1	0.0	2.6	2.4	0.0	0.0	16.7	8.9	0.1	80.1	19.8	16.5	0.0	0.0	0.1	203.0	170.2	35.6	5.5	9.8	0.3	0.2	31.6	0.0	0.1	36.1	0.0	0.4	55.5	3.9	0.0	0.0	0.0	0.8	0.1	0.0	0.1	127.8	24.4	0.0	0.0	9.0	1.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	226.4	0.4	0.2	15.6	263.7	30.0	19.2	0.0	0.0	0.0	1.0	11.1	0.1	7.3	0.0	0.0	0.6	0.0	100.9	9.9
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004305	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 58.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;REH: 3.7;TIME: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051264			Uncertain	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	2.0	0.3	3.2	0.5	2.5	0.3	2.2	1.8	1.2	6.1	12.7	0.4	0.2	0.6	0.3	0.2	58.2	0.7	1.5	4.1	4.2	1.9	0.2	10.4	0.4	12.7	16.0	0.6	0.3	0.9	10.7	0.3	7.3	0.7	0.0	0.0	0.5	0.6	0.6	0.4	0.7	0.2	9.0	5.7	0.3	13.9	4.0	0.2	4.7	0.0	0.3	0.8	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.7	0.1	3.7	0.0	1.5	0.3	0.0	0.2	1.0	0.0	0.1	0.2	0.5	0.5	0.0	2.8	0.1	1.1	0.4	0.1	0.4	0.1	0.2	0.4	0.1	0.0	0.9	0.2	0.0	0.4	0.5	0.1	0.1	0.4	0.2	0.1	0.2	0.7	0.4	0.2	0.2	0.4	0.0	0.2	0.3	3.2	2.5	1.8	1.2	4.1	4.2	12.7	16.0	7.3	9.0	4.0	3.9	3.3	0.0	2.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	1.5	9.9	3.7	0.0	0.0	0.7	0.0	0.0	0.1	12.4	57.4	0.5	2.1	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	0.0	1.6	1.8	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	10.5	0.0	0.9	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.1	89.6	0.0	0.0	0.3	0.3	18.1	1.4	0.0	0.0	0.3	0.7	3.5	0.0	0.1
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349309-37457292	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.4"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	8.6	3.7	12.3	2.1	24.9	0.2	5.2	21.6	19.7	4.4	4.7	4.0	2.9	4.3	1.5	4.1	2.6	8.8	6.4	12.9	15.9	10.5	7.9	5.5	1.7	26.7	21.3	4.2	1.6	1.2	1.4	8.1	25.3	3.4	4.1	1.5	2.9	7.8	15.9	2.2	3.0	5.4	18.4	2.9	2.4	1.5	18.4	1.5	8.3	7.8	1.0	5.6	3.8	39.4	32.3	7.2	5.6	5.6	18.7	15.4	2.4	14.1	17.6	4.7	8.2	17.1	20.2	0.0	21.8	10.4	8.9	10.7	15.6	10.0	8.3	0.1	5.2	5.2	7.7	5.7	22.6	0.0	7.2	23.2	8.1	9.1	7.7	9.4	24.8	0.0	2.6	0.1	16.5	2.4	0.1	0.1	6.8	5.1	13.4	0.0	13.1	0.0	79.2	1.7	0.0	0.1	9.7	15.6	6.1	15.3	0.1	3.5	17.6	7.5	4.2	14.2	4.1	0.0	0.1	0.0	7.3	0.0	7.3	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	24.9	21.6	19.7	12.9	15.9	26.7	21.3	25.3	18.4	18.4	39.4	29.7	6.4	4.2	15.7	0.0	11.3	4.8	7.6	5.2	2.2	5.3	5.3	8.1	15.7	2.7	33.1	0.0	7.0	0.2	7.6	7.9	6.8	0.7	3.3	12.9	18.4	3.0	0.0	23.3	3.1	14.9	9.6	4.6	9.2	1.3	3.9	17.9	16.3	4.8	18.5	10.8	5.7	14.2	4.1	5.3	0.4	4.7	1.4	3.6	31.9	0.8	2.2	0.0	12.5	229.8	18.7	7.5	2.6	0.0	9.1	4.3	9.4	2.9	0.5	6.6	8.3	8.4	2.5	4.2	5.2	6.3	10.4	0.4	3.5	4.8	8.1
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	58	"lymphoid tissue: 826.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 42.1;Extravillous trophoblasts: 25.4;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;RPMI-8226: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.2	0.4	0.0	0.3	0.0	0.0	6.0	0.1	0.3	3.6	0.0	5.7	4.4	0.7	13.5	2.9	5.6	4.0	0.0	0.1	0.0	1.8	0.0	3.8	0.1	0.0	0.0	2.5	14.1	7.8	1.4	4.1	0.1	3.2	6.7	0.1	7.5	4.2	0.0	5.1	3.3	0.2	0.0	0.3	4.8	1.0	0.0	826.7	13.1	0.0	1.4	2.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	3.8	4.7	0.0	0.7	0.0	0.0	1.5	2.7	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.5	0.0	20.4	0.0	4.1	0.5	0.0	1.7	2.5	1.9	0.0	1.2	0.5	0.0	0.7	2.1	0.5	0.0	0.0	11.5	2.4	3.6	0.0	0.0	1.4	3.2	0.0	4.5	2.0	0.9	0.0	0.0	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.7	2.1	0.9	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	7.7	0.0	2.6	6.4	10.8	4.6	8.6	0.0	16.6	9.5	0.4	15.7	4.6	14.7	0.0	42.1	0.2	22.9	1.9	10.0	0.6	2.5	0.8	0.4	4.2	0.0	0.7	17.6	25.4	0.7	12.8	8.0	5.7	0.1	0.0	0.0	4.0	0.0	0.2	20.0	14.2	0.3	0.4	0.5	0.6	0.3	5.4	0.0	0.2	1.2	0.0	0.0	0.1	9.4	18.7	0.0	13.7	6.9	16.5	0.7	3.4	0.0	0.0	0.0	1.2	2.0	6.1	8.6	6.5	31.7	1.1	0.0	14.9	8.5
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852730-2858170	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 79.6;salivary gland: 26.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 221.0;Club cells: 343.9;Ionocytes: 207.5;Pancreatic endocrine cells: 380.6;Urothelial cells: 479.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 17.3;MCF7: 14.6;RT4: 10.4;SK-BR-3: 22.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	23.4	0.0	0.5	0.3	0.7	0.4	79.6	1.3	0.8	0.0	0.0	0.0	16.7	0.5	2.9	0.0	0.0	0.0	0.0	5.8	1.5	2.4	1.1	0.0	6.0	0.5	0.0	26.9	0.3	0.0	3.2	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.3	0.0	2.2	2.5	23.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.3	17.3	0.0	0.0	0.0	0.0	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	22.9	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.2	4.2	0.0	0.2	23.2	221.0	128.8	28.5	0.0	42.8	23.7	0.3	38.6	343.9	16.5	0.0	36.7	1.9	18.5	1.9	113.1	0.0	28.4	4.6	1.8	3.6	0.0	0.0	98.3	37.1	1.3	52.5	56.6	0.0	0.0	0.0	0.1	2.3	0.0	0.0	7.5	207.5	0.0	1.4	0.0	0.0	0.9	7.2	0.0	1.0	0.0	0.0	0.0	0.0	380.6	32.3	0.0	0.3	75.4	0.6	0.2	108.0	0.0	0.0	0.0	13.7	0.1	0.2	22.7	27.6	10.5	2.7	0.0	6.9	479.5
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 249.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 367.1;Endothelial cells: 502.1;Granulosa cells: 347.3;Hepatic stellate cells: 591.8;Theca cells: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 104.6"	"Group enriched"	"Detected in many"	25	"NK-cells: 34.2;T-cells: 104.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 1093.7;hTERT-RPE1: 1296.9;TIME: 1138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		440000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	55.0	21.4	7.8	35.3	7.8	2.1	43.2	7.1	8.7	249.1	12.9	103.6	19.2	103.4	13.4	22.1	24.9	83.8	28.3	7.9	8.0	42.4	15.0	63.3	21.8	14.0	13.9	26.8	29.8	36.0	16.4	61.7	8.8	61.3	50.3	2.7	52.4	128.2	79.6	19.4	29.0	115.5	7.1	18.0	54.2	31.8	14.1	17.5	40.9	18.7	10.2	99.6	79.1	7.4	62.7	153.3	161.1	1.0	70.4	172.3	0.7	269.0	244.4	293.2	232.6	368.1	484.7	0.2	208.2	414.7	1093.7	126.2	2.6	205.0	70.9	0.7	13.0	21.1	74.7	1.4	36.3	0.1	0.9	137.4	26.8	143.2	162.1	1296.9	604.8	0.9	1.3	0.3	223.4	87.7	0.2	0.3	9.8	211.7	16.8	0.0	0.0	0.7	111.5	82.3	1.5	1.0	59.9	4.5	18.7	397.6	6.0	0.6	1138.2	174.0	2.3	351.7	154.5	1.3	1.3	0.8	124.2	0.5	176.3	0.2	0.2	0.1	104.6	0.1	0.2	0.2	17.8	60.0	0.2	0.0	4.7	50.4	1.6	34.2	2.7	0.2	0.0	39.9	7.8	7.8	7.1	8.7	7.9	8.0	14.0	13.9	8.8	7.1	14.1	7.4	95.8	28.9	14.5	14.0	3.2	15.4	96.2	367.1	2.8	1.6	44.7	78.0	4.3	37.1	231.3	53.3	2.1	18.4	53.4	154.8	7.9	162.6	3.1	10.3	130.3	502.1	13.8	20.4	26.3	83.5	15.7	117.1	22.4	7.0	2.5	347.3	591.8	5.2	5.0	0.0	16.5	30.6	85.5	36.6	18.2	6.6	14.3	5.4	72.9	39.4	1.5	0.8	180.2	11.6	2.3	257.7	80.1	7.5	5.8	100.1	5.2	5.7	90.1	0.9	39.5	14.4	105.9	3.0	7.3	1.7	9.8	4.5	24.0	445.1	11.1	60.2
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750679-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	268	"pancreas: 31113.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	104	"basophil: 158.7"	"Lineage enriched"	"Detected in many"	104	"granulocytes: 158.7"	"Group enriched"	"Detected in many"	5	"OE19: 316.6;PC-3: 852.5"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		700000000	"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	3.8	4.6	23.5	7.2	29.3	0.6	1.7	25.8	35.4	30.8	16.9	87.0	92.6	0.4	0.0	116.2	0.3	22.8	6.3	28.2	25.6	3.7	12.4	0.6	0.7	25.0	24.5	12.9	31113.6	0.0	0.7	1.7	25.7	1.1	77.8	0.3	20.9	0.3	0.5	79.7	105.4	3.1	19.4	0.7	22.8	5.1	25.6	0.8	0.4	0.0	15.2	4.2	56.9	24.7	12.0	13.7	0.7	0.0	0.2	5.9	0.1	33.6	7.7	4.1	1.6	34.3	3.0	0.0	0.2	14.9	0.2	15.0	0.0	31.7	10.1	0.4	0.2	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	10.8	110.2	0.3	68.8	0.2	0.0	0.0	0.0	0.2	0.7	0.4	0.2	316.6	852.5	0.0	0.0	0.0	0.0	1.7	0.3	81.2	0.2	0.0	0.0	0.5	0.0	0.0	78.3	0.0	0.0	12.8	0.0	0.0	0.0	0.1	18.1	0.0	0.1	158.7	0.0	0.0	0.2	1.5	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.3	23.5	29.3	25.8	35.4	28.2	25.6	25.0	24.5	25.7	19.4	25.6	24.7	0.1	0.0	0.0	0.7	1.9	57.1	0.6	1.3	0.0	0.2	0.1	2.8	1.0	47.1	1.2	1.8	0.0	0.0	0.1	1022.9	3.9	43.2	31.4	0.0	0.0	3.2	192.6	0.0	32.8	2040.4	0.0	0.8	39.3	0.0	8.9	0.0	0.7	4.2	0.0	0.0	4.7	146.4	0.0	0.3	12.1	79.7	1.5	1.2	7.2	3.7	5.7	0.0	0.0	3.5	1.2	478.8	969.9	0.7	0.3	12.1	1127.1	14.7	0.1	0.2	0.0	0.0	1.7	0.5	0.9	1.1	134.1	0.1	2.1	0.0	329.0	56.2
PRSS36	FLJ90661	ENSG00000178226	"Serine protease 36"	Q5K4E3	16	31138926-31150083	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.6"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 11.7;Distal enterocytes: 13.2;Hofbauer cells: 18.7;Paneth cells: 15.4;Proximal enterocytes: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HeLa: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA036079	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA036079: AB_10602290"	"unprognostic (3.74e-2)"	"prognostic favorable (2.97e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-5)"	"unprognostic (4.18e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-1)"	1.4	0.8	0.4	0.3	0.6	0.4	0.5	0.4	0.8	0.2	0.3	0.7	1.0	0.1	0.0	0.3	0.3	0.1	0.3	0.5	0.5	0.2	0.3	0.7	0.1	0.5	0.4	0.1	0.2	0.1	2.6	0.7	0.5	0.1	0.2	0.0	0.5	0.1	0.2	1.0	0.7	0.3	0.4	0.1	0.3	0.4	0.6	0.8	0.3	0.0	0.2	0.4	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.8	2.6	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.0	0.1	0.0	0.2	0.0	0.0	0.4	0.6	0.4	0.8	0.5	0.5	0.5	0.4	0.5	0.4	0.6	0.5	0.3	0.0	1.1	0.7	0.2	1.9	2.6	8.9	1.8	0.5	5.9	11.7	1.1	2.8	3.5	0.0	0.0	0.8	1.2	13.2	0.0	1.7	1.7	0.9	0.6	0.6	0.0	0.4	0.6	2.8	1.2	1.3	1.1	0.9	0.0	0.5	3.3	3.3	18.7	0.0	0.8	4.1	2.0	3.2	3.8	0.9	2.8	4.2	0.0	0.0	5.4	0.6	4.1	0.0	0.1	1.8	15.4	2.6	0.0	1.7	46.9	1.9	1.2	0.0	0.0	0.4	0.4	0.6	4.4	1.5	2.6	0.5	0.5	1.1	3.9	1.9
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135727	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 245.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 403.5;Extravillous trophoblasts: 648.4;Paneth cells: 262.6;Proximal enterocytes: 358.0;Syncytiotrophoblasts: 450.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 243.7;CACO-2: 165.9;CAPAN-2: 111.9;hTCEpi: 157.8;OE19: 79.6;SK-BR-3: 186.3"	"Region enriched"	"Detected in single"	8	"hippocampal formation: 1.4"	"Low region specificity"	"Detected in single"			HPA030436	Uncertain				"Secreted - unknown location"	NA	NA		4400000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.8	0.4	0.3	15.0	0.4	0.2	25.5	2.1	0.6	31.1	6.7	129.4	155.7	9.9	113.0	136.2	15.4	47.7	0.4	0.6	0.2	90.6	28.0	54.1	0.3	0.3	0.2	0.6	139.4	56.0	8.4	51.0	0.4	49.0	72.6	0.0	245.4	8.5	0.3	115.3	151.8	3.5	0.1	0.2	156.2	0.5	0.2	15.4	50.8	0.0	11.8	4.9	56.0	0.2	63.4	0.2	0.1	0.2	0.0	0.0	243.7	0.0	0.0	0.0	0.0	165.9	111.9	0.0	1.3	0.0	0.0	73.5	0.1	69.7	0.0	0.3	0.4	0.1	0.3	6.5	0.0	0.0	0.3	0.0	157.8	0.0	2.4	0.0	0.0	0.1	1.9	0.1	0.0	68.1	0.6	1.4	20.5	79.6	0.1	0.5	0.0	1.2	7.5	13.1	0.9	0.7	0.0	186.3	0.1	18.8	42.8	0.8	0.0	0.1	1.9	0.6	0.4	0.3	0.5	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.1	0.6	0.6	0.2	0.3	0.2	0.4	0.1	0.2	0.2	0.4	99.3	60.1	0.0	1.0	37.9	82.7	108.9	76.2	0.5	74.4	39.2	0.3	62.9	107.4	42.3	0.0	168.8	0.8	403.5	29.4	192.4	0.0	35.2	11.4	2.6	9.6	2.7	0.1	224.4	648.4	3.5	82.6	109.5	7.0	0.0	0.0	18.2	22.8	0.0	0.2	132.1	87.5	0.3	2.7	0.0	0.6	1.9	3.6	0.0	4.2	0.3	0.0	0.0	0.0	240.7	262.6	0.0	0.1	66.0	358.0	28.6	21.2	0.1	0.0	0.1	4.7	0.0	0.2	81.9	54.0	450.7	2.2	0.0	150.8	91.0
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795808-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 106.3"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 229.9"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	0.1	0.3	70.8	0.3	91.3	0.2	0.5	86.5	63.1	0.8	22.0	0.2	0.1	0.2	1.6	0.0	0.4	0.2	0.2	58.7	76.3	0.1	0.1	0.1	0.0	90.6	106.2	0.1	0.4	0.0	0.9	0.0	79.2	0.2	0.1	4.1	1.7	0.4	0.3	0.1	0.1	0.1	70.5	0.2	0.1	1.1	106.3	1.0	0.1	0.0	0.1	0.1	0.2	56.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	91.3	86.5	63.1	58.7	76.3	90.6	106.2	79.2	70.5	106.3	56.3	0.0	0.0	0.0	229.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	2.6	0.0	52.8	24.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSD4	"EFA6B, TIC"	ENSG00000125637	"Pleckstrin and Sec7 domain containing 4"	Q8NDX1	2	113157325-113209396	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 51.2;Proximal enterocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.8;NB-4: 9.3"	"Low region specificity"	"Detected in single"							"HPA034722, HPA077847"	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA034722: AB_10669730, HPA077847: "	"unprognostic (1.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.13e-3)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.56e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-2)"	"prognostic favorable (4.00e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.60e-3)"	1.7	13.7	1.4	3.1	1.3	3.7	3.9	0.5	1.2	2.3	0.7	7.0	2.0	0.7	4.0	10.8	1.7	1.3	0.8	1.0	1.0	5.2	21.2	5.8	3.9	1.0	0.8	0.5	11.6	3.0	3.4	0.9	1.1	8.7	1.9	0.5	11.3	1.2	0.6	9.0	17.7	0.4	0.9	23.3	12.4	1.5	1.5	5.9	10.1	0.3	4.0	3.7	4.2	0.9	5.7	1.0	0.3	0.1	0.0	0.0	6.1	0.4	2.2	0.4	0.5	1.5	8.1	9.8	1.2	0.2	1.7	7.4	0.0	2.0	0.1	8.3	0.1	4.1	0.8	2.2	0.1	6.9	6.9	0.1	1.9	0.2	0.5	0.9	0.0	3.8	3.9	4.1	0.0	3.2	7.1	9.3	0.1	1.8	1.1	0.1	0.1	4.3	0.4	1.4	0.5	0.0	0.7	5.1	0.0	0.2	1.6	5.6	0.1	0.3	0.2	0.2	1.6	5.0	4.0	3.0	0.9	3.3	0.1	1.7	0.9	1.7	2.0	0.6	1.7	1.0	1.5	1.8	0.6	1.2	1.7	1.9	3.9	2.4	0.7	1.5	1.1	1.4	1.4	1.3	0.5	1.2	1.0	1.0	1.0	0.8	1.1	0.9	1.5	0.9	0.9	19.2	12.0	7.5	28.6	12.7	10.4	7.6	13.1	0.3	22.5	11.2	1.8	11.5	5.8	33.1	0.0	20.7	41.6	39.1	0.0	21.3	0.3	9.0	1.6	2.1	7.2	13.0	0.9	23.6	11.2	3.0	31.1	20.4	3.8	2.9	2.9	51.2	12.1	3.3	1.7	10.7	4.1	13.8	17.0	0.9	0.9	14.3	1.8	2.8	13.8	10.1	47.4	2.5	0.2	23.1	17.8	0.0	18.3	15.8	50.3	7.1	4.6	0.4	0.0	3.0	1.7	0.2	1.1	17.4	15.8	7.5	28.2	1.7	18.6	11.1
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTGES3L		ENSG00000267060	"Prostaglandin E synthase 3 like"		17	42968088-42980433	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	7	"heart muscle: 41.4;skeletal muscle: 124.3;tongue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 45.6;Cone photoreceptor cells: 8.4;Early spermatids: 13.1;Spermatocytes: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 4.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.80e-4)"	"unprognostic (9.24e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.08e-2)"	0.9	0.6	1.9	1.4	3.1	3.0	1.1	2.1	2.8	1.5	1.8	13.2	1.4	8.2	1.4	3.4	2.5	1.6	41.4	1.9	1.5	0.6	0.3	0.7	1.1	1.6	1.5	0.6	0.5	0.4	1.3	0.5	1.8	2.9	2.8	1.7	2.4	3.4	124.3	1.0	2.5	7.2	1.1	0.7	3.4	2.2	1.5	0.6	0.8	95.1	0.9	5.7	1.2	2.4	0.8	0.6	1.9	2.8	0.1	0.3	1.6	1.2	0.5	1.0	0.6	1.7	0.7	0.7	0.5	0.5	1.0	1.6	1.4	1.5	1.9	0.5	0.7	4.3	3.1	3.1	0.1	0.8	7.1	0.5	1.1	2.2	1.8	0.7	0.3	3.1	1.8	1.4	2.1	0.7	2.8	2.1	1.8	2.2	0.6	1.4	6.3	0.7	1.7	1.5	1.5	4.9	1.3	3.4	2.0	2.2	1.9	16.7	0.4	2.0	1.8	0.6	1.2	3.0	2.1	0.8	0.3	1.0	0.7	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.5	0.3	0.1	4.1	0.1	0.4	1.9	3.1	2.1	2.8	1.9	1.5	1.6	1.5	1.8	1.1	1.5	2.4	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.8	1.5	1.3	45.6	0.0	0.1	0.0	8.4	0.1	2.9	1.4	0.0	1.4	13.1	1.2	0.4	1.0	1.8	0.0	0.0	0.2	0.6	2.4	0.0	1.1	0.0	0.8	0.7	0.1	1.1	0.0	0.0	0.9	0.0	0.6	0.7	4.5	0.6	2.1	0.0	0.0	1.7	0.8	1.0	0.0	0.0	0.7	2.8	0.4	0.0	0.7	1.1	0.5	0.9	2.6	0.0	2.7	2.5	8.2	3.4	0.0	0.0	0.1	0.2	4.8	1.1	0.3
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116909916-116990353	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 66.2;Cardiomyocytes: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 146.8;WM-115: 111.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved					NA	NA		340000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA017074: AB_1855888"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-2)"	11.6	21.1	3.2	10.1	3.5	0.0	10.6	3.3	4.8	14.9	8.3	40.6	11.3	31.2	10.6	21.2	23.9	17.2	48.8	3.3	2.6	4.0	6.6	6.6	2.5	2.8	4.5	15.9	13.3	6.3	2.9	5.0	2.2	18.0	21.7	1.4	18.5	23.6	2.9	17.8	14.0	46.6	4.6	3.1	10.5	5.3	4.1	5.3	6.9	3.9	6.2	20.1	15.1	3.2	40.0	10.3	18.4	42.8	3.2	8.3	2.6	2.8	4.4	15.4	5.8	7.2	8.7	0.0	35.7	10.6	12.7	69.7	41.4	74.4	9.7	0.4	25.1	2.9	24.0	11.1	1.1	0.1	3.9	37.3	66.0	2.0	36.4	21.9	30.0	4.2	16.5	0.2	23.5	50.9	0.0	5.5	21.5	3.3	0.1	0.0	100.6	0.2	51.3	32.4	9.0	20.8	80.0	55.9	22.9	32.1	48.8	12.3	77.6	22.4	33.2	37.2	25.1	0.0	0.1	0.1	146.8	0.0	111.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	3.5	3.3	4.8	3.3	2.6	2.8	4.5	2.2	4.6	4.1	3.2	2.3	3.2	5.9	15.0	0.5	66.2	13.4	25.6	22.2	6.5	10.9	11.9	79.4	10.0	12.2	3.7	0.0	0.8	0.3	20.6	1.9	31.2	4.8	10.2	19.3	12.1	13.9	0.0	13.6	31.8	5.5	32.0	10.7	16.9	0.0	22.1	3.9	11.1	4.4	0.0	7.4	18.2	14.2	8.8	9.7	6.3	19.3	4.7	8.8	3.7	3.1	1.2	0.0	31.2	0.9	27.9	11.1	30.1	0.0	15.1	15.8	1.2	13.6	0.2	19.7	48.5	12.5	0.8	5.2	20.3	45.3	0.8	1.4	28.3	26.3	17.4
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537376	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 109.4;skin 1: 53.9;vagina: 43.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 132.1;Gastric mucus-secreting cells: 59.1;Intestinal goblet cells: 42.5;Paneth cells: 97.6;Proximal enterocytes: 80.2;Squamous epithelial cells: 48.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 22.1;CAPAN-2: 41.4;HaCaT: 33.9;hTCEpi: 45.0;OE19: 57.0;RT4: 26.4;T-47d: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.5	0.1	0.6	3.6	1.7	0.8	3.8	2.9	1.7	19.8	0.0	26.5	28.9	0.4	0.1	109.4	0.4	3.5	0.2	0.6	0.9	0.8	5.2	2.6	0.6	1.6	1.0	0.3	3.6	0.0	0.2	0.3	1.7	3.1	15.7	0.8	19.1	0.6	0.6	53.9	22.2	0.8	0.6	0.8	26.2	0.3	1.1	0.3	0.2	0.0	6.4	9.8	43.2	5.4	22.1	2.6	0.3	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	41.4	0.1	7.2	0.0	0.1	33.9	0.0	0.1	0.0	5.4	0.4	0.0	10.2	0.1	0.1	0.0	6.7	0.0	45.0	0.0	0.2	0.2	0.0	0.1	0.2	2.5	0.2	12.5	0.0	0.2	0.2	57.0	15.5	0.1	1.2	0.5	0.0	26.4	0.3	2.2	2.6	8.1	0.0	0.1	25.2	1.6	0.2	0.3	0.4	0.8	0.3	0.5	0.1	0.1	0.4	0.5	1.1	0.4	0.7	0.1	0.1	0.5	0.5	0.3	0.1	0.0	1.3	0.3	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.3	0.6	1.7	2.9	1.7	0.6	0.9	1.6	1.0	1.7	0.6	1.1	5.4	0.3	12.8	25.6	0.3	1.4	5.9	2.6	7.7	5.2	2.2	7.0	4.3	0.4	12.8	14.9	0.0	2.1	0.2	0.2	132.1	0.0	1.4	0.2	0.4	0.5	3.2	5.4	0.0	0.1	1.6	0.2	1.4	59.1	1.3	9.5	0.2	0.4	1.7	0.6	0.0	0.1	42.5	2.0	2.2	2.0	0.0	0.3	2.6	0.0	0.0	1.0	1.6	1.0	0.0	0.8	17.6	97.6	0.0	0.1	1.5	80.2	0.2	8.9	3.7	0.0	2.3	1.1	0.2	0.3	48.0	15.5	0.1	2.0	0.2	32.1	15.9
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Metabolic proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.1;Oligodendrocytes: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	3.7	5.7	7.8	2.2	14.1	0.7	3.1	9.7	12.4	3.1	2.5	4.3	1.4	3.1	2.2	2.0	3.3	2.2	7.0	8.0	8.9	3.3	1.5	4.4	1.9	10.9	11.5	3.0	5.9	3.6	6.7	1.7	10.8	3.2	2.8	4.4	2.9	2.0	4.8	3.1	2.3	4.1	6.7	1.8	4.3	7.8	10.2	1.8	3.3	6.7	1.9	2.5	2.7	18.3	6.1	2.7	4.7	6.1	5.8	7.9	6.2	4.4	3.0	4.4	3.7	2.6	5.0	5.1	2.9	3.4	10.1	4.7	4.9	2.8	4.3	6.8	1.3	1.2	7.7	2.8	7.4	1.4	3.8	7.9	10.0	6.7	9.2	2.6	4.7	8.3	3.0	0.0	8.4	3.3	5.2	2.2	3.3	5.0	4.8	5.6	9.3	0.0	2.4	1.5	4.1	5.1	6.1	5.7	9.5	6.2	3.1	2.5	6.7	5.8	3.5	9.1	5.4	7.2	8.4	0.7	4.3	2.5	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	14.1	9.7	12.4	8.0	8.9	10.9	11.5	10.8	6.7	10.2	18.3	5.7	0.0	7.7	19.2	4.7	4.8	3.0	2.2	5.7	10.7	2.3	3.3	11.3	5.7	1.4	5.5	10.4	0.4	2.6	2.1	3.9	3.1	11.7	2.3	7.3	5.8	3.5	0.8	36.1	2.9	2.0	8.1	14.3	3.1	5.7	6.7	4.2	1.0	3.1	5.0	27.0	2.6	4.1	1.0	4.6	6.2	3.7	3.6	3.6	14.0	0.5	2.2	0.0	18.6	82.6	6.1	2.9	14.3	2.0	1.4	1.1	1.7	2.1	9.8	19.7	7.4	5.5	21.0	20.8	4.7	4.3	0.3	4.0	2.3	2.3	1.8
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 234.3;pituitary gland: 182.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 59.0;Cone photoreceptor cells: 60.5;Enteroendocrine cells: 47.1;Excitatory neurons: 44.6;Horizontal cells: 97.6;Inhibitory neurons: 48.1;Rod photoreceptor cells: 38.4"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 66.4;U-87 MG: 249.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		38000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	0.7	25.2	91.6	4.8	98.3	0.6	0.2	12.2	139.0	0.2	0.0	5.3	1.6	0.3	0.0	0.3	0.1	0.3	0.3	116.6	234.3	0.3	0.2	0.2	0.1	62.4	85.5	0.2	36.3	0.0	182.3	0.2	138.1	0.4	0.8	21.4	0.1	0.0	0.1	0.9	2.0	1.6	22.2	0.1	6.0	0.7	98.9	0.0	0.4	0.0	0.0	0.9	0.9	70.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	2.5	0.0	0.8	0.0	0.1	0.0	0.0	1.2	4.6	6.8	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.8	1.9	0.0	0.6	8.4	0.0	20.8	0.0	0.2	0.0	0.0	0.4	0.5	1.5	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	10.8	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.1	66.4	0.0	0.2	0.1	0.3	1.1	249.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	91.6	98.3	12.2	139.0	116.6	234.3	62.4	85.5	138.1	22.2	98.9	70.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.1	0.0	59.0	0.1	0.1	2.0	0.0	0.0	0.0	60.5	0.0	0.1	0.1	1.9	0.1	0.3	0.1	0.2	0.7	47.1	2.7	44.6	0.0	0.3	1.9	2.6	0.0	0.0	0.0	0.0	0.3	0.1	97.6	48.1	0.7	2.0	0.0	0.4	0.8	0.3	1.8	1.8	4.7	0.0	6.0	0.0	1.5	4.0	2.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	38.4	0.0	0.1	1.9	4.2	2.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"PTTG1 regulator of sister chromatid separation, securin"	O95997	5	160421855-160428739	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.1;lymphoid tissue: 144.9;testis: 175.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 218.0"	"Lineage enriched"	"Detected in all"	7	"T-cells: 218.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192"	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	3.7	3.5	4.2	25.2	5.3	160.1	10.9	4.1	11.5	9.6	4.0	33.9	24.6	4.8	9.6	59.7	5.0	6.1	3.5	8.1	6.6	3.0	5.3	8.7	81.5	3.9	4.8	1.8	1.5	2.3	4.3	21.2	4.2	3.1	44.1	2.4	10.3	2.7	2.5	36.0	24.1	19.2	4.0	18.6	11.8	175.6	5.3	127.0	79.3	1.3	144.9	12.5	19.9	4.7	345.4	178.2	385.8	279.5	64.4	63.3	120.8	177.5	406.1	463.4	503.5	341.1	294.9	373.3	154.7	204.2	527.5	176.1	243.5	496.1	661.2	428.3	220.3	196.7	241.8	208.6	13.0	181.5	165.6	29.6	81.5	315.4	189.5	139.9	333.4	243.3	160.7	282.3	485.4	162.3	220.7	446.1	197.5	279.3	251.4	199.4	452.4	320.7	239.6	82.6	241.0	151.3	258.6	156.3	535.6	309.3	319.9	195.7	144.8	208.3	275.9	164.9	531.3	239.2	235.6	432.3	225.9	310.4	379.6	9.7	3.2	10.3	25.5	8.7	9.6	30.9	52.3	60.6	23.9	23.5	12.7	31.4	3.0	14.6	5.8	22.6	218.0	19.8	4.2	5.3	4.1	11.5	8.1	6.6	3.9	4.8	4.2	4.0	5.3	4.7	11.8	6.4	21.5	0.0	40.0	247.9	64.5	163.6	142.3	3.4	15.8	40.5	4.0	4.3	31.1	5.5	0.0	125.4	38.3	17.7	3.9	5.8	770.5	22.7	9.3	20.6	6.0	415.9	1.3	5.3	196.2	35.6	28.1	16.7	37.5	66.2	18.5	7.1	87.5	0.0	1.6	39.2	126.1	36.3	412.3	105.1	11.1	39.1	87.2	0.0	24.7	3.5	6.2	0.0	0.6	3.0	10.7	7.9	91.4	54.1	9.0	2.0	17.1	1.0	6.6	18.6	43.2	708.0	57.3	232.0	156.1	31.9	73.7	16.8	70.3	50.3
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
PYGM	GSD5	ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64759974	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	65	"skeletal muscle: 8468.3;tongue: 3594.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.7;Cardiomyocytes: 47.5;Late spermatids: 49.2;Peritubular cells: 44.0;Skeletal myocytes: 64.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 8.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.7;NB-4: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced					NA	NA		10000000	"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"			"HPA056003: AB_2683006"	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	15.2	3.0	35.4	2.1	30.1	1.2	7.7	55.5	29.4	5.8	15.5	25.5	1.5	10.4	6.4	92.2	14.6	3.8	70.8	26.8	26.1	2.4	1.2	2.7	2.2	48.8	30.4	4.0	1.6	0.3	1.7	1.4	39.6	25.6	3.6	2.9	50.0	26.3	8468.3	4.2	7.0	14.7	44.9	3.3	6.9	6.7	47.3	1.3	5.2	3594.2	1.2	16.7	5.2	38.1	0.1	0.0	0.7	0.1	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.6	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.3	0.4	0.1	3.7	0.2	0.2	0.1	0.0	0.0	1.1	0.7	0.6	0.0	1.1	0.7	2.2	0.7	0.1	0.1	0.4	0.7	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.4	0.4	0.3	0.4	0.3	0.0	0.4	0.1	0.0	1.0	1.4	0.4	0.0	0.1	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.3	0.0	0.2	0.2	0.1	35.4	30.1	55.5	29.4	26.8	26.1	48.8	30.4	39.6	44.9	47.3	38.1	2.4	0.0	2.3	29.7	3.0	0.8	0.6	0.2	5.2	3.5	2.9	4.7	47.5	0.0	0.8	0.0	4.2	0.6	1.9	1.0	0.0	0.1	11.7	1.6	5.2	2.0	0.0	0.0	0.2	0.0	0.2	5.1	1.1	4.0	0.0	0.8	1.8	0.0	0.5	0.0	0.2	0.9	0.0	0.6	1.3	49.2	16.4	2.3	0.0	1.0	0.5	9.9	4.1	0.5	0.4	0.3	0.2	44.0	0.3	1.3	0.6	0.0	0.1	1.3	6.6	64.3	12.8	1.2	0.9	2.5	0.6	0.1	2.9	0.9	1.1	0.3
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cell line enriched"	"Detected in some"	6	"U-698: 49.1"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"	2.3	0.6	0.2	8.3	0.3	5.5	1.2	0.2	0.4	1.0	0.4	1.7	1.6	1.1	0.8	0.8	0.9	3.8	0.6	0.3	0.4	0.7	3.2	3.7	23.1	0.7	0.3	0.8	0.3	0.2	0.3	0.9	0.6	1.0	2.1	0.1	1.6	0.5	0.3	0.5	5.4	0.7	0.2	13.9	2.7	0.4	0.5	3.7	1.4	0.6	12.5	3.3	0.8	1.2	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.9	0.0	49.1	0.0	7.7	0.0	1.5	0.3	0.4	97.3	0.4	56.3	14.8	40.8	74.7	0.3	8.7	13.5	45.1	3.5	36.8	0.5	0.6	67.3	21.0	0.2	0.3	0.2	0.4	0.3	0.4	0.7	0.3	0.6	0.2	0.5	1.2	1.3	12.8	2.8	1.0	17.0	0.4	0.6	0.0	0.0	0.5	1.2	0.9	0.6	0.0	2.0	3.7	0.0	0.1	165.9	0.1	0.0	0.1	0.3	0.5	0.3	1.2	0.0	7.4	0.5	0.0	0.0	2.7	2.6	0.2	2.5	0.1	3.9	1.2	2.7	0.0	0.5	0.0	0.0	5.0	1.5	0.3	0.0	3.5	1.8	6.5	2.3	0.5	324.4	0.0	0.2	0.0	0.0	0.0	37.9	0.6	0.0	0.6	5.3	1.1	0.0	0.7	0.7	0.1	0.2	0.1	0.6	0.1	104.7	0.0	0.2	0.4
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"intestine: 52.5"	"Cell type enriched"	"Detected in some"	96	"Enteroendocrine cells: 19377.2"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.9"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Low region specificity"	"Detected in single"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"	NA	NA	87100			"Cluster 9: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	1.7	0.2	1.4	0.3	0.1	0.4	0.2	0.7	0.3	0.1	52.5	2.5	0.4	0.4	0.0	0.4	0.0	0.0	0.3	0.3	1.4	0.2	0.2	0.3	0.3	0.3	0.0	0.6	0.2	0.0	0.0	0.4	0.3	36.6	0.8	0.1	0.8	0.1	0.1	41.6	0.1	0.1	0.1	0.5	1.1	0.4	0.3	0.5	0.1	0.1	0.0	0.0	0.5	0.1	0.2	0.2	0.4	0.3	0.6	0.0	0.4	0.1	0.5	0.3	0.5	0.3	0.2	0.6	0.5	0.4	0.2	0.4	0.1	0.3	1.2	0.2	0.7	0.2	0.0	0.4	0.2	2.9	0.8	0.1	0.5	0.2	0.6	0.1	0.3	0.2	0.5	0.4	0.6	0.2	0.4	0.6	0.4	0.2	0.1	0.1	0.0	0.8	0.0	0.4	0.1	0.3	0.0	0.7	0.3	0.5	0.0	0.5	0.6	0.5	0.1	0.4	0.0	0.5	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.7	0.3	0.3	0.3	0.3	0.4	0.1	0.4	0.5	0.1	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	65.0	1.9	0.0	1.0	7.9	1.3	0.1	19377.2	0.0	3.5	0.0	0.1	0.0	0.0	18.9	8.9	0.1	0.0	0.0	0.0	0.0	3.3	199.9	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	35.5	0.0	0.0	0.0	20.7	0.1	0.0	0.0	0.0	0.0	0.1	2.3	4.3	0.0	0.1	0.0	1.0	0.0	36.8	0.0
RAB19	RAB19B	ENSG00000146955	"RAB19, member RAS oncogene family"	A4D1S5	7	140404058-140427974	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.9"	"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HDLM-2: 5.4;MCF7: 3.3;RT4: 4.8;SK-BR-3: 4.6;T-47d: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA051077	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA051077: AB_2681336"	"unprognostic (3.40e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (1.73e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (6.09e-3)"	0.1	0.2	1.0	1.1	0.7	3.9	0.5	1.7	1.1	0.2	0.5	2.2	2.2	0.3	0.9	0.2	0.7	0.7	0.2	0.6	0.6	1.6	0.3	0.7	1.1	0.7	0.5	0.1	1.7	3.1	0.9	0.3	0.9	0.6	2.7	0.3	0.6	0.2	0.6	0.6	2.0	0.2	0.1	0.5	1.5	0.2	1.1	1.0	2.1	0.0	0.8	0.7	0.0	1.9	0.7	0.2	0.1	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	3.8	0.2	0.4	0.0	0.1	0.8	0.0	0.6	0.0	5.4	0.3	0.1	0.6	0.2	0.0	0.2	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.4	0.0	3.3	0.5	0.3	0.1	0.4	0.3	0.1	0.1	0.1	1.8	4.8	0.8	0.1	0.1	4.6	0.0	0.3	4.8	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.8	0.3	0.4	0.9	0.2	1.6	0.5	1.0	1.5	0.1	0.6	1.1	1.3	1.3	0.9	0.2	0.4	2.1	0.3	1.0	0.7	1.7	1.1	0.6	0.6	0.7	0.5	0.9	0.1	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561722	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 91.3;Hofbauer cells: 105.0;Kupffer cells: 92.1;Macrophages: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 60.9;SK-BR-3: 85.7;T-47d: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	31.1	55.4	5.7	21.7	5.5	25.3	23.4	5.6	7.9	11.7	9.6	20.7	27.6	6.9	4.8	4.6	11.5	18.0	21.4	5.2	7.0	26.1	51.4	30.7	16.4	7.0	6.0	20.5	24.2	6.2	9.7	22.8	6.8	12.1	14.3	2.6	10.7	5.0	5.8	4.6	25.3	7.6	6.6	44.5	28.6	10.6	7.4	3.9	22.0	2.3	5.1	20.6	6.7	8.4	20.1	2.9	1.9	3.8	12.4	3.3	31.3	1.7	6.2	8.1	12.5	47.9	39.9	0.0	13.9	1.7	10.8	7.5	3.8	12.3	4.2	22.5	3.0	19.8	3.6	22.6	7.8	2.8	5.7	6.9	2.0	4.2	1.2	6.3	3.1	3.3	3.8	0.0	1.8	24.0	0.1	29.0	4.0	60.9	8.5	1.9	0.1	9.0	14.2	26.3	0.5	2.1	3.8	85.7	27.4	6.2	54.4	30.5	2.3	2.0	4.2	0.2	2.7	0.1	0.0	0.2	27.7	38.9	4.2	7.8	35.5	7.1	1.0	33.3	1.3	3.5	2.8	0.9	15.8	2.8	6.5	2.3	26.3	0.0	26.6	0.8	0.9	11.2	5.7	5.5	5.6	7.9	5.2	7.0	7.0	6.0	6.8	6.6	7.4	8.4	18.6	19.2	20.4	4.2	10.6	4.5	10.9	14.1	10.8	0.2	12.8	13.0	5.0	48.6	16.2	25.8	0.0	34.6	1.8	31.1	31.3	60.3	1.6	20.7	2.6	10.3	18.0	0.0	0.4	67.9	91.3	11.5	15.3	23.2	21.0	41.1	53.6	34.5	105.0	0.0	0.4	23.9	28.5	92.1	19.9	1.6	3.7	100.5	7.2	8.4	16.2	7.4	0.0	4.5	0.1	36.4	17.2	6.4	0.4	8.0	48.1	68.9	20.4	2.0	13.1	6.2	26.2	1.0	13.2	1.9	3.0	20.0	3.6	7.2	24.0	11.1
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070504	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 423.3;skin 1: 210.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 249.6;Squamous epithelial cells: 300.6;Undifferentiated cells: 244.6;Urothelial cells: 232.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 120.9;CAPAN-2: 119.9;MCF7: 171.5;OE19: 392.3;RT4: 153.4;SK-BR-3: 243.3;T-47d: 227.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.6	0.1	0.1	10.2	0.1	0.1	52.0	0.3	0.3	76.2	0.0	86.2	72.9	7.3	37.5	423.3	47.5	26.4	0.1	0.0	0.0	41.6	1.7	39.2	0.4	0.1	0.1	0.4	57.1	68.9	27.5	12.4	0.1	36.3	78.1	0.0	105.3	28.4	0.9	210.0	65.6	3.7	0.2	0.2	80.9	0.3	0.1	10.1	50.6	0.0	44.0	69.9	148.2	0.3	93.3	0.0	0.0	0.0	0.0	0.0	120.9	0.0	0.0	0.0	0.0	90.4	119.9	0.0	0.1	0.0	0.0	109.5	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	105.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	171.5	0.0	0.4	4.8	392.3	0.0	0.1	0.0	0.3	0.0	153.4	13.3	0.0	0.0	243.3	0.3	21.1	227.9	0.4	0.0	0.2	0.2	0.0	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	1.2	28.9	41.0	0.0	1.5	55.1	102.9	113.9	74.0	0.0	121.4	137.7	0.1	94.4	98.7	86.5	0.0	102.1	2.3	197.8	166.3	170.4	0.0	58.6	6.4	2.6	85.4	0.0	0.1	150.3	30.0	2.3	96.4	66.2	5.7	0.0	0.0	0.4	7.3	0.0	0.1	208.5	89.5	0.0	5.8	0.0	0.3	2.1	21.4	0.0	3.6	0.0	0.0	0.0	0.1	197.3	249.6	0.0	0.3	114.0	195.9	35.5	66.3	0.0	0.0	0.0	6.8	0.2	1.1	300.6	154.7	80.3	2.7	0.0	244.6	232.3
RAB39B	"MRX72, WSN"	ENSG00000155961	"RAB39B, member RAS oncogene family"	Q96DA2	X	155258235-155264491	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Autism spectrum disorder, Disease variant, Mental retardation, Parkinson disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;retina: 9.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.8;Horizontal cells: 10.1;Inhibitory neurons: 9.8;Muller glia cells: 11.6;Oligodendrocytes: 10.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 27.8;Karpas-707: 35.6;U-266/70: 35.5;U-266/84: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001114, HPA042505"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA001114: AB_1079732, HPA042505: AB_2678030"	"prognostic favorable (8.95e-4)"	"unprognostic (1.20e-3)"	"unprognostic (3.52e-2)"	"unprognostic (7.10e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.00e-4)"	"unprognostic (1.78e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	0.2	1.9	6.5	2.8	6.7	0.9	0.7	6.8	10.7	0.4	3.0	0.7	0.6	0.3	6.4	0.3	0.5	0.6	0.3	7.0	7.0	0.7	0.3	0.6	5.3	6.4	6.1	0.4	2.5	3.8	6.5	0.2	6.9	1.9	0.6	9.9	0.4	1.3	0.0	0.0	1.2	0.2	6.1	3.1	1.3	0.9	7.0	5.3	2.4	0.0	5.9	0.8	0.1	8.2	0.0	0.4	5.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	27.8	1.2	0.1	14.9	0.0	0.0	0.2	0.1	11.8	0.5	2.3	0.0	0.0	1.7	0.0	4.8	0.1	0.0	0.4	7.8	0.9	0.0	10.3	0.0	35.6	0.1	2.1	10.3	0.0	6.9	0.0	0.6	0.0	0.0	2.3	0.0	0.0	13.4	10.3	0.0	0.0	6.4	1.8	0.4	0.2	0.0	0.7	2.2	0.0	1.1	35.5	26.7	6.2	6.2	0.0	0.0	0.8	0.3	2.2	4.6	0.2	4.7	4.2	6.0	6.0	4.6	2.8	6.1	6.9	2.7	3.3	0.4	1.1	4.8	3.2	6.5	6.7	6.8	10.7	7.0	7.0	6.4	6.1	6.9	6.1	7.0	8.2	0.9	0.0	0.0	2.6	7.9	0.5	0.5	0.0	0.0	11.8	0.6	0.9	2.4	0.0	0.0	1.8	8.4	0.0	7.6	0.0	0.0	0.2	0.2	0.0	0.7	0.8	1.8	3.0	7.7	0.9	0.0	0.7	1.1	0.1	0.0	2.6	1.8	0.0	0.1	10.1	9.8	0.0	0.0	0.3	3.1	0.0	0.0	1.5	3.6	1.0	2.2	11.6	6.2	8.0	10.3	0.4	0.0	1.9	9.2	0.6	0.0	0.9	0.0	8.0	0.0	0.1	2.4	0.4	0.8	0.0	0.1	0.0	9.1	8.2	0.0	0.0
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990700	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 31.0;pituitary gland: 10.6;prostate: 11.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Alveolar cells type 2: 103.2;Enteroendocrine cells: 293.8;Pancreatic endocrine cells: 92.8"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 125.8;BJ hTERT+: 48.4;fHDF/TERT166: 45.8;TIME: 97.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.0	3.0	11.3	0.6	8.6	0.2	0.7	2.9	14.9	0.0	0.0	1.6	0.7	0.1	0.2	0.0	0.2	1.3	0.0	10.9	23.0	0.5	0.7	0.0	0.1	11.4	17.5	1.5	1.0	0.0	10.6	1.6	31.0	11.0	2.3	1.7	0.2	0.1	0.5	1.9	0.9	0.3	2.3	0.1	1.2	0.3	19.5	0.2	0.0	0.0	0.1	0.1	0.1	3.4	1.8	8.5	1.2	1.3	0.2	2.3	0.2	125.8	48.4	24.8	12.0	10.4	3.7	0.6	2.0	45.8	3.6	0.1	15.4	13.0	41.7	0.0	1.1	0.1	0.6	3.4	2.1	0.0	0.1	1.1	0.4	41.1	9.4	15.4	7.8	1.1	0.4	0.4	27.9	0.3	0.1	0.1	19.9	2.4	1.2	0.3	0.2	0.2	4.0	0.8	4.3	1.1	0.1	0.3	0.1	24.6	0.2	0.3	97.9	24.0	8.8	0.5	41.5	0.2	0.6	0.4	21.9	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	11.3	8.6	2.9	14.9	10.9	23.0	11.4	17.5	31.0	2.3	19.5	3.4	1.4	147.4	103.2	0.3	1.1	2.4	6.2	0.3	0.0	5.0	2.2	3.4	0.7	12.8	27.9	0.0	2.1	0.5	0.4	2.0	3.9	4.0	2.4	1.5	1.3	8.2	293.8	0.0	6.6	18.4	0.3	13.9	3.6	1.4	7.6	27.9	0.7	2.7	0.3	0.0	48.1	14.7	14.2	1.3	1.2	1.3	0.6	3.7	1.8	1.0	1.0	31.2	1.0	1.5	1.5	92.8	1.4	1.2	2.3	18.8	1.4	0.2	29.5	3.7	0.0	4.1	4.8	10.4	4.3	0.0	1.4	4.0	3.3	1.1	1.6	2.7
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"	Q7Z6P3	6	36697826-36733184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"bone marrow: 58.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basophil: 10.6;eosinophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079390			Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Vesicles		"HPA079390: "	"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	0.5	0.0	0.0	0.6	0.1	58.9	0.4	0.0	0.1	0.4	0.0	0.4	0.6	0.3	0.2	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.5	0.9	0.4	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	30.9	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	10.6	0.8	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	4.4	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.3	0.3	0.2	0.0	0.3	0.0	0.5	14.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.1	0.0	0.1
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124978-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		480000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	133.5	118.1	91.7	113.7	99.2	203.5	119.4	97.4	107.9	90.9	77.1	106.9	135.7	103.1	67.3	92.3	87.3	88.6	69.7	89.0	101.9	145.9	99.7	120.1	94.6	98.5	98.1	82.4	76.4	102.6	48.7	106.8	98.5	70.6	86.3	40.5	84.5	84.3	46.7	91.5	124.1	97.6	96.7	116.4	118.0	41.7	104.3	87.1	109.7	54.6	79.2	115.1	83.0	100.6	169.5	311.3	96.2	140.1	210.7	144.8	184.7	201.6	212.5	273.9	238.1	223.5	163.5	81.5	172.9	254.4	194.8	231.8	179.1	197.9	175.7	104.9	232.6	124.8	120.6	326.1	206.4	165.8	195.6	187.3	204.7	208.1	144.6	143.1	292.6	110.2	145.8	123.6	189.7	154.7	170.3	148.6	95.2	294.7	0.9	110.0	165.2	139.4	209.0	246.1	53.6	136.2	103.7	651.5	220.6	149.5	288.7	159.9	276.6	279.8	155.0	237.9	218.5	113.0	157.1	104.1	185.1	127.6	290.4	56.9	119.7	129.5	45.7	103.4	40.6	42.8	44.5	46.2	83.4	43.6	36.5	37.2	194.5	56.8	110.0	55.1	56.0	99.2	91.7	99.2	97.4	107.9	89.0	101.9	98.5	98.1	98.5	96.7	104.3	100.6	185.1	6.4	9.7	23.5	83.7	111.3	89.6	139.6	62.0	51.0	86.8	80.0	5.4	77.2	66.3	106.7	12.5	189.6	95.3	198.8	252.4	207.0	63.7	43.5	51.3	146.6	78.6	64.6	12.0	173.8	210.6	81.8	78.0	51.1	44.4	59.1	165.2	63.9	443.6	38.7	12.6	115.2	142.4	204.1	213.8	100.4	108.7	171.2	158.3	24.4	207.5	105.7	133.9	18.6	21.2	247.2	189.9	155.7	64.3	105.0	243.3	408.8	33.7	43.1	131.5	57.5	137.3	28.9	60.8	74.8	130.8	274.9	83.0	65.0	99.9	145.1
RAB9B	RAB9L	ENSG00000123570	"RAB9B, member RAS oncogene family"	Q9NP90	X	103822327-103832257	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 21.3;Cardiomyocytes: 79.0;Excitatory neurons: 28.4;Inhibitory neurons: 18.7;Muller glia cells: 32.2;Oligodendrocyte precursor cells: 37.7;Peritubular cells: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 4.5;MOLT-4: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061932	Approved				"Intracellular and membrane"	NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA061932: AB_2684640"	"unprognostic (1.69e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.28e-5)"	"unprognostic (5.81e-2)"	"unprognostic (3.89e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.34e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.52e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.21e-4)"	"unprognostic (1.37e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	1.8	2.8	6.4	0.9	6.6	0.1	1.3	8.1	7.2	3.0	0.0	6.5	1.0	5.0	2.4	8.3	6.8	2.4	21.5	6.2	8.8	0.4	0.1	0.7	0.6	4.0	3.6	7.2	1.0	3.9	5.1	0.2	6.8	7.1	2.2	5.2	1.1	9.5	9.4	0.5	1.7	9.8	3.7	0.5	2.2	1.8	8.8	1.5	1.4	5.6	0.4	7.0	1.6	4.7	0.0	0.0	2.9	1.5	0.8	0.1	0.1	0.7	1.8	1.8	1.7	0.2	0.0	0.1	1.7	1.5	1.1	0.0	0.5	0.1	1.6	0.1	1.9	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.8	0.0	1.8	0.1	4.5	0.0	1.1	0.1	1.3	3.7	0.0	0.5	0.0	0.5	3.2	3.3	0.1	1.0	0.3	3.0	2.1	0.2	0.1	0.6	0.5	0.3	0.2	0.1	0.1	0.5	1.0	0.6	0.1	0.0	0.2	1.6	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.1	0.1	0.0	6.4	6.6	8.1	7.2	6.2	8.8	4.0	3.6	6.8	3.7	8.8	4.7	1.0	0.0	2.4	8.5	0.7	0.4	0.7	0.1	0.6	21.3	1.6	1.9	79.0	0.0	0.7	0.0	0.0	0.4	0.2	0.5	0.0	0.5	0.0	0.3	0.7	2.4	7.7	1.3	28.4	1.0	0.3	4.1	0.0	0.2	4.5	2.8	0.7	0.0	0.3	0.0	18.7	0.7	0.0	0.0	0.4	0.9	6.5	0.2	0.0	1.9	0.0	32.2	2.1	37.7	6.2	1.0	2.5	30.1	0.1	0.2	0.1	0.2	0.8	3.6	6.6	2.3	5.0	0.8	0.9	0.5	0.3	0.0	0.2	4.7	0.6	0.2
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.7;testis: 24.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 19.9"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010381, HPA039310"	Enhanced		Supported	"Nucleoli rim,Cytosol"		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoli rim"	Cytosol	"CAB010381: AB_2253533, HPA039310: AB_2676434"	"prognostic unfavorable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	0.9	0.6	0.4	5.5	0.5	10.5	1.9	1.7	0.7	1.0	0.6	8.3	3.2	1.2	0.4	4.2	0.7	1.3	0.6	0.4	0.5	0.5	1.3	1.1	11.0	0.4	0.3	0.6	1.4	0.5	0.2	6.8	0.5	0.8	9.1	0.3	1.0	0.3	1.0	3.1	4.1	2.4	0.1	2.4	1.8	24.3	0.3	15.7	0.6	0.5	13.3	1.7	1.5	0.5	33.8	16.1	33.4	16.3	4.4	7.8	31.1	54.9	16.5	43.3	43.8	35.4	22.1	20.4	26.8	20.9	18.9	67.7	56.6	22.1	42.3	39.0	22.2	47.7	28.2	30.4	0.4	37.9	28.5	1.7	2.9	30.0	13.5	6.4	22.5	48.5	59.6	55.8	36.6	28.5	54.4	43.6	35.2	69.2	19.0	61.0	49.0	30.7	15.4	45.3	15.4	27.0	23.6	41.4	8.5	39.2	27.0	39.4	9.9	32.8	22.2	48.7	27.2	12.0	65.1	59.8	16.3	78.0	33.5	1.3	0.6	1.7	2.4	1.3	0.6	1.7	2.5	3.2	1.0	1.1	0.6	1.2	1.2	1.8	1.4	0.9	5.9	1.2	0.4	0.5	1.7	0.7	0.4	0.5	0.4	0.3	0.5	0.1	0.3	0.5	0.0	0.0	0.0	0.3	1.9	3.6	1.5	2.0	0.0	0.8	0.1	0.0	0.9	0.0	1.0	0.0	0.0	35.3	1.4	3.0	0.0	0.0	5.7	0.2	0.2	1.0	0.0	16.0	1.6	0.0	67.2	1.3	2.0	0.2	0.0	0.6	2.2	0.2	12.7	0.0	1.2	5.3	2.0	1.6	1.7	5.3	0.6	0.5	0.0	1.0	0.3	0.3	2.1	0.5	0.6	0.1	5.0	0.7	8.2	0.9	1.0	0.0	0.1	0.0	0.0	0.5	0.9	53.6	24.8	3.9	1.6	25.3	1.2	0.1	8.0	2.1
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560047	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Meiosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.9;lymphoid tissue: 14.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 33.4;Erythroid cells: 47.8;Extravillous trophoblasts: 34.1;Hofbauer cells: 40.8;Late spermatids: 68.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	0.9	0.8	0.3	4.8	0.4	16.9	2.7	0.4	0.7	0.9	0.3	5.2	5.2	1.2	0.6	3.2	1.0	1.1	0.5	0.3	0.3	0.8	1.8	1.4	8.9	0.4	0.4	0.5	0.4	0.6	0.3	3.8	0.4	1.3	6.5	1.5	1.0	1.0	0.5	3.2	4.8	1.9	0.4	3.4	2.7	6.3	0.4	14.4	1.0	0.6	7.9	1.7	1.3	0.5	37.5	13.0	45.3	22.7	2.7	5.7	53.0	48.2	21.2	52.6	68.9	35.4	35.4	48.6	7.0	10.4	24.7	23.1	31.8	14.5	80.0	38.7	27.0	61.4	21.6	24.8	0.6	56.6	29.9	1.2	1.5	31.6	30.4	7.5	21.4	33.0	39.2	54.4	33.7	13.6	46.5	20.5	110.4	36.3	14.4	46.0	54.3	19.2	16.1	18.3	15.1	16.6	35.9	27.7	11.6	45.5	11.3	32.6	9.5	35.5	36.5	38.8	52.4	7.8	10.0	93.3	13.3	40.0	29.4	0.0	0.5	0.7	0.1	2.3	0.5	3.1	0.4	1.0	0.4	3.4	0.1	0.2	0.0	1.4	2.0	6.9	1.0	0.6	0.3	0.4	0.4	0.7	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.5	1.4	0.0	0.5	0.7	6.1	5.2	2.3	6.6	1.2	3.1	3.4	5.7	1.4	2.8	4.5	0.0	4.2	20.3	11.3	5.7	0.0	3.0	33.4	3.3	2.9	2.9	2.4	47.8	2.7	2.7	34.1	5.2	6.1	3.6	1.3	22.6	2.5	1.2	40.8	0.0	1.1	6.4	16.2	6.2	5.6	68.1	1.2	10.1	0.0	3.7	6.8	2.7	3.1	0.5	2.4	1.5	0.8	1.5	15.5	1.0	1.2	1.5	0.9	4.8	0.0	2.4	4.2	35.9	25.0	10.0	2.6	4.7	4.6	2.0	14.6	2.7
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RALGPS2	"FLJ10244, FLJ25604, KIAA0351"	ENSG00000116191	"Ral GEF with PH domain and SH3 binding motif 2"	Q86X27	1	178725147-178921841	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Alzheimer disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.2;testis: 77.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 263.1;Cone photoreceptor cells: 206.4;Late spermatids: 185.9;Rod photoreceptor cells: 397.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 26.7;naive B-cell: 21.0"	"Lineage enriched"	"Detected in many"	11	"B-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"U-266/84: 250.4;U-698: 194.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027143, HPA028328"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA027143: AB_10602071, HPA028328: AB_10601889"	"unprognostic (8.13e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.45e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.97e-2)"	5.5	8.5	3.5	24.0	5.0	13.2	8.1	4.9	4.6	6.5	3.3	13.4	11.5	9.4	5.4	16.3	8.0	8.1	4.6	7.1	5.8	6.7	32.0	2.8	52.4	3.0	2.4	18.3	5.7	7.8	2.9	9.2	2.6	7.3	12.1	52.5	5.4	5.5	1.4	19.6	16.4	11.8	3.4	28.3	13.7	77.0	5.5	15.2	6.8	4.8	56.2	12.6	7.6	2.1	39.9	12.7	38.7	0.4	42.3	61.6	15.2	34.0	74.8	27.1	24.3	15.1	38.3	83.7	11.2	100.8	13.5	32.2	17.2	8.6	35.4	0.1	10.3	0.0	8.7	14.6	7.1	11.1	0.4	27.5	7.5	35.1	24.6	18.8	23.7	15.3	20.6	3.1	17.8	6.3	17.0	3.5	26.5	15.3	13.4	23.5	39.9	0.7	9.3	24.9	6.0	17.2	22.2	24.5	48.4	26.3	29.3	5.6	17.9	12.4	11.8	45.4	16.4	91.8	250.4	194.3	7.2	5.7	14.2	0.8	0.1	2.4	0.3	0.1	0.3	26.7	0.2	0.1	0.4	21.0	0.7	0.2	1.3	0.4	0.1	0.8	0.0	1.1	3.5	5.0	4.9	4.6	7.1	5.8	3.0	2.4	2.6	3.4	5.5	2.1	5.4	12.8	6.9	29.4	263.1	14.8	16.3	5.4	14.8	97.4	27.9	15.1	17.5	15.7	8.7	14.7	206.4	7.5	11.6	39.5	21.5	15.2	123.0	23.3	25.6	4.9	35.9	22.7	84.0	12.0	10.1	18.7	48.9	33.0	8.8	60.3	2.9	55.2	6.3	13.5	92.3	22.5	0.0	8.5	4.8	185.9	50.1	7.3	8.8	41.2	5.1	27.8	10.3	107.5	4.0	31.0	52.4	46.6	105.2	26.0	22.7	9.7	23.9	397.3	19.7	41.5	18.6	146.6	34.8	29.1	34.1	3.3	10.3	20.7	15.6	72.0
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 144.6"	"Group enriched"	"Detected in many"	12	"Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"Karpas-707: 2.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075527: "	"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	86.9	32.6	17.7	23.0	19.7	0.2	71.7	26.9	22.7	33.5	21.3	24.4	10.2	25.9	3.9	18.9	22.8	28.7	91.3	19.2	25.8	84.1	23.9	144.6	55.0	37.3	25.7	7.4	19.7	28.1	22.3	8.6	34.2	29.7	8.6	1.1	22.1	12.9	19.3	22.8	30.0	24.4	31.6	11.4	25.7	6.3	23.5	7.3	71.9	26.9	30.3	28.5	30.5	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	17.7	19.7	26.9	22.7	19.2	25.8	37.3	25.7	34.2	31.6	23.5	42.4	287.8	0.0	1.9	0.3	3.6	16.3	0.3	0.0	2.2	0.6	5.9	2.8	8.7	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	20.8	0.4	7.3	366.0	0.0	13.5	3.5	0.7	0.1	10.7	0.0	0.2	0.0	0.0	555.4	7.3	0.5	0.0	0.2	0.0	0.0	31.2	19.1	6.7	1.2	1.3	26.6	5.6	0.0	0.2	0.0	0.0	6.5	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.5	0.0	2.8	4.9	0.3	0.9	0.9	14.5	0.0	1.7	1.5	0.0	0.5
RAPGEF3	"bcm910, cAMP-GEFI, EPAC"	ENSG00000079337	"Rap guanine nucleotide exchange factor 3"	O95398	12	47734363-47771040	"Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 130.6;Astrocytes: 143.0;Collecting duct cells: 69.9;Endothelial cells: 53.0;Oligodendrocytes: 45.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.9;HUVEC TERT2: 12.1;NB-4: 14.3;RPTEC TERT1: 13.3;TIME: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004386, HPA040365, HPA043518"	Approved		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Endoplasmic reticulum"	"CAB004386: AB_627521, HPA040365: AB_2676941, HPA043518: AB_2678524"	"unprognostic (2.12e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (6.67e-7)"	"unprognostic (9.16e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.61e-3)"	"unprognostic (3.38e-2)"	44.6	2.8	29.2	2.6	35.0	1.4	44.0	30.3	29.2	26.0	12.5	9.9	4.0	16.4	6.9	13.2	24.1	13.2	21.1	31.4	21.3	40.0	1.9	11.9	4.4	33.6	29.6	38.2	4.7	5.8	6.4	8.9	28.0	13.5	2.4	0.9	21.2	11.0	11.4	9.8	8.8	5.1	22.4	16.2	11.5	3.5	28.9	1.6	32.4	9.0	2.1	14.9	21.3	39.7	2.3	0.6	0.7	2.4	0.3	2.3	0.9	1.7	1.5	0.7	0.4	0.3	6.1	0.1	26.9	3.0	1.1	2.4	0.8	4.5	0.3	3.0	0.4	0.2	2.6	0.2	0.2	0.4	0.3	0.9	0.3	1.3	0.8	3.4	12.1	0.6	0.1	2.9	0.5	1.5	0.0	14.3	0.6	1.0	3.7	0.4	0.1	1.0	13.3	2.5	0.2	0.3	0.2	1.7	0.4	0.8	6.7	0.6	12.0	6.6	1.1	1.5	0.6	1.0	0.4	0.2	4.1	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	35.0	30.3	29.2	31.4	21.3	33.6	29.6	28.0	22.4	28.9	39.7	130.6	0.0	11.7	143.0	0.7	2.7	5.8	2.6	13.1	0.5	4.5	4.8	15.7	2.8	3.6	69.9	0.0	0.2	1.4	1.7	7.9	1.1	1.6	11.8	2.4	53.0	0.0	0.0	1.5	0.7	0.4	6.3	18.3	21.2	3.8	1.5	20.7	0.2	0.9	0.0	2.9	6.6	4.1	0.6	2.6	3.7	24.2	1.5	5.4	12.2	0.0	1.5	2.1	10.6	45.7	5.8	6.3	8.6	4.4	11.6	0.8	41.3	1.9	0.5	6.6	2.7	5.1	1.2	1.6	1.4	3.3	0.3	1.3	6.6	0.8	17.2
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 142.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 441.1;Inhibitory neurons: 416.6;Microglial cells: 142.4;Oligodendrocyte precursor cells: 303.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.5;SCLC-21H: 8.3;U-266/70: 11.0;U-266/84: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	5.3	45.6	105.0	1.8	113.1	0.2	6.8	69.8	141.6	6.1	49.1	2.1	2.4	5.6	3.1	2.6	3.4	4.7	7.5	142.3	77.7	5.3	34.6	11.4	2.0	61.2	75.0	13.1	4.5	4.0	6.2	2.6	60.8	4.1	1.6	18.8	2.4	3.3	1.5	14.9	2.3	5.4	55.7	0.6	7.7	4.7	128.3	2.2	5.5	1.7	2.0	5.3	3.2	121.9	0.1	0.2	3.2	0.5	0.1	0.3	0.1	1.1	0.7	0.1	0.3	0.0	3.7	0.0	0.2	0.0	0.2	0.7	2.8	0.7	0.3	0.2	5.9	0.6	2.8	0.0	0.0	3.2	0.9	0.1	0.9	0.0	0.0	3.2	3.5	1.6	0.0	21.5	0.1	0.1	0.2	0.2	0.4	1.8	0.4	0.1	0.7	0.0	0.0	6.6	8.3	3.0	0.1	0.1	1.1	1.6	0.1	0.1	1.0	0.1	0.3	0.0	0.3	11.0	23.0	0.0	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.0	113.1	69.8	141.6	142.3	77.7	61.2	75.0	60.8	55.7	128.3	121.9	14.7	3.2	2.8	23.2	1.9	6.1	1.1	0.1	2.8	3.5	5.5	3.9	6.9	0.0	0.0	0.0	45.9	0.1	0.1	0.0	0.0	1.7	2.5	1.2	0.2	32.4	7.8	0.0	441.1	2.7	0.1	4.8	3.1	0.9	0.0	3.3	23.9	11.8	0.1	1.7	416.6	0.5	0.0	1.2	2.1	1.4	4.4	0.2	3.6	142.4	0.0	1.3	0.0	303.1	28.4	1.5	0.1	1.5	1.6	0.5	0.0	0.0	0.0	9.2	0.0	0.4	1.2	0.7	4.1	1.6	3.8	0.1	0.6	4.2	0.1	0.7
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 199.1;skin 1: 237.7;vagina: 113.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 87.7;Excitatory neurons: 47.8;Proximal enterocytes: 55.3;Squamous epithelial cells: 95.4;Suprabasal keratinocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"HaCaT: 92.4;hTCEpi: 45.8;T-47d: 80.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Microtubules"	"Cytokinetic bridge"	"HPA022895: AB_1856071"	"prognostic favorable (8.43e-4)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	6.3	4.4	38.4	6.8	36.1	4.4	9.1	12.1	58.3	48.7	1.8	53.8	48.3	4.6	9.9	199.1	6.6	8.8	6.8	55.1	12.9	3.8	10.5	8.0	2.2	12.0	11.4	3.7	7.9	1.1	14.2	2.3	10.9	17.7	44.5	6.1	27.4	6.9	12.6	237.7	40.6	4.0	8.3	7.3	31.8	10.2	15.2	3.3	4.5	2.8	20.7	21.9	113.2	30.6	5.3	2.6	13.7	10.2	1.5	3.3	6.6	1.9	1.4	2.7	3.2	6.0	7.6	4.2	1.9	2.7	2.4	92.4	2.7	3.3	3.8	7.7	6.9	2.5	3.6	6.0	1.7	5.2	8.5	3.9	45.8	2.8	1.3	4.0	4.1	13.9	1.9	2.8	2.1	14.6	4.9	6.3	4.3	26.1	2.6	8.8	1.6	2.6	1.7	27.6	26.2	5.3	3.3	31.2	1.3	11.5	80.7	3.9	7.9	3.3	6.8	3.5	3.2	4.6	4.7	3.4	7.8	3.2	4.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	38.4	36.1	12.1	58.3	55.1	12.9	12.0	11.4	10.9	8.3	15.2	30.6	1.9	0.0	1.1	7.5	1.0	45.5	9.7	14.0	13.1	5.7	2.6	3.7	2.4	11.5	10.9	1.8	6.2	0.2	0.7	87.7	0.0	0.9	2.7	5.9	2.1	2.2	4.9	2.7	47.8	0.8	0.3	1.4	32.6	9.4	5.7	1.7	3.9	4.4	0.5	1.7	32.1	31.9	6.1	1.2	5.2	2.2	3.4	1.9	5.4	1.0	2.4	2.9	1.0	8.0	5.0	1.6	44.6	3.8	0.1	10.9	55.3	0.1	6.5	4.4	0.0	2.1	1.9	12.0	15.0	95.4	97.0	0.7	1.1	1.8	44.1	39.2
RAPSN	"CMS1D, CMS1E, RNF205"	ENSG00000165917	"Receptor associated protein of the synapse"	Q13702	11	47437764-47449143	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 88.9;tongue: 33.1"	"Cell type enriched"	"Detected in some"	4	"Skeletal myocytes: 63.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 238.7"	"Low region specificity"	"Detected in some"							HPA039475	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Centrosome, Cytosol"		"HPA039475: AB_10794196"	"unprognostic (5.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.64e-4)"	"unprognostic (3.83e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.48e-2)"	0.3	1.5	0.5	0.2	0.5	0.3	0.2	0.3	1.2	0.2	0.9	0.8	0.1	0.0	0.1	1.2	0.1	0.1	2.6	0.5	0.5	0.3	0.5	0.4	0.2	0.3	0.5	0.0	0.2	0.0	0.1	2.1	0.5	0.7	0.0	0.1	1.3	0.0	88.9	0.5	0.5	0.1	0.4	0.6	0.2	0.3	0.6	0.1	0.2	33.1	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.2	0.7	0.1	0.2	1.2	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	238.7	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.3	0.1	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.2	0.5	0.5	0.3	0.5	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.3	1.4	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	2.7	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.5	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.3	13.8	0.0	0.5	0.0	0.0	0.6	1.3	0.0	0.5	0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	63.8	0.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.2	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RASEF	"FLJ31614, RAB45"	ENSG00000165105	"RAS and EF-hand domain containing"	Q8IZ41	9	82979590-83063177	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 41.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 101.7;Gastric mucus-secreting cells: 356.8;Prostatic glandular cells: 106.4;Respiratory ciliated cells: 100.6;Urothelial cells: 107.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 53.2;RT4: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021431, HPA078596"	Approved		Uncertain	Microtubules		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"	Microtubules		"HPA021431: AB_1856087, HPA078596: "	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	1.1	1.6	16.2	2.8	15.4	3.6	17.6	21.2	21.9	2.9	18.0	15.2	6.3	2.7	10.2	7.1	6.3	12.6	1.1	13.9	9.2	5.3	2.4	8.2	1.5	10.0	6.3	1.5	23.1	5.3	3.9	3.4	9.8	15.2	15.2	5.1	15.3	3.8	1.9	3.8	8.6	1.1	1.0	1.5	41.0	4.0	9.8	3.4	25.9	0.0	3.5	13.8	2.3	24.7	14.0	15.5	1.8	1.5	0.3	0.5	5.6	1.0	0.2	1.6	3.9	8.7	16.9	2.3	13.7	0.4	11.0	16.3	0.3	0.4	1.9	1.4	17.3	1.9	11.9	2.2	0.2	1.7	1.6	0.3	6.7	7.6	0.2	2.1	0.1	2.4	2.5	16.8	0.2	27.2	2.3	1.8	10.5	53.2	6.1	2.5	4.8	6.0	18.0	38.5	5.6	8.3	2.8	26.8	1.1	6.7	22.9	2.0	2.6	2.6	14.6	2.1	1.7	11.3	10.1	1.4	5.8	1.0	3.0	6.5	2.0	1.9	3.7	1.4	3.5	3.9	3.5	2.9	1.1	5.3	3.8	3.3	9.8	3.6	1.6	3.8	2.9	0.7	16.2	15.4	21.2	21.9	13.9	9.2	10.0	6.3	9.8	1.0	9.8	24.7	0.7	76.9	101.7	0.3	1.1	0.8	5.4	7.9	4.0	1.1	61.3	21.1	0.6	42.9	59.7	9.2	4.2	5.5	0.5	61.8	7.9	35.4	0.6	39.7	7.9	4.5	3.6	0.8	1.0	37.4	10.3	5.7	356.8	88.2	22.1	0.4	0.7	1.7	0.8	0.0	0.6	85.7	48.8	0.0	0.4	2.1	0.3	4.2	1.8	4.7	1.6	0.1	0.0	0.0	0.2	46.2	40.0	0.0	1.5	106.4	10.4	8.3	100.6	1.3	0.0	0.7	2.8	0.5	4.8	28.2	0.9	7.5	3.1	1.2	35.7	107.7
RASGEF1C	FLJ35841	ENSG00000146090	"RasGEF domain family member 1C"	Q8N431	5	180100795-180209211	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.9;testis: 5.8"	"Cell type enriched"	"Detected in some"	9	"Microglial cells: 188.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;HEK 293: 1.7;MCF7: 2.2;SCLC-21H: 7.6;U-2 OS: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028242	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA028242: AB_10602294"	"unprognostic (2.21e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.75e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-4)"	"unprognostic (5.89e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-2)"	0.3	0.2	6.2	0.2	16.4	0.0	0.4	21.9	8.5	1.3	0.0	3.4	0.1	0.0	0.1	0.3	0.5	0.3	1.3	7.1	3.2	0.2	0.0	0.0	0.0	7.3	4.4	0.1	0.1	0.0	0.1	0.1	7.5	0.9	0.2	0.3	1.1	0.9	0.0	0.5	0.8	0.1	5.2	0.0	0.7	5.8	4.1	0.0	1.1	0.0	0.0	0.7	1.1	7.6	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	16.4	21.9	8.5	7.1	3.2	7.3	4.4	7.5	5.2	4.1	7.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	1.8	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.5	0.0	0.0	20.2	0.0	0.6	0.1	0.0	0.5	0.0	1.5	0.0	0.0	0.1	0.0	12.5	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	188.3	0.0	0.2	0.0	15.1	19.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.7	1.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;lymphoid tissue: 45.7;retina: 29.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 71.4;Excitatory neurons: 54.1;Muller glia cells: 86.9;Plasma cells: 43.0;T-cells: 84.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 10.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 10.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 54.5;JURKAT: 70.2;MOLT-4: 52.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.1	0.8	6.7	10.5	16.8	8.5	1.7	23.7	13.2	0.8	0.0	1.4	2.4	1.4	0.4	5.9	4.4	2.5	1.2	11.6	3.3	5.5	1.1	4.1	21.4	15.3	2.5	0.4	1.8	0.5	0.5	0.9	17.9	0.7	2.1	29.7	1.7	0.7	0.4	6.9	3.6	0.6	0.0	8.9	4.5	2.0	8.8	45.7	0.6	0.7	16.4	3.4	2.0	9.2	0.0	0.4	1.0	0.3	0.0	0.0	0.1	4.1	1.2	2.0	1.7	4.5	0.0	11.6	0.9	0.1	0.2	0.2	2.4	0.0	1.9	54.5	2.2	0.9	0.5	0.0	0.6	0.5	0.8	0.0	0.1	1.1	0.0	0.0	0.0	70.2	0.5	3.6	0.0	1.7	52.3	0.1	0.7	0.0	0.0	14.4	0.3	0.0	2.0	0.1	4.7	1.7	2.6	0.1	0.2	1.5	1.2	0.0	0.2	0.4	1.6	5.6	0.8	8.7	4.6	13.6	0.2	0.1	0.6	0.0	0.0	0.9	5.2	0.0	3.7	1.1	5.7	5.2	0.0	0.6	5.2	5.3	0.2	2.4	0.0	0.0	10.3	1.4	6.7	16.8	23.7	13.2	11.6	3.3	15.3	2.5	17.9	0.0	8.8	9.2	0.9	6.4	10.7	6.5	26.5	2.4	0.4	6.8	4.6	9.6	3.4	2.0	4.5	5.7	2.7	33.1	10.4	0.3	71.4	0.1	3.9	18.4	1.5	7.6	1.6	0.8	0.0	0.0	54.1	10.0	0.2	1.2	1.1	6.6	3.8	0.4	1.1	0.5	0.7	6.7	16.5	1.3	0.0	0.8	6.1	0.7	0.0	3.0	7.2	9.4	3.0	86.9	34.0	2.5	3.9	34.1	0.0	0.0	43.0	0.7	0.3	7.8	0.4	21.3	0.0	1.9	1.3	1.2	3.8	4.0	8.2	0.0	84.7	0.3	0.9	0.5
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 20.8;lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 18.1;granulocytes: 26.6;Hofbauer cells: 15.1;Kupffer cells: 32.9;Langerhans cells: 11.6;Macrophages: 19.1;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 39.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 25.7;HMC-1: 24.0;U-937: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	3.2	0.8	0.3	6.7	0.3	20.8	0.7	0.3	0.9	1.1	0.4	1.2	1.2	0.5	0.1	1.0	1.0	1.9	0.6	0.2	0.3	0.3	0.7	3.3	1.1	0.9	0.4	0.4	1.1	0.3	0.2	2.3	0.6	0.5	0.8	0.0	0.4	0.5	0.8	0.5	1.8	2.0	0.7	8.9	0.9	0.2	1.1	1.1	0.2	1.4	0.7	2.5	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.7	0.0	0.0	0.0	0.1	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	12.5	13.5	20.1	0.0	15.4	0.0	0.1	0.3	0.0	9.4	0.1	0.0	0.0	39.4	0.0	17.9	0.7	1.4	4.4	0.3	0.3	0.3	0.9	0.2	0.3	0.9	0.4	0.6	0.7	1.1	1.0	0.2	0.0	0.6	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.3	18.1	0.0	1.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.7	0.0	0.2	0.4	0.0	0.0	26.6	0.0	1.4	0.0	15.1	0.0	0.4	0.0	0.0	32.9	11.6	0.0	0.0	19.1	1.8	0.0	25.7	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.1
RASIP1	"FLJ20401, RAIN"	ENSG00000105538	"Ras interacting protein 1"	Q5U651	19	48720585-48740610	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 121.8;Endothelial cells: 83.9;Hepatic stellate cells: 94.2;Theca cells: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 14.7;HeLa: 13.9;HUVEC TERT2: 38.5;SiHa: 21.1;TIME: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077251	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA077251: AB_2732337"	"unprognostic (9.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (7.17e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.46e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	24.4	7.0	5.9	2.6	4.3	0.7	21.0	4.4	4.6	9.2	1.4	5.6	2.5	11.2	1.1	5.1	9.9	3.8	18.8	3.6	4.0	12.6	2.6	27.9	2.2	4.9	5.3	4.9	13.2	1.6	4.1	7.9	5.9	5.5	0.7	0.1	4.8	2.7	7.7	6.0	5.7	4.2	4.5	16.8	10.3	6.8	7.3	1.5	10.5	4.0	1.4	7.6	7.7	3.6	10.2	0.1	0.2	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.6	1.1	0.8	2.2	0.0	0.0	2.5	0.2	2.2	0.0	0.0	14.7	0.2	13.9	0.4	2.2	0.0	0.7	2.2	1.2	0.0	0.0	0.0	38.5	1.3	1.3	0.1	0.0	0.9	0.0	1.3	0.3	0.4	0.0	0.2	0.0	0.4	0.0	0.8	6.7	0.5	21.1	0.0	0.0	0.1	0.1	0.0	52.4	0.0	0.4	0.2	0.0	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	4.3	4.4	4.6	3.6	4.0	4.9	5.3	5.9	4.5	7.3	3.6	121.8	0.0	1.3	0.0	1.2	6.5	5.7	2.0	0.6	1.1	5.9	10.8	7.3	1.5	1.2	1.8	0.0	0.4	0.7	0.1	0.0	0.7	5.9	3.2	4.8	83.9	0.0	2.7	3.4	0.7	1.9	9.5	2.0	3.8	0.0	6.0	94.2	1.9	0.7	6.7	1.1	0.1	4.1	6.3	3.0	5.2	10.2	1.0	19.6	16.9	0.0	2.1	0.0	1.5	1.5	0.8	0.0	11.3	1.4	10.1	0.2	0.3	2.1	0.7	19.7	1.9	6.2	1.0	11.0	3.7	6.0	0.3	1.0	40.2	0.2	6.4
RASSF6		ENSG00000169435	"Ras association domain family member 6"	Q6ZTQ3	4	73571550-73620631	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.6;stomach 1: 34.9"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 120.3;Gastric mucus-secreting cells: 171.8;Ionocytes: 103.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 2.7"	"Lineage enriched"	"Detected in single"	13	"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.0;hTERT-HME1: 21.5;RPTEC TERT1: 23.5;RT4: 70.2;U-266/70: 20.2;U-698: 61.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA037712	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA037712: AB_2675625"	"unprognostic (9.08e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.09e-3)"		"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.03e-2)"	0.2	0.1	0.0	4.9	0.0	0.1	8.4	0.0	0.2	2.3	5.0	11.9	9.8	0.5	2.8	1.9	2.7	4.4	0.0	0.1	0.2	6.0	2.2	1.3	5.7	0.0	0.8	1.3	16.6	0.7	0.4	7.4	0.0	5.7	12.7	1.6	3.5	3.7	0.0	5.3	12.3	0.3	0.0	0.2	34.9	0.1	0.7	30.6	5.7	0.4	6.9	9.2	1.8	0.1	0.3	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.2	12.0	76.0	1.1	0.0	0.3	3.8	0.0	6.0	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	5.8	0.0	21.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	11.1	0.2	0.0	0.1	0.5	23.5	70.2	2.8	0.0	0.2	1.8	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	20.2	0.1	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.8	0.0	0.0	0.7	0.1	0.3	12.8	5.1	0.0	25.0	9.8	38.5	70.5	18.8	0.1	25.1	42.2	1.2	21.5	37.7	7.3	0.0	55.7	0.1	81.1	17.6	18.2	0.3	45.4	2.0	0.8	120.3	0.4	0.3	80.9	23.0	1.7	171.8	22.8	1.3	2.2	0.4	4.0	4.4	0.0	0.1	57.9	103.7	0.3	1.0	0.0	0.0	1.2	1.8	0.0	0.6	18.7	0.0	0.0	0.3	67.1	65.8	0.0	21.3	24.6	30.1	37.8	29.8	0.5	0.0	0.0	1.6	0.0	0.2	11.9	1.4	47.2	3.5	0.7	23.2	60.5
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870362	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 440.4;Syncytiotrophoblasts: 532.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	47.1	280.4	28.9	57.0	35.7	99.8	63.8	27.7	39.8	133.1	40.1	73.0	55.0	90.5	293.7	67.1	96.3	49.8	86.5	32.0	31.0	60.9	56.7	42.9	89.8	29.4	25.9	132.8	46.8	194.2	42.5	96.4	28.8	81.9	73.0	61.4	62.1	166.4	132.8	61.2	57.2	101.0	30.1	47.7	64.4	94.5	27.4	88.7	57.9	90.0	106.5	67.9	51.7	34.2	298.0	219.5	159.5	212.2	99.8	116.6	103.0	143.7	144.7	207.7	233.9	128.6	190.4	328.0	215.2	141.6	236.3	153.1	291.5	214.4	275.2	186.2	400.6	138.9	247.7	153.1	83.8	212.1	160.3	91.3	77.8	240.6	174.9	133.3	211.9	134.6	141.5	167.2	166.9	200.2	236.1	194.0	181.7	141.5	199.5	204.3	295.3	386.7	151.9	197.6	149.3	110.7	271.9	128.3	133.9	225.8	426.8	126.5	99.0	99.5	102.1	265.7	162.8	116.6	178.6	429.3	127.7	140.8	123.3	50.9	45.3	62.3	85.1	79.5	82.6	92.0	70.6	89.4	63.6	80.0	73.3	82.9	18.2	89.2	111.7	74.1	72.1	77.2	28.9	35.7	27.7	39.8	32.0	31.0	29.4	25.9	28.8	30.1	27.4	34.2	52.0	51.3	65.0	18.6	69.5	74.8	105.7	98.0	33.6	31.4	53.5	51.1	105.1	42.9	80.8	55.2	29.2	440.4	89.8	41.9	78.2	87.3	14.5	55.0	58.0	50.7	60.7	70.2	26.6	74.3	170.8	87.7	44.9	54.8	57.7	101.8	41.4	36.4	109.3	25.2	20.7	57.4	81.4	33.5	39.6	31.2	113.7	43.7	83.6	16.9	60.4	79.4	72.1	46.3	24.7	75.7	39.0	187.3	89.6	75.3	48.6	64.2	63.8	43.6	138.1	73.8	134.3	109.9	121.1	52.5	61.1	532.2	67.8	81.9	79.3	74.2
RBBP8NL	"C20orf151, dJ908M14.3"	ENSG00000130701	"RBBP8 N-terminal like"	Q8NC74	20	62410237-62427539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 51.2;Intestinal goblet cells: 58.0;Paneth cells: 54.5;Proximal enterocytes: 157.4;Undifferentiated cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.6;CACO-2: 27.5;MCF7: 11.5;SK-BR-3: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (8.99e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.18e-1)"		"unprognostic (1.86e-2)"		"unprognostic (1.27e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.76e-1)"		"unprognostic (2.15e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.91e-4)"	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.3	1.5	0.0	1.7	4.5	0.1	0.7	9.1	0.7	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	2.1	1.9	2.0	0.4	0.0	3.8	0.6	0.0	4.4	1.0	0.0	4.7	4.7	0.0	0.0	0.0	2.7	2.9	0.0	0.0	3.6	0.0	0.3	1.7	3.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	27.5	2.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	12.5	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	1.3	0.3	0.0	0.0	3.3	2.2	2.7	7.2	1.7	1.8	0.0	6.0	0.0	51.2	0.0	0.3	13.4	1.0	0.0	0.0	9.6	0.0	0.4	0.2	5.1	0.2	2.0	1.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	58.0	2.0	0.0	0.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	54.5	0.0	0.0	0.7	157.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	2.6	0.1	0.0	26.2	1.0
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 443.5;liver: 324.2"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	6.4	11.7	0.0	15.0	0.1	1.6	5.1	0.3	0.3	11.2	0.2	8.5	4.6	8.6	3.2	3.8	8.1	5.9	1.4	0.0	0.0	443.5	324.2	3.8	31.2	0.5	0.3	4.9	5.2	1.3	6.2	0.3	0.3	10.0	4.9	0.8	3.7	5.0	0.7	2.4	20.6	5.4	0.0	97.1	5.2	2.2	0.2	14.2	7.9	0.0	21.4	7.4	4.6	0.0	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.5	0.3	0.3	0.0	0.2	0.0	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
RBP7	CRBPIV	ENSG00000162444	"Retinol binding protein 7"	Q96R05	1	9997206-10016021	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 401.0;breast: 394.6"	"Cell type enriched"	"Detected in many"	7	"Adipocytes: 3631.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 311.5;neutrophil: 344.7"	"Group enriched"	"Detected in many"	31	"granulocytes: 344.7;monocytes: 311.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;SK-MEL-30: 9.8;T-47d: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA034749	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Cytosol"		"HPA034749: AB_10602084"	"unprognostic (1.93e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (9.59e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.90e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.61e-2)"	401.0	15.0	20.7	8.9	27.0	28.6	394.6	23.8	38.3	22.6	23.4	15.0	2.6	20.4	4.2	34.4	14.7	51.6	86.6	20.4	22.4	72.9	9.6	8.8	8.3	23.7	24.0	12.7	11.9	68.9	16.7	15.9	23.7	18.6	4.4	5.0	22.3	8.1	16.0	35.4	11.5	14.9	23.5	112.1	17.2	9.2	22.4	12.6	36.2	24.9	5.6	23.6	27.9	36.4	0.0	0.6	0.3	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.9	2.5	3.2	0.0	13.0	1.3	0.0	0.0	0.1	1.0	4.4	0.0	2.8	0.0	0.1	1.3	1.6	0.0	0.0	0.0	2.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	3.4	0.0	0.0	0.0	0.7	0.0	0.2	0.5	2.6	0.2	9.8	3.5	34.8	2.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	311.5	2.8	0.4	138.4	0.2	0.1	0.0	0.1	10.6	0.2	0.2	0.1	344.7	0.0	68.3	2.0	0.7	96.8	20.7	27.0	23.8	38.3	20.4	22.4	23.7	24.0	23.7	23.5	22.4	36.4	3631.8	0.0	1.3	0.7	9.5	20.6	9.5	2.6	9.1	0.2	43.0	73.9	22.9	10.0	1.2	1.8	0.0	5.0	16.2	0.1	23.5	2.0	3.2	2.5	15.8	349.2	0.0	5.7	0.4	2.8	1.9	36.1	0.0	4.8	3.8	7.1	69.7	3.7	63.7	0.0	0.4	0.4	2.0	502.5	14.1	6.1	6.2	42.5	21.4	1.0	149.7	2.1	3.1	0.0	13.4	2.7	0.1	0.7	2.7	20.7	0.0	1.4	0.9	1.5	0.0	3.9	20.5	1.8	2.8	26.2	17.6	6.2	3.8	3.6	0.6	6.3
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739891-64775589	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 300.8;intestine: 147.2"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 215.3"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 37.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 39.0;AN3-CA: 55.4;HEL: 86.2;NTERA-2: 76.4;SuSa: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	20.0	4.9	5.2	6.7	6.1	1.6	12.5	2.7	4.7	18.4	14.7	147.2	6.0	53.1	7.5	20.3	30.8	9.9	300.8	3.7	4.3	17.8	13.9	7.6	1.0	3.3	5.0	10.6	2.7	16.5	4.1	7.7	3.0	27.5	8.1	2.0	2.5	45.8	5.6	4.9	30.2	37.6	2.9	4.4	51.9	6.4	12.6	2.5	13.8	4.9	0.6	94.0	14.4	3.2	0.0	6.3	39.0	55.4	0.0	0.0	5.9	1.2	0.2	7.0	1.6	4.9	0.5	0.0	5.2	1.1	6.5	0.0	28.8	0.0	2.6	0.0	9.0	86.2	9.5	9.9	3.7	0.0	0.7	0.1	0.0	4.4	0.0	1.5	0.7	1.9	0.5	0.0	0.5	2.9	0.0	0.3	76.4	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	13.5	8.5	0.1	1.6	86.5	7.9	0.3	0.0	0.0	28.4	3.7	3.7	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	5.2	6.1	2.7	4.7	3.7	4.3	3.3	5.0	3.0	2.9	12.6	3.2	3.1	0.0	0.0	0.0	1.1	0.8	0.3	0.0	0.6	0.3	0.5	0.5	215.3	0.0	0.0	3.7	0.0	0.6	2.0	0.0	9.8	0.4	4.7	0.4	3.4	6.4	0.0	7.4	0.3	1.6	1.1	11.1	5.1	0.7	0.0	0.9	2.9	8.5	0.3	0.0	0.2	0.0	0.0	1.3	1.3	1.0	3.7	10.4	1.8	1.0	0.2	3.3	9.2	0.0	0.0	1.2	0.0	6.4	0.0	1.5	0.0	31.0	0.0	1.7	46.0	1.7	51.0	0.8	14.1	0.3	1.1	3.1	0.7	1.0	0.0	0.2
RCSD1	"CapZIP, MGC21854, MK2S4"	ENSG00000198771	"RCSD domain containing 1"	Q6JBY9	1	167630093-167708696	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 115.5;skeletal muscle: 147.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 258.0;Kupffer cells: 137.5;Macrophages: 80.7;Microglial cells: 78.7;monocytes: 121.6;NK-cells: 142.2;Sertoli cells: 78.9;T-cells: 97.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 195.2;HDLM-2: 91.0;REH: 224.0;RPMI-8226: 139.7;THP-1: 103.4;U-266/70: 132.0;U-698: 132.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016597, HPA073490"	Enhanced		Approved	"Plasma membrane"		NA	NA		200000	"Cluster 37: B-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA016597: AB_2669397, HPA073490: "	"unprognostic (2.13e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.97e-4)"	"unprognostic (5.51e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.65e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.97e-2)"	14.2	5.8	5.5	42.9	6.1	55.7	11.6	5.8	6.3	5.6	5.9	12.0	8.8	4.6	2.5	8.6	4.0	11.7	25.6	5.2	6.3	5.2	8.0	16.8	88.7	9.9	7.3	2.8	1.5	2.4	2.0	17.5	8.4	3.7	11.9	0.6	4.7	3.9	147.9	2.8	29.3	8.6	6.8	52.4	12.4	3.7	7.7	115.5	6.1	50.6	73.7	14.0	3.4	10.0	0.3	0.0	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	195.2	0.6	0.2	0.0	0.2	0.0	0.0	0.0	91.0	0.3	1.6	0.1	0.1	0.2	34.4	3.7	0.5	0.3	0.4	0.0	0.0	0.0	76.0	67.8	56.7	25.4	0.0	69.3	49.8	1.7	0.0	0.0	224.0	0.8	139.7	0.0	0.1	0.1	0.1	0.2	0.6	0.1	2.7	0.1	103.4	0.5	0.2	0.6	0.2	0.4	132.0	42.5	132.0	0.1	64.6	0.0	249.3	170.3	271.3	63.5	119.8	76.9	216.4	81.7	80.0	103.4	201.7	68.1	64.7	165.7	130.0	122.7	54.3	129.4	148.9	5.5	6.1	5.8	6.3	5.2	6.3	9.9	7.3	8.4	6.8	7.7	10.0	18.7	3.2	6.7	0.3	258.0	1.1	1.2	0.0	3.4	0.7	6.2	10.7	46.8	0.0	3.1	1.8	0.0	0.5	73.9	0.1	0.0	0.2	0.8	0.4	2.1	18.8	0.0	30.1	4.2	0.0	0.5	12.4	4.1	0.3	13.9	0.2	19.2	1.5	44.2	0.0	0.7	0.0	0.0	137.5	26.9	1.7	0.9	80.7	5.4	78.7	121.6	0.2	142.2	2.0	0.6	0.1	0.0	0.4	55.1	0.8	0.0	0.5	0.0	0.8	78.9	5.8	39.7	0.0	0.3	1.0	1.7	1.2	97.2	0.6	0.1	0.3
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794017-119811580	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 662.5"	"Cell type enriched"	"Detected in some"	7	"Intestinal goblet cells: 3458.1"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive CD8 T-cell: 24.6"	"Lineage enriched"	"Detected in single"	101	"T-cells: 24.6"	"Cell line enriched"	"Detected in some"	60	"OE19: 6164.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	NA	NA		460000	"Cluster 32: T-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.7	0.0	0.0	34.4	0.1	0.3	0.0	0.1	0.2	0.4	0.1	236.2	264.5	0.5	0.0	1.5	0.0	0.5	0.0	0.1	0.1	0.7	0.3	0.0	1.6	0.1	0.1	0.0	133.7	0.0	0.0	0.0	0.2	2.6	314.0	0.0	2.3	0.2	0.0	0.0	662.5	8.5	0.0	0.2	19.0	2.4	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	2.3	0.1	6164.0	102.7	0.0	0.0	0.8	0.0	29.2	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.8	24.6	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	10.8	0.0	0.0	0.0	441.8	0.0	0.0	1.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3458.1	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	140.0	0.0	0.1	3.8	178.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.1	52.0	0.2
REM1	"GES, REM"	ENSG00000088320	"RRAD and GEM like GTPase 1"	O75628	20	31475288-31484895	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Peritubular cells: 11.7;Sertoli cells: 59.2;Smooth muscle cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"WM-115: 22.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.6"	HPA049821	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049821: AB_2680898"	"unprognostic (6.16e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.39e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (7.79e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-2)"	13.9	2.2	1.2	1.7	1.1	0.0	7.5	0.9	2.1	20.1	1.3	6.5	1.3	10.5	7.2	2.0	10.0	2.2	6.2	1.0	1.0	3.2	0.8	4.6	3.0	1.0	1.1	3.9	1.1	1.1	2.7	2.1	1.1	5.5	1.0	0.0	1.6	4.9	3.3	3.2	3.7	3.2	0.9	2.5	2.4	1.4	1.3	0.7	4.8	2.4	1.5	4.8	9.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.9	2.1	1.0	1.0	1.0	1.1	1.1	0.9	1.3	1.0	7.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	7.1	2.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	5.6	0.3	3.6	1.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.8	0.0	59.2	0.6	28.1	0.0	0.2	0.1	0.9	0.0	0.1	1.5	0.0	0.0
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.8;brain: 27.3;parathyroid gland: 31.8"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 79.1;Ionocytes: 26.4;Skeletal myocytes: 23.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 74.6;NB-4: 42.2;SH-SY5Y: 329.3;THP-1: 95.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 53.3;spinal cord: 19.4"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		2100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	20.8	1.0	1.3	0.9	0.4	1.1	5.1	5.6	1.0	0.2	3.4	1.4	0.6	0.3	0.4	0.5	0.6	2.2	0.3	5.5	0.9	3.0	0.4	0.6	14.4	27.3	0.4	1.3	31.8	5.3	0.5	12.0	1.8	1.4	4.7	5.1	2.0	5.9	0.9	1.4	1.0	4.8	0.2	2.2	2.7	7.6	1.6	0.8	3.1	0.2	0.6	1.4	5.8	0.1	0.4	0.1	1.7	0.0	0.0	0.1	0.7	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	5.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.6	0.0	42.2	7.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	329.3	0.1	0.0	0.1	0.5	4.1	95.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	1.0	0.9	5.1	5.6	0.3	5.5	14.4	27.3	12.0	4.8	7.6	5.8	0.4	0.0	0.5	1.6	0.0	0.3	0.8	0.0	0.0	1.7	6.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	1.5	0.0	0.3	1.1	0.0	0.0	4.2	0.2	2.3	6.8	0.0	0.0	1.3	0.5	0.0	1.2	0.1	79.1	8.6	1.9	26.4	0.0	0.6	1.5	0.3	0.5	0.0	1.0	0.0	0.8	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8	1.7	0.0	23.1	1.2	1.1	4.7	0.0	0.6	0.0	0.2	0.3	0.2	0.1
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"intestine: 245.5"	"Cell type enriched"	"Detected in some"	38	"Intestinal goblet cells: 210.1"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000			"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	75.7	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	245.5	0.0	0.0	0.1	0.0	0.0	34.5	0.8	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.5	0.0
RFTN1	"FLJ23866, KIAA0084, MIG2, Raftlin"	ENSG00000131378	"Raftlin, lipid raft linker 1"	Q14699	3	16313574-16514026	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 117.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 87.6;monocytes: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048725	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 3: Monocytes - Immune response regulation"			"HPA048725: AB_2680502"	"unprognostic (1.98e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.55e-3)"	"unprognostic (9.99e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.29e-7)"	"unprognostic (6.19e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.81e-1)"	57.2	11.2	15.1	44.7	18.3	13.3	33.2	13.6	22.7	28.2	15.8	15.2	9.3	36.6	4.9	14.5	26.0	15.4	44.7	18.3	20.2	18.4	24.8	46.9	117.0	21.7	14.9	30.4	4.7	9.0	7.4	51.0	16.1	16.4	14.1	11.4	11.3	10.3	25.5	17.1	22.8	31.3	13.9	45.5	11.8	7.0	15.2	73.2	53.4	26.6	117.4	26.2	14.5	17.5	0.1	2.9	5.3	0.0	151.7	75.7	7.7	38.8	65.9	19.3	15.6	21.5	1.0	122.9	18.6	71.2	4.3	0.6	0.1	51.4	25.5	177.5	9.0	19.8	4.9	0.3	78.6	14.7	10.8	111.3	3.4	60.7	19.0	67.5	40.5	19.8	0.5	0.4	47.0	6.6	31.3	5.0	3.5	0.0	1.4	29.6	60.8	15.0	8.0	0.1	0.1	132.6	1.3	1.3	7.2	7.4	0.2	12.2	59.9	47.3	23.0	47.8	16.8	0.4	0.5	82.5	22.0	38.6	19.2	56.0	19.6	13.2	35.3	46.4	18.1	16.3	27.2	37.6	33.6	32.0	18.4	27.8	1.2	80.1	81.7	25.8	60.4	38.3	15.1	18.3	13.6	22.7	18.3	20.2	21.7	14.9	16.1	13.9	15.2	17.5	37.9	22.4	40.0	8.1	51.2	6.5	0.3	2.3	0.0	3.2	0.7	1.5	14.3	5.7	6.9	0.0	0.0	6.2	61.1	0.1	0.0	7.2	38.0	2.6	51.8	34.4	1.2	10.3	87.6	0.9	1.1	32.4	3.1	2.0	24.7	2.1	36.0	7.2	10.5	0.0	16.5	0.0	0.0	17.6	63.6	12.2	18.6	27.0	10.6	19.7	143.8	37.2	64.9	3.0	2.4	0.9	0.1	8.6	43.2	0.6	0.0	0.4	3.3	3.2	0.0	28.2	35.2	2.8	2.4	0.8	5.1	2.5	39.5	12.6	0.3	0.4
RFTN2	"C2orf11, FLJ30574, Raftlin-2"	ENSG00000162944	"Raftlin family member 2"	Q52LD8	2	197568224-197676045	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 70.9"	"Group enriched"	"Detected in many"	7	"Astrocytes: 152.8;Early spermatids: 125.0;Late spermatids: 351.7;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 320.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.8;ASC diff: 15.5;ASC TERT1: 8.7;HSkMC: 10.7;TIME: 6.4;WM-115: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035232, HPA043190"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA035232: AB_10601495, HPA043190: "	"unprognostic (1.15e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.05e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.77e-2)"	10.8	4.7	30.0	1.9	48.9	0.3	3.2	39.2	32.6	4.4	3.7	1.8	0.7	4.6	1.2	2.5	2.2	4.4	3.4	28.3	29.4	2.0	1.0	2.4	2.5	42.5	36.6	9.9	1.9	0.6	0.7	6.2	49.5	1.7	1.9	4.3	3.3	1.6	1.5	2.3	1.3	3.3	40.2	1.9	1.5	3.0	33.7	0.8	1.9	5.8	1.5	2.7	2.4	70.9	0.2	0.0	19.8	0.4	15.5	8.7	0.7	0.2	1.3	0.0	1.1	0.3	0.4	0.4	0.5	1.8	0.4	0.6	0.0	0.0	0.0	0.8	0.1	0.1	1.0	0.0	2.2	0.3	0.3	10.7	0.4	0.1	0.0	0.1	2.3	0.6	0.0	0.2	0.4	0.9	0.1	0.1	0.8	0.8	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.2	0.0	0.0	3.0	3.4	0.1	0.0	6.4	1.7	0.3	0.1	0.3	0.5	1.1	0.2	1.6	0.0	9.6	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.4	0.4	0.0	0.0	0.1	0.1	0.0	30.0	48.9	39.2	32.6	28.3	29.4	42.5	36.6	49.5	40.2	33.7	70.9	14.8	0.0	0.6	152.8	0.2	2.4	0.2	0.1	0.0	1.3	1.3	1.4	2.2	2.8	0.1	0.0	0.0	0.2	0.5	0.1	0.0	1.0	125.0	0.9	9.7	13.0	0.0	0.0	1.2	0.0	0.1	16.3	0.0	0.4	0.0	8.6	19.6	0.3	0.4	3.3	1.5	0.0	0.0	0.6	3.3	351.7	15.8	0.7	16.0	32.8	0.0	23.5	0.0	198.5	320.6	0.1	0.0	22.2	1.6	0.3	0.0	0.1	0.2	1.5	6.6	16.2	8.3	4.5	2.8	0.5	2.3	0.0	0.6	3.3	0.0	0.1
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.5;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
RGS11		ENSG00000076344	"Regulator of G protein signaling 11"	O94810	16	268301-275980	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.2;pituitary gland: 56.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.0;Bipolar cells: 69.7;Cone photoreceptor cells: 120.9;Excitatory neurons: 31.9;Inhibitory neurons: 33.6;Oligodendrocytes: 28.0;Rod photoreceptor cells: 67.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;ASC TERT1: 2.2;fHDF/TERT166: 2.0;HHSteC: 3.1;hTERT-RPE1: 2.4;SCLC-21H: 3.0;SH-SY5Y: 2.3;T-47d: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041692, HPA043039"	Uncertain					NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA041692: AB_2677619, HPA043039: AB_2678282"	"unprognostic (8.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-1)"	14.7	4.5	13.4	1.0	14.8	0.0	8.4	21.8	40.2	8.8	7.5	21.7	7.1	4.2	0.3	7.4	4.5	0.9	22.3	13.4	11.2	5.4	2.4	9.0	0.4	15.4	14.2	0.8	16.8	4.4	56.4	2.6	15.3	19.2	0.7	8.9	3.8	2.7	2.2	2.5	6.9	1.1	10.2	3.4	15.0	0.8	12.8	0.0	4.2	1.1	0.0	9.2	8.8	14.4	0.0	0.0	0.0	0.0	2.1	2.2	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.0	0.2	0.0	0.0	3.0	2.3	1.2	0.0	0.5	0.0	2.5	0.0	1.6	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	14.8	21.8	40.2	13.4	11.2	15.4	14.2	15.3	10.2	12.8	14.4	1.8	0.0	0.0	31.0	0.1	0.1	0.2	0.1	0.6	69.7	1.0	0.6	7.5	1.5	0.0	0.0	120.9	0.1	0.3	0.9	0.0	0.1	0.0	1.9	5.2	1.8	10.3	0.0	31.9	1.0	0.2	8.6	3.1	3.3	0.0	0.4	6.1	0.0	0.2	10.1	33.6	0.4	2.0	0.0	1.1	0.0	0.9	0.2	1.8	4.7	0.6	3.3	0.0	18.1	28.0	0.4	7.1	1.9	0.0	0.5	5.8	0.0	0.0	67.5	0.0	1.5	7.2	0.5	1.5	0.3	0.6	0.8	0.3	0.1	1.4	0.1
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660311	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 48.0"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 520.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	39	"basophil: 6.8"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 6.8"	"Cell line enriched"	"Detected in some"	20	"Daudi: 47.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA076656	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA076656: "	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	0.5	0.0	0.0	9.5	0.0	0.7	2.3	0.0	0.0	1.6	0.0	2.3	3.1	1.0	0.7	1.7	0.3	3.7	0.1	0.0	0.0	0.0	0.0	3.9	48.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	1.6	0.0	0.3	0.6	0.0	0.3	5.7	1.2	0.0	0.3	2.0	0.1	0.1	1.3	0.0	0.2	35.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	30.8	0.0	4.8	1.9	2.1	0.0	0.0	0.0	0.1	0.3	0.3	0.0	1.3	0.0	0.0	0.0	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	7.1	0.0	0.2	0.0	0.0	0.9	12.2	0.0	520.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.6	7.1	0.0	0.0	3.8	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	3.9	1.7	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	7.9	0.5	1.6	0.1
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 34.6;brain: 120.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 51.6;Excitatory neurons: 115.4;Inhibitory neurons: 59.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 120.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"hTERT-RPE1: 527.4;LHCN-M2: 244.2;SH-SY5Y: 429.5;TIME: 959.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030802			Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	8.2	34.6	35.6	3.0	46.7	0.0	1.7	0.0	120.6	5.9	0.0	4.3	4.2	7.8	1.2	9.7	7.3	18.3	8.7	49.3	42.2	1.9	4.0	3.0	3.7	0.0	5.2	2.2	4.7	2.3	14.3	1.6	2.0	4.7	2.5	6.7	0.8	6.5	0.4	0.3	2.8	4.7	0.0	1.7	8.4	3.0	0.0	1.8	3.1	1.4	0.4	5.9	1.4	39.7	0.3	0.0	1.2	7.2	25.1	115.9	0.2	77.8	92.1	12.6	31.9	0.0	0.3	0.3	35.6	50.2	0.5	0.2	0.0	0.1	42.2	0.4	0.1	0.3	0.0	0.0	11.0	0.2	0.2	19.0	0.0	123.0	14.3	527.4	127.5	0.0	0.1	0.6	244.2	0.0	0.0	0.5	6.5	0.0	9.6	0.1	0.0	0.4	0.0	0.0	2.9	429.5	0.0	0.1	0.2	4.0	0.1	0.1	959.6	91.5	5.2	19.1	129.5	0.1	0.1	0.3	11.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	46.7	0.0	120.6	49.3	42.2	0.0	5.2	2.0	0.0	0.0	39.7	0.8	0.0	0.0	15.7	0.0	0.3	1.7	0.1	0.0	4.3	0.7	0.0	0.7	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.3	12.6	0.5	16.9	2.6	51.6	0.0	115.4	0.2	0.1	20.2	0.0	0.4	0.0	1.1	1.1	0.0	0.4	0.0	59.9	0.0	0.0	0.0	0.5	3.8	0.0	0.1	0.0	13.1	0.0	15.7	0.0	13.0	13.0	2.7	0.1	0.0	0.0	0.5	0.0	0.0	0.7	1.6	0.0	0.2	17.0	0.1	0.6	0.5	0.3	0.1	0.6	0.1	0.1	0.3
RHBDF1	"C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1"	ENSG00000007384	"Rhomboid 5 homolog 1"	Q96CC6	16	58059-76355	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077399			Uncertain	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA077399: "	"unprognostic (2.62e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.54e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.22e-2)"	41.9	11.5	14.5	6.0	14.4	0.5	44.3	13.5	19.5	65.1	13.3	38.2	7.5	38.1	13.0	47.0	36.4	22.1	51.7	14.3	13.5	24.7	13.2	58.5	5.5	14.5	14.4	55.6	23.4	8.9	13.3	27.5	13.9	61.2	7.1	2.5	38.3	16.5	34.1	46.1	24.8	10.5	14.0	19.3	28.5	8.0	14.7	1.2	33.4	16.9	5.5	44.6	61.4	13.5	10.8	17.3	9.7	22.5	37.2	45.7	31.8	29.1	53.8	20.1	19.1	23.5	36.9	0.6	11.8	31.1	10.2	33.6	4.8	19.6	3.4	0.5	5.3	0.4	18.8	6.6	41.4	0.3	18.3	38.3	20.3	51.9	8.6	35.5	31.4	0.1	4.1	0.4	32.2	60.6	0.1	3.5	8.8	22.7	14.5	0.3	11.5	0.9	22.7	11.0	0.3	2.4	8.4	31.8	18.7	11.9	49.1	3.8	32.6	31.5	21.9	24.8	8.1	0.2	0.7	0.3	22.0	0.6	50.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	14.4	13.5	19.5	14.3	13.5	14.5	14.4	13.9	14.0	14.7	13.5	10.5	19.2	6.2	9.1	0.3	6.8	9.9	15.2	5.2	0.8	17.8	13.5	9.9	22.8	15.8	9.2	66.7	19.0	0.3	21.9	0.0	21.4	1.1	3.8	9.9	9.2	0.0	0.0	1.7	8.0	16.3	20.6	15.8	11.2	0.0	8.7	8.2	3.0	2.2	0.0	0.6	9.8	18.3	0.6	5.1	1.1	19.6	0.4	16.0	5.6	0.0	6.9	0.0	16.6	0.7	28.4	13.6	13.9	0.2	25.8	2.1	2.3	5.3	4.9	13.1	10.8	22.3	0.3	1.9	6.6	5.5	30.6	0.8	16.4	3.8	17.9
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206053173-206102449	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.4"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 202.9;Glandular and luminal cells: 337.5;granulocytes: 334.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 42.8;ovarian cancer: 41.1;renal cancer: 27.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	152	"basophil: 1312.1"	"Lineage enriched"	"Detected in single"	1544	"granulocytes: 1312.1"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 1562.9"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.1	0.4	0.0	2.9	0.0	1.3	4.7	0.0	0.0	24.4	0.0	7.5	3.3	12.8	16.3	7.7	5.3	16.3	0.9	0.0	0.0	14.3	0.9	10.7	4.1	0.0	0.0	0.2	1.4	0.3	0.4	0.6	0.0	2.8	7.4	0.0	2.8	20.0	1.0	4.5	6.7	7.3	0.0	3.0	6.4	1.0	0.1	3.1	2.0	2.5	4.6	7.7	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	143.8	0.0	0.9	0.0	75.2	1562.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	330.8	0.0	0.0	0.0	0.1	0.2	0.7	20.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.6	0.9	1.1	0.8	1312.1	0.0	8.6	0.0	0.1	0.1	0.5	0.2	0.0	0.6	0.2	0.1	0.2	0.5	0.0	0.2	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	20.2	0.0	2.3	0.7	0.0	1.9	3.6	0.0	202.9	17.6	1.3	0.0	0.0	0.0	0.2	0.2	0.4	0.0	337.5	334.3	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0
RIMBP2	"KIAA0318, MGC15831, PPP1R133, RBP2, RIM-BP2"	ENSG00000060709	"RIMS binding protein 2"	O15034	12	130396137-130716281	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;parathyroid gland: 24.6;pituitary gland: 32.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 75.5;Excitatory neurons: 128.2;Inhibitory neurons: 191.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 28.9;SH-SY5Y: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041494, HPA044114"			Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA041494: , HPA044114: AB_2678815"	"unprognostic (4.15e-4)"	"unprognostic (9.77e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.91e-3)"	"unprognostic (3.63e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (4.16e-4)"	"unprognostic (2.86e-1)"	"unprognostic (6.41e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.73e-2)"	0.6	14.5	6.3	0.9	11.3	0.2	0.2	0.0	17.5	7.2	17.3	1.5	2.9	2.7	2.5	0.5	7.8	0.9	0.0	25.9	19.2	5.9	0.2	0.4	0.1	1.7	19.6	2.1	2.5	24.6	32.2	0.0	20.6	1.1	1.8	11.2	0.3	1.3	0.2	2.7	2.5	2.4	0.1	1.0	5.9	2.6	0.9	0.3	0.6	3.9	0.1	0.3	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.0	0.4	7.3	0.0	0.0	28.9	55.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	11.3	0.0	17.5	25.9	19.2	1.7	19.6	20.6	0.1	0.9	2.7	0.4	0.0	0.0	5.9	0.0	2.0	0.1	0.0	0.6	19.4	0.0	0.1	1.4	0.0	0.0	0.0	31.3	0.0	0.0	0.4	0.0	0.0	3.8	3.0	1.4	0.4	75.5	0.0	128.2	0.0	0.0	0.7	4.1	6.4	0.0	0.0	0.0	0.0	0.0	10.1	191.4	2.6	6.1	0.0	0.5	2.1	0.9	0.0	0.0	1.0	0.0	3.2	0.0	19.6	5.3	0.1	0.1	0.7	0.0	0.1	0.0	0.1	0.7	14.0	0.0	0.0	0.2	1.7	1.5	0.1	0.6	0.0	0.1	0.0	0.8	0.0
RIMS2	"KIAA0751, OBOE, RAB3IP3, RIM2"	ENSG00000176406	"Regulating synaptic membrane exocytosis 2"	Q9UQ26	8	103500696-104256094	"Human disease related genes, Predicted intracellular proteins"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 50.6;brain: 48.2;retina: 102.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 383.6;Cone photoreceptor cells: 706.8;Excitatory neurons: 1589.3;Inhibitory neurons: 1234.9;Oligodendrocyte precursor cells: 577.0;Rod photoreceptor cells: 1088.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 9.2;RT4: 7.3;SCLC-21H: 16.5;SuSa: 8.8;U-2 OS: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046538, HPA066498, CAB079049"	Enhanced	Supported	Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"		"CAB079049: , HPA046538: , HPA066498: AB_2685678"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.09e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (8.01e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.67e-5)"	"unprognostic (8.12e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	0.2	50.6	22.4	0.2	27.1	0.4	0.7	35.5	48.2	7.5	0.0	0.1	0.4	0.6	0.9	0.3	5.9	0.9	0.1	18.4	16.4	0.3	0.1	0.1	0.3	5.5	9.7	2.0	0.7	0.0	15.0	0.4	6.4	1.7	0.1	102.3	0.8	1.0	0.2	0.3	0.5	1.3	3.5	0.1	0.6	2.8	16.7	0.8	1.3	0.1	0.2	1.7	2.4	29.4	4.6	0.0	4.8	0.0	0.0	0.1	0.0	0.4	0.3	1.0	1.3	0.1	0.3	9.2	0.1	0.1	1.4	0.3	1.9	0.8	2.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.0	1.5	0.0	1.2	0.0	0.5	0.0	0.4	0.9	0.0	4.0	0.0	0.5	0.0	0.0	0.0	0.0	7.3	16.5	3.3	0.0	0.1	0.7	8.8	0.4	0.2	0.0	0.0	6.5	0.1	0.1	1.2	0.0	0.1	0.4	0.3	0.3	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	22.4	27.1	35.5	48.2	18.4	16.4	5.5	9.7	6.4	3.5	16.7	29.4	0.4	28.9	22.5	38.5	0.2	0.3	1.8	2.8	1.8	383.6	0.7	0.6	0.9	1.5	16.9	0.0	706.8	0.5	0.1	0.2	1.9	0.1	34.2	2.1	0.4	4.9	8.4	0.0	1589.3	0.0	0.3	3.7	0.0	3.7	16.4	18.0	0.7	0.3	0.3	67.3	1234.9	0.9	0.0	0.6	0.8	20.1	72.1	2.5	1.8	63.7	0.6	86.6	1.0	577.0	27.0	0.3	1.2	29.3	0.3	4.1	2.0	0.2	10.6	1088.7	0.0	0.8	1.0	34.8	15.7	0.8	0.4	0.1	2.1	0.1	1.5	1.1
RIPOR3	"C20orf175, C20orf176, dJ530I15.2, dJ530I15.3, FAM65C"	ENSG00000042062	"RIPOR family member 3"	Q96MK2	20	50586108-50691542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Collecting duct cells: 3.7;Endometrial stromal cells: 6.5;Fibroblasts: 3.8;monocytes: 2.0;Proximal tubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 16.7;HEL: 55.9;HSkMC: 33.0;K-562: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051823, HPA054759"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA051823: AB_2681626, HPA054759: AB_2682596"	"unprognostic (7.23e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.66e-5)"	"unprognostic (4.96e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.98e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.58e-2)"	19.4	13.3	2.7	3.4	3.0	22.4	11.7	2.7	3.5	38.5	5.1	8.5	2.5	18.2	1.0	5.3	27.7	3.2	16.6	2.7	2.6	28.9	14.1	5.3	4.7	3.0	2.9	8.3	3.0	0.8	9.1	1.9	2.9	6.0	1.5	0.1	6.9	0.6	7.8	5.5	11.3	4.4	2.6	7.5	5.8	6.1	2.8	4.7	7.5	3.8	1.3	8.2	16.6	2.6	0.0	0.0	0.9	0.0	36.0	16.7	0.1	0.0	11.6	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.2	4.3	0.0	0.0	33.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.9	0.0	3.2	0.0	0.0	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	2.7	3.0	2.7	3.5	2.7	2.6	3.0	2.9	2.9	2.6	2.8	2.6	1.1	3.2	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.6	3.7	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.8	6.5	0.2	0.0	0.0	0.0	0.4	0.4	3.8	0.0	1.6	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.9	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RMDN1	"CGI-90, FAM82B, FLJ20665, RMD1"	ENSG00000176623	"Regulator of microtubule dynamics 1"	Q96DB5	8	86468257-86514357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026495	Approved		Supported	"Actin filaments,Centrosome"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Centrosome	"Actin filaments"	"HPA026495: AB_1848414"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (8.51e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.71e-3)"	"unprognostic (3.47e-1)"	35.6	26.1	25.8	20.9	30.1	24.7	24.3	30.4	27.8	15.5	25.3	26.7	28.7	17.6	19.8	29.4	21.1	22.5	63.0	23.0	29.5	51.7	56.8	23.4	30.3	29.8	29.7	17.0	17.5	26.3	12.9	18.9	30.0	21.2	29.0	30.9	16.4	20.7	71.7	32.8	29.2	20.2	28.3	25.2	30.6	26.4	29.6	23.0	50.4	70.5	31.5	20.1	16.3	30.5	64.0	27.1	31.3	17.8	60.3	97.8	38.5	45.9	41.1	35.8	34.6	32.2	39.9	76.2	38.1	38.2	33.2	61.0	39.8	46.0	42.1	64.6	31.9	40.2	32.8	82.1	32.1	18.4	1.0	53.3	42.6	47.6	72.9	63.9	81.6	44.3	42.4	40.7	57.5	57.3	65.1	8.6	15.9	111.3	67.5	36.6	43.6	78.9	42.5	39.3	14.8	32.8	38.2	149.2	67.6	32.5	83.9	33.6	44.6	39.5	64.0	50.8	28.2	52.4	46.5	59.7	51.2	28.7	54.4	16.4	38.5	94.2	26.6	50.7	31.1	42.2	27.1	31.3	45.2	30.8	22.3	29.0	15.5	39.0	70.3	51.3	43.2	30.7	25.8	30.1	30.4	27.8	23.0	29.5	29.8	29.7	30.0	28.3	29.6	30.5	24.0	41.7	39.0	38.8	23.8	13.5	13.2	40.1	22.2	14.5	16.8	15.0	117.3	20.0	42.4	20.2	16.7	42.5	29.9	22.2	49.0	42.9	97.8	28.3	26.6	24.3	10.2	27.3	22.5	53.0	57.1	24.0	32.1	24.8	1.3	18.9	21.8	57.7	53.7	20.2	29.9	20.6	18.3	40.1	14.8	77.1	13.1	28.3	16.0	33.7	48.5	27.4	21.6	42.3	51.9	45.8	17.2	9.1	21.8	9.2	45.7	73.0	34.4	21.5	0.0	19.9	32.9	65.7	33.5	31.0	15.5	28.5	21.6	53.1	26.9	15.2
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20802855	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"pancreas: 9121.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 826.6;Alveolar cells type 1: 929.5;Alveolar cells type 2: 818.4;Gastric mucus-secreting cells: 821.1;Hepatic stellate cells: 650.3;Hofbauer cells: 1583.4;Intestinal goblet cells: 663.8;Macrophages: 632.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7;myeloid DC: 20.3"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.3;monocytes: 9.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 286.8;OE19: 67.4;RT4: 114.2;TIME: 179.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"	NA	NA		1100000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	694.2	501.3	336.6	131.3	466.1	6.2	353.3	404.4	556.1	203.9	294.9	378.4	176.7	139.4	112.0	194.0	232.0	406.4	377.7	351.3	380.9	253.0	54.5	775.9	187.8	438.9	408.3	190.6	9121.6	60.6	43.9	897.4	403.7	83.9	425.2	3.1	168.0	149.7	127.6	118.1	201.8	285.6	357.3	353.1	1003.5	977.5	465.4	177.6	119.7	280.6	68.8	374.7	107.9	533.7	0.0	1.4	0.5	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	0.0	0.3	1.7	0.0	2.2	0.6	0.0	1.4	0.0	0.1	0.1	5.3	0.1	0.8	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	286.8	0.0	31.4	0.4	0.0	0.0	0.3	2.0	1.2	67.4	0.0	0.2	0.1	1.5	0.2	114.2	1.2	1.4	0.0	0.8	0.3	2.0	0.3	0.1	179.3	0.0	2.7	1.8	0.3	0.6	0.1	0.1	4.6	0.1	3.8	1.6	9.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	2.4	336.6	466.1	404.4	556.1	351.3	380.9	438.9	408.3	403.7	357.3	465.4	533.7	826.6	929.5	818.4	1.6	11.1	35.6	1.0	1.9	15.9	0.1	6.2	11.7	59.8	27.1	174.0	16.5	0.0	12.9	5.7	261.8	0.0	8.8	20.0	3.8	1.9	581.7	48.7	28.0	0.5	315.2	14.6	58.4	821.1	3.4	25.2	103.8	650.3	7.9	1583.4	1.7	0.8	663.8	8.2	267.9	197.5	57.1	32.0	632.8	40.9	36.5	3.4	0.8	0.0	1.0	232.3	286.8	246.7	10.9	7.5	1.4	81.7	0.9	34.9	2.7	98.6	20.7	31.4	16.4	6.6	16.6	28.1	25.9	10.6	392.8	162.9	3.8
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781268-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 1238.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 65.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000698	Approved				"Secreted to blood"	NA	NA		2600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.2	29.5	8.0	59.6	7.5	27.5	24.0	7.8	13.6	31.6	10.0	27.7	17.3	10.6	78.4	16.0	11.3	47.7	11.7	7.3	10.9	12.2	21.1	29.6	110.5	13.6	10.1	9.9	8.4	9.0	4.3	44.8	11.9	7.9	34.0	1.8	11.2	17.2	2.0	8.6	33.4	23.6	10.8	62.1	14.9	4.5	12.6	43.8	5.5	6.0	84.5	43.3	5.1	19.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	1.7	4.7	0.6	0.2	0.0	0.0	1.9	4.6	0.0	0.0	0.0	0.2	0.0	65.6	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	441.1	537.3	12.8	5.3	124.8	12.0	324.7	13.6	5.6	513.3	410.3	6.4	1.0	199.0	36.7	2.0	1238.8	1.1	329.8	8.0	7.5	7.8	13.6	7.3	10.9	13.6	10.1	11.9	10.8	12.6	19.5	1.6	6.4	7.5	0.0	108.0	4.5	0.2	0.0	1.8	0.0	1.4	2.8	0.6	14.3	1.2	0.0	0.0	1.1	221.7	2.6	0.0	0.0	0.8	0.1	0.0	3.8	0.0	12.0	0.0	0.0	1.6	1.4	1.1	0.2	0.0	0.0	8.6	3.3	207.9	0.0	0.0	0.5	2.0	551.2	198.4	4.8	2.8	270.3	21.4	1.9	115.8	0.0	9.2	0.0	0.0	0.0	12.6	0.7	52.4	0.2	0.4	0.5	0.2	0.4	13.1	0.6	0.6	0.1	0.7	0.6	3.8	2.2	7.8	0.0	3.4	1.2
RNF122	FLJ12526	ENSG00000133874	"Ring finger protein 122"	Q9H9V4	8	33547754-33567128	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 34.7;Glandular and luminal cells: 19.8;Plasma cells: 13.1;Skeletal myocytes: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 83.7;Karpas-707: 53.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003888	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA003888: AB_1079822"	"unprognostic (2.36e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.46e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.95e-2)"	"prognostic favorable (5.37e-4)"	"prognostic unfavorable (4.50e-7)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (7.15e-2)"	36.0	15.0	2.4	9.5	2.2	7.4	19.0	13.7	3.6	11.0	2.2	13.5	2.7	10.4	5.4	6.4	29.1	13.4	28.4	2.2	3.0	10.1	7.3	28.9	7.1	4.8	4.1	48.1	5.6	3.4	4.3	3.0	3.6	10.2	5.0	4.9	7.9	2.4	25.8	9.9	10.1	14.7	3.4	12.4	11.1	5.7	4.3	5.9	6.5	5.8	8.8	13.7	12.8	3.2	0.7	4.4	22.3	9.4	2.0	0.6	3.0	1.4	2.1	2.8	4.5	0.7	0.9	10.7	6.8	3.6	3.8	0.8	4.9	2.0	1.5	0.7	83.7	2.2	1.1	6.1	1.2	0.7	16.9	2.1	1.8	1.5	1.1	4.6	9.0	9.2	2.2	53.9	2.3	2.0	9.5	7.2	12.2	3.4	2.5	10.3	4.3	8.5	3.3	1.3	4.3	24.8	1.6	0.6	3.5	7.7	1.0	3.0	5.2	3.8	3.5	7.0	1.6	21.5	13.0	19.5	2.4	2.9	0.6	5.9	1.0	8.9	1.6	5.0	1.4	3.1	0.9	1.1	0.9	4.9	1.5	1.6	7.6	2.0	11.9	16.2	0.7	0.4	2.4	2.2	13.7	3.6	2.2	3.0	4.8	4.1	3.6	3.4	4.3	3.2	34.7	0.0	0.6	0.0	5.3	4.2	0.6	0.2	6.2	0.0	2.6	1.3	5.1	2.8	0.1	0.0	0.0	0.1	8.1	1.9	0.0	2.7	2.2	9.1	3.8	10.1	0.0	4.0	0.8	0.6	0.6	7.3	4.1	19.8	0.0	1.8	5.7	0.1	1.5	0.0	0.9	1.0	0.0	5.9	7.6	0.9	1.5	4.8	0.0	3.7	0.6	0.7	1.0	2.0	0.9	1.0	2.8	1.2	13.1	0.3	0.2	0.8	0.0	1.5	0.0	13.4	6.7	0.0	0.7	2.8	2.0	0.0	3.0	1.2	1.3	1.1
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128"	Q8TEB7	X	106693794-106797016	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.1;liver: 124.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Cholangiocytes: 50.1;Distal enterocytes: 49.3;Gastric mucus-secreting cells: 54.6;Hepatocytes: 76.9;Proximal enterocytes: 85.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 41.9;CAPAN-2: 35.0;Hep G2: 30.6;OE19: 96.2;RPTEC TERT1: 30.5;RT4: 88.8;WM-115: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	0.7	35.0	2.6	1.8	2.4	0.0	7.9	1.9	2.4	0.6	0.8	21.8	62.1	0.1	0.5	4.6	1.0	33.1	0.5	2.5	4.2	31.5	124.6	14.7	0.2	2.7	2.2	2.0	16.4	0.7	6.6	11.1	3.3	2.8	19.6	0.1	28.6	2.1	8.9	6.9	60.8	0.6	1.6	0.1	46.9	0.6	4.3	2.8	29.4	4.1	0.2	20.0	2.0	1.6	11.1	0.0	0.0	0.0	3.4	1.8	41.9	0.1	0.3	0.0	0.0	18.8	35.0	0.0	0.0	0.6	0.4	13.3	0.1	0.0	0.0	0.0	20.6	0.0	0.3	30.6	0.0	0.0	0.0	0.1	14.4	0.0	0.1	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.4	96.2	0.3	0.0	0.1	0.1	30.5	88.8	0.2	0.0	0.0	2.3	2.2	0.3	2.3	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	15.1	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.4	1.9	2.4	2.5	4.2	2.7	2.2	3.3	1.6	4.3	1.6	0.1	67.3	19.6	6.2	0.5	6.8	6.6	13.1	10.2	0.0	9.7	4.2	0.5	50.1	15.0	33.1	0.0	23.4	0.1	49.3	0.0	14.7	0.1	0.0	0.0	0.3	24.7	2.7	17.9	15.6	3.3	0.3	54.6	0.0	0.0	0.1	1.8	76.9	1.9	0.0	19.6	33.3	2.0	2.7	0.4	0.2	0.0	0.4	3.6	3.7	0.0	0.0	0.0	25.1	13.8	25.6	23.6	0.0	0.0	1.9	85.4	25.3	8.7	0.0	0.0	0.0	1.3	0.0	2.0	11.5	5.3	16.6	0.2	0.5	28.7	8.5
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
RNF175	FLJ34190	ENSG00000145428	"Ring finger protein 175"	Q8N4F7	4	153710160-153760024	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;choroid plexus: 10.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 72.8;Excitatory neurons: 91.4;Inhibitory neurons: 95.7;Oligodendrocyte precursor cells: 38.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HSkMC: 5.8;REH: 6.7;SH-SY5Y: 7.6;THP-1: 17.5;U-87 MG: 4.5"									HPA035837	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035837: AB_10601609"	"unprognostic (3.23e-2)"	"unprognostic (4.12e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.63e-4)"	"unprognostic (7.25e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	1.5	2.5	18.8	2.9	19.2	6.1	0.8	15.0	27.6	3.0	10.8	0.6	0.1	0.2	0.9	0.6	0.5	1.0	4.0	18.3	21.8	0.2	0.4	1.4	1.2	17.7	15.3	0.1	0.3	0.0	4.0	0.1	17.6	2.4	0.1	3.5	1.4	3.4	0.1	0.7	0.5	0.1	14.1	2.5	0.3	1.6	18.0	0.1	0.2	0.5	0.6	0.5	1.5	17.5	0.2	0.0	8.8	0.0	0.0	0.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	6.7	0.0	0.3	0.0	0.1	0.0	7.6	0.0	0.0	0.2	0.1	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.9	0.0	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.9	0.0	2.2	0.0	2.4	0.0	2.1	0.0	0.6	0.6	18.8	19.2	15.0	27.6	18.3	21.8	17.7	15.3	17.6	14.1	18.0	17.5	0.1	0.0	0.5	6.8	0.0	0.4	0.1	0.6	0.6	0.7	0.1	0.6	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.8	0.0	0.1	0.2	0.0	0.4	91.4	0.0	0.0	2.9	0.0	0.2	0.0	0.4	0.0	0.0	0.5	0.0	95.7	0.0	0.0	5.9	2.9	14.6	0.0	1.5	1.8	2.8	0.7	0.8	0.0	38.7	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	1.6	0.0	0.0	0.3	1.5	1.3	0.0	0.3	0.0	0.6	0.0	0.0	0.2
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815283	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 67.2;intestine: 131.1;pancreas: 43.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 41.6;Enteroendocrine cells: 86.6;Intestinal goblet cells: 46.6;Paneth cells: 123.4;Proximal tubular cells: 142.7;Undifferentiated cells: 110.3"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 18.5;renal cancer: 12.1;stomach cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034547, HPA035558"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.3	0.0	0.0	5.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	18.7	131.1	0.1	67.2	0.0	0.0	0.4	0.0	0.0	0.0	26.1	0.8	0.0	0.0	0.0	0.0	0.2	43.4	0.0	0.0	0.0	0.0	0.3	15.4	0.0	0.3	0.4	0.0	0.0	44.8	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	5.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	41.6	5.9	9.6	0.0	0.8	0.1	0.1	86.6	0.0	0.0	18.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	123.4	0.0	0.0	0.1	16.1	142.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	110.3	0.2
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781696	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.5;Late spermatids: 257.6;Spermatocytes: 159.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	14.3	12.3	14.3	12.8	15.9	15.6	13.1	12.6	14.6	13.2	10.0	25.5	8.1	21.9	8.2	12.3	15.8	8.7	21.7	13.8	17.5	10.0	10.1	12.8	17.0	14.9	15.4	16.5	14.9	13.9	15.4	7.7	14.8	14.6	5.8	7.2	11.4	13.7	19.6	13.3	17.9	15.0	12.8	19.2	14.6	30.1	16.2	12.8	12.7	11.9	11.5	16.4	10.9	14.3	22.0	23.6	17.0	32.8	21.6	14.6	11.5	20.7	19.3	17.6	15.8	16.7	12.3	17.3	11.4	22.0	38.7	17.1	13.6	15.3	10.3	11.4	19.3	12.5	13.6	18.0	27.7	19.5	25.3	21.4	20.4	16.2	14.6	18.4	15.0	19.2	28.4	12.9	18.9	35.2	8.8	44.7	25.7	13.1	20.0	26.1	23.4	12.2	13.9	13.9	14.1	25.3	11.8	33.9	13.2	15.3	14.2	28.2	20.5	24.9	39.9	25.2	22.8	11.4	9.0	16.0	19.6	21.7	37.4	3.5	7.7	24.2	10.1	8.3	9.4	8.3	9.3	8.7	6.3	8.8	10.9	11.3	13.2	12.7	8.7	7.1	8.3	6.9	14.3	15.9	12.6	14.6	13.8	17.5	14.9	15.4	14.8	12.8	16.2	14.3	33.4	6.4	23.9	34.9	33.6	16.6	20.8	11.9	15.9	36.4	16.1	17.8	33.3	8.6	13.6	12.9	52.1	14.1	47.7	10.3	25.4	17.6	145.5	14.6	33.7	29.7	6.0	8.8	50.2	13.7	12.9	26.7	16.3	16.9	19.6	34.0	26.4	15.1	22.9	28.6	61.7	15.4	6.1	23.0	29.3	257.6	37.3	23.1	12.4	49.6	37.0	30.2	56.7	46.3	64.2	15.6	7.0	30.1	20.3	24.2	13.0	14.9	13.7	48.5	26.3	46.0	30.0	159.8	124.2	12.9	16.2	15.2	40.2	22.8	11.8	15.2
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 181.5;Endothelial cells: 119.7;Hepatic stellate cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 247.6;TIME: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"		NA	NA		380000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA065212: AB_2685434"	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favorable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	41.4	7.2	11.4	6.6	9.6	0.2	31.8	9.0	9.4	10.0	5.8	6.5	2.9	10.9	2.1	5.5	10.3	9.7	25.8	7.9	9.2	18.5	5.3	34.8	7.8	11.3	10.7	4.1	4.3	4.7	4.6	28.6	11.2	7.0	1.7	0.2	4.1	4.6	13.9	6.9	7.3	9.9	9.5	43.5	6.3	1.4	13.2	1.8	16.7	11.9	2.0	9.4	7.0	8.6	0.4	0.0	0.4	0.0	0.0	1.1	0.1	0.2	3.1	0.7	1.5	0.0	0.0	0.0	23.6	0.1	1.0	0.0	0.0	0.4	1.2	0.0	0.0	0.9	0.0	0.1	0.6	0.0	0.0	0.1	0.0	8.9	3.0	0.4	247.6	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	224.8	1.2	0.6	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	9.6	9.0	9.4	7.9	9.2	11.3	10.7	11.2	9.5	13.2	8.6	181.5	0.0	4.2	2.3	1.6	2.2	1.0	0.2	0.6	0.2	0.6	1.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.5	0.2	0.3	119.7	0.0	4.0	0.0	0.2	0.0	5.2	0.0	0.3	2.5	0.6	148.9	1.5	0.1	0.0	0.0	0.0	0.0	8.1	3.7	1.7	4.4	2.8	1.8	20.6	0.1	1.1	0.0	0.5	0.1	0.1	0.0	1.2	2.6	0.3	0.0	0.0	0.0	5.2	0.0	4.5	2.1	0.0	0.1	0.6	1.3	0.0	0.9	2.0	0.1	0.2
RPH3A	"exophilin-1, KIAA0985, rabphilin"	ENSG00000089169	"Rabphilin 3A"	Q9Y2J0	12	112570380-112898881	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.5;Excitatory neurons: 71.6;Inhibitory neurons: 100.6"	"Cancer enriched"	"Detected in some"	5	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.3;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 7.4;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002475	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002475: AB_1079837"	"unprognostic (5.50e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.46e-2)"	0.5	3.6	15.0	1.5	23.9	20.7	0.8	23.8	85.5	0.3	0.0	0.8	1.0	1.3	2.4	0.9	0.6	1.9	0.6	16.8	14.4	0.6	0.8	0.5	3.4	27.2	24.0	0.8	2.4	0.2	0.4	1.3	7.7	0.7	1.2	9.7	0.9	0.4	0.6	2.1	1.1	1.3	17.3	1.8	0.6	1.4	50.1	0.6	1.1	0.4	1.9	0.8	0.2	46.0	0.7	0.3	0.7	1.2	0.3	0.5	2.0	0.0	0.4	0.5	0.1	0.6	1.0	1.1	0.3	0.0	0.6	2.0	0.3	0.5	0.9	0.4	1.4	1.9	3.2	2.1	0.4	1.1	1.8	0.6	0.2	1.3	1.0	0.7	0.0	0.3	0.1	2.7	1.8	0.7	0.6	1.5	1.1	0.2	1.1	0.0	0.9	7.4	0.0	1.5	0.9	16.5	0.2	0.1	0.1	1.6	0.7	0.1	0.1	1.6	1.2	1.5	0.9	1.2	0.3	1.1	1.0	0.8	0.4	1.2	6.3	0.2	0.2	3.0	0.1	0.3	0.1	0.2	0.6	0.8	0.2	0.3	2.3	0.5	4.6	0.2	0.0	1.8	15.0	23.9	23.8	85.5	16.8	14.4	27.2	24.0	7.7	17.3	50.1	46.0	0.0	0.0	0.0	5.5	0.2	0.0	0.0	0.0	0.0	24.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.2	0.0	0.0	71.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.6	0.0	0.0	1.2	0.0	7.2	0.0	3.2	0.0	2.8	5.8	1.2	0.0	12.5	3.8	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPL10L		ENSG00000165496	"Ribosomal protein L10 like"	Q96L21	14	46651010-46651781	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 92.0"	"Group enriched"	"Detected in some"	17	"Early spermatids: 581.2;Late spermatids: 224.4;Spermatocytes: 310.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"U-2 OS: 41.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011311	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum, Cytosol"		"HPA011311: AB_1856431"	"unprognostic (7.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.70e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.44e-2)"		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	92.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	41.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	10.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.2	0.0	2.2	0.0	0.0	581.2	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.3	19.2	224.4	6.2	0.9	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	6.6	0.1	0.1	0.1	0.0	6.6	2.9	20.8	310.1	14.7	0.0	18.8	0.3	2.4	0.2	2.0	4.3
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.2;esophagus: 18.4;intestine: 19.7;lymphoid tissue: 58.1"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 214.0;Extravillous trophoblasts: 254.1;Plasma cells: 248.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056994	Enhanced		Supported	Cytosol		Yes	Yes		13000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	1.5	1.3	0.3	12.4	0.3	44.2	2.9	0.5	0.4	3.0	1.9	14.2	9.4	2.2	0.7	18.4	0.8	1.1	0.5	0.3	0.3	0.9	3.2	2.4	35.5	0.4	0.4	0.3	1.1	0.3	0.2	4.6	0.4	0.9	19.7	0.2	2.1	0.5	0.1	3.7	7.5	6.1	0.3	11.1	6.0	2.9	0.8	58.1	0.9	0.1	37.6	6.0	4.6	0.5	110.2	25.0	127.1	49.9	7.4	22.5	116.8	209.2	128.6	170.2	187.9	70.8	59.1	114.4	9.5	88.6	151.1	55.0	188.0	136.6	198.0	210.7	41.8	146.3	52.1	105.1	0.8	146.7	87.4	8.1	3.4	234.6	16.2	27.7	103.3	110.4	63.4	328.6	214.3	57.1	167.3	90.9	83.0	133.3	103.6	87.6	187.0	67.8	87.1	62.7	67.7	56.2	198.0	116.6	17.3	51.8	69.2	31.4	57.6	93.1	125.1	66.9	289.6	212.1	184.9	195.9	51.0	134.4	107.7	0.3	0.1	0.1	1.2	0.0	0.0	0.1	0.3	0.8	0.1	0.1	0.1	0.4	0.4	0.8	0.0	0.1	0.2	0.2	0.3	0.3	0.5	0.4	0.3	0.3	0.4	0.4	0.4	0.3	0.8	0.5	0.2	3.2	1.5	0.0	25.0	10.5	3.0	9.2	1.2	0.0	3.9	4.4	1.4	1.5	2.3	0.0	0.0	42.3	5.6	12.9	1.9	1.2	3.9	2.2	3.5	4.2	0.0	214.0	0.1	0.0	254.1	11.2	11.7	3.6	5.7	12.2	3.9	3.7	47.9	0.0	0.0	26.9	2.0	7.2	8.8	6.8	0.3	5.0	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.5	0.3	0.4	248.0	1.5	2.4	2.1	4.6	0.0	0.0	0.2	14.6	22.9	34.0	51.5	1.6	48.7	11.9	1.2	36.7	5.6
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025927	Uncertain		Approved	Vesicles		NA	NA		33000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	35.6	14.2	8.8	22.0	8.9	27.9	25.4	8.8	10.1	21.2	10.1	27.8	12.0	30.3	19.9	27.7	19.2	19.7	25.1	8.7	10.1	19.4	16.7	27.7	22.3	10.5	9.4	21.8	21.2	14.1	3.9	23.2	9.8	17.9	23.8	9.9	14.5	27.0	15.8	15.9	13.7	41.8	8.6	20.4	15.6	5.5	10.4	18.1	18.7	13.8	22.3	24.0	18.0	9.6	27.3	18.6	15.0	88.5	78.4	80.3	18.3	66.3	28.2	45.1	48.6	17.3	25.0	27.0	10.5	91.2	24.1	23.9	18.3	34.7	48.3	40.6	14.6	85.2	11.1	16.7	34.5	13.1	47.8	40.0	36.0	43.3	13.7	40.9	47.8	27.8	14.0	18.2	61.6	17.6	30.5	23.5	15.7	39.6	10.5	19.6	20.3	18.4	44.0	10.0	5.9	11.6	33.1	21.6	33.6	26.8	7.6	34.4	58.8	38.4	13.3	48.5	34.6	15.9	20.6	23.3	51.0	37.1	16.9	33.0	20.9	22.8	24.7	26.0	28.0	16.6	28.1	26.7	34.7	17.9	20.5	25.8	14.6	31.3	25.5	25.9	36.0	48.5	8.8	8.9	8.8	10.1	8.7	10.1	10.5	9.4	9.8	8.6	10.4	9.6	111.1	35.3	24.5	26.4	29.9	36.7	30.3	74.0	12.0	1.7	22.5	36.2	41.2	27.1	48.3	42.3	2.1	131.9	41.6	57.0	68.4	72.1	80.5	20.7	47.2	69.6	7.2	74.7	52.8	119.2	83.0	52.8	28.5	24.8	34.2	20.5	64.2	32.7	121.7	3.3	34.7	19.0	52.9	61.1	80.7	163.3	39.4	106.2	60.5	52.5	92.3	5.8	66.9	45.8	51.7	81.2	16.8	68.4	36.7	17.4	14.9	58.3	48.8	17.9	65.7	32.4	136.1	3.9	22.6	34.1	42.8	96.2	46.8	35.9	27.2	24.9
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 288.0"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 350.3;Rod photoreceptor cells: 524.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.3;SH-SY5Y: 5.4;U-266/84: 23.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.0	3.5	5.1	0.1	5.9	0.2	0.0	1.9	10.0	0.0	0.9	1.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	6.7	2.7	0.0	0.0	0.1	0.0	2.7	1.9	0.0	1.2	0.3	34.3	0.0	5.8	0.0	0.3	288.0	0.0	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.1	3.3	2.9	8.7	0.0	0.0	0.0	0.0	0.1	3.2	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.0	0.9	0.9	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.3	2.7	0.0	0.1	0.1	0.0	0.9	0.7	1.1	0.7	0.1	1.1	0.1	0.0	8.3	5.4	0.1	0.0	0.4	0.4	2.8	0.7	0.0	0.8	1.0	0.7	0.1	1.2	23.1	4.3	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	5.9	1.9	10.0	6.7	2.7	2.7	1.9	5.8	0.9	2.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	50.5	0.0	0.0	1.4	0.0	0.1	0.0	350.3	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	1.8	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	2.5	0.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	84.4	0.0	1.0	0.7	0.1	0.1	0.0	0.5	0.0	0.7	0.1	0.0	524.0	0.0	0.1	0.0	16.2	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"RUNX family transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.8;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 336.4;Langerhans cells: 133.9;NK-cells: 251.3;Plasma cells: 87.1;T-cells: 215.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 124.9;Karpas-707: 155.6;SK-MEL-30: 92.4;U-266/70: 54.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.5	1.4	3.7	21.1	3.6	68.8	3.5	3.8	4.6	19.7	3.7	3.7	5.0	1.6	0.7	2.6	1.6	5.3	1.1	3.6	3.8	1.6	3.7	9.5	34.7	4.7	4.4	0.6	0.9	0.4	0.7	0.9	4.3	1.9	4.2	0.1	4.7	0.8	3.8	11.5	15.0	1.6	4.1	35.1	5.5	2.3	4.3	11.2	1.8	0.7	29.0	6.5	1.5	4.5	0.3	10.4	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.5	0.0	0.5	0.0	19.3	18.4	16.4	0.1	0.4	11.1	0.0	0.7	124.9	1.9	0.4	1.8	0.1	0.0	4.5	42.8	0.1	0.0	0.0	1.1	0.0	0.0	3.1	0.1	155.6	0.0	0.0	1.5	37.9	0.7	0.0	3.2	0.0	0.1	22.7	0.0	0.5	3.5	0.0	7.3	0.1	92.4	2.9	0.0	25.7	0.0	0.0	1.9	0.0	0.5	54.6	40.4	18.2	0.1	42.0	4.4	0.7	1.1	7.0	21.7	4.5	11.3	6.7	7.9	18.7	1.4	5.7	3.9	14.6	1.3	28.7	7.7	1.5	9.2	5.5	3.7	3.6	3.8	4.6	3.6	3.8	4.7	4.4	4.3	4.1	4.3	4.5	4.4	0.0	3.6	0.0	57.7	7.6	0.8	4.6	2.2	0.0	9.8	11.3	2.4	0.0	1.5	1.8	0.0	0.1	336.4	0.5	0.0	0.2	2.3	1.1	1.2	2.4	0.0	13.7	0.0	0.2	0.1	3.3	13.3	2.3	45.2	0.0	2.2	1.5	4.6	0.0	0.0	0.5	0.0	22.9	133.9	1.0	0.0	55.6	46.2	1.0	51.1	0.0	251.3	0.0	0.1	0.1	0.1	0.7	87.1	1.2	0.0	0.3	0.5	0.0	0.0	3.5	3.6	0.3	4.1	2.3	5.8	0.3	215.4	0.1	0.4	0.4
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;pituitary gland: 29.9;retina: 24.3;skeletal muscle: 49.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 13.4;Cone photoreceptor cells: 25.0;Melanocytes: 28.4;Muller glia cells: 16.8;Sertoli cells: 13.1;Skeletal myocytes: 35.9"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 39.4"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (9.40e-5)"	"unprognostic (5.03e-2)"	2.4	3.2	14.6	0.4	16.6	0.0	1.0	11.7	17.4	3.0	11.7	4.1	0.7	1.1	0.7	1.0	2.8	0.6	5.3	12.4	21.5	0.2	0.3	2.8	0.3	25.6	14.8	1.0	2.1	0.1	29.9	0.7	22.2	1.1	2.0	24.3	1.2	1.4	49.7	2.3	1.6	1.2	13.6	0.4	1.4	1.0	32.1	0.1	0.7	7.6	0.0	1.6	2.1	15.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.0	0.0	39.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	16.6	11.7	17.4	12.4	21.5	25.6	14.8	22.2	13.6	32.1	15.6	0.9	0.0	0.0	13.4	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.6	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	2.8	5.0	0.0	28.4	0.0	0.0	16.8	0.0	1.0	1.3	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	4.5	13.1	35.9	3.4	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373711-153375621	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 3489.7"	"Group enriched"	"Detected in many"	20	"Kupffer cells: 711.7;Macrophages: 475.0;monocytes: 998.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 1321.1;neutrophil: 1781.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 1781.4;monocytes: 1321.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.6;THP-1: 1.6"					"Region enhanced"	"Detected in some"		"cerebral cortex: 4.0"	"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	NA	NA	28500000	8300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	54.9	3.2	2.6	82.0	3.1	3489.7	7.0	2.9	7.7	21.9	3.2	5.5	1.7	2.1	0.0	52.4	19.3	6.7	16.6	2.7	2.6	15.2	25.6	148.4	1.9	3.2	2.9	2.1	3.6	1.3	4.3	19.8	3.9	3.5	0.4	0.3	11.4	0.2	4.0	3.7	4.4	40.4	3.0	523.2	8.9	0.9	2.9	30.2	6.0	14.8	46.5	41.9	33.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	1321.1	5.2	1.9	44.9	1.0	3.2	0.8	1.5	122.7	1.0	1.1	0.5	1781.4	0.4	9.6	8.3	2.0	1031.8	2.6	3.1	2.9	7.7	2.7	2.6	3.2	2.9	3.9	3.0	2.9	2.9	0.0	19.2	24.4	0.0	6.1	0.1	0.3	9.8	0.0	0.0	0.1	0.0	1.1	8.6	9.2	1.8	0.0	0.5	2.9	0.0	0.0	0.1	1.4	0.0	0.0	2.1	0.0	14.1	0.1	0.2	0.9	4.1	1.1	0.0	13.9	0.0	6.8	3.8	8.6	0.0	0.1	0.0	0.0	711.7	0.8	1.8	0.0	475.0	0.0	1.0	998.3	0.0	36.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	7.8	0.0	0.0	0.8	0.4	0.0	0.2	5.7	0.0	0.5	6.9	0.0	0.1	0.2
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 3719.5;vagina: 1174.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 2340.8;Paneth cells: 1098.9;Proximal enterocytes: 1549.1;Squamous epithelial cells: 3205.8;Suprabasal keratinocytes: 3612.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 798.6;HaCaT: 1072.9;HBEC3-KT: 1527.6;hTCEpi: 2232.0;OE19: 1675.1;SK-BR-3: 1579.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		260000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	2.2	0.8	1.5	24.9	1.6	0.2	78.3	1.5	2.0	530.8	1.3	241.0	265.4	5.4	14.7	3719.5	20.4	18.5	4.2	1.5	1.5	70.1	16.3	82.7	0.6	1.5	1.5	1.4	17.7	125.2	5.1	1.1	1.5	19.6	240.0	0.0	550.3	39.0	2.2	608.0	209.0	13.1	1.4	1.3	119.2	0.7	1.7	149.0	98.6	0.0	449.7	32.9	1174.2	1.5	798.6	0.2	0.1	0.2	0.2	0.3	7.4	0.2	0.1	0.2	0.1	97.6	140.1	0.6	2.3	0.2	0.5	1072.9	0.0	1527.6	0.1	0.5	0.3	0.1	10.8	7.3	0.0	0.0	0.9	0.6	2232.0	0.5	20.7	0.3	0.3	0.1	0.6	1.1	0.2	140.0	0.7	1.1	0.4	1675.1	1.9	0.6	0.6	2.8	8.1	51.2	0.7	0.7	2.2	1579.1	2.1	36.5	3.9	1.7	0.0	0.7	0.8	1.1	2.0	0.4	0.8	0.9	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.5	2.0	1.5	1.5	1.5	1.5	1.5	1.4	1.7	1.5	2.7	60.9	162.6	2.3	4.2	2340.8	448.6	770.5	657.9	0.0	256.2	178.3	5.3	270.2	387.7	35.0	0.0	2.7	2.2	1058.2	49.0	197.5	0.0	37.3	6.4	21.5	153.4	0.0	0.0	65.8	1.5	22.8	85.6	80.3	28.0	0.2	1.1	9.5	0.3	0.0	0.0	660.1	126.1	0.3	213.7	0.0	0.0	3.0	241.9	0.0	2.0	0.0	0.0	0.0	0.1	343.0	1098.9	0.0	7.5	619.3	1549.1	4.9	56.2	0.0	0.0	1.3	27.1	0.0	0.0	3205.8	3612.0	0.3	8.7	13.6	580.9	824.9
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391073	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35382.0;esophagus: 24565.6;vagina: 11166.4"	"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 4126.5;Kupffer cells: 6348.0;Macrophages: 3758.3;monocytes: 6932.6;Squamous epithelial cells: 8480.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"classical monocyte: 26833.7;neutrophil: 52973.6"	"Group enriched"	"Detected in all"	9	"granulocytes: 52973.6;monocytes: 26833.7"	"Group enriched"	"Detected in some"	24	"hTCEpi: 241.8;SK-BR-3: 719.0;THP-1: 400.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	NA	NA	10900000	370000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	582.3	54.3	41.7	1245.8	45.6	35382.0	70.0	43.4	88.0	5650.6	45.5	55.2	15.4	23.1	5.5	24565.6	236.1	99.0	121.1	40.9	42.7	103.0	176.7	1061.7	29.5	47.7	44.8	25.8	52.0	9.6	41.7	205.8	50.7	43.1	14.7	5.6	3988.2	5.0	48.5	267.3	47.7	430.2	44.2	3239.5	93.8	16.2	45.5	281.3	48.8	174.8	8952.6	561.9	11166.4	46.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.0	1.3	0.0	0.3	12.4	0.0	18.7	0.0	0.1	0.0	3.5	0.0	0.0	0.0	5.6	0.1	0.0	241.8	0.0	7.5	0.0	0.0	0.0	9.6	1.2	0.0	0.9	0.4	1.5	0.3	0.0	0.0	0.4	5.8	1.0	0.0	0.0	0.4	0.5	3.6	719.0	0.0	0.0	4.7	400.6	10.6	0.0	0.2	0.9	0.1	0.2	1.3	2.7	0.3	13.9	0.0	848.0	26833.7	3023.7	33.4	1999.2	49.2	57.2	21.8	18.2	4686.1	23.5	21.6	23.3	52973.6	27.1	493.1	188.1	37.1	24979.9	41.7	45.6	43.4	88.0	40.9	42.7	47.7	44.8	50.7	44.2	45.5	46.2	1.1	224.4	489.8	0.0	77.2	19.6	3.5	4126.5	50.7	0.0	13.2	3.9	10.0	70.1	817.0	14.7	0.0	5.8	67.1	0.3	0.0	1.0	210.7	0.5	0.6	33.1	0.0	143.5	0.0	0.9	8.5	61.3	1.1	0.5	227.1	0.1	76.1	54.6	417.5	0.0	0.0	0.2	207.5	6348.0	5.1	172.4	4.1	3758.3	0.0	0.0	6932.6	0.0	289.4	0.0	0.0	1.4	0.0	1.5	26.1	0.9	0.0	25.0	162.8	0.0	0.0	7.7	32.3	2.1	1.0	8480.1	113.2	6.7	91.4	0.0	0.0	31.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062127-137070557	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.1;esophagus: 8.5;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 10.8;Oligodendrocyte precursor cells: 29.7;Undifferentiated cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 122.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	Yes				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	0.5	0.3	6.9	2.4	5.1	2.0	1.3	4.7	5.4	1.2	1.3	3.7	4.3	0.4	0.0	8.5	0.3	0.2	0.2	5.4	4.5	1.2	0.2	0.5	2.7	7.1	6.8	0.1	0.4	0.0	0.5	0.9	5.7	3.1	1.8	0.1	4.1	0.1	0.1	6.2	4.3	0.4	5.0	2.2	2.4	0.5	6.8	2.3	0.3	0.0	2.5	0.4	2.3	7.0	52.1	27.5	10.7	32.0	0.3	0.7	57.1	8.4	5.7	8.8	4.1	52.5	23.2	53.8	26.5	4.1	8.2	72.3	33.6	9.7	2.0	37.4	38.9	23.6	32.7	59.6	0.2	27.0	39.2	0.1	1.5	3.0	5.8	2.3	14.4	27.1	33.1	23.7	2.6	122.1	7.8	72.7	19.9	119.2	61.9	82.9	40.7	60.1	10.9	14.8	55.2	32.7	32.2	89.1	12.2	2.4	71.9	51.1	9.4	7.9	26.6	24.0	41.9	8.2	25.5	26.3	18.4	31.8	25.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	5.1	4.7	5.4	5.4	4.5	7.1	6.8	5.7	5.0	6.8	7.0	0.5	0.0	0.0	0.7	1.9	4.2	0.7	0.5	0.6	0.2	5.0	5.2	1.3	0.0	1.1	0.0	0.0	2.8	1.6	5.4	1.9	0.3	0.0	1.6	0.8	0.9	0.0	3.6	0.2	0.0	3.5	1.1	6.1	6.0	0.0	3.3	1.4	0.0	3.1	0.0	0.2	10.8	0.0	2.8	1.5	0.1	0.0	2.2	0.0	0.0	1.5	0.5	0.0	29.7	5.6	0.6	4.0	0.0	1.8	2.1	0.5	0.0	0.1	0.6	0.0	0.2	1.0	0.0	1.4	5.8	2.7	0.5	1.3	0.6	12.1	1.1
SASH3	"753P9, CXorf9, HACS2, SH3D6C, SLY"	ENSG00000122122	"SAM and SH3 domain containing 3"	O75995	X	129779949-129795201	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 108.1;intestine: 36.5;lymphoid tissue: 120.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 69.5;dendritic cells: 66.3;Hofbauer cells: 51.3;Kupffer cells: 58.9;Macrophages: 40.0;monocytes: 45.3;NK-cells: 101.0;Plasma cells: 39.8;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 164.1;JURKAT: 119.4;MOLT-4: 120.6;NB-4: 89.1;REH: 88.5;U-698: 150.2;U-937: 117.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001085	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		14000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Nucleoplasm, Nuclear bodies"	"HPA001085: AB_2184289"	"unprognostic (1.88e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.49e-3)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.92e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (3.30e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.53e-1)"	8.6	5.6	5.2	61.8	5.6	108.1	4.3	5.4	7.4	3.2	5.1	9.4	11.6	3.1	1.8	3.6	4.9	10.2	2.7	4.8	6.4	3.7	5.9	21.3	120.6	9.6	7.0	1.8	2.5	1.5	2.2	7.5	8.4	4.2	9.9	0.2	7.9	2.2	1.3	2.1	36.5	7.5	7.5	100.3	13.6	1.3	8.4	120.7	3.9	1.7	108.2	15.4	3.0	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	58.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	119.4	0.2	13.6	0.0	0.0	120.6	89.1	0.0	0.0	0.0	88.5	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	24.0	0.3	0.0	0.3	0.1	0.1	0.1	35.0	150.2	0.0	117.2	0.0	41.6	135.4	245.5	192.2	195.3	159.1	79.1	108.2	178.9	121.5	90.8	76.9	120.9	128.0	153.3	209.9	55.1	145.6	343.7	5.2	5.6	5.4	7.4	4.8	6.4	9.6	7.0	8.4	7.5	8.4	10.2	0.8	0.0	3.6	0.0	69.5	0.5	0.1	0.0	0.0	0.0	0.5	1.1	1.0	1.5	0.0	0.0	0.0	0.5	66.3	0.1	0.0	0.1	0.1	0.2	0.2	1.2	0.0	13.5	0.2	0.0	0.6	0.9	2.6	0.3	22.2	0.0	3.3	0.9	51.3	0.0	0.2	0.1	0.0	58.9	19.1	0.0	0.3	40.0	0.0	7.5	45.3	0.0	101.0	0.0	0.1	0.0	0.0	0.0	39.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.1	1.3	0.5	60.6	0.0	0.1	0.0
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 13.9;intestine: 39.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 129.7;Enteroendocrine cells: 99.7;Excitatory neurons: 363.9;Intestinal goblet cells: 66.9;Paneth cells: 70.0;Undifferentiated cells: 84.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Group enriched"	"Detected in many"	84	"basal ganglia: 10.9;cerebral cortex: 13.9;hippocampal formation: 4.6;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 45.1;THP-1: 59.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 29.2"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 46.4;hippocampal formation: 37.1"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"CAB023669: AB_1129287, CAB062562: AB_2665615, CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.7	4.8	0.0	4.3	10.9	0.3	2.2	0.0	13.9	2.7	0.0	34.2	1.5	1.7	0.9	0.8	1.4	1.3	0.7	4.6	0.0	4.0	3.0	0.9	0.5	0.0	0.0	1.9	3.9	2.1	1.0	0.6	0.0	1.9	39.5	0.8	1.5	2.8	2.2	1.8	5.7	3.0	0.0	0.7	1.0	2.8	0.0	0.2	1.6	2.7	1.0	1.6	3.1	3.9	2.6	1.7	17.6	8.1	8.3	9.9	1.3	6.2	8.9	4.4	5.7	0.4	5.8	0.9	0.2	13.3	6.9	0.5	14.0	3.7	7.0	9.4	12.3	40.3	4.1	4.9	1.9	18.7	17.1	4.8	6.4	8.8	5.6	11.3	0.4	6.0	45.1	0.0	12.8	0.9	0.8	22.9	3.2	2.0	2.9	1.7	6.0	0.1	6.6	0.6	3.8	0.0	3.1	0.0	9.5	3.1	3.6	59.8	6.2	31.5	5.9	10.1	16.6	2.6	8.9	25.9	21.7	14.6	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	13.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.4	0.0	1.1	18.6	0.6	1.8	2.7	0.5	0.6	2.4	0.9	0.4	1.5	0.0	0.7	0.0	4.2	0.1	0.2	129.7	1.9	0.3	1.0	0.9	3.9	1.5	99.7	0.0	363.9	2.7	0.3	3.6	0.0	0.7	0.0	1.6	1.8	5.4	0.8	0.0	3.5	66.9	0.0	2.5	3.0	0.9	2.5	1.0	5.4	9.4	0.6	0.5	0.0	21.1	34.1	1.2	70.0	1.2	0.0	4.3	19.1	7.6	0.2	0.5	0.0	1.7	10.4	6.1	4.1	0.8	3.0	0.1	1.3	3.9	84.7	2.2
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 179.9;parathyroid gland: 103.1;retina: 283.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"plasmacytoid DC: 27.7"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 27.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	3.0	20.6	106.7	4.3	125.2	2.6	3.1	75.1	179.9	2.8	12.5	5.8	41.6	5.7	3.6	1.5	5.0	5.6	5.5	128.7	74.8	16.7	4.2	2.8	7.9	113.9	67.4	6.0	53.4	103.1	67.7	6.7	112.5	4.6	4.9	283.7	7.2	2.7	0.6	2.1	30.4	3.2	35.8	8.5	15.6	10.7	80.6	4.4	6.5	0.8	10.0	5.9	1.8	124.4	1.5	17.8	3.8	12.6	0.3	0.2	0.5	0.4	0.6	4.0	1.4	4.9	8.9	28.0	8.5	1.1	3.3	1.2	15.6	1.1	1.4	4.4	2.0	3.5	2.1	25.8	2.7	0.4	11.5	1.3	2.1	1.0	0.3	2.8	1.7	10.1	0.2	22.1	1.0	15.1	1.1	10.2	13.4	2.1	7.1	0.4	3.2	6.7	1.0	8.6	88.1	49.3	19.8	13.6	27.6	2.7	7.7	34.0	1.1	1.2	8.2	1.6	1.3	1.8	2.4	2.6	3.0	21.2	4.3	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.8	0.4	0.1	27.7	0.0	0.4	106.7	125.2	75.1	179.9	128.7	74.8	113.9	67.4	112.5	35.8	80.6	124.4	2.2	0.0	1.1	14.7	2.5	0.3	0.5	0.4	2.8	113.3	3.2	2.7	3.0	7.2	0.4	5.5	125.1	0.1	35.5	2.9	1.9	4.4	0.5	0.4	0.7	3.6	62.5	0.0	75.1	43.3	0.3	1.9	12.8	0.3	0.0	4.1	6.8	0.6	13.8	70.7	99.3	5.0	0.0	6.9	0.2	0.7	2.1	2.0	1.8	6.5	0.4	29.9	0.0	32.2	26.2	6.8	5.3	6.4	8.9	0.8	34.0	13.0	2.7	168.0	0.0	0.9	2.8	1.8	4.7	1.7	0.1	0.1	0.6	2.0	2.7	0.3
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645744	"Predicted intracellular proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.9;Endothelial cells: 51.3;Hepatic stellate cells: 62.4;Langerhans cells: 37.7;Microglial cells: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 12.1;REH: 11.5;TIME: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035108, HPA072936"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA035108: AB_10670289, HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.2	5.0	1.5	3.1	1.8	0.4	12.7	1.4	3.4	5.6	1.4	5.2	0.0	6.0	0.9	2.7	6.5	2.2	11.8	1.6	1.8	7.5	7.5	16.3	2.1	2.7	1.7	2.6	3.1	0.1	3.8	4.3	2.2	4.6	1.2	0.2	4.2	0.0	5.3	3.1	5.4	1.2	1.7	25.6	4.2	1.6	1.7	0.5	18.8	1.9	1.0	5.6	4.6	2.8	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.3	12.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	11.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	37.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	1.8	1.4	3.4	1.6	1.8	2.7	1.7	2.2	1.7	1.7	2.8	65.9	22.4	17.6	6.5	0.6	3.4	0.4	0.7	1.2	1.2	0.8	0.9	3.5	0.0	2.9	3.7	4.2	0.4	2.0	4.9	1.9	0.4	0.3	0.5	0.9	51.3	0.0	3.4	5.4	0.2	0.2	2.5	4.1	1.1	3.8	0.3	62.4	2.3	9.0	0.0	3.5	4.4	0.0	15.7	37.7	0.4	1.2	10.1	3.6	26.2	4.8	0.7	0.0	0.5	1.1	0.3	1.2	1.2	0.0	0.7	3.0	0.2	3.0	2.0	0.0	2.1	3.0	0.5	0.6	0.3	2.7	1.2	1.0	1.3	2.2	0.8
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.0;pituitary gland: 402.7"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.7	61.1	54.0	3.3	62.0	0.3	3.7	52.2	100.4	1.0	77.3	7.9	17.9	5.3	42.5	0.5	3.4	5.5	1.3	58.9	75.1	0.9	3.6	3.8	1.3	56.5	48.3	3.2	133.0	73.7	402.7	0.3	58.7	5.0	9.8	26.7	0.2	0.9	0.2	1.3	5.6	6.7	57.7	0.5	37.8	5.3	56.3	0.3	5.8	0.1	0.3	2.6	2.7	58.9	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	62.0	52.2	100.4	58.9	75.1	56.5	48.3	58.7	57.7	56.3	58.9	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208673-62213943	"Cancer-related genes, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix: 2021.0;epididymis: 1372.0"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2506.4;Glandular and luminal cells: 2597.0"	"Cancer enriched"	"Detected in many"	5	"endometrial cancer: 971.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 8.6"									HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (1.22e-4)"	"prognostic favorable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favorable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.2	0.0	0.0	57.8	0.0	0.0	2021.0	0.1	12.7	1.3	118.8	1372.0	4.2	238.4	13.4	0.2	0.1	0.4	1.9	0.1	2.4	0.0	3.5	1.4	0.7	17.2	1.1	5.1	0.1	0.8	6.8	16.3	0.0	29.6	15.6	0.0	8.6	1.0	2.2	0.5	0.0	45.9	0.0	1.1	2.7	5.8	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.7	0.1	0.0	1.6	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.5	1.4	0.8	0.5	1.1	0.2	0.6	0.0	4.8	0.0	0.4	0.1	3.8	4.8	0.0	0.0	123.6	71.0	0.0	48.6	10.1	16.5	0.0	0.2	1.6	9.7	3.9	6.6	0.0	2506.4	397.7	7.6	37.1	0.0	0.0	5.3	0.0	3.8	26.5	2597.0	0.0	0.3	0.0	0.1	4.9	0.0	0.0	59.9	10.2	0.3	0.0	0.0	0.0	14.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	15.3	10.8	0.0	0.0	27.0	0.7	0.1	109.3	0.0	0.0	0.0	8.5	0.0	0.0	1.7	0.4	0.0	13.7	0.1	7.0	16.6
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCIMP	"C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783"	ENSG00000161929	"SLP adaptor and CSK interacting membrane protein"	Q6UWF3	17	5208920-5234860	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.4;Hofbauer cells: 26.2;Kupffer cells: 120.3;Macrophages: 66.3;monocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.7"	"Group enriched"	"Detected in many"	8	"classical monocyte: 110.6;intermediate monocyte: 239.0;memory B-cell: 145.8;myeloid DC: 84.2;naive B-cell: 124.5;non-classical monocyte: 265.5"	"Group enriched"	"Detected in all"	9	"B-cells: 145.8;dendritic cells: 84.2;monocytes: 265.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 6.8;U-698: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006117	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA006117: AB_1858633"	"unprognostic (2.53e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.95e-2)"	5.9	4.1	0.0	30.4	0.1	5.1	1.4	2.7	1.3	1.5	3.6	4.5	5.4	2.9	1.1	1.9	3.1	7.3	1.7	0.3	0.0	2.3	10.6	16.2	39.4	0.6	0.1	3.6	3.9	0.8	0.7	3.9	0.1	3.1	4.6	7.5	4.0	1.4	4.3	3.2	10.2	6.1	0.0	49.2	5.0	2.8	0.0	5.1	3.4	0.8	44.9	6.0	0.6	0.4	1.0	1.5	2.5	3.3	0.0	0.0	2.5	1.1	0.0	0.0	0.0	0.7	2.1	4.8	0.9	0.0	1.8	1.0	0.0	0.0	0.0	0.8	2.1	2.0	6.8	0.7	0.0	0.2	0.7	0.0	0.1	0.0	0.2	1.2	0.0	4.2	0.1	1.2	0.0	1.6	2.4	0.7	1.1	0.3	1.4	2.2	0.5	0.5	0.0	0.6	1.8	0.8	1.8	0.6	1.3	0.7	2.6	2.4	0.3	0.3	1.1	1.4	0.6	0.7	0.3	10.8	1.2	0.3	0.7	16.8	110.6	3.0	1.3	239.0	1.5	145.8	0.8	1.2	84.2	124.5	1.7	1.2	19.0	5.3	265.5	3.2	1.4	68.0	0.0	0.1	2.7	1.3	0.3	0.0	0.6	0.1	0.1	0.0	0.0	0.4	0.5	0.0	4.4	2.6	66.4	0.4	0.4	0.0	0.0	2.5	0.4	0.5	0.4	1.5	0.6	0.0	12.5	0.3	1.5	0.0	0.0	0.7	1.4	0.4	0.3	2.0	0.0	0.4	6.5	0.9	0.3	0.6	0.0	0.1	1.3	0.4	3.3	1.9	26.2	1.7	4.9	0.0	0.0	120.3	4.2	0.7	0.3	66.3	0.0	8.4	60.3	0.4	10.3	4.0	2.3	0.4	0.0	0.4	1.7	0.3	0.0	1.0	1.6	4.1	0.0	0.7	0.3	0.5	0.8	0.0	0.4	0.1	3.2	0.2	0.0	0.4
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845764-39052157	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;placenta: 1.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.4;Astrocytes: 7.8;Early spermatids: 7.0;Sertoli cells: 6.6;Spermatocytes: 4.4;Spermatogonia: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036746, HPA036747"	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.5	0.1	0.4	0.2	0.2	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.4	0.3	0.5	0.2	0.1	0.2	0.3	0.4	0.1	0.1	0.0	0.3	1.9	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.4	0.5	0.3	0.3	3.0	0.1	1.3	0.5	0.2	0.1	0.0	0.1	0.8	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.5	0.4	5.4	0.0	0.0	7.8	0.1	0.8	0.9	0.0	0.0	0.2	0.2	0.3	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	7.0	0.4	0.5	2.5	0.0	2.7	1.6	0.2	0.1	0.6	0.0	0.2	0.0	1.1	1.4	0.4	0.3	0.0	1.0	0.0	0.0	0.3	1.6	2.1	0.0	0.2	1.8	0.0	0.1	0.5	0.0	1.5	2.4	0.1	0.0	0.0	0.1	0.7	0.0	0.2	2.3	0.5	6.6	1.0	0.4	4.4	6.3	0.0	0.9	0.3	0.6	0.7	0.0	0.8
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 26.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 440.4;Inhibitory neurons: 364.7;Oligodendrocyte precursor cells: 246.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.1;U-138 MG: 3.4;U-266/84: 8.1;U-87 MG: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	0.2	1.3	15.8	0.1	17.5	0.0	0.7	26.1	20.1	0.2	0.0	0.1	0.2	0.5	0.9	0.0	0.1	0.8	0.1	22.2	8.0	3.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.1	0.0	0.1	0.1	4.6	0.2	0.4	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.3	2.5	0.3	0.0	0.0	0.0	0.1	0.3	5.8	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.3	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.2	0.2	0.0	0.3	8.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	17.5	26.1	20.1	22.2	8.0	0.0	0.0	0.0	0.0	2.5	5.8	0.1	0.0	1.7	18.3	0.5	0.3	0.1	0.2	0.0	49.8	0.3	4.7	0.8	0.0	0.0	11.0	47.9	0.1	0.2	0.0	5.9	0.2	1.6	0.1	2.3	0.3	0.0	0.0	440.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.2	364.7	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	60.9	0.0	3.4	0.0	246.3	17.0	0.3	0.0	6.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	0.6	0.0	0.9	0.1	0.1	0.0	0.4	1.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 subunit alpha"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 157.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 114.0;Distal enterocytes: 230.9;Glandular and luminal cells: 189.8;Intestinal goblet cells: 180.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 6.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 300.5;HBEC3-KT: 202.4;hTCEpi: 85.3;RPTEC TERT1: 103.7;RT4: 114.1;SK-BR-3: 96.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	3.4	12.5	0.2	5.6	0.1	0.5	20.6	1.1	0.2	64.7	113.6	66.4	18.7	7.6	43.2	140.1	57.9	17.7	0.7	6.8	0.0	148.5	8.2	62.9	0.2	0.1	0.3	3.5	40.0	0.7	16.6	0.4	0.1	43.7	65.4	0.0	157.3	49.5	0.5	54.6	26.0	2.9	0.1	0.7	63.6	4.7	1.3	1.9	94.3	0.1	12.5	20.8	57.6	0.1	21.6	4.1	0.0	1.9	0.3	0.4	17.6	0.0	0.1	0.1	0.0	6.1	300.5	0.3	0.8	0.1	0.1	14.0	0.0	202.4	0.0	0.0	0.0	0.0	17.5	3.1	20.9	0.0	0.1	5.1	85.3	0.0	61.6	0.4	0.0	0.5	0.0	0.1	0.5	1.9	0.1	0.3	17.6	38.9	0.8	0.2	0.0	0.5	103.7	114.1	1.2	0.1	2.3	96.7	0.1	17.1	22.3	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	1.5	0.0	0.0	1.0	0.5	0.1	0.2	0.1	1.1	0.2	6.8	0.0	0.1	0.3	0.1	0.1	1.3	0.1	1.7	73.7	75.7	0.0	1.3	1.9	25.1	17.0	10.8	0.9	17.7	21.2	0.8	54.3	52.5	114.0	4.2	1.4	1.8	230.9	5.9	45.0	0.5	85.3	17.8	3.2	27.1	0.0	0.3	33.9	0.3	2.0	97.3	189.8	2.5	1.3	1.4	3.2	0.3	1.7	0.2	180.3	63.1	1.9	3.1	0.6	1.8	2.5	0.0	0.0	1.6	0.3	1.0	0.5	0.1	39.4	95.8	1.5	0.3	30.9	12.2	6.2	36.7	1.4	0.0	5.6	4.3	1.2	3.7	48.1	8.8	1.6	3.6	0.2	31.5	42.1
SCRG1	SCRG-1	ENSG00000164106	"Stimulator of chondrogenesis 1"	O75711	4	173384701-173406380	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;choroid plexus: 15.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.4;Muller glia cells: 148.3;Oligodendrocyte precursor cells: 102.1"	"Cancer enriched"	"Detected in many"	6	"glioma: 35.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"WM-115: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012882	Approved				"Secreted in brain"	NA	NA		240000	"Cluster 17: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"HPA012882: AB_1856635"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-5)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.95e-10)"	"unprognostic (4.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.34e-3)"	"unprognostic (8.74e-4)"	1.3	0.8	19.0	0.6	20.5	0.7	0.5	20.6	30.7	1.6	15.2	4.4	0.5	1.8	0.9	0.4	2.5	1.5	2.9	19.4	20.3	0.2	0.1	0.4	0.2	22.8	19.9	0.8	0.3	0.0	1.0	0.2	22.5	2.3	0.5	2.3	1.1	3.2	0.5	0.5	0.9	4.7	21.6	0.5	2.8	10.8	19.4	0.0	0.3	0.0	0.1	2.0	0.8	24.7	0.1	0.0	0.6	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.5	0.2	0.1	3.5	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	17.1	1.8	0.5	0.3	0.2	0.4	0.1	0.2	0.1	0.2	0.2	0.3	0.2	0.3	1.2	0.5	0.5	0.3	0.1	0.1	19.0	20.5	20.6	30.7	19.4	20.3	22.8	19.9	22.5	21.6	19.4	24.7	1.3	0.0	3.0	46.4	1.0	3.6	1.1	0.0	0.0	14.5	2.4	3.9	1.3	0.0	0.7	0.0	37.5	0.2	3.3	0.3	0.0	0.3	18.3	0.7	1.7	2.1	1.2	0.0	19.0	0.0	0.4	17.3	1.1	0.4	8.9	0.9	4.2	0.3	0.6	16.8	20.9	0.5	0.0	3.3	2.6	32.3	26.1	3.8	23.2	2.8	1.9	148.3	2.1	102.1	26.4	0.2	0.1	20.7	1.0	1.9	0.4	0.3	0.8	28.3	13.1	2.4	20.3	3.1	2.4	0.1	2.6	0.7	3.1	0.5	0.3	1.0
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 491.6;liver: 484.7;skin 1: 447.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"midbrain: 17.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	3100000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 22: Epithelial cell types - Mixed function"	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	2.4	17.4	0.7	17.2	0.2	1.2	23.8	2.3	0.8	127.2	0.7	61.8	75.8	2.2	19.9	491.6	10.5	77.1	0.6	0.3	2.0	99.5	484.7	59.6	7.3	0.6	17.3	1.6	16.6	5.4	2.0	32.6	0.8	56.3	33.3	0.7	85.8	25.9	1.6	447.4	53.6	2.2	0.2	20.1	87.3	3.3	2.5	5.1	18.3	0.0	43.2	104.8	242.1	0.1	252.6	137.6	42.7	108.1	11.6	1.6	134.9	68.7	65.4	62.7	52.8	29.5	148.9	0.3	24.8	48.8	34.8	241.4	19.0	482.2	41.8	1.3	12.5	0.0	12.2	150.2	10.3	11.0	1.0	6.4	436.6	56.5	132.9	87.2	6.9	0.0	6.4	94.7	34.0	149.6	0.6	2.6	38.7	189.6	263.1	5.3	15.7	189.9	80.5	370.0	12.4	99.7	51.9	342.4	15.2	17.1	34.5	2.8	10.7	246.9	78.6	9.2	470.0	467.4	1069.8	1.0	74.5	0.6	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	2.3	0.8	0.3	2.0	0.6	17.3	0.8	0.2	2.5	0.1	0.4	93.0	99.0	0.0	33.0	113.9	189.1	162.8	81.4	0.6	29.9	26.7	0.9	267.4	161.8	42.3	0.0	3.8	0.7	147.2	31.3	61.3	0.1	16.6	5.0	3.5	10.8	13.5	0.3	21.8	46.3	5.0	55.0	22.9	6.3	7.5	7.5	603.1	2.3	21.9	0.2	73.1	50.8	10.6	11.9	0.3	0.6	2.5	21.4	0.0	0.6	0.3	0.0	1.0	0.0	111.4	78.0	1.2	165.1	78.0	106.5	88.5	43.4	0.4	0.0	0.1	15.0	1.0	14.0	246.6	229.0	250.8	4.0	0.1	85.1	492.8
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493813-96611790	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 460.8;thyroid gland: 424.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 229.7;Hepatocytes: 235.5;Smooth muscle cells: 183.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.6"	"Cell line enhanced"	"Detected in many"		"AF22: 643.1;EFO-21: 297.8;fHDF/TERT166: 288.4;RPTEC TERT1: 341.3;U-138 MG: 305.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA044416"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB025123: , HPA044416: AB_2678934"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.23e-1)"	109.5	36.3	35.2	35.9	41.0	10.2	66.6	37.6	49.9	157.0	26.4	77.9	21.8	76.0	15.2	50.1	84.6	44.5	68.9	32.1	51.8	88.9	460.8	56.8	18.9	41.1	46.6	170.5	61.2	30.2	61.5	124.4	37.5	63.4	40.1	29.7	25.0	104.4	19.9	25.3	39.8	90.9	38.5	25.8	41.9	25.5	49.6	5.3	424.5	58.5	8.0	84.0	58.1	33.7	0.5	0.3	643.1	0.3	230.2	214.1	0.6	94.8	113.4	54.3	60.5	19.8	0.2	0.2	297.8	288.4	8.0	0.5	114.3	1.8	47.1	0.3	44.4	0.6	56.7	250.2	7.4	1.9	2.9	83.1	2.8	123.5	3.1	210.2	1.9	0.1	64.3	0.3	23.1	6.0	0.3	16.9	68.1	0.0	0.7	0.7	101.5	2.4	341.3	57.2	19.1	49.5	0.2	0.3	4.9	217.8	27.6	73.0	51.3	305.1	91.5	1.5	53.2	6.0	0.3	1.1	96.9	0.4	97.5	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	13.6	0.0	0.1	0.0	0.0	0.6	35.2	41.0	37.6	49.9	32.1	51.8	41.1	46.6	37.5	38.5	49.6	33.7	11.9	57.7	38.1	93.7	1.7	53.8	78.9	29.6	15.9	36.6	41.4	30.2	32.7	37.1	5.1	57.0	12.5	1.9	0.5	0.1	29.4	14.4	31.6	29.3	65.1	10.7	3.5	10.7	4.6	15.3	2.5	229.7	9.7	76.4	1.3	44.3	17.5	235.5	109.8	5.0	22.0	1.5	138.4	20.5	154.7	18.6	52.5	62.9	62.2	21.5	68.2	17.4	0.0	7.1	1.7	8.9	1.2	104.9	2.5	41.7	0.8	56.4	4.0	12.5	32.9	100.0	183.1	5.5	57.6	1.3	39.2	3.8	4.2	33.3	5.7	17.6
SDC3	"N-syndecan, SYND3"	ENSG00000162512	"Syndecan 3"	O75056	1	30869466-30908758	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 140.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.6;Endometrial stromal cells: 59.8;Kupffer cells: 174.8;Late spermatids: 82.4;Oligodendrocyte precursor cells: 108.6"	"Group enriched"	"Detected in all"	5	"glioma: 115.2;melanoma: 102.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 249.5;WM-115: 342.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017087, CAB025786, HPA048085"	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"CAB025786: , HPA017087: AB_1857706, HPA048085: AB_2680256"	"unprognostic (1.42e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.83e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (9.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (6.45e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.80e-3)"	"unprognostic (1.46e-1)"	33.9	99.1	103.9	22.9	123.9	3.0	17.9	97.0	105.4	36.5	38.1	57.3	12.3	62.3	12.3	17.6	29.8	30.0	22.7	91.6	111.1	10.4	22.3	22.5	36.4	140.3	121.2	9.3	7.5	13.2	11.8	18.1	107.9	26.9	14.6	27.2	15.9	52.7	27.1	10.1	16.5	66.2	112.4	91.0	19.7	3.3	124.4	6.4	9.8	9.1	7.6	32.7	13.4	91.9	12.9	10.4	80.4	36.5	60.6	14.8	13.8	31.4	48.0	15.0	9.5	2.0	12.3	0.9	68.6	95.3	21.8	16.3	8.7	7.6	10.0	5.7	6.3	0.0	4.1	1.8	56.9	0.3	8.2	35.4	35.9	1.0	15.4	86.6	20.1	3.6	6.2	0.5	30.6	15.0	0.3	0.2	36.4	10.2	9.4	0.8	75.2	2.8	19.7	14.9	28.9	17.5	40.3	5.7	249.5	50.8	5.7	6.1	19.3	18.6	28.2	2.0	7.5	0.1	0.5	0.9	1.9	0.2	342.9	1.1	0.3	0.2	0.1	0.6	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.2	0.2	0.2	103.9	123.9	97.0	105.4	91.6	111.1	140.3	121.2	107.9	112.4	124.4	91.9	37.3	0.0	2.2	64.6	0.5	2.5	3.4	4.7	4.0	9.6	14.9	25.5	4.9	14.3	2.6	47.8	0.0	2.1	0.2	0.8	0.0	10.7	17.7	14.1	59.8	17.9	3.0	0.0	14.7	3.1	3.4	16.6	3.1	28.6	0.0	17.5	20.3	1.0	14.3	0.0	13.9	1.1	6.1	174.8	3.1	82.4	2.1	24.4	19.6	18.7	4.0	2.5	1.0	108.6	6.8	6.0	1.3	7.9	1.5	8.5	0.0	0.6	0.4	27.8	0.0	1.1	9.1	0.7	0.4	1.3	2.3	3.6	2.3	15.4	1.6	5.7
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329139	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 141.8;intestine: 136.9;stomach 1: 101.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 782.5;Pancreatic endocrine cells: 755.4;Paneth cells: 948.5;Proximal enterocytes: 470.3;Urothelial cells: 641.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.6;OE19: 57.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	7.3	3.4	19.9	10.1	20.7	0.7	6.9	16.3	24.3	25.8	15.2	85.8	136.9	5.7	9.0	141.8	4.3	41.8	4.6	19.6	20.2	16.0	18.1	20.9	1.3	17.2	17.9	3.5	15.2	2.5	3.9	3.3	17.4	6.5	55.5	1.0	29.8	2.5	2.8	62.9	133.0	3.6	16.9	3.1	101.8	5.6	20.3	1.5	14.6	1.4	13.7	38.2	49.9	18.0	10.9	0.5	1.4	0.5	5.8	5.1	0.9	3.2	6.3	2.8	2.7	2.3	18.6	1.1	2.1	1.2	2.0	8.2	0.5	15.5	1.4	0.4	1.0	0.9	0.6	1.5	5.8	1.1	1.2	1.8	10.8	2.2	2.2	6.0	9.6	2.0	1.5	0.7	1.1	2.6	1.7	3.0	1.3	57.3	0.7	1.6	0.7	2.2	1.2	14.4	2.4	1.9	1.5	9.3	3.6	0.6	0.4	0.9	6.5	1.5	0.6	2.8	1.2	2.8	2.7	1.1	0.7	4.1	0.9	0.1	0.8	1.9	0.9	0.3	0.7	0.2	1.2	0.9	1.0	0.4	1.0	1.8	0.8	0.9	0.6	0.7	2.3	0.7	19.9	20.7	16.3	24.3	19.6	20.2	17.2	17.9	17.4	16.9	20.3	18.0	15.6	16.0	4.2	0.0	4.1	55.7	112.0	198.1	3.4	1.0	4.9	4.8	0.8	72.9	172.6	16.5	0.0	1.8	1.0	782.5	27.4	114.5	17.1	25.8	11.7	14.1	35.9	0.0	0.0	209.7	1.1	4.6	201.8	85.4	8.9	1.0	7.1	5.1	0.9	1.7	0.0	150.8	156.6	1.9	6.4	1.9	1.5	1.8	8.8	0.0	2.3	1.0	2.1	0.0	0.0	755.4	948.5	0.0	0.7	107.0	470.3	1.8	89.6	0.9	0.0	1.7	9.9	5.0	7.6	31.1	95.6	1.6	3.5	2.0	109.2	641.9
SDK2	"FLJ10832, KIAA1514"	ENSG00000069188	"Sidekick cell adhesion molecule 2"	Q58EX2	17	73334384-73644445	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.5;cervix: 5.5;testis: 9.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 16.0;Enteroendocrine cells: 14.9;Excitatory neurons: 18.9;Extravillous trophoblasts: 17.1;Horizontal cells: 20.2;Inhibitory neurons: 14.8;Late spermatids: 20.0;Syncytiotrophoblasts: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.8;BEWO: 11.4;RPMI-8226: 4.7;SuSa: 7.2;U-2 OS: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014725			Approved	Nucleoplasm		NA	NA		5300000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA014725: AB_2183303"	"unprognostic (7.22e-4)"	"unprognostic (5.57e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.62e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (7.69e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.64e-2)"	0.1	0.5	3.9	1.1	2.9	0.6	0.6	1.2	2.8	5.5	0.0	0.6	0.1	1.6	1.3	0.6	2.4	0.6	0.9	5.4	1.9	0.3	0.1	1.1	1.1	6.5	3.2	0.3	0.1	0.9	1.4	0.3	6.5	1.8	0.3	0.9	0.6	0.7	0.2	0.5	0.8	0.2	2.0	2.7	0.5	9.7	3.7	0.7	1.3	0.3	1.0	0.4	0.7	3.7	0.0	2.0	13.8	3.9	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	3.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.5	0.0	4.7	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.7	0.0	0.0	4.2	1.8	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	3.9	2.9	1.2	2.8	5.4	1.9	6.5	3.2	6.5	2.0	3.7	3.7	0.4	0.0	2.7	6.5	4.4	0.9	4.6	9.9	2.8	6.8	0.8	5.0	2.0	1.5	1.9	0.0	0.0	6.7	0.2	0.2	0.0	0.3	16.0	0.5	3.9	0.8	14.9	0.4	18.9	0.2	17.1	4.6	0.5	1.0	1.3	5.6	0.0	0.0	0.6	20.2	14.8	0.4	0.0	0.0	0.2	20.0	0.6	0.6	1.8	2.8	1.1	9.7	0.0	6.6	6.6	0.0	0.0	0.0	1.3	2.3	0.0	0.3	0.2	0.8	0.0	1.2	0.9	10.7	3.5	0.3	0.1	17.8	0.8	10.4	0.0	1.1
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	142.9	138.1	66.2	83.4	69.4	172.2	136.2	69.0	80.4	147.1	76.6	110.8	82.9	111.0	202.5	81.6	103.6	97.5	98.4	63.7	72.6	137.2	152.3	107.9	112.6	74.1	67.2	168.6	139.4	114.6	84.5	115.1	73.9	82.0	124.9	37.0	95.9	87.5	154.3	70.5	86.4	96.3	72.4	86.2	95.3	61.5	69.4	93.2	177.5	147.4	98.2	137.3	94.0	75.3	201.7	320.7	286.7	425.4	368.5	462.8	225.4	310.1	356.5	241.9	291.2	347.1	443.0	99.0	198.8	370.3	277.2	408.3	409.1	243.4	255.5	267.1	239.4	279.4	358.8	324.9	311.7	213.4	281.2	315.8	305.0	169.1	285.1	366.0	337.9	116.7	295.8	244.3	315.1	363.1	89.2	345.8	282.1	266.2	135.4	101.6	368.4	302.9	472.6	424.4	131.2	300.8	257.3	239.5	598.5	407.0	248.5	416.6	254.3	240.0	181.0	209.8	361.9	224.4	509.6	150.0	226.4	331.7	180.6	83.5	161.1	89.7	95.1	173.7	95.0	101.0	114.8	104.7	165.8	90.0	95.1	98.0	111.6	134.3	184.8	160.9	168.8	200.8	66.2	69.4	69.0	80.4	63.7	72.6	74.1	67.2	73.9	72.4	69.4	75.3	261.1	89.8	99.1	25.8	131.8	107.1	179.4	356.6	90.5	30.0	163.7	202.6	68.2	228.8	188.0	128.8	22.9	309.1	171.9	111.1	238.7	258.8	46.3	118.5	268.0	217.2	157.4	101.7	21.2	247.3	655.3	206.0	120.8	184.1	218.4	191.0	197.7	165.5	363.3	20.2	22.8	218.7	168.9	386.7	337.2	100.6	299.5	337.3	158.3	24.4	396.7	110.5	204.9	26.7	38.3	183.4	136.3	166.3	197.9	185.7	142.7	350.9	99.3	38.2	170.9	173.5	225.5	233.5	169.6	135.2	119.9	305.8	153.4	237.6	210.7	242.2
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77088749-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 430.3;Hepatic stellate cells: 286.3;Late spermatids: 740.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 355.0"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 355.0"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 398.1;TIME: 251.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	66.7	54.2	42.6	44.6	63.3	65.5	57.6	75.4	60.7	39.5	36.3	19.5	21.8	24.6	28.2	31.5	27.3	34.3	50.2	49.5	57.5	42.0	25.3	66.9	49.7	64.0	63.0	20.7	30.8	25.1	27.9	76.7	54.6	18.3	19.8	19.0	35.0	16.8	94.1	20.5	21.7	27.1	46.2	49.9	31.7	51.9	63.6	24.1	41.6	54.7	46.2	26.0	20.6	50.9	55.0	45.4	65.6	105.0	27.4	36.3	24.1	47.4	42.0	57.8	49.5	55.7	39.6	143.1	93.3	65.0	71.1	26.3	36.0	47.8	72.6	27.3	50.1	81.1	42.4	75.9	44.4	26.8	39.8	46.6	20.7	47.8	47.8	69.1	398.1	24.3	55.8	136.0	79.2	36.2	28.5	22.4	25.0	25.7	43.7	20.3	104.2	112.2	91.2	26.2	59.5	44.8	51.1	31.3	32.1	58.3	27.9	20.7	251.1	65.4	60.6	35.0	37.7	71.1	64.8	79.9	27.9	22.1	21.6	33.8	19.4	48.9	7.1	28.3	8.9	14.6	6.9	5.3	12.7	10.8	10.9	5.9	355.0	10.0	33.3	18.9	12.5	11.5	42.6	63.3	75.4	60.7	49.5	57.5	64.0	63.0	54.6	46.2	63.6	50.9	430.3	41.7	18.6	55.8	69.4	29.3	23.5	22.5	37.0	31.5	86.5	37.8	17.6	15.7	28.9	27.6	18.8	10.8	77.5	20.3	99.7	18.0	242.6	114.8	46.7	205.9	19.7	86.5	33.0	20.7	10.8	34.0	35.2	240.5	34.7	104.3	286.3	11.1	51.6	37.0	54.6	14.0	61.1	127.2	48.1	740.3	26.4	115.1	35.6	62.8	76.1	31.4	34.0	23.1	44.4	41.8	15.2	17.3	269.1	39.5	9.6	24.8	69.5	17.2	39.5	36.4	36.3	45.1	42.5	25.1	30.4	13.3	51.6	64.3	11.5	39.1
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"epididymis: 21.2;parathyroid gland: 30.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.5;Cholangiocytes: 11.5;Collecting duct cells: 12.9;Ductal cells: 6.6;Muller glia cells: 18.6"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 12.3;RPTEC TERT1: 21.8;SiHa: 6.6"									HPA067695			Approved	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	1.4	1.4	5.3	0.3	4.6	2.1	3.9	4.5	4.7	3.5	5.9	0.5	0.6	3.2	21.2	0.3	1.7	4.5	0.3	4.4	5.0	8.4	0.4	11.9	0.4	8.6	6.2	2.4	5.5	30.5	2.5	0.5	8.8	1.7	0.3	5.0	0.4	2.6	0.2	10.0	0.5	2.2	5.2	0.4	1.2	5.4	8.7	0.3	0.3	0.8	0.6	0.4	0.4	4.9	0.2	0.1	0.9	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.1	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	3.0	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.7	0.0	0.1	12.3	0.2	0.0	0.5	0.1	0.4	0.5	0.0	0.1	0.2	0.0	0.1	21.8	0.2	0.2	0.1	6.6	0.1	0.0	0.2	1.8	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.1	0.1	0.5	0.0	5.3	4.6	4.5	4.7	4.4	5.0	8.6	6.2	8.8	5.2	8.7	4.9	0.0	12.8	10.5	0.3	0.2	0.1	0.5	0.0	0.0	0.2	0.4	0.5	0.3	11.5	3.7	12.9	0.0	0.0	0.0	0.0	1.9	6.6	0.0	0.3	0.4	1.0	0.0	0.0	0.7	0.8	0.0	0.2	0.0	1.5	1.3	0.2	0.7	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	18.6	0.0	1.5	0.6	1.8	0.0	0.7	0.0	0.1	0.0	2.9	0.0	0.5	0.0	2.7	0.1	0.9	0.4	0.0	0.0	0.1	0.9	0.0	0.0	0.2
SEC23A		ENSG00000100934	"Sec23 homolog A, COPII coat complex component"	Q15436	14	39031919-39109646	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA		83000	"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: AB_2686223"	"unprognostic (2.40e-1)"	"prognostic unfavorable (5.75e-4)"	"prognostic favorable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.69e-4)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	45.9	32.0	11.4	31.8	14.2	13.1	20.9	18.3	16.8	36.2	31.4	40.0	57.7	42.7	19.9	34.1	21.5	32.1	46.9	13.3	18.9	23.1	80.8	20.2	21.0	13.8	14.0	33.9	12.0	8.1	10.5	27.1	15.3	34.0	34.2	38.5	10.5	52.6	54.2	12.8	52.6	90.5	7.6	20.5	16.8	23.5	12.7	18.9	17.9	58.5	22.0	40.7	17.9	15.4	52.1	90.8	76.9	74.7	161.3	173.0	25.9	195.1	176.4	135.2	166.8	93.2	44.2	12.6	46.9	279.6	54.9	41.2	99.6	86.3	208.6	39.6	36.9	21.8	67.7	347.3	122.4	35.9	31.3	134.0	48.8	91.6	73.7	114.6	130.8	26.9	15.6	30.1	125.8	47.5	32.9	16.9	18.4	81.7	91.3	44.0	111.8	19.1	84.7	75.6	8.5	20.5	132.8	43.0	51.8	68.6	51.5	12.4	138.4	75.0	57.8	110.8	52.0	27.0	36.6	56.0	50.3	31.4	70.2	70.5	34.3	38.6	26.6	29.3	38.4	23.6	33.1	34.9	31.1	21.1	34.9	28.0	29.5	42.1	27.3	26.7	38.1	31.4	11.4	14.2	18.3	16.8	13.3	18.9	13.8	14.0	15.3	7.6	12.7	15.4	35.4	16.0	26.9	34.9	30.5	25.9	33.5	15.5	15.4	39.7	11.8	10.3	54.6	15.7	18.8	31.3	68.8	16.0	36.0	87.0	7.9	9.8	13.4	11.3	42.8	41.1	24.5	6.1	48.3	5.6	43.7	55.0	26.5	18.8	27.9	56.9	118.9	133.6	25.6	30.3	51.1	31.6	12.2	36.4	32.3	18.6	74.9	24.3	24.9	48.7	25.6	19.4	32.0	34.2	44.3	17.8	34.1	71.5	38.5	37.5	88.6	32.8	10.1	58.7	39.5	27.6	51.4	18.0	15.5	15.7	24.0	24.8	32.3	31.0	30.2	56.5
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.7;Endothelial cells: 51.8;Hepatic stellate cells: 33.9;Macrophages: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 8.3;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.3;T-cells: 8.8"	"Group enriched"	"Detected in some"	38	"EFO-21: 36.0;HEL: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced					NA	NA		520000000	"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	11.3	2.3	0.2	11.9	0.6	2.2	10.6	0.0	0.6	8.9	3.7	3.3	5.1	6.4	4.1	5.1	6.7	9.5	6.7	0.3	0.0	5.6	2.5	12.6	7.0	0.2	0.2	1.8	1.2	3.1	2.2	6.3	0.2	6.1	4.1	0.0	2.7	5.7	1.0	3.6	4.8	14.2	0.1	1.0	2.8	0.7	0.7	2.6	4.0	1.8	12.6	14.4	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.3	0.4	0.6	0.0	0.2	0.0	1.1	0.5	0.2	0.0	0.1	0.2	0.1	2.1	0.3	0.0	0.1	8.8	7.8	0.2	0.6	0.0	0.6	0.3	0.0	0.2	0.2	0.2	0.1	0.7	0.2	14.7	0.0	3.6	0.3	0.4	3.7	0.1	0.0	0.6	0.0	0.2	0.1	1.9	1.5	0.0	1.8	0.0	2.6	0.1	0.0	0.0	0.0	2.0	0.1	0.1	51.8	0.0	5.2	0.5	0.2	0.0	1.5	0.0	0.0	0.0	0.0	33.9	0.4	0.2	0.0	0.2	0.0	0.0	1.5	3.6	0.1	0.3	10.1	3.6	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	3.4	4.1	0.5	0.0	0.0	0.3
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 159.7;Kupffer cells: 84.9;Macrophages: 64.8;monocytes: 123.8;NK-cells: 154.5;Plasma cells: 65.1;T-cells: 65.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 136.2;HMC-1: 130.0;JURKAT: 102.2;Karpas-707: 195.1;RPMI-8226: 286.7;U-266/70: 326.8;U-266/84: 214.5"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles		NA	NA		2700000	"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	17.5	9.1	12.1	47.4	10.5	21.1	6.9	11.7	12.1	9.2	8.2	9.6	8.6	3.7	2.1	8.6	7.8	17.0	5.0	12.0	14.1	4.0	6.5	40.8	62.2	17.8	13.5	2.8	3.4	4.4	3.0	13.0	16.4	3.3	8.4	0.7	7.0	3.9	2.2	4.7	15.5	11.5	17.0	86.6	11.3	2.2	17.2	52.1	3.4	7.3	30.6	21.5	3.3	24.5	0.5	0.4	1.4	0.8	0.7	1.5	0.8	4.9	4.8	1.8	1.4	0.3	1.9	0.5	1.7	7.4	2.0	0.3	0.1	0.1	1.3	136.2	0.0	45.7	0.2	0.2	0.4	35.1	130.0	1.8	0.5	2.5	0.6	5.0	0.4	102.2	0.8	195.1	6.0	0.0	28.3	18.9	0.2	0.1	1.6	0.3	0.5	286.7	2.9	0.0	0.3	0.0	0.6	0.2	2.2	3.3	0.1	42.6	1.7	2.6	0.8	3.5	1.4	326.8	214.5	6.4	1.5	74.2	1.9	1543.6	297.6	940.2	419.2	509.2	344.3	22.0	396.6	362.9	299.9	22.3	300.3	323.7	1257.2	309.2	762.7	518.3	662.2	1035.5	12.1	10.5	11.7	12.1	12.0	14.1	17.8	13.5	16.4	17.0	17.2	24.5	1.2	3.2	12.4	0.0	11.6	3.4	0.1	0.2	0.0	0.2	0.6	1.4	2.2	4.3	2.7	0.0	0.0	0.5	159.7	0.2	0.0	0.3	8.2	1.8	0.6	2.6	0.0	10.9	0.2	0.2	2.3	2.4	2.6	0.9	29.7	0.4	3.6	2.2	40.1	0.0	0.3	0.0	0.0	84.9	49.6	12.2	0.3	64.8	7.2	15.9	123.8	0.0	154.5	0.0	0.1	0.5	0.0	0.0	65.1	0.1	0.0	0.5	6.4	0.2	0.0	1.2	0.9	0.8	0.5	0.5	1.8	1.0	65.9	0.1	0.0	0.0
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 174.5;brain: 184.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Distal enterocytes: 129.1;Gastric mucus-secreting cells: 208.0;Oligodendrocytes: 157.8;Proximal enterocytes: 336.4;Syncytiotrophoblasts: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 73.7;Hep G2: 105.7;SK-BR-3: 54.5;WM-115: 173.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 27.9"	HPA030651	Uncertain				"Secreted in other tissues"	NA	NA		790000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"			"HPA030651: AB_10602224"	"prognostic favorable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	33.6	174.5	50.2	9.0	124.4	0.2	17.3	87.7	78.2	46.2	35.2	53.6	41.3	45.7	2.2	9.1	37.0	10.0	40.3	53.1	66.4	70.9	6.1	49.2	0.3	125.7	101.9	24.5	41.4	10.6	10.4	35.3	98.6	34.0	10.5	2.0	12.7	20.6	7.4	7.9	62.8	14.2	76.2	5.1	56.8	14.8	110.4	0.6	24.2	8.7	0.3	19.6	32.3	184.2	12.7	8.2	0.8	8.0	0.6	1.0	2.0	16.3	22.3	4.7	7.9	5.5	29.7	0.0	14.3	15.3	0.0	1.8	0.4	26.2	1.8	0.2	0.7	0.0	73.7	105.7	16.8	0.0	0.8	5.1	0.5	5.4	4.1	19.9	0.0	0.1	0.2	2.2	0.8	22.4	0.0	0.7	1.1	23.4	4.5	0.3	1.2	0.6	7.4	1.4	1.0	3.8	4.2	54.5	9.2	2.4	3.6	0.1	0.5	1.3	15.4	4.3	5.3	4.4	0.2	0.2	7.9	0.2	173.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	124.4	87.7	78.2	53.1	66.4	125.7	101.9	98.6	76.2	110.4	184.2	6.5	163.5	18.6	45.1	1.8	0.0	8.3	0.0	6.2	3.7	19.3	8.5	14.5	44.3	18.6	64.4	0.0	3.6	1.2	129.1	1.9	38.3	11.2	29.8	11.6	6.1	10.3	0.0	0.6	23.1	1.0	35.3	208.0	73.1	11.4	11.4	5.7	1.2	1.9	0.0	0.8	45.7	0.0	1.6	0.0	21.4	4.1	2.8	0.0	12.2	0.7	17.3	0.0	3.0	157.8	32.5	79.9	3.0	0.6	14.1	336.4	40.4	5.1	1.6	6.6	19.0	7.5	6.6	11.4	2.0	0.0	111.6	2.4	0.2	31.5	32.7
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 40.2;Bipolar cells: 23.4;Endothelial cells: 24.4;Hepatic stellate cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 108.1;HUVEC TERT2: 187.0;RT4: 112.3;SK-BR-3: 170.2;TIME: 338.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	NA	NA	1700000	7900000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	33.8	9.0	8.8	8.6	5.7	2.7	31.9	5.1	8.1	28.3	12.0	10.5	13.4	14.5	5.4	100.8	15.6	10.8	22.6	5.0	9.2	49.2	4.8	46.2	3.7	10.2	12.7	3.6	6.7	5.5	11.1	30.4	8.7	32.7	6.3	22.0	24.6	32.5	10.4	75.1	12.5	9.1	6.3	50.7	17.3	2.4	21.8	6.1	27.1	6.1	12.6	27.0	55.4	4.7	13.9	3.1	0.7	14.2	0.2	1.3	3.0	8.0	24.2	6.5	10.2	5.4	6.1	0.5	77.9	1.1	0.7	47.5	6.9	100.7	2.4	0.1	1.8	0.8	108.1	18.5	5.7	1.7	3.2	6.2	55.3	15.1	45.4	90.7	187.0	1.2	2.9	0.1	1.3	12.4	1.5	7.5	8.6	6.2	10.1	11.8	0.0	0.5	7.2	112.3	1.1	2.6	12.8	170.2	0.3	10.4	67.2	7.3	338.6	4.2	31.9	29.7	5.5	0.2	0.0	0.9	0.3	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	5.7	5.1	8.1	5.0	9.2	10.2	12.7	8.7	6.3	21.8	4.7	40.2	0.0	1.1	0.0	0.2	6.8	3.0	9.2	5.7	23.4	10.7	6.0	9.2	1.5	6.6	18.4	10.4	11.2	0.6	5.5	0.0	0.3	0.0	6.5	2.4	24.4	0.0	0.0	0.7	0.8	0.5	1.1	16.3	6.9	0.0	0.2	25.4	0.6	1.4	6.7	1.1	10.7	0.0	0.3	0.8	0.3	0.3	0.2	0.0	3.7	0.0	8.7	0.0	0.0	0.1	6.8	3.8	0.0	0.0	2.5	5.7	0.7	5.4	19.8	0.0	0.5	2.5	0.0	0.4	17.7	8.9	6.3	0.4	0.2	5.2	8.6
SEMA3G	"FLJ00014, sem2"	ENSG00000010319	"Semaphorin 3G"	Q9NS98	3	52433035-52445103	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 80.1;breast: 64.2"	"Cell type enriched"	"Detected in many"	6	"Adipocytes: 151.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 26.1;Hep G2: 7.1;HUVEC TERT2: 7.4;THP-1: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001761	Uncertain				"Secreted to blood"	NA	NA		5600000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA001761: AB_1079902"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.79e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.14e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.14e-1)"	"prognostic favorable (8.86e-5)"	"unprognostic (5.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.14e-1)"	80.1	1.9	9.9	3.4	9.4	0.1	64.2	18.9	11.4	5.1	6.2	6.8	3.0	5.9	1.3	4.5	5.2	5.9	18.6	8.4	9.0	19.8	1.3	23.9	1.6	10.8	10.0	3.2	3.1	1.8	2.4	26.7	11.3	4.6	3.7	0.4	10.6	2.5	12.8	12.7	9.6	3.9	9.9	8.0	5.7	1.3	12.1	1.7	7.7	18.6	1.8	8.3	7.8	9.1	0.0	0.1	0.1	0.2	26.1	0.2	2.5	0.0	0.0	0.0	0.0	0.7	0.3	3.3	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	3.9	0.2	7.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	7.4	2.6	0.0	0.4	0.0	0.3	0.2	4.3	1.2	0.7	0.1	0.0	0.0	4.1	0.0	0.3	0.5	0.5	0.0	0.4	0.5	0.1	1.9	6.5	2.9	0.1	2.4	0.0	0.0	0.5	2.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	9.9	9.4	18.9	11.4	8.4	9.0	10.8	10.0	11.3	9.9	12.1	9.1	151.5	3.2	1.3	0.0	0.3	0.4	0.1	0.1	0.0	1.7	5.1	5.5	10.7	0.0	0.0	3.7	0.0	1.7	0.9	0.3	0.0	0.0	3.0	2.8	1.6	20.4	9.6	0.0	0.0	0.0	0.2	3.6	1.1	5.8	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	5.0	0.3	0.5	0.0	24.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	9.4	0.0	0.1	0.2	0.0	4.1	3.0	0.1	0.1	0.5	0.1	7.5	0.4	0.1	0.2	0.0
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 260.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.5;NK-cells: 92.7;Oligodendrocytes: 310.5;T-cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 133.2;HMC-1: 97.2;JURKAT: 89.1;MOLT-4: 120.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved					NA	NA		7500000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (4.06e-5)"	7.2	12.8	73.5	35.1	149.7	28.7	6.1	129.0	122.7	9.1	34.2	10.4	10.6	6.5	12.2	27.3	11.0	12.3	12.1	72.0	88.4	32.0	4.1	14.2	62.4	165.2	145.6	6.5	8.0	6.0	13.8	5.5	147.8	11.9	9.7	5.0	12.0	6.6	88.0	17.4	28.9	5.5	119.1	51.3	16.7	10.6	127.0	43.4	11.8	27.5	49.8	11.4	16.2	260.2	12.7	9.2	8.4	12.4	0.4	0.8	19.0	1.1	0.5	2.6	1.7	6.1	13.8	47.3	5.1	0.2	9.7	6.4	7.5	3.6	1.1	133.2	7.5	20.1	3.3	0.7	1.5	26.4	97.2	0.3	2.8	0.6	0.3	0.3	4.9	89.1	4.8	31.5	0.0	20.9	120.9	33.9	20.6	25.0	0.5	38.2	2.8	13.4	16.5	13.0	19.7	13.1	3.4	8.9	0.3	11.7	10.1	14.4	3.2	0.1	7.6	1.0	6.1	34.9	16.3	6.6	6.0	32.1	7.6	17.2	7.5	38.2	22.0	7.0	13.3	4.3	17.5	18.6	2.6	2.5	19.9	23.2	37.0	9.4	8.1	8.0	17.7	14.5	73.5	149.7	129.0	122.7	72.0	88.4	165.2	145.6	147.8	119.1	127.0	260.2	3.4	6.4	15.7	33.6	35.4	4.6	3.3	2.1	3.4	12.4	9.5	5.5	18.7	5.7	6.9	11.0	2.1	9.0	76.5	1.5	3.9	5.4	2.2	10.9	6.4	5.2	1.8	23.1	44.5	3.3	2.1	6.7	7.7	15.4	42.5	8.0	5.3	1.6	21.6	33.7	17.2	6.3	4.1	28.2	6.1	3.8	7.5	37.4	1.8	49.6	43.7	8.9	92.7	12.1	310.5	3.7	0.7	15.1	53.7	6.5	0.5	14.2	5.7	5.1	0.0	11.4	2.6	0.9	26.1	7.1	5.4	3.7	89.7	2.3	3.3	7.7
SEPTIN3	"SEP3, SEPT3"	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 233.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 27.9"	"Group enriched"	"Detected in many"	5	"glioma: 24.6;melanoma: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.6;Daudi: 22.3;SCLC-21H: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Supported	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	0.2	4.6	134.7	0.4	160.5	0.1	1.3	82.4	233.7	0.2	30.5	0.8	0.3	0.2	1.4	0.2	0.1	0.4	0.2	167.0	89.5	0.3	0.1	0.7	0.5	86.2	73.4	0.2	1.2	18.6	7.8	5.7	83.8	1.3	0.5	28.4	0.4	0.0	0.1	1.6	0.4	0.3	56.9	0.2	0.7	2.1	91.4	0.9	0.8	0.2	0.5	0.3	0.4	150.7	1.5	1.7	26.6	20.1	0.3	0.0	13.3	0.3	0.3	1.8	0.8	0.4	3.1	22.3	0.7	0.2	11.4	0.1	14.0	0.1	0.7	9.2	4.6	0.1	0.5	0.0	0.2	0.0	0.9	0.2	1.0	0.1	0.0	0.0	0.0	12.1	0.0	3.4	0.0	2.4	3.7	0.2	18.2	0.2	0.7	17.9	0.0	1.3	0.0	2.7	71.4	14.8	10.9	0.1	18.2	2.5	2.6	6.7	0.0	0.0	9.2	0.9	1.0	14.1	13.1	0.2	0.3	9.0	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	134.7	160.5	82.4	233.7	167.0	89.5	86.2	73.4	83.8	56.9	91.4	150.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0
SEPTIN7	"CDC10, CDC3, SEPT7, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 570.9"	"Group enriched"	"Detected in some"	4	"Adipocytes: 192.1;Cardiomyocytes: 227.0;Cytotrophoblasts: 171.4;dendritic cells: 196.6;Extravillous trophoblasts: 198.2;Fibroblasts: 153.5;Hofbauer cells: 191.0;Smooth muscle cells: 190.0;Syncytiotrophoblasts: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Approved	"Nucleoli,Plasma membrane,Actin filaments,Midbody,Cytosol"		Yes	No		4300000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"	"Nucleoli, Plasma membrane, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	127.1	95.1	352.6	98.8	386.1	131.0	99.5	334.3	570.9	111.5	289.5	116.4	55.7	126.5	121.5	106.6	84.1	117.5	172.1	344.1	341.6	82.9	76.9	98.6	150.9	337.4	355.9	138.2	37.0	81.1	62.6	143.5	339.1	93.9	94.8	119.5	50.3	95.5	82.9	105.0	74.9	145.2	345.1	108.3	59.4	70.3	367.7	159.0	78.2	104.3	149.7	125.0	86.9	411.9	198.1	94.3	232.0	153.2	256.7	263.1	119.3	248.6	228.6	206.7	177.0	147.7	148.9	186.2	164.2	254.9	274.9	146.3	166.3	166.4	294.0	127.8	88.4	149.8	123.4	80.8	149.4	182.7	157.7	171.7	127.1	163.8	159.4	215.6	221.0	143.3	120.1	141.9	341.6	92.8	185.6	304.3	249.7	183.1	132.6	188.3	220.9	107.6	202.6	146.1	124.3	217.4	173.5	220.1	151.8	377.1	163.1	198.7	187.3	207.2	246.7	129.9	278.5	165.9	163.4	470.2	132.4	301.2	449.3	266.8	86.0	150.1	214.8	100.1	220.7	165.6	151.5	199.6	100.8	155.5	134.4	171.2	160.9	298.7	110.5	71.0	147.4	241.7	352.6	386.1	334.3	570.9	344.1	341.6	337.4	355.9	339.1	345.1	367.7	411.9	192.1	0.0	0.0	0.0	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	227.0	0.0	0.0	0.0	0.0	171.4	196.6	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.0	0.0	0.0	0.0	198.2	153.5	0.0	0.0	0.0	0.0	0.0	0.0	191.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	190.0	0.0	0.0	0.0	0.0	124.2	30.4	0.0	0.0	0.0
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERINC2	"FKSG84, PRO0899, TDE2, TDE2L"	ENSG00000168528	"Serine incorporator 2"	Q96SA4	1	31409565-31434680	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 235.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.3;Distal enterocytes: 530.1;Ductal cells: 735.4;Pancreatic endocrine cells: 457.4;Paneth cells: 465.1;Proximal enterocytes: 422.0;Syncytiotrophoblasts: 446.6;Urothelial cells: 432.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 10.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 305.6;HaCaT: 349.2;HBEC3-KT: 553.0;hTCEpi: 307.8;RT4: 381.9;SK-BR-3: 311.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005974	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	Nucleoplasm	"HPA005974: AB_10603239"	"unprognostic (1.41e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.78e-3)"	"prognostic favorable (1.69e-7)"	"unprognostic (6.78e-2)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (2.11e-4)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.63e-3)"	"unprognostic (2.67e-2)"	6.5	23.8	1.2	15.0	1.4	8.1	33.8	1.5	1.2	68.9	2.9	111.0	118.7	15.3	21.4	120.7	18.9	59.1	3.2	1.0	1.7	114.1	235.5	20.9	3.5	1.8	2.2	0.9	37.7	45.8	9.7	44.5	1.9	56.6	56.2	0.1	151.0	62.1	76.8	53.5	105.6	2.6	1.6	3.4	90.7	4.9	5.8	8.8	28.4	24.5	9.5	116.5	39.3	1.8	87.3	20.5	17.7	57.0	37.3	50.4	48.2	162.8	119.5	10.6	13.1	31.1	305.6	57.0	209.5	154.6	12.9	349.2	2.3	553.0	2.1	5.5	13.2	0.0	17.2	16.6	42.0	0.5	64.1	46.0	307.8	66.5	144.2	45.5	6.7	6.9	2.6	0.5	18.2	14.2	2.1	2.0	18.3	172.1	42.4	0.4	34.8	19.5	57.9	381.9	7.6	42.4	41.7	311.0	6.5	8.5	182.8	9.9	40.7	2.8	13.0	1.8	3.4	2.9	2.1	2.6	1.4	1.6	13.7	0.0	2.4	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	10.4	0.0	0.6	1.2	1.4	1.5	1.2	1.0	1.7	1.8	2.2	1.9	1.6	5.8	1.8	2.2	16.0	8.9	0.0	2.7	12.4	108.7	374.7	37.0	0.0	162.9	72.9	0.7	138.7	173.3	117.7	0.0	466.3	4.2	530.1	72.4	735.4	6.4	61.6	18.2	8.8	116.6	3.6	0.4	326.3	91.2	5.4	80.0	140.7	0.0	1.6	5.7	54.5	47.5	0.0	0.4	195.0	183.1	5.1	5.0	12.9	2.1	13.1	40.9	1.0	48.4	0.6	0.0	0.0	0.2	457.4	465.1	0.0	0.1	192.2	422.0	71.0	54.3	0.0	0.0	23.5	19.3	0.7	9.5	30.8	21.2	446.6	3.5	0.1	145.7	432.5
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 418.0"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 165.1;Fibroblasts: 162.1;Pancreatic endocrine cells: 231.8;Smooth muscle cells: 239.3;Syncytiotrophoblasts: 651.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 9.5"	"Cell line enhanced"	"Detected in many"		"BJ: 3483.8;HUVEC TERT2: 4014.7;LHCN-M2: 3874.5;TIME: 10032.6;U-138 MG: 4609.6;U-251 MG: 4256.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"	No	No	142000000	13000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"CAB068501: AB_1642775, HPA050039: AB_2680997"	"unprognostic (5.02e-2)"	"prognostic unfavorable (5.01e-4)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavorable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (5.88e-8)"	"prognostic unfavorable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (5.51e-4)"	215.5	75.3	3.1	91.6	3.4	1.7	56.2	5.2	12.8	62.1	5.0	31.7	7.4	31.1	1.0	16.4	41.3	360.3	136.0	3.9	6.6	166.2	345.8	260.2	21.3	6.4	3.7	105.6	135.1	11.8	12.3	418.0	4.5	37.8	5.4	4.9	10.6	8.0	17.8	21.2	13.1	74.3	4.8	13.8	30.3	5.5	12.7	6.7	59.5	4.3	3.5	359.9	19.2	6.0	77.3	64.4	1.2	5.1	766.6	1511.0	89.3	3483.8	654.6	1717.6	1487.4	9.4	5.5	2.7	812.6	1117.9	2367.3	18.1	0.4	269.4	1756.2	4.3	0.7	1.1	5.2	61.4	1532.6	0.2	3.8	596.1	106.9	2641.4	1374.8	928.5	4014.7	0.2	6.4	2.5	3874.5	0.4	0.6	2.2	18.2	1.3	41.7	0.6	6.1	4.8	5.1	30.3	1.0	0.8	286.3	77.2	8.3	410.9	3.3	9.9	10032.6	4609.6	204.0	1593.8	4256.0	0.6	2.9	4.2	1150.5	2.4	45.9	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	9.5	0.0	0.3	0.0	0.8	3.1	3.4	5.2	12.8	3.9	6.6	6.4	3.7	4.5	4.8	12.7	6.0	35.8	0.0	7.7	0.0	1.1	40.0	43.7	97.4	14.2	0.3	0.3	2.3	2.5	4.3	11.0	5.5	0.0	56.0	1.0	0.4	0.0	65.1	0.0	4.7	53.8	165.1	5.3	0.0	0.5	4.5	75.1	162.1	0.5	3.2	10.2	12.4	40.4	112.3	15.9	0.0	0.3	0.2	8.2	4.6	9.6	1.1	17.7	11.1	7.2	5.6	1.1	0.7	0.0	0.0	0.0	231.8	0.0	12.0	3.6	9.7	0.1	0.0	8.2	0.3	39.5	55.4	239.3	0.0	0.1	9.0	24.7	651.7	2.3	2.1	0.5	8.1
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36674020-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;endometrium 1: 23.9;fallopian tube: 35.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 9.6;Bipolar cells: 17.9;Endometrial ciliated cells: 5.7;Excitatory neurons: 10.8;Granulosa cells: 14.2;Inhibitory neurons: 17.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Region enhanced"	"Detected in many"		"hippocampal formation: 18.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 1.2;HEK 293: 1.4;NTERA-2: 3.6;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"			Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		6.2	1.3	7.3	0.0	6.0	0.0	0.6	0.1	8.1	12.3	0.0	0.2	0.1	23.9	0.7	0.0	35.3	0.0	0.4	18.9	0.0	0.1	0.0	5.4	0.0	0.0	1.7	6.4	0.3	1.3	11.5	0.0	3.6	0.9	0.0	3.3	0.0	0.6	0.0	0.2	0.0	17.1	0.3	0.0	0.4	0.3	0.4	0.0	9.2	0.0	0.0	0.3	6.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	6.0	0.1	8.1	18.9	0.0	0.0	1.7	3.6	0.3	0.4	1.2	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	10.8	0.0	0.0	1.3	0.0	0.6	0.0	14.2	0.0	0.0	0.0	1.7	17.9	0.0	0.0	0.0	0.4	0.0	0.3	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SEZ6		ENSG00000063015	"Seizure related 6 homolog"	Q53EL9	17	28954901-29006440	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 54.7;pituitary gland: 15.8;retina: 27.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 58.7;Cone photoreceptor cells: 47.9;Excitatory neurons: 15.9;Horizontal cells: 43.7;Inhibitory neurons: 24.6;Rod photoreceptor cells: 18.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 16.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.1;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011777	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"HPA011777: AB_1856758"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.15e-3)"	"unprognostic (3.63e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	0.1	0.6	48.4	0.2	54.7	0.4	0.0	50.8	36.3	0.0	5.5	0.9	1.0	0.0	0.3	0.0	0.0	0.0	0.1	36.3	25.0	0.1	0.0	0.1	0.0	20.4	33.0	0.1	0.6	0.0	15.8	0.0	53.5	0.2	0.5	27.0	0.0	0.1	0.2	0.2	0.5	0.1	13.7	0.1	0.5	0.5	25.4	0.0	0.1	0.0	0.0	0.1	0.0	21.1	0.0	0.4	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.1	0.1	0.1	0.0	0.0	53.5	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.1	1.1	0.2	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0.2	2.0	0.1	0.2	0.3	0.0	0.1	48.4	54.7	50.8	36.3	36.3	25.0	20.4	33.0	53.5	13.7	25.4	21.1	0.4	0.0	0.0	3.3	0.9	0.4	0.7	0.0	0.0	58.7	0.1	0.1	0.6	1.5	0.0	0.0	47.9	0.3	5.0	0.3	0.0	0.2	0.1	0.1	0.2	0.7	7.3	0.0	15.9	0.4	0.3	0.3	0.0	0.2	8.9	1.0	0.4	0.0	0.2	43.7	24.6	0.1	0.0	1.9	1.0	0.4	0.9	1.1	0.0	4.7	5.0	6.1	5.2	3.5	4.7	0.5	0.1	0.0	0.1	0.8	0.7	0.1	0.0	18.2	0.0	0.9	0.3	1.3	1.8	0.0	0.0	0.3	1.4	0.2	0.6	0.2
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169462-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 60.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 222.1;Inhibitory neurons: 137.7;Oligodendrocyte precursor cells: 586.1"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 5.9;myeloid DC: 5.7;non-classical monocyte: 5.3"	"Group enriched"	"Detected in many"	58	"dendritic cells: 5.7;monocytes: 5.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 39.9;SH-SY5Y: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles		NA	NA		6700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA045135: AB_2732518"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	0.1	10.0	25.0	0.5	37.5	0.2	0.0	8.9	50.6	1.1	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	1.3	60.8	52.0	0.0	0.0	0.2	0.0	24.5	23.6	0.0	1.5	0.0	5.8	0.0	19.0	0.2	0.2	4.5	0.2	0.1	0.1	0.3	0.4	0.3	4.0	0.2	1.4	0.3	49.0	0.9	0.1	0.0	0.0	0.1	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	10.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.9	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.5	25.0	37.5	8.9	50.6	60.8	52.0	24.5	23.6	19.0	4.0	49.0	24.9	0.0	0.0	0.0	21.9	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.1	0.2	0.0	0.4	222.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.9	137.7	0.0	0.0	0.0	2.1	2.0	0.6	1.5	0.0	10.3	3.5	0.7	0.0	586.1	5.5	0.6	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SEZ6L2	"FLJ90517, PSK-1"	ENSG00000174938	"Seizure related 6 homolog like 2"	Q6UXD5	16	29871159-29899547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.6;pituitary gland: 91.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.6;Cone photoreceptor cells: 185.6;Enteroendocrine cells: 132.5;Horizontal cells: 188.4;Rod photoreceptor cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064471	Enhanced					NA	NA		5600000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA064471: AB_2685271"	"unprognostic (2.56e-2)"	"prognostic unfavorable (7.46e-4)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.43e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.08e-1)"	4.6	23.2	47.3	1.4	43.6	0.1	4.5	37.0	101.6	11.8	0.0	4.5	10.3	9.0	0.7	1.1	4.0	9.6	2.3	43.7	93.1	7.8	0.6	4.5	0.9	69.2	29.2	5.4	41.2	21.3	91.9	3.0	62.5	14.4	3.4	25.8	22.1	4.3	1.0	2.4	5.8	4.1	21.1	1.9	16.6	11.2	46.4	0.4	1.0	0.0	1.4	3.1	1.8	57.3	1.4	11.6	0.9	11.0	0.1	0.5	7.7	14.4	6.7	13.3	7.3	17.2	53.8	5.8	76.7	17.5	11.1	4.9	4.4	3.4	4.0	0.1	9.6	0.9	9.2	35.7	28.7	0.0	33.9	32.3	6.5	15.8	4.3	48.1	1.0	5.1	1.8	34.5	6.7	59.4	0.2	0.1	17.2	19.6	19.8	0.0	0.0	1.6	12.1	5.1	51.3	41.2	4.9	36.5	2.3	9.1	34.3	51.3	0.6	44.3	21.6	0.3	0.9	3.9	3.6	0.3	53.8	9.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	43.6	37.0	101.6	43.7	93.1	69.2	29.2	62.5	21.1	46.4	57.3	3.2	3.2	16.4	4.2	0.8	2.9	9.4	6.2	2.8	236.6	49.6	30.6	8.6	77.2	5.5	3.7	185.6	0.3	0.5	19.9	0.0	61.7	2.8	25.1	48.2	4.9	132.5	0.0	28.6	39.4	2.7	12.2	34.7	33.4	1.3	3.5	2.5	0.2	1.3	188.4	46.3	32.9	10.2	0.3	0.0	5.4	1.2	1.0	12.4	3.7	0.6	20.8	0.0	5.5	13.1	45.2	22.1	1.9	1.4	23.5	15.3	5.0	3.4	230.3	13.1	0.9	15.2	8.2	4.7	1.0	1.4	1.4	0.7	26.8	29.0	9.1
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863149-26864456	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 2461.5;skin 1: 1219.1;vagina: 692.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 7750.0;Basal prostatic cells: 2119.7;Squamous epithelial cells: 3587.1;Suprabasal keratinocytes: 10714.0;Urothelial cells: 2780.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 1510.8;head and neck cancer: 2526.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	17	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"A-431: 770.8;HaCaT: 1181.6;HBEC3-KT: 1819.0;hTCEpi: 1196.7"	"Low region specificity"	"Detected in many"							"CAB006268, HPA011105, CAB040552"	Enhanced		Supported	Cytosol	"Secreted in other tissues"	NA	Yes		29000000	"Cluster 34: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339"	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	3.1	0.8	1.9	11.6	1.8	2.0	29.1	1.8	9.5	350.2	0.4	95.4	48.8	8.0	0.7	2461.5	2.2	21.4	1.3	1.9	1.6	16.0	3.7	56.1	0.2	9.0	4.4	0.9	2.2	0.1	2.7	1.6	4.3	77.2	32.5	0.6	332.8	3.2	5.0	1219.1	40.8	3.3	1.2	0.9	66.6	0.7	5.2	22.1	2.0	0.1	147.9	167.6	692.0	2.3	770.8	126.9	0.1	1.1	0.3	0.1	37.2	0.5	0.0	0.1	0.3	46.6	393.6	6.7	32.2	0.2	0.6	1181.6	0.3	1819.0	0.0	183.4	5.4	0.9	119.6	138.4	0.1	0.4	1.4	0.4	1196.7	0.6	310.1	0.2	0.2	0.7	1.8	4.5	0.1	163.8	0.7	0.3	2.3	132.6	208.7	0.5	0.4	43.1	281.3	173.9	0.7	0.7	181.2	31.9	1.8	2.9	83.6	1.5	0.5	0.5	337.2	0.3	4.9	1.0	5.8	3.8	1.5	0.7	0.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.9	1.8	1.8	9.5	1.9	1.6	9.0	4.4	4.3	1.2	5.2	2.3	1.6	179.5	162.2	0.0	5.0	7750.0	2119.7	1374.7	1714.2	0.0	72.6	119.9	0.8	24.3	285.6	16.5	0.0	18.6	0.7	972.0	3.9	48.8	0.0	138.0	20.1	45.3	67.4	0.0	0.0	76.2	59.9	46.2	221.2	251.8	32.3	0.0	0.4	4.5	1.9	0.0	0.1	140.7	114.0	0.6	479.7	0.0	0.0	9.7	533.6	0.0	1.0	0.0	0.0	0.0	0.1	524.8	933.0	0.0	21.2	1030.2	318.5	0.6	158.2	0.0	0.0	0.7	55.2	0.0	0.6	3587.1	10714.0	6.0	23.4	0.1	292.4	2780.0
SFRP2	"FRP-2, SARP1, SDF-5"	ENSG00000145423	"Secreted frizzled related protein 2"	Q96HF1	4	153780591-153789083	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 318.8;urinary bladder: 306.7"	"Cell type enriched"	"Detected in many"	4	"Fibroblasts: 806.1"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 370.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"AF22: 229.1;ASC diff: 85.2;HSkMC: 140.2;NTERA-2: 318.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002652			Approved	"Intermediate filaments"	"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA002652: AB_2732394"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.44e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (9.29e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.39e-4)"	188.2	16.0	4.9	84.6	4.0	0.3	154.9	3.6	6.3	23.2	11.2	72.2	18.4	12.0	22.2	212.7	62.1	318.8	6.2	12.3	13.8	4.5	0.3	62.5	11.8	4.5	3.7	8.3	45.1	7.0	72.5	0.4	4.6	56.5	44.3	2.3	83.4	70.5	6.5	80.5	57.3	89.5	3.8	0.7	34.4	1.5	2.2	9.6	92.3	38.7	3.6	306.7	63.0	12.3	0.0	0.0	229.1	0.2	85.2	15.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	140.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	318.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.1	0.1	0.0	8.1	0.2	0.0	0.0	0.4	0.1	0.0	12.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	4.0	3.6	6.3	12.3	13.8	4.5	3.7	4.6	3.8	2.2	12.3	15.5	3.2	0.6	9.4	0.5	115.5	0.8	0.0	5.7	0.0	3.7	7.9	0.3	0.0	1.9	0.0	0.0	0.1	2.0	0.0	0.0	0.2	0.0	0.1	0.1	11.8	0.0	0.0	0.7	0.0	0.2	806.1	38.7	0.3	1.3	0.0	0.0	0.0	4.4	0.0	0.6	0.0	0.0	0.0	175.0	0.5	4.1	5.0	119.2	0.0	0.6	0.0	0.0	0.5	0.1	0.1	0.0	7.2	4.1	0.7	0.0	0.1	2.9	0.0	0.0	6.7	59.4	0.0	0.1	6.9	106.0	0.1	8.6	0.0	0.0	0.9
SGIP1	DKFZp761D221	ENSG00000118473	"SH3GL interacting endocytic adaptor 1"	Q9BQI5	1	66533383-66751139	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 131.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 390.1;Cone photoreceptor cells: 350.3;Excitatory neurons: 323.3;Inhibitory neurons: 401.5;Oligodendrocyte precursor cells: 482.0;Oligodendrocytes: 363.6;Rod photoreceptor cells: 344.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 29.9;BJ hTERT+: 38.0;fHDF/TERT166: 24.5;hTERT-RPE1: 15.8;RPTEC TERT1: 27.5;SH-SY5Y: 15.3;U-138 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	7.4	4.3	12.2	1.9	15.5	0.2	2.7	6.3	17.4	10.4	0.0	3.1	1.6	10.6	4.6	2.7	3.8	4.6	5.0	15.3	5.8	18.0	0.7	8.3	0.7	5.1	5.7	1.6	0.5	0.2	7.7	1.9	5.3	5.8	1.5	131.4	1.7	5.0	2.5	1.6	2.0	3.8	1.6	0.3	3.3	4.4	5.5	0.7	8.9	1.2	0.4	2.7	5.4	10.1	0.0	0.0	0.0	0.0	0.9	5.5	0.0	29.9	38.0	2.3	3.4	0.0	0.0	0.0	0.1	24.5	0.2	0.0	0.0	0.1	4.3	0.0	0.0	1.1	0.4	0.0	6.5	0.0	0.0	4.1	0.0	2.3	0.0	15.8	11.3	0.2	0.0	0.0	13.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	27.5	0.0	0.7	15.3	0.0	0.0	0.0	0.6	0.0	1.1	1.9	27.3	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	15.5	6.3	17.4	15.3	5.8	5.1	5.7	5.3	1.6	5.5	10.1	5.0	0.0	0.0	390.1	0.1	1.0	0.3	0.4	0.0	89.8	0.2	4.7	2.5	2.8	0.0	9.2	350.3	0.1	0.0	0.1	7.9	0.5	0.6	2.9	7.8	13.8	0.0	0.0	323.3	0.0	0.0	15.8	0.5	5.7	10.1	0.0	0.4	0.2	0.2	74.0	401.5	0.0	0.0	0.0	1.1	1.2	2.1	0.4	10.6	48.7	0.0	49.4	0.0	482.0	363.6	0.0	0.0	11.3	0.8	0.8	0.0	0.2	0.0	344.1	13.1	3.2	32.2	0.2	0.4	0.1	1.0	0.3	0.5	0.0	0.1	0.3
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186206	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;lymphoid tissue: 13.0;testis: 6.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 16.5;Extravillous trophoblasts: 42.6;Granulosa cells: 20.3;Hofbauer cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 10.0;memory B-cell: 8.8;naive B-cell: 8.9;plasmacytoid DC: 4.1;T-reg: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.3	0.1	0.3	3.3	0.7	8.7	0.5	0.9	0.5	0.4	0.0	2.1	2.3	0.4	0.0	1.9	0.1	0.4	0.1	0.3	0.4	0.3	0.6	0.3	6.2	0.8	0.6	0.2	0.1	0.2	0.0	1.7	0.6	0.2	2.8	0.1	0.4	0.1	0.1	1.1	2.5	1.0	0.3	1.4	1.5	6.7	0.6	13.0	0.2	0.0	6.6	0.9	0.7	1.2	20.3	23.9	29.9	18.5	1.4	2.6	20.2	21.3	10.1	31.2	33.6	16.5	24.0	30.7	10.6	8.6	21.2	11.4	28.7	11.3	37.6	40.9	19.6	34.6	15.6	12.8	0.2	32.0	28.8	0.3	0.9	33.3	13.1	4.0	18.5	34.9	31.3	52.2	24.6	19.4	52.4	15.4	30.0	20.3	17.0	31.8	38.4	17.7	7.5	14.9	14.2	15.4	23.6	27.2	13.1	22.7	18.2	21.3	4.7	22.5	27.3	20.5	43.3	22.8	57.4	35.2	12.5	31.1	35.0	10.0	0.1	1.4	0.2	0.2	0.1	8.8	0.6	0.7	0.3	8.9	0.2	0.3	1.4	0.3	0.2	4.1	2.6	0.6	0.3	0.7	0.9	0.5	0.3	0.4	0.8	0.6	0.6	0.3	0.6	1.2	0.1	0.0	0.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	3.4	0.0	0.0	0.0	1.8	0.0	16.5	1.5	0.0	0.0	1.1	0.0	2.3	1.6	1.2	0.0	0.0	0.0	1.8	42.6	3.3	0.0	2.9	1.3	20.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	4.9	1.0	4.3	0.0	0.0
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405923-111451623	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.7"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 113.6;Langerhans cells: 130.9;Macrophages: 84.1;monocytes: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 122.2;hTEC/SVTERT24-B: 140.7;U-87 MG: 211.6;WM-115: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	22.2	10.9	10.2	21.9	6.8	60.7	13.3	3.5	9.3	8.6	8.5	11.4	8.1	8.5	3.3	7.7	8.1	18.6	23.4	5.8	6.5	14.3	17.4	20.5	21.0	12.0	7.3	5.5	10.2	5.8	8.0	24.4	10.0	7.3	13.5	3.7	5.3	5.9	9.6	4.1	12.5	13.6	10.1	37.1	7.1	9.5	12.1	10.5	11.1	9.5	15.8	15.7	6.0	14.7	9.2	5.5	7.0	7.3	23.9	35.5	4.8	29.2	79.5	21.9	23.3	8.4	5.2	15.6	20.3	44.6	73.6	1.7	5.5	16.9	35.2	13.3	2.7	53.2	2.6	6.2	23.3	23.5	122.2	21.2	3.8	140.7	12.7	48.4	119.1	12.8	38.9	6.1	80.2	3.2	9.7	46.7	11.0	2.4	21.0	9.5	15.9	10.2	10.5	3.7	4.6	4.9	5.4	0.6	42.2	6.2	3.5	33.4	93.0	20.0	11.3	17.4	48.1	13.9	15.8	17.6	211.6	16.6	165.3	0.9	3.5	1.2	1.2	8.4	1.0	1.5	1.1	1.3	4.8	0.5	0.7	1.0	3.0	1.8	6.6	4.9	0.4	1.8	10.2	6.8	3.5	9.3	5.8	6.5	12.0	7.3	10.0	10.1	12.1	14.7	26.8	3.2	22.0	2.6	26.2	6.8	1.5	4.2	1.2	4.6	4.3	3.8	17.5	4.3	4.3	1.8	2.1	0.4	40.6	15.0	1.9	3.6	13.1	1.0	2.2	39.2	3.5	11.2	11.0	9.0	1.4	8.1	0.5	1.2	38.6	0.8	46.1	11.1	40.4	3.3	7.3	3.0	6.1	113.6	130.9	5.3	2.8	84.1	16.0	38.4	67.1	1.1	18.6	11.1	9.0	7.2	5.9	4.1	4.9	3.0	0.8	1.5	3.5	3.4	0.0	4.0	12.7	12.5	4.5	0.7	4.1	1.0	12.1	4.4	3.2	1.2
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"lymphoid tissue: 262.5"	"Group enriched"	"Detected in some"	7	"dendritic cells: 77.6;NK-cells: 138.0;T-cells: 108.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	54	"gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3"	"Group enriched"	"Detected in many"	70	"NK-cells: 162.2;T-cells: 175.8"	"Group enriched"	"Detected in some"	6	"HDLM-2: 101.1;JURKAT: 193.0;Karpas-707: 201.3;MOLT-4: 257.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072265			Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA072265: "	"prognostic favorable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	1.4	1.1	0.0	10.8	0.1	5.4	1.2	0.1	0.2	0.9	0.1	1.6	1.5	0.6	0.6	1.1	0.5	4.1	0.3	0.1	0.1	0.4	2.8	3.2	38.4	0.2	0.1	0.4	0.2	0.2	0.2	0.3	0.1	1.1	1.5	0.0	1.3	0.3	0.3	0.4	2.5	0.6	0.2	14.7	2.7	0.2	0.1	262.5	0.7	1.2	16.6	5.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	101.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	193.0	0.0	201.3	0.0	0.0	257.2	4.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	32.7	33.3	0.0	0.2	0.0	0.0	1.4	0.6	0.1	120.2	0.5	162.9	1.1	90.4	175.8	0.5	0.2	91.2	108.3	2.4	162.2	1.2	0.8	125.3	91.3	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	1.1	3.2	4.7	0.0	3.0	1.5	0.1	0.0	0.0	0.0	0.7	0.8	0.2	1.5	0.0	0.0	0.0	0.1	77.6	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	7.4	0.1	0.0	0.0	2.0	1.1	0.2	3.8	0.0	3.6	0.9	0.1	0.0	0.0	0.0	0.0	5.6	4.4	0.0	0.0	4.3	5.4	0.0	2.3	0.0	138.0	0.5	0.2	0.0	0.0	0.0	14.1	0.2	0.0	0.5	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	1.0	0.1	108.9	0.0	0.0	0.0
SH2D3C	NSP3	ENSG00000095370	"SH2 domain containing 3C"	Q8N5H7	9	127738317-127778710	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 52.6;dendritic cells: 29.7;Endothelial cells: 52.2;Hepatic stellate cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.3;HUVEC TERT2: 60.0;REH: 60.7;RPMI-8226: 46.1;TIME: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047586	Enhanced		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047586: AB_2680093"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.28e-2)"	"prognostic favorable (9.47e-4)"	"unprognostic (5.23e-2)"	"prognostic favorable (1.98e-4)"	"unprognostic (3.75e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.28e-2)"	27.3	7.6	11.2	15.9	10.5	11.2	24.9	11.7	13.2	12.2	2.8	7.6	4.5	15.8	1.2	5.8	12.6	9.2	44.7	10.7	9.6	19.9	4.7	52.2	25.8	8.6	7.5	5.0	4.8	3.9	7.1	15.8	8.4	8.5	1.8	0.8	6.8	3.5	14.6	7.4	15.1	7.3	8.1	47.2	7.3	5.1	8.9	27.8	22.9	11.4	10.5	10.9	9.4	8.0	0.1	0.2	0.9	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.5	1.1	0.0	1.1	0.7	0.0	0.0	0.0	15.6	0.3	7.3	0.1	0.0	0.3	5.6	53.3	0.3	0.2	0.3	0.1	0.0	60.0	11.6	0.2	20.6	0.0	0.1	5.1	16.8	0.8	0.0	0.0	60.7	0.9	46.1	0.0	0.0	14.5	4.4	0.3	0.1	0.0	1.4	0.1	9.6	50.1	0.0	1.2	0.1	0.1	20.3	22.2	20.3	0.4	4.8	0.0	34.0	29.9	37.8	32.3	94.7	26.4	26.2	18.8	30.4	32.8	29.5	16.6	17.5	82.2	34.6	124.8	59.8	21.6	34.2	11.2	10.5	11.7	13.2	10.7	9.6	8.6	7.5	8.4	8.1	8.9	8.0	52.6	3.2	5.8	0.7	15.9	1.3	0.3	1.9	0.6	3.2	1.1	1.7	10.5	2.8	0.9	0.0	0.0	0.3	29.7	0.0	0.0	0.5	13.8	2.2	2.8	52.2	4.2	3.6	10.8	0.0	0.2	3.1	2.0	0.8	11.4	0.0	41.7	0.7	6.0	3.3	10.7	0.3	0.0	6.0	3.7	16.3	1.2	10.7	1.8	23.4	13.4	3.6	21.6	3.0	0.7	0.1	0.0	0.7	7.6	0.1	0.0	0.1	0.8	2.4	6.6	1.2	12.5	1.8	1.5	0.9	0.4	0.7	15.5	2.0	0.1	0.2
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"		2	85418931-85437029	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"intestine: 1.9"	"Group enriched"	"Detected in some"	5	"Enteroendocrine cells: 10.7;Gastric mucus-secreting cells: 18.3;Proximal tubular cells: 16.7;Spermatocytes: 6.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"LHCN-M2: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA053873	Uncertain					NA	NA					"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.8	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0		0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.4	0.1	0.2	0.3	0.2	0.3	0.1	0.3	0.4	0.0	0.0	0.0	1.3	0.2	0.0	0.5	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	1.9	0.0	0.3	0.1	0.1	0.0	10.7	0.0	0.6	0.0	0.0	0.1	18.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.2	2.0	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.0	2.4	0.1	2.3	0.4	0.1	0.3	0.6	16.7	0.0	0.2	0.0	0.8	0.2	6.8	2.3	0.0	0.0	0.1	0.3	0.1	1.5	0.0
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81202102-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles		NA	NA		13000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA051248: AB_2681405"	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	112.1	120.0	92.4	101.1	92.4	176.7	170.8	98.1	126.3	146.2	94.3	180.8	87.6	208.5	148.8	130.4	112.3	149.1	61.1	88.0	108.2	126.0	62.6	133.0	154.9	104.8	95.6	130.7	81.3	112.3	83.5	86.4	105.2	153.1	108.5	24.9	112.5	284.9	16.5	67.1	98.1	231.7	104.4	144.4	87.0	54.3	96.1	145.1	104.7	50.2	126.8	178.3	76.0	116.3	1.0	38.2	133.4	154.1	172.1	232.0	9.2	83.4	158.3	30.1	61.1	12.5	114.6	113.7	70.1	122.9	42.4	20.7	95.9	60.0	48.0	98.7	33.3	151.2	59.7	7.4	41.6	107.3	286.0	135.6	42.9	42.4	37.6	231.4	133.8	75.9	53.0	279.6	165.9	53.9	117.0	138.7	105.2	1.4	62.3	102.0	60.9	60.8	155.7	52.8	0.4	58.5	0.1	4.2	77.9	88.0	44.8	321.2	136.9	82.7	34.1	76.4	35.0	64.3	60.6	105.6	95.1	215.9	62.9	793.9	358.5	570.7	124.9	477.3	134.8	236.3	154.7	147.8	306.2	207.4	140.8	148.8	126.7	183.0	560.5	148.0	257.5	462.3	92.4	92.4	98.1	126.3	88.0	108.2	104.8	95.6	105.2	104.4	96.1	116.3	191.3	112.2	92.6	73.8	216.1	126.3	131.5	150.4	83.1	16.2	174.6	150.2	19.7	72.9	106.4	121.4	0.0	7.1	183.9	33.2	344.4	86.9	6.3	74.9	120.0	130.7	93.3	172.9	62.8	74.7	6.0	152.4	63.2	62.6	219.7	92.8	139.9	17.8	431.4	5.0	82.4	87.0	109.9	400.9	430.7	19.2	174.3	379.0	147.7	102.1	459.0	154.2	224.6	82.9	54.3	48.0	104.2	314.1	114.4	83.5	91.2	214.3	113.6	8.5	263.0	132.4	308.8	4.5	5.9	76.0	119.5	5.7	163.4	205.9	90.3	146.4
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579066-17797124	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 123.8;retina: 75.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 89.4;Excitatory neurons: 390.8;Inhibitory neurons: 140.9"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 9.3;HeLa: 21.1;JURKAT: 18.7;RT4: 41.8;SCLC-21H: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No				"Cluster 6: Brain - Smell perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: AB_2685045"	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	0.3	0.2	63.0	0.1	69.0	0.0	0.1	92.3	123.8	2.3	1.9	0.5	0.2	2.2	1.2	0.5	2.0	0.0	4.3	77.7	26.6	16.8	0.2	1.1	0.0	27.9	28.5	1.8	3.0	0.3	26.2	0.0	25.9	1.8	0.6	75.0	0.1	0.1	0.1	0.1	0.5	1.7	29.3	0.1	8.7	6.5	41.1	0.7	1.5	0.0	0.0	4.3	0.4	55.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	7.5	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	9.3	0.0	21.1	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	18.7	0.0	0.1	0.0	0.0	0.1	0.2	2.5	0.0	2.4	0.0	0.0	0.0	0.0	41.8	26.5	0.0	0.3	0.0	0.8	0.8	0.0	0.0	0.0	0.0	2.2	0.0	1.5	0.0	0.4	0.0	1.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.0	69.0	92.3	123.8	77.7	26.6	27.9	28.5	25.9	29.3	41.1	55.5	0.0	0.0	0.0	16.3	0.0	0.1	0.4	0.0	0.0	89.4	0.1	0.0	1.8	0.0	0.0	7.3	22.9	0.0	0.0	0.1	11.7	0.0	16.7	0.2	0.1	0.3	5.3	0.0	390.8	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	13.5	140.9	0.7	0.0	0.0	0.3	47.4	1.2	0.1	0.0	13.1	0.1	9.0	0.0	41.7	10.2	0.2	0.1	0.4	0.0	2.2	0.0	22.2	0.0	28.0	0.0	0.0	0.1	2.4	6.1	0.0	0.0	0.1	0.0	1.2	0.7	0.4
SHANK3	"KIAA1650, prosap2, PSAP2, SPANK-2"	ENSG00000251322	"SH3 and multiple ankyrin repeat domains 3"		22	50674415-50733298	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.3;Endothelial cells: 65.0;Hepatic stellate cells: 70.3;Microglial cells: 44.0;Oligodendrocytes: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.3;TIME: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003446	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA003446: AB_1079958"	"unprognostic (3.62e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (6.02e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-1)"	34.9	4.0	38.9	4.9	21.6	1.1	33.5	73.5	54.7	12.8	0.0	7.5	3.4	13.4	2.0	5.2	12.4	5.8	26.2	44.7	14.9	11.9	4.4	20.3	4.2	10.0	15.3	4.3	4.0	3.5	5.2	13.7	2.6	8.3	1.2	0.7	8.2	4.2	23.3	7.1	6.4	5.1	0.0	50.4	5.7	2.2	38.6	1.7	14.8	8.9	1.4	10.7	10.1	16.2	6.6	2.6	6.2	4.8	0.5	1.6	3.2	1.3	0.0	0.4	0.5	1.6	2.4	0.0	4.0	1.0	3.1	1.2	0.9	2.3	0.0	0.0	10.4	8.0	1.8	7.1	1.9	1.8	0.4	2.2	1.8	0.1	0.3	0.1	33.3	1.9	0.2	0.2	0.5	2.6	1.4	0.5	3.2	0.6	2.2	7.5	0.0	1.7	0.4	1.3	2.3	3.0	2.7	0.0	3.1	0.7	0.3	0.7	37.6	0.4	9.3	2.0	0.7	0.3	0.4	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	21.6	73.5	54.7	44.7	14.9	10.0	15.3	2.6	0.0	38.6	16.2	195.3	0.0	1.1	4.6	0.5	0.3	0.1	0.5	4.0	1.2	1.3	2.4	27.6	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.9	3.9	2.4	65.0	2.4	0.0	28.3	0.0	0.0	3.3	0.0	1.5	0.0	0.3	70.3	6.5	0.4	0.0	21.7	0.0	2.0	3.1	0.0	0.4	0.0	0.3	0.0	44.0	0.0	1.4	0.0	25.1	31.3	0.1	0.0	0.4	0.0	0.2	0.0	0.9	0.9	0.0	0.0	1.0	3.8	0.2	0.8	1.0	0.3	0.0	0.6	0.7	0.1	0.3
SHC4	"RaLP, SHCD"	ENSG00000185634	"SHC adaptor protein 4"	Q6S5L8	15	48823741-48963919	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.6;testis: 10.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 16.6;Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 81.8"	"Cancer enhanced"	"Detected in some"		"melanoma: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AN3-CA: 10.0;SK-MEL-30: 19.1;WM-115: 16.5"	"Low region specificity"	"Detected in all"							HPA074146			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA074146: AB_2686667"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.04e-5)"	"unprognostic (9.84e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.36e-2)"	0.5	0.9	12.7	1.0	21.0	0.1	1.6	15.8	18.9	1.0	6.7	2.8	0.3	0.4	0.9	0.5	1.0	1.4	3.3	14.0	14.3	0.3	0.1	0.3	0.3	18.3	16.9	0.5	0.2	0.1	1.0	0.4	19.0	0.7	0.5	0.9	2.1	1.3	0.9	0.6	0.8	0.7	13.6	0.2	0.7	10.5	17.8	0.3	0.3	1.2	0.1	0.4	0.9	36.6	0.0	0.4	1.0	10.0	0.4	1.3	0.0	1.5	2.9	0.6	1.2	0.0	0.3	0.1	2.6	0.6	0.1	0.0	0.2	0.4	0.8	2.2	0.1	0.6	0.0	0.0	1.1	0.0	0.2	1.9	0.0	1.3	0.1	1.3	0.1	1.0	0.0	0.2	1.4	1.9	0.4	0.2	0.1	0.0	3.7	0.2	2.7	0.3	2.1	0.4	0.5	0.8	0.2	0.1	19.1	0.9	0.0	0.1	0.0	0.9	0.5	0.6	1.0	0.9	0.1	0.1	0.8	0.5	16.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	21.0	15.8	18.9	14.0	14.3	18.3	16.9	19.0	13.6	17.8	36.6	0.2	0.0	0.0	16.6	0.0	0.3	0.0	2.3	0.0	0.6	1.6	6.7	2.5	0.0	2.8	0.0	0.0	0.7	0.0	0.0	0.0	6.4	2.5	0.4	0.4	0.2	0.0	0.0	9.3	0.0	0.2	1.8	0.0	0.3	0.0	0.0	0.7	0.0	0.1	1.7	6.1	0.0	0.0	0.0	0.4	4.5	1.2	0.1	7.2	1.0	0.0	2.7	0.0	30.7	81.8	0.2	0.0	3.4	0.0	0.0	0.0	0.1	2.6	1.0	0.0	0.5	0.3	6.0	6.3	0.1	0.3	0.8	0.3	0.5	0.0	0.0
SHD		ENSG00000105251	"Src homology 2 domain containing transforming protein D"	Q96IW2	19	4279266-4290722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 10.0;heart muscle: 17.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 137.5;Hepatocytes: 57.3;Intestinal goblet cells: 54.6;Paneth cells: 78.8;Proximal enterocytes: 43.1;Undifferentiated cells: 49.4"	"Cancer enhanced"	"Detected in some"		"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	178	"plasmacytoid DC: 17.8"	"Lineage enriched"	"Detected in single"	178	"dendritic cells: 17.8"	"Group enriched"	"Detected in some"	45	"RH-30: 58.4;SH-SY5Y: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017955	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centriolar satellite, Cytosol"		"HPA017955: AB_1856828"	"unprognostic (2.41e-3)"	"unprognostic (7.68e-3)"	"unprognostic (4.77e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.69e-2)"	"unprognostic (8.16e-4)"	0.0	0.1	4.2	0.6	3.6	0.7	0.0	7.0	8.6	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.1	17.8	2.4	9.6	0.0	1.5	0.0	0.6	7.4	6.4	0.0	0.0	0.1	0.2	0.0	5.6	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	4.6	0.1	0.0	0.1	10.0	0.1	0.0	1.7	0.3	0.1	0.0	6.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.2	58.4	0.1	0.0	0.0	0.5	193.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	4.2	3.6	7.0	8.6	2.4	9.6	7.4	6.4	5.6	4.6	10.0	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	1.8	21.7	137.5	1.9	0.0	0.1	0.1	0.0	0.2	13.2	5.3	2.8	0.0	0.6	0.4	0.0	0.1	8.9	0.0	0.7	57.3	0.4	10.1	4.2	54.6	0.0	0.6	0.0	0.4	0.0	0.6	0.0	1.0	0.2	0.9	0.0	9.0	0.3	0.0	78.8	0.0	0.0	0.0	43.1	0.0	0.0	0.4	0.0	2.5	0.1	0.0	2.9	0.0	0.0	4.4	0.8	0.0	49.4	0.0
SHE		ENSG00000169291	"Src homology 2 domain containing E"	Q5VZ18	1	154469772-154502412	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.9;Alveolar cells type 2: 23.4;Endothelial cells: 64.4;Hepatic stellate cells: 85.3;Kupffer cells: 26.7;Late spermatids: 23.0;Microglial cells: 26.2;Spermatocytes: 30.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 49.1;TIME: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037417	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA037417: AB_10672384"	"unprognostic (3.24e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.40e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.33e-2)"	23.4	9.8	9.4	3.3	8.8	1.2	20.9	7.7	10.6	13.2	7.4	7.4	3.4	12.1	4.3	5.0	12.5	6.9	22.7	8.3	8.3	10.5	5.8	20.6	3.9	8.4	9.1	7.6	3.0	4.9	3.7	16.5	8.8	8.1	4.2	0.6	5.4	4.2	7.1	6.4	8.9	8.0	8.1	21.4	5.5	22.2	10.2	2.6	22.1	11.3	2.3	9.7	9.9	8.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	49.1	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.5	0.0	1.0	13.6	0.0	0.3	1.4	0.0	0.1	0.2	0.1	0.0	1.0	0.0	0.5	0.3	0.2	1.5	1.5	1.1	0.9	0.6	0.6	0.1	0.9	0.8	0.9	2.4	1.7	1.1	4.0	0.0	0.5	9.4	8.8	7.7	10.6	8.3	8.3	8.4	9.1	8.8	8.1	10.2	8.0	56.9	0.0	23.4	3.9	0.3	3.3	0.4	0.3	1.2	0.1	0.4	1.3	4.4	1.5	1.3	1.8	0.0	0.0	0.2	0.0	0.0	0.1	13.0	0.4	0.3	64.4	0.0	2.7	0.3	0.0	0.0	6.7	0.0	0.5	3.8	2.1	85.3	3.4	1.4	0.0	0.3	0.0	0.0	26.7	6.6	23.0	1.5	2.0	0.0	26.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.7	0.0	0.1	0.0	0.4	0.0	3.3	2.2	30.6	13.0	0.3	1.6	0.1	0.7	0.3	0.0	0.3
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SHH	"HHG1, HLP3, HPE3, MCOPCB5, SMMCI, TPT, TPTPS"	ENSG00000164690	"Sonic hedgehog signaling molecule"	Q15465	7	155799980-155812463	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant, Holoprosencephaly, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 13.6;stomach 1: 10.5;urinary bladder: 16.2"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 8.3;Cholangiocytes: 18.6;Collecting duct cells: 9.2;Gastric mucus-secreting cells: 9.7;Hepatocytes: 20.1;Intestinal goblet cells: 8.6;Pancreatic endocrine cells: 11.7;Urothelial cells: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.9;GAMG: 39.8;OE19: 10.2;RT4: 25.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	NA	NA		5500000		"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (7.17e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.70e-2)"	"prognostic favorable (8.62e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.66e-2)"	0.0	8.7	1.3	0.3	1.2	0.0	0.0	1.6	1.2	4.4	0.3	1.3	1.4	0.4	3.0	0.0	0.1	3.8	0.0	0.8	6.2	3.3	13.6	1.7	0.0	3.3	1.6	0.0	0.2	0.0	0.1	0.0	4.6	1.2	1.0	0.3	0.0	1.2	0.0	0.1	1.4	0.0	1.0	0.0	10.5	0.1	2.6	0.0	0.0	0.0	0.0	16.2	0.3	1.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.2	0.0	8.9	0.0	39.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	10.2	4.0	0.0	0.0	0.0	2.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	1.2	1.6	1.2	0.8	6.2	3.3	1.6	4.6	1.0	2.6	1.6	0.0	3.2	7.8	0.0	0.0	0.0	8.3	0.0	0.0	1.5	0.0	0.0	0.7	18.6	1.3	9.2	0.0	0.0	0.0	3.7	0.0	1.2	4.7	5.4	0.5	0.2	0.0	0.0	0.1	0.8	0.2	0.1	9.7	7.6	0.0	0.0	0.4	20.1	0.0	0.0	0.4	8.6	0.0	0.6	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.7	0.5	0.4	0.1	1.3	2.5	6.6	0.0	0.1	0.0	0.0	0.1	2.7	0.2	0.0	0.0	0.0	0.0	0.0	3.0	8.3
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397488-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.3;heart muscle: 15.5;kidney: 21.4"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 7.6;renal cancer: 7.8"	"Group enriched"	"Detected in all"	4	"midbrain: 13.3;thalamus: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AN3-CA: 219.6;PC-3: 130.4"	"Region enriched"	"Detected in many"	23	"olfactory bulb: 51.7"	"Region enriched"	"Detected in many"	8	"spinal cord: 21.4"	HPA054754			Approved	"Lipid droplets,Cytosol"		NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.1	1.8	1.8	1.8	1.6	0.0	2.3	1.1	1.6	0.7	1.2	6.2	2.2	0.2	0.3	1.7	0.5	1.0	15.5	1.0	2.2	21.4	0.6	5.7	7.0	1.7	13.3	0.3	0.2	0.2	0.6	0.0	2.6	0.8	3.0	0.1	0.6	1.0	1.6	0.5	10.4	4.3	1.4	0.4	2.9	0.6	10.1	0.1	5.0	1.4	0.8	3.5	1.3	1.2	0.0	0.0	0.0	219.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.1	0.0	0.0	23.3	0.0	0.0	0.0	2.6	0.0	0.1	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	1.2	0.0	10.1	0.0	130.4	0.2	0.0	0.0	9.0	0.0	0.1	0.3	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.1	1.6	1.0	2.2	1.7	13.3	2.6	1.4	10.1	1.2	4.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	3.7	0.0	0.0	0.1	0.1	43.0	0.0	0.0	0.1	2.5	3.7	0.0	5.3	0.0	0.0	0.0	19.4	0.5	0.1	0.0	1.1	55.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.0	3.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	2.4	0.0	0.1	0.0	0.2	1.4	0.5	0.4	0.1	0.0	0.0	0.0	2.4	0.1	0.0
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901598-13240416	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 48.5;LHCN-M2: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	0.5	2.8	12.5	0.8	12.7	1.3	0.6	0.0	14.8	0.3	0.0	3.2	0.8	0.4	1.1	0.5	0.2	0.4	0.6	10.9	6.3	1.9	0.6	0.2	0.4	6.9	5.9	0.4	0.6	0.1	0.9	0.4	6.2	4.2	0.9	3.7	0.9	0.7	1.5	0.9	0.9	0.6	1.7	0.4	0.5	0.7	11.0	0.1	2.1	0.0	0.3	0.2	0.2	4.2	0.8	0.4	0.6	0.5	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.5	0.5	48.5	0.1	0.7	0.6	0.1	0.2	0.1	0.6	0.2	0.6	0.9	0.3	0.1	0.6	0.6	1.5	0.1	0.1	3.3	0.4	0.1	0.6	0.4	1.0	40.5	5.5	0.4	0.7	10.2	0.7	0.5	0.6	0.4	0.3	10.9	1.5	10.1	0.5	0.4	1.4	0.4	4.4	0.9	0.4	0.4	0.6	5.8	0.6	0.4	0.9	1.0	0.5	0.4	0.3	1.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	12.5	12.7	0.0	14.8	10.9	6.3	6.9	5.9	6.2	1.7	11.0	4.2	0.0	25.6	20.1	5.2	0.1	0.1	0.5	0.2	0.0	0.8	1.7	0.8	1.3	1.5	7.0	1.8	0.0	0.1	0.0	0.3	1.9	1.4	4.8	0.1	0.5	1.1	0.0	0.0	265.0	0.0	0.0	2.0	0.0	0.3	11.4	0.0	0.0	0.0	0.0	0.0	427.9	0.3	0.0	0.0	0.4	3.4	0.3	1.0	0.0	5.6	0.0	0.5	0.0	636.3	4.9	0.1	2.3	0.0	0.0	1.8	0.0	1.3	11.8	0.3	0.0	6.6	0.2	0.5	2.0	0.0	0.1	0.1	1.3	0.0	0.8	0.6
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 168.5;liver: 398.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 307.7;Proximal tubular cells: 435.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023314, HPA078682"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		1500000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA023314: AB_1856830, HPA078682: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favorable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	37.5	9.4	8.1	4.0	9.4	9.5	36.3	12.6	9.5	13.6	7.1	17.5	13.8	7.6	4.9	59.2	13.1	7.7	5.7	8.8	8.5	168.5	398.7	10.3	9.0	10.8	9.3	11.7	8.8	85.7	4.1	7.7	10.7	10.1	6.1	3.1	30.0	10.0	18.8	22.6	24.4	3.7	8.0	21.7	13.3	12.8	9.4	21.1	23.5	18.6	17.6	11.5	19.3	16.0	39.6	28.9	5.5	34.5	29.9	15.8	63.0	11.3	10.3	30.8	31.2	22.1	22.5	26.8	27.8	3.6	16.4	18.8	32.4	39.7	24.3	17.3	30.6	13.0	39.9	21.6	7.2	4.4	11.0	21.1	13.6	23.1	7.2	10.9	9.7	32.3	10.0	10.9	11.3	12.4	46.0	13.9	17.4	43.6	5.1	29.7	48.5	34.7	69.3	17.0	24.0	5.3	82.7	14.9	21.4	50.2	64.5	19.4	2.6	5.7	14.0	71.4	17.6	10.7	20.5	7.1	10.3	12.7	16.5	10.2	4.7	5.2	5.3	5.9	8.1	4.4	6.6	5.5	3.5	3.7	6.8	6.4	0.2	8.5	5.2	1.1	11.2	4.3	8.1	9.4	12.6	9.5	8.8	8.5	10.8	9.3	10.7	8.0	9.4	16.0	11.2	12.8	31.0	3.3	10.4	10.3	21.7	16.5	18.8	3.1	22.7	13.8	2.7	42.9	11.2	36.8	4.2	23.7	5.2	8.9	82.2	13.7	10.9	6.2	1.9	7.4	1.2	28.0	5.2	7.7	76.1	8.0	9.2	10.1	8.2	9.9	13.6	307.7	39.6	0.0	4.8	12.9	4.1	36.8	3.5	5.5	5.9	17.2	12.4	9.4	4.4	33.8	5.2	2.0	11.4	5.3	9.7	3.0	20.3	5.9	53.7	435.7	3.5	4.2	19.7	8.1	4.4	30.0	21.4	35.4	10.5	8.5	10.1	4.9	32.2	10.9
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229573-57234935	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 182.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 2292.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Supported	Microtubules,Mitochondria		NA	NA		390000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 85: Liver - Metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavorable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	25.4	25.4	18.5	43.3	18.6	41.4	23.8	20.7	22.2	22.5	18.4	32.4	35.5	19.4	18.9	46.5	23.3	20.2	24.2	21.1	20.3	32.4	182.3	23.6	52.2	20.6	20.6	25.8	62.2	15.6	15.8	33.6	21.2	13.8	27.2	13.9	30.7	11.7	36.6	36.4	27.0	27.3	20.1	34.9	32.2	5.1	21.8	36.0	34.7	30.5	58.6	26.4	23.6	23.0	246.9	137.6	123.5	368.0	101.8	152.4	238.1	140.8	237.9	197.0	176.5	200.1	120.4	499.8	217.3	186.5	80.6	167.3	229.4	250.6	108.9	265.0	201.9	199.7	79.6	180.1	680.9	333.1	181.0	191.2	351.9	163.4	538.4	176.0	175.3	283.8	223.0	472.3	141.0	210.6	271.0	217.9	123.1	111.8	223.4	181.2	2292.7	433.6	95.9	151.1	265.4	119.9	73.0	170.1	518.3	48.5	222.9	424.2	108.8	84.6	150.5	96.1	185.0	574.1	338.4	421.4	169.6	320.2	154.0	34.9	41.2	23.3	26.6	50.6	31.5	127.5	46.3	29.4	59.6	137.9	21.1	22.0	2.0	40.1	34.1	20.4	202.8	53.8	18.5	18.6	20.7	22.2	21.1	20.3	20.6	20.6	21.2	20.1	21.8	23.0	9.1	9.6	14.1	4.2	58.2	34.7	23.0	43.5	39.9	7.0	26.5	24.0	12.1	21.5	23.5	3.7	0.0	55.4	11.6	9.6	13.7	45.7	0.4	6.3	22.6	17.1	9.6	53.8	3.7	47.7	52.7	25.5	23.4	10.9	29.2	18.7	22.1	182.8	50.2	8.4	3.2	24.2	34.6	36.0	25.1	0.9	18.0	23.5	39.2	3.7	32.0	45.3	21.6	4.0	2.4	40.1	18.7	16.1	74.4	18.2	15.9	63.6	13.3	6.2	6.6	23.9	40.2	1.9	6.6	52.9	32.5	37.4	21.1	39.5	37.4	23.8
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 545.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	545.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.0	0.0	0.0	0.0	0.0	0.0	448.2	0.8	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3712600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Hofbauer cells: 78.6;Kupffer cells: 93.4;Macrophages: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Cell line enriched"	"Detected in single"	19	"THP-1: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053457	Supported				"Intracellular and membrane"	NA	NA		260000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA053457: AB_2682158"	"unprognostic (2.05e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.83e-4)"	"unprognostic (4.87e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (4.36e-4)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	23.0	13.7	2.0	7.7	2.9	12.3	8.6	1.9	6.5	1.8	7.5	10.2	5.1	2.0	1.8	2.2	7.0	8.5	6.4	1.8	2.2	3.9	8.4	16.7	12.7	10.2	3.3	2.7	1.6	0.5	2.3	18.8	10.9	1.9	6.6	0.3	5.4	1.2	3.7	3.0	11.2	7.7	5.0	18.9	5.1	2.5	10.9	3.6	3.7	2.6	1.9	7.6	3.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.0	2.9	1.9	6.5	1.8	2.2	10.2	3.3	10.9	5.0	10.9	3.9	0.5	3.2	4.4	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	0.3	2.4	0.0	0.6	0.0	2.1	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.0	0.2	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.3	0.0	0.0	93.4	6.3	0.1	0.0	42.6	0.0	3.7	2.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	1.4	1.0	0.0	0.1	0.6	0.6	1.9	0.4	0.0	0.0	0.0
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410020-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.0;granulocytes: 39.3;Kupffer cells: 93.9;Macrophages: 51.5"	"Cancer enhanced"	"Detected in all"		"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 765.3;intermediate monocyte: 252.0;non-classical monocyte: 539.2"	"Group enriched"	"Detected in many"	16	"granulocytes: 765.3;monocytes: 539.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HDLM-2: 9.0;HEL: 14.9;HMC-1: 10.7;NB-4: 10.4;U-698: 21.3;U-937: 12.0"	"Not detected"	"Not detected"							"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	3.5	6.4	3.9	33.9	4.8	14.9	2.1	4.3	6.0	2.1	3.5	5.4	7.0	2.1	1.0	2.0	2.4	3.7	1.4	3.9	6.2	1.7	3.2	8.5	19.9	11.4	6.9	1.6	3.5	1.0	1.4	1.8	8.8	3.0	4.6	1.1	2.2	1.1	0.7	1.2	12.2	4.5	6.3	38.5	4.7	1.3	6.3	4.0	1.0	1.1	19.5	5.5	1.2	9.4	0.2	0.0	0.5	0.5	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	1.3	28.8	0.9	0.1	0.3	0.5	0.0	0.2	0.0	9.0	2.5	14.9	0.3	0.1	0.0	6.4	10.7	0.1	0.0	0.1	0.0	0.1	0.0	1.7	0.7	1.4	0.0	0.6	0.2	10.4	0.8	0.7	0.4	1.9	0.1	0.5	0.0	0.3	0.4	0.4	0.3	0.1	0.2	0.5	0.1	5.2	0.7	0.7	1.3	0.6	0.2	1.3	0.3	21.3	0.5	12.0	0.5	14.0	41.9	765.3	0.8	252.0	0.4	41.4	0.5	0.5	38.0	27.4	0.3	0.5	87.2	0.4	539.2	2.2	1.1	40.7	3.9	4.8	4.3	6.0	3.9	6.2	11.4	6.9	8.8	6.3	6.3	9.4	0.7	3.2	1.3	0.3	33.0	0.1	1.2	0.0	0.0	1.4	0.4	0.9	0.3	0.0	0.0	1.8	2.1	0.1	0.6	0.1	0.0	0.0	0.9	0.0	0.0	4.2	0.0	5.2	0.6	0.0	0.1	0.8	0.0	0.1	39.3	0.1	0.4	1.0	8.1	0.0	0.2	0.1	0.0	93.9	6.3	0.4	0.0	51.5	0.0	15.0	14.8	0.2	6.2	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.1	0.0	0.7	0.0	2.0	0.4	0.5	0.7	0.0	1.3	0.1	2.7	0.1	0.0	0.9
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.3;lymphoid tissue: 40.3"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 18.5;Kupffer cells: 41.5;Macrophages: 13.5;monocytes: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 109.1;intermediate monocyte: 125.1;myeloid DC: 65.4;neutrophil: 200.1;non-classical monocyte: 93.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 65.4;granulocytes: 200.1;monocytes: 125.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 98.7;U-937: 24.7"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		24000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	3.4	2.4	1.4	25.2	1.5	28.3	1.0	1.6	3.2	1.8	1.3	1.8	0.7	0.9	0.3	1.1	2.3	2.6	1.3	1.4	2.4	0.7	3.5	7.3	13.3	4.7	3.0	0.4	1.1	0.4	0.5	2.5	3.9	0.9	1.6	0.1	1.1	0.9	0.4	0.3	6.1	2.5	2.7	40.3	1.6	2.4	3.9	1.9	0.6	0.0	14.2	4.1	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	1.6	98.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	16.6	109.1	1.8	0.3	125.1	0.1	19.3	0.2	0.3	65.4	18.2	0.1	0.1	200.1	0.7	93.3	12.0	0.2	40.3	1.4	1.5	1.6	3.2	1.4	2.4	4.7	3.0	3.9	2.7	3.9	4.1	0.0	0.0	1.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.0	41.5	6.0	0.8	0.3	13.5	0.0	1.0	24.1	0.0	2.1	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 106.7"	"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 76.0;granulocytes: 55.0;Syncytiotrophoblasts: 188.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 4.9;memory B-cell: 7.2;naive B-cell: 4.5;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	13	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 500.7"									"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (1.97e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (9.31e-3)"		"unprognostic (8.46e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.57e-3)"	0.6	0.1	0.2	3.0	0.3	0.5	0.7	0.4	0.3	1.6	0.1	2.2	2.2	1.5	1.0	2.5	0.3	2.5	0.4	0.2	0.0	0.1	0.1	4.3	3.8	0.1	0.1	0.1	0.3	0.1	0.0	106.7	0.2	1.0	3.1	0.4	0.5	0.7	0.5	0.5	3.3	1.3	0.0	1.7	2.6	0.3	0.2	0.7	0.0	0.6	4.2	1.8	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	15.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	73.1	0.0	0.0	0.0	1.2	500.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.9	0.2	4.9	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	1.6	4.5	0.0	0.0	0.2	0.6	0.0	11.0	0.0	0.4	0.2	0.3	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.2	0.5	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	5.2	0.7	0.0	0.0	55.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.7	0.5	0.0	0.0	0.0
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 31.3;Kupffer cells: 57.4;Macrophages: 33.1;monocytes: 15.5;NK-cells: 69.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 242.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Karpas-707: 55.4;RPMI-8226: 33.7;U-937: 35.0"									HPA075513			Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Vesicles	"HPA075513: "	"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	3.7	2.9	0.9	10.6	1.0	4.6	1.0	1.0	1.9	0.6	1.2	1.9	1.6	0.5	0.4	0.4	1.2	2.6	1.3	0.8	1.3	1.6	7.4	5.0	7.7	2.1	1.5	0.4	0.5	0.7	0.6	6.2	1.9	0.7	2.4	0.2	0.7	0.4	0.2	0.2	2.2	3.8	1.4	19.2	0.9	0.9	2.2	1.5	0.5	0.3	2.4	3.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	33.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	1.2	1.1	0.0	0.2	35.0	0.0	3.2	140.2	242.1	10.6	105.8	18.9	3.8	0.2	4.8	65.5	0.2	0.3	4.4	116.7	96.8	44.0	2.9	0.0	80.9	0.9	1.0	1.0	1.9	0.8	1.3	2.1	1.5	1.9	1.4	2.2	2.4	0.4	0.0	2.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.8	0.0	0.2	8.3	0.1	0.0	0.0	0.4	0.0	0.2	0.6	0.0	8.8	0.0	0.0	0.2	0.3	0.0	0.0	1.3	0.0	6.1	0.8	31.3	0.0	0.0	0.0	0.0	57.4	3.5	0.0	1.5	33.1	0.0	0.0	15.5	0.0	69.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.5	0.4	0.0	0.0
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.9;lymphoid tissue: 6.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 44.9;Kupffer cells: 17.7;Microglial cells: 11.2"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;renal cancer: 2.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	38	"eosinophil: 290.2"	"Lineage enriched"	"Detected in single"	719	"granulocytes: 290.2"	"Cell line enriched"	"Detected in some"	44	"HMC-1: 147.5"									HPA012556	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.3	4.0	4.9	1.6	5.2	0.5	1.4	5.3	6.1	0.9	1.7	1.8	1.8	0.6	0.7	0.7	0.7	1.4	0.2	4.5	6.2	0.1	0.8	2.5	6.8	13.3	6.6	0.2	0.5	1.0	0.4	0.1	10.1	0.6	1.6	0.7	0.6	0.5	0.1	0.5	2.8	0.9	7.3	6.3	1.4	0.3	11.6	2.1	0.4	0.2	2.5	1.0	0.3	14.9	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.1	0.0	0.0	147.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.3	0.0	0.0	0.2	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	1.1	0.1	7.6	0.4	290.2	0.2	0.3	0.1	0.2	0.2	0.1	0.1	0.3	0.1	0.2	2.5	0.3	0.4	0.2	0.1	0.2	4.9	5.2	5.3	6.1	4.5	6.2	13.3	6.6	10.1	7.3	11.6	14.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	2.5	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 5.1;Kupffer cells: 20.0;Macrophages: 9.5;Microglial cells: 14.0;monocytes: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 51.1;eosinophil: 31.7;intermediate monocyte: 30.4;myeloid DC: 21.1;neutrophil: 69.5;non-classical monocyte: 24.4"	"Group enriched"	"Detected in many"	329	"dendritic cells: 21.1;granulocytes: 69.5;monocytes: 51.1"	"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HBEC3-KT: 4.0;HMC-1: 7.8;hTCEpi: 8.5;HUVEC TERT2: 4.3;THP-1: 7.7;TIME: 3.7;U-937: 8.3"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	5.6	2.4	1.1	12.0	1.2	6.5	1.6	1.3	1.6	1.8	1.8	1.5	0.9	0.9	0.1	1.8	1.6	3.7	1.4	1.1	1.5	1.1	1.8	7.2	7.0	2.7	2.1	0.5	0.7	0.6	0.6	7.5	2.4	0.9	1.7	0.2	1.3	0.6	0.5	0.9	2.0	4.1	1.6	13.1	1.2	0.5	2.7	1.4	0.7	1.8	3.2	3.9	0.9	2.6	4.7	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.8	0.0	8.5	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	3.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	8.3	0.0	3.0	51.1	31.7	0.1	30.4	0.0	0.0	0.0	0.0	21.1	0.1	0.0	0.0	69.5	0.0	24.4	0.6	0.0	18.9	1.1	1.2	1.3	1.6	1.1	1.5	2.7	2.1	2.4	1.6	2.7	2.6	0.0	0.0	1.1	0.0	0.5	0.3	0.9	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.1	1.3	0.0	1.4	0.2	5.1	0.0	0.1	0.0	0.0	20.0	3.3	0.0	0.0	9.5	0.0	14.0	8.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.1	0.7	0.3	0.1	0.0	0.6
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 39.1"	"Group enriched"	"Detected in some"	8	"Early spermatids: 48.9;Late spermatids: 14.1;T-cells: 41.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 369.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 369.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.8;JURKAT: 10.7;NB-4: 13.8;RT4: 3.6;THP-1: 2.3"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"	0.4	0.7	0.0	12.9	0.0	2.9	0.9	0.0	0.2	1.0	0.0	2.5	1.8	0.4	0.2	1.1	0.4	2.3	0.6	0.0	0.0	0.3	1.0	1.5	34.3	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.7	3.0	0.0	1.2	0.6	0.0	0.3	5.8	0.7	0.1	9.4	3.0	0.3	0.0	39.1	0.7	0.1	28.1	3.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	4.8	0.0	10.7	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.9	1.5	1.2	67.6	0.7	186.4	0.7	207.6	157.7	0.9	0.7	215.8	176.2	6.0	59.1	1.1	6.7	369.4	101.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	1.3	1.4	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	48.9	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.2	0.5	0.1	1.3	0.0	0.4	0.2	0.0	0.0	0.4	0.2	0.0	1.0	0.4	14.1	0.3	0.7	0.0	1.0	1.4	0.0	2.1	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	41.3	0.0	0.0	0.0
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 95.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 78.9;dendritic cells: 31.2;Plasma cells: 19.8;T-cells: 86.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	46	"gdT-cell: 119.1;MAIT T-cell: 202.7;memory B-cell: 213.6;memory CD4 T-cell: 249.2;memory CD8 T-cell: 223.4;naive B-cell: 192.1;naive CD4 T-cell: 170.4;naive CD8 T-cell: 169.5;plasmacytoid DC: 203.1;T-reg: 352.4"	"Group enriched"	"Detected in many"	56	"B-cells: 213.6;dendritic cells: 203.1;T-cells: 352.4"	"Group enriched"	"Detected in some"	5	"Daudi: 113.1;HDLM-2: 70.6;JURKAT: 58.7;U-698: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018506	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favorable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"	0.9	0.7	0.1	19.1	0.1	1.9	0.9	0.0	0.2	0.5	0.1	2.4	2.9	0.5	1.1	0.8	0.5	1.7	0.5	0.1	0.1	0.7	0.7	2.8	50.6	0.3	0.1	0.5	0.2	0.1	0.1	0.2	0.3	0.6	2.2	0.0	2.6	0.3	0.3	0.7	13.2	0.6	0.1	23.6	4.7	0.2	0.6	95.4	0.8	0.1	32.5	3.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.1	0.0	0.0	0.0	19.1	0.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.0	0.1	0.0	0.0	104.4	0.0	0.0	0.0	1.4	1.3	0.7	119.1	0.8	202.7	213.6	249.2	223.4	1.8	192.1	170.4	169.5	4.5	0.8	0.8	203.1	352.4	123.9	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.3	0.1	0.6	0.2	0.9	0.0	0.0	0.0	78.9	5.6	0.0	0.0	1.2	0.0	1.0	1.0	0.2	1.5	0.0	0.0	0.0	0.0	31.2	0.7	0.0	0.0	0.0	0.1	0.1	0.6	0.0	2.7	0.0	0.0	1.9	0.9	2.0	0.0	0.0	0.0	1.4	0.2	5.3	0.0	0.0	0.0	0.0	2.7	7.4	0.0	0.0	3.4	5.4	0.0	2.5	0.0	4.1	0.0	0.0	0.1	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.5	3.7	0.3	86.8	0.0	0.3	0.0
SKA1	"C18orf24, MGC10200"	ENSG00000154839	"Spindle and kinetochore associated complex subunit 1"	Q96BD8	18	50375040-50394168	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.0;lymphoid tissue: 4.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 22.3;Extravillous trophoblasts: 9.2;Plasma cells: 10.0;Spermatocytes: 16.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 82.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045495	Approved		Approved	Microtubules		NA	Yes			"Cluster 17: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Microtubules		"HPA045495: AB_10960405"	"unprognostic (2.18e-2)"	"unprognostic (7.85e-3)"	"unprognostic (7.66e-3)"	"unprognostic (5.93e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (9.60e-8)"	"unprognostic (1.03e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.91e-3)"	"unprognostic (0.00e+0)"	"unprognostic (4.50e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	0.4	0.5	0.9	2.2	0.8	12.0	0.3	2.5	1.1	0.4	0.8	1.6	1.7	0.6	0.2	2.5	0.2	0.3	0.2	1.0	0.5	0.1	0.3	0.4	4.9	1.0	0.9	0.2	0.4	0.1	0.0	1.6	1.2	0.3	2.1	0.4	0.3	0.1	0.6	1.5	1.4	1.1	0.3	1.3	0.8	4.3	1.3	3.6	0.3	0.2	4.8	0.5	0.7	2.4	27.1	10.8	18.6	19.0	1.2	2.1	9.9	30.7	10.6	29.9	28.5	4.7	10.6	21.1	7.6	11.0	25.8	23.6	25.6	13.0	31.4	34.6	2.6	27.0	5.5	18.3	2.3	42.2	26.8	1.5	1.3	20.7	8.2	3.2	20.0	20.0	30.8	82.6	26.4	5.7	34.6	12.1	14.2	6.5	6.4	17.3	18.3	23.5	8.5	1.6	13.7	10.9	17.2	9.9	13.6	15.3	11.4	20.2	10.1	32.8	19.0	12.8	31.8	27.5	41.6	32.4	18.2	34.9	33.3	0.9	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.2	0.3	0.2	0.1	0.6	0.6	0.2	0.2	0.4	0.2	0.9	0.8	2.5	1.1	1.0	0.5	1.0	0.9	1.2	0.3	1.3	2.4	0.2	0.0	2.2	0.0	2.8	1.0	0.2	0.4	0.0	0.4	0.7	0.6	0.4	0.0	0.8	0.0	2.1	4.4	0.7	1.6	0.0	0.1	4.5	0.5	0.7	0.4	1.2	22.3	0.2	0.0	9.2	1.4	0.5	1.1	0.0	4.9	2.2	0.1	5.3	0.0	0.1	2.7	0.0	0.8	0.9	2.2	0.3	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	1.1	0.0	10.0	0.4	0.1	0.1	0.2	0.8	0.0	0.2	1.4	16.7	13.5	3.7	0.3	1.5	1.4	0.5	3.4	1.0
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176552	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;lymphoid tissue: 12.1;testis: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 12.8;Extravillous trophoblasts: 21.0;Spermatocytes: 21.7;Spermatogonia: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Mitotic spindle"	"Centrosome, Cytosol"	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.2	0.1	0.2	2.5	0.2	4.7	0.8	0.1	0.3	0.2	0.0	1.7	1.0	0.5	0.0	1.9	0.2	0.4	0.0	0.5	0.2	0.1	0.2	0.2	4.3	0.2	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.0	3.0	0.0	0.2	0.0	0.0	1.8	2.1	1.1	0.2	0.7	1.0	6.3	0.3	12.1	0.1	0.1	3.7	0.4	0.5	0.2	26.1	13.0	25.8	20.5	0.9	5.1	19.1	35.0	14.8	42.1	28.7	23.4	27.8	35.6	10.0	19.3	18.5	24.4	34.4	15.2	54.7	30.3	15.9	47.3	7.7	12.7	0.0	39.5	17.7	1.5	1.0	34.9	15.4	4.2	20.7	30.6	26.3	14.2	33.9	21.0	60.7	37.8	27.9	42.8	23.8	36.5	50.3	15.8	12.2	9.9	30.1	11.1	11.8	17.1	8.1	17.9	15.3	33.5	8.7	16.0	23.8	17.0	43.9	9.0	19.7	34.5	4.4	31.1	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.2	0.2	0.1	0.3	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.4	0.0	0.0	0.0	2.6	2.0	0.7	2.4	0.0	0.1	0.9	0.8	0.8	0.0	1.8	0.0	0.0	8.7	1.0	2.1	0.0	1.2	6.3	2.8	0.9	1.4	0.0	12.8	0.8	1.3	21.0	2.1	1.5	1.6	0.0	5.8	1.8	0.4	5.5	0.0	0.6	1.8	2.0	1.9	2.9	7.7	1.5	1.6	0.0	1.9	0.8	0.3	3.1	0.0	0.2	1.0	1.6	1.2	8.5	0.3	0.4	0.6	2.0	0.4	0.0	0.3	2.3	21.7	18.2	5.8	2.8	2.2	1.2	0.5	5.0	0.7
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036728-133102912	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 97.4;lymphoid tissue: 156.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 224.2;Hofbauer cells: 67.4;Kupffer cells: 199.4;Macrophages: 154.2;NK-cells: 109.2;Plasma cells: 83.0;T-cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 47.9;JURKAT: 201.5;Karpas-707: 129.2;MOLT-4: 35.8;U-266/84: 76.1;U-937: 55.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	25.2	13.1	9.5	82.9	6.4	97.4	9.5	6.1	11.5	11.1	8.2	10.8	7.9	5.2	2.9	9.4	7.0	20.9	5.2	8.2	9.1	6.4	16.9	25.9	78.6	12.0	8.4	3.0	5.8	3.1	3.1	15.2	10.3	5.2	8.4	1.3	4.6	3.6	1.5	4.0	20.7	12.5	9.7	70.3	12.5	1.4	16.9	156.6	27.6	4.4	71.0	22.0	4.2	14.6	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	0.1	2.3	0.0	0.0	0.0	6.3	47.9	0.8	0.0	0.6	0.0	0.2	0.0	201.5	0.1	129.2	0.0	0.0	35.8	9.3	0.0	0.0	0.0	0.2	0.3	7.8	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.1	0.0	15.3	0.0	0.1	0.3	0.2	0.1	6.9	76.1	0.0	0.6	55.6	0.0	0.7	110.2	203.6	87.6	123.1	110.1	41.0	79.7	88.2	79.8	48.3	75.3	77.4	262.3	132.6	148.4	6.3	124.4	158.9	9.5	6.4	6.1	11.5	8.2	9.1	12.0	8.4	10.3	9.7	16.9	14.6	2.4	9.6	19.1	0.7	36.6	2.2	0.3	0.0	0.0	9.7	0.9	1.3	3.3	1.5	10.5	0.0	0.0	0.4	224.2	0.2	0.0	0.2	0.2	0.7	0.7	5.9	0.0	13.2	1.0	0.0	1.2	4.5	3.6	0.5	37.2	1.7	8.9	2.9	67.4	0.0	1.3	0.5	0.0	199.4	15.0	1.0	0.3	154.2	5.4	14.0	36.7	0.1	109.2	0.0	0.1	0.0	0.0	0.0	83.0	0.1	0.0	0.3	5.1	0.3	6.6	1.4	1.9	0.0	0.1	0.3	2.7	0.1	160.0	0.1	0.1	0.2
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 97.0;Macrophages: 21.8;NK-cells: 44.3;Plasma cells: 25.8;T-cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Group enriched"	"Detected in some"	7	"HEL: 91.2;JURKAT: 51.8"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	1.3	0.6	0.4	5.7	0.6	12.5	0.8	1.6	0.7	0.8	0.3	1.7	2.7	1.0	0.5	0.7	0.9	2.4	0.7	0.4	0.2	0.5	1.5	4.1	10.4	0.7	0.4	0.4	0.4	0.1	0.4	0.6	0.8	0.7	1.7	0.5	1.4	0.5	0.6	0.7	3.1	0.5	0.3	8.0	2.6	0.5	0.6	18.3	0.7	0.2	9.0	2.2	0.6	1.1	0.0	0.2	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	91.2	0.6	3.4	0.0	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	51.8	0.1	0.2	0.0	0.2	10.9	7.6	0.1	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	2.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	7.6	0.1	3.0	0.4	3.8	28.8	0.7	24.1	0.4	23.8	27.1	0.4	0.3	21.8	30.5	4.8	39.2	0.1	48.5	33.4	26.5	0.4	0.6	1.6	0.7	0.4	0.2	0.7	0.4	0.8	0.3	0.6	1.1	0.6	0.0	3.9	0.0	1.6	0.4	0.1	0.0	0.0	0.3	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.1	97.0	0.6	0.0	0.2	1.1	0.4	0.4	0.4	0.0	8.2	2.2	0.0	0.2	0.5	4.1	0.6	1.3	0.0	0.7	0.1	0.2	0.0	1.7	0.0	0.0	1.6	0.4	0.0	0.3	21.8	0.0	1.9	1.2	0.4	44.3	1.5	1.4	0.3	0.1	0.0	25.8	0.1	0.0	0.1	0.0	0.9	0.0	0.3	0.4	0.0	0.2	0.2	0.1	0.1	59.2	0.0	0.2	0.3
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;dendritic cells: 19.7;Late spermatids: 22.1;NK-cells: 45.3;Plasma cells: 21.4;T-cells: 26.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Daudi: 88.2;U-698: 127.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"	1.7	1.1	0.2	20.6	0.2	3.2	2.2	0.8	0.4	2.0	0.3	3.8	2.7	1.3	1.4	2.1	1.3	4.6	1.0	0.2	0.1	0.9	4.0	4.4	61.7	0.3	0.1	1.2	0.9	0.2	0.2	1.8	0.3	1.3	3.5	0.1	2.2	0.5	0.4	0.6	13.8	1.4	0.1	32.2	5.5	1.2	0.4	19.3	1.7	0.5	48.6	5.7	1.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	6.7	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.8	0.1	0.0	0.0	21.8	1.3	0.1	0.7	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.1	14.2	127.4	0.0	0.6	0.0	11.2	0.3	23.1	56.1	1.0	38.9	36.2	35.6	71.4	0.3	35.4	19.5	39.5	2.5	41.3	3.1	1.0	45.6	22.2	0.2	0.2	0.8	0.4	0.2	0.1	0.3	0.1	0.3	0.1	0.4	0.3	0.1	0.0	1.3	0.0	23.6	0.4	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	19.7	0.1	0.0	0.1	9.4	0.1	0.1	0.3	0.0	3.2	0.0	0.2	0.0	0.4	0.5	0.1	1.3	0.0	3.3	1.1	1.1	0.0	0.0	0.0	0.0	4.3	0.8	22.1	0.0	1.1	0.0	0.0	1.6	0.0	45.3	0.0	0.0	0.1	0.1	0.0	21.4	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.3	0.0	26.1	0.0	0.0	0.0
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.8"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.5	0.2	1.8	1.1	0.1	0.0	4.6	0.9	0.0	1.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	9.0	0.2	0.1	0.2	0.0	8.6	36.8	0.1	0.1	0.0	6.7	0.0	23.3	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.6	0.1	0.5	0.4	3.8	0.0	0.4	0.0	0.0	0.1	0.6	2.6	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	4.6	0.2	9.0	8.6	36.8	23.3	0.6	3.8	2.6	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 78.6;lymphoid tissue: 46.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	14.1	8.5	3.5	7.1	4.3	6.7	4.9	3.9	11.1	2.7	4.7	3.5	0.2	2.2	0.1	1.6	7.4	1.0	8.0	3.3	5.0	3.4	5.1	78.6	0.2	7.4	5.2	1.7	3.2	0.3	3.1	2.7	6.9	3.2	0.0	0.6	3.2	0.1	1.7	1.5	2.2	1.9	5.2	46.6	3.0	0.9	17.3	0.3	2.7	1.3	0.0	7.2	2.4	7.4	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.2	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	6.1	0.6	0.3	4.5	0.2	0.1	0.2	0.1	1.9	0.2	0.3	0.2	4.1	0.2	6.0	0.2	0.2	2.0	3.5	4.3	3.9	11.1	3.3	5.0	7.4	5.2	6.9	5.2	17.3	7.4	1.5	22.4	38.5	1.6	4.1	0.9	4.3	1.9	1.2	3.1	4.5	4.6	8.6	2.8	13.8	9.2	0.0	1.8	3.1	1.8	9.8	1.3	1.8	6.1	2.3	17.0	1.2	1.7	1.3	2.1	7.8	5.8	2.0	2.8	25.3	0.9	6.8	7.3	108.0	1.7	0.9	4.0	6.1	166.8	6.3	0.5	2.1	209.4	1.8	4.7	101.2	12.9	10.3	0.5	1.4	0.4	1.6	0.7	5.6	3.9	2.5	11.7	11.0	3.3	19.7	2.9	4.2	0.8	1.8	2.1	1.0	8.1	6.7	3.3	2.9	3.3
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050384-1112063	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.3"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	21.1	14.6	8.9	7.2	8.0	4.0	18.8	7.2	10.4	15.8	12.3	24.1	24.0	13.8	1.0	8.0	16.6	12.0	77.3	7.9	12.0	45.1	72.4	23.1	5.7	8.0	10.7	12.3	27.6	4.4	20.5	2.9	8.0	20.7	5.4	5.5	18.9	3.0	6.3	15.8	31.9	3.3	6.8	34.9	28.1	29.9	9.4	7.8	24.7	3.1	2.2	14.5	10.8	7.1	3.8	10.0	5.5	17.3	0.8	0.9	8.7	0.2	1.1	0.8	0.0	24.5	6.4	0.0	20.0	0.3	6.8	7.6	4.6	6.1	0.0	23.0	6.1	4.8	13.4	8.6	12.2	0.0	10.4	1.8	0.8	0.0	1.8	0.3	5.5	2.2	7.6	0.2	0.0	12.0	14.8	0.1	11.9	14.4	16.3	43.9	24.0	20.5	6.5	14.8	3.1	3.8	5.6	0.1	6.0	3.3	9.7	2.7	4.8	0.0	5.7	0.0	0.0	0.3	0.0	2.5	0.0	0.6	2.8	0.2	1.8	0.0	1.1	2.7	1.2	0.6	1.1	1.3	2.1	0.6	1.2	1.2	0.0	1.4	3.8	0.9	1.1	1.3	8.9	8.0	7.2	10.4	7.9	12.0	8.0	10.7	8.0	6.8	9.4	7.1	21.3	9.6	15.2	8.5	7.3	7.0	6.3	8.9	6.8	25.3	18.4	13.8	35.8	31.5	13.6	29.5	2.1	0.2	14.2	42.0	1.9	23.5	0.4	40.9	11.0	27.9	13.2	19.1	0.3	18.1	0.4	11.6	39.8	63.4	8.2	16.6	11.7	34.5	19.8	281.0	0.5	19.4	18.3	28.0	19.8	1.9	3.7	29.0	16.0	14.0	9.1	5.2	5.2	1.5	0.0	28.8	35.8	5.7	5.3	15.7	27.3	23.2	23.1	3.6	19.7	5.2	8.4	1.0	3.4	3.5	6.8	0.3	9.8	5.4	19.3	15.2
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 119.6;kidney: 38.2;salivary gland: 44.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 290.2;Proximal tubular cells: 97.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014963	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	6.1	119.6	0.0	3.0	0.0	0.0	6.8	0.0	0.0	0.0	38.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.8	44.9	11.4	0.0	3.1	90.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	13.7	10.9	0.6	27.1	1.6	3.7	12.5	0.0	0.7	29.3	9.8	0.7	0.0	0.0	0.0	0.2	4.8	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	31.4	0.0	0.0	0.4	0.0	0.0	0.7	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	15.7	0.0	0.0	0.0	290.2	97.8	0.3	0.4	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	25.8	0.5
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 203.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.3	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.4	4.5	151.6	5.5	5.9	2.1	0.1	43.1	0.0	0.2	0.6	6.1	18.2	0.1	0.3	0.3	0.6	0.1	8.3	20.6	0.3	0.1	0.4	1.4	2.7	0.0	0.5	0.5	0.7	23.2	203.0	0.4	0.1	0.1	1.2	0.2	1.4	0.2	0.3	0.0	0.6	2.5	3.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.6	0.4	0.2	0.6	0.3	0.6	0.4	0.1	1.4	0.7	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610310-49612720	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 78.1"	CAB079011		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.0	0.0	0.7	0.3	2.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	18.9	8.0	0.0	0.0	0.0	1.2	0.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.6	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	6.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	19.7	0.1	4.9	18.9	8.0	25.6	3.6	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	7.3	30.1	159.4	3.9	159.6	0.6	11.8	98.0	159.1	25.4	372.6	24.6	4.6	14.8	10.3	4.4	19.1	6.4	22.0	145.5	304.0	16.3	2.5	8.3	3.4	165.6	143.8	17.0	17.2	11.4	149.1	5.0	145.5	39.8	2.4	26.4	25.4	25.7	1.5	7.6	10.2	7.0	125.5	4.2	13.3	8.9	231.8	1.7	19.1	2.7	1.6	15.2	17.9	139.5	0.0	1.9	20.7	31.4	23.2	11.4	3.4	7.5	11.6	2.5	1.9	0.0	1.9	0.0	2.8	11.0	6.6	0.4	0.7	0.5	0.0	0.0	1.4	4.4	0.0	0.2	13.1	0.0	4.4	16.7	1.2	2.6	0.0	11.3	0.8	9.1	0.0	0.2	3.8	3.2	0.1	0.2	11.3	0.0	0.0	0.0	0.7	0.2	0.0	2.0	19.9	41.5	5.8	0.0	0.0	4.0	3.5	0.6	0.0	2.9	8.9	16.6	0.0	0.1	3.2	0.0	1.9	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	159.4	159.6	98.0	159.1	145.5	304.0	165.6	143.8	145.5	125.5	231.8	139.5	7.7	0.0	2.7	46.7	2.3	12.6	18.6	2.6	12.5	53.0	23.4	30.1	10.0	2.8	5.5	20.2	43.8	2.4	1.0	0.0	1.9	0.7	0.2	1.8	10.6	12.0	20.8	1.7	71.4	1.3	4.9	21.7	3.6	0.6	4.5	12.0	16.8	0.9	1.0	201.9	111.1	0.0	0.0	0.6	5.1	2.3	21.1	1.2	7.2	19.7	0.7	74.2	0.0	120.6	49.2	1.5	0.0	42.9	9.2	31.3	0.0	16.9	3.2	69.0	0.0	14.1	18.0	1.1	2.3	3.0	10.9	4.8	2.0	4.5	0.3	6.1
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887344-2903575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 17.7;kidney: 11.1;liver: 14.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 163.3;Paneth cells: 124.4;Proximal enterocytes: 75.7;Proximal tubular cells: 104.0;Syncytiotrophoblasts: 80.7;Undifferentiated cells: 48.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 7.0"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.9;granulocytes: 4.0;monocytes: 7.0"	"Cell line enhanced"	"Detected in some"		"A549: 9.4;CAPAN-2: 9.4;MCF7: 18.8;OE19: 8.4;SK-MEL-30: 35.8;WM-115: 14.8"									HPA068288	Enhanced		Approved	Nucleoplasm		No	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	3.2	0.6	0.5	2.2	0.6	0.2	0.7	0.5	1.7	0.7	0.5	17.7	13.4	0.8	0.4	1.2	0.4	1.7	0.3	0.6	1.0	11.1	14.9	0.6	0.4	0.9	0.9	0.4	0.3	0.0	0.3	2.3	1.1	0.8	10.2	0.3	1.8	0.1	0.1	1.1	9.7	0.7	0.8	0.7	1.6	0.5	0.8	0.1	0.3	0.0	0.1	0.7	0.9	1.1	1.2	9.4	0.3	0.5	0.0	0.0	0.9	0.5	0.4	0.0	0.2	2.2	9.4	0.0	0.8	0.0	0.6	0.5	0.0	0.3	0.0	0.4	0.1	0.0	0.8	5.8	0.7	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.3	0.5	0.0	0.9	0.0	18.8	0.0	0.4	0.2	8.4	0.3	0.3	0.0	1.0	0.8	0.0	0.1	0.3	0.9	0.4	35.8	0.2	0.0	0.9	1.9	0.0	0.7	0.3	0.2	0.0	0.0	0.2	0.2	2.6	14.8	4.0	7.0	1.2	0.2	3.9	0.1	0.0	0.1	0.2	3.9	0.0	0.0	0.1	1.6	0.4	2.9	0.0	0.6	2.4	0.5	0.6	0.5	1.7	0.6	1.0	0.9	0.9	1.1	0.8	0.8	1.1	0.6	0.0	0.5	0.0	1.3	0.5	1.1	6.3	1.2	0.0	1.2	0.9	0.4	1.5	2.7	7.3	0.0	19.5	0.4	163.3	9.8	1.7	0.1	0.1	0.3	0.7	9.1	3.2	0.4	0.8	9.8	1.4	2.6	0.5	1.3	0.0	2.9	22.7	17.7	0.0	0.1	26.2	6.1	6.3	5.5	0.2	0.3	6.4	3.6	0.0	4.6	0.0	0.0	0.0	0.1	2.4	124.4	0.0	0.0	1.0	75.7	104.0	1.0	0.0	0.0	0.0	0.6	0.1	0.4	2.1	1.1	80.7	0.9	0.8	48.5	2.5
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 117.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 2710.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 0.5;glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079359			Supported	"Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA079359: "	"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.1	5.9	28.4	0.0	64.7	0.1	0.0	42.3	64.6	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.5	0.1	0.0	19.2	19.1	0.1	0.0	0.0	0.0	81.3	36.3	0.0	0.0	0.0	0.8	0.1	87.7	0.1	0.0	18.7	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.1	0.1	0.2	81.9	0.0	0.0	0.3	0.0	0.0	0.0	117.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	28.4	64.7	42.3	64.6	19.2	19.1	81.3	36.3	87.7	19.4	81.9	117.1	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	58.7	0.0	0.0	2.3	0.0	0.0	0.0	273.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	668.6	0.0	0.1	0.9	0.0	0.1	0.0	0.0	1.4	0.0	0.1	97.6	637.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	25.3	0.0	4.1	0.0	217.6	2710.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	10.4	0.0	3.2	0.2	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.1	0.0
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 238.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.2;Proximal enterocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	28.8	38.0	144.8	12.0	238.7	0.8	18.0	77.5	200.1	32.1	72.0	94.4	39.3	41.8	24.0	64.7	36.6	21.4	79.0	206.5	95.1	45.0	38.5	24.0	9.2	108.8	98.2	33.6	24.2	58.8	22.2	4.7	109.5	35.0	49.1	41.2	68.9	40.0	90.8	33.5	40.5	65.5	82.7	11.9	41.3	9.5	101.4	7.2	60.7	78.2	31.2	55.8	31.1	115.8	58.2	22.9	32.2	101.9	42.3	18.6	14.9	17.0	26.4	31.0	37.2	58.2	37.1	32.2	40.0	41.3	34.1	48.0	66.3	39.0	24.3	0.1	58.6	23.2	46.7	46.2	39.2	1.6	52.5	53.3	33.4	27.6	12.0	62.9	32.8	34.7	68.8	39.4	6.2	41.6	20.7	32.8	23.6	61.0	71.1	10.0	8.8	49.4	83.3	10.2	2.4	31.9	11.7	70.8	30.0	34.8	37.1	50.1	11.7	9.8	41.8	2.6	11.2	7.3	10.7	28.3	4.5	54.2	15.6	0.5	0.0	0.0	2.0	0.0	0.4	1.0	1.1	0.9	0.2	0.4	1.5	1.4	0.0	0.3	0.0	0.4	1.3	0.4	144.8	238.7	77.5	200.1	206.5	95.1	108.8	98.2	109.5	82.7	101.4	115.8	6.2	9.6	20.9	11.8	7.0	10.5	8.8	11.5	12.0	13.1	18.9	15.6	39.5	47.1	10.0	46.0	8.4	1.4	4.5	164.2	19.6	54.7	15.9	8.2	6.4	8.0	13.8	1.3	24.7	28.5	1.8	10.2	12.8	17.5	7.0	17.9	16.1	38.0	2.7	8.4	17.9	34.5	10.2	3.0	2.6	71.2	19.0	1.4	17.8	12.2	1.0	28.7	4.1	17.1	12.6	55.5	57.9	29.3	17.6	13.6	106.8	28.7	6.4	22.0	13.1	12.1	12.7	0.5	4.6	34.1	23.3	0.8	5.2	39.5	34.2	30.3
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	55.3	22.9	16.0	12.5	16.5	9.5	22.9	14.7	19.7	33.2	10.6	17.2	11.9	26.8	3.3	35.0	40.7	39.9	12.8	18.1	17.4	28.6	136.5	27.9	11.2	19.9	18.1	25.3	82.6	19.6	45.7	11.5	17.9	15.2	7.8	31.2	16.5	14.2	82.0	24.4	18.3	26.3	15.4	15.6	23.7	7.6	19.6	15.3	18.9	21.1	6.2	19.0	21.4	14.9	9.5	9.8	13.6	19.8	10.1	8.6	9.0	19.3	17.8	15.9	10.5	17.7	9.7	12.2	5.8	9.0	8.8	16.6	10.8	6.3	6.0	14.3	8.9	7.1	21.6	10.7	16.0	8.3	15.7	11.0	6.0	15.5	11.3	5.2	10.9	20.1	26.1	25.7	10.1	22.9	14.7	8.4	13.8	30.5	15.1	14.3	11.6	26.1	6.1	9.8	33.6	14.5	20.2	12.9	27.8	5.3	14.2	4.7	7.0	17.9	10.6	13.6	19.3	22.3	42.2	13.2	12.1	4.4	15.0	2.6	1.7	0.9	3.0	5.1	1.6	1.2	3.4	3.1	3.1	1.8	2.7	4.9	0.3	1.0	6.1	1.0	2.7	3.2	16.0	16.5	14.7	19.7	18.1	17.4	19.9	18.1	17.9	15.4	19.6	14.9	59.3	22.4	34.2	17.6	9.3	26.1	46.2	24.3	56.3	18.8	71.7	73.5	3.2	58.6	22.8	20.2	127.2	10.1	7.6	45.6	11.7	11.2	0.3	72.0	34.5	44.7	51.7	11.0	19.7	11.5	12.9	21.0	43.8	110.3	8.2	18.7	26.0	84.5	9.1	18.5	20.5	26.5	28.5	20.1	42.9	1.5	9.3	16.8	21.4	13.1	12.6	15.2	12.3	11.1	2.4	12.1	42.7	8.2	14.5	28.6	47.7	10.2	30.8	70.4	19.7	48.1	40.3	5.6	7.9	89.5	43.0	23.0	14.2	11.9	22.3	58.3
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960758-149993455	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 212.0"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	5.2	30.7	2.2	7.8	2.3	2.5	9.2	9.5	3.8	6.3	4.0	212.0	12.9	9.3	22.8	10.7	5.0	5.5	2.8	2.2	3.5	4.9	1.7	7.3	4.0	3.8	3.4	4.8	3.4	37.7	7.1	34.0	3.5	12.2	189.6	20.8	35.8	18.4	3.9	7.8	16.1	9.3	3.8	3.7	3.3	4.2	3.9	4.2	4.5	3.7	5.9	4.7	3.0	3.4	9.5	8.6	10.5	17.3	12.6	8.8	2.5	8.9	8.0	7.0	8.5	44.7	5.1	7.4	66.1	9.5	16.8	6.8	10.0	20.5	12.4	6.0	6.4	9.3	6.7	5.2	9.4	17.3	15.2	9.8	11.8	11.7	15.2	17.3	16.8	9.0	2.4	7.1	29.6	3.0	6.6	9.1	3.2	3.2	13.5	9.5	16.3	3.9	151.7	41.6	3.2	8.1	15.6	3.6	27.2	8.1	7.3	10.0	80.4	16.0	11.8	14.2	10.7	5.2	7.3	4.3	14.7	20.6	23.5	4.9	0.5	0.3	0.9	0.3	1.1	0.5	0.5	0.8	0.7	0.5	0.8	0.9	0.3	1.1	1.6	0.7	1.1	0.5	2.2	2.3	9.5	3.8	2.2	3.5	3.8	3.4	3.5	3.8	3.9	3.4	47.4	44.8	11.3	3.3	8.5	4.6	13.2	22.9	7.4	17.1	23.8	14.6	7.8	7.2	24.2	33.1	16.7	219.2	11.5	2026.2	1.9	6.1	32.7	237.0	92.3	29.8	21.1	16.6	5.4	9.9	7.7	21.5	5.1	684.5	90.0	29.6	17.2	2.0	30.4	6.7	7.9	52.5	20.3	15.3	11.8	15.7	17.4	17.4	90.7	17.8	19.6	15.2	15.5	16.6	6.0	12.1	177.4	12.4	15.2	15.1	91.7	5.1	26.6	84.5	0.0	18.7	13.9	8.7	11.4	73.9	5.1	808.9	14.0	26.3	208.9	5.5
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 1120.4"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 2328.4"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036055	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	1.1	0.0	0.0	19.7	0.0	0.0	59.5	0.2	0.1	0.3	0.0	1120.4	576.9	0.9	15.3	0.5	0.8	17.8	0.0	0.0	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.1	878.8	0.1	0.0	129.9	0.0	0.1	118.5	15.0	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	165.9	4.2	0.0	0.3	0.0	0.0	0.0	51.4	41.7	0.3	34.3	0.0	0.0	0.0	0.0	0.0	2328.4	0.0	0.0	6.4	1.8	0.1	0.3	14.3	0.0	110.2	0.0	0.0	0.1	0.0	0.2	26.7	0.2	0.0	0.1	0.0	0.0	114.3	32.5	0.0	0.0	0.0	0.6	0.3	0.1	0.0	89.9	0.0	0.0	0.0	101.6	182.1	0.0	503.4	0.0	0.0	0.3	388.9	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	86.0	0.1
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 157.7;liver: 288.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.0	1.7	2.9	2.0	6.5	13.3	1.7	3.2	1.6	9.2	18.2	11.1	0.3	65.9	2.6	10.9	2.3	0.0	2.7	2.4	157.7	288.0	1.7	1.5	0.8	1.1	0.1	7.2	4.1	12.4	17.3	0.8	5.4	16.2	3.4	0.9	1.0	0.0	1.2	21.3	0.8	0.8	0.4	1.8	0.9	2.5	0.5	4.6	0.0	1.7	3.6	1.2	0.7	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.7	2.0	1.7	3.2	2.7	2.4	0.8	1.1	0.8	0.8	2.5	0.7	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 23.9;liver: 33.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HEL: 1.5;K-562: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.0	0.0	6.0	0.0	6.1	0.3	0.0	4.4	7.6	0.0	7.4	3.8	23.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	5.7	0.0	33.5	0.0	0.0	5.4	5.9	0.2	0.0	0.0	0.0	0.0	5.6	0.1	5.0	0.4	0.0	0.0	0.7	0.1	8.9	0.0	4.5	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.1	6.0	6.1	4.4	7.6	5.9	5.7	5.4	5.9	5.6	4.5	6.5	4.7	0.0	0.0	0.0	20.2	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	1.2	1.5	0.1	0.0	0.0	0.1	0.0	44.3	0.0	0.2	38.3	0.0	0.0	1.0	0.0	2.7	4.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.4	21.1	0.1	0.0	4.3	0.6	0.0	0.6	0.3	36.1	1.2	0.0	1.8	9.4	0.0	3.1	0.0	3.0	3.3	0.0	14.4	1.5	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.9	0.0	0.1	0.3	0.0	1.3	0.8	0.0
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063302-125090516	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.5;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	4.2	24.2	1.7	16.9	2.6	1.4	4.6	2.4	3.7	2.3	2.1	8.0	9.1	1.0	1.3	13.4	1.2	5.1	1.5	1.9	2.3	0.7	5.9	5.9	5.7	4.3	2.7	1.0	1.2	1.1	0.2	7.4	3.8	2.6	10.2	0.5	78.8	1.4	0.6	20.9	7.7	3.1	3.2	15.8	2.1	1.6	5.2	2.1	0.6	0.9	5.1	11.9	7.7	7.3	33.8	0.1	1.0	0.4	0.6	0.8	0.6	1.6	2.8	1.0	2.5	0.2	70.3	0.4	9.4	0.4	2.5	21.0	0.4	20.9	3.8	0.9	0.6	6.6	1.6	2.4	0.1	0.3	0.9	0.7	34.9	2.6	64.8	2.7	1.7	1.3	0.5	2.2	3.1	0.3	0.3	4.6	1.9	0.2	1.0	0.4	2.7	0.8	1.0	17.6	0.3	0.3	4.8	2.9	2.6	0.5	0.3	1.8	3.7	47.2	1.9	0.7	1.6	1.8	1.5	1.1	1.7	2.4	4.1	0.2	12.3	0.0	0.0	14.1	0.0	0.4	0.0	0.1	5.5	0.1	0.1	0.1	1.3	0.0	19.2	0.2	0.0	5.4	1.7	2.6	2.4	3.7	1.9	2.3	4.3	2.7	3.8	3.2	5.2	7.3	0.7	0.0	0.6	0.3	3.8	0.3	1.4	0.5	1.2	1.5	1.4	1.1	1.1	1.5	1.6	0.0	2.1	0.6	0.7	13.4	0.0	0.1	1.6	1.9	1.4	1.3	0.0	2.7	0.3	0.0	0.8	0.5	0.0	4.9	2.5	0.4	1.8	0.3	36.5	0.0	0.3	0.1	0.0	22.0	1.4	2.2	0.9	22.7	0.0	8.4	7.3	0.3	3.1	1.0	0.2	0.1	3.3	1.2	1.7	1.0	0.0	0.1	0.2	0.8	0.0	0.8	0.6	2.7	1.1	5.7	0.9	3.4	1.2	0.4	0.1	3.2
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	12.6	7.8	14.0	10.8	27.8	21.2	17.4	22.5	17.2	14.9	9.5	24.0	20.3	5.5	15.7	15.5	9.1	11.0	4.9	14.1	17.9	13.4	39.4	10.9	8.8	25.7	23.7	3.4	29.3	4.7	2.9	8.7	24.0	7.7	24.1	2.3	30.3	8.0	4.5	14.2	22.8	7.3	16.9	7.9	48.2	6.8	23.9	5.5	36.1	3.5	12.4	12.5	9.3	35.3	20.5	36.8	4.3	17.2	30.7	24.8	24.4	21.6	19.0	9.7	13.0	13.7	90.7	25.4	21.5	22.1	15.4	17.2	6.2	10.9	14.8	27.6	12.8	23.8	9.9	16.3	18.3	25.4	217.5	21.2	20.3	20.1	11.6	10.6	10.1	13.1	12.6	31.0	12.4	28.9	16.3	55.1	3.5	62.4	15.6	10.9	16.3	21.5	16.0	20.9	10.2	13.8	11.6	84.7	12.7	16.8	58.4	34.9	8.5	19.0	17.7	16.3	13.4	24.9	12.2	17.9	30.8	50.6	11.1	19.3	39.9	26.0	16.7	40.4	10.9	16.7	12.5	12.5	37.9	9.8	8.8	12.1	6.6	22.6	33.1	26.8	17.1	18.1	14.0	27.8	22.5	17.2	14.1	17.9	25.7	23.7	24.0	16.9	23.9	35.3	4.9	0.0	6.3	205.3	7.6	4.5	5.3	5.6	10.2	2.6	13.7	5.5	2.3	4.3	8.6	3.7	0.0	5.6	6.9	15.8	0.0	9.4	18.5	5.6	3.6	4.0	8.4	9.9	107.7	14.1	17.4	4.7	29.0	9.5	29.9	7.9	3.6	30.1	26.3	5.0	32.1	79.0	10.2	21.0	5.6	66.7	4.1	14.4	10.6	64.6	19.6	4.1	8.2	22.6	360.3	9.1	20.5	3.4	15.1	6.0	24.8	11.5	7.8	1.6	13.1	2.6	7.1	2.0	2.9	10.3	4.4	4.9	5.4	4.4	18.3	7.5
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 146.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 85.8;monocytes: 146.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.3"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	61.4	16.8	5.2	34.8	5.9	58.0	50.3	5.9	7.3	40.2	6.8	23.7	8.3	28.1	4.5	34.8	30.0	28.5	34.8	5.5	7.1	15.9	146.9	46.9	26.5	6.7	6.4	24.3	13.7	3.9	4.9	14.3	7.3	14.4	11.8	0.9	35.2	7.5	15.6	34.6	20.6	25.5	6.3	20.8	20.1	4.7	11.1	23.2	76.3	13.3	28.9	30.7	28.2	8.5	289.2	0.0	16.0	0.4	52.9	76.9	0.7	22.0	93.0	31.6	54.1	0.0	61.4	165.0	9.8	52.0	16.3	161.8	47.0	28.8	63.3	1.0	0.2	257.3	93.0	0.0	106.6	513.8	428.4	231.7	0.9	306.5	3.5	22.9	89.7	75.0	299.8	154.4	123.7	0.6	108.6	328.2	24.3	0.0	5.3	221.8	3.3	570.9	76.1	0.0	38.0	0.0	62.2	1.4	263.5	1.5	24.1	77.3	48.1	1.5	81.4	209.2	62.5	0.3	0.9	41.3	187.3	183.2	532.1	15.2	105.7	23.4	19.6	127.0	22.2	9.6	13.5	26.8	85.8	7.1	10.4	10.5	9.0	3.9	146.3	85.7	26.5	60.7	5.2	5.9	5.9	7.3	5.5	7.1	6.7	6.4	7.3	6.3	11.1	8.5	19.8	16.0	49.1	1.6	6.1	46.8	7.4	30.8	48.3	0.5	8.0	14.2	3.7	28.6	26.1	1.8	0.0	0.6	11.9	0.3	0.0	75.5	1.0	1.0	3.1	33.0	0.0	38.3	0.1	6.4	5.0	33.4	2.0	3.0	67.0	2.9	14.3	61.7	73.7	0.0	0.2	0.6	16.2	21.0	74.6	1.7	9.9	47.0	30.2	8.4	10.2	0.6	3.1	8.5	0.8	9.4	0.5	12.4	22.5	14.5	0.0	0.1	4.9	0.1	65.7	15.5	22.0	0.7	1.1	13.6	17.6	0.8	11.8	12.3	1.2	3.0
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.3;choroid plexus: 121.4;retina: 34.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 604.4;Inhibitory neurons: 560.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 21.3"	"Immune cell enriched"	"Detected in some"	8	"MAIT T-cell: 63.3"	"Lineage enriched"	"Detected in single"	65	"T-cells: 63.3"	"Cell line enriched"	"Detected in single"	11	"Karpas-707: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034755, HPA076725"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034755: AB_10670296, HPA076725: "	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	0.0	2.0	6.3	0.7	10.3	0.2	0.2	0.2	21.3	0.1	121.4	1.8	0.3	0.0	1.3	0.0	0.6	0.4	0.0	11.8	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.2	1.3	34.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	63.3	0.0	1.2	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.5	6.3	10.3	0.2	21.3	11.8	1.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	21.2	0.1	0.0	0.0	0.0	0.0	116.3	0.0	0.0	0.6	0.0	0.0	0.0	8.4	0.0	2.6	1.1	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.0	604.4	0.0	0.0	0.0	0.5	0.0	2.5	0.0	1.8	0.6	0.0	0.0	560.9	2.8	0.0	0.6	0.0	10.5	0.0	0.1	0.0	16.9	0.5	2.8	1.0	129.2	16.5	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	9.4	0.0	0.3	0.0
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859491-84913629	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.9;retina: 15.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.2;melanoma: 7.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	0.6	1.4	8.0	0.2	7.8	0.0	0.4	4.0	12.7	0.9	0.0	0.4	0.1	0.5	0.0	2.8	0.2	0.0	0.0	6.9	12.9	0.2	0.0	0.1	0.0	7.4	21.9	0.3	0.0	0.0	5.5	3.8	16.7	0.2	0.2	15.7	0.8	0.1	0.0	1.4	0.4	0.3	0.2	0.0	0.1	0.4	8.8	0.1	0.3	1.6	0.2	0.2	1.3	5.0	0.0	2.5	10.3	0.0	93.5	55.4	0.1	0.1	21.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	12.0	1.2	0.0	23.7	0.1	0.0	25.1	0.0	4.1	0.0	33.5	0.0	0.2	31.4	48.2	11.9	135.3	25.3	0.3	0.0	0.0	0.0	25.9	0.0	0.1	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.7	22.6	0.1	31.1	71.0	0.2	0.0	0.0	0.0	12.7	6.5	0.1	0.0	0.0	0.0	0.1	23.1	0.0	27.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	7.8	4.0	12.7	6.9	12.9	7.4	21.9	16.7	0.2	8.8	5.0	0.0	0.0	0.0	4.2	0.1	2.7	0.0	3.1	42.1	19.7	0.1	0.1	0.5	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	63.9	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	57.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	32.0	1.9	0.0	1.1	0.0	4.0	46.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.1	0.0	0.5	1.0	0.4	0.5	5.8	0.6	0.3	0.0	0.0	0.0	0.0
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150494-110202202	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.9;pituitary gland: 25.3"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 60.6;Inhibitory neurons: 59.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	0.4	5.9	21.6	0.2	26.3	0.1	0.3	1.2	52.9	0.1	0.0	0.3	0.0	0.1	1.0	0.4	0.1	0.1	0.1	20.1	9.6	1.3	0.0	0.1	0.0	13.7	8.2	0.0	1.4	8.8	25.3	0.8	10.5	0.1	0.1	6.0	0.6	0.1	0.1	6.2	0.1	0.1	0.0	0.0	0.7	1.8	24.8	0.0	0.3	0.1	0.0	0.1	0.1	15.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.5	0.5	2.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.8	6.2	1.9	36.0	1.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	7.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	26.3	1.2	52.9	20.1	9.6	13.7	8.2	10.5	0.0	24.8	15.7	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.1	0.0	5.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	1.2	0.0	0.0	0.5	0.0	0.0	60.6	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	59.4	0.0	4.1	0.0	0.0	0.7	0.0	0.0	10.6	3.7	0.0	0.7	0.0	4.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.7	0.4	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150190062-150222788	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	37	"brain: 21.5;intestine: 5.5"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 41.5"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.1	0.0	10.2	0.3	12.7	0.0	0.1	14.6	21.5	0.1	0.0	5.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	10.6	3.2	0.0	0.0	0.1	0.1	1.9	3.4	0.0	0.0	0.0	0.1	0.0	2.1	0.0	4.0	0.1	0.2	0.0	0.0	0.0	3.3	0.1	2.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	12.7	14.6	21.5	10.6	3.2	1.9	3.4	2.1	2.0	9.4	8.9	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	41.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	5.4	0.0	0.0	0.4	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.5	1.6	0.1	8.7	0.0	0.0	0.1	1.9	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.1
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 176.7;parathyroid gland: 224.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 93.1;Glandular and luminal cells: 139.8;Hepatocytes: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 204.3;RT4: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	28.6	11.6	7.9	3.4	7.0	0.2	17.2	9.5	9.6	32.5	16.6	6.2	2.4	15.2	17.8	11.3	42.5	11.2	12.2	10.0	8.0	8.0	176.7	7.5	2.7	14.1	6.2	84.4	83.1	224.1	7.1	9.8	12.6	14.2	4.3	17.6	5.1	7.2	114.5	8.1	4.5	13.4	12.7	3.8	8.3	15.4	7.1	3.1	45.1	45.8	3.5	10.5	14.9	15.9	0.0	3.1	1.0	32.4	0.2	0.3	35.1	0.3	22.1	1.7	2.0	10.7	0.1	0.0	7.4	0.0	4.7	0.0	23.5	5.4	7.4	0.0	12.3	0.0	24.8	23.2	204.3	10.3	0.0	27.7	4.5	27.2	25.7	0.0	10.2	0.0	0.2	0.0	24.9	35.5	1.3	11.7	11.8	7.4	2.9	0.0	16.2	17.6	2.7	55.3	0.4	4.3	1.7	0.8	9.9	23.5	0.0	1.2	22.9	0.0	11.8	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.0	9.5	9.6	10.0	8.0	14.1	6.2	12.6	12.7	7.1	15.9	9.4	12.8	78.1	58.8	0.4	8.3	6.6	5.8	20.5	2.9	52.0	25.8	15.5	38.6	16.3	7.3	35.5	22.6	0.1	0.4	0.0	8.3	12.8	67.0	40.4	5.6	87.9	10.7	0.5	93.1	15.1	20.6	0.5	139.8	2.5	0.4	7.1	249.0	5.8	0.0	19.9	3.6	0.0	6.7	2.3	22.9	37.9	1.4	3.6	1.9	0.6	23.5	0.0	11.6	2.6	20.5	0.6	27.8	0.1	50.2	0.3	3.7	53.9	38.0	59.2	8.8	75.7	0.3	1.1	7.8	3.8	26.0	1.6	9.5	3.2	8.4
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47471893	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.6;Excitatory neurons: 40.3;Inhibitory neurons: 13.6;Oligodendrocytes: 6.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 3.0;SCLC-21H: 8.9;SH-SY5Y: 4.4;SiHa: 3.9;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	0.3	2.6	16.9	0.1	22.5	0.0	0.1	31.6	34.0	0.8	0.0	5.9	0.2	6.5	0.1	1.1	1.9	0.1	0.1	38.3	7.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	7.7	0.0	7.8	0.0	0.0	0.8	0.3	3.4	0.2	2.5	0.2	0.1	0.8	3.5	0.0	0.0	1.3	1.5	2.5	0.1	0.1	0.0	0.0	2.0	0.5	13.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	8.9	4.4	3.9	0.4	0.3	0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	22.5	31.6	34.0	38.3	7.6	0.0	0.0	0.0	0.0	2.5	13.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	14.6	0.6	0.3	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.3	2.1	0.3	0.1	0.2	1.8	0.0	40.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.4	0.0	5.0	6.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.4	1.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044215-70189070	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 10.8;retina: 9.6;skeletal muscle: 20.6;tongue: 9.4"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.3	1.2	7.1	0.3	6.0	0.3	0.2	1.7	6.6	0.4	0.0	0.3	0.3	0.2	0.2	0.3	0.1	0.4	0.6	5.3	7.7	0.1	0.1	0.6	0.2	6.1	7.6	0.0	0.2	0.7	0.9	0.1	7.1	0.3	0.2	9.6	0.3	0.1	20.6	0.3	0.4	0.3	5.4	0.1	0.3	0.1	10.8	0.2	0.0	9.4	0.2	1.2	0.2	4.7	0.0	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	24.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	6.0	1.7	6.6	5.3	7.7	6.1	7.6	7.1	5.4	10.8	4.7	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	80.5	0.0	0.4	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.1	8.4	129.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	4.7	0.0	0.8	0.0	107.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932701-134052184	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 123.7"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 90.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013742	Enhanced					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	30.4	42.5	1.6	16.8	1.6	0.0	18.1	1.3	2.7	30.9	9.1	24.7	10.2	46.3	6.1	18.8	28.3	18.8	26.4	1.5	1.6	52.8	2.4	123.7	9.2	2.0	1.6	5.2	20.8	28.7	15.8	23.4	2.2	36.5	18.0	0.0	20.8	84.7	2.1	13.5	29.3	33.5	1.9	24.2	23.6	1.3	2.3	8.4	89.3	3.4	9.6	21.3	20.3	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	4.3	0.5	0.0	0.1	0.1	0.0	90.6	0.9	0.0	11.2	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	2.4	0.0	0.0	3.4	0.2	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.6	6.0	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	4.6	1.5	0.0	3.7	0.1	0.0	22.1	0.0	4.5	0.1	0.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.6	1.3	2.7	1.5	1.6	2.0	1.6	2.2	1.9	2.3	1.7	19.8	0.0	2.5	0.0	2.1	5.1	9.1	0.5	8.6	0.0	0.8	3.9	4.6	1.5	1.6	3.7	0.0	1.5	0.0	47.1	0.0	2.8	1.0	0.9	0.2	65.2	1.2	0.0	8.1	3.3	4.0	8.7	18.8	1.6	1.3	0.1	146.7	0.6	0.2	0.0	1.7	4.1	0.0	2.2	0.4	0.8	0.3	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.1	14.0	15.8	0.0	0.0	1.5	3.2	2.1	0.8	0.0	0.0	0.4	1.1	0.4	0.2	2.0	1.7	0.8	1.1	0.1	0.6	2.2
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;dendritic cells: 39.9;Endothelial cells: 38.8;Langerhans cells: 53.0;Macrophages: 47.0;Smooth muscle cells: 38.8;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 118.2"					"Low region specificity"	"Detected in many"			"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	31.7	8.2	5.6	20.0	6.1	12.8	17.1	6.4	5.2	21.1	8.2	10.2	6.2	12.1	42.2	8.4	20.6	18.3	20.0	6.0	8.0	6.4	6.8	37.7	21.2	9.5	6.3	23.1	5.4	6.1	6.5	10.5	9.7	9.1	11.1	1.4	11.8	12.3	7.3	5.2	13.9	19.1	7.6	23.3	9.0	2.7	11.0	22.9	24.1	19.0	20.9	17.9	12.6	9.4	29.3	25.6	0.1	0.0	25.4	72.0	0.4	35.3	25.2	59.9	103.9	0.0	0.0	0.2	0.6	46.4	18.8	13.9	78.8	0.0	72.1	16.6	94.2	63.0	0.3	0.0	33.0	82.4	0.1	29.5	0.9	66.5	0.2	0.0	99.4	46.8	0.1	0.3	10.1	0.0	118.2	66.4	0.6	0.0	0.1	98.9	73.3	0.2	0.7	13.8	0.2	0.1	0.0	13.0	0.1	0.0	20.7	58.6	52.1	16.3	0.4	61.9	53.7	2.3	1.0	0.2	12.2	70.3	36.0	0.5	18.2	2.1	6.1	27.6	8.4	4.6	3.8	5.5	14.0	1.5	2.8	4.1	1.4	3.1	18.2	19.4	6.3	8.7	5.6	6.1	6.4	5.2	6.0	8.0	9.5	6.3	9.7	7.6	11.0	9.4	70.6	0.0	5.2	0.3	19.5	7.5	1.1	1.1	5.7	0.4	6.7	2.8	9.2	1.5	2.7	1.8	0.0	1.4	39.9	0.1	0.0	0.0	1.4	5.9	16.0	38.8	0.0	9.9	0.3	0.6	0.5	29.2	6.6	2.2	3.8	0.3	15.0	0.4	32.8	0.0	2.6	0.1	0.0	36.5	53.0	1.7	10.2	47.0	12.4	17.8	17.2	0.3	3.1	0.0	0.1	0.1	1.2	3.0	24.7	1.3	0.1	0.2	13.3	0.1	6.6	7.9	38.8	0.0	0.2	1.9	8.5	0.8	37.3	7.7	0.1	0.7
SLFN12L		ENSG00000205045	"Schlafen family member 12 like"	Q6IEE8	17	35464249-35487857	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	8	"dendritic cells: 16.0;NK-cells: 42.2;T-cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.0;NK-cells: 3.6;T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.7;Karpas-707: 5.5"									HPA024447	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA024447: AB_1856614"	"unprognostic (1.93e-3)"	"unprognostic (2.10e-4)"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.18e-3)"	"unprognostic (2.98e-5)"	"unprognostic (4.59e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.25e-6)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (8.88e-3)"	0.6	0.3	0.9	2.4	0.9	3.0	0.6	2.5	1.8	0.5	0.9	0.6	1.7	0.5	0.3	0.3	0.3	1.0	0.2	0.7	0.4	0.3	0.6	1.3	3.0	0.3	0.0	0.4	0.3	0.1	0.0	0.2	0.3	0.3	0.8	0.8	0.9	0.2	0.5	0.6	1.5	0.4	0.0	3.1	1.2	0.3	0.5	1.0	0.4	0.3	2.2	0.7	0.1	1.5	0.5	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.6	1.4	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.0	0.0	0.7	9.7	0.1	1.3	0.8	0.1	0.0	0.3	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.3	5.5	0.1	0.0	0.4	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.1	0.1	0.0	2.0	0.6	0.3	1.2	0.5	0.2	2.0	2.0	0.1	0.2	0.3	0.5	1.0	0.3	1.0	1.9	0.0	0.8	0.3	0.8	1.4	0.2	0.3	1.0	1.0	0.9	3.6	0.1	0.2	0.5	0.4	0.9	0.9	2.5	1.8	0.7	0.4	0.3	0.0	0.3	0.0	0.5	1.5	3.5	3.2	2.7	0.0	1.5	0.3	0.6	0.4	0.0	0.0	0.3	0.3	1.3	1.5	0.7	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.8	0.5	0.2	1.4	0.0	0.4	0.0	0.0	0.0	0.5	1.5	0.3	1.3	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	1.1	0.0	1.0	0.8	0.0	42.2	0.0	0.1	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.7	0.4	0.0	0.3	0.1	0.0	31.7	0.1	0.1	0.2
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301139	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 202.3;Fibroblasts: 112.7;Sertoli cells: 85.5;Smooth muscle cells: 99.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 12.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 310.3;fHDF/TERT166: 116.0;RT4: 101.1;SH-SY5Y: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	61.9	20.7	10.0	11.9	10.6	0.1	32.7	11.9	7.5	36.4	0.3	20.0	5.4	23.9	8.8	21.4	22.2	43.5	39.7	12.3	4.3	16.7	1.5	38.1	6.2	12.9	0.7	17.0	7.8	44.9	4.4	21.7	11.6	10.3	9.7	3.1	16.8	15.4	4.4	25.8	10.4	27.1	0.3	14.3	10.1	2.7	6.9	20.0	23.3	6.5	4.2	55.5	24.3	2.2	0.0	11.0	0.1	0.0	310.3	5.7	0.0	18.1	3.1	4.0	8.4	0.1	0.0	0.0	4.2	116.0	13.1	0.0	2.9	1.2	0.3	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.8	4.2	0.5	3.9	44.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	101.1	1.1	73.3	0.0	0.0	0.0	12.5	0.0	0.0	0.0	3.0	1.9	25.5	0.1	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	10.0	10.6	11.9	7.5	12.3	4.3	12.9	0.7	11.6	0.3	6.9	2.2	11.7	0.0	2.3	4.2	0.5	26.6	1.8	5.5	3.4	8.6	1.1	3.8	25.9	0.0	0.4	0.0	0.0	2.3	0.5	0.0	0.0	0.2	11.9	1.3	35.7	5.4	0.0	0.0	202.3	0.0	0.5	112.7	4.6	3.6	1.3	0.5	1.8	0.0	1.2	0.0	20.2	0.0	0.0	0.0	32.5	8.2	0.9	1.1	35.6	14.0	0.0	13.7	0.0	8.0	2.9	0.0	0.0	0.4	0.8	1.1	0.1	1.9	0.2	0.9	85.5	1.8	99.3	1.2	2.2	1.1	17.6	1.1	1.8	0.3	0.0	0.8
SLITRK2	"CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257"	ENSG00000185985	"SLIT and NTRK like family member 2"	Q9H156	X	145817829-145829856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.5;retina: 32.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 33.3;Melanocytes: 26.6;Muller glia cells: 188.6;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 25.7"	"Cancer enhanced"	"Detected in some"		"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"HAP1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		150000		"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.79e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.89e-4)"	"unprognostic (6.23e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.13e-8)"	"unprognostic (3.12e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.14e-2)"	1.6	0.2	9.7	0.1	12.3	0.0	0.3	8.4	12.5	0.8	0.0	0.8	0.1	0.2	0.0	0.1	1.8	0.1	1.1	9.7	9.6	0.9	0.1	0.9	0.4	12.1	11.0	0.3	0.7	0.0	0.8	0.0	10.8	0.6	0.2	32.8	0.5	3.3	0.1	2.4	0.4	0.3	9.6	6.0	0.3	0.1	9.5	0.2	0.6	0.1	0.0	0.8	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	12.3	8.4	12.5	9.7	9.6	12.1	11.0	10.8	9.6	9.5	12.1	0.2	0.0	0.0	33.3	0.0	1.1	0.0	0.0	0.0	4.8	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	1.8	0.0	9.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	1.4	0.0	0.0	6.7	17.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	26.6	5.6	0.0	188.6	0.0	48.7	25.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	10.8	0.0	1.3	0.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;fallopian tube: 2.9;salivary gland: 3.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 9.7;Excitatory neurons: 20.4;Horizontal cells: 21.9;Inhibitory neurons: 13.3;Oligodendrocyte precursor cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;HeLa: 3.7;hTERT-RPE1: 3.2;U-138 MG: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013843, HPA073230"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Vesicles		"HPA013843: AB_1857233, HPA073230: "	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.1	1.3	0.0	1.9	0.0	0.1	0.8	2.6	0.1	0.0	0.3	0.0	0.0	0.4	0.1	2.9	0.0	0.1	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.2	0.0	0.0	0.7	0.1	0.7	3.7	1.3	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	1.5	0.0	0.9	0.1	0.1	0.0	0.5	1.1	0.0	0.7	7.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.3	0.9	3.7	0.0	0.4	0.0	0.0	1.5	0.1	0.0	0.6	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.7	0.1	0.1	0.2	0.0	1.1	0.1	0.0	0.2	0.0	0.0	0.5	1.7	0.0	2.4	0.0	0.0	0.4	1.1	0.0	0.0	2.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.3	1.9	0.8	2.6	1.9	0.6	0.0	0.1	0.0	0.2	1.5	1.1	0.0	0.0	1.1	1.3	0.0	0.1	1.5	0.0	0.0	9.7	0.6	1.7	1.8	1.5	0.0	0.0	4.2	0.0	5.9	0.2	0.0	0.4	0.7	2.1	0.5	1.0	0.0	2.7	20.4	0.0	0.0	1.6	0.0	5.0	1.3	0.5	0.0	0.0	0.0	21.9	13.3	1.9	0.0	0.0	0.0	1.0	5.9	0.5	0.0	1.0	0.1	7.0	0.0	11.1	0.9	0.0	0.1	4.9	0.0	2.5	0.0	0.1	1.5	1.6	0.0	4.6	0.3	5.5	0.2	0.4	0.0	0.0	0.1	0.0	0.2	1.1
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57930003	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 295.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		9200	"Cluster 49: Eosinophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Endoplasmic reticulum"		"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	25.9	28.1	8.3	35.2	14.7	15.5	21.9	13.4	9.2	25.6	11.3	126.5	34.0	93.5	14.2	116.8	48.6	31.6	134.7	7.5	7.3	24.9	16.4	17.6	16.4	7.8	7.4	37.5	16.1	36.6	11.5	23.5	8.3	65.6	38.2	20.4	20.1	100.3	64.0	21.5	37.7	137.6	6.5	14.9	52.3	31.8	9.2	19.8	28.7	42.0	18.3	87.5	29.0	8.7	43.3	23.1	23.0	25.7	31.8	28.9	24.2	40.8	41.9	27.0	25.5	59.4	54.6	25.1	17.9	30.4	48.4	23.5	38.5	54.5	36.8	32.2	20.6	49.9	31.1	47.6	29.1	47.8	26.5	20.0	39.1	33.6	60.8	38.1	31.8	25.0	39.7	23.7	28.5	11.7	28.0	20.4	29.7	29.3	38.7	12.4	21.0	28.0	47.7	44.3	10.0	12.8	49.9	37.4	23.7	26.7	19.9	27.4	38.1	33.0	23.1	28.2	52.8	28.9	57.1	36.7	25.5	45.4	27.9	3.3	3.8	10.9	3.6	2.7	3.2	3.7	2.8	3.2	3.2	2.5	3.2	3.4	9.5	5.2	2.4	1.4	4.1	3.6	8.3	14.7	13.4	9.2	7.5	7.3	7.8	7.4	8.3	6.5	9.2	8.7	17.3	38.5	39.6	90.1	25.6	92.0	45.4	49.3	54.1	28.0	25.0	23.7	295.9	40.0	40.0	33.1	50.1	19.0	34.4	53.9	19.6	45.8	40.2	45.9	24.6	22.8	14.4	28.6	113.3	34.3	12.2	28.6	41.3	72.4	3.8	34.8	18.2	22.7	15.6	32.0	121.5	26.8	20.3	20.3	25.9	26.2	32.6	27.8	28.4	76.8	25.1	86.8	34.0	101.0	97.7	64.1	36.6	71.8	39.0	93.3	36.4	24.8	46.5	32.4	52.6	26.8	82.2	87.4	47.0	54.5	73.3	16.3	26.1	52.0	28.7	126.9
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 216.3"	"Cell type enhanced"	"Detected in all"		"B-cells: 338.4;dendritic cells: 258.0;Kupffer cells: 284.4;Macrophages: 256.8;monocytes: 291.7;Plasma cells: 224.4;T-cells: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 177.1;THP-1: 302.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	65.3	24.0	44.2	136.7	50.7	80.9	33.3	35.7	54.3	43.9	33.8	33.5	17.5	17.9	14.1	26.2	30.7	46.3	17.2	52.1	48.2	19.2	73.5	58.4	205.8	41.8	41.1	17.1	23.8	27.4	43.9	38.0	42.9	20.0	32.1	48.5	29.5	19.0	30.0	33.3	99.2	40.1	38.3	216.3	41.8	17.0	48.0	158.3	19.2	21.2	199.5	52.2	19.3	47.2	25.1	9.3	22.0	22.2	31.4	60.0	12.2	38.4	34.7	38.9	37.9	11.7	16.8	93.1	18.4	34.4	16.0	10.2	41.1	29.4	53.3	177.1	34.8	51.7	14.2	25.5	28.1	54.3	153.7	51.7	24.3	50.4	21.6	19.1	22.4	71.6	94.9	95.2	47.0	16.8	79.3	51.2	13.4	24.7	84.7	30.3	20.4	96.3	18.9	28.9	37.1	17.1	18.1	46.1	29.9	16.8	14.8	302.3	12.4	42.8	17.6	40.2	29.9	31.3	37.1	75.9	38.8	53.1	28.2	12.4	87.7	102.0	14.5	153.8	18.2	43.7	23.3	22.1	49.3	58.6	32.4	30.1	195.4	31.6	195.8	9.3	35.5	52.1	44.2	50.7	35.7	54.3	52.1	48.2	41.8	41.1	42.9	38.3	48.0	47.2	12.8	25.6	28.4	10.1	338.4	18.0	11.4	8.5	4.0	34.7	17.5	13.6	15.3	30.0	24.5	7.3	22.9	5.5	258.0	11.0	5.9	12.6	12.7	78.2	15.8	18.7	9.5	66.7	75.7	18.7	9.6	17.1	26.0	25.0	28.4	10.4	38.6	66.3	43.5	26.9	52.4	9.8	12.2	284.4	140.1	19.5	5.3	256.8	28.4	89.9	291.7	15.0	129.8	54.8	33.6	17.1	8.9	4.9	224.4	9.6	10.0	9.1	70.2	25.6	32.9	12.8	27.9	15.9	11.6	12.7	17.8	4.1	199.9	14.6	9.5	14.6
SMIM18		ENSG00000253457	"Small integral membrane protein 18"	P0DKX4	8	30638580-30646064	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;pituitary gland: 5.4;retina: 3.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.3;Excitatory neurons: 2.9;Horizontal cells: 5.0;Inhibitory neurons: 5.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 5.5;Proximal tubular cells: 4.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066648	Supported		Uncertain	Nucleoplasm,Centrosome		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Centrosome	"HPA066648: AB_2685697"	"unprognostic (2.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.60e-1)"		"unprognostic (7.29e-2)"	"unprognostic (4.70e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-1)"	0.0	0.9	2.2	0.0	1.9	0.9	0.0	4.0	3.7	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.8	0.9	0.0	0.0	0.0	2.3	4.4	0.0	0.4	0.0	5.4	0.0	3.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.2	0.6	0.6	1.1	0.4	1.1	0.9	0.7	0.6	0.3	0.9	0.9	1.3	0.7	0.0	0.8	1.4	1.0	0.1	2.2	1.9	4.0	3.7	2.0	3.8	2.3	4.4	3.0	1.7	2.7	1.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.2	0.1	1.8	0.0	2.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	5.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0
SMIM22	CASIMO1	ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.6;pancreas: 154.3;salivary gland: 147.2;stomach 1: 201.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2005.0;Intestinal goblet cells: 1223.5;Paneth cells: 1462.9;Proximal enterocytes: 1685.8;Respiratory ciliated cells: 686.7;Undifferentiated cells: 775.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CAPAN-2: 261.7;OE19: 247.3;RT4: 89.8;SCLC-21H: 70.7;SK-BR-3: 201.2"	"Low region specificity"	"Detected in many"							HPA077331			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	1.2	0.3	0.1	14.6	1.2	3.5	48.2	4.6	2.0	45.4	0.0	193.6	129.6	8.9	50.4	10.3	77.3	33.3	0.5	0.5	0.4	42.0	1.4	24.1	0.6	2.6	0.9	0.5	154.3	0.1	48.9	2.0	2.1	42.6	122.7	1.5	147.2	36.3	0.2	10.4	128.4	6.3	0.8	0.2	201.7	33.8	2.6	0.2	1.1	0.0	2.7	46.1	6.5	3.1	0.2	0.0	0.1	0.6	0.0	0.0	1.9	0.3	0.1	0.1	0.1	0.6	261.7	0.3	7.3	0.0	0.3	1.3	0.1	0.0	0.1	0.4	1.9	0.1	5.8	0.9	0.1	0.7	0.3	0.2	1.4	0.0	0.0	0.2	0.1	0.4	0.0	0.6	0.0	1.9	0.1	0.6	0.8	247.3	0.0	0.8	0.3	23.6	1.5	89.8	70.7	0.8	0.5	201.2	0.0	0.5	15.2	0.0	0.0	0.6	0.8	1.1	0.1	0.2	0.6	0.9	0.0	0.7	0.6	1.2	0.3	0.4	0.3	0.1	0.1	0.1	0.3	0.1	0.0	0.4	0.3	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.1	1.2	4.6	2.0	0.5	0.4	2.6	0.9	2.1	0.8	2.6	3.1	1.4	48.1	117.7	0.0	5.8	2.2	22.7	92.7	0.0	4.2	363.3	267.5	0.5	183.0	154.9	250.1	0.0	3.9	3.0	2005.0	25.4	259.8	40.1	430.4	26.5	4.4	470.3	0.0	0.5	381.9	0.4	4.7	438.8	258.3	18.4	0.1	0.4	0.2	0.4	1.7	0.3	1223.5	152.5	0.0	0.8	107.3	0.6	4.2	23.2	0.0	5.3	0.6	0.0	0.0	1.3	539.9	1462.9	1.2	1.0	29.5	1685.8	99.4	686.7	4.2	0.0	0.0	15.9	38.6	0.6	2.3	2.3	3.7	6.6	0.2	775.6	148.6
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480525	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"epididymis: 1580.8;intestine: 753.9;kidney: 844.8"	"Group enriched"	"Detected in many"	12	"Proximal enterocytes: 4096.4;Proximal tubular cells: 1884.8"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.7;pancreatic cancer: 37.4;renal cancer: 78.4;stomach cancer: 52.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 154.9;HEL: 74.0;Hep G2: 117.7;MOLT-4: 113.8;OE19: 185.0;REH: 61.5;U-937: 87.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.0	4.2	2.7	5.0	91.3	0.8	4.1	6.8	0.6	5.5	30.4	753.9	0.7	1580.8	0.4	2.8	82.0	0.1	4.7	4.3	844.8	35.8	0.4	1.6	4.3	4.6	0.3	8.0	0.2	3.5	0.1	4.3	1.0	24.5	91.6	0.3	2.3	0.3	1.2	628.2	0.8	4.0	1.2	150.1	2.9	4.6	50.4	0.2	0.1	2.0	0.2	0.2	4.4	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	154.9	0.5	0.2	7.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	74.0	1.0	117.7	0.0	6.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	1.5	0.1	0.1	0.0	113.8	15.8	0.0	185.0	0.3	61.5	0.1	4.3	1.6	0.1	1.4	2.3	0.1	0.1	1.6	0.4	0.0	1.9	0.0	0.0	0.4	1.2	0.1	0.0	0.0	6.5	0.0	87.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.3	0.4	1.0	0.0	5.9	0.0	1.5	1.6	0.8	4.2	5.0	4.1	6.8	4.7	4.3	4.3	4.6	4.3	4.0	4.6	4.4	0.1	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	14.1	0.1	0.8	0.2	188.8	0.0	58.8	27.1	0.0	0.5	35.1	238.7	4.0	5.1	7.7	0.8	0.3	139.0	22.3	0.7	12.4	0.2	0.3	205.4	13.0	1.3	0.2	0.4	36.3	0.1	0.0	0.1	136.6	0.0	0.6	0.0	15.0	0.3	11.6	0.0	0.0	0.7	4.1	0.0	0.0	0.2	12.4	178.9	0.0	1.7	0.3	4096.4	1884.8	0.0	34.9	0.0	0.2	0.3	0.6	0.7	0.0	0.0	0.0	7.4	0.0	141.3	0.2
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383486	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"intestine: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 37: Intestine - Unknown function"																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"	A0A1B0GVY4	4	164754064-164803795	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 7.8;intestine: 24.6;prostate: 11.0"	"Group enriched"	"Detected in some"	5	"Exocrine glandular cells: 93.3;Pancreatic endocrine cells: 139.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted - unknown location"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.1	0.1	0.3	1.4	0.3	1.0	1.0	0.6	0.5	5.0	0.3	15.4	22.0	0.3	0.9	0.1	0.1	7.8	0.1	0.3	0.1	0.1	0.1	0.4	0.3	0.4	0.2	0.1	0.4	0.1	0.0	0.1	0.4	11.0	15.5	0.2	1.2	0.1	0.2	0.2	24.6	0.7	0.1	0.1	0.6	0.1	0.4	0.0	0.1	0.0	0.1	1.7	0.0	0.9	0.1	0.8	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.0	0.3	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.3	1.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.2	0.4	0.1	0.4	0.9	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	0.0	0.0	9.3	3.7	0.0	0.1	0.0	0.0	0.0	3.8	0.0	2.5	2.2	0.3	0.0	0.0	0.0	93.3	0.0	0.2	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.7	0.0	0.0	0.0	0.0	0.0	0.8	10.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0
SMIM32		ENSG00000271824	"Small integral membrane protein 32"	A0A1B0GUA5	5	136191468-136193162	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	13	"brain: 17.7;intestine: 12.9;kidney: 49.2"	"Cell type enriched"	"Detected in some"	11	"Proximal tubular cells: 394.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"	"Group enriched"	"Detected in many"	6	"basal ganglia: 17.7;cerebral cortex: 4.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favorable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	1.0	0.2	17.7	0.0	0.0	1.8	4.5	0.0	0.0	4.9	12.9	0.0	0.0	0.0	0.0	2.0	0.0	1.1	1.4	49.2	0.3	0.0	0.0	1.0	1.4	0.0	0.4	0.0	0.0	0.0	0.8	0.4	1.5	0.0	0.1	0.0	0.6	0.0	6.2	0.0	0.8	0.0	1.4	0.3	0.9	0.0	1.2	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	17.7	1.8	4.5	1.1	1.4	1.0	1.4	0.8	0.8	0.9	1.7	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	33.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	394.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0
SMIM43		ENSG00000164112	"Small integral membrane protein 43"	Q4W5P6	4	121758881-121765427	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 8.3"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 16.7;Syncytiotrophoblasts: 4.5"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 8.3;cerebral cortex: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"MOLT-4: 3.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 24.8"											NA	NA					"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.0	0.0	0.4	0.0	8.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.3	0.0	2.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
SMIM5	C17orf109	ENSG00000204323	"Small integral membrane protein 5"	Q71RC9	17	75633434-75641404	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	56	"plasmacytoid DC: 207.6"	"Lineage enriched"	"Detected in many"	56	"dendritic cells: 207.6"	"Cell line enhanced"	"Detected in some"		"HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA065332, HPA071268"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles	"Golgi apparatus"	"HPA065332: AB_2685471, HPA071268: AB_2686377"	"unprognostic (6.97e-2)"	"prognostic favorable (5.52e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.29e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (2.64e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.58e-1)"	1.3	0.6	4.5	1.9	8.5	11.4	1.5	8.5	6.4	8.4	10.7	10.5	9.6	1.2	0.8	27.4	7.4	4.4	12.2	5.0	5.6	28.4	1.4	3.1	1.1	11.2	8.8	2.7	2.5	3.4	2.4	1.9	9.6	4.2	2.6	0.7	7.8	1.9	0.5	14.3	15.2	0.5	7.2	4.8	10.1	2.2	7.8	0.6	15.9	0.3	3.6	6.1	14.6	16.4	1.8	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	10.5	0.1	0.0	0.0	2.8	0.1	0.3	0.3	0.0	0.0	2.0	0.8	0.0	0.0	4.5	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.5	0.5	1.1	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.1	0.0	207.6	0.0	13.7	4.5	8.5	8.5	6.4	5.0	5.6	11.2	8.8	9.6	7.2	7.8	16.4	0.7	9.6	7.0	0.7	1.6	1.1	7.3	4.8	0.6	1.5	1.2	0.9	25.1	10.0	13.9	125.0	2.1	3.1	51.9	48.4	92.0	2.9	0.1	69.4	10.1	1.8	14.4	142.5	0.0	0.5	5.8	2.3	26.0	67.6	0.0	0.3	1.8	0.2	0.7	0.0	0.0	16.1	44.7	0.6	0.9	0.3	0.6	17.0	7.2	0.0	1.2	3.3	1.0	0.0	17.9	10.7	54.2	1.5	0.9	7.4	15.5	0.9	48.0	2.1	0.0	1.4	3.1	0.4	0.5	10.0	8.4	32.8	0.8	0.3	2.3	90.6
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27935000-27959157	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.1;pancreas: 49.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 38.1;Ductal cells: 31.5;Paneth cells: 47.5;Proximal enterocytes: 37.4;Undifferentiated cells: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.3;myeloid DC: 1.3;neutrophil: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.3;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;CAPAN-2: 35.3;NTERA-2: 27.6;RPMI-8226: 30.1;SK-BR-3: 45.9;T-47d: 33.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA		400000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA030561: AB_10604095"	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.5	0.3	0.5	2.2	0.6	2.0	5.7	2.5	0.6	2.8	2.0	22.2	24.1	1.9	15.8	1.1	7.0	2.2	0.3	1.1	0.7	5.2	0.4	6.6	1.2	0.4	0.4	0.2	49.4	7.9	1.0	0.3	0.5	3.6	23.6	0.1	12.5	0.5	0.0	0.9	14.2	1.0	0.6	1.7	16.5	0.7	0.8	0.5	13.9	0.0	3.1	2.2	0.4	0.6	5.4	2.5	0.0	0.3	0.0	0.0	46.0	0.0	1.1	0.6	3.4	12.1	35.3	1.7	8.3	0.0	0.7	5.9	3.8	3.2	0.5	0.0	23.6	7.9	0.5	3.0	0.0	2.6	0.0	0.2	2.9	7.0	0.4	1.0	1.0	0.3	1.0	0.4	0.0	19.5	0.1	0.8	27.6	4.1	4.3	0.5	0.2	30.1	24.6	9.5	23.4	0.5	0.0	45.9	1.3	4.7	33.3	1.4	0.0	0.0	7.6	0.1	0.0	0.3	12.9	0.6	0.8	0.0	0.1	0.1	0.1	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.2	0.1	0.0	1.8	0.3	0.0	0.0	0.0	0.1	0.5	0.6	2.5	0.6	1.1	0.7	0.4	0.4	0.5	0.6	0.8	0.6	0.1	9.6	17.9	0.0	2.3	0.1	2.7	4.0	0.0	0.0	15.0	6.5	0.4	1.5	13.8	9.2	0.0	2.5	0.5	38.1	0.0	31.5	0.4	2.2	0.3	1.1	20.4	1.3	0.8	23.3	0.2	0.2	18.3	5.6	0.0	2.0	0.4	0.0	0.3	0.0	0.1	21.6	10.2	0.0	0.4	0.2	0.0	0.9	0.0	1.0	0.0	0.0	0.0	1.0	0.0	21.7	47.5	0.0	16.6	3.7	37.4	8.7	2.7	0.0	0.0	0.0	0.8	0.0	0.2	0.6	0.1	7.7	0.8	0.1	31.2	3.0
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 887.2;urinary bladder: 450.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 283.5;Hepatic stellate cells: 121.3;Sertoli cells: 184.1;Smooth muscle cells: 116.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		No	Yes		140000	"Cluster 30: Non-specific - Translation"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: AB_2681607, HPA058590: AB_2683765"	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	54.7	19.2	10.8	25.3	12.5	4.7	42.2	10.3	13.1	100.2	7.6	887.2	30.0	251.0	7.0	65.1	132.4	20.8	152.0	9.0	9.3	35.6	15.3	38.2	5.6	11.7	12.5	34.0	25.2	3.3	9.8	17.4	11.0	150.9	29.2	15.2	16.3	177.9	95.7	38.7	151.5	127.2	10.5	54.5	231.2	12.5	12.4	2.9	26.4	26.2	2.5	450.6	91.5	10.0	73.0	21.2	7.2	27.0	11.0	17.2	58.0	106.8	49.1	85.7	58.4	29.9	22.4	32.1	9.3	59.3	17.3	10.6	7.2	62.8	40.4	10.6	58.2	33.9	18.3	36.1	9.7	51.5	57.4	14.2	5.8	114.0	18.7	29.2	74.7	12.3	37.3	25.9	59.6	64.5	5.9	11.4	8.2	36.1	90.0	20.3	20.5	34.6	34.5	23.2	11.5	12.7	33.4	15.9	15.7	7.4	18.8	8.2	118.7	62.1	58.4	59.4	79.8	24.6	32.5	18.8	91.0	19.7	200.5	0.0	1.0	0.0	0.1	0.2	0.0	1.3	0.1	0.3	0.4	0.0	1.0	0.5	0.1	0.1	0.2	0.2	0.0	0.6	10.8	12.5	10.3	13.1	9.0	9.3	11.7	12.5	11.0	10.5	12.4	10.0	94.5	6.4	3.3	23.8	2.0	65.1	33.5	16.1	19.4	46.6	18.6	26.7	39.5	5.7	6.1	9.2	283.5	13.4	2.7	12.8	9.8	14.8	1.2	4.0	52.1	62.8	29.2	0.0	0.2	20.1	68.8	35.9	18.3	7.3	0.0	11.0	121.3	2.6	6.0	5.0	1.9	29.9	14.2	6.8	14.6	1.9	22.4	4.7	14.2	7.5	1.0	31.2	1.0	4.5	2.0	73.2	11.4	48.5	2.1	21.7	5.6	18.4	2.2	54.0	184.1	18.4	116.4	5.7	7.9	9.7	69.3	21.9	3.7	16.3	27.0	14.9
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 675.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		3900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	44.4	30.3	23.0	62.9	27.7	35.1	38.2	25.7	46.3	37.5	28.6	52.8	50.3	43.2	35.3	31.9	29.8	40.2	44.6	23.5	24.8	42.4	44.4	45.2	84.6	28.0	25.9	34.6	24.2	36.2	12.9	68.9	31.3	49.2	51.2	12.8	45.2	30.9	43.9	26.5	56.4	48.3	25.6	70.3	39.9	36.1	27.5	38.0	33.1	28.7	78.7	42.5	23.9	37.2	58.3	29.7	55.7	54.7	91.8	70.4	85.1	77.6	61.8	50.8	59.1	93.0	27.8	35.1	91.3	52.3	48.1	52.7	63.2	50.1	70.9	58.4	35.3	149.2	30.5	89.1	66.8	57.4	136.6	59.1	37.9	43.5	70.4	64.7	192.9	69.4	121.6	31.4	67.1	24.1	68.3	69.4	46.0	94.3	22.8	122.4	33.8	55.1	71.8	57.8	9.0	36.3	57.2	51.3	56.4	83.5	76.2	91.6	155.0	46.6	61.2	52.1	80.4	59.1	122.3	153.2	56.3	120.0	62.8	244.8	159.8	675.6	51.4	237.6	60.2	110.2	53.5	50.2	148.2	103.9	68.0	52.4	361.9	70.7	236.0	62.6	66.4	179.4	23.0	27.7	25.7	46.3	23.5	24.8	28.0	25.9	31.3	25.6	27.5	37.2	58.9	112.2	30.5	30.7	79.0	50.7	107.6	30.8	34.7	7.7	41.9	19.8	19.2	38.6	32.8	20.2	20.9	75.9	45.3	61.3	56.7	71.1	207.6	34.4	38.6	77.1	14.9	25.0	21.2	52.2	109.5	44.3	32.6	41.2	83.5	22.4	77.4	28.0	88.9	5.0	23.6	80.2	52.9	125.4	112.8	326.0	39.1	131.8	44.4	36.5	120.0	14.6	53.5	39.7	54.6	110.8	52.8	60.5	27.9	79.9	55.0	76.2	42.6	18.4	52.6	42.1	40.6	16.7	7.9	29.3	38.5	142.6	48.2	47.8	39.7	64.7
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	20	"brain: 1658.7;retina: 492.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 28.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		9000		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	1.5	43.6	251.0	4.1	383.5	0.2	4.4	598.0	1658.7	0.8	0.0	5.7	3.7	7.9	12.9	0.5	7.7	2.3	3.2	420.4	142.2	1.4	1.0	1.8	0.4	427.4	24.7	6.9	6.3	1.2	54.3	0.6	386.6	3.2	2.3	492.0	0.5	19.6	0.8	0.7	3.9	8.1	38.1	0.2	6.3	3.6	147.6	0.5	0.7	0.1	0.4	1.1	1.6	726.9	0.0	4.7	3.9	0.0	0.4	0.1	0.0	2.0	0.0	4.8	1.4	0.0	0.0	0.0	4.3	0.0	3.4	0.8	0.6	0.0	9.6	0.5	0.3	0.0	6.8	0.7	3.5	0.0	0.5	4.4	0.0	3.9	0.0	10.7	0.0	2.8	0.0	23.8	1.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.1	0.9	0.0	78.2	46.6	0.7	0.1	0.0	2.4	0.0	6.5	0.0	5.0	6.8	0.0	2.3	0.1	12.9	0.1	56.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	251.0	383.5	598.0	1658.7	420.4	142.2	427.4	24.7	386.6	38.1	147.6	726.9	0.5	0.0	0.0	117.2	0.0	0.8	1.4	0.1	0.0	559.2	0.2	1.3	0.5	8.6	0.0	0.0	106.3	0.0	0.2	0.0	0.0	0.2	16.3	0.1	0.7	5.2	43.5	0.0	1015.8	0.0	0.1	3.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	65.6	552.8	3.4	0.0	0.0	0.4	83.3	17.1	0.1	1.8	120.9	0.0	71.9	0.0	179.4	113.3	1.0	2.6	68.8	0.0	0.6	0.1	3.0	0.0	254.4	0.0	0.0	1.3	1.1	0.4	0.0	0.9	0.0	0.0	2.6	0.1	0.1
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 80.8;pituitary gland: 25.8;retina: 91.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5;prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	25	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.8"	"Group enriched"	"Detected in some"	10	"GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA		28000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	0.3	7.9	42.1	1.0	52.0	0.0	0.6	61.2	80.8	1.1	0.0	1.2	0.3	0.7	0.1	0.1	0.7	1.0	0.7	51.3	31.6	0.1	0.0	0.3	3.0	40.9	11.1	2.1	1.5	1.1	25.8	0.5	41.1	3.1	0.6	91.8	0.5	0.6	0.2	0.1	0.8	0.7	7.2	1.4	0.9	12.1	23.0	0.3	0.9	1.5	1.9	0.4	0.4	40.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	7.4	0.3	1.0	0.0	0.0	0.4	1.4	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.2	0.3	23.7	14.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	42.1	52.0	61.2	80.8	51.3	31.6	40.9	11.1	41.1	7.2	23.0	40.8	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	49.8	0.1	0.0	1.3	0.0	0.0	0.0	62.6	1.5	0.1	0.1	0.0	0.0	23.9	0.2	1.4	0.3	0.0	0.0	336.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.0	296.9	0.0	0.0	0.0	0.0	12.8	0.9	0.0	0.0	31.9	0.0	10.9	0.0	209.1	89.0	0.4	0.0	1.2	0.0	0.5	0.0	0.0	0.0	59.8	0.0	0.0	0.1	29.6	4.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
SNCB		ENSG00000074317	"Synuclein beta"	Q16143	5	176620082-176630556	"Human disease related genes, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 439.2;retina: 182.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 105.1;Excitatory neurons: 36.8;Horizontal cells: 50.5;Inhibitory neurons: 32.6;Rod photoreceptor cells: 49.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 11.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002681, HPA035876"	Enhanced	Supported				NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB002681: , HPA035876: AB_10670592"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-2)"		"unprognostic (6.07e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.41e-5)"	"unprognostic (1.31e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.42e-3)"	0.1	3.2	81.7	0.0	154.5	0.0	0.1	74.3	439.2	0.1	0.0	1.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	136.3	41.9	0.1	0.2	0.2	0.2	104.2	23.8	0.3	0.8	0.0	17.1	0.0	77.7	0.1	0.0	182.2	0.1	0.0	1.9	0.3	0.4	0.0	1.3	0.2	0.3	0.6	63.1	0.0	0.2	2.8	0.0	0.1	0.1	237.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.7	0.0	6.0	0.3	2.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	1.8	1.0	0.0	0.0	3.9	0.0	2.3	0.0	0.0	0.3	0.0	0.0	54.6	2.0	0.0	0.2	5.4	0.1	2.5	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	154.5	74.3	439.2	136.3	41.9	104.2	23.8	77.7	1.3	63.1	237.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	105.1	0.0	0.0	1.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	50.5	32.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	10.3	0.0	3.5	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950849-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 68.2;Excitatory neurons: 24.4;Horizontal cells: 90.9;Late spermatids: 44.7;Spermatocytes: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HAP1: 1.7;JURKAT: 1.6;MOLT-4: 1.1;NTERA-2: 2.0;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	2.0	0.3	0.6	0.0	0.7	0.0	1.8	1.0	0.6	1.0	1.1	0.5	0.1	1.2	0.2	0.5	1.2	0.2	0.4	1.7	0.7	0.1	0.0	0.3	0.0	1.7	0.9	0.2	0.9	0.0	2.9	0.0	1.3	0.6	0.2	2.1	0.5	0.0	0.4	1.1	0.6	0.7	0.4	3.2	0.3	1.8	0.7	0.2	0.7	0.9	0.1	0.8	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	1.0	0.6	1.7	0.7	1.7	0.9	1.3	0.4	0.7	0.6	6.8	0.0	0.0	0.7	0.4	0.9	0.1	0.0	0.6	0.8	0.2	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	68.2	0.1	0.9	7.3	0.0	0.0	24.4	0.2	0.5	0.8	0.0	0.0	0.0	3.0	0.0	0.0	0.1	90.9	10.7	0.0	0.0	0.0	1.2	44.7	0.3	0.0	1.8	9.4	0.0	0.6	0.0	1.5	1.3	0.0	0.0	4.1	0.0	0.3	0.0	0.5	0.0	4.6	0.0	0.3	0.4	22.0	5.4	0.1	0.1	0.0	0.2	0.2	0.0	0.2
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 501.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.5;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 9.8"	"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	501.5	50.3	19.1	99.0	20.2	126.4	114.1	18.8	27.5	35.1	21.7	119.0	19.4	53.4	1.9	72.7	306.5	190.4	76.8	16.8	21.2	72.1	84.2	234.8	46.9	43.1	22.1	55.5	46.2	23.6	55.7	77.5	24.6	61.8	27.2	4.2	36.3	17.1	26.1	55.3	64.2	125.2	23.7	52.0	123.9	5.9	32.2	115.9	54.1	37.1	11.8	187.9	31.6	19.6	6.4	10.2	7.3	3.8	2.8	44.3	19.1	31.4	28.3	32.1	13.6	6.6	4.4	0.2	6.7	7.5	20.4	2.0	1.5	3.1	12.7	154.2	0.9	5.8	24.1	1.4	14.5	0.1	2.7	73.3	2.6	24.9	9.3	19.4	14.0	0.5	17.4	58.2	15.1	3.3	3.3	1.0	5.2	1.2	12.8	0.2	36.9	1.1	51.4	6.3	0.3	4.6	9.5	2.5	1.3	26.8	2.9	1.4	8.4	62.7	17.6	22.2	18.4	76.0	46.9	0.1	51.6	0.8	4.1	0.0	1.0	0.2	0.8	0.1	1.9	0.0	2.1	0.9	1.1	0.0	3.1	0.6	9.5	0.3	0.0	1.0	1.3	0.5	19.1	20.2	18.8	27.5	16.8	21.2	43.1	22.1	24.6	23.7	32.2	19.6	989.2	48.1	125.6	0.7	64.7	164.3	120.7	75.0	125.2	1.0	176.3	136.4	23.1	18.6	51.7	38.6	2.1	14.9	42.1	20.5	5.9	44.4	0.8	106.7	207.6	635.9	33.0	11.6	0.0	38.6	46.0	394.4	125.4	166.8	36.0	5.8	307.3	20.2	94.6	0.0	0.1	25.0	30.5	78.4	381.5	1.7	78.3	231.0	85.4	1.0	33.6	7.7	1.0	0.0	1.0	43.0	28.1	2.2	115.5	72.0	24.3	11.5	38.1	2.7	13.1	485.9	381.7	0.4	1.0	36.3	133.0	62.1	88.7	5.3	41.0	90.5
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 800.2;Cardiomyocytes: 612.3;Excitatory neurons: 401.1;Inhibitory neurons: 295.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.0;Hep G2: 19.5;HMC-1: 48.3;SK-MEL-30: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	370.8	21.6	128.5	53.3	153.3	4.7	78.3	101.7	144.1	46.0	42.6	312.8	25.6	169.4	32.1	155.5	99.2	81.3	351.6	127.0	165.4	17.6	49.3	34.4	3.1	164.0	161.5	19.0	22.0	26.4	11.5	30.3	126.7	140.6	67.0	39.0	24.5	217.4	190.5	24.5	62.7	151.0	138.9	8.1	143.1	14.4	127.0	3.7	14.8	155.9	1.5	235.3	47.1	139.9	1.6	1.2	12.4	3.1	4.2	0.2	2.4	0.4	0.1	0.4	0.1	28.0	10.9	0.0	2.2	0.2	4.2	0.6	2.4	0.6	0.4	3.2	4.5	7.2	0.4	19.5	1.5	0.0	48.3	0.9	0.4	0.5	0.3	0.2	4.9	1.9	11.7	2.3	1.3	0.8	0.1	0.8	5.7	6.2	2.6	1.0	4.0	0.4	15.1	18.3	4.9	3.7	1.8	0.6	45.2	8.9	2.1	0.4	0.3	0.1	4.0	0.1	2.4	1.8	0.5	0.2	4.8	0.5	11.7	6.1	0.1	1.2	0.4	0.6	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.3	0.1	128.5	153.3	101.7	144.1	127.0	165.4	164.0	161.5	126.7	138.9	127.0	139.9	42.2	22.4	20.9	800.2	0.8	11.6	8.7	0.0	5.2	7.5	6.5	19.3	612.3	12.8	1.3	1.8	2.1	20.2	1.0	4.0	3.9	7.2	70.4	1.4	15.8	25.7	6.0	16.0	401.1	3.1	2.4	21.4	8.6	1.6	16.4	8.2	30.4	50.5	3.1	6.7	295.1	10.9	0.0	3.8	12.0	48.6	7.5	1.1	14.2	163.9	0.7	22.1	1.0	155.3	22.6	2.3	2.8	76.8	1.1	4.7	1.2	6.1	0.1	5.5	0.0	11.8	51.6	3.4	3.7	1.9	12.5	29.6	1.6	0.1	5.1	5.9
SORCS1		ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;thyroid gland: 11.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"RH-30: 80.8;SH-SY5Y: 104.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	0.6	3.1	3.0	1.9	6.2	0.0	1.3	0.0	10.3	2.5	0.0	9.4	0.7	1.1	0.3	0.9	1.6	1.1	3.1	5.4	5.8	4.7	0.1	0.1	1.0	0.6	4.5	0.7	1.6	0.0	0.9	0.0	2.7	2.2	1.9	9.6	1.1	2.5	0.3	1.5	3.6	1.4	0.5	0.8	2.5	1.2	5.8	1.0	11.0	1.7	1.5	3.6	2.8	6.6	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	80.8	0.1	0.0	0.0	0.0	104.9	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	6.2	0.0	10.3	5.4	5.8	0.6	4.5	2.7	0.5	5.8	6.6	0.0	0.0	0.5	7.2	0.0	0.6	0.0	0.0	1.2	2.0	0.1	0.5	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.6	0.1	4.9	0.2	0.0	0.0	522.2	0.0	0.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	1.7	179.7	0.0	0.0	0.3	0.3	5.2	0.0	0.2	1.8	26.2	0.0	49.1	0.0	381.5	10.0	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	2.1	0.0	1.0	0.3	0.2	1.9	0.2	0.1	0.0	0.3	0.0	0.0	0.0
SOWAHA	ANKRD43	ENSG00000198944	"Sosondowah ankyrin repeat domain family member A"	Q2M3V2	5	132813302-132816786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 100.9;intestine: 39.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 39.5;Horizontal cells: 132.9;Muller glia cells: 26.8;Proximal enterocytes: 108.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 13.4;T-47d: 32.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 61.0"	HPA064621	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"			"HPA064621: AB_2685302"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.75e-3)"	"unprognostic (5.34e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.65e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.92e-2)"	"prognostic favorable (9.38e-5)"	"unprognostic (4.36e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.42e-1)"	0.4	0.8	62.6	0.6	100.9	0.0	0.5	13.2	59.2	0.3	5.3	8.3	36.4	0.0	6.1	0.1	1.4	1.6	0.1	49.7	13.3	4.8	1.8	0.1	0.0	12.9	13.0	0.2	2.4	1.2	2.6	0.1	15.3	2.6	6.7	4.3	3.2	2.8	0.0	0.2	39.3	0.0	15.0	0.0	5.6	0.5	24.3	2.0	1.1	0.0	0.1	1.1	0.1	23.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	1.5	0.0	0.7	0.0	0.1	0.0	2.6	0.4	0.1	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	1.0	1.7	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.7	13.4	0.5	0.1	0.0	0.0	1.6	32.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	100.9	13.2	59.2	49.7	13.3	12.9	13.0	15.3	15.0	24.3	23.5	0.0	0.0	0.0	1.6	0.2	0.0	0.4	0.1	0.0	0.7	1.0	0.1	0.3	14.3	0.2	5.5	0.0	0.4	0.0	39.5	0.0	0.3	0.0	0.5	0.1	0.1	11.5	0.0	4.8	1.1	0.0	0.1	2.6	0.5	0.0	0.0	0.0	2.1	0.1	132.9	0.6	19.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	26.8	0.0	5.5	15.2	0.4	21.0	0.4	0.0	2.2	108.7	5.5	0.8	3.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.2	0.0	19.1	0.6
SOWAHB	ANKRD56	ENSG00000186212	"Sosondowah ankyrin repeat domain family member B"	A6NEL2	4	76894152-76898144	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.1"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Gastric mucus-secreting cells: 4.6;Squamous epithelial cells: 2.7;Urothelial cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.9;BEWO: 8.3;CACO-2: 3.9;OE19: 7.4;RT4: 19.4;T-47d: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036809, HPA036810"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli fibrillar center"		"HPA036809: AB_10672479, HPA036810: AB_2675327"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.73e-3)"	0.0	0.3	1.2	0.7	1.4	0.0	1.3	0.0	2.8	1.0	0.7	7.7	5.5	0.3	0.8	6.2	1.1	1.3	0.0	1.8	0.1	7.7	19.1	1.6	0.0	0.5	0.0	0.0	5.8	6.9	0.4	0.6	0.6	0.8	6.3	0.2	2.4	2.7	0.0	1.5	8.1	0.2	0.0	0.0	4.6	0.0	0.0	0.2	2.4	0.0	2.3	6.0	2.2	1.1	3.9	0.1	0.3	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	3.9	2.6	0.0	0.1	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	7.4	0.0	0.0	0.0	0.0	0.5	19.4	0.1	0.0	0.0	1.7	0.0	0.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.4	0.0	2.8	1.8	0.1	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	0.2	0.0	1.5	1.9	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	4.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	1.1	1.1	0.9	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.5	6.1
SOX1		ENSG00000182968	"SRY-box transcription factor 1"	O00570	13	112067149-112071706	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 14.8"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 4.0;Melanocytes: 3.6;Spermatogonia: 2.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 0.9;glioma: 2.3;melanoma: 2.0"	"Region enhanced"	"Detected in all"		"thalamus: 14.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 29.3"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"						"unprognostic (1.12e-1)"		"unprognostic (4.95e-2)"	"unprognostic (1.71e-3)"			"unprognostic (6.03e-2)"	"unprognostic (6.41e-2)"				"unprognostic (4.85e-1)"	"unprognostic (5.93e-2)"			0.0	0.0	2.1	0.0	3.7	0.0	0.0	1.3	2.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.3	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.8	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.7	1.3	2.7	1.6	5.3	1.8	4.1	2.1	1.2	14.8	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1
SOX17		ENSG00000164736	"SRY-box transcription factor 17"	Q9H6I2	8	54457935-54460892	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.1"	"Group enriched"	"Detected in many"	8	"Adipocytes: 464.9;Endometrial ciliated cells: 377.3;Endothelial cells: 171.5;Glandular and luminal cells: 520.0"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 122.8;ovarian cancer: 96.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"EFO-21: 108.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025594, HPA068399"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"CAB025594: , HPA068399: AB_2685981"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.76e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.90e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.98e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.88e-1)"	49.1	1.6	2.9	1.4	2.3	0.0	32.6	2.6	3.3	20.4	1.4	8.3	0.7	18.8	1.2	3.6	23.0	7.7	19.1	2.1	2.2	5.6	1.3	9.9	0.7	2.9	2.5	4.2	1.9	0.8	2.3	5.7	2.7	6.0	0.8	0.1	3.9	1.1	10.3	5.1	5.0	4.3	2.5	13.2	5.7	3.4	2.8	0.4	5.8	5.8	0.4	8.4	9.4	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.3	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.3	2.6	3.3	2.1	2.2	2.9	2.5	2.7	2.5	2.8	2.6	464.9	0.0	0.0	0.0	0.2	13.9	0.3	0.0	0.0	0.1	0.7	1.3	2.1	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.6	377.3	44.5	171.5	0.0	2.7	0.0	0.2	0.1	7.7	0.0	520.0	0.0	0.0	46.8	0.1	0.1	0.0	0.0	0.0	0.0	0.9	16.6	1.8	2.5	3.5	19.6	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	7.3	5.1	3.2	6.4	0.3	13.5	0.0	4.5	0.2	0.0	3.7
SOX18		ENSG00000203883	"SRY-box transcription factor 18"	P35713	20	64047582-64049639	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 78.4"	"Group enriched"	"Detected in many"	9	"Adipocytes: 370.9;Endothelial cells: 212.4;Hepatic stellate cells: 306.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 20.8;NB-4: 35.8;REH: 8.5;TIME: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073703			Approved	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA073703: AB_2686628"	"unprognostic (2.51e-1)"	"unprognostic (3.23e-1)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.63e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-1)"	"unprognostic (5.40e-2)"	51.8	14.3	8.9	3.1	6.4	0.0	43.1	6.5	6.3	19.5	1.7	16.3	3.1	38.4	0.3	12.0	29.2	3.7	78.4	4.4	5.5	21.4	5.2	29.1	3.1	10.1	8.0	8.0	8.2	1.3	6.6	5.5	9.5	17.6	0.4	0.0	12.6	1.3	13.9	12.2	17.0	1.5	6.7	22.5	15.6	5.6	9.9	0.8	29.0	3.8	0.5	19.7	21.9	5.4	0.0	0.3	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.0	0.0	0.2	0.3	0.0	0.0	0.5	1.0	0.0	3.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	20.8	0.0	3.7	0.0	0.0	0.7	0.0	35.8	0.1	0.0	0.3	8.5	0.0	0.6	0.0	1.4	0.6	0.6	0.3	0.0	0.5	0.0	0.5	1.8	9.6	0.1	2.6	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	6.5	6.3	4.4	5.5	10.1	8.0	9.5	6.7	9.9	5.4	370.9	0.0	0.6	0.3	3.7	1.0	0.2	0.0	2.2	0.9	1.9	3.0	8.8	1.5	0.0	1.8	0.0	0.0	1.6	0.1	0.0	0.3	22.1	1.0	11.9	212.4	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.7	4.5	0.0	306.6	0.6	0.1	0.0	0.0	0.0	0.0	6.0	2.2	4.8	1.2	1.3	1.8	15.9	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	3.6	6.5	32.4	2.5	0.9	1.1	0.3	0.7	2.3	0.0	0.3
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Group enriched"	"Detected in some"	6	"Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	0.3	0.9	58.0	0.5	58.5	0.0	0.2	47.1	56.6	2.1	8.6	5.5	0.4	0.1	0.2	24.5	3.1	0.2	0.5	46.5	59.0	0.0	0.1	1.8	0.0	50.5	58.9	0.3	0.1	0.0	13.6	0.0	45.2	2.5	0.4	15.0	18.4	0.3	0.1	0.6	1.4	0.2	59.8	0.0	7.9	1.9	59.2	0.4	0.1	0.1	5.3	1.3	4.8	62.2	0.1	9.0	277.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.1	0.0	0.2	0.7	118.6	3.2	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	226.2	12.4	0.5	0.0	0.6	0.0	31.0	0.4	0.5	1.2	0.0	0.0	0.1	45.7	1.7	0.1	0.0	0.0	4.2	0.0	54.0	0.0	0.0	0.0	0.2	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	58.5	47.1	56.6	46.5	59.0	50.5	58.9	45.2	59.8	59.2	62.2	0.2	0.0	6.0	0.0	0.0	0.3	35.5	28.5	362.0	4.9	0.2	0.4	0.5	0.0	48.4	3.7	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.1	1.6	19.4	0.0	1.3	0.2	0.7	0.1	0.1	0.0	0.0	0.5	38.7	0.0	0.4	0.4	0.6	0.8	3.6	0.0	0.0	383.5	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	0.0	0.1	52.8	13.1	0.0	0.2	1.6	3.9	0.4	229.1	0.4	0.3	0.6	0.2	0.0	7.5
SOX6		ENSG00000110693	"SRY-box transcription factor 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 308.9;Early spermatids: 256.8;Inhibitory neurons: 481.0;Oligodendrocyte precursor cells: 1687.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;HAP1: 4.4;hTCEpi: 5.0;SK-MEL-30: 4.9;WM-115: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favorable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.8	1.3	5.4	0.4	5.9	26.9	0.7	2.6	4.7	1.7	5.5	1.2	6.5	0.6	2.0	2.1	4.0	2.6	3.0	4.0	7.2	11.1	4.8	0.8	0.1	7.2	7.8	0.7	6.8	0.1	2.9	2.5	6.0	0.4	1.3	3.2	0.5	0.6	9.3	5.8	11.0	0.5	7.7	0.5	1.0	14.4	4.1	1.6	3.4	5.9	0.2	0.8	0.8	6.8	0.0	0.7	3.9	3.7	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.7	0.0	0.0	3.6	0.0	0.0	0.1	4.4	1.1	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	1.8	0.0	0.0	0.1	0.4	0.0	4.9	0.5	0.0	0.0	0.0	2.6	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	5.4	5.9	2.6	4.7	4.0	7.2	7.2	7.8	6.0	7.7	4.1	6.8	2.7	3.2	6.3	308.9	1.0	40.1	5.8	6.8	66.6	26.3	3.7	2.5	21.6	54.3	3.8	36.8	10.4	1.3	0.1	1.4	9.8	19.8	256.8	29.4	5.3	4.8	7.8	126.7	2.8	3.7	0.6	14.5	2.0	27.8	0.0	1.6	2.2	7.5	1.1	0.0	481.0	6.6	0.0	2.9	3.2	70.1	3.4	1.4	35.6	21.5	0.0	48.4	0.0	1687.9	8.9	5.5	20.3	2.2	0.1	3.2	99.8	27.1	8.3	4.3	0.0	26.2	14.6	22.1	4.5	32.7	16.1	0.5	1.1	3.0	11.8	3.7
SOX7		ENSG00000171056	"SRY-box transcription factor 7"	Q9BT81	8	10723768-10730511	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 42.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.4;Basal keratinocytes: 61.2;Basal prostatic cells: 67.6;Basal squamous epithelial cells: 148.5;Endothelial cells: 115.1;Squamous epithelial cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 11.8;hTCEpi: 21.3;HUVEC TERT2: 25.2;TIME: 6.8"	"Low region specificity"	"Detected in many"							HPA009065	Approved		Approved	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles"	"Golgi apparatus"	"HPA009065: AB_1857390"	"unprognostic (1.21e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.45e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.41e-3)"	"unprognostic (4.84e-3)"	22.6	3.8	2.5	1.0	2.3	0.1	11.9	1.9	2.6	27.0	1.4	4.2	0.1	4.3	1.1	26.8	4.5	3.6	18.5	2.1	1.8	5.1	4.3	23.2	1.7	2.6	2.2	1.5	2.6	1.0	5.6	17.3	2.5	5.4	1.1	0.4	10.5	2.7	9.8	20.2	3.6	2.3	2.5	2.4	3.7	0.7	2.7	1.5	7.6	6.4	1.9	4.6	42.4	2.0	5.8	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.3	0.6	11.8	3.4	4.2	0.1	0.1	0.4	0.1	0.3	0.1	0.0	0.2	0.2	0.1	21.3	0.0	4.3	0.0	25.2	0.0	0.6	0.3	0.0	0.2	0.2	0.2	1.6	0.9	3.2	1.2	0.0	0.0	0.0	2.1	0.6	3.4	2.2	0.0	0.0	1.4	0.0	0.1	6.8	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	1.9	2.6	2.1	1.8	2.6	2.2	2.5	2.5	2.7	2.0	115.4	0.0	11.5	0.3	1.1	61.2	67.6	24.5	148.5	1.2	5.2	4.7	4.8	1.5	6.3	0.0	4.2	4.3	0.1	0.2	0.0	0.2	0.2	14.9	1.9	115.1	0.0	0.0	4.6	0.2	0.8	4.7	0.0	22.9	3.8	0.5	48.5	4.9	0.7	0.0	2.9	0.2	10.2	1.9	8.7	0.1	0.9	0.9	3.6	10.3	0.3	0.5	0.0	1.5	0.8	0.5	0.0	0.4	1.2	17.8	0.1	0.6	3.2	2.2	0.0	8.5	4.4	2.4	1.6	98.9	40.6	12.4	1.8	1.2	0.4	26.6
SOX8		ENSG00000005513	"SRY-box transcription factor 8"	P57073	16	981770-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 127.4"	"Group enriched"	"Detected in some"	9	"Muller glia cells: 156.1;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 66.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 114.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm		No	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA041640: AB_10964357, HPA058665: AB_2683792"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	0.9	0.5	58.3	0.9	90.4	0.1	1.7	66.7	71.8	1.3	23.6	3.1	0.1	0.4	0.1	0.4	0.6	0.5	4.1	54.0	57.9	0.7	0.2	0.3	2.0	73.6	79.8	0.3	1.0	0.1	1.2	0.4	64.9	1.2	0.6	14.8	8.3	0.4	0.8	5.4	1.8	0.2	58.7	1.0	0.9	2.5	71.2	0.4	0.5	0.6	2.3	1.4	1.6	127.4	0.0	0.6	2.2	21.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.4	5.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	3.3	1.8	0.2	0.0	114.7	4.5	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.3	0.4	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	58.3	90.4	66.7	71.8	54.0	57.9	73.6	79.8	64.9	58.7	71.2	127.4	1.5	0.0	0.0	10.1	0.2	0.4	0.5	0.0	0.0	1.8	8.7	10.4	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.5	0.0	0.0	0.6	2.6	0.0	0.0	4.6	0.2	0.1	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.3	0.5	3.4	0.3	1.8	3.7	0.6	156.1	0.0	64.3	66.0	0.1	0.3	1.9	0.5	1.9	0.0	0.0	0.0	8.0	0.0	9.9	0.9	0.0	3.9	0.4	1.0	0.0	0.9	0.1	0.9	0.3
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230165186-230225729	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 99.3"					"Low region specificity"	"Detected in all"			HPA058554			Supported	Nucleoplasm		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA058554: AB_2683754"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	14.0	7.3	8.4	38.5	10.3	29.8	11.8	9.4	10.8	11.6	11.5	12.6	11.9	10.5	7.9	9.2	9.6	18.0	8.1	8.1	10.3	11.9	14.8	21.0	53.7	15.3	10.9	16.5	7.9	9.7	5.3	17.5	11.6	9.6	14.0	2.0	17.0	7.6	5.7	7.8	17.6	13.4	12.1	49.8	12.9	3.1	10.9	35.7	7.4	8.4	50.1	18.9	9.3	12.3	8.3	4.4	2.7	4.7	14.2	23.6	8.3	14.8	30.8	70.3	99.3	0.2	12.7	34.5	13.8	15.8	67.0	5.1	9.0	23.0	25.7	30.5	6.0	14.9	6.2	8.9	14.5	22.1	17.1	32.7	11.8	20.8	27.4	13.2	25.3	23.6	5.3	12.1	20.6	4.9	33.0	43.5	8.6	4.2	5.1	20.1	25.4	12.8	56.2	11.1	0.5	5.7	5.7	12.7	32.7	0.9	9.6	18.5	18.8	12.9	7.9	3.2	7.5	12.9	4.6	16.2	14.4	20.6	10.7	92.2	49.7	124.4	55.2	85.8	47.8	142.8	53.5	50.5	44.1	135.8	54.1	58.7	268.6	56.9	143.4	84.4	70.7	48.5	8.4	10.3	9.4	10.8	8.1	10.3	15.3	10.9	11.6	12.1	10.9	12.3	77.8	44.8	23.8	17.3	141.7	9.9	5.2	25.7	16.5	0.4	21.6	19.3	3.7	7.2	19.6	11.0	0.0	3.8	84.0	17.0	13.7	19.9	5.2	17.2	21.3	28.6	6.7	9.7	1.1	28.5	12.7	22.8	9.2	20.1	38.0	21.2	26.4	6.2	26.9	0.0	2.1	11.4	73.2	47.4	25.8	4.2	11.8	62.3	19.6	42.2	56.7	9.7	59.8	19.6	18.2	26.0	11.6	10.1	35.7	3.5	10.7	14.4	21.0	4.9	6.6	8.6	16.2	4.8	2.3	9.8	10.1	4.7	68.8	23.5	6.1	3.0
SP140	"LYSP100-A, LYSP100-B"	ENSG00000079263	"SP140 nuclear body protein"	Q13342	2	230203110-230313215	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 15.6;lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.9;dendritic cells: 37.4;NK-cells: 50.4;Plasma cells: 77.2;T-cells: 62.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 97.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.1;HDLM-2: 52.4;Karpas-707: 25.2;RPMI-8226: 16.3"	"Low region specificity"	"Detected in all"							"HPA006162, HPA067493"	Enhanced		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoli fibrillar center"	Mitochondria	"HPA006162: AB_1857403, HPA067493: AB_2685851"	"unprognostic (8.15e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-3)"	"unprognostic (5.72e-4)"	"unprognostic (5.66e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.20e-9)"	"unprognostic (9.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.30e-3)"	1.7	0.8	0.7	25.0	0.8	6.6	1.2	0.8	1.6	0.6	1.0	3.5	2.9	0.9	0.8	0.9	0.7	2.9	0.6	0.8	1.1	0.9	1.6	4.4	54.6	1.8	1.2	0.4	0.3	0.2	0.6	1.2	1.5	0.9	3.9	1.0	2.6	0.5	0.2	1.6	15.6	1.0	1.3	27.8	5.1	1.5	2.1	6.8	1.3	0.1	55.8	4.3	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	2.4	0.0	0.3	31.1	0.0	0.0	5.2	0.0	0.0	0.1	1.8	52.4	0.0	0.0	0.0	0.6	0.2	4.4	0.1	0.5	0.0	0.5	0.6	0.4	0.0	0.3	0.0	25.2	0.6	0.0	0.0	1.5	1.3	0.0	0.0	0.1	2.8	16.3	8.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.1	0.3	1.3	0.0	0.0	9.2	4.0	1.1	2.2	0.7	0.0	0.1	3.5	12.0	23.1	7.3	25.6	97.5	22.8	25.3	8.3	71.0	11.5	15.0	33.4	15.1	10.6	0.5	22.5	10.6	0.7	0.8	0.8	1.6	0.8	1.1	1.8	1.2	1.5	1.3	2.1	1.5	1.6	0.0	2.3	3.9	149.9	0.9	0.0	0.2	0.0	0.7	0.3	0.5	0.5	0.0	0.8	0.0	8.4	0.1	37.4	0.1	0.0	0.0	17.2	0.5	0.2	1.1	0.0	9.7	5.0	0.0	0.2	0.8	1.5	0.1	0.0	0.2	2.2	0.9	11.4	0.0	5.0	0.1	0.0	8.4	8.6	4.8	0.0	13.2	7.2	26.2	13.7	0.5	50.4	2.5	2.8	0.1	0.1	1.2	77.2	0.1	0.0	0.4	2.4	1.7	0.0	0.2	1.0	1.2	0.4	0.7	1.1	0.3	62.1	0.3	0.2	0.2
SPAAR	"LINC00961, SPAR"	ENSG00000235387	"Small regulatory polypeptide of amino acid response"	A0A1B0GVQ0	9	35909490-35937153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.4;breast: 10.8"	"Cell type enriched"	"Detected in some"	7	"Adipocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HUVEC TERT2: 34.0;TIME: 40.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (3.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.40e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.22e-1)"	12.4	1.2	2.9	0.6	2.5	0.0	10.8	2.2	3.3	0.7	1.1	1.2	0.3	1.2	0.1	0.5	1.2	0.6	8.9	2.3	2.2	4.2	0.8	3.2	0.4	3.0	2.6	0.7	0.5	0.5	0.6	4.7	3.1	1.0	0.4	1.4	0.7	0.5	3.1	0.9	0.9	0.6	2.3	0.7	0.9	7.5	3.3	0.2	1.9	1.8	0.0	1.5	0.8	2.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.4	0.1	0.2	0.0	0.0	34.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	40.1	0.0	0.8	2.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.5	2.2	3.3	2.3	2.2	3.0	2.6	3.1	2.3	3.3	2.4	42.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0
SPACA4	SAMP14	ENSG00000177202	"Sperm acrosome associated 4"	Q8TDM5	19	48606742-48607714	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 117.8"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 1014.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041927, HPA061302"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA041927: AB_10794162, HPA061302: AB_2684475"	"unprognostic (2.48e-2)"	"unprognostic (6.37e-4)"	"unprognostic (6.59e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.09e-3)"	"unprognostic (9.43e-6)"		"unprognostic (6.67e-3)"		"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.78e-1)"		"unprognostic (3.43e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.47e-1)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.3	0.6	0.0	3.6	3.0	0.0	0.0	2.0	0.2	1.1	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.9	0.0	0.1	1.4	3.1	0.0	0.0	0.0	3.4	117.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.2	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1014.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	185.9	4.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	9.8	3.3	0.0	1.6	0.0	0.0	0.0	0.0	0.2
SPARC	"BM-40, ON, ONT"	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151686975	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 2184.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 737.1;Endometrial stromal cells: 1209.0;Endothelial cells: 781.9;Fibroblasts: 1032.1;Peritubular cells: 1111.1;Sertoli cells: 2353.5;Smooth muscle cells: 1527.3;Theca cells: 987.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 10.4;classical monocyte: 8.7;neutrophil: 24.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 24.3;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 4911.5;BJ: 4101.8;fHDF/TERT166: 6492.5;WM-115: 4789.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	8300000	130000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	1661.2	406.4	578.0	436.4	922.0	32.4	528.6	733.1	339.2	837.2	297.8	355.6	110.5	538.9	112.7	307.7	271.4	1526.8	563.5	362.9	1554.2	176.1	158.5	498.0	232.1	1370.4	1251.5	348.2	119.2	273.1	111.4	2184.6	1224.8	227.1	185.2	36.4	113.1	378.0	258.2	286.1	157.4	1251.5	995.9	260.8	143.3	406.7	1135.4	70.9	294.1	473.5	131.6	829.5	249.0	1088.4	5.9	5.0	1196.5	57.5	4911.5	1596.0	112.6	4101.8	1336.6	1649.3	1693.8	5.5	4.2	2.0	953.7	6492.5	272.0	56.7	153.4	316.2	555.0	4.8	57.1	56.7	0.4	116.8	1441.6	2.9	5.4	2567.2	436.9	1233.8	170.8	1903.1	2315.1	13.5	53.7	44.6	944.1	0.4	4.7	35.5	556.2	0.4	4.4	2.9	1192.9	4.3	0.5	0.5	45.5	88.4	2.8	1.4	534.9	1922.1	4.7	138.2	2759.9	771.0	1195.2	350.2	1304.4	3.7	6.0	7.6	648.4	3.7	4789.0	10.4	8.7	2.7	1.0	0.3	0.0	0.1	0.0	0.1	2.3	0.2	0.3	0.0	24.3	0.0	0.1	1.9	0.0	123.9	578.0	922.0	733.1	339.2	362.9	1554.2	1370.4	1251.5	1224.8	995.9	1135.4	1088.4	737.1	83.3	27.5	7.2	6.8	164.8	25.7	23.8	28.5	85.7	11.2	100.5	43.6	5.7	18.8	16.5	2.1	115.4	2.8	0.1	0.0	4.6	14.2	41.6	1209.0	781.9	0.0	15.1	4.3	0.4	354.3	1032.1	9.7	31.5	12.0	146.5	668.6	9.9	108.2	1.7	2.9	0.0	0.0	50.0	175.7	46.8	319.3	92.0	234.7	38.4	10.7	13.6	3.1	21.6	37.3	5.5	0.0	1111.1	4.1	7.7	0.0	42.0	7.8	72.7	2353.5	510.4	1527.3	14.2	10.9	4.8	108.3	147.4	21.1	987.4	0.0	5.3
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25 component of NDC80 kinetochore complex"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 23.5;Erythroid cells: 29.9;Extravillous trophoblasts: 37.9;Muller glia cells: 17.2;Spermatocytes: 26.2;Spermatogonia: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.74e-6)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.6	0.8	0.6	0.7	0.6	4.2	1.0	0.3	1.5	0.7	0.5	2.1	3.7	0.5	0.0	4.4	0.3	0.5	0.4	1.6	0.7	1.1	0.8	0.9	3.9	0.6	0.7	0.5	1.3	0.1	0.1	1.1	0.8	0.4	1.6	1.7	1.0	0.0	0.6	1.1	2.1	1.0	0.1	2.1	1.6	3.4	0.6	8.5	0.2	0.1	3.7	0.5	1.5	1.8	1.0	16.8	40.6	22.8	1.8	1.9	14.5	22.9	9.3	23.5	18.1	5.6	16.2	15.7	9.0	3.4	31.9	20.9	15.9	0.0	20.7	10.0	21.5	30.2	7.2	2.2	0.1	20.3	8.9	0.3	1.0	14.3	0.0	4.7	10.3	28.2	0.8	15.7	6.4	9.8	16.1	26.3	0.9	11.2	21.0	28.8	38.1	5.6	9.6	13.7	30.4	0.5	16.8	14.4	3.9	13.5	0.4	16.4	2.5	3.6	42.1	13.4	18.2	31.4	56.0	12.5	4.1	0.5	14.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.1	0.6	0.6	0.3	1.5	1.6	0.7	0.6	0.7	0.8	0.1	0.6	1.8	0.4	0.0	1.1	0.7	4.2	5.4	1.5	7.1	1.2	0.0	1.5	2.4	0.6	0.0	2.6	0.0	0.0	23.5	1.5	3.7	0.0	0.2	2.0	0.5	1.8	1.6	0.0	29.9	0.3	0.0	37.9	4.6	2.0	1.8	0.0	10.1	2.9	1.2	15.1	0.0	0.5	5.2	2.0	1.9	2.4	1.6	0.6	2.0	0.0	0.0	0.0	17.2	0.0	5.0	0.2	0.5	0.1	1.2	15.3	1.0	1.0	0.2	0.1	0.6	0.0	1.3	4.4	26.2	20.1	7.3	1.4	5.7	2.7	1.7	9.9	2.5
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 140.7;salivary gland: 114.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 388.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 2.9"	HPA055707			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.4	0.1	0.5	1.4	0.5	0.1	36.6	0.8	1.1	28.0	0.0	18.4	11.6	9.0	0.5	2.2	6.3	2.4	0.4	0.5	0.2	0.1	0.1	1.1	0.0	0.3	0.4	0.1	0.6	0.0	0.2	0.0	0.2	140.7	10.2	0.0	114.8	0.1	0.3	9.3	14.3	0.6	0.1	0.1	35.4	0.3	0.5	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	30.9	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.4	0.3	0.4	0.0	118.0	38.6	0.1	0.0	0.3	0.3	0.3	2.1	0.2	0.0	192.2	0.0	0.0	154.0	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	1.1	0.5	0.2	0.3	0.4	0.2	0.1	0.5	0.5	0.8	0.0	2.2	0.7	0.3	0.1	13.3	20.7	0.0	0.0	94.2	61.1	0.3	5.7	31.7	0.0	0.0	0.0	1.4	27.1	0.0	2.6	1.1	6.2	0.7	0.6	5.4	0.0	0.8	1.2	0.0	0.4	28.1	18.7	0.0	0.2	0.4	0.0	0.0	0.0	0.6	315.1	12.2	0.0	0.2	5.5	0.0	0.9	3.6	0.0	0.0	0.0	0.0	0.0	0.2	20.2	12.3	0.0	0.1	72.7	5.7	0.0	2.9	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.3	0.8	0.0	30.0	11.5
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 105.4;Muller glia cells: 165.1;Pancreatic endocrine cells: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.6;TIME: 108.9;U-251 MG: 142.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"olfactory bulb: 5.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	18.9	4.1	4.0	10.5	3.0	17.3	18.0	2.1	3.9	11.0	2.3	7.0	1.9	6.7	3.9	23.8	9.4	11.9	17.5	2.9	3.9	21.4	3.8	24.3	8.1	4.0	4.1	4.3	14.4	4.8	4.9	2.5	4.5	7.3	1.1	8.4	19.9	1.5	3.2	15.6	7.0	3.2	2.3	5.0	6.7	5.8	8.5	3.5	10.6	0.8	4.1	11.3	13.1	3.9	36.9	3.7	15.2	0.8	7.6	7.0	15.8	82.6	54.0	67.8	40.8	19.4	3.9	1.8	7.4	61.0	28.9	7.7	11.7	105.4	16.4	1.6	6.2	0.5	28.3	127.6	16.6	1.3	2.9	13.6	2.1	105.9	41.3	28.8	66.0	3.7	17.3	0.2	13.5	46.6	3.5	0.6	0.9	8.2	29.7	2.5	4.1	2.8	3.7	0.5	2.0	3.6	8.3	0.9	74.4	9.1	3.0	5.1	108.9	105.8	20.8	82.3	142.1	1.7	0.4	1.6	80.5	6.5	16.1	1.5	1.9	0.0	0.7	0.9	0.2	0.0	0.1	0.2	0.5	0.1	0.0	0.1	0.2	0.0	0.2	4.8	0.0	0.8	4.0	3.0	2.1	3.9	2.9	3.9	4.0	4.1	4.5	2.3	8.5	3.9	22.0	0.0	0.0	1.0	2.8	12.6	57.0	18.6	2.8	1.5	31.1	29.1	5.3	47.1	6.6	1.8	0.0	1.2	9.1	1.0	0.0	105.4	0.2	15.3	13.5	51.2	0.0	22.3	0.5	12.7	16.9	27.5	3.1	60.7	7.0	0.4	4.2	0.2	30.1	33.7	1.6	2.4	6.1	8.9	45.4	1.4	3.7	39.9	12.4	1.0	61.5	165.1	3.1	0.0	0.1	101.8	1.2	19.9	3.5	68.9	0.8	2.5	2.0	3.9	0.0	17.3	54.3	0.0	9.5	6.7	10.7	1.4	4.2	0.8	0.4	27.0
SPHKAP	SKIP	ENSG00000153820	"SPHK1 interactor, AKAP domain containing"	Q2M3C7	2	227979955-228181687	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"brain: 78.3;heart muscle: 29.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 82.2;Excitatory neurons: 67.7;Granulosa cells: 33.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 78.3;cerebral cortex: 49.3;hippocampal formation: 41.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"BJ hTERT+: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042499, HPA048168"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042499: AB_2678027, HPA048168: AB_2680296"	"unprognostic (4.91e-3)"				"unprognostic (6.46e-2)"						"unprognostic (1.33e-1)"	"unprognostic (2.59e-2)"		"unprognostic (2.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-3)"		0.0	0.1	10.6	0.0	8.8	0.0	0.8	78.3	49.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	41.1	4.2	0.0	0.0	0.1	0.0	6.8	13.3	2.1	0.0	0.0	0.0	0.0	7.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.2	11.2	0.3	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	45.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	8.8	78.3	49.3	41.1	4.2	6.8	13.3	7.1	4.2	11.2	3.3	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	7.2	2.6	3.0	82.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	67.7	0.0	0.0	2.1	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	128.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	9.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378547	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 335.1;lung: 101.0;lymphoid tissue: 172.7"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 432.9;Kupffer cells: 411.9;Langerhans cells: 537.6;Macrophages: 453.3;monocytes: 357.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 179.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 179.7"	"Cell line enhanced"	"Detected in some"		"HEL: 90.1;HL-60: 159.7;HMC-1: 282.2;NB-4: 267.8;THP-1: 206.7;U-698: 85.3;U-937: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	36.5	19.7	12.0	107.3	13.1	335.1	17.7	14.3	19.4	7.9	15.8	15.6	21.5	7.3	2.1	9.1	19.1	21.3	13.5	11.7	16.4	10.6	15.6	101.0	65.0	31.2	20.9	5.2	7.8	3.1	7.6	28.0	24.7	10.3	10.2	1.0	14.6	6.1	5.0	13.8	29.3	21.9	19.8	172.7	17.0	3.7	26.2	15.7	8.8	8.3	32.0	29.9	7.6	30.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	72.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	90.1	0.0	0.0	0.0	159.7	282.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.7	0.0	0.0	0.2	267.8	0.2	0.0	0.0	48.7	0.2	47.5	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	206.7	0.3	0.0	0.5	0.5	0.1	0.1	0.3	85.3	0.3	117.5	0.1	14.1	19.2	179.7	0.0	27.4	0.0	3.9	0.0	0.0	16.4	2.4	0.0	0.0	83.8	0.0	34.7	0.9	0.0	7.3	12.0	13.1	14.3	19.4	11.7	16.4	31.2	20.9	24.7	19.8	26.2	30.3	2.1	3.2	1.1	10.4	72.6	10.5	0.5	0.0	1.2	1.3	2.1	5.0	2.9	4.3	0.6	5.5	0.0	2.3	6.3	0.5	19.6	0.1	7.5	0.1	0.3	5.5	4.2	39.7	3.1	0.4	3.1	2.6	1.1	0.3	33.7	0.2	7.9	3.2	432.9	0.0	3.3	0.3	0.0	411.9	537.6	27.5	1.8	453.3	10.6	36.5	357.5	7.0	8.2	3.5	1.5	0.0	0.1	0.0	21.8	0.4	0.2	2.3	0.7	1.7	13.1	1.5	1.4	5.1	9.3	0.8	9.9	4.2	4.8	1.1	0.4	0.5
SPIB	SPI-B	ENSG00000269404	"Spi-B transcription factor"	Q01892	19	50418938-50431314	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 27.9;lymphoid tissue: 99.4"	"Cell type enriched"	"Detected in many"	4	"Paneth cells: 787.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	54	"memory B-cell: 307.8;naive B-cell: 260.6;plasmacytoid DC: 572.6"	"Group enriched"	"Detected in many"	106	"B-cells: 307.8;dendritic cells: 572.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 166.3;HDLM-2: 107.3;Karpas-707: 52.8;U-698: 238.2"									HPA018523	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA018523: AB_1857443"	"prognostic favorable (4.76e-5)"	"unprognostic (1.06e-5)"	"unprognostic (9.15e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.72e-3)"	"prognostic favorable (2.14e-5)"	"unprognostic (2.33e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.96e-8)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	1.2	0.1	0.4	41.7	0.5	6.1	0.2	1.3	0.6	0.1	0.5	22.2	13.1	0.4	0.2	0.7	0.8	1.6	0.2	0.4	0.6	0.6	0.5	1.0	87.0	1.4	0.2	0.1	1.5	0.0	0.1	0.2	0.5	1.2	18.2	0.2	2.7	0.2	1.3	0.5	27.9	0.8	0.1	29.3	8.2	0.4	0.4	7.6	0.8	0.2	99.4	4.1	0.3	1.4	0.4	1.1	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.2	3.1	0.2	166.3	0.2	0.1	0.0	0.2	1.4	0.0	0.0	107.3	0.3	0.7	0.3	0.1	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.8	4.6	52.8	0.1	0.5	0.1	0.6	1.5	0.1	0.0	11.6	0.9	2.0	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	5.4	0.8	0.1	3.0	0.1	0.3	5.0	3.5	238.2	0.1	2.6	0.2	4.1	0.5	0.8	0.5	0.2	0.4	307.8	0.3	0.3	6.9	260.6	0.4	0.3	2.6	3.9	0.3	572.6	0.6	14.8	0.4	0.5	1.3	0.6	0.4	0.6	1.4	0.2	0.5	0.1	0.4	1.4	0.5	0.0	1.8	0.3	162.7	1.8	2.1	0.0	0.0	0.7	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.3	192.8	28.3	0.0	0.7	0.0	1.1	0.3	0.8	19.8	0.4	0.3	1.1	0.2	1.1	2.6	0.5	4.5	0.2	0.0	0.5	1.4	0.0	0.3	18.4	0.0	0.6	38.0	0.0	0.0	13.0	7.2	0.0	1.6	0.6	1.0	0.0	0.2	0.0	787.8	0.4	2.0	1.4	5.0	0.3	0.7	1.0	0.0	1.3	0.8	0.2	1.1	0.0	1.3	0.3	2.7	0.1	37.6	1.3
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor Kazal type 1"	P00995	5	147824572-147831671	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"pancreas: 53063.4"	"Group enriched"	"Detected in many"	9	"Exocrine glandular cells: 50621.7;Pancreatic endocrine cells: 16750.7"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"CACO-2: 417.2;RT4: 1139.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"	NA	NA		8000000		"Cluster 25: Pancreas - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favorable (2.15e-5)"	8.8	1.5	0.1	36.4	0.1	6.8	4.1	0.3	1.2	3.1	0.3	428.2	394.4	5.5	0.8	2.9	1.3	111.9	12.0	0.2	0.2	142.5	491.8	2.7	2.7	0.1	0.1	25.6	53063.4	0.0	1.9	3.2	0.2	4.4	441.3	0.6	12.8	1.4	1.2	21.1	403.9	14.1	0.0	2.5	1475.2	0.9	0.3	0.4	1.0	0.0	0.3	995.6	10.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	417.2	0.3	0.1	6.8	0.0	0.8	0.9	2.2	0.0	0.0	3.9	0.0	0.0	0.0	107.0	0.3	0.0	3.9	0.0	2.1	0.0	3.0	5.8	0.0	0.0	0.0	0.3	0.0	0.3	0.8	1.3	2.1	138.9	0.8	0.8	0.0	2.5	0.0	1139.0	0.5	1.7	0.0	0.2	0.1	5.4	0.1	0.0	0.0	0.1	13.7	1.1	3.8	2.2	5.9	3.0	16.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.2	0.2	0.2	0.1	0.1	0.2	0.0	0.3	0.6	0.0	0.0	3.6	0.0	9.7	0.0	15.1	0.3	0.0	0.0	5.5	0.8	0.1	1451.2	11.1	377.0	0.0	0.0	0.0	280.8	86.1	1286.7	0.1	0.3	0.4	9.4	517.2	18.7	1.0	50621.7	0.1	1.9	1580.5	5.0	4.5	2.0	39.3	3385.8	0.1	0.0	0.2	2087.4	0.0	30.9	0.0	0.2	0.0	13.7	0.0	0.0	269.8	0.0	0.0	0.0	0.1	16750.7	563.8	0.0	1.3	173.5	1457.1	1.6	0.7	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1365.3	649.1
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 980.5"	"Cell type enriched"	"Detected in some"	14	"Intestinal goblet cells: 8017.1"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	6	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	12	"HMC-1: 175.7;OE19: 480.7"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in single"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	1.4	0.6	0.0	84.2	0.0	0.6	0.1	0.7	0.3	0.0	0.1	639.5	263.4	1.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.1	0.1	0.0	0.9	2.1	0.9	0.0	0.1	0.0	980.5	92.1	0.1	0.5	0.2	0.1	638.1	42.2	0.0	0.2	1.4	0.3	0.0	0.1	0.0	0.0	0.0	17.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	11.7	27.8	1.1	0.0	0.0	175.7	0.0	0.0	0.0	0.4	0.5	0.0	0.1	4.1	0.3	0.0	3.9	0.4	2.3	0.0	480.7	0.4	0.0	0.0	0.2	0.0	0.5	0.4	1.4	15.2	3.1	0.0	0.1	14.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.3	0.1	1.4	0.3	0.0	1.8	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.3	0.0	0.0	0.0	21.7	0.1	0.0	0.0	0.0	0.0	5.5	12.5	0.1	0.0	56.5	0.0	0.2	1.0	0.1	0.0	0.6	88.2	0.0	0.0	0.0	0.0	0.0	43.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8017.1	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.5	0.1	0.1	106.8	0.0	0.1	0.2	541.4	0.0	0.0	129.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.1	191.5	0.2
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 255.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		7400000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.8	0.7	0.9	16.4	1.5	1.4	34.7	5.0	1.3	42.8	6.4	108.7	159.9	13.2	78.9	255.5	33.6	38.0	1.3	0.9	2.0	79.9	3.5	47.6	6.4	2.8	3.2	2.4	69.2	132.9	31.4	144.9	2.2	52.3	89.2	0.4	162.7	31.4	0.6	148.9	138.2	4.3	1.7	6.9	88.3	1.8	3.2	9.9	34.7	0.4	45.5	57.1	90.1	2.3	124.8	1.0	0.0	0.9	0.1	0.0	323.2	2.3	3.0	4.0	2.4	195.3	202.4	0.3	141.2	0.4	3.6	377.6	30.8	181.9	2.4	1.0	10.6	5.6	3.3	10.8	2.2	21.9	93.9	0.3	264.0	3.9	16.5	3.4	14.7	12.1	2.7	1.1	0.2	96.5	0.9	16.6	37.4	207.6	17.7	12.6	0.0	24.9	179.3	308.2	79.8	3.9	9.3	558.8	15.7	56.9	267.7	16.1	0.0	0.2	2.0	1.2	0.5	1.2	24.5	0.8	0.8	16.3	1.1	0.0	19.7	14.3	0.4	15.9	0.8	8.4	3.0	1.4	32.4	6.0	1.1	0.3	25.9	5.5	18.1	4.0	0.5	7.6	0.9	1.5	5.0	1.3	0.9	2.0	2.8	3.2	2.2	1.7	3.2	2.3	0.8	57.7	14.7	0.0	7.6	76.0	96.7	220.0	55.8	0.1	96.2	63.5	0.5	105.8	207.3	134.3	0.0	1254.0	1.4	477.6	25.4	429.4	0.8	63.3	14.2	6.9	147.3	4.8	0.5	255.1	105.1	10.4	106.5	155.6	10.2	1.9	0.4	0.5	135.4	0.0	0.5	169.4	221.8	10.0	23.8	1.1	3.7	19.8	14.2	0.0	68.6	0.0	0.0	0.0	0.0	309.8	375.2	0.0	2.1	135.7	514.5	44.2	46.6	0.3	0.0	0.1	12.6	0.6	5.9	93.2	87.9	1673.8	6.6	0.1	182.7	222.3
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1371.3;Syncytiotrophoblasts: 1413.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 852.5;CAPAN-2: 1219.1;OE19: 1500.4;RPTEC TERT1: 896.7;SK-BR-3: 789.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"		No	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	10.5	44.6	56.9	65.3	57.3	81.1	178.5	47.2	66.3	145.6	80.0	297.0	247.4	44.6	269.6	351.9	189.7	105.1	13.6	58.9	92.9	216.1	14.3	138.3	37.4	52.0	54.8	83.3	234.2	252.9	435.9	156.4	56.2	181.8	251.7	23.6	503.9	111.3	1.8	257.0	267.0	19.0	47.6	50.2	219.4	215.7	70.3	82.6	321.3	0.9	101.3	140.1	157.6	51.0	852.5	603.0	3.0	3.4	0.4	0.0	387.4	16.2	1.7	1.2	2.6	426.8	1219.1	6.7	65.8	4.6	1.2	274.6	42.7	587.0	1.4	7.9	51.7	159.4	15.3	0.9	0.9	1.5	0.8	0.1	662.5	0.7	278.6	71.5	2.0	144.2	4.0	0.4	1.0	652.8	25.6	2.8	60.4	1500.4	172.1	87.9	0.6	386.2	896.7	707.4	222.2	3.4	246.5	789.2	2.1	231.0	353.7	104.5	0.7	1.2	4.7	3.4	3.2	56.1	76.4	47.6	1.0	11.2	1.0	515.9	127.4	531.9	3.8	91.1	7.9	143.2	44.2	21.5	297.7	160.4	86.1	80.4	56.4	19.0	64.4	523.5	19.1	142.8	56.9	57.3	47.2	66.3	58.9	92.9	52.0	54.8	56.2	47.6	70.3	51.0	8.0	368.6	233.9	10.4	90.9	376.9	563.9	954.0	278.9	14.3	487.2	518.2	2.8	316.0	655.6	559.1	6.2	1371.3	79.5	1028.3	101.8	866.9	61.8	401.4	47.3	24.3	360.5	83.9	20.7	659.8	502.0	34.6	234.5	490.4	115.5	371.8	32.5	2.0	230.3	3.3	39.8	672.8	734.5	55.5	139.0	55.6	19.0	133.6	88.9	24.4	364.3	129.6	1.0	4.5	9.0	910.4	889.4	17.0	61.3	684.9	918.6	208.8	495.1	17.2	52.6	1.2	76.7	545.2	264.1	507.7	428.3	1413.2	42.6	3.4	582.2	989.6
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPOCK2	"KIAA0275, testican-2"	ENSG00000107742	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2"	Q92563	10	72059034-72089032	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 220.1;lymphoid tissue: 114.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 288.4;Bipolar cells: 116.5;dendritic cells: 86.4;Inhibitory neurons: 81.1;Microglial cells: 75.9;NK-cells: 90.6;T-cells: 195.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 117.5;MAIT T-cell: 198.8;memory CD4 T-cell: 115.9;memory CD8 T-cell: 93.5;naive CD4 T-cell: 87.8;naive CD8 T-cell: 89.4;T-reg: 174.3"	"Lineage enriched"	"Detected in all"	8	"T-cells: 198.8"	"Group enriched"	"Detected in some"	7	"Hep G2: 50.2;SCLC-21H: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044605	Enhanced				"Secreted to blood"	NA	NA		34000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA044605: AB_10965991"	"prognostic favorable (4.05e-4)"	"unprognostic (3.11e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.95e-5)"	"unprognostic (4.18e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (4.72e-4)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (4.53e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.24e-2)"	9.4	46.6	152.6	44.5	108.0	58.1	3.8	160.4	143.2	4.2	2.8	7.6	9.2	4.0	3.1	3.3	6.2	15.3	10.0	117.4	150.1	68.0	2.7	86.5	67.3	212.1	157.7	7.1	1.6	2.0	44.0	3.4	220.1	4.7	5.4	33.4	3.3	5.6	5.1	1.8	32.3	4.4	127.9	29.1	13.6	25.1	207.3	114.4	10.4	6.7	45.3	9.9	3.8	95.6	0.2	0.4	0.3	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	8.2	0.3	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.8	0.2	1.4	50.2	1.6	0.4	1.2	0.1	0.4	0.0	0.0	0.2	0.1	2.7	0.1	0.8	0.0	0.3	0.9	0.3	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.3	68.2	4.1	0.1	1.5	0.4	0.3	0.0	1.9	0.2	0.0	0.3	0.3	0.1	0.7	1.7	7.3	0.3	0.1	0.2	0.6	0.4	0.2	117.5	1.2	198.8	23.6	115.9	93.5	0.3	18.3	87.8	89.4	13.5	14.4	0.4	3.5	174.3	48.4	152.6	108.0	160.4	143.2	117.4	150.1	212.1	157.7	220.1	127.9	207.3	95.6	17.3	288.4	10.0	51.9	54.6	3.8	0.4	2.1	0.0	116.5	1.9	2.0	3.1	1.5	4.1	14.7	6.2	0.1	86.4	2.4	0.0	3.6	8.1	2.5	1.0	29.9	4.9	3.6	39.6	0.8	0.1	8.4	3.6	1.0	3.8	0.2	7.9	0.4	0.2	3.3	81.1	1.3	2.0	1.6	7.9	10.5	5.3	5.5	5.4	75.9	4.1	5.0	90.6	28.6	8.3	0.0	4.4	6.0	34.2	0.5	0.1	0.5	2.4	17.6	0.0	17.9	2.4	6.3	1.1	0.5	4.4	0.4	195.1	0.8	0.7	0.3
SPOCK3	testican-3	ENSG00000196104	"SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.9;parathyroid gland: 175.0;prostate: 73.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 1010.6;Oligodendrocyte precursor cells: 399.1;Oligodendrocytes: 1851.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 1.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.2;hTERT-RPE1: 6.5;PC-3: 2.7;RH-30: 7.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	0.3	24.7	51.4	0.6	87.2	0.1	0.3	73.0	97.3	0.9	18.7	0.9	0.8	2.9	18.8	0.2	1.1	0.3	0.3	48.4	63.8	0.2	0.4	0.4	0.5	83.2	64.9	17.4	0.7	175.0	0.3	0.0	79.4	73.9	0.5	14.3	0.3	34.9	0.2	0.0	1.3	2.8	72.8	0.4	0.7	0.5	68.4	0.3	0.2	24.0	0.3	1.7	0.2	143.9	0.0	1.6	0.2	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.4	0.1	0.2	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	6.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	2.7	0.0	7.1	0.4	0.0	1.1	2.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	51.4	87.2	73.0	97.3	48.4	63.8	83.2	64.9	79.4	72.8	68.4	143.9	0.0	0.0	0.0	12.7	0.1	0.0	1.5	8.1	0.0	43.7	0.0	0.0	1.6	0.0	10.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	15.0	0.0	0.2	1.6	0.0	1.3	106.7	0.0	0.1	15.7	2.0	0.0	1.3	3.2	0.0	0.0	0.1	15.2	1010.6	0.0	6.1	0.0	0.0	2.9	0.9	0.5	0.0	98.4	0.2	1.3	0.0	399.1	1851.1	0.1	0.0	0.4	0.0	3.3	0.0	0.1	6.7	6.3	0.0	0.0	2.5	0.5	0.7	0.0	0.0	0.1	0.0	55.4	0.0	0.8
SPOP	"BTBD32, TEF2"	ENSG00000121067	"Speckle type BTB/POZ protein"	O43791	17	49598884-49678163	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.83e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (1.89e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.29e-1)"	32.3	26.8	33.4	28.7	37.6	13.6	30.2	49.8	39.8	45.7	35.9	92.2	27.4	50.1	35.8	56.9	42.2	29.8	41.0	36.1	37.3	29.5	37.1	33.1	38.9	33.1	34.0	40.9	25.1	30.9	22.7	32.5	34.6	64.8	39.2	38.2	32.8	81.7	57.2	26.5	34.0	77.8	31.8	32.8	35.0	17.0	38.4	43.6	35.2	52.4	42.8	46.7	30.6	42.8	33.7	30.9	40.9	18.3	49.0	51.8	28.0	44.1	47.6	57.6	62.8	71.1	36.8	56.4	84.2	41.3	38.5	29.2	49.3	29.1	68.8	111.4	57.6	70.6	38.9	47.8	54.6	45.9	50.3	39.0	41.4	42.9	46.2	43.1	60.9	39.6	73.3	54.2	42.4	33.3	79.2	44.0	11.4	80.9	46.3	48.8	64.5	79.9	32.9	21.0	65.2	26.7	29.7	14.1	37.2	22.5	54.2	45.8	55.4	65.9	41.0	49.9	39.5	52.3	51.7	50.6	37.6	41.0	32.9	145.3	71.2	93.0	61.3	68.7	59.8	76.4	66.0	68.9	91.8	80.2	98.2	78.9	107.9	74.9	88.8	67.9	63.9	92.4	33.4	37.6	49.8	39.8	36.1	37.3	33.1	34.0	34.6	31.8	38.4	42.8	54.5	48.1	41.6	80.6	59.2	42.8	36.2	26.7	34.7	72.7	44.5	38.7	51.6	35.8	30.4	29.5	43.8	23.3	47.3	25.9	29.4	36.5	24.4	30.3	38.8	57.5	51.5	53.2	50.5	28.2	23.3	55.9	18.8	28.4	31.0	39.2	66.8	47.3	38.5	75.7	50.1	46.2	30.5	62.2	59.4	8.9	56.2	49.0	39.2	45.9	67.7	100.2	33.0	54.3	49.3	25.6	30.5	73.4	61.4	30.6	40.1	29.6	32.4	58.7	72.3	37.1	59.2	36.6	45.8	28.2	43.9	36.1	46.7	50.1	33.3	22.8
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66682497-66729226	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.6;skin 1: 85.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Cone photoreceptor cells: 104.3;Early spermatids: 30.9;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 45.6;NTERA-2: 49.1;SCLC-21H: 49.9;SK-BR-3: 52.3;T-47d: 67.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cytosol"	Vesicles	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	1.3	14.4	26.8	1.0	32.6	2.3	7.7	29.7	73.6	14.3	0.0	0.9	0.9	1.7	1.2	39.8	3.7	1.7	1.4	38.8	0.3	37.5	23.3	1.1	0.2	4.8	0.9	0.9	16.7	13.1	16.4	0.4	3.2	12.4	0.7	14.7	29.6	4.7	0.5	85.5	1.0	1.1	0.0	0.9	2.9	52.8	4.6	1.0	0.3	0.1	6.7	1.6	16.5	24.2	20.5	7.4	3.4	0.3	0.1	0.0	0.6	0.3	0.1	0.1	0.0	4.8	28.2	0.2	3.7	0.0	0.7	16.9	25.2	2.4	0.0	0.1	10.4	0.1	45.6	3.0	0.8	7.3	0.6	0.2	11.5	0.0	7.4	4.2	6.3	5.2	7.3	0.1	0.1	35.2	6.3	3.5	49.1	28.7	21.1	23.8	2.8	14.7	9.6	4.8	49.9	29.4	14.0	52.3	3.2	2.7	67.2	2.4	1.4	0.1	8.6	1.3	11.5	0.7	3.0	14.7	0.1	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	26.8	32.6	29.7	73.6	38.8	0.3	4.8	0.9	3.2	0.0	4.6	24.2	0.7	3.2	1.1	4.9	0.3	3.7	2.7	3.2	2.8	11.0	4.7	4.6	1.8	1.5	4.6	86.5	104.3	0.9	0.0	0.6	0.0	2.6	30.9	3.6	1.8	1.1	3.0	7.2	29.3	10.0	0.3	0.8	1.5	3.6	0.0	1.4	1.4	24.7	0.1	0.0	20.7	1.6	0.0	0.3	0.7	77.6	1.8	0.1	0.0	2.8	0.6	1.6	0.0	7.5	4.6	7.5	0.2	1.5	0.8	3.2	0.2	1.3	3.5	21.3	0.0	0.2	0.5	8.5	9.4	14.6	12.5	0.3	0.2	0.1	0.8	1.7
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526296-21541249	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 111.4"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 86.1;Proximal tubular cells: 202.2"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 17.5;HBEC3-KT: 8.9;hTERT-HME1: 12.4;SuSa: 14.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 17.1;hippocampal formation: 17.9;olfactory bulb: 7.5;pons: 8.0"						"Secreted to blood"	NA	NA	2650000			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	111.4	0.1	8.7	0.1	9.2	0.4	4.1	8.6	24.2	0.0	7.2	0.1	0.0	1.3	0.6	0.2	0.2	0.1	2.8	8.1	11.5	26.4	2.3	0.6	0.2	8.6	13.9	0.0	20.7	0.4	0.0	17.7	26.6	0.0	0.0	1.7	6.9	0.5	2.0	0.0	0.3	0.1	8.0	0.4	0.5	0.2	9.6	3.0	20.2	8.8	0.1	0.0	0.0	9.9	0.0	0.5	0.8	0.0	3.0	1.2	0.0	0.0	0.1	0.1	1.2	17.5	0.0	0.7	0.3	0.0	0.3	0.0	0.0	8.9	1.6	0.0	0.0	4.7	0.0	0.1	1.8	0.0	0.0	5.7	0.9	0.3	12.4	0.2	0.0	0.1	0.1	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.7	0.0	2.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	1.7	14.6	0.0	0.2	0.3	0.0	5.3	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.7	9.2	8.6	24.2	8.1	11.5	8.6	13.9	26.6	8.0	9.6	9.9	1.4	0.0	0.0	1.3	1.3	0.0	0.1	0.0	0.0	3.0	0.7	0.9	28.9	0.0	0.0	25.8	0.0	0.0	0.1	0.0	86.1	0.4	0.0	0.5	0.3	0.6	0.0	0.0	0.0	19.1	0.0	1.7	0.0	2.5	0.0	0.0	0.7	0.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	13.7	0.0	0.0	1.2	4.9	4.1	0.0	0.1	2.5	0.0	0.0	0.0	0.1	0.0	202.2	0.0	0.5	0.0	2.4	0.9	0.0	1.8	0.0	0.0	0.4	1.0	0.1	0.0	0.1
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530031-38605952	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.3;Horizontal cells: 102.6;Inhibitory neurons: 58.5;Oligodendrocytes: 261.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"		"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.76e-4)"	1.9	1.3	11.1	0.1	32.1	0.2	3.1	22.1	29.9	2.1	0.0	4.2	0.6	1.0	0.6	2.2	3.0	0.0	2.1	13.6	14.1	1.6	13.9	1.2	0.2	36.4	28.8	0.5	6.6	2.4	15.5	0.2	33.7	2.3	0.2	0.4	7.8	0.8	0.5	6.1	1.4	0.1	13.8	0.6	2.1	1.4	29.9	0.1	0.7	0.0	0.0	1.7	1.1	66.2	0.4	0.4	0.6	2.7	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.4	1.1	0.9	0.0	0.7	1.0	1.2	0.2	0.1	1.1	1.2	0.0	0.5	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.5	0.1	3.9	0.0	2.4	0.0	0.0	1.5	0.5	0.0	0.1	0.0	0.1	0.4	1.7	18.0	2.0	0.0	1.0	0.7	0.6	1.8	0.4	0.0	0.0	1.2	0.0	0.0	0.8	0.2	0.0	0.1	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	32.1	22.1	29.9	13.6	14.1	36.4	28.8	33.7	13.8	29.9	66.2	0.4	0.0	1.1	5.5	0.3	0.8	1.0	0.3	0.6	31.5	6.1	5.1	2.9	21.5	0.3	3.7	0.0	0.1	0.3	0.7	0.0	2.7	0.2	9.0	1.0	0.6	9.7	0.0	66.3	0.2	0.1	0.9	0.0	0.9	0.0	2.7	0.4	12.6	0.4	102.6	58.5	1.8	2.0	0.0	0.4	0.6	0.6	0.1	0.0	3.7	0.0	1.8	0.0	6.6	261.8	0.3	0.3	0.4	0.1	1.4	0.6	0.2	5.3	3.4	0.0	0.4	0.5	0.9	2.1	0.8	0.9	0.1	0.2	0.0	1.5	1.6
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
SRRM4	"KIAA1853, nSR100"	ENSG00000139767	"Serine/arginine repetitive matrix 4"	A7MD48	12	118981541-119163051	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 18.3;retina: 29.1"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 330.4;Cone photoreceptor cells: 429.5;Excitatory neurons: 182.0;Inhibitory neurons: 322.2;Rod photoreceptor cells: 372.4"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 4.4;SCLC-21H: 3.9;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052783	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA052783: AB_2681945"	"unprognostic (2.44e-2)"	"unprognostic (2.66e-1)"		"unprognostic (2.40e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"		"unprognostic (1.37e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.61e-5)"	"unprognostic (1.10e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.61e-1)"	0.0	1.1	7.1	0.0	10.4	0.1	0.0	16.4	18.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	29.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.3	0.0	0.1	0.1	0.0	0.0	0.0	6.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	10.4	16.4	18.3	8.8	0.1	0.0	0.1	0.1	0.0	1.3	6.4	0.0	6.4	0.0	3.6	0.0	0.0	0.1	0.0	0.0	330.4	0.0	0.0	9.9	0.0	0.6	0.0	429.5	0.8	0.0	0.0	0.0	0.0	5.6	10.6	0.9	1.5	0.0	0.0	182.0	0.0	0.3	0.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	28.6	322.2	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	9.4	0.0	12.1	0.0	5.5	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	372.4	6.6	0.2	1.0	0.2	1.2	0.0	0.0	2.3	0.1	0.0	0.0	0.1
SSTR4		ENSG00000132671	"Somatostatin receptor 4"	P31391	20	23035312-23039237	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"brain: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064252	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"					"HPA064252: AB_2685227"																		0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.8	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
ST3GAL6	"SIAT10, ST3GALVI"	ENSG00000064225	"ST3 beta-galactoside alpha-2,3-sialyltransferase 6"	Q9Y274	3	98732236-98821201	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.0"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 128.8;Hepatocytes: 86.8;Microglial cells: 134.0;Oligodendrocyte precursor cells: 171.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 49.6;neutrophil: 57.6"	"Group enriched"	"Detected in many"	143	"dendritic cells: 24.2;granulocytes: 57.6;monocytes: 17.4"	"Group enriched"	"Detected in many"	4	"RPMI-8226: 96.5;SK-MEL-30: 114.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018792	Approved					NA	NA		5800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA018792: AB_10964349"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (4.17e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.32e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (9.47e-3)"	"unprognostic (6.79e-4)"	14.6	7.9	8.2	3.8	8.9	2.4	6.3	14.0	9.9	4.8	3.0	3.8	2.0	2.2	12.0	1.9	6.3	2.2	26.5	9.3	8.5	14.0	56.0	7.8	1.6	19.5	10.1	1.2	3.5	1.1	4.1	8.5	14.3	3.3	2.7	1.5	19.5	2.0	7.9	16.7	1.9	2.0	14.8	3.2	4.5	1.6	9.2	10.6	2.9	6.4	2.8	1.6	1.4	13.1	0.3	1.3	1.8	2.7	3.3	1.1	12.5	0.4	1.5	1.2	2.2	8.7	0.5	6.4	3.3	0.0	4.6	2.1	3.9	2.0	1.1	0.0	2.7	0.2	0.6	15.1	14.0	13.2	23.7	1.5	0.1	3.5	6.6	22.4	14.2	2.6	0.0	6.3	1.3	0.0	2.1	22.6	3.5	0.0	3.5	1.3	1.5	96.5	3.4	0.0	3.8	19.2	5.1	0.5	114.2	3.6	0.4	23.1	10.8	2.9	2.4	0.8	1.3	24.1	2.0	0.0	4.6	18.6	10.3	18.5	17.4	49.6	0.0	9.6	0.0	0.1	0.0	0.0	24.2	0.0	0.2	0.0	57.6	0.1	4.9	5.5	0.0	4.7	8.2	8.9	14.0	9.9	9.3	8.5	19.5	10.1	14.3	14.8	9.2	13.1	10.1	12.8	35.2	2.3	2.3	11.5	2.6	7.0	2.2	1.2	6.4	5.7	40.4	2.8	2.8	3.7	8.4	45.2	0.0	0.0	13.7	6.8	0.3	128.8	4.2	20.2	16.1	6.6	78.5	2.0	69.5	3.8	9.2	41.0	39.1	1.8	32.5	86.8	34.4	0.0	64.2	0.1	30.5	29.5	64.2	1.0	2.8	38.4	65.8	134.0	38.0	0.9	0.0	171.4	51.6	6.2	0.1	6.8	18.0	5.2	0.0	10.0	27.5	3.5	6.6	1.7	2.2	0.1	1.0	2.1	12.8	27.0	2.0	0.3	0.3	1.8
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643786	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.1;intestine: 195.9;stomach 1: 64.9"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 801.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 8.9;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	32	"T-cells: 8.9"	"Group enriched"	"Detected in some"	4	"K-562: 65.5;OE19: 107.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		3500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"	Nucleoplasm	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.9	0.1	6.0	12.6	5.6	2.8	2.0	5.7	9.2	61.1	4.5	155.3	62.5	5.1	3.9	24.4	3.8	18.3	3.4	5.5	6.0	0.4	0.1	5.7	1.2	6.1	6.0	0.8	0.7	0.1	0.0	2.1	6.4	6.9	195.9	1.0	26.3	0.5	1.4	0.9	75.8	5.4	5.8	14.6	64.9	3.1	6.1	0.2	0.3	0.9	2.3	3.1	4.5	5.6	0.2	2.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.2	11.9	0.0	0.0	12.4	0.0	2.9	0.0	0.0	0.0	19.5	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	65.5	0.0	0.0	0.0	0.2	0.2	0.0	107.5	0.4	0.0	0.0	0.4	0.1	0.7	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.3	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.9	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	1.3	0.9	6.0	5.6	5.7	9.2	5.5	6.0	6.1	6.0	6.4	5.8	6.1	5.6	8.6	16.0	7.5	0.7	0.3	0.1	5.7	90.2	12.0	0.1	0.1	0.0	2.0	17.2	143.4	0.0	0.0	0.3	0.0	133.3	0.0	1.4	0.3	85.1	7.6	27.2	33.0	6.7	0.4	18.2	0.1	1.3	65.7	77.6	0.0	0.3	8.6	0.0	0.3	0.0	0.3	801.0	50.8	0.0	0.0	0.9	1.5	1.1	0.0	18.7	0.0	0.0	0.0	1.5	0.3	42.8	76.1	0.0	0.0	2.4	51.6	0.0	117.4	1.2	0.0	0.3	5.3	0.4	0.1	12.8	0.1	0.1	1.8	63.3	123.1	24.5
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565377-76586956	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 501.1;Late spermatids: 1763.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 22.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"neutrophil: 47.0"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 47.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.4;HaCaT: 33.8;HBEC3-KT: 28.5;hTCEpi: 73.1;MCF7: 36.4;SK-MEL-30: 112.5;T-47d: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	5.6	2.9	1.0	1.9	1.1	1.0	12.2	1.2	1.4	14.9	33.0	13.8	1.0	4.8	10.3	16.4	50.5	1.9	4.5	2.0	1.6	9.6	1.2	17.5	0.6	5.4	6.7	1.2	6.3	7.5	2.1	6.0	4.1	11.1	6.0	52.8	11.3	10.2	18.3	51.6	4.8	2.3	4.2	3.7	7.1	33.9	2.6	1.5	25.2	18.5	4.8	9.5	14.5	2.7	2.6	0.0	0.0	0.0	0.5	0.0	25.4	0.0	0.6	0.0	0.0	0.0	2.1	0.0	0.5	1.7	0.1	33.8	0.3	28.5	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.0	73.1	0.1	9.0	3.8	0.1	0.0	0.0	0.0	0.4	36.4	0.0	0.0	0.0	0.9	1.0	0.0	0.0	0.0	0.0	9.8	0.5	0.0	4.1	0.1	112.5	1.3	23.4	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	2.9	5.2	0.0	1.8	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	47.0	0.2	0.4	0.0	0.0	0.4	1.0	1.1	1.2	1.4	2.0	1.6	5.4	6.7	4.1	4.2	2.6	2.7	0.2	0.0	1.5	2.6	0.8	32.9	44.0	104.2	23.9	7.9	0.4	1.5	5.1	7.2	21.0	0.0	27.1	12.5	0.0	2.4	0.0	0.3	501.1	4.5	1.1	3.9	0.0	0.0	0.5	0.0	21.1	2.0	4.6	0.6	1.3	0.0	7.9	1.5	3.0	0.0	1.3	4.8	8.2	5.0	6.9	1763.3	7.5	3.8	65.8	1.0	2.7	84.9	0.0	0.0	0.2	0.1	0.5	7.2	0.2	15.2	0.7	0.5	39.3	79.7	19.7	7.3	3.4	7.6	4.6	28.8	30.3	10.5	2.2	0.0	1.6	37.6
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57352557-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.7;pituitary gland: 8.1;retina: 7.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA063398: AB_2685004, HPA066783: AB_2685721"					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.0	4.3	8.0	0.0	21.7	0.0	0.0	6.7	15.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	12.5	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	8.1	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	21.7	6.7	15.6	12.5	14.5	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	1.6	5.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	63.9	56.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	1.2	0.0	22.1	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558727-67607337	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 51.0"	"Group enriched"	"Detected in some"	5	"B-cells: 60.8;granulocytes: 80.8;Ionocytes: 65.1;Plasma cells: 147.2"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 88.1;naive B-cell: 107.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 185.4;U-698: 83.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.3"	"Low region specificity"	"Detected in all"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Vesicles"		"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.4	0.1	0.0	15.5	0.0	5.8	0.8	0.0	0.0	0.3	0.0	2.3	1.8	0.6	1.9	0.7	0.1	1.4	0.2	0.5	0.0	9.2	0.4	1.4	40.8	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	2.3	0.0	1.3	2.8	0.1	0.1	8.1	0.4	0.0	16.0	2.3	2.7	0.0	6.4	0.4	0.0	51.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	83.2	0.0	24.7	0.0	5.3	0.1	24.3	0.9	0.1	1.9	88.1	2.0	0.8	1.2	107.8	7.9	0.2	1.0	38.9	0.1	5.2	0.4	4.7	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	60.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	5.5	0.0	0.0	5.8	0.0	9.8	0.0	13.0	0.1	0.0	0.6	0.0	2.5	0.3	0.0	0.0	0.1	0.0	0.0	80.8	0.0	0.4	0.0	0.8	0.0	0.2	0.1	65.1	0.3	0.7	7.1	0.3	1.2	16.0	0.0	0.2	0.0	6.2	0.0	0.3	0.0	0.0	0.4	147.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.1	0.0	4.3	0.1	0.0	0.2
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 294.5;Paneth cells: 343.4;Proximal enterocytes: 415.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 7.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.2;NK-cells: 7.9;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A-431: 87.3;HaCaT: 70.3;MCF7: 104.3;RT4: 138.1"	"Region enriched"	"Detected in many"	13	"cerebellum: 20.5"	"Low region specificity"	"Detected in some"			"HPA002375, HPA027761"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favorable (4.13e-4)"	5.6	18.1	2.6	7.5	2.7	0.4	16.6	3.6	4.2	18.1	3.5	72.8	77.5	5.7	10.6	91.0	15.1	7.1	4.9	2.7	2.4	28.5	55.3	8.2	3.2	2.4	2.2	11.5	30.6	21.3	4.4	3.4	2.7	37.9	59.7	0.5	45.4	9.8	1.2	73.9	72.0	4.0	2.0	1.5	24.2	2.0	2.5	7.9	15.3	0.7	13.0	16.5	41.0	2.6	87.3	0.4	6.2	5.8	0.4	4.7	35.7	1.6	8.8	2.8	2.2	52.0	34.8	0.1	13.3	2.8	17.9	70.3	1.1	50.3	1.6	14.9	0.7	0.3	0.4	35.1	10.9	0.1	0.7	3.5	41.7	4.8	12.2	7.0	8.9	2.1	3.4	18.6	1.3	104.3	1.3	0.7	4.8	55.3	20.4	3.6	0.8	2.2	29.4	138.1	2.1	3.5	0.1	25.9	14.6	2.2	60.7	0.3	12.5	0.2	1.2	0.7	1.8	0.1	1.4	1.3	0.3	0.4	5.7	0.4	0.1	0.0	0.6	0.0	2.3	0.6	0.8	0.1	0.7	0.1	2.3	1.4	0.1	7.9	0.0	2.2	2.5	0.8	2.6	2.7	3.6	4.2	2.7	2.4	2.4	2.2	2.7	2.0	2.5	2.6	6.7	9.6	14.4	0.3	2.4	40.5	59.8	171.4	42.7	0.6	33.8	30.1	6.9	38.6	87.2	29.5	0.0	16.9	2.3	294.5	25.4	137.5	1.2	9.0	3.6	10.1	85.8	4.4	1.5	101.0	3.0	4.5	55.5	13.4	8.9	5.2	7.5	29.6	1.8	0.0	1.2	147.5	91.6	4.1	9.4	0.9	4.7	1.8	19.6	0.0	12.5	1.0	1.0	0.5	1.8	139.4	343.4	1.9	1.4	92.6	415.7	125.0	44.9	0.8	0.0	1.7	7.9	0.6	2.6	86.0	61.8	12.4	3.3	5.7	173.2	117.0
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388540	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		55000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: AB_2665663, CAB068242: AB_2665662, HPA001671: AB_1080102, HPA058603: AB_2683772"	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	105.6	68.1	32.4	78.5	34.5	63.2	84.4	38.7	30.2	62.6	32.4	76.9	45.9	71.6	28.2	81.6	74.0	71.7	101.2	28.6	44.6	77.2	143.1	106.0	55.3	48.4	40.7	65.4	67.3	35.3	53.3	55.6	43.4	62.9	46.5	29.9	63.5	48.2	123.9	66.8	68.1	72.1	43.9	68.0	62.3	24.6	43.0	50.5	61.9	92.1	65.2	88.6	64.3	43.1	61.5	116.0	47.4	48.2	103.7	97.6	35.4	66.5	89.7	59.6	58.3	30.3	55.8	18.5	68.2	71.2	90.3	89.2	45.8	72.6	47.7	160.6	31.4	131.2	60.4	62.4	77.3	31.8	79.0	152.1	69.8	47.4	68.9	62.2	81.1	33.4	80.1	56.4	40.1	43.8	118.7	31.3	28.5	63.4	0.0	26.6	133.8	28.1	91.3	77.2	45.2	29.8	81.4	184.9	29.2	57.2	100.5	49.1	68.7	88.9	44.9	54.8	56.5	82.9	75.3	16.4	56.1	32.8	41.6	121.1	78.4	100.0	79.5	79.9	64.4	40.2	57.5	62.6	54.3	36.6	58.7	56.5	262.6	58.3	80.8	29.3	47.9	124.5	32.4	34.5	38.7	30.2	28.6	44.6	48.4	40.7	43.4	43.9	43.0	43.1	216.0	93.0	173.7	46.0	111.6	129.5	105.3	76.8	138.3	92.6	147.1	113.0	59.7	54.3	103.2	134.3	281.5	25.2	115.1	148.9	17.6	83.2	33.5	129.3	187.0	164.7	124.0	54.3	24.2	96.8	38.2	154.0	109.1	153.9	142.0	86.3	115.3	115.7	69.1	25.2	35.8	97.8	69.2	71.0	121.7	13.7	71.7	111.7	72.9	51.5	94.1	131.3	78.2	30.7	41.7	82.9	94.5	60.9	104.6	147.9	206.4	46.3	88.5	406.7	65.7	189.5	169.7	31.5	15.3	93.4	160.1	31.2	170.2	102.3	117.5	90.6
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	9.1	6.3	4.3	3.9	3.7	16.9	14.5	7.1	4.6	16.7	10.6	9.5	22.1	3.6	5.3	15.8	7.7	2.3	9.5	7.0	7.5	6.9	189.5	9.1	0.9	14.4	9.4	4.4	27.1	78.9	13.8	11.3	12.8	11.8	6.9	0.7	34.3	7.5	29.9	9.0	10.9	3.1	7.6	1.8	22.5	1.9	7.2	2.2	5.4	12.5	3.1	7.0	7.2	12.7	21.8	25.6	0.0	8.7	12.1	112.9	22.1	6.8	7.4	13.1	11.8	19.5	29.0	0.1	49.9	38.5	94.1	35.9	11.1	22.4	14.9	0.1	35.9	42.1	22.2	38.8	30.0	10.5	7.7	67.3	38.7	78.0	27.7	89.8	11.4	0.0	20.9	4.2	37.6	20.6	0.1	6.2	34.2	33.3	52.7	0.2	14.7	18.5	16.2	54.1	41.9	7.7	18.8	64.1	4.9	4.9	12.7	13.7	49.6	81.2	46.8	17.4	37.4	0.1	0.1	0.2	149.1	26.2	17.2	0.0	2.4	0.4	0.1	2.7	0.0	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.4	0.2	0.0	1.0	4.3	3.7	7.1	4.6	7.0	7.5	14.4	9.4	12.8	7.6	7.2	12.7	9.1	0.0	7.9	2.3	1.0	2.0	7.4	11.9	8.0	0.6	15.5	10.7	6.2	2.8	16.2	0.0	0.0	33.3	0.2	12.2	0.0	8.1	0.2	8.1	1.9	6.2	1.8	29.5	1.3	36.2	4.1	3.6	23.4	5.7	3.8	3.5	1.4	91.6	10.9	0.0	1.0	6.0	8.2	5.9	3.8	0.7	1.8	6.1	0.0	1.9	1.4	0.1	0.0	0.5	0.0	20.8	7.7	7.5	0.1	8.3	11.8	1.5	36.1	0.1	6.6	4.1	3.3	0.6	0.2	19.5	1.4	23.7	0.4	13.1	11.6	8.9
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STING1	"ERIS, FLJ38577, MITA, MPYS, NET23, STING, TMEM173"	ENSG00000184584	"Stimulator of interferon response cGAMP interactor 1"	Q86WV6	5	139475533-139482935	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 25.3;Cardiomyocytes: 27.7;dendritic cells: 17.0;Hofbauer cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 64.4;EFO-21: 83.8;HDLM-2: 200.5;THP-1: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038116, HPA038534"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"HPA038116: AB_2675841, HPA038534: AB_2676067"	"unprognostic (1.45e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.59e-8)"	"unprognostic (9.18e-3)"	"unprognostic (4.14e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.34e-1)"	38.9	9.3	4.6	18.4	5.0	16.9	26.2	4.4	5.4	32.6	12.8	16.6	6.7	25.0	6.8	21.5	36.2	11.9	35.7	4.3	4.9	17.3	5.5	48.1	15.0	5.5	4.9	21.9	5.4	3.3	11.8	12.9	5.1	20.7	11.6	0.3	24.5	15.5	7.5	15.5	19.0	18.7	5.3	37.8	11.6	3.1	6.0	12.4	20.2	8.5	27.1	21.7	28.4	4.8	2.9	0.7	0.2	0.0	4.0	12.0	0.2	15.3	64.4	7.6	24.4	0.0	18.8	0.0	83.8	49.0	1.9	10.8	0.4	22.9	4.8	200.5	3.3	13.5	6.6	0.8	7.5	4.1	0.8	16.2	1.2	4.6	5.7	12.8	27.8	1.4	3.9	58.3	33.6	0.0	2.2	24.1	0.1	0.8	4.7	0.7	6.1	18.0	9.4	7.0	5.8	0.0	6.5	5.3	16.0	0.6	0.7	73.3	17.2	1.9	1.3	6.8	5.6	0.0	20.0	0.1	0.3	56.2	11.3	16.6	60.9	0.1	56.9	40.0	29.3	0.6	57.4	47.8	55.6	0.3	40.3	35.0	5.0	90.6	17.5	19.2	65.3	60.6	4.6	5.0	4.4	5.4	4.3	4.9	5.5	4.9	5.1	5.3	6.0	4.8	25.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.8	17.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	1.8	5.8	0.0	0.0	0.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042079-172188224	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.5;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 107.7;Kupffer cells: 91.4;NK-cells: 171.0;T-cells: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		16000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: AB_2669151"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	14.9	5.7	3.1	37.1	3.6	76.5	11.4	18.4	5.6	4.5	3.5	8.5	8.4	4.9	1.7	5.6	4.7	13.2	7.6	3.1	4.0	5.9	6.2	18.4	44.1	6.2	4.4	2.5	7.2	3.1	4.1	17.2	5.8	4.4	6.9	1.2	4.7	3.5	5.0	14.2	16.0	7.8	5.4	45.2	11.1	14.0	6.4	20.6	5.3	5.5	25.0	14.9	5.2	7.0	22.2	20.2	12.7	18.8	14.7	18.1	31.5	28.4	24.0	20.2	18.9	10.6	28.6	26.8	14.6	35.6	42.3	25.4	5.7	35.1	13.5	35.0	9.3	32.1	8.2	6.1	20.2	32.7	36.4	17.4	7.5	27.4	23.1	7.5	18.3	10.4	3.0	36.2	14.7	35.7	23.5	73.4	5.0	11.3	16.1	38.2	9.9	17.7	8.2	27.6	8.3	10.2	16.4	22.5	77.9	15.6	8.2	68.7	24.8	22.3	11.3	15.8	15.5	30.2	48.4	17.1	29.4	49.8	143.3	16.7	26.5	23.4	36.5	46.3	26.9	10.0	19.3	26.3	22.5	8.1	11.0	20.0	48.9	16.9	71.8	7.1	26.7	44.0	3.1	3.6	18.4	5.6	3.1	4.0	6.2	4.4	5.8	5.4	6.4	7.0	35.8	3.2	11.2	1.6	40.5	6.6	8.4	7.2	5.7	4.3	3.3	3.7	3.8	5.7	6.1	1.8	6.2	4.1	107.7	11.8	1.9	4.5	2.5	3.5	4.6	23.9	12.0	11.8	8.5	6.2	27.2	9.3	20.9	7.1	28.4	3.6	18.2	2.3	36.3	47.1	7.9	19.9	2.0	91.4	43.8	3.2	2.8	61.3	8.8	32.8	49.8	2.1	171.0	10.1	14.4	10.7	11.8	1.5	42.8	11.7	6.5	2.0	6.1	2.2	13.1	5.1	10.2	5.3	7.8	2.6	4.1	5.1	81.4	11.4	5.3	10.7
STK32A	"MGC22688, YANK1"	ENSG00000169302	"Serine/threonine kinase 32A"	Q8WU08	5	147234963-147387855	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.2;brain: 24.4"	"Cell type enriched"	"Detected in many"	19	"Oligodendrocyte precursor cells: 306.6"	"Group enriched"	"Detected in many"	5	"glioma: 4.3;melanoma: 11.9;thyroid cancer: 9.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RT4: 13.6;SK-MEL-30: 48.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040236			Approved	Centrosome		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Centrosome		"HPA040236: AB_10795416"	"unprognostic (1.90e-1)"	"unprognostic (4.71e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.87e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.50e-3)"	"unprognostic (5.53e-5)"	"unprognostic (2.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.67e-3)"	1.3	11.2	5.9	0.6	9.5	0.0	1.2	13.2	3.1	1.0	1.0	2.3	0.5	0.5	2.6	0.3	0.8	1.5	1.0	3.5	14.4	3.4	0.1	1.2	0.0	11.7	24.4	2.5	2.6	0.1	8.1	0.1	17.0	1.0	0.3	2.6	0.9	0.8	0.2	3.7	0.7	0.4	10.4	0.3	1.2	1.0	14.0	0.1	8.7	0.5	0.0	1.7	1.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.2	4.4	13.6	1.2	0.5	0.0	0.0	48.6	0.2	0.0	0.0	0.1	0.0	0.5	0.7	0.4	1.0	0.2	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	9.5	13.2	3.1	3.5	14.4	11.7	24.4	17.0	10.4	14.0	10.1	0.2	0.0	2.6	8.5	0.0	1.5	0.2	1.4	0.0	1.8	1.3	0.5	0.5	0.0	1.0	1.8	0.0	0.0	0.0	0.1	1.9	1.8	6.9	0.2	0.5	0.1	0.0	0.0	4.6	2.7	0.0	2.7	0.0	0.7	0.0	4.2	0.0	0.0	0.1	0.0	5.2	0.0	2.0	0.0	1.0	10.5	0.9	0.2	16.0	0.0	0.0	4.0	0.0	306.6	0.7	5.5	0.0	4.1	0.0	0.3	0.0	4.1	0.2	1.0	0.0	5.4	0.5	0.0	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.6
STMN2	"SCG10, SCGN10"	ENSG00000104435	"Stathmin 2"	Q93045	8	79611117-79666158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 524.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 182.2;Horizontal cells: 148.0;Inhibitory neurons: 133.0;Rod photoreceptor cells: 53.4"	"Group enriched"	"Detected in many"	5	"glioma: 26.1;pancreatic cancer: 10.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 2.2"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 663.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026922			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Endoplasmic reticulum"	"HPA026922: AB_1857605"	"unprognostic (4.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.20e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-13)"	"unprognostic (1.14e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.77e-3)"	"unprognostic (9.59e-2)"	5.8	68.6	161.3	9.6	148.3	0.1	2.8	162.9	524.1	8.4	0.0	22.0	13.9	1.1	0.0	1.0	0.1	3.5	1.0	135.7	343.1	0.2	0.9	0.3	0.7	213.6	140.1	0.5	4.7	0.0	8.9	0.1	257.5	2.6	28.9	87.0	0.9	1.7	0.3	11.5	18.5	6.3	60.9	4.5	5.4	1.9	148.2	0.3	0.2	0.3	1.4	0.4	5.0	165.0	0.0	0.0	5.6	0.0	0.9	0.2	0.3	72.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	59.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	64.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	60.5	663.5	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	161.3	148.3	162.9	524.1	135.7	343.1	213.6	140.1	257.5	60.9	148.2	165.0	0.1	0.0	0.0	26.1	0.0	1.0	0.0	0.0	0.0	27.8	0.0	0.3	0.1	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	18.2	0.0	1.5	1.4	24.9	0.0	182.2	0.0	0.5	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	148.0	133.0	0.0	0.0	0.0	2.0	8.2	0.3	0.0	1.8	19.7	0.0	16.3	0.0	19.1	23.5	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	53.4	0.0	0.0	0.6	0.5	0.7	0.0	0.9	0.0	0.1	0.0	0.0	0.5
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 333.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 45.6;Horizontal cells: 92.5;Oligodendrocyte precursor cells: 27.6;Oligodendrocytes: 217.4"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	0.3	10.2	128.0	0.2	147.2	0.1	0.2	154.9	333.3	0.5	66.3	4.3	0.6	0.4	0.9	0.1	0.3	0.2	0.1	148.1	150.9	0.1	0.1	0.1	0.0	185.1	152.3	0.2	0.1	0.0	1.1	0.0	184.4	0.5	1.4	21.4	0.1	0.2	0.2	0.4	1.6	0.6	151.1	0.0	0.9	0.6	150.9	0.0	0.1	0.0	0.0	0.6	0.6	265.7	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	86.8	3.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.0	147.2	154.9	333.3	148.1	150.9	185.1	152.3	184.4	151.1	150.9	265.7	0.1	0.0	0.0	4.6	0.0	0.4	0.1	0.0	0.0	45.6	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	21.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	92.5	18.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.6	0.0	9.7	0.0	27.6	217.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.8	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014365-94028597	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.3;intestine: 13.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0"	"Not detected"	"Not detected"							HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.1	0.0	0.3	1.7	0.5	0.0	5.4	0.4	0.6	2.8	3.7	13.0	7.6	0.8	16.3	6.0	1.4	1.8	0.1	0.3	0.2	0.4	0.1	4.0	0.0	0.3	0.6	0.1	6.7	4.6	0.1	0.1	0.2	3.9	13.4	1.2	8.8	0.1	0.1	9.1	8.1	0.3	0.1	0.4	7.3	0.2	0.2	0.2	0.1	0.0	1.2	0.2	2.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	4.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.6	0.3	0.2	0.3	0.6	0.2	0.1	0.2	0.3	0.4	16.0	15.9	1.0	0.2	1.7	2.2	6.4	2.8	3.0	5.6	3.7	0.1	0.0	9.9	0.0	12.5	0.2	0.1	39.4	1.9	4.4	1.9	15.9	2.1	0.2	0.0	0.0	3.9	8.2	0.0	0.1	10.2	19.7	0.0	0.1	0.0	0.0	0.2	0.0	2.4	31.7	10.2	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.5	0.0	1.0	1.6	7.1	38.0	0.7	0.0	1.5	19.2	0.1	16.1	14.8	0.0	1.0	0.5	0.2	0.1	2.7	1.8	0.3	0.3	0.0	15.7	1.6
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618923-10674318	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.1;stomach 1: 17.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Excitatory neurons: 20.6;Gastric mucus-secreting cells: 15.3;Paneth cells: 12.6;Proximal enterocytes: 10.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 5.2"	"Immune cell enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.7;HDLM-2: 17.5;HMC-1: 18.3;HUVEC TERT2: 25.5;TIME: 23.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	Nucleoplasm	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.4	0.3	1.2	1.8	3.0	1.1	3.9	0.0	5.2	1.9	0.0	15.9	2.4	0.5	1.2	7.3	2.2	3.5	0.1	3.6	0.0	0.6	0.3	1.3	1.4	0.0	0.0	0.3	0.3	0.0	2.4	0.7	0.0	11.6	17.1	0.9	6.7	0.9	0.1	2.8	11.2	0.6	0.0	0.9	17.5	0.2	0.0	0.2	0.4	0.0	2.5	5.1	3.3	0.3	4.8	0.2	0.0	0.6	0.0	0.0	1.3	7.3	0.7	3.5	3.4	2.6	28.7	0.3	4.7	1.8	4.5	1.4	1.6	8.0	7.4	17.5	0.4	1.0	2.4	0.2	0.0	2.2	18.3	0.4	0.4	5.1	0.3	0.5	25.5	0.2	0.3	0.3	8.1	3.1	0.2	1.3	4.2	11.8	2.0	0.1	2.0	0.3	2.5	14.6	0.9	0.1	4.5	4.9	0.0	6.7	3.5	0.6	23.8	1.0	3.8	0.5	0.8	0.0	1.0	0.2	3.5	0.2	5.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.1	12.5	0.0	0.0	0.0	0.3	1.2	3.0	0.0	5.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	2.2	0.0	0.0	0.3	0.8	3.1	1.2	0.6	3.3	2.0	0.7	1.5	3.3	0.0	0.0	0.1	1.8	19.6	0.0	0.5	0.2	7.3	0.5	0.4	4.2	0.8	20.6	0.2	0.6	0.2	15.3	4.5	1.3	6.3	0.0	0.0	0.0	0.0	1.6	8.9	2.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	6.2	0.0	0.5	5.9	12.6	0.0	0.9	4.7	10.6	0.0	8.8	0.4	0.0	1.2	0.2	0.2	0.8	3.1	1.0	0.3	1.9	0.0	6.9	5.5
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SULT1C4	"SULT1C, SULT1C2"	ENSG00000198075	"Sulfotransferase family 1C member 4"	O75897	2	108377911-108388989	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 7.1;renal cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6"					"Low region specificity"	"Detected in many"			HPA034530			Approved	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA034530: AB_10670170"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-3)"	"prognostic favorable (9.99e-7)"	"unprognostic (1.79e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.38e-1)"	6.2	2.0	15.5	1.1	16.1	0.5	5.2	16.9	17.2	21.9	12.9	3.4	1.5	11.1	8.0	2.3	9.3	27.1	10.9	13.6	18.9	18.2	3.7	10.3	1.8	18.8	27.3	27.9	2.9	1.0	5.2	13.0	20.4	6.6	2.2	8.6	1.6	8.9	3.1	0.7	3.2	5.5	18.1	1.4	2.0	1.4	19.0	5.0	4.5	6.2	1.3	3.8	5.3	15.8	0.0	0.1	9.5	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	1.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.0	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.5	16.1	16.9	17.2	13.6	18.9	18.8	27.3	20.4	18.1	19.0	15.8	13.3	0.0	0.5	10.4	0.0	0.3	0.7	0.0	0.0	2.0	0.4	0.3	0.7	37.1	0.0	9.2	0.0	0.3	0.0	0.0	0.0	0.3	5.9	10.9	3.1	13.2	0.0	2.7	0.6	0.2	0.1	4.9	0.0	3.8	0.0	15.3	17.9	0.0	0.9	1.7	0.5	0.0	0.0	1.3	1.0	1.1	1.5	0.4	0.0	7.5	0.1	12.3	0.0	17.6	0.4	0.1	0.0	4.5	1.4	0.7	0.0	7.7	0.0	1.0	0.0	1.4	1.8	0.6	0.7	0.0	0.4	0.3	0.2	7.2	0.0	0.2
SULT4A1	"hBR-STL-1, SULTX3"	ENSG00000130540	"Sulfotransferase family 4A member 1"	Q9BR01	22	43824509-43862513	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 90.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 23.0;Early spermatids: 23.7;Excitatory neurons: 53.1;Horizontal cells: 23.5;Inhibitory neurons: 55.2;Late spermatids: 29.4;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 90.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003129	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003129: AB_1080130"	"unprognostic (2.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.59e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-3)"	"unprognostic (8.34e-3)"	0.0	2.7	22.3	0.3	23.2	0.0	0.0	1.6	90.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.2	21.7	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	2.5	0.0	8.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.8	5.9	0.0	0.0	0.0	0.0	0.0	0.3	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	23.2	1.6	90.2	22.2	21.7	9.6	0.0	8.0	0.0	5.9	25.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	23.0	0.2	0.5	1.4	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	23.7	1.1	1.3	0.4	0.0	0.0	53.1	0.0	0.0	0.4	0.0	3.7	0.0	1.9	0.0	0.0	0.1	23.5	55.2	0.0	0.0	0.0	0.0	29.4	0.0	0.1	0.0	10.3	0.0	4.0	0.0	8.0	6.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	19.5	0.0	0.0	0.2	3.0	5.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917844	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 128.2;parathyroid gland: 48.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.9;Excitatory neurons: 63.4;Horizontal cells: 95.9;Inhibitory neurons: 107.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (8.05e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.24e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.81e-3)"	1.5	8.9	59.2	2.9	64.7	6.0	1.6	30.2	128.2	6.9	0.0	4.5	1.5	8.4	23.4	1.6	4.8	3.3	1.5	65.1	61.6	1.7	0.5	2.0	2.1	68.2	40.2	3.5	1.4	48.4	22.9	1.4	61.2	4.2	1.8	38.6	1.3	3.7	0.5	0.9	3.0	8.0	14.1	1.6	2.5	1.1	48.9	3.8	4.4	0.5	1.7	3.1	3.9	67.5	0.3	0.0	26.0	0.1	2.6	7.4	2.8	11.2	38.8	32.6	46.7	0.8	1.2	0.3	9.9	16.9	34.3	0.6	0.3	2.4	27.9	0.1	6.2	35.2	2.0	2.0	24.5	0.3	0.5	16.7	0.2	52.3	3.9	36.2	2.9	31.7	0.4	35.8	21.8	0.3	34.8	1.7	66.3	0.0	0.2	12.0	16.4	0.7	0.2	0.9	54.2	43.8	0.1	0.4	25.6	24.6	0.4	21.4	0.2	30.1	29.9	1.2	41.3	0.2	0.5	0.2	53.0	0.3	12.3	0.4	0.1	0.0	0.3	0.0	0.3	0.1	0.3	0.2	0.0	0.2	0.1	0.4	0.3	0.3	0.0	0.1	0.6	0.1	59.2	64.7	30.2	128.2	65.1	61.6	68.2	40.2	61.2	14.1	48.9	67.5	0.8	0.0	1.1	12.4	0.3	0.1	1.9	0.7	4.6	111.9	0.7	4.2	0.8	1.5	0.1	0.0	4.2	0.3	0.7	0.3	0.0	0.1	0.6	0.4	4.6	2.4	4.2	2.1	63.4	0.4	0.6	3.3	1.5	1.3	0.0	10.9	7.5	0.1	0.3	95.9	107.2	0.4	0.0	0.0	0.9	0.2	0.0	0.3	0.0	7.5	0.0	22.9	0.0	28.1	15.7	0.2	0.1	5.7	0.5	0.9	0.1	0.1	0.9	16.1	0.0	2.7	4.9	1.3	0.9	0.4	0.4	0.4	2.7	3.0	0.5	0.7
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083383-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 55.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 85.0;Inhibitory neurons: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	15	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.0	1.2	4.7	0.2	31.4	0.1	0.2	11.1	32.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.0	55.7	0.0	0.0	0.0	0.0	26.1	39.5	0.5	0.1	0.0	0.4	0.0	42.2	0.1	0.1	4.3	0.3	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.5	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	31.4	11.1	32.0	0.0	55.7	26.1	39.5	42.2	9.1	20.2	10.2	0.5	0.0	0.0	5.5	0.1	0.0	0.7	0.4	0.0	5.4	0.7	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	2.5	0.6	0.4	19.8	0.0	85.0	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.7	0.0	0.1	0.0	82.6	0.6	2.0	0.6	0.3	0.8	0.0	0.2	3.6	2.8	0.0	1.0	0.0	3.0	3.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.1	5.6	0.0	0.2	0.4	0.2	0.7	0.0	0.1	0.0	0.2	0.8	0.2	1.5
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021068	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 14.3;pituitary gland: 7.4;retina: 13.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 41.7;Early spermatids: 65.4;Excitatory neurons: 70.3;Inhibitory neurons: 75.8;Late spermatids: 121.5"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Karpas-707: 2.8;RPMI-8226: 3.0;SCLC-21H: 1.5;SH-SY5Y: 1.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.0	1.5	11.2	0.1	12.4	0.1	0.0	2.2	14.3	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	1.0	11.3	9.5	0.1	0.2	0.0	0.0	2.9	2.1	0.0	0.7	0.0	7.4	0.0	3.7	0.0	0.1	13.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.7	0.5	6.4	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.5	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	11.2	12.4	2.2	14.3	11.3	9.5	2.9	2.1	3.7	0.4	6.4	6.0	0.2	12.8	9.6	2.6	0.1	0.0	0.7	0.0	0.0	19.7	0.1	0.0	1.3	0.0	5.0	1.8	41.7	1.3	0.0	0.1	0.0	0.1	65.4	0.1	0.1	1.0	16.8	0.0	70.3	0.0	0.3	0.6	0.0	0.2	2.5	0.1	1.1	0.1	0.1	11.8	75.8	0.0	0.0	0.0	0.0	121.5	0.3	1.0	0.0	1.0	0.1	2.1	0.0	4.0	2.8	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.0	21.9	0.0	1.5	0.7	0.7	0.9	0.0	0.0	0.8	0.5	0.1	0.0	0.4
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752993	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 80.6;naive B-cell: 84.8"	"Group enriched"	"Detected in all"	7	"B-cells: 84.8;granulocytes: 48.6;monocytes: 29.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 161.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		21000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	39.3	10.4	12.8	37.5	13.7	20.9	31.9	13.6	15.9	22.6	17.2	15.0	15.4	17.8	10.4	17.8	16.3	22.0	16.2	12.2	14.1	17.2	10.0	24.9	66.1	16.7	13.6	10.2	15.0	19.4	5.7	39.0	16.7	14.1	12.8	3.9	18.0	15.3	9.8	26.4	20.3	19.7	16.5	59.5	15.9	4.8	14.3	17.3	22.3	14.7	75.3	31.2	17.6	16.5	40.6	22.2	30.8	0.1	62.9	54.6	54.0	43.4	52.6	40.3	44.1	24.7	31.3	161.0	41.6	83.5	57.9	47.7	37.9	24.2	51.6	14.8	15.2	42.6	25.7	12.1	35.2	33.3	76.2	38.4	29.6	29.5	52.3	32.6	124.4	20.2	3.9	0.6	42.4	6.4	10.0	16.1	28.4	10.7	11.3	23.6	28.9	4.7	33.6	106.1	1.5	15.5	41.3	52.6	35.2	42.9	20.9	25.1	143.6	70.3	25.1	59.4	41.2	4.2	12.4	111.5	27.9	36.6	29.3	19.7	5.7	48.6	1.2	13.5	0.5	80.6	1.4	1.1	8.2	84.8	1.2	1.3	1.1	7.9	29.6	2.3	4.2	5.4	12.8	13.7	13.6	15.9	12.2	14.1	16.7	13.6	16.7	16.5	14.3	16.5	154.0	67.3	60.8	33.0	183.7	35.6	68.1	40.1	36.5	3.4	35.1	28.3	17.6	22.8	57.7	20.2	0.0	82.6	9.9	11.3	13.7	47.4	1.6	66.5	18.6	136.0	13.1	9.7	9.0	21.6	128.0	39.1	15.8	71.6	137.8	10.3	53.2	7.2	65.0	26.9	14.5	8.7	18.3	61.9	50.8	2.9	29.8	58.5	28.4	77.8	88.8	9.2	6.2	22.1	22.4	37.0	15.1	34.6	20.7	63.0	22.4	11.7	50.9	2.3	19.7	46.2	35.5	5.5	10.8	17.4	31.3	140.1	15.5	33.4	9.0	78.8
SYN1	MRX50	ENSG00000008056	"Synapsin I"	P17600	X	47571901-47619857	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 271.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 81.4;basal ganglia: 127.5;cerebral cortex: 271.3;hippocampal formation: 118.3;white matter: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced					NA	NA		48000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 41: Macrophages - Immune response"			"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	3.9	11.0	81.4	3.5	127.5	2.0	0.9	9.0	271.3	1.2	0.0	3.7	0.6	1.3	1.4	0.7	1.9	2.6	15.3	118.3	30.7	2.2	3.0	2.9	0.4	28.5	2.3	2.9	2.2	0.7	35.7	4.4	12.7	2.3	1.8	44.0	1.2	1.7	1.9	1.3	1.8	1.7	0.0	1.1	1.9	2.6	9.9	0.9	0.5	3.8	0.7	4.1	1.6	150.4	0.0	0.0	5.0	0.7	0.2	1.0	0.0	0.9	0.2	1.4	0.4	0.0	0.0	0.0	1.6	0.1	1.6	9.0	0.5	0.0	0.4	0.6	0.1	0.5	0.0	0.0	8.1	0.0	2.1	1.9	0.0	1.5	0.3	0.0	0.1	0.7	0.6	0.3	0.2	0.2	0.3	0.3	17.4	0.0	0.1	0.1	0.1	0.3	0.0	0.0	30.2	7.9	0.0	0.1	0.1	7.2	2.2	0.0	0.2	0.0	0.9	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	127.5	9.0	271.3	118.3	30.7	28.5	2.3	12.7	0.0	9.9	150.4	0.2	0.0	0.0	5.5	0.0	0.9	0.6	0.6	0.6	27.1	0.2	0.1	3.7	1.5	0.1	0.0	10.4	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.4	4.2	0.8	37.3	0.7	0.0	2.7	1.1	0.1	0.0	1.6	3.3	1.5	0.2	28.6	34.1	0.3	2.0	1.6	3.4	1.0	2.8	5.1	0.0	7.5	4.7	6.4	0.0	10.6	5.1	0.6	0.2	3.4	0.0	1.2	0.0	0.1	0.1	7.3	6.6	0.8	2.1	3.6	2.1	0.0	0.6	0.0	0.1	3.2	0.5	0.3
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"	Q92777	3	12004388-12192032	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 96.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 338.3;Inhibitory neurons: 543.3;Oligodendrocyte precursor cells: 128.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"	"Group enriched"	"Detected in many"	5	"amygdala: 67.0;basal ganglia: 77.7;cerebral cortex: 96.8;hippocampal formation: 92.9;white matter: 44.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;HMC-1: 4.5;NTERA-2: 3.3;SCLC-21H: 2.7;SH-SY5Y: 11.1;SuSa: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB079005: , HPA037012: AB_2675431"	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	7.0	3.1	67.0	0.4	77.7	0.1	7.1	3.8	96.8	1.4	0.0	2.3	0.4	2.0	1.0	0.3	1.2	0.4	1.0	92.9	2.9	1.5	0.0	1.1	0.0	13.4	0.0	1.5	0.5	4.1	3.4	2.8	10.8	0.5	0.5	7.8	2.4	0.2	0.9	2.5	1.6	1.8	0.0	0.6	1.8	3.6	15.3	0.1	0.2	0.4	0.0	0.3	1.3	44.9	0.0	0.2	0.0	0.0	1.8	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.2	0.0	0.0	0.0	0.0	0.2	2.7	11.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.0	77.7	3.8	96.8	92.9	2.9	13.4	0.0	10.8	0.0	15.3	44.9	43.4	0.0	0.0	7.8	0.0	0.0	0.4	0.0	0.6	13.9	0.4	2.4	1.4	0.0	0.0	0.0	6.2	1.7	0.1	0.0	0.0	0.0	0.6	0.2	0.1	4.5	0.0	0.0	338.3	0.0	0.4	0.9	0.0	0.3	0.0	0.2	0.7	0.0	0.6	13.5	543.3	0.0	0.0	1.8	0.0	1.8	0.0	0.3	0.0	4.7	0.1	2.5	0.0	128.2	8.3	0.3	0.0	0.0	0.0	0.3	0.0	2.7	0.0	3.7	0.0	0.7	0.7	4.9	6.9	0.0	0.0	0.8	0.1	0.1	0.0	0.2
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 122.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 24.2;Inhibitory neurons: 33.7;Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.9;NK-cells: 2.0;T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 49.9;HMC-1: 30.3;Karpas-707: 25.8;SK-BR-3: 32.1;U-266/70: 40.2"									"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: AB_2678198"	"unprognostic (8.89e-3)"	"prognostic favorable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	0.3	9.4	83.0	2.9	86.4	0.9	0.3	35.7	106.5	0.5	10.6	5.3	1.3	0.2	0.0	0.5	0.4	0.4	0.9	74.7	110.7	3.8	0.3	1.0	3.2	88.2	95.3	0.6	0.8	7.3	12.3	1.6	122.6	0.8	1.1	9.5	1.1	0.1	0.1	0.6	5.9	0.7	34.3	2.5	2.3	5.6	121.3	0.5	0.4	0.0	3.7	0.4	1.3	70.5	0.9	4.0	3.7	0.5	0.4	0.4	4.5	1.9	3.1	1.5	1.2	6.3	2.9	6.2	1.4	1.4	4.1	3.5	4.1	0.5	0.4	49.9	2.9	0.1	5.9	3.1	2.1	0.0	30.3	0.9	0.2	0.1	1.0	7.2	0.4	1.9	17.9	25.8	0.7	4.7	0.3	0.3	19.0	0.7	1.8	0.0	0.5	4.9	2.4	0.1	8.6	10.7	4.4	32.1	0.4	2.0	4.5	0.4	0.7	0.9	14.5	0.1	0.7	40.2	5.0	7.2	0.6	5.5	0.6	0.0	0.3	0.0	0.3	0.1	0.8	1.2	0.6	1.1	0.3	1.9	0.7	0.3	0.0	2.0	0.3	0.0	0.6	0.4	83.0	86.4	35.7	106.5	74.7	110.7	88.2	95.3	122.6	34.3	121.3	70.5	0.1	0.0	0.6	3.3	5.0	0.3	0.8	0.6	1.2	5.0	0.2	0.3	5.4	0.0	0.6	0.0	2.1	0.5	2.1	0.9	1.9	2.0	0.8	0.0	0.1	0.5	0.0	0.0	24.2	0.5	0.8	1.2	0.5	0.1	1.3	1.4	0.0	0.0	0.3	6.7	33.7	0.5	0.0	0.6	0.4	0.5	0.0	0.5	0.0	1.9	2.7	1.1	2.1	2.5	3.5	1.2	0.0	0.0	2.3	5.5	0.1	0.1	0.9	2.1	0.0	0.1	0.3	3.0	8.6	0.4	0.3	3.1	2.9	0.4	0.3	1.7
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.8;HeLa: 58.0;WM-115: 124.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	37.2	20.3	51.4	26.5	66.0	0.4	56.7	70.1	58.2	11.8	52.5	594.1	27.1	50.8	12.7	169.6	36.5	19.2	144.2	44.4	75.4	6.9	4.8	23.1	4.2	81.7	66.6	14.1	6.3	8.2	23.2	14.0	81.6	150.6	52.0	40.3	25.6	291.3	624.7	17.0	105.7	160.9	71.6	2.9	158.4	5.2	69.3	3.7	11.2	277.1	4.0	406.3	41.0	79.8	6.6	36.8	8.1	21.9	15.9	0.9	0.5	3.7	5.3	2.1	1.3	5.4	4.9	0.0	5.3	5.3	17.7	4.2	5.5	0.1	1.6	0.5	9.0	0.1	58.0	5.4	9.0	0.0	1.0	0.9	0.3	3.7	0.8	6.0	4.3	0.0	0.2	7.4	5.5	3.7	0.7	0.8	7.2	0.7	11.4	0.0	7.5	5.5	2.1	3.6	3.6	4.2	21.9	3.4	13.5	12.7	0.2	3.6	4.8	4.1	0.4	2.9	8.9	0.1	1.0	0.0	0.4	0.0	124.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	51.4	66.0	70.1	58.2	44.4	75.4	81.7	66.6	81.6	71.6	69.3	79.8	14.8	0.0	1.7	15.3	0.9	2.3	0.7	0.9	2.8	12.6	32.7	103.5	502.5	0.0	1.2	0.0	16.7	1.5	6.6	2.1	0.0	0.5	9.5	1.3	1.0	24.2	3.0	0.0	15.6	1.3	0.7	20.3	5.1	4.2	0.0	1.1	3.6	1.3	0.3	42.1	9.8	0.9	0.0	0.0	5.1	4.5	1.2	2.0	5.4	12.2	0.6	127.8	1.0	2.5	14.0	0.2	2.3	4.1	5.4	2.0	0.6	0.3	3.1	10.2	32.9	19.6	98.5	7.9	11.5	2.1	3.7	0.4	5.9	0.2	0.7	0.9
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 991.6;tongue: 493.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Endometrial stromal cells: 130.0;Excitatory neurons: 149.6;Peritubular cells: 101.5;Sertoli cells: 131.5;Skeletal myocytes: 93.4;Smooth muscle cells: 206.1"	"Group enriched"	"Detected in all"	5	"prostate cancer: 25.7;stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 57.8;LHCN-M2: 18.5;SH-SY5Y: 83.2"	"Region enriched"	"Detected in all"	4	"thalamus: 27.1"	"Low region specificity"	"Detected in all"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	57.5	10.8	6.1	47.4	7.9	0.3	35.9	4.1	5.7	55.0	2.2	346.4	34.3	137.1	33.4	197.1	89.5	50.0	66.8	10.7	13.3	8.7	7.0	16.2	10.5	5.4	7.5	39.0	3.8	3.6	7.5	20.8	6.1	180.5	58.0	1.2	16.0	267.4	991.6	17.9	75.5	244.4	9.2	10.2	126.2	6.7	5.8	14.3	16.0	493.5	6.5	226.5	54.0	12.0	0.2	4.2	0.2	0.0	10.5	3.5	0.7	13.4	14.1	0.4	0.5	0.0	0.7	1.5	0.1	57.8	0.9	0.2	0.4	0.3	0.7	5.9	0.1	0.8	1.3	0.0	2.4	0.1	0.2	14.5	0.3	4.0	0.2	3.7	0.2	0.2	0.0	0.7	18.5	0.3	0.7	7.2	1.4	0.0	0.0	0.5	1.5	0.4	0.2	0.3	0.4	83.2	0.4	0.3	0.1	3.3	0.0	7.0	0.4	0.6	0.1	0.2	0.1	0.1	0.3	0.1	1.1	0.6	0.2	0.8	0.1	0.5	0.2	0.0	0.4	0.3	0.4	0.2	0.0	0.4	0.4	0.3	0.2	0.3	0.1	0.0	0.5	0.1	6.1	7.9	4.1	5.7	10.7	13.3	5.4	7.5	6.1	9.2	5.8	12.0	25.5	3.2	1.1	42.7	1.1	13.5	17.9	3.7	46.1	2.5	6.3	30.7	135.4	0.0	0.3	1.8	0.0	1.4	0.5	0.1	0.0	0.1	2.2	6.9	130.0	11.3	0.0	1.7	149.6	1.8	0.5	41.5	0.5	10.6	0.0	16.1	13.9	0.4	1.4	0.0	31.5	0.2	0.0	0.9	11.4	7.0	27.1	3.8	5.4	76.8	12.9	0.0	0.0	6.0	3.0	0.2	0.4	101.5	0.8	24.9	0.1	0.3	2.5	0.5	131.5	93.4	206.1	1.3	0.5	5.3	8.1	0.8	2.6	33.4	0.2	4.0
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187815-49200199	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 259.4;pituitary gland: 106.8;retina: 316.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 529.2;Cone photoreceptor cells: 546.3;Rod photoreceptor cells: 594.4"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 20.3;SCLC-21H: 102.6;SH-SY5Y: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999, HPA079659"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153, HPA079659: "	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.6	40.1	115.7	3.6	132.0	0.8	1.9	26.0	259.4	1.8	0.0	7.4	12.4	1.5	2.0	1.2	1.7	0.8	3.1	144.0	137.9	5.0	0.8	3.0	0.9	89.5	25.8	1.7	7.6	3.3	106.8	0.8	76.2	1.6	3.9	316.3	1.3	1.1	1.9	1.8	13.9	1.9	4.7	2.0	5.3	1.7	86.0	4.2	2.3	1.4	0.7	1.5	2.2	116.9	0.9	3.9	2.9	5.8	3.2	0.5	0.4	0.2	0.1	0.7	0.8	3.6	2.1	3.2	0.5	0.1	4.4	2.9	3.1	0.4	0.7	6.5	3.5	4.9	1.4	1.1	0.1	0.6	10.5	0.4	0.1	0.5	0.7	0.4	0.3	2.7	20.3	7.6	0.6	1.1	1.7	0.4	9.6	2.5	0.8	0.6	0.6	1.5	0.2	0.4	102.6	36.8	1.1	0.4	1.5	0.9	1.9	1.8	0.6	0.6	3.2	1.0	0.4	0.5	6.7	0.8	1.7	1.3	3.2	0.7	0.2	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	1.9	0.2	0.1	0.6	0.1	0.0	115.7	132.0	26.0	259.4	144.0	137.9	89.5	25.8	76.2	4.7	86.0	116.9	7.5	0.0	3.9	24.2	6.3	2.5	2.8	1.0	1.2	529.2	5.8	8.1	1.8	2.8	2.9	9.2	546.3	1.1	1.9	11.3	0.0	0.9	10.3	1.4	3.1	6.5	116.4	0.4	115.1	2.6	0.6	3.7	10.2	3.1	8.8	3.4	6.1	1.2	1.2	122.8	118.4	37.7	10.2	1.9	4.9	12.6	4.1	3.6	3.6	17.8	2.7	54.4	3.1	28.1	33.7	1.2	2.1	3.8	1.5	1.5	16.3	0.9	4.6	594.4	6.6	5.4	7.8	2.4	2.8	3.4	2.6	1.4	3.5	41.3	10.8	1.0
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 403.3;retina: 197.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	0.5	21.7	113.1	2.2	153.7	0.6	0.7	19.7	403.3	1.4	0.0	4.4	1.5	9.9	0.7	0.7	0.8	1.3	0.2	134.2	2.0	1.9	1.9	0.9	0.3	0.0	0.0	5.2	0.3	0.0	6.4	2.6	3.0	6.6	2.8	197.7	0.2	5.5	0.2	0.2	3.4	25.2	0.0	2.6	1.3	0.7	12.5	0.5	0.3	0.5	0.3	1.6	2.5	146.0	0.0	19.2	14.2	0.0	1.4	4.0	0.0	1.4	1.7	1.0	1.1	1.0	0.5	0.0	2.8	0.2	5.0	0.6	0.3	2.2	1.6	0.3	0.7	1.0	0.5	0.0	3.6	0.0	0.3	1.1	1.4	5.2	39.4	37.1	13.6	0.7	0.7	2.2	31.9	3.1	1.8	0.0	10.3	2.1	5.3	0.0	14.3	0.0	0.0	5.5	18.8	30.9	0.0	2.4	0.3	9.5	6.8	0.0	5.4	2.0	0.7	0.0	6.2	3.4	8.0	0.1	4.5	0.0	29.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	153.7	19.7	403.3	134.2	2.0	0.0	0.0	3.0	0.0	12.5	146.0	2.2	0.0	0.6	124.7	9.0	0.9	0.1	0.0	0.0	1287.6	0.2	3.4	0.6	0.0	1.3	0.0	894.5	5.6	0.1	0.1	0.0	0.0	1.4	0.6	20.2	10.4	96.9	1.3	3753.2	0.2	2.2	5.9	0.0	0.7	0.0	0.7	1.8	0.1	13.9	62.2	2910.4	0.1	0.0	4.7	7.2	2.9	69.3	1.6	1.8	137.7	0.0	337.7	0.0	126.2	105.1	0.1	7.6	4.5	8.5	11.5	0.1	0.1	0.0	905.8	0.0	0.0	6.7	1.5	5.7	0.2	0.6	5.9	0.4	1.8	0.1	0.3
SYT10		ENSG00000110975	"Synaptotagmin 10"	Q6XYQ8	12	33374238-33439819	"Predicted membrane proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.3;fallopian tube: 2.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Distal tubular cells: 7.9;Excitatory neurons: 4.4;Inhibitory neurons: 15.4;Late spermatids: 16.2"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.7;K-562: 1.0;MCF7: 3.5;RT4: 1.3;SCLC-21H: 1.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 49.5"	"Low region specificity"	"Detected in all"			HPA055426			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA055426: AB_2682812"	"unprognostic (3.60e-1)"	"unprognostic (4.93e-2)"		"unprognostic (9.34e-4)"				"unprognostic (5.53e-2)"		"unprognostic (3.67e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.97e-6)"	"unprognostic (4.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.91e-1)"	0.0	0.3	0.9	0.1	1.9	0.0	0.0	0.0	0.9	0.5	0.4	0.8	0.2	0.0	0.1	0.0	2.2	0.0	0.0	0.6	5.1	0.8	0.3	0.0	0.0	4.1	1.7	0.0	0.0	0.0	0.5	0.0	4.3	0.4	0.4	0.1	0.0	0.7	0.0	0.0	0.3	0.1	2.4	0.0	0.4	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.3	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.0	0.9	0.6	5.1	4.1	1.7	4.3	2.4	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.5	0.0	2.5	0.0	0.0	0.1	0.0	0.0	7.9	0.0	1.5	1.8	0.3	0.1	0.0	0.0	4.4	0.0	0.0	0.3	0.0	1.0	0.0	0.8	1.4	0.0	0.0	0.0	15.4	0.2	0.0	0.0	0.0	16.2	0.3	0.0	0.0	1.0	0.0	0.6	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.7	0.2	0.0	0.0	0.3	0.2	3.7	0.0	0.0	0.1	0.0	3.2	0.1	0.1
SYT3		ENSG00000213023	"Synaptotagmin 3"	Q9BQG1	19	50621307-50639881	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 28.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Excitatory neurons: 10.4;Inhibitory neurons: 15.6;Oligodendrocyte precursor cells: 6.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.8;HMC-1: 5.3;JURKAT: 3.1;NTERA-2: 5.5;SH-SY5Y: 6.1;U-2 OS: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (5.17e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.82e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	0.0	0.5	8.7	0.1	10.4	0.0	0.2	6.9	28.4	0.2	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.2	12.8	9.8	0.6	0.0	0.2	0.1	13.6	5.8	0.0	0.6	1.3	3.8	0.7	12.5	0.7	0.0	2.2	0.3	0.4	0.0	0.1	0.2	0.1	3.5	0.0	0.2	1.3	8.9	0.0	0.4	0.0	0.0	0.1	0.2	13.8	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.3	0.0	0.3	0.0	0.0	0.1	7.8	0.0	0.0	0.0	0.3	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.1	3.1	0.9	0.0	0.0	2.3	0.0	0.0	5.5	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	6.1	0.3	0.0	0.1	0.1	0.1	1.8	0.0	0.0	3.8	0.0	0.0	0.6	0.1	0.0	0.2	2.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	10.4	6.9	28.4	12.8	9.8	13.6	5.8	12.5	3.5	8.9	13.8	0.0	0.0	3.0	1.6	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.1	0.6	0.0	0.0	1.8	4.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	15.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.1	0.0	6.0	1.9	0.0	0.0	0.7	0.0	0.2	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.7	2.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267892-43277535	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.7;pituitary gland: 30.7;retina: 25.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1"	"Group enriched"	"Detected in some"	5	"glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 245.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		3.7	15.9	21.5	1.4	18.6	0.1	0.0	74.7	42.6	0.0	0.0	1.2	0.8	0.0	0.0	0.1	0.0	0.0	1.3	18.6	50.4	0.1	0.0	0.9	0.0	10.5	15.3	0.5	3.7	0.0	30.7	0.1	39.3	0.6	0.8	25.2	0.1	8.3	0.0	0.0	0.7	0.6	13.5	0.0	3.2	1.6	18.3	0.4	0.3	0.0	0.0	0.0	0.5	10.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	245.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	18.6	74.7	42.6	18.6	50.4	10.5	15.3	39.3	13.5	18.3	10.9	0.0	0.0	1.1	8.8	0.0	0.1	0.0	0.0	0.0	66.8	0.0	0.0	3.6	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	28.7	0.0	50.9	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	0.0	2.5	0.0	7.5	7.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171196-55180289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 72.6;pituitary gland: 59.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	0.2	9.7	40.1	1.9	46.0	0.5	0.1	0.0	72.6	0.8	0.0	2.0	1.3	0.1	0.0	0.2	0.2	0.2	0.2	53.4	58.5	0.1	0.1	0.2	0.2	12.2	20.3	0.0	2.5	0.7	59.3	0.0	22.1	0.1	0.7	4.4	0.0	0.0	0.1	0.8	1.1	0.5	13.3	0.1	1.9	5.4	32.4	0.2	0.1	0.0	0.3	0.1	0.3	39.9	0.2	0.2	0.4	0.4	0.9	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.1	1.7	27.1	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.1	1.1	0.1	60.2	0.7	0.2	0.0	0.1	0.0	0.5	0.5	22.7	3.8	0.0	0.6	0.5	0.0	0.1	95.7	3.8	0.1	0.4	0.3	0.0	0.1	15.9	7.1	0.0	1.1	0.9	0.0	0.5	0.1	0.1	1.4	1.3	1.7	0.1	0.2	1.4	0.9	0.5	0.1	0.3	1.4	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.5	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.1	40.1	46.0	0.0	72.6	53.4	58.5	12.2	20.3	22.1	13.3	32.4	39.9	0.2	0.0	0.0	3.3	1.0	0.6	0.1	1.4	0.0	2.8	0.1	0.6	1.1	0.0	0.4	0.0	4.2	0.0	1.0	0.8	0.0	0.3	15.4	9.1	0.3	0.1	57.6	2.7	20.3	0.4	0.1	0.3	5.6	0.2	0.0	0.7	0.4	0.0	0.2	6.7	11.9	0.8	4.1	0.6	0.0	41.4	0.3	0.1	0.0	3.7	0.1	0.4	0.0	1.5	2.5	0.9	0.1	0.4	0.1	0.1	2.1	0.0	4.0	0.4	0.0	0.0	0.7	8.2	7.6	0.0	0.1	0.0	1.0	0.2	0.6	0.4
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153880	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 13.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.1;Early spermatids: 6.1;Excitatory neurons: 5.9;Late spermatids: 14.1;Microglial cells: 27.2;Oligodendrocyte precursor cells: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 22.0;WM-115: 15.2"	"Group enriched"	"Detected in all"	7	"basal ganglia: 31.2;olfactory bulb: 71.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.0	0.8	2.7	0.2	4.2	0.0	0.7	1.5	2.8	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.0	13.5	1.5	0.0	0.0	0.0	4.8	4.5	0.8	3.1	0.1	0.1	0.5	3.9	0.4	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.2	1.5	2.8	3.0	13.5	4.8	4.5	3.9	7.9	9.5	4.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	6.1	0.0	0.2	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	2.4	0.0	0.0	0.0	0.4	14.1	0.0	1.2	3.6	27.2	0.0	0.7	0.0	7.5	0.6	0.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.7	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.1	3.9	0.0	0.0
SYT9		ENSG00000170743	"Synaptotagmin 9"	Q86SS6	11	7238778-7469043	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.9;retina: 7.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.6;Late spermatids: 23.5;Oligodendrocyte precursor cells: 55.3;Oligodendrocytes: 139.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEK 293: 10.3;RT4: 17.9;SH-SY5Y: 13.2;TIME: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.47e-1)"	"unprognostic (9.41e-2)"		"unprognostic (1.39e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.31e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.22e-4)"	0.0	2.0	9.1	0.0	9.2	0.0	0.8	11.7	5.9	0.4	1.4	0.1	0.0	1.2	0.0	0.0	0.1	0.1	0.3	4.7	7.6	2.0	3.6	0.0	0.0	9.9	11.8	0.1	1.3	0.9	1.5	0.0	9.6	1.0	0.0	7.6	0.0	3.6	0.0	0.1	0.1	0.1	8.1	0.0	0.1	0.9	15.9	0.0	1.1	0.0	0.0	0.2	0.3	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	17.9	3.2	13.2	0.0	0.0	0.0	0.4	0.0	0.0	20.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	9.2	11.7	5.9	4.7	7.6	9.9	11.8	9.6	8.1	15.9	11.7	0.0	0.0	0.0	48.6	0.5	0.0	0.1	0.0	0.0	13.6	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.9	0.0	0.2	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	3.3	9.8	0.0	0.0	0.3	0.0	23.5	0.0	0.0	0.0	5.6	0.0	2.0	0.0	55.3	139.2	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	3.5	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;pancreas: 106.3;skin 1: 87.2"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 158.8;NK-cells: 208.1;Squamous epithelial cells: 179.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 4.3;cerebellum: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CAPAN-2: 55.8;NB-4: 81.8;U-266/70: 44.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 24: NB-4 - Immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favorable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	2.0	0.6	4.3	19.1	0.7	46.7	7.7	8.8	1.4	22.6	6.1	6.7	7.8	1.3	1.2	103.9	15.5	8.6	0.9	1.0	1.0	2.8	2.1	13.1	32.9	0.7	0.8	0.6	106.3	4.2	15.6	2.9	0.8	63.6	3.3	0.0	47.6	12.7	0.5	87.2	17.6	0.4	0.5	42.0	41.8	0.9	1.2	21.4	9.8	0.5	20.0	21.6	50.9	0.6	11.3	0.2	0.0	0.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	1.2	55.8	8.5	10.9	0.0	0.3	34.7	0.0	21.0	0.0	0.0	2.1	1.0	0.9	15.3	0.8	21.9	0.0	0.0	37.8	0.0	7.8	0.2	0.0	28.2	0.7	9.5	0.0	15.5	12.9	81.8	0.5	19.1	5.7	14.9	0.1	40.2	8.6	9.6	15.9	0.9	0.0	15.9	0.6	0.5	40.4	23.3	0.2	0.1	5.1	0.0	0.0	44.3	11.7	8.0	1.6	27.7	0.0	47.0	18.9	176.5	65.0	49.1	58.4	42.8	51.5	53.2	51.0	32.3	30.6	37.3	34.1	49.0	100.8	3.0	63.4	40.0	4.3	0.7	8.8	1.4	1.0	1.0	0.7	0.8	0.8	0.5	1.2	0.6	1.9	22.4	13.6	0.0	68.6	41.2	78.2	84.4	158.8	0.6	33.6	49.8	3.9	8.6	69.2	0.0	0.0	37.4	92.3	4.8	7.9	3.7	0.8	67.8	2.4	2.3	11.4	15.8	0.3	25.5	10.1	3.1	100.9	18.3	1.3	0.2	2.2	1.1	3.2	0.0	0.3	47.6	32.6	6.7	12.7	0.7	0.3	15.7	10.6	0.0	18.8	2.0	208.1	0.0	0.1	12.1	3.7	0.7	52.3	46.8	3.1	6.4	62.8	0.8	0.0	1.3	5.6	30.3	23.1	179.1	55.3	14.1	74.9	0.2	9.4	95.3
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.4	15.8	9.8	7.2	9.9	13.5	20.6	8.1	12.9	25.9	5.4	16.0	7.9	23.5	2.2	15.9	21.4	10.1	18.3	10.9	7.7	20.6	14.8	17.0	11.1	10.5	8.7	31.7	17.9	4.2	20.6	6.2	8.6	21.7	2.9	1.8	15.3	8.3	12.3	17.8	19.3	5.3	7.3	32.2	18.7	13.8	8.9	7.4	23.7	6.7	3.6	18.5	19.1	8.9	11.8	12.7	7.5	23.6	5.7	5.9	34.3	13.8	5.3	11.5	3.7	15.0	8.3	12.7	17.3	5.0	6.1	21.2	4.3	5.4	2.6	11.4	18.2	6.8	21.0	9.7	4.8	7.6	21.8	8.9	6.9	9.1	3.7	5.0	20.4	20.7	17.9	4.1	5.6	25.4	11.3	24.9	27.8	5.1	12.2	29.2	6.1	10.5	4.7	9.5	34.0	16.8	26.3	7.8	43.0	4.6	28.9	8.1	8.9	19.2	16.5	19.2	12.0	19.6	16.9	26.7	9.8	9.2	12.4	0.0	1.3	0.4	1.5	1.3	1.8	0.9	0.6	0.9	1.5	1.1	0.7	1.3	0.0	1.5	0.5	0.6	0.9	1.2	9.8	9.9	8.1	12.9	10.9	7.7	10.5	8.7	8.6	7.3	8.9	8.9	24.9	19.2	15.8	22.5	9.2	6.5	5.1	5.2	5.2	9.3	10.2	10.2	3.0	2.8	8.2	3.7	20.9	9.4	6.5	9.9	5.9	5.1	0.5	6.9	7.4	18.7	7.2	7.4	16.5	7.1	6.7	8.4	20.9	8.8	6.3	24.6	22.9	12.9	6.6	1.7	13.0	8.2	0.0	9.8	6.3	2.5	11.8	7.3	7.2	15.9	6.3	7.8	5.2	13.6	12.5	5.2	5.1	9.1	12.1	3.9	7.6	4.0	6.1	10.4	6.6	8.3	7.8	9.9	10.6	8.7	5.3	7.4	8.0	16.8	10.2	4.4
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199370-117207464	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 9628.1;intestine: 11712.2"	"Group enriched"	"Detected in many"	4	"Breast myoepithelial cells: 2508.6;Peritubular cells: 2306.4;Sertoli cells: 2866.2;Smooth muscle cells: 4563.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 279.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 41.6;non-classical monocyte: 63.1"	"Lineage enriched"	"Detected in many"	12	"monocytes: 63.1"	"Cell line enhanced"	"Detected in all"		"BJ: 1913.4;BJ hTERT+ SV40 Large T+: 1641.8;CACO-2: 1531.4;EFO-21: 2145.6;fHDF/TERT166: 2094.4;hTERT-RPE1: 1499.7;LHCN-M2: 1377.1;U-138 MG: 1598.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		6300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	2235.7	512.7	118.5	963.9	144.4	12.1	1680.5	126.1	215.9	3611.3	172.5	11712.2	451.2	9628.1	693.9	1954.6	4610.6	893.8	1583.5	119.6	120.4	774.5	302.8	1258.6	245.5	137.0	127.0	1643.4	218.6	65.3	254.6	348.0	129.2	4624.1	1154.6	22.9	461.8	6383.6	356.4	619.8	1948.4	7108.7	127.2	532.0	3148.4	202.5	138.2	52.2	723.2	152.4	59.9	5521.7	2331.2	130.0	17.5	5.5	293.3	8.2	140.0	123.8	226.7	1913.4	788.1	1641.8	609.0	1531.4	28.4	3.2	2145.6	2094.4	1.7	46.1	4.4	16.8	543.3	6.8	4.4	5.0	66.9	130.2	708.7	1.7	5.2	304.6	57.5	267.1	36.1	1499.7	3.3	4.5	3.3	6.7	1377.1	4.5	1.7	15.8	84.6	18.8	2.1	2.7	23.1	12.0	4.4	25.8	1.9	9.6	29.9	11.0	1.5	807.6	9.2	5.1	182.0	1598.8	276.9	14.4	86.6	8.9	8.8	21.7	9.1	7.7	6.2	1.8	2.7	0.1	0.3	41.6	0.5	3.6	0.1	0.0	3.2	5.1	0.2	0.1	0.3	0.0	63.1	1.6	0.5	2.1	118.5	144.4	126.1	215.9	119.6	120.4	137.0	127.0	129.2	127.2	138.2	130.0	264.8	38.5	6.1	4.6	10.3	63.9	453.4	248.6	10.8	9.9	74.0	2508.6	1.3	4.3	22.5	40.5	18.8	57.0	8.6	3.1	0.0	577.8	3.3	14.6	455.5	260.3	3.0	2.7	4.5	74.5	35.3	464.4	41.3	12.8	1.3	32.4	639.7	8.9	41.5	1.7	6.5	18.3	24.4	23.1	91.8	23.9	48.4	33.8	96.0	37.5	8.1	4.9	2.1	3.0	11.9	38.4	4.5	2306.4	3.2	414.0	12.1	2.2	23.0	9.9	2866.2	177.6	4563.9	6.0	13.7	8.6	60.9	32.2	15.1	8.3	3.1	62.0
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998739-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 442.4;choroid plexus: 172.3;pituitary gland: 100.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 104.3;Excitatory neurons: 78.1;Horizontal cells: 297.8;Inhibitory neurons: 49.3;Rod photoreceptor cells: 50.7"	"Cancer enriched"	"Detected in many"	4	"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 104.1;RPTEC TERT1: 41.6;SCLC-21H: 55.5;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced					NA	NA		9000000		"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA062620: AB_2684810"	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	0.3	33.5	291.3	1.5	313.2	0.0	0.1	250.3	442.4	0.0	172.3	11.4	0.6	0.0	0.0	0.2	0.0	0.2	0.6	318.0	310.2	4.5	0.3	0.5	0.2	300.5	235.8	0.3	5.6	0.0	100.9	0.0	292.8	0.5	2.3	74.3	0.2	0.2	0.2	0.6	2.4	1.1	212.3	0.1	3.3	0.3	254.2	1.3	0.4	0.0	0.2	0.2	1.1	309.3	0.0	0.0	104.1	0.2	0.0	0.0	0.1	2.6	1.9	0.1	0.1	0.4	0.2	0.0	3.8	0.0	0.1	0.7	0.1	7.2	1.4	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.5	0.0	0.0	0.8	0.4	0.0	0.1	0.0	4.0	0.0	9.0	15.1	2.8	0.0	41.6	0.0	55.5	94.5	0.0	0.1	0.0	2.1	0.1	0.3	0.0	0.3	0.3	0.0	0.3	0.1	0.1	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.3	313.2	250.3	442.4	318.0	310.2	300.5	235.8	292.8	212.3	254.2	309.3	0.1	0.0	0.0	16.6	0.0	0.8	1.2	1.0	0.0	104.3	0.2	0.3	0.7	0.0	1.8	5.5	8.4	0.0	0.1	0.0	0.0	0.1	2.6	0.2	0.0	1.1	5.3	0.0	78.1	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	297.8	49.3	0.0	30.5	0.0	0.0	0.9	0.0	0.4	0.0	15.0	0.0	16.3	0.0	32.2	18.8	2.3	0.0	0.0	0.0	1.1	0.0	31.9	12.8	50.7	0.0	0.4	0.5	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.9
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.4"	"Cell type enriched"	"Detected in some"	4	"Erythroid cells: 151.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 153.7;HMC-1: 70.6;HUVEC TERT2: 31.2;JURKAT: 60.0;K-562: 48.9;MOLT-4: 26.3;TIME: 34.4"	"Region enriched"	"Detected in many"	5	"midbrain: 14.3"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	7.5	2.5	4.9	1.0	4.5	29.4	6.3	4.7	4.4	2.9	3.0	2.1	0.8	2.9	0.6	1.8	3.5	2.3	5.9	4.6	4.6	4.4	1.5	13.0	1.4	6.5	7.1	1.2	0.9	0.9	1.7	6.9	6.8	2.1	1.3	0.2	1.1	0.8	2.1	1.7	3.1	2.7	6.9	7.1	1.8	0.9	6.4	0.4	5.4	2.5	0.7	2.4	2.5	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	0.1	153.7	0.0	0.0	0.0	0.0	70.6	0.0	0.0	0.0	0.0	0.0	31.2	60.0	48.9	0.1	0.0	0.0	26.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	34.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.5	4.9	4.5	4.7	4.4	4.6	4.6	6.5	7.1	6.8	6.9	6.4	6.8	23.9	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.5	1.3	1.8	0.0	0.1	0.0	0.0	0.0	0.1	5.3	0.0	0.1	18.1	0.0	151.5	0.0	0.0	0.3	0.6	0.0	0.0	36.8	0.0	26.7	0.1	10.6	0.0	0.1	0.0	0.0	1.6	1.5	18.2	0.0	4.8	1.8	29.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	1.3	0.4	0.1	1.0	0.0	2.0	0.0	0.0	0.0
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747415-765012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 820.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 2870.4;neutrophil: 3726.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol		NA	NA		29000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	139.5	80.7	108.0	121.8	128.8	464.8	121.0	129.3	119.3	101.9	105.2	99.6	116.0	68.4	66.4	330.6	79.1	100.0	95.5	108.0	113.8	111.6	136.2	109.1	107.8	135.8	119.3	77.0	107.5	49.3	53.0	88.0	130.0	91.9	78.4	34.2	132.8	60.1	120.7	132.7	101.0	60.8	124.0	152.6	132.5	40.4	120.1	109.9	140.3	107.1	115.8	160.8	142.1	148.2	331.0	405.5	115.4	218.1	235.8	136.5	338.0	242.2	313.8	238.2	194.5	176.6	694.8	179.5	323.1	324.7	181.9	345.5	185.6	263.5	122.8	238.9	372.5	310.9	146.0	616.4	250.3	498.4	449.0	112.0	210.6	159.6	129.0	170.4	331.6	224.0	413.5	294.3	224.5	318.0	296.4	601.2	183.9	478.9	326.0	243.5	131.5	656.4	437.9	185.4	284.2	100.1	224.9	466.1	243.3	102.4	220.0	383.9	434.1	107.9	99.5	86.0	232.9	122.9	132.1	223.5	238.5	440.5	444.7	1456.7	1203.5	2870.4	94.1	432.7	102.3	145.5	125.7	115.5	654.2	127.2	100.9	94.9	3726.6	112.2	457.8	267.0	192.7	1066.0	108.0	128.8	129.3	119.3	108.0	113.8	135.8	119.3	130.0	124.0	120.1	148.2	90.2	141.1	117.2	10.7	91.1	73.5	199.8	354.0	61.5	50.3	113.0	122.2	46.4	100.1	253.4	150.8	14.6	419.8	83.8	151.0	250.5	230.4	82.1	156.5	85.4	85.6	101.5	507.0	13.1	272.1	427.6	97.3	144.3	216.7	161.4	86.0	93.5	149.7	418.3	50.5	11.6	186.0	268.5	271.8	169.4	21.2	117.8	352.8	140.5	7.5	820.0	142.1	84.5	10.6	54.8	257.6	200.3	104.2	129.4	361.9	197.7	309.1	232.6	61.7	72.3	59.6	115.0	143.2	140.6	257.6	83.1	526.6	86.8	77.5	215.1	342.6
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 40.4;intestine: 25.6;lymphoid tissue: 58.6"	"Group enriched"	"Detected in many"	4	"B-cells: 109.6;dendritic cells: 144.4;NK-cells: 284.2;T-cells: 147.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 19.0;JURKAT: 27.3;MOLT-4: 47.1;NB-4: 64.7;U-937: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069743	Enhanced		Approved	"Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA069743: AB_2686186"	"prognostic favorable (3.83e-4)"	"prognostic favorable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favorable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	2.3	0.7	0.7	25.8	1.2	40.4	1.1	0.4	1.2	1.4	0.8	4.1	5.5	0.9	0.1	2.3	1.9	3.2	0.9	0.6	0.6	2.5	2.6	8.9	56.7	0.9	0.5	0.5	0.8	0.2	0.5	0.8	0.6	1.9	1.5	0.0	3.8	0.7	0.9	1.4	25.6	0.5	0.5	58.6	7.6	0.5	0.7	46.0	7.6	0.6	21.8	3.2	1.7	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.7	0.1	1.2	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	27.3	0.1	0.0	0.0	0.3	47.1	64.7	0.0	0.0	0.0	6.6	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.2	0.0	0.4	0.5	12.2	0.0	24.6	0.0	191.0	46.0	270.4	237.7	120.4	169.7	177.3	201.5	208.3	65.6	184.2	206.7	192.0	237.6	148.0	167.0	55.8	286.6	261.6	0.7	1.2	0.4	1.2	0.6	0.6	0.9	0.5	0.6	0.5	0.7	1.1	2.5	6.4	19.5	0.0	109.6	1.1	0.1	0.1	0.6	1.0	1.4	1.9	1.5	2.8	2.5	0.0	0.0	0.2	144.4	0.2	0.0	0.2	0.2	2.4	0.4	1.9	1.2	12.6	0.2	0.0	0.3	2.0	2.0	1.1	23.4	0.1	5.0	1.4	23.7	0.0	0.1	0.0	0.0	16.0	6.9	0.6	0.0	23.1	3.6	1.0	24.5	0.3	284.2	0.0	0.5	0.0	0.0	0.0	40.2	0.1	0.1	1.1	1.3	0.5	0.0	1.3	1.1	0.1	0.2	0.0	1.0	0.4	147.7	0.1	0.1	0.1
TBC1D2	"Armus, PARIS1, TBC1D2A"	ENSG00000095383	"TBC1 domain family member 2"	Q9BYX2	9	98199011-98255649	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Oligodendrocytes: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 77.0;HaCaT: 98.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030871, HPA076521"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA030871: AB_10670046, HPA076521: "	"unprognostic (2.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.30e-1)"	8.8	5.3	11.1	5.7	16.0	13.1	7.8	12.3	26.0	10.8	8.5	8.6	12.6	4.4	1.5	37.4	5.5	4.0	3.7	10.6	12.9	6.4	19.8	32.0	3.8	14.9	14.9	2.9	3.0	3.5	4.4	7.2	16.4	12.0	4.4	3.4	14.7	6.1	4.3	24.3	10.1	2.8	11.4	9.4	7.0	3.4	23.3	3.0	8.1	1.4	4.9	11.7	17.3	23.9	77.0	10.8	0.5	2.5	8.2	15.9	24.3	33.2	18.4	23.8	19.6	6.9	32.8	1.3	24.7	19.6	5.2	98.1	0.7	36.8	8.3	2.6	1.4	0.7	38.0	5.4	37.6	1.7	2.9	21.7	59.8	23.6	58.7	41.5	8.6	2.1	2.4	1.0	19.0	9.9	0.4	4.6	1.6	7.4	6.2	1.2	4.8	0.2	36.0	46.7	0.9	1.4	11.3	24.4	3.4	1.7	8.1	2.6	51.7	28.8	8.6	4.8	13.6	1.6	1.5	0.6	29.0	2.9	3.2	2.1	27.5	8.4	2.5	15.3	1.8	1.2	3.8	2.2	10.0	0.8	1.6	1.9	11.9	1.2	12.3	1.3	5.5	10.8	11.1	16.0	12.3	26.0	10.6	12.9	14.9	14.9	16.4	11.4	23.3	23.9	2.9	57.7	12.5	5.2	2.4	8.3	18.5	30.4	21.6	3.3	2.7	5.6	0.7	4.3	23.3	3.7	0.0	21.5	0.9	16.2	3.9	3.3	1.8	4.6	3.7	5.0	7.7	0.4	4.6	3.2	10.9	2.4	6.1	10.3	0.0	0.6	1.1	6.1	32.0	1.7	5.4	12.6	18.3	16.2	1.8	1.2	1.8	18.3	3.6	4.7	7.5	4.4	3.1	12.1	64.9	14.4	10.7	0.7	1.7	9.2	16.4	3.2	10.8	2.4	0.0	1.8	3.4	2.1	3.0	29.8	10.9	17.4	2.4	0.7	5.7	17.1
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box transcription factor 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	14	"intestine: 9.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.8;Intestinal goblet cells: 103.8;Paneth cells: 20.4;Proximal enterocytes: 42.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.4;NTERA-2: 5.3;RPMI-8226: 3.6;SK-BR-3: 12.5;U-2 OS: 2.5"					"Low region specificity"	"Detected in single"			"HPA047881, HPA076197"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm	Cytosol	"HPA047881: AB_2680199, HPA076197: "	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.4	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	8.0	0.0	0.4	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	12.5	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.9	0.0	0.0	0.0	103.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	20.4	0.0	0.0	0.2	42.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.1
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.1;lung: 3.3;lymphoid tissue: 11.7"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 92.8;NK-cells: 119.4;Plasma cells: 22.8;T-cells: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 16.3"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.2"	"CAB009524, CAB030043"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	0.9	0.4	0.3	1.9	0.3	11.1	0.4	0.3	0.3	0.4	0.4	0.5	0.9	0.3	0.4	0.3	0.4	0.8	0.3	0.2	0.3	0.5	1.2	3.3	7.5	0.4	0.3	0.2	0.2	0.0	0.2	0.2	0.3	0.4	0.5	0.0	0.6	0.2	0.5	0.2	1.6	0.4	0.3	11.7	1.2	0.4	0.3	1.0	0.7	0.2	2.2	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	3.6	2.0	3.1	8.9	0.0	0.5	0.4	7.8	0.2	14.3	0.0	0.1	0.1	2.4	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.3	0.3	0.3	1.1	0.0	0.6	0.0	7.6	0.0	0.0	0.0	0.6	0.0	0.6	0.9	1.3	1.5	0.0	0.0	0.0	0.1	92.8	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.3	0.1	0.0	0.0	0.2	1.1	0.2	2.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	1.9	0.0	1.9	0.8	0.0	119.4	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.1	0.0	45.6	0.0	0.0	0.0
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 71.0;Hofbauer cells: 88.8;Kupffer cells: 193.6;Macrophages: 132.9;Microglial cells: 191.1;monocytes: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"basophil: 324.3;classical monocyte: 322.4;eosinophil: 333.6;intermediate monocyte: 466.0;myeloid DC: 129.0;neutrophil: 271.1;non-classical monocyte: 423.1"	"Group enriched"	"Detected in all"	22	"dendritic cells: 129.0;granulocytes: 333.6;monocytes: 466.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 76.7;PC-3: 23.7;RPTEC TERT1: 21.0;U-937: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA031257, HPA031258, HPA031259"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		890000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"		"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.2	10.8	5.3	28.1	5.1	24.8	8.2	5.4	5.9	5.4	5.8	10.1	10.3	3.2	2.0	5.4	4.9	21.2	3.3	4.5	6.8	5.8	12.8	23.9	12.4	10.0	6.6	2.9	3.6	2.9	2.3	14.2	8.8	6.4	13.0	1.6	9.0	4.0	1.0	1.3	11.9	12.6	8.9	57.8	11.2	1.4	9.7	15.1	1.8	3.3	8.3	13.9	2.1	14.7	0.2	5.4	0.3	0.1	1.2	3.9	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	12.1	0.0	0.3	0.0	0.0	0.0	0.0	9.4	0.7	17.8	0.0	0.0	1.6	6.2	15.3	2.1	0.0	0.0	0.9	1.1	2.3	0.1	0.6	2.2	0.6	0.2	2.4	76.7	0.2	18.0	23.7	2.6	0.0	1.2	21.0	0.0	0.2	1.1	0.2	0.0	0.8	0.0	0.0	14.4	2.0	0.6	0.2	1.4	1.0	4.6	0.9	0.3	0.4	60.8	1.7	324.3	322.4	333.6	7.3	466.0	11.9	8.3	13.5	3.7	129.0	4.5	2.3	1.3	271.1	11.9	423.1	22.6	13.9	216.7	5.3	5.1	5.4	5.9	4.5	6.8	10.0	6.6	8.8	8.9	9.7	14.7	3.9	3.2	10.8	8.1	9.9	0.4	1.2	0.5	2.8	1.0	3.0	3.0	1.1	5.7	1.7	1.8	6.2	0.6	16.4	0.8	9.8	5.2	0.4	1.0	0.6	5.0	1.8	12.8	1.2	9.5	0.5	2.9	7.1	3.8	71.0	0.5	16.8	8.6	88.8	3.3	1.8	1.9	12.2	193.6	19.5	0.7	0.3	132.9	3.6	191.1	63.7	4.9	26.8	3.0	5.9	4.4	7.9	0.0	16.4	5.8	0.2	6.3	1.0	4.1	19.7	1.3	1.7	0.5	0.7	26.2	0.6	0.5	13.4	0.3	2.7	1.2
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.2;Hepatocytes: 12.3;Syncytiotrophoblasts: 15.7;T-cells: 9.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 10.6;HUVEC TERT2: 11.6;TIME: 18.5;U-87 MG: 13.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	2.1	1.9	1.5	4.0	1.5	4.1	5.8	4.6	3.4	4.0	0.0	1.2	1.0	1.7	0.8	9.2	1.9	2.2	1.2	1.5	1.9	2.6	4.5	3.7	4.2	2.2	2.5	2.6	2.0	2.1	2.6	5.2	2.5	2.8	1.1	3.2	3.7	1.2	0.7	4.3	2.4	1.5	0.7	2.8	2.0	1.6	1.7	3.3	1.3	0.7	3.4	2.8	5.9	3.2	5.5	0.3	0.1	0.2	1.0	1.0	2.0	1.5	3.1	0.7	2.2	0.1	0.3	0.2	2.1	1.3	0.5	0.8	0.1	3.0	2.3	10.6	0.5	0.8	0.6	0.1	1.2	0.3	0.4	2.9	1.3	0.3	0.9	2.1	11.6	0.7	3.0	5.1	4.3	0.8	0.6	0.8	0.2	5.0	2.7	0.4	2.1	2.4	0.0	1.9	0.1	0.1	0.5	4.3	0.2	0.8	1.9	0.2	18.5	1.3	0.9	5.5	0.4	7.7	2.6	0.1	13.8	0.4	3.2	5.7	0.2	0.2	2.9	0.2	3.1	1.9	4.8	3.1	0.2	1.8	4.2	3.3	0.9	2.2	0.2	0.7	5.6	1.2	1.5	1.5	4.6	3.4	1.5	1.9	2.2	2.5	2.5	0.7	1.7	3.2	0.5	0.0	1.8	0.0	4.5	0.0	1.3	0.0	3.4	0.7	5.6	3.4	0.4	0.0	1.8	0.0	0.0	16.2	5.6	0.2	0.0	0.9	1.0	0.8	1.4	3.5	0.0	0.4	3.7	0.4	4.9	2.4	2.6	1.3	2.5	0.3	0.7	12.3	2.0	0.0	3.6	0.2	0.0	1.6	0.0	1.1	1.8	1.8	0.0	0.0	0.4	2.1	7.2	1.5	0.1	1.3	0.1	0.7	5.0	2.1	2.1	0.4	0.0	0.1	0.0	2.3	1.1	3.5	2.0	4.9	0.0	15.7	9.1	0.8	0.4	1.1
TCEAL6	WEX2	ENSG00000204071	"Transcription elongation factor A like 6"	Q6IPX3	X	102140476-102142970	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.4;pituitary gland: 73.4;testis: 26.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 40.4;Excitatory neurons: 9.1;Horizontal cells: 15.2;Inhibitory neurons: 10.4;Late spermatids: 6.7"	"Cancer enriched"	"Detected in single"	9	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045564, HPA058982"	Supported		Uncertain	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA045564: AB_2679369, HPA058982: AB_2683870"	"unprognostic (5.43e-2)"			"unprognostic (6.54e-2)"	"unprognostic (1.87e-3)"			"unprognostic (6.69e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.18e-1)"		1.6	10.7	27.3	0.2	24.3	0.0	0.6	23.1	41.4	1.5	3.6	1.7	0.2	3.6	1.4	0.0	5.7	0.1	0.5	23.8	35.4	1.0	0.0	0.1	0.0	27.3	32.9	8.5	0.4	1.8	73.4	0.0	26.3	0.8	0.2	16.7	1.8	0.6	0.0	0.3	0.7	0.7	19.2	0.0	0.8	26.8	26.0	0.0	0.5	0.2	0.0	0.0	1.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.3	24.3	23.1	41.4	23.8	35.4	27.3	32.9	26.3	19.2	26.0	22.5	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	40.4	0.0	0.1	4.6	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.0	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	15.2	10.4	0.0	0.0	0.0	0.3	6.7	2.5	0.1	1.8	1.0	0.0	1.9	0.0	4.5	1.7	0.4	0.0	0.7	0.0	0.5	0.0	0.0	0.0	4.3	0.0	1.4	0.9	1.9	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.1
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0"	"Low region specificity"	"Detected in many"							HPA028375	Approved					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	41.4	0.2	0.0	0.0	2.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	6.4	0.1	0.5	2.8	0.5	1.2	2.5	2.0	0.0	0.3	1.8	0.0	0.6	0.0	0.3	0.0	0.0	0.2	1.4	0.2	3.5	1.8	0.0	0.5	0.2	7.5	0.9	0.0	0.8	0.0	0.1	2.5	0.0	0.6	0.0	0.5	0.5	0.0	26.2	9.5	0.2	0.3	21.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.7	0.0	0.0	3.2	1.4	22.6	29.1	1.0	2.4	5.2	0.8	0.1	0.0	0.1
TDRD10	DKFZp434M202	ENSG00000163239	"Tudor domain containing 10"	Q5VZ19	1	154502219-154548147	"Cancer-related genes, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 55.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 61.8;Late spermatids: 89.0;Spermatocytes: 103.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;TIME: 1.4"					"Not detected"	"Not detected"			HPA054327			Approved	Vesicles		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA054327: AB_2682452"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.33e-3)"	"unprognostic (9.69e-3)"	"unprognostic (5.80e-3)"	"unprognostic (2.99e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (8.04e-5)"	"unprognostic (1.62e-1)"	11.1	4.5	3.7	0.5	3.7	0.1	6.8	3.1	3.7	5.1	3.3	2.8	0.7	4.2	2.3	2.4	6.5	1.6	7.6	3.3	3.2	3.5	4.5	8.1	0.8	3.2	3.5	10.1	0.9	0.9	2.6	1.7	3.3	3.9	1.3	0.1	1.8	1.2	1.9	2.3	3.5	1.8	3.2	8.9	1.9	55.6	3.7	0.5	11.0	1.4	0.4	3.9	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.7	3.1	3.7	3.3	3.2	3.2	3.5	3.3	3.2	3.7	3.1	10.0	3.2	6.7	4.9	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.5	1.3	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.1	8.2	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	1.3	0.7	6.1	0.4	0.4	0.0	0.5	0.0	0.0	4.0	2.1	89.0	2.5	1.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	103.7	16.5	0.1	0.3	0.0	0.0	0.1	0.0	0.0
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 46.3"	"Group enriched"	"Detected in many"	10	"Adipocytes: 70.8;Endothelial cells: 73.9;Hepatic stellate cells: 122.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 137.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 90.9;NTERA-2: 45.2;TIME: 99.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	20.1	9.1	8.1	5.8	7.0	0.2	14.0	6.1	8.4	9.3	4.3	5.0	3.7	12.4	2.3	5.3	6.7	11.2	16.8	7.1	6.8	23.0	10.5	28.8	3.7	7.2	6.6	3.5	3.5	4.4	3.0	46.3	7.6	3.8	5.4	0.7	3.1	6.2	10.5	2.8	5.5	12.7	6.8	28.8	4.0	1.4	9.4	1.8	9.1	22.9	2.8	6.9	3.9	6.8	0.3	0.0	3.5	0.0	0.4	5.6	0.1	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	2.4	0.0	1.6	0.0	0.0	1.8	0.0	2.2	0.8	0.1	90.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	45.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	99.1	0.0	0.5	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.1	7.0	6.1	8.4	7.1	6.8	7.2	6.6	7.6	6.8	9.4	6.8	70.8	3.2	1.3	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.5	8.6	0.0	0.6	1.8	0.0	0.4	0.4	0.0	0.0	0.0	0.6	0.6	0.8	73.9	0.0	2.7	4.3	0.0	2.8	4.2	0.0	0.7	0.0	0.3	122.0	1.3	0.3	0.0	5.0	0.0	0.0	6.7	2.2	0.9	0.6	0.4	0.0	38.4	0.0	0.1	0.0	137.7	2.1	1.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.2	0.0	1.6	1.9	0.1	0.4	0.3	1.3	1.4	0.5	1.8	0.0	0.0
TENT5B	"FAM46B, MGC16491"	ENSG00000158246	"Terminal nucleotidyltransferase 5B"	Q96A09	1	27005020-27012850	"Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 111.8;skin 1: 121.3"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 26.8;Breast myoepithelial cells: 24.8;Distal tubular cells: 23.5;Endometrial ciliated cells: 11.7;Glandular and luminal cells: 10.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 62.0;hTERT-HME1: 31.6;NTERA-2: 32.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"				"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	8.5	0.9	0.5	2.6	0.5	0.0	15.7	1.5	0.8	30.9	0.5	45.9	1.1	24.8	0.8	111.8	16.4	1.8	26.3	0.4	0.7	5.8	0.4	12.8	0.2	2.2	0.5	3.6	1.9	1.9	2.6	3.2	1.3	12.3	1.7	3.0	27.6	15.5	2.1	121.3	10.6	12.2	0.3	0.6	17.4	6.4	0.5	0.6	5.0	1.7	5.5	37.3	47.3	0.5	3.9	0.6	7.6	2.3	0.9	1.2	1.9	5.5	1.8	21.5	8.5	15.3	5.0	0.0	9.1	3.0	4.8	12.4	1.3	20.1	5.8	0.0	1.2	0.2	2.9	2.6	10.6	0.1	0.3	4.8	62.0	6.6	31.6	0.0	0.3	0.0	0.4	0.0	2.8	3.0	0.0	1.2	32.8	2.8	1.5	0.4	0.0	0.2	21.3	0.0	0.9	0.6	10.6	23.4	14.3	15.9	18.6	0.3	0.5	5.2	18.0	0.6	1.1	0.3	0.8	0.0	1.1	0.1	3.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.5	0.8	0.4	0.7	2.2	0.5	1.3	0.3	0.5	0.5	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.8	24.8	0.0	0.0	0.0	0.0	0.0	3.2	0.4	0.0	23.5	1.8	0.0	11.7	1.8	0.5	0.0	0.0	0.0	1.9	3.1	0.5	0.0	10.8	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210506-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 197.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 386.6;Glandular and luminal cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA		34000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	29.3	7.2	2.7	54.4	2.7	44.1	32.2	3.4	3.6	29.0	10.0	134.7	41.1	105.9	21.7	58.2	45.2	37.4	14.7	2.3	2.9	19.3	10.1	41.0	49.6	6.4	3.5	7.3	20.8	15.3	5.7	25.6	3.4	55.2	69.0	13.4	34.2	197.1	5.1	23.2	47.5	147.6	3.2	30.0	52.1	39.9	4.3	33.5	66.4	8.9	51.3	87.1	41.1	3.0	115.9	24.0	27.0	0.2	11.7	29.7	62.3	58.9	28.9	10.9	10.6	60.4	126.2	0.0	230.0	41.7	1.3	116.9	14.4	87.3	26.4	57.3	46.0	11.5	53.1	30.5	69.9	53.6	0.2	66.4	263.6	37.7	95.0	74.9	31.1	0.0	11.9	39.5	3.0	24.4	0.2	0.7	17.8	134.0	67.4	0.2	0.4	46.0	110.9	44.0	12.4	113.4	85.5	267.1	68.2	77.6	0.3	21.5	52.3	0.6	1.5	86.2	0.7	92.6	48.9	1.3	7.4	27.2	89.3	274.7	79.2	221.5	150.2	132.1	144.7	104.6	113.4	137.6	86.9	95.5	111.0	127.6	41.6	205.1	170.5	20.7	130.4	162.8	2.7	2.7	3.4	3.6	2.3	2.9	6.4	3.5	3.4	3.2	4.3	3.0	40.8	243.6	47.0	0.0	60.4	200.4	196.2	64.8	60.3	2.2	62.2	57.0	16.1	47.1	81.7	36.8	12.5	23.2	121.3	140.8	21.5	110.7	386.6	176.7	29.9	49.0	50.6	17.7	0.1	112.3	78.1	23.6	84.1	283.9	18.9	54.1	25.7	11.9	15.4	1.7	0.1	100.7	34.6	58.0	119.0	112.5	1.8	78.0	28.4	10.3	77.6	24.7	201.8	0.0	0.3	196.8	112.1	0.4	76.3	102.4	65.3	13.6	68.1	13.9	6.6	9.0	42.3	19.1	10.6	55.9	122.7	29.1	79.2	8.8	79.7	135.9
TESPA1	"ITPRID3, KIAA0748"	ENSG00000135426	"Thymocyte expressed, positive selection associated 1"	A2RU30	12	54948015-54984762	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.3;lymphoid tissue: 75.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 202.7;granulocytes: 120.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HEL: 247.1;HMC-1: 187.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058823, HPA079222"	Approved		Supported	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058823: AB_2683828, HPA079222: "	"unprognostic (1.98e-5)"	"unprognostic (3.70e-4)"	"unprognostic (3.87e-4)"	"unprognostic (1.13e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.55e-4)"	"unprognostic (2.29e-3)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-4)"	"unprognostic (1.35e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	1.3	0.5	19.6	13.9	37.6	14.5	1.7	12.0	81.3	1.9	11.9	3.7	3.0	2.3	4.8	1.9	1.3	4.8	1.0	36.6	13.2	0.8	0.9	5.8	36.4	11.6	12.2	6.9	0.9	0.7	0.6	0.5	12.1	1.5	4.8	1.0	1.4	1.1	1.4	1.0	7.5	2.1	11.4	13.5	3.9	0.9	16.1	75.2	1.1	0.6	36.4	4.0	1.1	44.2	0.2	0.4	0.6	0.4	0.7	0.7	3.2	0.0	0.7	0.2	0.3	0.0	0.4	17.5	0.2	0.7	0.6	0.4	0.7	0.4	0.3	20.0	0.6	247.1	0.8	0.3	0.6	13.6	187.7	0.5	0.4	0.4	0.7	0.5	0.0	41.5	1.0	16.3	0.4	0.4	39.1	1.5	0.5	0.2	0.2	9.3	0.3	2.7	0.6	0.9	0.5	0.2	0.6	0.1	0.5	0.7	0.2	3.6	0.3	0.4	0.4	0.2	0.2	11.1	0.4	12.0	1.7	4.0	0.4	43.1	1.4	1.6	38.3	1.3	43.5	17.9	126.0	57.5	16.0	15.0	175.8	98.8	3.1	57.2	1.5	5.6	92.6	64.5	19.6	37.6	12.0	81.3	36.6	13.2	11.6	12.2	12.1	11.4	16.1	44.2	0.7	0.0	4.3	10.1	9.9	0.5	0.0	0.0	0.0	0.0	0.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	32.4	202.7	0.0	0.0	1.3	0.0	0.1	120.1	0.0	0.4	0.5	0.1	0.0	2.5	0.0	0.0	1.3	1.6	0.0	0.9	4.6	1.8	2.8	3.3	0.0	25.7	7.1	5.1	0.0	0.0	1.2	3.4	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.0	0.0	0.2	0.0	0.3	0.0	37.0	0.8	0.1	0.0
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7525.8;retina: 2433.0"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000	"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	80.9	1.2	186.3	1.0	412.5	2.4	13.3	591.8	274.2	2.0	58.9	2.3	0.9	1.7	1.4	11.0	1.4	1.9	12.1	173.7	287.7	3.4	7525.8	1.9	1.3	786.9	385.4	2.1	4.6	2.2	4.4	1.3	628.2	5.4	1.2	2433.0	55.8	1.8	2.1	4.2	1.6	1.5	484.9	2.9	1.9	14.3	398.1	1.2	2.2	2.7	3.0	1.2	2.8	862.1	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	186.3	412.5	591.8	274.2	173.7	287.7	786.9	385.4	628.2	484.9	398.1	862.1	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
TFCP2L1	"CRTR1, LBP-9"	ENSG00000115112	"Transcription factor CP2 like 1"	Q9NZI6	2	121216587-121285202	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 49.1;salivary gland: 97.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 79.1;Distal enterocytes: 117.9;Glandular and luminal cells: 83.0;Ionocytes: 262.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 21.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.2;HEL: 15.7;hTCEpi: 17.3;RPTEC TERT1: 42.4;RT4: 31.8;SCLC-21H: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029708	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoli fibrillar center"	Mitochondria	"HPA029708: AB_10602479"	"unprognostic (8.85e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"prognostic favorable (7.72e-6)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.01e-1)"	1.9	0.3	0.9	1.7	1.6	0.2	28.7	1.7	1.1	18.1	19.0	19.0	0.6	0.5	8.3	13.3	3.5	2.9	0.2	1.7	0.9	49.1	0.2	5.6	0.2	1.6	2.1	0.1	6.4	2.6	0.8	7.4	1.1	13.6	22.6	0.0	97.5	2.0	2.6	31.9	3.2	0.6	0.7	1.8	16.3	1.1	1.9	0.2	37.6	0.1	1.2	1.8	10.9	0.7	0.0	1.6	0.0	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.7	0.0	0.7	0.4	4.4	4.5	0.0	0.0	3.2	15.7	0.0	0.0	0.0	0.0	0.6	0.0	17.3	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.9	0.1	0.0	0.5	2.1	42.4	31.8	13.3	0.1	1.7	0.1	0.0	6.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.7	1.1	1.7	0.9	1.6	2.1	1.1	0.7	1.9	0.7	0.1	6.4	28.8	3.9	0.3	1.7	38.0	10.3	28.5	0.0	22.1	11.6	2.6	17.2	35.4	79.1	0.0	32.2	0.9	117.9	31.3	2.7	0.1	43.5	5.8	1.0	10.2	0.0	0.2	1.5	2.3	0.8	58.6	83.0	0.0	1.2	0.0	0.4	4.9	0.0	0.3	31.2	262.4	4.6	0.8	0.5	0.3	5.5	7.2	9.4	0.2	0.5	0.0	0.0	0.1	7.4	28.0	0.0	2.1	36.3	0.3	27.7	11.9	0.0	0.0	1.9	1.1	0.1	1.5	41.0	3.3	20.2	1.1	9.5	44.3	40.7
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 17.2;kidney: 20.5;lymphoid tissue: 22.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 45.5;Kupffer cells: 56.3;Macrophages: 61.6;Microglial cells: 60.0;monocytes: 44.1;Proximal tubular cells: 77.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 7.1;intermediate monocyte: 2.8;memory B-cell: 3.8;myeloid DC: 6.3;naive B-cell: 2.5;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	29	"B-cells: 3.8;dendritic cells: 6.3;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"HEL: 15.9;HUVEC TERT2: 11.0;THP-1: 21.5;TIME: 12.5;U-937: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	3.5	2.4	1.3	19.2	1.2	17.2	2.6	1.5	1.6	1.9	2.1	2.7	4.2	1.4	0.6	1.0	1.0	4.9	1.0	0.8	1.7	20.5	3.1	9.9	22.1	3.3	1.9	1.3	1.0	0.4	0.6	4.7	2.7	1.0	4.2	0.1	1.3	0.9	0.3	0.4	9.7	3.1	2.7	14.6	3.0	1.6	3.7	2.8	0.9	0.4	12.6	4.0	0.6	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	3.7	0.0	1.7	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	21.5	12.5	2.1	0.2	1.3	0.0	5.5	0.0	0.0	0.1	24.4	1.1	0.0	7.1	0.0	0.0	2.8	0.0	3.8	0.0	0.0	6.3	2.5	0.0	0.0	0.1	0.0	0.4	3.3	0.0	1.5	1.3	1.2	1.5	1.6	0.8	1.7	3.3	1.9	2.7	2.7	3.7	4.8	0.5	0.0	2.2	0.3	18.1	0.5	0.0	0.0	0.0	0.0	0.3	0.8	0.8	1.5	0.0	3.7	0.0	0.2	8.3	0.0	0.0	0.0	2.4	0.0	0.0	1.7	0.0	7.2	0.6	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	45.5	0.0	0.5	0.4	0.0	56.3	17.8	3.8	0.0	61.6	0.0	60.0	44.1	0.0	1.0	1.0	0.1	0.1	0.0	0.0	1.3	0.1	15.6	77.8	0.0	0.0	0.0	0.3	0.1	0.3	2.5	0.1	0.4	0.8	0.8	0.1	0.7	0.1
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366535	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"stomach 1: 7973.0"	"Group enriched"	"Detected in many"	9	"Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"MCF7: 13512.4;OE19: 5337.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"	NA	NA		950000		"Cluster 4: Stomach - Digestion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favorable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	2.3	0.3	0.0	20.3	0.0	0.0	26.7	0.0	0.0	9.7	0.0	114.7	34.8	0.2	0.0	18.3	0.9	167.2	0.6	0.0	0.0	0.9	0.8	1.3	0.2	0.0	0.0	0.2	10.7	0.0	0.2	1.1	0.0	25.0	108.4	0.0	32.4	0.7	0.2	0.1	68.4	4.8	0.0	3.1	7973.0	0.1	0.0	0.2	5.3	0.0	0.2	30.6	2.2	0.0	0.0	42.7	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	16.2	5.7	0.0	1.1	0.0	1.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	13512.4	4.6	0.5	5.5	5337.9	223.4	1.7	0.0	0.2	0.0	1.4	0.3	0.2	0.0	5.0	0.0	1.3	5.0	0.1	0.0	0.0	3.5	0.1	0.0	3.6	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	18.7	0.0	6.1	5.9	0.0	0.0	432.7	197.2	0.0	564.7	12.1	35.0	0.0	0.1	3.1	601.9	0.0	245.7	0.0	1.8	0.2	3.5	430.2	0.0	0.0	821.8	3.1	5.1	12908.9	2.9	13.4	0.0	0.0	1.6	0.2	0.0	0.0	1395.6	111.9	0.0	0.0	0.0	0.0	9.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	14603.3	500.9	0.0	40.6	432.4	78.0	0.0	2.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	8.9	0.0	80.0	232.6
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 265.6;intestine: 264.4"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 92.2;Peritubular cells: 179.0;Sertoli cells: 223.5;Smooth muscle cells: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 100.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		800000	"Cluster 34: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	65.5	17.0	4.8	22.7	5.1	1.0	52.8	4.6	6.9	119.0	4.4	264.4	14.5	265.6	12.4	38.2	143.2	14.4	48.5	4.6	4.7	26.6	9.7	54.7	4.8	5.6	4.6	78.6	8.2	8.6	8.2	19.7	5.0	87.6	23.9	0.7	21.0	80.8	13.1	28.5	61.7	106.1	4.7	33.0	78.5	10.2	5.1	1.4	26.8	10.5	4.9	171.1	73.6	4.4	13.3	16.6	25.9	0.0	25.4	46.1	0.3	70.8	64.8	43.6	30.1	6.6	4.5	0.0	65.1	62.3	29.1	20.6	6.0	13.3	56.4	0.1	0.3	17.5	29.1	3.7	67.4	0.0	19.8	31.1	18.7	27.5	16.3	100.0	29.2	0.0	1.5	0.0	51.9	0.1	0.0	1.6	1.4	1.4	16.2	0.0	30.9	0.1	12.5	6.6	0.0	19.0	27.5	0.2	14.1	20.9	0.1	1.7	82.4	79.8	19.2	21.4	31.8	0.1	0.1	0.2	34.9	0.8	49.6	9.5	0.0	0.1	0.2	0.0	0.3	0.9	0.9	0.1	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.3	1.6	1.3	4.8	5.1	4.6	6.9	4.6	4.7	5.6	4.6	5.0	4.7	5.1	4.4	76.9	6.4	4.8	0.0	0.4	12.6	23.9	34.8	14.8	0.4	4.1	71.5	13.4	5.7	3.4	7.3	0.0	1.2	1.5	1.8	7.9	33.3	1.2	3.6	76.2	48.8	0.0	11.0	0.1	22.5	1.2	64.4	4.6	2.9	6.3	35.3	29.6	0.3	14.6	0.0	0.1	4.7	0.0	0.3	15.4	3.3	92.2	9.3	40.9	2.8	4.2	7.0	0.0	3.5	0.1	28.4	2.2	179.0	1.4	20.1	13.3	19.7	1.1	1.4	223.5	17.4	176.0	1.5	3.6	1.9	11.2	1.8	2.6	20.3	5.3	4.6
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 391.5;Endothelial cells: 236.4;Hepatic stellate cells: 478.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 313.6;ASC TERT1: 472.3;HSkMC: 430.0;LHCN-M2: 381.7;TIME: 418.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		810000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	230.0	56.1	16.5	73.8	12.9	29.4	145.7	13.8	19.3	90.0	30.6	96.0	44.2	69.1	18.2	44.9	69.6	91.9	95.2	10.6	13.4	67.9	59.1	148.0	70.1	17.6	16.5	26.6	52.0	59.0	16.9	81.6	16.7	44.1	54.1	2.1	49.2	60.8	31.1	39.1	77.7	107.2	17.3	111.1	63.4	7.8	21.5	49.7	91.8	62.2	60.7	98.0	55.1	17.2	16.6	100.2	5.3	0.1	313.6	472.3	15.9	83.9	116.1	28.5	27.7	22.9	86.6	2.2	298.2	117.2	32.2	33.3	4.0	125.4	42.0	7.0	8.9	10.1	10.7	104.5	128.5	14.9	76.6	430.0	93.6	126.3	114.4	117.0	296.0	10.9	1.8	0.0	381.7	1.3	16.2	10.5	2.2	75.7	39.8	14.1	36.4	2.1	113.5	40.5	0.1	5.6	24.9	6.1	22.0	6.6	0.0	14.0	418.6	134.7	33.2	61.4	32.0	2.8	0.3	12.5	80.1	16.1	55.8	9.0	3.0	11.5	3.4	3.1	3.3	4.5	4.8	3.3	2.6	6.4	16.6	7.3	13.1	1.9	8.0	6.6	0.7	3.8	16.5	12.9	13.8	19.3	10.6	13.4	17.6	16.5	16.7	17.3	21.5	17.2	391.5	144.2	99.7	0.7	77.0	37.3	18.9	23.5	39.9	5.1	23.7	24.1	84.5	50.1	39.5	27.6	0.0	6.8	85.3	10.5	3.9	13.1	2.5	28.3	57.5	236.4	8.4	20.4	0.4	15.8	5.1	129.2	39.3	30.8	29.8	0.7	478.0	55.5	30.4	0.0	1.0	12.4	22.4	147.0	58.0	3.8	32.9	67.9	30.2	170.5	47.5	0.2	56.7	6.0	2.4	37.6	12.1	47.4	37.5	8.6	13.6	7.2	14.7	1.2	32.9	60.8	53.4	0.3	1.2	8.0	30.5	3.7	68.2	1.7	14.5	10.8
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52416373	"Disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.0;Astrocytes: 25.5;Basal respiratory cells: 16.5;Endothelial cells: 29.9;Hepatic stellate cells: 17.2;Microglial cells: 17.8;Spermatocytes: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.9;HBEC3-KT: 19.9;hTCEpi: 19.0;hTERT-HME1: 19.5;HUVEC TERT2: 40.6;LHCN-M2: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796"	Uncertain		Supported	Cytosol	"Intracellular and membrane"	No	No		1400000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB020796: , HPA012611: AB_1857990"	"unprognostic (1.21e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.90e-2)"	10.0	2.0	7.9	1.0	7.4	0.2	8.7	5.5	8.5	5.3	4.5	2.8	0.7	5.2	2.8	3.1	5.1	3.3	9.0	8.2	5.5	3.0	2.2	11.5	2.1	6.0	5.4	2.1	1.4	1.4	3.4	11.3	5.8	4.1	1.4	6.8	3.9	1.9	4.5	6.3	2.7	4.7	5.6	5.9	2.1	2.1	6.4	1.4	5.0	10.4	1.6	3.8	4.5	5.9	0.9	3.9	0.5	3.5	3.1	10.3	0.8	8.4	4.1	3.2	5.1	0.1	0.7	0.3	1.0	19.9	3.1	4.4	0.0	19.9	4.9	9.3	2.9	0.5	0.0	0.0	1.9	2.1	0.6	4.1	19.0	15.4	19.5	1.8	40.6	1.2	0.0	0.3	18.6	0.0	0.7	0.4	0.3	0.2	0.9	0.6	4.3	0.0	4.5	0.2	0.1	0.7	0.2	0.1	0.8	0.2	0.4	0.3	9.6	1.0	1.7	0.0	6.3	0.6	0.1	0.1	1.8	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.4	5.5	8.5	8.2	5.5	6.0	5.4	5.8	5.6	6.4	5.9	22.0	0.0	1.1	25.5	0.9	1.5	1.1	16.5	0.6	8.0	1.5	3.0	3.1	0.0	1.8	1.8	2.1	5.4	3.6	0.3	3.9	0.3	1.4	0.8	1.0	29.9	0.0	0.0	3.5	0.6	1.8	6.4	1.1	0.7	0.0	1.5	17.2	2.0	3.1	0.0	3.1	0.3	0.0	1.6	1.6	0.6	3.4	0.6	5.4	17.8	0.4	1.2	1.0	3.0	0.9	0.4	0.2	3.8	0.6	1.8	0.4	0.8	1.3	3.2	6.6	4.4	2.3	18.5	10.1	1.0	1.6	3.4	0.9	0.6	0.3	0.4
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300982-43323108	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 130.8;Endothelial cells: 108.8;Hepatic stellate cells: 128.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 2.1;NK-cell: 2.5"	"Group enriched"	"Detected in many"	24	"granulocytes: 2.1;NK-cells: 2.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 106.3;HUVEC TERT2: 238.4;TIME: 210.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		87000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	47.0	10.1	16.6	8.1	14.8	0.9	37.8	14.6	16.9	14.0	10.1	11.2	5.2	20.4	5.3	6.5	16.0	13.3	34.2	13.1	14.2	19.8	6.7	35.3	10.1	16.4	16.5	7.5	4.2	3.2	8.0	48.6	16.8	10.8	3.1	0.4	7.4	6.5	14.0	7.9	11.0	14.1	13.9	19.9	8.8	3.0	21.1	2.1	24.2	20.7	2.9	15.1	11.8	14.8	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	106.3	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	41.9	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	1.7	238.4	0.0	0.0	0.0	0.0	0.0	0.0	20.4	1.3	0.0	0.1	8.1	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.1	210.0	1.2	0.4	0.0	0.2	0.0	0.2	0.4	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	16.6	14.8	14.6	16.9	13.1	14.2	16.4	16.5	16.8	13.9	21.1	14.8	130.8	0.0	4.2	0.0	0.4	2.2	0.6	0.0	1.2	0.3	1.0	0.9	4.9	1.5	1.8	0.0	0.0	0.3	0.7	0.9	0.0	0.0	2.0	0.1	0.4	108.8	0.0	2.5	0.4	0.2	0.1	3.1	0.0	0.4	20.3	0.1	128.8	1.3	0.5	0.0	0.2	0.1	0.0	5.6	3.1	2.5	2.1	1.1	1.8	29.0	0.1	0.1	1.0	1.0	1.1	0.0	0.0	0.7	0.1	0.7	0.1	0.9	3.6	0.9	0.0	2.2	2.2	0.9	0.7	0.5	1.4	0.3	2.3	0.5	0.2	0.7
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 38.7"	"Group enriched"	"Detected in some"	10	"dendritic cells: 64.2;NK-cells: 69.0;T-cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 195.5"	"Lineage enriched"	"Detected in many"	11	"T-cells: 195.5"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.24e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"	0.7	0.3	0.3	12.1	0.5	2.1	0.7	0.6	0.5	0.8	0.2	2.1	1.7	0.9	0.7	2.1	0.5	3.6	0.7	0.4	0.4	0.4	2.9	2.9	38.7	0.8	0.5	0.5	0.2	0.1	0.2	0.3	0.7	1.4	2.4	0.3	1.8	0.2	0.1	1.0	5.2	0.9	0.4	15.0	3.7	0.8	0.7	9.0	0.9	0.0	20.4	5.1	0.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.5	0.0	0.2	0.1	0.0	0.4	0.2	0.1	29.8	0.2	3.5	1.4	48.5	90.3	0.2	0.9	5.2	39.8	0.7	17.3	0.2	1.0	195.5	22.0	0.3	0.5	0.6	0.5	0.4	0.4	0.8	0.5	0.7	0.4	0.7	0.9	0.9	0.0	3.3	0.0	3.7	3.1	0.1	0.0	0.6	0.4	0.4	0.6	0.6	0.0	1.3	0.0	2.1	0.1	64.2	0.0	0.0	0.0	0.0	0.2	1.0	0.6	0.0	0.4	0.0	0.0	0.0	0.9	2.6	0.4	1.3	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	1.8	4.2	0.3	0.0	2.3	3.6	0.0	0.9	0.1	69.0	0.0	0.1	0.0	0.0	0.0	6.9	0.2	0.0	0.1	0.0	0.6	0.0	1.0	0.5	0.7	3.0	0.2	3.3	0.0	78.4	0.0	0.2	0.0
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 941.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 475.9;Late spermatids: 491.0;Leydig cells: 353.6;Peritubular cells: 770.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.6;monocytes: 5.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1327.4;ASC TERT1: 1618.4;BJ hTERT+: 960.2;fHDF/TERT166: 1070.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	461.0	185.1	171.5	92.3	140.8	20.1	290.6	110.6	122.1	576.3	117.9	280.5	71.0	525.4	116.8	176.0	272.7	397.9	244.8	128.6	157.0	120.7	62.8	231.7	77.7	157.4	161.5	941.0	79.1	64.0	103.6	218.1	156.2	196.2	107.6	43.5	107.2	267.5	56.6	245.2	149.5	381.6	141.5	172.0	140.9	150.4	178.0	80.0	155.6	119.8	38.7	261.2	331.0	168.1	170.0	84.0	93.0	178.8	1327.4	1618.4	50.2	585.0	960.2	280.1	221.1	30.8	288.6	0.2	200.8	1070.2	307.4	32.9	29.1	25.2	291.4	3.4	16.6	0.1	156.0	48.1	392.7	2.6	1.2	641.1	12.0	276.8	44.3	722.5	375.9	54.4	0.2	0.5	292.5	19.5	176.8	29.7	16.6	34.2	122.8	118.0	213.2	73.4	178.7	2.3	47.6	290.3	366.6	170.8	776.3	111.6	86.8	42.2	450.3	744.2	140.5	438.0	102.8	84.1	74.9	1.5	171.0	32.0	367.6	0.0	5.0	7.4	0.0	3.4	0.0	0.1	0.1	0.0	2.2	0.2	0.2	0.3	13.6	0.2	4.3	1.4	0.1	0.9	171.5	140.8	110.6	122.1	128.6	157.0	157.4	161.5	156.2	141.5	178.0	168.1	147.9	112.2	34.3	24.2	18.7	98.9	9.0	5.7	9.1	37.5	9.7	37.6	41.9	52.9	20.8	25.8	8.4	4.3	6.1	46.0	0.0	78.0	143.7	17.0	190.3	115.0	7.8	12.4	9.8	22.0	87.7	475.9	17.9	24.4	7.0	97.5	259.5	7.9	208.8	3.3	107.7	14.3	12.2	177.4	171.4	491.0	353.6	184.8	275.7	96.5	87.3	39.9	5.2	60.8	143.5	83.3	6.0	770.7	33.1	10.1	12.8	0.8	5.4	12.7	92.1	111.8	171.9	8.5	7.7	5.6	75.9	14.8	17.5	96.0	2.3	6.9
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708362-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.0;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 238.7;Early spermatids: 405.1;Paneth cells: 140.4;Proximal enterocytes: 130.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 1.2;MAIT T-cell: 3.9;memory CD4 T-cell: 3.1;memory CD8 T-cell: 2.4;naive CD4 T-cell: 3.3;naive CD8 T-cell: 1.2;T-reg: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.0;CAPAN-2: 41.1;MCF7: 20.3;OE19: 37.4;SK-BR-3: 25.7;T-47d: 52.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.2	4.7	0.1	0.1	4.0	0.1	0.4	6.3	7.4	34.1	43.0	1.5	2.4	25.5	13.7	6.2	0.0	0.4	0.1	5.8	7.1	5.2	0.4	0.2	0.4	0.1	6.4	7.5	1.7	1.6	0.2	4.0	13.2	0.1	20.8	5.3	0.7	7.3	37.4	0.5	0.0	0.5	27.0	2.5	0.0	0.2	6.9	0.0	2.6	4.1	6.0	0.3	0.3	8.3	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	13.0	41.1	8.2	1.3	0.0	0.1	10.4	0.6	0.0	0.0	0.5	0.2	0.0	0.7	2.9	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.3	0.0	20.3	0.0	0.3	0.9	37.4	0.2	0.1	0.0	6.2	1.4	6.8	0.2	0.2	1.6	25.7	0.0	3.3	52.2	0.2	0.0	0.1	1.0	0.1	0.0	1.7	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	3.9	0.4	3.1	2.4	0.0	0.6	3.3	1.2	0.0	0.0	0.0	0.0	3.8	1.2	0.2	0.1	0.1	0.4	0.4	0.1	0.2	0.4	0.2	0.0	0.0	0.3	0.1	9.6	13.7	0.3	1.9	0.0	7.0	21.0	0.0	0.0	20.3	6.3	0.9	34.3	42.1	31.3	0.0	32.1	0.8	238.7	19.6	21.1	405.1	31.2	1.1	0.5	12.5	0.0	0.9	23.6	4.2	0.6	52.5	13.2	4.5	0.1	0.0	7.3	2.7	0.0	0.9	50.9	24.4	0.3	0.3	36.5	1.8	0.8	3.6	0.0	0.1	0.0	0.0	0.5	1.4	21.8	140.4	1.2	0.2	6.5	130.4	8.0	86.1	0.0	0.0	0.0	3.4	4.3	4.8	8.0	0.1	40.2	4.3	0.0	62.1	25.6
TLCD3B	"DKFZP434I2117, FAM57B"	ENSG00000149926	"TLC domain containing 3B"	Q71RH2	16	30024427-30052978	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 41.7;retina: 67.9;testis: 104.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 16.7;SCLC-21H: 89.2;SH-SY5Y: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (9.31e-2)"	"unprognostic (9.72e-4)"	"unprognostic (7.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.40e-11)"	"unprognostic (1.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.09e-3)"	0.1	2.0	10.7	0.2	13.1	1.3	0.2	27.9	41.7	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	17.0	15.5	0.1	0.1	0.1	0.3	32.8	8.4	0.0	0.3	0.0	21.4	0.0	33.0	0.2	0.1	67.9	1.3	0.0	11.5	0.2	0.2	0.0	12.0	0.1	0.2	104.8	22.3	1.1	0.1	1.7	0.2	0.0	0.1	18.2	1.9	0.6	3.3	1.5	0.0	0.0	0.0	1.5	0.0	1.0	0.1	0.0	2.4	1.2	0.1	0.0	0.4	0.8	0.2	0.1	0.9	2.8	0.4	0.0	0.2	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	1.1	0.0	9.7	0.1	9.6	0.2	0.8	2.9	0.6	16.7	0.2	0.9	7.4	1.2	1.2	0.0	0.0	89.2	33.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.4	2.3	0.4	0.4	8.8	0.3	0.3	1.7	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	13.1	27.9	41.7	17.0	15.5	32.8	8.4	33.0	12.0	22.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLCD5	"MGC17839, TMEM136"	ENSG00000181264	"TLC domain containing 5"	Q6ZRR5	11	120325296-120333686	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 51.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA074432: AB_2686689"	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	13.1	11.3	1.0	15.2	0.2	3.3	13.4	10.9	5.0	8.8	2.8	0.6	5.1	7.6	1.5	5.7	3.2	11.0	10.9	12.1	3.6	0.8	4.8	1.4	12.3	15.3	7.7	3.9	4.5	7.0	7.2	12.0	4.9	1.1	51.9	2.0	3.3	1.2	1.3	1.9	3.8	11.3	2.6	2.5	3.1	12.6	0.8	5.4	1.9	1.4	3.5	3.5	14.0	2.4	6.0	15.8	10.9	10.9	16.8	3.0	5.0	12.3	8.4	12.7	3.2	10.2	0.0	15.3	3.2	16.2	1.6	10.1	3.8	9.8	0.0	6.3	8.1	6.1	5.4	12.4	0.0	0.0	14.7	2.8	11.4	17.0	19.7	9.2	9.5	2.2	14.8	10.9	2.9	0.0	0.1	5.1	0.6	3.8	6.3	4.9	0.8	10.4	2.2	8.3	7.2	7.3	0.9	1.5	13.4	9.3	0.2	6.9	8.7	9.0	2.0	3.1	0.2	0.0	0.0	2.6	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	11.3	15.2	13.4	10.9	10.9	12.1	12.3	15.3	12.0	11.3	12.6	14.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732195	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Macrophages: 323.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		1300000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	125.7	62.7	31.1	84.7	42.1	79.2	79.4	39.3	31.1	80.0	43.1	196.2	36.5	151.8	25.3	78.0	102.9	53.2	81.2	26.2	34.9	47.3	42.3	91.8	63.1	50.8	41.9	66.0	33.1	41.6	36.7	70.4	49.7	72.6	41.4	7.7	42.5	111.4	70.9	46.7	77.9	145.4	41.5	89.7	91.8	23.3	44.9	61.1	49.0	55.8	52.7	147.7	66.3	44.6	63.4	103.8	62.7	86.9	210.8	158.7	71.4	171.2	186.8	162.9	146.4	86.3	27.4	76.5	55.5	319.0	103.0	33.3	74.2	106.9	118.3	172.8	48.0	173.0	132.1	77.4	130.6	105.8	276.2	193.4	50.2	240.1	112.7	223.7	253.4	64.7	60.2	76.0	218.5	27.8	71.5	27.8	51.3	28.4	78.8	95.0	36.6	44.8	81.4	49.8	14.1	59.6	83.7	46.3	53.4	56.5	39.3	72.6	308.5	257.8	99.6	80.0	140.6	26.2	27.6	51.7	199.9	55.9	238.4	6.0	5.9	7.3	5.4	6.1	4.4	2.6	3.1	4.1	4.3	2.3	1.4	3.1	10.0	4.1	8.1	5.4	2.3	6.9	31.1	42.1	39.3	31.1	26.2	34.9	50.8	41.9	49.7	41.5	44.9	44.6	123.2	109.0	66.9	11.4	99.8	40.1	69.4	43.5	42.7	11.7	40.3	61.3	134.1	31.5	55.7	53.3	10.4	44.3	186.3	43.8	23.5	94.3	47.2	36.0	156.9	106.8	34.1	127.0	7.7	61.9	82.6	103.9	51.0	73.0	206.6	72.0	93.9	54.7	112.4	15.2	7.6	29.0	26.4	196.9	91.0	26.4	99.4	323.4	23.2	21.5	174.1	33.0	288.4	4.5	9.1	107.7	33.2	128.6	61.4	58.4	40.6	62.8	34.3	17.6	203.8	126.5	267.9	32.0	28.5	47.4	26.6	58.8	143.8	89.4	28.9	46.4
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 10.7;lymphoid tissue: 16.8"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 49.8;Macrophages: 21.1;monocytes: 39.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	74	"classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.6"	"Group enriched"	"Detected in many"	78	"dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001608	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	3.6	0.5	0.2	16.8	0.2	5.7	0.9	0.2	0.3	0.7	0.5	1.7	0.8	0.4	0.1	0.9	0.6	2.5	0.8	0.1	0.3	0.5	2.2	10.7	6.1	1.1	0.7	0.4	0.6	0.3	0.1	4.3	0.8	0.3	1.8	0.0	0.3	0.2	0.2	0.2	1.5	3.8	0.5	13.3	0.8	0.4	0.4	1.7	0.4	1.3	1.9	3.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	14.9	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.0	27.6	0.0	15.6	0.0	0.0	3.8	0.2	0.2	0.2	0.3	0.1	0.3	1.1	0.7	0.8	0.5	0.4	0.9	0.0	0.0	3.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.7	5.3	0.0	0.0	0.0	0.0	49.8	5.1	0.0	0.0	21.1	0.0	0.0	39.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TLX2	"Enx, HOX11L1, NCX"	ENSG00000115297	"T cell leukemia homeobox 2"	O43763	2	74513463-74517148	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.0;retina: 3.1"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 20.9;Rod photoreceptor cells: 18.0;Spermatocytes: 4.3;Spermatogonia: 7.4"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"SH-SY5Y: 64.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062254			Approved	Nucleoplasm		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA062254: AB_2684727"	"unprognostic (7.30e-2)"	"unprognostic (3.03e-4)"	"unprognostic (9.54e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.40e-1)"	"unprognostic (3.92e-7)"	"unprognostic (2.51e-1)"	"unprognostic (6.86e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.18e-1)"	0.0	2.0	1.0	0.2	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	1.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.9	0.0	3.4	0.0	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.0	3.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	3.8	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.4	0.8	0.1	0.1	0.5	0.4	0.4	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	20.9	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	4.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377692	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 5463.1;Endothelial cells: 1843.0;Pancreatic endocrine cells: 2557.3;Prostatic glandular cells: 2717.0;Urothelial cells: 4902.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 703.8;hTERT-RPE1: 925.5;HUVEC TERT2: 633.3;LHCN-M2: 687.7;OE19: 672.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	365.9	71.3	41.9	50.5	43.1	2.6	192.8	44.1	68.2	82.6	65.6	61.6	38.3	74.9	58.2	210.9	74.7	237.6	181.7	42.2	45.2	155.1	92.6	229.8	25.2	45.1	43.9	49.7	211.7	19.9	20.2	194.6	47.7	79.9	59.9	6.0	180.9	32.0	50.2	63.5	62.2	94.6	45.4	120.5	129.7	19.5	53.5	17.0	72.5	64.2	60.2	150.9	115.5	45.9	367.9	401.9	0.0	1.0	108.4	422.2	0.6	115.2	455.5	23.9	8.8	159.7	703.8	0.1	351.3	23.5	545.5	434.0	1.9	80.0	22.9	0.9	0.0	3.9	391.8	521.8	39.4	0.0	0.5	40.0	19.1	169.7	81.5	925.5	633.3	0.0	0.3	0.8	687.7	0.5	0.0	0.7	1.5	672.9	170.7	0.2	0.9	0.8	449.3	54.8	0.2	0.5	46.8	25.1	4.4	6.0	0.8	1.7	404.7	233.6	38.9	4.8	244.3	0.5	0.7	1.1	337.4	0.4	62.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	43.1	44.1	68.2	42.2	45.2	45.1	43.9	47.7	45.4	53.5	45.9	1131.0	576.9	342.3	0.3	7.5	278.0	5463.1	668.3	272.6	0.1	956.5	363.1	24.0	274.5	984.3	57.0	0.0	0.8	17.0	176.6	0.0	1383.5	5.2	514.1	168.0	1843.0	39.2	15.6	0.0	1600.9	0.9	297.2	147.8	1807.5	31.5	0.2	1263.6	21.8	1.9	0.0	0.0	15.9	382.5	27.8	222.1	11.3	255.7	35.6	300.6	30.9	26.4	0.0	0.0	0.0	0.3	2557.3	251.8	176.0	11.1	2717.0	0.3	1.2	238.5	0.0	322.1	37.7	311.0	6.6	1.4	925.8	253.7	1.4	44.1	44.2	46.6	4902.9
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107572-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 195.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"			"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	6.5	3.9	5.4	5.2	6.0	5.3	4.6	7.7	8.8	3.3	6.3	2.6	2.0	2.8	2.1	3.1	2.8	3.7	9.6	5.2	5.6	1.9	2.3	10.7	5.7	6.8	6.0	1.7	1.2	1.8	0.9	7.8	6.6	2.1	2.6	2.8	2.9	1.3	47.3	1.8	2.6	3.9	6.9	6.2	2.1	3.6	5.4	2.2	10.4	21.8	3.0	3.8	1.5	7.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.3	5.6	0.0	0.2	0.0	0.3	0.1	1.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.3	23.2	0.0	0.0	49.6	1.6	0.1	0.2	0.0	0.0	0.1	0.3	27.7	36.4	0.9	0.0	0.4	0.0	0.0	3.0	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.4	1.2	0.3	0.2	0.0	1.9	0.5	0.0	14.9	68.3	0.6	0.9	0.1	0.3	2.1	0.0	17.0	0.1	3.4	0.1	76.6	31.7	195.8	5.0	13.4	0.0	0.3	0.5	0.8	18.9	0.9	0.1	0.8	118.1	5.0	6.4	2.6	0.0	11.8	5.4	6.0	7.7	8.8	5.2	5.6	6.8	6.0	6.6	6.9	5.4	7.6	30.5	0.0	6.0	2.9	0.9	2.4	0.1	0.4	0.6	1.6	0.5	1.8	1.2	1.5	0.8	0.0	0.0	0.3	7.5	0.0	0.0	0.2	13.1	0.6	0.2	16.7	0.0	4.4	18.7	2.0	0.4	1.5	0.0	0.3	44.4	0.0	7.9	0.1	50.9	0.0	22.4	0.0	0.0	37.8	46.4	7.4	0.9	45.9	3.6	46.9	19.4	0.5	16.5	2.0	1.9	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.4	1.3	0.0	1.4	0.6	13.1	7.5	0.1	1.7	0.3	4.2	0.1	0.0	0.1
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189149-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	28.0	35.2	7.5	10.5	7.6	3.7	25.6	7.9	7.9	29.2	18.2	23.9	12.7	31.1	31.3	25.4	27.9	17.5	21.7	7.4	7.7	25.1	34.6	26.7	7.7	8.8	9.4	24.8	46.8	36.6	20.0	18.1	8.4	23.4	15.5	5.9	35.6	21.3	19.5	24.2	21.4	18.1	8.5	19.4	29.4	20.2	8.3	8.3	30.7	11.1	12.4	23.8	23.6	8.4	22.0	45.1	17.7	18.0	59.4	40.4	22.4	37.6	55.4	53.7	60.5	19.1	49.0	12.5	25.2	50.3	30.7	50.5	14.9	29.7	39.3	18.4	15.4	9.4	21.3	56.2	41.8	18.5	22.8	41.3	56.1	36.9	50.5	42.3	32.3	7.9	11.2	30.7	43.6	51.2	12.1	15.7	8.4	62.1	39.2	15.6	22.1	24.7	42.5	37.9	16.3	18.6	39.0	44.3	24.5	16.8	28.8	14.1	26.0	47.5	21.2	23.1	28.1	31.0	25.5	7.4	18.1	11.5	39.5	33.4	20.5	25.0	14.1	18.1	15.3	15.0	14.6	12.6	23.4	16.3	13.0	12.9	28.3	23.1	18.5	39.2	17.2	13.5	7.5	7.6	7.9	7.9	7.4	7.7	8.8	9.4	8.4	8.5	8.3	8.4	5.5	16.0	5.3	8.8	11.2	3.3	6.1	7.3	18.8	4.4	6.1	5.0	1.5	7.2	7.6	1.8	14.6	9.8	5.0	4.0	0.0	8.2	13.9	5.2	7.4	8.7	1.8	5.5	6.6	4.9	10.4	14.9	13.7	6.3	2.5	5.3	5.0	4.8	4.1	0.0	7.1	3.5	6.1	2.5	4.5	6.2	5.3	5.6	1.8	4.7	5.3	5.4	4.1	9.0	7.3	5.3	6.1	4.5	54.3	7.7	3.5	3.0	30.0	7.6	6.6	10.1	7.4	7.0	5.4	19.5	4.7	11.9	9.1	5.7	4.1	3.8
TMC3		ENSG00000188869	"Transmembrane channel like 3"	Q7Z5M5	15	81331088-81374213	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	30	"parathyroid gland: 83.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040265, HPA040510"	Enhanced		Supported	Cytosol		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol		"HPA040265: AB_10795379, HPA040510: AB_10796123"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.20e-5)"	"unprognostic (2.32e-1)"	"unprognostic (1.97e-7)"	"unprognostic (1.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.96e-2)"	0.1	0.2	0.7	0.4	0.7	0.8	0.4	2.4	0.9	0.3	0.3	0.4	0.6	0.4	1.6	0.1	0.9	0.6	0.2	0.6	0.2	0.2	0.3	0.1	0.4	0.7	1.0	0.4	0.2	83.6	0.1	0.2	2.7	0.4	0.1	0.7	0.6	0.5	0.2	0.4	0.4	0.1	0.5	0.3	0.2	0.7	0.5	0.1	0.8	0.1	0.1	0.1	0.8	0.7	0.3	0.3	0.1	0.9	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.2	0.6	0.8	0.0	0.0	0.8	0.2	0.1	0.0	0.0	0.5	0.5	0.6	0.3	0.3	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.9	0.2	1.0	0.0	0.3	0.3	0.4	0.5	0.3	0.3	0.2	0.3	1.5	0.0	0.2	0.3	0.6	0.2	0.3	0.6	0.2	0.7	0.3	0.1	0.5	0.6	0.4	0.2	1.5	0.6	0.5	0.3	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.7	0.7	2.4	0.9	0.6	0.2	0.7	1.0	2.7	0.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.6	0.1	0.6	0.0	0.0	1.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.4;stomach 1: 46.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 69.7;OE19: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.6	0.1	0.2	3.1	0.4	1.5	12.7	0.5	0.3	8.9	5.6	21.6	45.4	2.1	17.5	1.2	5.1	25.5	0.1	0.3	0.0	0.3	0.6	18.9	0.2	0.2	0.2	0.1	2.3	6.0	0.1	3.2	0.2	12.2	22.7	0.2	22.8	0.2	0.1	1.8	53.4	1.1	0.0	0.1	46.0	3.8	0.2	0.1	0.7	0.0	1.1	3.2	0.5	0.2	6.9	10.8	0.0	0.3	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.1	69.7	0.0	0.3	0.0	0.2	4.4	1.1	0.0	0.0	0.1	0.1	0.0	1.8	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.1	0.0	0.2	2.5	41.5	3.1	0.0	0.0	2.6	0.1	0.3	0.7	0.2	0.1	2.1	0.0	1.1	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.1	157.0	162.5	0.0	1.8	0.8	22.9	46.6	2.8	0.3	57.4	17.9	0.9	102.9	282.4	22.0	2.1	39.0	1.0	173.7	0.0	121.1	32.8	107.0	6.9	2.9	38.9	8.0	1.9	166.3	3.4	3.3	188.1	88.4	5.7	11.0	0.7	0.6	2.7	3.3	2.0	101.5	26.4	0.0	1.1	32.6	0.3	1.8	1.8	0.0	1.0	0.2	0.0	0.5	0.9	302.2	180.9	0.7	0.5	103.1	374.3	2.0	624.7	1.9	0.0	0.4	9.5	1.3	1.1	2.2	1.7	16.3	1.3	1.5	125.1	55.9
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397775	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.2;skeletal muscle: 23.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.9;Excitatory neurons: 357.3;Inhibitory neurons: 475.3;Oligodendrocyte precursor cells: 480.0"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 24.2;LHCN-M2: 13.8;SCLC-21H: 21.0;SH-SY5Y: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		55000		"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: AB_2684993"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	1.4	11.3	6.3	1.5	9.6	0.2	1.5	3.4	10.0	2.0	3.2	1.5	0.4	2.4	0.6	9.6	1.7	0.8	6.8	9.6	2.9	0.4	0.1	11.0	1.7	0.0	4.1	0.3	0.3	3.0	2.2	2.4	4.0	1.0	1.3	35.2	1.3	2.0	23.1	1.4	1.6	5.5	0.0	1.3	1.3	13.9	7.9	1.3	3.1	7.0	2.3	8.3	0.8	0.8	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.7	1.0	1.8	8.5	0.0	0.0	0.0	0.0	24.2	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	13.8	0.7	0.1	0.3	3.8	0.0	0.0	0.0	4.8	0.1	1.1	0.0	21.0	92.6	0.0	0.1	0.3	5.5	0.2	0.0	0.0	0.1	0.1	0.0	3.4	1.3	0.0	0.7	1.8	0.0	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.6	3.4	10.0	9.6	2.9	0.0	4.1	4.0	0.0	7.9	0.8	0.6	3.2	4.6	209.9	0.0	2.4	0.5	0.2	0.0	10.4	1.3	2.8	1.7	1.5	5.0	0.0	102.2	1.8	0.0	0.0	0.0	0.0	80.6	1.0	0.6	1.3	0.0	0.0	357.3	0.4	8.6	4.6	4.1	0.2	1.3	5.5	0.4	0.0	0.3	1.7	475.3	0.0	0.0	0.0	0.8	38.2	0.9	0.1	0.0	33.7	0.0	5.7	0.0	480.0	22.2	0.3	0.0	0.7	1.2	0.2	0.0	0.0	0.0	57.6	0.0	6.8	3.3	17.2	11.2	0.0	1.6	1.1	1.0	4.9	0.0	0.4
TMEM114		ENSG00000232258	"Transmembrane protein 114"	B3SHH9	16	8537605-8590193	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"seminal vesicle: 19.6"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hypothalamus: 6.6"							NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 50: Fibroblasts - ECM organization"							"unprognostic (3.72e-5)"	"unprognostic (2.26e-1)"	"unprognostic (3.98e-3)"		"unprognostic (7.33e-2)"			"unprognostic (2.19e-1)"			"unprognostic (2.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"		0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	1.1	1.7	0.0	0.0	0.0	0.6	0.0	2.9	0.1	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.8	0.0	3.1	1.1	1.7	2.9	0.3	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM121B	CECR6	ENSG00000183307	"Transmembrane protein 121B"	Q9BXQ6	22	17116297-17121367	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.3;Hofbauer cells: 2.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;monocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;SCLC-21H: 14.2;THP-1: 11.9;U-937: 9.8"	"Low region specificity"	"Detected in all"							HPA068790	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA068790: AB_2686036"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.49e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-3)"	"unprognostic (5.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.88e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.10e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.37e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.71e-1)"	0.3	0.6	6.4	0.9	7.5	1.0	0.7	3.5	7.6	0.2	1.5	0.2	0.2	0.3	0.9	0.3	0.3	0.2	1.2	8.7	3.9	0.3	0.1	0.3	0.1	3.8	3.3	0.2	1.1	0.1	1.6	0.7	3.3	6.6	0.2	1.3	0.4	0.2	1.3	0.5	0.2	0.3	3.6	0.7	0.2	1.9	4.9	0.1	0.1	0.4	0.1	0.3	0.2	5.1	0.0	0.0	6.0	0.8	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.1	0.3	0.0	0.8	3.2	2.1	0.0	0.1	0.2	3.0	0.0	0.3	0.1	14.2	2.1	0.0	0.0	0.3	0.8	0.0	11.9	0.6	0.6	0.2	0.2	0.0	0.2	0.4	0.9	0.0	9.8	0.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	7.5	3.5	7.6	8.7	3.9	3.8	3.3	3.3	3.6	4.9	5.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	1.3	0.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269983-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 75.7;pancreas: 89.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 121.8;Alveolar cells type 2: 136.9;Distal enterocytes: 72.7;Proximal enterocytes: 164.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.8;BEWO: 21.8;CACO-2: 20.6;CAPAN-2: 48.3;OE19: 31.3;SK-BR-3: 41.2;T-47d: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015796			Approved	Midbody,Cytosol		Yes	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favorable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.3	0.7	17.4	3.2	32.2	0.2	11.5	27.6	29.9	16.4	12.8	21.2	35.4	1.6	18.3	10.9	15.5	11.3	0.9	17.0	20.7	16.4	1.1	75.7	0.3	31.5	28.5	1.4	89.6	22.2	31.0	4.4	29.0	22.0	21.0	0.1	31.8	7.1	0.0	12.9	27.5	0.8	22.6	0.3	27.4	1.5	26.8	0.4	44.9	0.0	2.5	2.9	3.4	42.8	26.8	0.0	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	20.6	48.3	0.1	1.2	0.0	0.0	11.7	0.0	7.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	12.1	0.1	0.1	1.1	31.3	0.0	0.0	0.0	0.7	0.4	8.5	12.4	0.1	0.0	41.2	0.0	3.6	33.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	17.4	32.2	27.6	29.9	17.0	20.7	31.5	28.5	29.0	22.6	26.8	42.8	0.2	121.8	136.9	0.0	0.9	0.0	2.3	18.0	0.6	0.0	30.4	15.2	0.5	42.9	56.0	16.5	0.0	33.5	0.1	72.7	17.6	39.1	3.7	20.1	1.4	0.6	21.7	0.0	0.2	38.5	2.2	0.6	45.3	13.1	1.3	4.9	0.0	0.0	2.4	0.0	0.2	63.0	34.6	0.0	0.2	7.9	0.3	0.6	0.0	0.0	0.6	1.7	1.0	0.0	55.3	22.7	40.1	1.2	0.6	12.2	164.2	33.9	43.8	0.0	0.0	0.0	2.3	1.4	0.3	2.1	0.4	7.3	1.0	0.1	38.6	9.1
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Uncertain		Supported	"Golgi apparatus"		NA	NA		9400	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	0.5	37.1	63.7	1.5	64.2	0.6	1.2	0.0	116.6	3.2	0.0	3.9	0.8	1.1	9.4	1.6	1.0	1.8	0.6	67.3	141.0	3.4	0.1	6.2	2.3	11.6	8.2	0.9	0.8	2.7	100.3	0.5	17.0	2.4	1.2	17.9	0.4	6.7	2.0	0.4	1.5	0.8	7.2	0.7	1.4	37.4	55.7	1.8	0.5	0.1	0.3	0.9	4.9	42.4	0.0	0.6	0.0	0.0	0.2	0.0	0.3	2.9	6.7	0.5	0.4	0.1	0.1	0.1	6.4	1.7	6.9	0.1	0.0	0.0	0.1	0.2	0.3	0.1	0.3	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	11.0	0.3	0.2	0.1	0.4	0.3	0.5	0.1	0.2	3.8	0.0	0.2	0.1	0.0	0.6	0.0	0.1	0.4	7.8	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.4	0.4	0.2	0.8	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	1.6	0.3	0.2	0.2	0.1	0.1	63.7	64.2	0.0	116.6	67.3	141.0	11.6	8.2	17.0	7.2	55.7	42.4	0.1	0.0	0.0	2.6	0.0	0.4	0.4	0.1	0.0	51.2	0.3	0.4	1.0	1.5	2.0	1.8	2.1	0.1	1.5	0.1	0.0	0.0	1.6	0.1	0.2	0.5	0.0	0.0	43.8	0.2	0.1	2.1	0.0	0.2	0.0	0.5	0.7	0.0	0.1	0.0	53.9	0.0	2.0	0.0	1.2	2.7	0.9	0.3	0.0	3.7	0.0	1.7	0.0	11.6	4.2	0.0	0.0	6.8	0.0	0.3	0.2	0.1	0.3	4.3	0.0	0.6	0.8	0.6	0.6	0.0	0.3	0.3	0.2	0.0	0.1	0.2
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM150B	"DRAM3, TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"intestine: 64.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	3.7	1.8	0.5	5.8	0.8	0.7	1.1	0.4	1.0	0.3	1.2	10.2	64.1	0.4	0.1	0.6	0.8	2.9	0.8	0.4	0.7	3.2	2.2	11.9	3.5	1.3	0.7	0.3	0.9	0.1	0.2	5.6	1.6	0.3	7.3	0.0	0.6	0.4	0.2	0.2	57.0	4.1	0.5	5.7	1.4	0.5	3.4	0.7	0.3	0.2	1.6	2.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.0	1.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	1.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	18.1	0.1	1.9	5.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.5	0.8	0.4	1.0	0.4	0.7	1.3	0.7	1.6	0.5	3.4	1.3	0.0	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	1.5	0.0	1.8	0.0	0.0	0.0	18.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.7	3.5	0.0	11.8	1.3	0.0	0.0	3.2	0.0	0.0	8.0	0.0	0.0	0.0	0.9	0.3	1.4	0.0	0.9	0.6	68.9	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.7	0.3
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291894-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 112.9"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 70.1"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	3.1	1.4	41.3	0.0	68.0	0.0	0.0	73.5	60.8	0.0	3.8	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.8	45.2	44.0	0.1	0.2	0.1	0.0	86.0	68.1	0.2	1.1	0.3	9.7	0.0	69.6	0.1	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	61.8	0.0	5.4	0.3	70.6	0.0	0.0	0.0	0.0	0.0	0.1	112.9	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.0	1.1	0.0	3.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	15.3	3.5	0.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	68.0	73.5	60.8	45.2	44.0	86.0	68.1	69.6	61.8	70.6	112.9	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.7	4.3	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.1	0.0	7.7	0.0	11.6	0.4	0.0	1.0	9.2	0.1	0.0	0.0	0.0	0.0	0.1	15.2	11.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.8	0.0	2.5	0.0	2.0	70.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270450-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 53.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 27.0;Inhibitory neurons: 31.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055167	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055167: AB_2682723"	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	0.1	2.9	12.4	0.4	20.9	0.2	0.2	47.4	53.7	0.3	0.0	0.9	0.5	0.2	0.0	0.2	0.3	0.0	0.6	34.8	2.9	0.2	0.2	0.1	0.2	8.4	4.3	0.3	0.4	0.0	3.9	0.0	11.3	0.3	0.3	2.8	0.3	0.0	0.2	0.2	0.7	0.1	1.5	0.3	0.5	0.8	12.9	0.1	0.3	0.0	0.0	0.1	0.4	15.7	0.0	0.1	6.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	0.7	4.9	0.1	0.2	0.5	0.0	0.1	0.0	0.1	28.6	5.9	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.9	47.4	53.7	34.8	2.9	8.4	4.3	11.3	1.5	12.9	15.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	5.3	0.1	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	31.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.8	0.0	0.4	0.0	4.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120569-73131809	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 35.6;kidney: 10.8;lymphoid tissue: 14.3;stomach 1: 25.4;thyroid gland: 31.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 28.6;Distal enterocytes: 106.0;Gastric mucus-secreting cells: 29.6;Ionocytes: 40.7;Paneth cells: 63.4;Proximal enterocytes: 41.9;Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"MAIT T-cell: 24.1;memory CD8 T-cell: 8.2"	"Lineage enriched"	"Detected in single"	89	"T-cells: 24.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.0;LHCN-M2: 66.1;RPTEC TERT1: 51.5;WM-115: 177.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"spinal cord: 3.7"	HPA042308	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.1	0.1	2.0	3.1	3.5	0.0	1.6	1.8	2.8	0.3	1.3	35.6	27.7	0.0	0.7	4.8	0.4	0.8	0.0	2.1	2.5	10.8	2.1	0.2	0.4	1.9	2.9	0.1	0.8	0.9	0.1	0.5	2.2	0.1	33.1	0.1	0.5	3.8	0.7	1.0	19.8	1.2	1.5	14.3	25.4	0.6	2.9	0.5	31.1	0.6	3.0	0.7	0.2	3.7	23.4	1.0	0.0	0.2	7.3	10.3	0.0	7.1	35.0	13.6	23.1	0.7	10.7	0.0	15.0	9.4	2.7	17.3	0.3	1.1	11.2	0.0	3.7	0.0	0.2	0.0	2.7	0.0	1.1	2.2	0.9	18.9	1.6	5.3	8.7	0.0	0.0	0.3	66.1	2.3	0.0	0.1	1.9	0.3	1.4	0.0	0.0	12.5	51.5	0.3	0.1	0.0	5.4	0.2	0.1	3.9	1.2	0.1	0.0	0.2	1.2	19.8	0.4	0.0	0.0	0.0	18.1	0.0	177.2	0.0	0.0	0.0	1.6	0.0	24.1	0.0	0.9	8.2	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.8	2.0	3.5	1.8	2.8	2.1	2.5	1.9	2.9	2.2	1.5	2.9	3.7	0.2	0.0	0.0	0.0	0.6	1.8	0.6	25.4	1.2	0.0	6.8	0.4	0.3	28.6	9.2	7.3	0.0	0.2	0.0	106.0	15.6	6.9	0.0	0.2	0.1	0.9	2.4	0.0	0.3	9.9	0.4	1.4	29.6	0.5	0.0	0.0	0.7	1.5	1.3	0.0	0.3	21.2	40.7	0.0	0.4	0.0	0.0	0.1	1.8	1.9	0.0	0.0	5.2	1.0	9.7	10.4	63.4	0.0	0.1	0.8	41.9	8.9	4.4	0.0	0.0	0.0	0.4	0.2	1.7	6.5	1.7	0.5	1.0	0.0	51.4	1.0
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074064-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2"	"Group enriched"	"Detected in many"	5	"Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048771	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoli	"HPA048771: AB_2680517"	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favorable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.3	1.4	3.7	0.6	5.4	0.0	0.5	0.2	7.4	0.3	0.0	0.8	0.0	0.8	0.4	0.7	0.3	0.3	11.3	7.0	5.0	1.3	0.0	0.3	1.4	1.5	5.9	0.1	0.9	11.9	4.2	0.0	5.6	2.3	0.3	5.5	1.2	0.5	4.6	0.2	0.4	1.0	0.6	0.7	0.3	0.5	5.2	1.4	8.5	12.2	3.1	0.5	0.2	1.9	0.0	0.1	0.0	0.0	0.5	0.2	1.5	0.1	2.3	0.7	0.8	0.0	0.0	1.9	2.0	0.1	0.5	0.0	6.0	0.0	1.9	5.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	5.1	0.0	0.0	0.4	0.9	2.6	8.2	2.4	6.4	3.9	0.1	0.2	0.9	1.2	0.8	0.0	0.0	0.1	0.9	2.7	0.0	0.0	0.0	0.0	0.4	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.4	0.2	7.4	7.0	5.0	1.5	5.9	5.6	0.6	5.2	1.9	1.3	0.0	0.0	175.0	0.0	0.5	0.7	0.9	0.6	25.5	1.4	0.5	48.7	0.0	1.3	1.8	2.1	0.0	0.0	0.0	1.9	0.1	1.3	0.2	0.1	1.2	0.0	0.0	584.8	0.4	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.1	30.3	566.2	0.0	2.0	0.0	0.0	1.6	0.0	0.1	1.8	24.4	0.0	4.2	0.0	306.1	81.3	0.8	0.0	0.7	0.0	2.2	0.0	3.4	0.2	1.8	0.0	3.9	0.8	1.4	0.7	2.9	0.1	0.3	0.3	0.2	0.1	2.0
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 31.5;pituitary gland: 88.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 58.1;Horizontal cells: 65.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	0.2	11.4	18.9	0.3	19.3	0.0	0.1	12.0	29.7	0.1	4.6	3.8	0.2	0.1	0.4	0.1	0.3	0.1	1.0	17.8	24.6	0.5	0.5	0.1	0.0	25.9	24.9	0.1	4.0	0.1	88.1	0.8	31.5	0.8	0.2	6.2	0.1	0.1	0.1	0.0	1.4	0.3	12.5	0.0	1.3	5.2	18.8	0.0	0.1	0.0	0.0	0.1	0.7	20.5	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	37.3	11.6	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	19.3	12.0	29.7	17.8	24.6	25.9	24.9	31.5	12.5	18.8	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	65.6	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	1.5	0.0	7.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 94.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053790, HPA071312"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.3	0.1	1.4	0.1	0.7	3.0	0.1	1.0	20.6	0.2	12.1	24.4	1.1	0.3	94.6	7.0	3.6	0.4	0.0	0.2	6.2	24.4	2.2	0.2	0.2	0.0	0.2	22.9	5.2	11.4	1.7	0.1	11.3	6.6	0.1	22.5	4.5	4.9	37.0	23.6	0.3	0.0	0.1	12.6	3.7	0.2	0.6	0.6	0.6	4.3	12.8	41.0	0.1	23.7	15.0	0.1	0.0	0.0	0.1	5.0	0.8	0.3	0.9	0.1	20.9	25.4	0.5	7.6	0.3	7.5	17.0	0.0	9.7	0.3	0.2	0.9	0.1	15.3	9.7	0.2	0.0	0.0	0.0	8.9	0.3	8.0	0.4	0.1	6.3	0.2	0.1	0.0	34.2	0.2	0.1	0.7	13.5	19.3	0.5	0.0	10.9	7.3	37.9	40.8	0.1	6.4	58.4	0.1	0.5	53.7	0.1	0.0	0.0	8.2	9.7	1.1	0.1	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	2.9	3.2	4.4	0.0	1.6	4.0	5.8	7.2	2.2	1.1	12.1	5.5	7.5	11.5	18.2	9.2	0.0	7.1	1.4	65.9	1.9	13.2	0.0	19.3	3.4	1.4	7.2	0.0	0.3	11.0	8.7	1.7	23.4	31.7	1.3	0.5	0.0	14.2	0.8	0.0	0.1	40.4	14.2	0.6	2.6	0.0	0.0	1.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.1	41.7	0.0	4.6	10.4	60.5	5.1	28.0	0.6	0.0	1.8	3.0	0.0	0.1	15.4	9.2	16.8	1.2	0.1	19.4	16.0
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719315-19773617	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.4;retina: 21.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 116.4;Endometrial stromal cells: 90.9;Excitatory neurons: 45.1;Inhibitory neurons: 23.9;Oligodendrocyte precursor cells: 127.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 4.8;ASC TERT1: 4.5"					"Low region specificity"	"Detected in many"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.3	1.3	2.6	0.0	4.4	0.0	0.0	0.0	4.1	0.4	0.0	0.1	0.0	1.4	0.4	0.0	0.3	0.0	0.0	2.7	10.4	0.0	0.0	0.0	0.0	3.6	6.7	0.0	1.1	0.0	3.7	0.0	3.3	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.7	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	4.8	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.4	0.0	4.1	2.7	10.4	3.6	6.7	3.3	1.9	7.1	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	116.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	90.9	0.4	0.0	0.0	45.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	3.3	23.9	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	1.9	0.0	2.6	0.0	127.6	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030921-124033067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.6;intestine: 8.4;testis: 5.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 130.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056391	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.0	1.0	7.5	0.0	11.0	0.0	0.0	9.8	9.0	0.1	2.5	0.1	8.4	0.1	0.4	0.0	0.6	0.0	0.2	7.7	9.6	0.0	0.0	0.0	0.0	9.1	12.6	0.2	0.0	0.8	0.9	0.1	9.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	3.9	0.1	7.9	0.1	1.8	5.3	10.2	0.0	0.0	0.0	0.0	0.3	0.0	11.7	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	130.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	11.0	9.8	9.0	7.7	9.6	9.1	12.6	9.0	7.9	10.2	11.7	0.0	0.0	0.0	9.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.2	0.0	2.0	11.4	0.0	2.5	0.0	0.0	0.1	10.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	1.2	0.7	0.2
TMEM238L	LINC00675	ENSG00000263429	"Transmembrane protein 238 like"		17	10794913-10804099	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	6	"intestine: 37.5;stomach 1: 45.2;urinary bladder: 21.8"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 16.5;Theca cells: 4.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"OE19: 6.4;RT4: 4.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (7.23e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.30e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.19e-2)"	0.1	0.1	0.5	1.8	0.6	0.0	1.7	0.4	0.6	1.6	0.0	37.1	18.2	0.1	0.7	5.4	0.4	2.7	0.0	0.4	0.5	2.1	0.8	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.6	37.5	0.0	0.6	3.4	0.0	1.1	16.6	1.3	0.4	0.0	45.2	0.3	0.9	0.0	0.0	0.0	0.4	21.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815848-129860003	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.5;intestine: 136.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 325.6;Paneth cells: 221.6;Proximal enterocytes: 288.7;Respiratory ciliated cells: 133.9;Undifferentiated cells: 122.2;Urothelial cells: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.0;naive CD4 T-cell: 3.6;neutrophil: 11.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 11.7;T-cells: 3.6"	"Group enriched"	"Detected in some"	5	"OE19: 333.1;RT4: 133.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.7	0.6	1.5	8.3	1.6	1.1	13.2	1.9	1.8	14.9	7.6	95.1	136.4	1.1	13.6	66.5	21.7	24.1	0.1	2.1	2.0	20.6	24.7	6.0	0.9	1.5	2.8	0.2	1.2	12.4	4.2	1.4	1.5	3.6	94.6	0.4	15.4	8.2	0.3	25.4	127.4	2.8	0.9	0.8	24.3	0.3	2.0	0.4	6.5	0.0	15.0	30.8	27.3	1.4	0.1	0.1	0.1	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	39.1	16.8	0.2	7.0	0.0	0.2	22.3	0.0	0.0	0.0	0.1	0.5	0.3	2.1	40.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.4	0.2	0.2	0.1	0.0	13.3	0.2	1.5	0.2	333.1	49.2	0.3	0.1	2.6	21.0	133.1	4.1	0.6	0.2	10.8	0.1	0.1	37.1	0.2	0.3	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.1	0.3	0.1	1.2	0.5	0.1	0.2	0.1	0.2	0.2	3.0	0.8	0.0	0.4	3.6	0.6	11.7	0.5	0.1	0.3	0.5	0.9	1.5	1.6	1.9	1.8	2.1	2.0	1.5	2.8	1.5	0.9	2.0	1.4	0.1	19.2	12.5	0.3	1.1	3.3	16.4	29.1	0.0	0.1	6.7	2.5	0.8	18.6	68.8	46.0	0.0	3.8	0.0	325.6	13.7	26.9	0.4	27.7	2.9	1.0	55.4	0.0	0.8	8.6	0.8	0.8	17.9	29.5	2.5	0.3	0.4	8.4	0.5	0.0	0.4	49.3	20.3	0.6	0.4	0.3	0.3	2.9	3.6	2.8	0.1	0.1	0.0	0.0	0.3	50.2	221.6	0.0	0.0	23.8	288.7	1.4	133.9	0.2	0.0	0.7	3.6	0.1	0.2	4.4	20.9	0.4	1.8	0.1	122.2	162.0
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 282.6;pituitary gland: 82.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	1.9	16.8	205.4	1.3	228.2	0.0	1.6	90.2	282.6	2.7	29.6	8.4	0.5	2.6	0.4	2.3	1.4	1.9	10.4	238.3	265.6	3.1	0.5	1.3	0.2	133.0	121.9	0.6	3.2	3.9	82.1	0.9	119.1	1.8	0.8	21.2	1.2	1.3	2.9	0.7	3.5	2.2	100.3	0.5	2.6	2.4	177.3	0.1	5.8	0.2	0.1	0.7	2.3	166.3	0.0	1.0	0.3	36.0	42.6	2.0	0.0	3.9	0.7	1.4	0.8	0.1	1.8	0.1	25.3	2.3	3.6	0.5	10.7	0.1	1.2	0.2	1.7	0.0	0.5	27.3	6.5	0.0	0.5	15.8	0.0	0.5	1.2	23.3	0.0	1.5	0.0	0.3	1.0	1.6	0.2	0.0	3.3	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.6	21.0	2.5	0.0	0.0	0.3	0.3	0.0	0.4	0.8	8.4	0.3	2.4	5.3	2.1	0.3	1.4	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	205.4	228.2	90.2	282.6	238.3	265.6	133.0	121.9	119.1	100.3	177.3	166.3	0.2	0.0	0.0	35.9	0.0	0.0	0.2	1.9	0.0	92.2	0.1	2.5	0.5	0.0	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.5	1.7	0.4	11.7	0.4	0.0	0.0	110.7	0.0	0.1	4.1	0.0	0.3	0.0	0.3	0.0	0.0	0.2	50.5	88.0	0.0	0.0	0.0	0.3	1.6	0.3	0.1	0.0	18.7	0.6	67.9	0.0	42.3	18.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	27.5	0.0	1.2	4.1	3.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.7;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.2	9.6	9.2	0.6	5.9	0.8	3.3	28.7	10.5	2.6	0.0	4.5	1.2	0.1	4.5	6.4	0.2	0.2	0.9	5.6	24.6	0.5	0.1	0.5	0.3	4.5	8.3	0.1	4.8	1.5	41.9	0.7	16.9	0.2	3.0	2.4	2.7	0.0	0.5	9.7	2.7	0.6	4.2	3.3	1.9	11.3	18.2	0.1	2.2	0.4	0.3	0.0	7.1	4.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	18.5	3.4	0.0	3.0	2.5	3.8	1.5	0.0	1.2	1.4	0.3	1.8	0.0	0.0	3.2	0.1	0.0	7.5	0.0	0.2	0.0	0.0	8.7	0.0	24.1	0.0	9.3	2.6	0.1	0.8	0.0	0.0	0.0	1.2	12.7	0.3	0.0	32.5	4.9	0.4	29.1	0.0	0.6	2.8	1.6	0.0	0.0	5.9	0.0	0.0	1.9	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.1	9.2	5.9	28.7	10.5	5.6	24.6	4.5	8.3	16.9	4.2	18.2	4.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	3.3	2.2	0.8	0.7	0.0	1.7	0.0	2.1	0.0	1.5	3.8	1.9	0.0	9.5	0.3	0.4	0.1	19.2	0.0	25.8	0.2	0.1	0.3	0.0	2.4	0.0	0.2	0.0	0.0	2.7	3.3	22.2	3.0	4.1	0.0	0.0	6.2	0.0	0.2	0.0	3.7	0.6	0.3	0.0	16.1	1.1	0.2	7.0	0.4	0.1	0.0	0.5	0.2	0.1	0.6	0.0	0.0	0.3	0.6	0.1	2.4	0.0	0.0	0.2	0.7	0.7	0.1
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.5;heart muscle: 37.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 39.9;Kupffer cells: 20.7;Langerhans cells: 25.7;Macrophages: 26.2;monocytes: 25.5;NK-cells: 54.6;T-cells: 35.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 9.7"	"Immune cell enhanced"	"Detected in all"		"neutrophil: 269.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 269.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.7;HDLM-2: 54.5;Karpas-707: 11.1;U-937: 31.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	5.6	2.0	1.0	13.1	1.3	33.5	8.5	1.0	9.7	2.5	2.2	11.3	2.2	1.3	1.1	2.8	1.9	5.5	37.1	1.1	1.8	2.6	3.9	8.2	13.2	1.6	1.3	1.0	2.4	0.7	1.1	1.8	2.1	2.0	3.4	0.5	5.7	2.2	1.6	1.1	7.3	3.6	1.1	18.4	2.8	1.0	2.4	19.2	2.0	4.6	10.6	4.6	1.9	1.6	0.4	0.0	4.9	0.0	0.0	0.0	0.0	1.3	12.7	0.5	0.9	0.0	0.0	0.1	0.6	4.1	0.1	0.0	0.0	0.3	1.5	54.5	0.0	0.0	0.0	0.0	0.3	3.6	0.0	0.1	0.0	0.1	2.0	1.4	1.0	6.7	0.0	11.1	2.4	0.0	2.9	2.2	1.2	0.0	0.4	0.1	1.8	0.8	4.8	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	2.1	0.5	0.9	1.2	5.7	0.1	2.9	0.0	9.0	31.6	3.7	61.9	55.9	101.6	31.3	16.1	57.9	6.6	22.8	22.2	33.7	4.7	33.9	25.1	269.0	12.9	14.7	1.1	3.0	39.0	1.0	1.3	1.0	9.7	1.1	1.8	1.6	1.3	2.1	1.1	2.4	1.6	0.5	0.0	3.0	0.0	6.9	0.9	1.0	2.5	0.6	0.0	4.2	2.7	15.9	0.0	5.5	0.0	0.0	0.0	39.9	0.1	0.0	0.0	6.5	0.1	0.3	1.5	0.0	8.8	0.5	0.0	0.0	4.1	1.1	0.2	1.3	0.0	3.3	0.2	3.2	0.0	1.3	0.2	0.0	20.7	25.7	5.1	0.0	26.2	5.4	17.8	25.5	1.9	54.6	0.0	0.1	0.1	0.0	0.0	11.3	0.1	0.0	0.4	2.9	0.0	0.0	3.7	0.8	0.0	0.6	0.4	0.3	0.3	35.9	0.1	0.0	4.5
TMEM72	"bA285G1.3, C10orf127, KSP37"	ENSG00000187783	"Transmembrane protein 72"	A0PK05	10	44911316-44937010	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 51.2;kidney: 74.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 27.6;Distal enterocytes: 21.1;Distal tubular cells: 33.2;Late spermatids: 15.9;Paneth cells: 8.9"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	123	"RPMI-8226: 44.0;U-937: 26.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA039894, HPA062907"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039894: AB_10795261, HPA062907: AB_2684900"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.08e-1)"		"unprognostic (4.57e-2)"	"unprognostic (3.24e-2)"		"unprognostic (8.58e-2)"	"unprognostic (5.45e-2)"		"prognostic favorable (1.01e-4)"	"unprognostic (4.99e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"		0.0	0.0	0.6	0.0	0.4	0.4	0.0	0.7	0.5	0.0	51.2	6.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	1.5	74.4	0.1	0.0	0.0	1.7	1.5	0.0	9.1	0.5	0.2	0.0	1.4	0.0	7.7	0.2	2.4	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.2	2.8	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	3.5	1.5	1.7	1.5	1.4	0.2	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	27.6	0.0	0.0	0.0	21.1	33.2	0.1	5.5	0.7	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742499-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.4;kidney: 11.5;liver: 52.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"CACO-2: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.6	24.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	52.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	1.6	0.0	42.8	7.9	0.0	0.0	0.0	0.0	0.0	2.4	2.7	0.0	0.2	2.9	0.0	1.5	0.1	0.0	0.0	0.4	49.3	0.1	0.0	0.0	9.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	60.2	0.0	0.0	0.0	173.6	53.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	12.5	0.0
TMEM88	"FLJ20025, MGC71744"	ENSG00000167874	"Transmembrane protein 88"	Q6PEY1	17	7855066-7856099	"Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 98.5"	"Group enriched"	"Detected in many"	7	"Adipocytes: 177.3;Endothelial cells: 142.1;Hepatic stellate cells: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.3"	"Group enriched"	"Detected in many"	6	"AN3-CA: 65.2;HHSteC: 42.3;HUVEC TERT2: 51.4;NTERA-2: 26.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052991	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052991: AB_2682006"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (3.44e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.49e-2)"	"prognostic favorable (4.43e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.68e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.56e-2)"	"unprognostic (2.72e-1)"	63.2	22.3	11.2	7.9	11.0	6.9	29.5	12.4	24.4	20.0	14.3	18.1	5.7	24.1	3.6	6.4	26.4	12.7	98.5	11.3	11.6	37.7	5.9	14.1	3.6	12.6	11.6	8.5	10.8	7.4	21.4	23.7	12.0	19.3	2.7	2.4	9.3	6.3	35.4	3.8	15.4	10.1	11.0	15.9	18.2	4.9	12.9	2.5	39.6	36.8	0.8	19.1	14.0	10.9	0.2	0.8	8.1	65.2	0.0	0.3	3.9	0.4	0.2	0.1	0.2	1.9	0.3	0.4	0.3	0.7	0.4	0.5	0.6	0.4	0.1	0.0	0.1	0.5	1.2	1.1	42.3	0.6	2.6	1.0	1.8	1.2	0.3	0.6	51.4	0.9	1.2	0.1	0.8	5.0	0.5	1.2	26.5	0.3	0.0	0.3	0.2	0.1	0.6	1.6	0.7	3.7	0.5	0.8	2.0	2.2	1.4	0.2	5.2	0.4	1.6	2.2	0.5	0.2	0.1	0.4	0.2	0.4	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	11.0	12.4	24.4	11.3	11.6	12.6	11.6	12.0	11.0	12.9	10.9	177.3	6.4	2.2	2.0	6.2	4.1	4.0	1.4	2.2	4.7	7.9	5.2	5.9	0.0	2.4	1.8	4.2	3.1	3.1	2.0	0.0	2.2	3.0	3.1	2.0	142.1	6.6	0.0	0.6	2.2	1.0	19.2	4.6	6.7	4.5	1.8	109.9	2.4	2.6	3.3	0.9	2.5	0.0	7.3	9.3	8.6	0.9	9.9	0.0	5.6	0.2	0.6	0.0	0.0	0.1	4.0	5.7	0.0	1.0	6.5	2.4	0.6	1.5	1.4	0.0	11.3	6.5	1.7	1.8	2.7	3.1	5.2	2.5	0.8	1.5	3.2
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 140.5"	"Group enriched"	"Detected in some"	28	"Distal enterocytes: 291.9;Paneth cells: 125.5;Proximal enterocytes: 476.6"	"Cancer enriched"	"Detected in single"	5	"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021946			Approved	Mitochondria		NA	NA				"Cluster 9: Intestine - Unknown function"		"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA021946: AB_1858140"			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	140.5	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	291.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	125.5	0.0	0.0	0.0	476.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751597-51816363	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 63.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 101.9;Excitatory neurons: 147.3;Horizontal cells: 87.5;Inhibitory neurons: 125.9;Oligodendrocyte precursor cells: 98.0;Oligodendrocytes: 94.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 13.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 13.1;monocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favorable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	6.1	5.2	30.0	5.6	43.1	0.7	4.2	9.8	63.0	8.8	0.0	12.2	2.2	5.2	3.3	3.9	6.9	4.4	6.3	48.3	17.9	2.5	1.3	3.7	4.4	16.8	12.7	5.4	2.3	4.3	6.0	2.0	21.3	4.3	4.1	15.7	3.1	8.3	2.0	3.7	5.8	5.8	9.5	3.8	3.7	2.2	18.1	4.8	4.0	3.7	4.0	4.7	7.6	27.3	1.2	0.7	2.4	5.7	11.3	12.1	0.4	6.5	2.2	4.8	5.2	0.1	0.6	5.3	0.2	5.1	5.0	3.4	10.2	5.8	1.5	0.1	5.0	0.0	1.0	0.1	1.9	2.1	0.4	7.1	7.7	0.7	1.4	6.4	1.0	13.6	0.0	0.1	6.0	0.9	4.4	0.7	1.6	0.0	1.2	3.4	1.4	0.1	0.8	1.7	37.0	9.1	6.0	0.0	1.7	3.0	1.4	0.3	2.4	12.9	1.0	8.3	4.7	0.0	0.0	0.0	4.1	14.2	6.0	0.2	5.9	8.6	2.3	2.4	0.9	2.7	1.3	1.0	1.6	1.6	1.6	0.7	13.1	1.3	10.6	1.3	0.5	1.2	30.0	43.1	9.8	63.0	48.3	17.9	16.8	12.7	21.3	9.5	18.1	27.3	13.8	0.0	4.1	101.9	7.4	4.8	3.6	1.2	3.4	26.3	3.0	3.0	7.9	0.0	1.7	11.0	22.9	0.1	1.8	0.1	7.9	3.3	30.8	0.9	4.3	13.5	23.4	0.8	147.3	1.8	0.1	12.2	1.1	0.5	0.0	3.0	12.8	0.4	4.9	87.5	125.9	0.7	2.0	7.9	4.4	19.6	11.1	9.1	1.8	53.4	29.8	12.6	3.1	98.0	94.1	2.2	0.2	5.7	2.6	1.9	1.8	1.2	2.8	19.7	6.6	13.1	5.8	6.6	4.9	6.3	7.5	0.3	6.5	1.3	0.5	1.8
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 397.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		1200000	"Cluster 42: Non-specific - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	12.2	7.4	4.8	13.6	4.9	9.7	9.4	4.2	5.3	11.4	6.7	15.4	15.5	9.9	10.3	43.4	13.2	11.8	6.9	4.2	3.7	13.5	13.7	21.7	12.8	5.0	5.2	6.9	8.0	7.3	3.4	21.9	4.9	7.5	15.4	3.6	12.8	9.8	3.4	15.0	16.0	9.6	4.9	13.7	16.9	3.4	5.8	12.6	9.6	6.4	19.5	16.4	18.7	5.0	59.4	56.0	22.3	5.8	21.6	35.9	25.8	26.1	35.5	26.7	23.8	21.8	42.4	13.9	21.7	28.0	18.9	82.3	20.7	58.5	33.9	23.8	9.1	20.6	62.6	17.9	24.0	26.6	22.1	24.2	55.7	21.5	66.2	32.9	47.7	20.0	22.3	20.6	32.6	43.9	17.8	17.7	12.4	36.3	10.3	21.0	26.7	37.8	43.5	41.5	5.4	14.6	43.5	28.9	15.6	29.7	19.7	21.0	53.8	33.9	22.6	27.8	31.3	12.5	39.5	15.6	21.7	48.0	20.4	47.6	27.9	41.4	22.7	34.7	20.2	20.4	19.8	20.3	20.6	23.8	16.7	15.7	45.5	18.8	39.3	29.0	26.0	16.7	4.8	4.9	4.2	5.3	4.2	3.7	5.0	5.2	4.9	4.9	5.8	5.0	147.9	397.4	68.2	23.8	43.5	106.9	91.4	66.3	70.6	8.3	38.8	27.3	45.8	30.0	112.7	42.3	14.6	56.1	63.3	117.4	41.1	85.8	38.9	67.5	87.6	131.6	18.6	50.9	29.4	71.6	66.3	84.1	71.9	91.3	143.0	28.8	101.4	52.9	53.9	15.2	25.5	52.0	36.7	51.7	74.1	99.3	45.1	88.4	32.0	33.7	67.5	19.2	60.8	17.1	17.1	152.6	79.0	44.4	44.1	160.3	65.5	56.5	82.2	12.6	13.1	35.2	58.0	14.5	13.9	137.0	132.1	51.3	74.3	57.4	59.9	215.9
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.7;intestine: 43.5;urinary bladder: 74.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 101.7;Club cells: 103.5;Distal enterocytes: 187.9;Squamous epithelial cells: 119.2;Urothelial cells: 258.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"	"Immune cell enriched"	"Detected in single"	7	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 103.7;HaCaT: 39.2;OE19: 141.6;RPTEC TERT1: 70.6;RT4: 95.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain				"Secreted in other tissues"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.2	0.0	0.1	6.1	0.1	0.8	0.3	1.8	0.3	16.6	0.3	43.5	25.4	2.1	3.2	108.7	1.0	14.3	0.2	0.1	0.0	21.1	0.2	1.4	0.2	0.1	0.0	0.1	0.3	0.0	0.2	0.1	0.2	7.8	42.9	0.4	6.5	0.2	0.2	4.1	22.4	1.5	0.0	0.2	31.4	1.1	0.2	1.1	0.2	0.1	14.9	74.6	16.7	0.3	18.5	0.1	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.7	103.7	0.1	3.5	0.0	0.1	39.2	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	3.4	0.3	0.0	1.3	0.3	4.5	0.1	141.6	0.0	0.1	0.1	0.2	70.6	95.9	0.1	0.1	0.0	8.4	0.1	0.2	0.5	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	1.8	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.0	1.7	0.0	0.4	1.1	35.2	101.7	38.1	0.0	0.0	0.0	0.7	0.0	103.5	11.0	0.0	0.2	0.0	187.9	0.0	1.5	3.0	45.3	4.6	0.8	4.2	0.0	0.2	7.3	3.0	0.5	53.5	66.4	5.7	0.0	0.0	0.1	0.2	0.0	0.2	55.3	34.6	0.3	0.3	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	52.6	67.5	0.0	2.7	17.5	55.2	2.4	69.4	0.0	0.0	0.0	4.7	0.0	0.1	119.2	6.3	0.3	0.5	0.0	71.2	258.6
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019575-115118257	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 376.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.3;Basal prostatic cells: 72.1;Basal respiratory cells: 150.6;Basal squamous epithelial cells: 126.3;Prostatic glandular cells: 69.2;Smooth muscle cells: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 798.5;hTEC/SVTERT24-B: 634.4;U-138 MG: 526.0;U-251 MG: 484.5;U-87 MG: 711.8;WM-115: 1253.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	NA	NA	560000000	840000000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	61.0	4.7	16.4	170.4	28.5	0.9	41.2	14.0	9.8	43.6	3.0	174.3	16.7	106.8	12.2	23.9	25.5	14.1	32.6	15.6	34.3	82.0	7.7	54.2	39.8	20.3	43.8	5.3	4.8	2.3	7.2	4.0	28.0	39.1	28.3	4.8	19.8	33.3	6.2	25.9	56.5	376.2	15.0	40.8	62.4	4.8	65.4	17.1	13.3	3.2	22.6	96.7	15.9	20.5	25.1	6.0	6.9	1.3	37.5	10.1	0.1	205.7	798.5	425.4	203.6	5.3	55.3	0.0	32.8	291.7	6.9	89.9	0.0	12.0	241.3	0.4	2.2	0.0	4.8	0.0	0.7	0.4	3.9	6.2	1.7	634.4	289.9	42.9	0.1	0.0	0.0	5.2	11.4	0.0	0.1	0.3	65.2	0.9	85.3	0.2	451.9	0.1	373.3	0.1	0.6	5.9	91.4	0.2	19.3	140.9	1.0	1.4	0.1	526.0	88.4	94.2	484.5	14.3	0.4	0.4	711.8	0.6	1253.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.4	28.5	14.0	9.8	15.6	34.3	20.3	43.8	28.0	15.0	65.4	20.5	0.7	12.8	43.5	160.3	0.4	12.1	72.1	150.6	126.3	0.1	9.3	33.3	1.4	0.0	14.8	1.8	0.0	1.1	0.3	0.0	0.0	25.8	15.4	6.7	47.8	11.1	0.0	0.0	7.0	4.5	0.6	19.0	0.0	24.9	2.5	0.5	6.1	0.0	1.2	0.0	0.9	0.0	0.0	0.6	4.7	18.4	3.4	0.9	5.4	1.9	0.1	1.3	0.0	4.0	0.8	3.9	0.0	0.4	0.3	69.2	0.0	0.3	3.5	0.2	0.0	1.3	58.9	0.4	0.2	4.8	4.5	1.0	2.6	0.1	0.1	5.8
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 166.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavorable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	36.1	30.4	32.4	19.3	31.1	8.1	30.3	28.5	32.0	22.0	38.6	19.9	17.7	21.7	14.9	39.6	19.2	28.9	46.7	30.9	29.1	35.9	54.8	40.9	17.0	30.3	30.1	17.4	37.6	23.0	17.5	44.7	29.4	20.5	16.9	26.3	23.9	20.5	23.3	29.0	17.7	30.9	28.9	50.2	25.4	17.2	35.7	22.0	24.0	23.8	19.5	35.1	23.4	28.9	43.3	61.3	40.2	28.4	34.3	30.1	39.0	50.4	62.4	60.6	47.6	166.1	25.8	8.7	34.4	67.0	29.4	49.1	22.3	86.9	46.5	24.0	28.0	7.7	66.0	24.2	45.9	13.5	12.5	38.9	99.7	47.7	37.0	56.9	71.7	17.4	20.0	12.8	28.8	25.8	25.6	7.4	9.3	36.4	22.3	11.3	50.8	15.5	89.5	45.9	29.3	31.7	62.3	102.5	25.8	55.8	42.9	11.4	76.4	44.2	43.7	34.4	39.3	20.8	18.7	9.3	34.3	9.0	28.5	1.7	7.2	9.5	6.5	7.0	7.7	5.3	4.7	5.9	9.3	3.9	4.5	5.5	2.5	9.1	8.7	4.5	4.3	5.0	32.4	31.1	28.5	32.0	30.9	29.1	30.3	30.1	29.4	28.9	35.7	28.9	66.6	38.5	12.9	5.5	4.6	24.6	47.5	32.0	12.5	25.6	18.2	11.9	21.8	20.0	17.5	22.0	16.7	31.5	6.2	14.3	23.5	60.5	40.1	23.0	13.9	62.4	17.4	7.4	11.7	82.5	34.9	13.5	12.8	30.2	7.0	14.0	60.3	29.5	11.0	11.8	7.5	11.0	10.2	12.5	12.1	6.9	7.8	7.0	0.0	9.4	30.1	10.0	4.1	7.1	7.2	112.9	15.1	7.9	7.1	46.9	13.6	16.9	20.2	9.8	13.1	10.9	22.3	5.4	5.6	15.9	28.4	69.2	5.0	18.1	9.7	43.0
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156649-151159749	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.2"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 70.4;Kupffer cells: 65.4;Macrophages: 35.8;monocytes: 34.7;NK-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 29.8;HL-60: 17.6;HMC-1: 44.1;NB-4: 25.2;THP-1: 95.2;U-937: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favorable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	4.7	4.3	4.9	19.6	5.4	6.1	3.4	5.1	7.5	2.3	5.7	4.5	5.3	1.5	1.4	2.5	2.2	5.5	2.3	4.7	5.2	2.0	5.6	10.8	32.0	6.5	5.7	1.0	1.4	1.2	1.2	6.9	7.0	2.1	6.1	0.9	2.6	1.8	0.8	3.8	7.6	5.4	6.4	39.2	3.4	0.8	6.3	19.2	1.3	2.2	17.7	7.8	1.4	8.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	29.8	0.4	0.0	0.0	17.6	44.1	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.1	0.1	0.0	0.1	0.4	25.2	0.0	0.0	0.1	5.3	0.1	4.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	95.2	2.5	0.2	0.1	0.1	0.2	0.3	0.0	1.9	0.1	37.8	0.1	317.0	238.8	246.7	103.2	220.2	101.9	78.3	125.7	105.2	265.4	83.2	189.5	137.3	292.3	232.9	210.6	63.0	155.7	249.5	4.9	5.4	5.1	7.5	4.7	5.2	6.5	5.7	7.0	6.4	6.3	8.1	0.3	0.0	1.7	0.0	6.9	0.3	0.0	0.0	0.0	0.8	0.8	0.3	0.1	2.8	1.3	0.0	0.0	0.3	11.1	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	8.8	0.0	0.0	0.5	0.2	0.0	0.0	5.1	0.0	0.7	0.3	70.4	0.0	0.0	0.0	0.0	65.4	12.8	0.4	0.3	35.8	0.0	0.0	34.7	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.4	10.6	0.0	0.0	0.0
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	5.7	2.3	2.6	9.9	2.5	9.3	5.7	2.2	2.7	4.3	2.2	7.0	6.2	2.9	1.1	8.4	4.1	8.2	3.0	2.0	2.4	3.8	5.3	6.6	13.4	3.4	2.8	0.8	2.4	2.7	0.8	7.1	3.1	2.9	7.1	0.2	4.8	2.5	1.5	4.9	6.5	3.9	2.8	6.8	6.5	0.5	3.4	6.4	3.0	2.8	14.0	10.8	5.8	2.8	18.7	33.0	1.7	0.1	1.2	6.4	0.1	3.8	2.3	1.9	5.2	25.4	31.8	42.9	41.9	2.4	9.1	34.6	29.5	47.2	3.1	10.7	0.2	22.7	20.4	14.7	16.2	12.3	20.7	11.0	38.2	41.1	35.0	5.5	21.9	1.4	35.7	14.9	8.9	14.5	0.4	7.8	22.6	33.0	20.0	0.3	0.0	31.2	24.4	39.5	0.9	1.1	9.3	23.0	0.0	6.9	12.3	9.3	31.3	0.1	0.2	1.8	0.1	17.4	26.7	32.7	0.2	3.9	0.5	2.8	6.1	5.7	5.0	2.6	13.8	15.3	16.1	10.2	6.3	19.1	15.7	9.2	0.6	6.1	2.6	0.0	20.8	6.5	2.6	2.5	2.2	2.7	2.0	2.4	3.4	2.8	3.1	2.8	3.4	2.8	21.5	3.2	8.7	0.7	22.3	23.6	20.7	9.1	21.6	0.2	8.2	7.1	1.1	7.2	15.5	11.0	0.0	0.1	3.1	10.1	0.0	10.1	0.1	8.6	1.9	16.6	2.4	1.3	0.4	4.0	0.4	2.2	10.2	23.9	7.6	0.7	2.9	5.1	3.1	0.0	0.4	7.0	8.2	2.2	12.7	0.0	0.0	8.5	3.6	9.4	4.2	0.0	2.1	1.0	0.5	20.3	7.3	0.0	14.0	11.7	4.5	2.9	5.7	0.0	0.0	0.9	1.1	0.0	0.5	25.6	27.4	0.0	12.8	0.1	9.1	27.4
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 55.3;skin 1: 107.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.8	2.9	1.8	0.9	1.7	1.7	9.9	1.8	1.9	7.0	4.2	2.4	1.8	8.6	13.4	9.4	30.5	3.4	22.1	2.0	2.5	15.7	1.1	17.2	0.7	3.3	3.2	2.7	2.8	0.9	8.5	8.4	2.6	27.4	1.9	4.7	55.3	7.6	2.4	107.5	1.3	3.0	3.1	5.1	5.4	2.2	2.7	6.7	3.4	2.1	1.8	4.5	4.8	2.5	0.1	3.3	3.2	0.0	4.7	46.5	3.5	3.7	73.2	2.0	2.8	23.6	0.1	0.0	0.0	55.9	0.5	0.1	3.3	2.9	3.6	0.0	2.9	0.6	2.4	83.0	2.2	0.2	0.9	22.5	0.7	23.1	0.3	1.5	0.1	0.0	0.1	0.0	13.2	1.1	0.0	0.1	2.3	29.7	5.1	0.0	13.6	0.0	8.4	0.4	30.9	4.9	0.1	0.0	128.4	3.4	0.0	0.3	0.0	11.5	0.5	0.1	3.5	0.0	0.1	0.0	4.5	0.1	76.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	1.8	1.7	1.8	1.9	2.0	2.5	3.3	3.2	2.6	3.1	2.7	2.5	3.1	0.0	20.8	1.0	0.2	62.2	3.0	2.0	23.9	0.8	6.3	2.9	23.4	2.8	9.3	9.2	8.4	0.1	0.3	0.1	0.0	11.1	1.7	10.4	4.4	5.1	0.0	0.0	6.9	1.0	0.0	14.4	2.6	3.9	1.3	0.5	0.0	0.5	0.1	0.0	6.7	0.0	6.1	0.0	8.5	1.0	11.5	0.2	14.2	71.2	0.0	3.3	0.0	12.5	1.1	11.3	0.0	13.9	0.0	13.3	0.0	20.9	62.4	3.3	0.0	3.2	4.9	1.5	2.3	8.3	80.3	0.0	0.6	3.5	0.0	0.6
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	8100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	45.6	5.4	3.9	68.4	3.8	52.1	34.7	4.8	17.9	14.3	5.6	12.8	16.8	11.6	0.4	5.5	14.6	15.6	10.9	3.7	9.0	7.5	15.7	32.0	32.1	18.3	7.2	6.3	5.9	2.3	4.5	35.8	10.6	6.4	10.8	0.8	6.5	2.6	10.7	7.8	23.9	16.8	9.0	53.3	16.4	2.2	8.9	12.7	7.6	6.3	21.3	28.9	8.8	14.1	0.0	0.3	4.1	0.0	9.6	13.5	8.9	1.1	2.0	4.0	4.3	1.8	34.0	0.2	0.6	3.9	5.6	0.0	0.8	0.0	2.2	14.5	0.0	0.0	0.2	0.0	25.2	0.3	3.8	14.8	0.0	13.0	0.0	7.2	19.6	0.2	45.7	6.4	1.5	0.0	0.0	8.1	0.2	4.9	1.4	1.2	0.4	25.9	0.0	0.8	0.0	0.1	0.6	0.4	1.4	6.4	0.0	51.8	7.8	5.3	0.2	27.0	0.0	1.9	0.0	0.0	30.8	37.0	1.4	0.6	127.1	18.2	48.4	260.5	26.5	13.5	34.4	40.5	71.7	8.4	9.8	15.5	138.0	13.4	387.1	15.1	70.9	150.4	3.9	3.8	4.8	17.9	3.7	9.0	18.3	7.2	10.6	9.0	8.9	14.1	99.4	9.6	15.9	0.7	42.8	16.8	3.9	1.0	1.2	0.2	3.2	4.1	3.6	5.7	6.5	3.7	0.0	0.9	268.7	12.8	0.0	0.5	0.6	1.7	5.1	46.0	0.0	7.4	0.2	0.6	6.3	13.2	12.8	4.9	2.5	1.4	31.1	17.0	72.6	0.0	0.2	3.0	0.0	200.5	288.0	1.2	2.1	230.2	16.0	30.9	175.3	0.3	109.2	0.0	0.1	0.7	4.2	0.4	72.5	8.0	25.8	0.4	1.5	1.2	32.9	6.8	9.8	0.0	0.9	0.7	10.5	30.1	138.4	1.9	4.8	8.8
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.1;Early spermatids: 3.5;Kupffer cells: 5.3;Langerhans cells: 3.3;Late spermatids: 9.8;Macrophages: 5.8;monocytes: 5.1"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 96.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 96.6"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 552.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"					"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	5.3	0.0	0.1	3.1	2.3	0.6	3.5	0.0	0.6	0.2	0.1	0.4	0.0	0.8	0.0	0.2	0.9	0.6	1.9	0.0	0.2	0.3	0.0	0.9	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.7	0.2	0.2	0.1	0.0	0.3	0.1	0.9	0.9	0.7	0.5	0.1	1.4	2.5	1.4	0.7	1.0	0.1	1.2	1.1	0.9	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.4	0.0	0.1	0.8	11.7	0.0	0.0	0.0	0.0	0.0	0.1	552.9	0.1	0.0	0.1	0.0	0.0	10.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	26.3	1.5	0.0	0.0	1.5	0.2	21.7	0.0	0.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	1.4	1.4	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	17.6	1.0	0.1	59.4	0.3	0.1	0.1	0.0	8.7	0.0	0.0	0.0	18.3	0.0	96.6	2.3	0.8	8.5	0.1	2.3	0.0	0.6	0.0	0.2	0.2	0.1	0.2	0.1	0.7	0.2	7.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.5	0.1	0.5	2.2	0.0	0.0	0.6	0.0	0.2	1.1	2.6	0.1	0.0	0.1	2.2	0.1	1.5	0.0	0.5	0.0	0.0	5.3	3.3	9.8	0.3	5.8	0.0	1.0	5.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.3	1.0	0.0	0.1	0.3	0.4	0.2	0.0	0.1
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 141.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 10.4;Basal squamous epithelial cells: 8.0;Erythroid cells: 5.9;Gastric mucus-secreting cells: 11.2;Macrophages: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 438.1;intermediate monocyte: 420.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 283.5;granulocytes: 158.9;monocytes: 438.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 43.6;RPMI-8226: 39.9;RPTEC TERT1: 110.6;U-937: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	NA	NA	6770000	35000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	27.7	31.6	39.5	37.7	43.7	48.4	29.5	39.7	47.3	33.5	66.7	45.9	74.7	13.3	19.2	12.5	31.8	54.1	18.0	35.3	37.6	55.6	16.2	100.7	33.1	44.8	43.3	24.8	41.1	18.0	19.7	14.7	41.1	22.6	41.9	13.0	141.9	32.1	5.3	10.5	39.5	24.8	40.0	30.6	54.0	4.6	44.8	14.1	27.0	10.1	24.5	26.0	15.5	38.8	20.8	8.3	2.8	5.5	3.2	1.7	3.4	3.7	2.7	1.5	1.3	4.6	12.8	9.1	43.6	3.8	5.2	13.1	0.1	3.6	1.6	16.2	7.0	5.9	18.2	9.7	6.7	5.1	5.9	3.6	3.6	1.0	5.7	8.8	4.7	6.5	4.6	3.5	1.3	3.1	2.3	16.6	2.7	20.3	6.0	16.5	3.4	39.9	110.6	13.5	5.1	4.9	7.2	18.8	2.5	4.1	25.2	12.4	2.4	4.8	5.8	2.1	8.1	0.8	2.8	2.4	1.9	44.1	9.5	75.2	438.1	158.9	0.9	420.9	0.8	13.7	0.5	0.7	283.5	25.0	2.4	1.5	56.9	7.9	265.4	130.8	0.9	257.1	39.5	43.7	39.7	47.3	35.3	37.6	44.8	43.3	41.1	40.0	44.8	38.8	0.2	6.4	10.4	0.0	2.1	0.0	0.2	0.2	8.0	0.1	0.4	0.1	0.0	0.0	2.0	1.8	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.2	0.1	0.0	1.2	5.9	0.0	0.2	0.0	2.9	11.2	0.4	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.0	19.5	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.2	0.7	0.3	1.5	0.2	0.0	0.1	0.2	0.0	0.0	2.6	0.0	0.0	0.8	0.1	0.6	0.2
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743616	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 31.3;retina: 16.2"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.9;U-937: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		58000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	0.0	1.4	30.7	0.2	24.3	0.1	0.0	15.2	26.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.3	27.7	0.0	0.4	0.5	0.2	23.3	16.4	0.0	0.4	0.0	2.7	0.0	20.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.2	0.3	0.4	18.2	0.1	0.1	0.0	0.3	0.0	0.0	30.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.7	24.3	15.2	26.3	31.3	27.7	23.3	16.4	20.3	20.8	18.2	30.5	0.0	0.0	0.0	20.2	2.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	226.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	580.5	179.6	0.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	3.7	0.0	1.8	0.0	2288.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.8	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218033982	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 173.1;Cardiomyocytes: 339.0;Leydig cells: 169.6;Peritubular cells: 504.0;Sertoli cells: 368.1;Smooth muscle cells: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 135.1;ASC TERT1: 74.1;fHDF/TERT166: 66.6;REH: 75.4;TIME: 63.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA		47000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	248.2	60.3	51.6	42.9	98.0	42.3	100.9	71.7	45.5	99.5	45.1	373.4	23.4	253.7	44.3	117.8	136.2	80.4	170.4	34.0	53.4	74.6	39.6	117.2	11.5	82.3	79.2	110.4	55.2	33.2	15.4	54.5	106.4	126.1	41.7	7.7	52.9	225.0	171.6	47.8	78.9	178.0	72.2	70.1	115.2	23.5	80.9	21.5	65.8	207.2	7.5	228.4	82.6	82.9	0.3	0.4	8.9	0.1	135.1	74.1	0.8	22.9	7.8	1.3	0.9	10.0	0.1	0.0	13.1	66.6	1.5	1.7	1.4	1.3	0.7	9.4	0.8	19.8	5.7	2.6	9.8	0.1	2.3	35.2	0.0	24.4	0.2	43.6	32.2	0.1	0.6	2.6	18.8	4.4	0.1	1.4	0.9	0.2	0.4	75.4	16.8	1.0	4.8	0.2	2.1	10.1	3.9	9.7	2.0	6.1	3.1	8.5	63.2	16.6	29.5	17.5	4.9	1.1	0.1	0.1	9.8	2.7	1.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.8	51.6	98.0	71.7	45.5	34.0	53.4	82.3	79.2	106.4	72.2	80.9	82.9	93.3	173.1	85.9	29.7	1.1	16.2	48.6	29.5	42.1	4.8	7.2	21.2	339.0	38.6	27.5	14.7	0.0	8.7	0.5	0.1	7.9	36.1	2.2	3.0	29.5	76.6	0.0	143.1	3.9	19.1	1.5	52.4	1.1	3.8	30.4	8.8	71.7	38.5	13.0	42.1	5.3	0.0	6.1	15.3	19.3	11.9	169.6	16.7	10.6	32.8	1.3	14.1	0.0	15.6	52.0	17.0	0.0	504.0	0.4	12.1	0.0	26.1	22.3	1.3	368.1	29.7	183.5	1.1	1.9	5.7	11.8	1.9	4.1	20.7	0.2	17.3
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.3;Hepatic stellate cells: 93.1;Leydig cells: 141.7;Peritubular cells: 114.0;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 114.2;ASC TERT1: 78.1;HHSteC: 59.9;HSkMC: 86.2;hTERT-RPE1: 61.9;TIME: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	156.3	66.9	59.3	14.8	66.2	0.3	121.6	46.4	57.8	121.2	33.3	79.0	14.4	98.8	14.0	28.3	121.0	32.5	99.6	43.7	49.2	67.3	66.5	83.4	15.8	58.0	63.5	104.1	34.6	17.0	43.3	33.1	54.0	66.3	11.5	6.0	35.7	41.1	69.0	42.1	56.7	28.5	50.8	79.5	58.2	15.9	58.3	7.2	80.6	58.8	6.4	82.6	81.1	57.9	2.0	21.2	2.7	2.2	114.2	78.1	0.7	11.8	27.1	6.2	3.2	1.4	5.7	0.1	25.3	32.1	2.6	1.5	0.1	7.8	2.4	0.5	0.8	0.4	25.5	11.3	59.9	0.3	0.5	86.2	0.3	7.9	4.7	61.9	36.3	0.4	0.6	0.3	24.9	5.1	0.2	0.4	1.9	1.4	5.8	0.7	6.6	0.3	8.2	0.4	1.2	2.7	4.4	2.4	8.8	1.6	26.1	0.7	52.1	12.9	14.8	4.7	2.0	0.6	0.3	0.1	20.4	0.3	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.3	66.2	46.4	57.8	43.7	49.2	58.0	63.5	54.0	50.8	58.3	57.9	109.3	3.2	25.7	33.3	0.5	0.0	6.8	0.0	5.2	21.1	15.1	13.0	7.9	10.0	2.5	5.5	0.0	0.5	0.9	0.4	3.9	5.8	2.8	4.4	41.1	69.6	1.2	2.7	3.1	4.4	0.4	40.5	2.0	14.5	0.0	7.7	93.1	37.5	2.4	30.3	7.8	3.9	0.0	4.4	0.0	7.2	141.7	2.9	0.0	31.9	0.1	29.6	0.0	46.3	35.6	2.4	9.0	114.0	1.8	4.5	2.1	2.6	1.5	11.3	151.2	51.3	64.7	4.2	4.4	1.3	0.0	0.8	1.4	2.6	1.8	2.1
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041153-32115334	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 274.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	68.0	274.8	2.0	0.9	3.1	3.4	40.0	4.4	1.8	45.1	3.5	35.9	3.0	66.7	3.2	18.1	37.4	4.7	73.8	0.7	0.8	13.0	17.6	51.1	0.8	1.5	1.1	67.0	3.7	0.4	6.8	3.8	1.5	15.6	1.7	0.3	19.5	1.0	14.2	27.4	29.0	3.1	2.2	30.7	18.8	11.4	3.0	0.7	27.7	7.2	0.4	34.5	35.2	0.4	0.1	0.3	0.3	0.2	12.4	20.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.2	0.0	0.1	0.0	0.0	0.1	1.3	1.1	0.2	0.6	0.0	2.8	0.0	0.3	0.2	0.2	0.5	0.0	0.5	0.0	0.5	0.7	0.4	0.0	0.2	0.0	0.1	0.3	0.0	3.5	0.3	0.1	0.2	0.0	0.1	0.1	0.2	1.3	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.4	15.8	0.0	0.4	0.4	0.2	8.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.1	4.4	1.8	0.7	0.8	1.5	1.1	1.5	2.2	3.0	0.4	54.7	3.2	2.4	2.6	0.5	32.9	0.2	0.3	0.6	1.3	1.3	1.8	2.5	4.3	0.2	0.0	0.0	0.5	1.0	0.0	0.0	0.2	3.0	1.3	39.7	38.8	0.0	25.0	7.1	0.0	2.6	318.4	6.1	1.1	0.0	94.8	12.8	0.9	0.7	0.0	4.2	0.1	0.0	0.6	39.1	2.8	27.1	4.7	32.0	17.8	0.0	1.2	0.0	1.0	1.2	0.0	0.1	4.5	2.5	0.5	0.0	0.3	0.9	0.6	0.0	21.7	20.8	4.1	2.1	1.6	26.6	1.0	4.8	5.6	0.2	0.4
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 127.8;testis: 65.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in some"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.2	2.5	0.2	20.0	0.2	42.0	5.4	0.1	0.7	5.0	1.1	17.8	18.1	3.9	0.3	29.0	1.5	2.6	1.2	0.2	0.2	1.2	2.8	4.1	40.3	0.2	0.8	1.0	0.9	0.3	0.3	15.9	0.5	1.4	19.8	0.1	4.3	0.5	0.3	15.3	17.0	7.6	0.2	9.9	8.9	65.7	1.1	127.8	1.9	0.2	42.5	6.0	9.6	0.4	212.6	275.6	343.1	158.0	16.8	33.9	76.3	283.3	151.5	255.0	224.2	130.5	157.6	339.4	140.1	96.7	152.7	326.5	266.8	113.5	339.5	182.7	177.8	224.8	167.9	216.7	1.6	318.4	228.6	7.4	9.2	179.8	181.4	55.1	136.3	216.5	247.5	225.8	279.2	72.6	372.3	209.6	143.0	152.4	108.3	310.7	531.9	141.3	61.6	133.3	201.6	144.6	229.3	281.4	89.4	198.2	236.9	143.2	90.3	167.0	233.2	195.5	276.7	128.4	154.9	290.7	94.3	214.9	285.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.3	0.1	0.1	0.0	0.0	0.1	1.4	0.1	0.0	2.4	0.4	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.8	0.5	0.2	1.1	0.4	1.0	0.0	2.0	0.3	17.4	11.7	3.7	15.0	2.2	0.0	18.7	17.1	1.3	2.8	5.8	0.0	0.0	72.9	6.1	19.8	0.0	0.8	20.3	12.7	15.8	9.3	0.0	216.8	0.2	0.0	92.4	23.3	23.0	10.0	0.0	117.5	20.7	5.4	83.5	0.0	0.1	34.2	18.3	33.9	13.2	19.1	4.7	14.1	1.8	0.0	2.6	0.0	3.1	0.0	0.1	0.3	3.5	1.9	31.3	3.1	3.4	0.1	1.8	0.0	72.3	0.5	19.5	621.2	269.6	45.1	6.1	8.9	14.8	4.3	61.0	6.9
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631389-189897276	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.6;skin 1: 137.3"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 275.4;Basal squamous epithelial cells: 335.2;Squamous epithelial cells: 173.4;Suprabasal keratinocytes: 283.1"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 87.1;HBEC3-KT: 167.3;hTCEpi: 124.0;hTERT-HME1: 117.3;RT4: 185.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	0.5	0.3	0.3	0.6	0.3	0.4	18.0	0.9	0.5	23.5	0.3	0.3	0.1	0.3	10.5	69.6	1.0	0.3	0.6	0.5	0.5	0.3	0.4	1.9	1.0	0.4	0.6	0.1	0.3	0.0	0.5	10.8	0.7	17.4	0.2	0.0	20.8	18.0	42.4	137.3	0.2	0.3	0.2	0.2	0.4	3.4	0.4	23.1	0.3	12.4	17.7	18.6	54.4	0.4	2.3	4.6	0.0	0.1	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.6	0.1	0.2	87.1	0.0	167.3	0.0	1.4	0.0	1.9	1.3	0.4	0.0	0.0	0.3	0.2	124.0	0.2	117.3	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.3	0.2	0.0	1.0	0.3	0.0	0.2	185.1	0.2	0.1	0.2	0.0	0.0	2.5	0.9	0.2	0.3	0.2	0.1	0.2	0.0	25.3	0.3	1.1	0.5	0.1	0.8	0.6	0.0	0.2	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.3	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.9	0.5	0.5	0.5	0.4	0.6	0.7	0.2	0.4	0.4	0.2	0.0	5.3	1.0	0.9	275.4	26.8	61.9	335.2	0.0	0.9	30.1	0.7	0.0	8.5	0.0	0.0	24.9	0.1	0.1	0.0	0.2	1.8	0.0	0.1	1.1	0.0	0.0	1.3	0.2	2.8	1.4	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	4.8	0.0	2.0	0.0	11.9	0.4	0.3	0.7	8.8	14.0	0.6	0.0	0.0	0.5	1.4	1.6	0.0	1.2	1.6	5.6	0.0	0.0	2.8	0.0	0.0	5.3	0.9	0.5	2.4	173.4	283.1	8.9	0.6	0.2	0.0	15.2
TPBGL		ENSG00000261594	"Trophoblast glycoprotein like"	P0DKB5	11	75240774-75243704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 10.7;testis: 4.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 16.9;Melanocytes: 3.6;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.1"	"Region enhanced"	"Detected in many"		"medulla oblongata: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.4;HMC-1: 1.8;SCLC-21H: 1.8"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.55e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.93e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.49e-14)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.62e-2)"	0.3	1.6	2.0	0.4	3.7	0.0	0.2	0.0	4.0	0.4	0.0	0.3	0.1	0.9	0.0	0.1	0.3	0.3	0.2	1.1	0.6	0.2	0.1	0.2	0.2	10.7	0.3	0.1	0.1	0.0	0.3	0.0	0.7	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	0.6	0.8	0.2	0.1	4.4	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.7	0.0	4.0	1.1	0.6	10.7	0.3	0.7	0.8	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 13012.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 48.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 3141.3;SuSa: 3810.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		120000000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	372.0	103.6	49.8	232.9	53.2	21.6	348.8	52.4	53.9	577.4	59.3	2947.3	289.6	1566.9	250.5	639.0	823.8	288.0	10621.0	53.3	42.2	215.5	94.8	247.1	48.1	42.5	44.3	320.3	383.4	37.5	70.6	206.4	43.7	809.6	523.1	83.9	258.2	1545.5	12678.0	150.7	680.8	1754.9	44.8	134.3	976.5	52.3	50.0	21.1	156.8	5183.6	29.4	1511.0	425.8	42.2	554.5	357.3	418.1	20.9	143.1	89.9	1335.5	1509.1	552.8	905.9	669.2	253.9	107.6	1.7	677.7	1517.1	602.7	295.9	361.8	243.4	597.0	14.5	50.9	81.2	376.3	124.5	403.3	3.8	17.9	125.7	138.0	742.1	198.2	3141.3	243.2	14.7	8.7	20.4	695.3	286.4	25.6	7.1	496.0	129.0	61.1	9.0	146.5	15.8	1308.7	298.8	101.1	71.7	180.9	284.4	65.1	3810.3	204.8	15.3	1095.8	1178.8	572.0	181.6	1094.8	5.9	4.3	7.8	335.9	22.4	842.1	48.7	9.9	4.8	4.0	19.2	3.1	5.5	3.6	4.3	14.1	5.6	4.0	3.6	10.7	1.9	14.3	2.4	6.3	15.6	49.8	53.2	52.4	53.9	53.3	42.2	42.5	44.3	43.7	44.8	50.0	42.2	542.3	57.7	86.3	19.9	12.1	71.9	202.0	344.1	18.2	49.0	450.1	953.1	13012.4	346.0	147.0	318.2	383.7	212.1	20.6	561.3	187.9	2502.6	6.5	147.2	614.4	294.3	267.7	137.0	44.2	1671.1	3094.8	557.1	279.3	211.2	52.0	85.3	175.6	138.1	201.5	52.2	53.2	964.7	183.1	42.5	72.1	27.3	205.0	114.3	81.8	111.5	47.5	47.4	28.8	36.2	6.0	2372.3	623.4	1130.3	8.8	244.3	724.7	361.1	104.2	447.5	1038.7	484.0	1685.9	27.4	82.2	29.4	50.4	103.0	29.0	130.7	385.3	198.2
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690056	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease variant, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"skeletal muscle: 39012.3;tongue: 16773.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 1066.2;Peritubular cells: 2072.1;Sertoli cells: 2222.0;Smooth muscle cells: 2341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	812	"plasmacytoid DC: 398.6"	"Lineage enriched"	"Detected in single"	920	"dendritic cells: 398.6"	"Cell line enhanced"	"Detected in many"		"BJ: 2309.6;fHDF/TERT166: 1289.0;hTERT-RPE1: 1399.1"									"HPA047089, HPA053624"	Approved					NA	NA		140000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	331.1	285.0	88.0	411.0	89.8	16.7	260.8	92.5	117.3	651.3	127.3	3498.4	217.7	1928.1	201.9	1018.0	849.7	442.4	788.5	84.8	81.1	144.0	41.0	283.1	62.2	86.1	79.2	388.4	73.7	24.1	82.6	142.3	80.5	1219.0	238.0	8.0	393.6	1988.7	39012.3	148.5	636.2	2340.8	78.6	140.1	1252.6	82.9	83.3	26.3	138.9	16773.7	21.2	1630.1	454.9	79.8	375.4	291.2	213.9	33.6	335.4	893.3	129.3	2309.6	934.4	983.0	667.9	12.2	24.2	0.4	213.0	1289.0	144.6	9.2	3.7	291.2	457.0	716.2	10.8	9.1	1054.1	11.8	540.2	2.3	102.7	1067.7	44.9	738.8	0.4	1399.1	235.7	25.3	5.6	0.8	1052.1	15.3	2.7	29.1	269.6	1.5	17.0	18.5	391.5	3.0	31.1	7.2	3.8	13.3	470.0	7.9	18.2	273.8	6.8	27.7	30.0	16.5	585.7	11.6	730.6	0.6	2.7	2.9	34.0	6.5	29.2	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.4	0.2	0.0	398.6	0.0	2.1	88.0	89.8	92.5	117.3	84.8	81.1	86.1	79.2	80.5	78.6	83.3	79.8	110.0	3.2	4.1	10.4	5.9	57.1	81.2	274.1	24.5	0.8	29.9	1066.2	619.5	4.3	42.1	7.3	0.0	12.1	116.7	1.4	0.0	21.4	4.3	20.3	488.3	80.3	2.4	4.0	2.5	5.7	104.8	332.6	99.4	18.7	2.5	142.0	181.3	1.4	32.4	1.7	4.6	1.9	48.8	3.1	77.9	32.4	283.0	24.2	67.6	9.4	6.5	11.7	1.0	3.0	0.4	8.4	0.1	2072.1	2.9	169.8	0.4	1.3	23.5	0.9	2222.0	594.8	2341.4	2.5	27.3	6.7	42.8	14.6	16.0	106.7	2.8	28.7
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	96.6	2.9	0.3	23.6	0.5	2.4	47.2	0.3	0.9	53.7	0.9	83.0	71.6	73.3	6.0	64.3	26.6	129.7	14.7	0.4	0.4	13.9	12.2	128.5	21.3	0.4	0.3	3.2	18.9	2.3	3.5	1.2	0.6	65.9	34.6	0.0	60.2	22.5	10.1	122.7	148.7	17.9	0.4	5.9	104.0	8.9	0.4	14.2	4.7	13.0	13.2	113.5	52.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.9	0.4	0.4	0.4	0.3	0.6	0.4	0.4	0.3	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2"	P20231	16	1227272-1230184	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	25	"granulocytes: 8966.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	50	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 297.5"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		16000000	"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	95.1	2.5	0.3	20.2	0.6	4.3	47.8	0.3	0.9	53.2	1.0	77.8	35.5	71.8	9.8	64.6	30.4	103.9	15.0	0.5	0.5	15.5	12.2	127.8	26.2	0.5	0.4	3.5	18.9	1.5	3.9	1.3	0.5	67.0	19.8	0.0	64.5	13.3	10.0	122.5	146.1	22.0	0.5	5.2	102.1	9.9	0.5	4.9	4.7	10.4	9.9	118.6	53.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.2	0.4	297.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	4.7	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.9	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.3	0.1	38.5	275.3	0.0	2.8	0.0	4.4	0.0	0.0	0.0	1.5	0.0	1.5	0.0	16.7	0.0	0.0	0.1	0.6	0.7	0.0	2.4	0.6	0.0	0.0	3.2	0.0	18.9	0.0	0.0	0.2	6.0	2.0	0.0	8966.1	0.0	0.0	0.0	3.8	0.0	0.1	0.7	0.0	0.0	0.0	1.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.8	5.4	0.7	0.1	3.6	0.0	0.0	0.4	1.1	0.0	0.7	0.0	0.0	0.1	345.1	0.0	1.0	6.1
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1259008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.2"	"Cell type enriched"	"Detected in some"	19	"granulocytes: 202.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	29	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	49	"HEL: 28.2;HMC-1: 40.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	8.0	0.5	1.2	1.9	1.3	1.6	4.5	1.3	2.7	5.1	1.0	7.8	3.8	8.5	1.9	8.1	3.2	13.8	1.1	1.4	1.1	1.2	0.7	17.8	5.4	1.4	1.3	0.3	1.5	0.1	0.4	0.1	1.5	5.5	0.8	0.1	4.8	1.2	1.4	9.5	13.4	5.4	1.1	0.4	21.2	1.3	1.4	1.2	0.3	1.0	2.3	13.3	5.0	1.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.2	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	2.7	1.4	1.1	1.4	1.3	1.5	1.1	1.4	1.2	0.0	3.2	7.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.2	0.0	0.0	202.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2 microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.0;lymphoid tissue: 70.3;testis: 30.7"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 90.7;Extravillous trophoblasts: 68.5;Granulosa cells: 46.6;Spermatocytes: 114.5;Spermatogonia: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.1;NK-cells: 3.6;T-cells: 8.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.9	1.4	0.9	13.0	0.9	48.0	2.7	0.8	1.0	2.3	0.5	11.6	9.4	2.4	0.2	13.2	0.9	1.8	0.8	1.1	0.6	0.7	4.2	1.9	26.6	0.6	1.0	0.5	0.4	0.4	0.2	8.3	0.7	0.7	14.2	0.5	2.0	0.5	1.4	9.8	9.4	6.8	0.6	5.2	6.2	30.7	1.3	70.3	1.0	0.8	32.3	3.4	4.1	0.9	455.1	149.1	176.4	139.1	13.8	25.2	169.8	186.1	104.5	264.0	197.7	319.1	190.4	212.4	106.7	104.5	196.8	232.7	203.7	169.0	298.8	92.3	78.8	416.3	139.7	219.6	4.2	161.9	102.8	8.7	9.1	166.0	120.0	37.9	144.6	157.1	313.8	187.8	209.7	186.2	272.2	125.3	197.1	174.0	159.3	152.5	475.5	128.2	71.2	72.8	127.5	85.7	284.6	106.3	82.0	120.9	185.1	97.3	98.3	294.1	179.7	136.5	290.0	74.4	138.6	187.3	92.2	565.1	195.8	5.1	0.0	0.4	0.4	0.0	0.2	0.6	1.4	1.7	0.5	0.2	0.3	0.5	0.2	3.6	0.1	1.0	8.1	1.0	0.9	0.9	0.8	1.0	1.1	0.6	0.6	1.0	0.7	0.6	1.3	0.9	1.0	0.0	4.2	0.0	5.9	6.9	1.5	4.3	1.2	0.9	3.0	3.4	0.9	4.3	3.8	0.0	0.0	23.3	3.8	6.4	0.0	1.2	9.3	7.3	6.6	3.9	1.2	90.7	2.9	0.4	68.5	9.2	16.3	8.4	0.0	46.6	8.9	3.0	19.5	1.7	0.9	9.8	10.2	8.0	5.5	13.1	0.9	7.6	0.0	1.0	2.1	0.4	3.1	0.5	0.5	1.8	1.4	0.0	30.8	2.5	0.9	0.0	0.7	0.4	0.0	1.1	15.4	114.5	63.1	31.2	6.1	4.7	8.2	4.2	18.4	2.9
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 42.7;lymphoid tissue: 11.4;ovary: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 575.5;Granulosa cells: 108.7;Late spermatids: 326.8;Undifferentiated cells: 141.9"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 14.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 71.9"	"Lineage enriched"	"Detected in many"	18	"T-cells: 71.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 41.7;HDLM-2: 35.1;HSkMC: 22.3;hTEC/SVTERT24-B: 17.8;SiHa: 17.8"									HPA045817	Approved				"Intracellular and membrane"	NA	NA		18000	"Cluster 32: T-cells - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	2.5	0.4	2.1	8.9	2.1	3.7	2.2	0.3	3.4	0.3	0.3	40.0	4.2	0.2	0.7	0.3	0.8	0.5	0.3	1.9	1.5	0.6	1.0	2.8	11.4	0.3	2.7	26.7	0.1	2.1	0.3	0.9	0.3	0.2	42.7	0.0	0.5	0.1	0.1	1.0	10.7	2.8	0.4	3.8	1.1	0.4	3.8	8.1	0.4	0.6	7.8	0.7	0.4	1.6	1.3	1.1	0.4	0.2	12.4	13.4	41.7	2.0	3.3	5.8	10.8	0.5	4.7	0.0	0.5	6.5	10.8	0.0	2.8	0.6	8.6	35.1	0.7	0.0	8.4	0.0	1.5	0.1	0.0	22.3	0.0	17.8	8.1	1.3	0.0	0.3	0.0	0.1	0.8	0.0	0.1	0.1	1.1	2.3	0.9	0.3	0.7	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.2	0.3	0.0	0.2	0.3	5.8	0.8	0.0	2.1	4.0	0.0	0.1	5.3	3.5	0.0	0.0	0.3	0.0	8.5	0.3	10.5	0.7	33.6	12.4	1.8	3.9	71.9	46.1	1.3	3.9	0.2	1.6	23.5	13.2	2.1	2.1	0.3	3.4	1.9	1.5	0.3	2.7	0.3	0.4	3.8	1.6	9.0	3.2	11.0	0.0	7.8	1.0	0.6	0.6	0.0	1.1	1.4	0.4	85.4	0.0	0.9	0.0	0.0	9.4	4.6	51.1	0.0	0.1	575.5	4.3	0.6	7.5	12.7	0.8	10.6	0.9	41.5	6.1	2.6	1.9	2.5	108.7	2.2	0.1	2.6	0.0	0.7	67.9	0.0	1.3	6.6	326.8	5.0	4.6	3.6	3.7	12.6	0.0	3.1	1.0	0.7	0.6	73.8	2.6	5.4	0.5	17.4	1.2	1.7	0.1	6.6	0.9	7.3	3.5	5.6	0.4	0.6	4.4	29.7	0.2	141.9	0.5
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47997385	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.5;Cholangiocytes: 15.7;Fibroblasts: 6.6;Hepatocytes: 11.3;Microglial cells: 7.5;Proximal tubular cells: 22.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 6.7;U-2197: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		41000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	2.3	0.9	0.1	0.6	0.2	0.0	2.7	1.0	0.3	2.8	0.5	2.9	0.4	1.5	0.8	1.3	1.9	1.6	7.0	0.1	0.0	16.6	4.2	1.7	0.0	0.1	0.2	0.8	2.6	0.0	1.5	0.4	0.2	3.6	0.7	0.0	1.6	3.3	0.6	1.6	1.6	0.9	0.1	1.2	1.6	0.9	0.1	0.4	1.0	0.6	0.1	3.8	2.6	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	6.7	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	1.6	0.0	0.5	0.3	0.3	0.8	1.4	0.6	2.8	0.0	0.6	2.9	7.5	15.7	0.1	1.8	0.0	0.0	0.0	0.0	5.9	3.8	0.1	0.1	0.5	1.9	0.0	0.0	0.3	2.2	0.0	6.6	0.0	0.1	0.0	0.0	1.4	11.3	0.1	0.0	0.3	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	7.5	0.0	0.0	0.0	0.5	0.7	1.3	0.0	2.2	0.1	0.4	0.0	22.8	0.0	0.0	0.0	0.3	4.1	0.0	4.0	0.1	0.3	0.0	0.2	0.1	0.0	0.2
TRAC		ENSG00000277734	"T cell receptor alpha constant"		14	22547506-22552156	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	7	"lymphoid tissue: 787.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 166.3;Rod photoreceptor cells: 75.9;T-cells: 428.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"MAIT T-cell: 2123.1;memory CD4 T-cell: 2939.7;memory CD8 T-cell: 2508.6;naive CD4 T-cell: 2671.8;naive CD8 T-cell: 2388.0;T-reg: 4379.2"	"Lineage enriched"	"Detected in all"	41	"T-cells: 4379.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 127.0;JURKAT: 294.7;NB-4: 83.1;U-266/84: 126.2;U-698: 62.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"prognostic favorable (3.21e-4)"	"prognostic favorable (4.87e-6)"	"unprognostic (9.92e-3)"	"prognostic favorable (4.15e-6)"	"unprognostic (3.71e-2)"	"prognostic favorable (5.25e-5)"	"unprognostic (2.83e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.51e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.40e-5)"	"unprognostic (2.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.75e-2)"	17.5	7.7	5.4	157.5	14.8	29.5	16.9	6.9	3.9	12.0	2.4	33.6	46.6	9.3	39.3	17.2	10.0	42.2	45.3	2.0	2.0	10.5	16.5	47.0	394.3	3.4	8.2	7.3	3.3	1.9	11.4	2.3	4.0	15.3	43.4	112.7	25.8	5.5	3.3	19.5	78.3	10.4	2.5	134.1	54.9	7.2	2.2	787.9	12.2	2.7	287.6	58.4	9.7	2.3	0.3	0.0	11.6	0.0	0.0	0.0	0.2	0.1	0.4	0.3	0.4	1.8	0.0	11.4	1.5	0.0	0.2	0.0	0.2	0.1	1.1	127.0	0.0	0.2	0.0	0.0	0.0	16.4	0.8	0.0	0.0	4.3	0.2	0.0	3.1	294.7	0.4	0.1	1.2	0.0	45.7	83.1	3.1	0.1	0.6	22.9	2.8	0.2	0.7	0.0	0.0	0.2	0.0	0.0	1.1	1.7	0.0	1.6	8.3	3.4	0.7	0.3	1.0	2.7	126.2	62.1	1.0	0.5	0.1	24.5	10.2	9.8	520.5	6.7	2123.1	105.6	2939.7	2508.6	7.9	94.6	2671.8	2388.0	57.7	89.7	11.0	11.8	4379.2	2965.8	5.4	14.8	6.9	3.9	2.0	2.0	3.4	8.2	4.0	2.5	2.2	2.3	9.0	3.2	25.6	0.0	46.3	0.0	1.0	0.0	5.7	9.0	4.9	8.5	35.7	0.0	6.2	0.0	12.5	0.2	166.3	0.9	17.6	0.7	46.2	0.9	0.6	3.3	0.0	16.4	0.0	0.0	0.2	15.9	4.1	0.5	10.1	0.0	9.3	1.4	1.3	0.0	0.0	0.9	0.0	8.1	0.0	4.8	1.8	12.2	0.0	0.0	20.2	11.8	44.3	0.0	0.0	0.1	1.2	5.3	25.4	0.2	0.5	4.6	0.0	75.9	0.0	2.6	4.7	2.2	0.8	5.4	0.0	0.3	428.0	0.0	0.7	0.2
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"		7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1520.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 338.0;NK-cells: 580.9;T-cells: 399.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3232.4"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3232.4"	"Cell line enriched"	"Detected in some"	5	"JURKAT: 1467.5"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.08e-4)"	"unprognostic (7.96e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.81e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.76e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.18e-6)"	"unprognostic (3.98e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.19e-3)"	9.2	5.1	1.3	140.0	1.5	53.5	9.5	1.1	2.1	7.7	1.5	18.5	26.8	6.4	5.7	12.0	7.0	26.7	5.0	1.0	1.1	5.4	11.4	31.5	322.2	2.0	1.2	6.4	2.7	0.9	2.0	2.3	1.7	9.0	19.4	0.0	19.0	4.6	1.0	9.9	49.7	4.2	1.7	92.5	27.1	2.7	1.6	1520.1	8.4	2.1	227.0	33.2	6.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1467.5	2.0	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	296.5	2.0	0.0	1.9	0.0	45.6	7.2	4.7	869.6	3.5	693.8	17.1	1893.1	1259.3	5.8	15.7	1989.8	1450.7	37.3	359.8	8.3	9.7	3232.4	1917.5	1.3	1.5	1.1	2.1	1.0	1.1	2.0	1.2	1.7	1.7	1.6	1.9	7.3	19.2	40.8	0.0	11.7	0.0	0.3	0.0	0.0	0.0	5.9	5.5	0.0	0.0	3.1	1.8	0.0	0.2	338.0	0.0	0.0	0.5	0.6	1.1	0.7	1.5	0.0	10.7	0.0	0.0	0.1	3.2	4.6	0.8	20.2	0.0	5.3	1.5	0.3	0.0	0.0	0.1	0.0	8.4	0.0	1.9	17.4	13.9	0.0	0.0	17.3	0.0	580.9	0.0	0.0	0.0	0.1	8.2	23.6	0.3	0.0	2.4	0.7	0.0	0.0	1.1	3.5	0.0	0.1	0.5	0.0	0.1	399.0	0.1	0.1	0.4
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"		7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 115.8;lymphoid tissue: 190.2"	"Group enriched"	"Detected in many"	4	"B-cells: 164.7;dendritic cells: 358.8;NK-cells: 264.7;T-cells: 498.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.0"	"Cell line enriched"	"Detected in some"	45	"MOLT-4: 277.9"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"prognostic favorable (8.04e-5)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.19e-3)"	"prognostic favorable (3.42e-8)"	"unprognostic (5.53e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.53e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.09e-3)"	18.9	3.1	0.4	3.9	0.3	1.5	8.6	0.1	1.2	11.9	0.1	21.2	1.7	8.7	0.0	14.6	15.7	2.2	4.9	0.3	0.0	9.6	12.7	32.3	8.6	0.2	0.3	18.3	3.5	0.1	4.0	0.0	0.2	14.2	2.7	0.0	7.9	0.1	3.3	6.5	115.8	0.5	0.1	190.2	16.9	8.7	0.3	109.2	16.4	1.2	10.9	14.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	3.5	0.0	0.0	0.0	0.0	277.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	14.4	0.0	35.0	8.1	47.6	47.3	0.3	7.7	46.6	40.3	2.0	10.5	0.1	0.0	76.0	42.4	0.4	0.3	0.1	1.2	0.3	0.0	0.2	0.3	0.2	0.1	0.3	0.1	8.3	9.6	52.4	0.0	164.7	0.0	0.3	0.0	1.8	0.1	6.2	9.7	4.8	5.7	3.7	1.8	0.0	0.4	358.8	1.4	0.0	2.9	1.0	1.1	0.8	4.0	0.0	16.6	0.0	1.3	0.1	10.8	8.6	0.9	20.2	0.0	15.0	1.6	0.4	0.0	0.0	0.8	0.0	9.0	0.0	4.2	63.6	18.9	0.0	0.0	19.0	15.6	264.7	0.0	0.0	20.1	0.1	70.3	30.6	0.4	0.1	2.2	2.9	0.4	65.7	4.2	12.4	0.1	0.8	1.3	0.0	0.3	498.0	1.4	0.9	0.2
TRBV20-1	"TCRBV20S1, TCRBV2S1, TRBV201"	ENSG00000211747	"T cell receptor beta variable 20-1"	A0A075B6N2	7	142626649-142627399	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 161.4"	"Cell type enriched"	"Detected in some"	15	"T-cells: 26.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 351.7"	"Lineage enriched"	"Detected in many"	115	"T-cells: 351.7"	"Group enriched"	"Detected in some"	8	"Karpas-707: 2.4;MOLT-4: 5.0;REH: 2.5;RH-30: 3.0"	"Not detected"	"Not detected"													NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.25e-3)"	"prognostic favorable (4.40e-5)"	"unprognostic (1.39e-2)"	"prognostic favorable (8.49e-4)"	"unprognostic (8.83e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.34e-2)"	"unprognostic (8.75e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (1.11e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.41e-2)"	1.7	0.2	0.1	13.6	0.1	5.1	0.6	0.1	0.2	0.6	0.0	2.4	0.5	0.3	0.0	0.7	0.7	3.2	0.2	0.1	0.0	0.5	0.6	2.7	53.3	0.2	0.0	0.5	0.2	0.0	0.8	0.0	0.3	0.9	3.1	0.0	0.5	0.2	0.1	1.9	6.0	0.9	0.1	7.3	3.6	0.3	0.1	161.4	1.0	0.0	6.0	2.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.0	0.0	0.0	2.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.6	0.2	4.6	0.3	231.9	1.1	192.7	76.4	0.6	0.6	144.0	58.9	2.3	0.3	0.8	0.4	351.7	50.2	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0
TRBV5-1	"TCRBV5S1, TCRBV5S1A1T, TRBV51"	ENSG00000211734	"T cell receptor beta variable 5-1"	A0A578	7	142320677-142321544	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 44.0"	"Cell type enriched"	"Detected in some"	11	"T-cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 211.6;T-reg: 295.5"	"Lineage enriched"	"Detected in many"	111	"T-cells: 295.5"	"Not detected"	"Not detected"																	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 58: T-cells - T-cell receptor"				"unprognostic (2.26e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.49e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.02e-5)"	"unprognostic (2.55e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.29e-3)"	"unprognostic (5.85e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.96e-7)"	"unprognostic (2.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.97e-2)"	0.3	0.0	0.0	4.8	0.0	1.1	0.2	0.0	0.0	0.4	0.0	0.7	1.0	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.2	0.7	9.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.3	1.9	0.1	0.0	2.6	1.6	0.2	0.0	44.0	0.2	0.0	8.9	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.3	2.6	0.2	11.0	0.4	166.1	65.4	0.4	0.4	211.6	128.7	2.6	0.5	0.5	0.3	295.5	82.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0
TRBV7-2	"TCRBV6S5A1N1, TCRBV7S2, TRBV72"	ENSG00000282939	"T cell receptor beta variable 7-2"	A0A1B0GXF2	7	142352819-142353358	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	11	"epididymis: 35.6;lymphoid tissue: 85.5"	"Cell type enriched"	"Detected in some"	5	"T-cells: 33.0"					"Region enriched"	"Detected in single"	5	"hypothalamus: 1.1"	"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 397.4;T-reg: 570.3"	"Lineage enriched"	"Detected in many"	79	"T-cells: 570.3"	"Group enriched"	"Detected in some"	9	"JURKAT: 55.7;MOLT-4: 93.6;U-937: 49.0"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"																					0.9	0.1	0.0	15.0	0.1	0.0	2.2	0.0	0.2	2.2	0.0	1.2	1.7	0.0	35.6	0.6	0.5	0.0	0.2	0.0	1.1	0.5	0.3	5.5	49.0	0.0	0.0	0.1	0.2	0.0	1.0	0.1	0.0	0.3	4.6	0.0	0.4	0.4	0.0	0.2	4.7	1.1	0.0	5.8	4.7	0.0	0.2	85.5	0.7	0.0	43.0	2.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.3	0.0	0.0	49.0	0.0	1.1	2.3	0.7	11.9	1.2	55.5	0.7	397.4	178.6	2.7	0.7	302.2	110.6	1.2	0.5	1.9	7.2	570.3	104.9	0.0	0.1	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRGC1	"C1, TCRGC1"	ENSG00000211689	"T cell receptor gamma constant 1"		7	38257879-38265678	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"bone marrow: 31.7;prostate: 76.6"	"Group enriched"	"Detected in some"	5	"dendritic cells: 95.8;NK-cells: 230.7;Prostatic glandular cells: 61.9;T-cells: 65.6"	"Cancer enriched"	"Detected in some"	141	"prostate cancer: 107.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"gdT-cell: 384.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 384.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 21.0;MCF7: 89.8;SK-BR-3: 49.6;U-937: 45.5"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.37e-2)"	"unprognostic (2.38e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.04e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.56e-2)"	0.6	0.2	1.6	1.1	1.6	31.7	2.1	1.4	2.0	0.1	1.1	0.5	1.0	0.2	0.5	0.1	0.3	1.0	0.2	1.4	1.4	0.8	0.8	1.9	2.0	1.7	1.5	0.1	0.0	0.0	0.2	0.5	1.6	76.6	0.6	0.0	0.4	0.2	0.1	0.1	1.4	0.2	1.6	6.0	0.6	0.4	2.1	7.0	0.3	0.0	1.3	0.6	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	21.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	89.8	0.2	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	49.6	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	3.8	0.3	0.5	384.7	0.4	56.7	0.2	6.8	33.5	0.3	0.0	2.3	21.7	1.8	87.5	0.3	0.5	0.1	43.7	1.6	1.6	1.4	2.0	1.4	1.4	1.7	1.5	1.6	1.6	2.1	1.5	0.5	0.0	1.1	0.0	2.1	0.0	1.3	0.0	0.0	0.0	1.8	0.6	0.2	0.0	0.6	0.0	0.0	0.0	95.8	0.1	0.0	0.0	2.3	0.0	0.1	0.5	1.2	2.7	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	2.2	0.9	0.1	0.0	0.0	0.2	0.0	1.9	0.0	0.9	0.0	2.1	0.0	0.0	19.5	0.0	230.7	0.0	0.0	0.0	0.0	0.0	14.3	61.9	0.0	0.3	0.7	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	65.6	0.0	0.3	1.2
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	7	"dendritic cells: 149.1;NK-cells: 90.6;T-cells: 122.0"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.4;JURKAT: 36.6;NB-4: 29.9;SK-BR-3: 9.8;U-937: 53.9"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"	3.6	1.1	8.8	5.1	9.0	30.5	1.8	8.6	19.6	1.5	7.1	3.5	4.5	1.3	3.2	1.1	2.2	3.9	0.9	8.4	8.5	1.6	3.6	9.7	17.5	9.6	8.9	0.5	0.8	0.2	1.0	0.5	9.2	23.7	4.0	0.1	1.8	0.8	0.4	0.6	8.0	1.0	9.3	29.7	3.8	2.2	10.2	34.6	2.1	0.1	7.0	3.4	2.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	3.7	1.2	29.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.9	0.0	1.1	1.3	1.4	720.5	1.2	287.4	0.6	64.8	341.6	1.0	0.3	13.5	212.9	4.9	149.7	1.0	1.2	1.3	167.5	8.8	9.0	8.6	19.6	8.4	8.5	9.6	8.9	9.2	9.3	10.2	9.5	1.2	0.0	2.4	0.0	2.4	0.0	0.2	0.0	0.0	0.0	1.0	1.3	0.7	1.5	0.6	0.0	0.0	0.0	149.1	0.3	0.0	0.2	15.5	0.2	0.1	0.8	0.0	6.6	0.0	0.0	0.0	0.4	2.6	0.2	0.0	0.2	3.9	1.0	0.0	0.0	0.0	0.5	0.0	3.5	0.0	6.7	0.0	2.8	0.0	0.0	10.6	0.0	90.6	0.0	0.0	0.0	0.0	0.4	14.2	2.8	0.0	0.5	0.0	0.0	0.0	0.2	1.3	0.8	0.2	0.3	0.0	0.3	122.0	0.0	0.2	0.3
TRGV10	"TCRGV10, V3P"	ENSG00000211694	"T cell receptor gamma variable 10 (non-functional)"		7	38299811-38300322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.5;Plasma cells: 7.1;T-cells: 29.9"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 7.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 196.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 196.5"	"Group enriched"	"Detected in some"	24	"NB-4: 79.7;U-937: 20.5"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.59e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-4)"	"unprognostic (2.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.07e-2)"	1.7	0.6	0.1	2.7	0.3	14.1	1.8	0.1	0.4	1.2	0.6	2.0	2.1	0.8	0.7	1.1	1.3	3.3	0.4	0.0	0.1	0.6	1.8	4.1	11.0	0.4	0.1	0.3	0.2	0.1	0.2	0.4	0.3	6.1	2.7	0.0	1.1	0.7	0.2	0.6	4.1	0.6	0.2	13.9	2.6	0.3	0.2	12.5	1.1	0.0	5.0	3.8	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	79.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.5	0.0	0.7	0.4	1.0	196.5	0.1	156.1	0.5	47.2	137.6	0.2	0.1	11.3	159.7	2.9	26.0	0.3	0.8	0.1	33.3	0.1	0.3	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.2	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0
TRGV2	"TCRGV2, VIS2"	ENSG00000233306	"T cell receptor gamma variable 2"	A0A075B6R0	7	38362864-38363518	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	5	"T-cells: 19.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 147.8"	"Lineage enriched"	"Detected in many"	22	"T-cells: 147.8"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 17.4"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.51e-3)"	"unprognostic (8.88e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.21e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-3)"	0.4	0.6	0.0	1.6	0.0	0.9	0.1	0.0	0.2	0.2	0.2	0.8	0.8	0.3	0.1	0.1	0.3	1.0	0.2	0.0	0.0	0.1	0.3	0.9	5.0	0.7	0.4	0.0	0.1	0.0	0.1	0.0	0.2	1.2	0.6	0.1	0.9	0.1	0.1	0.2	1.4	0.4	0.1	6.6	0.7	0.3	0.4	4.8	0.3	0.0	0.7	0.6	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	2.4	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	17.4	0.0	0.0	0.5	0.8	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	1.7	0.1	0.0	3.8	0.0	0.2	0.4	0.0	59.4	0.2	58.4	0.1	29.7	147.8	1.4	0.2	7.0	54.9	0.9	6.8	0.1	1.5	0.6	22.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.1;kidney: 6.0;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.8	17.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	12.2	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.1;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.4	12.1	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 8.5;retina: 3.5"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 69.0;Inhibitory neurons: 24.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.0	0.2	1.0	0.0	0.8	0.0	0.0	8.5	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.0	0.0	0.0	0.0	3.5	1.5	0.0	0.0	0.0	0.5	0.1	2.7	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	8.5	2.2	1.4	1.5	3.5	1.5	2.7	1.7	1.5	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.0	24.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.5	0.0	6.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TROAP	TASTIN	ENSG00000135451	"Trophinin associated protein"	Q12815	12	49323236-49331731	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0;lymphoid tissue: 36.7;testis: 29.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 71.5;Erythroid cells: 75.6;Late spermatids: 70.2;Spermatocytes: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 8.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.6"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044102	Uncertain					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"			"HPA044102: AB_10963691"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (3.43e-3)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.17e-2)"	1.3	1.5	0.2	7.3	0.3	51.0	1.4	0.2	0.7	2.8	0.2	6.7	9.0	1.2	0.5	13.5	0.7	0.8	0.8	0.2	0.2	0.9	1.6	2.4	11.2	0.4	0.2	0.8	0.8	0.7	0.4	5.1	0.3	0.9	9.2	0.6	2.5	0.4	0.3	7.7	7.6	2.8	0.1	7.0	5.4	29.1	0.5	36.7	0.8	0.3	14.5	1.9	5.3	0.3	95.9	73.9	92.4	69.7	2.8	6.2	71.2	45.4	43.4	129.5	73.1	163.7	73.5	64.6	21.9	33.7	70.7	74.6	70.4	44.0	75.7	51.9	101.8	90.9	120.4	53.7	1.9	66.5	93.8	1.5	6.0	86.9	59.8	21.1	75.1	68.0	57.2	108.9	52.7	123.0	122.9	101.8	43.4	269.3	110.2	62.5	78.6	83.9	31.7	35.0	59.9	41.0	56.0	107.4	32.7	53.6	88.2	50.1	25.0	33.5	91.2	69.4	124.8	58.3	68.8	83.0	32.3	73.8	38.4	0.2	0.0	0.1	0.1	0.0	0.2	1.4	2.1	2.3	0.3	1.4	0.1	0.5	0.0	2.0	0.1	0.0	8.6	0.5	0.2	0.3	0.2	0.7	0.2	0.2	0.4	0.2	0.3	0.1	0.5	0.3	0.1	0.0	0.0	0.0	4.6	3.8	1.5	2.8	1.2	0.6	2.1	2.8	0.5	0.0	1.8	0.0	0.0	14.1	1.0	3.7	0.0	0.7	71.5	1.9	1.3	1.9	1.2	75.6	0.0	0.7	23.6	3.3	10.2	2.7	0.0	16.0	5.7	1.1	15.7	0.0	0.0	7.9	10.2	6.7	3.7	70.2	1.8	4.0	1.8	0.0	0.9	0.0	6.2	0.0	0.0	0.8	1.8	0.4	17.0	1.1	0.7	0.1	0.2	0.4	0.0	0.7	3.5	29.1	9.3	15.6	2.0	4.0	2.5	0.9	12.7	3.6
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.7"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 9.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 29: Non-specific - Vesicular transport"		"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	2.9	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	1.7	0.0	0.0	3.3	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.1
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185962	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 593.8;kidney: 244.3"	"Cell type enhanced"	"Detected in many"		"Club cells: 723.5;Distal enterocytes: 1983.8;Late spermatids: 838.1;Paneth cells: 1127.7;Respiratory ciliated cells: 1817.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	57	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	57	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.6;CAPAN-2: 216.7;HaCaT: 151.4;hTCEpi: 173.6;OE19: 257.9;RPTEC TERT1: 628.4;RT4: 308.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favorable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.9	4.3	0.5	53.2	0.7	0.0	6.2	1.7	1.1	78.2	1.4	523.3	25.4	17.7	34.7	5.5	122.4	28.9	0.9	0.5	0.5	244.3	3.9	32.1	0.4	1.2	0.6	0.4	3.1	72.0	17.3	1.1	1.1	194.7	593.8	0.0	101.0	65.9	0.8	2.5	96.7	20.8	1.0	0.7	213.1	27.3	0.6	1.9	121.9	0.1	4.9	104.9	9.9	1.8	129.6	2.0	0.0	0.0	0.2	0.0	1.8	0.1	2.7	0.1	0.0	0.0	216.7	0.0	40.2	0.3	0.2	151.4	0.0	111.2	0.1	0.0	0.0	0.0	1.1	7.6	0.0	0.0	0.2	0.0	173.6	0.7	60.9	3.6	0.3	1.3	0.0	0.0	1.6	4.9	0.0	0.5	0.1	257.9	8.1	0.1	0.1	1.6	628.4	308.2	1.9	0.0	0.3	13.0	0.5	0.5	9.0	0.1	1.4	0.0	0.7	0.4	0.7	1.5	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.5	0.7	1.7	1.1	0.5	0.5	1.2	0.6	1.1	1.0	0.6	1.8	2.5	25.6	29.5	0.3	7.4	1.0	194.4	499.9	4.0	0.0	14.5	11.0	0.7	11.5	723.5	579.4	0.0	0.3	0.2	1983.8	46.9	61.3	141.3	268.3	14.1	4.5	201.8	0.0	1.2	525.1	0.1	6.0	223.3	144.3	11.4	0.0	1.4	3.6	0.3	0.0	1.3	648.1	242.1	0.3	0.3	838.1	5.0	5.3	5.4	1.0	1.6	0.0	0.0	0.5	1.6	484.4	1127.7	1.9	0.7	211.7	505.4	477.8	1817.6	0.0	0.0	0.4	54.1	4.7	2.6	2.9	1.3	0.0	7.4	0.0	275.9	517.0
TSPAN11		ENSG00000110900	"Tetraspanin 11"	A1L157	12	30926428-30996602	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.7;Inhibitory neurons: 5.7;Late spermatids: 10.6;Oligodendrocyte precursor cells: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.2;HSkMC: 22.8;NTERA-2: 18.2;SCLC-21H: 9.7;SH-SY5Y: 18.6;SuSa: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066789			Approved	Vesicles		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA066789: AB_2685723"	"unprognostic (4.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.51e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.28e-2)"	"prognostic favorable (3.43e-4)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.79e-1)"	2.5	2.1	5.5	7.5	5.1	0.0	1.9	9.3	5.0	6.5	0.8	25.9	3.9	1.7	5.8	3.5	1.9	7.1	6.5	5.0	3.9	1.0	0.7	3.4	2.2	4.5	5.7	0.8	1.1	0.1	1.0	0.7	3.7	4.1	8.8	1.4	2.4	4.8	0.4	5.6	9.6	6.4	2.3	2.4	3.8	1.0	6.3	0.8	3.1	1.2	4.1	4.5	3.6	4.8	0.0	0.3	25.2	0.0	0.1	0.3	0.2	0.3	0.8	0.0	0.0	0.0	0.8	0.0	1.4	2.2	0.1	0.6	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.1	22.8	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	18.2	0.0	0.2	0.1	0.1	0.5	0.0	0.1	9.7	18.6	0.2	0.0	0.1	11.2	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.1	9.3	5.0	5.0	3.9	4.5	5.7	3.7	2.3	6.3	4.8	0.6	0.0	0.0	3.6	0.0	0.8	0.0	0.0	0.0	1.7	0.1	0.0	2.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.5	2.4	3.3	0.0	0.0	1.5	0.0	0.0	4.3	0.0	0.4	0.0	0.2	5.7	0.2	0.1	0.0	5.7	0.0	0.0	0.0	1.7	10.6	4.7	0.2	1.8	1.0	0.0	3.6	0.0	27.2	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.9	0.5	0.0	0.3	1.1	0.2	0.5	0.1	1.1	0.0	0.2	0.1	0.0	0.1
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932423	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 83.5"	"Group enriched"	"Detected in many"	6	"Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	22.2	46.1	5.8	10.4	4.3	1.2	10.0	30.5	8.2	14.4	3.6	47.9	6.7	46.7	3.6	21.0	20.8	13.3	83.5	26.1	4.6	14.5	4.9	22.4	7.7	5.1	10.4	7.4	1.6	3.9	5.4	30.2	4.9	15.8	9.9	1.0	3.3	41.4	14.7	6.3	16.4	46.6	8.9	14.1	16.6	4.0	10.8	4.0	14.8	19.9	4.2	23.1	10.2	2.3	0.0	0.6	36.7	0.5	0.0	0.0	0.0	0.6	0.5	2.3	0.1	7.3	61.5	0.0	16.4	1.0	35.2	0.0	6.6	0.2	0.6	48.7	2.4	0.2	5.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	14.3	0.2	1.1	0.0	0.1	0.0	0.0	0.1	33.0	0.1	1.0	0.1	38.4	0.2	0.0	0.0	31.9	36.2	0.4	0.1	0.1	99.8	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	1.6	1.0	0.0	0.0	1.6	0.1	0.0	0.8	0.2	1.1	0.5	0.0	0.0	1.3	0.2	0.3	0.5	0.0	0.0	0.3	1.7	5.8	4.3	30.5	8.2	26.1	4.6	5.1	10.4	4.9	8.9	10.8	2.3	72.2	0.0	3.7	5.5	1.5	1.7	0.1	0.0	0.6	1.8	1.0	0.3	22.3	0.0	0.0	7.3	0.0	0.1	1.1	0.0	0.0	0.4	29.7	0.7	0.9	51.8	0.0	3.6	2.7	0.2	0.2	6.8	0.5	1.4	1.3	0.0	70.3	1.0	0.4	1.7	4.1	0.0	0.0	2.5	2.6	5.6	2.8	3.4	7.2	2.8	0.2	0.1	0.0	4.0	1.3	0.7	0.0	1.5	0.6	0.2	0.0	20.2	0.0	0.5	0.0	4.9	2.0	0.6	1.0	0.0	1.1	0.3	3.0	3.2	0.0	0.1
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089503	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.4;intestine: 55.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 35.3;Enteroendocrine cells: 39.4;NK-cells: 40.2;Prostatic glandular cells: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 109.0;neutrophil: 109.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 109.8;NK-cells: 86.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 58.8;hTERT-RPE1: 16.9;U-937: 26.9"	"Region enhanced"	"Detected in all"		"white matter: 842.5"	"Low region specificity"	"Detected in many"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	7.2	1.8	3.5	10.1	1.9	20.8	4.5	0.9	1.4	10.7	1.3	55.4	5.4	47.4	7.5	14.6	22.2	7.4	7.4	1.0	3.6	8.4	0.8	6.5	1.4	5.4	4.1	2.9	2.9	10.2	2.1	3.0	5.7	15.4	12.0	2.0	3.0	28.3	2.8	2.0	11.0	42.7	2.1	3.8	13.8	1.1	5.7	2.7	2.7	5.2	1.1	24.7	8.0	1.2	15.1	0.3	1.2	0.0	0.0	0.2	0.1	2.1	1.0	2.4	3.8	3.1	9.5	0.0	58.8	3.5	3.3	2.2	1.9	0.0	2.7	3.1	1.2	0.5	1.1	0.0	0.2	0.1	0.0	0.0	0.4	0.7	0.0	16.9	0.1	11.1	0.0	0.9	0.0	0.8	8.2	1.3	13.8	3.2	1.6	0.1	0.8	0.0	0.4	5.8	3.0	4.5	3.5	1.6	0.2	8.2	0.3	0.6	0.2	0.2	5.7	0.4	14.1	12.5	0.4	0.1	0.1	26.9	6.9	109.0	9.1	55.8	17.4	0.2	5.6	0.6	20.5	22.6	4.1	0.3	3.4	17.0	109.8	86.2	0.1	3.8	3.3	13.1	3.5	1.9	0.9	1.4	1.0	3.6	5.4	4.1	5.7	2.1	5.7	1.2	18.7	0.0	0.6	0.3	1.4	8.0	23.2	10.9	1.8	2.5	1.5	7.6	9.6	0.0	4.4	11.0	0.0	1.4	19.9	0.1	0.0	35.3	12.2	14.3	0.9	16.3	39.4	3.0	2.8	2.4	4.3	4.0	0.5	16.3	0.0	2.0	6.4	0.0	0.7	0.0	5.4	1.3	4.1	0.6	3.7	4.6	0.6	3.0	3.6	2.8	2.7	0.0	40.2	1.5	0.2	10.9	0.0	3.0	3.3	30.0	0.0	1.3	10.7	0.4	6.6	1.4	16.2	0.1	0.9	0.2	2.7	0.3	17.2	0.1	1.4	21.6
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 542.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2"	"Low region specificity"	"Detected in all"							"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	56.1	125.6	355.5	17.2	433.8	1.3	33.5	369.5	542.1	42.6	271.3	68.1	36.3	43.8	37.6	33.6	36.5	25.8	70.3	413.7	334.3	56.2	45.0	67.4	41.1	290.3	298.8	19.6	19.8	13.9	28.0	25.1	283.6	18.8	64.6	286.9	12.5	26.8	153.9	19.4	34.0	51.1	291.7	96.3	14.5	4.8	331.7	15.7	51.3	232.3	28.9	29.7	16.9	384.6	0.1	0.0	2.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.8	1.6	0.0	109.5	14.9	0.5	0.0	67.2	0.0	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.0	380.9	0.0	0.4	1.7	0.4	239.7	0.0	11.2	0.1	0.0	14.6	4.6	0.0	11.0	1.4	129.0	14.4	0.0	0.0	4.3	6.5	0.0	0.3	0.0	0.1	3.1	0.1	1.0	163.2	54.8	0.0	5.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	355.5	433.8	369.5	542.1	413.7	334.3	290.3	298.8	283.6	291.7	331.7	384.6	116.1	12.8	23.8	274.9	1.1	10.6	2.7	6.3	6.2	92.0	1.0	3.8	34.1	1.5	4.6	11.0	43.8	0.4	0.2	69.1	23.5	0.4	0.0	2.1	1.6	153.3	18.7	5.3	215.6	0.6	0.4	14.0	4.6	5.6	10.1	108.1	407.3	4.8	45.1	97.6	249.8	23.5	0.0	15.0	10.0	1.9	0.6	1.5	14.2	46.9	0.0	102.3	0.0	353.4	50.6	0.9	21.9	3.0	1.5	2.4	40.3	9.8	1.2	107.4	59.2	26.5	11.7	0.6	3.3	9.9	6.5	0.8	2.6	27.0	35.7	0.9
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 951.1;stomach 1: 631.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1688.5;Ductal cells: 943.3;Intestinal goblet cells: 886.7;Paneth cells: 2225.8;Proximal enterocytes: 3546.1;Undifferentiated cells: 1583.9"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 283.9;pancreatic cancer: 156.9;stomach cancer: 194.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 2160.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022273, CAB026009, HPA044337"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB026009: , HPA022273: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favorable (7.36e-5)"	11.1	9.7	1.9	126.9	5.2	0.0	17.0	6.1	7.1	28.6	1.6	951.1	916.0	12.5	11.7	5.5	13.4	208.2	5.5	1.8	3.4	57.6	53.2	23.0	4.6	12.4	4.9	41.8	60.0	0.4	2.5	2.0	10.5	163.9	862.0	0.3	76.4	10.8	63.7	13.6	848.3	39.2	8.5	0.3	631.0	5.8	4.4	1.1	6.5	12.4	3.8	11.0	4.0	14.6	0.0	0.7	0.0	0.0	5.2	0.8	2.8	0.0	0.0	0.0	0.0	48.8	3.1	0.0	0.2	0.0	0.6	6.5	0.0	0.0	0.0	0.2	0.1	0.0	52.2	3.3	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.3	0.0	0.2	3.0	0.3	2160.7	173.3	0.2	0.0	4.9	34.1	41.0	4.1	7.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.3	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	6.1	7.1	1.8	3.4	12.4	4.9	10.5	8.5	4.4	14.6	0.8	0.0	2.2	0.0	6.1	20.8	32.5	14.0	0.6	0.3	8.5	1.8	0.3	346.0	76.7	44.1	0.0	1.2	0.0	1688.5	127.2	943.3	34.5	3.7	4.5	3.8	174.1	0.0	0.1	654.9	0.6	37.3	645.3	44.8	4.5	0.0	2.2	26.0	0.2	0.0	0.1	886.7	16.2	2.2	29.1	17.9	44.1	2.6	64.0	0.0	7.8	10.3	0.0	0.5	14.3	325.0	2225.8	32.0	2.2	376.2	3546.1	2.5	30.2	0.6	0.0	7.7	23.6	0.5	1.0	2.7	13.5	1.1	5.8	10.7	1583.9	46.0
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 59.5"	"Group enriched"	"Detected in many"	9	"Early spermatids: 425.0;Late spermatids: 616.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 31.7"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 31.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 70.6;MCF7: 52.4;SK-BR-3: 153.7;T-47d: 111.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	2.2	8.2	3.5	3.3	3.5	1.7	35.9	3.0	9.6	14.1	0.0	29.5	6.1	1.0	15.9	18.4	7.5	14.9	15.3	1.0	11.4	26.6	2.8	9.1	1.4	7.4	5.3	0.3	13.5	13.5	11.0	0.3	14.0	20.5	35.2	4.6	11.5	4.2	4.1	10.5	8.1	1.6	2.2	0.3	29.4	59.5	7.7	0.5	10.1	1.7	2.0	8.0	9.4	3.7	6.4	3.4	0.7	0.3	0.4	0.7	28.2	0.3	0.2	0.2	0.2	18.2	2.8	0.1	9.6	0.4	0.4	0.2	3.8	0.2	0.1	70.6	9.7	0.5	1.8	3.2	1.1	0.0	0.7	0.1	1.6	0.1	0.0	0.8	1.4	0.2	0.4	0.1	0.2	52.4	0.6	0.2	4.8	33.8	0.6	0.1	0.2	4.3	28.6	9.1	22.1	1.6	0.5	153.7	1.8	2.0	111.7	0.8	0.8	0.4	2.5	0.5	0.5	5.4	7.1	0.2	2.1	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	31.7	0.0	0.3	3.5	3.5	3.0	9.6	1.0	11.4	7.4	5.3	14.0	2.2	7.7	3.7	0.4	3.2	25.2	1.3	1.1	1.5	5.3	1.7	0.0	2.5	30.8	15.1	13.0	5.7	6.4	9.2	0.0	0.5	15.3	29.3	11.7	38.9	425.0	5.4	3.0	1.9	41.4	9.7	9.7	52.7	4.8	0.9	21.9	9.5	3.8	0.5	0.4	0.6	2.0	0.0	10.2	56.0	6.1	0.3	1.3	616.8	2.5	0.9	0.0	1.0	2.6	1.7	0.0	0.0	0.9	30.5	13.7	2.6	0.4	12.0	2.7	24.4	9.3	7.3	6.6	1.8	1.3	22.8	6.5	4.8	6.5	3.4	1.7	0.5	20.7	14.6
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"brain: 110.8;choroid plexus: 32.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 39.1;Excitatory neurons: 39.3;Horizontal cells: 18.5;Inhibitory neurons: 19.7;Oligodendrocyte precursor cells: 27.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria	"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	0.0	0.6	73.9	0.3	74.7	0.0	0.0	49.7	110.8	0.0	32.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	84.2	60.6	0.2	0.0	0.0	0.0	45.1	46.3	0.0	0.0	0.0	0.9	0.0	46.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.1	43.0	0.0	0.2	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.1	69.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	26.8	1.4	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.4	0.1	0.0	0.3	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	73.9	74.7	49.7	110.8	84.2	60.6	45.1	46.3	46.4	43.0	60.4	69.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	39.1	0.2	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.8	0.2	0.2	1.8	0.0	39.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	18.5	19.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	0.0	4.7	0.0	1.7	0.0	27.2	5.0	0.1	1.2	0.7	0.0	0.1	0.0	0.0	1.2	8.4	0.0	0.0	0.1	7.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
TTLL11	"bA244O19.1, C9orf20"	ENSG00000175764	"Tubulin tyrosine ligase like 11"	Q8NHH1	9	121821928-122093606	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 24.3"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 201.7;Inhibitory neurons: 157.5;Oligodendrocytes: 412.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021828	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021828: AB_2670841"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-3)"	"unprognostic (7.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.71e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.61e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.53e-2)"	3.8	5.5	7.7	2.7	11.4	1.3	3.6	7.7	18.0	4.2	0.0	10.3	2.6	5.2	3.0	7.0	4.9	3.4	5.1	3.3	7.6	2.8	5.4	3.8	2.4	9.2	8.8	4.3	4.9	4.3	2.9	4.4	9.1	4.4	4.0	6.0	4.7	5.2	24.3	4.2	3.2	9.3	8.4	3.2	4.2	12.1	8.1	2.7	3.5	8.7	2.6	5.7	4.2	19.0	2.4	1.2	3.9	5.3	5.4	6.5	1.6	4.5	5.5	7.7	4.4	3.6	1.4	5.4	1.4	9.3	2.5	5.8	6.8	5.4	4.7	3.7	5.6	2.6	5.2	3.7	6.2	4.7	2.9	4.7	7.6	3.1	4.9	2.9	2.8	4.6	8.1	5.3	2.7	3.8	3.3	3.8	2.1	8.2	8.3	3.4	6.8	8.4	4.0	1.9	8.2	3.4	2.7	5.0	3.6	2.1	4.0	4.0	3.2	3.6	0.7	6.5	6.1	5.8	7.9	2.3	3.3	5.2	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	7.7	11.4	7.7	18.0	3.3	7.6	9.2	8.8	9.1	8.4	8.1	19.0	2.1	0.0	1.5	18.3	1.6	2.5	0.9	0.8	6.2	3.0	2.2	2.4	1.4	1.5	0.4	1.8	10.4	1.7	1.2	1.1	1.9	1.9	22.3	2.8	2.7	1.5	1.2	3.4	201.7	1.8	0.7	2.2	1.1	1.3	1.3	1.0	0.7	1.8	1.6	6.7	157.5	1.6	0.0	0.9	1.2	23.1	3.7	0.9	3.6	22.5	0.9	2.4	2.1	58.8	412.6	1.9	0.1	3.0	2.2	0.8	0.5	2.0	1.8	2.6	0.0	5.5	2.6	13.3	2.5	4.2	4.1	1.0	1.8	2.7	1.0	0.9
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 49.7;Late spermatids: 176.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"HDLM-2: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules	Vesicles	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.6	0.1	0.6	0.0	0.1	0.5	1.0	0.2	1.6	2.8	1.3	0.1	0.0	0.0	3.6	0.5	0.0	0.7	0.6	2.5	0.0	0.6	0.0	0.8	0.9	0.0	0.6	0.0	0.4	0.0	0.6	0.1	3.9	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.6	0.0	0.2	18.9	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.0	0.7	0.6	0.8	0.9	0.6	0.6	0.8	0.6	0.1	3.2	2.6	5.2	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.6	0.0	3.8	1.8	0.0	0.0	0.0	7.4	1.9	0.3	49.7	2.6	0.1	0.5	4.2	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.1	0.1	0.0	1.0	2.6	0.0	0.0	0.0	176.1	1.2	0.1	0.0	0.0	0.0	0.4	0.0	13.0	0.7	0.0	2.2	0.0	0.0	0.4	4.1	3.2	23.8	0.7	0.0	0.0	0.0	11.2	0.4	0.0	0.0	0.0	0.0	0.4	3.5	0.1
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436904	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 80.9;choroid plexus: 35.6;testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005725, HPA023617, HPA050655"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	0.9	0.9	64.3	0.0	67.9	0.0	3.5	64.0	80.9	4.0	35.6	10.0	0.2	1.6	0.0	1.1	10.4	0.2	3.6	57.6	59.7	1.2	0.7	0.2	0.0	69.4	66.5	1.5	19.4	0.0	17.7	0.0	63.5	3.5	0.0	3.2	3.6	0.4	3.3	5.9	2.6	0.0	67.6	1.4	2.5	53.4	69.3	0.0	0.3	0.0	0.0	1.7	4.2	66.8	0.1	0.0	7.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.3	67.9	64.0	80.9	57.6	59.7	69.4	66.5	63.5	67.6	69.3	66.8	0.4	3.2	0.6	257.6	0.4	0.8	1.2	0.6	0.0	138.6	44.3	42.2	1.3	4.3	3.0	0.0	20.9	0.9	1.3	0.2	0.0	30.4	3.9	0.3	0.9	2.8	1.2	0.0	26.4	0.6	0.7	1.5	0.0	0.7	0.0	13.7	0.7	0.1	0.3	10.1	3.3	0.0	0.0	0.0	1.5	4.8	1.8	0.3	23.2	19.7	0.3	653.4	0.0	48.2	97.5	2.2	0.0	0.7	0.1	1.9	0.4	0.7	2.8	155.3	6.6	2.3	7.8	2.2	5.1	0.0	0.9	4.2	0.6	0.5	0.3	1.9
TTYH2	C17orf29	ENSG00000141540	"Tweety family member 2"	Q9BSA4	17	74213571-74262020	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 214.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.0;Bipolar cells: 59.2;Langerhans cells: 52.1;Oligodendrocytes: 206.9"	"Group enriched"	"Detected in all"	6	"glioma: 16.7;melanoma: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.3;intermediate monocyte: 22.3;myeloid DC: 14.6;non-classical monocyte: 28.6;plasmacytoid DC: 18.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 18.2;monocytes: 28.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 22.2;SK-MEL-30: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.19e-1)"	"unprognostic (5.08e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.51e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.74e-5)"	"unprognostic (8.98e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.50e-3)"	"unprognostic (3.51e-3)"	5.5	4.7	75.4	7.3	132.2	3.3	4.4	101.4	103.2	7.1	34.7	8.2	2.6	4.9	3.5	3.2	6.3	5.1	18.1	83.7	91.3	2.0	1.6	5.5	7.7	129.0	115.2	17.2	8.3	4.0	7.0	10.3	123.3	4.6	2.5	19.8	6.9	4.0	14.8	5.2	4.8	3.9	88.2	11.7	3.9	15.2	113.6	5.1	10.1	9.4	5.7	5.3	4.7	214.5	0.2	1.9	9.0	8.7	1.1	1.3	0.2	0.5	0.1	0.5	0.1	5.9	0.1	5.3	1.3	0.2	1.0	14.5	8.9	0.3	0.3	12.5	5.0	5.7	0.3	0.5	6.2	0.6	3.8	22.2	4.6	0.1	1.6	0.6	0.3	3.8	1.0	2.6	0.2	1.0	2.7	0.4	1.7	8.7	15.7	8.8	16.1	10.1	0.2	0.7	3.1	11.0	0.0	5.5	81.3	4.6	2.9	1.2	0.2	0.0	4.4	0.1	0.3	0.5	0.3	0.1	0.3	1.7	4.9	1.0	13.3	1.2	2.4	22.3	0.3	0.3	4.6	3.8	14.6	0.3	0.7	1.7	1.2	0.1	28.6	18.2	4.5	7.0	75.4	132.2	101.4	103.2	83.7	91.3	129.0	115.2	123.3	88.2	113.6	214.5	8.0	0.0	4.1	46.0	1.3	2.3	0.6	0.2	1.2	59.2	1.5	2.4	1.9	2.8	0.1	0.0	6.2	0.3	7.9	0.0	0.0	0.2	27.7	0.4	0.7	6.9	1.8	0.0	1.0	0.2	0.4	4.1	0.5	0.9	21.6	0.5	1.8	0.5	5.0	3.3	0.9	0.2	0.0	12.3	52.1	11.5	9.6	13.7	23.2	15.0	16.5	18.4	0.0	10.6	206.9	0.1	0.1	2.6	1.3	0.8	0.0	0.2	0.3	10.8	19.7	3.2	2.7	2.4	1.5	0.4	2.6	0.3	2.3	4.3	0.0	0.4
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184686-49189080	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 1313.3"	"Cell type enhanced"	"Detected in all"		"Ductal cells: 1162.0;Respiratory ciliated cells: 1173.3;Smooth muscle cells: 1005.3"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1660.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 3100.7;SCLC-21H: 1983.9"	"Low region specificity"	"Detected in all"							"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Microtubules		"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	150.3	133.5	803.3	166.9	990.4	152.0	179.7	1083.4	882.6	185.8	692.7	466.4	54.4	406.3	166.6	140.0	342.0	193.1	156.5	784.4	1066.9	64.9	21.1	214.3	71.7	1209.8	1002.4	172.8	53.5	79.1	163.4	123.9	1136.6	173.4	126.5	259.7	104.7	267.3	37.4	107.9	125.9	865.4	1083.5	84.7	135.6	69.0	987.8	162.7	39.7	94.1	55.9	210.1	117.1	1313.3	3.2	154.4	3100.7	419.3	263.1	613.9	10.5	286.4	325.6	163.2	390.4	9.4	54.8	120.7	322.4	824.7	304.0	6.4	388.0	97.3	120.3	97.0	138.1	41.5	27.6	34.4	54.1	70.2	3.2	359.5	33.8	325.0	31.8	627.1	945.9	237.2	45.0	124.5	888.7	70.3	276.5	59.2	335.0	3.6	112.5	225.4	232.3	14.1	718.9	13.8	1983.9	1150.3	79.1	4.5	106.0	449.9	210.4	97.3	929.1	178.6	108.5	21.2	80.5	41.5	126.9	234.2	93.8	117.2	191.6	503.5	260.5	824.7	159.0	554.9	118.1	158.2	140.0	146.7	314.0	166.9	134.2	125.2	1660.9	89.9	812.8	101.1	172.8	495.5	803.3	990.4	1083.4	882.6	784.4	1066.9	1209.8	1002.4	1136.6	1083.5	987.8	1313.3	296.9	230.8	181.5	49.9	220.8	87.2	250.6	179.3	59.7	233.0	140.0	291.6	187.9	25.8	148.1	64.4	77.2	10.5	202.9	4.5	25.4	1162.0	10.0	414.9	413.6	334.2	785.8	48.0	78.2	16.2	12.8	391.5	63.2	102.4	547.9	695.0	165.6	2.8	452.0	249.0	60.6	15.5	329.6	80.7	277.6	20.7	193.6	204.2	183.2	37.5	616.6	788.9	77.2	73.4	432.6	333.3	12.8	142.6	32.5	60.4	1.5	73.3	1173.3	349.6	164.3	542.7	1005.3	15.4	31.2	20.9	99.3	15.9	266.5	40.6	12.4	95.7
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393101-5404828	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 28.3"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 19.8;Proximal enterocytes: 19.7"	"Cancer enriched"	"Detected in some"	4	"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEL: 13.3;JURKAT: 7.7;K-562: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045900, HPA063394"	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.1	0.0	0.4	0.5	0.3	0.1	0.4	0.4	0.6	0.1	1.4	11.9	24.3	0.0	0.0	0.3	0.2	0.1	0.7	0.3	0.4	5.8	0.0	0.2	0.1	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.1	10.8	0.0	0.8	0.0	0.1	0.3	28.3	0.3	0.6	0.0	0.2	1.0	0.8	0.3	0.0	1.4	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.7	0.0	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	13.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	0.4	0.8	0.5	0.9	0.6	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	19.7	4.4	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.4	0.1
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 313.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Ductal cells: 28.7;Excitatory neurons: 37.9;Exocrine glandular cells: 21.4;Gastric mucus-secreting cells: 27.0;Inhibitory neurons: 45.1;Pancreatic endocrine cells: 49.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"A549: 421.3;SCLC-21H: 424.9;SH-SY5Y: 433.8"					"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		89000000	"Cluster 24: B-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 1: Pancreatic cells - Digestion"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.7	24.8	99.4	12.1	93.3	3.4	2.1	100.5	127.6	3.3	0.0	18.4	3.7	9.7	0.2	3.6	2.3	8.8	5.5	88.6	313.3	13.3	0.9	4.1	7.1	208.8	132.7	3.9	3.2	0.4	55.1	1.8	266.2	3.0	2.6	24.8	10.6	0.4	0.6	5.2	8.0	12.7	74.2	1.3	7.2	38.0	183.4	1.0	2.5	0.3	5.2	7.3	5.3	82.5	30.1	421.3	152.6	173.9	17.9	170.8	6.8	181.0	31.0	105.8	48.2	57.2	53.5	89.6	93.6	136.8	74.3	112.1	148.9	26.7	26.3	22.7	15.5	0.7	32.5	383.7	6.0	0.0	67.6	98.4	7.9	161.9	14.0	136.8	88.4	5.9	9.2	2.5	122.3	288.6	1.2	31.5	274.3	11.2	237.3	0.1	54.1	9.5	131.8	8.1	424.9	433.8	251.2	4.4	137.1	27.5	15.0	1.9	110.9	142.8	156.9	197.3	185.3	1.4	19.6	35.2	150.2	11.5	260.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	99.4	93.3	100.5	127.6	88.6	313.3	208.8	132.7	266.2	74.2	183.4	82.5	0.4	0.0	0.0	20.2	0.0	0.0	0.0	0.0	3.4	1.8	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.0	28.7	8.2	0.5	2.6	3.8	4.9	0.0	37.9	21.4	0.7	6.1	27.0	0.7	0.0	0.0	0.0	0.0	0.2	5.0	45.1	0.1	0.0	0.0	0.0	16.8	0.3	0.2	0.0	9.4	0.0	0.3	0.0	16.1	9.2	49.2	0.0	0.4	0.4	0.0	0.0	0.1	0.0	1.4	0.0	0.0	5.1	0.2	0.4	3.0	0.0	1.0	0.1	0.0	0.2	0.0
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 828.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 22.2;Muller glia cells: 33.0;Oligodendrocytes: 94.1;Theca cells: 81.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 3.8;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 100.7;HAP1: 58.3;HEL: 91.7;PC-3: 49.6;REH: 43.4;SH-SY5Y: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA		110000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010768: AB_261775, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	0.9	203.4	209.7	1.7	404.6	0.2	0.6	452.3	388.7	0.6	0.0	6.3	1.1	0.6	0.3	0.7	0.9	0.6	2.5	249.2	229.1	2.2	1.2	0.6	1.1	425.9	254.4	1.5	3.0	0.6	4.0	0.7	440.0	0.8	0.8	22.6	1.2	0.4	4.4	5.2	3.0	0.8	221.4	9.5	2.1	76.0	373.5	0.3	0.6	1.0	0.7	0.6	1.8	828.2	0.2	28.3	0.1	100.7	0.2	0.0	0.2	0.7	0.0	0.1	0.0	1.4	0.4	0.1	30.3	0.0	3.5	0.7	58.3	0.0	0.6	0.0	10.7	91.7	1.9	0.9	0.0	0.0	5.5	0.0	0.0	2.3	0.0	1.0	0.0	17.1	8.6	0.8	0.0	3.0	18.1	4.1	7.5	0.0	49.6	43.4	0.1	20.3	10.9	0.1	0.2	36.6	0.3	0.2	30.9	2.7	0.8	1.9	0.0	0.2	12.2	0.1	0.4	2.4	1.7	11.7	1.1	0.1	0.5	0.0	0.0	0.0	5.4	0.0	3.3	3.8	0.7	5.0	0.0	1.1	1.6	3.8	0.1	0.3	0.0	0.0	0.0	1.4	209.7	404.6	452.3	388.7	249.2	229.1	425.9	254.4	440.0	221.4	373.5	828.2	0.1	0.0	0.0	6.8	3.2	1.9	0.7	0.3	0.0	2.8	0.1	0.1	9.8	1.5	0.0	0.0	0.0	0.2	1.6	0.1	5.9	1.6	2.9	0.1	0.2	1.2	0.0	2.1	22.2	0.0	0.2	1.8	0.0	0.1	0.0	16.3	1.4	0.3	0.4	10.1	15.0	0.0	0.0	0.0	1.2	9.4	5.3	0.3	14.2	13.1	0.0	33.0	1.0	8.5	94.1	0.1	0.0	0.4	0.9	0.2	0.0	1.8	0.5	2.3	6.6	0.4	4.6	1.9	1.1	0.0	1.6	0.1	3.8	81.7	0.0	0.2
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 190.2;Extravillous trophoblasts: 494.3;Pancreatic endocrine cells: 221.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 157.3"	"Group enriched"	"Detected in many"	6	"B-cells: 58.7;dendritic cells: 157.3"	"Cell line enhanced"	"Detected in many"		"TIME: 821.6"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 19.9"	"Region enhanced"	"Detected in all"		"spinal cord: 10.3"	"HPA043640, HPA046280"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		52000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (9.69e-4)"	197.9	37.9	12.3	82.1	11.7	34.8	134.6	14.7	14.6	106.5	28.6	193.6	31.4	173.5	24.9	217.5	121.2	66.4	166.2	11.8	13.7	66.0	40.8	92.9	31.6	19.2	16.3	81.2	52.7	5.6	33.1	59.7	15.1	84.2	28.8	3.6	69.6	91.3	37.3	78.2	75.8	151.9	14.1	34.0	89.1	28.3	18.4	12.2	52.2	20.2	31.3	129.9	124.2	12.5	211.8	142.3	149.5	76.1	149.0	208.8	108.1	648.5	424.2	492.0	459.1	113.0	65.2	1.3	281.7	440.8	148.6	99.5	84.7	653.6	380.6	1.8	46.1	32.3	159.2	73.6	151.0	2.7	59.5	219.1	146.0	429.4	222.7	148.8	366.1	12.5	159.7	2.5	432.5	216.1	0.8	162.4	79.1	3.3	70.0	1.6	260.0	2.2	99.7	5.8	19.3	27.2	360.3	34.8	113.9	153.7	76.5	203.8	821.6	600.0	510.6	565.7	574.2	11.5	3.8	3.8	458.9	46.9	219.8	2.0	19.4	0.3	0.6	7.6	0.3	42.0	0.1	0.2	25.5	58.7	0.2	0.3	0.4	0.9	7.5	157.3	0.2	13.2	12.3	11.7	14.7	14.6	11.8	13.7	19.2	16.3	15.1	14.1	18.4	12.5	67.0	83.3	7.9	0.7	16.1	69.6	42.7	151.4	16.5	1.2	30.4	44.8	54.3	8.6	37.4	7.3	0.0	53.8	23.6	0.6	1.9	167.6	190.2	6.4	76.9	128.9	0.0	12.2	0.8	104.9	494.3	112.8	1.5	7.1	45.6	7.4	82.5	0.4	69.4	0.0	0.6	0.4	42.7	13.2	85.2	114.9	70.2	36.5	33.8	12.2	65.9	0.2	0.0	0.5	0.4	221.1	0.1	91.4	1.0	51.5	0.1	1.2	18.2	1.6	26.3	89.2	130.5	4.3	6.3	55.7	66.9	22.2	3.6	9.5	0.5	65.2
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.5;lymphoid tissue: 113.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 105.8;Erythroid cells: 189.3;Extravillous trophoblasts: 115.3;Plasma cells: 112.7;Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.7;T-cells: 14.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002784, HPA074922"	Enhanced					NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"			"CAB002784: , HPA074922: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	4.5	3.1	4.3	24.2	7.5	88.5	6.7	4.1	6.5	4.8	2.7	22.9	10.5	5.1	1.3	14.8	5.6	3.8	2.2	5.0	4.9	6.5	11.8	4.9	36.1	4.9	5.2	2.1	3.6	1.8	1.6	22.3	4.4	3.1	27.1	4.2	3.9	2.0	0.4	6.2	14.8	12.7	4.8	10.6	8.8	34.3	6.1	113.6	2.1	0.4	44.5	8.4	5.5	10.3	102.7	156.6	320.4	154.9	35.1	57.9	159.9	238.9	141.1	251.7	299.9	132.8	80.1	160.0	91.5	129.9	143.2	45.1	225.3	89.7	216.1	152.3	244.9	273.1	135.8	229.4	8.2	564.8	286.5	51.5	20.7	159.6	49.6	48.4	214.4	334.0	222.0	249.6	321.8	118.1	687.7	311.4	114.7	124.3	114.0	446.8	287.0	191.3	95.6	88.9	106.0	175.7	201.4	91.6	61.1	197.3	63.5	253.5	85.0	289.7	569.5	267.3	474.2	305.9	405.2	367.3	75.2	240.6	339.2	0.0	0.0	1.3	1.1	0.1	0.0	1.1	2.8	2.2	1.8	0.0	0.0	0.6	0.7	6.7	0.1	0.3	14.1	2.9	4.3	7.5	4.1	6.5	5.0	4.9	4.9	5.2	4.4	4.8	6.1	10.3	2.1	0.0	2.3	1.6	15.7	14.4	15.9	13.0	27.9	0.5	7.8	11.7	3.6	2.8	6.7	0.0	0.0	105.8	14.5	15.5	1.9	2.3	34.4	5.6	8.4	12.5	1.2	189.3	0.4	0.8	115.3	28.3	14.3	7.4	7.0	76.2	6.8	4.3	71.4	0.0	0.6	20.9	10.2	15.6	19.4	31.9	6.2	10.7	10.6	1.0	3.9	45.0	5.2	0.5	15.6	1.5	8.9	3.8	112.7	5.0	13.8	36.6	1.0	2.4	13.1	1.3	32.6	180.8	30.7	48.0	7.2	27.0	21.3	10.5	54.9	18.7
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583589	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;ovary: 49.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved					NA	NA		17000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071245: AB_2686371"	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	21.5	3.5	18.2	1.4	30.3	0.8	5.2	17.7	27.1	2.1	0.0	2.3	1.6	4.6	3.5	13.1	11.5	2.5	2.2	27.7	10.7	11.3	0.8	3.3	1.3	20.9	22.6	49.7	9.8	0.9	0.9	5.7	18.6	2.6	0.9	2.6	1.9	6.1	0.9	13.8	2.4	4.4	14.4	5.5	3.2	18.8	15.7	0.4	1.1	1.8	3.7	2.1	4.1	32.0	10.3	6.7	20.7	22.7	18.9	12.8	69.2	14.6	9.3	14.2	13.1	37.7	3.4	0.4	18.3	11.9	19.9	23.7	23.3	3.6	6.5	5.8	15.5	3.2	20.2	18.1	13.3	5.2	0.4	4.1	7.3	10.9	3.6	5.8	10.6	9.8	19.1	4.3	7.9	9.8	2.4	1.0	47.7	16.0	6.7	31.9	18.6	3.8	1.2	19.7	24.6	7.0	13.7	21.6	16.3	29.8	17.8	6.0	8.4	28.0	12.2	21.0	22.5	1.7	3.5	3.1	17.2	33.8	17.2	1.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0.2	1.5	0.3	0.1	0.3	0.1	0.1	18.2	30.3	17.7	27.1	27.7	10.7	20.9	22.6	18.6	14.4	15.7	32.0	3.4	3.2	1.1	17.6	0.9	6.8	8.5	0.4	0.6	2.7	2.2	2.2	2.9	2.8	0.7	3.7	6.2	2.9	1.1	1.3	0.0	3.9	3.6	1.1	13.0	5.4	1.8	0.0	42.4	3.6	10.2	10.5	8.6	1.9	0.0	7.6	9.7	0.4	1.2	0.0	4.6	0.9	0.0	1.9	1.3	5.1	44.4	0.9	8.8	1.0	0.1	8.3	1.0	29.1	46.8	4.6	0.1	47.0	0.3	6.4	1.2	1.2	0.5	4.0	0.0	3.9	4.3	4.0	6.5	4.2	10.9	18.9	0.7	5.8	2.3	5.7
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UBASH3A	"CLIP4, STS-2, TULA"	ENSG00000160185	"Ubiquitin associated and SH3 domain containing A"	P57075	21	42403447-42447684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 5.9;Erythroid cells: 3.8;T-cells: 20.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.9;MAIT T-cell: 22.9;memory CD4 T-cell: 28.2;memory CD8 T-cell: 24.8;naive CD4 T-cell: 32.2;naive CD8 T-cell: 24.0;T-reg: 27.9"	"Lineage enriched"	"Detected in many"	12	"T-cells: 32.2"	"Group enriched"	"Detected in some"	7	"HEL: 23.0;JURKAT: 39.0;MOLT-4: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035367			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm	"Golgi apparatus"	"HPA035367: AB_2732466"	"unprognostic (5.14e-4)"	"unprognostic (3.91e-4)"	"unprognostic (1.57e-2)"	"unprognostic (4.10e-5)"	"unprognostic (4.33e-2)"	"unprognostic (1.85e-6)"	"unprognostic (5.54e-4)"	"unprognostic (1.46e-3)"	"unprognostic (6.17e-4)"	"unprognostic (2.47e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.37e-6)"	"unprognostic (1.65e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"	0.4	0.6	0.0	5.2	0.0	2.5	0.2	0.0	0.1	0.5	0.1	0.8	1.6	0.5	0.0	0.4	0.4	2.0	0.4	0.0	0.1	0.4	0.7	1.7	11.1	0.2	0.0	0.3	0.1	0.0	0.1	0.2	0.1	0.4	0.9	0.0	0.9	0.1	0.2	0.3	2.4	0.1	0.1	4.4	1.9	0.1	0.0	18.9	0.5	0.1	5.1	1.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	23.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.4	0.0	0.0	0.0	47.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.9	0.0	22.9	0.1	28.2	24.8	0.0	0.0	32.2	24.0	0.5	2.5	0.1	0.1	27.9	10.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.8	0.0	0.0	0.2	0.3	1.0	0.0	0.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.0	3.8	0.0	0.0	0.0	0.4	1.1	0.5	1.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.0	20.5	0.0	0.0	0.0
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.5;lymphoid tissue: 113.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 129.6;Erythroid cells: 182.1;Extravillous trophoblasts: 449.1;Granulosa cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 8.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.1;NK-cells: 2.1;T-cells: 8.2"	"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 4.3;white matter: 11.4"	"Low region specificity"	"Detected in some"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Approved	"Plasma membrane,Cytosol"		Yes	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	2.6	2.9	0.3	21.5	0.3	78.5	4.3	0.9	0.6	6.1	0.7	26.7	21.4	5.7	0.6	37.2	1.9	2.7	1.4	0.2	0.3	1.9	2.9	5.4	45.3	0.3	0.7	1.3	1.0	0.4	0.4	20.4	0.7	1.5	30.9	0.2	5.0	0.9	0.9	18.5	20.6	10.5	0.2	15.8	13.0	16.4	1.6	113.5	1.1	0.2	69.5	6.9	12.3	0.4	312.8	223.9	390.9	188.3	10.4	24.0	225.2	238.5	121.6	390.7	278.4	743.8	345.4	327.6	233.2	115.5	475.6	294.9	2.2	260.5	395.8	141.7	213.7	101.5	168.5	196.0	3.0	145.4	241.6	7.6	27.8	265.7	257.3	57.4	193.4	206.4	1.8	261.6	325.4	516.2	243.5	41.1	237.1	350.8	529.4	256.0	354.8	1.4	134.9	105.9	226.1	188.7	378.3	271.7	154.4	196.2	276.6	209.4	70.1	341.2	298.4	236.2	473.4	84.3	2.9	369.4	208.0	103.4	328.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	1.7	0.6	0.1	0.1	0.1	2.1	2.1	0.5	0.3	8.2	3.2	0.3	0.3	0.9	0.6	0.2	0.3	0.3	0.7	0.7	0.2	1.6	0.4	0.9	0.0	3.7	0.0	17.9	17.3	7.8	39.0	5.7	0.0	8.6	14.6	0.0	1.5	9.3	0.0	0.0	129.6	3.6	27.4	0.0	1.3	12.0	5.8	5.9	9.5	1.2	182.1	0.0	0.5	449.1	28.5	25.5	9.6	5.7	119.0	18.2	3.6	92.6	0.0	0.1	41.1	50.8	20.8	18.1	6.4	0.9	24.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	7.2	0.0	37.0	12.6	6.2	0.6	1.8	0.0	0.0	0.5	19.2	52.2	50.7	83.2	11.6	31.2	13.7	2.5	68.4	18.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.9"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 294.5;Urothelial cells: 534.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.7"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 195.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	39.1	65.6	9.5	34.6	9.6	112.9	25.2	11.1	10.9	23.1	10.4	20.5	23.8	16.3	7.3	40.8	15.7	42.6	14.4	9.7	13.1	29.7	32.5	33.7	41.8	11.0	12.4	12.0	16.6	5.5	12.5	27.6	10.3	13.8	17.8	12.2	14.1	7.7	9.0	32.8	31.7	21.4	10.2	35.5	47.9	7.9	11.6	20.5	9.9	7.7	46.8	72.3	28.5	13.7	93.4	9.8	15.7	10.5	33.2	39.7	8.3	57.0	59.7	65.3	87.9	19.8	70.0	21.9	44.1	38.0	142.9	46.6	18.4	24.7	69.6	8.9	10.7	8.9	14.3	9.8	23.7	9.8	13.8	39.6	18.9	62.4	89.1	151.0	20.3	10.8	49.4	41.5	195.7	15.9	10.7	10.9	17.9	31.4	10.1	12.4	111.5	7.1	151.0	35.2	7.6	12.0	25.3	21.1	66.1	92.2	113.6	10.1	96.6	30.0	15.2	84.8	41.1	7.7	30.3	10.2	37.0	6.1	41.6	0.1	0.3	0.2	1.2	0.7	2.0	4.2	2.2	1.6	1.9	5.3	2.0	2.0	1.2	1.4	1.0	109.7	3.6	1.4	9.5	9.6	11.1	10.9	9.7	13.1	11.0	12.4	10.3	10.2	11.6	13.7	128.0	41.7	51.1	17.6	66.6	75.7	151.6	90.6	76.8	29.8	71.8	37.8	11.8	47.1	130.7	29.5	62.6	7.3	262.4	69.8	17.6	108.2	20.6	125.0	83.4	116.1	18.5	26.5	40.4	50.6	12.8	64.6	121.8	294.5	10.8	18.3	90.7	20.6	21.4	18.5	41.9	55.1	36.7	34.0	109.2	5.9	49.0	49.1	58.7	24.4	44.4	8.4	9.2	25.1	12.8	72.2	65.1	38.4	33.3	216.6	42.6	77.2	143.9	16.5	13.1	153.2	74.9	1.8	8.7	99.7	122.2	3.4	41.4	30.5	22.1	534.7
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 201.2;liver: 322.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"						"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.6	0.2	0.5	0.5	0.2	1.5	0.8	0.1	0.2	3.0	201.2	0.2	0.4	3.5	0.1	1.0	0.2	0.4	0.8	4.0	322.4	0.2	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.2	2.4	0.9	0.5	0.3	0.1	1.8	79.2	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.0	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.6	0.5	1.5	0.8	0.4	0.8	0.2	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 22.0;intestine: 79.5;stomach 1: 32.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.8;Gastric mucus-secreting cells: 3.6;Intestinal goblet cells: 1.0;Paneth cells: 1.4;Proximal enterocytes: 3.9;Squamous epithelial cells: 4.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	143	"RT4: 523.3"														"Intracellular and membrane"	NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	49.5	79.5	0.1	0.0	14.6	0.0	22.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	36.5	0.0	0.9	0.0	0.0	0.9	53.1	1.9	0.0	0.0	32.7	1.5	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	523.3	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.3
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.9;liver: 20.1;urinary bladder: 30.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 4.5;Club cells: 1.0;Ionocytes: 2.0;Paneth cells: 2.5;Proximal enterocytes: 1.3;Squamous epithelial cells: 1.1"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 2.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	64	"RT4: 121.4"															NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"						"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	2.8	0.0	0.0	1.9	0.0	6.5	0.0	0.0	0.0	1.8	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.8	0.0	0.5	0.0	0.0	0.1	4.3	1.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	30.0	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	121.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.4	0.2
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951804	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 31.4;kidney: 21.0;liver: 13.3;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 91.5;Distal enterocytes: 89.8;Hepatocytes: 53.5;Paneth cells: 54.7;Proximal enterocytes: 248.9;Proximal tubular cells: 130.8;Undifferentiated cells: 101.1"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	59	"Hep G2: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045108	Supported					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	21.0	13.3	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	91.5	0.0	3.7	0.0	0.0	0.0	89.8	11.7	26.3	0.0	0.0	0.0	0.0	12.2	2.7	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	53.5	0.0	0.0	0.0	34.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	54.7	0.0	0.0	0.0	248.9	130.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	101.1	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646597-68670652	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 77.7;liver: 291.2"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.7;Hepatocytes: 142.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	21.6	5.1	0.0	0.0	0.0	0.1	77.7	0.0	0.0	0.0	0.0	291.2	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	0.1	17.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	4.4	0.9	0.1	168.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	24.2	3.0	0.2	0.0	0.2	0.0	2.7	0.1	3.6	0.1	0.1	0.0	0.0	0.0	0.0	2.9	142.8	0.0	0.0	0.1	3.3	0.0	3.2	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.1	0.6	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.9
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 460.0;liver: 136.2"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"memory B-cell: 2.8;naive B-cell: 8.8"	"Lineage enriched"	"Detected in single"	61	"B-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7"									HPA045108	Supported					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.3	0.0	0.0	38.8	0.0	0.0	0.7	0.0	0.0	1.5	0.0	365.7	364.3	1.4	1.5	0.1	0.2	0.6	0.0	0.0	0.0	0.2	136.2	0.2	1.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	125.8	0.0	0.2	0.7	0.0	0.0	460.0	9.1	0.1	0.6	0.8	0.0	0.1	0.4	0.0	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	1.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	130.1	0.0	0.0	0.0	11.1	0.1	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.3	0.1	35.1	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	100.6	0.2
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1299.8;liver: 1612.1"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.2	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.0	0.0	3.8	68.7	8.9	24.2	0.2	49.9	10.4	0.0	0.0	0.0	1299.8	1612.1	0.4	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.1	0.0	0.3	6.9	0.0	3.6	27.5	0.0	0.3	66.6	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035021-36071358	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.5;lymphoid tissue: 14.7;skin 1: 10.3"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 3.7;Early spermatids: 4.4;Late spermatids: 8.2;Proximal tubular cells: 3.8"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;JURKAT: 6.3;MOLT-4: 12.4;REH: 29.9;SuSa: 11.8;T-47d: 7.2;THP-1: 18.0"	"Low region specificity"	"Detected in many"							HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA				"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.0	0.8	0.0	0.0	0.0	6.5	1.1	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	2.6	0.6	0.0	0.0	1.0	1.1	0.0	0.0	0.1	0.9	0.2	1.2	0.4	0.0	0.1	0.1	0.0	0.1	10.3	0.0	0.0	0.1	1.2	0.1	2.9	0.6	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.3	0.4	0.0	1.3	0.0	0.5	6.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	12.4	0.0	5.3	0.0	0.0	29.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	7.2	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	1.0	1.1	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	1.1	8.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598770-114678225	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 266.4"	"Cell type enriched"	"Detected in many"	8	"Oligodendrocytes: 821.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 6.9;naive B-cell: 10.7"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 58.4;OE19: 123.7;RPTEC TERT1: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria		No	No			"Cluster 19: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA014405: AB_1858606, HPA065785: AB_2685559"	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.6	0.6	58.6	4.6	153.7	1.1	4.6	166.2	94.5	7.0	9.7	26.8	30.3	3.8	0.3	1.5	4.4	11.0	0.3	66.2	94.7	31.0	0.2	1.1	4.9	220.9	132.8	0.4	8.5	0.2	0.2	0.2	200.6	0.5	27.7	2.2	7.3	0.7	0.5	2.2	27.7	1.6	139.2	1.7	16.8	5.0	132.4	0.6	13.5	0.4	5.0	0.6	0.6	266.4	0.6	0.2	4.4	0.6	0.3	0.0	0.7	0.2	0.0	0.1	3.4	17.7	58.4	17.6	1.2	0.2	13.8	25.8	0.0	0.1	0.1	0.3	14.3	0.3	24.6	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	5.4	0.1	0.2	16.1	3.0	0.1	0.3	0.3	1.7	6.4	123.7	8.8	1.6	28.9	0.3	55.2	0.6	31.4	4.6	0.2	5.4	0.8	1.1	0.9	5.4	1.0	1.1	19.2	0.7	19.6	6.3	0.8	0.6	29.2	0.9	17.9	0.2	0.0	0.8	0.0	0.0	0.6	6.9	0.0	0.0	0.0	10.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.3	58.6	153.7	166.2	94.5	66.2	94.7	220.9	132.8	200.6	139.2	132.4	266.4	0.1	6.4	1.5	1.0	22.0	0.0	1.8	0.3	6.8	0.0	5.7	6.1	0.8	8.6	3.9	25.8	0.0	0.0	0.1	19.0	9.8	1.4	9.2	9.6	1.7	0.5	48.4	0.0	1.0	13.1	0.0	0.6	19.4	21.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	27.9	0.0	0.0	0.0	3.5	1.2	0.5	1.8	2.8	0.0	0.0	0.0	98.5	821.1	10.8	14.6	0.0	4.0	0.7	24.2	1.4	1.5	0.0	0.0	0.0	0.4	20.9	34.0	5.9	0.1	0.0	0.4	0.1	26.9	0.9
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 27.0;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 49.7;Plasma cells: 21.0;Squamous epithelial cells: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.8;T-cells: 2.3"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 450.9;REH: 1004.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 14: REH - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	1.0	0.9	2.1	9.6	2.7	27.0	1.7	2.1	2.3	1.6	1.8	2.9	3.7	1.0	0.1	6.5	0.4	0.8	0.5	2.0	2.2	0.6	0.9	1.3	15.8	2.8	2.8	0.3	0.6	0.2	0.2	2.1	2.7	0.6	2.6	0.4	1.5	0.2	1.2	3.4	3.9	1.9	1.9	3.7	3.3	5.2	3.5	67.2	0.3	0.3	10.3	1.6	2.5	4.6	111.3	78.7	116.6	83.4	3.3	13.3	18.5	88.3	42.0	89.9	86.8	94.6	54.9	62.7	21.1	39.4	32.7	54.1	81.2	47.7	63.0	102.7	92.2	54.3	74.3	102.4	1.3	135.1	78.9	6.5	3.5	48.9	12.6	14.1	27.2	97.2	79.3	70.5	54.5	86.7	450.9	82.5	52.5	40.0	84.3	1004.5	259.7	45.4	24.9	80.1	86.0	68.5	69.2	37.7	12.1	18.8	68.2	127.6	34.2	94.6	76.7	124.3	108.3	29.8	33.1	183.5	54.8	129.7	123.3	0.3	0.2	0.1	0.6	0.0	0.0	0.2	0.8	1.0	1.3	0.1	0.2	0.8	0.8	0.5	0.2	4.8	2.3	0.6	2.1	2.7	2.1	2.3	2.0	2.2	2.8	2.8	2.7	1.9	3.5	4.6	0.2	0.0	0.0	1.6	2.1	0.0	0.8	0.0	3.4	2.5	4.4	2.8	4.3	1.5	0.6	0.0	0.0	6.6	6.9	2.6	0.0	2.2	2.9	1.3	1.8	2.2	0.0	49.7	0.4	0.4	7.8	4.7	8.6	2.4	0.0	10.4	0.4	0.7	8.9	3.3	0.4	2.3	0.0	1.9	0.0	1.8	0.6	3.8	0.0	0.0	2.0	0.6	1.0	3.0	1.3	4.2	1.9	0.4	21.0	0.6	1.4	0.2	0.7	0.7	0.0	1.2	6.1	6.1	11.9	15.8	0.0	1.4	3.7	1.5	8.3	1.3
UNC13A	"KIAA1032, Munc13-1"	ENSG00000130477	"Unc-13 homolog A"	Q9UPW8	19	17601328-17688365	"Predicted intracellular proteins"	"Differentiation, Exocytosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 24.0;pituitary gland: 32.2;retina: 18.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 43.9;Cone photoreceptor cells: 54.2;Excitatory neurons: 85.3;Horizontal cells: 119.5;Inhibitory neurons: 67.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Group enriched"	"Detected in many"	15	"amygdala: 8.3;basal ganglia: 15.8;cerebral cortex: 24.0;hippocampal formation: 19.0;white matter: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 16.2;NTERA-2: 23.7;SCLC-21H: 38.9;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.50e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.00e-1)"	0.1	2.5	8.3	0.4	15.8	0.0	0.0	0.0	24.0	0.3	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.0	19.0	1.0	0.3	0.0	0.2	0.3	0.0	0.0	0.2	1.4	0.1	32.2	0.2	0.0	0.1	0.2	18.8	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.0	0.8	0.7	0.0	0.1	0.2	0.0	0.3	0.1	0.1	8.8	0.0	2.4	2.0	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	2.4	0.6	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	16.2	0.0	0.0	0.0	1.5	0.4	0.0	0.1	2.0	0.1	0.0	0.2	0.0	0.0	23.7	0.2	0.6	0.6	0.0	0.3	0.0	0.0	38.9	9.2	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	15.8	0.0	24.0	19.0	1.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	6.5	0.0	0.3	0.3	0.1	0.0	43.9	0.1	0.3	2.1	0.0	0.0	0.0	54.2	0.0	0.2	0.3	0.0	1.5	0.0	0.1	0.2	1.0	8.4	0.0	85.3	0.2	0.0	1.5	0.0	0.5	0.0	0.4	0.0	0.0	0.2	119.5	67.0	0.0	2.0	0.0	0.3	0.1	0.0	0.2	0.0	3.7	1.6	3.3	0.0	18.1	2.8	1.1	0.0	1.5	0.0	0.4	0.0	0.1	0.0	22.7	0.0	0.6	0.6	0.2	1.8	0.0	0.0	0.0	0.0	1.8	0.5	0.3
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235475-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.8;intestine: 6.0"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 638.7;Inhibitory neurons: 768.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4;renal cancer: 1.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.8;thalamus: 7.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;HeLa: 2.9;NTERA-2: 8.6;SH-SY5Y: 2.9;SuSa: 2.8;U-251 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.0	1.7	1.7	0.0	2.4	0.0	0.0	0.0	3.1	2.3	0.0	0.3	6.0	1.7	0.0	0.0	0.1	0.0	0.0	2.4	19.8	2.1	0.0	0.0	0.0	0.4	1.6	0.0	0.1	0.1	3.3	0.0	0.0	4.8	0.5	4.9	0.0	0.2	0.0	0.0	1.9	0.9	0.0	0.0	0.1	0.7	7.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.5	0.2	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.4	0.0	3.1	2.4	19.8	0.4	1.6	0.0	0.0	7.0	0.0	0.0	0.0	0.0	129.6	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.1	0.1	0.0	0.0	638.7	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	40.4	768.3	0.7	0.0	0.0	0.0	4.4	0.0	0.0	0.0	42.2	0.0	1.8	0.0	43.2	10.2	0.0	0.0	0.0	0.0	1.8	2.0	0.6	0.0	2.6	0.0	0.0	0.7	0.7	1.2	0.1	0.1	0.0	0.0	0.0	2.6	0.0
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;pituitary gland: 11.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	0.0	0.7	2.2	0.0	2.8	0.0	0.0	5.1	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	1.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	11.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.3	0.0	0.0	0.1	0.1	3.0	1.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	5.1	4.7	2.1	1.9	0.0	0.1	0.0	0.0	0.4	2.3	0.3	0.0	0.0	89.8	0.4	0.3	0.3	0.5	0.0	41.9	0.3	0.3	2.8	0.0	0.1	0.0	10.4	0.1	0.3	0.7	0.0	0.3	36.9	4.8	0.9	0.6	0.0	0.4	524.0	0.2	0.1	0.6	1.1	0.8	0.0	0.3	0.4	0.2	0.3	40.4	463.6	0.3	0.0	0.6	0.4	16.4	0.6	0.4	0.0	23.4	0.1	2.1	0.0	270.4	202.6	0.4	0.1	0.4	0.0	0.3	0.6	1.9	0.9	5.7	0.0	0.5	0.8	3.4	2.5	0.2	0.3	0.7	0.2	0.5	0.2	0.3
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
URAD	PRHOXNB	ENSG00000183463	"Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase"	A6NGE7	13	27977717-27988693	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Purine metabolism"	"Decarboxylase, Lyase"		"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	14	"intestine: 25.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 44.4;Intestinal goblet cells: 110.6;Paneth cells: 43.3;Proximal enterocytes: 196.3;Undifferentiated cells: 54.7"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BEWO: 2.6;CACO-2: 2.4"									HPA038972	Uncertain					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA038972: AB_10671869"			"unprognostic (2.00e-1)"											"unprognostic (1.05e-1)"	"unprognostic (5.21e-2)"			0.2	0.0	0.0	1.7	0.0	0.0	0.2	0.7	0.1	0.0	0.0	25.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	17.0	0.3	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	44.4	3.9	0.1	0.3	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	110.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	43.3	0.0	0.0	0.0	196.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	54.7	0.0
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 97.8;kidney: 54.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 190.0;Muller glia cells: 163.6;Paneth cells: 203.0;Proximal enterocytes: 430.7;Proximal tubular cells: 190.3;Undifferentiated cells: 115.7"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 60.6;HeLa: 21.8;OE19: 57.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.4	0.3	2.8	5.9	6.8	0.0	0.2	2.8	3.9	0.1	1.5	51.5	97.8	0.1	0.3	0.0	2.9	25.9	0.1	9.0	4.7	54.0	0.6	0.1	0.1	6.1	5.7	0.0	3.9	0.0	6.7	0.0	7.0	0.0	48.3	19.0	0.0	0.3	0.0	0.0	96.5	2.1	4.1	0.0	26.7	0.2	5.9	0.1	1.1	0.0	0.0	0.6	0.1	8.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	60.6	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	6.8	2.8	3.9	9.0	4.7	6.1	5.7	7.0	4.1	5.9	8.3	0.0	0.0	0.0	18.3	1.6	0.0	0.1	0.0	0.0	0.7	0.0	1.3	0.6	52.9	0.7	5.5	2.1	0.0	0.0	190.0	21.5	20.5	1.0	1.7	0.0	0.4	64.0	0.0	0.6	27.5	0.0	0.3	53.5	0.0	4.5	0.0	0.0	0.0	0.0	1.7	0.2	92.9	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	163.6	0.0	0.5	36.4	56.0	203.0	0.0	0.2	0.0	430.7	190.3	1.0	4.9	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.8	0.1	115.7	0.1
USHBP1	"AIEBP, FLJ38709, MCC2"	ENSG00000130307	"USH1 protein network component harmonin binding protein 1"	Q8N6Y0	19	17249171-17282786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Adipocytes: 41.5;Endothelial cells: 28.3;Hepatic stellate cells: 21.4;Ionocytes: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.9;HeLa: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052471	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA052471: AB_2681843"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.44e-3)"	"unprognostic (3.94e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.12e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.88e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.88e-1)"	8.8	1.9	5.0	1.6	4.9	2.9	8.2	7.2	5.2	2.9	4.1	1.9	1.9	3.6	1.1	1.3	3.1	1.7	12.6	5.0	4.1	4.5	1.2	6.9	2.6	4.6	4.5	1.4	4.8	0.8	1.2	5.6	5.1	2.3	0.5	1.1	2.0	0.9	6.2	2.1	2.2	1.3	3.3	3.5	1.7	1.0	5.1	0.5	4.5	4.8	0.5	2.8	2.3	4.6	0.6	0.9	1.7	0.4	0.0	0.0	10.9	0.3	0.0	0.0	0.0	1.9	0.9	2.9	3.4	0.0	0.1	1.2	0.1	0.2	0.0	0.7	1.3	0.7	5.0	1.1	0.0	2.4	2.4	0.3	0.0	0.2	0.2	0.6	3.2	1.1	1.4	1.5	0.0	0.1	0.4	2.4	1.3	0.3	2.7	1.4	0.2	0.7	0.0	1.3	1.1	0.7	0.7	0.7	0.2	0.9	1.3	0.9	1.9	1.8	0.5	1.5	1.0	2.6	0.9	2.8	0.6	1.5	0.6	2.0	0.4	0.7	0.7	0.3	0.6	0.6	0.6	0.7	0.1	1.0	0.9	0.8	1.6	0.7	0.2	0.8	0.8	0.5	5.0	4.9	7.2	5.2	5.0	4.1	4.6	4.5	5.1	3.3	5.1	4.6	41.5	3.2	0.5	0.7	0.0	0.5	0.9	0.1	0.6	0.3	0.5	0.1	6.7	0.0	0.7	0.0	0.0	1.1	3.1	0.2	0.0	0.1	0.7	0.7	0.8	28.3	0.0	0.0	0.4	0.6	0.9	0.9	0.0	1.5	1.3	0.1	21.4	0.3	0.1	0.0	0.5	0.2	20.3	0.6	1.2	0.2	0.6	0.3	5.4	6.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	1.3	0.1	1.7	0.0	2.2	1.5	0.2	0.4	0.2	1.0	4.5	0.7	0.3	0.0	0.8
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788564-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adrenal gland: 70.1;brain: 186.9;choroid plexus: 232.4;retina: 188.7"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 297.8;Muller glia cells: 106.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.1;BJ hTERT+: 68.7;fHDF/TERT166: 38.1;NTERA-2: 79.9;U-87 MG: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.8	70.1	30.0	3.3	38.1	0.8	0.5	45.7	24.1	0.7	232.4	3.6	2.3	5.4	6.8	1.7	0.9	4.0	15.2	19.6	186.9	5.3	1.0	0.3	0.4	60.2	53.2	0.3	1.8	0.7	4.5	1.9	84.0	0.3	5.6	188.7	1.4	0.4	0.2	0.1	3.2	2.5	49.9	0.0	1.9	1.9	67.4	0.1	2.4	0.3	2.3	1.4	1.2	37.4	0.0	0.0	23.1	0.0	7.8	0.0	0.0	2.8	68.7	0.9	0.7	0.0	0.0	0.0	0.0	38.1	0.7	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.4	79.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.0	3.7	0.0	1.1	0.0	14.1	0.1	18.6	0.1	0.0	8.6	0.0	0.0	0.0	0.0	0.0	82.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	38.1	45.7	24.1	19.6	186.9	60.2	53.2	84.0	49.9	67.4	37.4	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.5	9.2	4.3	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.2	4.4	0.0	0.2	0.9	3.0	0.0	20.7	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.4	0.0	0.2	297.8	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.0	0.6	106.9	0.0	44.7	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 339.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 568.3;hTERT-RPE1: 547.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		750000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	85.8	19.1	9.9	52.2	10.6	41.5	45.3	8.4	11.3	73.9	33.4	180.3	35.3	167.6	45.9	92.2	75.9	69.4	132.2	10.5	11.3	37.2	24.1	68.7	18.7	10.3	10.3	45.2	40.3	51.3	13.8	88.6	13.3	131.7	73.1	12.5	31.6	151.9	136.9	37.9	52.7	224.7	9.9	41.9	63.5	41.3	12.1	12.8	39.6	144.1	23.9	135.7	56.3	8.4	147.2	97.0	174.2	123.8	213.2	246.2	95.8	188.5	568.3	126.3	141.9	88.4	124.0	6.5	153.1	331.6	86.3	183.3	115.7	95.0	132.5	12.3	49.6	69.4	92.2	37.2	116.5	14.1	101.8	205.0	25.0	171.5	154.8	547.4	171.0	11.6	50.7	14.3	213.1	25.2	2.0	16.6	82.8	69.9	342.4	24.0	90.9	18.6	180.4	185.8	6.5	25.8	104.7	117.2	53.9	152.8	54.5	21.2	230.9	136.9	57.0	67.0	179.4	2.6	6.0	28.4	160.0	38.9	39.7	15.0	13.6	36.2	14.9	17.1	10.4	5.6	7.1	7.8	20.7	2.3	2.6	5.3	11.2	4.4	19.0	8.0	1.9	28.3	9.9	10.6	8.4	11.3	10.5	11.3	10.3	10.3	13.3	9.9	12.1	8.4	68.0	99.3	39.7	56.5	13.4	114.7	161.4	68.4	30.7	13.4	39.4	58.5	339.5	37.1	79.8	42.3	85.5	51.5	46.7	91.2	3.9	60.8	5.0	98.2	152.6	60.4	38.3	5.9	63.2	61.6	78.6	74.4	66.3	149.1	35.4	45.5	56.7	34.4	23.6	16.8	47.5	44.5	22.4	31.9	51.0	7.5	50.1	77.9	26.6	55.3	44.7	9.7	61.8	18.6	4.6	125.5	48.3	76.8	8.0	100.1	13.7	14.8	37.7	34.5	105.2	49.6	179.9	18.6	13.7	45.6	93.1	39.7	18.3	44.5	48.7	94.8
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419121-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 436.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 243.8;Enteroendocrine cells: 113.6;Intestinal goblet cells: 143.6;Paneth cells: 216.2;Proximal enterocytes: 558.5;Undifferentiated cells: 161.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 56.4;stomach cancer: 23.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	97	"CACO-2: 762.5;Hep G2: 365.3;OE19: 321.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		6800	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.6	1.1	0.0	10.3	0.1	0.3	0.8	0.3	0.2	0.7	0.0	175.9	395.0	0.5	0.0	0.9	0.7	28.1	1.0	0.0	0.0	25.9	31.4	0.7	0.3	0.0	0.0	1.1	29.4	0.0	1.4	0.3	0.0	1.0	184.0	0.0	0.6	0.4	0.4	1.1	436.3	8.1	0.0	1.2	6.9	2.0	0.0	0.0	0.6	0.0	0.0	0.8	0.9	0.1	0.0	1.5	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	762.5	0.5	0.1	5.0	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.3	365.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.0	1.7	0.8	321.9	0.0	0.0	0.0	1.4	0.0	0.2	0.3	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	4.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	1.3	0.8	0.4	0.1	0.0	1.8	0.3	0.6	0.5	24.3	0.1	0.0	2.1	0.3	0.8	243.8	3.9	12.3	1.9	1.3	0.9	0.4	113.6	3.2	0.7	42.9	0.2	0.8	6.6	1.6	8.9	0.3	0.7	32.6	0.1	1.7	0.5	143.6	0.0	2.2	1.5	0.5	0.0	5.1	0.0	0.0	0.2	0.5	0.0	0.0	0.3	10.9	216.2	0.0	0.3	0.9	558.5	35.1	0.0	1.2	0.0	1.7	0.7	0.8	0.8	0.6	0.9	0.3	1.5	0.0	161.8	0.3
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750797-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 72.2;lymphoid tissue: 155.5"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 80.6;Melanocytes: 28.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;TIME: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000			"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	2.7	12.2	5.5	155.5	7.9	0.1	1.9	4.9	10.9	1.8	4.6	72.2	16.6	1.2	0.4	4.3	1.5	3.7	4.3	7.3	28.7	2.5	1.1	3.4	0.4	6.9	40.0	0.8	8.3	0.3	0.8	0.6	7.7	2.7	61.4	1.0	0.5	0.5	1.4	0.4	45.8	41.6	4.8	9.7	22.2	1.0	11.9	0.1	2.3	1.7	0.1	1.6	9.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	7.9	4.9	10.9	7.3	28.7	6.9	40.0	7.7	4.8	11.9	5.9	2.5	0.0	0.0	3.3	0.2	0.4	0.0	0.0	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	80.6	0.0	0.0	0.3	0.0	6.5	0.0	0.0	28.4	4.7	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 132.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0"	"Group enriched"	"Detected in many"	4	"amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	17.5	2.6	10.1	3.4	12.7	2.3	16.9	13.5	15.2	2.9	5.1	28.0	34.5	1.2	6.6	5.3	1.3	6.0	6.5	13.0	5.5	2.7	32.4	132.1	4.6	5.3	4.8	0.6	2.5	4.2	1.9	2.8	6.3	25.0	27.7	4.2	22.7	8.9	1.2	29.8	30.0	1.3	4.4	5.7	6.1	1.4	4.7	1.9	15.1	4.9	2.4	8.7	5.0	12.1	0.1	2.4	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.4	2.2	60.8	0.2	3.1	0.0	0.0	2.4	0.0	1.6	0.1	0.0	5.2	3.8	1.8	0.0	0.3	0.0	0.5	0.0	3.8	0.2	1.2	0.0	0.7	0.6	0.0	0.0	0.0	5.2	0.0	0.3	3.8	36.2	0.2	0.5	0.0	2.8	0.0	44.0	1.3	0.0	0.0	24.7	0.0	7.1	15.2	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.0	1.8	0.0	0.2	1.5	1.0	0.0	2.4	1.0	2.1	0.0	2.7	0.8	0.0	0.0	1.3	0.0	0.4	0.9	10.1	12.7	13.5	15.2	13.0	5.5	5.3	4.8	6.3	4.4	4.7	12.1	16.0	3.2	6.0	3.3	1.3	7.6	4.5	2.2	22.2	0.2	19.2	21.5	2.6	5.7	2.1	1.8	8.4	0.1	0.4	71.8	0.0	0.3	3.0	0.2	0.1	2.8	4.8	0.0	26.9	0.9	1.0	1.0	16.3	0.6	0.0	0.3	19.6	0.4	0.7	0.0	1.5	48.6	0.0	8.7	4.0	0.6	0.0	5.9	0.0	3.7	8.9	1.4	0.0	3.0	1.7	1.2	96.2	0.0	1.5	6.3	58.6	0.1	1.0	5.4	32.9	0.2	20.8	0.1	0.1	4.1	7.7	0.3	2.9	0.1	24.0	3.9
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132736935	"Enzymes, Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 34.9;liver: 34.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 76.2"	"Lineage enriched"	"Detected in many"	33	"granulocytes: 76.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	150000000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.2	0.1	0.1	2.2	0.1	34.9	0.2	0.1	0.5	1.6	0.2	0.1	0.0	0.1	0.0	0.8	1.9	1.0	0.4	0.1	0.1	0.3	34.7	4.5	0.4	0.1	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.3	0.0	0.0	1.0	0.1	0.1	0.2	0.2	0.2	0.1	5.5	0.4	0.1	0.2	0.4	0.1	1.1	0.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	20.7	0.0	0.0	0.2	0.0	0.4	0.0	42.5	0.0	0.0	0.0	0.1	0.2	0.0	3.7	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.8	1.7	0.0	0.0	0.4	10.0	0.1	0.0	0.0	0.0	6.1	5.8	0.0	0.2	0.0	3.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.0	0.1	86.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.3	4.1
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747474-124752255	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"stomach 1: 619.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 87.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"OE19: 429.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	6.5	0.8	3.1	7.0	6.4	3.4	9.5	0.8	7.1	29.7	0.2	136.2	6.2	4.9	0.4	26.4	17.5	26.5	5.3	2.8	1.5	6.3	3.0	45.7	0.9	1.7	3.6	1.1	2.0	1.9	1.7	6.0	2.0	58.2	137.8	0.6	31.8	4.3	2.3	1.5	2.8	4.7	1.1	1.6	619.2	0.9	3.1	0.2	43.7	2.5	2.5	84.5	9.3	3.6	0.4	0.1	4.8	3.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	1.5	2.4	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3	16.6	0.0	7.9	0.7	0.5	3.0	0.1	0.0	0.0	0.0	0.3	2.8	0.3	0.3	0.6	0.0	1.6	0.1	0.1	0.6	429.0	3.7	0.4	3.6	0.1	0.1	69.2	0.3	0.9	0.1	4.6	0.0	0.7	0.4	2.4	4.1	1.8	1.1	0.3	0.8	0.3	0.0	0.0	0.6	1.7	0.9	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.4	0.0	0.6	0.4	0.1	0.3	0.2	0.0	0.7	0.9	3.1	6.4	0.8	7.1	2.8	1.5	1.7	3.6	2.0	1.1	3.1	3.6	4.6	125.0	51.6	0.0	1.5	0.8	19.2	25.3	2.8	1.5	31.5	18.4	0.7	82.9	99.3	3.7	0.0	0.0	0.6	514.3	1.9	14.6	0.0	12.1	1.8	5.0	66.8	0.0	0.2	90.9	0.1	0.9	623.4	18.3	1.3	0.1	3.9	0.2	0.1	0.0	0.1	285.6	20.3	0.3	2.7	0.0	1.5	2.4	3.6	1.0	0.0	0.0	0.0	0.0	0.1	260.2	509.9	0.0	0.7	61.6	1.3	0.1	36.7	0.0	0.0	0.3	6.2	0.2	0.7	0.7	0.4	0.0	2.2	0.3	207.0	285.3
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 166.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 989.8;Kupffer cells: 590.9;Macrophages: 328.4"	"Cancer enriched"	"Detected in all"	5	"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	31	"dendritic cells: 17.8;monocytes: 18.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		59000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 19: Lung - Lung function"		"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	137.1	68.8	17.9	44.2	18.8	7.8	44.2	17.0	36.6	14.1	21.5	40.9	22.5	15.5	5.3	15.4	66.8	39.6	30.0	18.2	18.3	17.9	51.0	166.0	27.8	25.1	23.6	12.9	14.3	6.8	7.0	139.6	25.8	10.6	31.7	2.2	24.5	9.3	8.2	10.8	43.9	108.3	18.9	69.3	22.9	7.3	37.6	5.4	12.3	12.5	1.8	61.5	11.6	26.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	18.7	0.1	0.0	11.1	0.0	0.0	0.0	0.2	17.8	0.1	0.0	0.0	0.5	0.0	0.4	0.1	0.0	5.6	17.9	18.8	17.0	36.6	18.2	18.3	25.1	23.6	25.8	18.9	37.6	26.7	1.3	3.2	16.1	0.0	1.2	2.3	0.3	0.0	0.0	0.0	2.6	0.5	1.8	7.2	3.1	0.0	0.0	5.3	0.3	0.0	0.0	0.1	7.9	0.0	0.0	10.4	0.0	0.0	0.0	0.0	4.9	2.7	0.0	0.0	3.8	0.0	5.0	3.2	989.8	0.0	0.0	0.0	0.0	590.9	111.8	16.6	1.5	328.4	3.6	12.2	1.5	0.5	0.0	0.5	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	4.4	0.0	6.6	0.6	2.0	0.3	0.9	0.5	1.7	12.3	1.5	0.0	0.0	0.2
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295316	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.3;ovary: 7.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Cone photoreceptor cells: 29.2;Hepatocytes: 16.4;Rod photoreceptor cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.2;Hep G2: 26.3;HSkMC: 13.4;REH: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2200000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.8	1.1	0.6	0.1	0.9	1.6	1.5	0.3	1.6	2.9	0.0	0.6	0.3	1.3	0.6	0.9	3.5	0.6	0.8	0.7	0.7	0.5	14.3	0.3	0.2	0.5	1.2	7.9	0.3	0.1	0.6	2.4	0.4	1.0	0.4	0.8	0.9	0.5	0.7	0.7	0.4	0.4	0.0	0.4	0.4	1.8	0.5	2.5	0.8	0.4	0.1	0.6	1.2	0.2	0.0	0.1	1.5	0.2	0.2	1.8	0.6	0.2	2.0	0.0	0.3	7.2	0.0	0.5	0.0	0.4	0.1	0.0	2.3	0.0	0.1	0.4	0.0	0.8	0.0	26.3	1.2	0.0	0.3	13.4	0.6	0.7	0.0	0.1	2.3	3.3	0.2	0.3	0.3	0.1	5.5	0.0	2.2	0.0	0.0	14.0	0.2	0.0	0.1	0.1	0.6	1.0	0.0	0.1	0.7	2.4	0.9	0.0	0.8	0.3	0.3	0.5	0.2	0.2	0.6	1.2	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.3	1.6	0.7	0.7	0.5	1.2	0.4	0.0	0.5	0.2	2.1	3.2	1.7	19.2	0.3	1.8	1.8	3.8	3.4	3.6	1.7	0.5	1.0	1.5	2.3	0.0	29.2	1.0	0.5	0.2	0.0	0.1	0.5	2.9	1.0	5.5	1.8	6.1	7.5	0.5	5.0	2.6	0.0	1.8	3.8	6.5	2.5	16.4	1.2	0.0	5.8	0.1	2.0	3.5	2.4	0.8	6.8	2.6	1.8	2.8	2.3	2.3	1.0	2.5	1.4	0.0	0.0	1.9	0.4	1.1	0.1	0.3	5.4	21.1	0.0	0.9	1.1	1.1	3.4	1.3	2.3	4.4	0.9	7.7	0.3	0.7
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948877-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Adipocytes: 904.3;Endothelial cells: 737.5;Hepatic stellate cells: 424.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 76.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"HUVEC TERT2: 560.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	NA	NA	28300000000	5600000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	151.9	5.9	40.0	20.2	38.8	0.8	117.3	32.9	31.4	46.0	29.2	32.7	12.8	51.1	10.6	21.9	45.7	30.2	137.8	27.4	32.3	9.7	2.1	106.2	22.8	37.6	37.4	22.0	15.0	27.3	6.3	72.7	41.7	27.4	9.2	2.9	18.1	19.2	57.0	23.5	34.5	44.2	32.2	44.1	25.7	10.8	52.4	7.0	50.8	51.6	9.5	39.7	35.5	37.1	0.0	0.0	0.0	0.0	0.7	0.6	0.5	0.0	0.6	0.2	0.4	0.0	0.3	0.0	1.2	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	560.9	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.3	0.5	0.4	0.0	0.1	10.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	40.0	38.8	32.9	31.4	27.4	32.3	37.6	37.4	41.7	32.2	52.4	37.1	904.3	12.8	25.7	3.6	1.0	6.6	0.6	1.3	4.6	0.0	4.5	4.7	112.2	1.5	1.7	11.0	0.0	1.1	2.6	0.0	0.0	0.5	6.8	2.0	1.6	737.5	0.0	2.7	2.9	0.0	0.9	21.1	0.0	2.1	5.7	0.1	424.4	3.3	0.5	0.0	2.2	0.0	4.1	5.3	3.4	15.5	5.9	2.6	5.4	75.9	0.3	0.7	0.0	1.5	4.2	0.0	0.0	0.7	0.0	1.3	0.0	0.1	1.0	1.7	0.0	12.4	34.7	2.9	5.7	4.7	4.3	1.0	2.0	10.6	0.0	1.7
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"WASP actin nucleation promoting factor"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 58.4;lymphoid tissue: 83.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 83.2;dendritic cells: 91.7;Hofbauer cells: 111.5;Kupffer cells: 110.7;Macrophages: 118.1;monocytes: 88.2;NK-cells: 84.5;Plasma cells: 57.8;T-cells: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 37.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 37.4;monocytes: 9.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 76.5;HEL: 67.6;HMC-1: 157.0;MOLT-4: 70.8;NB-4: 75.7;RPMI-8226: 94.0;THP-1: 68.8;U-266/70: 83.1;U-937: 87.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		600000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	10.2	5.2	6.3	52.2	5.8	58.4	4.4	5.9	8.1	3.3	6.3	6.4	8.0	2.8	3.0	3.5	5.6	6.9	3.5	6.0	8.0	4.4	7.2	19.1	54.2	11.1	8.2	1.8	2.4	1.4	2.9	9.0	8.6	4.2	5.0	0.4	4.9	2.8	1.4	2.8	23.0	6.1	8.0	83.0	7.0	1.9	8.6	42.0	3.5	3.4	36.2	10.3	3.0	10.8	0.8	0.2	0.4	1.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.6	0.9	76.5	0.3	0.0	0.3	2.0	0.3	0.2	0.0	44.2	0.4	67.6	0.9	0.0	0.8	34.9	157.0	0.3	0.1	0.1	0.0	0.0	0.0	40.3	0.7	45.7	0.0	7.6	70.8	75.7	0.4	1.1	0.4	61.1	0.3	94.0	0.1	0.0	0.5	0.9	1.0	0.7	0.5	0.2	0.4	68.8	0.5	0.1	0.4	1.2	0.1	83.1	43.6	53.7	0.5	87.4	0.2	3.3	7.6	37.4	4.6	8.4	3.4	3.0	3.5	3.9	5.7	3.3	3.1	3.5	29.2	3.6	9.5	3.1	5.4	4.0	6.3	5.8	5.9	8.1	6.0	8.0	11.1	8.2	8.6	8.0	8.6	10.8	1.5	3.2	14.3	0.7	83.2	2.4	0.2	0.2	2.2	0.2	1.1	1.8	1.1	0.0	0.1	0.0	0.0	0.9	91.7	0.3	1.9	0.4	0.6	0.4	0.4	2.6	1.2	14.1	0.3	0.4	1.1	1.5	5.6	0.3	48.1	0.2	3.9	1.6	111.5	0.0	0.3	0.2	0.0	110.7	54.5	1.1	0.0	118.1	3.6	4.7	88.2	0.2	84.5	0.5	0.0	0.1	0.1	0.0	57.8	0.2	0.1	1.8	1.6	0.2	0.0	1.0	1.3	1.3	1.1	0.8	1.4	1.4	99.3	0.4	0.1	0.2
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1232.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		63000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	133.7	77.7	60.2	194.5	58.1	150.9	107.8	56.8	65.4	147.1	104.2	200.8	149.1	261.1	91.0	165.1	179.5	117.4	134.2	69.7	69.7	119.4	84.2	142.8	174.6	68.4	69.7	120.5	63.7	89.6	58.4	105.4	68.6	124.5	141.5	93.0	124.9	173.7	94.8	110.4	148.3	214.6	63.1	110.0	131.7	131.9	62.6	188.0	109.8	89.5	149.6	203.0	139.3	68.8	249.5	246.9	213.2	179.4	160.1	265.9	336.9	612.9	561.7	542.9	423.1	296.4	303.3	173.6	193.3	744.4	579.3	158.8	237.3	451.0	582.4	270.7	82.8	494.1	244.6	213.8	377.9	159.4	538.6	256.7	228.4	552.9	276.3	418.7	599.3	301.6	151.6	273.3	540.7	142.8	700.1	229.0	253.4	200.7	250.4	327.8	197.7	146.7	344.9	394.7	72.4	80.5	265.6	141.3	257.3	282.9	120.1	173.9	909.9	415.7	174.6	345.7	548.0	173.4	296.4	225.5	439.7	240.4	522.9	177.4	115.7	213.6	172.3	195.9	134.4	81.6	143.8	173.0	141.4	61.1	145.6	156.9	201.5	129.0	246.9	154.5	214.9	298.4	60.2	58.1	56.8	65.4	69.7	69.7	68.4	69.7	68.6	63.1	62.6	68.8	66.5	35.3	52.9	10.1	77.0	145.3	204.6	103.5	46.7	22.0	65.9	68.7	62.9	52.9	87.4	104.8	41.7	172.5	126.7	347.1	86.1	282.5	500.8	72.2	63.8	103.6	109.2	56.8	4.7	211.3	302.4	68.7	118.3	111.7	82.4	78.7	84.3	71.8	249.2	33.7	8.4	152.6	138.4	159.4	135.8	1232.1	46.9	174.9	80.0	15.0	303.7	82.6	147.2	11.6	9.6	322.8	244.4	92.2	78.3	150.7	169.0	113.1	73.5	28.0	98.6	46.1	168.1	81.6	64.3	74.9	137.0	231.6	132.2	77.2	172.8	193.6
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054649-36105108	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 110.3;testis: 63.7;tongue: 63.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 43.4;Cone photoreceptor cells: 85.5;Early spermatids: 42.5;Late spermatids: 46.2;Rod photoreceptor cells: 41.7;Spermatocytes: 67.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.7"	"Lineage enriched"	"Detected in single"	4	"monocytes: 2.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.4	0.4	0.3	2.1	0.5	5.4	0.4	0.9	0.7	0.9	0.2	0.9	1.1	0.6	0.2	3.7	0.7	0.2	22.1	0.4	0.2	0.4	0.7	0.7	2.9	0.5	0.5	0.3	0.2	0.1	0.4	0.5	0.5	0.7	0.5	6.7	1.3	0.2	110.3	2.7	1.2	0.7	0.2	2.0	0.9	63.7	0.4	5.0	0.4	63.1	1.8	0.3	1.4	0.8	19.9	37.8	12.3	12.6	1.1	0.3	7.8	18.0	7.6	24.1	20.8	20.0	6.7	24.7	10.9	9.3	11.3	6.1	18.6	6.8	13.5	16.1	8.8	16.9	20.5	13.5	0.8	16.8	19.6	0.3	0.7	17.7	5.2	1.7	6.0	17.3	21.7	26.8	11.3	20.6	33.1	9.0	7.3	16.0	7.4	23.3	12.5	11.7	3.3	7.5	15.3	8.6	12.1	16.7	2.8	7.6	9.6	14.3	4.1	20.8	19.9	16.7	29.6	14.0	22.1	32.0	9.1	13.0	24.6	0.5	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.2	2.7	0.1	0.5	0.1	0.3	0.5	0.9	0.7	0.4	0.2	0.5	0.5	0.5	0.2	0.4	0.8	1.8	0.0	5.5	0.3	1.0	2.2	1.3	0.5	0.6	1.6	0.9	0.6	43.4	0.0	0.8	0.0	85.5	1.9	1.2	2.5	1.9	0.4	42.5	0.8	0.8	2.0	0.0	11.0	1.4	0.9	1.9	1.8	5.6	0.8	0.0	4.3	1.1	0.8	2.2	3.3	1.0	2.2	2.0	1.3	1.6	46.2	1.2	1.9	1.8	1.0	0.8	2.1	0.0	1.0	1.0	0.5	0.2	0.4	7.1	0.8	0.3	0.3	0.2	41.7	6.6	2.8	1.9	67.6	15.4	2.0	3.7	0.3	2.2	1.2	3.0	0.7
WDR86		ENSG00000187260	"WD repeat domain 86"	Q86TI4	7	151375909-151410727	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.6;thyroid gland: 29.1"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 17.9;Endometrial ciliated cells: 13.9;Endometrial stromal cells: 22.5;Fibroblasts: 10.0;Microglial cells: 7.5;Muller glia cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 13.7;NTERA-2: 2.6;SCLC-21H: 5.8;SH-SY5Y: 4.1;SuSa: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (8.93e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.13e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.32e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-6)"	"unprognostic (7.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-1)"	10.9	1.3	7.0	0.3	4.9	0.1	8.1	0.2	5.4	23.6	6.6	10.5	0.8	9.1	0.2	1.4	19.2	0.9	0.6	5.1	0.4	3.0	0.8	1.3	1.1	2.5	3.3	6.2	0.9	7.6	8.0	2.9	0.9	4.1	0.1	0.4	1.3	4.7	0.5	0.7	3.1	0.4	1.4	18.5	5.8	0.8	0.5	0.2	29.1	0.0	0.1	2.2	6.6	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	4.1	0.0	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.0	4.9	0.2	5.4	5.1	0.4	2.5	3.3	0.9	1.4	0.5	0.4	3.4	0.0	0.5	2.6	1.3	0.0	0.2	1.9	1.2	0.3	3.4	17.9	1.4	0.0	1.5	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	13.9	22.5	1.5	0.0	0.0	1.8	0.0	1.4	10.0	0.5	3.1	0.0	0.7	0.4	0.2	0.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	7.5	1.2	11.5	1.0	1.5	0.2	0.0	0.0	3.0	0.4	0.0	0.0	0.0	5.4	0.8	0.0	0.2	4.6	0.1	0.5	0.0	0.3	0.8	3.1	0.1	0.0	0.3
WFDC1	PS20	ENSG00000103175	"WAP four-disulfide core domain 1"	Q9HC57	16	84294846-84329844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 99.8;seminal vesicle: 115.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 111.1;Fibroblasts: 72.6;Peritubular cells: 257.3;Smooth muscle cells: 95.8;Theca cells: 325.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 29.8;BJ: 20.5;HEL: 18.2;HeLa: 27.6;THP-1: 9.9;U-937: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031411	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA031411: AB_10600921"	"unprognostic (6.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.04e-1)"	8.1	26.9	16.5	10.5	16.5	1.9	4.3	19.1	21.2	21.5	12.9	79.3	8.9	17.3	18.8	24.5	7.9	35.1	4.4	16.1	15.5	16.7	5.5	29.5	0.6	17.0	16.2	3.7	1.0	0.4	5.7	99.8	15.3	69.0	17.4	8.4	6.2	115.1	1.2	3.2	14.6	32.2	14.9	3.5	20.8	12.5	16.3	0.3	4.8	1.6	0.8	54.2	13.5	14.9	0.0	0.0	4.4	29.8	0.0	0.1	0.2	20.5	2.5	0.0	0.0	0.0	0.0	0.0	5.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	27.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.5	0.0	0.4	0.0	0.0	2.3	0.0	0.0	5.3	0.1	0.0	0.5	3.2	0.1	0.1	9.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	16.5	19.1	21.2	16.1	15.5	17.0	16.2	15.3	14.9	16.3	14.9	3.4	3.2	0.5	9.1	0.0	1.8	0.9	0.1	0.0	111.1	2.0	0.9	1.4	0.0	0.1	1.8	0.0	2.1	0.1	0.9	11.7	0.0	27.8	0.6	10.6	3.9	4.2	0.0	4.1	0.0	2.0	72.6	7.7	0.5	0.0	0.2	12.5	0.0	6.6	5.0	0.9	4.7	0.0	0.0	3.0	41.1	15.8	2.3	0.0	2.8	0.0	1.4	0.0	29.1	0.6	0.1	0.6	257.3	0.3	1.3	0.4	1.3	0.7	4.2	0.0	1.0	95.8	5.5	0.9	0.1	0.4	3.8	0.5	325.9	3.1	1.0
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780610-42797066	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 11.0;kidney: 37.6;prostate: 11.6"	"Cell type enriched"	"Detected in some"	4	"Distal tubular cells: 160.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 32.6;K-562: 36.8;TIME: 34.1;WM-115: 23.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.3	0.0	0.7	1.1	0.9	0.0	2.8	0.8	3.3	0.6	0.3	9.8	1.9	0.2	0.7	8.9	0.4	0.0	0.1	1.7	1.1	37.6	0.2	0.1	0.1	1.1	0.7	4.3	0.2	0.0	1.2	0.0	0.7	11.6	11.0	0.6	1.8	1.1	0.0	0.5	3.7	0.4	0.6	0.1	3.4	0.2	1.0	0.0	0.0	0.3	0.1	0.2	0.4	1.0	2.1	1.2	0.6	0.0	0.7	0.2	4.8	11.9	4.8	4.5	1.3	0.7	1.0	0.6	6.8	32.6	1.2	0.0	0.2	0.3	8.6	0.6	1.8	0.1	0.0	4.7	7.4	0.3	0.7	3.9	1.4	6.4	2.1	2.1	0.3	0.4	36.8	1.3	0.0	1.0	0.0	1.1	0.3	2.0	8.2	0.6	1.2	0.0	0.0	0.5	0.0	0.2	0.1	0.2	1.7	4.1	2.4	2.7	34.1	0.3	3.1	0.5	0.4	6.2	5.3	1.2	0.0	2.1	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.8	3.3	1.7	1.1	1.1	0.7	0.7	0.6	1.0	1.0	0.2	0.0	0.6	0.0	0.5	0.0	0.2	0.0	0.6	0.2	7.1	4.1	1.0	1.5	0.6	7.3	0.0	0.0	0.3	8.0	160.4	0.0	0.0	5.1	1.1	0.2	13.1	0.0	0.2	0.2	0.2	0.1	3.1	6.7	4.5	0.1	0.7	0.0	0.0	0.0	0.2	40.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.4	0.0	3.6	0.9	1.0	2.9	0.5	0.0	0.2	0.5	0.8	0.8	12.1	0.4	0.0	0.2	0.0	13.1	0.3
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 6.0;skin 1: 20.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.6;Basal keratinocytes: 10.1;Endometrial stromal cells: 3.6;Inhibitory neurons: 6.0;Microglial cells: 3.7;Plasma cells: 2.6;Suprabasal keratinocytes: 11.5"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	145	"memory B-cell: 15.6;naive B-cell: 15.4"	"Lineage enriched"	"Detected in single"	146	"B-cells: 15.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;HEK 293: 5.4;hTEC/SVTERT24-B: 1.6;U-2197: 2.6;U-266/70: 1.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"spinal cord: 4.4"						"Secreted to extracellular matrix"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.2	0.3	0.3	0.3	0.6	0.0	1.4	0.2	0.4	6.0	0.5	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.3	1.1	0.2	0.2	0.0	0.1	0.0	0.3	0.4	0.1	0.6	0.1	0.1	0.1	1.8	0.1	20.5	0.5	0.2	0.3	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.1	3.2	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.6	0.2	0.4	0.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	10.1	0.1	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.1	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	11.5	0.0	0.1	0.0	0.1	0.0
XCL2	"SCM-1b, SCYC2"	ENSG00000143185	"X-C motif chemokine ligand 2"	Q9UBD3	1	168540768-168543997	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 513.6;NK-cells: 277.1;T-cells: 240.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"NK-cell: 423.5"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 423.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;RT4: 1.1;SuSa: 1.1"									HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (9.88e-3)"	"unprognostic (7.89e-3)"	"unprognostic (4.77e-2)"	"unprognostic (9.32e-3)"	"unprognostic (8.21e-2)"	"unprognostic (6.79e-4)"	"unprognostic (9.33e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (8.36e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.06e-1)"	1.1	0.8	0.3	3.2	0.3	14.1	0.9	0.3	0.5	1.0	0.4	1.9	3.2	3.6	0.9	0.6	1.8	1.9	0.7	0.3	0.4	0.4	5.6	3.3	5.6	0.5	0.3	0.4	0.6	0.3	0.2	1.4	0.4	0.5	1.5	0.0	1.9	1.0	0.3	0.1	2.0	1.4	0.4	13.4	2.9	0.3	0.6	3.8	0.6	0.5	3.6	2.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.4	0.1	0.4	47.2	0.2	2.7	0.3	3.6	50.1	0.3	0.1	2.1	37.1	1.9	423.5	0.3	0.1	0.0	17.1	0.3	0.3	0.3	0.5	0.3	0.4	0.5	0.3	0.4	0.4	0.6	0.4	2.9	0.0	1.1	0.0	3.3	2.4	0.0	0.0	1.8	0.0	1.6	1.4	0.8	0.0	0.0	0.0	0.0	0.1	513.6	0.3	0.0	0.1	0.0	2.4	2.0	1.0	0.0	19.2	0.0	0.0	0.0	1.1	8.2	2.2	1.3	0.0	1.4	0.6	0.4	0.0	0.0	0.7	0.0	5.0	4.0	0.0	0.0	3.7	33.8	0.0	0.8	0.0	277.1	0.0	0.0	0.0	1.1	0.0	13.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.9	1.1	0.0	240.6	0.0	0.1	0.1
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 42.2;intestine: 49.5;liver: 68.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No		77000		"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.0	0.0	4.8	0.0	0.1	42.2	0.3	0.0	0.3	0.4	11.1	44.9	0.9	2.3	9.8	0.1	4.5	0.0	0.0	0.0	0.2	68.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.1	1.3	9.5	0.1	3.6	0.1	0.5	1.1	49.5	0.7	0.0	0.0	3.2	0.1	0.0	0.2	0.3	0.0	2.3	2.7	2.0	0.1	2.0	0.4	0.0	0.0	0.0	0.1	0.1	8.2	4.7	1.0	1.4	0.3	2.3	0.1	1.6	0.3	0.8	4.2	0.0	20.0	1.0	1.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	1.8	1.1	31.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.4	1.2	0.2	0.0	1.4	4.5	5.7	5.2	0.0	0.1	0.1	0.3	0.0	1.7	0.0	0.0	0.0	3.8	2.4	0.2	8.9	2.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	2.4	0.0	0.2	0.5	6.0	5.5	2.8	0.3	262.1	6.5	0.4	2.8	3.6	0.0	0.0	0.3	1.1	143.5	0.0	3.9	0.3	7.9	2.8	0.3	11.9	0.0	0.2	8.2	0.6	0.2	2.0	37.0	0.0	0.0	1.4	46.9	0.0	0.0	0.2	8.4	2.0	1.9	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	48.8	0.0	0.0	2.2	96.8	0.0	1.0	0.7	0.0	0.3	0.7	0.0	0.2	1.2	0.1	0.4	0.7	0.2	22.2	16.9
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
XKR7	"C20orf159, dJ310O13.4"	ENSG00000260903	"XK related 7"	Q5GH72	20	31968151-32003387	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 8.9;pituitary gland: 4.3;retina: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Collecting duct cells: 1.8;Cone photoreceptor cells: 2.1;Early spermatids: 2.1;Excitatory neurons: 4.5;Horizontal cells: 1.7;Inhibitory neurons: 4.8;Late spermatids: 2.1;Rod photoreceptor cells: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 8.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 20.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	HPA040854	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA040854: AB_10795481"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.03e-2)"	"unprognostic (3.74e-7)"	"unprognostic (4.29e-2)"	"unprognostic (9.34e-2)"		"unprognostic (1.45e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-5)"	"unprognostic (1.99e-1)"	0.0	0.2	1.5	0.0	3.7	0.0	0.0	8.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.3	0.0	4.3	0.0	0.7	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	20.9	4.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.7	8.9	2.5	1.3	0.9	0.8	0.2	0.7	0.1	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.8	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
YBX3	"CSDA, CSDA1, dbpA, ZONAB"	ENSG00000060138	"Y-box binding protein 3"	P16989	12	10699089-10723323	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 4915.7;tongue: 1635.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1418.1;Prostatic glandular cells: 1553.4;Skeletal myocytes: 1316.7;Urothelial cells: 1339.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034838	Approved		Supported	Cytosol		NA	NA		230000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA034838: AB_10670980"	"unprognostic (1.93e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.17e-13)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.44e-1)"	250.4	96.7	17.6	77.5	17.6	151.1	200.2	18.8	25.5	152.1	28.4	249.1	37.5	136.8	47.3	271.0	166.7	65.0	469.9	16.5	22.3	194.1	53.8	209.5	32.9	25.4	22.4	134.6	291.0	18.6	84.1	72.5	23.9	177.1	58.8	82.8	218.1	67.5	4915.7	358.1	99.0	100.9	20.9	79.5	149.7	265.7	22.2	36.7	136.1	1635.6	54.6	225.4	204.8	19.7	117.2	90.3	41.4	136.1	165.7	310.7	307.4	173.4	142.7	138.7	132.0	160.4	259.5	109.3	57.7	130.3	96.5	215.5	173.3	338.1	124.6	1.2	325.2	91.3	123.6	108.4	198.3	171.7	10.4	343.3	452.3	124.2	414.6	148.9	313.6	152.3	123.1	0.4	154.7	112.6	137.8	141.9	435.5	103.7	76.9	76.9	192.6	127.4	192.6	150.0	52.2	0.3	129.1	130.9	174.1	288.0	37.1	133.9	221.3	94.5	282.6	108.4	201.5	0.5	38.1	13.4	133.1	0.2	104.8	0.0	4.2	0.0	0.6	4.2	0.0	1.6	0.0	1.5	3.2	6.5	0.0	1.6	0.8	0.8	2.4	0.1	0.1	1.0	17.6	17.6	18.8	25.5	16.5	22.3	25.4	22.4	23.9	20.9	22.2	19.7	680.9	150.6	164.4	14.0	192.8	764.9	1226.9	212.9	552.7	36.1	288.8	292.7	497.7	105.8	177.8	145.3	89.6	145.7	39.2	94.3	133.1	125.3	1418.1	563.0	402.1	563.1	67.6	1081.5	2.4	143.3	84.3	484.8	119.8	551.3	63.3	291.0	235.6	23.1	97.7	16.8	1.0	139.5	120.1	223.2	494.7	470.2	264.7	292.2	259.7	21.5	83.9	67.2	2.1	4.5	0.1	122.0	76.3	223.8	80.6	1553.4	43.9	240.4	240.4	365.4	124.9	1316.7	643.1	594.6	158.4	638.6	1050.5	125.7	72.5	70.8	157.4	1339.7
YIF1B	FinGER8	ENSG00000167645	"Yip1 interacting factor homolog B, membrane trafficking protein"	Q5BJH7	19	38303558-38317273	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039328, HPA055257, HPA062675"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA		37000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Vesicles	"Golgi apparatus"	"HPA039328: AB_2676445, HPA055257: AB_2682762, HPA062675: AB_2684830"	"unprognostic (2.51e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.53e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.53e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.94e-3)"	30.1	30.7	29.3	33.0	32.4	69.1	26.7	37.0	38.3	33.5	29.0	26.6	20.4	24.1	10.9	33.2	25.6	16.5	40.6	30.2	32.6	27.2	58.3	35.7	32.1	36.3	30.9	26.7	27.1	16.9	29.1	23.5	38.6	23.7	16.1	13.6	30.2	12.5	35.0	26.0	24.0	18.1	33.4	47.7	22.0	23.1	34.0	20.9	19.8	26.7	20.9	26.8	25.6	38.5	43.7	108.9	48.3	57.5	68.4	63.5	37.8	103.2	79.0	75.7	110.7	53.5	32.6	75.7	44.4	121.1	81.5	27.4	85.9	54.6	28.7	81.1	43.3	117.0	48.2	56.5	94.8	82.4	132.9	52.3	47.9	78.0	33.8	76.1	71.3	99.4	152.9	205.3	68.5	46.0	87.6	98.9	37.0	74.9	33.7	89.0	58.6	117.9	48.9	40.6	34.8	58.1	34.5	76.7	55.4	37.2	29.9	163.2	68.8	74.6	73.2	108.4	83.9	76.4	122.1	51.8	96.1	150.5	54.6	81.9	155.7	179.0	60.8	119.4	54.4	49.3	57.3	54.8	300.3	42.7	46.7	47.5	42.8	44.0	70.8	127.0	59.0	120.2	29.3	32.4	37.0	38.3	30.2	32.6	36.3	30.9	38.6	33.4	34.0	38.5	27.4	0.0	5.5	5.5	22.8	17.7	19.4	25.8	18.2	12.2	22.6	18.7	4.7	18.6	14.2	22.0	12.5	44.7	17.0	16.0	0.0	39.4	6.3	17.5	18.2	23.9	14.4	33.2	7.3	27.7	52.9	23.8	16.3	18.6	22.9	43.4	37.1	30.5	94.4	11.8	7.4	24.7	32.6	42.3	37.4	8.5	9.0	53.3	35.6	3.7	34.4	20.8	16.5	4.0	12.7	15.5	13.5	9.1	69.4	14.8	8.1	16.1	20.7	15.5	6.6	11.1	40.3	20.6	31.9	30.7	20.0	27.6	18.8	26.2	25.9	19.5
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944522-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 501.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025918	Uncertain					NA	NA		42000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB025918: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	104.9	82.7	244.8	87.2	309.8	86.8	76.6	96.2	501.2	54.6	4.6	106.3	64.8	68.7	92.8	60.4	73.1	82.4	78.1	386.6	217.9	77.6	61.4	112.2	68.3	156.7	109.2	53.0	69.6	29.5	64.4	100.0	145.9	57.8	111.1	114.1	59.4	70.9	68.7	65.0	68.9	131.0	74.1	57.9	109.3	16.2	118.1	70.4	62.0	54.8	82.4	89.9	58.3	229.8	344.5	142.4	180.8	91.8	112.7	107.0	97.0	321.9	172.0	208.1	228.6	157.8	124.2	202.8	76.6	329.4	116.6	169.1	208.7	183.7	271.4	177.0	157.7	118.7	108.2	156.8	108.5	391.4	132.8	84.9	113.0	176.9	135.6	137.3	201.3	76.9	171.5	155.6	249.6	148.5	121.0	189.8	185.2	197.1	150.8	173.7	201.2	115.1	216.5	153.1	323.5	104.4	184.2	134.7	124.7	245.9	78.2	119.3	248.4	206.0	190.1	138.2	216.6	80.7	130.5	257.7	137.3	162.0	170.9	11.9	19.8	22.0	7.6	16.8	11.1	12.4	9.4	10.8	22.9	13.0	3.7	4.9	11.6	25.4	18.4	6.2	19.5	14.0	244.8	309.8	96.2	501.2	386.6	217.9	156.7	109.2	145.9	74.1	118.1	229.8	259.0	51.3	21.7	27.1	106.6	334.1	223.5	27.3	125.2	54.8	123.6	79.0	51.2	125.8	26.5	126.9	22.9	171.7	53.0	242.8	232.8	148.0	3.9	180.0	81.1	211.7	75.4	269.8	132.0	160.6	145.4	118.8	139.1	153.0	40.0	33.4	120.3	72.1	245.6	53.8	62.9	125.4	34.6	155.6	269.8	13.7	61.2	397.6	300.6	66.5	102.1	80.1	44.3	22.1	42.0	203.3	115.7	80.9	120.4	240.7	93.4	125.5	52.5	73.7	157.8	55.8	197.1	23.3	35.5	164.1	340.0	34.8	95.2	25.7	116.1	191.8
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 101.0;NK-cells: 155.5;T-cells: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	11	"JURKAT: 121.0;MOLT-4: 183.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	3.3	1.3	0.5	28.0	0.6	24.8	1.9	0.5	0.9	1.7	0.7	4.0	5.8	1.4	0.5	2.3	2.2	5.4	1.4	0.5	0.7	2.8	3.9	8.7	57.0	0.8	1.3	0.8	1.0	0.4	1.1	0.9	0.7	2.5	1.5	0.0	2.3	0.8	2.0	2.4	18.5	0.5	0.6	35.5	6.7	2.7	1.2	79.9	3.5	2.8	17.7	4.9	2.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	121.0	0.0	0.7	0.0	0.0	183.4	0.5	0.1	0.0	0.0	7.2	0.1	9.1	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	14.1	0.1	0.0	0.0	0.3	0.3	0.5	137.4	0.4	93.2	0.2	71.7	108.3	0.3	1.6	50.8	79.8	2.2	112.2	1.0	0.9	80.1	64.2	0.5	0.6	0.5	0.9	0.5	0.7	0.8	1.3	0.7	0.6	1.2	0.6	0.8	9.6	13.6	0.3	3.9	1.5	0.0	0.0	0.0	0.0	0.8	0.5	3.0	0.0	0.0	0.0	0.0	0.1	101.0	0.2	1.9	0.2	1.0	1.6	0.5	0.8	0.0	8.8	0.2	0.0	0.0	1.8	4.6	0.4	2.5	0.1	2.5	0.7	2.2	0.0	0.2	0.0	0.0	2.8	2.2	0.7	0.0	3.4	1.8	2.8	5.0	0.0	155.5	0.0	0.1	0.0	0.0	0.0	28.0	0.1	0.0	0.5	0.0	0.0	0.0	14.3	0.6	1.3	2.1	0.2	1.4	0.0	105.6	0.1	0.1	0.2
ZBP1	"C20orf183, DAI, dJ718J7.3, DLM-1, DLM1"	ENSG00000124256	"Z-DNA binding protein 1"	Q9H171	20	57603846-57620576	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.7;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 34.0;dendritic cells: 42.7;NK-cells: 53.5;Plasma cells: 189.2;T-cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.1;U-266/70: 16.6;U-266/84: 22.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA041256	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041256: AB_2677380"	"unprognostic (5.78e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.58e-8)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	"unprognostic (9.79e-2)"	2.6	1.4	0.6	18.8	0.7	28.7	3.6	4.6	2.8	2.1	0.1	9.8	13.1	1.9	2.2	2.1	1.0	7.8	1.9	1.5	0.0	1.3	2.1	5.1	23.9	0.6	0.2	1.8	2.0	0.2	0.4	1.3	1.3	1.8	10.8	4.1	6.2	1.6	0.8	3.9	10.6	1.2	0.7	21.8	8.4	2.2	0.4	5.0	2.7	1.3	25.1	8.5	0.8	2.9	0.8	0.6	1.9	3.5	0.6	0.5	1.0	0.6	0.3	0.2	0.9	3.0	1.6	9.3	0.7	0.0	1.1	1.5	0.0	1.1	0.0	0.8	2.0	2.9	5.5	1.4	0.5	2.5	2.2	0.0	0.4	1.1	0.9	1.8	0.4	1.5	1.2	34.1	1.3	4.7	1.5	4.8	2.2	0.5	4.1	1.4	0.2	10.0	0.0	4.3	1.9	2.0	0.3	1.6	1.4	1.3	1.3	1.4	1.6	4.3	1.5	2.8	1.6	16.6	22.8	4.1	1.6	2.8	0.8	1.6	3.8	17.5	18.8	3.9	12.5	16.2	12.6	11.4	4.4	12.1	5.6	7.8	38.0	19.6	2.4	0.2	18.4	7.0	0.6	0.7	4.6	2.8	1.5	0.0	0.6	0.2	1.3	0.7	0.4	2.9	1.2	0.0	0.6	0.0	34.0	0.3	1.0	0.2	0.0	0.0	0.5	0.3	1.0	0.0	0.0	0.0	2.1	0.1	42.7	12.9	0.0	0.1	0.1	0.1	0.2	0.5	0.0	0.8	0.0	0.2	0.0	0.5	3.1	0.4	3.8	0.0	0.0	0.0	1.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.0	2.1	14.2	0.0	3.1	0.5	53.5	0.0	0.1	1.3	3.4	0.0	189.2	1.8	0.8	0.2	0.0	0.3	0.0	1.5	0.8	0.0	0.0	0.0	0.3	0.0	25.8	0.0	1.0	0.8
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823824-118826968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 281.2;endometrium 1: 101.5;fallopian tube: 132.2;smooth muscle: 141.6"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 4.6;Spermatogonia: 5.6"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Group enriched"	"Detected in all"	5	"hypothalamus: 281.2;thalamus: 156.5"	"Immune cell enriched"	"Detected in single"	6	"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.9;HEK 293: 10.1;NTERA-2: 3.2;SH-SY5Y: 2.5;SuSa: 2.0"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"		"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.42e-5)"	"unprognostic (1.18e-1)"	0.2	7.7	35.8	0.8	24.5	0.0	0.4	19.4	30.0	32.1	0.4	1.2	0.3	101.5	8.7	0.0	132.2	0.4	0.1	22.2	281.2	0.1	0.1	0.5	0.6	26.5	48.1	3.1	0.1	0.0	26.9	0.0	37.8	0.4	0.4	4.2	0.0	0.5	0.0	0.0	0.9	141.6	12.4	0.2	0.9	0.5	156.5	0.6	3.1	0.0	0.7	0.0	6.1	5.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.0	3.9	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.5	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	35.8	24.5	19.4	30.0	22.2	281.2	26.5	48.1	37.8	12.4	156.5	5.5	0.2	0.0	0.0	0.7	0.6	0.0	0.1	0.0	0.6	0.9	0.2	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	1.2	0.2	1.2	0.0	0.4	0.0	0.0	0.3	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	4.6	0.5	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.5	1.4	1.2	5.6	0.1	0.1	0.0	0.7	0.5	0.1	0.0
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type palmitoyltransferase 22"	Q8N966	14	77131270-77142734	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 51.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.3;Excitatory neurons: 8.8;Inhibitory neurons: 13.4;Late spermatids: 5.0;Oligodendrocyte precursor cells: 24.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 3.6;NTERA-2: 3.8;RH-30: 6.4;SCLC-21H: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA049471: AB_2732553, HPA072213: AB_2686496"	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	0.0	0.2	14.9	0.0	15.3	0.0	0.0	25.9	33.8	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	21.2	12.8	0.0	0.0	0.0	0.0	1.2	22.7	0.0	0.0	0.0	4.7	0.0	1.0	0.0	0.1	7.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.5	51.3	0.0	0.1	0.4	0.0	0.1	0.0	13.9	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	3.8	0.0	0.5	0.0	6.4	0.0	0.0	0.0	7.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	15.3	25.9	33.8	21.2	12.8	1.2	22.7	1.0	0.0	51.3	13.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	24.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778256-29782973	"Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"intestine: 479.5"	"Cell type enriched"	"Detected in some"	10	"Intestinal goblet cells: 20216.0"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	NA	NA		1300000		"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.5	0.0	0.0	7.8	0.2	0.1	0.7	0.1	0.1	0.0	0.0	362.9	57.8	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.4	22.2	0.0	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	479.5	0.1	0.0	0.5	0.0	0.1	136.9	12.9	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.0	1107.2	0.0	0.0	0.0	0.1	0.0	0.1	145.5	0.0	0.1	11.9	0.0	0.1	0.0	0.2	40.1	0.0	0.4	44.6	0.0	0.0	0.1	20216.0	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	484.8	0.0	0.0	0.2	1950.6	1.6	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.5	7.1	0.0	306.7	0.3
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 154.0;Early spermatids: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015705, HPA056325"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli	Nucleoplasm	"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	29.1	26.8	11.9	20.3	12.6	35.5	22.8	14.3	15.7	23.1	15.0	30.9	18.5	26.0	17.6	25.2	25.6	19.8	100.3	11.0	12.8	26.0	51.7	25.1	28.6	13.3	12.6	25.1	26.9	23.9	15.5	20.2	13.2	21.0	22.7	25.0	48.1	20.1	67.1	19.0	21.2	32.1	12.9	23.2	22.8	26.3	13.1	21.5	37.4	43.4	26.7	23.4	18.7	14.6	20.7	24.8	29.5	23.4	51.7	46.1	41.3	54.0	31.1	34.1	32.1	33.5	38.6	87.6	32.4	34.3	19.3	16.1	52.6	35.0	51.7	40.8	34.4	40.7	39.2	47.6	55.2	103.8	31.6	46.6	40.3	32.0	46.4	41.4	36.1	53.1	84.3	57.9	43.8	46.4	80.9	48.6	26.3	63.2	46.7	65.0	42.2	55.9	36.7	22.6	51.1	23.8	19.0	42.9	55.7	33.0	21.5	28.1	38.7	43.3	29.4	26.3	39.1	96.1	74.7	83.2	36.2	63.8	31.6	16.3	27.4	16.7	15.9	22.7	22.3	21.6	20.1	20.7	28.9	17.7	21.6	20.0	4.1	20.1	18.8	19.6	25.9	16.3	11.9	12.6	14.3	15.7	11.0	12.8	13.3	12.6	13.2	12.9	13.1	14.6	32.5	54.5	32.4	8.1	31.9	49.2	53.9	22.3	35.3	63.0	21.5	29.1	154.0	27.1	26.2	9.2	14.6	38.2	29.8	21.2	58.7	32.7	197.7	34.9	58.2	31.5	16.8	29.6	13.0	51.0	37.9	35.3	18.8	26.9	22.9	25.7	32.5	70.6	73.5	16.8	13.4	25.7	20.3	56.2	36.0	50.5	39.1	48.2	46.2	20.6	38.1	38.4	14.4	11.6	17.3	43.5	27.8	28.6	27.4	43.6	26.0	78.3	20.3	26.1	13.1	42.4	34.9	46.2	17.7	33.6	51.6	34.3	29.7	38.4	26.9	56.6
ZNF366	FLJ39796	ENSG00000178175	"Zinc finger protein 366"	Q8N895	5	72439903-72507410	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 19.0;Cone photoreceptor cells: 31.3;Endothelial cells: 18.3;Langerhans cells: 9.3;Microglial cells: 54.4;monocytes: 14.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"myeloid DC: 10.4"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 10.4"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.3;TIME: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023128, HPA023526, HPA074074"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA023128: AB_1859223, HPA023526: AB_1859224, HPA074074: "	"unprognostic (3.49e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (9.25e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.29e-2)"	5.8	0.8	6.1	3.4	5.0	0.1	3.2	4.5	5.6	2.8	2.4	1.4	1.5	3.1	0.7	1.8	2.4	2.3	3.8	4.1	4.6	2.1	1.0	2.6	5.0	5.8	5.5	0.8	0.7	1.1	0.4	8.9	6.0	0.9	1.5	0.5	0.8	1.5	5.0	2.2	1.9	3.9	4.1	6.4	1.4	0.5	7.1	3.1	2.2	5.6	4.0	1.7	1.0	4.5	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.5	6.1	5.0	4.5	5.6	4.1	4.6	5.8	5.5	6.0	4.1	7.1	4.5	19.0	0.0	0.6	0.0	0.1	0.5	0.4	0.0	0.6	0.4	0.1	0.3	1.6	0.0	0.6	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	18.3	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.4	0.5	0.0	0.3	0.0	0.0	4.6	9.3	0.5	0.3	2.4	0.0	54.4	14.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.7	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.0
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.7"	"Group enriched"	"Detected in some"	9	"Inhibitory neurons: 506.0;Oligodendrocytes: 794.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 5.0;HAP1: 11.0;SH-SY5Y: 29.5;U-937: 7.5;WM-115: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	0.4	2.6	20.7	0.7	43.1	0.0	0.2	28.1	33.2	1.6	17.7	3.6	1.0	0.5	0.3	3.1	0.3	0.3	2.2	18.1	20.2	0.1	0.0	0.2	0.0	36.7	31.2	0.1	0.2	0.3	4.2	0.0	33.9	2.1	1.6	13.7	0.4	0.8	0.4	0.3	1.9	0.3	19.9	0.5	1.1	2.2	36.1	0.0	3.2	0.8	0.0	2.1	1.1	80.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	11.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	7.5	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	43.1	28.1	33.2	18.1	20.2	36.7	31.2	33.9	19.9	36.1	80.7	0.0	0.0	0.0	11.1	0.0	0.4	0.2	0.0	0.0	33.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.0	2.3	0.0	0.0	0.7	70.7	506.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	13.1	0.0	48.6	0.0	46.8	794.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	9.7	0.0	9.1	1.6	0.3	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.3
ZNF804A	C2orf10	ENSG00000170396	"Zinc finger protein 804A"	Q7Z570	2	184598529-184939492	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.0;retina: 3.8"	"Group enriched"	"Detected in many"	9	"Excitatory neurons: 267.9;Inhibitory neurons: 676.0;Oligodendrocyte precursor cells: 186.5"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.3;RH-30: 17.7;THP-1: 13.9;U-698: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029195	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA029195: AB_10603011"	"unprognostic (1.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.98e-4)"	"unprognostic (6.21e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.93e-2)"	0.0	0.2	1.6	1.0	4.7	0.6	0.0	4.7	5.0	0.1	0.0	0.2	0.5	0.0	0.0	0.1	0.0	1.1	0.0	3.3	3.5	0.6	0.1	0.3	0.9	2.1	0.8	0.2	0.0	0.0	0.0	0.1	1.6	1.2	0.3	3.8	0.1	1.3	0.0	0.0	1.2	0.1	0.5	0.6	0.4	0.2	1.8	0.0	1.4	0.0	1.0	0.4	0.0	0.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.9	6.3	2.1	1.9	0.0	0.0	28.3	0.0	0.0	2.6	0.0	0.4	0.0	4.6	0.2	0.0	7.4	1.0	0.1	10.0	7.1	0.0	3.1	0.0	0.0	1.6	3.2	4.9	0.0	0.0	1.2	0.0	0.0	0.0	6.8	0.0	0.0	4.8	0.0	17.7	1.1	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.1	0.0	13.9	0.0	6.8	0.1	0.2	2.8	3.1	0.0	20.5	7.7	2.0	2.2	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	4.7	4.7	5.0	3.3	3.5	2.1	0.8	1.6	0.5	1.8	0.6	0.1	0.0	0.6	13.4	9.2	0.0	0.0	0.0	0.0	38.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	2.2	0.6	0.0	5.5	267.9	0.0	0.0	2.2	0.0	0.3	0.0	0.9	0.0	0.2	2.9	3.3	676.0	1.1	0.0	1.6	3.7	0.6	0.3	5.4	0.0	6.5	3.5	1.0	0.0	186.5	5.4	0.0	0.0	0.0	21.5	0.0	1.5	0.1	0.0	2.9	6.6	0.1	0.7	5.3	1.2	0.0	0.0	0.0	0.5	1.1	2.7	0.1
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 20.5;Excitatory neurons: 19.5;NK-cells: 17.5;Plasma cells: 9.5;T-cells: 31.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Group enriched"	"Detected in some"	6	"Daudi: 4.0;HMC-1: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"	0.3	0.1	2.2	2.3	1.6	0.9	0.3	0.0	2.7	0.1	0.0	0.3	0.2	0.1	0.2	0.2	0.2	0.5	0.0	3.4	0.3	0.1	0.2	0.6	6.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.1	1.9	0.0	0.0	2.6	0.6	0.2	0.9	1.5	0.3	0.0	3.8	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	1.4	0.2	1.0	1.5	0.0	0.1	0.8	1.0	0.1	1.2	0.0	0.0	2.1	0.4	2.2	1.6	0.0	2.7	3.4	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.6	0.7	4.8	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.0	0.0	1.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	19.5	0.0	0.0	0.1	0.5	0.1	2.5	0.0	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	17.5	0.5	0.9	0.0	0.0	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	0.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0
ZNF875	HKR1	ENSG00000181666	"Zinc finger protein 875"	P10072	19	37312837-37369365	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 141.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.1;Cardiomyocytes: 19.8;Cytotrophoblasts: 11.0;Extravillous trophoblasts: 5.7;Hofbauer cells: 7.3;Syncytiotrophoblasts: 9.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036126, HPA044855"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Mitochondria"		"HPA036126: AB_10670708, HPA044855: AB_2679113"	"unprognostic (1.04e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.92e-3)"	"unprognostic (9.82e-2)"	"prognostic favorable (4.41e-4)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	18.9	37.4	29.0	10.8	26.2	14.8	25.9	36.8	30.9	24.1	46.5	22.6	8.3	20.4	23.9	17.4	23.9	14.4	31.9	28.0	30.3	34.0	18.3	18.7	16.7	25.4	26.5	28.1	20.0	31.8	36.5	18.3	26.4	39.4	14.0	141.0	27.1	19.2	21.3	28.4	19.4	17.4	19.3	27.9	21.1	30.4	28.7	19.2	37.9	18.1	18.9	21.7	22.0	30.2	7.8	19.7	24.9	32.3	18.0	15.1	17.2	13.2	20.0	23.7	25.8	10.0	9.1	27.8	31.4	14.0	11.1	6.6	16.5	17.7	24.9	14.5	28.4	9.8	26.9	10.4	23.3	8.6	23.9	23.4	21.5	16.4	35.4	23.8	14.8	19.9	1.9	1.6	17.6	16.0	20.0	17.7	51.0	13.9	11.3	13.7	10.7	10.9	21.2	31.9	32.1	42.5	13.1	16.7	16.9	36.2	24.1	17.4	13.6	18.8	13.1	14.2	21.0	34.9	40.4	29.8	2.2	10.7	21.3	12.8	4.5	7.4	7.6	5.8	14.9	11.1	10.6	11.5	6.9	12.6	14.3	12.0	4.1	11.4	4.0	8.4	13.9	6.8	29.0	26.2	36.8	30.9	28.0	30.3	25.4	26.5	26.4	19.3	28.7	30.2	5.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	11.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	5.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	9.9	0.4	0.0	0.0	0.0
ZPLD1		ENSG00000170044	"Zona pellucida like domain containing 1"	Q8TCW7	3	102099244-102479841	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;gallbladder: 2.2;retina: 2.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 4.3;Ductal cells: 3.6;Early spermatids: 2.8;Late spermatids: 5.9;Muller glia cells: 16.0;Pancreatic endocrine cells: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.5"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 2.8"	"Low region specificity"	"Detected in many"			HPA077519			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA077519: AB_2732349"	"unprognostic (2.49e-1)"	"unprognostic (2.83e-3)"		"unprognostic (6.38e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.63e-1)"	"unprognostic (2.89e-4)"	"unprognostic (4.59e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.2	1.1	0.2	0.0	0.0	0.1	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.1	0.3	0.5	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	1.1	0.2	0.1	0.3	1.6	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	2.8	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357227-56361273	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.6;lymphoid tissue: 43.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 133.0;Extravillous trophoblasts: 108.6;Late spermatids: 208.8;Spermatocytes: 121.0;Spermatogonia: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 17.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	2.6	2.5	1.2	15.7	1.3	41.6	6.5	1.1	1.8	3.9	1.0	18.8	13.7	3.2	1.7	12.4	2.8	2.4	1.5	1.5	1.2	4.4	4.8	2.9	26.5	1.2	1.3	1.5	2.4	5.4	0.8	10.8	1.2	2.5	22.4	0.5	3.3	1.4	0.3	10.8	14.8	6.8	1.2	5.0	12.5	26.1	1.6	43.5	3.9	0.7	33.0	5.0	4.3	1.4	199.8	154.8	107.9	120.9	7.5	10.8	88.1	143.1	108.0	169.6	153.4	275.4	116.1	102.0	53.2	49.6	79.1	99.9	153.2	108.3	156.7	259.9	80.2	101.6	120.8	129.4	0.7	169.6	131.0	5.1	6.8	157.7	64.9	20.8	86.8	134.2	140.2	121.4	151.1	160.1	150.7	108.3	77.0	135.9	188.7	151.7	209.5	54.0	53.5	87.5	99.8	61.2	135.2	304.2	35.3	62.2	197.3	163.4	47.4	73.6	189.4	76.9	223.2	105.8	55.3	176.0	103.8	210.0	94.7	0.0	0.8	0.7	2.4	3.0	0.3	1.6	5.3	3.6	1.4	0.3	6.3	3.6	0.0	3.5	2.3	1.1	17.0	3.1	1.2	1.3	1.1	1.8	1.5	1.2	1.2	1.3	1.2	1.2	1.6	1.4	0.9	3.2	1.7	0.3	11.1	18.4	6.0	20.2	4.6	2.0	9.4	5.5	1.4	2.8	7.3	5.5	0.0	73.7	3.3	17.9	0.0	9.7	74.0	7.0	4.3	5.7	0.0	133.0	1.3	13.3	108.6	10.3	16.8	8.0	0.0	27.6	7.9	3.5	49.4	0.0	0.3	22.8	14.2	8.5	8.8	208.8	5.0	9.2	7.2	0.0	2.6	1.3	0.0	0.0	0.6	8.6	16.4	2.6	42.4	1.9	8.7	6.0	2.5	0.9	0.0	1.4	10.6	121.0	100.3	24.5	8.2	23.1	7.9	6.5	39.4	8.4
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381295-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 596.6"	"Cell type enhanced"	"Detected in many"		"Macrophages: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 163.3"	"Group enriched"	"Detected in all"	4	"dendritic cells: 58.4;granulocytes: 163.3;monocytes: 83.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		180000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Focal adhesion sites"	"Plasma membrane, Actin filaments"	"CAB009321: AB_2221290, CAB075747: AB_2665753, HPA004835: AB_1080771, HPA073497: AB_2686611"	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	211.5	75.4	21.6	82.5	24.3	106.3	191.0	24.4	33.5	275.7	24.8	382.6	28.1	596.6	16.5	136.7	294.9	57.0	152.0	21.9	21.9	99.4	89.9	316.8	53.9	27.5	24.7	168.7	78.5	84.3	52.4	38.4	27.5	171.9	20.2	5.2	108.1	75.3	113.3	130.7	148.7	127.7	23.8	213.6	154.0	98.9	28.8	27.6	89.0	19.1	31.1	301.6	185.9	26.8	73.9	39.3	50.6	70.5	93.9	208.2	63.4	152.1	158.9	146.5	122.7	135.4	42.6	4.6	57.5	168.5	84.1	55.8	31.7	138.0	67.8	81.6	18.7	105.9	45.7	46.9	163.8	86.4	162.6	222.9	60.5	160.1	54.0	90.5	187.9	9.1	28.0	42.8	159.6	73.4	1.3	165.9	110.0	25.4	273.1	16.3	28.0	6.4	112.2	34.6	2.8	39.5	112.3	99.2	57.0	45.9	12.1	80.5	343.7	176.5	74.1	187.9	152.4	15.6	20.4	11.7	154.6	87.4	119.8	18.9	70.8	48.2	20.2	70.4	16.2	3.1	19.4	23.3	58.4	2.0	11.7	13.8	163.3	14.7	83.6	14.5	19.1	44.1	21.6	24.3	24.4	33.5	21.9	21.9	27.5	24.7	27.5	23.8	28.8	26.8	51.6	6.4	6.4	8.1	26.7	33.8	174.0	78.4	26.7	3.7	40.2	85.3	11.6	25.8	45.4	35.0	0.0	40.6	51.7	40.1	7.9	100.3	1.5	23.4	172.6	58.2	38.2	19.3	36.9	94.1	95.8	66.6	44.9	42.0	36.8	13.7	55.3	32.0	164.6	0.0	18.3	26.7	24.4	195.7	95.1	6.8	28.6	207.1	14.2	7.5	171.9	15.1	40.2	7.5	5.2	169.8	48.2	55.3	20.3	61.3	19.8	19.6	9.9	3.0	85.5	48.7	103.9	7.3	9.9	46.3	20.2	28.0	91.9	8.8	28.6	106.4